PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jakosky, BM; Grebowsky, JM; Luhmann, JG; Connerney, J; Eparvier, F; Ergun, R; Halekas, J; Larson, D; Mahaffy, P; McFadden, J; Mitchell, DF; Schneider, N; Zurek, R; Bougher, S; Brain, D; Ma, YJ; Mazelle, C; Andersson, L; Andrews, D; Baird, D; Baker, D; Bell, JM; Benna, M; Chaffin, M; Chamberlin, P; Chaufray, YY; Clarke, J; Collinson, G; Combi, M; Crary, F; Cravens, T; Crismani, M; Curry, S; Curtis, D; Deighan, J; Delory, G; Dewey, R; DiBraccio, G; Dong, C; Dong, Y; Dunn, P; Elrod, M; England, S; Eriksson, A; Espley, J; Evans, S; Fang, X; Fillingim, M; Fortier, K; Fowler, CM; Fox, J; Groller, H; Guzewich, S; Hara, T; Harada, Y; Holsclaw, G; Jain, SK; Jolitz, R; Leblanc, F; Lee, CO; Lee, Y; Lefevre, F; Lillis, R; Livi, R; Lo, D; Mayyasi, M; McClintock, W; McEnulty, T; Modolo, R; Montmessin, F; Morooka, M; Nagy, A; Olsen, K; Peterson, W; Rahmati, A; Ruhunusiri, S; Russell, CT; Sakai, S; Sauvaud, JA; Seki, K; Steckiewicz, M; Stevens, M; Stewart, AIF; Stiepen, A; Stone, S; Tenishev, V; Thiemann, E; Tolson, R; Toublanc, D; Vogt, M; Weber, T; Withers, P; Woods, T; Yelle, R				Jakosky, B. M.; Grebowsky, J. M.; Luhmann, J. G.; Connerney, J.; Eparvier, F.; Ergun, R.; Halekas, J.; Larson, D.; Mahaffy, P.; McFadden, J.; Mitchell, D. F.; Schneider, N.; Zurek, R.; Bougher, S.; Brain, D.; Ma, Y. J.; Mazelle, C.; Andersson, L.; Andrews, D.; Baird, D.; Baker, D.; Bell, J. M.; Benna, M.; Chaffin, M.; Chamberlin, P.; Chaufray, Y. -Y.; Clarke, J.; Collinson, G.; Combi, M.; Crary, F.; Cravens, T.; Crismani, M.; Curry, S.; Curtis, D.; Deighan, J.; Delory, G.; Dewey, R.; DiBraccio, G.; Dong, C.; Dong, Y.; Dunn, P.; Elrod, M.; England, S.; Eriksson, A.; Espley, J.; Evans, S.; Fang, X.; Fillingim, M.; Fortier, K.; Fowler, C. M.; Fox, J.; Groeller, H.; Guzewich, S.; Hara, T.; Harada, Y.; Holsclaw, G.; Jain, S. K.; Jolitz, R.; Leblanc, F.; Lee, C. O.; Lee, Y.; Lefevre, F.; Lillis, R.; Livi, R.; Lo, D.; Mayyasi, M.; McClintock, W.; McEnulty, T.; Modolo, R.; Montmessin, F.; Morooka, M.; Nagy, A.; Olsen, K.; Peterson, W.; Rahmati, A.; Ruhunusiri, S.; Russell, C. T.; Sakai, S.; Sauvaud, J. -A.; Seki, K.; Steckiewicz, M.; Stevens, M.; Stewart, A. I. F.; Stiepen, A.; Stone, S.; Tenishev, V.; Thiemann, E.; Tolson, R.; Toublanc, D.; Vogt, M.; Weber, T.; Withers, P.; Woods, T.; Yelle, R.			MAVEN observations of the response of Mars to an interplanetary coronal mass ejection	SCIENCE			English	Article							SOLAR-WIND INTERACTION; MAGNETIC-FLUX ROPES; ION ESCAPE RATE; EXPRESS; FIELD	Coupling between the lower and upper atmosphere, combined with loss of gas from the upper atmosphere to space, likely contributed to the thin, cold, dry atmosphere of modern Mars. To help understand ongoing ion loss to space, the Mars Atmosphere and Volatile Evolution (MAVEN) spacecraft made comprehensive measurements of the Mars upper atmosphere, ionosphere, and interactions with the Sun and solar wind during an interplanetary coronal mass ejection impact in March 2015. Responses include changes in the bow shock and magnetosheath, formation of widespread diffuse aurora, and enhancement of pick-up ions. Observations and models both show an enhancement in escape rate of ions to space during the event. Ion loss during solar events early in Mars history may have been a major contributor to the long-term evolution of the Mars atmosphere.	[Jakosky, B. M.; Eparvier, F.; Ergun, R.; Schneider, N.; Brain, D.; Andersson, L.; Baker, D.; Chaffin, M.; Crary, F.; Crismani, M.; Deighan, J.; Dewey, R.; Dong, Y.; Fang, X.; Fortier, K.; Fowler, C. M.; Holsclaw, G.; Jain, S. K.; McClintock, W.; McEnulty, T.; Morooka, M.; Peterson, W.; Stewart, A. I. F.; Stiepen, A.; Thiemann, E.; Weber, T.; Woods, T.] Univ Colorado, Boulder, CO 80309 USA; [Grebowsky, J. M.; Connerney, J.; Mahaffy, P.; Benna, M.; Chamberlin, P.; Collinson, G.; DiBraccio, G.; Elrod, M.; Espley, J.; Guzewich, S.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Luhmann, J. G.; Larson, D.; McFadden, J.; Mitchell, D. F.; Curry, S.; Curtis, D.; Delory, G.; Dunn, P.; England, S.; Fillingim, M.; Hara, T.; Harada, Y.; Jolitz, R.; Lee, C. O.; Lillis, R.; Livi, R.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Halekas, J.; Ruhunusiri, S.] Univ Iowa, Iowa City, IA USA; [Zurek, R.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Bougher, S.; Combi, M.; Dong, C.; Lee, Y.; Nagy, A.; Olsen, K.; Tenishev, V.] Univ Michigan, Ann Arbor, MI 48109 USA; [Ma, Y. J.; Russell, C. T.] Univ Calif Los Angeles, Los Angeles, CA USA; [Mazelle, C.; Sauvaud, J. -A.; Steckiewicz, M.; Toublanc, D.] CNRS, IRAP, Toulouse, France; [Mazelle, C.; Sauvaud, J. -A.; Steckiewicz, M.; Toublanc, D.] Univ Paul Sabatier, Toulouse, France; [Andrews, D.; Eriksson, A.] Swedish Inst Space Phys, Uppsala, Sweden; [Baird, D.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Chaufray, Y. -Y.; Leblanc, F.; Lefevre, F.; Modolo, R.; Montmessin, F.] CNRS, Lab Atmospheres Milieux & Observat Spatiales, Paris, France; [Clarke, J.; Mayyasi, M.; Vogt, M.; Withers, P.] Boston Univ, Boston, MA 02215 USA; [Cravens, T.; Rahmati, A.; Sakai, S.] Univ Kansas, Lawrence, KS 66045 USA; [Evans, S.] Computat Phys Inc, Boulder, CO USA; [Fox, J.] Wright State Univ, Dayton, OH 45435 USA; [Groeller, H.; Lo, D.; Stone, S.; Yelle, R.] Univ Arizona, Tucson, AZ USA; [Seki, K.] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Stevens, M.] Naval Res Lab, Washington, DC 20375 USA; [Tolson, R.] N Carolina State Univ, Raleigh, NC 27695 USA; [Bell, J. M.] Natl Inst Aerosp, Hampton, VA USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; University of Iowa; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Boston University; University of Kansas; University System of Ohio; Wright State University Dayton; University of Arizona; Nagoya University; United States Department of Defense; United States Navy; Naval Research Laboratory; University of North Carolina; North Carolina State University; National Institute for Aerospace	Jakosky, BM (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	bruce.jakosky@lasp.colorado.edu	Dong, Yaxue/AAN-6920-2020; Clarke, John/C-8644-2013; Fang, Xiaohua/C-2773-2008; Stone, Shane Wesley/C-4662-2017; Vogt, Marissa/C-6237-2014; Ma, Yingjuan/B-4895-2017; Morooka, Michiko/AAO-8594-2020; Dong, Chuanfei/E-6485-2010; Sakai, Shotaro/AAT-8518-2020; Holsclaw, Greg/AAX-2486-2021; Combi, Michael/J-1697-2012; Benna, Mehdi/F-3489-2012; Lillis, Robert J/A-3281-2008; Russell, Christopher T/E-7745-2012; Guzewich, Scott/AAI-1445-2021; Eriksson, Anders I/C-2887-2009; Andrews, David/B-2591-2009; Peterson, WK/A-8706-2009; Chamberlin, Phillip/C-9531-2012; Crismani, Matteo/H-3791-2016	Fang, Xiaohua/0000-0002-6584-2837; Stone, Shane Wesley/0000-0002-7290-2412; Vogt, Marissa/0000-0003-4885-8615; Ma, Yingjuan/0000-0003-2584-7091; Morooka, Michiko/0000-0001-9958-0241; Dong, Chuanfei/0000-0002-8990-094X; Sakai, Shotaro/0000-0001-9135-2076; Holsclaw, Greg/0000-0002-9059-9437; Combi, Michael/0000-0002-9805-0078; Lillis, Robert J/0000-0003-0578-517X; Russell, Christopher T/0000-0003-1639-8298; Eriksson, Anders I/0000-0003-2926-6761; Andrews, David/0000-0002-7933-0322; Peterson, WK/0000-0002-1513-6096; Chamberlin, Phillip/0000-0003-4372-7405; Crismani, Matteo/0000-0003-3127-2466; Guzewich, Scott/0000-0003-1149-7385; Montmessin, Franck/0000-0002-4187-1457; Thiemann, Edward/0000-0002-5305-9466; BRAIN, DAVID/0000-0001-8932-368X; England, Scott/0000-0001-5336-0040; Halekas, Jasper/0000-0001-5258-6128; Dong, Yaxue/0000-0003-3491-7506; Seki, Kanako/0000-0001-5557-9062; Lee, Christina/0000-0002-1604-3326; Dewey, Ryan/0000-0003-4437-0698; Lo, Daniel/0000-0002-9603-500X; Harada, Yuki/0000-0002-4001-6352; SCHNEIDER, NICHOLAS/0000-0001-6720-5519	NASA through the Mars Exploration Program; Belgian American Educational Foundation; Grants-in-Aid for Scientific Research [15H03731] Funding Source: KAKEN	NASA through the Mars Exploration Program; Belgian American Educational Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The results presented here represent the work of hundreds of scientists and engineers who designed, built, and operated the spacecraft and instruments and carried out the scientific analyses. We are indebted to them beyond words. The MAVEN mission has been funded by NASA through the Mars Exploration Program. Additional support was provided by CNES for the SWEA instrument and analysis, and by the Belgian American Educational Foundation. Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. M. L. Mays and D. Odstrcil provided valuable analysis with the WSA-ENLIL+Cone model. Data from the MAVEN mission have been made available via the Planetary Data System (accessible via http://atmos.nmsu.edu/data_and_services/atmospheres_data/MAVEN/maven_main.html).	Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Andersson L, 2015, SCIENCE, V350, DOI 10.1126/science.aad0398; Barabash S, 2007, SCIENCE, V315, P501, DOI 10.1126/science.1134358; BARTH CA, 1972, ICARUS, V17, P457, DOI 10.1016/0019-1035(72)90011-5; Bertaux JL, 2005, NATURE, V435, P790, DOI 10.1038/nature03603; Bougher S, 2015, SCIENCE, V350, DOI 10.1126/science.aad0459; Bougher SW, 2015, SPACE SCI REV, V195, P423, DOI 10.1007/s11214-014-0053-7; Brain DA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043916; CARR MH, 1987, NATURE, V326, P30, DOI 10.1038/326030a0; Chaffin MS, 2015, GEOPHYS RES LETT, V42, P9001, DOI 10.1002/2015GL065287; Cloutier PA, 1999, GEOPHYS RES LETT, V26, P2685, DOI 10.1029/1999GL900591; Connerney JEP, 2015, SPACE SCI REV, V195, P257, DOI 10.1007/s11214-015-0169-4; Crider DH, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010881; Curry SM, 2013, J GEOPHYS RES-SPACE, V118, P554, DOI 10.1029/2012JA017665; Des Marais D. J., 2008, MARTIAN SURFACE COMP, P599; Dong CF, 2014, GEOPHYS RES LETT, V41, P2708, DOI 10.1002/2014GL059515; Dubinin E, 2011, SPACE SCI REV, V162, P173, DOI 10.1007/s11214-011-9831-7; Dubinin E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036559; Edberg NJT, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041814; Futaana Y, 2008, PLANET SPACE SCI, V56, P873, DOI 10.1016/j.pss.2007.10.014; GOSLING JT, 1993, J GEOPHYS RES-SPACE, V98, P18937, DOI 10.1029/93JA01896; Halekas JS, 2015, SPACE SCI REV, V195, P125, DOI 10.1007/s11214-013-0029-z; Hara T, 2014, J GEOPHYS RES-SPACE, V119, P1262, DOI 10.1002/2013JA019414; Jakosky BM, 2015, SPACE SCI REV, V195, P3, DOI 10.1007/s11214-015-0139-x; Jakosky BM, 2015, GEOPHYS RES LETT, V42, P8791, DOI 10.1002/2015GL065271; Kamide Y, 2015, SPACE WEATHER, V13, P365, DOI 10.1002/2015SW001213; Larson D. E., 2015, LUNAR PLANET SCI C; Leblanc F, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900178; Ma Y, 2014, GEOPHYS RES LETT, V41, P6563, DOI 10.1002/2014GL060785; Mays ML, 2015, SOL PHYS, V290, P1775, DOI 10.1007/s11207-015-0692-1; McClintock WE, 2015, SPACE SCI REV, V195, P75, DOI 10.1007/s11214-014-0098-7; McFadden J.P., 2015, LUNAR PLANET SCI C; Mitchell D. L., 2015, LUNAR PLANET SCI C; Najib D, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016272; Nilsson H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0571; Nilsson H, 2011, ICARUS, V215, P475, DOI 10.1016/j.icarus.2011.08.003; Rahmati A, 2014, GEOPHYS RES LETT, V41, P4812, DOI 10.1002/2014GL060289; Ramstad R, 2015, J GEOPHYS RES-PLANET, V120, P1298, DOI 10.1002/2015JE004816; Ramstad R, 2013, GEOPHYS RES LETT, V40, P477, DOI 10.1002/grl.50149; RUSSELL CT, 1979, NATURE, V279, P616, DOI 10.1038/279616a0; Schneider NM, 2015, SCIENCE, V350, DOI 10.1126/science.aad0313; Vignes D, 2000, GEOPHYS RES LETT, V27, P49, DOI 10.1029/1999GL010703; Wood BE, 2005, ASTROPHYS J, V628, pL143, DOI 10.1086/432716	43	172	173	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261							aad0210	10.1126/science.aad0210	http://dx.doi.org/10.1126/science.aad0210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542576				2022-12-28	WOS:000364162800001
J	Goldstein, D; Moskowitz, AJ; Gelijns, AC; Ailawadi, G; Parides, MK; Perrault, LP; Hung, JW; Voisine, P; Dagenais, F; Gillinov, AM; Thourani, V; Argenziano, M; Gammie, JS; Mack, M; Demers, P; Atluri, P; Rose, EA; O'Sullivan, K; Williams, DL; Bagiella, E; Michler, RE; Weisel, RD; Miller, MA; Geller, NL; Taddei-Peters, WC; Smith, PK; Moquete, E; Overbey, JR; Kron, IL; O'Gara, PT; Acker, MA				Goldstein, D.; Moskowitz, A. J.; Gelijns, A. C.; Ailawadi, G.; Parides, M. K.; Perrault, L. P.; Hung, J. W.; Voisine, P.; Dagenais, F.; Gillinov, A. M.; Thourani, V.; Argenziano, M.; Gammie, J. S.; Mack, M.; Demers, P.; Atluri, P.; Rose, E. A.; O'Sullivan, K.; Williams, D. L.; Bagiella, E.; Michler, R. E.; Weisel, R. D.; Miller, M. A.; Geller, N. L.; Taddei-Peters, W. C.; Smith, P. K.; Moquete, E.; Overbey, J. R.; Kron, I. L.; O'Gara, P. T.; Acker, M. A.		CTSN	Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-FAILURE; VALVE-REPLACEMENT; REPAIR; ANNULOPLASTY; PREDICTORS; RECURRENCE; MECHANISM; DETERMINANTS; MANAGEMENT; MORTALITY	BACKGROUND In a randomized trial comparing mitral-valve repair with mitral-valve replacement in patients with severe ischemic mitral regurgitation, we found no significant difference in the left ventricular end-systolic volume index (LVESVI), survival, or adverse events at 1 year after surgery. However, patients in the repair group had significantly more recurrences of moderate or severe mitral regurgitation. We now report the 2-year outcomes of this trial. METHODS We randomly assigned 251 patients to mitral-valve repair or replacement. Patients were followed for 2 years, and clinical and echocardiographic outcomes were assessed. RESULTS Among surviving patients, the mean (+/- SD) 2-year LVESVI was 52.6 +/- 27.7 ml per square meter of body-surface area with mitral-valve repair and 60.6 +/- 39.0 ml per square meter with mitral-valve replacement (mean changes from baseline, -9.0 ml per square meter and -6.5 ml per square meter, respectively). Two-year mortality was 19.0% in the repair group and 23.2% in the replacement group (hazard ratio in the repair group, 0.79; 95% confidence interval, 0.46 to 1.35; P=0.39). The rank-based assessment of LVESVI at 2 years (incorporating deaths) showed no significant between-group difference (z score = -1.32, P=0.19). The rate of recurrence of moderate or severe mitral regurgitation over 2 years was higher in the repair group than in the replacement group (58.8% vs. 3.8%, P < 0.001). There were no significant between-group differences in rates of serious adverse events and overall readmissions, but patients in the repair group had more serious adverse events related to heart failure (P=0.05) and cardiovascular readmissions (P=0.01). On the Minnesota Living with Heart Failure questionnaire, there was a trend toward greater improvement in the replacement group (P=0.07). CONCLUSIONS In patients undergoing mitral-valve repair or replacement for severe ischemic mitral regurgitation, we observed no significant between-group difference in left ventricular reverse remodeling or survival at 2 years. Mitral regurgitation recurred more frequently in the repair group, resulting in more heart-failure-related adverse events and cardiovascular admissions.	[Goldstein, D.; Michler, R. E.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Cardiothorac Surg, New York, NY USA; [Moskowitz, A. J.; Gelijns, A. C.; Parides, M. K.; O'Sullivan, K.; Williams, D. L.; Bagiella, E.; Moquete, E.; Overbey, J. R.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Int Ctr Hlth Outcomes & Innovat Res, New York, NY 10029 USA; [Rose, E. A.] Icahn Sch Med Mt Sinai, Cardiovasc Inst, New York, NY USA; [Argenziano, M.] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Cardiothorac Surg, New York, NY USA; [Ailawadi, G.; Kron, I. L.] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Perrault, L. P.; Demers, P.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Voisine, P.; Dagenais, F.] Inst Univ Cardiol Quebec, Hop Laval, Quebec City, PQ, Canada; [Weisel, R. D.] Univ Toronto, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Weisel, R. D.] Univ Toronto, Div Cardiovasc Surg, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Weisel, R. D.] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada; [Hung, J. W.] Massachusetts Gen Hosp, Echocardiog Core Lab, Boston, MA 02114 USA; [O'Gara, P. T.] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA; [Gillinov, A. M.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH USA; [Thourani, V.] Emory Univ, Sch Med, Div Cardiothorac Surg, Clin Res Unit, Atlanta, GA 30322 USA; [Gammie, J. S.] Univ Maryland, Baltimore, MD 21201 USA; [Miller, M. A.; Taddei-Peters, W. C.] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Geller, N. L.] NHLBI, Off Biostat Res, Bldg 10, Bethesda, MD 20892 USA; [Mack, M.] Baylor Res Inst, Dallas, TX USA; [Atluri, P.; Acker, M. A.] Univ Penn, Sch Med, Div Cardiovasc Surg, Dept Surg, Philadelphia, PA 19104 USA; [Smith, P. K.] Duke Univ, Med Ctr, Dept Surg, Div Cardiovasc & Thorac Surg, Durham, NC 27710 USA	Montefiore Medical Center; Yeshiva University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; University of Virginia; Universite de Montreal; Laval University; University of Toronto; Peter Munk Cardiac Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Emory University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baylor Scott & White Health; Baylor University Medical Center; University of Pennsylvania; Duke University	Gelijns, AC (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, 1 Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	annetine.gelijns@mssm.edu	Rose, Eric/AAJ-2281-2020; thourani, vinod/AAP-5968-2020; Parides, Michael/GON-8474-2022	Douglas, Pamela/0000-0001-9876-4049; Browndyke, Jeffrey/0000-0002-8573-7073; Holubkov, Richard/0000-0003-0431-3381; Moskowitz, Alan/0000-0002-4412-9450; Overbey, Jessica/0000-0001-7283-1661	National Institutes of Health and Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL088953, UM1HL088939, UM1HL117924, U01HL088942, UM1HL088925, UM1HL088955] Funding Source: NIH RePORTER	National Institutes of Health and Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health and Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00807040.	Acker MA, 2014, NEW ENGL J MED, V370, P23, DOI 10.1056/NEJMoa1312808; Al-Radi OO, 2005, ANN THORAC SURG, V79, P1260, DOI 10.1016/j.athoracsur.2004.09.044; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Bax JJ, 2004, CIRCULATION, V110, pII103, DOI 10.1161/01.CIR-0000138196.06772.4e; Ciarka A, 2010, AM J CARDIOL, V106, P395, DOI 10.1016/j.amjcard.2010.03.042; De Bonis M, 2008, ANN THORAC SURG, V85, P932, DOI 10.1016/j.athoracsur.2007.11.021; Di Salvo TG, 2010, J AM COLL CARDIOL, V55, P271, DOI 10.1016/j.jacc.2009.08.059; Digiammarco Gabriele, 2007, Interact Cardiovasc Thorac Surg, V6, P340; Fino C, 2015, J THORAC CARDIOV SUR, V149, P1595, DOI 10.1016/j.jtcvs.2015.03.003; Gelsomino S, 2008, EUR HEART J, V29, P231; Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557; HICKEY MS, 1988, CIRCULATION, V78, P51; Hung J, 2004, CIRCULATION, V110, pII85, DOI 10.1161/01.CIR.0000138192.65015.45; Kang DH, 2006, CIRCULATION, V114, pI499, DOI 10.1161/CIRCULATIONAHA.105.000398; Kongsaerepong V, 2006, AM J CARDIOL, V98, P504, DOI 10.1016/j.amjcard.2006.02.056; Konstam MA, 2003, J CARD FAIL, V9, P350, DOI 10.1054/j.cardfail.2003.09.001; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; Kron IL, 2015, J THORAC CARDIOV SUR, V149, P752, DOI 10.1016/j.jtcvs.2014.10.120; Kuwahara E, 2006, CIRCULATION, V114, pI529, DOI 10.1161/CIRCULATIONAHA.105.000729; Lamas GA, 1997, CIRCULATION, V96, P827; Levine RA, 2005, CIRCULATION, V112, P745, DOI 10.1161/CIRCULATIONAHA.104.486720; Magne J, 2007, CIRCULATION, V115, P782, DOI 10.1161/CIRCULATIONAHA.106.649236; Magne J, 2009, J AM SOC ECHOCARDIOG, V22, P1256, DOI 10.1016/j.echo.2009.07.029; Magne J, 2009, CIRCULATION, V120, pS104, DOI 10.1161/CIRCULATIONAHA.108.843995; Magne J, 2009, CARDIOLOGY, V112, P244, DOI 10.1159/000151693; McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Perrault LP, 2012, J THORAC CARDIOV SUR, V143, P1396, DOI 10.1016/j.jtcvs.2011.05.030; Rector T S, 1995, J Card Fail, V1, P201, DOI 10.1016/1071-9164(95)90025-X; Reece TB, 2004, ANN SURG, V239, P671, DOI 10.1097/01.sla.0000124297.40815.86; Roshanali F, 2007, ANN THORAC SURG, V84, P745, DOI 10.1016/j.athoracsur.2007.04.106; Rossi A, 2011, HEART, V97, P1675, DOI 10.1136/hrt.2011.225789; *SOC THOR SURG, YEARS 2008 2012 AD C; Szymanski C, 2012, CIRCULATION, V126, P2720, DOI 10.1161/CIRCULATIONAHA.111.033472; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Vassileva CM, 2011, EUR J CARDIO-THORAC, V39, P295, DOI 10.1016/j.ejcts.2010.06.034; Wang JY, 2015, INT J CARDIOL, V185, P304, DOI 10.1016/j.ijcard.2015.03.170; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Yiu SF, 2000, CIRCULATION, V102, P1400, DOI 10.1161/01.CIR.102.12.1400; Yoshida K, 2014, GEN THORAC CARDIOVAS, V62, P38, DOI 10.1007/s11748-013-0297-2; Yun KL, 2002, J THORAC CARDIOV SUR, V123, P707, DOI 10.1067/mtc.2002.121048; Zhu F, 2005, CIRCULATION, V112, pI396, DOI 10.1161/CIRCULATIONAHA.104.524561; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	43	499	516	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					344	353		10.1056/NEJMoa1512913	http://dx.doi.org/10.1056/NEJMoa1512913			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26550689	Green Accepted			2022-12-28	WOS:000368760100008
J	Hudson, KL; Collins, FS				Hudson, Kathy L.; Collins, Francis S.			Bringing the Common Rule into the 21st Century	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hudson, Kathy L.] Natl Inst Hlth, Bethesda, MD 20817 USA	National Institutes of Health (NIH) - USA	Hudson, KL (corresponding author), Natl Inst Hlth, Bethesda, MD 20817 USA.							Department of Health and Human Services, 2015, NPRM FED POL PROT HU; Department of Health and Human Services, 2011, ANPRM REV COMM RUL; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hudson KL, 2013, NATURE, V500, P141, DOI 10.1038/500141a; Wagner TH, 2010, J CLIN ONCOL, V28, P662, DOI 10.1200/JCO.2009.23.2470	5	51	51	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2293	2296		10.1056/NEJMp1512205	http://dx.doi.org/10.1056/NEJMp1512205			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY0QW	26509903	Green Published, Bronze			2022-12-28	WOS:000366111600001
J	Shin, DS; Tainer, JA				Shin, David S.; Tainer, John A.			MOLECULAR BIOLOGY DNA repair without flipping out	NATURE			English	Editorial Material							EXCISION; MECHANISM; BINDING; DAMAGE		[Shin, David S.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; UTMD Anderson Cancer Center	Shin, DS (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	davidsshin@lbl.gov; jtainer@mdanderson.org	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429				Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mullins EA, 2015, NATURE, V527, P254, DOI 10.1038/nature15728; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Xu H, 2012, ANGEW CHEM INT EDIT, V51, P10532, DOI 10.1002/anie.201204109	12	2	2	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					168	169		10.1038/nature15646	http://dx.doi.org/10.1038/nature15646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26524524				2022-12-28	WOS:000364396700026
J	Osler, W				Osler, William			Angina Pectoris and Arteriosclerosis (Reprinted from JAMA, vol 43, pg 775-776, 1904)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Osler W, 1904, J AMER MED ASSOC, V43, P0775	1	1	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1981	1981		10.1001/jama.2014.12084	http://dx.doi.org/10.1001/jama.2014.12084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547477	Green Submitted			2022-12-28	WOS:000364490700027
J	Dares, CJ; Lapides, AM; Mincher, BJ; Meyer, TJ				Dares, Christopher J.; Lapides, Alexander M.; Mincher, Bruce J.; Meyer, Thomas J.			Electrochemical oxidation of Am-243(III) in nitric acid by a terpyridyl-derivatized electrode	SCIENCE			English	Article							AMERICIUM; EXTRACTION; COMPLEXATION; DISPOSAL; AM(III); AM(VI); LIGAND; STATES	Selective oxidation of trivalent americium (Am) could facilitate its separation from lanthanides in nuclear waste streams. Here, we report the application of a high-surface-area, tin-doped indium oxide electrode surface-derivatized with a terpyridine ligand to the oxidation of Am(III) to Am(V) and Am(VI) in nitric acid. Potentials as low as 1.8 volts (V) versus the saturated calomel electrode were applied, 0.7 V lower than the 2.6 V potential for one-electron oxidation of Am(III) to Am(IV) in 1 molar acid. This simple electrochemical procedure provides a method to access the higher oxidation states of Am in noncomplexing media for the study of the associated coordination chemistry and, more important, for more efficient separation protocols.	[Dares, Christopher J.; Lapides, Alexander M.; Meyer, Thomas J.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Mincher, Bruce J.] Idaho Natl Lab, Aqueous Separat & Radiochem Dept, Idaho Falls, ID 83415 USA	University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Idaho National Laboratory	Meyer, TJ (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	tjmeyer@unc.edu	Mincher, Bruce J/C-7758-2017; Dares, Christopher/AAW-8518-2021		U.S. Department of Energy (DOE) Office of Nuclear Energy, Fuel Cycle Research and Development Program under DOE Idaho Operations Office [DE-AC07-99ID13727]; U.S. DOE Office of Science, Office of Basic Energy Sciences [DE-SC0001011]; U.S. Department of Defense; Air Force Office of Scientific Research through National Defense Science and Engineering Graduate Fellowship [FA9550-11-C-0028]	U.S. Department of Energy (DOE) Office of Nuclear Energy, Fuel Cycle Research and Development Program under DOE Idaho Operations Office; U.S. DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Defense(United States Department of Defense); Air Force Office of Scientific Research through National Defense Science and Engineering Graduate Fellowship	This research was supported by the U.S. Department of Energy (DOE) Office of Nuclear Energy, Fuel Cycle Research and Development Program, under DOE Idaho Operations Office contract DE-AC07-99ID13727. This research made use of equipment for electrode fabrication including homogenizer, spin-coater, and annealing furnaces funded by the University of North Carolina Energy Frontier Research Center: Center for Solar Fuels, supported by the U.S. DOE Office of Science, Office of Basic Energy Sciences, under award number DE-SC0001011. A.M.L. thanks the U.S. Department of Defense, Air Force Office of Scientific Research, for funding through National Defense Science and Engineering Graduate Fellowship award FA9550-11-C-0028. Authors C.J.D., A.M.L., and T.J.M. at University of North Carolina at Chapel Hill and B.J.M. at Idaho National Laboratory have filed for a provisional patent application with the U.S. Patent and Trademark Office under application no. 62/202,428 on the electrochemical oxidation of americium at derivatized metal oxide electrodes. The authors also thank B. A. Moyer for encouragement and helpful technical discussions. Correspondence and requests for materials should be addressed to T.J.M. Author Contributions: C.J.D., T.J.M., and B.J.M. conceived experiments; A.M.L. synthesized the ligand p-tpy; C.J.D. prepared electrodes, designed and fabricated custom equipment, and conducted all experiments; C.J.D., T.J.M, and B.J.M. analyzed and interpreted data; C.J.D., A.M.L, B.J.M., and T.J.M. wrote the manuscript.	Adnet J. M., 1997, U.S. Patent Office, Patent No. 5609745; Afsar A, 2014, CHEM COMMUN, V50, P15082, DOI 10.1039/c4cc07478e; ANGINO EE, 1977, SCIENCE, V198, P885, DOI 10.1126/science.198.4320.885; Bard A. J., 1983, STANDARD POTENTIALS; Choppin G., 2013, RADIOCHEMISTRY NUCL; Coggins MK, 2014, J AM CHEM SOC, V136, P15845, DOI 10.1021/ja507979c; Drew M. G. B., 2000, DALTON T, V2000, P821; FRANCZYK TS, 1992, J AM CHEM SOC, V114, P8138, DOI 10.1021/ja00047a023; Frenkel, 1973, RADIOCHEM RADIOANAL, V14; Hanson K, 2013, CHEM MATER, V25, P3, DOI 10.1021/cm303172w; Kang P, 2014, ENERG ENVIRON SCI, V7, P4007, DOI 10.1039/c4ee01904k; KUBO AS, 1973, SCIENCE, V182, P1205, DOI 10.1126/science.182.4118.1205; Kulyako Y. M., 1981, RADIOKHIMIYA, V23, P837; Lebedev I. A., 1978, RADIOKHIMIYA, V20, P653; Lebedev I.A., 1976, RADIOKHIMIYA, V18, P652; LITVINA MN, 1988, J RADIOAN NUCL CH AR, V121, P355, DOI 10.1007/BF02041422; Mendez M. A., 2014, U.S. Patent Application, Patent No. [App. No.14/224,606, 14224606]; Mendez MA, 2013, ACS CATAL, V3, P1850, DOI 10.1021/cs4003595; Miguirditchian M, 2005, INORG CHEM, V44, P1404, DOI 10.1021/ic0488785; Milyukova M. S., 1983, RADIOKHIMIYA, V25, P706; Mincher BJ, 2008, INORG CHEM, V47, P6984, DOI 10.1021/ic800667h; Mincher BJ, 2014, SOLVENT EXTR ION EXC, V32, P153, DOI 10.1080/07366299.2013.850288; Mincher BJ, 2012, SOLVENT EXTR ION EXC, V30, P445, DOI 10.1080/07366299.2012.671108; MORSS LR, 1981, J INORG NUCL CHEM, V43, P2059, DOI 10.1016/0022-1902(81)80548-9; Moyer BA, 2013, INORG CHEM, V52, P3473, DOI 10.1021/ic3016832; Panak PJ, 2013, CHEM REV, V113, P1199, DOI 10.1021/cr3003399; Penneman R A., 1950, AECU936 US AT EN COM; Picart S., 1999, SCI REPORT; ROSE DJ, 1974, SCIENCE, V184, P351, DOI 10.1126/science.184.4134.351; Runde WH, 2011, CHEM REV, V111, P5723, DOI 10.1021/cr100181f; Schulz W. W., 1976, CHEM AMERICIUM; Song WJ, 2014, J AM CHEM SOC, V136, P9773, DOI 10.1021/ja505022f; Tamaki Y, 2014, J AM CHEM SOC, V136, P6854, DOI 10.1021/ja502637s; WOODS SM, 1974, J INORG NUCL CHEM, V36, P2605, DOI 10.1016/0022-1902(74)80480-X; YANIR E, 1970, INORG NUCL CHEM LETT, V6, P415, DOI 10.1016/0020-1650(70)80197-0; YANIR E, 1969, INORG NUCL CHEM LETT, V5, P369, DOI 10.1016/0020-1650(69)80082-6; Zaitsev A.A., 1960, RADIOKHIMIYA, V2, P348	37	47	49	6	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					652	655		10.1126/science.aac9217	http://dx.doi.org/10.1126/science.aac9217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542564	Green Submitted			2022-12-28	WOS:000364162800043
J	Alkass, K; Panula, J; Westman, M; Wu, TD; Guerquin-Kern, JL; Bergmann, O				Alkass, Kanar; Panula, Joni; Westman, Mattias; Wu, Ting-Di; Guerquin-Kern, Jean-Luc; Bergmann, Olaf			No Evidence for Cardiomyocyte Number Expansion in Preadolescent Mice	CELL			English	Article							CELL-CYCLE ARREST; PROLIFERATION CONTRIBUTES; MYOCARDIAL-INFARCTION; NUCLEAR NUMBER; DNA-SYNTHESIS; PLOIDY LEVEL; HEART GROWTH; RENEWAL; DIFFERENTIATION; HYPERTROPHY	The magnitude of cardiomyocyte generation in the adult heart has been heavily debated. A recent report suggests that duringmouse preadolescence, cardiomyocyte proliferation leads to a 40% increase in the number of cardiomyocytes. Such an expansion would change our understanding of heart growth and have far-reaching implications for cardiac regeneration. Here, using design-based stereology, we found that cardiomyocyte proliferation accounted for 30% of postnatal DNA synthesis; however, we were unable to detect any changes in cardiomyocyte number after postnatal day 11. N-15-thymidine and BrdU analyses provided no evidence for a proliferative peak in preadolescent mice. By contrast, cardiomyocyte multinucleation comprises 57% of postnatal DNA synthesis, followed by cardiomyocyte nuclear polyploidisation, contributing with 13% to DNA synthesis within the second and third postnatal weeks. We conclude that the majority of cardiomyocytes is set within the first postnatal week and that this event is followed by two waves of non-replicative DNA synthesis. This Matters Arising paper is in response to Naqvi et al. (2014), published in Cell. See also the associated Correspondence by Soonpaa et al. (2015), and the response by Naqvi et al. (2015), published in this issue.	[Alkass, Kanar; Panula, Joni; Bergmann, Olaf] Karolinska Inst, Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Alkass, Kanar] Natl Board Forens Med, Dept Forens Med, SE-17177 Stockholm, Sweden; [Westman, Mattias] Karolinska Inst, Dept Med, SE-14186 Huddinge, Sweden; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] CNRS, UMR9187, INSERM, U1196, F-91405 Orsay, France	Karolinska Institutet; Swedish National Board of Forensic Medicine; Karolinska Institutet; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bergmann, O (corresponding author), Karolinska Inst, Cell & Mol Biol, SE-17177 Stockholm, Sweden.	olaf.bergmann@ki.se	Bergmann, Olaf/A-5706-2009; Guerquin-Kern, Jean-Luc/M-5000-2018	Bergmann, Olaf/0000-0003-1065-4107; Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; WU, Ting-Di/0000-0002-6398-0363; alkass, kanar/0000-0002-9154-5393	Swedish Research Council; Karolinska Institutet; mobility program of the French Embassy in Sweden [FRO2014]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); mobility program of the French Embassy in Sweden	We thank A. Hernandez, K. Hultenby, and E. Idsund Jonsson for assistance with tissue processing for the MIMS analysis; S. Giatrellis and M. Toro for assistance with flow cytometry, and S. Jovinge and S. Zdunek for valuable discussions. This study was supported by the Swedish Research Council and the Karolinska Institutet. We acknowledge the PICT-IBiSA imaging facility at the Institut Curie for use of the ion microprobe (Nano-SIMS). O.B. was supported by the mobility program of the French Embassy in Sweden (FRO2014).	Adler C, 1991, DEV REGENERATIVE POT, P227; Adler CP, 1996, VIRCHOWS ARCH, V429, P159; Ali SR, 2014, P NATL ACAD SCI USA, V111, P8850, DOI 10.1073/pnas.1408233111; Andersen DC, 2013, ANAL BIOANAL CHEM, V405, P9585, DOI 10.1007/s00216-013-7387-y; Andersen DC, 2014, STEM CELL REP, V2, P406, DOI 10.1016/j.stemcr.2014.02.008; Anderson P, 2010, PEDIAT CARDIOLOGY, P57; Ang KL, 2010, AM J PHYSIOL-CELL PH, V298, pC1603, DOI 10.1152/ajpcell.00435.2009; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bergmann O, 2012, JOVE-J VIS EXP, DOI 10.3791/4205; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bruel A, 2005, BASIC RES CARDIOL, V100, P311, DOI 10.1007/s00395-005-0524-9; Carrasco L, 2014, J CELL BIOCHEM, V115, P712, DOI 10.1002/jcb.24712; Delaughter MC, 1999, FASEB J, V13, P1923, DOI 10.1096/fasebj.13.14.1923; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Haubner BJ, 2012, AGING-US, V4, P966, DOI 10.18632/aging.100526; Herget GW, 1997, CARDIOVASC RES, V36, P45, DOI 10.1016/S0008-6363(97)00140-5; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Leu M, 2001, ANAT EMBRYOL, V204, P217, DOI 10.1007/s004290100206; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Mayhew TM, 1997, J ANAT, V191, P107, DOI 10.1046/j.1469-7580.1997.19110107.x; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Naqvi N, 2015, CELL, V163, P783, DOI 10.1016/j.cell.2015.10.038; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Palpant NJ, 2014, CELL, V157, P765, DOI 10.1016/j.cell.2014.04.025; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Preissl S, 2015, CIRC RES, V117, P413, DOI 10.1161/CIRCRESAHA.115.306337; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Sadek HA, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.06.009; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 2015, CELL, V163, P781, DOI 10.1016/j.cell.2015.10.037; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Srsen V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-28; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Zhang CH, 2014, CIRC RES, V115, P690, DOI 10.1161/CIRCRESAHA.114.304632	46	138	142	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					1026	1036		10.1016/j.cell.2015.10.035	http://dx.doi.org/10.1016/j.cell.2015.10.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544945	Bronze			2022-12-28	WOS:000364829700025
J	Elliott, JH; Grimshaw, J; Altman, R; Bero, L; Goodman, SN; Henry, D; Macleod, M; Tovey, D; Tugwell, P; White, H; Sim, I				Elliott, Julian H.; Grimshaw, Jeremy; Altman, Russ; Bero, Lisa; Goodman, Steven N.; Henry, David; Macleod, Malcolm; Tovey, David; Tugwell, Peter; White, Howard; Sim, Ida			Informatics: Make sense of health data	NATURE			English	Editorial Material									[Elliott, Julian H.] Monash Univ, Australasian Cochrane Ctr, Melbourne, Vic, Australia; [Elliott, Julian H.] Alfred Hosp, Infect Dis Unit, Clin Res, Melbourne, Vic, Australia; [Grimshaw, Jeremy] Univ Ottawa, Res Inst, Ottawa Hosp, Ottawa, ON, Canada; [Grimshaw, Jeremy] Univ Ottawa, Med, Ottawa, ON, Canada	Monash University; Florey Institute of Neuroscience & Mental Health; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Elliott, JH (corresponding author), Monash Univ, Australasian Cochrane Ctr, Melbourne, Vic, Australia.; Elliott, JH (corresponding author), Alfred Hosp, Infect Dis Unit, Clin Res, Melbourne, Vic, Australia.	julian.elliott@alfred.org.au	Tugwell, Peter/AFD-8076-2022; Macleod, Malcolm Robert/B-2052-2010; Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020	Tugwell, Peter/0000-0001-5062-0556; Macleod, Malcolm Robert/0000-0001-9187-9839; Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242; White, Howard/0000-0002-6298-0310; Goodman, Steven/0000-0002-3872-5723; Bero, Lisa/0000-0003-1893-6651				Chalmers I, 2003, ANN AM ACAD POLIT SS, V589, P22, DOI 10.1177/0002716203254762; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Turner RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030711; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416	6	5	6	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					31	32		10.1038/527031a	http://dx.doi.org/10.1038/527031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB5XK	26536942	Bronze			2022-12-28	WOS:000415924500007
J	Fisher, L				Fisher, Len			Avoid major disasters by welcoming minor change	NATURE			English	Editorial Material											Fisher, L (corresponding author), Univ Bristol, Bristol BS8 1TH, Avon, England.	len.fisher@bristol.ac.uk	Fisher, Len/P-6157-2015	Fisher, Len/0000-0003-2880-1152				2015, NATURE, V525, P157	1	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					9	9		10.1038/527009a	http://dx.doi.org/10.1038/527009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV4XV	26536922	Bronze			2022-12-28	WOS:000364270700004
J	Giacoppo, D; Gargiulo, G; Aruta, P; Capranzano, P; Tamburino, C; Capodanno, D				Giacoppo, Daniele; Gargiulo, Giuseppe; Aruta, Patrizia; Capranzano, Piera; Tamburino, Corrado; Capodanno, Davide			Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DRUG-ELUTING STENT; BALLOON ANGIOPLASTY; ANGIOGRAPHIC PATTERNS; CLINICAL-OUTCOMES; PUBLICATION BIAS; LUMEN LOSS; TERM; INCONSISTENCY; IMPLANTATION; MECHANISMS	STUDY QUESTION What is the most safe and effective interventional treatment for coronary in-stent restenosis? METHODS In a hierarchical Bayesian network meta-analysis, PubMed, Embase, Scopus, Cochrane Library, Web of Science, ScienceDirect, and major scientific websites were screened up to 10 August 2015. Randomised controlled trials of patients with any type of coronary in-stent restenosis (either of bare metal stents or drug eluting stents; and either first or recurrent instances) were included. Trials including multiple treatments at the same time in the same group or comparing variants of the same intervention were excluded. Primary endpoints were target lesion revascularisation and late lumen loss, both at six to 12 months. The main analysis was complemented by network subanalyses, standard pairwise comparisons, and subgroup and sensitivity analyses. Study answer and limitations Twenty four trials (4880 patients), including seven interventional treatments, were identified. Compared with plain balloons, bare metal stents, brachytherapy, rotational atherectomy, and cutting balloons, drug coated balloons and drug eluting stents were associated with a reduced risk of target lesion revascularisation and major adverse cardiac events, and with reduced late lumen loss. Treatment ranking indicated that drug eluting stents had the highest probability (61.4%) of being the most effective for target lesion vascularisation; drug coated balloons were similarly indicated as the most effective treatment for late lumen loss (probability 70.3%). The comparative efficacy of drug coated balloons and drug eluting stents was similar for target lesion revascularisation (summary odds ratio 1.10, 95% credible interval 0.59 to 2.01) and late lumen loss reduction (mean difference in minimum lumen diameter 0.04 mm, 95% credible interval -0.20 to 0.10). Risks of death, myocardial infarction, and stent thrombosis were comparable across all treatments, but these analyses were limited by a low number of events. Trials had heterogeneity regarding investigation periods, baseline characteristics, and endpoint reporting, with a lack of information at long term follow-up. Direct and indirect evidence was also inconsistent for the comparison between drug eluting stents and drug coated balloons. What this study adds Compared with other currently available interventional treatments for coronary in-stent restenosis, drug coated balloons and drug eluting stents are associated with superior clinical and angiographic outcomes, with a similar comparative efficacy.	[Giacoppo, Daniele; Gargiulo, Giuseppe; Aruta, Patrizia; Capranzano, Piera; Tamburino, Corrado; Capodanno, Davide] Ferrarotto Hosp, Catania, Italy; [Capranzano, Piera; Tamburino, Corrado; Capodanno, Davide] Univ Catania, Ferrarotto Hosp, Dept Gen Surg & Med Surg Specialties, I-95124 Catania, Italy	University of Catania	Capodanno, D (corresponding author), Ferrarotto Hosp, Catania, Italy.	dcapodanno@gmail.com	Gargiulo, Giuseppe/AAC-2356-2022; Capranzano, Piera/AAG-2696-2019; GARGIULO, Giuseppe/AAC-2336-2022; Capodanno, Davide/AAP-4949-2020	Capranzano, Piera/0000-0001-8434-7367; GARGIULO, Giuseppe/0000-0003-4395-6742; Capodanno, Davide/0000-0002-5156-7723; TAMBURINO, Corrado/0000-0002-4940-9742				Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054; Alfonso F, 2003, J AM COLL CARDIOL, V42, P796, DOI 10.1016/S0735-1097(03)00852-0; Alfonso F, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.014; Alfonso F, 2015, INT J CARDIOL, V178, P213, DOI 10.1016/j.ijcard.2014.10.139; Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545; Alfonso F, 2014, J AM COLL CARDIOL, V63, P2875, DOI 10.1016/j.jacc.2013.05.107; Biondi-Zoccai G, 2015, INT J CARDIOL, V182, P309, DOI 10.1016/j.ijcard.2015.01.023; Borenstein M., 2009, INTRO METAANALYSIS; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Cortese B, 2014, CATHETER CARDIO INTE, V83, P427, DOI 10.1002/ccd.25149; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2012, J AM COLL CARDIOL, V59, P1752, DOI 10.1016/j.jacc.2011.12.042; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elezi S, 1998, CIRCULATION, V98, P1875, DOI 10.1161/01.CIR.98.18.1875; Grasso C, 2013, INT J CARDIOL, V168, P4490, DOI 10.1016/j.ijcard.2013.06.127; Habara S, 2016, EUROINTERVENTION, V11, P1098, DOI 10.4244/EIJY15M02_09; Habara S, 2011, JACC-CARDIOVASC INTE, V4, P149, DOI 10.1016/j.jcin.2010.10.012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Iqbal J, 2014, EUR HEART J, V35, P765, DOI 10.1093/eurheartj/eht542; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Kim YH, 2006, AM J CARDIOL, V98, P1451, DOI 10.1016/j.amjcard.2006.07.027; Kornowski R, 1997, CIRCULATION, V95, P1366; Kubo S, 2015, EUROINTERVENTION, V10, DOI 10.4244/EIJV10I9A180; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Lee JM, 2015, JACC-CARDIOVASC INTE, V8, P382, DOI 10.1016/j.jcin.2014.09.023; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mauri L, 2005, CIRCULATION, V112, P2833, DOI 10.1161/CIRCULATIONAHA105.570093; Mauri L, 2005, CIRCULATION, V111, P321, DOI 10.1161/01.CIR.0000153356.72810.97; Mauri L, 2008, CIRCULATION, V118, P1817, DOI 10.1161/CIRCULATIONAHA.108.781377; Mehran R, 1996, AM J CARDIOL, V78, P618, DOI 10.1016/S0002-9149(96)00381-5; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Mehran R, 2001, AM HEART J, V141, P610, DOI 10.1067/mhj.2001.113998; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Rathore S, 2010, EUROINTERVENTION, V5, P841, DOI 10.4244/EIJV5I7A141; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Shiran A, 1998, CIRCULATION, V98, P200, DOI 10.1161/01.CIR.98.3.200; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Tagliareni F, 2010, EUROINTERVENTION, V5, P703, DOI 10.4244/EIJV5I6A116; Tomey MI, 2014, JACC-CARDIOVASC INTE, V7, P345, DOI 10.1016/j.jcin.2013.12.196; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	57	95	95	1	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5392	10.1136/bmj.h5392	http://dx.doi.org/10.1136/bmj.h5392			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OS	26537292	Green Published, hybrid			2022-12-28	WOS:000364390100003
J	Chinthapalli, K				Chinthapalli, Krishna			HEADS UP Choosing who to treat	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal N Shore Hosp, Sydney, NSW, Australia	Royal North Shore Hospital; University of Sydney	Chinthapalli, K (corresponding author), Royal N Shore Hosp, Sydney, NSW, Australia.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				American Medical Association, COD MED ETH OP 10 05; Charatan F, 2004, BRIT MED J, V328, P1518, DOI 10.1136/bmj.328.7455.1518; Diekema DS, 2005, PEDIATRICS, V115, P1428, DOI 10.1542/peds.2005-0316; General Medical Council, GOOD MED PRACT TREAT; Gesundheit B, 2009, AM J BIOETHICS, V9, P40, DOI 10.1080/15265160902985035; Kenny C, 2014, PULSE; Marks JH, 2009, AM J BIOETHICS, V9, P49, DOI 10.1080/15265160903013811; Zambrana M, 2015, GUARDIAN	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2015	351								h5828	10.1136/bmj.h5828	http://dx.doi.org/10.1136/bmj.h5828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OC	26530700				2022-12-28	WOS:000364388500014
J	Erwin, DH				Erwin, Douglas H.			Eric Davidson (1937-2015)	SCIENCE			English	Biographical-Item									Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Erwin, DH (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA.	erwind@si.edu		Erwin, Douglas/0000-0003-2518-5614				DAVIDSON EH, PUBLICATION LIST	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					517	517		10.1126/science.aad6065	http://dx.doi.org/10.1126/science.aad6065			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516272				2022-12-28	WOS:000363660000032
J	Sohn, E				Sohn, Emily			Networking Hello, stranger	NATURE			English	Editorial Material																			0	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					729	731		10.1038/nj7575-729a	http://dx.doi.org/10.1038/nj7575-729a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26516640				2022-12-28	WOS:000363832100057
J	Welch, HG; Gorski, DH; Albertsen, PC				Welch, H. Gilbert; Gorski, David H.; Albertsen, Peter C.			Trends in Metastatic Breast and Prostate Cancer - Lessons in Cancer Dynamics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOLLOW-UP		[Welch, H. Gilbert] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA; [Gorski, David H.] Wayne State Univ, Sch Med, Dept Surg, Breast Surg Sect, Detroit, MI 48201 USA; [Gorski, David H.] Barbara Ann Karmanos Canc Ctr, Detroit, MI USA; [Albertsen, Peter C.] Univ Connecticut, Ctr Hlth, Dept Surg, Div Urol, Farmington, CT USA	Dartmouth College; Wayne State University; Barbara Ann Karmanos Cancer Institute; University of Connecticut	Welch, HG (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA.		Gorski, David/AAE-6399-2022	Gorski, David/0000-0002-9805-6699				GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587, DOI 10.1001/jama.1994.03510440047031; HELLMAN S, 1994, J CLIN ONCOL, V12, P2229, DOI 10.1200/JCO.1994.12.10.2229; Newcomer LM, 1997, J UROLOGY, V158, P1427, DOI 10.1016/S0022-5347(01)64231-9; Schroder FH, 2012, NEW ENGL J MED, V366, P2137; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278	6	132	135	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1685	1687		10.1056/NEJMp1510443	http://dx.doi.org/10.1056/NEJMp1510443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU4QH	26510017				2022-12-28	WOS:000363514100002
J	Baumann, S; Paul, W; Choi, T; Lutz, CP; Ardavan, A; Heinrich, AJ				Baumann, Susanne; Paul, William; Choi, Taeyoung; Lutz, Christopher P.; Ardavan, Arzhang; Heinrich, Andreas J.			Electron paramagnetic resonance of individual atoms on a surface	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; SPIN-RESONANCE; MAGNETIC-RESONANCE; SILICON	We combined the high-energy resolution of conventional spin resonance (here similar to 10 nano-electron volts) with scanning tunneling microscopy to measure electron paramagnetic resonance of individual iron (Fe) atoms placed on a magnesium oxide film. We drove the spin resonance with an oscillating electric field (20 to 30 gigahertz) between tip and sample. The readout of the Fe atom's quantum state was performed by spin-polarized detection of the atomic-scale tunneling magnetoresistance. We determine an energy relaxation time of T-1 approximate to 100 microseconds and a phase-coherence time of T-2 approximate to 210 nanoseconds. The spin resonance signals of different Fe atoms differ by much more than their resonance linewidth; in a traditional ensemble measurement, this difference would appear as inhomogeneous broadening.	[Baumann, Susanne; Paul, William; Choi, Taeyoung; Lutz, Christopher P.; Heinrich, Andreas J.] Almaden Res Ctr, IBM Res Div, San Jose, CA 95120 USA; [Baumann, Susanne] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Ardavan, Arzhang] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	International Business Machines (IBM); University of Basel; University of Oxford	Paul, W (corresponding author), Almaden Res Ctr, IBM Res Div, 650 Harry Rd, San Jose, CA 95120 USA.	wmppaul@gmail.com	Ardavan, Arzhang/AAY-9214-2020	Baumann, Susanne/0000-0002-3821-494X	Office of Naval Research; Natural Sciences and Engineering Research Council of Canada; Engineering and Physical Sciences Research Council [EP/M020517/1, EP/D048559/1, EP/H012613/1, EP/L011972/1] Funding Source: researchfish; EPSRC [EP/D048559/1, EP/H012613/1, EP/L011972/1, EP/M020517/1] Funding Source: UKRI	Office of Naval Research(Office of Naval Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank B. Melior for expert technical assistance and B. A. Jones, S. Gangopadhyay, and R. M. Macfarlane for fruitful discussions. We gratefully acknowledge financial support from the Office of Naval Research. W.P. thanks the Natural Sciences and Engineering Research Council of Canada for fellowship support.	Balatsky AV, 2012, ADV PHYS, V61, P117, DOI 10.1080/00018732.2012.668775; Baumann S., 2015, INTERPLAY ORBITAL MA; Bleaney, 2012, ELECT PARAMAGNETIC R; Chilian B, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.212401; Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Durkan C, 2002, APPL PHYS LETT, V80, P458, DOI 10.1063/1.1434301; George RE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.027601; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7; KIEL A, 1967, PHYS REV, V153, P378, DOI 10.1103/PhysRev.153.378; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Laucht A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500022; Loth S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125021; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; MANASSEN Y, 1989, PHYS REV LETT, V62, P2531, DOI 10.1103/PhysRevLett.62.2531; Manassen Y, 2000, PHYS REV B, V61, P16223, DOI 10.1103/PhysRevB.61.16223; Mullegger S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.133001; Muhonen JT, 2014, NAT NANOTECHNOL, V9, P986, DOI [10.1038/nnano.2014.211, 10.1038/NNANO.2014.211]; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Rau IG, 2014, SCIENCE, V344, P988, DOI 10.1126/science.1252841; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Stegner AR, 2006, NAT PHYS, V2, P835, DOI 10.1038/nphys465; Thiele S, 2014, SCIENCE, V344, P1135, DOI 10.1126/science.1249802; Tsukahara N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.167203; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495	27	208	209	6	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					417	420		10.1126/science.aac8703	http://dx.doi.org/10.1126/science.aac8703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494753				2022-12-28	WOS:000363213400035
J	Valsami-Jones, E; Lynch, I				Valsami-Jones, Eugenia; Lynch, Iseult			How safe are nanomaterials?	SCIENCE			English	Editorial Material							SILVER NANOPARTICLES; DISSOLVED METALS		[Valsami-Jones, Eugenia; Lynch, Iseult] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England	University of Birmingham	Valsami-Jones, E (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	e.valsamijones@bham.ac.uk	Valsami-Jones, Eva/I-1736-2016; Lynch, Iseult/I-3915-2014	Valsami-Jones, Eva/0000-0002-8850-7556; Lynch, Iseult/0000-0003-4250-4584	Natural Environment Research Council [FENAC010001] Funding Source: researchfish; NERC [FENAC010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bielmyer-Fraser GK, 2014, ENVIRON SCI TECHNOL, V48, P13443, DOI 10.1021/es501187g; Braakhuis HM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-18; Buck S, 2015, SCIENCE, V348, P1403, DOI 10.1126/science.aac8041; Croteau MN, 2011, ENVIRON SCI TECHNOL, V45, P6600, DOI 10.1021/es200880c; Harris G, 2015, NANOTOXICOLOGY, V9, P87, DOI 10.3109/17435390.2013.816797; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Krug HF, 2014, ANGEW CHEM INT EDIT, V53, P12304, DOI 10.1002/anie.201403367; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2015, ACS NANO, V9, P5627, DOI 10.1021/acsnano.5b03496; Notter DA, 2014, ENVIRON TOXICOL CHEM, V33, P2733, DOI 10.1002/etc.2732; Petersen EJ, 2015, ENVIRON SCI TECHNOL, V49, P9532, DOI 10.1021/acs.est.5b00997; Stegemeier JP, 2015, ENVIRON SCI TECHNOL, V49, P8451, DOI 10.1021/acs.est.5b01147; Sun BB, 2015, ACS NANO, V9, P9357, DOI 10.1021/acsnano.5b03443; Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q; Wang Z, 2013, ACS NANO, V7, P4171, DOI 10.1021/nn400594s	15	145	147	3	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					388	389		10.1126/science.aad0768	http://dx.doi.org/10.1126/science.aad0768			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494749				2022-12-28	WOS:000363213400026
J	Salehin, M; Estelle, M				Salehin, Mohammad; Estelle, Mark			Ethylene Prunes Translation	CELL			English	Editorial Material							ARABIDOPSIS; EIN2; RESPONSES	Ethylene regulates many aspects of plant growth and development. In the presence of ethylene, the C terminus of EIN2 (EIN2C) translocates into the nucleus and activates transcription. Li et al. and Merchante et al. show that EIN2C also regulates translation through an interaction with the 3' UTRs of transcripts.	[Salehin, Mohammad; Estelle, Mark] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Salehin, Mohammad; Estelle, Mark] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Estelle, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mestelle@ucsd.edu	Estelle, Mark/ABD-6742-2021					Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Li WY, 2015, CELL, V163, P670, DOI 10.1016/j.cell.2015.09.037; Maldonado-Bonilla LD, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00201; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Merchante C, 2015, CELL, V163, P684, DOI 10.1016/j.cell.2015.09.036; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974	10	8	8	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					543	544		10.1016/j.cell.2015.10.032	http://dx.doi.org/10.1016/j.cell.2015.10.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496600	Bronze			2022-12-28	WOS:000364828900008
J	Dokos, C				Dokos, Charalambos			Oral contraceptives or NSAIDs before surgery for a fracture distal to the knee were linked to postdischarge VTE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ORTHOPEDIC-SURGERY; THROMBOSIS		Aristotle Univ Thessaloniki, Sch Med, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki	Dokos, C (corresponding author), Aristotle Univ Thessaloniki, Sch Med, GR-54006 Thessaloniki, Greece.							Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Lapidus LJ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-177; Lassen MR, 2002, NEW ENGL J MED, V347, P726, DOI 10.1056/NEJMoa011327	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC12	10.7326/ACPJC-2015-163-8-012	http://dx.doi.org/10.7326/ACPJC-2015-163-8-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502137				2022-12-28	WOS:000363737400013
J	Gandhi, GY				Gandhi, Gunjan Y.			Review: In patients with type 2 diabetes who fast, sitagliptin reduces hypoglycemia more than sulfonylurea	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RAMADAN		Univ Florida, Jacksonville, FL 32209 USA	State University System of Florida; University of Florida	Gandhi, GY (corresponding author), Univ Florida, Jacksonville, FL 32209 USA.							Hanif W, 2013, CURR MED RES OPIN, V29, P807, DOI 10.1185/03007995.2013.803054; Lee JY, 2015, DIABET MED; McEwen LN, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000111; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC8	10.7326/ACPJC-2015-163-8-008	http://dx.doi.org/10.7326/ACPJC-2015-163-8-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502145				2022-12-28	WOS:000363737400009
J	Lazo-Langner, A				Lazo-Langner, Alejandro			Review: In AF or VTE, direct oral anticoagulants reduce fatal bleeding compared with vitamin K antagonists	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		Western Univ London, Dept Med, London, ON, Canada	Western University (University of Western Ontario)	Lazo-Langner, A (corresponding author), Western Univ London, Dept Med, London, ON, Canada.		Lazo-Langner, Alejandro/G-3318-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431				Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Sardar P, 2015, INT J CARDIOL, V179, P279, DOI 10.1016/j.ijcard.2014.11.101	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC2	10.7326/ACPJC-2015-163-8-002	http://dx.doi.org/10.7326/ACPJC-2015-163-8-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502139				2022-12-28	WOS:000363737400003
J	Warner, DO; Flick, RP				Warner, David O.; Flick, Randall P.			Anaesthetics, infants, and neurodevelopment: case closed?	LANCET			English	Editorial Material							NEUROTOXICITY; BRAIN; EXPOSURE; SURGERY		[Warner, David O.; Flick, Randall P.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Flick, Randall P.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Warner, DO (corresponding author), Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.	warner.david@mayo.edu						Backeljauw B, 2015, PEDIATRICS, V136, pE1, DOI 10.1542/peds.2014-3526; Davidson AJ, 2015, LANCET; Flick RP, 2012, ANESTHESIOLOGY, V117, P459, DOI 10.1097/ALN.0b013e31826446a5; Hansen TG, 2015, PEDIATR ANESTH, V25, P65, DOI 10.1111/pan.12548; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Ing CH, 2014, ANESTHESIOLOGY, V120, P1319, DOI 10.1097/ALN.0000000000000248; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Lee BH, 2014, INT J DEV NEUROSCI, V37, P87, DOI 10.1016/j.ijdevneu.2014.06.016; Lei SY, 2014, J NEUROSURG ANESTH, V26, P349, DOI 10.1097/ANA.0000000000000117; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Rappaport BA, 2015, NEW ENGL J MED, V372, P796, DOI 10.1056/NEJMp1414786; Sanders RD, 2013, BRIT J ANAESTH, V110, P53, DOI 10.1093/bja/aet054; Stratmann G, 2014, NEUROPSYCHOPHARMACOL, V39, P2275, DOI 10.1038/npp.2014.134; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]	14	13	13	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					202	204		10.1016/S0140-6736(15)00669-8	http://dx.doi.org/10.1016/S0140-6736(15)00669-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26507181				2022-12-28	WOS:000368130700005
J	Rangaka, MX; Cavalcante, SC; Marais, BJ; Thim, S; Martinson, NA; Swaminathan, S; Chaisson, RE				Rangaka, Molebogeng X.; Cavalcante, Solange C.; Marais, Ben J.; Thim, Sok; Martinson, Neil A.; Swaminathan, Soumya; Chaisson, Richard E.			Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection	LANCET			English	Article							ISONIAZID PREVENTIVE THERAPY; RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; DOUBLE-BLIND; HIV; ADULTS; CONTACTS; CHILDREN; TRIAL; RIFAPENTINE	The billions of people with latent tuberculosis infection serve as the seedbeds for future cases of active tuberculosis. Virtually all episodes of tuberculosis disease are preceded by a period of asymptomatic Mycobacterium tuberculosis infection; therefore, identifying infected individuals most likely to progress to disease and treating such subclinical infections to prevent future disease provides a crucial opportunity to interrupt tuberculosis transmission and reduce the global burden of tuberculosis disease. Programmes focusing on single strategies rather than comprehensive programmes that deliver an integrated arsenal for tuberculosis control might continue to struggle. Tuberculosis preventive therapy is a poorly used method that is essential for controlling the reservoirs of disease that drive the epidemic. Comprehensive control strategies that combine preventive therapy for the most high-risk populations and communities with improved case-finding and treatment, control of transmission, and health systems strengthening could ultimately lead to worldwide tuberculosis elimination. In this Series paper we outline challenges to implementation of preventive therapy and provide pragmatic suggestions for overcoming them. We further advocate for tuberculosis preventive therapy as the core of a renewed worldwide focus to implement a comprehensive epidemic control strategy that would reduce new tuberculosis cases to elimination targets. This strategy would be underpinned by accelerated research to further understand the biology of subclinical tuberculosis infections, develop novel diagnostics and drug regimens specifically for subclinical tuberculosis infection, strengthen health systems and community engagement, and enhance sustainable large scale implementation of preventive therapy programmes.	[Rangaka, Molebogeng X.] UCL, Inst Epidemiol & Hlth, London, England; [Rangaka, Molebogeng X.] Univ Cape Town, Dept Med, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Cavalcante, Solange C.] Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil; [Marais, Ben J.] Univ Sydney, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Marais, Ben J.] Univ Sydney, Ctr Res Excellence TB, Sydney, NSW 2006, Australia; [Thim, Sok] Cambodian Hlth Comm, Phnom Penh, Cambodia; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto, South Africa; [Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21287 USA	University of London; University College London; University of Cape Town; University of Sydney; University of Sydney; University of Witwatersrand; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Johns Hopkins University	Chaisson, RE (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21287 USA.	rchaiss@jhmi.edu	Marais, Ben/AAX-2626-2021	RANGAKA, Molebogeng/0000-0001-9594-188X	University College London Excellence Fellowship; National Institute for Health Research University College London Hospitals Biomedical Research Centre; US National Institutes of Health [R01 HD064354-03, R01 DA030276-01A1, P30-AI-094189]; US Centers for Disease Control and Prevention [2000-2009-32589]; Medical Research Council Soweto Matlosana Center for HIV/AIDS and TB Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030276] Funding Source: NIH RePORTER	University College London Excellence Fellowship; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Medical Research Council Soweto Matlosana Center for HIV/AIDS and TB Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Ed Nardell for his review and the important comments he contributed during drafting, and Carly Rodriguez for coordination and research assistance in the preparation of this manuscript. MXR was supported by a University College London Excellence Fellowship and reports grants from the National Institute for Health Research University College London Hospitals Biomedical Research Centre. NAM reports grants from the US National Institutes of Health (R01 HD064354-03 and R01 DA030276-01A1) and the Medical Research Council Soweto Matlosana Center for HIV/AIDS and TB Research, and NAM and REC report grants from the US Centers for Disease Control and Prevention (2000-2009-32589). REC reports grants from the US National Institutes of Health (P30-AI-094189).	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bristow CC, 2012, INT J TUBERC LUNG D, V16, P1020, DOI 10.5588/ijtld.11.0744; Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203; Cegielski JP, 2013, REV PANAM SALUD PUBL, V34, P284, DOI 10.2105/AJPH.2012.300781; Chavan S, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/130976; Chee CBE, 2004, INT J TUBERC LUNG D, V8, P226; Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI [10.1056/NEJMoa1214289, 10.1056/NEJMc1402073]; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; COMSTOCK GW, 1986, JAMA-J AM MED ASSOC, V256, P2729, DOI 10.1001/jama.256.19.2729; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367; Dowdy DW, 2014, JAIDS-J ACQ IMM DEF, V66, P552, DOI 10.1097/QAI.0000000000000219; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; EGSMOSE T, 1965, B WORLD HEALTH ORGAN, V33, P419; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2015, CLIN INFECT DIS, V60, P639, DOI 10.1093/cid/ciu849; HENDERSON DA, 1987, B WORLD HEALTH ORGAN, V65, P535; Hill RC, 2014, INT J TUBERC LUNG D, V18, P899, DOI 10.5588/ijtld.14.0007; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; KAPLAN GJ, 1972, AM REV RESPIR DIS, V105, P920; Keshavjee S, HUFFINGTON POST; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Kruk A, 2008, PEDIATRICS, V121, pE1646, DOI 10.1542/peds.2007-3138; LINCOLN EM, 1954, AM REV TUBERC PULM, V69, P682; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Mandalakas AM, 2012, INT J TUBERC LUNG D, V16, P1033, DOI 10.5588/ijtld.12.0027; Martinson NA, 2014, INT J TUBERC LUNG D, V18, P1005, DOI 10.5588/ijtld.13.0855; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Mills HL, 2011, J R SOC INTERFACE, V8, P1510, DOI 10.1098/rsif.2011.0160; Ortblad KF, 2015, LANCET, V386, P2354, DOI 10.1016/S0140-6736(15)00324-4; Podany AT, 2015, CLIN INFECT DIS, DOI [10.1093/cid/civ464, DOI 10.1093/CID/CIV464]; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Raviglione Mario, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P6, DOI 10.5588/ijtld.11.0158; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Stop TB, 2011, GUID INT TUB CAS FIN; Theron G, 2015, LANCET; Triasih R, 2015, CLIN INFECT DIS, V60, P12, DOI 10.1093/cid/ciu748; TSEVAT J, 1988, AM REV RESPIR DIS, V137, P215, DOI 10.1164/ajrccm/137.1.215; van Soelen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080803; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, GLOB STRAT TARG TUB; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0; Zhang TY, 2009, AM J RESP CRIT CARE, V180, P1151, DOI 10.1164/rccm.200905-0795OC	62	120	123	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					1	10		10.1016/S0140-6736(15)00323-2	http://dx.doi.org/10.1016/S0140-6736(15)00323-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26515679	Green Accepted, Green Published			2022-12-28	WOS:000365993200034
J	Hong, SJ; Kim, BK; Shin, DH; Nam, CM; Kim, JS; Ko, YG; Choi, D; Kang, TS; Kang, WC; Her, AY; Kim, Y; Hur, SH; Hong, BK; Kwon, H; Jang, Y; Hong, MK				Hong, Sung-Jin; Kim, Byeong-Keuk; Shin, Dong-Ho; Nam, Chung-Mo; Kim, Jung-Sun; Ko, Young-Guk; Choi, Donghoon; Kang, Tae-Soo; Kang, Woong-Chol; Her, Ae-Young; Kim, Yonghoon; Hur, Seung-Ho; Hong, Bum-Kee; Kwon, Hyuckmoon; Jang, Yangsoo; Hong, Myeong-Ki		IVUS-XPL Investigators	Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation The IVUS-XPL Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPERT CONSENSUS DOCUMENT; MYOCARDIAL-INFARCTION; CORONARY LESIONS; OUTCOMES; THROMBOSIS; GUIDANCE; RESTENOSIS; IMPACT; PREDICTORS; UNDEREXPANSION	IMPORTANCE Use of intravascular ultrasound (IVUS) promotes better clinical outcomes for coronary intervention in complex coronary lesions. However, randomized data demonstrating the clinical usefulness of IVUS are limited for lesions treated with drug-eluting stents. OBJECTIVE To determine whether the long-term clinical outcomes with IVUS-guided drug-eluting stent implantation are superior to those with angiography-guided implantation in patients with long coronary lesions. DESIGN, SETTING, AND PARTICIPANTS The Impact of Intravascular Ultrasound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL) randomized, multicenter trial was conducted in 1400 patients with long coronary lesions (implanted stent >= 28mm in length) between October 2010 and July 2014 at 20 centers in Korea. INTERVENTIONS Patients were randomly assigned to receive IVUS-guided (n = 700) or angiography-guided (n = 700) everolimus-eluting stent implantation. MAIN OUTCOMES AND MEASURES Primary outcome measure was the composite of major adverse cardiac events, including cardiac death, target lesion-related myocardial infarction, or ischemia-driven target lesion revascularization at 1 year, analyzed by intention-to-treat. RESULTS One-year follow-up was complete in 1323 patients (94.5%). Major adverse cardiac events at 1 year occurred in 19 patients (2.9%) undergoing IVUS-guided and in 39 patients (5.8%) undergoing angiography-guided stent implantation (absolute difference, -2.97% [95% CI, -5.14% to -0.79%]) (hazard ratio [HR], 0.48 [95% CI, 0.28 to 0.83], P =.007). The difference was driven by a lower risk of ischemia-driven target lesion revascularization in patients undergoing IVUS-guided (17 [2.5%]) compared with angiography-guided (33 [5.0%]) stent implantation (HR, 0.51 [95% CI, 0.28 to 0.91], P = .02). Cardiac death and target lesion-related myocardial infarction were not significantly different between the 2 groups. For cardiac death, there were 3 patients (0.4%) in the IVUS-guided group and 5 patients (0.7%) in the angiography-guided group (HR, 0.60 [95% CI, 0.14 to 2.52], P = .48). Target lesion-related myocardial infarction occurred in 1 patient (0.1%) in the angiography-guided stent implantation group (P = .32). CONCLUSIONS AND RELEVANCE Among patients requiring long coronary stent implantation, the use of IVUS-guided everolimus-eluting stent implantation, compared with angiography-guided stent implantation, resulted in a significantly lower rate of the composite of major adverse cardiac events at 1 year. These differences were primarily due to lower risk of target lesion revascularization.	[Hong, Sung-Jin] Inje Univ, Sanggye Paik Hosp, Dept Internal Med, Seoul, South Korea; [Hong, Sung-Jin; Kim, Byeong-Keuk; Shin, Dong-Ho; Kim, Jung-Sun; Ko, Young-Guk; Choi, Donghoon; Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea; [Nam, Chung-Mo] Yonsei Univ, Coll Med, Dept Prevent Med & Biostat, Seoul 120752, South Korea; [Kang, Tae-Soo] Dankook Univ, Coll Med, Cheonan, South Korea; [Kang, Woong-Chol] Gachon Univ, Coll Med, Gil Hosp, Inchon, South Korea; [Her, Ae-Young; Kim, Yonghoon] Kangwon Natl Univ, Sch Med, Chunchon, South Korea; [Hur, Seung-Ho] Keimyung Univ, Coll Med, Taegu, South Korea; [Hong, Bum-Kee; Kwon, Hyuckmoon] Kangnam Severance Hosp, Seoul, South Korea; [Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea; [Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul 120752, South Korea	Inje University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Dankook University; Gachon University; Kangwon National University; Keimyung University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Hong, MK (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 134 Sinchon Dong, Seoul 120752, South Korea.	michong61@yuhs.ac	Shim, Chi Young/AAK-1057-2021; Hong, Sung-Jin/GPC-6716-2022	Shim, Chi Young/0000-0002-6136-0136; Hong, Sung-Jin/0000-0003-4893-039X; Jang, Yangsoo/0000-0002-2169-3112; Hong, Myeong-Ki/0000-0002-2090-2031; Kim, Byeong-Keuk/0000-0003-2493-066X; Ko, Young-Guk/0000-0001-7748-5788; Shin, Dong-Ho/0000-0002-7874-5542; Choi, Donghoon/0000-0002-2009-9760; Choi, Jaewoong/0000-0002-2456-923X; Kim, Jung-Sun/0000-0003-2263-3274; Nam, Chung Mo/0000-0003-0985-0928; Kwon, Hyuck Moon/0000-0001-9901-5015; Hong, Bum Kee/0000-0002-6456-0184	Cardiovascular Research Center (Seoul, Korea); Abbott Vascular Inc.	Cardiovascular Research Center (Seoul, Korea); Abbott Vascular Inc.(Abbott Laboratories)	This study was supported by the Cardiovascular Research Center (Seoul, Korea) and funded by Abbott Vascular Inc.	Ahn JM, 2014, AM J CARDIOL, V113, P1338, DOI 10.1016/j.amjcard.2013.12.043; Chieffo A, 2013, AM HEART J, V165, P65, DOI 10.1016/j.ahj.2012.09.017; Cho S, 2015, CONTEMP CLIN TRIALS, V40, P90, DOI 10.1016/j.cct.2014.11.012; Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P1209, DOI 10.1016/j.jcin.2011.07.016; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066; Fujii K, 2004, CIRCULATION, V109, P1085, DOI 10.1161/01.CIR.0000121327.67756.19; Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; Jakabcin J, 2010, CATHETER CARDIO INTE, V75, P578, DOI 10.1002/ccd.22244; Jang JS, 2014, JACC-CARDIOVASC INTE, V7, pE27, DOI 10.1016/j.jcin.2013.09.013; Kastrati A, 2006, CIRCULATION, V113, P2293, DOI 10.1161/CIRCULATIONAHA.105.601823; Kim JS, 2015, CAN J CARDIOL, V31, P723, DOI 10.1016/j.cjca.2015.01.002; Kim JS, 2013, JACC-CARDIOVASC INTE, V6, P369, DOI 10.1016/j.jcin.2012.11.009; Kim JS, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.002; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Klersy C, 2013, INT J CARDIOL, V170, P54, DOI 10.1016/j.ijcard.2013.10.002; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Naidu SS, 2012, JACC-CARDIOVASC INTE, V5, P626, DOI 10.1016/j.jcin.2012.02.014; Oemrawsingh PV, 2003, CIRCULATION, V107, P62, DOI 10.1161/01.CIR.0000043240.87526.3F; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park DW, 2011, JACC-CARDIOVASC INTE, V4, P1096, DOI 10.1016/j.jcin.2011.05.024; Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Tian NL, 2015, EUROINTERVENTION, V10, P1409, DOI 10.4244/EIJV10I12A245; Turco MA, 2008, JACC-CARDIOVASC INTE, V1, P699, DOI 10.1016/j.jcin.2008.09.007; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942; Zhang YJ, 2012, EUROINTERVENTION, V8, P855, DOI 10.4244/EIJV8I7A129	34	285	290	3	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2155	2163		10.1001/jama.2015.15454	http://dx.doi.org/10.1001/jama.2015.15454			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26556051	Bronze			2022-12-28	WOS:000365351900019
J	Bronner, ME				Bronner, Marianne E.			On the crest of becoming vertebrate	NATURE			English	Editorial Material							NEURAL CREST; CHORDATE; ORIGIN		[Bronner, Marianne E.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Bronner, ME (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	mbronner@caltech.edu		Bronner, Marianne/0000-0003-4274-1862				Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Green SA, 2015, NATURE, V520, P474, DOI 10.1038/nature14436; Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3; Sansom RS, 2010, NATURE, V463, P797, DOI 10.1038/nature08745; Stolfi A, 2015, NATURE, V527, P371, DOI 10.1038/nature15758; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108	8	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					311	312		10.1038/nature15645	http://dx.doi.org/10.1038/nature15645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26524522				2022-12-28	WOS:000365356800040
J	Dale, J; Dey, CJ; Delhey, K; Kempenaers, B; Valcu, M				Dale, James; Dey, Cody J.; Delhey, Kaspar; Kempenaers, Bart; Valcu, Mihai			The effects of life history and sexual selection on male and female plumage colouration	NATURE			English	Article							SPERM COMPETITION; SOCIAL SELECTION; R PACKAGE; EVOLUTION; BIRDS; DICHROMATISM; MODELS; SIZE; REGRESSION; INFORMATION	Classical sexual selection theory(1-4) provides a well-supported conceptual framework for understanding the evolution and signalling function of male ornaments. It predicts that males obtain greater fitness benefits than females through multiple mating because sperm are cheaper to produce than eggs. Sexual selection should therefore lead to the evolution of male-biased secondary sexual characters. However, females of many species are also highly ornamented(5-7). The view that this is due to a correlated genetic response to selection on males(1,8) was widely accepted as an explanation for female ornamentation for over 100 years(5) and current theoretical(9,10) and empirical(11-13) evidence suggests that genetic constraints can limit sex-specific trait evolution. Alternatively, female ornamentation can be the outcome of direct selection for signalling needs(7,14). Since few studies have explored interspecific patterns of both male and female elaboration, our understanding of the evolution of animal ornamentation remains incomplete, especially over broad taxonomic scales. Here we use a new method to quantify plumage colour of all similar to 6,000 species of passerine birds to determine the main evolutionary drivers of ornamental colouration in both sexes. We found that conspecific male and female colour elaboration are strongly correlated, suggesting that evolutionary changes in one sex are constrained by changes in the other sex. Both sexes are more ornamented in larger species and in species living in tropical environments. Ornamentation in females (but not males) is increased in cooperative breeders-species in which female-female competition for reproductive opportunities and other resources related to breeding may be high(6). Finally, strong sexual selection on males has antagonistic effects, causing an increase in male colouration but a considerably more pronounced reduction in female ornamentation. Our results indicate that although there may be genetic constraints to sexually independent colour evolution, both female and male ornamentation are strongly and often differentially related to morphological, social and life-history variables.	[Dale, James] Massey Univ, Inst Nat & Math Sci, Auckland 0745, New Zealand; [Dey, Cody J.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Delhey, Kaspar] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Delhey, Kaspar] Max Planck Inst Ornithol, D-78315 Radolfzell am Bodensee, Germany; [Kempenaers, Bart; Valcu, Mihai] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany	Massey University; McMaster University; Monash University; Max Planck Society; Max Planck Society	Dale, J (corresponding author), Massey Univ, Inst Nat & Math Sci, Auckland 0745, New Zealand.	j.dale@massey.ac.nz	Valcu, Mihai/AAX-8842-2021; Delhey, Kaspar/AAZ-5362-2020	Valcu, Mihai/0000-0002-6907-7802; Delhey, Kaspar/0000-0001-5190-5406; Kempenaers, Bart/0000-0002-7505-5458; Dey, Cody/0000-0003-4947-8972	Massey University; Australian and Pacific Science Foundation [APSF 10/8]; Natural Sciences and Engineering Research Council of Canada (NSERC) Canadian Graduate Scholarship; Australian Research Council [DE120102323]; Max Planck Society	Massey University; Australian and Pacific Science Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC) Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank the many ornithologists and scientists who have published their data or contributed data to public databases, allowing us to conduct this study. Thanks to J. D. Aguirre, P. M. Buston, J. Clavel, P. B. Rainey, L. Redfern and J. A. Tobias for comments on manuscript drafts and to the staff of Museum Victoria and the Australian National Wildlife Collection for access to museum specimens. This work was supported by Massey University and a grant from the Australian and Pacific Science Foundation (APSF 10/8) to J. D. C.J.D. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Canadian Graduate Scholarship. K.D. was supported by the Australian Research Council (DE120102323). B.K. and M.V. were generously supported by the Max Planck Society.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Andersson Malte, 1994; [Anonymous], 1993, HDB AUSTR NZ ANTARCT; [Anonymous], 2002, CAUSE CORRELATION BI; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Badyaev AV, 2000, BIOL J LINN SOC, V69, P153, DOI 10.1111/j.1095-8312.2000.tb01196.x; Badyaev AV, 2003, ANNU REV ECOL EVOL S, V34, P27, DOI 10.1146/annurev.ecolsys.34.011802.132441; BAILEY SF, 1978, CONDOR, V80, P372, DOI 10.2307/1367187; Bartoszek K, 2012, J THEOR BIOL, V314, P204, DOI 10.1016/j.jtbi.2012.08.005; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Brown L.H., 1982, BIRDS AFRICA, V1; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Burns KJ, 1998, EVOLUTION, V52, P1219, DOI 10.1111/j.1558-5646.1998.tb01849.x; Calder WAI., 1996, SIZE FUNCTION LIFE H; Cardoso GC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-82; Clavel J, 2015, METHODS ECOL EVOL, V6, P1311, DOI 10.1111/2041-210X.12420; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Craig A., 2010, HDB BIRDS WORLD, V15; Cramp S., 1977, HDB BIRDS EUROPE MID; Cuthill Innes C., 2006, P3; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; Darwin C., 1871, P475; del Hoyo J., 2003, HDB BIRDS WORLD, V8; Dey CJ, 2015, J EVOLUTION BIOL, V28, P250, DOI 10.1111/jeb.12560; Dunn PO, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400155; Dunn PO, 2001, EVOLUTION, V55, P161; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FITZPATRICK S, 1994, P ROY SOC B-BIOL SCI, V257, P155, DOI 10.1098/rspb.1994.0109; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Galvan I, 2013, ACTA ORNITHOL, V48, P65, DOI 10.3161/000164513X670007; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Gonzalez-Voyer A., 2014, MODERN PHYLOGENETIC, P201, DOI [10.1007/978-3-662-43550-2_8, DOI 10.1007/978-3-662-43550-2_8]; Gray DA, 1996, AM NAT, V148, P453, DOI 10.1086/285935; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hansen T.F., 2014, MODERN PHYLOGENETIC, P351, DOI DOI 10.1007/978-3-662-43550-2_14; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; Hofmann CM, 2008, AUK, V125, P778, DOI 10.1525/auk.2008.07112; IRWIN RE, 1994, AM NAT, V144, P890, DOI 10.1086/285717; West-Eberhard MJ, 2014, NEUROSCI BIOBEHAV R, V46, P501, DOI 10.1016/j.neubiorev.2014.06.015; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johnson AE, 2013, ECOL EVOL, V3, P3030, DOI 10.1002/ece3.686; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; Kraaijeveld K, 2014, ANNU REV ECOL EVOL S, V45, P159, DOI 10.1146/annurev-ecolsys-120213-091550; Land Processes Distributed Active Archive Center (LP DAAC), 2014, MODIS TERR LAND SURF; LANDE R, 1987, SEXUAL SELECTION TES, P83; LYON BE, 1994, NATURE, V371, P240, DOI 10.1038/371240a0; Lyon BE, 2012, PHILOS T R SOC B, V367, P2266, DOI 10.1098/rstb.2012.0012; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Olson VA, 2005, J EVOLUTION BIOL, V18, P1534, DOI 10.1111/j.1420-9101.2005.00940.x; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; POOLE A, 1992, BIRDS N AM; Potti J, 2011, HEREDITY, V106, P945, DOI 10.1038/hdy.2010.142; Price JJ, 2014, EVOLUTION, V68, P2026, DOI 10.1111/evo.12417; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Ricklefs RE, 2010, AGING CELL, V9, P273, DOI 10.1111/j.1474-9726.2009.00542.x; Rubenstein DR, 2012, PHILOS T R SOC B, V367, P2248, DOI 10.1098/rstb.2011.0278; Rubenstein DR, 2009, NATURE, V462, P786, DOI 10.1038/nature08614; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; Simpson RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0375; Starck JM, 1996, ETHOLOGY, V102, P436; Stutchbury B.J.M., 2001, BEHAV ECOLOGY TROPIC; Tobias JA, 2011, J EVOLUTION BIOL, V24, P2118, DOI 10.1111/j.1420-9101.2011.02345.x; Tobias JA, 2012, PHILOS T R SOC B, V367, P2274, DOI 10.1098/rstb.2011.0280; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; VALCU M, 2014, COLORZAPPER COLOR EX; Valcu M, 2012, GLOBAL ECOL BIOGEOGR, V21, P945, DOI 10.1111/j.1466-8238.2011.00739.x; von Hardenberg A, 2013, EVOLUTION, V67, P378, DOI 10.1111/j.1558-5646.2012.01790.x; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	85	213	217	10	350	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					367	+		10.1038/nature15509	http://dx.doi.org/10.1038/nature15509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26536112				2022-12-28	WOS:000365356800054
J	Patel, A; Rajkumar, R; Colmers, JM; Kinzer, D; Conway, PH; Sharfstein, JM				Patel, Ankit; Rajkumar, Rahul; Colmers, John M.; Kinzer, Donna; Conway, Patrick H.; Sharfstein, Joshua M.			Maryland's Global Hospital Budgets - Preliminary Results from an All-Payer Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REFORM		[Patel, Ankit] Ctr Medicare & Medicaid Serv, Washington, DC 20201 USA; [Rajkumar, Rahul; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA; [Colmers, John M.] Johns Hopkins Med, Dept Hlth Care Transformat & Strateg Planning, Baltimore, MD USA; [Kinzer, Donna] Hlth Serv Cost Review Commiss, Baltimore, MD USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Patel, A (corresponding author), Ctr Medicare & Medicaid Serv, Washington, DC 20201 USA.							Blumenthal D, 2013, NEW ENGL J MED, V369, P2551, DOI 10.1056/NEJMhpr1310415; Murray R, 2009, HEALTH AFFAIR, V28, P1395, DOI 10.1377/hlthaff.28.5.1395; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Rajkumar R, 2014, NEW ENGL J MED, V370, P493, DOI 10.1056/NEJMp1314868	4	38	38	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1899	1901		10.1056/NEJMp1508037	http://dx.doi.org/10.1056/NEJMp1508037			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV7IL	26559570				2022-12-28	WOS:000364445500003
J	Spaulding, C				Spaulding, Catherine			What Now?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ Hosp, Dept Internal Med & Pediat, Washington, DC 20007 USA	Georgetown University	Spaulding, C (corresponding author), Georgetown Univ Hosp, Dept Internal Med & Pediat, Washington, DC 20007 USA.	catherine.d.spaulding@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1919	1920		10.1001/jama.2015.10138	http://dx.doi.org/10.1001/jama.2015.10138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547461				2022-12-28	WOS:000364490700012
J	Lin, ZC; Eaves, DJ; Sanchez-Moran, E; Franklin, FCH; Franklin-Tong, VE				Lin, Zongcheng; Eaves, Deborah J.; Sanchez-Moran, Eugenio; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.			The Papaver rhoeas S determinants confer self-incompatibility to Arabidopsis thaliana in planta	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; POLLEN; BRASSICA; LOCUS; GENE; EXPRESSION; CLONING	Self-incompatibility (SI) is a major genetically controlled system used to prevent inbreeding in higher plants. S determinants regulate allele-specific rejection of "self" pollen by the pistil. SI is an important model system for cell-to-cell recognition and signaling and could be potentially useful for first-generation (F-1) hybrid breeding. To date, the transfer of S determinants has used the complementation of orthologs to "restore" SI in close relatives. We expressed the Papaver rhoeas S determinants PrsS and PrpS in Arabidopsis thaliana. This enabled pistils to reject pollen expressing cognate PrpS. Moreover, plants coexpressing cognate PrpS and PrsS exhibit robust SI. This demonstrates that PrsS and PrpS are sufficient for a functional synthetic S locus in vivo. This transfer of novel S determinants into a highly divergent species (>140 million years apart) with no orthologs suggests their potential utility in crop production.	[Lin, Zongcheng; Eaves, Deborah J.; Sanchez-Moran, Eugenio; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Franklin-Tong, VE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	v.e.franklin-tong@bham.ac.uk	; Sanchez Moran, Eugenio/H-6356-2015	Franklin-Tong, Noni/0000-0003-1782-8413; Sanchez Moran, Eugenio/0000-0002-7417-0024; Ricci, Deborah/0000-0002-6122-3377	China Scholarship Council (CSC); Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/C501325/1] Funding Source: researchfish	China Scholarship Council (CSC)(China Scholarship Council); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Goring for the Binary Ti vector pORE O3 containing the SLR1 promoter and S. Price for technical assistance. Z.L. held a Ph.D. studentship from the China Scholarship Council (CSC). D.J.E. was funded by the Biotechnology and Biological Sciences Research Council (BBSRC). V.E.F-T. and F.C.H.F. are co-inventors on a patent application (2691/KOLNP/2011) filed by the University of Birmingham relating to PrsS and PrpS, to engineer plants (ornamental or crop) to exhibit SI by using a PrsS and PrpS S-allele pair, comprising a functional S locus with appropriate tissue-specific promoters. Materials will be freely available upon request for research purposes. The authors declare that they do not have other competing financial interests. The data reported here are available in the supplementary materials.	Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Boggs NA, 2009, GENETICS, V182, P1313, DOI 10.1534/genetics.109.102442; Boggs NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000426; Bosch M, 2007, P NATL ACAD SCI USA, V104, P18327, DOI 10.1073/pnas.0705826104; de Graaf BHJ, 2012, CURR BIOL, V22, P154, DOI 10.1016/j.cub.2011.12.006; Dresselhaus T, 2013, MOL PLANT, V6, P1018, DOI 10.1093/mp/sst061; FOOTE HCC, 1994, P NATL ACAD SCI USA, V91, P2265, DOI 10.1073/pnas.91.6.2265; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Goring DR, 2014, PLANT CELL, V26, P3842, DOI 10.1105/tpc.114.131243; HACKETT RM, 1992, PLANT J, V2, P613, DOI 10.1111/j.1365-313X.1992.00613.x; LALONDE BA, 1989, PLANT CELL, V1, P249, DOI 10.1105/tpc.1.2.249; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Tantikanjana T, 2010, CURR OPIN PLANT BIOL, V13, P520, DOI 10.1016/j.pbi.2010.06.004; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Van Hautegem T, 2015, TRENDS PLANT SCI, V20, P102, DOI 10.1016/j.tplants.2014.10.003; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Wilkins KA, 2015, PLANT PHYSIOL, V167, P766, DOI 10.1104/pp.114.252742; Wilkins KA, 2014, J EXP BOT, V65, P1331, DOI 10.1093/jxb/ert468; Yamamoto M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.54	23	30	33	8	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					684	687		10.1126/science.aad2983	http://dx.doi.org/10.1126/science.aad2983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542572	Green Published			2022-12-28	WOS:000364162800052
J	Mitchell, SF; Parker, R				Mitchell, Sarah F.; Parker, Roy			Modifications on Translation Initiation	CELL			English	Editorial Material							RNA	Two studies by Meyer et al. and Wang et al. demonstrate a role for m(6)A modification of mRNA in stimulating translation initiation. These findings add to the growing number of diverse mechanisms for translation initiation in eukaryotes.	[Mitchell, Sarah F.; Parker, Roy] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Parker, R (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	roy.parker@colorado.edu						Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Deforges J, 2015, BIOCHIMIE, V114, P48, DOI 10.1016/j.biochi.2014.12.008; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	9	15	15	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					796	798		10.1016/j.cell.2015.10.056	http://dx.doi.org/10.1016/j.cell.2015.10.056			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544933	Bronze			2022-12-28	WOS:000364829700007
J	Kiragu, D; Cifu, AS				Kiragu, David; Cifu, Adam S.			Evaluation of Patients With Asymptomatic Microhematuria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEMATURIA; ADULTS	GUIDELINE TITLE Evaluation of Patients With Asymptomatic Microhematuria DEVELOPER American Urological Association (AUA) RELEASE DATE October 23, 2012 PRIOR VERSION May 15, 2001 FUNDING SOURCE AUA TARGET POPULATION Adults with asymptomatic microhematuria MAJOR RECOMMENDATIONS 1. Definition: Asymptomatic microhematuria (AMH) is defined as 3 or more red blood cells per high-powered field in a properly collected urine specimen. A positive dipstick reading alone is not considered AMH (expert opinion). 2. Evaluation: After benign causes (eg, infection, menstruation, vigorous exercise) are excluded, evaluation should include assessment of renal function (clinical principle), complete urinalysis (grade C recommendation), and evaluation of the entire urinary tract. Lower urinary tract: cystoscopy should be performed in patients aged 35 years or older (grade C) and in all patients with risk factors for urinary tract malignancies (clinical principle). Risk factors include irritative voiding symptoms (urinary urgency, urge incontinence frequency, and nocturia) and current or past tobacco use, history of bladder irradiation, and chemical exposures (dyes, benzenes, aromatic amines, and alkylating chemotherapy agents). Upper urinary tract: computed tomography (CT) with and without intravenous (IV) contrast (CT urography) is the imaging mode of choice (grade C). For patients with contraindications to CT urography, magnetic resonance imaging (MRI) urography without and with IV contrast is an acceptable alternative (grade C). For patients with contraindications to both CT and MRI, combining noncontrast CT or renal ultrasound with retrograde pyelograms is an alternative for evaluating the upper urinary tract (expert opinion). 3. Follow-up: In patients with persistent microhematuria despite a negative workup or who have other risk factors, urine cytologymay be useful (grade C). For persistent AMH after a negative urological workup, yearly urinalyses should be conducted (grade C); if negative for 2 consecutive years, no further urinalyses for AMH are necessary (expert opinion). For persistent or recurrent AMH after initial negative urologic workup, consider repeat evaluation within 3 to 5 years (expert opinion). 4. Special circumstances: At initial evaluation, findings suspicious for renal parenchymal disease (eg, dysmorphic red blood cells, red blood cell casts, proteinuria, cellular casts) warrant concurrent nephrologic evaluation but do not preclude the need for a urologic evaluation. Asymptomatic microhematuria warrants the same management regardless of anticoagulation status (grade C).	[Kiragu, David] Wilson Med Grp, Wilson, NC USA; [Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu			AUA	AUA	AUA	Avidor Y, 2000, UROLOGY, V55, P22, DOI 10.1016/S0090-4295(99)00388-X; Davis R, 2012, J UROLOGY, V188, P2473, DOI 10.1016/j.juro.2012.09.078; El-Galley R, 2008, J ENDOUROL, V22, P51, DOI 10.1089/end.2006.0331; Madeb R, 2010, UROLOGY, V75, P20, DOI 10.1016/j.urology.2009.06.107; MESSING EM, 1992, J UROLOGY, V148, P289, DOI 10.1016/S0022-5347(17)36575-8; MOHR DN, 1986, JAMA-J AM MED ASSOC, V256, P224, DOI 10.1001/jama.256.2.224; Moschini M, 2016, CLIN GENITOURIN CANC, V14, pE245, DOI 10.1016/j.clgc.2015.08.003; National Cancer Institute, BLADD OTH UR CANC SC; Wollin T, 2009, CUAJ-CAN UROL ASSOC, V3, P77	9	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1865	1866		10.1001/jama.2015.13711	http://dx.doi.org/10.1001/jama.2015.13711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529165				2022-12-28	WOS:000363960200020
J	Benefit, BR; McCrossin, ML				Benefit, Brenda R.; McCrossin, Monte L.			A window into ape evolution	SCIENCE			English	Editorial Material							OLD-WORLD MONKEYS; DIVERGENCE; MIOCENE		[Benefit, Brenda R.; McCrossin, Monte L.] New Mexico State Univ, Dept Anthropol, Las Cruces, NM 88003 USA	New Mexico State University	Benefit, BR (corresponding author), New Mexico State Univ, Dept Anthropol, Las Cruces, NM 88003 USA.	bbenefit@nmsu.edu						Alba DM, 2015, SCIENCE, V350, DOI 10.1126/science.aab2625; Gonzales LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8580; Larson SG, 1998, EVOL ANTHROPOL, V6, P87, DOI 10.1002/(SICI)1520-6505(1998)6:3<87::AID-EVAN3>3.0.CO;2-T; MCCROSSIN ML, 1992, INT J PRIMATOL, V13, P659, DOI 10.1007/BF02551258; McCrossin Monte L., 1997, P241; Pickford M., 2010, GEO PAL UGANDA, V3, P1; PILBEAM D, 1990, NATURE, V348, P237, DOI 10.1038/348237a0; Rose Michael D., 1997, P79; Rossie JB, 2006, J HUM EVOL, V50, P568, DOI 10.1016/j.jhevol.2005.12.007; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094; ZAPFE HELMUTH, 1960, SCHWEIZ PALAEONTOL ABHANDL, V78, P1	12	5	5	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					515	516		10.1126/science.aad0677	http://dx.doi.org/10.1126/science.aad0677			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516271				2022-12-28	WOS:000363660000031
J	Aguirre, EK; Mytton, OT; Monsivais, P				Aguirre, Emilie K.; Mytton, Oliver T.; Monsivais, Pablo			Liberalising agricultural policy for sugar in Europe risks damaging public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWEETENED BEVERAGES; FOOD; CONSUMPTION; PREVENTION; DISEASE		[Aguirre, Emilie K.; Mytton, Oliver T.; Monsivais, Pablo] Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Act Res, Cambridge CB2 0QQ, England	University of Cambridge	Monsivais, P (corresponding author), Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Act Res, Cambridge CB2 0QQ, England.	pm491@medschl.cam.ac.uk		Monsivais, Pablo/0000-0002-7088-6674	Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MC_UU_12015/6] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/6, MR/K023187/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2012, CONSOLIDATED VERSION; Birt C., 2007, IMPACT EU COMMON AGR; Bonnet C, 2011, HEALTH ECON, V20, P1012, DOI 10.1002/hec.1721; Bowman SA, 2006, NUTR RES, V26, P318, DOI 10.1016/j.nutres.2006.06.012; Burgess K., 2015, FINANCIAL TIMES; Capewell S., 2014, BMJ-BRIT MED J, V348, pg3248; Department for Environment Food and Rural Affairs, 2013, COMM AGR POL DEAL ST; Department of Transport, 2010, LOC SUST TRANSP FUND; Dorward A, 2012, BMJ-BRIT MED J, V344, pd7834; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; European Commission, 2015, COMM PRIC DASHB NO 3; European Commission, 2015, CROSS COMPL AGR RUR; European Commission, 2015, FRUIT VEG 2007 REF; European Commission-Agriculture and Rural Development, 2014, PROSP AGR MARK INC E; Hawkesworth S, 2010, PHILOS T R SOC B, V365, P3083, DOI 10.1098/rstb.2010.0122; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Jackson RJ, 2009, J HUNGER ENVIRON NUT, V4, P393, DOI 10.1080/19320240903321367; Jones NRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109343; Kahlmeier S, 2010, J PHYS ACT HEALTH, V7, pS120, DOI 10.1123/jpah.7.s1.s120; Moeller SM, 2009, J AM COLL NUTR, V28, P619, DOI 10.1080/07315724.2009.10719794; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Nugent R., 2011, BRINGING AGR TABLE A; Pechey R, 2013, SOC SCI MED, V92, P22, DOI 10.1016/j.socscimed.2013.05.012; Pekka P, 2002, PUBLIC HEALTH NUTR, V5, P245, DOI 10.1079/PHN2001300; Richardson B, 2009, INT POLIT ECON SER, P1, DOI 10.1057/9780230251007; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; SCHORIN MD, 2005, NUTR TODAY, V40, P248; Tedstone A, 2014, SUGAR REDUCTION RESP; Wallinga D, 2010, HEALTH AFFAIR, V29, P405, DOI 10.1377/hlthaff.2010.0102; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2015, CARB HLTH R IN PRESS; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	35	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2015	351								h5085	10.1136/bmj.h5085	http://dx.doi.org/10.1136/bmj.h5085			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GN	26508518	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000364147200001
J	Yona, AH; Frumkin, I; Pilpel, Y				Yona, Avihu H.; Frumkin, Idan; Pilpel, Yitzhak			A Relay Race on the Evolutionary Adaptation Spectrum	CELL			English	Review							COPY NUMBER VARIATION; MUTATION-RATES; GENE-EXPRESSION; TRANSFER-RNA; C. ELEGANS; EPIGENETIC INHERITANCE; ENVIRONMENTAL-CHANGES; TRANSGENERATIONAL INHERITANCE; MORPHOLOGICAL EVOLUTION; CELLULAR ADAPTATION	Adaptation is the process in which organisms improve their fitness by changing their phenotype using genetic or non-genetic mechanisms. The adaptation toolbox consists of varied molecular and genetic means that we posit span an almost continuous "adaptation spectrum." Different adaptations are characterized by the time needed for organisms to attain them and by their duration. We suggest that organisms often adapt by progressing the adaptation spectrum, starting with rapidly attained physiological and epigenetic adaptations and culminating with slower long-lasting genetic ones. A tantalizing possibility is that earlier adaptations facilitate realization of later ones.	[Yona, Avihu H.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yona, Avihu H.] MIT, Dept Phys, Phys Living Syst, Cambridge, MA 02139 USA; [Frumkin, Idan; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Weizmann Institute of Science	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il		Yona, Avihu H./0000-0002-3923-4897	European Research Council (ERC); Human Frontier Science Program; Azrieli Foundation	European Research Council (ERC)(European Research Council (ERC)); Human Frontier Science Program(Human Frontier Science Program); Azrieli Foundation	We thank the Minerva Foundation for the establishment of the Minerva Center for Live Emulation of Genome Evolution, as well as the European Research Council (ERC) for grant support. We thank the Human Frontier Science Program for supporting A.H.Y. and the Azrieli Foundation for the Azrieli Fellowship to I.F.Y.P. is the incumbent of the Ben May Professorial Chair at the Weizmann Institute of Science.	Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Bloom-Ackermann Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004084; Bonney ME, 2015, GENE DEV, V29, P898, DOI 10.1101/gad.261743.115; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brunke S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004356; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burger R, 2006, GENETICS, V172, P197, DOI 10.1534/genetics.105.046599; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Cooke SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4644; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; DeArmond SJ, 2003, CLIN LAB MED, V23, P1, DOI 10.1016/S0272-2712(02)00041-0; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ford CB, 2015, ELIFE, V4, DOI 10.7554/eLife.00662; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gentile CF, 2011, BIOL LETTERS, V7, P422, DOI 10.1098/rsbl.2010.1036; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gingold H, 2012, NUCLEIC ACIDS RES, V40, P10053, DOI 10.1093/nar/gks772; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gordon AJE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003595; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hendrickson H, 2002, P NATL ACAD SCI USA, V99, P2164, DOI 10.1073/pnas.032680899; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Herman JD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0511-2; Hornung G, 2012, MOL CELL, V46, P362, DOI 10.1016/j.molcel.2012.02.019; Howan K, 2012, NATURE, V490, P431, DOI 10.1038/nature11430; Huettel B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000226; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; ISHII K, 1989, GENETICS, V121, P163; Jarosz DF, 2014, CELL, V158, P1072, DOI 10.1016/j.cell.2014.07.024; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jinks-Robertson S, 2014, ANNU REV GENET, V48, P341, DOI 10.1146/annurev-genet-120213-092015; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Koonin EV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100152; Koonin EV, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-27; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Lindquist S, 1996, MOL PSYCHIATR, V1, P376; Loh E, 2010, P NATL ACAD SCI USA, V107, P1154, DOI 10.1073/pnas.0912451107; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Meyerovich M, 2010, P NATL ACAD SCI USA, V107, P11543, DOI 10.1073/pnas.0912989107; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Pavelka N, 2010, CURR OPIN CELL BIOL, V22, P809, DOI 10.1016/j.ceb.2010.06.003; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Ptashne M, 2008, CURR BIOL, V18, pR25, DOI 10.1016/j.cub.2007.11.017; Ragunathan K., 2014, SCIENCE, V80; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Riddihough G, 2010, SCIENCE, V330, P611, DOI 10.1126/science.330.6004.611; Rogers HH, 2014, RNA, V20, P269, DOI 10.1261/rna.041681.113; Rohner N, 2013, SCIENCE, V342, P1372, DOI 10.1126/science.1240276; Rosin D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002579; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sapetschnig A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005078; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Stern S, 2012, CELL REP, V1, P528, DOI 10.1016/j.celrep.2012.03.012; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Whitehead DJ, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-18; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; Yona AH, 2013, ELIFE, V2, DOI 10.7554/eLife.01339; Yona AH, 2012, P NATL ACAD SCI USA, V109, P21010, DOI 10.1073/pnas.1211150109; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zhong SB, 2004, P NATL ACAD SCI USA, V101, P11719, DOI 10.1073/pnas.0404397101; Zhu YO, 2014, P NATL ACAD SCI USA, V111, pE2310, DOI 10.1073/pnas.1323011111	111	41	42	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					549	559		10.1016/j.cell.2015.10.005	http://dx.doi.org/10.1016/j.cell.2015.10.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496602	Bronze			2022-12-28	WOS:000364828900010
J	LIU, ZC; AMBROS, V				LIU, ZC; AMBROS, V			ALTERNATIVE TEMPORAL CONTROL-SYSTEMS FOR HYPODERMAL CELL-DIFFERENTIATION IN CAENORHABDITIS-ELEGANS	NATURE			English	Article							DEVELOPMENTAL SWITCH; C-ELEGANS; NEMATODE; GENES; LINEAGES; EXPRESSION; MUTANTS	IN certain multicellular organisms, genetic regulatory systems that specify the timing of cell division, differentiation and morphogenesis 1-3 must accommodate environmental and physiological contingencies that perturb or arrest development. For example, Caenorhabditis elegans can either develop continuously through four larval stages (L1-14) or arrest indefinitely as a 'dauer larva' at the second larval (L2) moult, and later resume L3 and L4 development 4-7. At the larva-to-adult (L4) moult of both continuous and 'post-dauer' development, hypodermal cells switch (the 'L/A switch') from a proliferating state to the terminally differentiated state. Four temporal regulators, lin-4, lin-14, lin-28 and lin-29, have been identified in C. elegans by mutations that cause precocious or retarded expression of stage-specific post-embryonic development events, including the L/A switch (refs 3, 8, 9; Fig. 1a). These genes have been organized into a genetic pathway that controls the timing of the L/A switch during continuous development 10: lin-29 activates the switch and the other heterochronic genes regulate it indirectly by regulating lin-29. We have now examined how the proper timing of this event is specified in alternative developmental pathways. In continuously developing lin-4, lin-14 and lin-28 mutants the L/A switch occurs at abnormally early or late moults 3,8, but during post-dauer development of the same mutants the L/A switch occurs normally. Thus hypodermal cell differentiation is regulated by separate temporal control systems, depending on the developmental history.			LIU, ZC (corresponding author), HARVARD UNIV,DEPT CELLULAR & DEV BIOL,16 DIVIN AVE,CAMBRIDGE,MA 02138, USA.							ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; COX GN, 1980, GENETICS, V95, P317; COX GN, 1985, MOL CELL BIOL, V5, P363, DOI 10.1128/MCB.5.2.363; COX GN, 1989, GENE, V76, P331, DOI 10.1016/0378-1119(89)90173-X; EVANS AAF, 1976, ORG NEMATODES; FERGUSON EL, 1985, GENETICS, V110, P17; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; GOLDEN JM, 1987, SCIENCE, V218, P578; Gould S. J., 1977, ONTOGENY PHYLOGENY; KRAMER JM, 1990, J MOL CELL BIOL, V10; LIU Z, 1989, GENE DEV, V3, P2069; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; RIDDLE DL, 1988, NEMATODE CAENORHABDI; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0	20	47	48	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 14	1991	350	6314					162	165		10.1038/350162a0	http://dx.doi.org/10.1038/350162a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB645	26502479				2022-12-28	WOS:A1991FB64500062
J	Greenwood, B; Doumbo, OK				Greenwood, Brian; Doumbo, Ogobara K.			Implementation of the malaria candidate vaccine RTS,S/AS01	LANCET			English	Editorial Material									[Greenwood, Brian] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali	University of London; London School of Hygiene & Tropical Medicine; University of Bamako	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	brian.greenwood@lshtm.ac.uk						[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; European Medicines Agency, 2015, 1 MAL VACC REC POS S; Hamel MJ, 2014, 63 ANN M AM SOC TROP; Penny MA, 2015, LANCET; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976	8	19	20	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					318	319		10.1016/S0140-6736(15)00807-7	http://dx.doi.org/10.1016/S0140-6736(15)00807-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26549465	hybrid, Green Accepted			2022-12-28	WOS:000368516500009
J	Periyakoil, VS				Periyakoil, Vyjeyanthi S.			A Never-Ending Battle	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Periyakoil, Vyjeyanthi S.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Periyakoil, Vyjeyanthi S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Periyakoil, VS (corresponding author), Stanford Univ, Sch Med, Palo Alto, CA 94304 USA.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2399	2401		10.1056/NEJMp1505976	http://dx.doi.org/10.1056/NEJMp1505976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY5QD	26536398				2022-12-28	WOS:000366461400006
J	Furin, J; Akugizibwe, P; Ditiu, L; Gray, G; Palmero, D; Zaidi, S				Furin, Jennifer; Akugizibwe, Paula; Ditiu, Lucica; Gray, Glenda; Palmero, Domingo; Zaidi, Sarah			No one with HIV should die from tuberculosis	LANCET			English	Editorial Material							ISONIAZID PREVENTIVE THERAPY; RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; TREATMENT OUTCOMES; RANDOMIZED TRIAL; TB; INITIATION; INFECTION; SETTINGS; BRAZIL		[Furin, Jennifer; Akugizibwe, Paula; Ditiu, Lucica; Gray, Glenda; Palmero, Domingo; Zaidi, Sarah] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA; [Akugizibwe, Paula] Clinton Hlth Access Initiat, Boston, MA USA; [Ditiu, Lucica] WHO, Stop TB Partnership Secretariat, CH-1211 Geneva, Switzerland; [Gray, Glenda] South African Med Res Council, Johannesburg, South Africa; [Gray, Glenda] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Palmero, Domingo] Hosp Infecciosas Dr FJ Muniz, Buenos Aires, DF, Argentina	Case Western Reserve University; World Health Organization; South African Medical Research Council; University of Witwatersrand	Furin, J (corresponding author), Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA.	jjf38@case.edu			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203; Clinton Health Access Initiative, 2014, SURV BARR TB HIV INT; Cohen M, 2015, 8 INT AIDS SOC C HIV; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Graham NMH, 1996, ARCH INTERN MED, V156, P889, DOI 10.1001/archinte.156.8.889; Gupta S, 2014, INT J TUBERC LUNG D, V18, P1149, DOI 10.5588/ijtld.13.0889; Gupta S, 2014, INT J TUBERC LUNG D, V18, P1159, DOI 10.5588/ijtld.13.0571; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Ortblad KF, 2015, LANCET; Rangaka MX, 2015, LANCET; Ritchie AV, 2014, J CLIN MICROBIOL, V52, P3377, DOI 10.1128/JCM.00593-14; Stop TB Partnership, 2015, GLOB PLAN STOP TB 20; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Swindells S, 2013, INT J TUBERC LUNG D, V17, P532, DOI 10.5588/ijtld.12.0737; Theron G, 2015, LANCET; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; WHO, 2014, GLOB TUB REP 2014; WHO, 2008, WHO HIV AIDS TB DEP; Yuen CM, 2015, LANCET; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	31	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					E48	E50		10.1016/S0140-6736(15)00319-0	http://dx.doi.org/10.1016/S0140-6736(15)00319-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26515682				2022-12-28	WOS:000365993200002
J	Gheorghiade, M; Greene, SJ; Butler, J; Filippatos, G; Lam, CSP; Maggioni, AP; Ponikowski, P; Shah, SJ; Solomon, SD; Kraigher-Krainer, E; Samano, ET; Muller, K; Roessig, L; Pieske, B				Gheorghiade, Mihai; Greene, Stephen J.; Butler, Javed; Filippatos, Gerasimos; Lam, Carolyn S. P.; Maggioni, Aldo P.; Ponikowski, Piotr; Shah, Sanjiv J.; Solomon, Scott D.; Kraigher-Krainer, Elisabeth; Samano, Eliana T.; Mueller, Katharina; Roessig, Lothar; Pieske, Burkert		SOCRATES-REDUCED Investigators Coo	Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction The SOCRATES-REDUCED Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL PROFILE; BLOOD-PRESSURE; HOSPITALIZATION; DYSFUNCTION; READMISSIONS; MORTALITY; DAMAGE	IMPORTANCE Worsening chronic heart failure (HF) is a major public health problem. OBJECTIVE To determine the optimal dose and tolerability of vericiguat, a soluble guanylate cyclase stimulator, in patients with worsening chronic HF and reduced left ventricular ejection fraction (LVEF). DESIGN, SETTING, AND PARTICIPANTS Dose-finding phase 2 study that randomized 456 patients across Europe, North America, and Asia between November 2013 and January 2015, with follow-up ending June 2015. Patients were clinically stable with LVEF less than 45% within 4 weeks of a worsening chronic HF event, defined as worsening signs and symptoms of congestion and elevated natriuretic peptide level requiring hospitalization or outpatient intravenous diuretic. INTERVENTIONS Placebo (n = 92) or 1 of 4 daily target doses of oral vericiguat (1.25 mg [n = 91], 2.5mg [n = 91], 5mg [n = 91], 10mg [n = 91]) for 12 weeks. MAIN OUTCOMES AND MEASURES The primary end point was change from baseline to week 12 in log-transformed level of N-terminal pro-B-type natriuretic peptide (NT-proBNP). The primary analysis specified pooled comparison of the 3 highest-dose vericiguat groups with placebo, and secondary analysis evaluated a dose-response relationship with vericiguat and the primary end point. RESULTS Overall, 351 patients (77.0%) completed treatment with the study drug with valid 12-week NT-proBNP levels and no major protocol deviation and were eligible for primary end point evaluation. In primary analysis, change in log-transformed NT-proBNP levels from baseline to week 12 was not significantly different between the pooled vericiguat group (log-transformed: baseline, 7.969; 12 weeks, 7.567; difference, -0.402; geometric means: baseline, 2890 pg/mL; 12 weeks, 1932 pg/mL) and placebo (log-transformed: baseline, 8.283; 12 weeks, 8.002; difference, -0.280; geometric means: baseline, 3955 pg/mL; 12 weeks, 2988 pg/mL) (difference of means, -0.122; 90% CI, -0.32 to 0.07; ratio of geometric means, 0.885, 90% CI, 0.73-1.08; P = .15). The exploratory secondary analysis suggested a dose-response relationship whereby higher vericiguat doses were associated with greater reductions in NT-proBNP level (P < .02). Rates of any adverse event were 77.2% and 71.4% among the placebo and 10-mg vericiguat groups, respectively. CONCLUSIONS AND RELEVANCE Among patients with worsening chronic HF and reduced LVEF, compared with placebo, vericiguat did not have a statistically significant effect on change in NT-proBNP level at 12 weeks but was well-tolerated. Further clinical trials of vericiguat based on the dose-response relationship in this study are needed to determine the potential role of this drug for patients with worsening chronic HF.	[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Greene, Stephen J.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Butler, Javed] SUNY Stony Brook, Div Cardiol, Stony Brook, NY 11794 USA; [Filippatos, Gerasimos] Univ Athens, Univ Athens, Hosp Attikon, Heart Failure Unit,Dept Cardiol,Sch Med, Athens 11528, Greece; [Lam, Carolyn S. P.] Natl Univ Singapore, Natl Heart Ctr Singapore & Duke, Dept Cardiol, Singapore 117548, Singapore; [Maggioni, Aldo P.] Associazione Nazl Med Cardiol Osped, Res Ctr, Florence, Italy; [Ponikowski, Piotr] Med Univ, Mil Hosp, Dept Heart Dis, Wroclaw, Poland; [Shah, Sanjiv J.] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Kraigher-Krainer, Elisabeth; Pieske, Burkert] Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Samano, Eliana T.] Bayer, Sao Paulo, Brazil; [Mueller, Katharina; Roessig, Lothar] Bayer Pharma, Wuppertal, Germany; [Pieske, Burkert] German Heart Ctr Berlin, Dept Internal Med & Cardiol, Berlin, Germany	Northwestern University; Feinberg School of Medicine; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; National Heart Centre Singapore; National University of Singapore; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Wroclaw Medical University; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer AG; Bayer Healthcare Pharmaceuticals; German Heart Center Berlin	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 201 E Huron St,Galter 3-150, Chicago, IL 60611 USA.	mgheorgh@nm.org	Shalganov, Tchavdar N./I-1343-2019; Bonadei, Ivano/P-9877-2015; Farag, Mohamed/X-1076-2019; Filippatos, Gerasimos/ABA-4656-2021; Knot, Jiri/P-8304-2016; Grau, Cai/I-8161-2014; Dolz, Luis Martinez/X-4627-2018; Böhm, Michael/C-3638-2011; Maggioni, Aldo Pietro/AAL-5334-2020; Gislason, Gunnar/B-7561-2009; Ponikowski, Piotr/O-6454-2015; Senni, Michele/J-9380-2018; Shah, Sanjiv J./AFQ-9480-2022; Salazar, Joel/AAN-3422-2020; Parati, Gianfranco/K-7151-2016; Lam, Carolyn SP/ABD-6810-2021; Lin, Yen-Hung/AAQ-1242-2020	Shalganov, Tchavdar N./0000-0003-2268-0759; Bonadei, Ivano/0000-0001-6275-608X; Farag, Mohamed/0000-0003-0811-7679; Knot, Jiri/0000-0002-2750-5151; Grau, Cai/0000-0003-3548-3527; Dolz, Luis Martinez/0000-0001-5145-8191; Maggioni, Aldo Pietro/0000-0003-2764-6779; Gislason, Gunnar/0000-0002-0548-402X; Ponikowski, Piotr/0000-0002-3391-7064; Senni, Michele/0000-0001-5502-7882; Salazar, Joel/0000-0003-2171-8508; Parati, Gianfranco/0000-0001-9402-7439; Lam, Carolyn SP/0000-0003-1903-0018; Lin, Yen-Hung/0000-0001-8153-1441; Shah, Sanjiv/0000-0002-5655-8201; Straburzynska-Migaj, Ewa/0000-0002-0545-3370; Flammer, Andreas/0000-0002-1373-0630; Zile, Michael/0000-0001-7076-221X; Ruiz Bustillo, Sonia/0000-0002-6074-914X; Hubbert, Laila/0000-0002-6578-8826; Matassini, Maria Vittoria/0000-0002-2443-5370; de Groote, Pascal/0000-0002-6211-0147; WU, YEN-WEN/0000-0003-1520-1166; Mayumi, Takuya/0000-0002-1847-3063; Vojacek, Jan F/0000-0001-7724-9734; Gomez-Bueno, Manuel/0000-0002-9764-7518; Westermann, Dirk/0000-0002-7542-1956; Nunez, Julio/0000-0003-1672-7119; RODRIGUEZ COSTOYA, IRIS/0000-0002-6690-9423; HAGEGE, Albert/0000-0003-4685-6077; Gackowski, Andrzej/0000-0003-4545-6514; Dwyer, Nathan/0000-0002-1583-8290; Mellemkjaer, Soren/0000-0002-3422-2387				Ambrosy AP, 2013, AM HEART J, V165, P216, DOI 10.1016/j.ahj.2012.11.004; Benz K, 2007, KIDNEY BLOOD PRESS R, V30, P224, DOI 10.1159/000104091; Blecker S, 2013, J AM COLL CARDIOL, V61, P1259, DOI 10.1016/j.jacc.2012.12.038; Bonderman D, 2013, CIRCULATION, V128, P502, DOI 10.1161/CIRCULATIONAHA.113.001458; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Gheorghiade M, 2013, HEART FAIL REV, V18, P123, DOI 10.1007/s10741-012-9323-1; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Greene SJ, 2015, EUR J HEART FAIL, V17, P98, DOI 10.1002/ejhf.201; Greene SJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000536; Gupta D, 2013, JACC-HEART FAIL, V1, P183, DOI 10.1016/j.jchf.2013.03.003; Krumholz HM, 2014, CIRCULATION, V130, P966, DOI 10.1161/CIRCULATIONAHA.113.007787; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Masuyama H, 2006, HYPERTENSION, V48, P972, DOI 10.1161/01.HYP.0000241087.12492.47; McKie PM, 2011, J AM COLL CARDIOL, V58, P2095, DOI 10.1016/j.jacc.2011.07.042; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Patel PA, 2014, CIRC-HEART FAIL, V7, P918, DOI 10.1161/CIRCHEARTFAILURE.113.000872; Pieske B, 2014, EUR J HEART FAIL, V16, P1026, DOI 10.1002/ejhf.135; Sharkovska Y, 2010, J HYPERTENS, V28, P1666, DOI 10.1097/HJH.0b013e32833b558c; Skali H, 2014, EUR J HEART FAIL, V16, P560, DOI 10.1002/ejhf.71; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; Vaduganathan M, 2015, CIRC-HEART FAIL, V8, P826, DOI 10.1161/CIRCHEARTFAILURE.115.002271	23	204	218	5	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2251	2262		10.1001/jama.2015.15734	http://dx.doi.org/10.1001/jama.2015.15734			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26547357	Bronze			2022-12-28	WOS:000365515700017
J	Desai, NR; Bradley, SM; Parzynski, CS; Nallamothu, BK; Chan, PS; Spertus, JA; Patel, MR; Ader, J; Soufer, A; Krumholz, HM; Curtis, JP				Desai, Nihar R.; Bradley, Steven M.; Parzynski, Craig S.; Nallamothu, Brahmajee K.; Chan, Paul S.; Spertus, John A.; Patel, Manesh R.; Ader, Jeremy; Soufer, Aaron; Krumholz, Harlan M.; Curtis, Jeptha P.			Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSIGHTS	IMPORTANCE Appropriate Use Criteria for Coronary Revascularization were developed to critically evaluate and improve patient selection for percutaneous coronary intervention (PCI). National trends in the appropriateness of PCI have not been examined. OBJECTIVE To examine trends in PCI utilization, patient selection, and procedural appropriateness following the introduction of Appropriate Use Criteria. DESIGN, SETTING, AND PARTICIPANTS Multicenter, longitudinal, cross-sectional analysis of patients undergoing PCI between July 1, 2009, and December 31, 2014, at hospitals continuously participating in the National Cardiovascular Data Registry CathPCI registry over the study period. MAIN OUTCOMES AND MEASURES Proportion of nonacute PCIs classified as inappropriate at the patient and hospital level using the 2012 Appropriate Use Criteria for Coronary Revascularization. RESULTS A total of 2.7 million PCI procedures from 766 hospitals were included. Annual PCI volume of acute indications was consistent over the study period (377 540 in 2010; 374 543 in 2014), but the volume of nonacute PCIs decreased from 89 704 in 2010 to 59 375 in 2014. Among patients undergoing nonacute PCI, there were significant increases in angina severity (Canadian Cardiovascular Society grade III/IV angina, 15.8% in 2010 and 38.4% in 2014), use of antianginal medications prior to PCI (at least 2 antianginal medications, 22.3% in 2010 and 35.1% in 2014), and high-risk findings on noninvasive testing (22.2% in 2010 and 33.2% in 2014) (P <.001 for all), but only modest increases in multivessel coronary artery disease (43.7% in 2010 and 47.5% in 2014, P <.001). The proportion of nonacute PCIs classified as inappropriate decreased from 26.2%(95% CI, 25.8%-26.6%) to 13.3%(95% CI, 13.1%-13.6%), and the absolute number of inappropriate PCIs decreased from 21 781 to 7921. Hospital-level variation in the proportion of PCIs classified as inappropriate persisted over the study period (median, 12.6%[interquartile range, 5.9%-22.9%] in 2014). CONCLUSIONS AND RELEVANCE Since the publication of the Appropriate Use Criteria for Coronary Revascularization in 2009, there have been significant reductions in the volume of nonacute PCI. The proportion of nonacute PCIs classified as inappropriate has declined, although hospital-level variation in inappropriate PCI persists.	[Desai, Nihar R.; Krumholz, Harlan M.; Curtis, Jeptha P.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Desai, Nihar R.; Parzynski, Craig S.; Krumholz, Harlan M.; Curtis, Jeptha P.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; [Bradley, Steven M.] VA Eastern Colorado Hlth Care Syst, Dept Med, Div Cardiol, Denver, CO USA; [Bradley, Steven M.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [Chan, Paul S.; Spertus, John A.] St Lukes Mid Amer Heart Inst, Dept Cardiovasc Res, Kansas City, MO USA; [Chan, Paul S.; Spertus, John A.] Univ Missouri Kansas City, Dept Med, Kansas City, MO 64112 USA; [Patel, Manesh R.] Duke Med, Duke Clin Res Inst, Duke Heart Ctr, Div Cardiovasc Med, Durham, NC USA; [Ader, Jeremy] Yale Univ, Sch Med, New Haven, CT USA; [Soufer, Aaron] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Duke University; Yale University; Yale University	Desai, NR (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, One Church St,Ste 200, New Haven, CT 06510 USA.	nihar.desai@yale.edu	Bradley, Steven/AID-7839-2022; Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020; Patel, Manesh/AAC-5385-2019		Agency for Healthcare Research and Quality [K12 HS023000-01]; Veterans Affairs Health Services Research and Development [HSRD-CDA2 10-199]; National Heart, Lung, and Blood Institute [U01 HL105270-05]; NCDR; American College of Cardiology; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023000] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Veterans Affairs Health Services Research and Development(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCDR; American College of Cardiology(General Electric); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Desai is supported by grant K12 HS023000-01 from the Agency for Healthcare Research and Quality. Dr Bradley is supported by a Career Development Award (HSR&D-CDA2 10-199) from Veterans Affairs Health Services Research and Development. Drs Krumholz and Curtis are supported by grant U01 HL105270-05 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. This research was supported by the NCDR. The analytic work for this investigator-initiated study was performed by the Yale Center for Outcomes Research and Evaluation Data Analytic Center, with financial support from the American College of Cardiology.	[Anonymous], P NAT SUMM OV JOINT; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Blue Cross Blue Shield of Michigan, 2014, 2014 HOSP PAY FOR PE; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bradley SM, 2015, CIRCULATION, V132, P20, DOI 10.1161/CIRCULATIONAHA.114.015156; Bradley SM, 2014, CIRC-CARDIOVASC QUAL, V7, P550, DOI 10.1161/CIRCOUTCOMES.114.001020; Bradley SM, 2012, CIRC-CARDIOVASC QUAL, V5, P445, DOI 10.1161/CIRCOUTCOMES.111.964320; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Chan PS, 2014, CIRC-CARDIOVASC QUAL, V7, P640, DOI 10.1161/CIRCOUTCOMES.114.000967; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Hendel RC, 2013, J AM COLL CARDIOL, V61, P1305, DOI 10.1016/j.jacc.2013.01.025; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Kliff S, 2012, WASHINGTON POST; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; New York State Medicaid Update, PERC COR INT COV GUI; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; Patel MR, 2005, J AM COLL CARDIOL, V46, P1606, DOI 10.1016/j.jacc.2005.08.030; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Society for Cardiovascular Angiography and Interventions, 5 THINGS PHYS PAT SH; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459; Winslow R, 2011, WALL STREET J	24	172	176	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2045	2053		10.1001/jama.2015.13764	http://dx.doi.org/10.1001/jama.2015.13764			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26551163	Green Accepted, Bronze			2022-12-28	WOS:000364764200019
J	Bougher, S; Jakosky, B; Halekas, J; Grebowsky, J; Luhmann, J; Mahaffy, P; Connerney, J; Eparvier, F; Ergun, R; Larson, D; McFadden, J; Mitchell, D; Schneider, N; Zurek, R; Mazelle, C; Andersson, L; Andrews, D; Baird, D; Baker, DN; Bell, JM; Benna, M; Brain, D; Chaffin, M; Chamberlin, P; Chaufray, JY; Clarke, J; Collinson, G; Combi, M; Crary, F; Cravens, T; Crismani, M; Curry, S; Curtis, D; Deighan, J; Delory, G; Dewey, R; DiBraccio, G; Dong, C; Dong, Y; Dunn, P; Elrod, M; England, S; Eriksson, A; Espley, J; Evans, S; Fang, X; Fillingim, M; Fortier, K; Fowler, CM; Fox, J; Groller, H; Guzewich, S; Hara, T; Harada, Y; Holsclaw, G; Jain, SK; Jolitz, R; Leblanc, F; Lee, CO; Lee, Y; Lefevre, F; Lillis, R; Livi, R; Lo, D; Ma, Y; Mayyasi, M; McClintock, W; McEnulty, T; Modolo, R; Montmessin, F; Morooka, M; Nagy, A; Olsen, K; Peterson, W; Rahmati, A; Ruhunusiri, S; Russell, CT; Sakai, S; Sauvaud, JA; Seki, K; Steckiewicz, M; Stevens, M; Stewart, AIF; Stiepen, A; Stone, S; Tenishev, V; Thiemann, E; Tolson, R; Toublanc, D; Vogt, M; Weber, T; Withers, P; Woods, T; Yelle, R				Bougher, S.; Jakosky, B.; Halekas, J.; Grebowsky, J.; Luhmann, J.; Mahaffy, P.; Connerney, J.; Eparvier, F.; Ergun, R.; Larson, D.; McFadden, J.; Mitchell, D.; Schneider, N.; Zurek, R.; Mazelle, C.; Andersson, L.; Andrews, D.; Baird, D.; Baker, D. N.; Bell, J. M.; Benna, M.; Brain, D.; Chaffin, M.; Chamberlin, P.; Chaufray, J. -Y.; Clarke, J.; Collinson, G.; Combi, M.; Crary, F.; Cravens, T.; Crismani, M.; Curry, S.; Curtis, D.; Deighan, J.; Delory, G.; Dewey, R.; DiBraccio, G.; Dong, C.; Dong, Y.; Dunn, P.; Elrod, M.; England, S.; Eriksson, A.; Espley, J.; Evans, S.; Fang, X.; Fillingim, M.; Fortier, K.; Fowler, C. M.; Fox, J.; Groeller, H.; Guzewich, S.; Hara, T.; Harada, Y.; Holsclaw, G.; Jain, S. K.; Jolitz, R.; Leblanc, F.; Lee, C. O.; Lee, Y.; Lefevre, F.; Lillis, R.; Livi, R.; Lo, D.; Ma, Y.; Mayyasi, M.; McClintock, W.; McEnulty, T.; Modolo, R.; Montmessin, F.; Morooka, M.; Nagy, A.; Olsen, K.; Peterson, W.; Rahmati, A.; Ruhunusiri, S.; Russell, C. T.; Sakai, S.; Sauvaud, J. -A.; Seki, K.; Steckiewicz, M.; Stevens, M.; Stewart, A. I. F.; Stiepen, A.; Stone, S.; Tenishev, V.; Thiemann, E.; Tolson, R.; Toublanc, D.; Vogt, M.; Weber, T.; Withers, P.; Woods, T.; Yelle, R.			Early MAVEN Deep Dip campaign reveals thermosphere and ionosphere variability	SCIENCE			English	Article							UPPER-ATMOSPHERE; MARTIAN ATMOSPHERE; MARS; VENUS	The Mars Atmosphere and Volatile Evolution (MAVEN) mission, during the second of its Deep Dip campaigns, made comprehensive measurements of martian thermosphere and ionosphere composition, structure, and variability at altitudes down to similar to 130 kilometers in the subsolar region. This altitude range contains the diffusively separated upper atmosphere just above the well-mixed atmosphere, the layer of peak extreme ultraviolet heating and primary reservoir for atmospheric escape. In situ measurements of the upper atmosphere reveal previously unmeasured populations of neutral and charged particles, the homopause altitude at approximately 130 kilometers, and an unexpected level of variability both on an orbit-to-orbit basis and within individual orbits. These observations help constrain volatile escape processes controlled by thermosphere and ionosphere structure and variability.	[Bougher, S.; Combi, M.; Dong, C.; Lee, Y.; Nagy, A.; Olsen, K.; Tenishev, V.] Univ Michigan, CLaSP Dept, Ann Arbor, MI 48109 USA; [Jakosky, B.; Eparvier, F.; Ergun, R.; Schneider, N.; Andersson, L.; Baker, D. N.; Brain, D.; Chaffin, M.; Crary, F.; Crismani, M.; Deighan, J.; Dewey, R.; Dong, Y.; Fang, X.; Fortier, K.; Fowler, C. M.; Holsclaw, G.; Jain, S. K.; McClintock, W.; McEnulty, T.; Morooka, M.; Peterson, W.; Stewart, A. I. F.; Stiepen, A.; Thiemann, E.; Weber, T.; Woods, T.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; [Halekas, J.; Ruhunusiri, S.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Grebowsky, J.; Mahaffy, P.; Connerney, J.; Benna, M.; Chamberlin, P.; Collinson, G.; DiBraccio, G.; Elrod, M.; Espley, J.; Guzewich, S.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Luhmann, J.; Larson, D.; McFadden, J.; Mitchell, D.; Curry, S.; Curtis, D.; Delory, G.; Dunn, P.; England, S.; Fillingim, M.; Hara, T.; Harada, Y.; Jolitz, R.; Lee, C. O.; Lillis, R.; Livi, R.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Zurek, R.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Mazelle, C.; Sauvaud, J. -A.; Steckiewicz, M.; Toublanc, D.] CNRS, Inst Rech Astrophys & Planetol, Toulouse, France; [Mazelle, C.; Sauvaud, J. -A.; Steckiewicz, M.; Toublanc, D.] Univ Paul Sabatier, Toulouse, France; [Andrews, D.; Eriksson, A.] Swedish Inst Space Phys, S-98128 Kiruna, Sweden; [Baird, D.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Bell, J. M.; Tolson, R.] Natl Inst Aerosp, Hampton, VA USA; [Chaufray, J. -Y.; Leblanc, F.; Lefevre, F.; Modolo, R.; Montmessin, F.] CNRS, Observat Spatiales, Milieux, Lab Atmospheres, Verrieres Le Buisson, France; [Clarke, J.; Mayyasi, M.; Vogt, M.; Withers, P.] Boston Univ, Dept Astron, Boston, MA 02215 USA; [Cravens, T.; Rahmati, A.; Sakai, S.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Fox, J.] Wright State Univ, Dept Phys, Fairborn, OH USA; [Groeller, H.; Lo, D.; Stone, S.; Yelle, R.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Ma, Y.; Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; [Seki, K.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Stevens, M.] Naval Res Lab, Washington, DC 20375 USA	University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Boulder; University of Iowa; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Institute for Aerospace; Centre National de la Recherche Scientifique (CNRS); Boston University; University of Kansas; University System of Ohio; Wright State University Dayton; University of Arizona; University of California System; University of California Los Angeles; Nagoya University; United States Department of Defense; United States Navy; Naval Research Laboratory	Bougher, S (corresponding author), Univ Michigan, CLaSP Dept, Ann Arbor, MI 48109 USA.	bougher@umich.edu	Benna, Mehdi/F-3489-2012; Clarke, John/C-8644-2013; Russell, Christopher T/E-7745-2012; Peterson, WK/A-8706-2009; Sakai, Shotaro/AAT-8518-2020; Stone, Shane Wesley/C-4662-2017; Fang, Xiaohua/C-2773-2008; Vogt, Marissa/C-6237-2014; Holsclaw, Greg/AAX-2486-2021; Lillis, Robert J/A-3281-2008; Chamberlin, Phillip/C-9531-2012; Andrews, David/B-2591-2009; Ma, Yingjuan/B-4895-2017; Dong, Chuanfei/E-6485-2010; Eriksson, Anders I/C-2887-2009; Morooka, Michiko/AAO-8594-2020; Dong, Yaxue/AAN-6920-2020; Guzewich, Scott/AAI-1445-2021; Combi, Michael/J-1697-2012; Crismani, Matteo/H-3791-2016	Russell, Christopher T/0000-0003-1639-8298; Peterson, WK/0000-0002-1513-6096; Sakai, Shotaro/0000-0001-9135-2076; Stone, Shane Wesley/0000-0002-7290-2412; Fang, Xiaohua/0000-0002-6584-2837; Vogt, Marissa/0000-0003-4885-8615; Holsclaw, Greg/0000-0002-9059-9437; Lillis, Robert J/0000-0003-0578-517X; Chamberlin, Phillip/0000-0003-4372-7405; Andrews, David/0000-0002-7933-0322; Ma, Yingjuan/0000-0003-2584-7091; Dong, Chuanfei/0000-0002-8990-094X; Eriksson, Anders I/0000-0003-2926-6761; Morooka, Michiko/0000-0001-9958-0241; Combi, Michael/0000-0002-9805-0078; Lo, Daniel/0000-0002-9603-500X; Seki, Kanako/0000-0001-5557-9062; Guzewich, Scott/0000-0003-1149-7385; Thiemann, Edward/0000-0002-5305-9466; Crismani, Matteo/0000-0003-3127-2466; Lee, Christina/0000-0002-1604-3326; Montmessin, Franck/0000-0002-4187-1457; SCHNEIDER, NICHOLAS/0000-0001-6720-5519; Dong, Yaxue/0000-0003-3491-7506; Harada, Yuki/0000-0002-4001-6352; Dewey, Ryan/0000-0003-4437-0698; BRAIN, DAVID/0000-0001-8932-368X; England, Scott/0000-0001-5336-0040; Halekas, Jasper/0000-0001-5258-6128	Centre National d'Etudes Spatiales; Belgian American Educational Foundation; Rotary District [1630]; NASA Postdoctoral Program appointment at NASA Goddard Space Flight Center; NASA through the Mars Exploration Program; Grants-in-Aid for Scientific Research [15H03731] Funding Source: KAKEN	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Belgian American Educational Foundation; Rotary District; NASA Postdoctoral Program appointment at NASA Goddard Space Flight Center; NASA through the Mars Exploration Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The MAVEN Deep Dip 2 data sets reported in the paper are archived on the public version of the MAVEN Science Data Center (SDC) website, at the LASP url (https://lasp.colorado.edu/maven/sdc/public/) and on the Planetary Data System (PDS). Datacubes from three-dimensional model simulations reported in this paper are also available on the public MAVEN SDC website at https://lasp.colorado.edu/maven/sdc/public/pages/models.html. This work was partially supported by the Centre National d'Etudes Spatiales for the part based on observations with the SWEA instrument embarked on Maven. Part of this research was also carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration (NASA). A. Stiepen was supported by the Belgian American Educational Foundation and the Rotary District 1630. G. DiBraccio was supported by a NASA Postdoctoral Program appointment at NASA Goddard Space Flight Center, administered by Oak Ridge Associated Universities through a contract with NASA. The MAVEN project is supported by NASA through the Mars Exploration Program.	Bougher SW, 2015, J GEOPHYS RES-PLANET, V120, P311, DOI 10.1002/2014JE004715; Bougher SW, 2015, SPACE SCI REV, V195, P423, DOI 10.1007/s11214-014-0053-7; Chaufray JY, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003130; Connerney J. E. P., 2015, SPACE SCI REV, DOI 10.1007s11214-015-0169-4; Dong CF, 2015, J GEOPHYS RES-SPACE, V120, P7857, DOI 10.1002/2015JA020990; Dong CF, 2014, GEOPHYS RES LETT, V41, P2708, DOI 10.1002/2014GL059515; Dubinin E, 2006, SPACE SCI REV, V126, P209, DOI 10.1007/s11214-006-9039-4; Duru F, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014711; Ergun RE, 2015, GEOPHYS RES LETT, V42, P8846, DOI 10.1002/2015GL065280; Fox JL, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011697; FOX JL, 1979, J GEOPHYS RES-SPACE, V84, P7315, DOI 10.1029/JA084iA12p07315; Gurnett DA, 2010, ICARUS, V206, P83, DOI 10.1016/j.icarus.2009.02.019; Halekas JS, 2015, GEOPHYS RES LETT, V42, P8901, DOI 10.1002/2015GL064693; Halekas JS, 2015, SPACE SCI REV, V195, P125, DOI 10.1007/s11214-013-0029-z; Hanson W. B., 1977, Journal of Geophysical Research, V82, P4351, DOI 10.1029/JS082i028p04351; Jakosky BM, 2015, SPACE SCI REV, V195, P3, DOI 10.1007/s11214-015-0139-x; Kallio E, 2001, J GEOPHYS RES-SPACE, V106, P165, DOI 10.1029/2000JA002003; Keating GM, 1998, SCIENCE, V279, P1672, DOI 10.1126/science.279.5357.1672; Kirkwood S, 2000, SPACE SCI REV, V91, P579, DOI 10.1023/A:1005241931650; Kopf AJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034948; Leblanc F, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011763; Lee Y., 2014, B AM ASTRONOMICAL SO, V46; LUHMANN JG, 1991, J GEOPHYS RES-SPACE, V96, P5457, DOI 10.1029/90JA01753; Mahaffy PR, 2015, GEOPHYS RES LETT, V42, P8951, DOI 10.1002/2015GL065329; Mahaffy PR, 2014, SPACE SCI REV, V185, P27, DOI 10.1007/s11214-014-0043-9; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Medvedev AS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050852; Medvedev AS, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003848; Nagy AF, 2004, SPACE SCI REV, V111, P33, DOI 10.1023/B:SPAC.0000032718.47512.92; Najib D, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016272; Nier A. O., 1977, Journal of Geophysical Research, V82, P4341, DOI 10.1126/science.194.4271.1298; SHINAGAWA H, 1992, J GEOPHYS RES-PLANET, V97, P1027, DOI 10.1029/91JE02720; Snowden D, 2013, ICARUS, V226, P552, DOI 10.1016/j.icarus.2013.06.006; Stiepen A, 2015, ICARUS, V245, P295, DOI 10.1016/j.icarus.2014.09.051; Valeille A, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003389; Withers P, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053193; Withers P, 2009, ADV SPACE RES, V44, P277, DOI 10.1016/j.asr.2009.04.027; ZHANG MHG, 1990, J GEOPHYS RES-SOLID, V95, P14829, DOI 10.1029/JB095iB09p14829; Zurek RW, 2015, SPACE SCI REV, V195, P303, DOI 10.1007/s11214-014-0095-x	39	75	75	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261							aad0459	10.1126/science.aad0459	http://dx.doi.org/10.1126/science.aad0459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542579				2022-12-28	WOS:000364162800004
J	Quinlan, RA				Quinlan, Roy A.			A new dawn for cataracts	SCIENCE			English	Editorial Material							ALPHA-CRYSTALLIN		Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Quinlan, RA (corresponding author), Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	r.a.quinlan@durham.ac.uk	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123				Borchman D, 2010, J LIPID RES, V51, P2473, DOI 10.1194/jlr.R004119; Kostis JB, 2015, J CARDIOVASC PHARM T, V20, P346, DOI 10.1177/1074248414560967; Lee FY, 2005, J BIOL CHEM, V280, P31792, DOI 10.1074/jbc.M503182200; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Perng MD, 2015, BIG BOOK SMALL HEAT, V8, P401, DOI [10.1007/978-3-319-16077-1, DOI 10.1007/978-3-319-16077-1]; Qi HP, 2012, MOL VIS, V18, P151; Quinlan RA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0091; Scheier B, 1996, MOL CELL ENDOCRINOL, V123, P187, DOI 10.1016/S0303-7207(96)03922-6; Song SH, 2011, CELL STRESS CHAPERON, V16, P475, DOI 10.1007/s12192-011-0259-5; Stewart DN, 2013, MOL VIS, V19, P463; Truscott RJ, 2009, EXP EYE RES, V88, P241, DOI 10.1016/j.exer.2008.07.003; Wu JJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0391; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	13	15	17	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					636	637		10.1126/science.aad6303	http://dx.doi.org/10.1126/science.aad6303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542559				2022-12-28	WOS:000364162800030
J	Eagen, KP; Hartl, TA; Kornberg, RD				Eagen, Kyle P.; Hartl, Tom A.; Kornberg, Roger D.			Stable Chromosome Condensation Revealed by Chromosome Conformation Capture	CELL			English	Article							SALIVARY-GLAND CHROMOSOMES; DROSOPHILA-MELANOGASTER; HUMAN GENOME; CHROMATIN ARCHITECTURE; ORGANIZATION; PRINCIPLES; DOMAINS; GENE; RESOLUTION; PATTERNS	Chemical cross-linking and DNA sequencing have revealed regions of intra-chromosomal interaction, referred to as topologically associating domains (TADs), interspersed with regions of little or no interaction, in interphase nuclei. We find that TADs and the regions between them correspond with the bands and interbands of polytene chromosomes of Drosophila. We further establish the conservation of TADs between polytene and diploid cells of Drosophila. From direct measurements on light micrographs of polytene chromosomes, we then deduce the states of chromatin folding in the diploid cell nucleus. Two states of folding, fully extended fibers containing regulatory regions and promoters, and fibers condensed up to 10-fold containing coding regions of active genes, constitute the euchromatin of the nuclear interior. Chromatin fibers condensed up to 30-fold, containing coding regions of inactive genes, represent the heterochromatin of the nuclear periphery. A convergence of molecular analysis with direct observation thus reveals the architecture of interphase chromosomes.	[Eagen, Kyle P.; Kornberg, Roger D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Hartl, Tom A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Hartl, Tom A.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Hartl, Tom A.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu		Eagen, Kyle/0000-0002-2610-8664	NIH [U01AI090905, GM36659, AI21144]; American Heart Association Predoctoral Fellowship [11PRE7320067]; Stanford Medical Scientist Training Program NIH Training Grant [T32GM007365]; American Cancer Society Postdoctoral Fellowship [PF-13-191-01-DDC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI090905, R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365, T32GM008294, R37GM036659, R01GM036659] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Stanford Medical Scientist Training Program NIH Training Grant; American Cancer Society Postdoctoral Fellowship(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A portion of this work was performed in the lab of Matthew P. Scott and we are grateful for his support of the project. We thank Michael Levitt for discussions and for advice and guidance regarding statistical analysis. We thank the Stanford Functional Genomics Facility and the Peter Parham lab for assistance with DNA sequencing and access to their Illumina MiSeq instrument (supported by NIH grant U01AI090905 to Peter Parham), Thomas Clandidin for use of fly facilities, and Ben A. Barres and Mariko L. Bennet for access to their fluorescence microscope and assistance with microscopy. We thank Shigeki Nagai for discussions and comments on the manuscript. Figures 2B and 5C adapted from Lefevre (1976). Figure 7, left panel adapted from Cross and Mercer (1993) is licensed under CC BY-NC-SA 3.0 US. This research was supported by NIH grants GM36659 and AI21144 to R.D.K. K.P.E. was supported by an American Heart Association Predoctoral Fellowship (11PRE7320067) and by the Stanford Medical Scientist Training Program NIH Training Grant (T32GM007365). T.A.H. was supported by an American Cancer Society Postdoctoral Fellowship (PF-13-191-01-DDC).	AGARD DA, 1983, NATURE, V302, P676, DOI 10.1038/302676a0; Andreyenkov OV, 2010, DOKL BIOCHEM BIOPHYS, V431, P57, DOI 10.1134/S1607672910020018; ASHBURNER M, 1967, CHROMOSOMA, V21, P398, DOI 10.1007/BF00336950; Balbiani E. G., 1881, Zoologischer Anzeiger, Viv, P637; Beermann W, 1972, Results Probl Cell Differ, V4, P1; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Cross PC., 1993, CELL TISSUE ULTRASTR; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flemming W., 1882, ZELLSUBSTANZ KERN ZE; Fung JC, 1998, J CELL BIOL, V141, P5, DOI 10.1083/jcb.141.1.5; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kennison J, 2000, DROSOPHILA PROTOCOLS, P111; KEPPY DO, 1977, GENETICS, V85, P497; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lefevre G., 1976, GENET BIOL DROSOPHIL, P31; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Painter TS, 1933, SCIENCE, V78, P585, DOI 10.1126/science.78.2034.585; Pardue M.-L., 2000, DROSOPHILA PROTOCOLS, P119; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; RYKOWSKI MC, 1988, CELL, V54, P461, DOI 10.1016/0092-8674(88)90067-0; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; URATA Y, 1995, J CELL BIOL, V131, P279, DOI 10.1083/jcb.131.2.279; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Vazquez J, 2000, GENETICS, V155, P1297; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; ZHIMULEV IF, 1975, CHROMOSOMA, V49, P219, DOI 10.1007/BF00361067; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631	43	96	100	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					934	946		10.1016/j.cell.2015.10.026	http://dx.doi.org/10.1016/j.cell.2015.10.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544940	Green Accepted, Bronze			2022-12-28	WOS:000364829700018
J	Xiang, SH; Kato, M; Wu, LC; Lin, Y; Ding, M; Zhang, YJ; Yu, YH; McKnight, SL				Xiang, Siheng; Kato, Masato; Wu, Leeju C.; Lin, Yi; Ding, Ming; Zhang, Yajie; Yu, Yonghao; McKnight, Steven L.			The LC Domain of hnRNPA2 Adopts Similar Conformations in Hydrogel Polymers, Liquid-like Droplets, and Nuclei	CELL			English	Article							LOW-COMPLEXITY DOMAINS; RNA-BINDING PROTEINS; CELL-FREE FORMATION; TRANSCRIPTIONAL ACTIVATION; PHASE-TRANSITION; GRANULES; BIOGENESIS; SEPARATION; SITE	Many DNA and RNA regulatory proteins contain poly-peptidedomains that are unstructuredwhenanalyzed in cell lysates. These domains are typified by an over-representation of a limited number of amino acids and have been termed prion-like, intrinsically disordered or low-complexity (LC) domains. When incubated at high concentration, certain of these LC domains polymerize into labile, amyloid-like fibers. Here, we report methods allowing the generation of a molecular footprint of the polymeric state of the LC domain of hnRNPA2. By deploying this footprinting technique to probe the structure of the native hnRNPA2 protein present in isolated nuclei, we offer evidence that its LC domain exists in a similar conformation as that described for recombinant polymers of the protein. These observations favor biologic utility to the polymerization of LC domains in the pathway of information transfer from gene to message to protein.	[Xiang, Siheng; Kato, Masato; Wu, Leeju C.; Lin, Yi; Ding, Ming; Zhang, Yajie; Yu, Yonghao; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, YH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	yonghao.yu@utsouthwestern.edu; steven.mcknight@utsouthwestern.edu	Xiang, Siheng/A-5063-2010; Lin, Yi/T-6547-2017	Xiang, Siheng/0000-0003-4475-5707; Lin, Yi/0000-0001-5294-0692; Ding, Ming/0000-0002-9135-9275	UTSWMC Endowed Scholars Program; Cancer Prevention and Research Institute of Texas (CPRIT) [R1103]; National Institutes of Health (NIH) [U01GM10762301]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM107623] Funding Source: NIH RePORTER	UTSWMC Endowed Scholars Program; Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Michael Rosen for generous provision of the MBP:PTB plasmid into which the LC domain of hnRNPA2 was cloned for use in the analysis of liquid-like droplets, his suggestion that we use NAI footprinting to interrogate the structure of the LC domain of hnRNPA2 as a function of liquid-like droplet formation and maturation, and his editing of this manuscript. We also thank Drs. Deepak Nijhawan and Ting Han for valuable input; Dr. Bruce Alberts for editorial comments, including recommendation for the inclusion of Figure 6; and the UTSWMC Live Cell Imaging Core for help with confocal microscopy. This work was supported by the UTSWMC Endowed Scholars Program (to Y.Y.), the Cancer Prevention and Research Institute of Texas (CPRIT grant R1103 to Y.Y.), the National Institutes of Health (NIH grant U01GM10762301 to S.L.M.); and unrestricted funding from an anonymous donor (to S.L.M.).	Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; ASTBURY WT, 1959, BIOCHIM BIOPHYS ACTA, V35, P17, DOI 10.1016/0006-3002(59)90330-0; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lauranzano E, 2015, BRAIN, V138, P974, DOI 10.1093/brain/awv005; Lee EK, 2012, CURR PROTEIN PEPT SC, V13, P331; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Miyashiro J, 2009, BIOORG MED CHEM LETT, V19, P4050, DOI 10.1016/j.bmcl.2009.06.016; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Petri M, 2012, BIOMACROMOLECULES, V13, P1882, DOI 10.1021/bm300412q; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; RIORDAN JF, 1965, BIOCHEMISTRY-US, V4, P1758, DOI 10.1021/bi00885a012; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; TIMASHEFF SN, 1967, ANNU REV BIOCHEM, V36, P13, DOI 10.1146/annurev.bi.36.070167.000305; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	33	183	186	1	80	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					829	839		10.1016/j.cell.2015.10.040	http://dx.doi.org/10.1016/j.cell.2015.10.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544936	Bronze, Green Accepted			2022-12-28	WOS:000364829700010
J	Auger, N; Fraser, WD; Healy-Profitos, J; Arbour, L				Auger, Nathalie; Fraser, William D.; Healy-Profitos, Jessica; Arbour, Laura			Association Between Preeclampsia and Congenital Heart Defects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANGIOGENIC FACTORS; HYPERTENSIVE DISORDERS; BIRTH-DEFECTS; PREVALENCE; DISEASE; POPULATION; DIAGNOSIS; MORTALITY; IMBALANCE; AGE	IMPORTANCE The risk of congenital heart defects in infants of women who had preeclampsia during pregnancy is poorly understood, despite shared angiogenic pathways in both conditions. OBJECTIVE To determine the prevalence of congenital heart defects in offspring of women with preeclampsia. DESIGN, SETTING, AND PARTICIPANTS Population-level analysis of live births before discharge, 1989-2012, was conducted for the entire province of Quebec, comprising a quarter of Canada's population. All women who delivered an infant with or without heart defects in any Quebec hospital were included (N = 1 942 072 neonates). EXPOSURES Preeclampsia or eclampsia with onset before or after 34 weeks of gestation. MAIN OUTCOMES AND MEASURES Presence of any critical or noncritical congenital heart defect detected in infants at birth, comparing prevalence in those exposed and not exposed to preeclampsia. RESULTS The absolute prevalence of congenital heart defects was higher for infants of women with preeclampsia than those without it. Infants of women with preeclampsia had no increased prevalence of critical heart defects but did have an increased prevalence of noncritical heart defects compared with infants of nonpreeclamptic women. [GRAPHICS] Among specific defects, prevalence was greatest for septal defects. Compared with infants of women with late-onset preeclampsia, those with early onset (<34 weeks) had greater prevalence of critical heart defects (364.4/100 000 [20/5488]; prevalence ratio, 2.78; 95% CI, 1.71-4.50; prevalence difference, 249.6/100 000; 95% CI, 89.7-409.6) and noncritical heart defects (7306.9/100 000 [401/5488]; prevalence ratio, 5.55; 95% CI, 4.98-6.19; prevalence difference, 6089.2/100 000; 95% CI, 5350.0-6828.3). CONCLUSIONS AND RELEVANCE In this population-based study, preeclampsia was significantly associated with noncritical heart defects in offspring, and preeclampsia before 34 weeks was associated with critical heart defects. However, the absolute risk of congenital heart defects was low.	[Auger, Nathalie; Healy-Profitos, Jessica] Inst Natl Sante Publ Quebec, Montreal, PQ H2P 1E2, Canada; [Auger, Nathalie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Auger, Nathalie; Fraser, William D.; Healy-Profitos, Jessica] Univ Montreal Hosp, Res Ctr, Montreal, PQ H2P 1E2, Canada; [Fraser, William D.] Univ Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ J1K 2R1, Canada; [Arbour, Laura] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; Universite de Montreal; University of Sherbrooke; University of British Columbia	Auger, N (corresponding author), Inst Natl Sante Publ Quebec, 190 Blvd Cremazie Est, Montreal, PQ H2P 1E2, Canada.	nathalie.auger@inspq.qc.ca	Auger, Nathalie/E-3736-2016	Auger, Nathalie/0000-0002-2412-0459; Arbour, Laura/0000-0002-9589-0880	Canadian Institutes for Health Research [MOP-130452]; Fonds de recherche du Quebec-Sante [25128]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported by the Canadian Institutes for Health Research (MOP-130452). Dr Auger was supported by a career award from the Fonds de recherche du Quebec-Sante (grant 25128).	Auger N, 2012, SOC SCI MED, V75, P1032, DOI 10.1016/j.socscimed.2012.04.033; Auger N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-67; Avila P, 2014, CAN J CARDIOL, V30, pS410, DOI 10.1016/j.cjca.2014.07.749; Bourke J, 2005, PAEDIATR PERINAT EP, V19, P284, DOI 10.1111/j.1365-3016.2005.00666.x; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Dhanantwari P, 2009, CIRCULATION, V120, P343, DOI 10.1161/CIRCULATIONAHA.108.796698; Forrester MB, 1998, AM J EPIDEMIOL, V148, P1206; Fox NS, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.035; Khoshnood B, 2012, HEART, V98, P1667, DOI 10.1136/heartjnl-2012-302543; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Liu SL, 2013, CIRCULATION, V128, P583, DOI 10.1161/CIRCULATIONAHA.112.001054; Llurba E, 2014, EUR HEART J, V35, P701, DOI 10.1093/eurheartj/eht389; Lu Y, 2014, AM HEART J, V168, P948, DOI 10.1016/j.ahj.2014.08.006; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Melamed N, 2014, J OBSTET GYNAECOL CA, V36, P642, DOI 10.1016/S1701-2163(15)30545-4; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sliwa K, 2014, EUR HEART J, V35, P680, DOI 10.1093/eurheartj/eht485; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Steinberg G, 2009, THROMB RES, V123, pS93, DOI 10.1016/S0049-3848(09)70020-9; Sugimoto M, 2015, PEDIATR CARDIOL, V36, P591, DOI 10.1007/s00246-014-1054-8; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; van Gelder MMHJ, 2015, BJOG-INT J OBSTET GY, V122, P1002, DOI 10.1111/1471-0528.13138; von Dadelszen P, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0454-8; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	83	88	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1588	1598		10.1001/jama.2015.12505	http://dx.doi.org/10.1001/jama.2015.12505			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501535				2022-12-28	WOS:000363028500019
J	Schattner, A				Schattner, Ami			Review: In RA, standard- and high-dose biologic drugs increase serious infection compared with traditional DMARDs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Schattner, A (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Bredemeier M, 2015, CLIN RHEUMATOL; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC5	10.7326/ACPJC-2015-163-8-005	http://dx.doi.org/10.7326/ACPJC-2015-163-8-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502142				2022-12-28	WOS:000363737400006
J	Woolston, C				Woolston, Chris			Scientist criticizes media portrayal of research	NATURE			English	Editorial Material																			0	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					505	505		10.1038/523505f	http://dx.doi.org/10.1038/523505f			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB7VO	26495455	Bronze			2022-12-28	WOS:000417405700005
J	Singh, H; Graber, ML				Singh, Hardeep; Graber, Mark L.			Improving Diagnosis in Health Care - The Next Imperative for Patient Safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERRORS		[Singh, Hardeep] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Houston Vet Affairs Ctr Innovat Qual Effectivenes, Houston, TX 77030 USA; [Singh, Hardeep] Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA; [Graber, Mark L.] RTI Int, Raleigh, NC USA; [Graber, Mark L.] Soc Improve Diag Med, New York, NY USA; [Graber, Mark L.] SUNY Stony Brook, Stony Brook, NY 11794 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; Research Triangle Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Singh, H (corresponding author), Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Houston Vet Affairs Ctr Innovat Qual Effectivenes, Houston, TX 77030 USA.			Graber, Mark/0000-0002-3600-0446				Graber ML, 2013, BMJ QUAL SAF, V22, pii21, DOI 10.1136/bmjqs-2012-001615; Graber ML, 2012, JAMA-J AM MED ASSOC, V308, P1211, DOI 10.1001/2012.jama.11913; Institute of Medicine, 2015, IMPR DIAGN HLTH CAR; Singh H, 2015, BMJ QUAL SAF, V24, P103, DOI 10.1136/bmjqs-2014-003675; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627	5	87	88	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2493	2495		10.1056/NEJMp1512241	http://dx.doi.org/10.1056/NEJMp1512241			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ7SG	26559457				2022-12-28	WOS:000367299700004
J	Chou, R; Gore, JL; Buckley, D; Fu, RW; Gustafson, K; Griffin, JC; Grusing, S; Selph, S				Chou, Roger; Gore, John L.; Buckley, David; Fu, Rongwei; Gustafson, Katie; Griffin, Jessica C.; Grusing, Sara; Selph, Shelley			Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							TRANSITIONAL-CELL CARCINOMA; IN-SITU HYBRIDIZATION; BTA STAT TEST; NUCLEAR-MATRIX PROTEIN-22; VOIDED URINE; UROTHELIAL CARCINOMA; IMMUNOCYT TEST; WASH CYTOLOGY; FOLLOW-UP; EMPIRICAL-EVIDENCE	Background: Urinary biomarkers may be a useful alternative or adjunct to cystoscopy for diagnosis of bladder cancer. Purpose: To systematically review the evidence on the accuracy of urinary biomarkers for diagnosis of bladder cancer in adults who have signs or symptoms of the disease or are undergoing surveillance for recurrent disease. Data Sources: Ovid MEDLINE (January 1990 through June 2015), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and reference lists. Study Selection: 57 studies that evaluated the diagnostic accuracy of quantitative or qualitative nuclear matrix protein 22 (NMP22), qualitative or quantitative bladder tumor antigen (BTA), fluorescence in situ hybridization (FISH), fluorescent immunohistochemistry (ImmunoCyt [Scimedx]), and Cxbladder (Pacific Edge Diagnostics USA) using cystoscopy and histopathology as the reference standard met inclusion criteria. Case-control studies were excluded. Data Extraction: Dual extraction and quality assessment of individual studies. Overall strength of evidence (SOE) was also assessed. Data Synthesis: Across biomarkers, sensitivities ranged from 0.57 to 0.82 and specificities ranged from 0.74 to 0.88. Positive likelihood ratios ranged from 2.52 to 5.53, and negative likelihood ratios ranged from 0.21 to 0.48 (moderate SOE for quan-titative NMP22, qualitative BTA, FISH, and ImmunoCyt; low SOE for others). For some biomarkers, sensitivity was higher for initial diagnosis of bladder cancer than for diagnosis of recurrence. Sensitivity increased with higher tumor stage or grade. Studies that directly compared the accuracy of quantitative NMP22 and qualitative BTA found no differences in diagnostic accuracy (moderate SOE); head-to-head studies of other biomarkers were limited. Urinary biomarkers plus cytologic evaluation were more sensitive than biomarkers alone but missed about 10% of bladder cancer cases. Limitation: Restricted to English-language studies; no search for studies published only as abstracts; statistical heterogeneity present in most analyses; few studies for qualitative NMP22, quantitative BTA, and Cxbladder; and methodological shortcomings in almost all studies. Conclusion: Urinary biomarkers miss a substantial proportion of patients with bladder cancer and are subject to false-positive results in others. Accuracy is poor for low-stage and low-grade tumors.	[Chou, Roger; Buckley, David; Fu, Rongwei; Gustafson, Katie; Griffin, Jessica C.; Grusing, Sara; Selph, Shelley] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Gore, John L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality [CRD42014013284]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO registration number: CRD42014013284)	[Anonymous], 1997, Br J Urol, V79, P362; [Anonymous], 2014, AHRQ PUBLICATION, V10(12)-EHC063-EF; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Banos JLG, 2001, UROL INT, V66, P185, DOI 10.1159/000056612; Cha EK, 2012, EUR UROL, V61, P185, DOI 10.1016/j.eururo.2011.08.073; Chahal R, 2001, EUR UROL, V40, P415, DOI 10.1159/000049809; Chappell FM, 2009, STAT MED, V28, P2653, DOI 10.1002/sim.3631; Chou R, 2015, EMERGING APPROACHES; Chou R, 2014, PROSPERO INT PROSPEC; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; Feil G, 2003, ANTICANCER RES, V23, P963; Friedrich MG, 2002, J UROLOGY, V168, P470, DOI 10.1016/S0022-5347(05)64660-5; Fu R., 2013, HANDLING CONTINUOUS; Gatsonis C, 2006, AM J ROENTGENOL, V187, P271, DOI 10.2214/AJR.06.0226; Giannopoulos A, 2001, J UROLOGY, V166, P470, DOI 10.1016/S0022-5347(05)65965-4; Gibanel R, 2002, ANTICANCER RES, V22, P1157; Grossman HB, 2006, JAMA-J AM MED ASSOC, V295, P299, DOI 10.1001/jama.295.3.299; Grossman HB, 2005, JAMA-J AM MED ASSOC, V293, P810, DOI 10.1001/jama.293.7.810; Gudjonsson S, 2008, EUR UROL, V54, P402, DOI 10.1016/j.eururo.2007.11.051; Gupta NP, 2009, UROLOGY, V73, P592, DOI 10.1016/j.urology.2008.04.051; Hajdinjak T, 2008, UROL ONCOL-SEMIN ORI, V26, P646, DOI 10.1016/j.urolonc.2007.06.002; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Halling KC, 2002, J UROLOGY, V167, P2001, DOI 10.1016/S0022-5347(05)65072-0; Herman M P, 2008, Minerva Urol Nefrol, V60, P217; Horstmann M, 2009, SCAND J UROL NEPHROL, V43, P461, DOI 10.3109/00365590903296837; Ianari A, 1997, UROLOGY, V49, P786, DOI 10.1016/S0090-4295(97)00081-2; Irani J, 1999, EUR UROL, V35, P89, DOI 10.1159/000019824; Jaeschke R, 1994, JAMA-J AM MED ASSOC, V271, P703; Junker K, 2006, CYTOGENET GENOME RES, V114, P279, DOI 10.1159/000094214; Karnwal A, 2010, CAN J UROL, V17, P5077; Leyh H, 1999, EUR UROL, V35, P52, DOI 10.1159/000019819; Leyh H, 1997, UROLOGY, V50, P49, DOI 10.1016/S0090-4295(97)00206-9; Leyh H, 1997, EUR UROL, V32, P425, DOI 10.1159/000480801; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Lodde M, 2003, UROLOGY, V61, P243, DOI 10.1016/S0090-4295(02)02073-3; Lotan Y, 2003, UROLOGY, V61, P109, DOI 10.1016/S0090-4295(02)02136-2; Lotan Y, 2010, UROL ONCOL-SEMIN ORI, V28, P441, DOI 10.1016/j.urolonc.2009.11.004; Lotan Y, 2009, BJU INT, V103, P1368, DOI 10.1111/j.1464-410X.2009.08360.x; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Messing EM, 2005, J UROLOGY, V174, P1238, DOI 10.1097/01.ju.0000173918.84006.4d; Mian C, 2000, UROLOGY, V56, P228, DOI 10.1016/S0090-4295(00)00664-6; Mian C, 1999, J UROLOGY, V161, P1486, DOI 10.1016/S0022-5347(05)68934-3; Nasuti JF, 1999, DIAGN CYTOPATHOL, V21, P27, DOI 10.1002/(SICI)1097-0339(199907)21:1<27::AID-DC8>3.3.CO;2-#; O'Sullivan P, 2012, J UROLOGY, V188, P741, DOI 10.1016/j.juro.2012.05.003; Olsson H, 2001, SCAND J UROL NEPHROL, V35, P280; Paoluzzi M, 1999, Arch Ital Urol Androl, V71, P13; Pfister C, 2003, J UROLOGY, V169, P921, DOI 10.1097/01.ju.0000048983.83079.4c; Piaton E, 2003, LAB INVEST, V83, P845, DOI 10.1097/01.LAB.0000074893.70675.2E; Placer J, 2002, EUR UROL, V42, P547, DOI 10.1016/S0302-2838(02)00448-7; Pode D, 1999, J UROLOGY, V161, P443, DOI 10.1016/S0022-5347(01)61918-9; Ponsky LE, 2001, J UROLOGY, V166, P75, DOI 10.1016/S0022-5347(05)66080-6; Quek P, 2002, ANN ACAD MED SINGAP, V31, P212; Raitanen MP, 2001, ANN CHIR GYNAECOL, V90, P261; Raitanen MP, 2001, EUR UROL, V40, P422, DOI 10.1159/000049810; Ru YB, 2011, CURR OPIN UROL, V21, P420, DOI 10.1097/MOU.0b013e32834956d6; Saad A, 2002, BJU INT, V89, P369, DOI 10.1046/j.1464-4096.2001.01699.x; Sanchez-Carbayo M, 2001, J UROLOGY, V165, P1462, DOI 10.1016/S0022-5347(05)66328-8; Sarosdy MF, 2002, J UROLOGY, V168, P1950, DOI 10.1016/S0022-5347(05)64270-X; Sawczuk IS, 2000, CANCER DETECT PREV, V24, P364; Schamhart DHJ, 1998, EUR UROL, V34, P99, DOI 10.1159/000019692; Schmitz-Drager B, 2008, BJU INT, V101, P455, DOI 10.1111/j.1464-410X.2007.07287.x; Schmitz-Drager BJ, 2007, EUR UROL, V51, P1582, DOI 10.1016/j.eururo.2006.10.046; Serretta V, 2000, EUR UROL, V38, P419, DOI 10.1159/000020318; Serretta V, 1998, UROLOGY, V52, P793, DOI 10.1016/S0090-4295(98)00332-X; Shariat SF, 2006, J UROLOGY, V176, P919, DOI 10.1016/j.juro.2006.04.017; Sharma S, 1999, J UROLOGY, V162, P53, DOI 10.1097/00005392-199907000-00014; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song MJ, 2010, CANCER GENET CYTOGEN, V198, P144, DOI 10.1016/j.cancergencyto.2010.01.007; Sullivan PS, 2009, CANCER CYTOPATHOL, V117, P167, DOI 10.1002/cncy.20026; Takwoingi Y, 2013, ANN INTERN MED, V158, P544, DOI 10.7326/0003-4819-158-7-201304020-00006; Tetu B, 2005, MODERN PATHOL, V18, P83, DOI 10.1038/modpathol.3800262; Thomas L, 1999, CLIN CHEM, V45, P472; Toma MI, 2004, WORLD J UROL, V22, P145, DOI 10.1007/s00345-003-0390-8; Trikalinos TA, 2012, J GEN INTERN MED, V27, pS56, DOI 10.1007/s11606-012-2029-1; Van der Poel HG, 1998, UROLOGY, V51, P44, DOI 10.1016/S0090-4295(97)00496-2; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; Varella-Garcia M, 2004, UROL ONCOL-SEMIN ORI, V22, P16, DOI 10.1016/S1078-1439(03)00098-X; Vriesema JLJ, 2001, UROLOGY, V58, P367, DOI 10.1016/S0090-4295(01)01217-1; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wiener HG, 1998, J UROLOGY, V159, P1876; Witjes JA, 1998, EUR UROL, V33, P387, DOI 10.1159/000019621; Zippe C, 1999, ANTICANCER RES, V19, P2621; Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992	84	141	147	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12					922	+		10.7326/M15-0997	http://dx.doi.org/10.7326/M15-0997			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26501851				2022-12-28	WOS:000366354200018
J	Yan, WP; Song, H; Song, FH; Guo, YS; Wu, CH; Her, AS; Pu, Y; Wang, S; Naowarojna, N; Weitz, A; Hendrich, MP; Costello, CE; Zhang, LX; Liu, PH; Zhang, YJ				Yan, Wupeng; Song, Heng; Song, Fuhang; Guo, Yisong; Wu, Cheng-Hsuan; Her, Ampon Sae; Pu, Yi; Wang, Shu; Naowarojna, Nathchar; Weitz, Andrew; Hendrich, Michael P.; Costello, Catherine E.; Zhang, Lixin; Liu, Pinghua; Zhang, Yan Jessie			RETRACTED: RETRACTED ARTICLE: Endoperoxide formation by an alpha-ketoglutarate-dependent mononuclear non-haem iron enzyme (Retracted article. See vol. 593, pg. 612, 2021)	NATURE			English	Article; Retracted Publication							COFACTOR-INDEPENDENT DIOXYGENATION; CRYSTAL-STRUCTURE; OXYGEN ACTIVATION; PHASE REFINEMENT; STRUCTURAL BASIS; MODEL; BIOSYNTHESIS; PURIFICATION; IMPROVEMENT; VALIDATION	Many peroxy-containing secondary metabolites(1,2) have been isolated and shown to provide beneficial effects to human health(3-5). Yet, the mechanisms of most endoperoxide biosyntheses are not well understood. Although endoperoxides have been suggested as key reaction intermediates in several cases(6-8), the only well-characterized endoperoxide biosynthetic enzyme is prostaglandin H synthase, a haem-containing enzyme(9). Fumitremorgin B endoperoxidase (FtmOx1) from Aspergillus fumigatus is the first reported alpha-ketoglutarate-dependent mononuclear non-haem iron enzyme that can catalyse an endoperoxide formation reaction(10-12). To elucidate the mechanistic details for this unique chemical transformation, we report the X-ray crystal structures of FtmOx1 and the binary complexes it forms with either the co-substrate (alpha-ketoglutarate) or the substrate (fumitremorgin B). Uniquely, after alpha-ketoglutarate has bound to the mononuclear iron centre in a bidentate fashion, the remaining open site for oxygen binding and activation is shielded from the substrate or the solvent by a tyrosine residue (Y224). Upon replacing Y224 with alanine or phenylalanine, the FtmOx1 catalysis diverts from endoperoxide formation to the more commonly observed hydroxylation. Subsequent characterizations by a combination of stopped-flow optical absorption spectroscopy and freeze-quench electron paramagnetic resonance spectroscopy support the presence of transient radical species in FtmOx1 catalysis. Our results help to unravel the novel mechanism for this endoperoxide formation reaction.	[Yan, Wupeng; Zhang, Yan Jessie] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Song, Heng; Wu, Cheng-Hsuan; Her, Ampon Sae; Pu, Yi; Wang, Shu; Naowarojna, Nathchar; Costello, Catherine E.; Liu, Pinghua] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA; [Song, Fuhang; Zhang, Lixin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Pu, Yi; Costello, Catherine E.] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [Zhang, Yan Jessie] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Guo, Yisong; Weitz, Andrew; Hendrich, Michael P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	University of Texas System; University of Texas Austin; Boston University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Boston University; University of Texas System; University of Texas Austin; Carnegie Mellon University	Liu, PH (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	lzhang03@gmail.com; pinghua@bu.edu; jzhang@cm.utexas.edu	Song, Heng/I-1381-2016; Guo, Yisong/C-7785-2009	Guo, Yisong/0000-0002-4132-3565; Naowarojna, Nathchar/0000-0002-7952-3458; Costello, Catherine/0000-0003-1594-5122; Weitz, Andrew/0000-0002-9001-1103; Zhang, Lixin/0000-0003-0894-9520	National Institutes of Health [R01 GM093903, P41 GM104603, R01 GM104896, R01 GM077387]; National Science Foundation [CHE-1309148, CHE-1126268]; Welch Foundation [F-1778]; 973 program [2013CB734000]; Carnegie Mellon University; National Distinguished Young Scholar Program in China [31125002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093903, P41GM104603, R01GM104896, R01GM077387] Funding Source: NIH RePORTER; Division Of Chemistry [1309148] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); 973 program(National Basic Research Program of China); Carnegie Mellon University; National Distinguished Young Scholar Program in China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank H.-w. Liu, S. Elliott and A. Liu for comments on the manuscript. We also thank R. Fan and J. Lee for assistance with the pre-steady state kinetics studies, J. Caradonna for use of stopped-flow instruments, and A. Monzingo for assistance with crystallography software. This work is supported in part by grants from the National Institutes of Health (R01 GM093903 to P.L.; P41 GM104603 to C.E.C.; R01 GM104896 to Y.J.Z.; and R01 GM077387 to M.P.H.), the National Science Foundation (CHE-1309148 to P.L.; CHE-1126268 for the EPR spectrometer), the Welch Foundation (F-1778 to Y.J.Z.), the 973 program (2013CB734000 to L.Z), and Y.G. acknowledges financial support from Carnegie Mellon University. Crystallographic data collection was conducted at advanced light sources (Beamline 5.0.3) and advanced photon sources (BL23-ID-B), Department of Energy (DOE) National User Facility. L.Z. is an awardee of the National Distinguished Young Scholar Program in China (31125002).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAKER D, 1993, ACTA CRYSTALLOGR D, V49, P429, DOI 10.1107/S0907444993004032; Baldwin J, 2000, J AM CHEM SOC, V122, P12195, DOI 10.1021/ja001278u; Berkholz DS, 2009, STRUCTURE, V17, P1316, DOI 10.1016/j.str.2009.08.012; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Blodgett JAV, 2007, NAT CHEM BIOL, V3, P480, DOI 10.1038/nchembio.2007.9; BRICOGNE G, 1974, ACTA CRYSTALLOGR A, VA 30, P395, DOI 10.1107/S0567739474010722; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CASTEEL DA, 1992, NAT PROD REP, V9, P289, DOI 10.1039/np9920900289; Casteel DA, 1999, NAT PROD REP, V16, P55; Chang WC, 2014, SCIENCE, V343, P1140, DOI 10.1126/science.1248000; Chaturvedi D, 2010, CHEM SOC REV, V39, P435, DOI 10.1039/b816679j; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Clifton IJ, 2003, J BIOL CHEM, V278, P20843, DOI 10.1074/jbc.M213054200; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dembitsky VM, 2008, EUR J MED CHEM, V43, P223, DOI 10.1016/j.ejmech.2007.04.019; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Helm I, 2009, ANAL CHIM ACTA, V648, P167, DOI 10.1016/j.aca.2009.06.067; Kato N, 2011, CHEMBIOCHEM, V12, P711, DOI 10.1002/cbic.201000562; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Liu A, 2001, J AM CHEM SOC, V123, P5126, DOI 10.1021/ja005879x; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Marnett LJ, 2000, CURR OPIN CHEM BIOL, V4, P545, DOI 10.1016/S1367-5931(00)00130-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddon CJ, 2014, NAT REV MICROBIOL, V12, P355, DOI 10.1038/nrmicro3240; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; SAYRE D, 1974, ACTA CRYSTALLOGR A, VA 30, P180, DOI 10.1107/S0567739474000404; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Schuller DJ, 1996, ACTA CRYSTALLOGR D, V52, P425, DOI 10.1107/S0907444995013291; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Steffan N, 2009, ORG BIOMOL CHEM, V7, P4082, DOI 10.1039/b908392h; Steiner RA, 2010, P NATL ACAD SCI USA, V107, P657, DOI 10.1073/pnas.0909033107; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; SWANSON SM, 1994, ACTA CRYSTALLOGR D, V50, P695, DOI 10.1107/S0907444994002398; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thierbach S, 2014, CHEM BIOL, V21, P217, DOI 10.1016/j.chembiol.2013.11.013; Tronrud DE, 2010, ACTA CRYSTALLOGR D, V66, P834, DOI 10.1107/S0907444910019207; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Widboom PF, 2007, NATURE, V447, P342, DOI 10.1038/nature05702; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZHANG KYJ, 1990, ACTA CRYSTALLOGR A, V46, P377, DOI 10.1107/S0108767389012158	62	69	76	3	148	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					539	+		10.1038/nature15519	http://dx.doi.org/10.1038/nature15519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26524521	Green Accepted, Green Submitted			2022-12-28	WOS:000365352500053
J	Asch, DA; Troxel, AB; Stewart, WF; Sequist, TD; Jones, JB; Hirsch, AG; Hoffer, K; Zhu, JS; Wang, WL; Hodlofski, A; Frasch, AB; Weiner, MG; Finnerty, DD; Rosenthal, MB; Gangemi, K; Volpp, KG				Asch, David A.; Troxel, Andrea B.; Stewart, Walter F.; Sequist, Thomas D.; Jones, James B.; Hirsch, AnneMarie G.; Hoffer, Karen; Zhu, Jingsan; Wang, Wenli; Hodlofski, Amanda; Frasch, Antonette B.; Weiner, Mark G.; Finnerty, Darra D.; Rosenthal, Meredith B.; Gangemi, Kelsey; Volpp, Kevin G.			Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PAY-FOR-PERFORMANCE; MYOCARDIAL-INFARCTION; HOSPITAL PAY; ADHERENCE; MORTALITY; IMPROVE; CARE; DISCONTINUATION; CHOLESTEROL; THERAPY	IMPORTANCE Financial incentives to physicians or patients are increasingly used, but their effectiveness is not well established. OBJECTIVE To determine whether physician financial incentives, patient incentives, or shared physician and patient incentives are more effective than control in reducing levels of low-density lipoprotein cholesterol (LDL-C) among patients with high cardiovascular risk. DESIGN, SETTING, AND PARTICIPANTS Four-group, multicenter, cluster randomized clinical trial with a 12-month intervention conducted from 2011 to 2014 in 3 primary care practices in the northeastern United States. Three hundred forty eligible primary care physicians (PCPs) were enrolled from a pool of 421. Of 25 627 potentially eligible patients of those PCPs, 1503 enrolled. Patients aged 18 to 80 years were eligible if they had a 10-year Framingham Risk Score (FRS) of 20% or greater, had coronary artery disease equivalents with LDL-C levels of 120mg/dL or greater, or had an FRS of 10% to 20% with LDL-C levels of 140 mg/dL or greater. Investigators were blinded to study group, but participants were not. INTERVENTIONS Primary care physicians were randomly assigned to control, physician incentives, patient incentives, or shared physician-patient incentives. Physicians in the physician incentives group were eligible to receive up to $1024 per enrolled patientmeeting LDL-C goals. Patients in the patient incentives group were eligible for the same amount, distributed through daily lotteries tied to medication adherence. Physicians and patients in the shared incentives group shared these incentives. Physicians and patients in the control group received no incentives tied to outcomes, but all patient participants received up to $355 each for trial participation. MAIN OUTCOMES AND MEASURES Change in LDL-C level at 12 months. RESULTS Only patients in the shared physician-patient incentives group achieved reductions in LDL-C levels statistically different from those in the control group (8.5mg/dL; 95% CI, 3.8-13.3; P=.002). For comparison of all 4 groups, P < .001. [GRAPHICS] CONCLUSIONS AND RELEVANCE In primary care practices, shared financial incentives for physicians and patients, but not incentives to physicians or patients alone, resulted in a statistically significant difference in reduction of LDL-C levels at 12 months. This reduction was modest, however, and further information is needed to understand whether this approach represents good value.	[Asch, David A.; Troxel, Andrea B.; Hoffer, Karen; Zhu, Jingsan; Wang, Wenli; Hodlofski, Amanda; Frasch, Antonette B.; Finnerty, Darra D.; Gangemi, Kelsey; Volpp, Kevin G.] Univ Penn, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Dept Vet Affairs, Philadelphia, PA 19104 USA; [Stewart, Walter F.; Jones, James B.] Sutter Hlth Syst, Sacramento, CA USA; [Sequist, Thomas D.] Partners Healthcare Syst, Boston, MA USA; [Sequist, Thomas D.] Harvard Univ, Sch Med, Boston, MA USA; [Hirsch, AnneMarie G.] Geisinger Hlth Syst, Danville, PA USA; [Weiner, Mark G.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Rosenthal, Meredith B.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	University of Pennsylvania; Partners Healthcare System; Harvard University; Harvard Medical School; Geisinger Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Harvard T.H. Chan School of Public Health	Volpp, KG (corresponding author), Univ Penn, 423 Guardian Dr,1120 Blockley Hall, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu		Troxel, Andrea/0000-0002-1393-3075; Volpp, Kevin/0000-0003-1423-4599; Asch, David/0000-0002-7970-286X	National Institute on Aging [RC4 AG039114]; NATIONAL INSTITUTE ON AGING [RC4AG039114, P30AG034546] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study received support from the National Institute on Aging (RC4 AG039114 to Drs Asch and Volpp).	Albert NM, 2008, AM J CARDIOL, V101, P1242, DOI 10.1016/j.amjcard.2007.12.020; Asch David A, 2012, LDI Issue Brief, V17, P1; Austin PC, 2006, AM HEART J, V151, P969, DOI 10.1016/j.ahj.2005.06.034; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blackburn DF, 2005, CAN J CARDIOL, V21, P485; Bosworth HB, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-54; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Connolly T, 2006, J BEHAV DECIS MAKING, V19, P139, DOI 10.1002/bdm.510; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Grady KE, 1997, PREV MED, V26, P791, DOI 10.1006/pmed.1997.0219; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; HOLM S, 1979, SCAND J STAT, V6, P65; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; Hudson M, 2007, PHARMACOEPIDEM DR S, V16, P773, DOI 10.1002/pds.1414; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kimmel SE, 2012, AM HEART J, V164, P268, DOI 10.1016/j.ahj.2012.05.005; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Loewenstein G, 2013, HEALTH AFFAIR, V32, P1244, DOI 10.1377/hlthaff.2012.1163; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P1375, DOI 10.1001/jama.2012.387; Luczak K, 2010, KARDIOL POL, V68, P806; Nauck M, 2002, CLIN CHEM, V48, P236; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Petersen LA, 2013, JAMA-J AM MED ASSOC, V310, P1042, DOI 10.1001/jama.2013.276303; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Read D, 1999, J RISK UNCERTAINTY, V19, P171, DOI 10.1023/A:1007879411489; Rosenson R., STATINS ACTIONS SIDE; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Thaler RH, 1997, Q J ECON, V112, P647, DOI 10.1162/003355397555226; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Wei L, 2002, HEART, V88, P229, DOI 10.1136/heart.88.3.229	38	120	121	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1926	1935		10.1001/jama.2015.14850	http://dx.doi.org/10.1001/jama.2015.14850			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV7XQ	26547464	Bronze, Green Accepted			2022-12-28	WOS:000364490700015
J	Smith, JM				Smith, Jeanette M.			Untitled Stephen Gilbert	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1898	1899		10.1001/jama.2014.12077	http://dx.doi.org/10.1001/jama.2014.12077			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547447				2022-12-28	WOS:000364490700001
J	Lin, SJ; Cheng, SF; Song, B; Zhong, X; Lin, X; Li, WJ; Li, L; Zhang, YQ; Zhang, H; Ji, ZL; Cai, MC; Zhuang, YY; Shi, XG; Lin, LX; Wang, L; Wang, ZB; Liu, X; Yu, S; Zeng, P; Hao, H; Zou, Q; Chen, CX; Li, YJ; Wang, Y; Xu, CY; Meng, SS; Xu, X; Wang, J; Yang, HM; Campbell, DA; Sturm, NR; Dagenais-Bellefeuille, S; Morse, D				Lin, Senjie; Cheng, Shifeng; Song, Bo; Zhong, Xiao; Lin, Xin; Li, Wujiao; Li, Ling; Zhang, Yaqun; Zhang, Huan; Ji, Zhiliang; Cai, Meichun; Zhuang, Yunyun; Shi, Xinguo; Lin, Lingxiao; Wang, Lu; Wang, Zhaobao; Liu, Xin; Yu, Sheng; Zeng, Peng; Hao, Han; Zou, Quan; Chen, Chengxuan; Li, Yanjun; Wang, Ying; Xu, Chunyan; Meng, Shanshan; Xu, Xun; Wang, Jun; Yang, Huanming; Campbell, David A.; Sturm, Nancy R.; Dagenais-Bellefeuille, Steve; Morse, David			The Symbiodinium kawagutii genome illuminates dinoflagellate gene expression and coral symbiosis	SCIENCE			English	Article							SMALL RNAS; HOST; GLUCOSE; SID-1; ALGAE	Dinoflagellates are important components of marine ecosystems and essential coral symbionts, yet little is known about their genomes. We report here on the analysis of a high-quality assembly from the 1180-megabase genome of Symbiodinium kawagutii. We annotated protein-coding genes and identified Symbiodinium-specific gene families. No whole-genome duplication was observed, but instead we found active (retro) transposition and gene family expansion, especially in processes important for successful symbiosis with corals. We also documented genes potentially governing sexual reproduction and cyst formation, novel promoter elements, and a microRNA system potentially regulating gene expression in both symbiont and coral. We found biochemical complementarity between genomes of S. kawagutii and the anthozoan Acropora, indicative of host-symbiont coevolution, providing a resource for studying the molecular basis and evolution of coral symbiosis.	[Lin, Senjie; Lin, Xin; Li, Ling; Zhang, Yaqun; Shi, Xinguo; Lin, Lingxiao; Wang, Lu; Meng, Shanshan] Xiamen Univ, State Key Lab Marine Environm Sci & Marine Biodiv, Xiamen 361101, Peoples R China; [Lin, Senjie; Lin, Xin; Li, Ling; Zhang, Yaqun; Shi, Xinguo; Lin, Lingxiao; Wang, Lu; Meng, Shanshan] Xiamen Univ, Global Change Res Ctr, Xiamen 361101, Peoples R China; [Lin, Senjie; Zhang, Huan; Zhuang, Yunyun] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Cheng, Shifeng; Song, Bo; Zhong, Xiao; Li, Wujiao; Wang, Zhaobao; Liu, Xin; Yu, Sheng; Zeng, Peng; Chen, Chengxuan; Li, Yanjun; Wang, Ying; Xu, Chunyan; Xu, Xun; Wang, Jun; Yang, Huanming] Beijing Genom Inst BGI Shenzhen, Shenzhen 518083, Peoples R China; [Cheng, Shifeng] Univ Hong Kong, Hong Kong Univ HKU BGI Bioinformat Algorithms & C, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Cheng, Shifeng] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Ji, Zhiliang; Cai, Meichun; Zou, Quan] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen 361101, Peoples R China; [Hao, Han] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun; Yang, Huanming] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21413, Saudi Arabia; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Campbell, David A.; Sturm, Nancy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Dagenais-Bellefeuille, Steve; Morse, David] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Xiamen University; Xiamen University; University of Connecticut; Beijing Genomics Institute (BGI); University of Hong Kong; University of Hong Kong; Xiamen University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); University of Copenhagen; King Abdulaziz University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universite de Montreal	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci & Marine Biodiv, Xiamen 361101, Peoples R China.	senjie.lin@uconn.edu	Zou, Quan/A-7801-2015; Xu, Xun/AAI-6763-2020; Chen, Chengxuan/HCH-3606-2022; Guo, chentao/G-7320-2016; Song, Bo/AAU-6535-2021; Lin, Senjie/A-7466-2011	Xu, Xun/0000-0002-5338-5173; Chen, Chengxuan/0000-0002-9650-1437; Morse, David/0000-0003-4131-4367; Liu, Xin/0000-0003-3256-2940; Dagenais Bellefeuille, Steve/0000-0001-5281-5971	Natural Science Foundation of China [K16110, K16044]; U.S. National Science Foundation [OCE-0854719]; U.S. NIH [AI056034, AI073806]; National Science and Engineering Research Council of Canada [171382-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073806, R01AI056034] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Natural Science Foundation of China grants K16110 and K16044 (to S.L.), U.S. National Science Foundation grant OCE-0854719 (to S.L. and H.Z.), U.S. NIH awards AI056034 and AI073806 (to D.A.C. and N.R.S.), National Science and Engineering Research Council of Canada grant 171382-03 (to D.M.), and various funds to BGI-Shenzhen, Shenzhen [State Key Laboratory of Agricultural Genomics, Guangdong Provincial Key Laboratory of core collection of crop genetic resources research and application (2011A091000047), Shenzhen Engineering Laboratory of Crop Molecular design breeding, and China National GeneBank-Shenzhen]. The genomic sequences and the annotated genes of S. kawagutii, as well as RNA sequencing data (unigenes), are available in our Symka Genome Database in Xiamen University: http://bioinf.xmu.edu.cn/symka_new; these data have also been deposited into the National Center for Biotechnology Information Short Read Archive (SRA) under accession number SRA148697.	ALBERTYN J, 1994, CURR GENET, V25, P12, DOI 10.1007/BF00712960; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Bay Line Kolind, 2011, Diversity, V3, P356; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Clode PL, 2009, PLANT CELL ENVIRON, V32, P170, DOI 10.1111/j.1365-3040.2008.01909.x; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Guillebault D, 2002, J BIOL CHEM, V277, P40881, DOI 10.1074/jbc.M205624200; Lin KL, 2000, ZOOL STUD, V39, P172; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	21	280	293	15	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					691	694		10.1126/science.aad0408	http://dx.doi.org/10.1126/science.aad0408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542574				2022-12-28	WOS:000364162800054
J	Schneider, NM; Deighan, JI; Jain, SK; Stiepen, A; Stewart, AIF; Larson, D; Mitchell, DL; Mazelle, C; Lee, CO; Lillis, RJ; Evans, JS; Brain, D; Stevens, MH; McClintock, WE; Chaffin, MS; Crismani, M; Holsclaw, GM; Lefevre, F; Lo, DY; Clarke, JT; Montmessin, F; Jakosky, BM				Schneider, N. M.; Deighan, J. I.; Jain, S. K.; Stiepen, A.; Stewart, A. I. F.; Larson, D.; Mitchell, D. L.; Mazelle, C.; Lee, C. O.; Lillis, R. J.; Evans, J. S.; Brain, D.; Stevens, M. H.; McClintock, W. E.; Chaffin, M. S.; Crismani, M.; Holsclaw, G. M.; Lefevre, F.; Lo, D. Y.; Clarke, J. T.; Montmessin, F.; Jakosky, B. M.			Discovery of diffuse aurora on Mars	SCIENCE			English	Article							VENUS ULTRAVIOLET AURORA; ELECTRON-PRECIPITATION; ATMOSPHERE; DEPENDENCE; TRANSPORT; NIGHTGLOW; SATELLITE; TRITON	Planetary auroras reveal the complex interplay between an atmosphere and the surrounding plasma environment. We report the discovery of low-altitude, diffuse auroras spanning much of Mars' northern hemisphere, coincident with a solar energetic particle outburst. The Imaging Ultraviolet Spectrograph, a remote sensing instrument on the Mars Atmosphere and Volatile Evolution (MAVEN) spacecraft, detected auroral emission in virtually all nightside observations for similar to 5 days, spanning nearly all geographic longitudes. Emission extended down to similar to 60 kilometer (km) altitude (1 microbar), deeper than confirmed at any other planet. Solar energetic particles were observed up to 200 kilo-electron volts; these particles are capable of penetrating down to the 60 km altitude. Given minimal magnetic fields over most of the planet, Mars is likely to exhibit auroras more globally than Earth.	[Schneider, N. M.; Deighan, J. I.; Jain, S. K.; Stiepen, A.; Stewart, A. I. F.; Brain, D.; McClintock, W. E.; Chaffin, M. S.; Crismani, M.; Holsclaw, G. M.; Jakosky, B. M.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Larson, D.; Mitchell, D. L.; Lee, C. O.; Lillis, R. J.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Mazelle, C.] CNRS, IRAP, Toulouse, France; [Mazelle, C.] Univ Toulouse 3, IRAP, CNRS, F-31062 Toulouse, France; [Evans, J. S.] Computat Phys Inc, Springfield, VA 22151 USA; [Stevens, M. H.] Naval Res Lab, Div Space Sci, Washington, DC 20375 USA; [Lefevre, F.] Inst Pierre Simon Laplace, Lab Atmospheres, Milieux, Observat Spatiales, Guyancourt, France; [Lo, D. Y.; Montmessin, F.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Clarke, J. T.] Boston Univ, Ctr Space Phys, Boston, MA 02215 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); United States Department of Defense; United States Navy; Naval Research Laboratory; UDICE-French Research Universities; Universite Paris Saclay; University of Arizona; Boston University	Schneider, NM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA.	nick.schneider@lasp.colorado.edu	Lillis, Robert J/A-3281-2008; Holsclaw, Greg/AAX-2486-2021; Clarke, John/C-8644-2013; Crismani, Matteo/H-3791-2016	Lillis, Robert J/0000-0003-0578-517X; Holsclaw, Greg/0000-0002-9059-9437; BRAIN, DAVID/0000-0001-8932-368X; Lee, Christina/0000-0002-1604-3326; Lo, Daniel/0000-0002-9603-500X; SCHNEIDER, NICHOLAS/0000-0001-6720-5519; Crismani, Matteo/0000-0003-3127-2466; Montmessin, Franck/0000-0002-4187-1457	NASA through the Mars Exploration Program; Belgian American Educational Foundation; Rotary District [1630]; NASA MAVEN Participating Scientist Program; Centre National d'Etudes Spatiales	NASA through the Mars Exploration Program; Belgian American Educational Foundation; Rotary District; NASA MAVEN Participating Scientist Program; Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	The MAVEN mission is supported by NASA through the Mars Exploration Program. A.S. was supported by the Belgian American Educational Foundation and the Rotary District 1630. M.H.S. was supported by the NASA MAVEN Participating Scientist Program. This work was partially supported by the Centre National d'Etudes Spatiales, for the part based on observations with the SWEA instrument. The IUVS data are publicly archived at the Planetary Atmospheres node of the Planetary Data System and can be identified by the file suffix v03_r01.	Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Bertaux JL, 2005, NATURE, V435, P790, DOI 10.1038/nature03603; Bertaux JL, 2005, SCIENCE, V307, P566, DOI 10.1126/science.1106957; Brain DA, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012435; Brain DA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024782; Evans JS, 2015, GEOPHYS RES LETT, V42, P9040, DOI 10.1002/2015GL065489; EVANS JS, 1994, J GEOPHYS RES-SPACE, V99, P17591, DOI 10.1029/94JA01143; FOX JL, 1993, GEOPHYS RES LETT, V20, P1339, DOI 10.1029/93GL01349; FOX JL, 1991, J GEOPHYS RES-SPACE, V96, P9821, DOI 10.1029/91JA00252; Gerard JC, 2015, J GEOPHYS RES-SPACE, V120, P6749, DOI 10.1002/2015JA021150; Gray C., 2015, THESIS; Jain SK, 2015, GEOPHYS RES LETT, V42, P9023, DOI 10.1002/2015GL065419; Jakosky BM, 2015, SCIENCE, V350, DOI [10.1126/science.aad0210, 10.1126/science.aad3443]; Jakosky BM, 2015, SPACE SCI REV, V195, P3, DOI 10.1007/s11214-015-0139-x; Larson D. E., 2015, 46 LUN PLAN SCI C LU; Leblanc F, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900178; Leblanc F, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011763; Leblanc F, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013033; Lillis RJ, 2013, J GEOPHYS RES-SPACE, V118, P3546, DOI 10.1002/jgra.50171; Lundin R, 2006, SCIENCE, V311, P980, DOI 10.1126/science.1122071; McClintock WE, 2015, SPACE SCI REV, V195, P75, DOI 10.1007/s11214-014-0098-7; McGrath MA, 2004, CAMB PLANET, P457; Millour E, 2014, 8 INT C MARS LUN PLA, P1184; Mitchell D. L., 2015, 46 LUN PLAN SCI C LU; Newell PT, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014326; PHILLIPS JL, 1986, GEOPHYS RES LETT, V13, P1047, DOI 10.1029/GL013i010p01047; Sandholt P. E., 2002, DAYSIDE POLAR CAP AU; Slanger TG, 2006, ICARUS, V182, P1, DOI 10.1016/J.ICARUS.2005.12.007; Snow M., 2013, ISSI SCI REPORT SERI, P191; Stevens MH, 2015, GEOPHYS RES LETT, V42, P9050, DOI 10.1002/2015GL065319; Stevens MH, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016284; Stiepen A., 2015, 46 LUN PLAN SCI C LU; STRICKLAND DJ, 1983, J GEOPHYS RES-SPACE, V88, P8051, DOI 10.1029/JA088iA10p08051; Strickland DJ, 1999, J QUANT SPECTROSC RA, V62, P689, DOI 10.1016/S0022-4073(98)00098-3; STRICKLAND DJ, 1989, J GEOPHYS RES-SPACE, V94, P13527, DOI 10.1029/JA094iA10p13527; STRICKLAND DJ, 1976, J GEOPHYS RES-SPACE, V81, P2755, DOI 10.1029/JA081i016p02755; STROBEL DF, 1991, GEOPHYS RES LETT, V18, P689, DOI 10.1029/91GL00133; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1729, DOI 10.1029/GL017i010p01729; Zhang Y, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031602	39	67	67	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261							aad0313	10.1126/science.aad0313	http://dx.doi.org/10.1126/science.aad0313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542577				2022-12-28	WOS:000364162800002
J	Jena, AB; Schoemaker, L; Bhattacharya, J; Seabury, SA				Jena, Anupam B.; Schoemaker, Lena; Bhattacharya, Jay; Seabury, Seth A.			Physician spending and subsequent risk of malpractice claims: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEFENSIVE MEDICINE PRACTICES; ADVERSE EVENTS; CESAREAN-SECTION; DOCTORS; ERRORS; MORTALITY; OUTCOMES; IMPACT; GASTROENTEROLOGISTS; LITIGATION	STUDY QUESTION Is a higher use of resources by physicians associated with a reduced risk of malpractice claims? METHODS Using data on nearly all admissions to acute care hospitals in Florida during 2000-09 linked to malpractice history of the attending physician, this study investigated whether physicians in seven specialties with higher average hospital charges in a year were less likely to face an allegation of malpractice in the following year, adjusting for patient characteristics, comorbidities, and diagnosis. To provide clinical context, the study focused on obstetrics, where the choice of caesarean deliveries are suggested to be influenced by defensive medicine, and whether obstetricians with higher adjusted caesarean rates in a year had fewer alleged malpractice incidents the following year. STUDY ANSWER AND LIMITATIONS The data included 24 637 physicians, 154 725 physician years, and 18 352 391 hospital admissions; 4342 malpractice claims were made against physicians (2.8% per physician year). Across specialties, greater average spending by physicians was associated with reduced risk of incurring a malpractice claim. For example, among internists, the probability of experiencing an alleged malpractice incident in the following year ranged from 1.5% (95% confidence interval 1.2% to 1.7%) in the bottom spending fifth ($ 19 725 (12 pound 800; (sic)17 400) per hospital admission) to 0.3% (0.2% to 0.5%) in the top fifth ($39 379 per hospital admission). In six of the specialties, a greater use of resources was associated with statistically significantly lower subsequent rates of alleged malpractice incidents. A principal limitation of this study is that information on illness severity was lacking. It is also uncertain whether higher spending is defensively motivated. WHAT THIS STUDY ADDS Within specialty and after adjustment for patient characteristics, higher resource use by physicians is associated with fewer malpractice claims.	[Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.; Bhattacharya, Jay; Seabury, Seth A.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Schoemaker, Lena; Bhattacharya, Jay] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Seabury, Seth A.] Univ So Calif, Dept Emergency Med, Los Angeles, CA USA; [Seabury, Seth A.] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research; Stanford University; University of Southern California; University of Southern California	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu			Office of the Director, National Institutes of Health (NIH early independence award) [1DP5OD017897-01]; National Institute of Aging [R37 AG036791]; NATIONAL INSTITUTE ON AGING [R37AG036791] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health (NIH early independence award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Office of the Director, National Institutes of Health (NIH early independence award, grant 1DP5OD017897-01 to ABJ) and National Institute of Aging (R37 AG036791 to JB).	[Anonymous], 2008, INVESTIGATION DEFENS; Baicker K, 2006, EFFECT MALPRACTICE L, P8; Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; BECKMAN HB, 1994, ARCH INTERN MED, V154, P1365, DOI 10.1001/archinte.154.12.1365; Bishop TF, 2011, JAMA-J AM MED ASSOC, V305, P2427, DOI 10.1001/jama.2011.813; Bishop TF, 2010, ARCH INTERN MED, V170, P1081, DOI 10.1001/archinternmed.2010.155; Bismark MM, 2013, BMJ QUAL SAF, V22, P532, DOI 10.1136/bmjqs-2012-001691; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; Carrier ER, 2013, HEALTH AFFAIR, V32, P1383, DOI 10.1377/hlthaff.2013.0233; Carrier ER, 2010, HEALTH AFFAIR, V29, P1585, DOI 10.1377/hlthaff.2010.0135; Catino M, 2009, STUD HEALTH TECHNOL, V148, P206, DOI 10.3233/978-1-60750-043-8-206; Chandra A, 2013, WALL STREET J; COPAS JB, 1983, J R STAT SOC B, V45, P311; Dubay L, 1999, J HEALTH ECON, V18, P491, DOI 10.1016/S0167-6296(99)00004-1; Elli L, 2013, DIGEST LIVER DIS, V45, P469, DOI 10.1016/j.dld.2013.01.004; ENTMAN SS, 1994, JAMA-J AM MED ASSOC, V272, P1588, DOI 10.1001/jama.272.20.1588; Fisher ES, 2009, LANDMARK PAPERS INTE, P30; Gimm GW, 2010, HEALTH SERV RES, V45, P195, DOI 10.1111/j.1475-6773.2009.01062.x; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Greenberg MD, 2010, EVIDENCE CALIFORNIA; Hermer LD, 2010, J GEN INTERN MED, V25, P470, DOI 10.1007/s11606-010-1259-3; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; Hiyama T, 2006, WORLD J GASTROENTERO, V12, P7671, DOI 10.3748/wjg.v12.i47.7671; Jena AB, 2015, JAMA INTERN MED, V175, P237, DOI 10.1001/jamainternmed.2014.6781; Jena AB, 2014, HEALTH AFFAIR, V33, P1832, DOI 10.1377/hlthaff.2014.0318; Jena AB, 2012, ARCH INTERN MED, V172, P892, DOI 10.1001/archinternmed.2012.1416; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kessler DP, 2002, J HEALTH ECON, V21, P931, DOI 10.1016/S0167-6296(02)00076-0; Kmietowicz Z, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4549; Lakdawalla DN, 2012, INT REV LAW ECON, V32, P356, DOI 10.1016/j.irle.2012.07.003; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; LOCALIO AR, 1993, JAMA-J AM MED ASSOC, V269, P366, DOI 10.1001/jama.269.3.366; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Ortashi O, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-42; Osterman Michelle J K, 2014, Natl Vital Stat Rep, V63, P1; Osti M, 2015, J EVAL CLIN PRACT, V21, P278, DOI 10.1111/jep.12305; Regenbogen SE, 2007, ANN SURG, V246, P705, DOI 10.1097/SLA.0b013e31815865f8; Rogers SO, 2006, SURGERY, V140, P25, DOI 10.1016/j.surg.2006.01.008; Romley JA, 2013, AM J MANAG CARE, V19, pE46; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Rothberg MB, 2014, JAMA INTERN MED, V174, P1867, DOI 10.1001/jamainternmed.2014.4649; Schaffer AC, 2014, J HOSP MED, V9, P750, DOI 10.1002/jhm.2244; Seabury SA, 2013, HEALTH AFFAIR, V32, P111, DOI 10.1377/hlthaff.2012.0967; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; SUMMERTON N, 1995, BRIT MED J, V310, P27, DOI 10.1136/bmj.310.6971.27; Summerton N, 2000, BRIT J GEN PRACT, V50, P565; Tehrani ASS, 2013, BMJ QUAL SAF, V22, P672, DOI 10.1136/bmjqs-2012-001550; VINCENT C, 1994, LANCET, V343, P1609, DOI 10.1016/S0140-6736(94)93062-7; Volpintesta E, 2013, JAMA INTERN MED, V173, P1927, DOI 10.1001/jamainternmed.2013.9743; Wallace E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002929; Weiler PC, 1993, MEASURE MALPRACTICE; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Yang YT, 2009, MED CARE, V47, P234, DOI 10.1097/MLR.0b013e31818475de	59	61	63	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5516	10.1136/bmj.h5516	http://dx.doi.org/10.1136/bmj.h5516			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV6OS	26538498	Green Published, hybrid			2022-12-28	WOS:000364390100005
J	Melnick, ER				Melnick, Edward R.			PERSONAL VIEW How to make less more: empathy can fill the gap left by reducing unnecessary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICINE		Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA	Yale University	Melnick, ER (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA.	edward.melnick@yale.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS021271] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Gawande A., 2015, NEW YORKER; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Hoffman JR, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5702; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Melnick ER, 2015, ACAD EMERG IN PRESS; Rolfe A, 2013, JAMA INTERN MED, V173, P407, DOI 10.1001/jamainternmed.2013.2762; Stacey D., 2014, COCHRANE DB SYST REV, V4, pCD001431, DOI [10.1002/14651858.CD001431.pub5, DOI 10.1002/14651858.CD001431.PUB5, 10.1002/14651858.CD001431.pub4, DOI 10.1002/14651858.CD001431.PUB4]; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; SZASZ TS, 1956, ARCH INTERN MED, V97, P585, DOI 10.1001/archinte.1956.00250230079008	11	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5831	10.1136/bmj.h5831	http://dx.doi.org/10.1136/bmj.h5831			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OS	26537887				2022-12-28	WOS:000364390100010
J	Bertisch, S				Bertisch, Suzanne			Restless Legs Syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERIODIC LIMB MOVEMENTS; DOUBLE-BLIND; DOPAMINE AGONISTS; GABAPENTIN ENACARBIL; DIAGNOSTIC-CRITERIA; PRACTICE PARAMETERS; SENSORY SYMPTOMS; CIRCADIAN-RHYTHM; SYNDROME RLS; EFFICACY						Levchenko, Anastasia/S-2510-2016; Bertisch, Suzanne/AFP-3293-2022	Levchenko, Anastasia/0000-0003-3509-1304; Bertisch, Suzanne/0000-0002-4627-8871				Allen RP, 2014, SLEEP MED, V15, P860, DOI 10.1016/j.sleep.2014.03.025; Allen RP, 2014, NEW ENGL J MED, V370, P621, DOI 10.1056/NEJMoa1303646; Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Aukerman MM, 2006, J AM BOARD FAM MED, V19, P487, DOI 10.3122/jabfm.19.5.487; Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988; Cheatle MD, 2014, J PAIN RES, V7, P301, DOI 10.2147/JPR.S37306; Cornell JE, 2008, ANN INTERN MED, V148, P786, DOI 10.7326/0003-4819-148-10-200805200-00012; Ellenbogen AL, 2011, CLIN NEUROPHARMACOL, V34, P8, DOI 10.1097/WNF.0b013e3182087d48; Fulda S, 2008, BRAIN, V131, P902, DOI 10.1093/brain/awm244; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Garcia-Borreguero D, 2012, EUR J NEUROL, V19, P1385, DOI 10.1111/j.1468-1331.2012.03853.x; Garcia-Borreguero D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-28; Giannaki CD, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-194; Hening W, 2004, SLEEP MED, V5, P237, DOI 10.1016/j.sleep.2004.03.006; Hening WA, 1999, SLEEP, V22, P901, DOI 10.1093/sleep/22.7.901; Hogl B, 2011, SLEEP MED, V12, P351, DOI 10.1016/j.sleep.2010.12.007; Hoque R, 2010, J CLIN SLEEP MED, V6, P79; Hornyak M, 2014, SLEEP MED REV, V18, P153, DOI 10.1016/j.smrv.2013.03.004; Hunt DL, 1997, ANN INTERN MED, V126, P532, DOI 10.7326/0003-4819-126-7-199704010-00006; Inoue Y, 2012, PROG NEURO-PSYCHOPH, V36, P251, DOI 10.1016/j.pnpbp.2011.10.009; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Letticri CJ, 2009, CHEST, V135, P74, DOI 10.1378/chest.08-1665; Mackie S, 2013, J CLIN SLEEP MED, V9, P513, DOI 10.5664/jcsm.2680; Michaud M, 2002, MOVEMENT DISORD, V17, P112, DOI 10.1002/mds.10004; Mitchell Ulrike H., 2011, Physiotherapy Theory and Practice, V27, P345, DOI 10.3109/09593985.2010.511440; Montplaisir J, 1998, MOVEMENT DISORD, V13, P324, DOI 10.1002/mds.870130220; Mortazavi M, 2013, SCI WORLD J, DOI 10.1155/2013/628142; *NIH, 2014, IRON DIETARY S; Oertel W, 2011, LANCET NEUROL, V10, P710, DOI 10.1016/S1474-4422(11)70127-2; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; OKEEFFE ST, 1994, AGE AGEING, V23, P200, DOI 10.1093/ageing/23.3.200; Ondo WG, 2005, MOVEMENT DISORD, V20, P345, DOI 10.1002/mds.20359; Plante DT, 2014, SLEEP MED REV, V18, P425, DOI 10.1016/j.smrv.2014.02.004; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; SCHOLZ H, 2011, COCHRANE DATABASE SY; Silber MH, 2013, MAYO CLIN PROC, V88, P977, DOI 10.1016/j.mayocp.2013.06.016; Silver N, 2011, SLEEP MED, V12, P440, DOI 10.1016/j.sleep.2010.11.002; Sun ER, 1998, SLEEP, V21, P371, DOI 10.1093/sleep/21.4.381; Trenkwalder C, 1999, MOVEMENT DISORD, V14, P102, DOI 10.1002/1531-8257(199901)14:1<102::AID-MDS1017>3.0.CO;2-E; Trenkwalder C, 2008, LANCET NEUROL, V7, P595, DOI 10.1016/S1474-4422(08)70112-1; Trenkwalder C, 2013, LANCET NEUROL, V12, P1141, DOI 10.1016/S1474-4422(13)70239-4; TROTTI LM, 2012, COCHRANE DB SYST REV, P5; Trotti LM, 2015, J CLIN SLEEP MED, V11, P293, DOI 10.5664/jcsm.4550; VONSCHEELE C, 1986, LANCET, V2, P426; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Wang J, 2009, SLEEP MED, V10, P973, DOI 10.1016/j.sleep.2008.11.003; Warner Margaret, 2009, NCHS Data Brief, P1; Weiss HD, 2014, JAMA INTERN MED, V174, P1935, DOI 10.1001/jamainternmed.2014.4097; Wilt TJ, 2013, JAMA INTERN MED, V173, P496, DOI 10.1001/jamainternmed.2013.3733; Wilt TJ, 2012, TREATMENT RESTLESS L; Winkelman JW, 2006, SLEEP MED, V7, P545, DOI 10.1016/j.sleep.2006.01.004; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830; Zhang W, 2013, NEUROPSYCH DIS TREAT, V9, P1035, DOI 10.2147/NDT.S49454; Zintzaras E, 2010, CLIN THER, V32, P221, DOI 10.1016/j.clinthera.2010.01.028	56	7	8	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9							ITC1	10.7326/AITC201511030	http://dx.doi.org/10.7326/AITC201511030			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26524584				2022-12-28	WOS:000365610600021
J	Stocks, SJ; Kontopantelis, E; Akbarov, A; Rodgers, S; Avery, AJ; Ashcroft, DM				Stocks, S. Jill; Kontopantelis, Evangelos; Akbarov, Artur; Rodgers, Sarah; Avery, Anthony J.; Ashcroft, Darren M.			Examining variations in prescribing safety in UK general practice: cross sectional study using the Clinical Practice Research Datalink	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; INDICATORS; INTERVENTION; TRIAL	STUDY QUESTION What is the prevalence of different types of potentially hazardous prescribing in general practice in the United Kingdom, and what is the variation between practices? METHODS A cross sectional study included all adult patients potentially at risk of a prescribing or monitoring error defined by a combination of diagnoses and prescriptions in 526 general practices contributing to the Clinical Practice Research Datalink (CPRD) up to 1 April 2013. Primary outcomes were the prevalence of potentially hazardous prescriptions of anticoagulants, anti-platelets, NSAIDs, beta blockers, glitazones, metformin, digoxin, antipsychotics, combined hormonal contraceptives, and oestrogens and monitoring by blood test less frequently than recommended for patients with repeated prescriptions of angiotensin converting enzyme inhibitors and loop diuretics, amiodarone, methotrexate, lithium, or warfarin. STUDY ANSWER and limitations 49 927 of 949 552 patients at risk triggered at least one prescribing indicator (5.26%, 95% confidence interval 5.21% to 5.30%) and 21 501 of 182 721 (11.8%, 11.6% to 11.9%) triggered at least one monitoring indicator. The prevalence of different types of potentially hazardous prescribing ranged from almost zero to 10.2%, and for inadequate monitoring ranged from 10.4% to 41.9%. Older patients and those prescribed multiple repeat medications had significantly higher risks of triggering a prescribing indicator whereas younger patients with fewer repeat prescriptions had significantly higher risk of triggering a monitoring indicator. There was high variation between practices for some indicators. Though prescribing safety indicators describe prescribing patterns that can increase the risk of harm to the patient and should generally be avoided, there will always be exceptions where the indicator is clinically justified. Furthermore there is the possibility that some information is not captured by CPRD for some practices-for example, INR results in patients receiving warfarin. WHAT THIS STUDY ADDS The high prevalence for certain indicators emphasises existing prescribing risks and the need for their appropriate consideration within primary care, particularly for older patients and those taking multiple medications. The high variation between practices indicates potential for improvement through targeted practice level intervention.	[Stocks, S. Jill; Ashcroft, Darren M.] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Greater Manchester Primary Care Patient Safe, Manchester M13 9PL, Lancs, England; [Kontopantelis, Evangelos] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Sch Primary Care Res, Manchester M13 9PL, Lancs, England; [Kontopantelis, Evangelos; Akbarov, Artur] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9PL, Lancs, England; [Rodgers, Sarah; Avery, Anthony J.] Univ Nottingham, Sch Med, Queens Med Ctr, Div Primary Care, Nottingham, England; [Ashcroft, Darren M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Pharm Sch, Ctr Pharmacoepidemiol & Drug Safety, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Nottingham; University of Manchester	Stocks, SJ (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Greater Manchester Primary Care Patient Safe, Manchester M13 9PL, Lancs, England.	jill.stocks@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Ashcroft, Darren/G-3244-2015	Kontopantelis, Evangelos/0000-0001-6450-5815; Rodgers, Sarah/0000-0003-1676-1982; Ashcroft, Darren/0000-0002-2958-915X; Stocks, Susan Jill/0000-0001-6034-476X; Avery, Anthony/0000-0001-7591-4438	National Institute for Health Research through the Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC) [GMPSTRC-2012-1]; Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish; National Institute for Health Research [SPCR-042] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	National Institute for Health Research through the Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the National Institute for Health Research through the Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC), grant No GMPSTRC-2012-1. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.	Akbarov A, 2015, DRUG SAFETY, V38, P671, DOI 10.1007/s40264-015-0304-x; [Anonymous], 2014, PRESCR DISP COMM 200; [Anonymous], 2013, RCGP GUID REV GEN PR; [Anonymous], IND DEPR UK 2014; Avery AJ, 1998, J CLIN PHARM THER, V23, P441, DOI 10.1046/j.1365-2710.1998.00187.x; Avery AJ, 2011, INVESTIGATING PREVAL; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Avery AJ, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588501; Campbell SM, 2000, BRIT MED J, V321, P425, DOI 10.1136/bmj.321.7258.425; Dreischulte T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-24; Dreischulte Tobias, 2012, BMC Clin Pharmacol, V12, P5, DOI 10.1186/1472-6904-12-5; Guthrie Bruce, 2011, BMJ, V342, pd3514, DOI 10.1136/bmj.d3514; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Kontopantelis E, 2013, BMJ OPEN, V3; Kontopantelis E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g330; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Morris CJ, 2004, QUAL SAF HEALTH CARE, V13, P181, DOI 10.1136/qshc.2003.008334; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; PRIMIS, PINC AUD TOOL; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Spencer R, 2014, BRIT J GEN PRACT, V64, pE181, DOI 10.3399/bjgp14X677806; Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825; Winterstein AG, 2002, ANN PHARMACOTHER, V36, P1238, DOI 10.1345/aph.1A225	23	50	51	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2015	351								h5501	10.1136/bmj.h5501	http://dx.doi.org/10.1136/bmj.h5501			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OC	26537416	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000364388500002
J	Vijan, S; Fagerlin, A				Vijan, Sandeep; Fagerlin, Angela			Diabetes Risk Assessment and Glycemic Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY IMPROVEMENT STRATEGIES; MANAGEMENT	IMPORTANCE Optimization of glycemic control is critical to reduce the number of diabetes mellitus-related complications, but long-term success is challenging. Although vision loss is among the greatest fears of individuals with diabetes, comprehensive personalized diabetes education and risk assessments are not consistently used in ophthalmologic settings. OBJECTIVE To determine whether the point-of-care measurement of hemoglobin A(1c) (HbA(1c)) and personalized diabetes risk assessments performed during retinal ophthalmologic visits improve glycemic control as assessed by HbA(1c) level. DESIGN, SETTING, AND PARTICIPANTS Ophthalmologist office-based randomized, multicenter clinical trial in which investigators from 42 sites were randomly assigned to provide either a study-prescribed augmented diabetes assessment and education or the usual care. Adults with type 1 or 2 diabetes enrolled into 2 cohorts: those with a more-frequent-than-annual follow-up (502 control participants and 488 intervention participants) and those with an annual follow-up (368 control participants and 388 intervention participants). Enrollment was from April 2011 through January 2013. INTERVENTIONS Point-of-care measurements of HbA(1c), blood pressure, and retinopathy severity; an individualized estimate of the risk of retinopathy progression derived from the findings from ophthalmologic visits; structured comparison and review of past and current clinical findings; and structured education with immediate assessment and feedback regarding the participant's understanding. These interventions were performed at enrollment and at routine ophthalmic follow-up visits scheduled at least 12 weeks apart. MAIN OUTCOMES AND MEASURES Mean change in HbA(1c) level from baseline to 1-year follow-up. Secondary outcomes included body mass index, blood pressure, and responses to diabetes self-management practices and attitudes surveys. RESULTS In the cohort with more-frequent-than-annual follow-ups, the mean (SD) change in HbA(1c) level at 1 year was -0.1%(1.5%) in the control group and -0.3%(1.4%) in the intervention group (adjusted mean difference, -0.09% [95% CI, -0.29% to 0.12%]; P = .35). In the cohort with annual follow-ups, the mean (SD) change in HbA(1c) level was 0.0% (1.1%) in the control group and -0.1%(1.6%) in the intervention group (mean difference, -0.05%[95% CI, -0.27% to 0.18%]; P = .63). Results were similar for all secondary outcomes. CONCLUSIONS AND RELEVANCE Long-term optimization of glycemic control is not achieved by a majority of individuals with diabetes. The addition of personalized education and risk assessment during retinal ophthalmologic visits did not result in a reduction in HbA(1c) level compared with usual care over 1 year. These data suggest that optimizing glycemic control remains a substantive challenge requiring interventional paradigms other than those examined in our study.	[Vijan, Sandeep; Fagerlin, Angela] Univ Michigan, Ctr Clin Management Res, Dept Internal Med, Ann Arbor Vet Affairs Hosp, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Vijan, S (corresponding author), Univ Michigan, 2800 Plymouth Rd,Bldg 16,Room 344E, Ann Arbor, MI 48109 USA.	svijan@med.umich.edu						Aiello LP, 2015, JAMA OPHTHALMOL, V133, P888, DOI 10.1001/jamaophthalmol.2015.1312; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; McAlister FA, 2000, CAN MED ASSOC J, V163, P403; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894	9	1	1	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1861	1862		10.1001/jama.2015.11518	http://dx.doi.org/10.1001/jama.2015.11518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529163				2022-12-28	WOS:000363960200018
J	[Anonymous]				[Anonymous]			Knowledge and Wisdom in Medicine (Reprinted from JAMA, vol 45, pg 1408, 1905)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1905, JAMA, V45, P1408	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1878	1878		10.1001/jama.2014.12070	http://dx.doi.org/10.1001/jama.2014.12070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529172				2022-12-28	WOS:000363960200027
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Nits-no hiding from head lice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2015	351								h5725	10.1136/bmj.h5725	http://dx.doi.org/10.1136/bmj.h5725			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6NI	26527713	Bronze			2022-12-28	WOS:000364386500001
J	Hope, TJ				Hope, Thomas J.			Visualizing trans-infection	SCIENCE			English	Editorial Material							T-CELLS		Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hope, TJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	thope@northwestern.edu			NIGMS NIH HHS [P50 GM082545] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Sewald X, 2015, SCIENCE, V350, P563, DOI 10.1126/science.aab2749	7	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					511	512		10.1126/science.aad5409	http://dx.doi.org/10.1126/science.aad5409			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516268				2022-12-28	WOS:000363660000028
J	Ma, EY; Cui, YT; Ueda, K; Tang, SJ; Chen, K; Tamura, N; Wu, PM; Fujioka, J; Tokura, Y; Shen, ZX				Ma, Eric Yue; Cui, Yong-Tao; Ueda, Kentaro; Tang, Shujie; Chen, Kai; Tamura, Nobumichi; Wu, Phillip M.; Fujioka, Jun; Tokura, Yoshinori; Shen, Zhi-Xun			Mobile metallic domain walls in an all-in-all-out magnetic insulator	SCIENCE			English	Article							HARTREE-FOCK	Magnetic domain walls are boundaries between regions with different configurations of the same magnetic order. In a magnetic insulator, where the magnetic order is tied to its bulk insulating property, it has been postulated that electrical properties are drastically different along the domain walls, where the order is inevitably disturbed. Here we report the discovery of highly conductive magnetic domain walls in a magnetic insulator, Nd2Ir2O7, that has an unusual all-in-all-out magnetic order, via transport and spatially resolved microwave impedance microscopy. The domain walls have a virtually temperature-independent sheet resistance of similar to 1 kilohm per square, show smooth morphology with no preferred orientation, are free from pinning by disorders, and have strong thermal and magnetic field responses that agree with expectations for all-in-all-out magnetic order.	[Ma, Eric Yue; Cui, Yong-Tao; Tang, Shujie; Wu, Phillip M.; Shen, Zhi-Xun] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Ma, Eric Yue; Shen, Zhi-Xun] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Ueda, Kentaro; Fujioka, Jun; Tokura, Yoshinori] Univ Tokyo, Dept Appl Phys, Tokyo 113, Japan; [Ueda, Kentaro; Fujioka, Jun; Tokura, Yoshinori] RIKEN Ctr Emergent Matter Sci CEMS, Saitama, Japan; [Tang, Shujie] SIMIT, State Key Lab Funct Mat Informat, Shanghai, Peoples R China; [Chen, Kai] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Ctr Adv Mat Performance Nanoscale CAMP Nano, Xian 710049, Peoples R China; [Tamura, Nobumichi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source ALS, Berkeley, CA 94720 USA	Stanford University; Stanford University; University of Tokyo; RIKEN; Xi'an Jiaotong University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tokura, Y (corresponding author), Univ Tokyo, Dept Appl Phys, 7-3-1 Hongo, Tokyo 113, Japan.	tokura@riken.jp; zxshen@stanford.edu	xjtu, campnano/Q-1904-2015; Tokura, Yoshinori/C-7352-2009; Tamura, Nobumichi/D-7410-2012; Fujioka, Jun/A-1590-2015; Wu, Phillip/M-9431-2014; Ueda, Kentaro/AAB-7056-2021; Ueda, Kentaro/AAB-6787-2021; Chen, Kai/O-5662-2014; Cui, Yong-Tao/G-8505-2015	Tokura, Yoshinori/0000-0002-2732-4983; Tamura, Nobumichi/0000-0002-3698-2611; Wu, Phillip/0000-0002-3210-9823; Ueda, Kentaro/0000-0002-6427-8701; Ueda, Kentaro/0000-0002-6427-8701; Chen, Kai/0000-0002-4917-4445; Ma, Eric Yue/0000-0002-0539-1501; Cui, Yong-Tao/0000-0002-8015-1049	NSF [DMR-1305731]; Gordon and Betty Moore Foundation [GBMF3133]; Emergent Phenomena in Quantum Systems (EPiQS) initiative [GBMF4546]; Japan Society for the Promotion of Science [80609488, 24224009]; Funding Program in World-Leading Innovative R&D on Science and Technology (FIRST Program); China Scholarship Council [201304910185]; National Young 1000 Talents Program; National Science Foundation of China (NSFC) [51302207]; U.S. Department of Energy at Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; University of California, Berkeley, California	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Emergent Phenomena in Quantum Systems (EPiQS) initiative; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program in World-Leading Innovative R&D on Science and Technology (FIRST Program); China Scholarship Council(China Scholarship Council); National Young 1000 Talents Program; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); University of California, Berkeley, California(University of California System)	We thank R. Laughlin for helpful discussions. We thank A. Bestwick, E. Fox, and D. Goldhaber-Gordon for help with the dilution refrigerator measurement. The measurement at Stanford University is supported by NSF grant DMR-1305731, the Gordon and Betty Moore Foundation through grant GBMF3133, and Emergent Phenomena in Quantum Systems (EPiQS) initiative GBMF4546. The crystal growth at University of Tokyo and RIKEN is supported by the Grant-in-Aid for Scientific Research (grant 80609488 and 24224009) from the Japan Society for the Promotion of Science and the Funding Program in World-Leading Innovative R&D on Science and Technology (FIRST Program). S.T. is partly supported by China Scholarship Council (grant 201304910185). K.C. is supported by the National Young 1000 Talents Program and the National Science Foundation of China (NSFC) under contract 51302207. The Advanced Light Source is supported by the director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the U.S. Department of Energy under contract DE-AC02-05CH11231 at Lawrence Berkeley National Laboratory and University of California, Berkeley, California. All additional data are available in the supplementary materials. Z.-X.S. is a cofounder of PrimeNano Inc., which licensed the sMIM technology from Stanford for commercial instrument. This technology was modified for low-temperature measurement in this report. Stanford University and RIKEN have filed a joint provisional U.S. patent application on memory devices based on conductive magnetic domain walls.	Arima T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.013705; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Koga T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.046801; Kundhikanjana W, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3554438; Kunz M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3096295; Lai K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2990638; Ma EY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8595; Matsuhira K., 2011, J PHYS SOC JPN, V80; Matsuhira K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.023706; Matsuhira K, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.043706; Meier D, 2012, NAT MATER, V11, P284, DOI [10.1038/nmat3249, 10.1038/NMAT3249]; Nayak C, 1997, PHYS REV LETT, V78, P2465, DOI 10.1103/PhysRevLett.78.2465; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Pesin D, 2010, NAT PHYS, V6, P376, DOI 10.1038/NPHYS1606; POILBLANC D, 1989, PHYS REV B, V39, P9749, DOI 10.1103/PhysRevB.39.9749; Sagayama H, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.100403; Salafranca J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245122; SCHULZ HJ, 1990, PHYS REV LETT, V64, P1445, DOI 10.1103/PhysRevLett.64.1445; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/NMAT2373, 10.1038/nmat2373]; Shinaoka H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.247204; Tomiyasu K., 2012, J PHYS SOC JPN, V81; Ueda K, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.056402; Ueda K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075127; Ueda K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.136402; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wu WD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.077203; Yamaji Y, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021035; Yang YL, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/11/115040	30	144	148	8	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					538	541		10.1126/science.aac8289	http://dx.doi.org/10.1126/science.aac8289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516280	Green Submitted			2022-12-28	WOS:000363660000043
J	Gupta, S				Gupta, Sujata			FROM GADGETS TO THE SMART GRID	NATURE			English	Editorial Material																			0	17	17	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S90	S91		10.1038/526S90a	http://dx.doi.org/10.1038/526S90a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509951	Bronze			2022-12-28	WOS:000363832100023
J	Liu, ZH; Xiao, TS				Liu, Zhonghua; Xiao, Tsan Sam			Assembling the wheel of death	SCIENCE			English	Editorial Material							CAUSES AUTOINFLAMMATION; BACTERIAL LIGANDS; NLRC4 CAUSES; INFLAMMASOMES; MUTATION; RECOGNITION; ACTIVATION; FLAGELLIN		[Liu, Zhonghua; Xiao, Tsan Sam] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Liu, ZH (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	tsx@case.edu	Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan Sam/0000-0001-9688-475X	Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NIAMS NIH HHS [R21 AR069908] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Chai JJ, 2014, NATL SCI REV, V1, P101, DOI 10.1093/nsr/nwt025; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	12	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					376	377		10.1126/science.aad3981	http://dx.doi.org/10.1126/science.aad3981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494742	Green Accepted			2022-12-28	WOS:000363213400018
J	Akiva, E; Babbitt, PC				Akiva, Eyal; Babbitt, Patricia C.			Evolutionary Reprograming of Protein-Protein Interaction Specificity	CELL			English	Editorial Material							SELECTION; NETWORK	Using mutation libraries and deep sequencing, Aakre et al. study the evolution of protein-protein interactions using a toxin-antitoxin model. The results indicate probable trajectories via "intermediate" proteins that are promiscuous, thus avoiding transitions via non-interactions. These results extend observations about other biological interactions and enzyme evolution, suggesting broadly general principles.	[Akiva, Eyal; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Babbitt, PC (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	babbitt@cgl.ucsf.edu						Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Kim J, 2012, P NATL ACAD SCI USA, V109, pE2856, DOI 10.1073/pnas.1208509109; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	9	1	1	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					535	537		10.1016/j.cell.2015.10.010	http://dx.doi.org/10.1016/j.cell.2015.10.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496596	Bronze			2022-12-28	WOS:000364828900004
J	Turner, M				Turner, Marian			Ecology Mangrove maintenance	NATURE			English	Editorial Material																		Lovelock CE, 2015, NATURE, V526, P559, DOI 10.1038/nature15538	1	1	2	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					515	515		10.1038/526515a	http://dx.doi.org/10.1038/526515a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB9ZD	26490618	Bronze			2022-12-28	WOS:000425299600001
J	Haukoos, JS; Lewis, RJ				Haukoos, Jason S.; Lewis, Roger J.			The Propensity Score	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Haukoos, Jason S.] Univ Colorado, Sch Med, Dept Emergency Med, Denver, CO USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Haukoos, JS (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St,Mail Code 0108, Denver, CO 80204 USA.	Jason.Haukoos@dhha.org			National Institute of Allergy and Infectious Diseases (NIAID) [R01AI106057]; Agency for Healthcare Research and Quality (AHRQ) [R01HS021749]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106057] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr Haukoos is supported, in part, by grants R01AI106057 from the National Institute of Allergy and Infectious Diseases (NIAID) and R01HS021749 from the Agency for Healthcare Research and Quality (AHRQ).	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Roze JC, 2015, JAMA-J AM MED ASSOC, V313, P2441, DOI 10.1001/jama.2015.6734; Schaffer JM, 2015, JAMA-J AM MED ASSOC, V313, P936, DOI 10.1001/jama.2015.1175	7	365	376	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1637	1638		10.1001/jama.2015.13480	http://dx.doi.org/10.1001/jama.2015.13480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501539	Green Accepted			2022-12-28	WOS:000363028500023
J	[Anonymous]				[Anonymous]			Transfusion of Blood (Reprinted form JAMA, vol 65, pg 1368-1369, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1914, BLOOD TRANSFUSION SY, P1542; [Anonymous], 1914, J A M A         0328, P993; Brewer GE, 1909, SURG GYNECOL OBSTET, V9, P293; Curtis AH, 1911, J AMER MED ASSOC, V56, P35; Kimpton A. R., 1913, J A M A         0712, P117; Lewinsohn Richard, 1915, SURG GYNECOL OBSTET, V21, P37; Lindeman E, 1913, AM J DIS CHILD, V6, P28; Ottenberg R., 1915, AM J MED SCI, P36; Rous Peyton, 1915, J AM MED ASS    0612, P1980; Satterlee H. S., 1914, J A M A          JUN, P1781; Simons Irving, 1915, J A M A         1016, P1339; UNGER LJ, 1915, JAMA-J AM MED ASSOC, V64, P582; Weil R, 1915, J AMER MED ASSOC, V64, P425; 1915, JAMA, V65, P1369	14	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1649	1649		10.1001/jama.2014.12042	http://dx.doi.org/10.1001/jama.2014.12042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501550				2022-12-28	WOS:000363028500033
J	Grove, J; Claeson, M; Bryce, J; Amouzou, A; Boerma, T; Waiswa, P; Victora, C				Grove, John; Claeson, Mariam; Bryce, Jennifer; Amouzou, Agbessi; Boerma, Ties; Waiswa, Peter; Victora, Cesar		Kirkland Grp	Maternal, newborn, and child health and the Sustainable Development Goals-a call for sustained and improved measurement	LANCET			English	Editorial Material									[Grove, John; Claeson, Mariam] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA; [Bryce, Jennifer] Johns Hopkins Univ, Baltimore, MD USA; [Amouzou, Agbessi] UNICEF, New York, NY USA; [Boerma, Ties] WHO, CH-1211 Geneva, Switzerland; [Waiswa, Peter] INDEPTH Network Maternal & Newborn Res Grp, Accra, Ghana; [Victora, Cesar] Univ Pelotas, Pelotas, Brazil	Bill & Melinda Gates Foundation; Johns Hopkins University; UNICEF; World Health Organization; INDEPTH Network	Grove, J (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.	john.grove@gatesfoundation.org	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Amouzou, Agbessi/0000-0002-6262-3866	Wellcome Trust [101815] Funding Source: Medline; World Health Organization [001] Funding Source: Medline	Wellcome Trust(Wellcome Trust); World Health Organization(World Health Organization)		Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; CLAESON M, 1990, PEDIATR INFECT DIS J, V9, P345, DOI 10.1097/00006454-199005000-00008; Common Road Map Steering Committee, 2015, ROADM HLTH MEAS ACC; GAVI the Vaccine Alliance, 2015, EV CHILD COUNTS SAV; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Requejo JH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001416; The World Bank, 2014, CONC NOT GLOB FIN FA; UNAIDS, 2004, 3 ON KEY PRINC COORD; United Nations, 2013, STAT IND POST 2015 D; United Nations, 2015, 2015 TIM GLOB ACT PE; WHO, 2013, WORLD MALARIA REPORT 2013, P1	12	36	39	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1511	1514		10.1016/S0140-6736(15)00517-6	http://dx.doi.org/10.1016/S0140-6736(15)00517-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5VC	26530604	Green Accepted			2022-12-28	WOS:000362878200006
J	Linehan, WM; Spellman, PT; Ricketts, CJ; Creighton, CJ; Fei, SS; Davis, C; Wheeler, DA; Murray, BA; Schmidt, L; Vocke, CD; Peto, M; Al Mamun, AAM; Shinbrot, E; Sethi, A; Brooks, S; Rathmell, WK; Brooks, AN; Hoadley, KA; Robertson, AG; Brooks, D; Bowlby, R; Sadeghi, S; Shen, H; Weisenberger, DJ; Bootwalla, M; Baylin, SB; Laird, PW; Cherniack, AD; Saksena, G; Haake, S; Li, J; Liang, H; Lu, YL; Mills, GB; Akbani, R; Leiserson, MDM; Raphael, BJ; Anur, P; Bottaro, D; Albiges, L; Barnabas, N; Choueiri, TK; Czerniak, B; Godwin, AK; Hakimi, AA; Ho, TH; Hsieh, J; Ittmann, M; Kim, WY; Krishnan, B; Merino, MJ; Shaw, KRM; Reuter, VE; Reznik, E; Shelley, CS; Shuch, B; Signoretti, S; Srinivasan, R; Tamboli, P; Thomas, G; Tickoo, S; Burnett, K; Crain, D; Gardner, J; Lau, K; Mallery, D; Morris, S; Paulauskis, JD; Penny, RJ; Shelton, C; Shelton, WT; Sherman, M; Thompson, E; Yena, P; Avedon, MT; Bowen, J; Gastier-Foster, JM; Gerken, M; Leraas, KM; Lichtenberg, TM; Ramirez, NC; Santos, T; Wise, L; Zmuda, E; Demchok, JA; Felau, I; Hutter, CM; Sheth, M; Sofia, HJ; Tarnuzzer, R; Wang, ZN; Yang, LM; Zenklusen, JC; Zhang, JS; Ayala, B; Baboud, J; Chudamani, S; Liu, J; Lolla, L; Naresh, R; Pihl, T; Sun, Q; Wan, YH; Wu, Y; Ally, A; Balasundaram, M; Balu, S; Beroukhim, R; Bodenheimer, T; Buhay, C; Butterfield, YSN; Carlsen, R; Carter, SL; Chao, H; Chuah, E; Clarke, A; Covington, KR; Dahdouli, M; Dewal, N; Dhalla, N; Doddapaneni, HV; Drummond, JA; Gabriel, SB; Gibbs, RA; Guin, R; Hale, W; Hawes, A; Hayes, DN; Holt, RA; Hoyle, AP; Jefferys, SR; Jones, SJM; Jones, CD; Kalra, D; Kovar, C; Lewis, L; Li, J; Ma, Y; Marra, MA; Mayo, M; Meng, SW; Meyerson, M; Mieczkowski, PA; Moore, RA; Morton, D; Mose, LE; Mungall, AJ; Muzny, D; Parker, JS; Perou, CM; Roach, J; Schein, JE; Schumacher, SE; Shi, Y; Simons, JV; Sipahimalani, P; Skelly, T; Soloway, MG; Sougnez, C; Tam, A; Tan, D; Thiessen, N; Veluvolu, U; Wang, M; Wilkerson, MD; Wong, T; Wu, JY; Xi, L; Zhou, J; Bedford, J; Chen, FJ; Fu, Y; Gerstein, M; Haussler, D; Kasaian, K; Lai, P; Ling, SY; Radenbaugh, A; Van Den Berg, D; Weinstein, JN; Zhu, JC; Albert, M; Alexopoulou, I; Andersen, JJ; Auman, JT; Bartlett, J; Bastacky, S; Bergsten, J; Blute, ML; Boice, L; Bollag, RJ; Boyd, J; Castle, E; Chen, YB; Cheville, JC; Curley, E; Davies, B; DeVolk, A; Dhir, R; Dike, L; Eckman, J; Engel, J; Harr, J; Hrebinko, R; Huang, M; Huelsenbeck-Dill, L; Iacocca, M; Jacobs, B; Lobis, M; Maranchie, JK; McMeekin, S; Myers, J; Nelson, J; Parfitt, J; Parwani, A; Petrelli, N; Rabeno, B; Roy, S; Salner, AL; Slaton, J; Stanton, M; Thompson, RH; Thorne, L; Tucker, K; Weinberger, PM; Winemiller, C; Zach, LA; Zuna, R				Linehan, W. Marston; Spellman, Paul T.; Ricketts, Christopher J.; Creighton, Chad J.; Fei, Suzanne S.; Davis, Caleb; Wheeler, David A.; Murray, Bradley A.; Schmidt, Laura; Vocke, Cathy D.; Peto, Myron; Al Mamun, Abu Amar M.; Shinbrot, Eve; Sethi, Anurag; Brooks, Samira; Rathmell, W. Kimryn; Brooks, Angela N.; Hoadley, Katherine A.; Robertson, A. Gordon; Brooks, Denise; Bowlby, Reanne; Sadeghi, Sara; Shen, Hui; Weisenberger, Daniel J.; Bootwalla, Moiz; Baylin, Stephen B.; Laird, Peter W.; Cherniack, Andrew D.; Saksena, Gordon; Haake, Scott; Li, Jun; Liang, Han; Lu, Yiling; Mills, Gordon B.; Akbani, Rehan; Leiserson, Mark D. M.; Raphael, Benjamin J.; Anur, Pavana; Bottaro, Donald; Albiges, Laurence; Barnabas, Nandita; Choueiri, Toni K.; Czerniak, Bogdan; Godwin, Andrew K.; Hakimi, A. Ari; Ho, Thai H.; Hsieh, James; Ittmann, Michael; Kim, William Y.; Krishnan, Bhavani; Merino, Maria J.; Shaw, Kenna R. Mills; Reuter, Victor E.; Reznik, Ed; Shelley, Carl S.; Shuch, Brian; Signoretti, Sabina; Srinivasan, Ramaprasad; Tamboli, Pheroze; Thomas, George; Tickoo, Satish; Burnett, Kenneth; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Mallery, David; Morris, Scott; Paulauskis, Joseph D.; Penny, Robert J.; Shelton, Candace; Shelton, W. Troy; Sherman, Mark; Thompson, Eric; Yena, Peggy; Avedon, Melissa T.; Bowen, Jay; Gastier-Foster, Julie M.; Gerken, Mark; Leraas, Kristen M.; Lichtenberg, Tara M.; Ramirez, Nilsa C.; Santos, Tracie; Wise, Lisa; Zmuda, Erik; Demchok, John A.; Felau, Ina; Hutter, Carolyn M.; Sheth, Margi; Sofia, Heidi J.; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean C.; Zhang, Jiashan; Ayala, Brenda; Baboud, Julien; Chudamani, Sudha; Liu, Jia; Lolla, Laxmi; Naresh, Rashi; Pihl, Todd; Sun, Qiang; Wan, Yunhu; Wu, Ye; Ally, Adrian; Balasundaram, Miruna; Balu, Saianand; Beroukhim, Rameen; Bodenheimer, Tom; Buhay, Christian; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Scott L.; Chao, Hsu; Chuah, Eric; Clarke, Amanda; Covington, Kyle R.; Dahdouli, Mahmoud; Dewal, Ninad; Dhalla, Noreen; Doddapaneni, Harsha V.; Drummond, Jennifer A.; Gabriel, Stacey B.; Gibbs, Richard A.; Guin, Ranabir; Hale, Walker; Hawes, Alicia; Hayes, D. Neil; Holt, Robert A.; Hoyle, Alan P.; Jefferys, Stuart R.; Jones, Steven J. M.; Jones, Corbin D.; Kalra, Divya; Kovar, Christie; Lewis, Lora; Li, Jie; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Moore, Richard A.; Morton, Donna; Mose, Lisle E.; Mungall, Andrew J.; Muzny, Donna; Parker, Joel S.; Perou, Charles M.; Roach, Jeffrey; Schein, Jacqueline E.; Schumacher, Steven E.; Shi, Yan; Simons, Janae V.; Sipahimalani, Payal; Skelly, Tara; Soloway, Matthew G.; Sougnez, Carrie; Tam, Angela; Tan, Donghui; Thiessen, Nina; Veluvolu, Umadevi; Wang, Min; Wilkerson, Matthew D.; Wong, Tina; Wu, Junyuan; Xi, Liu; Zhou, Jane; Bedford, Jason; Chen, Fengju; Fu, Yao; Gerstein, Mark; Haussler, David; Kasaian, Katayoon; Lai, Phillip; Ling, Shiyun; Radenbaugh, Amie; Van Den Berg, David; Weinstein, John N.; Zhu, Jingchun; Albert, Monique; Alexopoulou, Iakovina; Andersen, Jeremiah J.; Auman, J. Todd; Bartlett, John; Bastacky, Sheldon; Bergsten, Julie; Blute, Michael L.; Boice, Lori; Bollag, Roni J.; Boyd, Jeff; Castle, Erik; Chen, Ying-Bei; Cheville, John C.; Curley, Erin; Davies, Benjamin; DeVolk, April; Dhir, Rajiv; Dike, Laura; Eckman, John; Engel, Jay; Harr, Jodi; Hrebinko, Ronald; Huang, Mei; Huelsenbeck-Dill, Lori; Iacocca, Mary; Jacobs, Bruce; Lobis, Michael; Maranchie, Jodi K.; McMeekin, Scott; Myers, Jerome; Nelson, Joel; Parfitt, Jeremy; Parwani, Anil; Petrelli, Nicholas; Rabeno, Brenda; Roy, Somak; Salner, Andrew L.; Slaton, Joel; Stanton, Melissa; Thompson, R. Houston; Thorne, Leigh; Tucker, Kelinda; Weinberger, Paul M.; Winemiller, Cynthia; Zach, Leigh Anne; Zuna, Rosemary		Canc Genome Atlas Res Network	Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KIDNEY CANCER; MET PROTOONCOGENE; GENETIC-BASIS; MUTATIONS; HEREDITARY; FUMARATE; NRF2; EXPRESSION; PHENOTYPE; GERMLINE	BACKGROUND Papillary renal-cell carcinoma, which accounts for 15 to 20% of renal-cell carcinomas, is a heterogeneous disease that consists of various types of renal cancer, including tumors with indolent, multifocal presentation and solitary tumors with an aggressive, highly lethal phenotype. Little is known about the genetic basis of sporadic papillary renal-cell carcinoma, and no effective forms of therapy for advanced disease exist. METHODS We performed comprehensive molecular characterization of 161 primary papillary renal-cell carcinomas, using whole-exome sequencing, copy-number analysis, messenger RNA and microRNA sequencing, DNA-methylation analysis, and proteomic analysis. RESULTS Type 1 and type 2 papillary renal-cell carcinomas were shown to be different types of renal cancer characterized by specific genetic alterations, with type 2 further classified into three individual subgroups on the basis of molecular differences associated with patient survival. Type 1 tumors were associated with MET alterations, whereas type 2 tumors were characterized by CDKN2A silencing, SETD2 mutations, TFE3 fusions, and increased expression of the NRF2 antioxidant response element (ARE) pathway. A CpG island methylator phenotype (CIMP) was observed in a distinct subgroup of type 2 papillary renal-cell carcinomas that was characterized by poor survival and mutation of the gene encoding fumarate hydratase (FH). CONCLUSIONS Type 1 and type 2 papillary renal-cell carcinomas were shown to be clinically and biologically distinct. Alterations in the MET pathway were associated with type 1, and activation of the NRF2-ARE pathway was associated with type 2; CDKN2A loss and CIMP in type 2 conveyed a poor prognosis. Furthermore, type 2 papillary renal-cell carcinoma consisted of at least three subtypes based on molecular and phenotypic features. (Funded by the National Institutes of Health.)	[Linehan, W. Marston] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Linehan, WM (corresponding author), NCI, Urol Oncol Branch, Bldg 10 CRC Rm 1-5940, Bethesda, MD 20892 USA.	wml@nih.gov	Cherniack, Andrew/AAC-5310-2019; Jones, Steven J/C-3621-2009; parwani, anil/AAH-5464-2020; Shen, Hui/AAO-4387-2020; Marra, Marco A/B-5987-2008; Perou, Charles M/H-9934-2014; Bottaro, Donald P/F-8550-2010; Hirst, Martin/B-7684-2016; Choueiri, Toni/K-5238-2019; Li, Jun/AAE-4393-2022; Akbani, Rehan/AAG-1490-2019; Schein, Jacquie E/G-3674-2015; Mungall, Andrew J./U-7067-2018; Maranchie, Jodi/AAG-1035-2020; Bottaro, Donald P/AAF-3853-2020; Holt, Robert A/C-3303-2009; Weinberger, Paul/B-7007-2008; Van Den Berg, David J/G-8598-2017; Laird, Peter W/G-8683-2012; Drummond, Jennifer/AAG-1654-2020; Ricketts, Christopher/AAV-9580-2020; Shinbrot, Eve/V-2784-2019; Cherniack, Andrew D./AAY-8132-2020; Weisenberger, Daniel/AAA-8314-2020; Kalra, D/H-6661-2019; Parker, Joel/AAG-1108-2019; chen, ying/HHS-8254-2022	Jones, Steven J/0000-0003-3394-2208; Marra, Marco A/0000-0001-7146-7175; Perou, Charles M/0000-0001-9827-2247; Bottaro, Donald P/0000-0002-5057-5334; Choueiri, Toni/0000-0002-9201-3217; Li, Jun/0000-0002-1171-7141; Mungall, Andrew J./0000-0002-0905-2742; Bottaro, Donald P/0000-0002-5057-5334; Holt, Robert A/0000-0002-7259-1247; Weinberger, Paul/0000-0002-5885-2631; Van Den Berg, David J/0000-0002-5404-5218; Laird, Peter W/0000-0001-9117-3641; Drummond, Jennifer/0000-0002-2612-5958; Shinbrot, Eve/0000-0002-8879-3150; Cherniack, Andrew D./0000-0003-0470-0111; Weisenberger, Daniel/0000-0001-8303-2603; Kalra, D/0000-0001-5254-4067; Ho, Thai/0000-0003-0023-2939; Maranchie, Jodi/0000-0002-8534-9468; Shen, Hui/0000-0001-9767-4084; Mieczkowski, Piotr/0000-0003-2418-0096; Hoadley, Katherine/0000-0002-1216-477X; Thomas, George V/0000-0001-7416-8840; Tarnuzzer, Roy/0000-0002-3725-4173; Meyerson, Matthew/0000-0002-9133-8108; Auman, James/0000-0002-9328-8829; Bowen, Jay/0000-0001-6861-9043; Fei, Suzanne/0000-0002-9688-2890; doddapaneni, harshavardhan/0000-0002-2433-633X; Haake, Scott/0000-0003-3455-0791; Weinstein, John/0000-0001-9401-6908; Davis, Caleb/0000-0002-5125-0494; Chen, Ying-Bei/0000-0001-5207-3648	National Institutes of Health [U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, P30 CA016672]; NATIONAL CANCER INSTITUTE [U24CA180951, K24CA172355, U24CA143858, P30CA016086, U24CA143835, U24CA143866, U24CA143799, U24CA143843, P30CA015083, U24CA143848, U24CA143882, U24CA144025, U24CA143867, U24CA143840, P30CA008748, U24CA143845, R01CA169172, P30CA016056, U24CA199461, P30CA016672, ZIDBC011089, U24CA143883] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003079, U54HG003273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants (U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, and P30 CA016672) from the National Institutes of Health.	[Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boezio AA, 2009, BIOORG MED CHEM LETT, V19, P6307, DOI 10.1016/j.bmcl.2009.09.096; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Delahunt B, 1997, MODERN PATHOL, V10, P537; Durinck S, 2015, NAT GENET, V47, P13, DOI 10.1038/ng.3146; Gan HK, 2013, FEBS J, V280, P5350, DOI 10.1111/febs.12393; Grubb RL, 2007, J UROLOGY, V177, P2074, DOI 10.1016/j.juro.2007.01.155; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Jiang F, 1998, AM J PATHOL, V153, P1467, DOI 10.1016/S0002-9440(10)65734-3; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kauffman EC, 2014, NAT REV UROL, V11, P465, DOI 10.1038/nrurol.2014.162; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7336; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Linehan WM, 2013, CLIN CANCER RES, V19, P3345, DOI 10.1158/1078-0432.CCR-13-0304; Linehan WM, 2012, GENOME RES, V22, P2089, DOI 10.1101/gr.131110.111; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Muratani M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5361; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ooi A, 2013, CANCER RES, V73, P2044, DOI 10.1158/0008-5472.CAN-12-3227; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt L, 1998, CANCER RES, V58, P1719; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Sourbier C, 2014, CANCER CELL, V26, P840, DOI 10.1016/j.ccell.2014.10.005; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; ZBAR B, 1994, J UROLOGY, V151, P561, DOI 10.1016/S0022-5347(17)35015-2; Zhu XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062731, 10.1371/journal.pone.0060146, 10.1371/journal.pone.0081900, 10.1371/journal.pone.0070631, 10.3389/fnsyn.2013.00008, 10.1371/journal.pone.0070686]	39	755	771	9	107	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					135	145		10.1056/NEJMoa1505917	http://dx.doi.org/10.1056/NEJMoa1505917			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA7PQ	26536169	Bronze, Green Accepted			2022-12-28	WOS:000367996700008
J	Harmansa, S; Hamaratoglu, F; Affolter, M; Aussinus, EC				Harmansa, Stefan; Hamaratoglu, Fisun; Affolter, Markus; Aussinus, Emmanuel C.			Dpp spreading is required for medial but not for lateral wing disc growth	NATURE			English	Article							MORPHOGEN GRADIENT; CELL-PROLIFERATION; GENE-FUNCTION; SIZE CONTROL; I RECEPTORS; DROSOPHILA; EXPRESSION; PATTERN; BRINKER; TARGET	Drosophila Decapentaplegic (Dpp) has served as a paradigm to study morphogen-dependent growth control. However, the role of a Dpp gradient in tissue growth remains highly controversial. Two fundamentally different models have been proposed: the 'temporal rule' model suggests that all cells of the wing imaginal disc divide upon a 50% increase in Dpp signalling, whereas the 'growth equalization model' suggests that Dpp is only essential for proliferation control of the central cells. Here, to discriminate between these two models, we generated and used morphotrap, a membrane-tethered anti-green fluorescent protein (GFP) nanobody, which enables immobilization of enhanced (e)GFP:: Dpp on the cell surface, thereby abolishing Dpp gradient formation. We find that in the absence of Dpp spreading, wing disc patterning is lost; however, lateral cells still divide at normal rates. These data are consistent with the growth equalization model, but do not fit a global temporal rule model in the wing imaginal disc.	[Harmansa, Stefan; Affolter, Markus; Aussinus, Emmanuel C.] Univ Basel, Biozentrum, Growth & Dev, Klingelbergstr 50-70, CH-4056 Basel, Switzerland; [Hamaratoglu, Fisun] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Aussinus, Emmanuel C.] Univ Zurich, IMLS, CH-8057 Zurich, Switzerland	University of Basel; University of Lausanne; University of Zurich	Affolter, M (corresponding author), Univ Basel, Biozentrum, Growth & Dev, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	Markus.Affolter@unibas.ch		Harmansa, Stefan/0000-0001-6668-7608; Hamaratoglu, Fisun/0000-0002-1461-9248; Affolter, Markus/0000-0002-5171-0016	'Fellowships for Excellence' International PhD Program in Molecular Life Sciences of the Biozentrum, University of Basel; SystemsX.ch initiative; MorphogenetiX projects; Swiss National Science Foundation (SNSF) Professorship grant [PP00P3_150682]; Canton Basel-Stadt; Canton BaselLand; SNSF; SystemsX.ch	'Fellowships for Excellence' International PhD Program in Molecular Life Sciences of the Biozentrum, University of Basel; SystemsX.ch initiative; MorphogenetiX projects; Swiss National Science Foundation (SNSF) Professorship grant(Swiss National Science Foundation (SNSF)); Canton Basel-Stadt; Canton BaselLand; SNSF(Swiss National Science Foundation (SNSF)); SystemsX.ch	We would like to acknowledge the work of the late William (Bill) Gelbart, who initiated the work on Dpp. We thank S. Matsuda, I. Alborelli and H. Belting for discussions; T. Schaffter for help and support with WingJ; the Biozentrum Imaging Core Facility for maintenance of microscopes and support. We are grateful to G. Struhl, K. Basler and G. Pyrowolakis for their input and discussion on the project. We thank K. Basler, S. Cohen, G. Morata, R. Bario and E. Laufer for flies and reagents. S. H. was supported by the 'Fellowships for Excellence' International PhD Program in Molecular Life Sciences of the Biozentrum, University of Basel. Funding is also acknowledged from the SystemsX.ch initiative within the framework of the WingX (E.C. and F.H.) and the MorphogenetiX projects (E.C.). F.H. is now supported by a Swiss National Science Foundation (SNSF) Professorship grant (PP00P3_150682). The work in the laboratory was supported by grants from Cantons Basel-Stadt and BaselLand, from the SNSF and from SystemsX.ch (M.A.).	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; de Celis JF, 1999, DEVELOPMENT, V126, P2653; Doumpas N, 2013, EMBO REP, V14, P261, DOI 10.1038/embor.2013.1; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Foronda D, 2009, MECH DEVELOP, V126, P99, DOI 10.1016/j.mod.2008.12.002; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; Hamaratoglu F, 2014, SEMIN CELL DEV BIOL, V32, P128, DOI 10.1016/j.semcdb.2014.04.036; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; Hariharan IK, 2015, DEV CELL, V34, P255, DOI 10.1016/j.devcel.2015.07.012; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Kanca O, 2014, DEVELOPMENT, V141, P472, DOI 10.1242/dev.102913; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kunnapuu J, 2009, P NATL ACAD SCI USA, V106, P8501, DOI 10.1073/pnas.0809885106; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Restrepo S, 2014, CURR BIOL, V24, pR245, DOI 10.1016/j.cub.2014.01.055; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Schaffter T, 2014, GENES ORGANISMS BIOI; Schwank G, 2012, SCIENCE, V335, DOI 10.1126/science.1210997; Schwank G, 2011, DEV CELL, V20, P123, DOI 10.1016/j.devcel.2010.11.007; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635; Shen J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-23; Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Wartlick Ortrud, 2014, Development, V141, P1884, DOI 10.1242/dev.105650; Wartlick O, 2012, SCIENCE, V335, DOI 10.1126/science.1211373; Wartlick O, 2011, NAT REV MOL CELL BIO, V12, P594, DOI 10.1038/nrm3169; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zecca M, 2007, DEVELOPMENT, V134, P3011, DOI 10.1242/dev.006445; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386	59	73	73	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					317	+		10.1038/nature15712	http://dx.doi.org/10.1038/nature15712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26550827	Green Submitted, Green Accepted			2022-12-28	WOS:000365356800044
J	Jolma, A; Yin, YM; Nitta, KR; Dave, K; Popov, A; Taipale, M; Enge, M; Kivioja, T; Morgunova, E; Taipale, J				Jolma, Arttu; Yin, Yimeng; Nitta, Kazuhiro R.; Dave, Kashyap; Popov, Alexander; Taipale, Minna; Enge, Martin; Kivioja, Teemu; Morgunova, Ekaterina; Taipale, Jussi			DNA-dependent formation of transcription factor pairs alters their binding specificity	NATURE			English	Article							GENE-EXPRESSION; COOPERATIVE BINDING; PROTEIN; DOMAIN; COMPLEX; GENOME; SITES; ETS; RECOGNITION; ENHANCERS	Gene expression is regulated by transcription factors (TFs), proteins that recognize short DNA sequence motifs(1-3). Such sequences are very common in the human genome, and an important determinant of the specificity of gene expression is the cooperative binding of multiple TFs to closely located motifs(4-6). However, interactions between DNA-bound TFs have not been systematically characterized. To identify TF pairs that bind cooperatively to DNA, and to characterize their spacing and orientation preferences, we have performed consecutive affinity-purification systematic evolution of ligands by exponential enrichment (CAP-SELEX) analysis of 9,400 TF-TF-DNA interactions. This analysis revealed 315 TF-TF interactions recognizing 618 heterodimeric motifs, most of which have not been previously described. The observed cooperativity occurred promiscuously between TFs from diverse structural families. Structural analysis of the TF pairs, including a novel crystal structure of MEIS1 and DLX3 bound to their identified recognition site, revealed that the interactions between the TFs were predominantly mediated by DNA. Most TF pair sites identified involved a large overlap between individual TF recognition motifs, and resulted in recognition of composite sites that were markedly different from the individual TF's motifs. Together, our results indicate that the DNA molecule commonly plays an active role in cooperative interactions that define the gene regulatory lexicon.	[Jolma, Arttu; Yin, Yimeng; Nitta, Kazuhiro R.; Dave, Kashyap; Taipale, Minna; Enge, Martin; Morgunova, Ekaterina; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Stockholm, Sweden; [Popov, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Kivioja, Teemu; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, FI-00014 Helsinki, Finland	Karolinska Institutet; European Synchrotron Radiation Facility (ESRF); University of Helsinki	Taipale, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, SE-14183 Stockholm, Sweden.	jussi.taipale@ki.se	Jolma, Arttu/AAK-9649-2021; Morgunova, Ekaterina/G-2479-2018	Morgunova, Ekaterina/0000-0002-7754-9021; Popov, Alexander/0000-0002-3058-8912; Enge, Martin/0000-0001-8748-8931; Nitta, Kazuhiro/0000-0003-3151-0962; Jolma, Arttu/0000-0002-2543-7490	Finnish Academy CoE in Cancer Genetics; Center for Innovative Medicine; Knut and Alice Wallenberg Foundation; Goran Gustafsson Foundation; Vetenskapsradet	Finnish Academy CoE in Cancer Genetics; Center for Innovative Medicine; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Vetenskapsradet(Swedish Research Council)	We thank J. Yan, B. Schmierer, E. Kaasinen, C. Daub, E. Haapaniemi and A. Kolterud for their review of the manuscript, the Karolinska Institutet protein science facility for protein purification, and S. Augsten, L. Hu and A. Zetterlund for technical assistance. This work was supported by Finnish Academy CoE in Cancer Genetics, Center for Innovative Medicine, Knut and Alice Wallenberg and Goran Gustafsson Foundations and Vetenskapsradet.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bourenkov GP, 2006, ACTA CRYSTALLOGR D, V62, P58, DOI 10.1107/S0907444905033998; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Emery P, 1996, MOL CELL BIOL, V16, P4486; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Guturu H, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0029; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; Korhonen J, 2009, BIOINFORMATICS, V25, P3181, DOI 10.1093/bioinformatics/btp554; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meireles ACA, 2014, CURR BIOL, V24, P1, DOI 10.1016/j.cub.2013.11.017; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Moretti R, 2008, ACS CHEM BIOL, V3, P220, DOI 10.1021/cb700258r; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; NISHIZAWA M, 1992, FEBS LETT, V299, P36, DOI 10.1016/0014-5793(92)80094-W; Nitta KR, 2015, ELIFE, V4, DOI 10.7554/eLife.04837; Odrowaz Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049892; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vincentelli R, 2011, METHODS, V55, P65, DOI 10.1016/j.ymeth.2011.08.010; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Williams TM, 2005, DEV BIOL, V277, P457, DOI 10.1016/j.ydbio.2004.10.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48	74	288	293	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					384	+		10.1038/nature15518	http://dx.doi.org/10.1038/nature15518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26550823				2022-12-28	WOS:000365356800058
J	Bangalore, S; Maron, DJ; Hochman, JS				Bangalore, Sripal; Maron, David J.; Hochman, Judith S.			Evidence-Based Management of Stable Ischemic Heart Disease Challenges and Confusion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OPTIMAL MEDICAL THERAPY; CORONARY; OUTCOMES; PCI		[Bangalore, Sripal; Hochman, Judith S.] NYU, Sch Med, New York, NY 10016 USA; [Maron, David J.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	New York University; Stanford University	Bangalore, S (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, Cardiovasc Outcomes Grp, New York, NY 10016 USA.	sripal.bangalore@nyumc.org		Hochman, Judith/0000-0002-5889-5981; Bangalore, Sripal/0000-0001-9485-0652	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL117905, U01HL105907] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bangalore S, 2015, INT J CARDIOL, V183, P6, DOI 10.1016/j.ijcard.2015.01.053; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; De Bruyne B, 2012, NEW ENGL J MED, V367, P1768; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Shaw LJ, 2012, AM HEART J, V164, P243, DOI 10.1016/j.ahj.2012.05.018; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P232, DOI 10.1001/jamainternmed.2013.12855; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	9	13	13	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1917	1918		10.1001/jama.2015.11219	http://dx.doi.org/10.1001/jama.2015.11219			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547460				2022-12-28	WOS:000364490700011
J	Cooper, LB; Hammill, BG; Peterson, ED; Pitt, B; Maciejewski, ML; Curtis, LH; Hernandez, AF				Cooper, Lauren B.; Hammill, Bradley G.; Peterson, Eric D.; Pitt, Bertram; Maciejewski, Matthew L.; Curtis, Lesley H.; Hernandez, Adrian F.			Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SPIRONOLACTONE; POPULATION; MORTALITY		[Cooper, Lauren B.; Hammill, Bradley G.; Peterson, Eric D.; Curtis, Lesley H.; Hernandez, Adrian F.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Pitt, Bertram] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Maciejewski, Matthew L.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA	Duke University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Hernandez, AF (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021	Hernandez, Adrian F/0000-0003-3387-9616; 	AHRQ HHS [U19 HS021092, U19HS021092] Funding Source: Medline; NHLBI NIH HHS [T32HL069749-11A1, T32 HL069749] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069749] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Wei L, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1768; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	6	49	49	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1973	1975		10.1001/jama.2015.11904	http://dx.doi.org/10.1001/jama.2015.11904			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547470	Bronze, Green Accepted			2022-12-28	WOS:000364490700021
J	Cushman, M; Creager, MA				Cushman, Mary; Creager, Mark A.			Improving Awareness and Outcomes Related to Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; PUBLIC AWARENESS; RISK		[Cushman, Mary] Univ Vermont, Coll Med, Dept Med, Cardiovasc Res Inst Vermont, Burlington, VT 05405 USA; [Cushman, Mary] Univ Vermont, Med Ctr, Thrombosis & Hemostasis Program, Burlington, VT 05405 USA; [Creager, Mark A.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Heart & Vasc Ctr, Lebanon, NH 03766 USA	University of Vermont; University of Vermont; University of Vermont Medical Center; Dartmouth College	Cushman, M (corresponding author), Univ Vermont, Coll Med, Dept Med, 360 S Pk Dr, Colchester, VT 05446 USA.	mary.cushman@uvm.edu	Cushman, Mary/K-1157-2019	Cushman, Mary/0000-0002-7871-6143	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, RC1HL099460] Funding Source: NIH RePORTER; NHLBI NIH HHS [RC1 HL099460, RC1HL099460, R01 HL059367] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdollahi M, 2003, THROMB HAEMOSTASIS, V89, P493, DOI 10.1055/s-0037-1613379; Aggarwal A, 2015, CANCER INVEST, V33, P405, DOI 10.3109/07357907.2015.1048871; Engbers MJ, 2014, J THROMB HAEMOST, V12, P290, DOI 10.1111/jth.12480; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Planquette B, 2015, EUR J INTERN MED, V26, P18, DOI 10.1016/j.ejim.2014.11.005; Tomkowski WZ, 2012, J THROMB HAEMOST, V10, P2287, DOI 10.1111/j.1538-7836.2012.04915.x; Wendelboe AM, 2015, J THROMB HAEMOST, V13, P1365, DOI 10.1111/jth.13031; Zakai NA, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.686.686	9	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1913	1914		10.1001/jama.2015.15107	http://dx.doi.org/10.1001/jama.2015.15107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547458	Green Accepted			2022-12-28	WOS:000364490700009
J	Bernstein, R				Bernstein, Rachel			Improving student advising	SCIENCE			English	Editorial Material												SciCareerEditor@aaas.org							0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					710	710		10.1126/science.350.6261.710	http://dx.doi.org/10.1126/science.350.6261.710			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV3MH	26542575				2022-12-28	WOS:000364162800055
J	Delude, CM				Delude, Cathryn M.			Deep phenotyping: The details of disease	NATURE			English	Editorial Material													Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899				Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045	3	73	73	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					S14	S15		10.1038/527S14a	http://dx.doi.org/10.1038/527S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB5XK	26536218				2022-12-28	WOS:000415924500005
J	Dou, ZX; Xu, CY; Donahue, G; Shimi, T; Pan, JA; Zhu, JJ; Ivanov, A; Capelll, BC; Drake, AM; Shah, PP; Catanzaro, JM; Ricketts, MD; Lamark, T; Adam, SA; Marmorstein, R; Zong, WX; Johansen, T; Goldman, RD; Adams, PD; Berger, SL				Dou, Zhixun; Xu, Caiyue; Donahue, Greg; Shimi, Takeshi; Pan, Ji-An; Zhu, Jiajun; Ivanov, Andrejs; Capelll, Brian C.; Drake, Adam M.; Shah, Parisha P.; Catanzaro, Joseph M.; Ricketts, M. Daniel; Lamark, Trond; Adam, Stephen A.; Marmorstein, Ronen; Zong, Wei-Xing; Johansen, Terje; Goldman, Robert D.; Adams, Peter D.; Berger, Shelley L.			Autophagy mediates degradation of nuclear lamina	NATURE			English	Article							SELECTIVE AUTOPHAGY; SENESCENCE; B1; CHROMATIN; PROTEINS; DISEASE; P53; ORGANIZATION; EXPRESSION; DOMAINS	Macroautophagy (hereafter referred to as autophagy) is a catabolic membrane trafficking process that degrades a variety of cellular constituents and is associated with human diseases(1-3). Although extensive studies have focused on autophagic turnover of cytoplasmic materials, little is known about the role of autophagy in degrading nuclear components. Here we report that the autophagy machinery mediates degradation of nuclear lamina components in mammals. The autophagy protein LC3/Atg8, which is involved in autophagy membrane trafficking and substrate delivery(4-6), is present in the nucleus and directly interacts with the nuclear lamina protein lamin B1, and binds to lamin-associated domains on chromatin. This LC3-lamin B1 interaction does not downregulate lamin B1 during starvation, but mediates its degradation upon oncogenic insults, such as by activated RAS. Lamin B1 degradation is achieved by nucleus-to-cytoplasm transport that delivers lamin B1 to the lysosome. Inhibiting autophagy or the LC3-lamin B1 interaction prevents activated RAS-induced lamin B1 loss and attenuates oncogene-induced senescence in primary human cells. Our study suggests that this new function of autophagy acts as a guarding mechanism protecting cells from tumorigenesis.	[Dou, Zhixun; Xu, Caiyue; Donahue, Greg; Zhu, Jiajun; Capelll, Brian C.; Drake, Adam M.; Shah, Parisha P.; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Epigenet Program, Philadelphia, PA 19104 USA; [Shimi, Takeshi; Adam, Stephen A.; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Pan, Ji-An; Catanzaro, Joseph M.; Zong, Wei-Xing] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Ivanov, Andrejs; Adams, Peter D.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland; [Ivanov, Andrejs; Adams, Peter D.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Ricketts, M. Daniel; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Lamark, Trond; Johansen, Terje] Arctic Univ Norway, Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Glasgow; Beatson Institute; University of Pennsylvania; UiT The Arctic University of Tromso; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Berger, SL (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Epigenet Program, Philadelphia, PA 19104 USA.	bergers@upenn.edu	Braun, Andrejs/C-1942-2009; Zhu, Jiajun/R-6196-2016; Johansen, Terje/N-2971-2015; Xu, Caiyue/GQZ-4365-2022; Johansen, Terje/AAY-1753-2021; ZHU, JIAJUN/AAM-1459-2021; Shimi, Takeshi/AAC-2322-2022; Zhu, Jiajun/GQP-3551-2022	Braun, Andrejs/0000-0003-0925-5598; Zhu, Jiajun/0000-0002-1760-3081; Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Shimi, Takeshi/0000-0002-9864-1820; Berger, Shelley/0000-0001-5398-4400; Adam, Stephen/0000-0003-3444-7655; Adams, Peter/0000-0002-0684-1770; Xu, Caiyue/0000-0003-4056-5586; Lamark, Trond/0000-0001-6338-3342	Leukemia & Lymphoma Society; Dermatology Foundation; Melanoma Research Foundation; American Skin Association; NIA [P01AG031862]; NIH [R01 CA078831]; Progeria Research Foundation;  [R01 GM106023]; Cancer Research UK [22311] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA078831, R01CA129536, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097355, R01GM106023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Dermatology Foundation; Melanoma Research Foundation; American Skin Association; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Progeria Research Foundation; ; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Berger, Adams, and Goldman laboratories for technical assistance and discussions. We acknowledge A. L. Stout for help with confocal microscopy, and the electron microscopy resource laboratory for assistance on TEM. We thank Z. Yue for sharing the GFP antibody and reading the manuscript, and M. Narita and R. Salama for help with LADs definition. Z.D. is supported by a fellow award from the Leukemia & Lymphoma Society. B.C.C. is supported by career development awards from the Dermatology Foundation, Melanoma Research Foundation, and American Skin Association. S.L.B., P.D.A. and R.M. are supported by NIA P01 grant (P01AG031862). S.L.B. is also supported by NIH R01 CA078831. R.D.G. is supported by R01 GM106023 and the Progeria Research Foundation.	Butin-Israeli V, 2015, MOL CELL BIOL, V35, P884, DOI 10.1128/MCB.01145-14; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005864; Lund E, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku324; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Sadaie M, 2013, GENE DEV, V27, P1800, DOI 10.1101/gad.217281.113; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Simon HU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.308; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	30	366	375	8	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					105	109		10.1038/nature15548	http://dx.doi.org/10.1038/nature15548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26524528	Green Accepted, Green Submitted			2022-12-28	WOS:000364270700052
J	Muehlenbachs, A; Bhatnagar, J; Agudelo, CA; Hidron, A; Eberhard, ML; Mathison, BA; Frace, MA; Ito, A; Metcalfe, MG; Rollin, DC; Visvesvara, GS; Pham, CD; Jones, TL; Greer, PW; Hoyos, AV; Olson, PD; Diazgranados, LR; Zaki, SR				Muehlenbachs, Atis; Bhatnagar, Julu; Agudelo, Carlos A.; Hidron, Alicia; Eberhard, Mark L.; Mathison, Blaine A.; Frace, Michael A.; Ito, Akira; Metcalfe, Maureen G.; Rollin, Dominique C.; Visvesvara, Govinda S.; Pham, Cau D.; Jones, Tara L.; Greer, Patricia W.; Hoyos, Alejandro Velez; Olson, Peter D.; Diazgranados, Lucy R.; Zaki, Sherif R.			Malignant Transformation of Hymenolepis nana in a Human Host	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ECHINOCOCCUS-MULTILOCULARIS; INFECTION; PARASITE; TUMORS; MICE; DNA	Neoplasms occur naturally in invertebrates but are not known to develop in tapeworms. We observed nests of monomorphic, undifferentiated cells in samples from lymph-node and lung biopsies in a man infected with the human immunodeficiency virus (HIV). The morphologic features and invasive behavior of the cells were characteristic of cancer, but their small size suggested a nonhuman origin. A polymerase-chain-reaction (PCR) assay targeting eukaryotes identified Hymenolepis nana DNA. Although the cells were unrecognizable as tapeworm tissue, immunohistochemical staining and probe hybridization labeled the cells in situ. Comparative deep sequencing identified H. nana structural genomic variants that are compatible with mutations described in cancer. Invasion of human tissue by abnormal, proliferating, genetically altered tapeworm cells is a novel disease mechanism that links infection and cancer.	[Muehlenbachs, Atis; Bhatnagar, Julu; Metcalfe, Maureen G.; Rollin, Dominique C.; Jones, Tara L.; Greer, Patricia W.; Zaki, Sherif R.] Ctr Dis Control & Prevent CDC, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Eberhard, Mark L.; Mathison, Blaine A.] Ctr Dis Control & Prevent CDC, Parasit Dis Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Frace, Michael A.] Ctr Dis Control & Prevent CDC, Biotechnol Core Facil, Div Sci Resources, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Visvesvara, Govinda S.] Ctr Dis Control & Prevent CDC, Waterborne Dis Prevent Branch, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Pham, Cau D.] Ctr Dis Control & Prevent CDC, Mycot Dis Branch, Atlanta, GA USA; [Hidron, Alicia] Emory Univ, Sch Med, Atlanta, GA USA; [Agudelo, Carlos A.; Hidron, Alicia; Hoyos, Alejandro Velez; Diazgranados, Lucy R.] Univ Pontificia Bolivariana, Sch Hlth Sci, Medellin, Colombia; [Agudelo, Carlos A.] Clin Univ Bolivariana, Medellin, Colombia; [Hidron, Alicia; Hoyos, Alejandro Velez] Hosp Pablo Tobon Uribe, Medellin, Colombia; [Agudelo, Carlos A.] San Vicente Fdn, Ctr Especializados, Rionegro, Colombia; [Ito, Akira] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan; [Olson, Peter D.] Nat Hist Museum, Dept Life Sci, Div Parasites & Vectors, London, England	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Universidad Pontificia Bolivariana; Universidad Pontificia Bolivariana; Asahikawa Medical College; Natural History Museum London	Muehlenbachs, A (corresponding author), CDC, Infect Dis Pathol Branch, 1600 Clifton Rd NE,MS G32, Atlanta, GA 30329 USA.	vkd6@cdc.gov	Olson, Peter/D-4643-2009; Ito, A./E-9377-2014	Olson, Peter/0000-0002-4183-4533; Ito, A./0000-0002-5070-9187				BUERGELT CD, 1984, J PARASITOL, V70, P121, DOI 10.2307/3281933; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; CONNOR DH, 1976, ARCH PATHOL LAB MED, V100, P65; Crompton DWT, 1999, J PARASITOL, V85, P397, DOI 10.2307/3285768; Cunningham LJ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-123; Domazet-Loso T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5222; GAMAL-EDDIN F M, 1986, Journal of the Egyptian Society of Parasitology, V16, P517; Goldberg TL, 2014, EMERG INFECT DIS, V20, P109, DOI 10.3201/eid2001.131191; HALL F, 1986, J EXP ZOOL, V240, P211, DOI 10.1002/jez.1402400209; Hemer S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-5; ITO A, 1984, EXP PARASITOL, V58, P132, DOI 10.1016/0014-4894(84)90028-6; Ito A, 2015, PARASITE IMMUNOL, V37, P53, DOI 10.1111/pim.12167; Koziol U, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-10; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; LUCAS SB, 1980, J HELMINTHOL, V54, P75, DOI 10.1017/S0022149X00006386; Martin MP, 2003, MYCOLOGIA, V95, P474, DOI 10.2307/3761889; Munoz-Cadavid C, 2010, J CLIN MICROBIOL, V48, P2147, DOI 10.1128/JCM.00459-10; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Okamoto M, 1997, PARASITOLOGY, V115, P661, DOI 10.1017/S0031182097001741; Olson PD, 2003, J INFECT DIS, V187, P1962, DOI 10.1086/375357; Peter R., 2004, J APPL BIOMED, V2, P21; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; SantamariaFries M, 1996, LANCET, V347, P1797, DOI 10.1016/S0140-6736(96)91618-9; Schubert A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002870; SPARKS AK, 1969, NATL CANCER I MONOGR, P671; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031	26	49	54	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1845	1852		10.1056/NEJMoa1505892	http://dx.doi.org/10.1056/NEJMoa1505892			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26535513				2022-12-28	WOS:000364144000008
J	Arnott, D; Wessely, S; Fitzpatrick, M				Arnott, Deborah; Wessely, Simon; Fitzpatrick, Michael			MAUDSLEY DEBATE Should psychiatric hospitals completely ban smoking?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arnott, Deborah] Act Smoking & Hlth, London, England; [Wessely, Simon] Royal Coll Psychiatrists, London, England		Arnott, D (corresponding author), Act Smoking & Hlth, London, England.	Deborah.Arnott@ash.org.uk; fitz@easynet.co.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929				Allan C., 2013, GUARDIAN; Appleby L., 2007, GUARDIAN; Curtis B., 2015, SPIKED; Hawkins K., 2015, BBC NEWS; Hill A., 2011, GUARDIAN; Kant E., 1874, ANSWER QUESTION WHAT; Lawn SJ, 2002, SOC SCI MED, V54, P93, DOI 10.1016/S0277-9536(01)00008-9; Lowson R., 2015, TELEGRAPH ARGUS; McNeill A, 2015, ECIGARETTES EVIDENCE; McNicoll A., 2013, COMMUNITY CARE; NICE, 2013, NICE PUBL HLTH GUID, V48; NICE, 2013, SMOK AC MAT MENT HLT; Peterson HJ, 2013, GUARDIAN; Robson D, 2015, SMOK FREE C LOND 1 O; [Royal College of Psychiatrists Royal College of Physicians], 2013, SMOK MENT HLTH; South London and Maudsley NHS Foundation Trust, 2015, SMOK FREE POL; Yates M., 2015, SMOK FREE C LOND 1 O	18	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5654	10.1136/bmj.h5654	http://dx.doi.org/10.1136/bmj.h5654			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV6OS	26536887				2022-12-28	WOS:000364390100007
J	Neutze, R				Neutze, Richard			Snapshots of a protein quake	SCIENCE			English	Editorial Material							FREE-ELECTRON LASER; CRYSTALLOGRAPHY; MYOGLOBIN		Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Neutze, R (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	richard.neutze@chem.gu.se						ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Feynman R., 1963, FEYNMAN LECT PHYS, V1; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Levantino M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7772; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357	11	2	2	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					381	381		10.1126/science.aad3371	http://dx.doi.org/10.1126/science.aad3371			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494745				2022-12-28	WOS:000363213400021
J	Woodson, JD; Joens, MS; Sinson, AB; Gilkerson, J; Salom, PA; Weigel, D; Fitzpatrick, JA; Chory, J				Woodson, Jesse D.; Joens, Matthew S.; Sinson, Andrew B.; Gilkerson, Jonathan; Salom, Patrice A.; Weigel, Detlef; Fitzpatrick, James A.; Chory, Joanne			Ubiquitin facilitates a quality-control pathway that removes damaged chloroplasts	SCIENCE			English	Article							NUCLEAR GENE-EXPRESSION; SINGLET OXYGEN; ARABIDOPSIS; PLANTS; LIGHT; FERROCHELATASE; SENESCENCE; AUTOPHAGY; RESPONSES; SIGNALS	Energy production by chloroplasts and mitochondria causes constant oxidative damage. A functioning photosynthetic cell requires quality-control mechanisms to turn over and degrade chloroplasts damaged by reactive oxygen species (ROS). Here, we generated a conditionally lethal Arabidopsis mutant that accumulated excess protoporphyrin IX in the chloroplast and produced singlet oxygen. Damaged chloroplasts were subsequently ubiquitinated and selectively degraded. A genetic screen identified the plant U-box 4 (PUB4) E3 ubiquitin ligase as being necessary for this process. pub4-6 mutants had defects in stress adaptation and longevity. Thus, we have identified a signal that leads to the targeted removal of ROS-overproducing chloroplasts.	[Woodson, Jesse D.; Sinson, Andrew B.; Gilkerson, Jonathan; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Joens, Matthew S.; Fitzpatrick, James A.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA USA; [Sinson, Andrew B.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Gilkerson, Jonathan; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA USA; [Salom, Patrice A.; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany	Salk Institute; Salk Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; Max Planck Society	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu	Salome, Patrice/E-5702-2017; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-04ER15540]; Howard Hughes Medical Institute; NIH [1F32GM096610]; NCI P30 Cancer Center Support Grant [CA014195]; NINDS P30 Neuroscience Center Core Grant [NS072031]; W.M. Keck Foundation; Gottfried Wilhelm Leibniz Award; Max Planck Society; Waitt Advanced Biophotonics Center; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072031] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI P30 Cancer Center Support Grant; NINDS P30 Neuroscience Center Core Grant; W.M. Keck Foundation(W.M. Keck Foundation); Gottfried Wilhelm Leibniz Award(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Waitt Advanced Biophotonics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Orchard for photographs of plants, C. Lanz for assistance with sequencing, X. Wang for help with SHORE analysis, C. Procko, E. Lee, and A. Tsang for technical assistance, and D. O'Keefe for useful discussions about the manuscript. J.D.W., A. S., J.G. and J.C. acknowledge long-term support from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-04ER15540 and from the Howard Hughes Medical Institute. J.G. was supported by an NIH Kirschstein fellowship (1F32GM096610). M.S.J. and J.A.J.F. received funding from the Waitt Advanced Biophotonics Center, NCI P30 Cancer Center Support Grant CA014195 (JAJF), NINDS P30 Neuroscience Center Core Grant NS072031 and the W.M. Keck Foundation. P.S. and D.W. were supported by a Gottfried Wilhelm Leibniz Award to the Deutsche Forschungsgemeinschaft (D.F.G.), and by the Max Planck Society. We thank J. Callis for sharing the anti-ubiquitin antibody and R. Tsien and L. Gross for use of their HPLC. Microarray data are deposited at Gene Expression Omnibus (GSE71764). All biological materials in this study are available from J. C. under a materials transfer agreement with the Salk Institute for Biological Studies/HHMI.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Chi W, 2013, ANNU REV PLANT BIOL, V64, P559, DOI 10.1146/annurev-arplant-050312-120147; Chiba A, 2003, PLANT CELL PHYSIOL, V44, P914, DOI 10.1093/pcp/pcg118; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; KENNEDY JC, 1992, J PHOTOCH PHOTOBIO B, V14, P275, DOI 10.1016/1011-1344(92)85108-7; Kinoshita A, 2015, DEVELOPMENT, V142, P444, DOI 10.1242/dev.113167; Kusaba M, 2013, PHOTOSYNTH RES, V117, P221, DOI 10.1007/s11120-013-9862-x; Leister D, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00135; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Michaeli S, 2014, PLANT CELL, V26, P4084, DOI 10.1105/tpc.114.129999; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; Ramel F, 2013, PLANT CELL, V25, P1445, DOI 10.1105/tpc.113.109827; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; Ruckle ME, 2007, PLANT CELL, V19, P3944, DOI 10.1105/tpc.107.054312; Scharfenberg M, 2015, PLANT CELL ENVIRON, V38, P280, DOI 10.1111/pce.12248; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Wang H, 2013, PLANT J, V74, P511, DOI 10.1111/tpj.12146; Wang SH, 2014, PLANT CELL, V26, P4875, DOI 10.1105/tpc.114.133116; Woodson JD, 2013, PLANT J, V73, P1, DOI 10.1111/tpj.12011; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038	27	122	124	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					450	454		10.1126/science.aac7444	http://dx.doi.org/10.1126/science.aac7444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494759	Green Accepted			2022-12-28	WOS:000363213400044
J	Cabeen, MT; Losick, R				Cabeen, Matthew T.; Losick, Richard			Bacterial Backstabbing: EF-Tu, Brute?	CELL			English	Editorial Material							VI SECRETION SYSTEM	Bacterial type VI secretion is an offensive and defensive weapon that utilizes a molecular warhead to inject toxins into neighboring cells. In this issue of Cell, Whitney et al. report a new class of toxin that disrupts the core metabolism of recipient cells and uncover a surprising requirement for EF-Tu.	[Cabeen, Matthew T.; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, R01GM018568] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007598, R01 GM018568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Wenren LM, 2013, MBIO, V4, DOI 10.1128/mBio.00374-13; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027	7	3	3	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					537	539		10.1016/j.cell.2015.10.007	http://dx.doi.org/10.1016/j.cell.2015.10.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496597	Bronze			2022-12-28	WOS:000364828900005
J	Hein, MY; Hubner, NC; Poser, I; Cox, J; Nagaraj, N; Toyoda, Y; Gak, IA; Weisswange, I; Mansfeld, J; Buchholz, F; Hyman, AA; Mann, M				Hein, Marco Y.; Hubner, Nina C.; Poser, Ina; Cox, Juergen; Nagaraj, Nagarjuna; Toyoda, Yusuke; Gak, Igor A.; Weisswange, Ina; Mansfeld, Joerg; Buchholz, Frank; Hyman, Anthony A.; Mann, Matthias			A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances	CELL			English	Article							PROTEOME-SCALE MAP; BAC TRANSGENEOMICS; COPY-NUMBER; COMPLEXES; REVEALS; ACCURATE; RESOURCE	The organization of a cell emerges from the interactions in protein networks. The interactome is critically dependent on the strengths of interactions and the cellular abundances of the connected proteins, both of which span orders of magnitude. However, these aspects have not yet been analyzed globally. Here, we have generated a library of HeLa cell lines expressing 1,125 GFP-tagged proteins under near-endogenous control, which we used as input for a next-generation interaction survey. Using quantitative proteomics, we detect specific interactions, estimate interaction stoichiometries, and measure cellular abundances of interacting proteins. These three quantitative dimensions reveal that the protein network is dominated by weak, substoichiometric interactions that play a pivotal role in defining network topology. The minority of stable complexes can be identified by their unique stoichiometry signature. This study provides a rich interaction dataset connecting thousands of proteins and introduces a framework for quantitative network analysis.	[Hein, Marco Y.; Hubner, Nina C.; Cox, Juergen; Nagaraj, Nagarjuna; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Poser, Ina; Toyoda, Yusuke; Buchholz, Frank; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Gak, Igor A.; Mansfeld, Joerg] Cell Cycle, Ctr Biotechnol, D-01307 Dresden, Germany; [Weisswange, Ina; Buchholz, Frank] Tech Univ Dresden, Med Fac Carl Gustav Carus, UCC, Med Syst Biol, D-01307 Dresden, Germany; [Weisswange, Ina] Eupheria Biotech GmbH, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hyman, AA (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	hyman@mpi-cbg.de; mmann@biochem.mpg.de	Hyman, Anthony A/B-3917-2017; Buchholz, Frank/B-4700-2017; Mansfeld, Joerg/B-4154-2014; Hein, Marco/C-2994-2014; Hubner, Nina C/C-4298-2008; Cox, Jurgen/B-9481-2008; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Buchholz, Frank/0000-0002-4577-3344; Hein, Marco/0000-0002-9490-2261; Hubner, Nina C/0000-0002-7864-2877; Cox, Jurgen/0000-0001-8597-205X; Mansfeld, Jorg/0000-0002-0562-8206; Toyoda, Yusuke/0000-0003-0534-6898	Federal Ministry of Education and Research [FKZ01GS0861]; Max Planck Society; European Commission [FP6-LSHG-CT-2004-503464, FP7-HEALTH-F4-2008-201648, FP7-HEALTH-2009-241548]; German Research Foundation (DFG) [MA 5831/1-1]; DIGS-BB PhD program	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG)(German Research Foundation (DFG)); DIGS-BB PhD program	This work was performed within the project framework of the German medical genome research funded by the Federal Ministry of Education and Research (FKZ01GS0861, DiGtoP). We acknowledge funding from the Max Planck Society and the European Commission's Sixth and Seventh Framework Programs (FP6-LSHG-CT-2004-503464, MitoCheck; FP7-HEALTH-F4-2008-201648, PROSPECTS; FP7-HEALTH-2009-241548, MitoSys). J.M. is supported by the German Research Foundation (DFG) (Emmy Noether, MA 5831/1-1), I.A.G. is a member of the DIGS-BB PhD program. Antibodies for BAC validation were a gift from C. Stadler and E. Lundberg. We thank M. Leuschner, A. Ssykor, M. Augsburg, A. Schwager, M. T. Pham, G. Sowa, K. Mayr, I. Paron, B. Splettstosser, D. Vogg, B. Chatterjee, M. Grotzinger, and S. Kroiss for technical assistance. C. Schaab, S. Schloissnig, P. Porras, and M. Oroshi provided bioinformatics support. We thank M. Sarov, M. Seiler, M. C. Bassik, S. Pinkert, A. Bracher, H. C. Eberl, T. Viturawong, E. C. Keilhauer, A. Hrle, G. Pichler, N. A. Kulak, and M. Raschle for helpful discussions.	Acquaviva C, 2004, NAT CELL BIOL, V6, P892, DOI 10.1038/ncb1167; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/NMETH.2703, 10.1038/nmeth.2703]; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Csermely P, 2006, WEAK LINKS STABILIZE; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fievet BT, 2013, NAT CELL BIOL, V15, P103, DOI 10.1038/ncb2639; Friederichs JM, 2012, G3-GENES GENOM GENET, V2, P1703, DOI 10.1534/g3.112.004614; Ganner A, 2009, P NATL ACAD SCI USA, V106, P17799, DOI 10.1073/pnas.0909465106; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hauri S, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304750; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hayes NVL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028271; Hein M.Y., 2013, HDB SYSTEMS BIOL, P3, DOI DOI 10.1016/B978-0-12-385944-0.00001-0; Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Phillips-Krawczak CA, 2015, MOL BIOL CELL, V26, P91, DOI 10.1091/mbc.E14-06-1073; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Simonis N, 2006, J MOL BIOL, V363, P589, DOI 10.1016/j.jmb.2006.06.024; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Sohaskey ML, 2010, J CELL BIOL, V189, P511, DOI 10.1083/jcb.201003006; Soulavie F, 2014, MOL BIOL CELL, V25, P1276, DOI 10.1091/mbc.E13-10-0616; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang W, 2014, ELIFE, V3, DOI 10.7554/eLife.03083; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515	61	741	743	6	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					712	723		10.1016/j.cell.2015.09.053	http://dx.doi.org/10.1016/j.cell.2015.09.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496610	Bronze			2022-12-28	WOS:000364828900023
J	Shadel, GS; Horvath, TL				Shadel, Gerald S.; Horvath, Tamas L.			Mitochondrial ROS Signaling in Organismal Homeostasis	CELL			English	Review							UNCOUPLING PROTEIN-2 UCP2; INCREASING OXIDATIVE STRESS; DEPENDENT ANION CHANNELS; CHRONOLOGICAL LIFE-SPAN; DIET-INDUCED OBESITY; REACTIVE OXYGEN; C. ELEGANS; CAENORHABDITIS-ELEGANS; FREE-RADICALS; AGRP NEURONS	Generation, transformation, and utilization of organic molecules in support of cellular differentiation, growth, and maintenance are basic tenets that define life. In eukaryotes, mitochondrial oxygen consumption plays a central role in these processes. During the process of oxidative phosphorylation, mitochondria utilize oxygen to generate ATP from organic fuel molecules but in the process also produce reactive oxygen species (ROS). While ROS have long been appreciated for their damage-promoting, detrimental effects, there is now a greater understanding of their roles as signaling molecules. Here, we review mitochondrial ROS-mediated signaling pathways with an emphasis on how they are involved in various basal and adaptive physiological responses that control organismal homeostasis.	[Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Shadel, Gerald S.; Horvath, Tamas L.] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06520 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA.	gerald.shadel@yale.edu; tamas.horvath@yale.edu	Datta, Sayantan/D-1369-2010		NATIONAL INSTITUTE ON AGING [R01AG047632, R01AG040236] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG047632, R01 AG040236] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2006, EUR J NEUROSCI, V24, P32, DOI 10.1111/j.1460-9568.2006.04906.x; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Budzinska M, 2009, J BIOENERG BIOMEMBR, V41, P361, DOI 10.1007/s10863-009-9231-9; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Caro-Maldonado A, 2012, SEMIN IMMUNOL, V24, P405, DOI 10.1016/j.smim.2012.12.002; Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Dancy BM, 2014, EXP GERONTOL, V56, P245, DOI 10.1016/j.exger.2014.03.028; Deierborg T, 2008, J CEREBR BLOOD F MET, V28, P1186, DOI 10.1038/jcbfm.2008.8; Diano S, 2000, ENDOCRINOLOGY, V141, P4226, DOI 10.1210/en.141.11.4226; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dietrich MO, 2012, NAT REV DRUG DISCOV, V11, P675, DOI 10.1038/nrd3739; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Ezerina D, 2014, J MOL CELL CARDIOL, V73, P43, DOI 10.1016/j.yjmcc.2013.12.023; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Horvath TL, 2009, TRENDS ENDOCRIN MET, V20, P78, DOI 10.1016/j.tem.2008.10.003; Horvath TL, 1999, J NEUROSCI, V19, P10417; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; Hwang AB, 2014, P NATL ACAD SCI USA, V111, pE4458, DOI 10.1073/pnas.1411199111; Johnson D, 2012, AM J PHYSIOL-CELL PH, V302, pC1045, DOI 10.1152/ajpcell.00411.2011; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Leloup C, 2006, DIABETES, V55, P2084, DOI 10.2337/db06-0086; Logan A, 2014, BBA-GEN SUBJECTS, V1840, P923, DOI 10.1016/j.bbagen.2013.05.026; Long LH, 2014, J CLIN INVEST, V124, P4017, DOI 10.1172/JCI76220; Lustgarten MS, 2012, BIOCHEM BIOPH RES CO, V422, P515, DOI 10.1016/j.bbrc.2012.05.055; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Richard D, 1998, J COMP NEUROL, V397, P549; Ricquier D, 1998, BIOCHEM SOC T, V26, P120, DOI 10.1042/bst0260120; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Schieber M, 2014, CELL REP, V9, P9, DOI 10.1016/j.celrep.2014.08.075; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Simon-Areces J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042911; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Varela L, 2012, EMBO J, V31, P4252, DOI 10.1038/emboj.2012.287; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woolley JF, 2013, TRENDS BIOCHEM SCI, V38, P556, DOI 10.1016/j.tibs.2013.08.009; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	95	660	687	14	189	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					560	569		10.1016/j.cell.2015.10.001	http://dx.doi.org/10.1016/j.cell.2015.10.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496603	Green Accepted, Bronze			2022-12-28	WOS:000364828900011
J	Dzau, VJ				Dzau, Victor J.			The National Academy of Medicine's Vision Leadership, Innovation, and Impact for a Healthier Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dzau, Victor J.] Natl Acad Med, Washington, DC 20001 USA	National Academies of Sciences, Engineering & Medicine	Dzau, VJ (corresponding author), Natl Acad Med, 500 Fifth St NW, Washington, DC 20001 USA.	vdzau@nas.edu						[Anonymous], INN INC BRIDG ACT HL; [Anonymous], CREAT GLOB HLTH RISK; *I MED, 2009, US COMM GLOB HLTH RE; Institute of Medicine, 2015, DYING AM IMPR QUAL H; National Academy of Medicine, VIT DIR HLTH HLTH CA	5	2	2	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2127	2128		10.1001/jama.2015.15820	http://dx.doi.org/10.1001/jama.2015.15820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26540559				2022-12-28	WOS:000365351900012
J	Hanna, RN; Cekic, C; Sag, D; Tacke, R; Thomas, GD; Nowyhed, H; Herrley, E; Rasquinha, N; McArdle, S; Wu, RP; Peluso, E; Metzger, D; Ichinose, H; Shaked, I; Chodaczek, G; Biswas, SK; Hedrick, CC				Hanna, Richard N.; Cekic, Caglar; Sag, Duygu; Tacke, Robert; Thomas, Graham D.; Nowyhed, Heba; Herrley, Erica; Rasquinha, Nicole; McArdle, Sara; Wu, Runpei; Peluso, Esther; Metzger, Daniel; Ichinose, Hiroshi; Shaked, Iftach; Chodaczek, Grzegorz; Biswas, Subhra K.; Hedrick, Catherine C.			Patrolling monocytes control tumor metastasis to the lung	SCIENCE			English	Article							NATURAL-KILLER-CELLS; T-CELLS; BLOOD MONOCYTES; IN-VIVO; SUBSETS; MACROPHAGES; EXPRESSION; CANCER; MOUSE; FRACTALKINE	The immune system plays an important role in regulating tumor growth and metastasis. Classical monocytes promote tumorigenesis and cancer metastasis, but how nonclassical "patrolling" monocytes (PMo) interact with tumors is unknown. Here we show that PMo are enriched in the microvasculature of the lung and reduce tumor metastasis to lung in multiple mouse metastatic tumor models. Nr4a1-deficient mice, which specifically lack PMo, showed increased lung metastasis in vivo. Transfer of Nr4a1-proficient PMo into Nr4a1-deficient mice prevented tumor invasion in the lung. PMo established early interactions with metastasizing tumor cells, scavenged tumor material from the lung vasculature, and promoted natural killer cell recruitment and activation. Thus, PMo contribute to cancer immunosurveillance and may be targets for cancer immunotherapy.	[Hanna, Richard N.; Tacke, Robert; Thomas, Graham D.; Nowyhed, Heba; Herrley, Erica; Rasquinha, Nicole; Wu, Runpei; Peluso, Esther; Shaked, Iftach; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Cekic, Caglar] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Sag, Duygu] Dokuz Eylul Univ, Izmir Biomed & Genome Ctr, Izmir, Turkey; [McArdle, Sara; Chodaczek, Grzegorz] La Jolla Inst Allergy & Immunol, Microscopy Core, La Jolla, CA 92037 USA; [Metzger, Daniel] Univ Strasbourg, CNRS UMR 7104, INSERM U964, Dept Funct Genom & Canc,IGBMC, Illkirch Graffenstaden, France; [Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Biswas, Subhra K.] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	La Jolla Institute for Immunology; Ihsan Dogramaci Bilkent University; Dokuz Eylul University; La Jolla Institute for Immunology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tokyo Institute of Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Hanna, RN (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.	rhanna@lji.org; hedrick@lji.org	Ichinose, Hiroshi/D-8986-2015; Chodaczek, Grzegorz/AAH-1681-2022; Chodaczek, Grzegorz/G-4073-2014; Sag, Duygu/ABI-8226-2020; Chodaczek, Grzegorz/AFL-9576-2022; Shaked, Iftach/GNM-9959-2022; Shaked, Iftach/AAS-9961-2020	Ichinose, Hiroshi/0000-0001-6008-6860; Cekic, Caglar/0000-0001-8081-508X; Thomas, Graham/0000-0001-9778-8874; Metzger, Daniel/0000-0002-5555-046X; Sag, Duygu/0000-0003-1690-6846; PELUSO, ESTHER/0000-0002-0252-6327	NIH [R01 HL118765, R01 CA202987, NIH F32 HL117533-02]; American Heart Association [3POST16990029, 125SDG12070005]; La Jolla Institute for Allergy and Immunology Board of Directors Fellowship; CNRS; INSERM; SIgN (A*STAR); NATIONAL CANCER INSTITUTE [R01CA202987] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL117533, R01HL118765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); La Jolla Institute for Allergy and Immunology Board of Directors Fellowship; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); SIgN (A*STAR)(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Ley and H. Shaked for critically reviewing and editing this manuscript, K. Hogquist for Nr4a1-GFP reporter mice, M. Kronenberg for B16F10 melanoma cells, A. Blatchley and D. Yoakum for assistance with mouse colony management, A. Strasner for help with establishing tumor models, and Z. Mikulski for assistance with imaging. The data presented here are tabulated in the main paper and in the supplementary materials. Nr4a1-floxed conditional mice are available from IGBMC under a material transfer agreement with D.M. and H.I. C.C.H., R.N.H., and the La Jolla Institute for Allergy and Immunology have filed a U.S. patent application (U.S. 13/646,183) that relates to specific topic "Methods and uses of Nur77 and Nur77 agonists to modulate macrophages and monocytes, and treat inflammation, inflammatory disease and cardiovascular disease" and an invention disclosure that relates to the specific topic "Patrolling monocytes control tumor metastasis to the lung." This work was supported by NIH grants R01 HL118765 and R01 CA202987 (both to C.C.H.), American Heart Association Postdoctoral Award 3POST16990029 (to R.T.), NIH F32 postdoctoral fellowship NIH F32 HL117533-02 (to H.N.), American Heart Association Scientist Development Grant 125SDG12070005 (to R.N.H.), the La Jolla Institute for Allergy and Immunology Board of Directors Fellowship (to R.N.H.), CNRS and INSERM (to D.M.), and core funding from SIgN (A*STAR) (to S.K.B.).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Ferretti E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/480941; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hyakudomi M, 2008, ANN SURG ONCOL, V15, P1775, DOI 10.1245/s10434-008-9876-3; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kee JY, 2013, MOL CLIN ONCOL, V1, P35, DOI 10.3892/mco.2012.30; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Park MH, 2012, J SURG ONCOL, V106, P386, DOI 10.1002/jso.23095; Pucci F, 2013, CLIN CANCER RES, V19, P2598, DOI 10.1158/1078-0432.CCR-12-0962; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sanford DE, 2013, CLIN CANCER RES, V19, P3404, DOI 10.1158/1078-0432.CCR-13-0525; Schmall A, 2015, AM J RESP CRIT CARE, V191, P437, DOI 10.1164/rccm.201406-1137OC; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tardaguila M., 2014, ONCOLOGY THEORY PRAC; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; Zhang JL, 2010, INT J CLIN EXP MED, V3, P233	39	260	264	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					985	990		10.1126/science.aac9407	http://dx.doi.org/10.1126/science.aac9407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26494174	Green Submitted, Green Accepted			2022-12-28	WOS:000364955200051
J	Kraus, PM; Mignolet, B; Baykusheva, D; Rupenyan, A; Horny, L; Penka, EF; Grassi, G; Tolstikhin, OI; Schneider, J; Jensen, F; Madsen, LB; Bandrauk, AD; Remacle, F; Worner, HJ				Kraus, P. M.; Mignolet, B.; Baykusheva, D.; Rupenyan, A.; Horny, L.; Penka, E. F.; Grassi, G.; Tolstikhin, O. I.; Schneider, J.; Jensen, F.; Madsen, L. B.; Bandrauk, A. D.; Remacle, F.; Woerner, H. J.			Measurement and laser control of attosecond charge migration in ionized iodoacetylene	SCIENCE			English	Article							TIME-SCALE; REAL-TIME; MOLECULES; DYNAMICS; SPECTRA; SYSTEMS; CATIONS; PULSES; STATES; LIGHT	The ultrafast motion of electrons and holes after light-matter interaction is fundamental to a broad range of chemical and biophysical processes. We advanced high-harmonic, spectroscopy to resolve spatially and temporally the migration of an electron hole immediately after ionization of iodoacetylene while simultaneously demonstrating extensive control over the process. A multidimensional approach, based on the measurement and accurate theoretical description of both even and odd harmonic orders, enabled us to reconstruct both quantum amplitudes and phases of the electronic states with a resolution of 100 attoseconds. We separately reconstructed quasi field-free and laser-controlled charge migration as a function of the spatial orientation of the molecule and determined the shape of the hole created by ionization. Our technique opens the prospect of laser control over electronic primary processes.	[Kraus, P. M.; Baykusheva, D.; Rupenyan, A.; Horny, L.; Grassi, G.; Schneider, J.; Woerner, H. J.] Swiss Fed Inst Technol, Lab Phys Chem, CH-8093 Zurich, Switzerland; [Mignolet, B.; Remacle, F.] Univ Liege, Dept Chem, B-4000 Liege, Belgium; [Mignolet, B.] Stanford Univ, PULSE Inst, Stanford, CA 94305 USA; [Mignolet, B.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Penka, E. F.; Bandrauk, A. D.] Univ Sherbrooke, Lab Chim Theor, Sherbrooke, PQ J1K 2R1, Canada; [Tolstikhin, O. I.] Moscow Inst Phys & Technol, Moscow 141700, Russia; [Jensen, F.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Madsen, L. B.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Liege; Stanford University; Stanford University; University of Sherbrooke; Moscow Institute of Physics & Technology; Aarhus University; Aarhus University	Worner, HJ (corresponding author), Swiss Fed Inst Technol, Lab Phys Chem, CH-8093 Zurich, Switzerland.	hwoerner@ethz.ch	Madsen, Lars Bojer/AAZ-7651-2021; Madsen, Lars Bojer/B-7912-2017; Tolstikhin, Oleg I./L-1899-2013; , frj/A-2809-2017; Wörner, Hans Jakob/B-1802-2013; Rupenyan, Alisa/AAR-8404-2021	Madsen, Lars Bojer/0000-0001-7403-2070; Madsen, Lars Bojer/0000-0001-7403-2070; Tolstikhin, Oleg I./0000-0001-7603-2322; , frj/0000-0002-4576-5838; Rupenyan, Alisa/0000-0002-2170-8564; Remacle, Francoise/0000-0001-7434-5245; Mignolet, Benoit/0000-0003-3746-6544; Kraus, Peter/0000-0002-2989-5560; Baykusheva, Denitsa/0000-0002-7438-1139	ERC [307270-ATTOSCOPE, 277767-TDMET]; Swiss National Science Foundation via National Centre of Competence in Research Molecular Ultrafast Science and Technology; Fonds National de la Recherche Scientifique of Belgium; Fonds de la Recherche Fondamentale Collective [2.4545.12]; Belgian American Education Foundation; Wallonie-Bruxelles International; Ministry of Education and Science of Russia [3.679.2014/K]; VKR Centre of Excellence QUSCOPE; Villum Fonden [00007335] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation via National Centre of Competence in Research Molecular Ultrafast Science and Technology; Fonds National de la Recherche Scientifique of Belgium(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); Belgian American Education Foundation; Wallonie-Bruxelles International; Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); VKR Centre of Excellence QUSCOPE; Villum Fonden(Villum Fonden)	We thank M. Lein for valuable discussions and F. Wine, V. Despre, P. Lopez, and U. Rothlisberger for performing supporting calculations. Supported by ERC starting grant (project no. 307270-ATTOSCOPE) and the Swiss National Science Foundation via the National Centre of Competence in Research Molecular Ultrafast Science and Technology (P.M.K. and H.J.W.), the Fonds National de la Recherche Scientifique of Belgium and Fonds de la Recherche Fondamentale Collective grant 2.4545.12 (B.M. and FR.), the Belgian American Education Foundation and Wallonie-Bruxelles International (B.M.), Compute Canada through access to high-performance computers (E.F.P. and A.D.B.), the Ministry of Education and Science of Russia state assignment no. 3.679.2014/K (O.I.T.), VKR Centre of Excellence QUSCOPE and ERC starting grant (project no. 277767-TDMET) (L.B.M.).	ALLAN M, 1977, J CHEM SOC FARAD T 2, V73, P1406, DOI 10.1039/f29777301406; Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Bandrauk AD, 2004, INT J QUANTUM CHEM, V100, P834, DOI 10.1002/qua.20252; Calegari F, 2014, SCIENCE, V346, P336, DOI 10.1126/science.1254061; Cederbaum LS, 1999, CHEM PHYS LETT, V307, P205, DOI 10.1016/S0009-2614(99)00508-4; De S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.153002; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Falke SM, 2014, SCIENCE, V344, P1001, DOI 10.1126/science.1249771; Fleischer A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.113003; Frolov MV, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/3/035601; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Haessler S, 2010, NAT PHYS, V6, P200, DOI 10.1038/NPHYS1511; Kling MF, 2013, PHYS CHEM CHEM PHYS, V15, P9448, DOI 10.1039/c3cp50591j; Le AT, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013401; Lein M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.053004; Leone SR, 2014, NAT PHOTONICS, V8, P162, DOI 10.1038/nphoton.2014.48; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Mairesse Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.213601; Mignolet B, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/12/124011; Mulliken RS, 1939, J CHEM PHYS, V7, P20, DOI 10.1063/1.1750319; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Penka EF, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023414; Remacle F, 2006, P NATL ACAD SCI USA, V103, P6793, DOI 10.1073/pnas.0601855103; Shafir D, 2012, NATURE, V485, P343, DOI 10.1038/nature11025; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Tolstikhin OI, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053423; Torres R, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.051802; Vozzi C, 2011, NAT PHYS, V7, P822, DOI 10.1038/nphys2029; Weinkauf R, 1996, J PHYS CHEM-US, V100, P18567, DOI 10.1021/jp960926m; Wirth A, 2011, SCIENCE, V334, P195, DOI 10.1126/science.1210268; Worner HJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233904; Zhou XB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073902	34	383	387	9	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					790	795		10.1126/science.aab2160	http://dx.doi.org/10.1126/science.aab2160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26494175	Green Submitted			2022-12-28	WOS:000364897000038
J	Blanchard, JL				Blanchard, Julia L.			CLIMATE CHANGE A rewired food web	NATURE			English	Editorial Material									Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia	University of Tasmania	Blanchard, JL (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia.	julia.blanchard@utas.edu.au	Blanchard, Julia L/E-4919-2010	Blanchard, Julia L/0000-0003-0532-4824				Blanchard JL, 2011, THEOR ECOL-NETH, V4, P289, DOI 10.1007/s12080-010-0078-9; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Gilljam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9412; Kortsch S, 2015, P ROY SOC B-BIOL SCI, V282, P31, DOI 10.1098/rspb.2015.1546; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Planque B., 2014, ECOLOGY, V95, P1430, DOI [DOI 10.1890/13-1062.1, 10.1890/13-1062.1]; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005	10	25	25	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					173	174		10.1038/nature16311	http://dx.doi.org/10.1038/nature16311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26536113				2022-12-28	WOS:000364396700030
J	Shain, AH; Yeh, I; Kovalyshyn, I; Sriharan, A; Talevich, E; Gagnon, A; Dummer, R; North, J; Pincus, L; Ruben, B; Rickaby, W; D'Arrigo, C; Robson, A; Bastian, BC				Shain, A. Hunter; Yeh, Iwei; Kovalyshyn, Ivanka; Sriharan, Aravindhan; Talevich, Eric; Gagnon, Alexander; Dummer, Reinhard; North, Jeffrey; Pincus, Laura; Ruben, Beth; Rickaby, William; D'Arrigo, Corrado; Robson, Alistair; Bastian, Boris C.			The Genetic Evolution of Melanoma from Precursor Lesions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DYSPLASTIC NEVUS SYNDROME; TERT PROMOTER MUTATIONS; SOMATIC MUTATIONS; UVEAL MELANOMA; BRAF MUTATIONS; RECURRENT; TISSUES; NUMBER; SF3B1; RISK	BACKGROUND The pathogenic mutations in melanoma have been largely catalogued; however, the order of their occurrence is not known. METHODS We sequenced 293 cancer-relevant genes in 150 areas of 37 primary melanomas and their adjacent precursor lesions. The histopathological spectrum of these areas included unequivocally benign lesions, intermediate lesions, and intraepidermal or invasive melanomas. RESULTS Precursor lesions were initiated by mutations of genes that are known to activate the mitogen-activated protein kinase pathway. Unequivocally benign lesions harbored BRAF V600E mutations exclusively, whereas those categorized as intermediate were enriched for NRAS mutations and additional driver mutations. A total of 77% of areas of intermediate lesions and melanomas in situ harbored TERT promoter mutations, a finding that indicates that these mutations are selected at an unexpectedly early stage of the neoplastic progression. Biallelic inactivation of CDKN2A emerged exclusively in invasive melanomas. PTEN and TP53 mutations were found only in advanced primary melanomas. The point-mutation burden increased from benign through intermediate lesions to melanoma, with a strong signature of the effects of ultraviolet radiation detectable at all evolutionary stages. Copy-number alterations became prevalent only in invasive melanomas. Tumor heterogeneity became apparent in the form of genetically distinct subpopulations as melanomas progressed. CONCLUSIONS Our study defined the succession of genetic alterations during melanoma progression, showing distinct evolutionary trajectories for different melanoma subtypes. It identified an intermediate category of melanocytic neoplasia, characterized by the presence of more than one pathogenic genetic alteration and distinctive histopathological features. Finally, our study implicated ultraviolet radiation as a major factor in both the initiation and progression of melanoma. (Funded by the National Institutes of Health and others.)	[Shain, A. Hunter; Yeh, Iwei; Talevich, Eric; Gagnon, Alexander; North, Jeffrey; Pincus, Laura; Ruben, Beth; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Shain, A. Hunter; Yeh, Iwei; Talevich, Eric; Gagnon, Alexander; North, Jeffrey; Pincus, Laura; Ruben, Beth; Bastian, Boris C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Shain, A. Hunter; Yeh, Iwei; Talevich, Eric; Gagnon, Alexander; Bastian, Boris C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Kovalyshyn, Ivanka] Cleveland Clin, Dept Dermatol, Cleveland, OH 44195 USA; [Kovalyshyn, Ivanka] Cleveland Clin, Dept Pathol, Cleveland, OH 44195 USA; [Sriharan, Aravindhan] Orlando Hlth, Dept Pathol, Orlando, FL USA; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [D'Arrigo, Corrado] Dorset Cty Hosp, Dept Dermatol, Dorchester, Dorset, England; [Rickaby, William; Robson, Alistair] St Johns Inst Dermatol, Dept Dermatol, London, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Zurich; University Zurich Hospital; University of London; King's College London	Bastian, BC (corresponding author), UCSF Dermatopathol Serv, 1701 Divisadero St,Suite 280, San Francisco, CA 94115 USA.	boris.bastian@ucsf.edu		Bastian, Boris/0000-0003-1836-6062; Yeh, Iwei/0000-0002-3941-3561; Talevich, Eric/0000-0002-8106-0720	National Institutes of Health; NATIONAL CANCER INSTITUTE [T32CA177555, R01CA131524, P01CA025874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Institutes of Health and others.	Bastian BC, 2014, ANNU REV PATHOL-MECH, V9, P239, DOI 10.1146/annurev-pathol-012513-104658; CARR J, 1994, BRIT J DERMATOL, V131, P72, DOI 10.1111/j.1365-2133.1994.tb08460.x; Chen LL, 2013, J AM ACAD DERMATOL, V68, P825, DOI 10.1016/j.jaad.2012.10.041; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Duffy K, 2012, J AM ACAD DERMATOL, V67, p1e1; ELDER DE, 1980, CANCER, V46, P1787, DOI 10.1002/1097-0142(19801015)46:8<1787::AID-CNCR2820460816>3.0.CO;2-S; GOLDGAR DE, 1991, J NATL CANCER I, V83, P1726, DOI 10.1093/jnci/83.23.1726; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; MACKIE RM, 1985, BRIT J DERMATOL, V113, P167, DOI 10.1111/j.1365-2133.1985.tb02060.x; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Palescandolo E, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-3178; Phadke PA, 2011, CLIN LAB MED, V31, P345, DOI 10.1016/j.cll.2011.03.011; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Raterman D, 2013, TARGET ENRICHMENT PR; Rivers JK, 2004, LANCET, V363, P728, DOI 10.1016/S0140-6736(04)15649-3; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shain AH, 2015, NAT GENET; Talevich E, 2014, BIORXIV; Tucker MA, 1997, JAMA-J AM MED ASSOC, V277, P1439, DOI 10.1001/jama.277.18.1439; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Wiesner T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4116; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710	36	570	574	1	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1926	1936		10.1056/NEJMoa1502583	http://dx.doi.org/10.1056/NEJMoa1502583			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26559571	Green Published, Bronze			2022-12-28	WOS:000364445500007
J	Bolton, JM; Gunnell, D; Turecki, G				Bolton, James M.; Gunnell, David; Turecki, Gustavo			Suicide risk assessment and intervention in people with mental illness	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; DELIBERATE SELF-HARM; MAJOR DEPRESSIVE DISORDER; EMERGENCY-DEPARTMENT; FOLLOW-UP; ELECTROCONVULSIVE-THERAPY; PSYCHOSOCIAL ASSESSMENT; COGNITIVE THERAPY; BEHAVIOR-THERAPY; EVENTUAL SUICIDE	Suicide is the 15th most common cause of death worldwide. Although relatively uncommon in the general population, suicide rates are much higher in people with mental health problems. Clinicians often have to assess and manage suicide risk. Risk assessment is challenging for several reasons, not least because conventional approaches to risk assessment rely on patient self reporting and suicidal patients may wish to conceal their plans. Accurate methods of predicting suicide therefore remain elusive and are actively being studied. Novel approaches to risk assessment have shown promise, including empirically derived tools and implicit association tests. Service provision for suicidal patients is often substandard, particularly at times of highest need, such as after discharge from hospital or the emergency department. Although several drug based and psychotherapy based treatments exist, the best approaches to reducing the risk of suicide are still unclear. Some of the most compelling evidence supports long established treatments such as lithium and cognitive behavioral therapy. Emerging options include ketamine and internet based psychotherapies. This review summarizes the current science in suicide risk assessment and provides an overview of the interventions shown to reduce the risk of suicide, with a focus on the clinical management of people with mental disorders.	[Bolton, James M.] Univ Manitoba, Dept Psychiat Psychol & Community Hlth Sci, Winnipeg, MB R3E 3N4, Canada; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	University of Manitoba; University of Bristol; McGill University	Bolton, JM (corresponding author), Univ Manitoba, Dept Psychiat Psychol & Community Hlth Sci, Winnipeg, MB R3E 3N4, Canada.	jbolton@hsc.mb.ca	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institutes of Health Research [113589]; Brain and Behavior Research Foundation NARSAD young investigator grant; Canadian Institute of Health Research [MOP93775, MOP11260, MOP119429, MOP119430]; National Institutes of Health [1R01DA033684-01]; Fonds de Recherche du Quebec-Sante through a Chercheur National salary award; Quebec Network on Suicide, Mood Disorders, and Related Disorders; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033684] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain and Behavior Research Foundation NARSAD young investigator grant; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de Recherche du Quebec-Sante through a Chercheur National salary award; Quebec Network on Suicide, Mood Disorders, and Related Disorders; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JMB is supported by a Canadian Institutes of Health Research new investigator award (113589) and a Brain and Behavior Research Foundation NARSAD young investigator grant. DG is a National Institute for Health Research senior investigator. GT is supported by grants from the Canadian Institute of Health Research MOP93775, MOP11260, MOP119429, and MOP119430; from the National Institutes of Health 1R01DA033684-01; and by the Fonds de Recherche du Quebec-Sante through a Chercheur National salary award and through the Quebec Network on Suicide, Mood Disorders, and Related Disorders.	Agid O, 2010, CAN J PSYCHIAT, V55, P677, DOI 10.1177/070674371005501007; Ahmedani BK, 2014, J GEN INTERN MED, V29, P870, DOI 10.1007/s11606-014-2767-3; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; [Anonymous], 2015, NAT CONF INQ SUIC HO; Appleby L, 1999, BRIT MED J, V318, P1235; Bajaj Priya, 2008, Ment Health Fam Med, V5, P229; Baldessarini RJ, 2006, BIPOLAR DISORD, V8, P625, DOI 10.1111/j.1399-5618.2006.00344.x; Ballard ED, 2014, J PSYCHIATR RES, V58, P161, DOI 10.1016/j.jpsychires.2014.07.027; Beautrais AL, 2010, BRIT J PSYCHIAT, V197, P55, DOI 10.1192/bjp.bp.109.075754; BECK AT, 1989, J AFFECT DISORDERS, V17, P203, DOI 10.1016/0165-0327(89)90001-3; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; Bergen H, 2010, J AFFECT DISORDERS, V127, P257, DOI 10.1016/j.jad.2010.05.001; Berman AL, 2011, SUICIDE LIFE-THREAT, V41, P110, DOI 10.1111/j.1943-278X.2010.00009.x; Bernert RA, 2014, ACAD PSYCHIATR, V38, P585, DOI 10.1007/s40596-014-0180-1; Bertolote JM, 2010, CRISIS, V31, P194, DOI [10.1027/0227-5910/a000052, 10.1027/0027-5910/a000052]; Bilen K, 2013, EMERG MED J, V30, P650, DOI 10.1136/emermed-2012-201235; Bluml V, 2013, J PSYCHIATR RES, V47, P407, DOI 10.1016/j.jpsychires.2012.12.002; Bolton JM, 2015, DEPRESS ANXIETY, V32, P73, DOI 10.1002/da.22320; Bolton JM, 2013, JAMA PSYCHIAT, V70, P158, DOI 10.1001/jamapsychiatry.2013.275; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Brown GK, 2014, AM J PREV MED, V47, pS209, DOI 10.1016/j.amepre.2014.06.006; Brown GK, 2014, AM J PREV MED, V47, pS186, DOI 10.1016/j.amepre.2014.06.008; Bruffaerts R, 2011, BRIT J PSYCHIAT, V199, P64, DOI 10.1192/bjp.bp.110.084129; Bryan CJ, 2006, J CLIN PSYCHOL, V62, P185, DOI 10.1002/jclp.20222; Busch KA, 2003, J CLIN PSYCHIAT, V64, P14, DOI 10.4088/JCP.v64n0105; Carroll R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089944; Carter GL, 2005, BMJ-BRIT MED J, V331, P805, DOI 10.1136/bmj.38579.455266.E0; Carter GL, 2007, BRIT J PSYCHIAT, V191, P548, DOI 10.1192/bjp.bp.107.038406; Carter GL, 2013, BRIT J PSYCHIAT, V202, P372, DOI 10.1192/bjp.bp.112.112664; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Cedereke M, 2002, EUR PSYCHIAT, V17, P82, DOI 10.1016/S0924-9338(02)00632-6; Cha CB, 2010, J ABNORM PSYCHOL, V119, P616, DOI 10.1037/a0019710; Chen WJ, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-191; Christensen H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002886; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Comtois KA, 2011, DEPRESS ANXIETY, V28, P963, DOI 10.1002/da.20895; Cooper J, 2006, ANN EMERG MED, V48, P459, DOI 10.1016/j.annemergmed.2006.07.944; Cooper J, 2011, GEN HOSP PSYCHIAT, V33, P166, DOI 10.1016/j.genhosppsych.2011.01.009; Crosby AE, 2011, MMWR SURVEILL SUMM, V63, p[2008, 1]; Crosby AE, 2013, MMWR-MORBID MORTAL W, V62, P179; Cuijpers P, 2013, J AFFECT DISORDERS, V144, P183, DOI 10.1016/j.jad.2012.06.025; Davidson K, 2006, J PERS DISORD, V20, P450, DOI 10.1521/pedi.2006.20.5.450; Dazzi T, 2014, PSYCHOL MED, V44, P3361, DOI 10.1017/S0033291714001299; DiazGranados N, 2010, J CLIN PSYCHIAT, V71, P1605, DOI 10.4088/JCP.09m05327blu; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Erlangsen A, 2015, LANCET PSYCHIAT, V2, P49, DOI 10.1016/S2215-0366(14)00083-2; Fink M, 2014, J ECT, V30, P5, DOI 10.1097/YCT.0b013e3182a6ad0d; Fleischmann A, 2008, B WORLD HEALTH ORGAN, V86, P703, DOI 10.2471/BLT.07.046995; Fowler JC, 2012, PSYCHOTHERAPY, V49, P81, DOI 10.1037/a0026148; Freedenthal S, 2008, ARCH SUICIDE RES, V12, P277, DOI 10.1080/13811110802324698; Friedman RA, 2014, NEW ENGL J MED, V371, P1666, DOI 10.1056/NEJMp1408480; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P580, DOI 10.1001/archgenpsychiatry.2011.2048; Gibbons RD, 2009, ARCH GEN PSYCHIAT, V66, P1354, DOI 10.1001/archgenpsychiatry.2009.159; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Glenn CR, 2014, AM J PREV MED, V47, pS176, DOI 10.1016/j.amepre.2014.06.004; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Gould MS, 2005, JAMA-J AM MED ASSOC, V293, P1635, DOI 10.1001/jama.293.13.1635; Griffiths JJ, 2014, AM J PREV MED, V47, pS195, DOI 10.1016/j.amepre.2014.06.012; Gunnell D, 2012, BRIT J PSYCHIAT, V201, P233, DOI 10.1192/bjp.bp.111.104422; Harriss L, 2005, J AFFECT DISORDERS, V86, P225, DOI 10.1016/j.jad.2005.02.009; Hassanian-Moghaddam H, 2017, ARCH SUICIDE RES, V21, P138, DOI 10.1080/13811118.2015.1004473; Hassanian-Moghaddam H, 2011, BRIT J PSYCHIAT, V198, P309, DOI 10.1192/bjp.bp.109.067199; Hatcher S, 2011, BRIT J PSYCHIAT, V199, P310, DOI 10.1192/bjp.bp.110.090126; Hatcher Simon, 2007, Evid Based Med, V12, P89, DOI 10.1136/ebm.12.3.89; Hawton K, 1998, BRIT MED J, V317, P441; Hawton K, 2015, J AFFECT DISORDERS, V175, P147, DOI 10.1016/j.jad.2014.12.062; Hawton K, 2010, BRIT J PSYCHIAT, V196, P354, DOI 10.1192/bjp.bp.109.070219; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hennen J, 2005, SCHIZOPHR RES, V73, P139, DOI 10.1016/j.schres.2004.05.015; Hepp Urs, 2004, Crisis, V25, P108, DOI 10.1027/0227-5910.25.3.108; Hjorthoj CR, 2014, SOC PSYCH PSYCH EPID, V49, P1357, DOI 10.1007/s00127-014-0860-x; Hunt IM, 2009, PSYCHOL MED, V39, P443, DOI 10.1017/S0033291708003644; Hunt IM, 2013, J AFFECT DISORDERS, V144, P123, DOI 10.1016/j.jad.2012.06.019; Inagaki M, 2015, J AFFECT DISORDERS, V175, P66, DOI 10.1016/j.jad.2014.12.048; Cebria AI, 2013, J AFFECT DISORDERS, V147, P269, DOI 10.1016/j.jad.2012.11.016; Isometsa ET, 1996, CONVULSIVE THER, V12, P152; Joiner TE, 1999, PROF PSYCHOL-RES PR, V30, P447, DOI 10.1037/0735-7028.30.5.447; Jokinen J, 2010, J CLIN PSYCHIAT, V71, P1025, DOI 10.4088/JCP.09m05944blu; Kapur N, 2013, PSYCHOL MED, V43, P61, DOI 10.1017/S0033291712000864; Kapur N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070434; Kapur N, 2008, J AFFECT DISORDERS, V106, P285, DOI 10.1016/j.jad.2007.07.010; Kapur N, 2013, BRIT J PSYCHIAT, V203, P73, DOI 10.1192/bjp.bp.113.126425; Kapusta ND, 2011, BRIT J PSYCHIAT, V198, P346, DOI 10.1192/bjp.bp.110.091041; Kasckow J, 2011, CNS DRUGS, V25, P129, DOI 10.2165/11586450-000000000-00000; Katz LY, 2008, CAN MED ASSOC J, V178, P1005, DOI 10.1503/cmaj.071265; Kellner CH, 2005, AM J PSYCHIAT, V162, P977, DOI 10.1176/appi.ajp.162.5.977; Kennedy SH, 2009, J AFFECT DISORDERS, V117, pS44, DOI 10.1016/j.jad.2009.06.039; Kessing LV, 2005, ARCH GEN PSYCHIAT, V62, P860, DOI 10.1001/archpsyc.62.8.860; Kurz A, 1988, CURRENT ISSUES SUICI, P174, DOI DOI 10.1007/978-3-642-73358-1; Larkin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084282; Larkin GL, 2011, INT J NEUROPSYCHOPH, V14, P1127, DOI 10.1017/S1461145711000629; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; Luxton DD, 2013, CRISIS, V34, P32, DOI 10.1027/0227-5910/a000158; Madsen T, 2012, J CLIN PSYCHIAT, V73, P144, DOI 10.4088/JCP.10m06473; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Maris RW, 2002, LANCET, V360, P319, DOI 10.1016/S0140-6736(02)09556-9; McGirr A, 2008, J CLIN PSYCHIAT, V69, P966, DOI 10.4088/JCP.v69n0612; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Milner AJ, 2015, BRIT J PSYCHIAT, V206, P184, DOI 10.1192/bjp.bp.114.147819; Morthorst B, 2012, BMJ-BRIT MED J, V351, P34972; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; Mundt JC, 2013, J CLIN PSYCHIAT, V74, P887, DOI 10.4088/JCP.13m08398; National Action Alliance for Suicide Prevention: Clinical Workforce Preparedness Task Force, 2014, SUIC PREV CLIN WORKF; National Institute for Health and Care Excellence, 2012, REV CLIN GUID CG16 S; National Institute for Health and Care Excellence, 2014, SELF HARM LONG TERM; National Statistics, 2007, HLTH STAT Q, p[2002, 66]; Nimeus A, 1997, J AFFECT DISORDERS, V42, P137, DOI 10.1016/S0165-0327(96)01404-8; Nimeus A, 2000, EUR PSYCHIAT, V15, P416, DOI 10.1016/S0924-9338(00)00512-5; NIMEUS A., 2002, ARCH SUICIDE RES, V6, P211, DOI DOI 10.1080/13811110214142; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2010, PSYCHOL SCI, V21, P511, DOI 10.1177/0956797610364762; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; O'Connor E, 2013, ANN INTERN MED, V158, P741, DOI 10.7326/0003-4819-158-10-201305210-00642; Ohgami H, 2009, BRIT J PSYCHIAT, V194, P464, DOI 10.1192/bjp.bp.108.055798; Olfson M, 2014, JAMA-J AM MED ASSOC, V311, P1107, DOI 10.1001/jama.2014.501; Olfson M, 2013, AM J PSYCHIAT, V170, P1442, DOI 10.1176/appi.ajp.2013.12121506; Olfson M, 2012, ARCH GEN PSYCHIAT, V69, P80, DOI 10.1001/archgenpsychiatry.2011.108; Patel M, 2006, J ECT, V22, P113, DOI 10.1097/00124509-200606000-00007; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Pirkola S, 2009, LANCET, V373, P147, DOI 10.1016/S0140-6736(08)61848-6; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Price RB, 2014, DEPRESS ANXIETY, V31, P335, DOI 10.1002/da.22253; Prudic J, 1999, J CLIN PSYCHIAT, V60, P104; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; Quinlivan L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004732; Randall JR, 2014, CAN J PSYCHIAT, V59, P531, DOI 10.1177/070674371405901006; Randall JR, 2013, PSYCHOL ASSESSMENT, V25, P714, DOI 10.1037/a0032391; Randall JR, 2011, J AFFECT DISORDERS, V134, P348, DOI 10.1016/j.jad.2011.05.032; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Rihmer Z, 2013, NEUROSCI BIOBEHAV R, V37, P2398, DOI 10.1016/j.neubiorev.2012.09.009; Rihmer Z, 2012, CNS NEUROSCI THER, V18, P238, DOI 10.1111/j.1755-5949.2011.00261.x; Roos L, 2013, NEUROPSYCHIATRY-LOND, V3, P483, DOI 10.2217/npy.13.60; Rostila M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002618; Selaman Z, 2012, J CLIN PSYCHIAT, V73, P1264, DOI [10.4088/JCP.12lr07984, 10.4088/JCP.11m07362]; Sharma V, 2001, CAN J PSYCHIAT, V46, P704, DOI 10.1177/070674370104600802; Simon GE, 2006, AM J PSYCHIAT, V163, P1861, DOI 10.1176/appi.ajp.163.11.1861; Slee N, 2008, BRIT J PSYCHIAT, V192, P202, DOI 10.1192/bjp.bp.107.037564; Sondergard L, 2008, BIPOLAR DISORD, V10, P87, DOI 10.1111/j.1399-5618.2008.00464.x; Spittal MJ, 2014, J AFFECT DISORDERS, V161, P36, DOI 10.1016/j.jad.2014.02.032; STANLEY B, 1986, PSYCHOPHARMACOL BULL, V22, P200; Steeg S, 2012, PSYCHOL MED, V42, P2383, DOI 10.1017/S0033291712000347; Stefansson J, 2012, J AFFECT DISORDERS, V136, P167, DOI 10.1016/j.jad.2010.11.016; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Suominen K, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-11; Thienhaus OJ, 1997, PSYCHIATR SERV, V48, P293; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; US Surgeon General and National Action Alliance for Suicide Prevention, 2012, NAT STRAT SUIC PREV; van Spijker BAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090118; Wang YQ, 2015, J NERV MENT DIS, V203, P507, DOI 10.1097/NMD.0000000000000320; Warden S, 2014, ARCH SUICIDE RES, V18, P313, DOI 10.1080/13811118.2013.824829; While D, 2012, LANCET, V379, P1005, DOI 10.1016/S0140-6736(11)61712-1; WHO, 2014, GLOB HLTH EST; World Health Organization, 2014, PREV SUIC GLOB IMP; Yaseen ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086768	159	152	155	2	75	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2015	351								h4978	10.1136/bmj.h4978	http://dx.doi.org/10.1136/bmj.h4978			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4FO	26552947				2022-12-28	WOS:000364947000001
J	Klein, L				Klein, Ludger			Aire Gets Company for Immune Tolerance	CELL			English	Editorial Material							PROMISCUOUS GENE-EXPRESSION; THYMIC EPITHELIAL-CELLS; SELF	A specialized subset of epithelial cells in the thymus "promiscuously" transcribes thousands of peripheral genes to ensure that developing T cells can test their antigen receptors for dangerous autoreactivity. New findings by Takaba et al. indicate that the transcription factor Fezf2 acts independently of Aire in thymic epithelial cells to generate "genetic noise" for immunological tolerance.	Univ Munich, Inst Immunol, D-80336 Munich, Germany	University of Munich	Klein, L (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-80336 Munich, Germany.	ludger.klein@med.uni-muenchen.de	Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Saltis M, 2008, IMMUNOGENETICS, V60, P105, DOI 10.1007/s00251-007-0268-9; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013	8	15	18	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					794	795		10.1016/j.cell.2015.10.057	http://dx.doi.org/10.1016/j.cell.2015.10.057			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544932	Bronze			2022-12-28	WOS:000364829700006
J	Alba, DM; Almecija, S; DeMiguel, D; Fortuny, J; de los Rios, MP; Pina, M; Robles, JM; Moya-Sola, S				Alba, David M.; Almecija, Sergio; DeMiguel, Daniel; Fortuny, Josep; de los Rios, Miriam Perez; Pina, Marta; Robles, Josep M.; Moya-Sola, Salvador			Miocene small-bodied ape from Eurasia sheds light on hominoid evolution	SCIENCE			English	Article							OLD-WORLD MONKEYS; VALLES-PENEDES BASIN; MIDDLE-MIOCENE; DENTAL MICROWEAR; PHYLOGENETIC-RELATIONSHIPS; DIAPHYSEAL STRUCTURE; MOLAR MICROWEAR; RUSINGA ISLAND; FOSSIL APES; WRIST JOINT	Miocene small-bodied anthropoid primates from Africa and Eurasia are generally considered to precede the divergence between the two groups of extant catarrhines-hominoids (apes and humans) and Old World monkeys-and are thus viewed as more primitive than the stem ape Proconsul. Here we describe Pliobates cataloniae gen. et sp. nov., a small-bodied (4 to 5 kilograms) primate from the Iberian Miocene (11.6 million years ago) that displays a mosaic of primitive characteristics coupled with multiple cranial and postcranial shared derived features of extant hominoids. Our cladistic analyses show that Pliobates is a stem hominoid that is more derived than previously described small catarrhines and Proconsul. This forces us to reevaluate the role played by small-bodied catarrhines in ape evolution and provides key insight into the last common ancestor of hylobatids (gibbons) and hominids (great apes and humans).	[Alba, David M.; Almecija, Sergio; DeMiguel, Daniel; Fortuny, Josep; de los Rios, Miriam Perez; Pina, Marta; Robles, Josep M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, Edifici ICTA ICP,Campus UAB, E-08193 Barcelona, Spain; [Almecija, Sergio] George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC 20052 USA; [Robles, Josep M.] FOSSILIA Serv Paleontol & Geol, Barcelona 08470, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, ICP, Inst Catalana Recerca & Estudis Avancats, E-08193 Barcelona, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); George Washington University; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona	Alba, DM (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, Edifici ICTA ICP,Campus UAB, E-08193 Barcelona, Spain.	david.alba@icp.cat	de los Ríos, Miriam Pérez/L-6699-2018; Fortuny, Josep/L-2523-2014; Alba, David/G-9716-2015; Almécija, Sergio/ABG-8129-2020; Pina, Marta/G-5974-2018	Fortuny, Josep/0000-0003-4282-1619; Alba, David/0000-0002-8886-5580; Almécija, Sergio/0000-0003-1373-1497; Pina, Marta/0000-0001-9762-6402; Perez de los Rios, Miriam/0000-0002-4928-1953; Moya-Sola, Salvador/0000-0001-8506-1061; DeMiguel, Daniel/0000-0001-6138-7227; Robles Gimenez, Josep Maria/0000-0002-5410-3529	Spanish Ministerio de Economia y Competitividad [CGL2014-54373-P, CGL2011-27343, CGL0211-28681, RYC-2009-04533, JCI-2011-11697, BES-2009-020612]; Spanish Ministerio de Educacion [AP2010-4579]; Generalitat de Catalunya [2014 SGR 416 GRC, 2014/100609, 2011 BE-DGR 00310]; NSF [1316947]; AAPA Professional Development Grant; Servei d'Arqueologia i Paleontologia of the Generalitat de Catalunya; ICREA Funding Source: Custom	Spanish Ministerio de Economia y Competitividad(Spanish Government); Spanish Ministerio de Educacion(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); NSF(National Science Foundation (NSF)); AAPA Professional Development Grant; Servei d'Arqueologia i Paleontologia of the Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	This work has been supported by the Spanish Ministerio de Economia y Competitividad (projects CGL2014-54373-P, CGL2011-27343, and CGL0211-28681; contracts RYC-2009-04533 to D.M.A. and JCI-2011-11697 to D.DM.; and grant BES-2009-020612 to M.P.R.), the Spanish Ministerio de Educacion (grant AP2010-4579 to M.P.), the Generalitat de Catalunya (research groups 2014 SGR 416 GRC and 2014/100609; and grant 2011 BE-DGR 00310 to D.M.A.), NSF (grant 1316947 to S.A.), and the AAPA Professional Development Grant (to S.A.). We further acknowledge the support of the Servei d'Arqueologia i Paleontologia of the Generalitat de Catalunya. Fieldwork was defrayed by CESPA Gestion de Residuos. The authors thank S. Larson for the estimation of humeral torsion; J. Arias-Martorell for discussion on the fossil material; M. Palmero for scientific artwork; E. Delson, D. Pilbeam, L. Costeur, U. Golich, and E. Mbua for access to casts and original fossil specimens; I. Sucarrats for assistance in data gathering; E. Sarmiento and T. Kivell for sharing measurements; the staff of the Preparation Division of the ICP for the preparation of the specimens; J. Thostenson and M. Hill for assistance with using the Microscopy and Imaging Facility of the American Museum of Natural History; S. Llacer for assistance in processing the movie; S. Grau for philological advice; M. Kohler for comments on the manuscript; and three anonymous reviewers for helpful and constructive suggestions. We are also grateful to the staff of the following museums for access to comparative specimens: American Museum of Natural History, New York; Museum of Comparative Zoology, Harvard; Kenyan National Museums; Museum National d'Histoire Naturelle, Paris; Naturhistorisches Museum Wien; and Naturhistorisches Museum Basel. Author contributions were as follows: D. M. A. and S.M.-S. designed the study and wrote the paper with input from other authors; D. M. A., S. A., M.P.R., M.P., and S.M.-S. performed the descriptions and comparisons; J.F., M.P.R., and S.M.-S. made the virtual cranial reconstruction; D.DM. carried out the microwear analyses; J.M.R. directed the fieldwork and performed the stratigraphic correlations; D. M. A., S. A., M.P.R., M.P., and S.M.-S. assembled the cladistic data matrix; and D. M. A. and J.F. performed the phylogenetic analyses. All authors approved the final manuscript and declare that all data reported here are fully and freely available from the date of publication. The new fossils described in this paper are curated at the ICP with catalog number IPS58443. Supporting data for this paper are presented in the supplementary materials.		0	47	47	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260							aab2625	10.1126/science.aab2625	http://dx.doi.org/10.1126/science.aab2625			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516285	Green Accepted			2022-12-28	WOS:000363660000039
J	Durand, DJ; Lewin, JS; Berkowitz, SA				Durand, Daniel J.; Lewin, Jonathan S.; Berkowitz, Scott A.			Medical-Imaging Stewardship in the Accountable Care Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Durand, Daniel J.; Lewin, Jonathan S.] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Berkowitz, Scott A.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Durand, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.							Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Centers for Disease Control and Prevention, COR EL HOSP ANT STEW; Hendee WR, 2010, RADIOLOGY, V257, P240, DOI 10.1148/radiol.10100063; Ohl CA, 2011, CLIN INFECT DIS, V53, pS23, DOI 10.1093/cid/cir365	4	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1691	1693		10.1056/NEJMp1507703	http://dx.doi.org/10.1056/NEJMp1507703			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU4QH	26510019				2022-12-28	WOS:000363514100004
J	Nikpay, SS; Ayanian, JZ				Nikpay, Sayeh S.; Ayanian, John Z.			Hospital Charity Care - Effects of New Community-Benefit Requirements	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nikpay, Sayeh S.; Ayanian, John Z.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Nikpay, Sayeh S.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Berkeley	Nikpay, SS (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.							Grassley C., 2015, COMMUNICATION   0116; Rosenbaum S, 2015, HLTH AFF MILLWOOD, V34, P1225; Senate Committee on Finance, 2007, TAX EX HOSP IN PRESS, DOI 10.1056/ NEJMp1508605; Young GJ, 2013, NEW ENGL J MED, V368, P1519, DOI 10.1056/NEJMsa1210239	4	23	24	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1687	1690		10.1056/NEJMp1508605	http://dx.doi.org/10.1056/NEJMp1508605			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU4QH	26510018				2022-12-28	WOS:000363514100003
J	Savage, N				Savage, Neil			Liquid assets	NATURE			English	Editorial Material							SCALE ENERGY-STORAGE; REDOX-FLOW BATTERY											Cho KT, 2012, J ELECTROCHEM SOC, V159, pA1806, DOI 10.1149/2.018211jes; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Fan FY, 2014, NANO LETT, V14, P2210, DOI 10.1021/nl500740t; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; Li LY, 2011, ADV ENERGY MATER, V1, P394, DOI 10.1002/aenm.201100008	5	3	3	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S98	S99		10.1038/526S98a	http://dx.doi.org/10.1038/526S98a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509955				2022-12-28	WOS:000363832100027
J	Dorner, SC; Jacobs, DB; Sommers, BD				Dorner, Stephen C.; Jacobs, Douglas B.; Sommers, Benjamin D.			Adequacy of Outpatient Specialty Care Access in Marketplace Plans Under the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Dorner, Stephen C.; Jacobs, Douglas B.; Sommers, Benjamin D.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Dorner, SC (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	stephen.dorner@post.harvard.edu						Centers for Disease Control and Prevention, NAT AMB MED CAR SURV; Haeder SF, 2015, HEALTH AFFAIR, V34, P741, DOI 10.1377/hlthaff.2014.1406; Jacobs DB, 2015, NEW ENGL J MED, V372, P399, DOI 10.1056/NEJMp1411376; Resneck JS, 2014, JAMA DERMATOL, V150, P1290, DOI 10.1001/jamadermatol.2014.3902; US Department of Health and Human Services, HLTH INS MARK 2015 O	5	45	45	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1749	1750		10.1001/jama.2015.9375	http://dx.doi.org/10.1001/jama.2015.9375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505601	Green Published, Bronze			2022-12-28	WOS:000363706300026
J	Verheugt, FWA				Verheugt, Freek W. A.			An anticoagulant too good to be true for revascularisation	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; FACTOR-IXA ACTIVITY; BIVALIRUDIN; HEPARIN; TRIAL		[Verheugt, Freek W. A.] Onze Lieve Vrouw Hosp, Heartctr, NL-1091 AC Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital	Verheugt, FWA (corresponding author), Onze Lieve Vrouw Hosp, Heartctr, NL-1091 AC Amsterdam, Netherlands.	f.verheugt@gmail.com						Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Han YL, 2015, JAMA-J AM MED ASSOC, V313, P1336, DOI 10.1001/jama.2015.2323; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; Lincoff AM, 2015, LANCET; Povsic TJ, 2013, EUR HEART J, V34, P2481, DOI 10.1093/eurheartj/ehs232; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215	9	7	8	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					314	315		10.1016/S0140-6736(15)00727-8	http://dx.doi.org/10.1016/S0140-6736(15)00727-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26547098				2022-12-28	WOS:000368516500007
J	Milner, J; Wilkinson, P				Milner, James; Wilkinson, Paul			Trends in cause-specific mortality in Chinese provinces	LANCET			English	Editorial Material							HEALTH		[Milner, James; Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Milner, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England.	james.milner@lshtm.ac.uk		Milner, James/0000-0003-0304-639X; Wilkinson, Paul/0000-0001-7456-259X				[Anonymous], 2014, CHINA TO DECLARE WAR; Baeten S, 2013, J HEALTH ECON, V32, P1214, DOI 10.1016/j.jhealeco.2013.10.002; Briggs H., 2015, BBC NEWS; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Parry J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1877; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Xu GL, 2013, STROKE, V44, P1775, DOI 10.1161/STROKEAHA.113.001238; Zhao YH, 2014, LANCET, V384, P723, DOI 10.1016/S0140-6736(14)61292-7; Zhou M, 2015, LANCET	10	3	6	0	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					204	+		10.1016/S0140-6736(15)00553-X	http://dx.doi.org/10.1016/S0140-6736(15)00553-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26510777	Green Accepted			2022-12-28	WOS:000368130700006
J	Swanson, JW; Bonnie, RJ; Appelbaum, PS				Swanson, Jeffrey W.; Bonnie, Richard J.; Appelbaum, Paul S.			Getting Serious About Reducing Suicide More "How" and Less "Why"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLICY		[Swanson, Jeffrey W.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Bonnie, Richard J.] Univ Virginia, Sch Law, Inst Law Psychiat & Publ Policy, Charlottesville, VA 22903 USA; [Appelbaum, Paul S.] Columbia Univ, Div Law Eth & Psychiat, New York, NY USA	Duke University; University of Virginia; Columbia University	Swanson, JW (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, POB 3017, Durham, NC 27710 USA.	jeffrey.swanson@duke.edu	Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; Bonnie, Richard/0000-0003-2945-7699				Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; Barry CL, 2015, PREV MED, V79, P55, DOI 10.1016/j.ypmed.2015.05.007; Beckett L, REPUBLICANS SAY NO C; *CDCP, BUDG REQ SUMM FISC Y; Centers for Disease Control and Prevention, CDC NAT HLTH REP HIG; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR DAT S; Centers for Disease Control and Prevention National Center for Health Statistics, 10 LEAD CAUS INJ DEA; Miller M, 2012, ANNU REV PUBL HEALTH, V33, P393, DOI 10.1146/annurev-publhealth-031811-124636; Reisch T, 2013, AM J PSYCHIAT, V170, P977, DOI 10.1176/appi.ajp.2013.12091256; Swanson JW, 2015, ANN EPIDEMIOL, V25, P366, DOI 10.1016/j.annepidem.2014.03.004	10	26	27	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2229	2230		10.1001/jama.2015.15566	http://dx.doi.org/10.1001/jama.2015.15566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26524461	Bronze			2022-12-28	WOS:000365515700010
J	Ru, H; Chambers, MG; Fu, TM; Tong, AB; Liao, MF; Wu, H				Ru, Heng; Chambers, Melissa G.; Fu, Tian-Min; Tong, Alexander B.; Liao, Maofu; Wu, Hao			Molecular Mechanism of V(D)J Recombination from Synaptic RAG1-RAG2 Complex Structures	CELL			English	Article							CHROMOSOMAL TRANSLOCATIONS; CRYSTAL-STRUCTURE; DNA; ORGANIZATION; RAG-1	Diverse repertoires of antigen-receptor genes that result from combinatorial splicing of coding segments by V(D)J recombination are hallmarks of vertebrate immunity. The (RAG1-RAG2)(2) recombinase (RAG) recognizes recombination signal sequences (RSSs) containing a heptamer, a spacer of 12 or 23 base pairs, and a nonamer (12-RSS or 23-RSS) and introduces precise breaks at RSS-coding segment junctions. RAG forms synaptic complexes only with one 12-RSS and one 23-RSS, a dogma known as the 12/23 rule that governs the recombination fidelity. We report cryo-electron microscopy structures of synaptic RAG complexes at up to 3.4 angstrom resolution, which reveal a closed conformation with base flipping and base-specific recognition of RSSs. Distortion at RSS-coding segment junctions and base flipping in coding segments uncover the two-metal-ion catalytic mechanism. Induced asymmetry involving tilting of the nonamer-binding domain dimer of RAG1 upon binding of HMGB1-bent 12-RSS or 23-RSS underlies the molecular mechanism for the 12/23 rule.	[Ru, Heng; Fu, Tian-Min; Tong, Alexander B.; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ru, Heng; Fu, Tian-Min; Tong, Alexander B.; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Chambers, Melissa G.; Liao, Maofu] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Liao, MF (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	maofu_liao@hms.harvard.edu; wu@crystal.harvard.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Tong, Alex/0000-0003-3793-2533	Cancer Research Institute Irvington Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050872, R01AI125535] Funding Source: NIH RePORTER	Cancer Research Institute Irvington Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Wei Mi for help with sample freezing for cryo-EM studies, Drs. Liron David and Maria Ericsson for help with negative-stain EM experiments, Drs. Yang Li and Wei Ding for suggestions on model building and refinement, and the support of the Cancer Research Institute Irvington Postdoctoral Fellowship (to H.R.).	AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; Bischerour J, 2009, MOL CELL BIOL, V29, P5889, DOI 10.1128/MCB.00187-09; Brandt VL, 2009, ADV EXP MED BIOL, V650, P32; Fanning L, 1996, IMMUNOGENETICS, V44, P146, DOI 10.1007/BF02660064; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Nikolov DB, 1996, P NATL ACAD SCI USA, V93, P4862, DOI 10.1073/pnas.93.10.4862; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SHIRAKATA M, 1991, MOL CELL BIOL, V11, P4528, DOI 10.1128/MCB.11.9.4528; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	20	99	100	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1138	1152		10.1016/j.cell.2015.10.055	http://dx.doi.org/10.1016/j.cell.2015.10.055			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26548953	Green Accepted, Bronze			2022-12-28	WOS:000366044700013
J	Wang, PH; Zhu, S; Yang, L; Cui, S; Pan, W; Jackson, R; Zheng, YJ; Rongvaux, A; Sun, QM; Yang, G; Gao, SD; Lin, RT; You, FP; Flavell, R; Fikrig, E				Wang, Penghua; Zhu, Shu; Yang, Long; Cui, Shuang; Pan, Wen; Jackson, Ruaidhri; Zheng, Yunjiang; Rongvaux, Anthony; Sun, Qjangming; Yang, Guang; Gao, Shandian; Lin, Rongtuan; You, Fuping; Flavell, Richard; Fikrig, Erol			Nlrp6 regulates intestinal antiviral innate immunity	SCIENCE			English	Article							NF-KAPPA-B; I INTERFERON; SIGNALING PATHWAYS; ADAPTER PROTEIN; HOST-DEFENSE; RESPONSES; VIRUS; NLRX1; MAVS; INFLAMMASOMES	The nucleotide-binding oligomerization domain-like receptor (Nlrp) 6 maintains gut microbiota homeostasis and regulates antibacterial immunity. We now report a role for Nlrp6 in the control of enteric virus infection. Nlrp6(-/-) and control mice systemically challenged with encephalomyocarditis virus had similar mortality; however, the gastrointestinal tract of Nlrp6(-/-) mice exhibited increased viral loads. Nirp6(-/-) mice orally infected with encephalomyocarditis virus had increased mortality and viremia compared with controls. Similar results were observed with murine norovirus 1. Nlrp6 bound viral RNA via the RNA helicase Dhx15 and interacted with mitochondrial antiviral signaling protein to induce type I/III interferons (IFNs) and IFN-stimulated genes (ISGs). These data demonstrate that Nlrp6 functions with Dhx15 as a viral RNA sensor to induce ISGs, and this effect is especially important in the intestinal tract.	[Wang, Penghua; Yang, Long; Cui, Shuang; Sun, Qjangming; Yang, Guang; Gao, Shandian; You, Fuping; Fikrig, Erol] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06510 USA; [Zhu, Shu; Jackson, Ruaidhri; Zheng, Yunjiang; Rongvaux, Anthony; Flavell, Richard] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Pan, Wen] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lin, Rongtuan] McGill Univ, Dept Med, Lady Davis Inst, Montreal, PQ, Canada; [Flavell, Richard; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wang, Penghua; Yang, Long] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	Yale University; Yale University; Yale University; Lady Davis Institute; McGill University; Howard Hughes Medical Institute; New York Medical College	Flavell, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06510 USA.	richard.flavell@yale.edu; erol.fikrig@yale.edu	wang, Penghua/AAL-4011-2020; Zhu, Shu/P-6163-2018; Pan, Wen/I-9965-2016	Zhu, Shu/0000-0002-8163-0869; 	National Institutes of Health [N01-HHSN272201100019C, AI099625, AI103807]; Howard Hughes Medical Institute-The Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103807, R03AI099625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute-The Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by National Institutes of Health grants N01-HHSN272201100019C, AI099625, and AI103807. E.F. and R.F. are Investigators of the Howard Hughes Medical Institute. S.Z. was supported by a fellowship from Howard Hughes Medical Institute-The Helen Hay Whitney Foundation.	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Lu HB, 2014, J IMMUNOL, V193, P1364, DOI 10.4049/jimmunol.1303322; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mosallanejad K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004841; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010	30	138	141	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					826	830		10.1126/science.aab3145	http://dx.doi.org/10.1126/science.aab3145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26494172	Green Accepted			2022-12-28	WOS:000364897000048
J	McCarrey, JR				McCarrey, John R.			The epigenome-a family affair	SCIENCE			English	Editorial Material							TRANSGENERATIONAL EPIGENETIC INHERITANCE; DISEASE		Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA)	McCarrey, JR (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	john.mccarrey@utsa.edu						de Waal E, 2012, P NATL ACAD SCI USA, V109, P4163, DOI 10.1073/pnas.1201990109; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; McCarrey JR, 2012, MOL CELL ENDOCRINOL, V354, P9, DOI 10.1016/j.mce.2011.09.014; Nilsson EE, 2015, TRANSL RES, V165, P12, DOI 10.1016/j.trsl.2014.02.003; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Xin F, 2015, SEMIN CELL DEV BIOL, V43, P66, DOI 10.1016/j.semcdb.2015.05.008	7	6	7	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					634	635		10.1126/science.aad5138	http://dx.doi.org/10.1126/science.aad5138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542557				2022-12-28	WOS:000364162800028
J	Soderquist, C				Soderquist, Chuck			How to isolate americium	SCIENCE			English	Editorial Material									Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Soderquist, C (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	chuck.soderquist@pnnl.gov						Dares CJ, 2015, SCIENCE, V350, P652, DOI 10.1126/science.aac9217; Kim MC, 2009, NUCL TECHNOL, V166, P283, DOI 10.13182/NT08-39; Lumetta GJ, 2006, ACS S SERIES, V933; Nash KL, 2011, WOODHEAD PUBL SER EN, P1, DOI 10.1533/9780857092274; Soderquist CZ, 2011, IND ENG CHEM RES, V50, P1813, DOI 10.1021/ie101386n; Wai C. M., 2010, ACS S SERIES, V1046	6	1	1	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					635	636		10.1126/science.aad5131	http://dx.doi.org/10.1126/science.aad5131			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542558				2022-12-28	WOS:000364162800029
J	Kantor, ED; Rehm, CD; Haas, JS; Chan, AT; Giovannucci, EL				Kantor, Elizabeth D.; Rehm, Colin D.; Haas, Jennifer S.; Chan, Andrew T.; Giovannucci, Edward L.			Trends in Prescription Drug Use Among Adults in the United States From 1999-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN PLUS PROGESTIN; MEDICATION USE; HEALTH; POPULATION; PREVALENCE	IMPORTANCE It is important to document patterns of prescription drug use to inform both clinical practice and research. OBJECTIVE To evaluate trends in prescription drug use among adults living in the United States. DESIGN, SETTING, AND PARTICIPANTS Temporal trends in prescription drug use were evaluated using nationally representative data from the National Health and Nutrition Examination Survey (NHANES). Participants included 37 959 noninstitutionalized US adults, aged 20 years and older. Seven NHANES cycles were included (1999-2000 to 2011-2012), and the sample size per cycle ranged from 4861 to 6212. EXPOSURES Calendar year, as represented by continuous NHANES cycle. MAIN OUTCOMES AND MEASURES Within each NHANES cycle, use of prescription drugs in the prior 30 days was assessed overall and by drug class. Temporal trends across cycles were evaluated. Analyses were weighted to represent the US adult population. RESULTS Results indicate an increase in overall use of prescription drugs among US adults between 1999-2000 and 2011-2012 with an estimated 51% of US adults reporting use of any prescription drugs in 1999-2000 and an estimated 59% reporting use of any prescription drugs in 2011-2012 (difference, 8%[95% CI, 3.8%-12%]; P for trend <. 001). The prevalence of polypharmacy (use of >= 5 prescription drugs) increased from an estimated 8.2% in 1999-2000 to 15% in 2011-2012 (difference, 6.6%[95% CI, 4.4%-8.2%]; P for trend <. 001). These trends remained statistically significant with age adjustment. Among the 18 drug classes used by more than 2.5% of the population at any point over the study period, the prevalence of use increased in 11 drug classes including antihyperlipidemic agents, antidepressants, prescription proton-pump inhibitors, and muscle relaxants. CONCLUSIONS AND RELEVANCE In this nationally representative survey, significant increases in overall prescription drug use and polypharmacy were observed. These increases persisted after accounting for changes in the age distribution of the population. The prevalence of prescription drug use increased in the majority of, but not all, drug classes.	[Kantor, Elizabeth D.; Giovannucci, Edward L.] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Kantor, Elizabeth D.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10017 USA; [Rehm, Colin D.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Rehm, Colin D.] Montefiore Med Ctr, Off Community & Populat Hlth, Bronx, NY 10467 USA; [Haas, Jennifer S.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [Haas, Jennifer S.] Harvard Univ, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Chan, Andrew T.; Giovannucci, Edward L.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Giovannucci, Edward L.] Harvard Univ, Dept Nutr, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Memorial Sloan Kettering Cancer Center; Tufts University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Kantor, ED (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave,Second Floor, New York, NY 10017 USA.	kantore@mskcc.org	REHM, COLIN D./J-1215-2019	REHM, COLIN D./0000-0002-7644-0040; HAAS, JENNIFER/0000-0001-7227-851X	National Cancer Institute [T32 CA 009001]; National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK098311]; Harvard Catalyst-The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst-The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Catalyst-The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst-The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was conducted with support from the National Cancer Institute (support for Kantor, T32 CA 009001) and the National Institute of Diabetes and Digestive and Kidney Diseases (support for Chan, K24 DK098311). Support for Haas: Harvard Catalyst-The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic health care centers.	Bennett WL, 2011, AHRQ PUBLICATION, V11-EHC038-EF; Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410; Blumner KH, 2009, PSYCHIAT SERV, V60, P306, DOI 10.1176/appi.ps.60.3.306; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chong Yinong, 2013, NCHS Data Brief, P1; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Daubresse M, 2015, AM J RESP CRIT CARE, V192, P40, DOI 10.1164/rccm.201409-1585OC; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Ford ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095305; Goodnick PJ, 1998, J PSYCHOPHARMACOL, V12, pS5, DOI 10.1177/0269881198012003021; Gu Q, 2014, NCHS DATA BRIEF, V177, P1; Gu Qiuping, 2010, NCHS Data Brief, P1; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Jewett PI, 2014, OBSTET GYNECOL, V124, P727, DOI 10.1097/AOG.0000000000000469; Johnson CL, 2013, VITAL HLTH STAT, V2, P1; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Klein Richard J, 2002, Healthy People 2010 Stat Notes, P1; Kornfield R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055504; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; National Center for Health Statistics, NHANES RESP RAT POP; National Center for Health Statistics. National Center for Health Statistics, NHANES 2003 2004 PUB; National Center for Health Statistics (U.S.), 2014, HLTH US 2013 SPEC FE; National Health and Nutrition Examination Survey, CONT NHANES; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Paulose-Ram R, 2004, J CLIN EPIDEMIOL, V57, P309, DOI 10.1016/j.jclinepi.2003.05.001; Perez AD, 2009, POPUL DEV REV, V35, P1, DOI 10.1111/j.1728-4457.2009.00260.x; Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892; Ross JS, 2009, ARCH INTERN MED, V169, P1976, DOI 10.1001/archinternmed.2009.394; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schumock GT, 2014, AM J HEALTH-SYST PH, V71, P482, DOI 10.2146/ajhp130767; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; SORLIE PD, 1993, JAMA-J AM MED ASSOC, V270, P2464, DOI 10.1001/jama.270.20.2464; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, DAWN REP ED VIS INV; Thielke SM, 2010, PAIN MED, V11, P248, DOI 10.1111/j.1526-4637.2009.00740.x; Viktil KK, 2007, BRIT J CLIN PHARMACO, V63, P187, DOI 10.1111/j.1365-2125.2006.02744.x; Yoon SS, 2015, HYPERTENSION, V65, P54, DOI 10.1161/HYPERTENSIONAHA.114.04012	40	740	753	2	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1818	1831		10.1001/jama.2015.13766	http://dx.doi.org/10.1001/jama.2015.13766			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529160	Green Accepted, Bronze			2022-12-28	WOS:000363960200014
J	Olsen, M; Thygesen, SK; Ostergaard, JR; Nielsen, H; Henderson, VW; Ehrenstein, V; Norgaard, M; Sorensen, HT				Olsen, Morten; Thygesen, Sandra K.; Ostergaard, John R.; Nielsen, Henrik; Henderson, Victor W.; Ehrenstein, Vera; Norgaard, Mette; Sorensen, Henrik Toft			Hospital-Diagnosed Pertussis Infection in Children and Long-term Risk of Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VACCINES; EPIDEMIOLOGY; RESURGENCE; INFANTS; DISEASE	IMPORTANCE Pertussis is associated with encephalopathy and seizures in infants. However, the risk of childhood epilepsy following pertussis is unknown. OBJECTIVE To examine whether pertussis is associated with the long-term risk of epilepsy. DESIGN, SETTING, AND PARTICIPANTS We used individually linked data from population-based medical registries covering all Danish hospitals to identify a cohort of all patients with pertussis born between 1978 and 2011, followed up through 2011. We used the Civil Registration System to identify 10 individuals from the general population for each patient with pertussis, matched on sex and year of birth. EXPOSURES Inpatient or hospital-based outpatient diagnosis of pertussis. MAIN OUTCOMES AND MEASURES Cumulative incidence and hazard ratio of time to hospital-based epilepsy diagnosis (pertussis cohort vs general population cohort), adjusted for birth year, sex, maternal history of epilepsy, presence of congenital malformations, and gestational age. Unique personal identifiers permitted unambiguous data linkage and complete follow-up for death, emigration, and hospital contacts. RESULTS We identified 4700 patients with pertussis (48% male), of whom 90 developed epilepsy during the follow-up. The cumulative incidence of epilepsy at age 10 years was 1.7% (95% CI, 1.4%-2.1%) for patients with pertussis and 0.9%(95% CI, 0.8%-1.0%) for the matched comparison cohort. The corresponding adjusted overall hazard ratio was 1.7 (95% CI, 1.3-2.1). CONCLUSIONS AND RELEVANCE In Denmark, risk of epilepsy was increased in children with hospital-diagnosed pertussis infections compared with the general population; however, the absolute risk was low.	[Olsen, Morten; Thygesen, Sandra K.; Nielsen, Henrik; Henderson, Victor W.; Ehrenstein, Vera; Norgaard, Mette; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Ostergaard, John R.] Aarhus Univ Hosp, Dept Pediat, DK-8200 Aarhus N, Denmark; [Henderson, Victor W.] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Henderson, Victor W.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Aarhus University; Aarhus University; Stanford University; Stanford University	Olsen, M (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus N, Denmark.	mo@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Henderson, V/AAW-4744-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Ehrenstein, Vera/0000-0002-3415-3254; Norgaard, Mette/0000-0001-6110-5891	Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R155-2014-2647] Funding Source: researchfish; Novo Nordisk Fonden [NNF14SA0015794] Funding Source: researchfish	Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by grants from the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation.	Arts WFM, 2009, EUR J PAEDIATR NEURO, V13, P93, DOI 10.1016/j.ejpn.2008.02.010; Bettinger JA, 2007, PEDIATR INFECT DIS J, V26, P31, DOI 10.1097/01.inf.0000247055.81541.04; Bonacruz-Kazzi G, 2003, J PAEDIATR CHILD H, V39, P586, DOI 10.1046/j.1440-1754.2003.00244.x; Browne TR, 2001, NEW ENGL J MED, V344, P1145, DOI 10.1056/NEJM200104123441507; Centers for Disease Control and Prevention, PERT WHOOP COUGH; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Chin LK, 2013, ARCH DIS CHILD, V98, P163, DOI 10.1136/archdischild-2012-303069; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Guerrini R, 2006, LANCET, V367, P499, DOI 10.1016/S0140-6736(06)68182-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hviid A, 2004, VACCINE, V22, P3530, DOI 10.1016/j.vaccine.2004.03.046; Hviid A, 2009, VACCINE, V27, P3035, DOI 10.1016/j.vaccine.2009.03.041; Nabbout R, 2012, EPILEPSIA, V53, P58, DOI 10.1111/j.1528-1167.2012.03614.x; Prober C, 2012, PRINCIPLES PRACTICE; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shapiro ED, 2012, JAMA-J AM MED ASSOC, V308, P2149, DOI 10.1001/jama.2012.65031; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Thierry-Carstensen B, 2013, VACCINE, V31, P5178, DOI 10.1016/j.vaccine.2013.08.034; Tiwari TSP, 2015, PEDIATRICS, V135, P990, DOI 10.1542/peds.2014-2291	24	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1844	1849		10.1001/jama.2015.13971	http://dx.doi.org/10.1001/jama.2015.13971			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529162	Bronze			2022-12-28	WOS:000363960200016
J	Evans, PN; Parks, DH; Chadwick, GL; Robbins, SJ; Orphan, VJ; Golding, SD; Tyson, GW				Evans, Paul N.; Parks, Donovan H.; Chadwick, Grayson L.; Robbins, Steven J.; Orphan, Victoria J.; Golding, Suzanne D.; Tyson, Gene W.			Methane metabolism in the archaeal phylum Bathyarchaeota revealed by genome-centric metagenomics	SCIENCE			English	Article							MISCELLANEOUS CRENARCHAEOTAL GROUP; COENZYME M REDUCTASE; ANAEROBIC OXIDATION; MARINE-SEDIMENTS; BENTHIC ARCHAEA; MCG ARCHAEA; IDENTIFICATION; ECOSYSTEMS; BACTERIA; INSIGHTS	Methanogenic and methanotrophic archaea play important roles in the global flux of methane. Culture-independent approaches are providing deeper insight into the diversity and evolution of methane-metabolizing microorganisms, but, until now, no compelling evidence has existed for methane metabolism in archaea outside the phylum Euryarchaeota. We performed metagenomic sequencing of a deep aquifer, recovering two near-complete genomes belonging to the archaeal phylum Bathyarchaeota (formerly known as the Miscellaneous Crenarchaeotal Group). These genomes contain divergent homologs of the genes necessary for methane metabolism, including those that encode the methyl-coenzyme M reductase (MCR) complex. Additional non-euryarchaeotal MCR-encoding genes identified in a range of environments suggest that unrecognized archaeal lineages may also contribute to global methane cycling. These findings indicate that methane metabolism arose before the last common ancestor of the Euryarchaeota and Bathyarchaeota.	[Evans, Paul N.; Parks, Donovan H.; Robbins, Steven J.; Tyson, Gene W.] Univ Queensland, Sch Chem & Mol Biosciences, Australian Ctr Ecogenom, St Lucia, Qld 4072, Australia; [Chadwick, Grayson L.; Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Golding, Suzanne D.] Univ Queensland, Sch Earth Sci, St Lucia, Qld 4072, Australia; [Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, St Lucia, Qld 4072, Australia	University of Queensland; California Institute of Technology; University of Queensland; University of Queensland	Tyson, GW (corresponding author), Univ Queensland, Sch Chem & Mol Biosciences, Australian Ctr Ecogenom, St Lucia, Qld 4072, Australia.	g.tyson@uq.edu.au	Chadwick, Grayson/AAE-1585-2019; Tyson, Gene W/C-6558-2013; Evans, Paul/C-4535-2012; Golding, Suzanne D/GLU-7324-2022; Golding, Suzanne/AAT-6068-2021; Orphan, Victoria/AAS-5989-2020; Evans, Paul/AAW-1654-2020; Parks, Donovan/AAA-2303-2019	Chadwick, Grayson/0000-0003-0700-9350; Tyson, Gene W/0000-0001-8559-9427; Evans, Paul/0000-0001-5995-2602; Golding, Suzanne D/0000-0002-2980-1798; Orphan, Victoria/0000-0002-5374-6178; Evans, Paul/0000-0001-5995-2602; Parks, Donovan/0000-0001-6662-9010	Australian Research Council (ARC) [LP100200730]; U.S. Department of Energy's Office of Biological Environmental Research [DE-SC0010574]; Natural Sciences and Engineering Research Council of Canada; Australian Postgraduate Award Industry scholarship; ARC Queen Elizabeth II Fellowship [DP1093175]	Australian Research Council (ARC)(Australian Research Council); U.S. Department of Energy's Office of Biological Environmental Research(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Postgraduate Award Industry scholarship(Australian Government); ARC Queen Elizabeth II Fellowship(Australian Research Council)	We thank E. Gagen and P. Hugenholtz for valuable comments and suggestions; K. Baublys, SGS-Leeder, and Australian Laboratory Services staff for sample collection; and M. Butler and S. Low for library preparation and sequencing. This study was supported by the Australian Research Council (ARC) Linkage Project (grant LP100200730) and the U.S. Department of Energy's Office of Biological Environmental Research (award no. DE-SC0010574). D.H.P. is supported by the Natural Sciences and Engineering Research Council of Canada. S.J.R. is supported by an Australian Postgraduate Award Industry scholarship. G.W.T. is supported by an ARC Queen Elizabeth II Fellowship (grant DP1093175). The authors declare no conflicts of interest. Our Whole Genome Shotgun projects have been deposited in the DNA DataBank of Japan, the European Molecular Biology Laboratory repository, and NIH's GenBank under the accession numbers LIHJ00000000 (BA1) and LIHK00000000 (BA2). The versions described in this paper are LIHJ01000000 (BA1) and LIHK01000000 (BA2). Non-euryarchaeotal Surat Basin mcrA sequences have been deposited under the accession numbers KT387805 to KT387832, and unprocessed reads have been deposited under the accession number SRX1122679.	Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Gagen EJ, 2013, APPL ENVIRON MICROB, V79, P6400, DOI 10.1128/AEM.02153-13; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Harms U, 1997, EUR J BIOCHEM, V250, P783, DOI 10.1111/j.1432-1033.1997.00783.x; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Hocking WP, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00095; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kelly S, 2011, P ROY SOC B-BIOL SCI, V278, P1009, DOI 10.1098/rspb.2010.1427; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Lang K, 2015, APPL ENVIRON MICROB, V81, P1338, DOI 10.1128/AEM.03389-14; Lazar CS, 2015, ENVIRON MICROBIOL, V17, P2228, DOI 10.1111/1462-2920.12659; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Ma K, 1997, P NATL ACAD SCI USA, V94, P9608, DOI 10.1073/pnas.94.18.9608; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Prakash D, 2014, J BACTERIOL, V196, P2491, DOI 10.1128/JB.01658-14; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	29	416	449	15	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					434	438		10.1126/science.aac7745	http://dx.doi.org/10.1126/science.aac7745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494757				2022-12-28	WOS:000363213400040
J	Theron, G; Jenkins, HE; Cobelens, F; Abubakar, I; Khan, AJ; Cohen, T; Dowdy, DW				Theron, Grant; Jenkins, Helen E.; Cobelens, Frank; Abubakar, Ibrahim; Khan, Aamir J.; Cohen, Ted; Dowdy, David W.			Data for action: collection and use of local data to end tuberculosis	LANCET			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; TREATMENT OUTCOMES; TRANSMISSION; SOUTH; DISEASE; HETEROGENEITY; HOTSPOTS; BURDEN; IMPACT; TB	Accelerating progress in the fight against tuberculosis will require a drastic shift from a strategy focused on control to one focused on elimination. Successful disease elimination campaigns are characterised by locally tailored responses that are informed by appropriate data. To develop such a response to tuberculosis, we suggest a three-step process that includes improved collection and use of existing programmatic data, collection of additional data (eg, geographic information, drug resistance, and risk factors) to inform tailored responses, and targeted collection of novel data (eg, sequencing data, targeted surveys, and contact investigations) to improve understanding of tuberculosis transmission dynamics. Development of a locally targeted response for tuberculosis will require substantial investment to reconfigure existing systems, coupled with additional empirical data to evaluate the effectiveness of specific approaches. Without adoption of an elimination strategy that uses local data to target hotspots of transmission, ambitious targets to end tuberculosis will almost certainly remain unmet.	[Theron, Grant] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Theron, Grant] Univ Stellenbosch, South African Med Res Council, Fac Med & Hlth Sci, Ctr Mol & Cellular Biol,Div Mol Biol & Human Gene, ZA-7505 Tygerberg, South Africa; [Theron, Grant] Univ Cape Town, Dept Med, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Jenkins, Helen E.] Brigham & Womens Hosp, Dept Global Hlth Equ, Boston, MA 02115 USA; [Cobelens, Frank] KNCV TB Fdn, The Hague, Netherlands; [Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Abubakar, Ibrahim] UCL, London, England; [Khan, Aamir J.] Interact Res & Dev, Karachi, Pakistan; [Cohen, Ted] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21236 USA	National Research Foundation - South Africa; Stellenbosch University; South African Medical Research Council; Stellenbosch University; University of Cape Town; Harvard University; Brigham & Women's Hospital; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Yale University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21236 USA.	ddowdy1@jhmi.edu	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415; Cohen, Ted/0000-0002-8091-7198; Jenkins, Helen/0000-0003-4749-1591; Abubakar, Ibrahim/0000-0002-0370-1430; Cobelens, Frank/0000-0002-4367-1133	Wellcome Trust [WT099854MA]; South African Medical Research Council Career Development Award; US National Institutes of Health [K01AI102944, R01AI112438]; B Frank and Kathleen Polk Assistant Professorship in Epidemiology; UK National Institute of Health Research; Medical Research Council; Public Health England; National Institute for Health Research [SRF-2011-04-001] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI102944, R01AI112438] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); South African Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); B Frank and Kathleen Polk Assistant Professorship in Epidemiology; UK National Institute of Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are supported by the Wellcome Trust (grant WT099854MA) and a South African Medical Research Council Career Development Award (to GT); the US National Institutes of Health (K01AI102944, awarded to HEJ; R01AI112438 awarded to TC); the B Frank and Kathleen Polk Assistant Professorship in Epidemiology (to DWD); and the UK National Institute of Health Research, Medical Research Council, and Public Health England (IA). The funders had no role in the conception, preparation, review, approval, or submission of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the views of the US National Institute of Allergy and Infectious Diseases or the US National Institutes of Health. We thank Carole Mitnick for her review and the important comments she contributed during drafting and Carly Rodriguez for coordination and research assistance in the preparation of this manuscript.	Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; Azman AS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001901; Bahl S, 2014, MMWR-MORBID MORTAL W, V63, pCOVER1; Bangha M, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5517; Bantubani N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090868; Bateman C, 2015, SAMJ S AFR MED J, V105, P165, DOI 10.7196/SAMJ.9475; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Blaya JA, 2010, INT J TUBERC LUNG D, V14, P1009; Blaya JA, 2009, INT J INFECT DIS, V13, P410, DOI 10.1016/j.ijid.2008.09.015; BLOCH AB, 1986, AM J PUBLIC HEALTH, V76, P14, DOI 10.2105/AJPH.76.1.14; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cain KP, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001791; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P234; Chapman Ann Ln, 2013, Clin Epidemiol, V5, P465, DOI 10.2147/CLEP.S37072; Chihota VN, 2012, J CLIN MICROBIOL, V50, P995, DOI 10.1128/JCM.05832-11; Chonde TM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-427; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Colijn C, 2007, J THEOR BIOL, V247, P765, DOI 10.1016/j.jtbi.2007.04.015; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093858; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Dowdy DW, 2014, ELIFE, V3, DOI 10.7554/eLife.02565; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gerberry DJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6454; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gurarie D, 2009, J R SOC INTERFACE, V6, P495, DOI 10.1098/rsif.2008.0265; Hedt BL, 2012, EPIDEMIOLOGY, V23, P293, DOI 10.1097/EDE.0b013e3182459455; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Huong NT, 2006, J INFECT DIS, V194, P1226, DOI 10.1086/507906; Isaakidis P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110461; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Jenkins HE, 2013, EUR RESPIR J, V42, P1291, DOI 10.1183/09031936.00111812; Jezek Z, 1988, HUMAN MONKEYPOX; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; LANATA C F, 1991, World Health Statistics Quarterly, V44, P133; Lorent N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092754; Mandeville KL, 2014, PUBLIC HEALTH ETH-UK, V7, P47, DOI 10.1093/phe/pht023; Mears J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1023; Memiah P., 2014, International Journal of Medicine and Public Health, V4, P194; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Muller B, 2011, INT J TUBERC LUNG D, V15, P344; Muller B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070919; Nanoo A, 2015, LANCET INFECT DIS, V15, P1066, DOI 10.1016/S1473-3099(15)00147-4; Ng N, 2009, GLOBAL HEALTH ACTION, V2, P7, DOI 10.3402/gha.v2i0.1984; Ortblad KF, 2015, LANCET; Partners in Health, 2014, PIH RUSS REC TB ACH; Perez-Lago L, 2015, CLIN MICROBIOL INFEC, V21; Rangaka MX, 2015, LANCET; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Salvo F, 2014, INT J TUBERC LUNG D, V18, P655, DOI 10.5588/ijtld.13.0516; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Soltan V, 2008, B WORLD HEALTH ORGAN, V86, P71, DOI 10.2471/BLT.06.038265; Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; Uchimura K, 2013, WEST PAC SURVEILL RE, V4, P11, DOI [10.5365/wpsar.2012.3.4.016, 10.5365/WPSAR.2012.3.4.016]; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Vandelaer J, 2008, B WHO, V86; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wand H, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-41; Wells WA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001842; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2007, IN DEPTH EV REACH EV; WHO, 2014, ENGAGE TB APPR INT C; WHO, 2014, WHOHQTB201412; WHO, 2014, WHOJTMTB201402; WHO, 2011, WHOHTMTB201017; WHO, 1999, WHAT IS DOTS GUID UN; WHO, 2012, WHOHTMTB201122; WHO, 2013, ROADM CHILDH TUB ZER; WHO, 2014, WHOHTMTB201409; WHO, 2014, WHO PUBL, VWHO/HTM/TB/2014.08; WHO, 2014, TB COUNTR PROF LES; WHO, 2013, WHO PUBL, VWHO/HTM/TB/2013.2; World Health Organization, 2014, WHOHTMTB201408; Yuen CM, 2015, LANCET; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959	84	70	71	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2324	2333		10.1016/S0140-6736(15)00321-9	http://dx.doi.org/10.1016/S0140-6736(15)00321-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26515676	Green Accepted			2022-12-28	WOS:000365993200032
J	Hanchate, NK; Kondoh, K; Lu, ZH; Kuang, DH; Ye, XL; Qiu, XJ; Pachter, L; Trapnell, C; Buck, LB				Hanchate, Naresh K.; Kondoh, Kunio; Lu, Zhonghua; Kuang, Donghui; Ye, Xiaolan; Qiu, Xiaojie; Pachter, Lior; Trapnell, Cole; Buck, Linda B.			Single-cell transcriptomics reveals receptor transformations during olfactory neurogenesis	SCIENCE			English	Article							ODORANT RECEPTORS; EXPRESSION; QUANTIFICATION; RULE	The sense of smell allows chemicals to be perceived as diverse scents. We used single-neuron RNA sequencing to explore the developmental mechanisms that shape this ability as nasal olfactory neurons mature in mice. Most mature neurons expressed only one of the similar to 1000 odorant receptor genes (Olfrs) available, and at a high level. However, many immature neurons expressed low levels of multiple Olfrs. Coexpressed Olfrs localized to overlapping zones of the nasal epithelium, suggesting regional biases, but not to single genomic loci. A single immature neuron could express Olfrs from up to seven different chromosomes. The mature state in which expression of Olfr genes is restricted to one per neuron emerges over a developmental progression that appears to be independent of neuronal activity involving sensory transduction molecules.	[Hanchate, Naresh K.; Kondoh, Kunio; Lu, Zhonghua; Kuang, Donghui; Ye, Xiaolan; Buck, Linda B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Qiu, Xiaojie; Trapnell, Cole] Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA; [Qiu, Xiaojie] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98115 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Trapnell, C (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA.	coletrap@uw.edu; lbuck@fhcrc.org	Hanchate, Naresh/O-5368-2019	Hanchate, Naresh/0000-0003-0849-3367; Pachter, Lior/0000-0002-9164-6231; Kondoh, Kunio/0000-0002-1139-328X	Howard Hughes Medical Institute; NIH [R01 DC009324, DP2 HD088158]; Alfred P. Sloan Fellowship; Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD088158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009324] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Delrow, A. Marty, and A. Dawson at the Fred Hutchinson Cancer Research Center (FHCRC) Genomics Facility for assistance with RNA-seq; M. Fitzgibbon and J. Davidson at the FHCRC Bioinformatics Resource for early assistance with sequence analyses; and J. Vasquez and the FHCRC Scientific Imaging Facility for help with confocal microscopy. We also thank members of the Buck laboratory for helpful discussions. This work was supported by the Howard Hughes Medical Institute (L.B.B.), NIH grants R01 DC009324 (L.B.B.) and DP2 HD088158 (C.T.), an Alfred P. Sloan Fellowship (C.T.), and a Dale F. Frey Award for Breakthrough Scientists from the Damon Runyon Cancer Research Foundation (C.T.). L.B.B. is on the Board of Directors of International Flavors & Fragrances. The supplementary materials contain additional data. N.K.H., C.T., and L.B.B. designed the research; N.K.H. and C.T. performed the research; N.K.H., C.T., K.K., Z.L., D.K., X.Y., X.Q., and L.B.B. analyzed the data; L.P. provided guidance; and N.K.H, C.T., and L.B.B. wrote the paper. Raw sequencing data related to this study have been archived in the Gene Expression Omnibus (GEO) database under accession number GSE75413 (available at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75413).	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2012, PRINCIPLES NEUROSCIE, P712; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Collins ML, 1997, NUCLEIC ACIDS RES, V25, P2979, DOI 10.1093/nar/25.15.2979; Dalton RP, 2015, ANNU REV NEUROSCI, V38, P331, DOI 10.1146/annurev-neuro-071714-034145; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; HINDS JW, 1976, J COMP NEUROL, V169, P15, DOI 10.1002/cne.901690103; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nicolay DJ, 2006, CELL MOL NEUROBIOL, V26, P803, DOI 10.1007/s10571-006-9058-4; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez-Gil DJ, 2015, P NATL ACAD SCI USA, V112, P5821, DOI 10.1073/pnas.1417955112; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tian HK, 2008, MOL CELL NEUROSCI, V38, P484, DOI 10.1016/j.mcn.2008.04.006; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	27	126	128	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1251	1255		10.1126/science.aad2456	http://dx.doi.org/10.1126/science.aad2456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26541607	Green Accepted			2022-12-28	WOS:000365700500077
J	Gostin, LO; Roberts, AE				Gostin, Lawrence O.; Roberts, Anna E.			Forced Migration The Human Face of a Health Crisis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Roberts, Anna E.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], INT MIGR HLTH HUM RI; [Anonymous], AN WEEK TRAG MARKS M; Baker Peter, 2015, NY TIMES, pA1; World Food Program, SYR EM	4	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2125	2126		10.1001/jama.2015.14906	http://dx.doi.org/10.1001/jama.2015.14906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26501847				2022-12-28	WOS:000365351900011
J	Adhikari, A; Lerner, TN; Finkelstein, J; Pak, S; Jennings, JH; Davidson, TJ; Ferenczi, E; Gunaydin, LA; Irzabekov, JJM; Ye, L; Kim, SY; Lei, A; Deisseroth, K				Adhikari, Avishek; Lerner, Talia N.; Finkelstein, Joel; Pak, Sally; Jennings, Joshua H.; Davidson, Thomas J.; Ferenczi, Emily; Gunaydin, Lisa A.; Irzabekov, Julie J. M.; Ye, Li; Kim, Sung-Yon; Lei, Anna; Deisseroth, Karl			Basomedial amygdala mediates top-down control of anxiety and fear	NATURE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; C-FOS EXPRESSION; INFRALIMBIC CORTEX; CONDITIONED FEAR; BASOLATERAL AMYGDALA; INTERCALATED NEURONS; CORTICOSTERONE INJECTIONS; PRELIMBIC CORTEX; IN-VIVO; RAT	nxiety-related conditions are among the most difficult neuropsychiatric diseases to treat pharmacologically, but respond to cognitive therapies. There has therefore been interest in identifying relevant top-down pathways from cognitive control regions in medial prefrontal cortex (mPFC). Identification of such pathways could contribute to our understanding of the cognitive regulation of affect, and provide pathways for intervention. Previous studies have suggested that dorsal and ventral mPFC subregions exert opposing effects on fear, as do subregions of other structures. However, precise causal targets for top-down connections among these diverse possibilities have not been established. Here we show that the basomedial amygdala (BMA) represents the major target of ventral mPFC in amygdala in mice. Moreover, BMA neurons differentiate safe and aversive environments, and BMA activation decreases fear-related freezing and high-anxiety states. Lastly, we show that the ventral mPFC-BMA projection implements top-down control of anxiety state and learned freezing, both at baseline and in stress-induced anxiety, defining a broadly relevant new top-down behavioural regulation pathway.	[Adhikari, Avishek; Lerner, Talia N.; Finkelstein, Joel; Pak, Sally; Jennings, Joshua H.; Davidson, Thomas J.; Ferenczi, Emily; Gunaydin, Lisa A.; Irzabekov, Julie J. M.; Ye, Li; Kim, Sung-Yon; Lei, Anna; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Adhikari, Avishek; Lerner, Talia N.; Jennings, Joshua H.; Davidson, Thomas J.; Ye, Li; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94304 USA; [Ferenczi, Emily; Gunaydin, Lisa A.; Kim, Sung-Yon; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Adhikari, Avishek/AAF-4444-2021; Lerner, Talia/AAB-5439-2020; Core, Vector/CAF-4832-2022; Lerner, Talia/AGW-7812-2022; Kim, Sung-Yon/AAO-8405-2020	Adhikari, Avishek/0000-0002-9187-9211; Lerner, Talia/0000-0002-3875-0654; Kim, Sung-Yon/0000-0003-0791-7308	Walter V. and Idun Berry award; K99 award [NIMH K99MH106649]; NARSAD Young Investigator fellowship; NIMH; DARPA Neuro-FAST program; NIDA; NSF; Simons Foundation; Gatsby Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H. L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Vincent V. C. Woo Fund; Albert Yu Foundation; Mary Bechman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH106649, R00MH106649, R01MH075957, F32MH105053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377] Funding Source: NIH RePORTER	Walter V. and Idun Berry award; K99 award; NARSAD Young Investigator fellowship; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DARPA Neuro-FAST program; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); Simons Foundation; Gatsby Foundation; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H. L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Vincent V. C. Woo Fund; Albert Yu Foundation; Mary Bechman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. K. Urn and the Malenka laboratory for providing Rabies-Delta G-GFP. We thank the Deisseroth laboratory for helpful discussions. AA is supported by the Walter V. and Idun Berry award, a K99 award (NIMH K99MH106649) and a NARSAD Young Investigator fellowship. T.L. is a NRSA (1F32MH105053-01) fellow. K.D. is supported by NIMH, the DARPA Neuro-FAST program, NIDA, Peter and Ann Tarlton, NSF, the Simons Foundation, the Gatsby Foundation, the Wiegers Family Fund, the Nancy and James Grosfeld Foundation, the H. L. Snyder Medical Foundation, the Samuel and Betsy Reeves Fund, the Vincent V. C. Woo Fund, and the Albert Yu and Mary Bechman Foundations. All optogenetics (http://www.optogenetics.org) and CLARITY (http://clarityresourcecenter.org) reagents and protocols are distributed and supported freely.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amir A, 2011, J NEUROPHYSIOL, V105, P3054, DOI 10.1152/jn.00136.2011; Berretta S, 2005, NEUROSCIENCE, V132, P943, DOI 10.1016/j.neuroscience.2005.01.020; Bi LL, 2013, NEUROPHARMACOLOGY, V72, P148, DOI 10.1016/j.neuropharm.2013.04.048; Bukalo O, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500251; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; Chaudieu I, 2008, J AFFECT DISORDERS, V106, P307, DOI 10.1016/j.jad.2007.07.025; Cho JH, 2013, NEURON, V80, P1491, DOI 10.1016/j.neuron.2013.09.025; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; De Abreu A. R., 2014, SOC NEUR ANN M 2014; Dimopoulou C, 2013, NEUROENDOCRINOLOGY, V97, P139, DOI 10.1159/000338408; Do-Monte FH, 2015, J NEUROSCI, V35, P3607, DOI 10.1523/JNEUROSCI.3137-14.2015; File SE, 1996, J NEUROSCI, V16, P4810; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Hubner C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00064; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Ji GC, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-36; Jinks AL, 1997, BRAIN RES, V772, P181, DOI 10.1016/S0006-8993(97)00810-X; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lee B, 2013, BIOMOL THER, V21, P313, DOI 10.4062/biomolther.2013.004; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Maaswinkel H, 1996, BEHAV BRAIN RES, V79, P51, DOI 10.1016/0166-4328(95)00261-8; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; MARTIN B, 1961, PSYCHOL BULL, V58, P234, DOI 10.1037/h0045492; Martinez RC, 2011, NEUROSCIENCE, V172, P314, DOI 10.1016/j.neuroscience.2010.10.033; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; Petrovich GD, 1996, J COMP NEUROL, V374, P387, DOI 10.1002/(SICI)1096-9861(19961021)374:3<387::AID-CNE6>3.0.CO;2-Y; Pinard CR, 2012, NEUROSCIENCE, V205, P112, DOI 10.1016/j.neuroscience.2011.12.036; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rebello TJ, 2014, J NEUROSCI, V34, P12379, DOI 10.1523/JNEUROSCI.1020-13.2014; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; SMITH J, 1992, ANAESTH INTENS CARE, V20, P255; Stevenson CW, 2011, NEUROBIOL LEARN MEM, V96, P315, DOI 10.1016/j.nlm.2011.06.005; Strobel C, 2015, CELL REP, V10, P1435, DOI 10.1016/j.celrep.2015.02.008; SUESS WM, 1980, PSYCHOPHYSIOLOGY, V17, P535, DOI 10.1111/j.1469-8986.1980.tb02293.x; Sullivan RM, 2002, BRAIN RES, V927, P69, DOI 10.1016/S0006-8993(01)03328-5; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Vreeburg SA, 2010, PSYCHOSOM MED, V72, P340, DOI 10.1097/PSY.0b013e3181d2f0c8; Wall PM, 2000, BRAIN RES, V856, P259, DOI 10.1016/S0006-8993(99)01990-3	50	254	256	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					179	+		10.1038/nature15698	http://dx.doi.org/10.1038/nature15698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26536109	Green Accepted, Green Submitted			2022-12-28	WOS:000364396700034
J	Turkbey, EB; Nacif, MS; Guo, MY; McClelland, RL; Teixeira, PBRP; Bild, DE; Barr, RG; Shea, S; Post, W; Burke, G; Budoff, MJ; Folsom, AR; Liu, CY; Lima, JA; Bluemke, DA				Turkbey, Evrim B.; Nacif, Marcelo S.; Guo, Mengye; McClelland, Robyn L.; Teixeira, Patricia B. R. P.; Bild, Diane E.; Barr, R. Graham; Shea, Steven; Post, Wendy; Burke, Gregory; Budoff, Matthew J.; Folsom, Aaron R.; Liu, Chia-Ying; Lima, Joao A.; Bluemke, David A.			Prevalence and Correlates of Myocardial Scar in a US Cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC MAGNETIC-RESONANCE; CARDIOVASCULAR RISK-FACTORS; CORONARY-ARTERY CALCIUM; INTIMA-MEDIA THICKNESS; HEART-DISEASE; ATHEROSCLEROSIS; INFARCTION; PREDICTION; PROGNOSIS; EVENTS	IMPORTANCE Myocardial scarring leads to cardiac dysfunction and poor prognosis. The prevalence of and factors associated with unrecognized myocardial infarction and scar have not been previously defined using contemporary methods in a multiethnic US population. OBJECTIVE To determine prevalence of and factors associated with myocardial scar in middle-and older-aged individuals in the United States. DESIGN, SETTING, AND PARTICIPANTS The Multi-Ethnic Study of Atherosclerosis (MESA) study is a population-based cohort in the United States. Participants were aged 45 through 84 years and free of clinical cardiovascular disease (CVD) at baseline in 2000-2002. In the 10th year examination (2010-2012), 1840 participants underwent cardiac magnetic resonance (CMR) imaging with gadolinium to detect myocardial scar. Cardiovascular disease risk factors and coronary artery calcium (CAC) scores were measured at baseline and year 10. Logistic regression models were used to estimate adjusted odds ratios (ORs) for myocardial scar. EXPOSURES Cardiovascular risk factors, CAC scores, left ventricle size and function, and carotid intima-media thickness. MAIN OUTCOMES AND MEASURES Myocardial scar detected by CMR imaging. RESULTS Of 1840 participants (mean [SD] age, 68 [9] years, 52% men), 146 (7.9%) had myocardial scars, of which 114 (78%) were undetected by electrocardiogram or by clinical adjudication. In adjusted models, age, male sex, body mass index, hypertension, and current smoking at baseline were associated with myocardial scar at year 10. The OR per 8.9-year increment was 1.61 (95% CI, 1.36-1.91; P < .001); for men vs women: OR, 5.76 (95% CI, 3.61-9.17; P < .001); per 4.8-SD body mass index: OR, 1.32 (95% CI, 1.09-1.61, P = .005); for hypertension: OR, 1.61 (95% CI, 1.12-2.30; P = .009); and for current vs never smokers: 2.00 (95% CI, 1.22-3.28; P = .006). Age-, sex-, and ethnicity-adjusted CAC scores at baseline were also associated with myocardial scar at year 10. Compared with a CAC score of 0, the OR for scores from 1 through 99 was 2.4 (95% CI, 1.5-3.9); from 100 through 399, 3.0 (95% CI, 1.7-5.1), and 400 or higher, 3.3 (95% CI, 1.7-6.1) (P < .001). The CAC score significantly added to the association of myocardial scar with age, sex, race/ethnicity, and traditional CVD risk factors (C statistic, 0.81 with CAC vs 0.79 without CAC, P =.01). CONCLUSIONS AND RELEVANCE The prevalence of myocardial scars in a US community-based multiethnic cohort was 7.9%, of which 78% were unrecognized by electrocardiography or clinical evaluation. Further studies are needed to understand the clinical consequences of these undetected scars.	[Turkbey, Evrim B.; Nacif, Marcelo S.; Liu, Chia-Ying; Bluemke, David A.] Natl Inst Biomed Imaging & Bioengn, Radiol & Imaging Sci, NIH, Ctr Clin, Bethesda, MD USA; [Turkbey, Evrim B.; Lima, Joao A.; Bluemke, David A.] Johns Hopkins Univ, Radiol & Radiol Sci, Baltimore, MD USA; [Guo, Mengye; McClelland, Robyn L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Teixeira, Patricia B. R. P.; Post, Wendy; Lima, Joao A.] Johns Hopkins Univ, Sch Med, Dept Cardiol, Baltimore, MD USA; [Bild, Diane E.] Patient Ctr Outcomes Res Inst, Washington, DC USA; [Barr, R. Graham; Shea, Steven] Columbia Univ, Dept Med, New York, NY USA; [Barr, R. Graham; Shea, Steven] Columbia Univ, Dept Epidemiol, New York, NY USA; [Burke, Gregory] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Winston Salem, NC USA; [Budoff, Matthew J.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Cardiol, Torrance, CA 90509 USA; [Folsom, Aaron R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Johns Hopkins University; University of Washington; University of Washington Seattle; Johns Hopkins University; Columbia University; Columbia University; Wake Forest University; Wake Forest University School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Minnesota System; University of Minnesota Twin Cities	Bluemke, DA (corresponding author), NIH, Ctr Clin, Radiol & Imaging Sci, 10 Ctr Dr,Bldg 10,Room 1C355, Bethesda, MD 20892 USA.	david.bluemke@nih.gov	Budoff, Matthew/ABD-5175-2021; Nacif, Marcelo Souto/C-9796-2010; Bluemke, David/GYU-8169-2022	Budoff, Matthew/0000-0002-9616-1946; Nacif, Marcelo Souto/0000-0003-2791-8375; Bluemke, David/0000-0002-8323-8086	National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169]; National Center for Research Resources [UL1-TR-000040, UL1-TR-001079]; NIH Intramural Research Program; Bayer Healthcare; US Environmental Protection Agency [RD831697]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095161, N01HC095163, N01HC095165, N01HC095166, N01HC095168, N01HC095164, N01HC095159, N01HC095160, N01HC095162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095167, R43HL095169, R01HL095163, R13HL095166, R43HL095160, R21HL095165, R43HL095161] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); US Environmental Protection Agency(United States Environmental Protection Agency); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, by grants UL1-TR-000040 and UL1-TR-001079 from National Center for Research Resources the NIH Intramural Research Program, and by a grant from Bayer Healthcare for the use of gadolinium contrast agent. This publication was developed under a STAR research assistance agreement RD831697 (MESA Air) from the US Environmental Protection Agency.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Barbier CE, 2007, RADIOLOGY, V245, P103, DOI 10.1148/radiol.2451061664; Barbier CE, 2006, J AM COLL CARDIOL, V48, P765, DOI 10.1016/j.jacc.2006.05.041; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Block R, 2012, PROSTAG LEUKOTR ESS, V86, P175, DOI 10.1016/j.plefa.2012.02.009; Boland LL, 2002, AM J CARDIOL, V90, P927, DOI 10.1016/S0002-9149(02)02655-3; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Christiansen JP, 2006, AM J CARDIOL, V97, P768, DOI 10.1016/j.amjcard.2005.10.016; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Doltra A, 2013, CURR CARDIOL REV, V9, P185, DOI 10.2174/1573403X113099990030; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Kim HW, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000057; Kwong RY, 2008, CIRCULATION, V118, P1011, DOI 10.1161/CIRCULATIONAHA.107.727826; KWONG RY, 2006, CIRCULATION, V113, P2733, DOI DOI 10.1161/CIRCULATIONHA.105.570648; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NEWMAN WP, 1982, ANN NY ACAD SCI, V382, P39, DOI 10.1111/j.1749-6632.1982.tb55205.x; Polak JF, 2011, ATHEROSCLEROSIS, V218, P344, DOI 10.1016/j.atherosclerosis.2011.05.033; Pride YB, 2013, AM J CARDIOL, V111, P914, DOI 10.1016/j.amjcard.2012.11.042; Prineas RJ., 1982, MINNESOTA CODE MANUA, P203; Schelbert EB, 2012, JAMA-J AM MED ASSOC, V308, P890, DOI 10.1001/2012.jama.11089; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; Silverman MG, 2014, EUR HEART J, V35, P2232, DOI 10.1093/eurheartj/eht508; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Turkbey EB, 2011, CIRCULATION, V124, P1737, DOI 10.1161/CIRCULATIONAHA.111.022327; Wattanakit K, 2008, ATHEROSCLEROSIS, V201, P212, DOI 10.1016/j.atherosclerosis.2007.12.044; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	30	71	74	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1945	1954		10.1001/jama.2015.14849	http://dx.doi.org/10.1001/jama.2015.14849			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547466	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000364490700017
J	Wilder-Smith, A; Gubler, DJ				Wilder-Smith, Annelies; Gubler, Duane J.			Dengue vaccines at a crossroad	SCIENCE			English	Editorial Material									[Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Gubler, Duane J.] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.	awilder-smith@ntu.edu.sg	Wilder-Smith, Annelies/F-8751-2015					Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Guy B, 2010, HUM VACCINES, V6, P696, DOI [10.4161/hv.6.9.12739, 10.4161.hv.6.9.12739]; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Thomas SJ, 2015, VACCINE, V33, pD24, DOI 10.1016/j.vaccine.2015.05.095; Thomas SJ, 2015, NEW ENGL J MED, V372, P172, DOI 10.1056/NEJMe1413146; Thomas SJ, 2013, CURR OPIN INFECT DIS, V26, P429, DOI 10.1097/01.qco.0000433310.28771.cc; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9	12	26	27	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					626	627		10.1126/science.aab4047	http://dx.doi.org/10.1126/science.aab4047			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV3MH	26542552				2022-12-28	WOS:000364162800023
J	Chung, AW; Kumar, MP; Arnold, KB; Yu, WH; Schoen, MK; Dunphy, LJ; Suscovich, TJ; Frahm, N; Linde, C; Mahan, AE; Hoffner, M; Streeck, H; Ackerman, ME; McElrath, MJ; Schuitemaker, H; Pau, MG; Baden, LR; Kim, JH; Michael, NL; Barouch, DH; Lauffenburger, DA; Alter, G				Chung, Amy W.; Kumar, Manu P.; Arnold, Kelly B.; Yu, Wen Han; Schoen, Matthew K.; Dunphy, Laura J.; Suscovich, Todd J.; Frahm, Nicole; Linde, Caitlyn; Mahan, Alison E.; Hoffner, Michelle; Streeck, Hendrik; Ackerman, Margaret E.; McElrath, M. Juliana; Schuitemaker, Hanneke; Pau, Maria G.; Baden, Lindsey R.; Kim, Jerome H.; Michael, Nelson L.; Barouch, Dan H.; Lauffenburger, Douglas A.; Alter, Galit			Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology	CELL			English	Article							EBOLA-VIRUS INFECTION; PROTECTIVE EFFICACY; NEONATAL MICE; ANTIBODY; IGA; CHALLENGES; BINDING; REGION; SERUM	While antibody titers and neutralization are considered the gold standard for the selection of successful vaccines, these parameters are often inadequate predictors of protective immunity. As antibodies mediate an array of extra-neutralizing Fc functions, when neutralization fails to predict protection, investigating Fc-mediated activitymay help identify immunological correlates and mechanism(s) of humoral protection. Here, we used an integrative approach termed Systems Serology to analyze relationships among humoral responses elicited in four HIV vaccine trials. Each vaccine regimen induced a unique humoral "Fc fingerprint." Moreover, analysis of case: control data from the first moderately protective HIV vaccine trial, RV144, pointed to mechanistic insights into immune complex composition that may underlie protective immunity to HIV. Thus, multi-dimensional relational comparisons of vaccine humoral fingerprints offer a unique approach for the evaluation and design of novel vaccines against pathogens for which correlates of protection remain elusive.	[Chung, Amy W.; Yu, Wen Han; Schoen, Matthew K.; Suscovich, Todd J.; Linde, Caitlyn; Mahan, Alison E.; Hoffner, Michelle; Baden, Lindsey R.; Barouch, Dan H.; Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Chung, Amy W.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Kumar, Manu P.; Arnold, Kelly B.; Yu, Wen Han; Dunphy, Laura J.; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Frahm, Nicole; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Streeck, Hendrik; Kim, Jerome H.; Michael, Nelson L.] US Mil HIV Res Program, Dept Mol Virol & Pathogenesis, Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Streeck, Hendrik] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Biol, D-45141 Essen, Germany; [Ackerman, Margaret E.] Thayer Sch Engn Dartmouth, Hanover, NH 03755 USA; [Schuitemaker, Hanneke; Pau, Maria G.] Crucell Holland BV, NL-2333 Leiden, Netherlands; [Baden, Lindsey R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02215 USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul 151742, South Korea; [Barouch, Dan H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Melbourne; Massachusetts Institute of Technology (MIT); Fred Hutchinson Cancer Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Duisburg Essen; Dartmouth College; Harvard University; Brigham & Women's Hospital; International Vaccine Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lauffenburger, DA (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lauffen@mit.edu; galter@mgh.harvard.edu	Barouch, Dan/Y-3918-2019	Arnold, Kelly/0000-0003-4756-7461; Dunphy, Laura/0000-0003-1797-8403	NIH [R01 AI080289]; Bill and Melinda Gates Foundation CAVD [OPP1032817]; Ragon Institute of MGH, MIT and Harvard; NIAID [HVTN204];  [DARPA-BAA-11-65]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080289, UM1AI068614, UM1AI068618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation CAVD; Ragon Institute of MGH, MIT and Harvard; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The following reagent was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), NIH: CEM. NKR-CCR5. We would like to thank (1) the NIAID and the NIAID-funded HVTN for providing specimens for the HVTN204 vaccine trial; (2) the MHRP for specimens from the RV144 vaccine trial; (3) the GSID for samples from the VAX003 vaccine trial; and (4) Dan Barouch for specimens from the experimental Ad26 vaccine trial. We would like to thank the RV144 study team for permission to include the case: control data in our manuscript and would like to specifically thank Drs. Peter Gilbert and Allan DeCamp and Ms. Elizabeth Heger for their assistance in RV144 case: control data collection. The opinions herein are those of the authors and should not be construed as official or representing the views of the U.S. Department of Defense or the Department of the Army. This work was supported by the NIH (grant R01 AI080289); the Bill and Melinda Gates Foundation CAVD (OPP1032817: Leveraging Antibody Effector Function); the Ragon Institute of MGH, MIT and Harvard; and DARPA-BAA-11-65. H. Schuitemaker and M.G.P. are employees of Crucell Holland B.V., a Janssen Pharmaceutical Company of Johnson & Johnson, and shareholders of Johnson & Johnson. H.S. and M.G.P. are employees of Crucell Holland B.V., The Janssen Pharmaceutical Companies of Johnson & Johnson, and shareholders of Johnson & Johnson.	Ackerman ME, 2013, CURR HIV RES, V11, P365, DOI 10.2174/1570162X113116660058; Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Arnold K. B., 2015, MUCOSAL IMMUNOL; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Black KP, 1996, CLIN IMMUNOL IMMUNOP, V81, P182, DOI 10.1006/clin.1996.0175; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Brown D, 2014, CLIN VACCINE IMMUNOL, V21, P1469, DOI 10.1128/CVI.00518-14; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chung AW, 2014, AIDS, V28, P2523, DOI 10.1097/QAD.0000000000000444; Chung AW, 2014, FUTURE VIROL, V9, P397, DOI 10.2217/fvl.14.19; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Dechant M, 2001, CRIT REV ONCOL HEMAT, V39, P69, DOI 10.1016/S1040-8428(01)00105-6; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hristodorov D, 2013, MOL BIOTECHNOL, V54, P1056, DOI 10.1007/s12033-012-9612-x; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; KOHL S, 1981, J IMMUNOL, V127, P1273; KOHL S, 1982, J IMMUNOL, V129, P370; Kreil TR, 2015, EMERG INFECT DIS, V21, P521, DOI 10.3201/eid2103.141838; Lau KS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001338; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Regules JA, 2015, N ENGL J MED; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Watkins JD, 2013, AIDS, V27, pF13, DOI 10.1097/QAD.0b013e328360eac6; White AL, 2014, CURR TOP MICROBIOL, V382, P355, DOI 10.1007/978-3-319-07911-0_16; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	43	235	236	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					988	998		10.1016/j.cell.2015.10.027	http://dx.doi.org/10.1016/j.cell.2015.10.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544943	Green Accepted, Bronze			2022-12-28	WOS:000364829700022
J	Yogev, R				Yogev, Ram			Antiretroviral Therapy for Nevirapine-Exposed Children With HIV Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIROLOGICAL FAILURE; TRIAL; MONOTHERAPY; REGIMENS; INHIBITORS; ADHERENCE; EFAVIRENZ		Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60614 USA	Ann & Robert H. Lurie Children's Hospital of Chicago	Yogev, R (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, 225 E Chicago Ave,POB 155, Chicago, IL 60614 USA.	ryogev@luriechildrens.org						Arribas JR, 2012, HIV MED, V13, P398, DOI 10.1111/j.1468-1293.2012.00989.x; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Coovadia A, 2015, JAMA-J AM MED ASSOC, V314, P1808, DOI 10.1001/jama.2015.13631; Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; Di Mascio M, 2004, MATH BIOSCI, V188, P47, DOI 10.1016/j.mbs.2003.08.003; Homkham N, 2013, 7 IAS C HIV PATH TRE; Karlstrom O, 2007, JAIDS-J ACQ IMM DEF, V44, P417, DOI 10.1097/QAI.0b013e31802e2940; Keiser Philip, 2002, HIV Clin Trials, V3, P296; Lowenthal ED, 2013, JAMA-J AM MED ASSOC, V309, P1803, DOI 10.1001/jama.2013.3710; Maggiolo Franco, 2002, HIV Clin Trials, V3, P371, DOI 10.1310/98B3-PWG8-PMYW-W5BP; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Ramjan R, 2014, TROP MED INT HEALTH, V19, P501, DOI 10.1111/tmi.12297; Rodriguez-Rosado R, 1998, AIDS, V12, P1112; SCOTT GB, 1989, NEW ENGL J MED, V321, P1791, DOI 10.1056/NEJM198912283212604; Stone VE, 2004, JAIDS-J ACQ IMM DEF, V36, P808, DOI 10.1097/00126334-200407010-00007; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; WHO, 2013, CONS ARV GUID 2013	17	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1801	1802		10.1001/jama.2015.13763	http://dx.doi.org/10.1001/jama.2015.13763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529157				2022-12-28	WOS:000363960200010
J	Liu, T; Leskes, M; Yu, WJ; Moore, AJ; Zhou, LN; Bayley, PM; Kim, G; Grey, CP				Liu, Tao; Leskes, Michal; Yu, Wanjing; Moore, Amy J.; Zhou, Lina; Bayley, Paul M.; Kim, Gunwoo; Grey, Clare P.			Cycling Li-O-2 batteries via LiOH formation and decomposition	SCIENCE			English	Article							LITHIUM-AIR BATTERY; OXYGEN REDUCTION; POROUS GRAPHENE; CARBONATE; CATALYST; LI2O2; EVOLUTION; SOLVENTS; OXIDE; CO2	The rechargeable aprotic lithium-air (Li-O-2) battery is a promising potential technology for next-generation energy storage, but its practical realization still faces many challenges. In contrast to the standard Li-O-2 cells, which cycle via the formation of Li-2 O-2, we used a reduced graphene oxide electrode, the additive LiI, and the solvent dimethoxyethane to reversibly form and remove crystalline LiOH with particle sizes larger than 15micrometers during discharge and charge. This leads to high specific capacities, excellent energy efficiency (93.2%) with a voltage gap of only 0.2 volt, and impressive rechargeability. The cells tolerate high concentrations of water, water being the dominant proton source for the LiOH; together with LiI, it has a decisive impact on the chemical nature of the discharge product and on battery performance.	[Liu, Tao; Leskes, Michal; Yu, Wanjing; Moore, Amy J.; Zhou, Lina; Bayley, Paul M.; Kim, Gunwoo; Grey, Clare P.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Yu, Wanjing; Kim, Gunwoo] Univ Cambridge, Cambridge Graphene Ctr, Cambridge CB3 0FA, England	University of Cambridge; University of Cambridge	Grey, CP (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cpg27@cam.ac.uk	Grey, Clare P/Q-8860-2017; Zhou, Li/GSE-4531-2022; Liu, Tao/K-3098-2017	Grey, Clare P/0000-0001-5572-192X; Liu, Tao/0000-0002-6515-0427	Assistant Secretary for Energy Efficiency and Renewable Energy, Office of Vehicle Technologies of the U.S. Department of Energy [DE-AC02-05CH11231, 7057154]; Engineering and Physical Sciences Research Council; Marie Curie Actions; EU Graphene Flagship [604391]	Assistant Secretary for Energy Efficiency and Renewable Energy, Office of Vehicle Technologies of the U.S. Department of Energy(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie Actions(European Commission); EU Graphene Flagship	This work was partially supported by the Assistant Secretary for Energy Efficiency and Renewable Energy, Office of Vehicle Technologies of the U.S. Department of Energy, under contract no. DE-AC02-05CH11231, under the Batteries for Advanced Transportation Technologies Program subcontract 7057154 (W.Y., M.J.L., P.M.B.); the Engineering and Physical Sciences Research Council (T.L.); Johnson Matthey (A.M.); Marie Curie Actions (P.M.B. and M.L.); and the EU Graphene Flagship under contract no. 604391 (G.K.). M.T.L. Casford and members of the Cambridge Graphene Centre are thanked for many useful discussions.	Adams BD, 2014, ACS NANO, V8, P12483, DOI 10.1021/nn505337p; Adams BD, 2013, ENERG ENVIRON SCI, V6, P1772, DOI 10.1039/c3ee40697k; Aetukuri NB, 2015, NAT CHEM, V7, P50, DOI [10.1038/NCHEM.2132, 10.1038/nchem.2132]; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Chen YH, 2013, NAT CHEM, V5, P489, DOI [10.1038/NCHEM.1646, 10.1038/nchem.1646]; Freunberger SA, 2011, ANGEW CHEM INT EDIT, V50, P8609, DOI 10.1002/anie.201102357; Freunberger SA, 2011, J AM CHEM SOC, V133, P8040, DOI 10.1021/ja2021747; Gallant BM, 2013, ENERG ENVIRON SCI, V6, P2518, DOI 10.1039/c3ee40998h; Gallant BM, 2012, J PHYS CHEM C, V116, P20800, DOI 10.1021/jp308093b; Girishkumar G, 2010, J PHYS CHEM LETT, V1, P2193, DOI 10.1021/jz1005384; Gowda SR, 2013, J PHYS CHEM LETT, V4, P276, DOI 10.1021/jz301902h; Guo ZY, 2014, J POWER SOURCES, V264, P1, DOI 10.1016/j.jpowsour.2014.04.079; HANSON KJ, 1987, J ELECTROCHEM SOC, V134, P2204, DOI 10.1149/1.2100852; Johnson L, 2014, NAT CHEM, V6, P1091, DOI [10.1038/nchem.2101, 10.1038/NCHEM.2101]; Jung HG, 2013, ACS NANO, V7, P3532, DOI 10.1021/nn400477d; Kwak WJ, 2015, J MATER CHEM A, V3, P8855, DOI 10.1039/c5ta01399b; Lacey MJ, 2013, ELECTROCHEM COMMUN, V26, P74, DOI 10.1016/j.elecom.2012.10.009; Leskes M, 2013, J PHYS CHEM C, V117, P26929, DOI 10.1021/jp410429k; Leskes M, 2012, ANGEW CHEM INT EDIT, V51, P8560, DOI 10.1002/anie.201202183; Lim H.D., 2014, ANGEW CHEM, V126, P4007, DOI DOI 10.1002/ANGE.201400711; Lim HD, 2013, ADV MATER, V25, P1348, DOI 10.1002/adma.201204018; Lim HK, 2013, J AM CHEM SOC, V135, P9733, DOI 10.1021/ja4016765; Liu YL, 2014, ENERG ENVIRON SCI, V7, P677, DOI 10.1039/c3ee43318h; Lu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3383; Lu YC, 2013, ENERG ENVIRON SCI, V6, P750, DOI 10.1039/c3ee23966g; Lu YC, 2011, J AM CHEM SOC, V133, P19048, DOI 10.1021/ja208608s; McCloskey BD, 2012, J PHYS CHEM LETT, V3, P997, DOI 10.1021/jz300243r; McCloskey BD, 2011, J PHYS CHEM LETT, V2, P1161, DOI 10.1021/jz200352v; McCloskey BD, 2011, J AM CHEM SOC, V133, P18038, DOI 10.1021/ja207229n; Mitchell RR, 2013, J PHYS CHEM LETT, V4, P1060, DOI 10.1021/jz4003586; Nasybulin E, 2013, J PHYS CHEM C, V117, P2635, DOI 10.1021/jp311114u; Oh SH, 2012, NAT CHEM, V4, P1004, DOI [10.1038/NCHEM.1499, 10.1038/nchem.1499]; Oh SH, 2012, ADV ENERGY MATER, V2, P903, DOI 10.1002/aenm.201200018; Sun B, 2014, NANO LETT, V14, P3145, DOI 10.1021/nl500397y; Sun D, 2014, J AM CHEM SOC, V136, P8941, DOI 10.1021/ja501877e; Thotiyl MMO, 2013, NAT MATER, V12, P1049, DOI [10.1038/nmat3737, 10.1038/NMAT3737]; Thotiyl MMO, 2013, J AM CHEM SOC, V135, P494, DOI 10.1021/ja310258x; Wang ZL, 2012, ADV FUNCT MATER, V22, P3699, DOI 10.1002/adfm.201200403; Xiao J, 2011, NANO LETT, V11, P5071, DOI 10.1021/nl203332e; Yilmaz E, 2013, NANO LETT, V13, P4679, DOI 10.1021/nl4020952; Zhai DY, 2013, J AM CHEM SOC, V135, P15364, DOI 10.1021/ja403199d; Zhang SS, 2010, J POWER SOURCES, V195, P1235, DOI 10.1016/j.jpowsour.2009.08.088	42	486	490	37	835	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					530	533		10.1126/science.aac7730	http://dx.doi.org/10.1126/science.aac7730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516278	Green Submitted, Green Accepted			2022-12-28	WOS:000363660000041
J	Bourzac, K				Bourzac, Katherine			Batteries: 4 big questions	NATURE			English	Editorial Material																			0	16	16	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S105	S105		10.1038/526S105a	http://dx.doi.org/10.1038/526S105a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509949	Bronze			2022-12-28	WOS:000363832100065
J	Pfaus, JG				Pfaus, James G.			Treatment for Hypoactive Sexual Desire	CELL			English	Editorial Material									Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H4B 1R6, Canada	Concordia University - Canada	Pfaus, JG (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H4B 1R6, Canada.	jim.pfaus@concordia.ca	Pfaus, James/AAL-8613-2020	Pfaus, James/0000-0001-6953-3663					0	1	1	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					533	533		10.1016/j.cell.2015.10.015	http://dx.doi.org/10.1016/j.cell.2015.10.015			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496594	Bronze			2022-12-28	WOS:000364828900002
J	Sommers, BD				Sommers, Benjamin D.			Health Care Reform's Unfinished Work - Remaining Barriers to Coverage and Access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACT		[Sommers, Benjamin D.] Harvard Univ, Dept Hlth Policy & Management, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Sommers, BD (corresponding author), Harvard Univ, Dept Hlth Policy & Management, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.							Dorner SC, 2015, JAMA-J AM MED ASSOC, V314, P1749, DOI 10.1001/jama.2015.9375; Garfield R., 2015, NEW ESTIMATES ELIGIB; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Sommers BD, 2015, HEALTH AFFAIR, V34, P1010, DOI 10.1377/hlthaff.2015.0215; Wilensky GR, 2015, JAMA-J AM MED ASSOC, V314, P339, DOI 10.1001/jama.2015.5468	5	39	39	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2395	2397		10.1056/NEJMp1509462	http://dx.doi.org/10.1056/NEJMp1509462			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY5QD	26509829	Green Published			2022-12-28	WOS:000366461400004
J	Ando, G; Capodanno, D				Ando, Giuseppe; Capodanno, Davide			Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; TRANSRADIAL APPROACH; TRANSFEMORAL APPROACH; ARTERY ACCESS; INTERVENTION; ANGIOGRAPHY; OUTCOMES; IMPACT; PCI; REVASCULARIZATION	Background: Studies in patients with acute coronary syndrome (ACS) undergoing invasive management showed conflicting conclusions regarding the effect of access site on outcomes. Purpose: To summarize evidence from recent, high-quality trials that compared clinical outcomes occurring with radial versus femoral access in invasively managed adults with ACS. Data Sources: English-language publications in MEDLINE, EMBASE, and Cochrane databases between January 1990 and August 2015. Study Selection: Randomized trials of radial versus femoral access in invasively managed patients with ACS. Data Extraction: Two investigators independently extracted the study data and rated the risk of bias. Data Synthesis: Of 17 identified randomized trials, 4 were high-quality multicenter trials that involved a total of 17 133 patients. Pooled data from the 4 trials showed that radial access reduced death (relative risk [RR], 0.73 [95% CI, 0.59 to 0.90]; P = 0.003), major adverse cardiovascular events (RR, 0.86 [CI, 0.75 to 0.98]; P = 0.025), and major bleeding (RR, 0.57 [CI, 0.37 to 0.88]; P = 0.011). Radial procedures lasted slightly longer (standardized mean difference, 0.11 minutes) and had higher risk for access-site crossover (6.3% vs. 1.7%) than did femoral procedures. Limitation: Heterogeneity in outcomes definitions and potential treatment modifiers across studies, including operator experience in radial procedures and concurrent anticoagulant regimens. Conclusion: Compared with femoral access, radial access reduces mortality, major adverse cardiovascular events, and major bleeding in patients with ACS undergoing invasive management.	[Ando, Giuseppe] Univ Messina, Cardiol Sect, Dept Clin & Expt Med, Azienda Osped Univ Policlin Gaetano Martino, I-98124 Messina, Italy; [Capodanno, Davide] Univ Catania, Ferrarotto Hosp, Dept Gen Surg & Med Surg Specialties, I-95124 Catania, Italy	University of Messina; University of Catania	Ando, G (corresponding author), Univ Messina, Cardiol Sect, Dept Clin & Expt Med, Azienda Osped Univ Policlin Gaetano Martino, Via Consolare Valeria, I-98124 Messina, Italy.	giuseppe.ando@unime.it	Capodanno, Davide/AAP-4949-2020; Andò, Giuseppe/E-6368-2015	Andò, Giuseppe/0000-0001-5552-6382; Capodanno, Davide/0000-0002-5156-7723	PROSPERO [CRD42015022031]	PROSPERO	None. (PROSPERO registration number: CRD42015022031)	Bernat I, 2014, J AM COLL CARDIOL, V63, P964, DOI 10.1016/j.jacc.2013.08.1651; Biggerstaff BJ, 1997, STAT MED, V16, P753, DOI 10.1002/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.0.CO;2-G; Brasselet C, 2007, HEART, V93, P1556, DOI 10.1136/hrt.2007.117309; Cantor WJ, 2005, AM HEART J, V150, P543, DOI 10.1016/j.ahj.2004.10.043; Chodor P, 2011, KARDIOL POL, V69, P763; Chodor P, 2009, CARDIOL J, V16, P332; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; De Luca G, 2013, INT J CARDIOL, V168, P2070, DOI 10.1016/j.ijcard.2013.01.161; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Egger M, 2003, Health Technol Assess, V7, P1; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Feldman DN, 2013, CIRCULATION, V127, P2295, DOI 10.1161/CIRCULATIONAHA.112.000536; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Gan L., 2009, J NANJING MED U INTE, V23, P270, DOI [10.1016/s1007-4376(09)60068-x, DOI 10.1016/S1007-4376(09)60068-X]; Hess CN, 2014, CIRCULATION, V129, P2277, DOI 10.1161/CIRCULATIONAHA.113.006356; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hou L, 2010, SAUDI MED J, V31, P158; Jolly SS, 2015, LANCET, V385, P2437, DOI 10.1016/S0140-6736(15)60507-4; Jolly SS, 2014, J AM COLL CARDIOL, V63, P954, DOI 10.1016/j.jacc.2013.10.052; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; Joyal D, 2012, AM J CARDIOL, V109, P813, DOI 10.1016/j.amjcard.2011.11.007; Karrowni W, 2013, JACC-CARDIOVASC INTE, V6, P814, DOI 10.1016/j.jcin.2013.04.010; Koltowski L, 2014, KARDIOL POL, V72, P604, DOI 10.5603/KP.a2014.0071; Kwok CS, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001645; Lee MS, 2013, JACC-CARDIOVASC INTE, V6, P1149, DOI 10.1016/j.jcin.2013.08.003; Li WM, 2007, CHINESE MED J-PEKING, V120, P598, DOI 10.1097/00029330-200704010-00014; Mann T, 1998, J AM COLL CARDIOL, V32, P572, DOI 10.1016/S0735-1097(98)00288-5; Mehran R, 2011, JACC-CARDIOVASC INTE, V4, P654, DOI 10.1016/j.jcin.2011.02.011; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Ndrepepa G, 2013, CIRC-CARDIOVASC INTE, V6, P354, DOI 10.1161/CIRCINTERVENTIONS.113.000433; Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039; Ratib K, 2015, JACC-CARDIOVASC INTE, V8, P20, DOI 10.1016/j.jcin.2014.06.026; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Saito S, 2003, CATHETER CARDIO INTE, V59, P26, DOI 10.1002/ccd.10493; Singh M, 2015, J AM COLL CARDIOL, V65, P2225, DOI 10.1016/j.jacc.2015.03.567; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6; Vazquez-Rodriquez JM, 2007, J AM COLL CARDIOL, V49, p12B; Wang YB, 2012, J INVASIVE CARDIOL, V24, P412; Yan ZX, 2008, CHINESE MED J-PEKING, V121, P782, DOI 10.1097/00029330-200805010-00004	47	70	72	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12					932	+		10.7326/M15-1277	http://dx.doi.org/10.7326/M15-1277			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26551857				2022-12-28	WOS:000366354200019
J	Thorslund, T; Ripplinger, A; Hoffmann, S; Wild, T; Uckelmann, M; Villumsen, B; Narita, T; Sixma, TK; Choudhary, C; Bekker-Jensen, S; Mailand, N				Thorslund, Tina; Ripplinger, Anita; Hoffmann, Saskia; Wild, Thomas; Uckelmann, Michael; Villumsen, Bine; Narita, Takeo; Sixma, Titia K.; Choudhary, Chunaram; Bekker-Jensen, Simon; Mailand, Niels			Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage	NATURE			English	Article							POLYUBIQUITIN CHAINS; DEPENDENT RESPONSE; UBIQUITYLATION; LOCALIZATION; PROTEINS; BINDING; SITES; 53BP1	DNA double-strand breaks (DSBs) are highly cytotoxic DNA lesions that trigger non-proteolytic ubiquitylation of adjacent chromatin areas to generate binding sites for DNA repair factors. This depends on the sequential actions of the E3 ubiquitin ligases RNF8 and RNF168 (refs 1-6), and UBC13 (also known as UBE2N), an E2 ubiquitin-conjugating enzyme that specifically generates K63-linked ubiquitin chains(7). Whereas RNF168 is known to catalyse ubiquitylation of H2A-type histones, leading to the recruitment of repair factors such as 53BP1 (refs 8-10), the critical substrates of RNF8 and K63-linked ubiquitylation remain elusive. Here we elucidate how RNF8 and UBC13 promote recruitment of RNF168 and downstream factors to DSB sites in human cells. We establish that UBC13-dependent K63-linked ubiquitylation at DSB sites is predominantly mediated by RNF8 but not RNF168, and that H1-type linker histones, but not core histones, represent major chromatin-associated targets of this modification. The RNF168 module (UDM1) recognizing RNF8-generated ubiquitylations(11) is a high-affinity reader of K63-ubiquitylated H1, mechanistically explaining the essential roles of RNF8 and UBC13 in recruiting RNF168 to DSBs. Consistently, reduced expression or chromatin association of linker histones impair accumulation of K63-linked ubiquitin conjugates and repair factors at DSB-flanking chromatin. These results identify histone H1 as a key target of RNF8-UBC13 in DSB signalling and expand the concept of the histone code(12,13) by showing that posttranslational modifications of linker histones can serve as important marks for recognition by factors involved in genome stability maintenance, and possibly beyond.	[Thorslund, Tina; Ripplinger, Anita; Hoffmann, Saskia; Villumsen, Bine; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Ubiquitin Signaling Grp,Prot Signaling Program, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Wild, Thomas; Narita, Takeo; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prote Program, DK-2200 Copenhagen, Denmark; [Uckelmann, Michael; Sixma, Titia K.] Netherlands Canc Inst, Canc Genom Ctr, Div Biochem, NL-1066 CX Amsterdam, Netherlands	University of Copenhagen; University of Copenhagen; Netherlands Cancer Institute	Mailand, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Ubiquitin Signaling Grp,Prot Signaling Program, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	niels.mailand@cpr.ku.dk	Uckelmann, Michael/AAA-6988-2020; choudhary, chunaram/ABE-6634-2020	choudhary, chunaram/0000-0002-9863-433X; Sixma, Titia K/0000-0001-6180-0632; Narita, Takeo/0000-0002-2705-7838; Hoffmann, Saskia/0000-0003-4835-0504; Thorslund, Tina/0000-0001-9207-0070; Uckelmann, Michael/0000-0002-4370-6009	Novo Nordisk Foundation [NNF14CC0001, NNF12OC0002114]; European Research Council; Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW); Danish Cancer Society; Danish Council for Independent Research; Novo Nordisk Fonden [NNF12OC0002114] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand, PI Chunaram Choudhary] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research	We thank D. Durocher and M. Bianchi for providing reagents and J. Lukas for helpful discussions. This work was supported by grants from the Novo Nordisk Foundation (grants NNF14CC0001 and NNF12OC0002114), European Research Council, Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW), The Danish Cancer Society, and The Danish Council for Independent Research.	Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jensen ON, 1999, METH MOL B, V112, P513; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338	41	248	258	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					389	+		10.1038/nature15401	http://dx.doi.org/10.1038/nature15401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26503038	Green Submitted			2022-12-28	WOS:000365356800059
J	Pershing, AJ; Alexander, MA; Hernandez, CM; Kerr, LA; Le Bris, A; Mills, KE; Nye, JA; Record, NR; Scannell, HA; Scott, JD; Sherwood, GD; Thomass, AC				Pershing, Andrew J.; Alexander, Michael A.; Hernandez, Christina M.; Kerr, Lisa A.; Le Bris, Arnault; Mills, Katherine E.; Nye, Janet A.; Record, Nicholas R.; Scannell, Hillary A.; Scott, James D.; Sherwood, Graham D.; Thomass, Andrew C.			Slow adaptation in the face of rapid warming leads to collapse of the Gulf of Maine cod fishery	SCIENCE			English	Article							GADUS-MORHUA; ATLANTIC; STREAM; VARIABILITY; OCEAN	Several studies have documented fish populations changing in response to long-term warming. Over the past decade, sea surface temperatures in the Gulf of Maine increased faster than 99% of the global ocean. The warming, which was related to a northward shift in the Gulf Stream and to changes in the Atlantic Multidecadal Oscillation and Pacific Decadal Oscillation, led to reduced recruitment and increased mortality in the region's Atlantic cod (Gadus morhua) stock. Failure to recognize the impact of warming on cod contributed to overfishing. Recovery of this fishery depends on sound management, but the size of the stock depends on future temperature conditions. The experience in the Gulf of Maine highlights the need to incorporate environmental factors into resource management.	[Pershing, Andrew J.; Hernandez, Christina M.; Kerr, Lisa A.; Le Bris, Arnault; Mills, Katherine E.; Scannell, Hillary A.; Sherwood, Graham D.] Gulf Maine Res Inst, Portland, ME 04101 USA; [Alexander, Michael A.; Scott, James D.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Nye, Janet A.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Record, Nicholas R.] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Scannell, Hillary A.; Thomass, Andrew C.] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Scott, James D.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	Gulf of Maine Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Bigelow Laboratory for Ocean Sciences; University of Maine System; University of Maine Orono; University of Colorado System; University of Colorado Boulder	Pershing, AJ (corresponding author), Gulf Maine Res Inst, 350 Commercial St, Portland, ME 04101 USA.	apershing@gmri.org	Alexander, Michael A/A-7097-2013; Hernández, Christina/GMW-8402-2022	Alexander, Michael A/0000-0001-9646-6427; Nye, Janet/0000-0001-8554-2084; Scott, James D/0000-0002-8709-8594; Scannell, Hillary/0000-0002-6604-1695	NSF [OCE-1325484]; Lenfest Ocean Program; Gulf of Maine Research Institute; Bigelow Laboratory for Ocean Sciences	NSF(National Science Foundation (NSF)); Lenfest Ocean Program; Gulf of Maine Research Institute; Bigelow Laboratory for Ocean Sciences	Supported by the NSF's Coastal SEES Program (OCE-1325484; A.J.P., M.A.A., C.M.H., A.L.B., K.E.M., J.A.N., H.A.S., J.D.S., and A.C.T.), the Lenfest Ocean Program (A.J.P., A.L.B., K.E.M., and G.D.S.), and institutional funds from the Gulf of Maine Research Institute (L.A.K.) and the Bigelow Laboratory for Ocean Sciences (N.R.R.). A.J.P.'s knowledge of fishery management was greatly enhanced by discussions with P. Sullivan, S. Cadrin, J. Kritzer, and other members of the New England Fishery Management Council Scientific and Statistical Committee. M. Palmer provided helpful comments on earlier drafts of the manuscript and facilitated access to the recent stock assessment. The manuscript also benefited from helpful feedback from J. Hare and two anonymous reviewers. The data reported in this paper are tabulated in the supplementary materials and are available from the referenced technical reports and from the National Climate Data Center.	Chen K, 2014, J GEOPHYS RES-OCEANS, V119, P218, DOI 10.1002/2013JC009393; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Dutil JD, 2000, CAN J FISH AQUAT SCI, V57, P826, DOI 10.1139/cjfas-57-4-826; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; Friedland KD, 2013, PROG OCEANOGR, V116, P1, DOI 10.1016/j.pocean.2013.05.011; Gawarkiewicz GG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00553; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Joyce TM, 2000, J CLIMATE, V13, P2550, DOI 10.1175/1520-0442(2000)013<2550:TRBDVO>2.0.CO;2; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Linehan JE, 2001, J EXP MAR BIOL ECOL, V263, P25, DOI 10.1016/S0022-0981(01)00287-8; Mahon R, 2008, MAR POLICY, V32, P104, DOI 10.1016/j.marpol.2007.04.011; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; MERCINA, 2001, OCEANOGRAPHY, V14, P76, DOI DOI 10.5670/OCEANOG.2001.25; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Mountain DG, 2010, MAR ECOL PROG SER, V398, P81, DOI 10.3354/meps08323; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; Northeast Fisheries Science Center, 2013, 55 NE REG STOCK ASS; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Palmer M. C., 2014, 2014 ASSESSMENT UPDA; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Rossby T, 2000, GEOPHYS RES LETT, V27, P117, DOI 10.1029/1999GL002356; Sherwood GD, 2007, DEEP-SEA RES PT II, V54, P2794, DOI 10.1016/j.dsr2.2007.08.007; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353	26	508	514	20	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					809	812		10.1126/science.aac9819	http://dx.doi.org/10.1126/science.aac9819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26516197				2022-12-28	WOS:000364897000043
J	Sedlis, SP; Hartigan, PM; Teo, KK; Maron, DJ; Spertus, JA; Mancini, GBJ; Kostuk, W; Chaitman, BR; Berman, D; Lorin, JD; Dada, M; Weintraub, WS; Boden, WE				Sedlis, Steven P.; Hartigan, Pamela M.; Teo, Koon K.; Maron, David J.; Spertus, John A.; Mancini, G. B. John; Kostuk, William; Chaitman, Bernard R.; Berman, Daniel; Lorin, Jeffrey D.; Dada, Marcin; Weintraub, William S.; Boden, William E.		COURAGE Trial Investigators	Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES UTILIZING REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; OPTIMAL MEDICAL THERAPY; DRUG-EVALUATION TRIAL; RANDOMIZED CLINICAL-TRIALS; FRACTIONAL FLOW RESERVE; ARTERY-DISEASE; COURAGE TRIAL; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR ANGIOGRAPHY	BACKGROUND Percutaneous coronary intervention (PCI) relieves angina in patients with stable ischemic heart disease, but clinical trials have not shown that it improves survival. Between June 1999 and January 2004, we randomly assigned 2287 patients with stable ischemic heart disease to an initial management strategy of optimal medical therapy alone (medical-therapy group) or optimal medical therapy plus PCI (PCI group) and did not find a significant difference in the rate of survival during a median follow-up of 4.6 years. We now report the rate of survival among the patients who were followed for up to 15 years. METHODS We obtained permission from the patients at the Department of Veterans Affairs (VA) sites and some non-VA sites in the United States to use their Social Security numbers to track their survival after the original trial period ended. We searched the VA national Corporate Data Warehouse and the National Death Index for survival information and the dates of death from any cause. We calculated survival according to the Kaplan-Meier method and used a Cox proportional-hazards model to adjust for significant between-group differences in baseline characteristics. RESULTS Extended survival information was available for 1211 patients (53% of the original population). The median duration of follow-up for all patients was 6.2 years (range, 0 to 15); the median duration of follow-up for patients at the sites that permitted survival tracking was 11.9 years (range, 0 to 15). A total of 561 deaths (180 during the follow-up period in the original trial and 381 during the extended follow-up period) occurred: 284 deaths (25%) in the PCI group and 277 (24%) in the medical-therapy group (adjusted hazard ratio, 1.03; 95% confidence interval, 0.83 to 1.21; P = 0.76). CONCLUSIONS During an extended-follow-up of up to 15 years, we did not find a difference in survival between an initial strategy of PCI plus medical therapy and medical therapy alone in patients with stable ischemic heart disease. (Funded by the VA Cooperative Studies Program and others; COURAGE ClinicalTrials.gov number, NCT00007657.)	[Sedlis, Steven P.; Lorin, Jeffrey D.] New York Vet Affairs VA Healthcare Network, New York, NY USA; [Boden, William E.] Upstate New York VA Healthcare Network, Albany, NY USA; [Boden, William E.] Albany Med Coll, Albany, NY 12208 USA; [Hartigan, Pamela M.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Dada, Marcin] Hartford Hosp, Hartford, CT 06115 USA; [Teo, Koon K.] McMaster Univ, Med Ctr, Hamilton, ON, Canada; [Mancini, G. B. John] Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC, Canada; [Kostuk, William] London Hlth Sci Ctr, London, England; [Maron, David J.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Spertus, John A.] Univ Missouri, Mid Amer Heart Inst, Kansas City, KS USA; [Chaitman, Bernard R.] St Louis Univ, Sch Med, St Louis, MO 63103 USA; [Berman, Daniel] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Weintraub, William S.] Christiana Care Hlth Syst, Newark, DE USA	Albany Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Hartford Hospital; McMaster University; University of British Columbia; Stanford University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Saint Louis University; Cedars Sinai Medical Center; Christiana Care Health System	Sedlis, SP (corresponding author), New York Harbor Hlth Care Syst, 423 E 23rd St, New York, NY 10010 USA.	steven.sedlis@va.gov	Spertus, John/ABD-3075-2021	Teo, Koon/0000-0002-3731-0956; Sedlis, Steven/0000-0002-8194-8017	VA Cooperative Studies Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104941] Funding Source: NIH RePORTER	VA Cooperative Studies Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the VA Cooperative Studies Program and others; COURAGE ClinicalTrials.gov number, NCT00007657.)	Arias Elizabeth, 2014, Natl Vital Stat Rep, V62, P1; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2009, AM J CARDIOL, V104, P1, DOI 10.1016/j.amjcard.2009.02.059; Chaitman BR, 2010, CIRC-CARDIOVASC QUAL, V3, P476, DOI 10.1161/CIRCOUTCOMES.109.901579; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Fihn SD, 2014, CIRCULATION, V130, P1749, DOI 10.1161/CIR.0000000000000095; Frohlich GM, 2014, JAMA INTERN MED, V174, P1360, DOI 10.1001/jamainternmed.2014.1595; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1; Mancini GBJ, 2014, JACC-CARDIOVASC INTE, V7, P195, DOI 10.1016/j.jcin.2013.10.017; Mancini GBJ, 2013, AM HEART J, V166, P481, DOI 10.1016/j.ahj.2013.07.007; Mancini GBJ, 2009, CIRC-CARDIOVASC QUAL, V2, P320, DOI 10.1161/CIRCOUTCOMES.108.830091; Maron DJ, 2010, J AM COLL CARDIOL, V55, P1348, DOI 10.1016/j.jacc.2009.10.062; Maron DJ, 2009, AM J CARDIOL, V104, P1055, DOI 10.1016/j.amjcard.2009.05.056; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Oemrawsingh RM, 2014, J AM COLL CARDIOL, V64, P2510, DOI 10.1016/j.jacc.2014.07.998; Patel MR, 2009, CIRCULATION, V119, P1330, DOI 10.1161/CIRCULATIONAHA.108.191768; Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043; Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044; Spertus JA, 2013, CIRC-CARDIOVASC QUAL, V6, P409, DOI 10.1161/CIRCOUTCOMES.113.000139; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P232, DOI 10.1001/jamainternmed.2013.12855; Teo KK, 2009, J AM COLL CARDIOL, V54, P1303, DOI 10.1016/j.jacc.2009.07.013; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; WINDECKER S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3859; Wu CT, 2013, ANN THORAC SURG, V95, P1297, DOI 10.1016/j.athoracsur.2012.11.073	26	158	171	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1937	1946		10.1056/NEJMoa1505532	http://dx.doi.org/10.1056/NEJMoa1505532			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26559572	Bronze, Green Accepted			2022-12-28	WOS:000364445500008
J	Fu, MX; Imai, T; Han, TH; Lee, YS				Fu, Mingxuan; Imai, Takashi; Han, Tian-Heng; Lee, Young S.			Evidence for a gapped spin-liquid ground state in a kagome Heisenberg antiferromagnet	SCIENCE			English	Article							LATTICE; EXCITATIONS; NMR	The kagome Heisenberg antiferromagnet is a leading candidate in the search for a spin system with a quantum spin-liquid ground state. The nature of its ground state remains a matter of active debate. We conducted oxygen-17 single-crystal nuclear magnetic resonance (NMR) measurements of the spin-1/2 kagome lattice in herbertsmithite [ZnCu3(OH)(6)Cl-2], which is known to exhibit a spinon continuum in the spin excitation spectrum. We demonstrated that the intrinsic local spin susceptibility chi(kagome), deduced from the oxygen-17 NMR frequency shift, asymptotes to zero below temperatures of 0.03J, where J similar to 200 kelvin is the copper-copper superexchange interaction. Combined with the magnetic field dependence of chi(kagome) that we observed at low temperatures, these results imply that the kagome Heisenberg antiferromagnet has a spin-liquid ground state with a finite gap.	[Fu, Mingxuan; Imai, Takashi] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Imai, Takashi] Canadian Inst Adv Res, Toronto, ON M5G1Z8, Canada; [Han, Tian-Heng] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Han, Tian-Heng] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Han, Tian-Heng] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Lee, Young S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lee, Young S.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Lee, Young S.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Lee, Young S.] SLAC Natl Accelerator Lab, Stanford, CA 94305 USA	McMaster University; Canadian Institute for Advanced Research (CIFAR); University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Imai, T (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	imai@mcmaster.ca	imai, takashi/H-7496-2017		Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02-07ER46134]; Grainger Fellowship by Department of Physics at the University of Chicago	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Grainger Fellowship by Department of Physics at the University of Chicago	We thank P. A. Lee and T. Sakai for helpful discussions and P. Dube, J. Britten, and V. Jarvis of the Brockhouse Institute for technical assistance. The work at McMaster University was supported by the Natural Sciences and Engineering Research Council of Canada and the Canadian Institute for Advanced Research. The work at the Massachusetts Institute of Technology was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under grant no. DE-FG02-07ER46134. T.-H.H. acknowledges support from a Grainger Fellowship, provided by the Department of Physics at the University of Chicago.	Asaba T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064417; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Bobroff J, 2001, PHYS REV LETT, V86, P4116, DOI 10.1103/PhysRevLett.86.4116; de Vries MA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237201; Depenbrock S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.067201; Freedman DE, 2010, J AM CHEM SOC, V132, P16185, DOI 10.1021/ja1070398; Han TH, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.100402; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Han TH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.157202; Hao ZH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.214404; Helton JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.107204; Imai T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.020411; Imai T, 1998, PHYS REV LETT, V81, P220, DOI 10.1103/PhysRevLett.81.220; Imai T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.077203; LANG DV, 1974, PHYS REV B, V9, P3077, DOI 10.1103/PhysRevB.9.3077; Lee PA, 2008, SCIENCE, V321, P1306, DOI 10.1126/science.1163196; Levi BG, 2007, PHYS TODAY, V60, P16, DOI 10.1063/1.2711623; Lu YM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.224413; Matan K, 2010, NAT PHYS, V6, P865, DOI [10.1038/NPHYS1761, 10.1038/nphys1761]; Mendels P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077204; Olariu A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087202; Ran Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117205; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.207204; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Shores MP, 2005, J AM CHEM SOC, V127, P13462, DOI 10.1021/ja053891p; Singh RRP, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144415; Tedoldi F, 1999, PHYS REV LETT, V83, P412, DOI 10.1103/PhysRevLett.83.412; Yan SM, 2011, SCIENCE, V332, P1173, DOI 10.1126/science.1201080	28	242	247	13	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					655	658		10.1126/science.aab2120	http://dx.doi.org/10.1126/science.aab2120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542565	Green Accepted, Green Submitted			2022-12-28	WOS:000364162800044
J	Hu, LL; Lu, JY; Cheng, JD; Rao, QH; Li, Z; Hou, HF; Lou, ZY; Zhang, L; Li, W; Gong, W; Liu, MJ; Sun, C; Yin, XT; Li, J; Tan, XS; Wang, PC; Wang, YS; Fang, D; Cui, Q; Yang, PY; He, C; Jiang, HL; Luo, C; Xu, YH				Hu, Lulu; Lu, Junyan; Cheng, Jingdong; Rao, Qinhui; Li, Ze; Hou, Haifeng; Lou, Zhiyong; Zhang, Lei; Li, Wei; Gong, Wei; Liu, Mengjie; Sun, Chang; Yin, Xiaotong; Li, Jie; Tan, Xiangshi; Wang, Pengcheng; Wang, Yinsheng; Fang, Dong; Cui, Qiang; Yang, Pengyuan; He, Chuan; Jiang, Hualiang; Luo, Cheng; Xu, Yanhui			Structural insight into substrate preference for TET- mediated oxidation	NATURE			English	Article							DNA; 5-FORMYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; DEMETHYLATION; REVEALS; ROLES; TDG	DNA methylation is an important epigenetic modification(1-3). Ten-eleven translocation (TET) proteins are involved in DNA demethylation through iteratively oxidizing 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC)(4-8). Here we show that human TET1 and TET2 are more active on 5mC-DNA than 5hmC/5fC-DNA substrates. We determine the crystal structures of TET2-5hmC-DNA and TET2-5fC-DNA complexes at 1.80 angstrom and 1.97 angstrom resolution, respectively. The cytosine portion of 5hmC/5fC is specifically recognized by TET2 in a manner similar to that of 5mC in the TET2-5mC-DNA structure(9), and the pyrimidine base of 5mC/5hmC/5fC adopts an almost identical conformation within the catalytic cavity. However, the hydroxyl group of 5hmC and carbonyl group of 5fC face towards the opposite direction because the hydroxymethyl group of 5hmC and formyl group of 5fC adopt restrained conformations through forming hydrogen bonds with the 1-carboxylate of NOG and N4 exocyclic nitrogen of cytosine, respectively. Biochemical analyses indicate that the substrate preference of TET2 results from the different efficiencies of hydrogen abstraction in TET2-mediated oxidation. The restrained conformation of 5hmC and 5fC within the catalytic cavity may prevent their abstractable hydrogen(s) adopting a favourable orientation for hydrogen abstraction and thus result in low catalytic efficiency. Our studies demonstrate that the substrate preference of TET2 results from the intrinsic value of its substrates at their 5mC derivative groups and suggest that 5hmC is relatively stable and less prone to further oxidation by TET proteins. Therefore, TET proteins are evolutionarily tuned to be less reactive towards 5hmC and facilitate the generation of 5hmC as a potentially stable mark for regulatory functions.	[Hu, Lulu; Cheng, Jingdong; Rao, Qinhui; Li, Ze; Zhang, Lei; Li, Wei; Gong, Wei; Liu, Mengjie; Sun, Chang; Yin, Xiaotong; Li, Jie; Tan, Xiangshi; Yang, Pengyuan; Xu, Yanhui] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Hu, Lulu; Cheng, Jingdong; Rao, Qinhui; Li, Ze; Zhang, Lei; Gong, Wei; Liu, Mengjie; Sun, Chang; Yin, Xiaotong; Li, Jie; Yang, Pengyuan; Xu, Yanhui] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Mol Med,Minist Educ,Dept Syst Biol Med, Shanghai 200032, Peoples R China; [Hu, Lulu; Xu, Yanhui] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Lu, Junyan; Jiang, Hualiang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Hou, Haifeng] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Lou, Zhiyong] Tsinghua Univ, Lab Struct Biol, Beijing 100084, Peoples R China; [Lou, Zhiyong] Tsinghua Univ, Sch Med, MOE Lab Prot Sci, Beijing 100084, Peoples R China; [Wang, Pengcheng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Fang, Dong; Cui, Qiang] Univ Wisconsin, Dept Chem, Theoret Chem Inst, Madison, WI 53706 USA; [He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Tsinghua University; Tsinghua University; University of California System; University of California Riverside; University of Wisconsin System; University of Wisconsin Madison; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Xu, YH (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.	cluo@simm.ac.cn; xuyh@fudan.edu.cn	Xu, Yanhui/D-5119-2019; Sun, Chang/AAT-7682-2021; Liu, Mengjie/AAZ-6249-2020; Liu, Mengjie/AAD-7684-2020	Sun, Chang/0000-0002-2080-5450; Liu, Mengjie/0000-0002-2889-2210; Liu, Mengjie/0000-0002-2889-2210; Lu, Junyan/0000-0002-9211-0746; hou, Haifeng/0000-0002-0808-3459; Wang, Pengcheng/0000-0003-4581-983X	National Basic Research Program of China [2011CB965300]; National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China [2014ZX09507-002]; National Natural Science Foundation of China [U1432242, 31425008, 91419301, 91313000, 31270779, 21210003]; Basic Research Project of Shanghai Science and Technology Commission [12JC1402700]; Program of Shanghai Subject Chief Scientist [14XD1400500]; Hi-Tech Research and Development Program of China [2012AA020302, 2012AA01A305]; Chinese Academy of Sciences [XDA01040305]	National Basic Research Program of China(National Basic Research Program of China); National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; Program of Shanghai Subject Chief Scientist; Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank the staff of beamlines BL17U and BL19U at Shanghai Synchrotron Radiation Facility for assistance in data collection, and staff of the Biomedical Core Facility, Fudan University, for their help with mass spectrometry. The computation resources were supported by the Computer Network Information Center, Chinese Academy of Sciences and Shanghai Supercomputing Center. This work was supported by grants from the National Basic Research Program of China (2011CB965300), the National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China (2014ZX09507-002), the National Natural Science Foundation of China (U1432242, 31425008, 91419301, 91313000, 31270779, 21210003), the Basic Research Project of Shanghai Science and Technology Commission (12JC1402700), the Program of Shanghai Subject Chief Scientist (14XD1400500), the Hi-Tech Research and Development Program of China (2012AA020302 and 2012AA01A305) and the Chinese Academy of Sciences (XDA01040305).	Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Baggaley KH, 1997, NAT PROD REP, V14, P309, DOI 10.1039/np9971400309; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaizer J, 2004, J AM CHEM SOC, V126, P472, DOI 10.1021/ja037288n; Liu HN, 2009, J PHYS CHEM B, V113, P4887, DOI 10.1021/jp810715t; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Munzel M, 2011, CHEM-EUR J, V17, P13782, DOI 10.1002/chem.201102782; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; WONDRACK LM, 1978, J BIOL CHEM, V253, P6511; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	28	160	173	5	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					118	122		10.1038/nature15713	http://dx.doi.org/10.1038/nature15713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26524525				2022-12-28	WOS:000364270700055
J	Plunkett, AL; Arce, HG; Mardones, D; van Dokkum, P; Dunham, MM; Fernandez-Lopez, M; Gallardo, J; Corder, SA				Plunkett, Adele L.; Arce, Hector G.; Mardones, Diego; van Dokkum, Pieter; Dunham, Michael M.; Fernandez-Lopez, Manuel; Gallardo, Jose; Corder, Stuartt A.			Episodic molecular outflow in the very young protostellar cluster Serpens South	NATURE			English	Article							JETS; CLOUDS; SIMULATIONS	The loss of mass from protostars, in the form of a jet or outflow, is a necessary counterpart to protostellar mass accretion(1,2). Outflow ejection events probably vary in their velocity and/or in the rate of mass loss. Such 'episodic' ejection events(3) have been observed during the class 0 protostellar phase (the early accretion stage)(4-10), and continue during the subsequent class I phase that marks the first one million years of star formation(11-14). Previously observed episodic-ejection sources were relatively isolated; however, the most common sites of star formation are clusters(15). Outflows link protostars with their environment and provide a viable source of the turbulence that is necessary for regulating star formation in clusters(3), but it is not known how an accretion-driven jet or outflow in a clustered environment manifests itself in its earliest stage. This early stage is important in establishing the initial conditions for momentum and energy transfer to the environment as the protostar and cluster evolve. Here we report that an outflow from a young, class 0 protostar, at the hub of the very active and filamentary Serpens South protostellar cluster(16-18), shows unambiguous episodic events. The (CO)-C-12-O-16 (J = 2-1) emission from the protostar reveals 22 distinct features of outflow ejecta, the most recent having the highest velocity. The outflow forms bipolar lobes one of the first detectable signs of star formation which originate from the peak of 1-mm continuum emission. Emission from the surrounding (CO)-O-18 envelope shows kinematics consistent with rotation and an infall of material onto the protostar. The data suggest that episodic, accretion-driven outflow begins in the earliest phase of protostellar evolution, and that the outflow remains intact in a very clustered environment, probably providing efficient momentum transfer for driving turbulence.	[Plunkett, Adele L.; Arce, Hector G.; van Dokkum, Pieter] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Mardones, Diego] Univ Chile, Dept Astron, Santiago, Chile; [Dunham, Michael M.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fernandez-Lopez, Manuel] CCT La Plata CONICET, Inst Argentino Radioastron, RA-1894 Villa Elisa, Argentina; [Gallardo, Jose; Corder, Stuartt A.] Joint ALMA Observ, Santiago, Chile	Yale University; Universidad de Chile; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Argentino de Radioastronomia	Plunkett, AL (corresponding author), Yale Univ, Dept Astron, New Haven, CT 06511 USA.	adele.plunkett@yale.edu; hectorarce@yale.edu	Mardones, Diego/I-5719-2016; Fernandez-Lopez, Manuel/ABH-4739-2020; Plunkett, Adele/ABC-2819-2020	Fernandez-Lopez, Manuel/0000-0001-5811-0454; Plunkett, Adele/0000-0002-9912-5705; Mardones, Diego/0000-0002-5065-9175	National Science Foundation (NSF) [DGE-1122492]; NSF [AST-0845619]; CONICYT [PFB-06]; Submillimeter Array	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Submillimeter Array	A.L.P. is supported by a National Science Foundation (NSF) Graduate Research Fellowship under grant DGE-1122492; this research was made possible by the US Student Program of Fulbright Chile. H.G.A. receives funding from the NSF under grant AST-0845619. D.M. acknowledges support from CONICYT project PFB-06. M.M.D. acknowledges support from the Submillimeter Array through a postdoctoral fellowship. ALMA is a partnership of the European Space Organization (ESO, representing its member states), NSF (USA) and National Institutes of Natural Sciences (Japan), together with the National Research Council (Canada) and National Security Council and Academia Sinica Institute of Astronomy and Astrophysics (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, Associated Universities Inc. (AUI)/National Radio Astronomy Observatory (NRAO) and National Astronomical Observatory of Japan. The NRAO is a facility of the NSF, operated under cooperative agreement by AUI. This paper makes use of the following ALMA data: ADS/JAO.ALMA 2012.1.00769.S.	Arce HG, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/39; Audard M., 2014, PROTOSTARS PLANETS, P387, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH017; Cabrit S, 2000, ASTRON ASTROPHYS, V354, P667; Dzib S, 2010, ASTROPHYS J, V718, P610, DOI 10.1088/0004-637X/718/2/610; Frank A., 2014, PROTOSTARS PLANETS, VVI, P451, DOI [DOI 10.2458/AZU_UAPRESS_9780816531240-CH020, 10.2458/azu_uapress_9780816531240-ch020]; Goodman AA, 2004, ASTROPHYS J, V608, P831, DOI 10.1086/383139; Gueth F, 1999, ASTRON ASTROPHYS, V343, P571; Gutermuth RA, 2008, ASTROPHYS J LETT, V673, pL151, DOI 10.1086/528710; Hirano N, 2010, ASTROPHYS J, V717, P58, DOI 10.1088/0004-637X/717/1/58; Ioannidis G, 2012, MON NOT R ASTRON SOC, V425, P1380, DOI 10.1111/j.1365-2966.2012.21556.x; Kirk H, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/115; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Lee CF, 2000, ASTROPHYS J, V542, P925, DOI 10.1086/317056; Lee CF, 2007, ASTROPHYS J, V670, P1188, DOI 10.1086/522333; Lee CF, 2007, ASTROPHYS J, V659, P499, DOI 10.1086/512540; Loinard L, 2013, MON NOT R ASTRON SOC, V430, pL10, DOI 10.1093/mnrasl/sls038; Nakamura F, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L23; Nakamura F, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/56; NORMAN C, 1980, ASTROPHYS J, V238, P158, DOI 10.1086/157969; Oya Y, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/152; Plunkett AL, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/22; RAGA AC, 1990, ASTROPHYS J, V364, P601, DOI 10.1086/169443; Raga AC, 2002, ASTRON ASTROPHYS, V395, P647, DOI 10.1051/0004-6361:20021180; Santiago-Garcia J, 2009, ASTRON ASTROPHYS, V495, P169, DOI 10.1051/0004-6361:200810739; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Smith MD, 1997, ASTRON ASTROPHYS, V323, P223; Suttner G, 1997, ASTRON ASTROPHYS, V318, P595; Tanaka T, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/34; Teixeira GDC, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201218845	29	50	50	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					70	73		10.1038/nature15702	http://dx.doi.org/10.1038/nature15702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536957	Green Submitted			2022-12-28	WOS:000364270700044
J	Sternberg, SH; LaFrance, B; Kaplan, M; Doucina, JA				Sternberg, Samuel H.; LaFrance, Benjamin; Kaplan, Matias; Doucina, Jennifer A.			Conformational control of DNA target cleavage by CRISPR-Cas9	NATURE			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; R-LOOP FORMATION; CRYSTAL-STRUCTURE; ENDONUCLEASE CAS9; ADAPTIVE IMMUNITY; GUIDE RNA; COMPLEX; RECOGNITION; SPECIFICITY; SYSTEMS	Cas9 is an RNA-guided DNA endonuclease that targets foreign DNA for destruction as part of a bacterial adaptive immune system mediated by clustered regularly interspaced short palindromic repeats (CRISPR)(1,2). Together with single-guide RNAs3, Cas9 also functions as a powerful genome engineering tool in plants and animals(4-6), and efforts are underway to increase the efficiency and specificity of DNA targeting for potential therapeutic applicatione(7,8). Studies of off-target effects have shown that DNA binding is far more promiscuous than DNA cleavage(9-11), yet the molecular cues that govern strand scission have not been elucidated. Here we show that the conformational state of the HNH nuclease domain directly controls DNA cleavage activity. Using intramolecular Forster resonance energy transfer experiments to detect relative orientations of the Cas9 catalytic domains when associated with on- and off-target DNA, we find that DNA cleavage efficiencies scale with the extent to which the HNH domain samples an activated conformation. We furthermore uncover a surprising mode of allosteric communication that ensures concerted firing of both Cas9 nuclease domains. Our results highlight a proofreading mechanism beyond initial protospacer adjacent motif (PAM) recognition(12) and RNA-DNA base-pairing(3) that serves as a final specificity checkpoint before DNA double-strand break formation.	[Sternberg, Samuel H.; Doucina, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [LaFrance, Benjamin; Doucina, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kaplan, Matias; Doucina, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doucina, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doucina, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doucina, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Sternberg, Samuel/0000-0001-8240-9114; Kaplan, Matias/0000-0003-3062-7026	National Science Foundation; National Defense Science & Engineering Graduate Research Fellowship programs; National Institutes of Health National Research Service Award Training Grant [T32GM007232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Defense Science & Engineering Graduate Research Fellowship programs; National Institutes of Health National Research Service Award Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Taylor and J. Chen for discussions, M. O'Connell, L. Ma, N. Ma, and K. Zhou for technical assistance, and members of the Doudna laboratory for reading the manuscript. S.H.S. acknowledges support from the National Science Foundation and National Defense Science & Engineering Graduate Research Fellowship programs. B.L. acknowledges support from a National Institutes of Health National Research Service Award Training Grant (T32GM007232). J.A.D. is an Investigator of the Howard Hughes Medical Institute.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Majumdar ZK, 2005, J MOL BIOL, V351, P1123, DOI 10.1016/j.jmb.2005.06.027; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Sternberg S. H., 2015, MOL CELL, V58, P566; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wu Xuebing, 2014, Quant Biol, V2, P59; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	29	348	381	10	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					110	113		10.1038/nature15544	http://dx.doi.org/10.1038/nature15544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26524520	Green Accepted			2022-12-28	WOS:000364270700053
J	Coovadia, A; Abrams, EJ; Strehlau, R; Shiau, S; Pinillos, F; Martens, L; Patel, F; Hunt, G; Tsai, WY; Kuhn, L				Coovadia, Ashraf; Abrams, Elaine J.; Strehlau, Renate; Shiau, Stephanie; Pinillos, Francoise; Martens, Leigh; Patel, Faeezah; Hunt, Gillian; Tsai, Wei-Yann; Kuhn, Louise			Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-RESISTANCE; VIRAL SUPPRESSION; TUBERCULOSIS; IMPACT; HAART; PHARMACOKINETICS; ACCEPTABILITY; METAANALYSIS; INDIVIDUALS; COTREATMENT	IMPORTANCE Advantages of using efavirenz as part of treatment for children infected with human immunodeficiency virus (HIV) include once-daily dosing, simplification of co-treatment for tuberculosis, preservation of ritonavir-boosted lopinavir for second-line treatment, and harmonization of adult and pediatric treatment regimens. However, there have been concerns about possible reduced viral efficacy of efavirenz in children exposed to nevirapine for prevention of mother-to-child transmission. OBJECTIVE To evaluate whether nevirapine-exposed children achieving initial viral suppression with ritonavir-boosted lopinavir-based therapy can transition to efavirenz-based therapy without risk of viral failure. DESIGN, SETTING, AND PARTICIPANTS Randomized, open-label noninferiority trial conducted at Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa, from June 2010 to December 2013, enrolling 300 HIV-infected children exposed to nevirapine for prevention of mother-to-child transmission who were aged 3 years or older and had plasma HIV RNA of less than 50 copies/mL during ritonavir-boosted lopinavir-based therapy; 298 were randomized and 292 (98%) were followed up to 48 weeks after randomization. INTERVENTIONS Participants were randomly assigned to switch to efavirenz-based therapy (n = 150) or continue ritonavir-boosted lopinavir-based therapy (n = 148). MAIN OUTCOMES AND MEASURES Risk difference between groups in (1) viral rebound (ie, >= 1 HIV RNA measurement of >50 copies/mL) and (2) viral failure (ie, confirmed HIV RNA >1000 copies/mL) with a noninferiority bound of -0.10. Immunologic and clinical responses were secondary end points. RESULTS The Kaplan-Meier probability of viral rebound by 48 weeks was 0.176 (n = 26) in the efavirenz group and 0.284 (n = 42) in the ritonavir-boosted lopinavir group. Probabilities of viral failure were 0.027 (n = 4) in the efavirenz group and 0.020 (n = 3) in the ritonavir-boosted lopinavir group. The risk difference for viral rebound was 0.107 (1-sided 95% CI, 0.028 to infinity) and for viral failure was -0.007 (1-sided 95% CI, -0.036 to infinity). We rejected the null hypothesis that efavirenz is inferior to ritonavir-boosted lopinavir (P < .001) for both end points. By 48 weeks, CD4 cell percentage was 2.88%(95% CI, 1.26%-4.49%) higher in the efavirenz group than in the ritonavir-boosted lopinavir group. CONCLUSIONS AND RELEVANCE Among HIV-infected children exposed to nevirapine for prevention of mother-to-child transmission and with initial viral suppression with ritonavir-boosted lopinavir-based therapy, switching to efavirenz-based therapy compared with continuing ritonavir-boosted lopinavir-based therapy did not result in significantly higher rates of viral rebound or viral failure. This therapeutic approach may offer advantages in children such as these.	[Coovadia, Ashraf; Strehlau, Renate; Pinillos, Francoise; Martens, Leigh; Patel, Faeezah] Univ Witwatersrand, Empilweni Serv & Res Unit, Rahima Moosa Mother & Child Hosp, Fac Hlth Sci, Johannesburg, South Africa; [Abrams, Elaine J.] Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Abrams, Elaine J.; Shiau, Stephanie; Kuhn, Louise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Shiau, Stephanie; Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Hunt, Gillian] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Tsai, Wei-Yann] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10032 USA	University of Witwatersrand; Columbia University; Columbia University; Columbia University; National Institute for Communicable Diseases (NICD); Columbia University	Kuhn, L (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	lk24@columbia.edu	Strehlau, Renate/AAX-9074-2021	Strehlau, Renate/0000-0001-9113-6584; Shiau, Stephanie/0000-0003-2944-3406	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD061255]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061255] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by grant HD061255 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Abrams EJ, 2012, JAIDS-J ACQ IMM DEF, V60, pS105, DOI 10.1097/QAI.0b013e31825cf4f5; Basson AE, 2015, ANTIMICROB AGENTS CH, V59, P960, DOI 10.1128/AAC.04215-14; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; Dahri K, 2007, CLIN PHARMACOKINET, V46, P109, DOI 10.2165/00003088-200746020-00002; Decloedt EH, 2013, EXPERT OPIN DRUG SAF, V12, P841, DOI 10.1517/14740338.2013.823396; Frohoff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017273; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Hirt D, 2009, ANTIMICROB AGENTS CH, V53, P4407, DOI 10.1128/AAC.01594-08; Kuhn L, 2014, AIDS, V28, P1673, DOI 10.1097/QAD.0000000000000261; Kuhn L, 2012, LANCET INFECT DIS, V12, P521, DOI 10.1016/S1473-3099(12)70051-8; Martinson NA, 2009, INT J TUBERC LUNG D, V13, P862; Moorthy A, 2011, CLIN INFECT DIS, V52, P514, DOI 10.1093/cid/ciq161; Musiime V, 2014, JAIDS-J ACQ IMM DEF, V66, P148, DOI 10.1097/QAI.0000000000000135; Musiime V, 2010, ANTIVIR THER, V15, P1115, DOI 10.3851/IMP1695; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; National Department of Health, 2010, GUID MAN HIV CHILDR; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Paredes R, 2013, J INFECT DIS, V207, pS93, DOI 10.1093/infdis/jit110; Pillay V, 2008, ANTIVIR THER, V13, P101; Ramjan R, 2014, TROP MED INT HEALTH, V19, P501, DOI 10.1111/tmi.12297; Reitz C, 2010, J INFECT DIS, V201, P1121, DOI 10.1086/651454; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Soeters HM, 2014, AIDS, V28, P245, DOI 10.1097/01.aids.0000434936.57880.cd; Sohn AH, 2010, CURR OPIN HIV AIDS, V5, P54, DOI 10.1097/COH.0b013e3283339bd8; Strehlau R, 2011, PEDIATR INFECT DIS J, V30, P1001, DOI 10.1097/INF.0b013e318223b680; Ton Q, 2013, CURR HIV RES, V11, P126, DOI 10.2174/1570162X11311020005; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, ANT DRUGS TREAT PREG; Zanoni BC, 2011, AIDS, V25, P49, DOI 10.1097/QAD.0b013e32833f9e04	32	40	40	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1808	1817		10.1001/jama.2015.13631	http://dx.doi.org/10.1001/jama.2015.13631			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529159	Green Accepted, Bronze			2022-12-28	WOS:000363960200013
J	Kirkcaldy, RD; Hook, EW; Soge, OO; del Rio, C; Kubin, G; Zenilman, JM; Papp, JR				Kirkcaldy, Robert D.; Hook, Edward W., III; Soge, Olusegun O.; del Rio, Carlos; Kubin, Grace; Zenilman, Jonathan M.; Papp, John R.			Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kirkcaldy, Robert D.; Papp, John R.] US Ctr Dis Control & Prevent CDC, Div STD Prevent, Atlanta, GA 30329 USA; [Hook, Edward W., III] Univ Alabama Birmingham, Birmingham, AL USA; [Soge, Olusegun O.] Univ Washington, Seattle, WA 98195 USA; [del Rio, Carlos] Emory Univ, Atlanta, GA 30322 USA; [Kubin, Grace] Texas Dept State Hlth Serv, Austin, TX USA; [Zenilman, Jonathan M.] Johns Hopkins Univ, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; Emory University; Texas Department of State Health Services; Johns Hopkins University	Kirkcaldy, RD (corresponding author), US Ctr Dis Control & Prevent CDC, Div STD Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA.	rkirkcaldy@cdc.gov	del Rio, Carlos/B-3763-2012; Papp, John/AAA-3073-2019; Kirkcaldy, Bob/ABB-1483-2020	del Rio, Carlos/0000-0002-0153-3517; Papp, John/0000-0002-7495-5454; Kirkcaldy, Robert/0000-0002-1749-4647	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, GON IS SURV PROJ GIS; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; European Centre for Disease Prevention and Control, 2012, GON ANT SUSC EUR 201; Ison CA, 2013, LANCET INFECT DIS, V13, P762, DOI 10.1016/S1473-3099(13)70143-9; Kidd S, 2013, SEX TRANSM DIS, V40, P756, DOI 10.1097/01.olq.0000431357.18959.30	5	26	26	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1869	1871		10.1001/jama.2015.10347	http://dx.doi.org/10.1001/jama.2015.10347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529166	Bronze, Green Accepted			2022-12-28	WOS:000363960200021
J	Frieden, TR				Frieden, Thomas R.			The Future of Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNDIAGNOSED HYPERTENSION; BLOOD-PRESSURE; UNITED-STATES; TUBERCULOSIS; PREVALENCE; MANAGEMENT; CHILDHOOD; OBESITY; TRENDS; US	The field of public health aims to improve the health of as many people as possible as rapidly as possible. Since 1900, the average life span in the United States has increased by more than 30 years; 25 years of this gain have been attributed to public health advances.(1,2) Globally, life expectancy doubled during the 20th century,(3) largely as a result of reductions in child mortality attributable to expanded immunization coverage, clean water, sanitation, and other child-survival programs.(4) Public health focuses on denominators - what proportion of all people who can benefit from an intervention actually benefit. Maximizing health requires contributions from many sectors of society, including broad social, economic, environmental, transportation, and other policies in which government plays key roles; involvement of civil society; innovation by the public and private sectors; and health care and public health action. Although there has sometimes been distrust and disrespect between the health care and public health fields, 5 they are inevitably and increasingly interdependent; maximizing potential health gains is a defining challenge for both fields.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	tfrieden@cdc.gov	van der Velden, J./H-8101-2014	Frieden, Thomas/0000-0002-4759-2256				Angell SY, 2015, LANCET, V385, P825, DOI 10.1016/S0140-6736(14)62256-X; [Anonymous], 2014, LANCET, V383, P1269, DOI 10.1016/S0140-6736(14)60629-2; [Anonymous], 2014, WKLY EPIDEMIOL REC, V90, P253; [Anonymous], 2014, GLOB UPD HLTH SECT R; [Anonymous], 2015, GLOB HLTH GLOB HLTH; [Anonymous], 2015, WHO REP GLOB TOB EP; [Anonymous], 2015, NATL VITAL STAT REPO; Banaei N, 2015, NEW ENGL J MED, V372, P2368, DOI 10.1056/NEJMc1505190; Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; BUNKER JP, 1994, MILBANK Q, V72, P225, DOI 10.2307/3350295; CDC National Health Report, 2005, MMWR SURVEILL SUM S4, V63, P3; *CDCP, 2015, COR EL HOSP ANT STEW; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Centre for Disease Control Prevention, 1999, MMWR-MORBID MORTAL W, V48, P241, DOI DOI 10.1001/JAMA.281.16.1481; Coxson PG, 2013, HYPERTENSION, V61, P564, DOI 10.1161/HYPERTENSIONAHA.111.201293; ELLIOTT P, 1988, BRIT MED J, V297, P319; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; Fee E, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.6.31; Frieden TR, 2014, JAMA-J AM MED ASSOC, V312, P1393, DOI 10.1001/jama.2014.11450; Frieden TR, 2014, LANCET, V383, P764, DOI 10.1016/S0140-6736(14)60189-6; Frieden TR, 2013, NEW ENGL J MED, V368, P1857, DOI 10.1056/NEJMp1303819; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Frieden TR, 2010, HEALTH AFFAIR, V29, P357, DOI 10.1377/hlthaff.2010.0039; Frieden TR, 1996, TUBERCLE LUNG DIS, V77, P407, DOI 10.1016/S0962-8479(96)90112-4; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Hopkins DR, 2014, MMWR-MORBID MORTAL W, V63, P1050; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P619; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Levy DT, 2013, B WORLD HEALTH ORGAN, V91, P509, DOI 10.2471/BLT.12.113878; Luepker RV, 2012, CIRCULATION, V126, P1852, DOI 10.1161/CIRCULATIONAHA.112.098517; Maltezou HC, 2013, AM J INFECT CONTROL, V41, P661, DOI 10.1016/j.ajic.2012.09.017; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Rakotz MK, 2014, ANN FAM MED, V12, P352, DOI 10.1370/afm.1665; Riley JC, 2005, POPUL DEV REV, V31, P537, DOI 10.1111/j.1728-4457.2005.00083.x; Riley JC., 2001, RISING LIFE EXPECTAN, DOI DOI 10.1093/infdis/jiv534; Shah NR, 2009, AHRQ COMP EFF RES ME; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703; Vital signs: estimated effects of a co-ordinated approach for action to reduce antibiotic-resistant infections in health care facilities-United States, 2015, MMWR MORB MORTAL WKL, V64, P826; Vital signs: HIV diagnosis care and treatment among persons living with HIV-United States, 2011, MMWR MORB MORTAL WKL, V63, P1113; Wall HK, 2014, JAMA-J AM MED ASSOC, V312, P1973, DOI 10.1001/jama.2014.15388; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2015, ACHIEVING MALARIA MD; World Health Organization, 2013, GLOB VACC ACT PLAN M; Xu X, 2015, AM J PREV MED, V48, P318, DOI 10.1016/j.amepre.2014.10.011	49	87	87	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1748	1754		10.1056/NEJMsa1511248	http://dx.doi.org/10.1056/NEJMsa1511248			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU4QH	26510022	Bronze			2022-12-28	WOS:000363514100010
J	Kunz, L; Schroder, TN; Lee, H; Montag, C; Lachmann, B; Sariyska, R; Reuter, M; Stirnberg, R; Stocker, T; Messing-Floeter, PC; Fell, J; Doeller, CF; Axmacher, N				Kunz, Lukas; Schroeder, Tobias Navarro; Lee, Hweeling; Montag, Christian; Lachmann, Bernd; Sariyska, Rayna; Reuter, Martin; Stirnberg, Ruediger; Stoecker, Tony; Messing-Floeter, Paul Christian; Fell, Juergen; Doeller, Christian F.; Axmacher, Nikolai			Reduced grid-cell-like representations in adults at genetic risk for Alzheimer's disease	SCIENCE			English	Article							APOLIPOPROTEIN-E; NEURONAL-ACTIVITY; PATH-INTEGRATION; MEMORY; APOE-EPSILON-4; HIPPOCAMPUS; MECHANISMS; BOUNDARIES; NAVIGATION; PATTERNS	Alzheimer's disease (AD) manifests with memory loss and spatial disorientation. AD pathology starts in the entorhinal cortex, making it likely that local neural correlates of spatial navigation, particularly grid cells, are impaired. Grid-cell-like representations in humans can be measured using functional magnetic resonance imaging. We found that young adults at genetic risk for AD (APOE-epsilon 4 carriers) exhibit reduced grid-cell-like representations and altered navigational behavior in a virtual arena. Both changes were associated with impaired spatial memory performance. Reduced grid-cell-like representations were also related to increased hippocampal activity, potentially reflecting compensatory mechanisms that prevent overt spatial memory impairment in APOE-epsilon 4 carriers. Our results provide evidence of behaviorally relevant entorhinal dysfunction in humans at genetic risk for AD, decades before potential disease onset.	[Kunz, Lukas; Lee, Hweeling; Stirnberg, Ruediger; Stoecker, Tony; Messing-Floeter, Paul Christian; Axmacher, Nikolai] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Kunz, Lukas; Messing-Floeter, Paul Christian; Fell, Juergen; Axmacher, Nikolai] Univ Bonn, Dept Epileptol, Bonn, Germany; [Schroeder, Tobias Navarro; Doeller, Christian F.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Montag, Christian; Lachmann, Bernd; Sariyska, Rayna] Univ Ulm, Dept Psychol, D-89069 Ulm, Germany; [Reuter, Martin] Univ Bonn, Dept Psychol, Bonn, Germany; [Reuter, Martin] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Axmacher, Nikolai] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Neuropsychol, Bochum, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Radboud University Nijmegen; Ulm University; University of Bonn; University of Bonn; Ruhr University Bochum	Axmacher, N (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	nikolai.axmacher@rub.de	Schöder, Tobias Navarro/AAT-6649-2020; Montag, Christian/H-6536-2019	Schöder, Tobias Navarro/0000-0001-6498-1846; Montag, Christian/0000-0001-8112-0837; Stirnberg, Rudiger/0000-0001-7021-1063; Axmacher, Nikolai/0000-0002-0475-6492; Kunz, Lukas/0000-0002-0665-7703	Medical Faculty of the University of Bonn; German National Academic Foundation (Studienstiftung des deutschen Volkes); German Research Foundation (DFG) [MO 2363/3-1]; Konrad Adenauer Foundation (Konrad-Adenauer-Stiftung); European Research Council [ERC-StG 261177]; Netherlands Organisation for Scientific Research [NWO-Vidi 452-12-009]; DFG from Emmy Noether grant [AX82/2]; DFG [Sonderforschungsbereich 1089]	Medical Faculty of the University of Bonn; German National Academic Foundation (Studienstiftung des deutschen Volkes); German Research Foundation (DFG)(German Research Foundation (DFG)); Konrad Adenauer Foundation (Konrad-Adenauer-Stiftung); European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); DFG from Emmy Noether grant(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The authors thank H. Boecker, V. Heise, W. Huijbers, T. Reber, and S. Remy for comments on the manuscript and A. Ruhling and Y. Sagik for their help with fMRI scanning. We also thank all of the participants for their participation in this study. L.K. was supported by a Bonfor dissertation stipend of the Medical Faculty of the University of Bonn and a stipend of the German National Academic Foundation (Studienstiftung des deutschen Volkes). C.M. is funded by a Heisenberg grant awarded to him by the German Research Foundation (DFG, MO 2363/3-1). P.C.M.F. was supported by a stipend of the Konrad Adenauer Foundation (Konrad-Adenauer-Stiftung). C.F.D. and T.N.S. are supported by the European Research Council (grant ERC-StG 261177) and the Netherlands Organisation for Scientific Research (grant NWO-Vidi 452-12-009). N.A. received DFG funding from Emmy Noether grant AX82/2 and together with J.F. via the Sonderforschungsbereich 1089. The authors declare no conflicts of interest. All raw data are archived at the German Center for Neurodegenerative Diseases (DZNE), Bonn.	Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Berteau-Pavy F, 2007, NEUROSCIENCE, V147, P6, DOI 10.1016/j.neuroscience.2007.03.005; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Bush D, 2014, TRENDS NEUROSCI, V37, P136, DOI 10.1016/j.tins.2013.12.003; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Cacucci F, 2008, P NATL ACAD SCI USA, V105, P7863, DOI 10.1073/pnas.0802908105; Chadwick MJ, 2015, CURR BIOL, V25, P87, DOI 10.1016/j.cub.2014.11.001; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hardcastle K, 2015, NEURON, V86, P827, DOI 10.1016/j.neuron.2015.03.039; Hasselmo Michael E., 2008, Neural Plasticity, V2008, P658323, DOI 10.1155/2008/658323; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Muessig L, 2015, NEURON, V86, P1167, DOI 10.1016/j.neuron.2015.05.011; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, P323, DOI 10.1016/j.neurobiolaging.2010.03.009; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007	31	144	151	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					430	433		10.1126/science.aac8128	http://dx.doi.org/10.1126/science.aac8128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494756	Green Published			2022-12-28	WOS:000363213400039
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Is Lord Prior right about scrapping beds?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2015, ECONOMIST; [Anonymous], 2015, HALF NHS BEDS COULD; Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; Buck D, 2015, CUTS PUBLIC HLTH SPE; Campbell, 2014, GUARDIAN; Commonwealth Fund, 2014, MIRR MIRR WALL 2014; Cowling TE, 2014, J ROY SOC MED, V107, P432, DOI 10.1177/0141076814542669; Donnelly L., 2013, DAILY TELEGRAPH; Health Education England, 2014, GP TASKF REP SEC FUT; Health Foundation King's Fund, 2015, MAK CHANG POSS TRANS; HM Treasury, 2015, COUNTR LIV ITS MEANS; King's Fund, 2015, 17 KINGS FUND; NHS Benchmarking, 2014, NAT AUD INT CAR 2014; Nuffield Trust, 2014, NHS HOSP PRESS 2014; O'Dowd A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4979; Oliver D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2684; Quality Compliance Systems, 2013, IN COMM CAR CREAT CR	17	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2015	351								h5661	10.1136/bmj.h5661	http://dx.doi.org/10.1136/bmj.h5661			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GL	26497195	Bronze			2022-12-28	WOS:000364146900004
J	Reilly, SM; Saltiel, AR				Reilly, Shannon M.; Saltiel, Alan R.			A Futile Approach to Fighting Obesity?	CELL			English	Editorial Material							BROWN ADIPOSE-TISSUE; THERMOGENESIS; SARCOLIPIN; MOUSE; COLD	The current obesity epidemic has focused a great deal of attention on mechanisms controlling energy balance. While diet and nutrient absorption affect energy intake, on the other side of the equation, energy expenditure is determined by basal metabolism, physical activity, and adaptive thermogenesis. Given various challenges in modulating these energy balance mechanisms to combat human obesity, many efforts have concentrated on how it might be possible to achieve weight loss through increased thermogenesis. In this issue of Cell, Kazak et al. describe a previously unrecognized molecular pathway for thermogenesis in fat cells.	[Reilly, Shannon M.; Saltiel, Alan R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Saltiel, AR (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	asaltiel@ucsd.edu	Reilly, Shannon Marie/ABB-6473-2021; Saltiel, Alan/L-3632-2019	Reilly, Shannon Marie/0000-0003-0412-2446; Saltiel, Alan/0000-0002-9726-9828				Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	8	2	2	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					539	540		10.1016/j.cell.2015.10.006	http://dx.doi.org/10.1016/j.cell.2015.10.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496598	Bronze			2022-12-28	WOS:000364828900006
J	Kadri, S; O'Grady, NP				Kadri, Sameer; O'Grady, Naomi P.			After source control in intraabdominal infections, 4-day and longer-duration antibiotics did not differ at 30 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kadri, Sameer; O'Grady, Naomi P.] NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kadri, S (corresponding author), NIH, Ctr Clin, Bethesda, MD 20892 USA.		Kadri, Sameer/Q-9081-2019					Blot S, 2005, DRUGS, V65, P1611, DOI 10.2165/00003495-200565120-00002	1	0	0	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC6	10.7326/ACPJC-2015-163-8-006	http://dx.doi.org/10.7326/ACPJC-2015-163-8-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502143				2022-12-28	WOS:000363737400007
J	Watkins, RD; Rondina, MT				Watkins, Ryan D.; Rondina, Matthew T.			Review: DOACs do not differ from standard anticoagulants for recurrent VTE; factor Xa inhibitors reduce bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Watkins, Ryan D.; Rondina, Matthew T.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Watkins, RD (corresponding author), Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA.			Rondina, Matthew/0000-0003-3455-3730	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126547] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Lefebvre Patrick, 2014, J Med Econ, V17, P52, DOI 10.3111/13696998.2013.858634; Mody Samir H, 2014, J Med Econ, V17, P492, DOI 10.3111/13696998.2014.914032	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC3	10.7326/ACPJC-2015-163-8-003	http://dx.doi.org/10.7326/ACPJC-2015-163-8-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502140				2022-12-28	WOS:000363737400004
J	de Waal, A				de Waal, Alex			Ending mass atrocity and ending famine	LANCET			English	Editorial Material									Tufts Univ, Fletcher Sch Law & Diplomacy, World Peace Fdn, Medford, MA 02155 USA	Tufts University	de Waal, A (corresponding author), Tufts Univ, Fletcher Sch Law & Diplomacy, World Peace Fdn, Medford, MA 02155 USA.	Alex.deWaal@tufts.edu						[Anonymous], 1999, DEV FREEDOM; Conley-Zilkic B, 2015, MASS ATROCITIES END; Davis Mike, 2002, LATE VICTORIAN HOLOC; Devereux S, 2007, ROUTL STUD DEV ECON, V52, P1; O Grada C., 2015, EATING PEOPLE IS WRO; von Grebmer K, 2015, 2015 GLOBAL HUNGER I	6	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1528	1529		10.1016/S0140-6736(15)00480-8	http://dx.doi.org/10.1016/S0140-6736(15)00480-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5VC	26530612				2022-12-28	WOS:000362878200016
J	McCall, B				McCall, Becky			Profile: Southern Africa Consortium for Research Excellence	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1524	1524		10.1016/S0140-6736(15)00526-7	http://dx.doi.org/10.1016/S0140-6736(15)00526-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CT5VC	26530608				2022-12-28	WOS:000362878200013
J	Rossignol, P; Massy, ZA; Azizi, M; Bakris, G; Ritz, E; Covic, A; Goldsmith, D; Heine, GH; Jager, KJ; Kanbay, M; Mallamaci, F; Ortiz, A; Vanholder, R; Wiecek, A; Zoccali, C; London, GM; Stengel, B; Fouque, D				Rossignol, Patrick; Massy, Ziad A.; Azizi, Michel; Bakris, George; Ritz, Eberhard; Covic, Adrian; Goldsmith, David; Heine, Gunnar H.; Jager, Kitty J.; Kanbay, Mehmet; Mallamaci, Francesca; Ortiz, Alberto; Vanholder, Raymond; Wiecek, Andrzej; Zoccali, Carmine; London, Gerard Michel; Stengel, Benedicte; Fouque, Denis		ERA EDTA EURECA m Working Grp; Red Invest Renal REDINREN Network; Cardiovasc Renal Clin Trialists F	The double challenge of resistant hypertension and chronic kidney disease	LANCET			English	Review							BLOOD-PRESSURE CONTROL; BAROREFLEX ACTIVATION THERAPY; STAGE RENAL-DISEASE; ARTERIAL STIFFNESS; DIETARY-SODIUM; UNITED-STATES; CLINICAL CHARACTERISTICS; SYMPATHETIC DENERVATION; PROGNOSTIC-SIGNIFICANCE; CARDIOVASCULAR-DISEASE	Resistant hypertension is defined as blood pressure above goal despite adherence to a combination of at least three optimally dosed antihypertensive medications, one of which is a diuretic. Chronic kidney disease is the most frequent of several patient factors or comorbidities associated with resistant hypertension. The prevalence of resistant hypertension is increased in patients with chronic kidney disease, while chronic kidney disease is associated with an impaired prognosis in patients with resistant hypertension. Recommended low-salt diet and triple antihypertensive drug regimens that include a diuretic, should be complemented by the sequential addition of other antihypertensive drugs. New therapeutic innovations for resistant hypertension, such as renal denervation and carotid barostimulation, are under investigation especially in patients with advanced chronic kidney disease. We discuss resistant hypertension in chronic kidney disease stages 3-5 (ie, patients with an estimated glomerular filtration rate below 60 mL/min per 1.73 m(2) and not on dialysis), in terms of worldwide epidemiology, outcomes, causes and pathophysiology, evidence-based treatment, and a call for action.	[Rossignol, Patrick] INSERM, CIC 1433, Nancy, France; [Rossignol, Patrick] INSERM, U1116, Nancy, France; [Rossignol, Patrick] CHU Nancy, Inst Lorrain Coeur & Vaisseaux, F-54500 Vandoeuvre Les Nancy, France; [Rossignol, Patrick] Univ Lorraine, Nancy, France; [Rossignol, Patrick] Assoc Lorraine Traitement Insuffisance Renale, Vandoeuvre Les Nancy, France; [Massy, Ziad A.] Univ Paris Ouest Versailles St Quentin En Yveline, Ambroise Pare Univ Hosp APHP, Div Nephrol, Paris, France; [Massy, Ziad A.] UVSQ, INSERM, Res Ctr Epidemiol & Populat Hlth CESP, U1018, Villejuif, France; [Azizi, Michel] Hop Europeen Georges Pompidou, APHP, Unite Hypertens Arterielle, Paris, France; [Azizi, Michel] Univ Paris 05, Paris, France; [Azizi, Michel] INSERM, CIC 1418, Paris, France; [Azizi, Michel] Univ Chicago Med, Dept Med, Chicago, IL USA; [Ritz, Eberhard] Ruperto Carola Univ Heidelberg, Dept Internal Med, Heidelberg, Germany; [Covic, Adrian] Grigore T Popa Univ Med, Parhon Univ Hosp, Iasi, Romania; [Goldsmith, David] Guys Hosp, Renal & Transplantat Dept, London SE1 9RT, England; [Goldsmith, David] St Thomas Hosp, Renal & Transplantat Dept, London, England; [Heine, Gunnar H.] Univ Saarland, Med Ctr, Internal Med Nephrol & Hypertens 4, Homburg, Germany; [Jager, Kitty J.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, ERA EDTA Registry, NL-1105 AZ Amsterdam, Netherlands; [Kanbay, Mehmet] Koc Univ, Sch Med, Dept Med, Div Nephrol, Istanbul, Turkey; [Mallamaci, Francesca] Osped Riuniti Reggio Calabria, Nephrol Hypertens & Renal Transplantat Unit, Reggio Di Calabria, Italy; [Mallamaci, Francesca; Zoccali, Carmine] Osped Riuniti Reggio Calabria, CNR Natl Res Council Italy, Inst Clin Physiol IFC, Clin Epidemiol & Pathophysiol Renal Dis & Hyperte, Reggio Di Calabria, Italy; [Ortiz, Alberto] IIS Fdn Jimenez Diaz, Div Nephrol, Madrid, Spain; [Ortiz, Alberto] Univ Autonoma Madrid, Sch Med, Madrid, Spain; [Ortiz, Alberto] Red Invest Renal REDINREN, Madrid, Spain; [Ortiz, Alberto] IRSIN, Madrid, Spain; [Vanholder, Raymond] Univ Hosp Ghent, Nephrol Sect, Dept Internal Med, Ghent, Belgium; [Wiecek, Andrzej] Med Univ Silesia, Dept Nephrol Transplantat & Internal Med, Katowice, Poland; [London, Gerard Michel] Hop Europeen Georges Pompidou, INSERM, U970, Paris, France; [Stengel, Benedicte] Paris South Univ, UMRS 1018, UVSQ, Villejuif, France; [Fouque, Denis] Univ Lyon, Dept Nephrol Nutr & Dialysis, Ctr Hosp Lyon Sud, Carmen CENS, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Grigore T Popa University of Medicine & Pharmacy; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Saarland University; University of Amsterdam; Academic Medical Center Amsterdam; Koc University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Fundacion Jimenez Diaz; Autonomous University of Madrid; Ghent University; Ghent University Hospital; Medical University Silesia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon	Rossignol, P (corresponding author), CHU Nancy, Ctr Invest Clin, INSERM, Inst Lorrain Coeur & Vaisseaux Louis Mathieu, F-54500 Vandoeuvre Les Nancy, France.	p.rossignol@chu-nancy.fr	Stengel, Benedicte/G-5730-2015; Azizi, Michel/Y-9580-2019; Goldsmith, David J A/H-6965-2018; ortiz, alberto/Y-7582-2018; Zoccali, Carmine/AAR-4473-2020; 1, 1/L-6277-2019; Covic, Adrian/G-5017-2016; Carmen, Team1/Y-7382-2019	Stengel, Benedicte/0000-0001-9469-0804; Goldsmith, David J A/0000-0002-4349-9193; ortiz, alberto/0000-0002-9805-9523; Zoccali, Carmine/0000-0002-6616-1996; Covic, Adrian/0000-0002-9985-2486; Carmen, Team1/0000-0003-4234-1746; Jager, Kitty/0000-0003-0444-8569; Lab, Carmen/0000-0002-5935-3236; Heine, Gunnar/0000-0001-8320-5260	Servier; Takeda; Medtronic; Relypsa; Bayer; AbbVie; Amgen; Shire; Fresenius Medical Care; Nipro; Baxter; GlaxoSmithKline; MSD; Eli Lilly; Sanofi- Genzyme as part of the CKD-REIN study Public-Private Partnership	Servier(Servier); Takeda(Takeda Pharmaceutical Company Ltd); Medtronic(Medtronic); Relypsa; Bayer(Bayer AG); AbbVie(AbbVie); Amgen(Amgen); Shire; Fresenius Medical Care; Nipro; Baxter; GlaxoSmithKline(GlaxoSmithKline); MSD; Eli Lilly(Eli Lilly); Sanofi- Genzyme as part of the CKD-REIN study Public-Private Partnership	PR has received speaker honoraria from CVRx. MA has received honoraria for advisory board meetings from Vessix, Boston Scientific Corporation, Cordis, Actelion, has received speakers' honoraria from Cordis, CVRx, Servier, was involved as investigator in Symplicity HTN-2 (Ardian/Medtronic) and Reduce-HTN (Vessix/Boston Scientific Corporation) trials and has received a research grant from Servier. GB has received grant support from the Investigator Initiated Grant/Research Support-Takeda (direct funding to University of Chicago), was a principal investigator on clinical trials sponsored by Medtronic, Relypsa, Bayer (direct funding to University of Chicago), has acted as an adviser or consultant for Takeda, AbbVie, CVRx, Janssen, Eli Lilly, Boehringer-Ingelheim, Medtronic, Bristol-Myers Squibb, Novartis, GlaxoSmithKline, Bayer, Tengion, Elcelyx, and ZS Pharma. AC has received honoraria for advisory board from AbbVie, ZS Pharma and speaker's fees from AbbVie, Amgen, and has acted as a consultant for Fresenius Medical Care. DG has received speaking and consulting honoraria from Merck, Pfizer, Sanofi, Sandoz, Amgen, AbbVie, Keryx, Relypsa, Astellas, and Novartis. AO has acted as a consultant for Genzyme, Servier, has received speaker's fees from Shire, Amgen, Fresenius Medical Care, and has received research support from Fresenius Medical Care and Abbvie. RV has acted as a consultant Baxter, Bellco, and has received speaker's fees from Nipro and Amgen. AW has received speaking and consulting honoraria from Amgen, Fresenius Medical Care, Boehringer Ingelheim, Astellas, Roche and Apotex. BS has received grant support from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, MSD, Eli Lilly, and Sanofi- Genzyme as part of the CKD-REIN study Public-Private Partnership, and has received lecture fees from MSD. DF has acted as a consultant for Genzyme, Baxter, Astellas, Fresenius Kabi, and has received speaker's fees from Shire, Amgen, Fresenius Medical Care. ZAM, ER, GHH, KJJ, MK, FM, CZ, and GML declare no competing interests.	Agarwal R, 2014, AM J NEPHROL, V39, P171, DOI 10.1159/000358603; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Azizi M, 2014, J HYPERTENS, V32, P2038, DOI 10.1097/HJH.0000000000000280; Bakris GL, 2015, J AM COLL CARDIOL, V65, P1314, DOI 10.1016/j.jacc.2015.01.037; Bax L, 2009, ANN INTERN MED, V150, P840, DOI 10.7326/0003-4819-150-12-200906160-00119; Bellizzi V, 2007, KIDNEY INT, V71, P245, DOI 10.1038/sj.ki.5001955; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Bisognano JD, 2011, J AM COLL CARDIOL, V57, P1787, DOI 10.1016/j.jacc.2010.11.048; Bobrie G, 2012, J HYPERTENS, V30, P1656, DOI 10.1097/HJH.0b013e3283551e98; Bolignano D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007004.pub3; Brambilla G, 2013, J HYPERTENS, V31, P2018, DOI 10.1097/HJH.0b013e328363823f; Briet M, 2012, KIDNEY INT, V82, P388, DOI 10.1038/ki.2012.131; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Burnier M, 2015, NEPHROL DIAL TRANSPL, V30, P39, DOI 10.1093/ndt/gfu015; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Cappuccio FP, 2007, BMJ-BRIT MED J, V334, P859, DOI 10.1136/bmj.39175.364954.BE; Chesterton LJ, 2005, NEPHROL DIAL TRANSPL, V20, P1140, DOI 10.1093/ndt/gfh808; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Dahlmann A, 2015, KIDNEY INT, V87, P434, DOI 10.1038/ki.2014.269; Dasgupta K, 2014, CAN J CARDIOL, V30, P485, DOI 10.1016/j.cjca.2014.02.002; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; De Nicola L, 2013, J AM COLL CARDIOL, V61, P2461, DOI 10.1016/j.jacc.2012.12.061; Desai N, 2013, J CLIN HYPERTENS, V15, P375, DOI 10.1111/jch.12095; Desch S, 2015, HYPERTENSION, V65, P1202, DOI 10.1161/HYPERTENSIONAHA.115.05283; Dussol B, 2012, J CLIN HYPERTENS, V14, P32, DOI 10.1111/j.1751-7176.2011.00564.x; Egan BM, 2013, HYPERTENSION, V62, P691, DOI 10.1161/HYPERTENSIONAHA.113.01448; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Fraser SDS, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-88; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Garg JP, 2005, AM J HYPERTENS, V18, P619, DOI 10.1016/j.amjhyper.2004.11.021; Gijon-Conde T, 2014, REV ESP CARDIOL, V67, P270, DOI 10.1016/j.rec.2013.09.027; Grossman E, 2012, AM J MED, V125, P14, DOI 10.1016/j.amjmed.2011.05.024; HEEG JE, 1989, KIDNEY INT, V36, P272, DOI 10.1038/ki.1989.190; Hering D, 2012, J AM SOC NEPHROL, V23, P1250, DOI 10.1681/ASN.2011111062; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Irvin MR, 2014, J AM SOC HYPERTENS, V8, P405, DOI 10.1016/j.jash.2014.03.003; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Jung O, 2013, J HYPERTENS, V31, P766, DOI 10.1097/HJH.0b013e32835e2286; Kalra PA, 2005, KIDNEY INT, V68, P293, DOI 10.1111/j.1523-1755.2005.00406.x; Kidney Disease Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337, DOI DOI 10.1038/kisup.2012.46; KidneyDisease Outcomes Quality Initiative (K/DOQI), 2004, AM J KIDNEY DIS, V43, pS1; Krause T, 2011, BMJ-BRIT MED J, V25, P343; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Kwakernaak AJ, 2014, LANCET DIABETES ENDO, V2, P385, DOI 10.1016/S2213-8587(14)70030-0; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Liu G, 2015, J HUM HYPERTENS, V29, P159, DOI 10.1038/jhh.2014.64; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mattace-Raso FUS, 2007, J HYPERTENS, V25, P1421, DOI 10.1097/HJH.0b013e32811d6a07; McAdam-Marx C, 2009, CLIN THER, V31, P1116, DOI 10.1016/j.clinthera.2009.05.007; McMahon EJ, 2013, J AM SOC NEPHROL, V24, P2096, DOI 10.1681/ASN.2013030285; Muntner P, 2014, HYPERTENSION, V64, P1012, DOI 10.1161/HYPERTENSIONAHA.114.03850; Muntner P, 2010, AM J KIDNEY DIS, V55, P441, DOI 10.1053/j.ajkd.2009.09.014; National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee), 2010, GUID MAN HYP 2008; National Institute for Health and Care Excellence, 2004, CHRON KIDN DIS; National Institute for Health and Care Excellence, 2014, TYP 2 DIAB MAN TYP 2; National Institute for Health and Care Excellence, 2011, HYP CLIN MAN PRIM HY; Niculescu DA, 2014, ENDOCR PRACT, V20, P139, DOI 10.4158/EP13251.OR; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Okada Y, 2012, HYPERTENSION, V59, P98, DOI 10.1161/HYPERTENSIONAHA.111.176560; Ott C, 2015, J HYPERTENS, V33, P1261, DOI 10.1097/HJH.0000000000000556; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Ritchie J, 2014, CURR OPIN NEPHROL HY, V23, P525, DOI 10.1097/MNH.0000000000000059; Salles GF, 2011, J HYPERTENS, V29, P2014, DOI 10.1097/HJH.0b013e32834adb09; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Sarafidis PA, 2011, J CLIN HYPERTENS, V13, P523, DOI 10.1111/j.1751-7176.2011.00445.x; Schmitt KE, 2010, AM J NEPHROL, V32, P541, DOI 10.1159/000321688; Shankar SS, 2003, AM J PHYSIOL-RENAL, V284, pF11, DOI 10.1152/ajprenal.00119.2002; Stengel B, 2011, NEPHROL DIAL TRANSPL, V26, P3286, DOI 10.1093/ndt/gfr323; Studinger P, 2006, KIDNEY INT, V69, P2236, DOI 10.1038/sj.ki.5000307; Subramanian S, 2013, J RENAL NUTR, V23, P450, DOI 10.1053/j.jrn.2012.12.004; Susantitaphong P, 2013, AM J HYPERTENS, V26, P424, DOI 10.1093/ajh/hps038; Tamargo J, 2014, EXPERT OPIN PHARMACO, V15, P605, DOI 10.1517/14656566.2014.879117; Tamargo J, 2014, EXPERT OPIN PHARMACO, V15, P527, DOI 10.1517/14656566.2014.879118; Tanner RM, 2014, AM J KIDNEY DIS, V63, P781, DOI 10.1053/j.ajkd.2013.11.016; Tanner RM, 2013, CLIN J AM SOC NEPHRO, V8, P1583, DOI 10.2215/CJN.00550113; Titze J, 2015, CURR OPIN NEPHROL HY, V24, P14, DOI 10.1097/MNH.0000000000000085; Tomaszewski M, 2014, HEART, V100, P855, DOI 10.1136/heartjnl-2013-305063; Vega J, 2014, SEMIN NEPHROL, V34, P247, DOI 10.1016/j.semnephrol.2014.04.002; Verbeke F, 2014, NEPHROL DIAL TRANSPL, V29, P490, DOI 10.1093/ndt/gft321; Vink EE, 2014, NEPHROL DIAL TRANSPL, V29, P1608, DOI 10.1093/ndt/gfu192; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693; Wallbach M, 2015, J HYPERTENS, V33, P181, DOI 10.1097/HJH.0000000000000361; Wallbach M, 2014, AM J NEPHROL, V40, P371, DOI 10.1159/000368723; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Weitzman D, 2014, HYPERTENSION, V64, P501, DOI 10.1161/HYPERTENSIONAHA.114.03718; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Williams B, 2015, LANCET, V386, P2059, DOI 10.1016/S0140-6736(15)00257-3; Zannad F, 2015, HYPERTENSION, V65, P5, DOI 10.1161/HYPERTENSIONAHA.114.04057	97	109	116	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1588	1598		10.1016/S0140-6736(15)00418-3	http://dx.doi.org/10.1016/S0140-6736(15)00418-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26530623				2022-12-28	WOS:000362878200033
J	Sivan, A; Corrales, L; Hubert, N; Williams, JB; Aquino-Michaels, K; Earley, ZM; Benyamin, FW; Lei, YM; Jabri, B; Alegre, ML; Chang, EB; Gajewski, TF				Sivan, Ayelet; Corrales, Leticia; Hubert, Nathaniel; Williams, Jason B.; Aquino-Michaels, Keston; Earley, Zachary M.; Benyamin, Franco W.; Lei, Yuk Man; Jabri, Bana; Alegre, Maria-Luisa; Chang, Eugene B.; Gajewski, Thomas F.			Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy	SCIENCE			English	Article							PRESENTING CELL-FUNCTION; DENDRITIC CELLS; T-CELLS; RESPONSES; MICROBIOTA; CANCER; METABOLITES; MATURATION; MELANOMA; SYSTEM	T cell infiltration of solid tumors is associated with favorable patient outcomes, yet the mechanisms underlying variable immune responses between individuals are not well understood. One possible modulator could be the intestinal microbiota. We compared melanoma growth in mice harboring distinct commensal microbiota and observed differences in spontaneous antitumor immunity, which were eliminated upon cohousing or after fecal transfer. Sequencing of the 16S ribosomal RNA identified Bifidobacterium as associated with the antitumor effects. Oral administration of Bifidobacterium alone improved tumor control to the same degree as programmed cell death protein 1 ligand 1 (PD-L1)-specific antibody therapy (checkpoint blockade), and combination treatment nearly abolished tumor outgrowth. Augmented dendritic cell function leading to enhanced CD8(+) T cell priming and accumulation in the tumor microenvironment mediated the effect. Our data suggest that manipulating the microbiota may modulate cancer immunotherapy.	[Sivan, Ayelet; Corrales, Leticia; Williams, Jason B.; Benyamin, Franco W.; Gajewski, Thomas F.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Hubert, Nathaniel; Earley, Zachary M.; Lei, Yuk Man; Jabri, Bana; Alegre, Maria-Luisa; Chang, Eugene B.; Gajewski, Thomas F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Aquino-Michaels, Keston] Univ Chicago, Med Genet Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Gajewski, TF (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu	wang, edwin/G-5372-2010		Melanoma Research Alliance; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, P30 Digestive Disease Research Core Center Grant [DK42086]; University of Chicago [5T32CA009594-25]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [T32CA009594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI115716, T32AI007090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	Melanoma Research Alliance; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, P30 Digestive Disease Research Core Center Grant; University of Chicago(University of Chicago); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R code for gene expression analyses can be found at https://github.com/kipkeston/TG_Microbiota; microarray data can be found at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73475 and www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73476; 16S rRNA sequencing data can be found at www.ncbi.nlm.nih.gov/bioproject/297465. The data reported in this manuscript are presented in the main paper and in the supplementary materials. We thank D. Ringus for anaerobic culture of bifidobacteria and colony quantification, Y. Zhang for providing Lactobacillus murinus cultures, and R. Sweis for providing the MB49 bladder cancer cell line. This work was supported by a Team Science Award from the Melanoma Research Alliance, and National Institute of Diabetes and Digestive and Kidney Diseases, NIH, P30 Digestive Disease Research Core Center Grant (DK42086), the University of Chicago Cancer Biology training program (5T32CA009594-25), and the Cancer Research Institute fellowship program. The University of Chicago has filed a patent application that relates to microbial community manipulation in cancer therapy.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bak SP, 2012, J IMMUNOL, V189, P1708, DOI 10.4049/jimmunol.1201271; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Dong P, 2010, EARLY HUM DEV, V86, P51, DOI 10.1016/j.earlhumdev.2010.01.002; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kawahara T, 2015, MICROBIOL IMMUNOL, V59, P1, DOI 10.1111/1348-0421.12210; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Mackey MF, 1998, J IMMUNOL, V161, P2094; McAleer JP, 2012, IMMUNITY, V37, P10, DOI 10.1016/j.immuni.2012.07.001; Menard O, 2008, APPL ENVIRON MICROB, V74, P660, DOI 10.1128/AEM.01261-07; Nukiwa M, 2006, EUR J IMMUNOL, V36, P1019, DOI 10.1002/eji.200535549; Pan JP, 2004, IMMUNOL LETT, V94, P141, DOI 10.1016/j.imlet.2004.05.003; Pettit AR, 1997, J IMMUNOL, V159, P3681; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	32	1929	2116	36	509	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1084	1089		10.1126/science.aac4255	http://dx.doi.org/10.1126/science.aac4255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26541606	Green Accepted			2022-12-28	WOS:000366422600042
J	Chobanian, AV				Chobanian, Aram V.			FOCUS ON RESEARCH Time to Reassess Blood-Pressure Goals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HYPERTENSION		[Chobanian, Aram V.] Boston Univ, Med Ctr, Boston, MA 02215 USA	Boston University	Chobanian, AV (corresponding author), Boston Univ, Med Ctr, Boston, MA 02215 USA.							Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Rosendorff C, 2015, CIRCULATION, V131, pE435, DOI [10.1161/CIR.0000000000000207, 10.1016/j.jacc.2015.02.038]	5	32	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2093	2095		10.1056/NEJMp1513290	http://dx.doi.org/10.1056/NEJMp1513290			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26550920				2022-12-28	WOS:000365354800001
J	Pauken, KE; Wherry, EJ				Pauken, Kristen E.; Wherry, E. John			SnapShot: T Cell Exhaustion	CELL			English	Editorial Material							CHRONIC VIRAL-INFECTION; MEMORY		[Pauken, Kristen E.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Pauken, KE (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.		Wherry, John/ABI-1280-2020; Pauken, Kristen E./ABA-9363-2020					Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	8	53	61	2	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					1038	U299		10.1016/j.cell.2015.10.054	http://dx.doi.org/10.1016/j.cell.2015.10.054			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544946	Bronze			2022-12-28	WOS:000364829700027
J	Ruud, J; Bruning, JC				Ruud, Johan; Bruening, Jens C.			METABOLISM Light on leptin link to lipolysis	NATURE			English	Editorial Material							GENE		[Ruud, Johan; Bruening, Jens C.] Max Planck Inst Metab Res, D-50931 Cologne, Germany		Ruud, J (corresponding author), Max Planck Inst Metab Res, D-50931 Cologne, Germany.	johan.ruud@sf.mpg.de; bruening@sf.mpg.de	Ruud, Johan/W-7407-2019					Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gettys TW, 1996, ENDOCRINOLOGY, V137, P4054, DOI 10.1210/en.137.9.4054; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	11	11	11	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					43	44		10.1038/527043a	http://dx.doi.org/10.1038/527043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536954				2022-12-28	WOS:000364270700036
J	Toyoda, K; Hiji, R; Noguchi, A; Urabe, S				Toyoda, Kenji; Hiji, Ryoto; Noguchi, Atsushi; Urabe, Shinji			Hong-Ou-Mandel interference of two phonons in trapped ions	NATURE			English	Article							ENTANGLEMENT	The quantum statistics of bosons and fermions manifest themselves in the manner in which two indistinguishable particles interfere quantum mechanically. When two photons, which are bosonic particles, enter a beam-splitter with one photon in each input port, they bunch together at either of the two output ports. The corresponding disappearance of the coincidence count is the Hong-Ou-Mandel effect(1). Here we show the phonon counterpart of this effect in a system of trapped-ion phonons, which are collective excitations derived by quantizing vibrational motions that obey Bose-Einstein statistics. We realize a beam-splitter transformation of the phonons by employing the mutual Coulomb repulsion between ions, and perform a two-phonon quantum interference experiment using that transformation. We observe an almost perfect disappearance of the phonon coincidence between two ion sites, confirming that phonons can be considered indistinguishable bosonic particles. The two-particle interference demonstrated here is purely a quantum effect, without a classical counterpart, hence it should be possible to demonstrate the existence of entanglement on this basis. We attempt to generate an entangled state of phonons at the centre of the Hong-Ou-Mandel dip in the coincidence temporal profile, under the assumption that the entangled phonon state is successfully generated if the fidelity of the analysis pulses is taken into account adequately. Two-phonon interference, as demonstrated here, proves the bosonic nature of phonons in a trapped-ion system. It opens the way to establishing phonon modes as carriers of quantum information in their own right(2-4), and could have implications for the quantum simulation of bosonic particles(5,6) and analogue quantum computation via boson sampling(7).	[Toyoda, Kenji; Hiji, Ryoto; Noguchi, Atsushi; Urabe, Shinji] Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan	Osaka University	Toyoda, K (corresponding author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	toyoda@ee.es.osaka-u.ac.jp	Noguchi, Atsushi/D-4599-2017; Toyoda, Kenji/F-8824-2019	Noguchi, Atsushi/0000-0001-9435-4608; 	JSPS KAKENHI [26400418]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Yamamoto for suggestions made at the early stages of this study, and K. Hayasaka for comments on the manuscript. This work was supported by JSPS KAKENHI, grant number 26400418.	Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Bocquillon E, 2013, SCIENCE, V339, P1054, DOI 10.1126/science.1232572; Broome MA, 2013, SCIENCE, V339, P794, DOI 10.1126/science.1231440; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Crespi A, 2013, NAT PHOTONICS, V7, P545, DOI [10.1038/nphoton.2013.112, 10.1038/NPHOTON.2013.112]; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Spring JB, 2013, SCIENCE, V339, P798, DOI 10.1126/science.1231692; Tillmann M, 2013, NAT PHOTONICS, V7, P540, DOI [10.1038/nphoton.2013.102, 10.1038/NPHOTON.2013.102]	11	60	60	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					74	77		10.1038/nature15735	http://dx.doi.org/10.1038/nature15735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536958				2022-12-28	WOS:000364270700045
J	D'Silva, J				D'Silva, Jeetha			BMJ AWARDS SOUTH ASIA 2015 Stories of South Asian clinical excellence: who won the 2015 BMJ Awards?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						Amrita Institute of Medical Sciences, 2015, 1 SUCC HAND TRANSPL; Aurora A., CLIN LAB EVALUATION; D'Silva J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5305; Kumar R, 2014, CRIT CARE MED, V42, P1775, DOI 10.1097/CCM.0000000000000298	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5911	10.1136/bmj.h5911	http://dx.doi.org/10.1136/bmj.h5911			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OS	26538248				2022-12-28	WOS:000364390100024
J	Cole, TB				Cole, Thomas B.			Panic Nikolay Viting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1780	1781		10.1001/jama.2014.12063	http://dx.doi.org/10.1001/jama.2014.12063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529146				2022-12-28	WOS:000363960200001
J	Fischhoff, B				Fischhoff, Baruch			The realities of risk-cost-benefit analysis	SCIENCE			English	Review							EXPERT JUDGMENTS; ELICITATION; DECISION; SCIENCE; LUNG; UNCERTAINTY; ENERGY; MODEL	Formal analyses can be valuable aids to decision-making if their limits are understood. Those limits arise from the two forms of subjectivity found in all analyses: ethical judgments, made when setting the terms of an analysis, and scientific judgments, made when conducting it. As formal analysis has assumed a larger role in policy decisions, awareness of those judgments has grown, as have methods for making them. The present review traces these developments, using examples that illustrate the issues that arise when designing, executing, and interpreting analyses. It concludes with lessons learned from the science and practice of analysis. One common thread in these lessons is the importance of collaborative processes, whereby analysts and decision-makers educate one another about their respective needs and capabilities.	Carnegie Mellon Univ, Dept Social & Decis Sci, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Fischhoff, B (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	baruch@cmu.edu	Fischhoff, Baruch/I-9859-2014	Fischhoff, Baruch/0000-0002-3030-6874	National Science Foundation Center for Climate and Energy Decision Making [SES-0949710]; Swedish Foundation for the Humanities and the Social Sciences (Riksbankens Jubileumsfond) Program on Science and Proven Experience; Direct For Social, Behav & Economic Scie [0949710] Funding Source: National Science Foundation; Divn Of Social and Economic Sciences [1463492] Funding Source: National Science Foundation	National Science Foundation Center for Climate and Energy Decision Making; Swedish Foundation for the Humanities and the Social Sciences (Riksbankens Jubileumsfond) Program on Science and Proven Experience; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Preparation of this article was supported by the National Science Foundation (SES-0949710) Center for Climate and Energy Decision Making and the Swedish Foundation for the Humanities and the Social Sciences (Riksbankens Jubileumsfond) Program on Science and Proven Experience. It is gratefully acknowledged, as are the comments of D. Caruso, S. Eggers, A. Finkel, N.-E. Sahlin, and three anonymous reviewers. The views expressed are those of the author.	Adams J., 1970, AREA, V2, P1; Anadon LD, 2012, ENVIRON SCI TECHNOL, V46, P11497, DOI 10.1021/es300612c; [Anonymous], 1983, HDB HUMAN RELIABILIT; [Anonymous], 2008, RISK GOVERNANCE; [Anonymous], 2012, REP SECR EN; Arrow K.J., 1993, REPORT NOAA PANEL CO, V58; Barker SF, 2014, RISK ANAL, V34, P803, DOI 10.1111/risa.12138; BENDOR J, 1995, AM POLIT SCI REV, V89, P819, DOI 10.2307/2082511; BROOME J, 1993, J PUBLIC ECON, V50, P149, DOI 10.1016/0047-2727(93)90047-W; Campbell P, 2011, PHILOS T R SOC A, V369, P4891, DOI 10.1098/rsta.2011.0068; Canadian Standards Association, 1997, Q850 CSA; Centers for Disease Control and Prevention, 2014, NAT VIT STAT REP 201; Chandra A, 2011, J ECON PERSPECT, V25, P27, DOI 10.1257/jep.25.2.27; Chapanis Alphonse., 1996, HUMAN FACTORS SYSTEM; Clawson M, 1966, EC OUTDOOR RECREATIO; Conkey M. W., 1984, ADV ARCH METHOD THEO, V11, P1; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Coombs CH, 1964, THEORY DATA, DOI 10.1177/001316446502500236; de Bruin WB, 2013, P NATL ACAD SCI USA, V110, P14062, DOI 10.1073/pnas.1212729110; Department of Homeland Security, 2006, BIOT RISK ASS; Department of Homeland Security, 2020, DEP HOM SEC BIOT RIS, P26; Dietz T., 2008, PUBLIC PARTICIPATION; Dietz T, 2013, P NATL ACAD SCI USA, V110, P14081, DOI 10.1073/pnas.1212740110; Duarte HD, 2014, RISK ANAL, V34, P831, DOI 10.1111/risa.12139; Dunlap RE, 2013, AM BEHAV SCI, V57, P699, DOI 10.1177/0002764213477096; Environmental Protection Agency, 1990, RED RISKS; Environmental Protection Agency, 2006, LIF CYCL ASS PRINC P; Environmental Protection Agency, 1987, UNF BUS; Environmental Protection Agency, 1993, GUID COMP RISKS SETT; Finkel A. M., 1994, WORST THINGS 1 DEB R; FISCHHOFF B, 1991, AM PSYCHOL, V46, P835, DOI 10.1037/0003-066X.46.8.835; Fischhoff B., 1981, ACCEPTABLE RISK; Fischhoff B., 2011, RISK VERY SHORT INTR; FISCHHOFF B, 2005, HDB ENV EC, P937; Fischhoff B, 2014, P NATL ACAD SCI USA, V111, P13664, DOI 10.1073/pnas.1317504111; Fischhoff B, 2013, P NATL ACAD SCI USA, V110, P14033, DOI 10.1073/pnas.1213273110; Food and Drug Administration, 2013, STRUCT APPR BEN RISK; Food and Drug Administration, VOIC PAT SER REP FDA; Funtowicz S. O., 1990, UNCERTAINTY QUALITY; Gattuso JP, 2013, CLIMATIC CHANGE, V117, P725, DOI 10.1007/s10584-012-0591-5; Gilligan C., 1982, DIFFERENT VOICE; GLEICK PH, 1981, AM J PUBLIC HEALTH, V71, P1046, DOI 10.2105/AJPH.71.9.1046; Green A. E., 1972, RELIABILITY TECHNOLO; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Guttman Amy, 2004, WHY DELIBERATIVE DEM; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Haward MF, 2008, PEDIATRICS, V122, P109, DOI 10.1542/peds.2007-0620; Heinzerling L, 2000, HARVARD ENVIRON LAW, V24, P189; Hendrickson C. T., 2006, ENV LIF CYCL ASS GOO; INHABER H, 1979, SCIENCE, V203, P718, DOI 10.1126/science.419404; Institute of Medicine, 1999, ENV JUST; Jasanoff S., 2012, SCI PUBLIC REASON; Jones -Lee M., 1976, VALUE LIFE EC ANAL; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; Kammen D., 1999, SHALL WE RISK IT; Khozin S, 2015, CLIN CANCER RES, V21, P2436, DOI 10.1158/1078-0432.CCR-14-3157; Kling CL, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.4.3; Kneese A.V., 1964, EC REGIONAL WATER QU; Knetsch JL, 2015, J BENEFIT-COST ANAL, V6, P217, DOI 10.1017/bca.2015.4; Kopits E, 2014, J BENEFIT-COST ANAL, V5, P173, DOI 10.1515/jbca-2014-0024; Levitan BS, 2011, CLIN PHARMACOL THER, V89, P217, DOI 10.1038/clpt.2010.280; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Lewis H. W., 1975, Reviews of Modern Physics, V47, pS1, DOI 10.1103/RevModPhys.47.S1; Lichtenstein S, 2006, CONSTRUCTION OF PREFERENCE, P1, DOI 10.2277/ 0521542200; LINDBLOM CE, 1959, PUBLIC ADMIN REV, V19, P79, DOI 10.2307/973677; Lofstedt RE, 2002, J POLICY ANAL MANAG, V21, P381, DOI 10.1002/pam.10051; Long J, 2000, RISK ANAL, V20, P339, DOI 10.1111/0272-4332.203033; Lowrance W., 1976, OF ACCEPTABLE RISK; Manski C.F., 2013, PUBLIC POLICY UNCERT; MCNEIL BJ, 1978, NEW ENGL J MED, V299, P1397, DOI 10.1056/NEJM197812212992506; Mitchell R.C., 1989, USING SURVEYS VALUE; Morgan KM, 2001, RISK ANAL, V21, P923, DOI 10.1111/0272-4332.215162; Morgan M. G., 1990, UNCERTAINTY; Morgan MG, 2014, P NATL ACAD SCI USA, V111, P7176, DOI 10.1073/pnas.1319946111; Mussen F, 2009, BENEFIT RISK APPRAIS; National Research Council, 2009, AM EN FUT; National Research Council, 1996, UND RISK; National Research Council, 1983, EN TRANS 1985 2010; National Research Council, 2010, HIDD COSTS EN; [National Research Council Committee on Improving Risk Analysis Approaches Used by the U. S. EPA.], 2009, SCIENCE AND DECISION; National Research Council, 2015, POT RISKS BEN GAIN O; Nickerson RS, 1999, PSYCHOL BULL, V125, P737, DOI 10.1037/0033-2909.125.6.737; Nuclear Regulatory Commission, 1978, NUREGCR0400 NRC; Nuclear Regulatory Commission, 1975, WASH1400 NRC; O'Brien M., 2000, MAKING BETTER ENV DE; O'Hagan A., 2006, UNCERTAIN JUDGMENTS; Oreskes N., 2008, MERCHANTS DOUBT; PATECORNELL ME, 1992, RISK ANAL, V12, P1, DOI 10.1111/j.1539-6924.1992.tb01302.x; Perrow C., 1982, NORMAL ACCIDENTS; Pidgeon N, 2014, P NATL ACAD SCI USA, V111, P13606, DOI 10.1073/pnas.1317512111; Presidential/Congressional Commission on Risk Assessment and Risk Management, 1997, RISK MANAGEMENT; Raiffa H., 1997, DECIS ANAL; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Schelling TC, 1968, PROBLEMS PUBLIC EXPE, DOI DOI 10.1037/12069-015; Scholz R.W., 2002, EMBEDDED CASE STUDY; Scholz R.W., 2011, ENV LITERACY SCI SOC; Schwartz LM, 2013, P NATL ACAD SCI USA, V110, P14069, DOI 10.1073/pnas.1214646110; Senders J.W., 1991, HUMAN ERROR CAUSE PR, DOI [10.1177/106480469300100111, DOI 10.1177/106480469300100111]; Simon H, 1957, MODELS MAN SOCIAL RA; Simpson RD, 2014, J BENEFIT-COST ANAL, V5, P315, DOI 10.1515/jbca-2014-0027; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P., 2010, THE FEELING OF RISK; STARR C, 1969, SCIENCE, V165, P1232, DOI 10.1126/science.165.3899.1232; STARR C., 1976, ANN REV ENERGY, V1, P629, DOI [10.1146/annurev.eg.01.110176.003213, DOI 10.1146/ANNUREV.EG.01.110176.003213]; Stokey E, 1978, PRIMER POLICY ANAL; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Treasury HM, 2005, MANAGING RISKS PEOPL; Turner Barry A., 1997, MAN MADE DISASTERS; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Viscusi WK, 2007, J ENVIRON ECON MANAG, V53, P377, DOI 10.1016/j.jeem.2006.10.005; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; von Krauss MPK, 2004, RISK ANAL, V24, P1515, DOI 10.1111/j.0272-4332.2004.00546.x; von Winterfeldt D, 2013, P NATL ACAD SCI USA, V110, P14055, DOI 10.1073/pnas.1213532110; WALLSTEN TS, 1986, J EXP PSYCHOL GEN, V115, P348, DOI 10.1037/0096-3445.115.4.348; Ward F.A., 2000, VALUING NATURE TRAVE; Wiener JB, 2011, REALITY OF PRECAUTION: COMPARING RISK REGULATION IN THE UNITED STATES AND EUROPE, P1; Wilson R., 2001, BENEFIT RISK ANAL; [No title captured]	119	61	61	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260							aaa6516	10.1126/science.aaa6516	http://dx.doi.org/10.1126/science.aaa6516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU6RG	26516286				2022-12-28	WOS:000363660000038
J	Crabtree, G				Crabtree, George			The energy-storage revolution	NATURE			English	Editorial Material									[Crabtree, George] Argonne Natl Lab, Joint Ctr Energy Storage Res, Argonne, IL 60439 USA; [Crabtree, George] Univ Illinois, Chicago, IL USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Crabtree, G (corresponding author), Argonne Natl Lab, Joint Ctr Energy Storage Res, Argonne, IL 60439 USA.	crabtree@anl.gov							0	96	98	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S92	S92		10.1038/526S92a	http://dx.doi.org/10.1038/526S92a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509952	Bronze			2022-12-28	WOS:000363832100024
J	White, C				White, Caroline			RESEARCH MISCONDUCT Ranjit Chandra: how reputation bamboozled the scientific community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												cwhite@bmj.com							0	7	7	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2015	351								h5683	10.1136/bmj.h5683	http://dx.doi.org/10.1136/bmj.h5683			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IK	26514155				2022-12-28	WOS:000364152500006
J	Merchante, C; Brumos, J; Yun, J; Hu, QW; Spencer, KR; Enriquez, P; Binder, BM; Heber, S; Stepanova, AN; Alonso, JM				Merchante, Catharina; Brumos, Javier; Yun, Jeonga; Hu, Qiwen; Spencer, Kristina R.; Enriquez, Paul; Binder, Brad M.; Heber, Steffen; Stepanova, Anna N.; Alonso, Jose M.			Gene-Specific Translation Regulation Mediated by the Hormone-Signaling Molecule EIN2	CELL			English	Article							F-BOX PROTEINS; MESSENGER-RNA; ARABIDOPSIS-THALIANA; ETHYLENE RESPONSES; AUXIN BIOSYNTHESIS; 3-HYBRID SYSTEM; IN-VIVO; MUTANTS; EBF2; EXPRESSION	The central role of translation in modulating gene activity has long been recognized, yet the systematic exploration of quantitative changes in translation at a genome-wide scale in response to a specific stimulus has only recently become technically feasible. Using the well-characterized signaling pathway of the phytohormone ethylene and plant-optimized genome-wide ribosome footprinting, we have uncovered a molecular mechanism linking this hormone's perception to the activation of a gene-specific translational control mechanism. Characterization of one of the targets of this translation regulatory machinery, the ethylene signaling component EBF2, indicates that the signaling molecule EIN2 and the nonsense-mediated decay proteins UPFs play a central role in this ethylene-induced translational response. Furthermore, the 3'UTR of EBF2 is sufficient to confer translational regulation and required for the proper activation of ethylene responses. These findings represent a mechanistic paradigm of gene-specific regulation of translation in response to a key growth regulator.	[Merchante, Catharina; Brumos, Javier; Yun, Jeonga; Spencer, Kristina R.; Enriquez, Paul; Stepanova, Anna N.; Alonso, Jose M.] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Hu, Qiwen; Heber, Steffen] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Binder, Brad M.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA; [Merchante, Catharina] Univ Malaga, IHSM UMA CSIC, Dept Biol Mol & Bioquim, Malaga 29071, Spain; [Stepanova, Anna N.; Alonso, Jose M.] N Carolina State Univ, Genet Grad Program, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); University of North Carolina; North Carolina State University	Stepanova, AN (corresponding author), N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	atstepan@ncsu.edu; jmalonso@ncsu.edu	Merchante, Catharina/A-4844-2016; Alonso, Jose M/K-6826-2014; Hu, Qiwen/A-8309-2019; Merchante, Catharina/AAP-7340-2021; Stepanova, Anna/P-9575-2019; Brumos, Javier/A-8055-2017	Merchante, Catharina/0000-0003-2214-9562; Alonso, Jose M/0000-0001-7087-1571; Merchante, Catharina/0000-0003-2214-9562; Stepanova, Anna/0000-0003-1018-4758; Brumos, Javier/0000-0002-6503-9593; Heber, Steffen/0000-0002-1050-3635; Enriquez, Paul/0000-0002-1987-0183; Binder, Brad/0000-0002-8172-2034	NSF [MCB 1158181, 0519869, MCB 0923727, IOS 1444561]; NCSU-RISF; Marie Curie COFUND U-Mobility postdoctoral fellowship; University of Malaga; EU [246550]; Ministerio de Educacion; NSF-REU [MCB 06103224]; NCBI SRA [SRP056795]; Direct For Biological Sciences [1254423] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NCSU-RISF; Marie Curie COFUND U-Mobility postdoctoral fellowship; University of Malaga; EU(European Commission); Ministerio de Educacion; NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); NCBI SRA; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Hongwei Guo for sharing unpublished data, Valerie Nicaise for technical advice on RNA-IP, Miguel A. Perez-Amador for stimulating discussions on RNA-protein interactions, and Xuemei Chen for dcl2-1 dcl3-1 dcl4-2. This work was supported by NSF grants MCB 1158181 and 0519869 to J.M.A.; MCB 0923727 to J.M.A. and A.N.S.; IOS 1444561 to J.M.A., A.N.S., and S.H.; NCSU-RISF to S.H. and J.M.A.; a Marie Curie COFUND U-Mobility postdoctoral fellowship to C.M. (co-funded by the University of Malaga and the EU 7FP GA No246550); a postdoctoral fellowship from Ministerio de Educacion 2008-2011 to J.B.; and an NSF-REU MCB 06103224 to K.R.S. Sequencing data have been deposited at the NCBI SRA (SRP056795).	Abeles F, 1992, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bernstein DS, 2002, METHODS, V26, P123, DOI 10.1016/S1046-2023(02)00015-4; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Deplancke B., 2006, CSH PROTOC, V2006; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Konishi M, 2008, PLANT J, V55, P821, DOI 10.1111/j.1365-313X.2008.03551.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li WY, 2015, CELL, V163, P670, DOI 10.1016/j.cell.2015.09.037; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mustroph A, 2009, METHODS MOL BIOL, V553, P109, DOI 10.1007/978-1-60327-563-7_6; Nicaise V, 2013, EMBO J, V32, P701, DOI 10.1038/emboj.2013.15; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Potuschak T, 2006, PLANT CELL, V18, P3047, DOI 10.1105/tpc.106.046508; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Szostak E, 2013, BRIEF FUNCT GENOMICS, V12, P58, DOI 10.1093/bfgp/els056; Vandenbussche F, 2012, NEW PHYTOL, V194, P895, DOI 10.1111/j.1469-8137.2012.04100.x; Wang GF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004674; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	45	186	193	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					684	697		10.1016/j.cell.2015.09.036	http://dx.doi.org/10.1016/j.cell.2015.09.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496608	Bronze			2022-12-28	WOS:000364828900021
J	Homoud, MK				Homoud, Munther K.			In atrial fibrillation treated with warfarin, intracranial hemorrhage was associated with ischemic events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTICOAGULATION; STROKE		Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Homoud, MK (corresponding author), Tufts Med Ctr, Boston, MA 02111 USA.							Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldstein JN, 2010, CLEV CLIN J MED, V77, P791, DOI 10.3949/ccjm.77a.10018; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061; Lip GYH, 2013, EUR HEART J, V34, P1041, DOI 10.1093/eurheartj/ehs435; Masoudi FA, 2015, HEART RHYTHM; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0	7	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC11	10.7326/ACPJC-2015-163-8-011	http://dx.doi.org/10.7326/ACPJC-2015-163-8-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502136				2022-12-28	WOS:000363737400012
J	Niessen, LW; Khan, JAM				Niessen, Louis W.; Khan, Jahangir A. M.			Universal access to medicines	LANCET			English	Editorial Material							COUNTRIES		[Niessen, Louis W.; Khan, Jahangir A. M.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Appl Hlth Res & Delivery, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Niessen, LW (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Appl Hlth Res & Delivery, Liverpool L3 5QA, Merseyside, England.	louis.niessen@lstmed.ac.uk	Niessen, Louis/F-6254-2015; Khan, Jahangir/AAG-4014-2019	Niessen, Louis/0000-0002-8639-5191; KHAN, JAHANGIR/0000-0002-6151-764X				Babar ZUD, 2013, PHARMACOECONOMICS, V31, P1063, DOI 10.1007/s40273-013-0095-9; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106072; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Checkley W, 2014, GLOB HEART, V9, P431, DOI 10.1016/j.gheart.2014.11.003; Huda T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001722; Hwang TJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001738; Khatib R, 2015, LANCET; MSF Access Campaign, 2014, UNT WEB ANT PRIC RED; van de Ven N, 2015, HEPATOLOGY, V61, P1174, DOI 10.1002/hep.27641; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Webster JP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0434; WHO, 2010, WOR HEALT REP, P1; World Health Organization, 2020, WHO GUID COUNTR PHAR, V2nd	13	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					9	11		10.1016/S0140-6736(15)00552-8	http://dx.doi.org/10.1016/S0140-6736(15)00552-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ9ZU	26498705				2022-12-28	WOS:000367457300008
J	Osswald, M; Jung, E; Sahm, F; Solecki, G; Venkataramani, V; Blaes, J; Weil, S; Horstmann, H; Wiestler, B; Syed, M; Huang, LL; Ratliff, M; Jazi, KK; Kurz, FT; Schmenger, T; Lemke, D; Gommel, M; Pauli, M; Liao, YX; Haring, P; Pusch, S; Herl, V; Steinhauser, C; Krunic, D; Jarahian, M; Miletic, H; Berghoff, AS; Griesbeck, O; Kalamakis, G; Garaschuk, O; Preusser, M; Weiss, S; Liu, HK; Heiland, S; Platten, M; Huber, PE; Kuner, T; von Deimling, A; Wick, W; Winkler, F				Osswald, Matthias; Jung, Erik; Sahm, Felix; Solecki, Gergely; Venkataramani, Varun; Blaes, Jonas; Weil, Sophie; Horstmann, Heinz; Wiestler, Benedikt; Syed, Mustafa; Huang, Lulu; Ratliff, Miriam; Jazi, Kianush Karimian; Kurz, Felix T.; Schmenger, Torsten; Lemke, Dieter; Goemmel, Miriam; Pauli, Martin; Liao, Yunxiang; Haering, Peter; Pusch, Stefan; Herl, Verena; Steinhaeuser, Christian; Krunic, Damir; Jarahian, Mostafa; Miletic, Hrvoje; Berghoff, Anna S.; Griesbeck, Oliver; Kalamakis, Georgios; Garaschuk, Olga; Preusser, Matthias; Weiss, Samuel; Liu, Haikun; Heiland, Sabine; Platten, Michael; Huber, Peter E.; Kuner, Thomas; von Deimling, Andreas; Wick, Wolfgang; Winkler, Frank			Brain tumour cells interconnect to a functional and resistant network	NATURE			English	Article							CALCIUM WAVES; SELF-RENEWAL; STEM-CELLS; GROWTH; GLIOMA; ASTROCYTES; NANOTUBES; GAP-43; CANCER; TRK	Astrocytic brain tumours, including glioblastomas, are incurable neoplasms characterized by diffusely infiltrative growth. Here we show that many tumour cells in astrocytomas extend ultra-long membrane protrusions, and use these distinct tumour microtubes as routes for brain invasion, proliferation, and to interconnect over long distances. The resulting network allows multicellular communication through microtube-associated gap junctions. When damage to the network occurred, tumour microtubes were used for repair. Moreover, the microtube-connected astrocytoma cells, but not those remaining unconnected throughout tumour progression, were protected from cell death inflicted by radiotherapy. The neuronal growth-associated protein 43 was important for microtube formation and function, and drove microtube-dependent tumour cell invasion, proliferation, interconnection, and radioresistance. Oligodendroglial brain tumours were deficient in this mechanism. In summary, astrocytomas can develop functional multicellular network structures. Disconnection of astrocytoma cells by targeting their tumour microtubes emerges as a new principle to reduce the treatment resistance of this disease.	[Osswald, Matthias; Jung, Erik; Solecki, Gergely; Blaes, Jonas; Weil, Sophie; Wiestler, Benedikt; Syed, Mustafa; Huang, Lulu; Jazi, Kianush Karimian; Schmenger, Torsten; Lemke, Dieter; Goemmel, Miriam; Liao, Yunxiang; Platten, Michael; Wick, Wolfgang; Winkler, Frank] Univ Heidelberg Hosp, Neurol Clin, D-69120 Heidelberg, Germany; [Osswald, Matthias; Jung, Erik; Solecki, Gergely; Blaes, Jonas; Weil, Sophie; Wiestler, Benedikt; Syed, Mustafa; Huang, Lulu; Jazi, Kianush Karimian; Schmenger, Torsten; Lemke, Dieter; Goemmel, Miriam; Liao, Yunxiang; Platten, Michael; Wick, Wolfgang; Winkler, Frank] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Osswald, Matthias; Jung, Erik; Solecki, Gergely; Blaes, Jonas; Weil, Sophie; Wiestler, Benedikt; Syed, Mustafa; Huang, Lulu; Ratliff, Miriam; Jazi, Kianush Karimian; Schmenger, Torsten; Lemke, Dieter; Goemmel, Miriam; Liao, Yunxiang; Wick, Wolfgang; Winkler, Frank] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Sahm, Felix; Pusch, Stefan; von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany; [Sahm, Felix; Pusch, Stefan; von Deimling, Andreas] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Venkataramani, Varun; Horstmann, Heinz; Kuner, Thomas] Heidelberg Univ, Inst Anat & Cell Biol, Dept Funct Neuroanat, D-69120 Heidelberg, Germany; [Wiestler, Benedikt] Tech Univ Munich, Klinikum Rechts Isar, Dept Diagnost & Intervent Neuroradiol, D-81675 Munich, Germany; [Ratliff, Miriam] Univ Heidelberg Hosp, Neurosurg Clin, D-69120 Heidelberg, Germany; [Kurz, Felix T.; Heiland, Sabine] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Pauli, Martin] Univ Wurzburg, Inst Physiol, Dept Neurophysiol, D-97070 Wurzburg, Germany; [Haering, Peter] German Canc Res Ctr, Dept Med Phys, D-69120 Heidelberg, Germany; [Herl, Verena; Steinhaeuser, Christian] Univ Bonn, Inst Cellular Neurosci, Fac Med, D-53105 Bonn, Germany; [Krunic, Damir] German Canc Res Ctr, Light Microscopy Facil, D-69120 Heidelberg, Germany; [Jarahian, Mostafa] German Canc Res Ctr, Dept Translat Immunol, D-69120 Heidelberg, Germany; [Miletic, Hrvoje] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Berghoff, Anna S.] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Berghoff, Anna S.; Preusser, Matthias] Med Univ Vienna, CNS Unit, Ctr Comprehens Canc, A-1090 Vienna, Austria; [Griesbeck, Oliver] Max Planck Inst Neurobiol, Tools Bioimaging, D-82152 Martinsried, Germany; [Kalamakis, Georgios; Garaschuk, Olga] Univ Tubingen, Inst Physiol 2, D-72074 Tubingen, Germany; [Preusser, Matthias] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Weiss, Samuel] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Weiss, Samuel] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB T2N 4Z6, Canada; [Weiss, Samuel] Univ Calgary, Fac Med, Southern Alberta Canc Res Inst, Clark Smith Brain Tumor Res Ctr, Calgary, AB T2N 4N1, Canada; [Liu, Haikun] German Canc Res Ctr, DKFZ ZMBH Alliance, Normal & Neoplast CNS Stem Cells, Helmholtz Young Investigator Grp, D-69120 Heidelberg, Germany; [Platten, Michael] German Canc Res Ctr, German Canc Consortium DKTK, Clin Cooperat Unit Neuroimmunol & Brain Tumor Imm, D-69120 Heidelberg, Germany; [Huber, Peter E.] German Canc Res Ctr, CCU Mol & Radiat Oncol, D-69120 Heidelberg, Germany; [Huber, Peter E.] Univ Heidelberg Hosp, Dept Radiat Oncol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technical University of Munich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Bergen; Medical University of Vienna; Medical University of Vienna; Max Planck Society; Eberhard Karls University of Tubingen; Medical University of Vienna; University of Calgary; University of Calgary; University of Calgary; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Winkler, F (corresponding author), Univ Heidelberg Hosp, Neurol Clin, INF 400, D-69120 Heidelberg, Germany.	frank.winkler@med.uni-heidelberg.de	Wick, Wolfgang/AAA-2545-2020; Sahm, Felix/GQY-8202-2022; Preusser, Matthias/C-8530-2011; von Deimling, Andreas/F-7774-2013; Platten, Michael/F-2902-2013; Pusch, Stefan/H-3152-2019; Karimian-Jazi, Kianush/N-5157-2015	Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Preusser, Matthias/0000-0003-3541-2315; von Deimling, Andreas/0000-0002-5863-540X; Platten, Michael/0000-0002-4746-887X; Pusch, Stefan/0000-0002-3407-4249; Karimian-Jazi, Kianush/0000-0002-5550-0489; Winkler, Frank/0000-0003-4892-6104; Kalamakis, Georgios/0000-0003-0832-482X; Jung, Erik/0000-0002-5016-8202; Wiestler, Benedikt/0000-0002-2963-7772; liu, hai-kun/0000-0003-3338-4066; Berghoff, Anna Sophie/0000-0001-9379-6797; Schmenger, Torsten/0000-0002-4335-9035; Ratliff, Miriam/0000-0002-9464-6544; Griesbeck, Oliver/0000-0001-5883-5594; Weil, Sophie/0000-0002-3373-5295; Venkataramani, Varun/0000-0002-2927-0886	German Research Foundation (DFG) [WI 1930/5-1]; Major Equipment Grant INST [114089/26-1 FUGG]; DKFZ; Heinrich F.C. Behr-Stipend; Alberta Innovates [201201230] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); Major Equipment Grant INST; DKFZ(Helmholtz Association); Heinrich F.C. Behr-Stipend; Alberta Innovates	We thank C. Ruiz de Almodovar and H.-H. Gerdes for discussions and comments; P. Rubman, B. Kast, A. Habel, A. Tietz-Dalfu beta and M. Fischer for technical assistance; R. Hermann for help with vibratome slices; G. Eisele for providing the WJ cell line; P. Friedl for the Lifeact-YFP-construct and the IDH1<SUP>R132H</SUP> thick section staining protocol; H. Glimm for the pCCL.PPT. SFFV.MCS.IRES.eGFP.WPRE-vector backbone; and M. Splinter, M. Brand, C. Lang for help with radiation experiments. This work was funded by grants from the German Research Foundation (DFG, WI 1930/5-1 (F.W.) and Major Equipment Grant INST 114089/26-1 FUGG (F.W., W.W.)), an intramural grant from the DKFZ to F.W. and H.L., Heinrich F.C. Behr-Stipend to S. Weil. F.S. is a fellow of the Medical Faculty Heidelberg PostDoc-Program. The results published here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Geiger JRP, 2002, PFLUG ARCH EUR J PHY, V443, P491, DOI 10.1007/s00424-001-0735-3; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Haag D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002572; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hitomi M, 2015, CELL REP, V11, P1031, DOI 10.1016/j.celrep.2015.04.021; Horstmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064764; Horstmann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035172; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; Kelly JJP, 2010, NEURO-ONCOLOGY, V12, P745, DOI 10.1093/neuonc/noq031; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Koponen E, 2004, MOL BRAIN RES, V130, P81, DOI 10.1016/j.molbrainres.2004.07.010; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; LAVENIUS E, 1995, CELL GROWTH DIFFER, V6, P727; Le HT, 2014, J BIOL CHEM, V289, P1345, DOI 10.1074/jbc.M113.508390; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lemke D, 2014, J NEUROCHEM, V131, P251, DOI 10.1111/jnc.12802; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; McFerrin MB, 2012, AM J PHYSIOL-CELL PH, V303, pC1070, DOI 10.1152/ajpcell.00040.2012; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sahm F, 2012, ARCH NEUROL-CHICAGO, V69, P523, DOI 10.1001/archneurol.2011.2910; Scherer HJ, 1940, BRAIN, V63, P1, DOI 10.1093/brain/63.1.1; Sherer NM, 2013, MOL BIOL CELL, V24, P1095, DOI 10.1091/mbc.E12-08-0622; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Sin WC, 2012, BBA-BIOMEMBRANES, V1818, P2058, DOI 10.1016/j.bbamem.2011.10.022; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; Smith IF, 2011, BIOPHYS J, V100, pL37, DOI 10.1016/j.bpj.2011.03.007; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Tombal B, 2002, CELL DEATH DIFFER, V9, P561, DOI 10.1038/sj.cdd.4400999; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Weiler M, 2014, P NATL ACAD SCI USA, V111, P409, DOI 10.1073/pnas.1314469111; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wiestler B, 2014, ACTA NEUROPATHOL, V128, P561, DOI 10.1007/s00401-014-1315-x; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Zhu Z, 2014, CELL STEM CELL, V15, P185, DOI 10.1016/j.stem.2014.04.007; ZUBER MX, 1989, SCIENCE, V244, P1193, DOI 10.1126/science.2658062	64	508	522	10	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					93	+		10.1038/nature16071	http://dx.doi.org/10.1038/nature16071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26536111				2022-12-28	WOS:000365606000054
J	Rodes-Cabau, J; Horlick, E; Ibrahim, R; Cheema, AN; Labinaz, M; Nadeem, N; Osten, M; Cote, M; Marsal, JR; Rivest, D; Marrero, A; Houde, C				Rodes-Cabau, Josep; Horlick, Eric; Ibrahim, Reda; Cheema, Asim N.; Labinaz, Marino; Nadeem, Najaf; Osten, Mark; Cote, Melanie; Ramon Marsal, Josep; Rivest, Donald; Marrero, Alier; Houde, Christine			Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure The CANOA Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; PATENT FORAMEN OVALE; NEW-ONSET MIGRAINE; PERCUTANEOUS CLOSURE; DOUBLE-BLIND; AURA; MULTICENTER; THERAPY; ATTACKS; STROKE	IMPORTANCE The occurrence of new-onset migraine attacks is a complication of transcatheter atrial septal defect (ASD) closure. It has been suggested that clopidogrel may reduce migraine attacks after ASD closure. OBJECTIVE To assess the efficacy of clopidogrel, used in addition to taking aspirin, for the prevention of migraine attacks following ASD closure. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind clinical trial performed in 6 university hospitals in Canada. Participants were 171 patients with an indication for ASD closure and no history of migraine. INTERVENTIONS Patients were randomized (1: 1) to receive dual antiplatelet therapy (aspirin + clopidogrel [the clopidogrel group], n = 84) vs single antiplatelet therapy (aspirin + placebo [the placebo group], n = 87) for 3 months following transcatheter ASD closure. The first patient was enrolled in December 2008, and the last follow-up was completed in February 2015. MAIN OUTCOMES AND MEASURES The primary efficacy outcome was the monthly number of migraine days within the 3 months following ASD closure in the entire study population. The incidence and severity of new-onset migraine attacks, as evaluated by the Migraine Disability Assessment questionnaire, were prespecified secondary end points. A zero-inflated Poisson regression model was used for data analysis. RESULTS The mean (SD) age of the participants was 49 (15) years and 62%(106) were women. Patients in the clopidogrel group had a reduced mean (SD) number of monthly migraine days within the 3 months following the procedure (0.4 [95% CI, 0.07 to 0.69] days) vs the placebo group (1.4 [95% CI, 0.54 to 2.26] days; difference, -1.02 days [95% CI, -1.94 to -0.10 days]; incident risk ratio [IRR], 0.61 [95% CI, 0.41 to 0.91]; P = .04) and a lower incidence of migraine attacks following ASD closure (9.5% for the clopidogrel group vs 21.8% for the placebo group; difference, -12.3%[95% CI, -23% to -1.6%]; odds ratio [OR], 0.38 [95% CI, 0.15 to 0.89]; P = .03). Among patients with migraines, those in the clopidogrel group had less-severe migraine attacks (zero patients with moderately or severely disabling migraine attacks vs 37%[7 patients] in the placebo group; difference, -36.8%[95% CI, -58.5% to -15.2%]; P = .046). There were no between-group differences in the rate of patients with at least 1 adverse event (16.7%[14 patients] in the clopidogrel group vs 21.8% [19 patients] in the placebo group; difference, -5.2%[95% CI, -17% to 6.6%]; P = .44). CONCLUSIONS AND RELEVANCE Among patients who underwent transcatheter ASD closure, the use of clopidogrel and aspirin, compared with aspirin alone, resulted in a lower monthly frequency of migraine attacks over 3 months. Further studies are needed to assess generalizability and durability of this effect.	[Rodes-Cabau, Josep; Cote, Melanie] Univ Laval, Quebec Heart & Lung Inst, Dept Cardiol, Quebec City, PQ G1V 4G5, Canada; [Horlick, Eric; Osten, Mark] Toronto Gen Hosp, Dept Cardiol, Toronto, ON, Canada; [Ibrahim, Reda] Montreal Heart Inst, Dept Cardiol, Montreal, PQ H1T 1C8, Canada; [Cheema, Asim N.] St Michaels Hosp, Dept Cardiol, Toronto, ON M5B 1W8, Canada; [Labinaz, Marino] Ottawa Heart Inst, Dept Cardiol, Ottawa, ON, Canada; [Nadeem, Najaf] Queen Elizabeth 2 Hlth Sci Ctr, Dept Cardiol, Halifax, NS, Canada; [Ramon Marsal, Josep] Univ Autonoma Barcelona, Vall dHebron Hosp, Dept Cardiol, Epidemiol Unit, E-08193 Barcelona, Spain; [Rivest, Donald] Hotel Dieu de Levis, Dept Neurol, Quebec City, PQ, Canada; [Marrero, Alier] CHU Georges L Dumont, Dept Neurol, New Brunswick, ON, Canada; [Houde, Christine] CHU Quebec, Dept Pediat Cardiol, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Universite de Montreal; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; University of Ottawa Heart Institute; Queen Elizabeth II Health Sciences Centre; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Laval University; Laval University	Rodes-Cabau, J (corresponding author), Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ G1V 4G5, Canada.	josep.rodes@criucpq.ulaval.ca	Ibrahim, Reda/AAX-7882-2021; Cheema, Asim N./AAA-7676-2020; Horlick, Eric/X-7085-2018; MARSAL MORA, JOSEP RAMON/A-9355-2013	Cheema, Asim N./0000-0002-3174-8957; Horlick, Eric/0000-0003-1303-0586; MARSAL MORA, JOSEP RAMON/0000-0003-0675-6119	Sanofi; St Jude Medical; Foundation of the Quebec Heart and Lung Institute	Sanofi(Sanofi-Aventis); St Jude Medical(St. Jude Medical); Foundation of the Quebec Heart and Lung Institute	This study was funded by unrestricted grants from Sanofi and St Jude Medical and a grant from the Foundation of the Quebec Heart and Lung Institute.	Borgdorff P, 2012, HEADACHE, V52, P1298, DOI 10.1111/j.1526-4610.2012.02162.x; Castellini P, 2009, NEUROL SCI, V30, P339, DOI 10.1007/s10072-009-0094-y; Chambers JB, 2014, CEPHALALGIA, V34, P1163, DOI 10.1177/0333102414531156; Danese E, 2014, THROMB RES, V134, P17, DOI 10.1016/j.thromres.2014.03.055; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4; Fernandez-Mayoralas DM, 2007, CEPHALALGIA, V27, P550, DOI 10.1111/j.1468-2982.2007.01331.x; Giachini FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091890; Heitzer T, 2006, ARTERIOSCL THROM VAS, V26, P1648, DOI 10.1161/01.ATV.0000225288.74170.dc; Hildick-Smith D, 2014, TRANSC CARD THER M W; Kato Y, 2013, CEPHALALGIA, V33, P1229, DOI 10.1177/0333102413490350; Kato Y, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-63; Kazmouz S, 2013, J INVASIVE CARDIOL, V25, P257; Kurth T, 2012, STROKE, V43, P3421, DOI 10.1161/STROKEAHA.112.656603; Linden MD, 2012, SEMIN THROMB HEMOST, V38, P200, DOI 10.1055/s-0032-1301417; Lip PZY, 2014, AM J MED, V127, P411, DOI 10.1016/j.amjmed.2013.12.006; Luermans JGLM, 2009, CATHETER CARDIO INTE, V74, P1078, DOI 10.1002/ccd.22226; Maggioni F, 2012, NEUROL SCI, V33, P1447, DOI 10.1007/s10072-011-0926-4; Mawet J, 2015, CEPHALALGIA, V35, P165, DOI 10.1177/0333102414550106; Mortelmans K, 2005, EUR HEART J, V26, P1533, DOI 10.1093/eurheartj/ehi170; Palta M., 2003, QUANTITATIVE METHODS; Pan G, 2014, GENET TEST MOL BIOMA, V18, P832, DOI 10.1089/gtmb.2014.0206; Rodes-Cabau J, 2003, CATHETER CARDIO INTE, V60, P540, DOI 10.1002/ccd.10713; Rodes-Cabau J, 2008, AM J CARDIOL, V101, P688, DOI 10.1016/j.amjcard.2007.10.034; Sarchielli P, 2004, CEPHALALGIA, V24, P623, DOI 10.1111/j.1468-2982.2003.00717.x; Sharifi Mohsen, 2005, J Interv Cardiol, V18, P181, DOI 10.1111/j.1540-8183.2005.04068.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Spencer BT, 2014, CEPHALALGIA, V34, P933, DOI 10.1177/0333102414523845; Tietjen GE, 2011, CEPHALALGIA, V31, P645, DOI 10.1177/0333102410392073; Voet A, 2008, ACTA CLIN BELG, V63, P262, DOI 10.1179/acb.2008.048; Wammes-van der Heijden EA, 2005, HEADACHE, V45, P137; Warnholtz A, 2008, ATHEROSCLEROSIS, V196, P689, DOI 10.1016/j.atherosclerosis.2006.12.009; Wei SH, 2012, HEADACHE, V52, P985, DOI 10.1111/j.1526-4610.2012.02152.x; Wilmshurst PT, 2005, HEART, V91, P1173, DOI 10.1136/hrt.2004.047746; Yew G, 2005, CATHETER CARDIO INTE, V64, P193, DOI 10.1002/ccd.20268; Zhang YZ, 2015, CLIN EXP PHARMACOL P, V42, P22, DOI 10.1111/1440-1681.12325	36	35	37	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2147	2154		10.1001/jama.2015.13919	http://dx.doi.org/10.1001/jama.2015.13919			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26551304	Bronze			2022-12-28	WOS:000365351900018
J	Hansen, KW; Sorensen, R; Madsen, M; Madsen, JK; Jensen, JS; von Kappelgaard, LM; Mortensen, PE; Lange, T; Galatius, S				Hansen, Kim Wadt; Sorensen, Rikke; Madsen, Mette; Madsen, Jan Kyst; Jensen, Jan Skov; von Kappelgaard, Lene Mia; Mortensen, Poul Erik; Lange, Theis; Galatius, Soren			Effectiveness of an Early Versus a Conservative Invasive Treatment Strategy in Acute Coronary Syndromes A Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SHORT-TERM; MORTALITY; MANAGEMENT; INTERVENTION; ROUTINE; ANGIOGRAPHY; ALGORITHMS; GUIDELINES; SURVIVAL	Background: Randomized clinical trials have found that early invasive strategies reduce mortality, myocardial infarction (MI), and rehospitalization compared with a conservative invasive approach in acute coronary syndromes (ACSs), but the effectiveness of such strategies in real-world settings is unknown. Objective: To investigate adverse cardiovascular outcomes of an early versus a conservative invasive strategy in a national cohort of patients with ACSs. Design: Retrospective cohort study. Setting: Administrative health care data on hospitalizations, procedures, and outcomes abstracted from the Danish national registries and covering all acute invasive procedures in patients presenting with an ACS. Patients: 19 704 propensity score-matched patients hospitalized with a first ACS between 1 January 2005 and 31 December 2011. Measurements: Risk for cardiac death or rehospitalization for MI within 60 days of hospitalization. Results: Compared with a conservative approach, early invasive strategies were associated with a lower risk for cardiac death (cumulative incidence, 5.9% vs. 7.6%; adjusted hazard ratio [HR], 0.75 [95% CI, 0.66 to 0.84]; P < 0.001). Similar results were found for rehospitalization for MI (cumulative incidence, 3.4% vs. 5.0%; adjusted odds ratio, 0.67 [CI, 0.58 to 0.77]; P < 0.001) and all-cause death (cumulative incidence, 7.3% vs. 10.6%; adjusted HR, 0.65 [CI, 0.59 to 0.72]; P < 0.001). Limitation: Potential residual confounding due to lack of core clinical variables. Conclusion: In this real-world cohort of patients with a first hospitalization for an ACS, the use of an early invasive treatment strategy was associated with a lower risk for cardiac death and rehospitalization for MI compared with a conservative invasive approach. Primary Funding Source: Department of Cardiology, University Hospital Gentofte.	[Hansen, Kim Wadt; Galatius, Soren] Bispebjerg Hosp, Dept Cardiol, DK-2400 Copenhagen, Denmark; [Sorensen, Rikke; Jensen, Jan Skov] Gentofte Univ Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Madsen, Mette] Univ Copenhagen, Dept Publ Hlth, DK-1014 Copenhagen, Denmark; [Madsen, Jan Kyst] Holbaek Univ Hosp, Emergency Dept, DK-4300 Holbaek, Denmark; [von Kappelgaard, Lene Mia] Univ Copenhagen, Natl Inst Publ Hlth, DK-1353 Copenhagen, Denmark; [Mortensen, Poul Erik] Odense Univ Hosp, Dept Thorac Surg, DK-5000 Odense, Denmark; [Lange, Theis] Univ Copenhagen, Sect Biostat, Dept Publ Hlth, DK-1014 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Hansen, KW (corresponding author), Bispebjerg Hosp, Dept Cardiol, Bldg 67,Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.	kim.wadt.hansen@regionh.dk		Lange, Theis/0000-0001-6807-8347; Sorensen, Rikke/0000-0001-9238-6681	Department of Cardiology, University Hospital Gentofte	Department of Cardiology, University Hospital Gentofte	Department of Cardiology, University Hospital Gentofte.	Abildstrom Steen Zabell, 2008, Ugeskr Laeger, V170, P532; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Andersen TF, 1999, DAN MED BULL, V46, P263; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bainey Kevin R, 2014, J Med Econ, V17, P415, DOI 10.3111/13696998.2014.911184; Baron T, 2015, HEART, V101, P101, DOI 10.1136/heartjnl-2014-306093; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; de Belder MA, 2012, HEART, V98, P1407, DOI 10.1136/heartjnl-2012-302459; Gaist D, 1997, DAN MED BULL, V44, P445; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hannan EL, 2008, JACC-CARDIOVASC INTE, V1, P211, DOI 10.1016/j.jcin.2008.01.008; Hansen KW, 2015, EUR HEART J-ACUTE CA, V4, P333, DOI 10.1177/2048872614562968; Hoenig MR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub3; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Juel K, 1999, DAN MED BULL, V46, P354; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucas FL, 2008, CIRCULATION, V118, P2797, DOI 10.1161/CIRCULATIONAHA.108.789446; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; O'Donoghue M, 2008, JAMA-J AM MED ASSOC, V300, P71, DOI 10.1001/jama.300.1.71; Pereira M, 2013, CIRC-CARDIOVASC QUAL, V6, P634, DOI 10.1161/CIRCOUTCOMES.113.000264; Qayyum R, 2008, ANN INTERN MED, V148, P186, DOI 10.7326/0003-4819-148-3-200802050-00005; Rasmussen JN, 2007, CARDIOVASC DRUG THER, V21, P449, DOI 10.1007/s10557-007-6058-7; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Rasmussen S, 2005, MED CARE, V43, P970, DOI 10.1097/01.mlr.0000178195.07110.d3; Rosenbaum P ., 2002, OBSERVATIONAL STUDIE; Saaby L, 2014, AM J MED, V127, P295, DOI 10.1016/j.amjmed.2013.12.020; Saaby L, 2013, AM J MED, V126, P789, DOI 10.1016/j.amjmed.2013.02.029; Savonitto S, 2012, JACC-CARDIOVASC INTE, V5, P906, DOI 10.1016/j.jcin.2012.06.008; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; Sorajja P, 2010, J AM COLL CARDIOL, V55, P1416, DOI 10.1016/j.jacc.2009.11.063; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3	43	6	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					737	+		10.7326/M15-0303	http://dx.doi.org/10.7326/M15-0303			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26502223				2022-12-28	WOS:000365746400016
J	Burke, M; Hsiang, SM; Miguel, E				Burke, Marshall; Hsiang, Solomon M.; Miguel, Edward			Global non-linear effect of temperature on economic production	NATURE			English	Article							MODELS	Growing evidence demonstrates that climatic conditions can have a profound impact on the functioning of modern human societies(1,2), but effects on economic activity appear inconsistent. Fundamental productive elements of modern economies, such as workers and crops, exhibit highly non-linear responses to local temperature even in wealthy countries(3,4). In contrast, aggregate macroeconomic productivity of entire wealthy countries is reported not to respond to temperature(5), while poor countries respond only linearly(5,6). Resolving this conflict between micro and macro observations is critical to understanding the role of wealth in coupled human-natural systems(7,8) and to anticipating the global impact of climate change(9,10). Here we unify these seemingly contradictory results by accounting for non-linearity at the macro scale. We show that overall economic productivity is non-linear in temperature for all countries, with productivity peaking at an annual average temperature of 13 degrees C and declining strongly at higher temperatures. The relationship is globally generalizable, unchanged since 1960, and apparent for agricultural and non-agricultural activity in both rich and poor countries. These results provide the first evidence that economic activity in all regions is coupled to the global climate and establish a new empirical foundation for modelling economic loss in response to climate change(11,12), with important implications. If future adaptation mimics past adaptation, unmitigated warming is expected to reshape the global economy by reducing average global incomes roughly 23% by 2100 and widening global income inequality, relative to scenarios without climate change. In contrast to prior estimates, expected global losses are approximately linear in global mean temperature, with median losses many times larger than leading models indicate.	[Burke, Marshall] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Burke, Marshall] Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA; [Hsiang, Solomon M.] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; [Hsiang, Solomon M.; Miguel, Edward] Univ Calif Berkeley, Natl Bur Econ Res, Berkeley, CA 94720 USA; [Miguel, Edward] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA	Stanford University; Stanford University; University of California System; University of California Berkeley; National Bureau of Economic Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Burke, M (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.	mburke@stanford.edu		Miguel, Edward/0000-0001-6927-709X; Burke, Marshall/0000-0003-4288-5858				[Anonymous], 2020, WORLD DEV IND; [Anonymous], 2012, KIKA; Barreca A., J POLIT EC IN PRESS; Burke M., AM EC J EC IN PRESS; Costinot A., J POLIT EC IN PRESS; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Dell M, 2009, AM ECON REV, V99, P198, DOI 10.1257/aer.99.2.198; Deryugina T., 2014, 20750 NBER; Heal G., 2013, 19725 NBER; Houser T., 2015, EC RISKS CLIMATE CHA; Hsiang S.M., 2014, CAUSAL EFFECT ENV CA; Hsiang S. M., 2012, 2265501 SSRN; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Nordhaus W. D., 2008, QUESTION BALANCE WEI; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Olmstead AL, 2011, P NATL ACAD SCI USA, V108, P480, DOI 10.1073/pnas.1008279108; Pindyck RS, 2013, J ECON LIT, V51, P860, DOI 10.1257/jel.51.3.860; Revesz RL, 2014, NATURE, V508, P173, DOI 10.1038/508173a; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Solow R., 2012, EC ENV; SUMMERS R, 1991, Q J ECON, V106, P327, DOI 10.2307/2937941; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766	27	745	761	62	395	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					235	+		10.1038/nature15725	http://dx.doi.org/10.1038/nature15725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RC	26503051				2022-12-28	WOS:000364396700045
J	Rodriguez-Gutierrez, R; Shah, ND; Montori, VM				Rodriguez-Gutierrez, Rene; Shah, Nilay D.; Montori, Victor M.			Predicting the Overuse of PCSK-9 Inhibitors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIGH CHOLESTEROL; STATIN THERAPY; GUIDELINES		[Rodriguez-Gutierrez, Rene; Shah, Nilay D.; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Rodriguez-Gutierrez, Rene; Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA; [Shah, Nilay D.] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Div Endocrinol Diabet Metab & Nutr, 200 First St SW, Rochester, MN 55905 USA.	montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898				Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Iglay K, 2015, CLIN THER, V37; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Shrank WH, 2015, JAMA-J AM MED ASSOC, V314, P1443, DOI 10.1001/jama.2015.10017; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	8	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1909	1910		10.1001/jama.2015.13414	http://dx.doi.org/10.1001/jama.2015.13414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547456				2022-12-28	WOS:000364490700007
J	Shabuer, G; Ishida, K; Pidot, SJ; Roth, M; Dahse, HM; Hertweck, C				Shabuer, Gulimila; Ishida, Keishi; Pidot, Sacha J.; Roth, Martin; Dahse, Hans-Martin; Hertweck, Christian			Plant pathogenic anaerobic bacteria use aromatic polyketides to access aerobic territory	SCIENCE			English	Article							CLOSTRIDIUM-ACETOBUTYLICUM; PECTOLYTIC CLOSTRIDIA; BIOSYNTHESIS; ANTIBIOTICS; DETOXIFICATION; GENERATION; SYNTHASE; STRAINS	Around 25% of vegetable food is lost worldwide because of infectious plant diseases, including microbe-induced decay of harvested crops. In wet seasons and under humid storage conditions, potato tubers are readily infected and decomposed by anaerobic bacteria (Clostridium puniceum). We found that these anaerobic plant pathogens harbor a gene locus (type II polyketide synthase) to produce unusual polyketide metabolites (clostrubins) with dual functions. The clostrubins, which act as antibiotics against other microbial plant pathogens, enable the anaerobic bacteria to survive an oxygen-rich plant environment.	[Shabuer, Gulimila; Ishida, Keishi; Pidot, Sacha J.; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, Jena, Germany; [Pidot, Sacha J.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3010, Australia; [Roth, Martin] Leibniz Inst Nat Prod Res & Infect Biol HKI, Bio Pilot Plant, Jena, Germany; [Dahse, Hans-Martin] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Infect Biol, Jena, Germany; [Hertweck, Christian] Univ Jena, Dept Nat Prod Chem, Jena, Germany	Hans Knoll Institute (HKI); University of Melbourne; Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Hertweck, C (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, Jena, Germany.	christian.hertweck@leibniz-hki.de	Hertweck, Christian/AAZ-8452-2021; Pidot, Sacha/Y-3421-2018	Hertweck, Christian/0000-0002-0367-337X; Pidot, Sacha/0000-0003-1202-6614	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [SFB 1127]; Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoell Institute) [WO 2015/113761 A1]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoell Institute)	We thank A. Perner for MS measurements, H. Heinecke for NMR measurements, U. Knupfer and M. Cyrulies for anaerobic fermentation support, K. Martin for assistance in sample preparation, S. Linde for recording micrographs, L. D. Halder for recording confocal fluorescence microscope images, and T. Stinear and T. Seemann for assistance with DNA sequencing and bioinformatic analyses. Supported by an Alexander von Humboldt Foundation fellowship (S.J.P.) and Deutsche Forschungsgemeinschaft grant SFB 1127 ChemBioSys. G.S., K. I., S.J.P., C.H., and the Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoell Institute) have filed a patent application (WO 2015/113761 A1) that relates to the structures of clostrubins A and B and their biological activities. Author contributions: G.S., K. I., and C.H. designed the research; G.S., K. I., S.J.P., and C.H. prepared the manuscript; G.S. performed anaerobic/aerobic bacterial culture experiments, potato tuber infection experiments, and antibacterial assays and constructed the Delta clrA mutant; K. I. and S.J.P. isolated clostrubins; K. I. elucidated structures; S.J.P. performed full genome sequencing and bioinformatic analyses and constructed the C. beijerinckii Delta clrA mutant; H.-M.D. performed FACS analyses; and M.R. designed and supervised anaerobic cultivation in fermenters. Supplement contains additional data.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babana A. H., 2011, British Microbiology Research Journal, V1, P41; Brachmann AO, 2007, CHEMBIOCHEM, V8, P1721, DOI 10.1002/cbic.200700300; Bull CT, 2010, J PLANT PATHOL, V92, P551; CAMPOS E, 1982, PLANT DIS, V66, P543, DOI 10.1094/PD-66-543; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hillmann F, 2008, MOL MICROBIOL, V68, P848, DOI 10.1111/j.1365-2958.2008.06192.x; Imlay JA, 2008, MOL MICROBIOL, V68, P801, DOI 10.1111/j.1365-2958.2008.06213.x; Jakobi K, 2004, J AM CHEM SOC, V126, P2298, DOI 10.1021/ja0390698; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Letzel AC, 2013, NAT PROD REP, V30, P392, DOI 10.1039/c2np20103h; Lombard M, 2000, J BIOL CHEM, V275, P115, DOI 10.1074/jbc.275.1.115; Lund B. M., 1982, PHYTOPATHOGENIC PROK, V1, P263; LUND BM, 1972, J APPL BACTERIOL, V35, P609, DOI 10.1111/j.1365-2672.1972.tb03742.x; LUND BM, 1981, J GEN MICROBIOL, V122, P17; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Pidot S, 2014, ANGEW CHEM INT EDIT, V53, P7856, DOI 10.1002/anie.201402632; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Riebe O, 2009, MICROBIOL-SGM, V155, P16, DOI 10.1099/mic.0.022756-0; Sandmann A, 2007, ANGEW CHEM INT EDIT, V46, P2712, DOI 10.1002/anie.200603513; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; van der Wolf Jan M., 2007, P595	29	36	37	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					670	674		10.1126/science.aac9990	http://dx.doi.org/10.1126/science.aac9990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542569				2022-12-28	WOS:000364162800048
J	Hengrung, N; El Omari, K; Martin, IS; Vreede, FT; Cusack, S; Rambo, RP; Vonrhein, C; Bricogne, G; Stuart, DI; Grimes, JM; Fodor, E				Hengrung, Narin; El Omari, Kamel; Martin, Itziar Serna; Vreede, Frank T.; Cusack, Stephen; Rambo, Robert P.; Vonrhein, Clemens; Bricogne, Gerard; Stuart, David I.; Grimes, Jonathan M.; Fodor, Ervin			Crystal structure of the RNA-dependent RNA polymerase from influenza C virus	NATURE			English	Article							REPLICATION; COMPLEX	Negative-sense RNA viruses, such as influenza, encode large, multidomain RNA-dependent RNA polymerases that can both transcribe and replicate the viral RNA genome(1). In influenza virus, the polymerase (FluPol) is composed of three polypeptides: PB1, PB2 and PA/P3. PB1 houses the polymerase active site, whereas PB2 and PA/P3 contain, respectively, cap-binding and endonuclease domains required for transcription initiation by cap-snatching(2). Replication occurs through de novo initiation and involves a complementary RNA intermediate. Currently available structures of the influenza A and B virus polymerases include promoter RNA (the 5' and 3' termini of viral genome segments), showing FluPol in transcription pre-initiation states(3,4). Here we report the structure of apo-FluPol from an influenza C virus, solved by X-ray crystallography to 3.9 angstrom, revealing a new 'closed' conformation. The apo-FluPol forms a compact particle with PB1 at its centre, capped on one face by PB2 and clamped between the two globular domains of P3. Notably, this structure is radically different from those of promoter-bound FluPols(3,4). The endonudease domain of P3 and the domains within the carboxy-terminal two-thirds of PB2 are completely rearranged. The cap-binding site is occluded by PB2, resulting in a conformation that is incompatible with transcription initiation. Thus, our structure captures FluPol in a closed, transcription pre-activation state. This reveals the conformation of newly made apo-FluPol in an infected cell, but may also apply to FluPol in the context of a non-transcribing ribonucleoprotein complex. Comparison of the apo-FluPol structure with those of promoter-bound FluPols allows us to propose a mechanism for FluPol activation. Our study demonstrates the remarkable flexibility of influenza virus RNA polymerase, and aids our understanding of the mechanisms controlling transcription and genome replication.	[Hengrung, Narin; Martin, Itziar Serna; Vreede, Frank T.; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Hengrung, Narin; El Omari, Kamel; Stuart, David I.; Grimes, Jonathan M.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Cusack, Stephen] Univ Grenoble Alpes, CNRS, EMBL Unit Virus Host Cell Interact, F-38042 Grenoble 9, France; [Rambo, Robert P.; Stuart, David I.; Grimes, Jonathan M.] Diamond Light Source Ltd, Didcot OX11 0DE, Oxon, England; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing Ltd, Cambridge CB3 0AX, England	University of Oxford; University of Oxford; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Diamond Light Source; Global Phasing Limited	Grimes, JM (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med, Oxford OX3 7BN, England.	jonathan@strubi.ox.ac.uk; ervin.fodor@path.ox.ac.uk		El Omari, Kamel/0000-0003-3506-6045; Cusack, Stephen/0000-0002-9324-0796; Grimes, Jonathan Mark/0000-0001-9698-0389; Stuart, David/0000-0002-3426-4210; Hengrung, Narin/0000-0003-0354-0507; Fodor, Ervin/0000-0003-3249-196X; Serna Martin, Itziar/0000-0003-0305-0057	Medical Research Council (MRC) [MR/K000241/1, G1100138, G1000099]; Wellcome Trust [092931/Z/10/Z, 075491/Z/04]; MRC; Medical Research Council [1374922, G1100138, MR/K000241/1, G1000099, G1100525, MR/N00065X/1] Funding Source: researchfish; MRC [MR/N00065X/1, MR/K000241/1, G1000099, G1100138] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Naffakh for providing plasmids and I. Berger for providing us with the MultiBac system. The authors thank Diamond Light Source for beamtime (proposal mx8423), and the staff of the MX beamlines for assistance. K. Harlos also provided valuable technical assistance. We thank G. G. Brownlee for initiating this project and for his comments and continuous encouragement, and members of the Fodor, Grimes and Stuart laboratories, particularly A. te Velthuis, for discussions. This work was supported by Medical Research Council (MRC) grants MR/K000241/1 (to E.F.), G1100138 (to F.T.V.) and G1000099 (to D.I.S.), Wellcome Trust Studentship 092931/Z/10/Z (to N.H.), an MRC Studentship (to I.S.M.), and Wellcome Trust administrative support grant 075491/Z/04.	Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Chang SH, 2015, MOL CELL, V57, P925, DOI 10.1016/j.molcel.2014.12.031; CIANCI C, 1995, J VIROL, V69, P3995, DOI 10.1128/JVI.69.7.3995-3999.1995; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Gabriel G, 2014, CURR TOP MICROBIOL, V385, P35, DOI 10.1007/82_2014_386; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Muraki Y, 2010, JPN J INFECT DIS, V63, P157; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Paterson D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003019; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110	18	108	110	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					114	117		10.1038/nature15525	http://dx.doi.org/10.1038/nature15525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26503046	Green Accepted			2022-12-28	WOS:000364270700054
J	Prindle, A; Liu, JT; Asally, M; Ly, S; Garcia-Ojalvo, J; Suel, GM				Prindle, Arthur; Liu, Jintao; Asally, Munehiro; Ly, San; Garcia-Ojalvo, Jordi; Sueel, Guerol M.			Ion channels enable electrical communication in bacterial communities	NATURE			English	Article							BACILLUS-SUBTILIS; POTASSIUM; VOLTAGE; PROTEIN; MECHANISM; BIOFILMS; DOMAINS; FORCES; KTRAB	The study of bacterial ion channels has provided fundamental insights into the structural basis of neuronal signalling; however, the native role of ion channels in bacteria has remained elusive. Here we show that ion channels conduct long-range electrical signals within bacterial biofilm communities through spatially propagating waves of potassium. These waves result from a positive feedback loop, in which a metabolic trigger induces release of intracellular potassium, which in turn depolarizes neighbouring cells. Propagating through the biofilm, this wave of depolarization coordinates metabolic states among cells in the interior and periphery of the biofilm. Deletion of the potassium channel abolishes this response. As predicted by a mathematical model, we further show that spatial propagation can be hindered by specific genetic perturbations to potassium channel gating. Together, these results demonstrate a function for ion channels in bacterial biofilms, and provide a prokaryotic paradigm for active, long-range electrical signalling in cellular communities.	[Prindle, Arthur; Liu, Jintao; Ly, San; Sueel, Guerol M.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Asally, Munehiro] Univ Warwick, Sch Life Sci, Warwick Integrat Synthet Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain	University of California System; University of California San Diego; University of Warwick; Pompeu Fabra University	Suel, GM (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	gsuel@ucsd.edu	Asally, Munehiro/AAZ-3693-2020; Liu, Jintao/P-9232-2018; Garcia-Ojalvo, Jordi/A-4574-2009	Asally, Munehiro/0000-0002-8273-7617; Liu, Jintao/0000-0002-6710-2605; Garcia-Ojalvo, Jordi/0000-0002-3716-7520	Ministerio de Economia y Competitividad (Spain); FEDER [FIS2012-37655-C02-01]; ICREA Academia Programme; National Institutes of Health, National Institute of General Medical Sciences [R01 GM088428]; National Science Foundation [MCB-1450867 50867]; San Diego Center for Systems Biology (NIH) [P50 GM085764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088428, P50GM085764] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad (Spain); FEDER(European Commission); ICREA Academia Programme(ICREA); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); San Diego Center for Systems Biology (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank S. Lockless, K. Suel, R. Wollman, T. Cagatay and M. Elowitz for comments during the writing of the manuscript, and C. Piggott for cloning help. A.P. is a Simons Foundation Fellow of the Helen Hay Whitney Foundation. J.G.-O. is supported by the Ministerio de Economia y Competitividad (Spain) and FEDER, under project FIS2012-37655-C02-01, and by the ICREA Academia Programme. This research was funded by the National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM088428 and the National Science Foundation Grant MCB-1450867 50867 (both to G.M.S.). This work was also supported by the San Diego Center for Systems Biology (NIH Grant P50 GM085764).	Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Cao Y, 2013, NATURE, V496, P317, DOI 10.1038/nature12056; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Gerstner W, 2002, SPIKING NEURON MODEL; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kato S, 2013, MICROBES ENVIRON, V28, P141, DOI 10.1264/jsme2.ME12161; Kinsinger RF, 2005, J BACTERIOL, V187, P8462, DOI 10.1128/JB.187.24.8462-8469.2005; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Lundberg ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060993; Lyer R., 2002, Nature, V419, P715, DOI 10.1038/nature01000; MacKinnon R, 2004, BIOSCIENCE REP, V24, P75, DOI 10.1007/s10540-004-7190-2; MARGOLIN Y, 1984, J BACTERIOL, V159, P605, DOI 10.1128/JB.159.2.605-610.1984; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Masi E., 2014, J R SOC INTERFACE, V12, P1; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; Payne S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.55; Petroff OAC, 2002, EPILEPSIA, V43, P703, DOI 10.1046/j.1528-1157.2002.38901.x; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rimmele TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109243; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Saimi Y, 1998, METHOD ENZYMOL, V294, P507; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; TOLNER B, 1995, J BACTERIOL, V177, P2863, DOI 10.1128/jb.177.10.2863-2869.1995; Vieira-Pires RS, 2013, NATURE, V496, P323, DOI 10.1038/nature12055; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; Wilking JN, 2013, P NATL ACAD SCI USA, V110, P848, DOI 10.1073/pnas.1216376110	46	340	345	23	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					59	63		10.1038/nature15709	http://dx.doi.org/10.1038/nature15709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26503040	Green Accepted, Green Submitted			2022-12-28	WOS:000364270700042
J	Smith, MY; Seligman, PJ				Smith, Meredith Y.; Seligman, Paul J.			New Opportunities for Integrating Drug Safety Risk Management Programs Into the Health Care System Bridging the Divide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Smith, Meredith Y.; Seligman, Paul J.] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen	Smith, MY (corresponding author), Amgen Inc, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mersmith@amgen.com	Seligman, Paul/AAX-2147-2020					[Anonymous], FDA LACKS COMPR DAT; Institute of Medicine, 2012, BEST CAR LOW COST PA; Kraus CN, 2013, CURR DRUG SAF, V8, P11, DOI 10.2174/1574886311308010003; Qato DM, 2011, JAMA-J AM MED ASSOC, V306, P1595, DOI 10.1001/jama.2011.1457; Smith MY, 2014, DRUG SAFETY, V37, P569, DOI 10.1007/s40264-014-0197-0; Tsapepas DS, 2014, J AM MED INFORM ASSN, V21, pE358, DOI 10.1136/amiajnl-2013-002446	6	3	3	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1793	1794		10.1001/jama.2015.11871	http://dx.doi.org/10.1001/jama.2015.11871			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529155				2022-12-28	WOS:000363960200006
J	Li, F; Liu, J; Zheng, Y; Garavito, RM; Ferguson-Miller, S				Li, Fei; Liu, Jian; Zheng, Yi; Garavito, R. Michael; Ferguson-Miller, Shelagh			Response to Comment on "Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism"	SCIENCE			English	Editorial Material								Wang comments that the diffraction data for the structure of the A139T mutant of translocator protein TSPO from Rhodobacter sphaeroides should be used to 1.65 instead of 1.8 angstroms and that the density interpreted as porphyrin and monoolein is better fitted as polyethylene glycol. Although different practices of data processing exist, in this case they do not substantially influence the final map. Additional data are presented supporting the fit of a porphyrin and monooleins.	[Li, Fei; Liu, Jian; Zheng, Yi; Garavito, R. Michael; Ferguson-Miller, Shelagh] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Ferguson-Miller, S (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	fergus20@msu.edu	Liu, Jian/C-4018-2015; zheng, yi/G-1917-2016	Liu, Jian/0000-0002-5668-542X; zheng, yi/0000-0002-4871-0779	NIGMS NIH HHS [R01 GM026916, R37 GM026916] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026916, R37GM026916] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; Protein Data Bank, US GUID WWPDB XRAY V; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Unno M, 2013, J BIOL CHEM, V288, P34443, DOI 10.1074/jbc.M113.486936; Wang JM, 2015, SCIENCE, V350, DOI 10.1126/science.aab1432; Wang JM, 2015, PROTEIN SCI, V24, P661, DOI 10.1002/pro.2639	12	12	15	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260								10.1126/science.aab2595	http://dx.doi.org/10.1126/science.aab2595			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516277	Green Accepted, Green Submitted			2022-12-28	WOS:000363660000037
J	Edwards, N				Edwards, Nigel			THE BEST POLICY Thinking the unthinkable about the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Nuffield Trust, London, England		Edwards, N (corresponding author), Nuffield Trust, London, England.	nigel.edwards@nuffieldtrust.org.uk						Department of Health for England, LORD CART RED VAR CA	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2015	351								h5697	10.1136/bmj.h5697	http://dx.doi.org/10.1136/bmj.h5697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GN	26506846				2022-12-28	WOS:000364147200017
J	Sorum, B; Czege, D; Csanady, L				Sorum, Ben; Czege, David; Csanady, Laszlo			Timing of CFTR Pore Opening and Structure of Its Transition State	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; ACETYLCHOLINE-RECEPTOR CHANNEL; CHLORIDE CHANNEL; ATP-BINDING; ABC TRANSPORTER; CRYSTAL-STRUCTURE; CATALYTIC CYCLE; P-GLYCOPROTEIN; MECHANISM	In CFTR, the chloride ion channel mutated in cystic fibrosis (CF) patients, pore opening is coupled to ATP-binding-induced dimerization of two cytosolic nucleotide binding domains (NBDs) and closure to dimer disruption following ATP hydrolysis. CFTR opening rate, unusually slow because of its highenergy transition state, is further slowed by CF mutation Delta F508. Here, we exploit equilibrium gating of hydrolysis-deficient CFTR mutant D1370N and apply rate-equilibrium free-energy relationship analysis to estimate relative timing of opening movements in distinct protein regions. We find clear directionality of motion along the longitudinal protein axis and identify an opening transition-state structure with the NBD dimer formed but the pore still closed. Thus, strain at the NBD/pore-domain interface, the Delta F508 mutation locus, underlies the energetic barrier for opening. Our findings suggest a therapeutic opportunity to stabilize this transition-state structure pharmacologically in Delta F508-CFTR to correct its opening defect, an essential step toward restoring CFTR function.	[Sorum, Ben; Csanady, Laszlo] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary; [Sorum, Ben; Czege, David; Csanady, Laszlo] Semmelweis Univ, MTA SE Ion Channel Res Grp, H-1094 Budapest, Hungary	Semmelweis University; Semmelweis University	Csanady, L (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto U 37-47, H-1094 Budapest, Hungary.	csanady.laszlo@med.semmelweis-univ.hu	Csanády, László/O-5784-2017	Csanády, László/0000-0002-6547-5889; SORUM, Em Ben./0000-0001-6742-1094	MTA Lendulet [LP2012-39/2012]; Cystic Fibrosis Foundation; Howard Hughes Medical Institute	MTA Lendulet; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Beata Torocsik for generous help and guidance in molecular biology, and David Gadsby and Paola Vergani for critical review and discussions. Supported by MTA Lendulet grant LP2012-39/2012, a Research Grant from the Cystic Fibrosis Foundation, and an International Early Career Scientist grant from the Howard Hughes Medical Institute to L.C.	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Auerbach A, 2007, J GEN PHYSIOL, V130, P543, DOI 10.1085/jgp.200709898; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Chaves LAP, 2015, J GEN PHYSIOL, V145, P261, DOI 10.1085/jgp.201411347; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Csanady L, 2014, J GEN PHYSIOL, V143, P269, DOI 10.1085/jgp.201311089; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Csanady L, 2009, J GEN PHYSIOL, V134, P129, DOI 10.1085/jgp.200910268; Cui GY, 2014, J GEN PHYSIOL, V144, P159, DOI 10.1085/jgp.201311122; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Fatehi M, 2009, J MEMBRANE BIOL, V228, P151, DOI 10.1007/s00232-009-9167-3; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; JACKSON MB, 1983, BIOPHYS J, V42, P109, DOI 10.1016/S0006-3495(83)84375-6; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Linsdell P, 2000, BIOPHYS J, V78, P2973, DOI 10.1016/S0006-3495(00)76836-6; Linsdell P, 2001, J PHYSIOL-LONDON, V531, P51, DOI 10.1111/j.1469-7793.2001.0051j.x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; MCDONOUGH S, 1994, NEURON, V13, P623, DOI 10.1016/0896-6273(94)90030-2; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Purohit P, 2015, J PHYSIOL-LONDON, V593, P2851, DOI 10.1113/JP270223; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rai V, 2006, BIOCHEMISTRY-US, V45, P14726, DOI 10.1021/bi061535t; RIORDAN JR, 1989, SCIENCE, V245, P1066; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2014, J BIOL CHEM, V289, P30364, DOI 10.1074/jbc.M114.595710; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang WL, 2002, AM J PHYSIOL-CELL PH, V282, pC1170, DOI 10.1152/ajpcell.00337.2001; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; WINTER MC, 1994, BIOPHYS J, V66, P1398, DOI 10.1016/S0006-3495(94)80930-0; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Yeh HI, 2015, J GEN PHYSIOL, V145, P47, DOI 10.1085/jgp.201411272; Zeltwanger S, 1999, J GEN PHYSIOL, V113, P541, DOI 10.1085/jgp.113.4.541; Zhang ZR, 2000, BIOPHYS J, V79, P298, DOI 10.1016/S0006-3495(00)76292-8; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	63	44	44	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					724	733		10.1016/j.cell.2015.09.052	http://dx.doi.org/10.1016/j.cell.2015.09.052			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496611	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000364828900024
J	Oeffinger, KC; Fontham, ETH; Etzioni, R; Herzig, A; Michaelson, JS; Shih, YCT; Walter, LC; Church, TR; Flowers, CR; LaMonte, SJ; Wolf, AMD; DeSantis, C; Lortet-Tieulent, J; Andrews, K; Manassaram-Baptiste, D; Saslow, D; Smith, RA; Brawley, OW; Wender, R				Oeffinger, Kevin C.; Fontham, Elizabeth T. H.; Etzioni, Ruth; Herzig, Abbe; Michaelson, James S.; Shih, Ya-Chen Tina; Walter, Louise C.; Church, Timothy R.; Flowers, Christopher R.; LaMonte, Samuel J.; Wolf, Andrew M. D.; DeSantis, Carol; Lortet-Tieulent, Joannie; Andrews, Kimberly; Manassaram-Baptiste, Deana; Saslow, Debbie; Smith, Robert A.; Brawley, Otis W.; Wender, Richard			Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CARCINOMA IN-SITU; COST-EFFECTIVENESS; QUANTITATIVE INTERPRETATION; TUMOR CHARACTERISTICS; MORTALITY REDUCTIONS; COMMUNITY PRACTICE; CHEST RADIATION; OLDER WOMEN; FOLLOW-UP; MAMMOGRAPHY	IMPORTANCE Breast cancer is a leading cause of premature mortality among US women. Early detection has been shown to be associated with reduced breast cancer morbidity and mortality. OBJECTIVE To update the American Cancer Society (ACS) 2003 breast cancer screening guideline for women at average risk for breast cancer. PROCESS The ACS commissioned a systematic evidence review of the breast cancer screening literature to inform the update and a supplemental analysis of mammography registry data to address questions related to the screening interval. Formulation of recommendations was based on the quality of the evidence and judgment (incorporating values and preferences) about the balance of benefits and harms. EVIDENCE SYNTHESIS Screening mammography in women aged 40 to 69 years is associated with a reduction in breast cancer deaths across a range of study designs, and inferential evidence supports breast cancer screening for women 70 years and older who are in good health. Estimates of the cumulative lifetime risk of false-positive examination results are greater if screening begins at younger ages because of the greater number of mammograms, as well as the higher recall rate in younger women. The quality of the evidence for overdiagnosis is not sufficient to estimate a lifetime risk with confidence. Analysis examining the screening interval demonstrates more favorable tumor characteristics when premenopausal women are screened annually vs biennially. Evidence does not support routine clinical breast examination as a screening method for women at average risk. RECOMMENDATIONS The ACS recommends that women with an average risk of breast cancer should undergo regular screening mammography starting at age 45 years (strong recommendation). Women aged 45 to 54 years should be screened annually (qualified recommendation). Women 55 years and older should transition to biennial screening or have the opportunity to continue screening annually (qualified recommendation). Women should have the opportunity to begin annual screening between the ages of 40 and 44 years (qualified recommendation). Women should continue screening mammography as long as their overall health is good and they have a life expectancy of 10 years or longer (qualified recommendation). The ACS does not recommend clinical breast examination for breast cancer screening among average-risk women at any age (qualified recommendation). CONCLUSIONS AND RELEVANCE These updated ACS guidelines provide evidence-based recommendations for breast cancer screening for women at average risk of breast cancer. These recommendations should be considered by physicians and women in discussions about breast cancer screening.	[Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Fontham, Elizabeth T. H.] Louisiana State Univ, Sch Publ Hlth, New Orleans, LA USA; [Etzioni, Ruth] Univ Washington, Seattle, WA 98195 USA; [Etzioni, Ruth] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Michaelson, James S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Michaelson, James S.] Harvard Univ, Sch Med, Boston, MA USA; [Shih, Ya-Chen Tina] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Walter, Louise C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Walter, Louise C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Church, Timothy R.] Mason Canc Ctr, Minneapolis, MN USA; [Church, Timothy R.] Univ Minnesota, Minneapolis, MN USA; [Flowers, Christopher R.] Emory Univ, Sch Med, Atlanta, GA USA; [Flowers, Christopher R.] Winship Canc Inst, Atlanta, GA USA; [Wolf, Andrew M. D.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [DeSantis, Carol; Lortet-Tieulent, Joannie; Andrews, Kimberly; Manassaram-Baptiste, Deana; Saslow, Debbie; Smith, Robert A.; Brawley, Otis W.; Wender, Richard] Amer Canc Soc, Atlanta, GA 30303 USA	Memorial Sloan Kettering Cancer Center; Louisiana State University System; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Emory University; University of Virginia; American Cancer Society	Smith, RA (corresponding author), Amer Canc Soc, Canc Control Dept, 250 Williams St,Ste 600, Atlanta, GA 30303 USA.	robert.smith@cancer.org	Church, Timothy/AAH-7017-2020; Smith, Robert/AAB-6682-2020; DeSantis, Carol/HGC-3925-2022; Flowers, Christopher R/F-1953-2010; Lortet-Tieulent, Joannie/AAE-9099-2019	Church, Timothy/0000-0003-3292-5035; DeSantis, Carol/0000-0002-9382-6009; Flowers, Christopher R/0000-0002-9524-3990; Lortet-Tieulent, Joannie/0000-0002-8816-7475; Shih, Ya-Chen Tina/0000-0001-7290-3864	American Cancer Society (ACS); Cancer Center Support Grant from the National Institutes of Health/National Cancer Institute [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG041180] Funding Source: NIH RePORTER	American Cancer Society (ACS)(American Cancer Society); Cancer Center Support Grant from the National Institutes of Health/National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The American Cancer Society (ACS) supported the development of this guideline through the use of general funds. Dr Oeffinger was supported in part through a Cancer Center Support Grant from the National Institutes of Health/National Cancer Institute (P30 CA008748).	Allen JD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1169; Anderson RT, 2014, HEALTH SERV RES, V49, P546, DOI 10.1111/1475-6773.12108; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], ASS IMPR IM INT BREA; [Anonymous], SYST REV CANC SCREEN; Bancej C, 2003, J MED SCREEN, V10, P16, DOI 10.1258/096914103321610761; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Blanchard K, 2004, CANCER-AM CANCER SOC, V101, P495, DOI 10.1002/cncr.20392; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bobo, 2000, Ann Epidemiol, V10, P463, DOI 10.1016/S1047-2797(00)00099-5; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd Norman F, 2014, Breast Cancer Res, V16, P417, DOI 10.1186/s13058-014-0417-7; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Brawley O, 2011, JAMA-J AM MED ASSOC, V306, P2495, DOI 10.1001/jama.2011.1800; Breast Cancer Surveillance Consortium, PERF MEAS 1838372 SC; Broeders M, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.012078; Brown ML, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130174; Buist DSM, 2014, RADIOLOGY, V273, P351, DOI 10.1148/radiol.14132806; Carles M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-192; Centers for Disease Control and Prevention, 2014, DEATHS FIN DAT 2011, V63; Chiu SYH, 2010, CANCER EPIDEM BIOMAR, V19, P1219, DOI 10.1158/1055-9965.EPI-09-1028; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; de Gelder R, 2009, EUR J CANCER, V45, P127, DOI 10.1016/j.ejca.2008.09.015; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; de Glas NA, 2013, BREAST CANCER RES TR, V138, P561, DOI 10.1007/s10549-013-2462-9; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; DEKONING HJ, 1995, JNCI-J NATL CANCER I, V87, P1217; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dickinson J, 2011, CAN MED ASSOC J, V183, P1991, DOI 10.1503/cmaj.110334; Dijkstra JB, 1999, BRIT J ANAESTH, V82, P867, DOI 10.1093/bja/82.6.867; Duffy SW, 2013, BREAST CANCER MANAG, V2, P519, DOI 10.2217/BMT.13.53; Duffy SW, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3427; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Elkin EB, 2013, CANCER CAUSE CONTROL, V24, P1057, DOI 10.1007/s10552-013-0180-6; Esserman L, 2015, JAMA ONCOL, V1, P881, DOI 10.1001/jamaoncol.2015.2607; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Gold EB, 2013, AM J EPIDEMIOL, V178, P70, DOI 10.1093/aje/kws421; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Habbema JDF, 2014, ANN INTERN MED, V161, P812, DOI 10.7326/M14-0845; Hackshaw A, 2012, J MED SCREEN, V19, P1, DOI 10.1258/jms.2012.012074; Hartmann LC, 2015, NEW ENGL J MED, V372, P78, DOI 10.1056/NEJMsr1407164; Hellquist BN, 2011, CANCER-AM CANCER SOC, V117, P714, DOI 10.1002/cncr.25650; Helvie MA, 2014, CANCER-AM CANCER SOC, V120, P2649, DOI 10.1002/cncr.28784; Henderson TO, 2010, ANN INTERN MED, V152, P444, DOI 10.7326/0003-4819-152-7-201004060-00009; Holm J, 2015, J CLIN ONCOL, V33, P1030, DOI 10.1200/JCO.2014.58.9986; Houssami N, 2013, CANCER EPIDEM BIOMAR, V22, P946, DOI 10.1158/1055-9965.EPI-12-1208-T; Howlander N., 2015, SEER CANC STAT REV 1; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Hurria A, 2012, J NATL COMPR CANC NE, V10, P162, DOI 10.6004/jnccn.2012.0019; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Jonsson H, 2007, J MED SCREEN, V14, P87, DOI 10.1258/096914107781261918; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Lee CI, 2015, RADIOLOGY, V274, P772, DOI 10.1148/radiol.14141237; Lee S, 2012, EPROGNOSIS ESTIMATIN; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McDonald S, 2004, CA-CANCER J CLIN, V54, P345, DOI 10.3322/canjclin.54.6.345; Michaelson J, 2002, CANCER, V94, P37, DOI 10.1002/cncr.10154; Michaelson JS, 2003, CANCER-AM CANCER SOC, V98, P2114, DOI 10.1002/cncr.11766; Miglioretti DL, 2015, JAMA ONCOL, V1, P1069, DOI 10.1001/jamaoncol.2015.3084; Moss SM, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.012079; Mulder RL, 2013, LANCET ONCOL, V14, pE621, DOI 10.1016/S1470-2045(13)70303-6; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; National Comprehensive Cancer Network, BREAST CANC SCREEN D; Nelson HD, 2009, ANN INTERN MED, V151, pW; Nelson HD, 2015, SCREENING BREAST CAN; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P703, DOI [10.7326/0000605-200911170-00147, 10.7326/0003-4819-151-10-200911170-00147]; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Otto SJ, 2003, LANCET, V361, P1411, DOI 10.1016/S0140-6736(03)13132-7; Ozanne EM, 2013, CANCER EPIDEM BIOMAR, V22, P146, DOI 10.1158/1055-9965.EPI-12-0570; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Pataky R, 2014, J MED SCREEN, V21, P180, DOI 10.1177/0969141314549758; Pisano ED, 2008, RADIOLOGY, V246, P376, DOI 10.1148/radiol.2461070200; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Raftery J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7627; Raik BL, 2004, J AM GERIATR SOC, V52, P440, DOI 10.1111/j.1532-5415.2004.52119.x; Roder D, 2008, BREAST CANCER RES TR, V108, P409, DOI 10.1007/s10549-007-9609-5; Samson D, AHRQ PUBLICATION, V12-EHC017; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Shapiro S, 1988, PERIODIC SCREENING B; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sima CS, 2010, JAMA-J AM MED ASSOC, V304, P1584, DOI 10.1001/jama.2010.1449; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Souza FH, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-366; Sox HC, 1998, J GEN INTERN MED, V13, P424, DOI 10.1046/j.1525-1497.1998.00126.x; Sprague BL, 2009, JAMA-J AM MED ASSOC, V302, P846, DOI 10.1001/jama.2009.1211; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Tabar L, 1996, J NATL CANCER I, V88, P52, DOI 10.1093/jnci/88.1.52-a; TABAR L, 1987, BRIT J CANCER, V55, P547, DOI 10.1038/bjc.1987.112; Tabar L, 2004, J MED SCREEN, V11, P126, DOI 10.1258/0969141041732175; Tabar L, 2015, BREAST J, V21, P13, DOI 10.1111/tbj.12354; Tabar L, 2011, RADIOLOGY, V260, P658, DOI 10.1148/radiol.11110469; Tan A, 2014, MED CARE, V52, P490, DOI 10.1097/MLR.0000000000000115; Thomson MD, 2015, WOMEN HEALTH ISS, V25, P128, DOI 10.1016/j.whi.2014.11.003; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tosteson ANA, 2014, JAMA INTERN MED, V174, P954, DOI 10.1001/jamainternmed.2014.981; Verbeek Andre L M, 2014, Ned Tijdschr Geneeskd, V158, pA7047; Vervoort MM, 2004, BRIT J CANCER, V91, P242, DOI 10.1038/sj.bjc.6601969; Walter LC, 2001, J GEN INTERN MED, V16, P779, DOI 10.1046/j.1525-1497.2001.10113.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Walter LC, 2014, JAMA-J AM MED ASSOC, V311, P1336, DOI 10.1001/jama.2014.2834; Welch HG, 2010, NEW ENGL J MED, V363, P1276, DOI 10.1056/NEJMe1008369; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	122	955	992	6	85	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1599	1614		10.1001/jama.2015.12783	http://dx.doi.org/10.1001/jama.2015.12783			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501536	Green Accepted, Bronze			2022-12-28	WOS:000363028500020
J	Sabate, M; Brugaletta, S; Cequier, A; Iniguez, A; Serra, A; Jimenez-Quevedo, P; Mainar, V; Campo, G; Tespili, M; den Heijer, P; Bethencourt, A; Vazquez, N; van Es, GA; Backx, B; Valgimigli, M; Serruys, PW				Sabate, Manel; Brugaletta, Salvatore; Cequier, Angel; Iniguez, Andres; Serra, Antonio; Jimenez-Quevedo, Pilar; Mainar, Vicente; Campo, Gianluca; Tespili, Maurizio; den Heijer, Peter; Bethencourt, Armando; Vazquez, Nicolas; van Es, Gerrit Anne; Backx, Bianca; Valgimigli, Marco; Serruys, Patrick W.			Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial	LANCET			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITOR; CYPHER STENT; FOLLOW-UP; IMPLANTATION; THROMBOSIS; NEOATHEROSCLEROSIS; MULTICENTER; PLACEMENT; DESIGN	Background Data for the safety and efficacy of new-generation drug-eluting stents at long-term follow-up, and specifically in patients with ST-segment elevation myocardial infarction, are scarce. In the EXAMINATION trial, we compared everolimus-eluting stents (EES) with bare-metal stents (BMS) in an all-comer population with ST-segment elevation myocardial infarction. In this study, we assessed the 5-year outcomes of the population in the EXAMINATION trial. Methods In the multicentre EXAMINATION trial, done in Italy, Spain, and the Netherlands, patients with ST-segment elevation myocardial infarction were randomly assigned in a 1: 1 ratio to receive EES or BMS. The random allocation schedule was computer-generated and central randomisation (by telephone) was used to allocate patients in blocks of four or six, stratified by centre. Patients were masked to treatment assignment. At 5 years, we assessed the combined patient-oriented outcome of all-cause death, any myocardial infarction, or any revascularisation. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00828087. Findings 1498 patients were randomly assigned to receive either EES (n=751) or BMS (n=747). At 5 years, complete clinical follow-up data were obtained for 731 patients treated with EES and 727 treated with BMS (97% of both groups). The patient-oriented endpoint occurred in 159 (21%) patients in the EES group versus 192 (26%) in the BMS group (hazard ratio 0.80, 95% CI 0.65-0.98; p=0.033). This difference was mainly driven by a reduced rate of all-cause mortality (65 [9%] vs 88 [12%]; 0.72, 0.52-0.10; p=0.047). Interpretation Our findings should be taken as a point of reference for the assessment of new bioresorbable polymer-based metallic stents or bioresorbable scaffolds in patients with ST-segment elevation myocardial infarction.	[Sabate, Manel; Brugaletta, Salvatore] Univ Hosp Clin, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Cequier, Angel] Univ Hosp Bellvitge, Barcelona, Spain; [Iniguez, Andres] Hosp Meixoeiro, Vigo, Spain; [Serra, Antonio] Univ Hosp St Pau, Barcelona, Spain; [Jimenez-Quevedo, Pilar] Univ Hosp San Carlos, Madrid, Spain; [Mainar, Vicente] Hosp Gen Alicante, Alicante, Spain; [Campo, Gianluca] Univ Hosp Ferrara, Ferrara, Italy; [Tespili, Maurizio] Univ Hosp Bolognini Seriate, Bergamo, Italy; [den Heijer, Peter] Amphia Ziekenhuis, Breda, Netherlands; [Bethencourt, Armando] Hosp Son Espases, Palma De Mallorca, Spain; [Vazquez, Nicolas] Hosp Juan Canalejo, La Coruna, Spain; [van Es, Gerrit Anne; Backx, Bianca] Cardialysis, Rotterdam, Netherlands; [Valgimigli, Marco] Erasmus MC, Rotterdam, Netherlands; [Valgimigli, Marco] Univ Hosp Bern, Inselhosp, CH-3010 Bern, Switzerland; [Serruys, Patrick W.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Complexo Hospitalario Universitario de Vigo; Hospital Clinico San Carlos; General University Hospital of Alicante; University of Ferrara; Arcispedale Sant'Anna; Amphia Hospital; Hospital Universitari Son Espases; Complejo Hospitalario Universitario A Coruna; Cardialysis; Erasmus University Rotterdam; Erasmus MC; University of Bern; University Hospital of Bern; Imperial College London	Sabate, M (corresponding author), Univ Barcelona, Hosp Clin, Dept Cardiol, C Villarroel 170, E-08036 Barcelona, Spain.	masabate@clinic.ub.es	Brugaletta, Salvatore/AAJ-2090-2020; Valgimigli, Marco/AAE-9103-2019; Sabate, Manel/AAX-7245-2021	Valgimigli, Marco/0000-0002-4353-7110; Campo, Gianluca/0000-0002-5150-188X; Sabate Tenas, Manel/0000-0002-2316-3705; Jimenez Quevedo, Pilar/0000-0001-7562-8677	Spanish Heart Foundation; Abbott Vascular	Spanish Heart Foundation; Abbott Vascular(Abbott Laboratories)	Spanish Heart Foundation.; This trial was partly funded by an unrestricted grant from the promoter Abbott Vascular to the Spanish Heart Foundation.	Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Gomez-Lara J, 2011, JACC-CARDIOVASC INTE, V4, P1271, DOI 10.1016/j.jcin.2011.08.016; Gonzalo N, 2009, JACC-CARDIOVASC INTE, V2, P445, DOI 10.1016/j.jcin.2009.01.012; Hofma SH, 2012, J AM COLL CARDIOL, V60, P381, DOI 10.1016/j.jacc.2012.01.073; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kastrati A, 2007, EUR HEART J, V28; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Mizoguchi T, 2014, INT J CARDIOL, V171, P224, DOI 10.1016/j.ijcard.2013.12.021; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Nakazawa G, 2014, EUROINTERVENTION, V10, P717, DOI 10.4244/EIJV10I6A124; Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Puricel S, 2015, J AM COLL CARDIOL, V65, P791, DOI 10.1016/j.jacc.2014.12.017; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P64, DOI 10.1016/j.jcin.2013.09.006; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sabate M, 2011, EUROINTERVENTION, V7, P977, DOI 10.4244/EIJV7I8A154; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Steg PG, 2009, EUR HEART J, V30, P321, DOI 10.1093/eurheartj/ehn604; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Tada N, 2010, CIRC-CARDIOVASC INTE, V3, P174, DOI 10.1161/CIRCINTERVENTIONS.109.877522; Takano M, 2013, INT J CARDIOL, V166, P181, DOI 10.1016/j.ijcard.2011.10.102; Valgimigli M, 2007, J AM COLL CARDIOL, V50, P138, DOI 10.1016/j.jacc.2007.04.029; Valgimigli M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6427; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006; Wilson GJ, 2009, CIRCULATION, V120, P141, DOI 10.1161/CIRCULATIONAHA.107.730010; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Yonetsu T, 2012, AM J CARDIOL, V110, P933, DOI 10.1016/j.amjcard.2012.05.027	36	131	133	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					357	366		10.1016/S0140-6736(15)00548-6	http://dx.doi.org/10.1016/S0140-6736(15)00548-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26520230	Green Published			2022-12-28	WOS:000368516500034
J	Zhou, MG; Wang, HD; Zhu, J; Chen, WQ; Wang, LH; Liu, SW; Li, YC; Wang, LJ; Liu, YN; Yin, P; Liu, JM; Yu, SC; Tan, F; Barber, RM; Coates, MM; Dicker, D; Fraser, M; Gonzalez-Medina, D; Hamavid, H; Hao, YT; Hu, GQ; Jiang, GH; Kan, HD; Lopez, AD; Phillips, MR; She, J; Vos, T; Wan, X; Xu, GL; Yan, LJL; Yu, CH; Zhao, Y; Zheng, YF; Zou, XN; Naghavi, M; Wang, Y; Murray, CJL; Yang, GH; Liang, XF				Zhou, Maigeng; Wang, Haidong; Zhu, Jun; Chen, Wanqing; Wang, Linhong; Liu, Shiwei; Li, Yichong; Wang, Lijun; Liu, Yunning; Yin, Peng; Liu, Jiangmei; Yu, Shicheng; Tan, Feng; Barber, Ryan M.; Coates, Matthew M.; Dicker, Daniel; Fraser, Maya; Gonzalez-Medina, Diego; Hamavid, Hannah; Hao, Yuantao; Hu, Guoqing; Jiang, Guohong; Kan, Haidong; Lopez, Alan D.; Phillips, Michael R.; She, Jun; Vos, Theo; Wan, Xia; Xu, Gelin; Yan, Lijing L.; Yu, Chuanhua; Zhao, Yong; Zheng, Yingfeng; Zou, Xiaonong; Naghavi, Mohsen; Wang, Yu; Murray, Christopher J. L.; Yang, Gonghuan; Liang, Xiaofeng			Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							REPUBLIC-OF-CHINA; SUICIDE-PREVENTION STRATEGIES; GASTRIC-CANCER; NUTRITION TRANSITION; INTEGRATED APPROACH; BLOOD-PRESSURE; RISK; STROKE; INJURY; DEATH	Background China has experienced a remarkable epidemiological and demographic transition during the past three decades. Far less is known about this transition at the subnational level. Timely and accurate assessment of the provincial burden of disease is needed for evidence-based priority setting at the local level in China. Methods Following the methods of the Global Burden of Disease Study 2013 (GBD 2013), we have systematically analysed all available demographic and epidemiological data sources for China at the provincial level. We developed methods to aggregate county-level surveillance data to inform provincial-level analysis, and we used local data to develop specific garbage code redistribution procedures for China. We assessed levels of and trends in all-cause mortality, causes of death, and years of life lost (YLL) in all 33 province-level administrative units in mainland China, all of which we refer to as provinces, for the years between 1990 and 2013. Findings All provinces in mainland China have made substantial strides to improve life expectancy at birth between 1990 and 2013. Increases ranged from 4.0 years in Hebei province to 14.2 years in Tibet. Improvements in female life expectancy exceeded those in male life expectancy in all provinces except Shanghai, Macao, and Hong Kong. We saw significant heterogeneity among provinces in life expectancy at birth and probability of death at ages 0-14, 15-49, and 50-74 years. Such heterogeneity is also present in cause of death structures between sexes and provinces. From 1990 to 2013, leading causes of YLLs changed substantially. In 1990, 16 of 33 provinces had lower respiratory infections or preterm birth complications as the leading causes of YLLs. 15 provinces had cerebrovascular disease and two (Hong Kong and Macao) had ischaemic heart disease. By 2013, 27 provinces had cerebrovascular disease as the leading cause, five had ischaemic heart disease, and one had lung cancer (Hong Kong). Road injuries have become a top ten cause of death in all provinces in mainland China. The most common non-communicable diseases, including ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and cancers (liver, stomach, and lung), contributed much more to YLLs in 2013 compared with 1990. Interpretation Rapid transitions are occurring across China, but the leading health problems and the challenges imposed on the health system by epidemiological and demographic change differ between groups of Chinese provinces. Localised health policies need to be implemented to tackle the diverse challenges faced by local health-care systems. Funding China National Science & Technology Pillar Program 2013 (2013BAI04B02) and Bill & Melinda Gates Foundation.	[Zhou, Maigeng; Wang, Linhong; Liu, Shiwei; Li, Yichong; Liu, Yunning] Natl Ctr Chron & Noncommun Dis Control & Prevent, Beijing, Peoples R China; [Tan, Feng] Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China; [Wang, Linhong; Yin, Peng; Liu, Jiangmei; Yu, Shicheng; Wang, Yu; Liang, Xiaofeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhou, Maigeng; Wang, Haidong; Barber, Ryan M.; Coates, Matthew M.; Dicker, Daniel; Fraser, Maya; Gonzalez-Medina, Diego; Hamavid, Hannah; Vos, Theo; Naghavi, Mohsen; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Zhu, Jun] Natl Off MCH Surveillance China, Chengdu, Peoples R China; [Chen, Wanqing; Zou, Xiaonong] Chinese Acad Med Sci, Inst Canc, Beijing 100730, Peoples R China; [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Hao, Yuantao; Zheng, Yingfeng] Sun Yat Sen Univ, Sch Publ Hlth, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Guoqing] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [She, Jun] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Phillips, Michael R.] Emory Univ, Atlanta, GA 30322 USA; [Xu, Gelin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Lijing L.] Duke Kunshan Univ, Kunshan, Peoples R China; Wuhan Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China; [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China; [Yang, Gonghuan] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Sun Yat Sen University; Central South University; Tianjin Center for Disease Control & Prevention; Fudan University; University of Melbourne; Shanghai Jiao Tong University; Emory University; Nanjing University; Duke Kunshan University; Wuhan University; Wuhan University; Chongqing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu; yangghuan@vip.sina.com; liangxf@hotmail.com	Lopez, Alan/AAA-2734-2022; Zhou, Maigeng/HCH-7703-2022; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022; Yin, Peng/AFP-5157-2022; Lopez, Alan D/F-1487-2010; Zhao, Yong/Z-3231-2019; wang, lin/HHM-2225-2022; Kan, Haidong/AGU-0328-2022; Phillips, Michael Robert/AAE-7585-2021; Zheng, Yingfeng/AAE-2983-2022; Li, Yichong/A-3559-2019; Zheng, Yingfeng/CAE-9225-2022	Lopez, Alan D/0000-0001-5818-6512; Zhao, Yong/0000-0001-9290-109X; Phillips, Michael Robert/0000-0002-5973-2439; Li, Yichong/0000-0003-3842-475X; Zheng, Yingfeng/0000-0002-0914-7864; Hu, Guoqing/0000-0002-5002-8015; Coates, Matthew/0000-0002-8474-4992; Xu, Gelin/0000-0002-6194-0341	China National Science & Technology Pillar Program [2013BAI04B02]; Bill & Melinda Gates Foundation; National Natural Science Foundation of China (NSFC) [81371502]; China Medical Board Grant on CMB-CP in Burden of Diseases in China [12-107]; National Natural Sciences Foundation of China [71233001, 71490732]; China Medical Board (China Medical Board Grant on CMB-CP in Burden of Diseases in China) [12-107]; National Science Foundation of China [81273179]	China National Science & Technology Pillar Program; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Medical Board Grant on CMB-CP in Burden of Diseases in China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China Medical Board (China Medical Board Grant on CMB-CP in Burden of Diseases in China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	China National Science & Technology Pillar Program 2013 (2013BAI04B02) and Bill & Melinda Gates Foundation.; This research was conducted as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2013 (GBD 2013). We thank all individuals who have contributed to this study and Jonathan Brown, Mollie Holmberg, Michael Kutz, and Grant Nguyen (Institute for Health Metrics and Evaluation, Seattle, WA, USA) for their important and much appreciated contribution to the preparation of this report. MRP would like to acknowledge support for his participation from the National Natural Science Foundation of China (NSFC, No. 81371502). XW acknowledges funding from the China Medical Board Grant on CMB-CP in Burden of Diseases in China (12-107). LLY is supported by the National Natural Sciences Foundation of China grants (71233001 and 71490732). GY acknowledges support from the China Medical Board (China Medical Board Grant on CMB-CP in Burden of Diseases in China [12-107]. CY acknowledges the grant support from the National Science Foundation of China (A Study on the Mortality Pattern of Chinese Population and Related Statistical Models [No. 81273179]).	Aiyagari V, 2009, STROKE, V40, P2251, DOI 10.1161/STROKEAHA.108.531574; Asaka M, 2013, INT J CANCER, V132, P1272, DOI 10.1002/ijc.27965; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Dong XQ, 2015, AGING DIS, V6, P121, DOI 10.14336/AD.2014.0223; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Ebrahim S, 2000, BRIT MED BULL, V56, P557, DOI 10.1258/0007142001903201; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Fu Z, 1987, WEI SHENG YAN JIU, V17, P50; Gaetano JN, 2014, DRUG HEALTHC PATIENT, V6, P37, DOI 10.2147/DHPS.S43304; GOLDMAN N, 1980, POP STUD-J DEMOG, V34, P5, DOI 10.1080/00324728.1980.10412832; Hao H, 1988, Popul Res, V5, P1; HE J, 1995, STROKE, V26, P2228; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; HE J, 1995, STROKE, V26, P2222, DOI 10.1161/01.STR.26.12.2222; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; JUNYAO L, 1981, INT J EPIDEMIOL, V10, P127, DOI 10.1093/ije/10.2.127; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Li N, 2009, BRIT J NUTR, V101, P1088, DOI 10.1017/S0007114508042360; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-180; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ma JX, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-122; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Bureau of Statistics of China, NAT DAT; O'Brien C, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-21; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; POPKIN BM, 1993, EUR J CLIN NUTR, V47, P333; Preston S, 2000, DEMOGRAPHY MEASURING, P308; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shen L, 2013, LANCET ONCOL, V14, pE535, DOI 10.1016/S1470-2045(13)70436-4; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; van der Feltz-Cornelis CM, 2011, CRISIS, V32, P319, DOI 10.1027/0227-5910/a000109; Wang CW, 2014, SOC PSYCH PSYCH EPID, V49, P929, DOI 10.1007/s00127-013-0789-5; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wei XL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-354; Xu A, 2009, CAUSE DEATH TREND DI; Xu GL, 2013, STROKE, V44, P1775, DOI 10.1161/STROKEAHA.113.001238; Yang DT, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.2.306; Yang G, 1992, Zhonghua Liu Xing Bing Xue Za Zhi, V13, P197; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yip P. S. F., 2003, Hong Kong Medical Journal, V9, P419; Yip PSF, 2001, SUICIDE LIFE-THREAT, V31, P62, DOI 10.1521/suli.31.1.62.21311; Yong H, 2013, CARDIOL REV, V21, P77, DOI 10.1097/CRD.0b013e3182748d37; Zhang J, 2010, EUR PSYCHIAT, V25, P159, DOI 10.1016/j.eurpsy.2009.07.013; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187; Zheng LZ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-300	57	854	1095	35	453	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					251	272		10.1016/S0140-6736(15)00551-6	http://dx.doi.org/10.1016/S0140-6736(15)00551-6			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26510778				2022-12-28	WOS:000368130700032
J	Keshavjee, S; Dowdy, D; Swaminathan, S				Keshavjee, Salmaan; Dowdy, David; Swaminathan, Soumya			Stopping the body count: a comprehensive approach to move towards zero tuberculosis deaths	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS; DISEASE; DOTS; STRATEGY		[Keshavjee, Salmaan; Dowdy, David; Swaminathan, Soumya] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Dowdy, David] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Swaminathan, Soumya] Indian Council Med Res, Off Director Gen, New Delhi, India; [Swaminathan, Soumya] Dept Hlth Res, New Delhi, India	Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indian Council of Medical Research (ICMR)	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	salmaan_keshavjee@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305				Bamrah S, 2014, INT J TUBERC LUNG D, V18, P912, DOI 10.5588/ijtld.13.0028; Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203; COMSTOCK GW, 1962, AM REV RESPIR DIS, V86, P810; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Graham NMH, 1996, ARCH INTERN MED, V156, P889, DOI 10.1001/archinte.156.8.889; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; McMillan CW, 2015, DISCOVERING TUBERCUL; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Ortblad KF, 2013, LANCET, V381, P104; Ortblad KF, 2015, LANCET; Rangaka MX, 2015, LANCET; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; Stop TB Partnership, 2015, GLOB PLAN STOP TB 20; Theron G, 2015, LANCET; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2015, INTR END TB STRAT; Yuen CM, 2015, LANCET	23	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					E46	E47		10.1016/S0140-6736(15)00320-7	http://dx.doi.org/10.1016/S0140-6736(15)00320-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26515680				2022-12-28	WOS:000365993200001
J	Watts, G				Watts, Geoff			Salmaan Keshavjee: tackling tuberculosis (without rocket science)	LANCET			English	Biographical-Item														Keshavjee, Salmaan/0000-0002-6967-3305				KESHAVJEE S, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2247	2247		10.1016/S0140-6736(15)00466-3	http://dx.doi.org/10.1016/S0140-6736(15)00466-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26515681	Bronze			2022-12-28	WOS:000365993200015
J	Sontheimer, H				Sontheimer, Harald			BRAIN CANCER Tumour cells on neighbourhood watch	NATURE			English	Editorial Material							GLIOMA		[Sontheimer, Harald] Virginia Tech, Caril Res Inst, Glial Biol Hlth, Dis & Canc Ctr, Roanoke, VA 24016 USA	Virginia Polytechnic Institute & State University	Sontheimer, H (corresponding author), Virginia Tech, Caril Res Inst, Glial Biol Hlth, Dis & Canc Ctr, Roanoke, VA 24016 USA.	sontheimer@vt.edu		Sontheimer, Harald/0000-0002-5843-9871	NINDS NIH HHS [R01 NS082851, R01 NS036692, R01 NS052634] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082851, R01NS036692, R01NS052634] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Central Brain Tumour Registry of the United States, 2012, STAT REP PRIM BRAIN; Chamberlain MC, 2015, J NEURO-ONCOL, V125, P249, DOI 10.1007/s11060-015-1906-y; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Grek CL, 2014, FEBS LETT, V588, P1349, DOI 10.1016/j.febslet.2014.02.047; Murphy S. F., CANC RES IN PRESS; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Seifert S, 2014, J PHYSIOL-LONDON, V592, P5109, DOI 10.1113/jphysiol.2014.274498; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Sontheimer H., 2015, DIS NERV SYST, P259; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031	11	15	15	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					49	50		10.1038/nature15649	http://dx.doi.org/10.1038/nature15649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26536108	Green Accepted			2022-12-28	WOS:000365606000047
J	Stampfel, G; Kazmar, T; Frank, O; Wienerroither, S; Reiter, F; Stark, A				Stampfel, Gerald; Kazmar, Tomas; Frank, Olga; Wienerroither, Sebastian; Reiter, Franziska; Stark, Alexander			Transcriptional regulators form diverse groups with context-dependent regulatory functions	NATURE			English	Article							IN-VIVO; PROTEIN; ACTIVATION; GENE; REPRESSION; MEDIATOR; COMPLEX; DISSECTION; MOTIFS; TOOLS	One of the most important questions in biology is how transcription factors (TFs) and cofactors control enhancer function and thus gene expression. Enhancer activation usually requires combinations of several TFs(1), indicating that TFs function synergistically and combinatorially(2,3). However, while TF binding has been extensively studied, little is known about how combinations of TFs and cofactors control enhancer function once they are bound. It is typically unclear which TFs participate in combinatorial enhancer activation, whether different TFs form functionally distinct groups, or if certain TFs might substitute for each other in defined enhancer contexts. Here we assess the potential regulatory contributions of TFs and cofactors to combinatorial enhancer control with enhancer complementation assays. We recruited GAL4-DNA-binding-domain fusions of 812 Drosophila TFs and cofactors to 24 enhancer contexts and measured enhancer activities by 82,752 luciferase assays in S2 cells. Most factors were functional in at least one context, yet their contributions differed between contexts and varied from repression to activation (up to 289-fold) for individual factors. Based on functional similarities across contexts, we define 15 groups of TFs that differ in developmental functions and protein sequence features. Similar TFs can substitute for each other, enabling enhancer re-engineering by exchanging TF motifs, and TF-cofactor pairs cooperate during enhancer control and interact physically. Overall, we show that activators and repressors can have diverse regulatory functions that typically depend on the enhancer context. The systematic functional characterization of TFs and cofactors should further our understanding of combinatorial enhancer control and gene regulation.	[Stampfel, Gerald; Kazmar, Tomas; Frank, Olga; Wienerroither, Sebastian; Reiter, Franziska; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012	Stark, Alexander/0000-0003-2611-0841	European Research Council (ERC) [242922]; Boehringer Ingelheim GmbH; Austrian Research Promotion Agency (FFG)	European Research Council (ERC)(European Research Council (ERC)European Commission); Boehringer Ingelheim GmbH(Boehringer Ingelheim); Austrian Research Promotion Agency (FFG)	We are grateful to K. Hens and B. Deplancke for sharing the TF entry clones, J. O. Yanez-Cuna for help designing the enhancer contexts, and O. Bell, J. Brennecke, L. Cochella and S. Westermann for comments on the manuscript. We thank IMP/IMBA services, especially H. Scheuch, R. Heinen and Z. Dzupinkova, for technical support, and A. Posekany and A. Aszodi for advice on multiple-testing correction. Deep sequencing was performed at the CSF Next-Generation Sequencing Unit (http://csf.ac.at). The Stark group is supported by a European Research Council (ERC) Starting Grant (no. 242922) awarded to A. S., Boehringer Ingelheim GmbH, and the Austrian Research Promotion Agency (FFG).	Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Arnone MI, 1997, DEVELOPMENT, V124, P1851; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brodu V, 2001, DEVELOPMENT, V128, P2593; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cheng JX, 2004, CURR BIOL, V14, P1675, DOI 10.1016/j.cub.2004.09.025; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gan M, 2011, J BIOSCIENCES, V36, P425, DOI 10.1007/s12038-011-9089-y; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; Hens K, 2011, NAT METHODS, V8, P1065, DOI [10.1038/NMETH.1763, 10.1038/nmeth.1763]; Ihry RJ, 2014, GENETICS, V196, P767, DOI 10.1534/genetics.113.159707; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Massouras A, 2010, NUCLEIC ACIDS RES, V38, pW378, DOI 10.1093/nar/gkq431; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Papadopoulos DK, 2011, P NATL ACAD SCI USA, V108, P11959, DOI 10.1073/pnas.1108686108; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; R Development Core Team, 2009, R LANG ENV STAT COMP; Rhee DY, 2014, CELL REP, V8, P2031, DOI 10.1016/j.celrep.2014.08.038; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schneider I, 1971, Curr Top Microbiol Immunol, V55, P1; Shlyueva D, 2014, MOL CELL, V54, P180, DOI 10.1016/j.molcel.2014.02.026; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stella X Yu, 2003, ICCV, V2, P313; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; von Luxburg U, 2010, FOUND TRENDS MACH LE, V2, P235, DOI 10.1561/2200000008; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V325, P1330, DOI 10.1016/j.bbrc.2004.10.159; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	54	100	100	1	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					147	+		10.1038/nature15545	http://dx.doi.org/10.1038/nature15545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26550828				2022-12-28	WOS:000365606000066
J	Svatikova, A; Covassin, N; Somers, KR; Somers, KV; Soucek, F; Kara, T; Bukartyk, J				Svatikova, Anna; Covassin, Naima; Somers, Kiran R.; Somers, Krishen V.; Soucek, Filip; Kara, Tomas; Bukartyk, Jan			A Randomized Trial of Cardiovascular Responses to Energy Drink Consumption in Healthy Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BLOOD-PRESSURE; STRESS		[Svatikova, Anna; Covassin, Naima; Somers, Kiran R.; Somers, Krishen V.; Soucek, Filip; Kara, Tomas; Bukartyk, Jan] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Svatikova, A (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA.	svatikova.anna@mayo.edu			NCATS NIH HHS [UL1 TR000135] Funding Source: Medline; NCRR NIH HHS [M01-RR00585] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Burrows T, 2013, NUTR REV, V71, P135, DOI 10.1111/nure.12005; Flaa A, 2008, HYPERTENSION, V52, P336, DOI 10.1161/HYPERTENSIONAHA.108.111625; Goldfarb M, 2014, AM J CARDIOL, V113, P168, DOI 10.1016/j.amjcard.2013.08.058; Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381; Jennings JR, 2004, CIRCULATION, V110, P2198, DOI 10.1161/01.CIR.0000143840.77061.E9; Sepkowitz KA, 2013, JAMA-J AM MED ASSOC, V309, P243, DOI 10.1001/jama.2012.173526	6	34	34	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2077	2080		10.1001/jama.2015.13744	http://dx.doi.org/10.1001/jama.2015.13744			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26547226	Bronze			2022-12-28	WOS:000364764200026
J	Coyte, KZ; Schluter, J; Foster, KR				Coyte, Katharine Z.; Schluter, Jonas; Foster, Kevin R.			The ecology of the microbiome: Networks, competition, and stability	SCIENCE			English	Article							GUT MICROBIOTA; BACTERIAL MUTUALISM; COMMUNITIES; DIVERSITY; COOPERATION; PERMANENCE; RESILIENCE; INTESTINE; ECOSYSTEM; MATRICES	The human gut harbors a large and complex community of beneficial microbes that remain stable over long periods. This stability is considered critical for good health but is poorly understood. Here we develop a body of ecological theory to help us understand microbiome stability. Although cooperating networks of microbes can be efficient, we find that they are often unstable. Counterintuitively, this finding indicates that hosts can benefit from microbial competition when this competition dampens cooperative networks and increases stability. More generally, stability is promoted by limiting positive feedbacks and weakening ecological interactions. We have analyzed host mechanisms formaintaining stability-including immune suppression, spatial structuring, and feeding of community members-and support our key predictions with recent data.	[Coyte, Katharine Z.; Schluter, Jonas; Foster, Kevin R.] Univ Oxford, Dept Zool, Oxford, England; [Coyte, Katharine Z.; Schluter, Jonas; Foster, Kevin R.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Schluter, Jonas] Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan	University of Oxford; University of Oxford; Graduate University for Advanced Studies - Japan	Schluter, J (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	jonas.schluter+sokendai@gmail.com; kevin.foster@zoo.ox.ac.uk		Coyte, Katharine/0000-0002-5231-9350; Schluter, Jonas/0000-0002-6214-9367; Foster, Kevin/0000-0003-4687-6633	European Research Council [242670]; Engineering and Physical Sciences Research Council; Japan Society for the Promotion of Science; Goldschmidt family	European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Goldschmidt family	We thank V. Bucci, S. Knowles, S. Rakoff-Nahoum, L. MacNally, S. Mitri, H. Ohtsuki, A. Sasaki, S. Murray, D. Palmer, B. Grenfell, D. Berry, K. Yashima, and J. Xavier for valuable comments and discussion. K.R.F. is supported by European Research Council grant 242670, K.Z.C. is supported by the Engineering and Physical Sciences Research Council, and J. S. is supported by Japan Society for the Promotion of Science and the Goldschmidt family.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bucci V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002497; Chen X, 2001, J THEOR BIOL, V212, P223, DOI 10.1006/jtbi.2001.2370; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; De Cruz P, 2012, INFLAMM BOWEL DIS, V18, P372, DOI 10.1002/ibd.21751; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Eberl G, 2010, MUCOSAL IMMUNOL, V3, P450, DOI 10.1038/mi.2010.20; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fiegna F, 2005, PLOS BIOL, V3, P1980, DOI 10.1371/journal.pbio.0030370; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Fredrickson JK, 2015, SCIENCE, V348, P1425, DOI 10.1126/science.aab0946; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; HOFBAUER J, 1989, J MATH BIOL, V27, P537, DOI 10.1007/BF00288433; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; JANSEN W, 1987, J MATH BIOL, V25, P411, DOI 10.1007/BF00277165; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kondoh M, 2015, POPUL ECOL, V57, P21, DOI 10.1007/s10144-014-0475-9; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Oliveira NM, 2014, P NATL ACAD SCI USA, V111, P17941, DOI 10.1073/pnas.1412673111; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Sleator RD, 2010, MED HYPOTHESES, V74, P214, DOI 10.1016/j.mehy.2009.08.047; SOMMERS HJ, 1988, PHYS REV LETT, V60, P1895, DOI 10.1103/PhysRevLett.60.1895; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Waller AS, 2014, ISME J, V8, P1391, DOI 10.1038/ismej.2014.30; WIGNER EP, 1958, ANN MATH, V67, P325, DOI 10.2307/1970008	46	892	914	95	960	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					663	666		10.1126/science.aad2602	http://dx.doi.org/10.1126/science.aad2602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542567				2022-12-28	WOS:000364162800046
J	Chiaruttini, N; Redondo-Morata, L; Colom, A; Humbert, F; Lenz, M; Scheuring, S; Roux, A				Chiaruttini, Nicolas; Redondo-Morata, Lorena; Colom, Adai; Humbert, Frederic; Lenz, Martin; Scheuring, Simon; Roux, Aurelien			Relaxation of Loaded ESCRT-III Spiral Springs Drives Membrane Deformation	CELL			English	Article							MULTIVESICULAR BODY BIOGENESIS; MVB VESICLE FORMATION; COMPLEX; FILAMENTS; ALIX; CONSTRICTION; CYTOKINESIS; ABSCISSION; DYNAMICS; MUTANTS	ESCRT-III is required for lipid membrane remodeling in many cellular processes, from abscission to viral budding and multi-vesicular body biogenesis. However, how ESCRT-III polymerization generates membrane curvature remains debated. Here, we show that Snf7, the main component of ESCRT-III, polymerizes into spirals at the surface of lipid bilayers. When covering the entire membrane surface, these spirals stopped growing when densely packed: they had a polygonal shape, suggesting that lateral compression could deform them. We reasoned that Snf7 spirals could function as spiral springs. By measuring the polymerization energy and the rigidity of Snf7 filaments, we showed that they were deformed while growing in a confined area. Furthermore, we observed that the elastic expansion of compressed Snf7 spirals generated an area difference between the two sides of the membrane and thus curvature. This spring-like activity underlies the driving force by which ESCRT-III could mediate membrane deformation and fission.	[Chiaruttini, Nicolas; Colom, Adai; Humbert, Frederic; Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Colom, Adai; Roux, Aurelien] Swiss Natl Ctr Competence Res Programme Chem Biol, CH-1211 Geneva, Switzerland; [Redondo-Morata, Lorena; Colom, Adai; Scheuring, Simon] Aix Marseille Univ, INSERM, U1006, F-13009 Marseille, France; [Lenz, Martin] Univ Paris Saclay, Univ Paris 11, CNRS, LPTMS, F-91405 Orsay, France	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Scheuring, S (corresponding author), Aix Marseille Univ, INSERM, U1006, F-13009 Marseille, France.	simon.scheuring@inserm.fr; aurelien.roux@unige.ch	Scheuring, Simon/L-9843-2018; Colom, Adai/GQP-9827-2022; Redondo-Morata, Lorena/A-3111-2015; Roux, Aurelien/AAU-1262-2021; Lenz, Martin/B-3329-2013; Roux, Aurelien R/G-9541-2013	Scheuring, Simon/0000-0003-3534-069X; Colom, Adai/0000-0003-4869-8981; Redondo-Morata, Lorena/0000-0002-6254-8261; Lenz, Martin/0000-0002-2307-1106; Roux, Aurelien R/0000-0002-6088-0711	Human Frontier Science Program (HFSP); European Research Council (ERC) [RGY0076-2008, 310080-MEM-STRUCT-AFM]; Swiss National Fund for Research [311536-MEMFIS]; European Commission [300532-2011]; Agence Nationale de la Recherche, France (ANR); ANR-Nano [ANR-12-BS10-009-01]; ANR-BBMS [ANR-12-BSV8-0006-01]; Universite Paris-Sud and CNRS; Marie Curie Integration Grant [PCIG12-GA-2012-334053]; "Investissements d'Avenir'' LabEx PALM [ANR-10-LABX-0039-PALM];  [131003A_130520];  [131003A_149975]	Human Frontier Science Program (HFSP)(Human Frontier Science Program); European Research Council (ERC)(European Research Council (ERC)); Swiss National Fund for Research(Swiss National Science Foundation (SNSF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche, France (ANR)(French National Research Agency (ANR)); ANR-Nano(French National Research Agency (ANR)); ANR-BBMS(French National Research Agency (ANR)); Universite Paris-Sud and CNRS; Marie Curie Integration Grant; "Investissements d'Avenir'' LabEx PALM(French National Research Agency (ANR)); ; 	The authors thank James Hurley and Scott Emr for their kind gifts of plasmids, and Bruno Antonny, Emmanuel Derivery, and Marcos Gonzalez-Gaitan for their useful comments on the manuscript. We thank Emmanuel Derivery for insights throughout the project. We thank Gorana Perrelet and Pilar Ruga Fahy for help for the EM samples. We thank Guillaume Molinard and Sarah Machado for careful reading of this manuscript and help with figure artwork. We thank GATTAquant GmbH for the kind gift of GATTA-Brightness 9R and 18R. A.R. acknowledges funding support from: Human Frontier Science Program (HFSP), Young Investigator Grant #RGY0076-2008: the European Research Council (ERC), starting (consolidator) grant #311536-MEMFIS: the Swiss National Fund for Research, grants #131003A_130520 and #131003A_149975. N.C. acknowledges the European Commission for the Marie-Curie postdoctoral fellowship CYTOCUT #300532-2011. S.S. acknowledges funding support from: Agence Nationale de la Recherche, France (ANR), ANR-Nano (ANR-12-BS10-009-01) and ANR-BBMS (ANR-12-BSV8-0006-01) grants, and a European Research Council (ERC) starting (consolidator) grant #310080-MEM-STRUCT-AFM. ML's group belongs to the CNRS consortium CellTiss and is supported by grants from Universite Paris-Sud and CNRS, Marie Curie Integration Grant PCIG12-GA-2012-334053 and "Investissements d'Avenir'' LabEx PALM (ANR-10-LABX-0039-PALM).	Adell MAY, 2014, J CELL BIOL, V205, P33, DOI 10.1083/jcb.201310114; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Buchkovich NJ, 2013, DEV CELL, V27, P201, DOI 10.1016/j.devcel.2013.09.009; Callan-Jones A, 2012, BIOPHYS J, V103, P2475, DOI 10.1016/j.bpj.2012.11.008; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Cashikar AG, 2014, ELIFE, V3, DOI 10.7554/eLife.02184; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Coonrod EM, 2010, MOL BIOL CELL, V21, P4057, DOI 10.1091/mbc.E09-07-0603; Cuvelier D, 2005, BIOPHYS J, V88, P2714, DOI 10.1529/biophysj.104.056473; Derganc J, 2013, TRENDS BIOCHEM SCI, V38, P576, DOI 10.1016/j.tibs.2013.08.006; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2012, CELL, V151, P356, DOI 10.1016/j.cell.2012.08.039; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Howard J., 2001, MECH MOTOR PROTEINS; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lenz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038101; Mabrouk E, 2009, P NATL ACAD SCI USA, V106, P7294, DOI 10.1073/pnas.0813157106; Mageswaran SK, 2015, MOL BIOL CELL, V26, P554, DOI 10.1091/mbc.E14-10-1469; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Saleem M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7249; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Shen QT, 2014, J CELL BIOL, V206, P763, DOI 10.1083/jcb.201403108; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Sundborger AC, 2014, CELL REP, V8, P734, DOI 10.1016/j.celrep.2014.06.054; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	35	195	204	0	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					866	879		10.1016/j.cell.2015.10.017	http://dx.doi.org/10.1016/j.cell.2015.10.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26522593	Green Published, hybrid			2022-12-28	WOS:000364829700013
J	Murray, SG; Wachter, RM; Cho, KC; Dhaliwal, G				Murray, Sara G.; Wachter, Robert M.; Cho, Kerry C.; Dhaliwal, Gurpreet			A Breakthrough Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLADDER RUPTURE; URINARY ASCITES		[Murray, Sara G.; Wachter, Robert M.; Cho, Kerry C.; Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Murray, Sara G.; Wachter, Robert M.] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA; [Cho, Kerry C.] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Murray, SG (corresponding author), Univ Calif San Francisco, 533 Parnassus Ave,U125, San Francisco, CA 94143 USA.	sara.murray@ucsf.edu			Governance Institute; Optima Health; QuantiaMD; IPC Healthcare; PatientSafe Solutions; Twine Health; EarlySense; QPID Health; Amino.com	Governance Institute; Optima Health; QuantiaMD; IPC Healthcare; PatientSafe Solutions; Twine Health; EarlySense; QPID Health; Amino.com	Dr. Wachter reports receiving fees paid to his institution for his membership on the board of directors and his service as chair of the quality committee for IPC Healthcare, receiving fees for serving on advisory boards for and holding stock options in PatientSafe Solutions, Twine Health, EarlySense, QPID Health, and Amino.com, receiving lecture fees from the Governance Institute and Optima Health, and receiving fees for developing and presenting patient safety educational material from QuantiaMD. No other potential conflict of interest relevant to this article was reported.	ARNOLD WC, 1986, SOUTHERN MED J, V79, P591, DOI 10.1097/00007611-198605000-00018; BASTABLE J R, 1959, Br J Urol, V31, P78, DOI 10.1111/j.1464-410X.1959.tb09386.x; Han Chien-Min, 2008, Chang Gung Med J, V31, P378; HARDING AE, 1977, BRIT MED J, V1, P270, DOI 10.1136/bmj.1.6056.270; Kato A, 2006, INTERNAL MED, V45, P815, DOI 10.2169/internalmedicine.45.1748; Kuroki Y, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2011.06.033; Litwiller SE, 1999, J UROLOGY, V161, P743, DOI 10.1016/S0022-5347(01)61760-9; Milingos S, 2007, J MINIM INVAS GYN, V14, P43, DOI 10.1016/j.jmig.2006.06.020; MOKOENA T, 1995, BRIT J SURG, V82, P69, DOI 10.1002/bjs.1800820124; Pintar TJ, 1998, AM J MED, V105, P347, DOI 10.1016/S0002-9343(98)00264-2; Ridinger HA, 2012, AM J MED, V125, pE1, DOI 10.1016/j.amjmed.2012.01.019; Saleem MA, 2009, SINGAP MED J, V50, pE410	12	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1866	1871		10.1056/NEJMcps1402621	http://dx.doi.org/10.1056/NEJMcps1402621			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26535516				2022-12-28	WOS:000364144000012
J	Schutzius, TM; Jung, S; Maitra, T; Graeber, G; Kohme, M; Poulikakos, D				Schutzius, Thomas M.; Jung, Stefan; Maitra, Tanmoy; Graeber, Gustav; Koehme, Moritz; Poulikakos, Dimos			Spontaneous droplet trampolining on rigid superhydrophobic surfaces	NATURE			English	Article							EXTRAORDINARY ICEPHOBICITY; BOUNCING DROP; CONTACT TIME; WATER; CONDENSATION; PHYSICS; SCALE	Spontaneous removal of condensed matter from surfaces is exploited in nature and in a broad range of technologies to achieve self-cleaning(1,2), anti-icing(3-6) and condensation control(7,8). But despite much progress(5-7,9-14), our understanding of the phenomena leading to such behaviour remains incomplete, which makes it challenging to rationally design surfaces that benefit from its manifestation(15-18). Here we show that water droplets resting on superhydrophobic textured surfaces in a low-pressure environment can self-remove through sudden spontaneous levitation and subsequent trampoline-like bouncing behaviour, in which sequential collisions with the surface accelerate the droplets. These collisions have restitution coefficients (ratios of relative speeds after and before collision) greater than unity(19) despite complete rigidity of the surface, and thus seemingly violate the second law of thermodynamics. However, these restitution coefficients result from an overpressure beneath the droplet produced by fast droplet vaporization while substrate adhesion and surface texture restrict vapour flow. We also show that the high vaporization rates experienced by the droplets and the associated cooling can result in freezing from a supercooled state(20,21) that triggers a sudden increase in vaporization, which in turn boosts the levitation process. This effect can spontaneously remove surface icing by lifting away icy drops the moment they freeze. Although these observations are relevant only to systems in a low-pressure environment, they show how surface texturing can produce droplet-surface interactions that prohibit liquid and freezing water-droplet retention on surfaces.	[Schutzius, Thomas M.; Jung, Stefan; Maitra, Tanmoy; Graeber, Gustav; Koehme, Moritz; Poulikakos, Dimos] ETH, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Poulikakos, D (corresponding author), ETH, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, CH-8092 Zurich, Switzerland.	dpoulikakos@ethz.ch	Schutzius, Thomas M/A-1686-2011; Maitra, Tanmoy/ABC-2487-2020; poulikakos, dimos/O-2853-2014; Graeber, Gustav/AAE-4413-2022	Schutzius, Thomas M/0000-0003-3309-3568; poulikakos, dimos/0000-0001-5733-6478; 	Marie Curie Actions for People COFUND programme [FEL-14 13-1]; Swiss National Science Foundation [200021_135479]	Marie Curie Actions for People COFUND programme; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	T.M.S. acknowledges the ETH Zurich Postdoctoral Fellowship Program and the Marie Curie Actions for People COFUND programme (FEL-14 13-1). Partial support of the Swiss National Science Foundation under grant number 200021_135479 is also acknowledged. We thank L. J. Yi for his participation in the trampoline experiment, U. Drechsler for advice on surface fabrication and J. Vidic and B. Kramer for assistance in chamber construction.	Arpaci V. S., 1984, CONVECTION HEAT TRAN, P187; Bartolo D, 2006, EUROPHYS LETT, V74, P299, DOI 10.1209/epl/i2005-10522-3; Bartolo D, 2005, J FLUID MECH, V545, P329, DOI 10.1017/S0022112005007184; Bird JC, 2013, NATURE, V503, P385, DOI 10.1038/nature12740; Boreyko JB, 2013, ACS NANO, V7, P1618, DOI 10.1021/nn3055048; Boreyko JB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.184501; BROWN GP, 1946, J APPL PHYS, V17, P802, DOI 10.1063/1.1707647; de Gennes P.-G., 2004, CAPILLARITY WETTING; de Ruiter J, 2015, NAT PHYS, V11, P48, DOI [10.1038/NPHYS3145, 10.1038/nphys3145]; Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115; Eberle P, 2014, NANOSCALE, V6, P4874, DOI 10.1039/c3nr06644d; Enright R, 2012, LANGMUIR, V28, P14424, DOI 10.1021/la302599n; Hou YM, 2015, ACS NANO, V9, P71, DOI 10.1021/nn505716b; Jung S, 2012, P NATL ACAD SCI USA, V109, P16073, DOI 10.1073/pnas.1206121109; Jung S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1630; Jung S, 2011, LANGMUIR, V27, P3059, DOI 10.1021/la104762g; Jung YC, 2008, J MICROSC-OXFORD, V229, P127, DOI 10.1111/j.1365-2818.2007.01875.x; LEIDENFR.JG, 1966, INT J HEAT MASS TRAN, V9, P1153, DOI 10.1016/0017-9310(66)90111-6; Liu TY, 2014, SCIENCE, V346, P1096, DOI 10.1126/science.1254787; Liu YH, 2014, NAT PHYS, V10, P515, DOI [10.1038/nphys2980, 10.1038/NPHYS2980]; Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002; Maitra T, 2014, NANO LETT, V14, P172, DOI 10.1021/nl4037092; Na B, 2003, INT J HEAT MASS TRAN, V46, P3797, DOI 10.1016/S0017-9310(03)00194-7; Richard D, 2000, EUROPHYS LETT, V50, P769, DOI 10.1209/epl/i2000-00547-6; Richard D, 2002, NATURE, V417, P811, DOI 10.1038/417811a; Rykaczewski K, 2012, SOFT MATTER, V8, P8786, DOI 10.1039/c2sm25502b; Schutzius TM, 2015, LANGMUIR, V31, P4807, DOI 10.1021/la502586a; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Wisdom KM, 2013, P NATL ACAD SCI USA, V110, P7992, DOI 10.1073/pnas.1210770110	30	272	278	35	656	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					82	85		10.1038/nature15738	http://dx.doi.org/10.1038/nature15738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536959				2022-12-28	WOS:000364270700047
J	Zeineh, NS; Eles, G				Zeineh, Nabil S.; Eles, Gustav			Apical Hypertrophic Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zeineh, Nabil S.; Eles, Gustav] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA	Allegheny General Hospital	Zeineh, NS (corresponding author), Allegheny Gen Hosp, Pittsburgh, PA 15212 USA.	nzeineh@gmail.com							0	3	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19							e22	10.1056/NEJMicm1413682	http://dx.doi.org/10.1056/NEJMicm1413682			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26535534				2022-12-28	WOS:000364144000011
J	Gornall, J				Gornall, Jonathan			PUBLIC HEALTH Public Health England's troubled trail	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							E-CIGARETTES; HARMS					jonathangornall@mac.com						Abrams D, 2014, COMMUNICATION   0526; Africa Medical Association, 2015, AFMA; Alexanderson K, 2014, COMMUNICATION   0616; [Anonymous], 2015, LANCET, V386, P829, DOI 10.1016/S0140-6736(15)00042-2; [Anonymous], 2014, BLOOMBERG; [Anonymous], 2015, COMMUNICATION   1005; [Anonymous], 2004, COMMMUNICATION  0408; [Anonymous], 2014, 1 GLOBAL FORUM NICOT; [Anonymous], 2013, FRAMEWORK AGREEMENT; Barry E, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4717; BAT, 2013, FOC HARM RED; BAT, SUST ENG; Caley M, 2014, BRIT J GEN PRACT, V64, pE516, DOI 10.3399/bjgp14X681013; Chapman S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5512; Department of Energy and Climate Change, 2015, GUID FRACK DEV SHAL; Donnelly L., 2015, TELEGRAPH; European Commission, 2014, EXPL PROD HYDR SUCH; Finkel M, 2013, AM J PUBLIC HEALTH, V103, P1161, DOI 10.2105/AJPH.2013.301285; Friends of the Earth England Wales and Northern Ireland, 2013, RESP PUBL HLTH ENGL; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3317; Health and Social Care Information Centre, 2015, SMOK DRINK DRUG US Y; Johnson A., 2009, GUARDIAN; Law A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2728; McCartney M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5834; McKee Martin, 2015, BMJ, V351, ph4863, DOI 10.1136/bmj.h4863; McNeill A, 2015, ECIGARETTES EVIDENCE; NHS England, 2015, NHS DIAB PREV PROGR; Nutt D., 2015, BLINDED SMOKE WHY DO; Nutt DJ, 2014, EUR ADDICT RES, V20, P218, DOI 10.1159/000360220; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; O'Connor R, 2015, LANCET, V386, P1237, DOI 10.1016/S0140-6736(15)00107-5; Physicians Scientists and Engineers for Health Energy, 2013, IMP PUBL HLTH RES SH; Price C, 2014, PULSE; Public Health England, 2013, OR EV HLTH COMM; Public Health England, 2015, UND EV EST EC US AR; Public Health England, 2014, REV POT PUBL HLTH IM; West R, 2014, ELECT CIGARETTES WHA; WHO, 2014, WHO 6 SESS C PART WH	38	25	26	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2015	351								h5826	10.1136/bmj.h5826	http://dx.doi.org/10.1136/bmj.h5826			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV6OC	26534902				2022-12-28	WOS:000364388500013
J	Wardlaw, JM; Dennis, MS				Wardlaw, Joanna M.; Dennis, Martin S.			Thrombectomy for Acute Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERSPECTIVE; TRIALS		[Wardlaw, Joanna M.; Dennis, Martin S.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh	Wardlaw, JM (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Chancellors Bldg,49 Little France, Edinburgh EH16 4SB, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Wardlaw, Joanna M/Y-3456-2019; Hernandez, María/GYU-3543-2022	Wardlaw, Joanna M/0000-0002-9812-6642; 				Apps A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3969; Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Baird S, 2015, AUDIT SCOTTISH HEALT; Balami JS, 2015, INT J STROKE, V10, P1168, DOI 10.1111/ijs.12618; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Ganesalingam J, 2015, STROKE, V46, P2591, DOI 10.1161/STROKEAHA.115.009396; Grotta JC, 2015, STROKE, V46, P1447, DOI 10.1161/STROKEAHA.115.008384; Jones LC, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4604; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Leppert MH, 2015, STROKE, V46, P1870, DOI 10.1161/STROKEAHA.115.009779; Pierot L, 2015, STROKE, V46, P1440, DOI 10.1161/STROKEAHA.115.008416; Rafii-Tari H, 2014, ANN BIOMED ENG, V42, P697, DOI 10.1007/s10439-013-0946-8; Wardlaw JM, 2014, EFFICACY MECH EVALUA, P11; Wardlaw JM, 2015, LANCET NEUROL, V14, P485, DOI 10.1016/S1474-4422(15)00012-5; White PM, 2015, STANDARDS PROVIDING, P1	17	3	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1803	1805		10.1001/jama.2015.14674	http://dx.doi.org/10.1001/jama.2015.14674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529158				2022-12-28	WOS:000363960200011
J	Eastman, C				Eastman, Charmane			Entraining the free-running circadian clocks of blind people	LANCET			English	Editorial Material							MELATONIN; RHYTHMS; PERIOD; SYSTEM		Rush Univ, Med Ctr, Biol Rhythms Res Lab, Chicago, IL 60612 USA	Rush University	Eastman, C (corresponding author), Rush Univ, Med Ctr, Biol Rhythms Res Lab, Chicago, IL 60612 USA.	ceastman@rush.edu		Eastman, Charmane/0000-0002-4057-1233				[Anonymous], 2014, Med Lett Drugs Ther, V56, P34; Burgess HJ, 2010, J CLIN ENDOCR METAB, V95, P3325, DOI 10.1210/jc.2009-2590; DEACON S, 1995, BRAIN RES, V688, P77, DOI 10.1016/0006-8993(95)96872-I; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Eastman CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep08381; Emens JS, 2013, SLEEP, V36, P1091, DOI 10.5665/sleep.2818; Ferguson SA, 2010, EXPERT REV NEUROTHER, V10, P305, DOI 10.1586/ERN.10.1; Hack LM, 2003, J BIOL RHYTHM, V18, P420, DOI 10.1177/0748730403256796; Kripke Daniel F, 2007, J Circadian Rhythms, V5, P4, DOI 10.1186/1740-3391-5-4; Lewy AJ, 2005, CHRONOBIOL INT, V22, P1093, DOI 10.1080/07420520500398064; Lockley SW, 2015, LANCET, V386, P1754, DOI 10.1016/S0140-6736(15)60031-9; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445; Revell VL, 2006, J CLIN ENDOCR METAB, V91, P54, DOI 10.1210/jc.2005-1009; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503	15	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1713	1714		10.1016/S0140-6736(15)61451-9	http://dx.doi.org/10.1016/S0140-6736(15)61451-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26554081				2022-12-28	WOS:000363974200010
J	Swinburn, B; Dietz, W; Kleinert, S				Swinburn, Boyd; Dietz, William; Kleinert, Sabine			A Lancet Commission on obesity	LANCET			English	Editorial Material									[Swinburn, Boyd] Univ Auckland, Sch Populat Hlth, Auckland 1072, New Zealand; [Swinburn, Boyd] Deakin Univ, Ctr Populat Hlth Res, Melbourne, Vic, Australia; [Dietz, William] George Washington Univ, Redstone Global Ctr Prevent & Wellness, Washington, DC USA; [Kleinert, Sabine] The Lancet, London NW1 7BY, England	University of Auckland; Deakin University; George Washington University	Swinburn, B (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland 1072, New Zealand.	boyd.swinburn@auckland.ac.nz						International Food Policy Research Institute, 2015, GLOB NUTR REP 2015 A; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Swinburn B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12087; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; World Health Organization, NCD GLOB MON FRAM; World Health Organization (WHO), 2015, FIN REP COM IN PRESS; World Obesity Federation, 2015, WORLD OB DAY STAT	8	29	31	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1716	+		10.1016/S0140-6736(15)00722-9	http://dx.doi.org/10.1016/S0140-6736(15)00722-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26545418				2022-12-28	WOS:000363974200012
J	Guessoum, N; Osama, A				Guessoum, Nidhal; Osama, Athar			Revive universities of the Muslim world	NATURE			English	Editorial Material									[Guessoum, Nidhal] Amer Univ Sharjah, Phys & Astron, Sharjah, U Arab Emirates; [Osama, Athar] UCL Inst Educ, London, England	American University of Sharjah; University of London; University College London; UCL Institute of Education	Guessoum, N (corresponding author), Amer Univ Sharjah, Phys & Astron, Sharjah, U Arab Emirates.	nguessoum@aus.edu; athar.osama@gmail.com	Guessoum, Nidhal/C-3051-2013	Guessoum, Nidhal/0000-0003-1585-8205				[Anonymous], 2012, TIMSS 2011 INT RESUL; Bloom D. E., 2003, LIBERAL EDUC, V89, P16; Djebbar A., 2009, DISCOVERIES ISLAMIC; Guessoum Nidhal [see also Qassum Nid al, 2011, ISLAMS QUANTUM QUEST; OECD, 2014, PISA 2012 RES FOC; Royal Society, 2014, ATL ISL WORLD SCI IN; Royal Society, 2010, NEW GOLD AG PROSP SC; 2014, NATURE, V514, P550	8	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					634	636		10.1038/526634a	http://dx.doi.org/10.1038/526634a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8ZH	26511563	Bronze			2022-12-28	WOS:000363832100014
J	Singh, D				Singh, Dishan			EASILY MISSED Acute Achilles tendon rupture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Natl Orthopaed Hosp, Foot & Ankle Unit, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Singh, D (corresponding author), Royal Natl Orthopaed Hosp, Foot & Ankle Unit, Stanmore HA7 4LP, Middx, England.	dishan.singh@rnoh.nhs.uk						Asplund CA, 2013, BMJ-BRIT MED J, V346, pf1262; Chiodo CP, 2006, FOOT ANKLE INT, V27, P305, DOI 10.1177/107110070602700415; CHRISTENSEN I, 1953, ACTA CHIR SCAND, V106, P50; Costa ML, 2006, J BONE JOINT SURG BR, V88B, P69, DOI 10.1302/0301-620X.88B1.16549; Garras DN, 2012, CLIN ORTHOP RELAT R, V470, P2268, DOI 10.1007/s11999-012-2355-y; Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191; INGLIS AE, 1976, J BONE JOINT SURG AM, V58, P990, DOI 10.2106/00004623-197658070-00015; JOZSA L, 1989, AM J SPORT MED, V17, P338, DOI 10.1177/036354658901700305; Khan RJK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003674.pub4; Leppilahti J, 1996, ACTA ORTHOP SCAND, V67, P277, DOI 10.3109/17453679608994688; Maffulli N, 1998, AM J SPORT MED, V26, P266, DOI 10.1177/03635465980260021801; Makhdom AM, 2013, J FOOT ANKLE SURG, V52, P584, DOI 10.1053/j.jfas.2013.03.001; Matles A L, 1975, Bull Hosp Joint Dis, V36, P48; MDU, 2010, GUID ADV CAS STUD RU; Padanilam TG, 2009, FOOT ANKLE CLIN, V14, P711, DOI 10.1016/j.fcl.2009.08.001; SCOTT BW, 1992, J BONE JOINT SURG BR, V74, P314, DOI 10.1302/0301-620X.74B2.1544978; SIMMONDS F A, 1957, Practitioner, V179, P56; THOMPSON T C, 1962, J Trauma, V2, P126, DOI 10.1097/00005373-196203000-00003	18	9	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2015	351								h4722	10.1136/bmj.h4722	http://dx.doi.org/10.1136/bmj.h4722			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GI	26494035				2022-12-28	WOS:000364146600001
J	Green, A				Green, Andrew			Emmanuel Gasakure Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1530	1530		10.1016/S0140-6736(15)00481-X	http://dx.doi.org/10.1016/S0140-6736(15)00481-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26530613				2022-12-28	WOS:000362878200017
J	Davidson, AJ; Disma, N; de Graaff, JC; Withington, DE; Dorris, L; Bell, G; Stargatt, R; Bellinger, DC; Schuster, T; Arnup, SJ; Hardy, P; Hunt, RW; Takagi, MJ; Giribaldi, G; Hartmann, PL; Salvo, I; Morton, NS; Sternberg, BSV; Locatelli, BG; Wilton, N; Lynn, A; Thomas, JJ; Polaner, D; Bagshaw, O; Szmuk, P; Absalom, AR; Frawley, G; Berde, C; Ormond, GD; Marmor, J; McCann, ME				Davidson, Andrew J.; Disma, Nicola; de Graaff, Jurgen C.; Withington, Davinia E.; Dorris, Liam; Bell, Graham; Stargatt, Robyn; Bellinger, David C.; Schuster, Tibor; Arnup, Sarah J.; Hardy, Pollyanna; Hunt, Rodney W.; Takagi, Michael J.; Giribaldi, Gaia; Hartmann, Penelope L.; Salvo, Ida; Morton, Neil S.; Sternberg, Britta S. von Ungern; Locatelli, Bruno Guido; Wilton, Niall; Lynn, Anne; Thomas, Joss J.; Polaner, David; Bagshaw, Oliver; Szmuk, Peter; Absalom, Anthony R.; Frawley, Geoff; Berde, Charles; Ormond, Gillian D.; Marmor, Jacki; McCann, Mary Ellen		Gas Consortium	Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial	LANCET			English	Article							EARLY EXPOSURE; LEARNING-DISABILITIES; ACADEMIC-PERFORMANCE; CHILDHOOD EXPOSURE; CLINICAL-RESEARCH; DEVELOPING BRAIN; BIRTH COHORT; CELL-DEATH; NEUROTOXICITY; CHILDREN	Background Preclinical data suggest that general anaesthetics affect brain development. There is mixed evidence from cohort studies that young children exposed to anaesthesia can have an increased risk of poor neurodevelopmental outcome. We aimed to establish whether general anaesthesia in infancy has any effect on neurodevelopmental outcome. Here we report the secondary outcome of neurodevelopmental outcome at 2 years of age in the General Anaesthesia compared to Spinal anaesthesia (GAS) trial. Methods In this international assessor-masked randomised controlled equivalence trial, we recruited infants younger than 60 weeks postmenstrual age, born at greater than 26 weeks ' gestation, and who had inguinal herniorrhaphy, from 28 hospitals in Australia, Italy, the USA, the UK, Canada, the Netherlands, and New Zealand. Infants were randomly assigned (1:1) to receive either awake-regional anaesthesia or sevoflurane-based general anaesthesia. Web-based randomisation was done in blocks of two or four and stratified by site and gestational age at birth. Infants were excluded if they had existing risk factors for neurological injury. The primary outcome of the trial will be the Wechsler Preschool and Primary Scale of Intelligence Third Edition (WPPSI-III) Full Scale Intelligence Quotient score at age 5 years. The secondary outcome, reported here, is the composite cognitive score of the Bayley Scales of Infant and Toddler Development III, assessed at 2 years. The analysis was as per protocol adjusted for gestational age at birth. A difference in means of five points (1/3 SD) was predefined as the clinical equivalence margin. This trial is registered with ANZCTR, number ACTRN12606000441516 and ClinicalTrials.gov, number NCT00756600. Findings Between Feb 9, 2007, and Jan 31, 2013, 363 infants were randomly assigned to receive awake-regional anaesthesia and 359 to general anaesthesia. Outcome data were available for 238 children in the awake-regional group and 294 in the general anaesthesia group. In the as-per-protocol analysis, the cognitive composite score (mean [SD]) was 98.6 (14.2) in the awake-regional group and 98.2 (14.7) in the general anaesthesia group. There was equivalence in mean between groups (awake-regional minus general anaesthesia 0.169, 95% CI-2.30 to 2.64). The median duration of anaesthesia in the general anaesthesia group was 54 min. Interpretation For this secondary outcome, we found no evidence that just less than 1 h of sevoflurane anaesthesia in infancy increases the risk of adverse neurodevelopmental outcome at 2 years of age compared with awake-regional anaesthesia. Funding Australia National Health and Medical Research Council (NHMRC), Health Technologies Assessment-National Institute for Health Research UK, National Institutes of Health, Food and Drug Administration, Australian and New Zealand College of Anaesthetists, Murdoch Childrens Research Institute, Canadian Institute of Health Research, Canadian Anesthesiologists ' Society, Pfizer Canada, Italian Ministry of Heath, Fonds NutsOhra, and UK Clinical Research Network (UKCRN).	[Davidson, Andrew J.; Takagi, Michael J.; Hartmann, Penelope L.; Frawley, Geoff; Ormond, Gillian D.] Murdoch Childrens Res Inst, Anaesthesia & Pain Management Res Grp, Melbourne, Vic, Australia; [Davidson, Andrew J.] Murdoch Childrens Res Inst, Melbourne Childrens Trials Ctr, Melbourne, Vic, Australia; [Davidson, Andrew J.; Frawley, Geoff] Royal Childrens Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia; [Davidson, Andrew J.; Hunt, Rodney W.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Disma, Nicola; Giribaldi, Gaia] Ist Giannina Gaslini, Dept Anesthesia, I-16148 Genoa, Italy; [de Graaff, Jurgen C.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Anaesthesia, Utrecht, Netherlands; [Withington, Davinia E.] Montreal Childrens Hosp, Dept Anesthesia, Montreal, PQ H3H 1P3, Canada; [Withington, Davinia E.] McGill Univ, Dept Anesthesia, Montreal, PQ, Canada; [Dorris, Liam] Royal Hosp Children, Paediat Neurosci Res Grp, Fraser Allander Unit, Glasgow, Lanark, Scotland; [Bell, Graham; Morton, Neil S.] Royal Hosp Children, Dept Anaesthesia, Glasgow, Lanark, Scotland; [Dorris, Liam] Univ Glasgow, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Stargatt, Robyn] La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia; [Stargatt, Robyn; Takagi, Michael J.] Murdoch Childrens Res Inst, Child Neuropsychol, Melbourne, Vic, Australia; [Bellinger, David C.; Marmor, Jacki] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Bellinger, David C.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [Bellinger, David C.] Harvard T H Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Schuster, Tibor] Murdoch Childrens Res Inst, Clin Epidemiol & Biostatist Unit, Melbourne, Vic, Australia; [Hunt, Rodney W.] Murdoch Childrens Res Inst, Neonatal Res Grp, Melbourne, Vic, Australia; [Hardy, Pollyanna] Univ Oxford, Clin Trials Unit, Natl Perinatal Epidemiol Unit, Oxford, England; [Hunt, Rodney W.] Royal Childrens Hosp, Dept Neonatal Med, Melbourne, Vic, Australia; [Salvo, Ida] Osped Pediat Vittore Buzzi, Dept Anesthesiol & Pediat Intens Care, Milan, Italy; [Morton, Neil S.] Univ Glasgow, Glasgow, Lanark, Scotland; [Sternberg, Britta S. von Ungern] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Sternberg, Britta S. von Ungern] Princess Margaret Hosp Children, Dept Anaesthesia & Pain Management, Perth, WA, Australia; [Locatelli, Bruno Guido] Osped Papa Giovanni XXIII, Dept Anesthesia, Bergamo, Italy; [Wilton, Niall] Starship Childrens Hosp, Auckland Dist Hlth Board, Dept Paediat Anaesthesia & Operating Rooms, Auckland, New Zealand; [Lynn, Anne] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Thomas, Joss J.] Univ Minnesota, Dept Anesthesia, Minneapolis, MN USA; [Polaner, David] Childrens Hosp Colorado, Dept Anesthesiol, Aurora, CO USA; [Polaner, David] Univ Colorado, Sch Med, Aurora, CO USA; [Bagshaw, Oliver] Birmingham Childrens Hosp, Dept Anaesthesia, Birmingham, W Midlands, England; [Szmuk, Peter] Childrens Med Ctr Dallas, Dept Anesthesiol, Dallas, TX USA; [Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, Groningen, Netherlands; [Berde, Charles; McCann, Mary Ellen] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA	Murdoch Children's Research Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Genoa; IRCCS Istituto Giannina Gaslini; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; McGill University; McGill University; University of Glasgow; La Trobe University; Murdoch Children's Research Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Murdoch Children's Research Institute; Murdoch Children's Research Institute; University of Oxford; Royal Children's Hospital Melbourne; University of Glasgow; University of Western Australia; University of Western Australia; ASST Papa Giovanni XXIII; Auckland District Health Board; Starship Children's Hospital; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Birmingham; University of Groningen; Harvard University; Boston Children's Hospital; Harvard Medical School	Davidson, AJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Anaesthesia & Pain Management Res Grp, Flemington Rd, Parkville, Vic 3052, Australia.	andrew.davidson@rch.org.au	Morton, Neil/AAE-6594-2020; Dorris, Liam/AAK-2273-2021; Absalom, Anthony/GPG-1582-2022; Soriano, Sulpicio/K-3501-2019; Polaner, David M/AAX-2514-2021; De Graaff, Jurgen C/G-2298-2017; von Ungern-Sternberg, Britta/S-5532-2019; Disma, Nicola/AAA-8868-2020; von Ungern-Sternberg, Britta/CAG-9904-2022	Morton, Neil/0000-0001-8848-7914; Dorris, Liam/0000-0002-9502-3154; Polaner, David M/0000-0001-8716-6289; De Graaff, Jurgen C/0000-0002-2168-7900; von Ungern-Sternberg, Britta/0000-0002-8043-8541; Arnup, Sarah/0000-0002-9497-1902; Takagi, Michael/0000-0003-2903-7598; Absalom, Anthony/0000-0001-7563-9157; Titler, Sarah/0000-0001-8433-3379; Hunt, Rodney/0000-0002-2446-1739; Myles, Paul/0000-0002-3324-5456; Disma, Nicola/0000-0002-2960-9333; Hartmann, Penelope/0000-0003-4706-4485; Hays, Stephen/0000-0003-2166-8811; Visser, Melissa/0000-0002-5313-3347	Australia National Health and Medical Research Council (NHMRC); Health Technologies Assessment-National Institute for Health Research UK; National Institutes of Health; Food and Drug Administration; Australian and New Zealand College of Anaesthetists; Murdoch Childrens Research Institute; Canadian Institute of Health Research; Canadian Anesthesiologists' Society; Pfizer Canada; Italian Ministry of Heath; Fonds NutsOhra; UK Clinical Research Network (UKCRN); The Australian National Health & Medical Research Council [1002906, 491226]; Australian and New Zealand College of Anaesthetists [11/021, 07/012]; Victorian Government's Operational Infrastructure Support Program; National Institute of Health [NIH 1-R01 hD06 1136-01A1]; Food and Drug Administration [FDA-SOL-08-SAFEKIDS-Clin 002-Project 2]; Italian Ministry of Heath, Young Researchers Grant [167/GR-2009-1476067]; Fonds NutsOhra grant [1305-144]; Vrienden WKZ [16.13.038]; Canadian Institute of Health Research [MCT-98031]; Pfizer Canada Inc.; Health Technologies Assessment-National Institute for Health Research UK [07/01/05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061336, R01HD084566, U54HD090255] Funding Source: NIH RePORTER; National Institute for Health Research [07/01/05] Funding Source: researchfish	Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Health Technologies Assessment-National Institute for Health Research UK; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration(United States Department of Health & Human Services); Australian and New Zealand College of Anaesthetists; Murdoch Childrens Research Institute; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Anesthesiologists' Society; Pfizer Canada(Pfizer); Italian Ministry of Heath; Fonds NutsOhra; UK Clinical Research Network (UKCRN); The Australian National Health & Medical Research Council; Australian and New Zealand College of Anaesthetists; Victorian Government's Operational Infrastructure Support Program; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration(United States Department of Health & Human Services); Italian Ministry of Heath, Young Researchers Grant; Fonds NutsOhra grant; Vrienden WKZ; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Canada Inc.; Health Technologies Assessment-National Institute for Health Research UK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Health Research(National Institute for Health Research (NIHR))	Australia National Health and Medical Research Council (NHMRC), Health Technologies Assessment-National Institute for Health Research UK, National Institutes of Health, Food and Drug Administration, Australian and New Zealand College of Anaesthetists, Murdoch Childrens Research Institute, Canadian Institute of Health Research, Canadian Anesthesiologists' Society, Pfizer Canada, Italian Ministry of Heath, Fonds NutsOhra, and UK Clinical Research Network (UKCRN).; All hospitals and centres were generously supported by departmental funding. In addition to this funding, specific grants received for this study are as follows: Australia: The Australian National Health & Medical Research Council (Project Grants #1002906 and 491226); Australian and New Zealand College of Anaesthetists (Project Grant #11/021 and 07/012); Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program. US: National Institute of Health (Project Grant # NIH 1-R01 hD06 1136-01A1); Food and Drug Administration (Project Grant #FDA-SOL-08-SAFEKIDS-Clin 002-Project 2). Italy: Italian Ministry of Heath, Young Researchers Grant (Project Grant #167/GR-2009-1476067). Netherlands: Fonds NutsOhra grant #1305-144 and Vrienden WKZ 16.13.038. Canada: Canadian Institute of Health Research (Project Grant #MCT-98031), Canadian Anesthesiologists' Society, Pfizer Canada Inc. UK: Health Technologies Assessment-National Institute for Health Research UK (Project Grant #07/01/05). We are also grateful to the following individuals who contributed to the running of the study: Mark Fagjman (Department of Anaesthesia, Monash Medical Centre, Melbourne, VIC, Australia); Daniela Tronconi (Department of Anesthesia, Istituto Giannina Gaslini, Genoa, Italy); David C van der Zee (Department of Pediatric Surgery, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Netherlands); Jan Hulscher (Department of Surgery, University Medical Center Groningen, Groningen University, Groningen, Netherlands); Michael Rivkin (Department of Neurology, Children's Hospital Boston, Boston, MA, USA); Michelle Sadler-Greever (University of Washington, Seattle Children's Hospital, Department of Anesthesia and Pain Medicine, Seattle, WA, USA); Debra Faulk (Children's Hospital Colorado and University of Colorado School of Medicine, Department of Anesthesiology, Colorado, CO, USA); Greta Wilkening (Neurosciences Institute, Children's Hospital Colorado, CO, USA); Edward Goldson (Department of Pediatrics, Division of Developmental-Behavioral Pediatrics, Children's Hospital Colorado, Colorado, USA). Danai Udomtecha and Sarah Titler (The University of Iowa Hospital, Department of Anesthesia, Iowa, IA, USA); Roxana Ploski and Alan Farrow-Gilespie (Children's Medical Centre Dallas, Department of Anesthesiology, University of Texas Southwestern Medical Center, Dallas and Children's Medical Center at Dallas and Outcome Research Consortium, Dallas, TX, USA); Timothy Cooper (Division of Developmental Medicine and the Center for Child Development, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, TN, USA); Elizabeth Card (Perioperative Clinical Research Institute, Vanderbilt University Medical Center, Nashville, TN, USA); Wendy Boardman (Dartmouth-Hitchcock Medical Center, Department of Anesthesiology, NH, USA); Theodora K Goebel (Department of Anesthesiology and Critical Care Children's Hospital of Philadelphia, Philadelphia, PA, USA).	[Anonymous], 2006, MACARTHUR BATES COMM; Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; Bayley N., 2019, BAYLEY SCALES INFANT; Block RI, 2012, ANESTHESIOLOGY, V117, P494, DOI 10.1097/ALN.0b013e3182644684; Bode MM, 2014, J DEV BEHAV PEDIATR, V35, P570, DOI 10.1097/DBP.0000000000000110; Bong CL, 2013, ANESTH ANALG, V117, P1419, DOI 10.1213/ANE.0b013e318299a7c2; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Briner A, 2011, ANESTHESIOLOGY, V115, P282, DOI 10.1097/ALN.0b013e318221fbbd; Crosby G, 2013, ANESTH ANALG, V117, P1270, DOI 10.1213/ANE.0b013e3182a9667f; Davidson AJ, 2015, ANESTHESIOLOGY, V123, P38, DOI 10.1097/ALN.0000000000000709; Davidson AJ, 2015, PEDIATR ANESTH, V25, P447, DOI 10.1111/pan.12652; Davidson AJ, 2011, PEDIATR ANESTH, V21, P716, DOI 10.1111/j.1460-9592.2010.03506.x; DiMaggio C, 2012, J NEUROSURG ANESTH, V24, P376, DOI 10.1097/ANA.0b013e31826a038d; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Frawley G, 2015, ANESTHESIOLOGY, V123, P55, DOI 10.1097/ALN.0000000000000708; Hansen TG, 2015, PEDIATR ANESTH, V25, P65, DOI 10.1111/pan.12548; Hansen TG, 2013, PEDIATR ANESTH, V23, P883, DOI 10.1111/pan.12225; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; Harris S R, 1994, J Perinatol, V14, P275; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Ing CH, 2014, ANESTHESIOLOGY, V120, P1319, DOI 10.1097/ALN.0000000000000248; Istaphanous GK, 2013, ANESTH ANALG, V116, P845, DOI 10.1213/ANE.0b013e318281e988; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Johnson SA, 2008, J NEUROSURG ANESTH, V20, P21, DOI 10.1097/ANA.0b013e3181271850; Lee BH, 2014, NEUROPHARMACOLOGY, V83, P9, DOI 10.1016/j.neuropharm.2014.03.011; Lei SY, 2014, J NEUROSURG ANESTH, V26, P349, DOI 10.1097/ANA.0000000000000117; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Psaty BM, 2015, JAMA-J AM MED ASSOC, V313, P1515, DOI 10.1001/jama.2015.1149; Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851; Rappaport BA, 2015, NEW ENGL J MED, V372, P796, DOI 10.1056/NEJMp1414786; Sanchez V, 2011, ANESTHESIOLOGY, V115, P992, DOI 10.1097/ALN.0b013e3182303a63; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	41	528	543	7	120	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					239	250		10.1016/S0140-6736(15)00608-X	http://dx.doi.org/10.1016/S0140-6736(15)00608-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26507180	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000368130700031
J	Picao-Osorio, J; Johnston, J; Landgraf, M; Berni, J; Alonso, CR				Picao-Osorio, Joao; Johnston, Jamie; Landgraf, Matthias; Berni, Jimena; Alonso, Claudio R.			MicroRNA-encoded behavior in Drosophila	SCIENCE			English	Article							BITHORAX-COMPLEX; GENE-EXPRESSION; REGULATORY RNAS; NERVOUS-SYSTEM; CNS	The relationship between microRNA (miRNA) regulation and the specification of behavior is only beginning to be explored. We found that mutation of a single miRNA locus (miR-iab4/iab8) in Drosophila larvae affects the animal's capacity to correct its orientation if turned upside down (self-righting). One of the miRNA targets involved in this behavior is the Hox gene Ultrabithorax, whose derepression in two metameric neurons leads to self-righting defects. In vivo neural activity analysis reveals that these neurons, the self-righting node (SRN), have different activity patterns in wild type and miRNA mutants, whereas thermogenetic manipulation of SRN activity results in changes in self-righting behavior. Our work thus reveals a miRNA-encoded behavior and suggests that other miRNAs might also be involved in behavioral control in Drosophila and other species.	[Picao-Osorio, Joao; Johnston, Jamie; Alonso, Claudio R.] Univ Sussex, Sch Life Sci, Sussex Neurosci, Brighton BN1 9QG, E Sussex, England; [Landgraf, Matthias; Berni, Jimena] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Sussex; University of Cambridge	Alonso, CR (corresponding author), Univ Sussex, Sch Life Sci, Sussex Neurosci, Brighton BN1 9QG, E Sussex, England.	c.alonso@sussex.ac.uk		Johnston, Jamie/0000-0002-9928-989X; Berni, Jimena/0000-0002-5068-1372; Landgraf, Matthias/0000-0001-5142-1997	Wellcome Trust [098410/Z/12/Z, 05568/Z/14/Z, 092986/Z]; Fundacao para a Ciencia e a Tecnologia (Portugal) [FCT] [SFRH/BD/63312/2009]; Royal Society [05568/Z/14/Z]; Biotechnology and Biological Sciences Research Council (UK) [BB/IO22414/1]; BBSRC [BB/I022414/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I022414/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Fundacao para a Ciencia e a Tecnologia (Portugal) [FCT](Portuguese Foundation for Science and Technology); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Lagnado for his support to this project and S. Pinho and P. Reed for technical assistance. We also thank R. White for antibodies; Welcome Bender, E. Sanchez-Herrero, and the Bloomington Stock Centre for Drosophila stocks; and P. Patraquim for bioinformatic support. This paper is dedicated to the memory of Amalia Lamuedra de Alonso for her devoted support to this work. This research was funded by a Wellcome Trust Investigator Award to C.R.A. [WT grant 098410/Z/12/Z] and a Ph.D. studentship to J.P.O. by Fundacao para a Ciencia e a Tecnologia (Portugal) [FCT grant SFRH/BD/63312/2009]. J.B. is funded by Sir Henry Dale Fellowship (Wellcome Trust and the Royal Society) Grant 105568/Z/14/Z, and M.L. was supported by grants from the Biotechnology and Biological Sciences Research Council (UK) (BB/IO22414/1) and the Wellcome Trust (092986/Z).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; BRENNER S, 1974, GENETICS, V77, P71; Bridges C.B., 1923, 3 CHROMOSOME GROUP M; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; de Navas LF, 2011, DEVELOPMENT, V138, P107, DOI 10.1242/dev.051409; Garaulet DL, 2014, DEV CELL, V29, P635, DOI 10.1016/j.devcel.2014.04.023; Gummalla M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00096; Gummalla M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002720; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; KARCH F, 1985, CELL, V43, P81, DOI 10.1016/0092-8674(85)90014-5; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Reed HC, 2010, GENETICS, V184, P745, DOI 10.1534/genetics.109.112086; Rogulja-Ortmann A, 2014, DEVELOPMENT, V141, P2046, DOI 10.1242/dev.101519; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Thomsen S, 2010, DEVELOPMENT, V137, P2951, DOI 10.1242/dev.047324; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208	26	38	41	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					815	820		10.1126/science.aad0217	http://dx.doi.org/10.1126/science.aad0217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26494171	Green Accepted			2022-12-28	WOS:000364897000045
J	Gilbody, S; Littlewood, E; Hewitt, C; Brierley, G; Tharmanathan, P; Araya, R; Barkham, M; Bower, P; Cooper, C; Gask, L; Kessler, D; Lester, H; Lovell, K; Parry, G; Richards, DA; Andersen, P; Brabyn, S; Knowles, S; Shepherd, C; Tallon, D; White, D				Gilbody, Simon; Littlewood, Elizabeth; Hewitt, Catherine; Brierley, Gwen; Tharmanathan, Puvan; Araya, Ricardo; Barkham, Michael; Bower, Peter; Cooper, Cindy; Gask, Linda; Kessler, David; Lester, Helen; Lovell, Karina; Parry, Glenys; Richards, David A.; Andersen, Phil; Brabyn, Sally; Knowles, Sarah; Shepherd, Charles; Tallon, Debbie; White, David		REEACT Team	Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADULT DEPRESSION; INTERNET; QUESTIONNAIRES; DISORDERS; ANXIETY; PHQ-9	STUDY QUESTION How effective is supported computerised cognitive behaviour therapy (cCBT) as an adjunct to usual primary care for adults with depression? METHODS This was a pragmatic, multicentre, three arm, parallel randomised controlled trial with simple randomisation. Treatment allocation was not blinded. Participants were adults with symptoms of depression (score >= 10 on nine item patient health questionnaire, PHQ-9) who were randomised to receive a commercially produced cCBT programme ("Beating the Blues") or a free to use cCBT programme (MoodGYM) in addition to usual GP care. Participants were supported and encouraged to complete the programme via weekly telephone calls. Control participants were offered usual GP care, with no constraints on the range of treatments that could be accessed. The primary outcome was severity of depression assessed with the PHQ-9 at four months. Secondary outcomes included health related quality of life (measured by SF-36) and psychological wellbeing (measured by CORE-OM) at four, 12, and 24 months and depression at 12 and 24 months. STUDY ANSWER AND LIMITATIONS Participants offered commercial or free to use cCBT experienced no additional improvement in depression compared with usual GP care at four months (odds ratio 1.19 (95% confidence interval 0.75 to 1.88) for Beating the Blues v usual GP care; 0.98 (0.62 to 1.56) for MoodGYM v usual GP care). There was no evidence of an overall difference between either programme compared with usual GP care (0.99 (0.57 to 1.70) and 0.68 (0.42 to 1.10), respectively) at any time point. Commercially provided cCBT conferred no additional benefit over free to use cCBT or usual GP care at any follow-up point. Uptake and use of cCBT was low, despite regular telephone support. Nearly a quarter of participants (24%) had dropped out by four months. The study did not have enough power to detect small differences so these cannot be ruled out. Findings cannot be generalised to cCBT offered with a much higher level of guidance and support. WHAT THIS STUDY ADDS Supported cCBT does not substantially improve depression outcomes compared with usual GP care alone. In this study, neither a commercially available nor free to use computerised CBT intervention was superior to usual GP care. FUNDING, COMPETING INTERESTS, DATA SHARING Commissioned and funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project No 06/43/05). The authors have no competing interests. Requests for patient level data will be considered by the REEACT trial management group	[Gilbody, Simon; Littlewood, Elizabeth; Andersen, Phil; Brabyn, Sally] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Hewitt, Catherine; Tharmanathan, Puvan] Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England; [Brierley, Gwen] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Araya, Ricardo] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England; [Barkham, Michael] Univ Sheffield, Dept Psychol, Ctr Psychol Serv Res, Sheffield S10 2TP, S Yorkshire, England; [Bower, Peter; Gask, Linda; Knowles, Sarah] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Sch Primary Care Res, Manchester M13 9NT, Lancs, England; [Cooper, Cindy; White, David] Univ Sheffield, Sch Hlth & Related Res, Clin Trials Res Unit, Sheffield S1 4DA, S Yorkshire, England; [Kessler, David; Tallon, Debbie] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 2BN, Avon, England; [Lester, Helen] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England; [Parry, Glenys] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; [Richards, David A.] Univ Exeter, Sch Med, Exeter EX1 2LU, Devon, England; [Shepherd, Charles] Univ Hull, Fac Hlth & Social Care, Kingston Upon Hull HU6 7RX, N Humberside, England	University of York - UK; University of York - UK; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; University of Manchester; University of Sheffield; University of Bristol; University of Birmingham; University of Manchester; University of Sheffield; University of Exeter; University of Hull	Gilbody, S (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	simon.gilbody@york.ac.uk	Gilbody, Simon/AAY-3720-2021; Araya, Ricardo/S-3144-2019; Bower, Peter/A-1508-2011; Kessler, david/ABB-6489-2021; Lovell, Karina S E/E-6410-2012; Richards, David/B-4807-2009	Gilbody, Simon/0000-0002-8236-6983; Araya, Ricardo/0000-0002-0420-5148; Bower, Peter/0000-0001-9558-3349; Lovell, Karina S E/0000-0001-8821-895X; Barkham, Michael/0000-0003-1687-6376; Richards, David/0000-0002-8821-5027; Hewitt, Catherine Elizabeth/0000-0002-0415-3536; Knowles, Sarah/0000-0002-0863-5866; Andersen, Phil/0000-0002-6609-5925	NIHR Health Technology Assessment programme [06/43/05]; National Institute for Health Research [NF-SI-0611-10203, 06/43/05, 06/43/504, NF-SI-0514-10037] Funding Source: researchfish	NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the NIHR Health Technology Assessment programme (project No 06/43/05). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the Department of Health. The funder played no role in the study design, in the collection, analysis or interpretation of the data, in the writing of the paper or in the decision to submit the article for publication. All authors were independent from the funders.	Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Barkham M, 2001, J CONSULT CLIN PSYCH, V69, P184, DOI 10.1037//0022-006X.69.2.184; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Clark DM, 2011, INT REV PSYCHIATR, V23, P318, DOI 10.3109/09540261.2011.606803; Cuijpers P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021274; Cuijpers P, 2009, BRIT J GEN PRACT, V59, P120, DOI 10.3399/bjgp09X395139; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Kaltenthaler E, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10330; Kendrick T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b750; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; King M, 2000, Health Technol Assess, V4, P1; Knowles SE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008581; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P811; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; Lester H, 2008, POSTGRAD MED J, V84, P545, DOI 10.1136/pgmj.2008.068387; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Littlewood E, 2015, HLTH TECHNO IN PRESS; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; National Institute for Health and Care Excellence, 2009, DEPR AD TREATM MAN D, V90; Papanikolaou PN, 2004, AM J PSYCHIAT, V161, P1692, DOI 10.1176/appi.ajp.161.9.1692; Peveler R, 2005, Health Technol Assess, V9, P1; Proudfoot J, 2003, PSYCHOL MED, V33, P217, DOI 10.1017/S0033291702007225; Roth A., 2005, WHAT WORKS WHOM CRIT, V2nd; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; So M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-113; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Waller R, 2009, PSYCHOL MED, V39, P705, DOI 10.1017/S0033291708004224; Ware JE Jr, 1993, SF 36 HLTH SURVEY MA; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 1990, INT STAT CLASS DIS R	38	265	267	3	58	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2015	351								h5627	10.1136/bmj.h5627	http://dx.doi.org/10.1136/bmj.h5627			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4FX	26559241	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000364947900002
J	Bourne, PE; Lorsch, JR; Green, ED				Bourne, Philip E.; Lorsch, Jon R.; Green, Eric D.			Perspective: Sustaining the big-data ecosystem	NATURE			English	Editorial Material									[Bourne, Philip E.] US NIH, Data Sci, Rockville, MD 20852 USA; [Bourne, Philip E.] Univ Calif San Diego, Off Res Affairs, Innovat Alliance, San Diego, CA 92103 USA; [Bourne, Philip E.] Univ Calif San Diego, Off Res Affairs, Ind Alliance, San Diego, CA 92103 USA; [Lorsch, Jon R.] NIGMS, Bethesda, MD USA; [Lorsch, Jon R.] Johns Hopkins Univ, Biophys & Biophys Chem, Baltimore, MD USA; [Green, Eric D.] NHGRI, Bethesda, MD 20892 USA; [Green, Eric D.] NIH, Intramural Sequencing Ctr, Bldg 10, Bethesda, MD 20892 USA; [Green, Eric D.] NIH, Intramural Sequencing Ctr, Genome Technol Branch, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bourne, PE (corresponding author), US NIH, Data Sci, Rockville, MD 20852 USA.	philip.bourne@nih.gov	Bourne, Philip/ABG-8967-2021	Bourne, Philip/0000-0002-7618-7292; Lorsch, Jon/0000-0002-4521-4999	NATIONAL LIBRARY OF MEDICINE [ZIALM000928] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))			0	60	63	1	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					S16	S17		10.1038/527S16a	http://dx.doi.org/10.1038/527S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB5XK	26536219	hybrid			2022-12-28	WOS:000415924500006
J	Talley, NJ; Ford, AC				Talley, Nicholas J.; Ford, Alexander C.			Functional Dyspepsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HELICOBACTER-PYLORI ERADICATION; DOUBLE-BLIND; GASTRIC ACCOMMODATION; GASTROINTESTINAL DISORDERS; DUODENAL EOSINOPHILIA; NONULCER DYSPEPSIA; CONTROLLED-TRIAL; SYMPTOMS; POPULATION; MEAL	Dyspepsia is a constellation of symptoms referable to the gastroduodenal region of the upper gastrointestinal tract. Functional dyspepsia, a relapsing and remitting disorder, is the most common cause of these symptoms. The current standard for the diagnosis of functional dyspepsia is the Rome III criteria, developed by the Rome III Committees, a multinational group of experts in the field, first convened in 1990, that meets regularly to review and revise the diagnostic criteria for all functional gastrointestinal disorders. The Rome III criteria for functional dyspepsia consist of a sensation of pain or burning in the epigastrium, early satiety (inability to finish a normal-sized meal), fullness during or after a meal, or a combination of these symptoms (Table S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org). Symptoms must be chronic, occurring at least weekly and over a period of at least 6 months, in the absence of an organic explanation. 1 The global prevalence of functional dyspepsia in the community according to this definition is between 5% and 11%.(2) Up to 40% of persons who have functional dyspepsia consult a physician,(3) and the condition negatively affects attendance and productivity in the workplace.(4) Functional dyspepsia has substantial financial implications for patients, health care organizations, and society as a whole; costs associated with the condition in the United States in 2009 were in excess of $18 billion.(5) It is therefore important that physicians be able to recognize functional dyspepsia, use investigations and diagnostic tests judiciously, and recommend effective treatments, in order to minimize the potential adverse social and economic effects of the condition.	[Talley, Nicholas J.] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW 2300, Australia; [Ford, Alexander C.] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England	University of Newcastle; Saint James's University Hospital; University of Leeds	Talley, NJ (corresponding author), Univ Newcastle, Hunter Med Res Inst, Rm 3419, New Lambton, NSW 2295, Australia.	nicholas.talley@newcastle.edu.cn	Ford, Alexander/K-5491-2012	Ford, Alexander/0000-0001-6371-4359	Rome Foundation; Takeda Pharmaceutical; Yuhan; Adelphi Values; Prometheus Medical; Abbott Laboratories; Actavis; Furiex; Synergy Pharmaceuticals; Focus Communications; Zeria Pharmaceutical; Ironwood Pharmaceuticals; Janssen-Cilag; Datapharm; Pfizer; Salix Pharmaceuticals	Rome Foundation; Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Yuhan; Adelphi Values; Prometheus Medical; Abbott Laboratories(Abbott Laboratories); Actavis; Furiex; Synergy Pharmaceuticals; Focus Communications; Zeria Pharmaceutical(Zeria Pharmaceutical Co Ltd); Ironwood Pharmaceuticals; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Datapharm; Pfizer(Pfizer); Salix Pharmaceuticals	Dr. Talley reports receiving lecture fees from the Rome Foundation and Takeda Pharmaceutical, receiving consulting fees from Yuhan, Adelphi Values, Prometheus Medical, Abbott Laboratories, Forest Laboratories (now Actavis), Furiex, Synergy Pharmaceuticals, Focus Communications, and Zeria Pharmaceutical, serving as an unpaid consultant to GI Therapies, receiving honoraria from Janssen, Danone, and GI Care, receiving study medication from Forest Laboratories, receiving grant support from the Rome Foundation, Ironwood Pharmaceuticals, Prometheus Medical, Janssen-Cilag, Takeda Pharmaceutical, Abbott Laboratories, Datapharm, Pfizer, and Salix Pharmaceuticals, licensing the Bowel Disease Questionnaire and Mayo Dysphagia Questionnaire to the Mayo Clinic, and holding a patent (U.S. 12735358.9-1405/2710383) related to the performance of a biomarker panel for the irritable bowel syndrome. No other potential conflict of interest relevant to this article was reported.	Allison JA, 2005, GASTROENTEROLOGY, V129, P1756, DOI 10.1053/j.gastro.2005.09.020; ARIENTI V, 1994, ALIMENT PHARM THERAP, V8, P631; Aro P, 2015, GASTROENTEROLOGY, V148, P928, DOI 10.1053/j.gastro.2015.01.039; Azpiroz F, 2014, J GASTROENTEROL, V49, P206, DOI 10.1007/s00535-013-0917-8; Bharucha AE, 2014, AM J GASTROENTEROL, V109, P1910, DOI 10.1038/ajg.2014.330; Bisschops R, 2008, GUT, V57, P1495, DOI 10.1136/gut.2007.137125; Bortolotti M, 2002, ALIMENT PHARM THER, V16, P1075, DOI 10.1046/j.1365-2036.2002.01280.x; Camilleri M, 2005, CLIN GASTROENTEROL H, V3, P543, DOI 10.1016/S1542-3565(05)00153-9; Camilleri M, 2013, AM J GASTROENTEROL, V108, P18, DOI 10.1038/ajg.2012.373; Carbone F, 2014, DIGEST DIS, V32, P222, DOI 10.1159/000357854; Drossman Douglas, 2014, Am J Gastroenterol Suppl, V2, P22, DOI 10.1038/ajgsup.2014.6; Fang YJ, 2015, GUT, V64, P1517, DOI 10.1136/gutjnl-2014-308114; Farre R, 2013, GASTROENTEROLOGY, V145, P566, DOI 10.1053/j.gastro.2013.05.018; Feinle-Bisset C, 2013, AM J GASTROENTEROL, V108, P737, DOI 10.1038/ajg.2013.76; Ford AC, 2009, ALIMENT PHARM THER, V30, P28, DOI 10.1111/j.1365-2036.2009.04008.x; Ford AC, 2007, AM J GASTROENTEROL, V102, P957, DOI 10.1111/j.1572-0241.2007.01080.x; Ford AC, 2015, GUT, V64, P1049, DOI 10.1136/gutjnl-2014-307843; Ford AC, 2014, GASTROENTEROLOGY, V146, P932, DOI 10.1053/j.gastro.2014.01.014; Ford AC, 2012, AM J GASTROENTEROL, V107, P912, DOI 10.1038/ajg.2012.69; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P830, DOI 10.1016/j.cgh.2010.05.031; Friesen Craig A, 2013, World J Gastrointest Pharmacol Ther, V4, P86, DOI 10.4292/wjgpt.v4.i4.86; Futagami S, 2015, ALIMENT PHARM THER, V41, P177, DOI 10.1111/apt.13006; Futagami S, 2010, AM J GASTROENTEROL, V105, P1835, DOI 10.1038/ajg.2010.151; Hallas J, 1998, EUR J GASTROEN HEPAT, V10, P27, DOI 10.1097/00042737-199801000-00006; Heikkinen M, 2005, SCAND J GASTROENTERO, V40, P980, DOI 10.1080/00365520510015845; Iwakiri R, 2013, ALIMENT PHARM THER, V38, P729, DOI 10.1111/apt.12444; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Kusunoki H, 2012, NEUROGASTROENT MOTIL, V24, P540, DOI 10.1111/j.1365-2982.2012.01897.x; Lacy BE, 2013, ALIMENT PHARM THER, V38, P170, DOI 10.1111/apt.12355; Lacy BE, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2014.18; Lacy BE, 2011, CLIN GASTROENTEROL H, V9, P410, DOI 10.1016/j.cgh.2011.02.010; Lahner E, 2013, UNITED EUR GASTROENT, V1, P385, DOI 10.1177/2050640613499567; Lan L, 2011, WORLD J GASTROENTERO, V17, P3242, DOI 10.3748/wjg.v17.i27.3242; Liebregts T, 2011, AM J GASTROENTEROL, V106, P1089, DOI 10.1038/ajg.2010.512; Ly HG, 2013, GASTROENTEROLOGY, V144, pS37; Matsueda K, 2012, GUT, V61, P821, DOI 10.1136/gutjnl-2011-301454; Matsuzaki J, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01859.x; Mazzoleni LE, 2011, ARCH INTERN MED, V171, P1929, DOI 10.1001/archinternmed.2011.533; Miwa H, 2009, AM J GASTROENTEROL, V104, P2779, DOI 10.1038/ajg.2009.427; Moayyedi P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002096.pub2, 10.1002/14651858.CD002096.pub4]; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; Moayyedi P., 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001960.PUB3; Olafsdottir LB, 2012, DIGEST LIVER DIS, V44, P211, DOI 10.1016/j.dld.2011.10.009; Orive M, 2015, J PSYCHOSOM RES, V78, P563, DOI 10.1016/j.jpsychores.2015.03.003; Oshima T, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2011.06639.x; Parkman HP, 2011, GASTROENTEROLOGY, V140, P101, DOI 10.1053/j.gastro.2010.10.015; Pauwels A, 2014, NEUROGASTROENT MOTIL, V26, P581, DOI 10.1111/nmo.12305; Piessevaux H, 2009, NEUROGASTROENT MOTIL, V21, P378, DOI 10.1111/j.1365-2982.2009.01262.x; Pilichiewicz AN, 2007, AM J GASTROENTEROL, V102, P1276, DOI 10.1111/j.1572-0241.2007.01142.x; Pleyer C, 2014, NEUROGASTROENT MOTIL, V26, P1163, DOI 10.1111/nmo.12377; Samsom M, 1999, GASTROENTEROLOGY, V116, P515, DOI 10.1016/S0016-5085(99)70171-X; Sander GB, 2011, VALUE HEALTH, V14, pS126, DOI 10.1016/j.jval.2011.05.021; Sarnelli G, 2003, AM J GASTROENTEROL, V98, P783, DOI 10.1111/j.1572-0241.2003.07389.x; Soo S, 2005, COCHRANE DB SYST REV, V2; Spiller R, 2010, GASTROENTEROLOGY, V138, P1660, DOI 10.1053/j.gastro.2010.03.024; Stanghellini V, 2014, GUT, V63, P1972, DOI 10.1136/gutjnl-2013-306084; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Talley NJ, 2008, GUT, V57, P740, DOI 10.1136/gut.2007.132449; Talley NJ, 2007, CLIN GASTROENTEROL H, V5, P1175, DOI 10.1016/j.cgh.2007.05.015; Talley NJ, 2015, GASTROENTEROLOGY, V149, P340, DOI 10.1053/j.gastro.2015.04.020; Tan VPY, 2012, WORLD J GASTROENTERO, V18, P6127, DOI 10.3748/wjg.v18.i42.6127; Thumshirn M, 1999, GUT, V44, P55, DOI 10.1136/gut.44.1.55; Tornblom H, 2015, NEUROGASTROENT MOTIL, V27, P455, DOI 10.1111/nmo.12509; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Vakil N, 2013, AM J GASTROENTEROL, V108, P767, DOI 10.1038/ajg.2013.89; Vakil N, 2009, CLIN GASTROENTEROL H, V7, P756, DOI 10.1016/j.cgh.2009.03.031; van Kerkhoven LAS, 2006, ENDOSCOPY, V38, P879, DOI 10.1055/s-2006-944661; Van Kerkhoven LAS, 2008, CLIN GASTROENTEROL H, V6, P746, DOI 10.1016/j.cgh.2008.02.051; van Kerkhoven LAS, 2009, J CLIN GASTROENTEROL, V43, P118, DOI 10.1097/MCG.0b013e31815591f7; Vandenberghe J, 2007, GASTROENTEROLOGY, V132, P1684, DOI 10.1053/j.gastro.2007.03.037; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; von Arnim U, 2007, AM J GASTROENTEROL, V102, P1268, DOI 10.1111/j.1572-0241.2006.01183.x; Walker MM, 2014, ALIMENT PHARM THER, V39, P767, DOI 10.1111/apt.12666; Walker MM, 2014, EXPERT REV GASTROENT, V8, P289, DOI 10.1586/17474124.2014.881716; Walker MM, 2014, J GASTROEN HEPATOL, V29, P474, DOI 10.1111/jgh.12419; Wilder-Smith CH, 2014, NEUROGASTROENT MOTIL, V26, P489, DOI 10.1111/nmo.12291; Zagari RM, 2010, GASTROENTEROLOGY, V138, P1302, DOI 10.1053/j.gastro.2009.12.057; Zuo XL, 2007, CLIN EXP ALLERGY, V37, P823, DOI 10.1111/j.1365-2222.2007.02727.x	80	244	265	9	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1853	1863		10.1056/NEJMra1501505	http://dx.doi.org/10.1056/NEJMra1501505			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26535514	Green Published			2022-12-28	WOS:000364144000009
J	Wood, N				Wood, Nick			WHAT YOUR PATIENT IS THINKING How to talk to someone with an "untreatable" lifelong condition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													Wood, Nick/AAU-2087-2021	Wood, Nick/0000-0003-1849-7505					0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5037	10.1136/bmj.h5037	http://dx.doi.org/10.1136/bmj.h5037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OS	26538430	Green Published, Bronze			2022-12-28	WOS:000364390100002
J	Ambrose, BK; Day, HR; Rostron, B; Conway, KP; Borek, N; Hyland, A; Villanti, AC				Ambrose, Bridget K.; Day, Hannah R.; Rostron, Brian; Conway, Kevin P.; Borek, Nicolette; Hyland, Andrew; Villanti, Andrea C.			Flavored Tobacco Product Use Among US Youth Aged 12-17 Years, 2013-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ambrose, Bridget K.; Day, Hannah R.; Rostron, Brian; Borek, Nicolette] US FDA, Ctr Tobacco Prod, Silver Spring, MD 20993 USA; [Conway, Kevin P.] NIDA, Div Epidemiol Serv & Prevent Res, Bethesda, MD 20892 USA; [Hyland, Andrew] Roswell Pk Canc Inst, Dept Hlth Behav, Buffalo, NY 14263 USA; [Villanti, Andrea C.] Truth Initiat, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA	US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Roswell Park Cancer Institute	Ambrose, BK (corresponding author), US FDA, Off Sci, Ctr Tobacco Prod, 10903 New Hampshire Ave,Bldg 75,Room 4432, Silver Spring, MD 20993 USA.	bridget.ambrose@fda.hhs.gov	Hyland, Andrew/ABE-6249-2020; Villanti, Andrea/AAM-9433-2021; Villanti, Andrea/ABE-6283-2020	Villanti, Andrea/0000-0003-3104-966X; Villanti, Andrea/0000-0003-3104-966X; Conway, Kevin/0000-0002-7638-339X	NCI NIH HHS [P50 CA111236] Funding Source: Medline; NIDA NIH HHS [HHSN271201100027C] Funding Source: Medline; PHS HHS [HHSN271201100027C] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA111236] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Biglan M, 2004, NICOTINE TOB RES, V6, P427, DOI 10.1080/14622200410001696592; Corey CG, 2015, MMWR-MORBID MORTAL W, V64, P1066, DOI 10.15585/mmwr.mm6438a2; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; US Office of Management and Budget, PATH STUD INT REP	5	219	222	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1871	1873		10.1001/jama.2015.13802	http://dx.doi.org/10.1001/jama.2015.13802			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26502219	Green Accepted, Bronze			2022-12-28	WOS:000363960200022
J	Hensen, B; Bernien, H; Dreau, AE; Reiserer, A; Kalb, N; Blok, MS; Ruitenberg, J; Vermeulen, RFL; Schouten, RN; Abellan, C; Amaya, W; Pruneri, V; Mitchell, MW; Markham, M; Twitchen, DJ; Elkouss, D; Wehner, S; Taminiau, TH; Hanson, R				Hensen, B.; Bernien, H.; Dreau, A. E.; Reiserer, A.; Kalb, N.; Blok, M. S.; Ruitenberg, J.; Vermeulen, R. F. L.; Schouten, R. N.; Abellan, C.; Amaya, W.; Pruneri, V.; Mitchell, M. W.; Markham, M.; Twitchen, D. J.; Elkouss, D.; Wehner, S.; Taminiau, T. H.; Hanson, R.			Loophole-free Bell inequality violation using electron spins separated by 1.3 kilometres	NATURE			English	Article							HERALDED ENTANGLEMENT; PHOTONS	More than 50 years ago(1), John Bell proved that no theory of nature that obeys locality and realism(2) can reproduce all the predictions of quantum theory: in any local-realist theory, the correlations between outcomes of measurements on distant particles satisfy an inequality that can be violated if the particles are entangled. Numerous Bell inequality tests have been reported(3-13); however, all experiments reported so far required additional assumptions to obtain a contradiction with local realism, resulting in 'loopholes'(13-16). Here we report a Bell experiment that is free of any such additional assumption and thus directly tests the principles underlying Bell's inequality. We use an event-ready scheme(17-19) that enables the generation of robust entanglement between distant electron spins (estimated state fidelity of 0.92 +/- 0.03). Efficient spin read-out avoids the fair-sampling assumption (detection loophole(14,15)), while the use of fast random-basis selection and spin read-out combined with a spatial separation of 1.3 kilometres ensure the required locality conditions(13). We performed 245 trials that tested the CHSH-Bell inequality(20) S <= 2 and found S = 2.42 +/- 0.20 (where S quantifies the correlation between measurement outcomes). A null-hypothesis test yields a probability of at most P = 0.039 that a local-realist model for space-like separated sites could produce data with a violation at least as large as we observe, even when allowing for memory(16,21) in the devices. Our data hence imply statistically significant rejection of the local-realist null hypothesis. This conclusion may be further consolidated in future experiments; for instance, reaching a value of P = 0.001 would require approximately 700 trials for an observed S = 2.4. With improvements, our experiment could be used for testing less-conventional theories, and for implementing device-independent quantum-secure communication(22) and randomness certification(23,24).	[Hensen, B.; Bernien, H.; Dreau, A. E.; Reiserer, A.; Kalb, N.; Blok, M. S.; Ruitenberg, J.; Vermeulen, R. F. L.; Schouten, R. N.; Elkouss, D.; Wehner, S.; Taminiau, T. H.; Hanson, R.] Delft Univ Technol, QuTech, NL-2600 GA Delft, Netherlands; [Hensen, B.; Bernien, H.; Dreau, A. E.; Reiserer, A.; Kalb, N.; Blok, M. S.; Ruitenberg, J.; Vermeulen, R. F. L.; Schouten, R. N.; Taminiau, T. H.; Hanson, R.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Abellan, C.; Amaya, W.; Pruneri, V.; Mitchell, M. W.] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Fotoniques, Castelldefels 08860, Barcelona, Spain; [Pruneri, V.; Mitchell, M. W.] ICREA, Barcelona 08010, Spain; [Markham, M.; Twitchen, D. J.] Element Six Innovat, Didcot OX11 0QR, Oxon, England	Delft University of Technology; Delft University of Technology; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA; Element Six	Hanson, R (corresponding author), Delft Univ Technol, QuTech, POB 5046, NL-2600 GA Delft, Netherlands.	r.hanson@tudelft.nl	Abellan, Carlos/N-4561-2014; Dréau, Anaïs/Q-5946-2017; Hanson, Ronald/B-9555-2008; Taminiau, Tim Hugo H/A-8094-2008; Reiserer, Andreas/G-4980-2017; Elkouss, David/F-8869-2012; Bernien, Hannes/AAM-5598-2020; Mitchell, Morgan W/I-9027-2012; Blok, Machiel/GNP-0018-2022; Amaya Ocampo, Waldimar/C-8667-2012	Abellan, Carlos/0000-0003-1122-6622; Dréau, Anaïs/0000-0002-9989-335X; Taminiau, Tim Hugo H/0000-0002-2355-727X; Reiserer, Andreas/0000-0001-9595-7363; Elkouss, David/0000-0003-2023-2768; Bernien, Hannes/0000-0002-1950-7368; Mitchell, Morgan W/0000-0001-8949-9407; Blok, Machiel/0000-0001-9736-4158; Amaya Ocampo, Waldimar/0000-0002-6930-8914; Pruneri, Valerio/0000-0002-6425-9332; Markham, Matthew/0000-0001-8898-5884	Dutch Organization for Fundamental Research on Matter (FOM); Dutch Technology Foundation (STW); Netherlands Organization for Scientific Research (NWO) through a VENI; Netherlands Organization for Scientific Research (NWO) through VIDI; Defense Advanced Research Projects Agency QuASAR; Spanish MINECO project MAGO [FIS2011-23520]; Explora Ciencia [FIS2014-62181-EXP]; European Regional Development Fund (FEDER) [TEC2013-46168-R]; Fundacio Privada CELLEX; FET Proactive project QUIC; European Research Council through project AQUMET; European Research Council through project HYSCORE; ICREA Funding Source: Custom	Dutch Organization for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Dutch Technology Foundation (STW)(Technologiestichting STW); Netherlands Organization for Scientific Research (NWO) through a VENI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO) through VIDI(Netherlands Organization for Scientific Research (NWO)); Defense Advanced Research Projects Agency QuASAR(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Spanish MINECO project MAGO; Explora Ciencia; European Regional Development Fund (FEDER)(European Commission); Fundacio Privada CELLEX(Foundation CELLEX); FET Proactive project QUIC; European Research Council through project AQUMET(European Research Council (ERC)); European Research Council through project HYSCORE(European Research Council (ERC)); ICREA(ICREA)	We thank A. Acin, A. Aspect, P. Bierhorst, A. Doherty, R. Gill, P. Grunwald, M. Giustina, L. Mancinska, J. E. Mooij, T. Vidick, H. Weinfurter and Y. Zhang for discussions and/or reading our manuscript, and M. Blauw, P. Dorenbos, R. de Stefano, C. Tiberius, T. Versluis, R. Zwagerman and Facilitair Management and Vastgoed for help with the realization of the laboratories and the optical fibre connections. We acknowledge support from the Dutch Organization for Fundamental Research on Matter (FOM), the Dutch Technology Foundation (STW), the Netherlands Organization for Scientific Research (NWO) through a VENI grant (T.H.T.) and a VIDI grant (S.W.), the Defense Advanced Research Projects Agency QuASAR program, the Spanish MINECO project MAGO (reference FIS2011-23520) and Explora Ciencia (reference FIS2014-62181-EXP), the European Regional Development Fund (FEDER) grant TEC2013-46168-R, Fundacio Privada CELLEX, FET Proactive project QUIC and the European Research Council through projects AQUMET and HYSCORE.	Abelian C., PREPRINT; Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Barrett J, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.042111; Barrett SD, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060310; Bell J.S., 1980, COMM AT MOLEC PHYS, V9, P121; Bell J.S., 2004, SPEAKABLE UNSPEAKABL, P14; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Brunner N, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.419; Christensen BG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130406; Colbeck R., 2007, THESIS U CAMBRIDGE; EBERHARD PH, 1993, PHYS REV A, V47, pR747, DOI 10.1103/PhysRevA.47.R747; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; GARG A, 1987, PHYS REV D, V35, P3831, DOI 10.1103/PhysRevD.35.3831; Gerhardt I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.170404; Gill R. D., 2003, MATH MODEL PHYS ENG, V2, P179; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Hofmann J, 2012, SCIENCE, V337, P72, DOI 10.1126/science.1221856; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Pironio S, 2010, NATURE, V464, P1021, DOI 10.1038/nature09008; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	32	1249	1269	16	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					682	686		10.1038/nature15759	http://dx.doi.org/10.1038/nature15759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26503041				2022-12-28	WOS:000363832100044
J	Welk, B; McArthur, E; Fraser, LA; Hayward, J; Dixon, S; Hwang, YJ; Ordon, M				Welk, Blayne; McArthur, Eric; Fraser, Lisa-Ann; Hayward, Jade; Dixon, Stephanie; Hwang, Y. Joseph; Ordon, Michael			The risk of fall and fracture with the initiation of a prostate-selective alpha antagonist: a population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							URINARY-TRACT SYMPTOMS; TAMSULOSIN; MEN; HYPERPLASIA; MANAGEMENT; BLOCKERS; EFFICACY; SAFETY; EPIDEMIOLOGY; HYPOTENSION	STUDY QUESTION Do men starting treatment with prostate-specific a antagonists have increased risk of fall and fracture? METHODS Administrative datasets from the province of Ontario, Canada, that contain patient level data were used to generate a cohort of 147 084 men aged >= 66 years who filled their first outpatient prescription for prostate-specific alpha antagonists tamsulosin, alfuzosin, or silodosin between June 2003 and December 2013 (exposed men) plus an equal sized cohort matched 1: 1 (using a propensity score model) who did not initiate alpha antagonist therapy. The primary outcome was a hospital emergency room visit or inpatient admission for a fall or fracture in the 90 days after exposure. STUDY ANSWER AND LIMITATIONS The men exposed to prostate-specific alpha antagonist had significantly increased risks of falling (odds ratio 1.14 (95% CI 1.07 to 1.21), absolute risk increase 0.17% (0.08 to 0.25%)) and of sustaining a fracture (odds ratio 1.16 (1.04 to 1.29), absolute risk increase 0.06% (0.02 to 0.11%)) compared with the unexposed cohort. This increased risk was not observed in the period before a antagonist use. Secondary outcomes of hypotension and head trauma were also significantly increased in the exposed cohort (odds ratios 1.80 (1.59 to 2.03) and 1.15 (1.04 to 1.27) respectively). The two cohorts were similar across 98 different covariates including demographics, comorbid conditions, medication use, healthcare use, and prior medical investigation. Potential unmeasured confounders, such as physical deconditioning, mobility impairment, and situational risk factors, may exist. The data used to identify the primary outcomes had limited sensitivity, so the absolute risks of the outcomes are probably underestimates. The study only included men >= 66 years old, and 84% of exposed men were prescribed tamsulosin, so results may not be generalizable to younger men, and there may not be statistical power to show small differences in outcomes between the drugs. WHAT THIS STUDY ADDS Prostate-specific alpha antagonists are associated with a small but significant increased risk of fall, fracture, and head trauma, probably as a result of induced hypotension.	[Welk, Blayne] Univ Western Ontario, Dept Surg, London, ON N6A 4V2, Canada; [Welk, Blayne; McArthur, Eric; Hayward, Jade; Dixon, Stephanie] Inst Clin Evaluat Sci, London, ON, Canada; [Welk, Blayne; Dixon, Stephanie] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 4V2, Canada; [Fraser, Lisa-Ann] Univ Western Ontario, Dept Med, London, ON N6A 4V2, Canada; [Hwang, Y. Joseph] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Ordon, Michael] Univ Toronto, Dept Surg, Div Urol, Toronto, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Case Western Reserve University; University of Toronto	Welk, B (corresponding author), Univ Western Ontario, Dept Surg, London, ON N6A 4V2, Canada.	bkwelk@gmail.com	Ordon, Michael/GLN-6601-2022; Fraser, Lisa-Ann/J-7628-2012	Ordon, Michael/0000-0001-9319-1747; 	Ontario Ministry of Health and Long-term Care; Academic Medical Organization of Southwestern Ontario	Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES) Western Site through the Kidney, Dialysis, and Transplantation (KDT) research program. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-term Care. ICES Western is funded by an operating grant from the Academic Medical Organization of Southwestern Ontario. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2008, JAMA-J AM MED ASSOC, V300, P1660; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bird ST, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6320; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Chrischilles E, 2001, CLIN THER, V23, P727, DOI 10.1016/S0149-2918(01)80022-9; Dunn CJ, 2002, DRUG AGING, V19, P135, DOI 10.2165/00002512-200219020-00004; Elhilali MM, 2006, EXPERT OPIN PHARMACO, V7, P583, DOI 10.1517/14656566.7.5.583; Filson CP, 2013, UROLOGY, V82, P1386, DOI 10.1016/j.urology.2013.07.062; Filson CP, 2013, J UROLOGY, V190, P2153, DOI 10.1016/j.juro.2013.05.058; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gibson Debbie, 2008, International Journal of Information Quality, V2, P97, DOI 10.1504/IJIQ.2008.022958; Hall GC, 2007, PHARMACOEPIDEM DR S, V16, P901, DOI 10.1002/pds.1402; Hollingsworth JM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4474; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Lepor H, 1998, UROLOGY, V51, P892, DOI 10.1016/S0090-4295(98)00126-5; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Mann RD, 2000, BJU INT, V85, P446, DOI 10.1046/j.1464-410x.2000.00546.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Narayan P, 1998, J UROLOGY, V160, P1701, DOI 10.1016/S0022-5347(01)62386-3; Oelke M, 2014, EXPERT OPIN DRUG SAF, V13, P1187, DOI 10.1517/14740338.2014.936376; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; Osman NI, 2012, EXPERT OPIN PHARMACO, V13, P2085, DOI 10.1517/14656566.2012.714368; Parsons JK, 2009, BJU INT, V104, P63, DOI 10.1111/j.1464-410X.2008.08317.x; Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Souverein PC, 2003, J INTERN MED, V254, P548, DOI 10.1111/j.1365-2796.2003.01227.x; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Vestergaard P, 2011, OSTEOPOROSIS INT, V22, P731, DOI 10.1007/s00198-010-1320-4; Williams J, 2000, PATTERNS HLTH CARE O, P339; Yuan JQ, 2013, CURR MED RES OPIN, V29, P279, DOI 10.1185/03007995.2013.766594	32	43	45	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2015	351								h5398	10.1136/bmj.h5398	http://dx.doi.org/10.1136/bmj.h5398			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IC	26502947	hybrid, Green Published			2022-12-28	WOS:000364151600001
J	Fuller, J; Cantiello, M; Stello, D; Garcia, RA; Bildsten, L				Fuller, Jim; Cantiello, Matteo; Stello, Dennis; Garcia, Rafael A.; Bildsten, Lars			Asteroseismology can reveal strong internal magnetic fields in red giant stars	SCIENCE			English	Article							SOLAR-LIKE OSCILLATIONS; MIXED-MODES; CORE ROTATION; KEPLER; EVOLUTION	Internal stellar magnetic fields are inaccessible to direct observations, and little is known about their amplitude, geometry, and evolution. We demonstrate that strong magnetic fields in the cores of red giant stars can be identified with asteroseismology. The fields can manifest themselves via depressed dipole stellar oscillation modes, arising from a magnetic greenhouse effect that scatters and traps oscillation-mode energy within the core of the star. The Kepler satellite has observed a few dozen red giants with depressed dipole modes, which we interpret as stars with strongly magnetized cores. We find that field strengths larger than similar to 10(5) gauss may produce the observed depression, and in one case we infer a minimum core field strength of approximate to 10(7) gauss.	[Fuller, Jim] CALTECH, TAPIR, Walter Burke Inst Theoret Phys, Pasadena, CA 91125 USA; [Fuller, Jim; Cantiello, Matteo; Bildsten, Lars] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Stello, Dennis] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Stello, Dennis] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus C, Denmark; [Garcia, Rafael A.] Univ Paris Diderot, Inst Recherches Iois Fondament Univers, Direct Sci Matiere,CNRS,Serv Astrophys,Ctr Saclay, Lab Astrophys Interact Multiechelles,Commissariat, F-91191 Gif Sur Yvette, France; [Bildsten, Lars] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	California Institute of Technology; University of California System; University of California Santa Barbara; University of Sydney; Aarhus University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of California System; University of California Santa Barbara	Fuller, J (corresponding author), CALTECH, TAPIR, Walter Burke Inst Theoret Phys, Mailcode 350-17, Pasadena, CA 91125 USA.	jfuller@caltech.edu; matteo@kitp.ucsb.edu	Stello, Dennis/Q-9754-2019	Stello, Dennis/0000-0002-4879-3519; Cantiello, Matteo/0000-0002-8171-8596; Garcia, Rafael A./0000-0002-8854-3776	NSF [AST-1205732, PHY 11-25915, AST 11-09174]; Lee DuBridge Fellowship at the California Instiute of Technology; European Community [312844]; Centre National d'Etudes Spatiales; Australian Research Council; NASA under Theory and Computational Astrophysics Network [NNX14AB53G]; Direct For Mathematical & Physical Scien [1205732] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1109174] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Lee DuBridge Fellowship at the California Instiute of Technology; European Community(European Commission); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Australian Research Council(Australian Research Council); NASA under Theory and Computational Astrophysics Network; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors of this paper thank the Kavli Institute for Theoretical Physics and the organizers of the Galactic Archaeology and Precision Stellar Astrophysics program held from January to April 2015. J.F. acknowledges partial support from NSF under grant no. AST-1205732 and through a Lee DuBridge Fellowship at the California Instiute of Technology. R.A.G. acknowledge the support of the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 312844 (SPACEINN), and from the Centre National d'Etudes Spatiales. D.S. acknowledges support from the Australian Research Council. This project was supported by NASA under Theory and Computational Astrophysics Network grant no. NNX14AB53G and NSF under grants PHY 11-25915 and AST 11-09174.	Auriere M, 2007, ASTRON ASTROPHYS, V475, P1053, DOI 10.1051/0004-6361:20078189; Ballot J, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201016230; Beck PG, 2011, SCIENCE, V332, P205, DOI 10.1126/science.1201939; Beck PG, 2012, NATURE, V481, P55, DOI 10.1038/nature10612; Bedding TR, 2010, ASTROPHYS J LETT, V713, pL176, DOI 10.1088/2041-8205/713/2/L176; Bedding T. R., 2014, SOLAR LIKE OSCILLATI; Bedding TR, 2011, NATURE, V471, P608, DOI 10.1038/nature09935; Benomar O, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/2/L29; BROWN TM, 1991, ASTROPHYS J, V368, P599, DOI 10.1086/169725; Chaplin WJ, 2013, ANNU REV ASTRON ASTR, V51, P353, DOI 10.1146/annurev-astro-082812-140938; Charbonnel C, 2007, ASTRON ASTROPHYS, V476, pL29, DOI 10.1051/0004-6361:20078740; Corsaro E, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201525895; Corsaro E, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/190; Deheuvels S, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322779; Dupret MA, 2009, ASTRON ASTROPHYS, V506, P57, DOI 10.1051/0004-6361/200911713; Garcia RA, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322823; GOLDREICH P, 1977, ASTROPHYS J, V212, P243, DOI 10.1086/155043; Grosjean M, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201423827; Mosser B, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201425039; Mosser B, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220106; Mosser B, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117352	21	100	100	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					423	426		10.1126/science.aac6933	http://dx.doi.org/10.1126/science.aac6933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494754	Green Submitted			2022-12-28	WOS:000363213400037
J	Glenn, NM; Clark, M				Glenn, Nicole M.; Clark, Marianne			When Accommodation Gets Complicated	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Glenn, Nicole M.] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Glenn, Nicole M.] Univ Montreal, Inst Rech Sante Publ, Montreal, PQ, Canada; [Clark, Marianne] Univ British Columbia, Sch Hlth & Exercise Sci, Vancouver, BC V5Z 1M9, Canada	Universite de Montreal; Universite de Montreal; University of British Columbia	Glenn, NM (corresponding author), Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada.	nicole.glenn@umontreal.ca						Carel H., 2013, ILLNESS; Leder Drew, 1990, ABSENT BODY; Throsby K, 2008, BODY SOC, V14, P117, DOI 10.1177/1357034X07087534; van Manen M, 2012, MED HUMANIT, V38, P91, DOI 10.1136/medhum-2012-010204	4	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1567	1568		10.1001/jama.2015.5978	http://dx.doi.org/10.1001/jama.2015.5978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501531				2022-12-28	WOS:000363028500015
J	Kistin, C; Silverstein, M				Kistin, Caroline; Silverstein, Michael			Pilot Studies A Critical but Potentially Misused Component of Interventional Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIALS		[Kistin, Caroline; Silverstein, Michael] Boston Med Ctr, Dept Pediat, Boston, MA 02118 USA; [Kistin, Caroline; Silverstein, Michael] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston Medical Center; Boston University	Kistin, C (corresponding author), Boston Med Ctr, Dept Pediat, 88 E Newton St,Vose Hall,Third Floor, Boston, MA 02118 USA.	caroline.kistin@bmc.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD081057, K23HD078503] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Langley Gj., 1996, IMPROVEMENT GUIDE PR; Lewin Simon, 2009, BMJ, V339, pb3496, DOI 10.1136/bmj.b3496; Meurer WJ, 2012, JAMA-J AM MED ASSOC, V307, P2377, DOI 10.1001/jama.2012.4174; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]	8	95	95	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1561	1562		10.1001/jama.2015.10962	http://dx.doi.org/10.1001/jama.2015.10962			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501530	Green Accepted, Green Published			2022-12-28	WOS:000363028500012
J	Watts, G				Watts, Geoff			Moffat Nyirenda: investigating diabetes and other NCDs in Malawi	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1527	1527		10.1016/S0140-6736(15)00479-1	http://dx.doi.org/10.1016/S0140-6736(15)00479-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26530611	Bronze			2022-12-28	WOS:000362878200015
J	Lincoff, AM; Mehran, R; Povsic, TJ; Zelenkofske, SL; Huang, Z; Armstrong, PW; Steg, PG; Bode, C; Cohen, MG; Buller, C; Laanmets, P; Valgimigli, M; Marandi, T; Fridrich, V; Cantor, WJ; Merkely, B; Lopez-Sendon, J; Cornel, JH; Kasprzak, JD; Aschermann, M; Guetta, V; Morais, J; Sinnaeve, PR; Huber, K; Stables, R; Sellers, MA; Borgman, M; Glenn, L; Levinson, AI; Lopes, RD; Hasselblad, V; Becker, RC; Alexander, JH				Lincoff, A. Michael; Mehran, Roxana; Povsic, Thomas J.; Zelenkofske, Steven L.; Huang, Zhen; Armstrong, Paul W.; Steg, P. Gabriel; Bode, Christoph; Cohen, Mauricio G.; Buller, Christopher; Laanmets, Peep; Valgimigli, Marco; Marandi, Toomas; Fridrich, Viliam; Cantor, Warren J.; Merkely, Bela; Lopez-Sendon, Jose; Cornel, Jan H.; Kasprzak, Jaroslaw D.; Aschermann, Michael; Guetta, Victor; Morais, Joao; Sinnaeve, Peter R.; Huber, Kurt; Stables, Rod; Sellers, Mary Ann; Borgman, Marilyn; Glenn, Lauren; Levinson, Arnold I.; Lopes, Renato D.; Hasselblad, Vic; Becker, Richard C.; Alexander, John H.		REGULATE-PCI Investigators	Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial	LANCET			English	Article							RNA APTAMERS; EFFICACY; ANTIBODY; SAFETY; REVASCULARIZATION; PHARMACODYNAMICS; METAANALYSIS; COAGULATION; INHIBITORS; THROMBOSIS	Background REG1 is a novel anticoagulation system consisting of pegnivacogin, an RNA aptamer inhibitor of coagulation factor IXa, and anivamersen, a complementary sequence reversal oligonucleotide. We tested the hypothesis that near complete inhibition of factor IXa with pegnivacogin during percutaneous coronary intervention, followed by partial reversal with anivamersen, would reduce ischaemic events compared with bivalirudin, without increasing bleeding. Methods We did a randomised, open-label, active-controlled, multicentre, superiority trial to compare REG1 with bivalirudin at 225 hospitals in North America and Europe. We planned to randomly allocate 13 200 patients undergoing percutaneous coronary intervention in a 1: 1 ratio to either REG1 (pegnivacogin 1 mg/kg bolus [>99% factor IXa inhibition] followed by 80% reversal with anivamersen after percutaneous coronary intervention) or bivalirudin. Exclusion criteria included ST segment elevation myocardial infarction within 48 h. The primary efficacy endpoint was the composite of all-cause death, myocardial infarction, stroke, and unplanned target lesion revascularisation by day 3 after randomisation. The principal safety endpoint was major bleeding. Analysis was by intention to treat. This trial is registered at ClinicalTrials.gov, identifier NCT01848106. The trial was terminated early after enrolment of 3232 patients due to severe allergic reactions. Findings 1616 patients were allocated REG1 and 1616 were assigned bivalirudin, of whom 1605 and 1601 patients, respectively, received the assigned treatment. Severe allergic reactions were reported in ten (1%) of 1605 patients receiving REG1 versus one (<1%) of 1601 patients treated with bivalirudin. The composite primary endpoint did not differ between groups, with 108 (7%) of 1616 patients assigned REG1 and 103 (6%) of 1616 allocated bivalirudin reporting a primary endpoint event (odds ratio [OR] 1.05, 95% CI 0.80-1.39; p=0.72). Major bleeding was similar between treatment groups (seven [<1%] of 1605 receiving REG1 vs two [<1%] of 1601 treated with bivalirudin; OR 3.49, 95% CI 0.73-16.82; p=0.10), but major or minor bleeding was increased with REG1 (104 [6%] vs 65 [4%]; 1.64, 1.19-2.25; p=0.002). Interpretation The reversible factor IXa inhibitor REG1, as currently formulated, is associated with severe allergic reactions. Although statistical power was limited because of early termination, there was no evidence that REG1 reduced ischaemic events or bleeding compared with bivalirudin.	[Lincoff, A. Michael; Borgman, Marilyn] Cleveland Clin Coordinating Ctr Clin Res C5Res, Cleveland, OH USA; [Mehran, Roxana] Mt Sinai Sch Med, New York, NY USA; [Povsic, Thomas J.; Huang, Zhen; Sellers, Mary Ann; Lopes, Renato D.; Hasselblad, Vic; Alexander, John H.] Duke Med, Duke Clin Res Inst, Durham, NC USA; [Zelenkofske, Steven L.; Glenn, Lauren] Regado Biosci, Basking Ridge, NJ USA; [Armstrong, Paul W.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [Steg, P. Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Bode, Christoph] Univ Freiburg, D-79106 Freiburg, Germany; [Cohen, Mauricio G.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Buller, Christopher] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Laanmets, Peep; Marandi, Toomas] North Estonia Med Ctr, Tallinn, Estonia; [Valgimigli, Marco] Univ Hosp Ferrara, Inst Cardiol, Ferrara, Italy; [Fridrich, Viliam] Natl Inst Cardiovasc Dis, Bratislava, Slovakia; [Cantor, Warren J.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Lopez-Sendon, Jose] Hosp Univ La Paz, IdiPaz, Madrid, Spain; [Cornel, Jan H.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Kasprzak, Jaroslaw D.] Med Univ Lodz, Bieganski Hosp, Lodz, Poland; [Aschermann, Michael] Gen Univ Hosp, Prague, Czech Republic; [Guetta, Victor] Tel Aviv Univ, Sheba Med Ctr, Inst Heart, Tel Hashomer, Israel; [Morais, Joao] Santo Andres Hosp, Leiria, Portugal; [Sinnaeve, Peter R.] Univ Hosp Leuven, Leuven, Belgium; [Huber, Kurt] Wilhelminen Hosp, Vienna, Austria; [Stables, Rod] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England; [Levinson, Arnold I.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Becker, Richard C.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Icahn School of Medicine at Mount Sinai; Duke University; University of Alberta; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Miami; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ferrara; Arcispedale Sant'Anna; Southlake Regional Health Centre; Semmelweis University; Hospital Universitario La Paz; Medical Center Of Alkmaar; Medical University Lodz; General University Hospital Prague; Chaim Sheba Medical Center; Tel Aviv University; KU Leuven; University Hospital Leuven; Wilhelminenspital; Liverpool Heart & Chest Hospital; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; University of Cincinnati	Lincoff, AM (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland Clin Coordinating Ctr Clin Res C5Res, Cleveland, OH 44195 USA.	lincofa@ccf.org	cornel, jan hein/Y-7065-2019; Frey, Norbert/A-9695-2010; Cohen, Mauricio G./H-7281-2019; Abdel-Latif, Ahmed/V-8097-2019; Alexander, John/GVS-7271-2022; STEG, Philippe Gabriel/Z-1567-2019; Mehran, Roxana/ABF-4160-2021; Kasprzak, Jaroslaw Damian/S-4496-2016; Valgimigli, Marco/AAE-9103-2019	cornel, jan hein/0000-0002-1006-2112; Cohen, Mauricio G./0000-0003-2038-6070; Abdel-Latif, Ahmed/0000-0002-8178-7102; Valgimigli, Marco/0000-0002-4353-7110; Jordan, Dedrick/0000-0002-0706-9583; Sinnaeve, Peter/0000-0003-4716-5892; Morais, Joao/0000-0003-3406-2878; STEG, Philippe Gabriel/0000-0001-6896-2941; Merkely, Bela/0000-0001-6514-0723; Garcia del Blanco, Bruno/0000-0002-4527-1600; Armstrong, Paul/0000-0002-0460-3445; Alexander, John/0000-0002-1444-2462	Regado Biosciences Inc.; Regado Biosciences	Regado Biosciences Inc.; Regado Biosciences	Regado Biosciences Inc.; The REGULATE-PCI trial and this analysis were funded by Regado Biosciences.	BENEDICT CR, 1991, J CLIN INVEST, V88, P1760, DOI 10.1172/JCI115495; Cavender MA, 2014, LANCET, V384, P599, DOI 10.1016/S0140-6736(14)61216-2; Chan MY, 2008, J THROMB HAEMOST, V6, P789, DOI 10.1111/j.1538-7836.2008.02932.x; Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Cohen MG, 2010, CIRCULATION, V122, P614, DOI 10.1161/CIRCULATIONAHA.109.927756; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; Feuerstein GZ, 1999, ARTERIOSCL THROM VAS, V19, P2554, DOI 10.1161/01.ATV.19.10.2554; Ganson NJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1861; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Howard EL, 2007, ARTERIOSCL THROM VAS, V27, P722, DOI 10.1161/01.ATV.0000259363.91070.f1; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kjalke M, 1998, THROMB HAEMOSTASIS, V80, P578; Mehran R, 2011, JACC-CARDIOVASC INTE, V4, P654, DOI 10.1016/j.jcin.2011.02.011; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Monroe DM, 1996, BLOOD COAGUL FIBRIN, V7, P459, DOI 10.1097/00001721-199606000-00005; Ni X, 2011, CURR MED CHEM, V18, P4206, DOI 10.2174/092986711797189600; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Povsic TJ, 2013, EUR HEART J, V34, P2481, DOI 10.1093/eurheartj/ehs232; Povsic TJ, 2011, EUR HEART J, V32, P2412, DOI 10.1093/eurheartj/ehr179; Povsic TJ, 2011, AM HEART J, V161, P261, DOI 10.1016/j.ahj.2010.10.022; Rao SV, 2008, AM HEART J, V155, P369, DOI 10.1016/j.ahj.2007.10.014; Refino CJ, 2002, ARTERIOSCL THROM VAS, V22, P517, DOI 10.1161/hq0302.105375; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Sundy John S, 2007, Curr Rheumatol Rep, V9, P258, DOI 10.1007/s11926-007-0041-y; Sundy JS, 2007, ARTHRITIS RHEUM-US, V56, P1021, DOI 10.1002/art.22403; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Winchester DE, 2011, J AM COLL CARDIOL, V57, P1190, DOI 10.1016/j.jacc.2010.10.030	29	84	87	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					349	356		10.1016/S0140-6736(15)00515-2	http://dx.doi.org/10.1016/S0140-6736(15)00515-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26547100				2022-12-28	WOS:000368516500033
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Tuberculosis-getting to zero	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London EC2Y 5AS, England		Das, P (corresponding author), The Lancet, London EC2Y 5AS, England.							Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Ortblad KF, 2013, LANCET, V381, P104; Ortblad KF, 2015, LANCET; Rangaka MX, 2015, LANCET; Theron G, 2015, LANCET; *WHO, WHO STOP TB STRAT; World Organisatio H, 2014, MULT RES TUB MDR TB; Yuen CM, 2015, LANCET	9	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2231	2232		10.1016/S0140-6736(15)00401-8	http://dx.doi.org/10.1016/S0140-6736(15)00401-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26515677				2022-12-28	WOS:000365993200008
J	Ruan, J; Martin, P; Shah, B; Schuster, SJ; Smith, SM; Furman, RR; Christos, P; Rodriguez, A; Svoboda, J; Lewis, J; Katz, O; Coleman, M; Leonard, JP				Ruan, Jia; Martin, Peter; Shah, Bijal; Schuster, Stephen J.; Smith, Sonali M.; Furman, Richard R.; Christos, Paul; Rodriguez, Amelyn; Svoboda, Jakub; Lewis, Jessica; Katz, Orel; Coleman, Morton; Leonard, John P.			Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; IN-VITRO; THERAPY; COMBINATION; INDOLENT; PHASE-2; CHOP; IMMUNOCHEMOTHERAPY; CYCLOPHOSPHAMIDE; MULTICENTER	BACKGROUND Mantle-cell lymphoma is generally incurable. Initial treatment is not standardized but usually includes cytotoxic chemotherapy. Lenalidomide, an immunomodulatory compound, and rituximab, an anti-CD20 antibody, are active in patients with recurrent mantle-cell lymphoma. We evaluated lenalidomide plus rituximab as a first-line therapy. METHODS We conducted a single-group, multicenter, phase 2 study with induction and maintenance phases. During the induction phase, lenalidomide was administered at a dose of 20 mg daily on days 1 through 21 of every 28-day cycle for 12 cycles; the dose was escalated to 25 mg daily after the first cycle if no dose-limiting adverse events occurred during the first cycle and was reduced to 15 mg daily during the maintenance phase. Rituximab was administered once weekly for the first 4 weeks and then once every other cycle until disease progression. The primary end point was the overall response rate. Secondary end points included outcomes related to safety, survival, and quality of life. RESULTS A total of 38 participants were enrolled at four centers from July 2011 through April 2014. The median age was 65 years. On the basis of the Mantle Cell Lymphoma International Prognostic Index scores, the proportions of participants with low-risk, intermediate-risk, and high-risk disease at baseline were similar (34%, 34%, and 32%, respectively). The most common grade 3 or 4 adverse events were neutropenia (in 50% of the patients), rash (in 29%), thrombocytopenia (in 13%), an inflammatory syndrome ("tumor flare") (in 11%), anemia (in 11%), serum sickness (in 8%), and fatigue (in 8%). At the median follow-up of 30 months (through February 2015), the overall response rate among the participants who could be evaluated was 92% (95% confidence interval [CI], 78 to 98), and the complete response rate was 64% (95% CI, 46 to 79); median progression-free survival had not been reached. The 2-year progression-free survival was estimated to be 85% (95% CI, 67 to 94), and the 2-year overall survival 97% (95% CI, 79 to 99). A response to treatment was associated with improvement in quality of life. CONCLUSIONS Combination biologic therapy consisting of lenalidomide plus rituximab was active as initial therapy for mantle-cell lymphoma.	[Ruan, Jia; Martin, Peter; Furman, Richard R.; Rodriguez, Amelyn; Lewis, Jessica; Katz, Orel; Coleman, Morton; Leonard, John P.] Weill Cornell Med Coll, Meyer Canc Ctr, Div Hematol & Med Oncol, New York, NY USA; [Christos, Paul] Weill Cornell Med Coll, Div Biostat & Epidemiol, New York, NY USA; New York Presbyterian Hosp, New York, NY 10021 USA; [Shah, Bijal] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Schuster, Stephen J.; Svoboda, Jakub] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Smith, Sonali M.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	Cornell University; Cornell University; NewYork-Presbyterian Hospital; H Lee Moffitt Cancer Center & Research Institute; University of Pennsylvania; Pennsylvania Medicine; University of Chicago; University of Chicago Medical Center	Ruan, J (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Meyer Canc Ctr, Div Hematol & Med Oncol, 1305 York Ave,7th Fl, New York, NY 10021 USA.	jruan@med.cornell.edu; jpleonard@med.cornell.edu	Smith, Sonali/AAD-9328-2020; Ruan, Jia/AAH-4450-2019		Celgene; Weill Cornell Medical College; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000458, UL1TR000457] Funding Source: NIH RePORTER	Celgene(Bristol-Myers SquibbCelgene Corporation); Weill Cornell Medical College; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Celgene and Weill Cornell Medical College	Abrahamsson A, 2014, BLOOD, V124, P1288, DOI 10.1182/blood-2014-03-559930; Ahmadi T, 2014, CANCER-AM CANCER SOC, V120, P222, DOI 10.1002/cncr.28405; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Campo E, 2015, BLOOD, V125, P48, DOI 10.1182/blood-2014-05-521898; Chang JE, 2014, BLOOD, V123, P1665, DOI 10.1182/blood-2013-08-523845; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chong EA, 2015, CLIN CANCER RES, V21, P1835, DOI 10.1158/1078-0432.CCR-14-2221; Delarue R, 2013, BLOOD, V121, P48, DOI 10.1182/blood-2011-09-370320; Forstpointner R, 2006, BLOOD, V108, P4003, DOI 10.1182/blood-2006-04-016725; Geisler CH, 2008, BLOOD, V112, P2687, DOI 10.1182/blood-2008-03-147025; Goy A, 2013, J CLIN ONCOL, V31, P3688, DOI 10.1200/JCO.2013.49.2835; Harrison CN, 2013, BRIT J HAEMATOL, V162, P229, DOI 10.1111/bjh.12375; Herrmann A, 2009, J CLIN ONCOL, V27, P511, DOI 10.1200/JCO.2008.16.8435; Howard OM, 2002, J CLIN ONCOL, V20, P1288, DOI 10.1200/JCO.20.5.1288; Kluin-Nelemans HC, 2012, NEW ENGL J MED, V367, P520, DOI 10.1056/NEJMoa1200920; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Martin P, 2009, J CLIN ONCOL, V27, P1209, DOI 10.1200/JCO.2008.19.6121; Moros A, 2014, CLIN CANCER RES, V20, P393, DOI 10.1158/1078-0432.CCR-13-1569; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Reddy N, 2008, BRIT J HAEMATOL, V140, P36, DOI 10.1111/j.1365-2141.2007.06841.x; Robak T, 2015, NEW ENGL J MED, V372, P944, DOI 10.1056/NEJMoa1412096; Romaguera JE, 2005, J CLIN ONCOL, V23, P7013, DOI 10.1200/JCO.2005.01.1825; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Smith SK, 2009, CANCER-AM CANCER SOC, V115, P3312, DOI 10.1002/cncr.24391; Song K, 2013, CANCER RES, V73, P7254, DOI 10.1158/0008-5472.CAN-13-0750; Till BG, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.149.149; Trneny M, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.626.626; Wang M, 2012, LANCET ONCOL, V13, P716, DOI 10.1016/S1470-2045(12)70200-0; Zhang L, 2009, AM J HEMATOL, V84, P553, DOI 10.1002/ajh.21468	30	179	191	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1835	1844		10.1056/NEJMoa1505237	http://dx.doi.org/10.1056/NEJMoa1505237			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26535512	Green Accepted			2022-12-28	WOS:000364144000007
J	Alivisatos, AP; Blaser, MJ; Brodie, EL; Chun, M; Dangl, JL; Donohue, TJ; Dorrestein, PC; Gilbert, JA; Green, JL; Jansson, JK; Knight, R; Maxon, ME; McFall-Ngai, MJ; Miller, JF; Pollard, KS; Ruby, EG; Taha, SA				Alivisatos, A. P.; Blaser, M. J.; Brodie, E. L.; Chun, M.; Dangl, J. L.; Donohue, T. J.; Dorrestein, P. C.; Gilbert, J. A.; Green, J. L.; Jansson, J. K.; Knight, R.; Maxon, M. E.; McFall-Ngai, M. J.; Miller, J. F.; Pollard, K. S.; Ruby, E. G.; Taha, S. A.			A unified initiative to harness Earth's microbiomes	SCIENCE			English	Editorial Material												jfmiller@ucla.edu	Cardon, Zoe/I-2119-2016; Brodie, Eoin L/A-7853-2008; Dorrestein, Pieter/ABF-2930-2020; Jansson, Janet/H-5478-2018; Ozcan, Aydogan/I-2608-2013; Gilbert, Jack/AAF-3270-2019; Knight, Rob/D-1299-2010	Cardon, Zoe/0000-0001-8725-7842; Brodie, Eoin L/0000-0002-8453-8435; Jansson, Janet/0000-0002-5487-4315; Ozcan, Aydogan/0000-0002-0717-683X; Knight, Rob/0000-0002-0975-9019; Henriksen, James/0000-0003-2485-0889; Moran, Mary Ann/0000-0002-0702-8167	Division Of Integrative Organismal Systems [1343020] Funding Source: National Science Foundation; Howard Hughes Medical Institute Funding Source: Medline	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Cox LM, 2015, NAT REV ENDOCRINOL, V11, P182, DOI 10.1038/nrendo.2014.210; da Silva RR, 2015, P NATL ACAD SCI USA, V112, P12549, DOI 10.1073/pnas.1516878112; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; Garber K, 2015, NAT BIOTECHNOL, V33, P228, DOI 10.1038/nbt.3161; Ge P, 2015, NAT STRUCT MOL BIOL, V22, P377, DOI 10.1038/nsmb.2995; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hultman J, 2015, NATURE, V521, P208, DOI 10.1038/nature14238; Joice R, 2014, CELL METAB, V20, P731, DOI 10.1016/j.cmet.2014.10.003; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	14	148	159	3	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					507	508		10.1126/science.aac8480	http://dx.doi.org/10.1126/science.aac8480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26511287	Green Submitted			2022-12-28	WOS:000363660000025
J	Bourane, S; Duan, B; Koch, SC; Dalet, A; Britz, O; Garcia-Campmany, L; Kim, E; Cheng, LZ; Ghosh, A; Ma, QF; Goulding, M				Bourane, Steeve; Duan, Bo; Koch, Stephanie C.; Dalet, Antoine; Britz, Olivier; Garcia-Campmany, Lidia; Kim, Euiseok; Cheng, Longzhen; Ghosh, Anirvan; Ma, Qiufu; Goulding, Martyn			Gate control of mechanical itch by a subpopulation of spinal cord interneurons	SCIENCE			English	Article							INHIBITORY INTERNEURONS; DORSAL-HORN; EVOKED ITCH; PAIN; CIRCUITS; TRANSMITTER; DYNORPHIN; NEURONS; GALANIN; CELLS	Light mechanical stimulation of hairy skin can induce a form of itch known as mechanical itch. This itch sensation is normally suppressed by inputs from mechanoreceptors; however, in many forms of chronic itch, including alloknesis, this gating mechanism is lost. Here we demonstrate that a population of spinal inhibitory interneurons that are defined by the expression of neuropeptide Y::Cre (NPY::Cre) act to gate mechanical itch. Mice in which dorsal NPY::Cre-derived neurons are selectively ablated or silenced develop mechanical itch without an increase in sensitivity to chemical itch or pain. This chronic itch state is histamine-independent and is transmitted independently of neurons that express the gastrin-releasing peptide receptor. Thus, our studies reveal a dedicated spinal cord inhibitory pathway that gates the transmission of mechanical itch.	[Bourane, Steeve; Koch, Stephanie C.; Dalet, Antoine; Britz, Olivier; Garcia-Campmany, Lidia; Goulding, Martyn] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Duan, Bo; Cheng, Longzhen; Ma, Qiufu] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Duan, Bo; Cheng, Longzhen; Ma, Qiufu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kim, Euiseok; Ghosh, Anirvan] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Cheng, Longzhen] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Cheng, Longzhen] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Salk Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Fudan University; Fudan University	Ma, QF (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	qiufu_ma@dfci.harvard.edu; goulding@salk.edu	Bourane, Steeve/AAI-6143-2020; Cheng, Longzhen/ABF-7581-2021	Bourane, Steeve/0000-0002-9805-2196; Koch, Stephanie/0000-0002-7131-4141	NIH [NS086372, NS080586, NS072031, NS072040, R01 NS 067216]; Caterina Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067216, P01NS072040, R01NS080586, R01NS086372, P30NS072031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caterina Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the NIH (NS086372 to M.G. and Q.M., NS080586 and NS072031 to M.G., and NS072040 to Q.M.) and by the Caterina Foundation (S.B. and S.C.K.). We thank C. Padilla and T. Velasquez for help in generating the R26GAG<SUP>ds-hM4D-tdTomato</SUP> mice. All data are contained in the manuscript and the supplementary materials. A.G. and E.K. were supported by the Gatsby Charitable Foundation and the NIH (grant R01 NS 067216).	Akiyama T, 2013, NEUROSCIENCE, V250, P697, DOI 10.1016/j.neuroscience.2013.07.035; Akiyama T, 2012, J INVEST DERMATOL, V132, P1886, DOI 10.1038/jid.2012.52; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Foster E, 2015, NEURON, V85, P1289, DOI 10.1016/j.neuron.2015.02.028; Fukuoka M, 2013, PAIN, V154, P897, DOI 10.1016/j.pain.2013.02.021; Han L, 2014, ANNU REV BIOPHYS, V43, P331, DOI 10.1146/annurev-biophys-051013-022826; Hosogi M, 2006, PAIN, V126, P16, DOI 10.1016/j.pain.2006.06.003; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Kardon AP, 2014, NEURON, V82, P573, DOI 10.1016/j.neuron.2014.02.046; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Reich A, 2013, ACTA DERM-VENEREOL, V93, P591, DOI 10.2340/00015555-1543; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Sardella TCP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-76; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tiong SYX, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-36; WAHLGREN CF, 1991, ACTA DERM-VENEREOL, V71, P488	26	170	172	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					550	554		10.1126/science.aac8653	http://dx.doi.org/10.1126/science.aac8653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516282	Green Accepted			2022-12-28	WOS:000363660000046
J	Markovic, N				Markovic, Nina			Randomness rules	SCIENCE			English	Editorial Material							QUANTUM PHASE-TRANSITIONS; BEHAVIOR		Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Johns Hopkins University	Markovic, N (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.	nina@pha.jhu.edu			Direct For Mathematical & Physical Scien [1507782] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		FISHER DS, 1992, PHYS REV LETT, V69, P534, DOI 10.1103/PhysRevLett.69.534; FISHER MPA, 1990, PHYS REV LETT, V65, P923, DOI 10.1103/PhysRevLett.65.923; Goldman AM, 1998, PHYS TODAY, V51, P39, DOI 10.1063/1.882069; GRIFFITHS RB, 1969, PHYS REV LETT, V23, P17, DOI 10.1103/PhysRevLett.23.17; HARRIS AB, 1974, J PHYS C SOLID STATE, V7, P1671, DOI 10.1088/0022-3719/7/9/009; MCCOY BM, 1968, PHYS REV, V176, P631, DOI 10.1103/PhysRev.176.631; Sondhi SL, 1997, REV MOD PHYS, V69, P315, DOI 10.1103/RevModPhys.69.315; Ubaid-Kassis S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066402; Vojta T, 2006, J PHYS A-MATH GEN, V39, pR143, DOI 10.1088/0305-4470/39/22/R01; Xing Y, 2015, SCIENCE, V350, P542, DOI 10.1126/science.aaa7154	10	10	10	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					509	509		10.1126/science.aad4136	http://dx.doi.org/10.1126/science.aad4136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516266				2022-12-28	WOS:000363660000026
J	Hart, MM; Boffito, M; Pozniak, A				Hart, Malika Mohabeer; Boffito, Marta; Pozniak, Anton			Unexpected rapid weight gain in a patient with HIV and anorexia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hart, Malika Mohabeer] Chelsea & Westminster Hosp NHS Fdn, Dept HIV & Sexual Hlth, London SW10 9NH, England; [Boffito, Marta; Pozniak, Anton] Chelsea & Westminster Hosp NHS Fdn, HIV Med, London SW10 9NH, England		Hart, MM (corresponding author), Chelsea & Westminster Hosp NHS Fdn, Dept HIV & Sexual Hlth, London SW10 9NH, England.	malikamohabeer@gmail.com						[Anonymous], 2015, DRUG INT REP; BHIVA, 2014, HIV MED, V15, P1; Boyd SD, 2013, JAIDS-J ACQ IMM DEF, V63, P355, DOI 10.1097/QAI.0b013e31829260d6; Ellis J, 2009, AUST FAM PHYSICIAN, V38, P816; Marshall NJ, 2012, ENDOCR ABSTRACTS, V28, P56; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Ramanathan R, 2008, CLIN INFECT DIS, V47, pE97, DOI 10.1086/593314; Samuel M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1555; Stribild, 2014, STRIB HIGHL PRESCR I; University of Liverpool, 2011, RIT PK FACTSH	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2015	351								h5551	10.1136/bmj.h5551	http://dx.doi.org/10.1136/bmj.h5551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IM	26514997				2022-12-28	WOS:000364152800002
J	O'Keefe, RJ				O'Keefe, Regis J.			Fibrinolysis as a Target to Enhance Fracture Healing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SKELETAL; BONE		Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63130 USA	Washington University (WUSTL)	O'Keefe, RJ (corresponding author), Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63130 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054041] Funding Source: NIH RePORTER; NIAMS NIH HHS [P50 AR054041] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Grimes R, 2011, J BONE MINER RES, V26, P2597, DOI 10.1002/jbmr.486; Taitsman LA, 2009, J TRAUMA, V67, P1389, DOI 10.1097/TA.0b013e318182afd0; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Yuasa M, 2015, J CLIN INVEST, V125, P3117, DOI 10.1172/JCI80313	5	28	30	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1776	1778		10.1056/NEJMcibr1510090	http://dx.doi.org/10.1056/NEJMcibr1510090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26510027	Green Accepted			2022-12-28	WOS:000363514100015
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Abuse-Deterrent Opioid Formulations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							EXTENDED-RELEASE OXYCODONE; SUBSTANCE-ABUSE; REFORMULATION; OXYCONTIN; SAFETY; SAMPLE; IMPACT; RATES						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2015, Med Lett Drugs Ther, V57, P71; [Anonymous], 2014, Med Lett Drugs Ther, V56, P45; [Anonymous], 2010, MED LETT DRUGS THER, V52, P22; Butler SF, 2013, J PAIN, V14, P351, DOI 10.1016/j.jpain.2012.08.008; Cassidy TA, 2014, PAIN MED, V15, P440, DOI 10.1111/pme.12295; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; Coplan PM, 2013, PHARMACOEPIDEM DR S, V22, P1274, DOI 10.1002/pds.3522; Degenhardt L, 2015, DRUG ALCOHOL DEPEN, V151, P56, DOI 10.1016/j.drugalcdep.2015.02.038; Food and Drug Administration, 2015, AB DET OP EV LAB GUI; Harris SC, 2014, J CLIN PHARMACOL, V54, P468, DOI 10.1002/jcph.235; Havens JR, 2014, DRUG ALCOHOL DEPEN, V139, P9, DOI 10.1016/j.drugalcdep.2014.02.018; Hwang CS, 2015, PHARMACOEPIDEM DR S, V24, P197, DOI 10.1002/pds.3723; Larochelle MR, 2015, JAMA INTERN MED, V175, P978, DOI 10.1001/jamainternmed.2015.0914; Sessler NE, 2014, PHARMACOEPIDEM DR S, V23, P1238, DOI 10.1002/pds.3658; Severtson SG, 2013, J PAIN, V14, P1122, DOI 10.1016/j.jpain.2013.04.011; Stauffer J, 2009, CLIN DRUG INVEST, V29, P777, DOI 10.2165/11530800-000000000-00000	16	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1744	1745		10.1001/jama.2015.12869	http://dx.doi.org/10.1001/jama.2015.12869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505600				2022-12-28	WOS:000363706300025
J	Smith, JM				Smith, Jeanette M.			Evening (Landscape in Brilliant Colors) Nikolai Nedashkovsky	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1676	1677		10.1001/jama.2014.12049	http://dx.doi.org/10.1001/jama.2014.12049			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505583	Bronze			2022-12-28	WOS:000363706300001
J	Barkley, D; Song, BF; Mukund, V; Lemoult, G; Avila, M; Hof, B				Barkley, Dwight; Song, Baofang; Mukund, Vasudevan; Lemoult, Gregoire; Avila, Marc; Hof, Bjoern			The rise of fully turbulent flow	NATURE			English	Article							PIPE; TRANSITION; INTERMITTENCY; SPOTS; PUFFS	Over a century of research into the origin of turbulence in wall-bounded shear flows has resulted in a puzzling picture in which turbulence appears in a variety of different states competing with laminar background flow(1-6). At moderate flow speeds, turbulence is confined to localized patches; it is only at higher speeds that the entire flow becomes turbulent. The origin of the different states encountered during this transition, the front dynamics of the turbulent regions and the transformation to full turbulence have yet to be explained. By combining experiments, theory and computer simulations, here we uncover a bifurcation scenario that explains the transformation to fully turbulent pipe flow and describe the front dynamics of the different states encountered in the process. Key to resolving this problem is the interpretation of the flow as a bistable system with nonlinear propagation (advection) of turbulent fronts. These findings bridge the gap between our understanding of the onset of turbulence(7) and fully turbulent flows(8,9).	[Barkley, Dwight] Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England; [Song, Baofang; Mukund, Vasudevan; Lemoult, Gregoire; Hof, Bjoern] IST Austria, A-3400 Klosterneuburg, Austria; [Song, Baofang] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Song, Baofang] Univ Erlangen Nurnberg, Inst Multiscale Simulat, D-91052 Erlangen, Germany; [Avila, Marc] Univ Erlangen Nurnberg, Inst Fluid Mech, D-91058 Erlangen, Germany	University of Warwick; Institute of Science & Technology - Austria; Max Planck Society; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Barkley, D (corresponding author), Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England.	D.Barkley@warwick.ac.uk; bhof@ist.ac.at	Barkley, Dwight/F-8218-2014; Song, Baofang/GRS-2136-2022; Avila, Marc/A-1263-2009	Barkley, Dwight/0000-0003-4317-3705; Song, Baofang/0000-0003-4469-8781; Avila, Marc/0000-0001-5988-1090	Deutsche Forschungsgemeinschaft [FOR 1182]; European Research Council under the European Union [306589]; Chinese State Scholarship Fund [2010629145]; International Max Planck Research School for the Physics of Biological and Complex Systems; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Julich Supercomputing Centre [HGU16]; Direct For Mathematical & Physical Scien [1440415] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council under the European Union(European Research Council (ERC)); Chinese State Scholarship Fund; International Max Planck Research School for the Physics of Biological and Complex Systems; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Julich Supercomputing Centre; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. P. Willis for sharing his hybrid spectral finite-difference code, and X. Tu for helping to set up and test the experiment. We acknowledge the Deutsche Forschungsgemeinschaft (Project No. FOR 1182), and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement 306589 for financial support. B.S. acknowledges financial support from the Chinese State Scholarship Fund under grant number 2010629145. B.S. acknowledges support from the International Max Planck Research School for the Physics of Biological and Complex Systems and the Gottingen Graduate School for Neurosciences and Molecular Biosciences. We acknowledge computing resources from GWDG (Gesellschaft fur wissenschaftliche Datenverarbeitung Gottingen) and the Julich Supercomputing Centre (grant HGU16) where the simulations were performed.	Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223; Avila M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.224502; Avila M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.063012; Barkley D, 2012, REV CUB FIS, V29, P27; Barkley D, 2011, J PHYS CONF SER, V318, DOI 10.1088/1742-6596/318/3/032001; Barkley D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016309; Chantry M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.164501; COLES D, 1965, J FLUID MECH, V21, P385, DOI 10.1017/S0022112065000241; Coles D., 1962, MECANIQUE TURBULENCE, V229; Cros A, 2002, PHYS FLUIDS, V14, P3755, DOI 10.1063/1.1508796; Duguet Y, 2010, J FLUID MECH, V663, P180, DOI 10.1017/S0022112010003435; Eckhardt B, 2007, ANNU REV FLUID MECH, V39, P447, DOI 10.1146/annurev.fluid.39.050905.110308; EMMONS HW, 1951, J AERONAUT SCI, V18, P490, DOI 10.2514/8.2010; Gibson JF, 2008, J FLUID MECH, V611, P107, DOI 10.1017/S002211200800267X; Hof B, 2010, SCIENCE, V327, P1491, DOI 10.1126/science.1186091; Holzner M, 2013, J FLUID MECH, V723, P140, DOI 10.1017/jfm.2013.127; Kawahara G, 2012, ANNU REV FLUID MECH, V44, P203, DOI 10.1146/annurev-fluid-120710-101228; Kerswell RR, 2005, NONLINEARITY, V18, pR17, DOI 10.1088/0951-7715/18/6/R01; Lemoult G, 2013, J FLUID MECH, V731, DOI 10.1017/jfm.2013.388; Lindgren E. R., 1957, ARK FYS, V12; LUNDBLADH A, 1991, J FLUID MECH, V229, P499, DOI 10.1017/S0022112091003130; Moxey D, 2010, P NATL ACAD SCI USA, V107, P8091, DOI 10.1073/pnas.0909560107; Mullin T, 2011, ANNU REV FLUID MECH, V43, P1, DOI 10.1146/annurev-fluid-122109-160652; Nishi M, 2008, J FLUID MECH, V614, P425, DOI 10.1017/S0022112008003315; Pope S. B., 2000, TURBULENT FLOWS, P264; RINZEL J, 1982, SIAM J APPL MATH, V42, P1111, DOI 10.1137/0142077; Samanta D, 2011, J FLUID MECH, V681, P193, DOI 10.1017/jfm.2011.189; Schlichting H., 2017, BOUNDARY LAYER THEOR, VNinth, DOI DOI 10.1007/978-3-642-85829-1; Sipos M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.035304; SREENIVASAN KR, 1986, PHYSICA D, V23, P246, DOI 10.1016/0167-2789(86)90134-X; TILLMARK N, 1992, J FLUID MECH, V235, P89, DOI 10.1017/S0022112092001046; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Willis AP, 2009, J FLUID MECH, V619, P213, DOI 10.1017/S0022112008004618; WYGNANSKI I, 1975, J FLUID MECH, V69, P283, DOI 10.1017/S0022112075001449; WYGNANSKI IJ, 1973, J FLUID MECH, V59, P281, DOI 10.1017/S0022112073001576	36	107	110	11	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					550	U191		10.1038/nature15701	http://dx.doi.org/10.1038/nature15701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490621	Green Submitted			2022-12-28	WOS:000364026100045
J	Rasmussen, S; Allentoft, ME; Nielsen, K; Orlando, L; Sikora, M; Sjogren, KG; Pedersen, AG; Schubert, M; Van Dam, A; Kapel, CMO; Nielsen, HB; Brunak, S; Avetisyan, P; Epimakhov, A; Khalyapin, MV; Gnuni, A; Kriiska, A; Lasak, I; Metspalu, M; Moiseyev, V; Gromov, A; Pokutta, D; Saag, L; Varul, L; Yepiskoposyan, L; Sicheritz-Ponten, T; Foley, RA; Lahr, MM; Nielsen, R; Kristiansen, K; Willerslev, E				Rasmussen, Simon; Allentoft, Morten Erik; Nielsen, Kasper; Orlando, Ludovic; Sikora, Martin; Sjoegren, Karl-Goeran; Pedersen, Anders Gorm; Schubert, Mikkel; Van Dam, Alex; Kapel, Christian Moliin Outzen; Nielsen, Henrik Bjorn; Brunak, Soren; Avetisyan, Pavel; Epimakhov, Andrey; Khalyapin, Mikhail Viktorovich; Gnuni, Artak; Kriiska, Aivar; Lasak, Irena; Metspalu, Mait; Moiseyev, Vyacheslav; Gromov, Andrei; Pokutta, Dalia; Saag, Lehti; Varul, Liivi; Yepiskoposyan, Levon; Sicheritz-Ponten, Thomas; Foley, Robert A.; Lahr, Marta Mirazon; Nielsen, Rasmus; Kristiansen, Kristian; Willerslev, Eske			Early Divergent Strains of Yersinia pestis in Eurasia 5,000 Years Ago	CELL			English	Article							FLEA-BORNE TRANSMISSION; MURINE TOXIN; GENOME; DNA; SEQUENCE; EVOLUTION; INSIGHTS; PLAGUE; AGENT	The bacteria Yersinia pestis is the etiological agent of plague and has caused human pandemics with millions of deaths in historic times. How and when it originated remains contentious. Here, we report the oldest direct evidence of Yersinia pestis identified by ancient DNA in human teeth from Asia and Europe dating from 2,800 to 5,000 years ago. By sequencing the genomes, we find that these ancient plague strains are basal to all known Yersinia pestis. We find the origins of the Yersinia pestis lineage to be at least two times older than previous estimates. We also identify a temporal sequence of genetic changes that lead to increased virulence and the emergence of the bubonic plague. Our results show that plague infection was endemic in the human populations of Eurasia at least 3,000 years before any historical recordings of pandemics.	[Rasmussen, Simon; Nielsen, Kasper; Pedersen, Anders Gorm; Van Dam, Alex; Nielsen, Henrik Bjorn; Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Allentoft, Morten Erik; Orlando, Ludovic; Sikora, Martin; Schubert, Mikkel; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Sjoegren, Karl-Goeran; Pokutta, Dalia; Kristiansen, Kristian] Univ Gothenburg, Dept Hist Studies, S-40530 Gothenburg, Sweden; [Kapel, Christian Moliin Outzen] Univ Copenhagen, Dept Plant & Environm Sci, Sect Organismal Biol, DK-1871 Frederiksberg C, Denmark; [Brunak, Soren] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Avetisyan, Pavel] Natl Acad Sci, Inst Archaeol & Ethnog, Div Armenol & Social Sci, Yerevan 0025, Armenia; [Epimakhov, Andrey] South Ural State Univ, Inst Hist & Archaeol RAS, South Ural Dept, Chelyabinsk 454080, Russia; [Khalyapin, Mikhail Viktorovich] Orenburg Museum Fine Arts, Orenburg 460000, Russia; [Gnuni, Artak] Yerevan State Univ, Dept Archaeol & Ethnog, Yerevan 0025, Armenia; [Kriiska, Aivar; Varul, Liivi] Univ Tartu, Dept Archaeol, EE-51003 Tartu, Estonia; [Lasak, Irena] Univ Wroclaw, Inst Archaeol, PL-50139 Wroclaw, Poland; [Metspalu, Mait; Saag, Lehti] Estonian Bioctr, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Metspalu, Mait; Saag, Lehti] Univ Tartu, EE-51010 Tartu, Estonia; [Moiseyev, Vyacheslav; Gromov, Andrei] RAS, Peter Great Museum Anthropol & Ethnog Kunstkamera, St Petersburg 199034, Russia; [Yepiskoposyan, Levon] Natl Acad Sci, Inst Mol Biol, Lab Ethnogenom, Yerevan 0014, Armenia; [Foley, Robert A.; Lahr, Marta Mirazon] Univ Cambridge, Dept Archaeol & Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Nielsen, Rasmus] Univ Calif Berkeley, Ctr Theoret Evolutionary Genet, Berkeley, CA 94720 USA; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Technical University of Denmark; University of Copenhagen; University of Gothenburg; University of Copenhagen; University of Copenhagen; National Academy of Sciences of Armenia; Institute of Archaeology & Ethnography - NAS RA; Institute of History & Archaeology of the Ural Branch of the Russian Academy of Sciences; South Ural State University; Yerevan State University; University of Tartu; University of Wroclaw; Estonian Biocentre; University of Tartu; Russian Academy of Sciences; The Kunstkamera; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; University of Cambridge; University of California System; University of California Berkeley; University of Cambridge	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Nielsen, Henrik/B-8961-2019; Moiseyev, Vyacheslav/AAD-2659-2019; Orlando, Ludovic/A-8932-2013; Epimakhov, Andrey V/N-8603-2014; Sikora, Martin/C-8609-2015; Pokutta, Dalia/AAV-2218-2020; Willerslev, Eske/AAA-5686-2019; Saag, Lehti/AAT-5535-2020; Metspalu, Mait/G-8671-2015; Rasmussen, Simon/AAA-2308-2020; Willerslev, Eske/A-9619-2011; Kapel, Christian M. O./G-9168-2014; Rasmussen, Simon/G-6258-2016; Gromov, Andrey/AAD-2989-2019; Schubert, Mikkel/I-6911-2013; Brunak, Soren/O-6621-2016; Nielsen, Rasmus/D-4405-2009; Sicheritz-Ponten, Thomas/A-4325-2017	Nielsen, Henrik/0000-0003-2281-5713; Orlando, Ludovic/0000-0003-3936-1850; Epimakhov, Andrey V/0000-0002-0141-1026; Sikora, Martin/0000-0003-2818-8319; Pokutta, Dalia/0000-0003-2049-6886; Saag, Lehti/0000-0002-2274-8138; Metspalu, Mait/0000-0003-3099-9161; Rasmussen, Simon/0000-0001-6323-9041; Willerslev, Eske/0000-0002-7081-6748; Kapel, Christian M. O./0000-0002-9539-457X; Rasmussen, Simon/0000-0001-6323-9041; Schubert, Mikkel/0000-0003-2401-9921; Avetisyan, Pavel/0000-0002-4469-9517; Brunak, Soren/0000-0003-0316-5866; Sjogren, Karl-Goran/0000-0003-1791-3175; Pedersen, Anders Gorm/0000-0001-9650-8965; Allentoft, Morten/0000-0003-4424-3568; Mirazon Lahr, Marta/0000-0001-5752-5770; Gromov, Andrey/0000-0002-3263-3801; Nielsen, Kasper/0000-0002-5510-7767; Nielsen, Rasmus/0000-0003-0513-6591; Sicheritz-Ponten, Thomas/0000-0001-6615-1141	European Research Council [269442]; Marie Curie Actions of the European Union [300554]; Villum Foundation [10120]; University of Copenhagen; Danish National Research Foundation; Lundbeck Foundation; National Science Foundation Postdoctoral Research Fellowship in Biology [1306489]; Novo Nordisk Foundation [NNF14CC0001]; Lundbeck Foundation [R70-2010-6286, R155-2013-16338, R24-2008-2527, R38-2008-3048, R109-2012-9995] Funding Source: researchfish; Villum Fonden [00010120] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Marie Curie Actions of the European Union(European Commission); Villum Foundation(Villum Fonden); University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); National Science Foundation Postdoctoral Research Fellowship in Biology; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Villum Fonden(Villum Fonden); Novo Nordisk Foundation Center for Protein Research	The project was funded by The European Research Council (FP/2007-2013, grant 269442, The Rise), Marie Curie Actions of the European Union (FP7/2007-2013, grant 300554), The Villum Foundation (Young Investigator Programme, grant 10120), University of Copenhagen (KU2016 Programme), The Danish National Research Foundation, and The Lundbeck Foundation. A.V.D. was supported by the National Science Foundation Postdoctoral Research Fellowship in Biology under grant 1306489. S.B. was supported financially by the Novo Nordisk Foundation Grant agreement NNF14CC0001. We thank Jesper Stenderup for technical assistance and want to acknowledge the Danish national supercomputer-Computerome (computerome.cbs.dtu.dk) for the computational resources to perform the BEAST divergence estimations.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BERCOVIER H, 1980, CURR MICROBIOL, V4, P225, DOI 10.1007/BF02605861; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Carniel E, 2003, ADV EXP MED BIOL, V529, P3; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drancourt M, 2002, MICROBES INFECT, V4, P105, DOI 10.1016/S1286-4579(01)01515-5; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Harbeck M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003349; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Hinz M, 2012, J ARCHAEOL SCI, V39, P3331, DOI 10.1016/j.jas.2012.05.028; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kristiansen K., 2005, RISE BRONZE AGE SOC; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Little LK, 2007, PLAGUE AND THE END OF ANTIQUITY: THE PANDEMIC OF 541-750, P1; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Minnich SA, 2007, ADV EXP MED BIOL, V603, P298; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radnedge L, 2002, MICROBIOL-SGM, V148, P1687, DOI 10.1099/00221287-148-6-1687; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun YC, 2014, CELL HOST MICROBE, V15, P578, DOI 10.1016/j.chom.2014.04.003; Treille G., 1894, 8 C INT HYG DEM; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Zimbler DL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8487	48	274	291	2	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					571	582		10.1016/j.cell.2015.10.009	http://dx.doi.org/10.1016/j.cell.2015.10.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496604	Green Published, hybrid			2022-12-28	WOS:000364828900012
J	Grams, ME; Sang, YY; Levey, AS; Matsushita, K; Ballew, S; Chang, AR; Chow, EKH; Kasiske, BL; Kovesdy, CP; Nadkarni, GN; Shalev, V; Segev, DL; Coresh, J; Lentine, KL; Garg, AX				Grams, Morgan E.; Sang, Yingying; Levey, Andrew S.; Matsushita, Kunihiro; Ballew, Shoshana; Chang, Alex R.; Chow, Eric K. H.; Kasiske, Bertram L.; Kovesdy, Csaba P.; Nadkarni, Girish N.; Shalev, Varda; Segev, Dorry L.; Coresh, Josef; Lentine, Krista L.; Garg, Amit X.		Chronic Kidney Dis Prognosis Conso	Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE RENAL-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; MEDICAL OUTCOMES; RACIAL VARIATION; FOLLOW-UP; DONATION; MORTALITY; OLDER; METAANALYSIS	BACKGROUND Evaluation of candidates to serve as living kidney donors relies on screening for individual risk factors for end-stage renal disease (ESRD). To support an empirical approach to donor selection, we developed a tool that simultaneously incorporates multiple health characteristics to estimate a person's probable long-term risk of ESRD if that person does not donate a kidney. METHODS We used risk associations from a meta-analysis of seven general population cohorts, calibrated to the population-level incidence of ESRD and mortality in the United States, to project the estimated long-term incidence of ESRD among persons who do not donate a kidney, according to 10 demographic and health characteristics. We then compared 15-year projections with the observed risk among 52,998 living kidney donors in the United States. RESULTS A total of 4,933,314 participants from seven cohorts were followed for a median of 4 to 16 years. For a 40-year-old person with health characteristics that were similar to those of age-matched kidney donors, the 15-year projections of the risk of ESRD in the absence of donation varied according to race and sex; the risk was 0.24% among black men, 0.15% among black women, 0.06% among white men, and 0.04% among white women. Risk projections were higher in the presence of a lower estimated glomerular filtration rate, higher albuminuria, hypertension, current or former smoking, diabetes, and obesity. In the model-based lifetime projections, the risk of ESRD was highest among persons in the youngest age group, particularly among young blacks. The 15-year observed risks after donation among kidney donors in the United States were 3.5 to 5.3 times as high as the projected risks in the absence of donation. CONCLUSIONS Multiple demographic and health characteristics may be used together to estimate the projected long-term risk of ESRD among living kidney-donor candidates and to inform acceptance criteria for kidney donors.	[Grams, Morgan E.] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA; [Grams, Morgan E.; Sang, Yingying; Matsushita, Kunihiro; Ballew, Shoshana; Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chow, Eric K. H.; Segev, Dorry L.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Chow, Eric K. H.; Segev, Dorry L.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Levey, Andrew S.] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Chang, Alex R.] Geisinger Med Ctr, Div Nephrol, Danville, PA 17822 USA; [Kasiske, Bertram L.] Univ Minnesota, Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA; [Kovesdy, Csaba P.] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Kovesdy, Csaba P.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Shalev, Varda] Tel Aviv Univ, Maccabi Healthcare Serv, Div Med, IL-69978 Tel Aviv, Israel; [Shalev, Varda] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Lentine, Krista L.] St Louis Univ, Ctr Abdominal Transplantat, St Louis, MO 63103 USA; [Lentine, Krista L.] St Louis Univ, Ctr Outcomes Res, St Louis, MO 63103 USA; [Garg, Amit X.] Univ Western Ontario, Dept Med, London, ON, Canada; [Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Garg, Amit X.] Inst Clin Evaluat Sci, London, ON, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Tufts Medical Center; Geisinger Medical Center; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Saint Louis University; Saint Louis University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Coresh, J (corresponding author), Chron Kidney Dis Prognosis Consortium, Data Coordinating Ctr, 2024 E Monument St, Baltimore, MD 21287 USA.	ckdpc@jhmi.edu	Matsushita, Kunihiro/B-1021-2018; Lentine, Krista/AAQ-6549-2020; Matsushita, Kunihiro/AAJ-5817-2020; Lam, Ngan/AAX-3472-2020; Chang, Alexander R/J-5563-2019; Garg, Amit X/G-3295-2011	Matsushita, Kunihiro/0000-0002-7179-718X; Lentine, Krista/0000-0002-9423-4849; Matsushita, Kunihiro/0000-0002-7179-718X; Lam, Ngan/0000-0002-0129-7091; Chang, Alexander R/0000-0002-8114-7447; Ballew, Shoshana/0000-0002-7547-3764; Woodward, Mark/0000-0001-9800-5296; Chow, Eric/0000-0002-3665-1249; Grams, Morgan/0000-0002-4430-6023; /0000-0002-5189-8995	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK106515, R01DK096008, K08DK092287, R01DK100446] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.	Ahmadi AR, 2015, KIDNEY INT, V87, P31, DOI 10.1038/ki.2014.118; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Cherikh WS, 2011, AM J TRANSPLANT, V11, P1650, DOI 10.1111/j.1600-6143.2011.03609.x; Garg AX, 2015, NEW ENGL J MED, V372, P124, DOI 10.1056/NEJMoa1408932; Garg AX, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1203; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Hemmelgarn BR, 2012, JAMA-J AM MED ASSOC, V307, P2507, DOI 10.1001/jama.2012.6455; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Kiberd BA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014251.87778.01; Kiberd BA, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-2; Lam NN, 2015, NAT REV NEPHROL, V11, P411, DOI 10.1038/nrneph.2015.58; Lentine KL, 2014, TRANSPLANTATION, V97, P316, DOI 10.1097/01.TP.0000436731.23554.5e; Lentine KL, 2010, NEW ENGL J MED, V363, P724, DOI 10.1056/NEJMoa1000950; Mandelbrot DA, 2007, AM J TRANSPLANT, V7, P2333, DOI 10.1111/j.1600-6143.2007.01932.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; Ommen ES, 2011, AM J TRANSPLANT, V11, P2575, DOI 10.1111/j.1600-6143.2011.03815.x; Rebholz CM, 2015, AM J KIDNEY DIS, V66, P231, DOI 10.1053/j.ajkd.2015.01.016; Reese PP, 2014, AM J TRANSPLANT, V14, P1853, DOI 10.1111/ajt.12822; Reese PP, 2015, LANCET, V385, P2003, DOI 10.1016/S0140-6736(14)62484-3; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Steiner RW, 2014, AM J TRANSPLANT, V14, P538, DOI 10.1111/ajt.12625; Steiner RW, 2010, AM J TRANSPLANT, V10, P737, DOI 10.1111/j.1600-6143.2010.03023.x; Thiessen C, 2015, AM J TRANSPLANT, V15, P2314, DOI 10.1111/ajt.13272; Tong A, 2011, TRANSPLANTATION, V92, P962, DOI 10.1097/TP.0b013e3182328276; US Renal Data System, 2013, USRDS 2013 ANN DAT R; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Young A, 2008, AM J TRANSPLANT, V8, P1878, DOI 10.1111/j.1600-6143.2008.02339.x	32	263	265	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					411	421		10.1056/NEJMoa1510491	http://dx.doi.org/10.1056/NEJMoa1510491			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26544982	Green Accepted, Bronze			2022-12-28	WOS:000369319100004
J	Wang, YP; Li, XH; Zhou, MG; Luo, SS; Liang, J; Liddell, CA; Coates, MM; Gao, YQ; Wang, LH; He, CH; Kang, CY; Liu, SW; Dai, L; Schumacher, AE; Fraser, MS; Wolock, TM; Pain, A; Levitz, CE; Singh, L; Coggeshall, M; Lind, M; Li, YC; Li, Q; Deng, K; Mu, Y; Deng, CF; Yi, L; Liu, Z; Ma, X; Li, HY; Mu, DZ; Zhu, J; Murray, CJL; Wang, HD				Wang, Yanping; Li, Xiaohong; Zhou, Maigeng; Luo, Shusheng; Liang, Juan; Liddell, Chelsea A.; Coates, Matthew M.; Gao, Yanqiu; Wang, Linhong; He, Chunhua; Kang, Chuyun; Liu, Shiwei; Dai, Li; Schumacher, Austin E.; Fraser, Maya S.; Wolock, Timothy M.; Pain, Amanda; Levitz, Carly E.; Singh, Lavanya; Coggeshall, Megan; Lind, Margaret; Li, Yichong; Li, Qi; Deng, Kui; Mu, Yi; Deng, Changfei; Yi, Ling; Liu, Zheng; Ma, Xia; Li, Hongtian; Mu, Dezhi; Zhu, Jun; Murray, Christopher J. L.; Wang, Haidong			Under-5 mortality in 2851 Chinese counties, 1996-2012: a subnational assessment of achieving MDG 4 goals in China	LANCET			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; FINANCIAL PROTECTION; TIME-SERIES; HEALTH; CHILDREN; DISEASE; DISPARITIES; COUNTRIES; INFANT	Background In the past two decades, the under-5 mortality rate in China has fallen substantially, but progress with regards to the Millennium Development Goal (MDG) 4 at the subnational level has not been quantified. We aimed to estimate under-5 mortality rates in mainland China for the years 1970 to 2012. Methods We estimated the under-5 mortality rate for 31 provinces in mainland China between 1970 and 2013 with data from censuses, surveys, surveillance sites, and disease surveillance points. We estimated under-5 mortality rates for 2851 counties in China from 1996 to 2012 with the reported child mortality numbers from the Annual Report System on Maternal and Child Health. We used a small area mortality estimation model, spatiotemporal smoothing, and Gaussian process regression to synthesise data and generate consistent provincial and county-level estimates. We compared progress at the county level with what was expected on the basis of income and educational attainment using an econometric model. We computed Gini coefficients to study the inequality of under-5 mortality rates across counties. Findings In 2012, the lowest provincial level under-5 mortality rate in China was about five per 1000 livebirths, lower than in Canada, New Zealand, and the USA. The highest provincial level under-5 mortality rate in China was higher than that of Bangladesh. 29 provinces achieved a decrease in under-5 mortality rates twice as fast as the MDG 4 target rate; only two provinces will not achieve MDG 4 by 2015. Although some counties in China have under-5 mortality rates similar to those in the most developed nations in 2012, some have similar rates to those recorded in Burkina Faso and Cameroon. Despite wide differences, the inter-county Gini coefficient has been decreasing. Improvement in maternal education and the economic boom have contributed to the fall in child mortality; more than 60% of the counties in China had rates of decline in under-5 mortality rates significantly faster than expected. Fast reduction in under-5 mortality rates have been recorded not only in the Han population, the dominant ethnic majority in China, but also in the minority populations. All top ten minority groups in terms of population sizes have experienced annual reductions in under-5 mortality rates faster than the MDG 4 target at 4.4%. Interpretation The reduction of under-5 mortality rates in China at the country, provincial, and county level is an extraordinary success story. Reductions of under-5 mortality rates faster than 8.8% (twice MDG 4 pace) are possible. Extremely rapid declines seem to be related to public policy in addition to socioeconomic progress. Lessons from successful counties should prove valuable for China to intensify efforts for those with unacceptably high under-5 mortality rates. Funding National '' Twelfth Five-Year '' Plan for Science and Technology Support, National Health and Family Planning Commission of The People's Republic of China, Program for Changjiang Scholars and Innovative Research Team in University, the National Institute on Aging, and the Bill & Melinda Gates Foundation.	[Wang, Yanping; Liang, Juan; He, Chunhua; Dai, Li; Yi, Ling; Liu, Zheng; Ma, Xia; Mu, Dezhi; Zhu, Jun] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance China, Chengdu 610041, Peoples R China; [Liddell, Chelsea A.; Coates, Matthew M.; Schumacher, Austin E.; Fraser, Maya S.; Wolock, Timothy M.; Pain, Amanda; Levitz, Carly E.; Singh, Lavanya; Coggeshall, Megan; Lind, Margaret; Murray, Christopher J. L.; Wang, Haidong] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Li, Xiaohong; Zhu, Jun] Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defect Surveillance China, Chengdu 610041, Peoples R China; [Li, Xiaohong] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu 610041, Peoples R China; [Zhou, Maigeng; Wang, Linhong; Liu, Shiwei; Li, Yichong] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Luo, Shusheng; Gao, Yanqiu; Kang, Chuyun; Li, Hongtian] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Off Natl Maternal & Child Hlth Stat China, Beijing 100871, Peoples R China; [Luo, Shusheng; Gao, Yanqiu; Kang, Chuyun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Child Adolescent & Womens Hlth, Beijing 100871, Peoples R China	Sichuan University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Sichuan University; Sichuan University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University; Peking University	Zhu, J (corresponding author), Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance China, Chengdu 610041, Peoples R China.	zhujun028@163.com; cjlm@uw.edu	wang, lin/HHM-2225-2022; Li, Yichong/A-3559-2019; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022; Zhou, Maigeng/HCH-7703-2022	Li, Yichong/0000-0003-3842-475X; Levitz, Carly/0000-0003-3094-411X; Coates, Matthew/0000-0002-8474-4992; Qu, Yi/0000-0002-9993-8810; Li, Xiaohong/0000-0003-0336-7302; Lind, Margaret/0000-0002-1572-4074	National "Twelfth Five-Year" Plan for Science and Technology Support; National Health and Family Planning Commission of The People's Republic of China; Program for Changjiang Scholars and Innovative Research Team in University; National Institute on Aging; Bill & Melinda Gates Foundation; National "Twelfth Five-Year" Plan for Science and Technology Support [2014BAI06B01]; National Health and Family Planning Commission of The People's Republic of China [QT2003-009, 05wsb-02]; University of Washington Center for Demography and Economics of Aging; National Institute on Aging [1-P30-AG047845]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0935]; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	National "Twelfth Five-Year" Plan for Science and Technology Support; National Health and Family Planning Commission of The People's Republic of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National "Twelfth Five-Year" Plan for Science and Technology Support; National Health and Family Planning Commission of The People's Republic of China; University of Washington Center for Demography and Economics of Aging; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National "Twelfth Five-Year" Plan for Science and Technology Support, National Health and Family Planning Commission of The People's Republic of China, Program for Changjiang Scholars and Innovative Research Team in University, the National Institute on Aging, and the Bill & Melinda Gates Foundation.; This study was funded by the National "Twelfth Five-Year" Plan for Science and Technology Support (2014BAI06B01), National Health and Family Planning Commission of The People's Republic of China (grants QT2003-009 and 05wsb-02), University of Washington Center for Demography and Economics of Aging, Grant Number 1-P30-AG047845 from the National Institute on Aging, Program for Changjiang Scholars and Innovative Research Team in University (IRT0935), and the Bill & Melinda Gates Foundation. We thank the countless health workers who have contributed to data collection in the Chinese MCH information system; and acknowledge the extensive support from all staff members at National Office for Maternal and Child Health Surveillance of China and Jonathan Brown from the Institute for Health Metrics and Evaluation for facilitating research between IHME and MCHS.	[Anonymous], CHIN NAT MAT CHILD H; [Anonymous], 2011, EQ PUBL GOV HLTH SYS; [Anonymous], 2013, MILL DEV GOAL REP 20; [Anonymous], 2007, 17 NAT C COMM PART C; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Chamberlain M, 1997, NURS ETHICS, V4, P511; Chen YY, 2012, J HEALTH ECON, V31, P1, DOI 10.1016/j.jhealeco.2011.11.001; Chinese Center for Disease Control and Prevention (CCDC), 2004, CHIN DIS SURV POINTS; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Hou ZY, 2014, HEALTH ECON, V23, P917, DOI 10.1002/hec.2965; Hulton L, 2014, INT J GYNECOL OBSTET, V127, P96, DOI 10.1016/j.ijgo.2014.07.002; Huo KM, 2010, PAEDIATR PERINAT EP, V24, P343, DOI 10.1111/j.1365-3016.2010.01126.x; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Knight J, 2008, ASIAN ECON POLICY R, V3, P140, DOI 10.1111/j.1748-3131.2008.00099.x; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037458; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Mosley WH, 2003, B WORLD HEALTH ORGAN, V81, P140; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Bureau of Statistics of China, 2010, CHIN POP HOUS CENS 2; National Bureau of Statistics of China, 2006, CHIN SAMPL SURV POP; National Bureau of Statistics of China, 2005, CHIN 1 NAT POP SAMPL; National Bureau of Statistics of China, 2010, CHIN POP HOUS CENS 1; National Bureau of Statistics of China, 1992, 1 PER 1000 SURV FERT; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; UNICEF, LEV TRENDS CHILD MOR; United Nations Department of Economics and Social Affairs Population Division, WORLD POP PROSP 2012; United Nations Inter-agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; Wang YP, 2011, PUBLIC HEALTH, V125, P301, DOI 10.1016/j.puhe.2011.01.003; Wang YP, 2012, ARCH DIS CHILD-FETAL, V97, pF285, DOI 10.1136/archdischild-2011-300412; Wang YP, 2010, J EPIDEMIOL COMMUN H, V64, P935, DOI 10.1136/jech.2009.093138; Wu Wen-Di, 2009, Zhongguo Yi Miao He Mian Yi, V15, P363; Zheng XY, 2011, BIOMED ENVIRON SCI, V24, P329, DOI 10.3967/0895-3988.2011.04.002	38	66	84	0	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					273	283		10.1016/S0140-6736(15)00554-1	http://dx.doi.org/10.1016/S0140-6736(15)00554-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26510780	Green Accepted, Bronze			2022-12-28	WOS:000368130700033
J	Mullan, F; Salsberg, E; Weider, K				Mullan, Fitzhugh; Salsberg, Edward; Weider, Katie			Why a GME Squeeze Is Unlikely	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mullan, Fitzhugh; Salsberg, Edward; Weider, Katie] George Washington Univ, Hlth Workforce Inst, Washington, DC 20052 USA	George Washington University	Mullan, F (corresponding author), George Washington Univ, Hlth Workforce Inst, Washington, DC 20052 USA.							Association of American Medical Colleges, RES 2014 MED SCH ENR; National Resident Matching Program, ADV DAT TABL 2015 MA	2	33	34	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2397	2399		10.1056/NEJMp1511707	http://dx.doi.org/10.1056/NEJMp1511707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY5QD	26536521				2022-12-28	WOS:000366461400005
J	Blair, TR; Espinoza, RT				Blair, Thomas R.; Espinoza, Randall T.			Medicare, Medicaid, and Mental Health Care Historical Perspectives on Reforms Before the US Congress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Blair, Thomas R.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Espinoza, Randall T.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Div Geriatr Psychiat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Espinoza, RT (corresponding author), 300 UCLA Med Plaza,Ste 2235, Los Angeles, CA 90095 USA.	respinoza@mednet.ucla.edu						Altman D, 2015, JAMA-J AM MED ASSOC, V314, P384, DOI 10.1001/jama.2015.7811; GOLDMAN HH, 1983, HOSP COMMUNITY PSYCH, V34, P129; Grob Gerald N., 1994, MAD US HIST CARE AME; Huskamp HA, 2015, AM J PSYCHIAT, V172, P113, DOI 10.1176/appi.ajp.2014.14111395; Katon WJ, 2013, J PSYCHOSOM RES, V74, P533, DOI 10.1016/j.jpsychores.2013.04.005; Sederer L., 2015, US NEWS WORLD REP; Sisti DA, 2015, JAMA-J AM MED ASSOC, V313, P243, DOI 10.1001/jama.2014.16088; STOTSKY BA, 1967, J PSYCHOL, V67, P341, DOI 10.1080/00223980.1967.10544939	8	6	6	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2231	2232		10.1001/jama.2015.13328	http://dx.doi.org/10.1001/jama.2015.13328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX2GT	26502380				2022-12-28	WOS:000365515700011
J	Turra, D; El Ghalid, M; Rossi, F; Di Pietro, A				Turra, David; El Ghalid, Mennat; Rossi, Federico; Di Pietro, Antonio			Fungal pathogen uses sex pheromone receptor for chemotropic sensing of host plant signals	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FUSARIUM-OXYSPORUM; HORSERADISH-PEROXIDASE; INVASIVE GROWTH; VIRULENCE; PATHWAY; YEAST; SITE; RHO1	For more than a century, fungal pathogens and symbionts have been known to orient hyphal growth towards chemical stimuli from the host plant(1,2). However, the nature of the plant signals as well as the mechanisms underlying the chemotropic response have remained elusive(3). Here we show that directed growth of the soil-inhabiting plant pathogen Fusarium oxysporum towards the roots of the host tomato (Solanum lycopersicum) is triggered by the catalytic activity of secreted class III peroxidases, a family of haem-containing enzymes present in all land plants(4). The chemotropic response requires conserved elements of the fungal cell integrity mitogen-activated protein kinase (MAPK) cascade(5) and the seven-pass transmembrane protein Ste2, a functional homologue of the Saccharomyces cerevisiae sex pheromone a receptor(6). We further show that directed hyphal growth of F. oxysporum towards nutrient sources such as sugars and amino acids is governed by a functionally distinct MAPK cascade. These results reveal a potentially conserved chemotropic mechanism in root-colonizing fungi, and suggest a new function for the fungal pheromone-sensing machinery in locating plant hosts in a complex environment such as the soil.	[Turra, David; El Ghalid, Mennat; Rossi, Federico; Di Pietro, Antonio] Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain	Universidad de Cordoba	Di Pietro, A (corresponding author), Univ Cordoba, Dept Genet, Campus Excelencia Int Agroalimentario ceiA3, E-14071 Cordoba, Spain.	ge2dipia@uco.es	Di Pietro, Antonio/K-9220-2014; Turrà, David/G-1193-2016; Turra, David/AAC-9453-2020	Di Pietro, Antonio/0000-0001-5930-5763; Turrà, David/0000-0002-0687-6754; 	Spanish Ministerio de Innovacion y Competitividad (MINECO) [BIO2010-15505, BIO2013-47870-R]; MINECO/ERA-NET PathoGenoMics [BIO2008-04479]; Marie Curie ITN ARIADNE from the European Commission [FP7-PEOPLE-ITN-237936]; ERASMUS student exchange program	Spanish Ministerio de Innovacion y Competitividad (MINECO); MINECO/ERA-NET PathoGenoMics; Marie Curie ITN ARIADNE from the European Commission; ERASMUS student exchange program	The authors are grateful to E. Martinez Aguilera for technical assistance. This work was supported by grants BIO2010-15505 and BIO2013-47870-R from the Spanish Ministerio de Innovacion y Competitividad (MINECO), and BIO2008-04479 from MINECO/ERA-NET PathoGenoMics to A.D.P. M.E.G. was supported by the Marie Curie ITN ARIADNE (FP7-PEOPLE-ITN-237936) from the European Commission. F.R. had a fellowship from the ERASMUS student exchange program.	Arkowitz RA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001958; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Bar EE, 2003, J BIOL CHEM, V278, P21798, DOI 10.1074/jbc.M212636200; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Brand A, 2009, CURR OPIN MICROBIOL, V12, P350, DOI 10.1016/j.mib.2009.05.007; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; de Bary A., 1884, VERGLEICHENDE MORPHO; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lopez-Berges MS, 2010, PLANT CELL, V22, P2459, DOI 10.1105/tpc.110.075937; Martinez-Rocha AL, 2008, CELL MICROBIOL, V10, P1339, DOI 10.1111/j.1462-5822.2008.01130.x; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Perez-Nadales E, 2011, PLANT CELL, V23, P1171, DOI 10.1105/tpc.110.075093; Rispail N, 2009, MOL PLANT MICROBE IN, V22, P830, DOI 10.1094/MPMI-22-7-0830; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; SMITH AT, 1992, EUR J BIOCHEM, V207, P507, DOI 10.1111/j.1432-1033.1992.tb17077.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turra D, 2014, ANNU REV PHYTOPATHOL, V52, P267, DOI 10.1146/annurev-phyto-102313-050143; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; ZENTMYER GA, 1961, SCIENCE, V133, P1595, DOI 10.1126/science.133.3464.1595	29	100	103	3	126	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					521	+		10.1038/nature15516	http://dx.doi.org/10.1038/nature15516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26503056				2022-12-28	WOS:000365352500049
J	Shibuya, H; Hernandez-Hernandez, A; Morimoto, A; Negishi, L; Hoog, C; Watanabe, Y				Shibuya, Hiroki; Hernandez-Hernandez, Abrahan; Morimoto, Akihiro; Negishi, Lumi; Hoog, Christer; Watanabe, Yoshinori			MAJIN Links Telomeric DNA to the Nuclear Membrane by Exchanging Telomere Cap	CELL			English	Article							MEIOTIC CHROMOSOME DYNAMICS; DOMAIN PROTEIN MPS3; SYNAPTONEMAL COMPLEX; MAMMALIAN TELOMERES; BOUQUET FORMATION; ANCHOR TELOMERES; ENVELOPE; MEIOSIS; ATTACHMENT; PROPHASE	In meiosis, telomeres attach to the inner nuclear membrane (INM) and drive the chromosome movement required for homolog pairing and recombination. Here, we address the question of how telomeres are structurally adapted for the meiotic task. We identify a multi-subunit meiotic telomere-complex, TERB1/2-MAJIN, which takes over telomeric DNA from the shelterin complex in mouse germ cells. TERB1/2-MAJIN initially assembles on the INM sequestered by its putative transmembrane subunit MAJIN. In early meiosis, telomere attachment is achieved by the formation of a chimeric complex of TERB1/2-MAJIN and shelterin. The chimeric complex matures during prophase into DNA-bound TERB1/2-MAJIN by releasing shelterin, forming a direct link between telomeric DNA and the INM. These hierarchical processes, termed ''telomere cap exchange,'' are regulated by CDK-dependent phosphorylation and the DNA-binding activity of MAJIN. Further, we uncover a positive feedback between telomere attachment and chromosome movement, revealing a comprehensive regulatory network underlying meiosis-specific telomere function in mammals.	[Shibuya, Hiroki; Morimoto, Akihiro; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Hernandez-Hernandez, Abrahan; Hoog, Christer] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Negishi, Lumi] Univ Tokyo, Inst Mol & Cellular Biosci, Ctr Struct Biol Challenging Prot, Lab Prot Express & Prod, Tokyo 1130032, Japan	University of Tokyo; Karolinska Institutet; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, 1-1-1Yayoi, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Hernandez-Hernandez, Abrahan/0000-0002-8454-9441; Negishi, Lumi/0000-0002-7297-0634; Watanabe, Yoshinori/0000-0002-5488-4812; Shibuya, Hiroki/0000-0002-3400-0741	JSPS; Swedish Research Council; Karolinska Institute; MEXT [25000014]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank N. Takeda (University of Kumamoto) for the constructions of Majin and Terb2 KO mice and T. de Lange (Rockefeller University) for anti-TIN2 anti-body. We thank Y. Okada (University of Tokyo) for technical advice concerning testis organ culture. We thank H. Sasaki and Y. Tomari (University of Tokyo) for valuable discussion and advice concerning the biochemistry. We thank H. Scherthan (Ulm University), M.P. Colaiacovo (Harvard Medical School), and N. Kleckner (Harvard University) for valuable discussion. We thank all the members of our laboratory for their valuable support and discussion. This work was supported in part by a JSPS Research Fellowship (to H.S.), the Swedish Research Council and the Karolinska Institute (to A.H. and C.H.) and MEXT KAKENHI grant 25000014 (to Y.W.).	Alsheimer M, 1999, MOL BIOL CELL, V10, P1235, DOI 10.1091/mbc.10.4.1235; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 2009, J CELL BIOL, V187, P413, DOI 10.1083/jcb.200902122; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; ESPONDA P, 1972, CHROMOSOMA, V38, P405, DOI 10.1007/BF00320159; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Godet M, 2000, EUR J CELL BIOL, V79, P816, DOI 10.1078/0171-9335-00107; Harper NC, 2011, DEV CELL, V21, P934, DOI 10.1016/j.devcel.2011.09.001; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; HOLM PB, 1977, CARLSBERG RES COMMUN, V42, P283, DOI 10.1007/BF02910454; Horn HF, 2013, J CELL BIOL, V202, P1023, DOI 10.1083/jcb.201304004; Jahn D, 2010, NUCLEUS-PHILA, V1, P273, DOI 10.4161/nucl.1.3.11800; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Labella S, 2011, DEV CELL, V21, P948, DOI 10.1016/j.devcel.2011.07.011; Lee CY, 2015, CELL REP, V11, P551, DOI 10.1016/j.celrep.2015.03.045; Liebe B, 2004, MOL BIOL CELL, V15, P827, DOI 10.1091/mbc.E03-07-0524; Link J, 2015, NUCLEUS-PHILA, V6, P93, DOI 10.1080/19491034.2015.1004941; Link J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004099; Link J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003261; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Martinerie L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004165; McKerlie M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1372; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Penkner AM, 2009, CELL, V139, P920, DOI 10.1016/j.cell.2009.10.045; Pfeifer C, 2001, CYTOGENET CELL GENET, V93, P304, DOI 10.1159/000057002; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Scherthan H, 2014, CHROMOSOMA, V123, P609, DOI 10.1007/s00412-014-0479-4; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Shibuya H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004821; Shibuya H, 2014, CELL CYCLE, V13, P2024, DOI 10.4161/cc.29350; Shibuya H, 2014, NAT CELL BIOL, V16, P145, DOI 10.1038/ncb2896; Siderakis M, 2007, CHROMOSOME RES, V15, P667, DOI 10.1007/s10577-007-1149-7; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Thilagavathi J, 2013, ANDROLOGIA, V45, P289, DOI 10.1111/and.12008; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Viera A, 2015, J CELL SCI, V128, P88, DOI 10.1242/jcs.154922; Wolgemuth DJ, 2013, INT J DEV BIOL, V57, P159, DOI 10.1387/ijdb.130047av; WOOLLAM DHM, 1967, NATURE, V213, P298, DOI 10.1038/213298a0	52	87	93	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1252	1266		10.1016/j.cell.2015.10.030	http://dx.doi.org/10.1016/j.cell.2015.10.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26548954	Bronze			2022-12-28	WOS:000366044700022
J	Lottersberger, F; Karssemeijer, RA; Dimitrova, N; de Lange, T				Lottersberger, Francisca; Karssemeijer, Roos Anna; Dimitrova, Nadya; de lange, Titia			53BP1 and the LINC Complex Promote Microtubule-Dependent DSB Mobility and DNA Repair	CELL			English	Article							DOUBLE-STRAND BREAKS; NUCLEAR-MEMBRANE PROTEIN; 5' END RESECTION; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; POSITIONAL STABILITY; MAMMALIAN TELOMERES; BRCA1 DEFICIENCY; CHROMATIN; ENVELOPE	Increased mobility of chromatin surrounding doublestrand breaks (DSBs) has been noted in yeast and mammalian cells but the underlying mechanism and its contribution to DSB repair remain unclear. Here, we use a telomere-based system to track DNA damage foci with high resolution in living cells. We find that the greater mobility of damaged chromatin requires 53BP1, SUN1/2 in the linker of the nucleoskeleton, and cytoskeleton (LINC) complex and dynamic microtubules. The data further demonstrate that the excursions promote non-homologous end joining of dysfunctional telomeres and implicated Nesprin-4 and kinesins in telomere fusion. 53BP1/LINC/ microtubule-dependent mobility is also evident at irradiation-induced DSBs and contributes to the mis-rejoining of drug-induced DSBs in BRCA1-deficient cells showing that DSB mobility can be detrimental in cells with numerous DSBs. In contrast, under physiological conditions where cells have only one or a few lesions, DSB mobility is proposed to prevent errors in DNA repair.	[Lottersberger, Francisca; Karssemeijer, Roos Anna; Dimitrova, Nadya; de lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Lottersberger, Francisca/0000-0002-0677-8986	Rockefeller University Women and Science postdoctoral fellowship; Boehringer Ingleheim Fonds graduate fellowship; NCI [5R01CA181090]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA181090] Funding Source: NIH RePORTER	Rockefeller University Women and Science postdoctoral fellowship; Boehringer Ingleheim Fonds graduate fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are deeply grateful to Devon White for his expert mouse husbandry. We are grateful to Dr. Andrea Panza for help in developing the automated image analysis, Alejandro Dottore for help with MSD analysis, and Dr. Franco Flandoli for helpful discussion. We thank members of the T.d.L. lab for discussion and help with this manuscript. We thank Drs. G. Hannon, D. Livingston, and P. Igarashi and L.S.W. Goldstein for reagents and Drs. T. Kapoor and S. Gasser for discussion. A. North (RU Bio-imaging Core Facility) is thanked for assistance with DeltaVision microscopy. F.L. was supported by a Rockefeller University Women and Science postdoctoral fellowship. R.K. is the recipient of a Boehringer Ingleheim Fonds graduate fellowship. This work was supported by grants from the NCI (5R01CA181090) and the Breast Cancer Research Foundation. T.d.L. is an American Cancer Society Research Professor.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; Becker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092640; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chang W, 2015, J CELL BIOL, V208, P11, DOI 10.1083/jcb.201409047; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gandhi M, 2012, P NATL ACAD SCI USA, V109, P9454, DOI 10.1073/pnas.1205759109; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Mahen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061893; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Peterson CL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012658; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Shibuya H, 2014, CELL CYCLE, V13, P2024, DOI 10.4161/cc.29350; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Swartz RK, 2014, MOL BIOL CELL, V25, P2461, DOI 10.1091/mbc.E13-10-0569; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Turgay Y, 2014, J CELL BIOL, V204, P1099, DOI 10.1083/jcb.201310116; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Wu P, 2010, MOL CELL, V39, P606, DOI 10.1016/j.molcel.2010.06.031; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Zidovska A, 2013, P NATL ACAD SCI USA, V110, P15555, DOI 10.1073/pnas.1220313110; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	53	174	177	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					880	893		10.1016/j.cell.2015.09.057	http://dx.doi.org/10.1016/j.cell.2015.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544937	Bronze, Green Accepted			2022-12-28	WOS:000364829700014
J	Perkel, JM				Perkel, Jeffrey M.			EIGHT WAYS TO CLEAN A DIGITAL LIBRARY	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	3	4	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					123	124		10.1038/527123a	http://dx.doi.org/10.1038/527123a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536960	Bronze			2022-12-28	WOS:000364270700056
J	Eichelkraut, T; Szameit, A				Eichelkraut, Toni; Szameit, Alexander			PHOTONICS Random sudoku light	NATURE			English	Editorial Material									[Eichelkraut, Toni; Szameit, Alexander] Univ Jena, Abbe Ctr Photon, Inst Appl Phys, D-07749 Jena, Germany	Friedrich Schiller University of Jena	Eichelkraut, T (corresponding author), Univ Jena, Abbe Ctr Photon, Inst Appl Phys, D-07749 Jena, Germany.	alexander.szameit@uni-jena.de	Szameit, Alexander/AGK-5446-2022	Szameit, Alexander/0000-0003-0071-6941				Fairchild M. D., 2005, COLOR APPEARANCE MOD, P65; Fischer R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073901; Markov A. A., 1906, PHYS MATH SOC, V15, P135	3	2	2	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					643	644		10.1038/526643a	http://dx.doi.org/10.1038/526643a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511573				2022-12-28	WOS:000363832100032
J	Schattman, GL				Schattman, Glenn L.			Cryopreservation of Oocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; BREAST-CANCER; FERTILITY PRESERVATION; OVARIAN STIMULATION; SPERM INJECTION; VITRIFICATION; CHEMOTHERAPY; PREGNANCY; TOXICITY; INCREASE	A 32-year-old woman who recently ended a relationship with her long-term boyfriend is concerned about her future fertility. She has received regular gynecologic checkups that have always been normal, and she has been taking oral contraceptive pills for the past 5 years. She is interested in exploring options to preserve her ability to have children in the future. How would you counsel her and what would you recommend regarding preservation of her fertility?	Weill Cornell Med Ctr, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10021 USA	Cornell University	Schattman, GL (corresponding author), Weill Cornell Med Ctr, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, 1305 York Ave, New York, NY 10021 USA.	glschatt@med.cornell.edu						Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; [Anonymous], 2014, Obstet Gynecol, V123, P719, DOI [10.1016/j.fertnstert.2013.12.032, 10.1097/01.AOG.0000444440.96486.61]; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Chang CC, 2013, FERTIL STERIL, V99, P1891, DOI 10.1016/j.fertnstert.2013.02.008; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Chian RC, 2008, REPROD BIOMED ONLINE, V16, P608, DOI 10.1016/S1472-6483(10)60471-3; Cobo A, 2001, FERTIL STERIL, V75, P354, DOI 10.1016/S0015-0282(00)01725-8; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Ginsburg ES, 2001, FERTIL STERIL, V75, P705, DOI 10.1016/S0015-0282(00)01802-1; Glujovsky D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010047.pub2; GOLDHIRSCH A, 1990, ANN ONCOL, V1, P183, DOI 10.1093/oxfordjournals.annonc.a057718; Gomes CM, 2008, FERTIL STERIL, V90, P1396, DOI 10.1016/j.fertnstert.2007.08.025; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365, DOI 10.1200/JCO.1999.17.8.2365; Huang JYJ, 2006, CELL PRESERV TECHNOL, V4, P149, DOI 10.1089/cpt.2006.4.149; Kuang YP, 2014, FERTIL STERIL, V101, P105, DOI 10.1016/j.fertnstert.2013.09.007; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Noyes N, 2009, REPROD BIOMED ONLINE, V18, P769, DOI 10.1016/S1472-6483(10)60025-9; Parmegiani L, 2009, REPROD BIOMED ONLINE, V19, P374, DOI 10.1016/S1472-6483(10)60171-X; Pereira N, 2015, FERTIL STERIL, V104, pe1; Petrek JA, 2006, J CLIN ONCOL, V24, P1045, DOI 10.1200/JCO.2005.03.3969; Pfeifer S, 2013, FERTIL STERIL, V100, P1214, DOI 10.1016/j.fertnstert.2013.08.012; Pfeifer S, 2013, FERTIL STERIL, V99, P663, DOI 10.1016/j.fertnstert.2012.12.031; Practice Comm Amer Soc Reprod Med, 2015, FERTIL STERIL, V103, pE9, DOI [10.1016/j.fertnstert.2014.12.093, 10.1016/j.fertnstert.2012.09.036]; RALL WF, 1987, CRYOBIOLOGY, V24, P387, DOI 10.1016/0011-2240(87)90042-3; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; SCHWARTZ D, 1982, NEW ENGL J MED, V306, P404, DOI 10.1056/NEJM198202183060706; Trokoudes KM, 2011, FERTIL STERIL, V95, P1996, DOI 10.1016/j.fertnstert.2011.02.035; Usta IM, 2008, AM J PERINAT, V25, P521, DOI 10.1055/s-0028-1085620	31	32	34	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1755	1760		10.1056/NEJMcp1307341	http://dx.doi.org/10.1056/NEJMcp1307341			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26510023				2022-12-28	WOS:000363514100011
J	Wiseman, H				Wiseman, Howard			QUANTUM PHYSICS Death by experiment for local realism	NATURE			English	Editorial Material							BELLS-INEQUALITY; VIOLATION		Griffith Univ, Ctr Quantum Dynam, Ctr Quantum Computat & Commun Technol, Brisbane, Qld 4111, Australia	Griffith University	Wiseman, H (corresponding author), Griffith Univ, Ctr Quantum Dynam, Ctr Quantum Computat & Commun Technol, Brisbane, Qld 4111, Australia.	h.wiseman@griffith.edu.au	Wiseman, Howard M/A-7266-2008	Wiseman, Howard M/0000-0001-6815-854X				ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Christensen BG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130406; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; Wiseman HM, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/42/424001	9	23	23	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					649	650		10.1038/nature15631	http://dx.doi.org/10.1038/nature15631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26503054				2022-12-28	WOS:000363832100037
J	Pasquali, SK; Dimick, JB; Ohye, RG				Pasquali, Sara K.; Dimick, Justin B.; Ohye, Richard G.			Time for a More Unified Approach to Pediatric Health Care Policy? The Case of Congenital Heart Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGERY; DATABASE		[Pasquali, Sara K.] Univ Michigan, CS Mott Childrens Hosp, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Pasquali, Sara K.; Dimick, Justin B.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48105 USA; [Dimick, Justin B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48105 USA; [Ohye, Richard G.] Univ Michigan, CS Mott Childrens Hosp, Dept Cardiac Surg, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pasquali, SK (corresponding author), Univ Michigan, CS Mott Childrens Hosp, Dept Pediat & Communicable Dis, 1540 E Hosp Dr, Ann Arbor, MI 48105 USA.	pasquali@med.umich.edu						Cohen E., PATIENT SAFETY EVALU; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Jacobs JP, 2011, ANN THORAC SURG, V92, P2184, DOI 10.1016/j.athoracsur.2011.06.008; Lundstrom NR, 2000, PEDIATR CARDIOL, V21, P353, DOI 10.1007/s002460010079; Mainwaring RD, 2008, J CARDIAC SURG, V23, P622, DOI 10.1111/j.1540-8191.2008.00675.x; Pasquali SK, 2014, PEDIATRICS, V133, pE553, DOI 10.1542/peds.2013-2870; Welke KF, 2009, J THORAC CARDIOV SUR, V137, P1133, DOI 10.1016/j.jtcvs.2008.12.012	7	19	19	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1689	1690		10.1001/jama.2015.10166	http://dx.doi.org/10.1001/jama.2015.10166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505593				2022-12-28	WOS:000363706300013
J	Myers, ER; Moorman, P; Gierisch, JM; Havrilesky, LJ; Grimm, LJ; Ghate, S; Davidson, B; Mongtomery, RC; Crowley, MJ; McCrory, DC; Kendrick, A; Sanders, GD				Myers, Evan R.; Moorman, Patricia; Gierisch, Jennifer M.; Havrilesky, Laura J.; Grimm, Lars J.; Ghate, Sujata; Davidson, Brittany; Mongtomery, Ranee Chatterjee; Crowley, Matthew J.; McCrory, Douglas C.; Kendrick, Amy; Sanders, Gillian D.			Benefits and Harms of Breast Cancer Screening A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; CARCINOMA IN-SITU; QUALITY-OF-LIFE; AGE 40 YEARS; DIGITAL MAMMOGRAPHY; COST-EFFECTIVENESS; FOLLOW-UP; MORTALITY; POPULATION; WOMEN	IMPORTANCE Patients need to consider both benefits and harms of breast cancer screening. OBJECTIVE To systematically synthesize available evidence on the association of mammographic screening and clinical breast examination (CBE) at different ages and intervals with breast cancer mortality, overdiagnosis, false-positive biopsy findings, life expectancy, and quality-adjusted life expectancy. EVIDENCE REVIEW We searched PubMed (to March 6, 2014), CINAHL (to September 10, 2013), and PsycINFO(to September 10, 2013) for systematic reviews, randomized clinical trials (RCTs) (with no limit to publication date), and observational and modeling studies published after January 1, 2000, as well as systematic reviews of all study designs. Included studies (7 reviews, 10 RCTs, 72 observational, 1 modeling) provided evidence on the association between screening with mammography, CBE, or both and prespecified critical outcomes among women at average risk of breast cancer (no known genetic susceptibility, family history, previous breast neoplasia, or chest irradiation). We used summary estimates from existing reviews, supplemented by qualitative synthesis of studies not included in those reviews. FINDINGS Across all ages of women at average risk, pooled estimates of association between mammography screening and mortality reduction after 13 years of follow-up were similar for 3 meta-analyses of clinical trials (UK Independent Panel: relative risk [RR], 0.80 [95% CI, 0.73-0.89]; Canadian Task Force: RR, 0.82 [95% CI, 0.74-0.94]; Cochrane: RR, 0.81 [95% CI, 0.74-0.87]); were greater in ameta-analysis of cohort studies (RR, 0.75 [95% CI, 0.69 to 0.81]); and were comparable in a modeling study (CISNET; median RR equivalent among 7 models, 0.85 [range, 0.77-0.93]). Uncertainty remains about the magnitude of associated mortality reduction in the entire US population, amongwomen 40 to 49 years, and with annual screening compared with biennial screening. There is uncertainty about the magnitude of overdiagnosis associated with different screening strategies, attributable in part to lack of consensus on methods of estimation and the importance of ductal carcinoma in situ in overdiagnosis. For women with a first mammography screening at age 40 years, estimated 10-year cumulative risk of a false-positive biopsy result was higher (7.0%[95% CI, 6.1%-7.8%]) for annual compared with biennial (4.8%[95% CI, 4.4%-5.2%]) screening. Although 10-year probabilities of false-positive biopsy results were similar for women beginning screening at age 50 years, indirect estimates of lifetime probability of false-positive results were lower. Evidence for the relationship between screening and life expectancy and quality-adjusted life expectancy was low in quality. There was no direct evidence for any additional mortality benefit associated with the addition of CBE to mammography, but observational evidence from the United States and Canada suggested an increase in false-positive findings compared with mammography alone, with both studies finding an estimated 55 additional false-positive findings per extra breast cancer detected with the addition of CBE. CONCLUSIONS AND RELEVANCE For women of all ages at average risk, screening was associated with a reduction in breast cancer mortality of approximately 20%, although there was uncertainty about quantitative estimates of outcomes for different breast cancer screening strategies in the United States. These findings and the related uncertainty should be considered when making recommendations based on judgments about the balance of benefits and harms of breast cancer screening.	[Myers, Evan R.; Moorman, Patricia; Gierisch, Jennifer M.; Havrilesky, Laura J.; Mongtomery, Ranee Chatterjee; Crowley, Matthew J.; McCrory, Douglas C.; Kendrick, Amy; Sanders, Gillian D.] Duke Clin Res Inst, Duke Evidence Synth Grp, Durham, NC 27705 USA; [Myers, Evan R.; Havrilesky, Laura J.; Davidson, Brittany] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC 27705 USA; [Moorman, Patricia] Duke Univ, Sch Med, Dept Community & Family Med, Durham, NC 27705 USA; [Gierisch, Jennifer M.; Mongtomery, Ranee Chatterjee; Crowley, Matthew J.; McCrory, Douglas C.; Sanders, Gillian D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27705 USA; [Gierisch, Jennifer M.; Crowley, Matthew J.; McCrory, Douglas C.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Grimm, Lars J.; Ghate, Sujata] Duke Univ, Sch Med, Dept Radiol, Durham, NC 27705 USA	Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Myers, ER (corresponding author), Duke Univ, Sch Med, Dept Obstet & Gynecol, 2400 Pratt St, Durham, NC 27705 USA.	evan.myers@duke.edu	Gierisch, Jennifer/GLU-1269-2022; Grimm, Lars J/P-3431-2015; Ghate, Sujata V/O-4774-2016	Grimm, Lars J/0000-0002-3865-3352; Davidson, Brittany/0000-0001-9698-0442; Kendrick, Amy/0000-0001-8769-1702	American Cancer Society	American Cancer Society(American Cancer Society)	This study was funded by the American Cancer Society.	Abuidris DO, 2013, LANCET ONCOL, V14, P363, DOI 10.1016/S1470-2045(12)70583-1; Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; Allgood PC, 2008, BRIT J CANCER, V98, P206, DOI 10.1038/sj.bjc.6604123; Andersson I, 1997, J Natl Cancer Inst Monogr, P63; Ascunce EN, 2007, J MED SCREEN, V14, P14, DOI 10.1258/096914107780154558; Autier P, 2015, J ROY SOC MED, V108, P440, DOI 10.1177/0141076815593403; Bansback N, 2016, MED DECIS MAKING, V36, P490, DOI 10.1177/0272989X15600708; Barton MB, 2004, J NATL CANCER I, V96, P529, DOI 10.1093/jnci/djh083; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Blanchard K, 2006, RADIOLOGY, V240, P335, DOI 10.1148/radiol.2402050107; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Brawley O, 2011, JAMA-J AM MED ASSOC, V306, P2495, DOI 10.1001/jama.2011.1800; Breen N, 2011, CANCER-AM CANCER SOC, V117, P2209, DOI 10.1002/cncr.25679; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Broeders M, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.012078; Broeders MJM, 2002, J MED SCREEN, V9, P163, DOI 10.1136/jms.9.4.163; Chiarelli AM, 2009, JNCI-J NATL CANCER I, V101, P1236, DOI 10.1093/jnci/djp241; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; Coldman A, 2013, CAN MED ASSOC J, V185, pE492, DOI 10.1503/cmaj.121791; Coldman AJ, 2008, J MED SCREEN, V15, P182, DOI 10.1258/jms.2008.008064; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Dittus K, 2013, J GEN INTERN MED, V28, P1454, DOI 10.1007/s11606-013-2507-0; Domingo L, 2013, ACTA ONCOL, V52, P48, DOI 10.3109/0284186X.2012.698750; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; Elmore JG, 2005, JNCI-J NATL CANCER I, V97, P1035, DOI 10.1093/jnci/dji183; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Falk RS, 2013, INT J CANCER, V133, P705, DOI 10.1002/ijc.28052; Fenton Joshua J, 2005, J Natl Cancer Inst Monogr, P67, DOI 10.1093/jncimonographs/lgi040; Fielder HM, 2004, J MED SCREEN, V11, P194, DOI 10.1258/0969141042467304; Fitzpatrick-Lewis D, 2011, CANADIAN TASK FORCE; Frisell J, 1997, J Natl Cancer Inst Monogr, P49; Gabe R, 2007, ACTA RADIOL, V48, P948, DOI 10.1080/02841850701501725; Gierisch JM, 2014, ANN INTERN MED, V160, P484, DOI 10.7326/M13-2548; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Hakama M, 1997, BRIT MED J, V314, P864; Hamashima C, 2015, CANCER SCI, V106, P812, DOI 10.1111/cas.12693; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Hellquist BN, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.011104; Hellquist BN, 2011, CANCER-AM CANCER SOC, V117, P714, DOI 10.1002/cncr.25650; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Hofvind S, 2012, J MED SCREEN, V19, P57, DOI 10.1258/jms.2012.012083; Hofvind S, 2012, BREAST CANCER RES TR, V135, P291, DOI 10.1007/s10549-012-2162-x; Honjo S, 2007, JPN J CLIN ONCOL, V37, P715, DOI 10.1093/jjco/hym090; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Johns LE, 2010, CANCER EPIDEM BIOMAR, V19, P2758, DOI 10.1158/1055-9965.EPI-10-0623; Jonsson H, 2000, ACTA ONCOL, V39, P617; Jonsson H, 2005, INT J CANCER, V117, P842, DOI 10.1002/ijc.21228; Jonsson H, 2003, CANCER DETECT PREV, V27, P360, DOI 10.1016/S0361-090X(03)00131-4; Jonsson H, 2003, BREAST, V12, P183, DOI 10.1016/S0960-9776(03)00031-6; Jonsson H, 2007, J MED SCREEN, V14, P87, DOI 10.1258/096914107781261918; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Kikuchi M, 2014, BREAST CANCER-TOKYO, V21, P135, DOI 10.1007/s12282-012-0367-9; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Lund E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-614; Lynge E, 2014, EUR J CANCER, V50, P185, DOI 10.1016/j.ejca.2013.08.013; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Molins E, 2009, PUBLIC HEALTH, V123, P635, DOI 10.1016/j.puhe.2009.07.007; Moody-Ayers SY, 2000, ARCH INTERN MED, V160, P1109, DOI 10.1001/archinte.160.8.1109; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Moss SM, 2015, LANCET ONCOL, V16, P1123, DOI 10.1016/S1470-2045(15)00128-X; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; National Cancer Institute Surveillance Epidemiology and End Results Program, SEER STAT SOFTW VERS; Nelson H, 2009, SCREENING BREAST CAN; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nickson C, 2012, CANCER EPIDEM BIOMAR, V21, P1479, DOI 10.1158/1055-9965.EPI-12-0468; Njor SH, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1064; Norman SA, 2007, CANCER CAUSE CONTROL, V18, P909, DOI 10.1007/s10552-007-9006-8; O'Meara ES, 2013, CANCER-AM CANCER SOC, V119, P3959, DOI 10.1002/cncr.28310; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Oestreicher N, 2005, AM J ROENTGENOL, V184, P428, DOI 10.2214/ajr.184.2.01840428; Ohlinger R, 2006, ANTICANCER RES, V26, P3943; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Otten JDM, 2013, ANN ONCOL, V24, P2501, DOI 10.1093/annonc/mdt227; Otto SJ, 2012, CANCER EPIDEM BIOMAR, V21, P66, DOI 10.1158/1055-9965.EPI-11-0476; Paap E, 2010, CANCER CAUSE CONTROL, V21, P1569, DOI 10.1007/s10552-010-9585-7; Paci E, 2004, J MED SCREEN, V11, P23, DOI 10.1258/096914104772950718; Paci E, 2002, EUR J CANCER, V38, P568, DOI 10.1016/S0959-8049(01)00382-3; Paci E, 2008, EUR J CANCER, V44, P858, DOI 10.1016/j.ejca.2008.02.026; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Parvinen I, 2006, J MED SCREEN, V13, P34, DOI 10.1258/096914106776179845; Parvinen I, 2011, BRIT J CANCER, V105, P1388, DOI 10.1038/bjc.2011.372; Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012; Puliti D, 2008, BRIT J CANCER, V99, P423, DOI 10.1038/sj.bjc.6604532; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Puliti D, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3090; Roder D, 2008, BREAST CANCER RES TR, V108, P409, DOI 10.1007/s10549-007-9609-5; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Sarkeala T, 2008, INT J CANCER, V122, P614, DOI 10.1002/ijc.23070; Schonberg MA, 2009, J CLIN ONCOL, V27, P1774, DOI 10.1200/JCO.2008.19.9877; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; SHAPIRO S, 1977, CANCER, V39, P2772, DOI 10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Skaane P, 2013, EUR RADIOL, V23, P2061, DOI 10.1007/s00330-013-2820-3; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Tabar L, 2001, CANCER-AM CANCER SOC, V91, P1724, DOI 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V; Tohno E, 2013, EUR J RADIOL, V82, P1227, DOI 10.1016/j.ejrad.2013.02.007; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; Tosteson ANA, 2014, JAMA INTERN MED, V174, P954, DOI 10.1001/jamainternmed.2014.981; Valente SA, 2012, ANN SURG ONCOL, V19, P1825, DOI 10.1245/s10434-011-2200-7; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; van Schoor G, 2011, BRIT J CANCER, V104, P910, DOI 10.1038/bjc.2011.44; van Schoor G, 2010, EUR J CANCER, V46, P3137, DOI 10.1016/j.ejca.2010.09.041; Vutuc C, 2006, EUR J CANCER PREV, V15, P343, DOI 10.1097/00008469-200608000-00007; Weedon-Fekjaer H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3701; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048; Yen AMF, 2012, CANCER-AM CANCER SOC, V118, P5728, DOI 10.1002/cncr.27580; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	132	325	340	2	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1615	1634		10.1001/jama.2015.13183	http://dx.doi.org/10.1001/jama.2015.13183			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501537				2022-12-28	WOS:000363028500021
J	Strnad, V; Ott, OJ; Hildebrandt, G; Kauer-Dorner, D; Knauerhase, H; Major, T; Lyczek, J; Guinot, JL; Dunst, J; Miguelez, CG; Slampa, P; Allgaeuer, M; Loessl, K; Polat, B; Kovacs, G; Fischedick, AR; Wendt, TG; Fietkau, R; Hindemith, M; Resch, A; Kulik, A; Arribas, L; Niehoff, P; Guedea, F; Schlamann, A; Poetter, R; Gall, C; Malzer, M; Uter, W; Polgar, C				Strnad, Vratislav; Ott, Oliver J.; Hildebrandt, Guido; Kauer-Dorner, Daniela; Knauerhase, Hellen; Major, Tibor; Lyczek, Jaroslaw; Guinot, Jose Luis; Dunst, Juergen; Gutierrez Miguelez, Cristina; Slampa, Pavel; Allgaeuer, Michael; Loessl, Kristina; Polat, Buelent; Kovacs, Gyoergy; Fischedick, Arnt-Rene; Wendt, Thomas G.; Fietkau, Rainer; Hindemith, Marion; Resch, Alexandra; Kulik, Anna; Arribas, Leo; Niehoff, Peter; Guedea, Fernando; Schlamann, Annika; Poetter, Richard; Gall, Christine; Malzer, Martina; Uter, Wolfgang; Polgar, Csaba		GEC ESTRO	5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial	LANCET			English	Article							LUMPECTOMY PLUS TAMOXIFEN; RADIATION-THERAPY; INTRAOPERATIVE RADIOTHERAPY; FOLLOW-UP; CANCER; WOMEN; MANAGEMENT; TOXICITY; SURVIVAL; OLDER	Background In a phase 3, randomised, non-inferiority trial, accelerated partial breast irradiation (APBI) for patients with stage 0, I, and IIA breast cancer who underwent breast-conserving treatment was compared with whole-breast irradiation. Here, we present 5-year follow-up results. Methods We did a phase 3, randomised, non-inferiority trial at 16 hospitals and medical centres in seven European countries. 1184 patients with low-risk invasive and ductal carcinoma in situ treated with breast-conserving surgery were centrally randomised to either whole-breast irradiation or APBI using multicatheter brachytherapy. The primary endpoint was local recurrence. Analysis was done according to treatment received. This trial is registered with ClinicalTrials.gov, number NCT00402519. Findings Between April 20, 2004, and July 30, 2009, 551 patients had whole-breast irradiation with tumour-bed boost and 633 patients received APBI using interstitial multicatheter brachytherapy. At 5-year follow-up, nine patients treated with APBI and five patients receiving whole-breast irradiation had a local recurrence; the cumulative incidence of local recurrence was 1.44% (95% CI 0.51-2.38) with APBI and 0.92% (0.12-1.73) with whole-breast irradiation (difference 0. 52%, 95% CI -0.72 to 1.75; p=0.42). No grade 4 late side-effects were reported. The 5-year risk of grade 2-3 late side-effects to the skin was 3.2% with APBI versus 5.7% with whole-breast irradiation (p=0.08), and 5-year risk of grade 2-3 subcutaneous tissue late side-effects was 7.6% versus 6.3% (p=0.53). The risk of severe (grade 3) fibrosis at 5 years was 0.2% with whole-breast irradiation and 0% with APBI (p=0.46). Interpretation The difference between treatments was below the relevance margin of 3 percentage points. Therefore, adjuvant APBI using multicatheter brachytherapy after breast-conserving surgery in patients with early breast cancer is not inferior to adjuvant whole-breast irradiation with respect to 5-year local control, disease-free survival, and overall survival. Funding German Cancer Aid.	[Strnad, Vratislav; Ott, Oliver J.; Fietkau, Rainer] Univ Hosp Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Major, Tibor; Polgar, Csaba] Natl Inst Oncol, Ctr Radiotherapy, Budapest, Hungary; [Hildebrandt, Guido; Hindemith, Marion; Schlamann, Annika] Univ Hosp Leipzig, Dept Radiat Oncol, Leipzig, Germany; [Hildebrandt, Guido; Knauerhase, Hellen; Fietkau, Rainer] Univ Hosp Rostock, Dept Radiat Oncol, Rostock, Germany; [Kauer-Dorner, Daniela; Resch, Alexandra; Poetter, Richard] Univ Hosp AKH Wien, Dept Radiat Oncol, Vienna, Austria; [Lyczek, Jaroslaw; Kulik, Anna] Inst Marii Sklodowskej, Ctr Onkol, Brachytherapy Dept, Warsaw, Poland; [Lyczek, Jaroslaw] Podkarpacki Hosp, Canc Ctr Brzozow, Brzozow, Poland; [Guinot, Jose Luis; Arribas, Leo] Valencian Inst Oncol, Dept Radiat Oncol, Valencia, Spain; [Dunst, Juergen; Niehoff, Peter] Univ Hosp Kiel, Dept Radiat Oncol, Kiel, Germany; [Niehoff, Peter] Univ Witten Herdecke, Dept Radiotherapy, Municipal Hosp Cologne, Witten, Germany; [Gutierrez Miguelez, Cristina; Guedea, Fernando] Catalan Inst Oncol, Dept Radiat Oncol, Barcelona, Spain; [Slampa, Pavel] Masaryk Mem Canc Inst, Dept Radiat Oncol, Brno, Czech Republic; [Loessl, Kristina] Univ Hosp Bern, Inselspital, Dept Radiat Oncol, CH-3010 Bern, Switzerland; [Allgaeuer, Michael] Hosp Barmherzige Bruder Regensburg, Dept Radiat Oncol, Regensburg, Germany; [Kovacs, Gyoergy] Med Univ Lubeck, Interdisciplinary Brachytherapy Unit, D-23538 Lubeck, Germany; [Fischedick, Arnt-Rene] Clemens Hosp, Dept Radiat Oncol, Munster, Germany; [Polat, Buelent] Univ Hosp Wurzburg, Dept Radiat Oncol, Wurzburg, Germany; [Wendt, Thomas G.] Univ Hosp Jena, Dept Radiat Oncol, Jena, Germany; [Gall, Christine; Malzer, Martina; Uter, Wolfgang] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; National Institute of Oncology Hungary; Leipzig University; University of Rostock; University Hospital Vienna; Instituto Valenciano De Oncologia; University of Kiel; Schleswig Holstein University Hospital; Witten Herdecke University; Catalan Institute of Oncology; Masaryk Memorial Cancer Institute; University of Bern; University Hospital of Bern; University of Lubeck; University of Wurzburg; Friedrich Schiller University of Jena; University of Erlangen Nuremberg	Strnad, V (corresponding author), Univ Hosp Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany.	vratislav.strnad@uk-erlangen.de	Dunst, Juergen/D-2138-2010; , Tibor/N-1003-2019; Niehoff, Peter/Y-4535-2018; Polat, Bülent/R-1481-2019; Fietkau, Rainer/A-9632-2017; Ott, Oliver J./AAH-2608-2021	Polat, Bülent/0000-0003-4677-424X; Ott, Oliver J./0000-0001-5806-6158; Major, Tibor/0000-0002-4672-6910; Potter, Richard/0000-0002-0703-572X; Resch, Alexandra/0000-0001-5413-6331	German Cancer Aid	German Cancer Aid(Deutsche Krebshilfe)	German Cancer Aid.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Abe O, 2005, LANCET, V366, P2087; Bartelink H, 2015, LANCET ONCOL, V16, P47, DOI 10.1016/S1470-2045(14)71156-8; Csaba P, 2010, RADIOTHER ONCOL, V94, P274, DOI 10.1016/j.radonc.2010.01.019; Dodwell DJ, 2005, CLIN ONCOL-UK, V17, P618, DOI 10.1016/j.clon.2005.07.018; Gilleard O, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-61; Hepel J, 2015, INT J RADIAT ONCOL, V91, P255, DOI 10.1016/j.ijrobp.2014.09.019; Hughes KS, 2013, J CLIN ONCOL, V31, P2382, DOI 10.1200/JCO.2012.45.2615; Khan AJ, 2012, ANN SURG ONCOL, V19, P1477, DOI 10.1245/s10434-011-2133-1; King TA, 2000, AM J SURG, V180, P299, DOI 10.1016/S0002-9610(00)00454-2; Kirova YM, 2007, INT J RADIAT ONCOL, V68, P359, DOI 10.1016/j.ijrobp.2006.12.011; Kunkler IH, 2015, LANCET ONCOL, V16, P266, DOI 10.1016/S1470-2045(14)71221-5; Lee LJ, 2009, BREAST, V18, pS103, DOI 10.1016/S0960-9776(09)70284-X; Lettmaier S, 2011, RADIOTHER ONCOL, V100, P189, DOI 10.1016/j.radonc.2010.07.011; Livi L, 2015, EUR J CANCER, V51, P451, DOI 10.1016/j.ejca.2014.12.013; Njeh CF, 2012, CRIT REV ONCOL HEMAT, V81, P1, DOI [10.1016/j.critrevonc.2011.01.01, 10.1016/j.critrevonc.2011.01.011]; Offersen BV, 2009, RADIOTHER ONCOL, V90, P1, DOI 10.1016/j.radonc.2008.08.005; Olivotto IA, 2013, J CLIN ONCOL, V31, P4038, DOI 10.1200/JCO.2013.50.5511; Potter R, 2007, INT J RADIAT ONCOL, V68, P334, DOI 10.1016/j.ijrobp.2006.12.045; Polgar C, 2013, RADIOTHER ONCOL, V108, P197, DOI 10.1016/j.radonc.2013.05.008; Polgar C, 2010, STRAHLENTHER ONKOL, V186, P113, DOI 10.1007/s00066-010-3001-9; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Rodriguez N, 2013, INT J RADIAT ONCOL, V87, P1051, DOI 10.1016/j.ijrobp.2013.08.046; RUBIN P, 1995, RADIOTHER ONCOL, V35, P5; Showalter SL, 2013, ANN SURG ONCOL, V20, P1287, DOI 10.1245/s10434-012-2693-8; Strnad V, 2011, INT J RADIAT ONCOL, V80, P17, DOI 10.1016/j.ijrobp.2010.01.020; Toutouzas K, 2013, NEW ENGL J MED, V368, P2524, DOI 10.1056/NEJMc1304601; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Veronesi U, 2013, LANCET ONCOL, V14, P1269, DOI 10.1016/S1470-2045(13)70497-2; Vicini FA, 1997, INT J RADIAT ONCOL, V38, P301, DOI 10.1016/S0360-3016(97)00035-7	30	439	447	2	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					229	238		10.1016/S0140-6736(15)00471-7	http://dx.doi.org/10.1016/S0140-6736(15)00471-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26494415				2022-12-28	WOS:000368130700030
J	Khatib, R; Mckee, M; Shannon, H; Chow, C; Rangarajan, S; Teo, K; Wei, L; Mony, P; Mohan, V; Gupta, R; Kumar, R; Vijayakumar, K; Lear, SA; Diaz, R; Avezum, A; Lopez-Jaramillo, P; Lanas, F; Yusoff, K; Ismail, N; Kazmi, K; Rahman, O; Rosengren, A; Monsef, N; Kelishadi, R; Kruger, A; Puoane, T; Szuba, A; Chifamba, J; Temizhan, A; Dagenais, G; Gafni, A; Yusuf, S				Khatib, Rasha; Mckee, Martin; Shannon, Harry; Chow, Clara; Rangarajan, Sumathy; Teo, Koon; Wei, Li; Mony, Prem; Mohan, Viswanathan; Gupta, Rajeev; Kumar, Rajesh; Vijayakumar, Krishnapillai; Lear, Scott A.; Diaz, Rafael; Avezum, Alvaro; Lopez-Jaramillo, Patricio; Lanas, Fernando; Yusoff, Khalid; Ismail, Noorhassim; Kazmi, Khawar; Rahman, Omar; Rosengren, Annika; Monsef, Nahed; Kelishadi, Roya; Kruger, Annamarie; Puoane, Thandi; Szuba, Andrzej; Chifamba, Jephat; Temizhan, Ahmet; Dagenais, Gilles; Gafni, Amiram; Yusuf, Salim		PURE Study Investigators	Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data	LANCET			English	Article								Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible individuals by 2025. We have previously reported that use of these medicines is very low, but now aim to assess how such low use relates to their lack of availability or poor affordability. Methods We analysed information about availability and costs of cardiovascular disease medicines (aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and statins) in pharmacies gathered from 596 communities in 18 countries participating in the Prospective Urban Rural Epidemiology (PURE) study. Medicines were considered available if present at the pharmacy when surveyed, and aff ordable if their combined cost was less than 20% of household capacity-to-pay. We compared results from high-income, upper middle-income, lower middle-income, and low-income countries. Data from India were presented separately given its large, generic pharmaceutical industry. Findings Communities were recruited between Jan 1, 2003, and Dec 31, 2013. All four cardiovascular disease medicines were available in 61 (95%) of 64 urban and 27 (90%) of 30 rural communities in high-income countries, 53 (80%) of 66 urban and 43 (73%) of 59 rural communities in upper middle-income countries, 69 (62%) of 111 urban and 42 (37%) of 114 rural communities in lower middle-income countries, eight (25%) of 32 urban and one (3%) of 30 rural communities in low-income countries (excluding India), and 34 (89%) of 38 urban and 42 (81%) of 52 rural communities in India. The four cardiovascular disease medicines were potentially unaffordable for 0.14% of households in high-income countries (14 of 9934 households), 25% of upper middle-income countries (6299 of 24 776), 33% of lower middle-income countries (13 253 of 40 023), 60% of low-income countries (excluding India; 1976 of 3312), and 59% households in India (9939 of 16 874). In low-income and middle-income countries, patients with previous cardiovascular disease were less likely to use all four medicines if fewer than four were available (odds ratio [OR] 0.16, 95% CI 0.04-0.57). In communities in which all four medicines were available, patients were less likely to use medicines if the household potentially could not afford them (0.16, 0.04-0.55). Interpretation Secondary prevention medicines are unavailable and unaff ordable for a large proportion of communities and households in upper middle-income, lower middle-income, and low-income countries, which have very low use of these medicines. Improvements to the availability and aff ordability of key medicines is likely to enhance their use and help towards achieving WHO's targets of 50% use of key medicines by 2025.	[Khatib, Rasha] Birzeit Univ, Inst Commun & Publ Hlth, Birzeit, Palestine; [Khatib, Rasha; Rangarajan, Sumathy; Teo, Koon; Yusuf, Salim] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Mckee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res Policy, London WC1, England; [Shannon, Harry; Gafni, Amiram] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Chow, Clara] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Chow, Clara] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Wei, Li] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100730, Peoples R China; [Wei, Li] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Mony, Prem] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Gupta, Rajeev] JLN Marg, Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Vijayakumar, Krishnapillai] Somervell Mem CSI, Coll Med, Thiruvananthapuram, Kerala, India; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Diaz, Rafael] Estudios Clin Latinoamer, Santa Fe, NM, Argentina; [Avezum, Alvaro] Dante Pazzanese, Inst Cardiol, Sao Paulo, SP, Brazil; [Lopez-Jaramillo, Patricio] Fdn Oftalmolog Santander, Floridablanca Santander, Colombia; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Yusoff, Khalid] Univ Teknol MARA, Sungai Buloh, Selangor, Malaysia; [Yusoff, Khalid] UCSI Univ, Cheras, Selangor, Malaysia; [Ismail, Noorhassim] Univ Kebangsaan Malaysia, Med Ctr, Dept Community Hlth, Kuala Lumpur, Malaysia; [Kazmi, Khawar] Aga Khan Univ, Dept Med, Div Cardiol, Karachi, Pakistan; [Rahman, Omar] Independent Univ, Dhaka, Bangladesh; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Monsef, Nahed] Dubai Hlth Author, Primary Hlth Care Serv Sector, Hlth Affairs Dept, Consultant Family Med, Dubai, U Arab Emirates; [Kelishadi, Roya] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Res Dept, Esfahan, Iran; [Kruger, Annamarie] North West Univ, Fac Hlth Sci, Potchefstroom, South Africa; [Puoane, Thandi] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Szuba, Andrzej] Wroclaw Med Univ, Dept Internal Med, Wroclaw, Poland; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Temizhan, Ahmet] Karabuk Univ, Fac Med, Dept Cardiol, Karabuk, Turkey; [Dagenais, Gilles] Univ Laval, Heart & Lungs Inst, Quebec City, PQ, Canada	Birzeit University; McMaster University; Population Health Research Institute; University of London; London School of Hygiene & Tropical Medicine; McMaster University; University of Sydney; George Institute for Global Health; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; St. John's National Academy of Health Sciences; St. John's Medical College; Madras Diabetes Research Foundation; Fortis Escorts Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Simon Fraser University; Fundacao Universitaria de Cardiologia; Instituto Dante Pazzanese de Cardiologia; Universidad de La Frontera; Universiti Teknologi MARA; UCSI University; Universiti Kebangsaan Malaysia; Aga Khan University; Independent University Bangladesh (IUB); University of Gothenburg; Isfahan University Medical Science; North West University - South Africa; University of the Western Cape; Wroclaw Medical University; University of Zimbabwe; Karabuk University; Laval University	Yusuf, S (corresponding author), McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	salim.yusuf@phri.ca	Mckee, Martin/E-6673-2018; Rahman, Omar/E-1329-2019; Avezum, Alvaro AA/K-6137-2016; Chifamba, Jephat/AHE-4535-2022; Avezum, Alvaro/AAP-7687-2020; Yusoff, Khalid/I-7029-2019; McKee, Marc D/E-2187-2011; Qorbani, Mostafa/M-8171-2017; Kelishadi, Roya/E-6154-2012; Lanas, Fernando/AAE-8842-2022; Mony, Prem K./GRF-4752-2022; Szuba, Andrzej/AAY-1162-2020; Gomez-Arbelaez, Diego/K-1883-2013; Igumbor, Ehimario/B-2652-2012	Mckee, Martin/0000-0002-0121-9683; Rahman, Omar/0000-0002-0606-2507; Avezum, Alvaro AA/0000-0002-3073-6890; Chifamba, Jephat/0000-0001-8166-1182; Yusoff, Khalid/0000-0001-5669-5188; McKee, Marc D/0000-0001-8349-965X; Kelishadi, Roya/0000-0001-7455-1495; Mony, Prem K./0000-0002-1399-0520; Gulec, Sadi/0000-0002-2685-2522; Szuba, Andrzej/0000-0002-7555-6201; Jerling, Johann/0000-0003-2600-3536; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Lanas, Fernando/0000-0003-3595-9759; Teo, Koon/0000-0002-3731-0956; Camacho, Paul Anthony/0000-0002-6233-9582; Yusuf, Salim/0000-0003-4776-5601; Ismail, Noor Hassim/0000-0003-1547-7904; Levitt, Naomi/0000-0001-6480-8066; Igumbor, Ehimario/0000-0002-6313-6031; Lopez-Jaramillo, Patricio/0000-0002-9122-8742	Population Health Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario (Canada); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); AstraZeneca (Canada); Sanofi - Aventis (France); Sanofi - Aventis (Canada); Servier; GlaxoSmithKline (GSK); Novartis; King Pharma; Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Universidad de la Frontera; National Centre for Cardiovascular Diseases; Colciencias [6566-04-18062]; Indian Council of Medical Research; Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 [13/2007], 07-05-IFN-MEB010]; Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 [2/2011]]; Universiti Teknologi MARA; Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; Occupied Palestinian territory-the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), occupied Palestinian territory; International Development Research Centre (IDRC), Canada; Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University; The North-West University; SANPAD (South Africa and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of South Africa; South African Sugar Association (SASA); Faculty of Community and Health Sciences (UWC); AFA Insurance; Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State under LakarUtbildningsAvtalet; Vastra Gotaland Region (FOUU); Metabolic Syndrome Society; AstraZeneca, Turkey; Sanofi - Aventis, Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai United Arab Emirates; Australian National Health and Medical Research Council Career Development Fellowship; National Heart Foundation	Population Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario (Canada)(Heart & Stroke Foundation of Ontario); Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Boehringer Ingelheim (Canada)(Boehringer Ingelheim); AstraZeneca (Canada)(AstraZeneca); Sanofi - Aventis (France)(Sanofi-Aventis); Sanofi - Aventis (Canada)(Sanofi-Aventis); Servier(Servier); GlaxoSmithKline (GSK)(GlaxoSmithKline); Novartis(Novartis); King Pharma; Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil(Unilever); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Universidad de la Frontera; National Centre for Cardiovascular Diseases; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Universiti Teknologi MARA; Universiti Kebangsaan Malaysia; Occupied Palestinian territory-the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), occupied Palestinian territory; International Development Research Centre (IDRC), Canada(CGIAR); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University; The North-West University; SANPAD (South Africa and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South African Sugar Association (SASA); Faculty of Community and Health Sciences (UWC); AFA Insurance; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State under LakarUtbildningsAvtalet; Vastra Gotaland Region (FOUU); Metabolic Syndrome Society; AstraZeneca, Turkey(AstraZeneca); Sanofi - Aventis, Turkey(Sanofi-Aventis); Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai United Arab Emirates; Australian National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia)	The PURE study and its components are funded by the Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario (Canada); through unrestricted grants from Boehringer Ingelheim (Germany and Canada), AstraZeneca (Canada), Sanofi - Aventis (France and Canada), Servier, and GlaxoSmithKline (GSK); and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These organisations include the following: Bangladesh-Independent University, Bangladesh, Mitra and Associates; Brazil-Unilever Health Institute, Brazil; Canada-Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile-Universidad de la Frontera; China-National Centre for Cardiovascular Diseases; Colombia-Colciencias (grant number: 6566-04-18062); India-Indian Council of Medical Research; Malaysia-Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007]; grant number: 07-05-IFN-MEB010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); Occupied Palestinian territory-the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), occupied Palestinian territory; International Development Research Centre (IDRC), Canada; Poland-Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0), Wroclaw Medical University; South Africa-The North-West University, SANPAD (South Africa and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of South Africa, The South African Sugar Association (SASA), Faculty of Community and Health Sciences (UWC); Sweden-AFA Insurance, Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, Grant from the Swedish State under LakarUtbildningsAvtalet, Agreement, Grant from the Vastra Gotaland Region (FOUU); Turkey-Metabolic Syndrome Society, AstraZeneca, Turkey, Sanofi - Aventis, Turkey; United Arab Emirates-Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai United Arab Emirates. CC was supported by an Australian National Health and Medical Research Council Career Development Fellowship cofunded by the National Heart Foundation. RKh received funds from the Population Health Research Institute and the International Development Research Centre (IDRC), Canada. We thank WHO and the World Health Survey from which some data in the appendix were obtained from. We also thank all the study investigators (appendix).	Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Chow CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014294; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Niens LM, 2013, HEALTH POLICY, V112, P45, DOI 10.1016/j.healthpol.2013.05.018; Niens LM, 2012, B WORLD HEALTH ORGAN, V90, P219, DOI 10.2471/BLT.10.084087; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Smolina K, 2012, EUR J PUBLIC HEALTH, V22, P848, DOI 10.1093/eurpub/ckr196; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; The World Bank, INFL CONS PRIC AN; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Vialle-Valentin Catherine E, 2008, Health Res Policy Syst, V6, P11, DOI 10.1186/1478-4505-6-11; World Bank, PPP CONV FACT PRIV C; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization, HLTH STAT INF SYST W; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	23	217	224	3	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					61	69		10.1016/S0140-6736(15)00469-9	http://dx.doi.org/10.1016/S0140-6736(15)00469-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26498706				2022-12-28	WOS:000367457300028
J	Everson, GT; Towner, WJ; Davis, MN; Wyles, DL; Nahass, RG; Thuluvath, PJ; Etzkorn, K; Hinestrosa, F; Tong, M; Rabinovitz, M; McNally, J; Brainard, DM; Han, LL; Doehle, B; McHutchison, JG; Morgan, T; Chung, RT; Tran, TT				Everson, Gregory T.; Towner, William J.; Davis, Mitchell N.; Wyles, David L.; Nahass, Ronald G.; Thuluvath, Paul J.; Etzkorn, Kyle; Hinestrosa, Federico; Tong, Myron; Rabinovitz, Mordechai; McNally, John; Brainard, Diana M.; Han, Lingling; Doehle, Brian; McHutchison, John G.; Morgan, Timothy; Chung, Raymond T.; Tran, Tram T.			Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NATURAL-HISTORY; EPIDEMIOLOGY	Background: Effective, pangenotypic treatments for hepatitis C virus (HCV) infection are needed. Objective: To assess the safety and efficacy of sofosbuvir with velpatasvir in patients infected with HCV genotypes 1 to 6. Design: Randomized, phase 2, open-label study. (ClinicalTrials.gov:NCT01858766) Setting: 48 U.S. sites. Patients: 377 treatment-naive noncirrhotic patients. In part A, patients infected with HCV genotypes 1 to 6 were randomly assigned to sofosbuvir, 400 mg, with velpatasvir, 25 or 100 mg, for 12 weeks. In part B, patients with genotype 1 or 2 HCV infection were randomly assigned to sofosbuvir, 400 mg, and velpatasvir, 25 or 100 mg, with or without ribavirin for 8 weeks. Measurements: Sustained virologic response at 12 weeks (SVR12). Results: In part A, SVR12 rates were 96% (26 of 27) with velpatasvir, 25 mg, and 100% (28 of 28) with velpatasvir, 100 mg, for genotype 1; 93% (25 of 27) in both groups for genotype 3; and 96% (22 of 23) with velpatasvir, 25 mg, and 95% (21 of 22) with velpatasvir, 100 mg, for genotypes 2, 4, 5, and 6. In part B, for genotype 1, SVR12 rates were 87% (26 of 30) with velpatasvir, 25 mg; 83% (25 of 30) with velpatasvir, 25 mg, plus ribavirin; 90% (26 of 29) with velpatasvir, 100 mg; and 81% (25 of 31) with velpatasvir, 100 mg, plus ribavirin. For genotype 2, SVR12 rates were 77% (20 of 26) with velpatasvir, 25 mg; 88% (22 of 25) with velpatasvir, 25 mg, plus ribavirin; 88% (23 of 26) with velpatasvir, 100 mg; and 88% (23 of 26) with velpatasvir, 100 mg, plus ribavirin. Adverse events included fatigue (21%), headache (20%), and nausea (12%). One patient committed suicide. Limitation: The study was open-label, no inferential statistics were planned, and sample sizes were small. Conclusion: Twelve weeks of sofosbuvir, 400 mg, and velpatasvir, 100 mg, was well-tolerated and resulted in high SVR in patients infected with HCV genotypes 1 to 6.	[Everson, Gregory T.] Univ Colorado Denver, Sch Med, Hepatol, Aurora, CO 80045 USA; [Towner, William J.] Kaiser Permanente, Los Angeles, CA 90027 USA; [Tran, Tram T.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Davis, Mitchell N.] South Florida Ctr Gastroenterol, Digest CARE, Wellington, FL 33414 USA; [Wyles, David L.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Nahass, Ronald G.] ID CARE, Hillsborough, NJ 08844 USA; [Thuluvath, Paul J.] Mercy Med Ctr, Baltimore, MD 21202 USA; [Etzkorn, Kyle] Borland Groover Clin, Jacksonville, FL 32256 USA; [Hinestrosa, Federico] Orlando Immunol Ctr, Orlando, FL 32803 USA; [Tong, Myron] Huntington Med Res Inst, Pasadena, CA 91105 USA; [Rabinovitz, Mordechai] Univ Pittsburgh, Pittsburgh, PA 15217 USA; [McNally, John; Brainard, Diana M.; Han, Lingling; Doehle, Brian; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Morgan, Timothy] VA Long Beach Healthcare Syst, Long Beach, CA 90822 USA; [Chung, Raymond T.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Cedars Sinai Medical Center; University of California System; University of California San Diego; Mercy Medical Center - Maryland; Orlando Immunology Center; Huntington Medical Research Institutes; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Gilead Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Harvard University; Massachusetts General Hospital	Everson, GT (corresponding author), Univ Colorado Denver, Sch Med, Hepatol, 1635 Aurora Court,B-154, Aurora, CO 80045 USA.	greg.everson@ucdenver.edu			Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; American Association for the Study of Liver Diseases and the Infectious Diseases Society of America, 2015, HCV GUID REC TEST MA; Buti M, 2015, EXPERT REV GASTROENT, V9, P375, DOI 10.1586/17474124.2015.960396; Cheng G, 2013, J HEPATOL, V58, pS484, DOI 10.1016/S0168-8278(13)61192-7; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; German P, 2013, EUR ASS STUD LIV 48; Gilead Sciences, 2013, SOV SOF US PRESCR IN; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Lawitz E, 2015, J VIRAL HEPAT; Merck, 2003, REB RIB CAPS US PRES; Mogalian E, 2013, LIV M 2013 64 ANN M; Narayanan S, 2014, HEPATOL INT, V8, P560, DOI 10.1007/s12072-014-9574-0; Nyalakonda H, 2015, CURR OPIN INFECT DIS, V28, P471, DOI 10.1097/QCO.0000000000000190; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	18	82	84	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					818	+		10.7326/M15-1000	http://dx.doi.org/10.7326/M15-1000			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26551051				2022-12-28	WOS:000365866500005
J	Hoshino, A; Costa-Silva, B; Shen, TL; Rodrigues, G; Hashimoto, A; Mark, MT; Molina, H; Kohsaka, S; Di Giannatale, A; Ceder, S; Singh, S; Williams, C; Soplop, N; Uryu, K; Pharmer, L; King, T; Bojmar, L; Davies, AE; Ararso, Y; Zhang, T; Zhang, H; Hernandez, J; Weiss, JM; Dumont-Cole, VD; Kramer, K; Wexler, LH; Narendran, A; Schwartz, GK; Healey, JH; Sandstrom, P; Labori, KJ; Kure, EH; Grandgenett, PM; Hollingsworth, MA; de Sousa, M; Kaur, S; Jain, M; Mallya, K; Batra, SK; Jarnagin, WR; Brady, MS; Fodstad, O; Muller, V; Pantel, K; Minn, AJ; Bissell, MJ; Garcia, BA; Kang, Y; Rajasekhar, VK; Ghajar, CM; Matei, I; Peinado, H; Bromberg, J; Lyden, D				Hoshino, Ayuko; Costa-Silva, Bruno; Shen, Tang-Long; Rodrigues, Goncalo; Hashimoto, Ayako; Mark, Milica Tesic; Molina, Henrik; Kohsaka, Shinji; Di Giannatale, Angela; Ceder, Sophia; Singh, Swarnima; Williams, Caitlin; Soplop, Nadine; Uryu, Kunihiro; Pharmer, Lindsay; King, Tari; Bojmar, Linda; Davies, Alexander E.; Ararso, Yonathan; Zhang, Tuo; Zhang, Haiying; Hernandez, Jonathan; Weiss, Joshua M.; Dumont-Cole, Vanessa D.; Kramer, Kimberly; Wexler, Leonard H.; Narendran, Aru; Schwartz, Gary K.; Healey, John H.; Sandstrom, Per; Labori, Knut Jorgen; Kure, Elin H.; Grandgenett, Paul M.; Hollingsworth, Michael A.; de Sousa, Maria; Kaur, Sukhwinder; Jain, Maneesh; Mallya, Kavita; Batra, Surinder K.; Jarnagin, William R.; Brady, Mary S.; Fodstad, Oystein; Muller, Volkmar; Pantel, Klaus; Minn, Andy J.; Bissell, Mina J.; Garcia, Benjamin A.; Kang, Yibin; Rajasekhar, Vinagolu K.; Ghajar, Cyrus M.; Matei, Irina; Peinado, Hector; Bromberg, Jacqueline; Lyden, David			Tumour exosome integrins determine organotropic metastasis	NATURE			English	Article							BREAST-CANCER METASTASIS; BONE METASTASES; IN-VIVO; CELLS; GROWTH; NICHE; MICROVESICLES; PROTEOMICS; PROTEINS; VESICLES	Ever since Stephen Paget's 1889 hypothesis, metastatic organotropism has remained one of cancer's greatest mysteries. Here we demonstrate that exosomes from mouse and human lung-, liver-and brain-tropic tumour cells fuse preferentially with resident cells at their predicted destination, namely lung fibroblasts and epithelial cells, liver Kupffer cells and brain endothelial cells. We show that tumour-derived exosomes uptaken by organ-specific cells prepare the pre-metastatic niche. Treatment with exosomes from lung-tropic models redirected the metastasis of bone-tropic tumour cells. Exosome proteomics revealed distinct integrin expression patterns, in which the exosomal integrins alpha(6)beta(4) and alpha(6)beta(1) were associated with lung metastasis, while exosomal integrin alpha(v)beta(5) was linked to liver metastasis. Targeting the integrins alpha(6)beta(4) and alpha(v)beta(5) decreased exosome uptake, as well as lung and liver metastasis, respectively. We demonstrate that exosome integrin uptake by resident cells activates Src phosphorylation and pro-inflammatory S100 gene expression. Finally, our clinical data indicate that exosomal integrins could be used to predict organ-specific metastasis.	[Hoshino, Ayuko; Costa-Silva, Bruno; Shen, Tang-Long; Rodrigues, Goncalo; Hashimoto, Ayako; Di Giannatale, Angela; Singh, Swarnima; Williams, Caitlin; Bojmar, Linda; Ararso, Yonathan; Zhang, Haiying; Hernandez, Jonathan; Weiss, Joshua M.; de Sousa, Maria; Brady, Mary S.; Matei, Irina; Peinado, Hector; Lyden, David] Weill Cornell Med, Meyer Canc Ctr, Drukier Inst Childrens Hlth, Dept Pediat,Childrens Canc & Blood Fdn Labs, New York, NY 10021 USA; [Hoshino, Ayuko; Costa-Silva, Bruno; Shen, Tang-Long; Rodrigues, Goncalo; Hashimoto, Ayako; Di Giannatale, Angela; Singh, Swarnima; Williams, Caitlin; Bojmar, Linda; Ararso, Yonathan; Zhang, Haiying; Hernandez, Jonathan; Weiss, Joshua M.; de Sousa, Maria; Brady, Mary S.; Matei, Irina; Peinado, Hector; Lyden, David] Weill Cornell Med, Meyer Canc Ctr, Drukier Inst Childrens Hlth, Dept Cell & Dev Biol,Childrens Canc & Blood Fdn L, New York, NY 10021 USA; [Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10617, Taiwan; [Shen, Tang-Long] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10617, Taiwan; [Rodrigues, Goncalo; de Sousa, Maria] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099003 Oporto, Portugal; [Hashimoto, Ayako] Univ Tokyo, Dept Obstet & Gynecol, Fac Med, Tokyo 1138655, Japan; [Mark, Milica Tesic; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Kohsaka, Shinji] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ceder, Sophia] Karolinska Inst, Dept Pathol & Oncol, S-17176 Stockholm, Sweden; [Soplop, Nadine; Uryu, Kunihiro] Rockefeller Univ, EMRC, New York, NY 10065 USA; [Pharmer, Lindsay; King, Tari] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10065 USA; [Bojmar, Linda; Sandstrom, Per] Linkoping Univ, Fac Hlth Sci, Dept Surg, Cty Council Ostergotland, S-58185 Linkoping, Sweden; [Bojmar, Linda; Sandstrom, Per] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Davies, Alexander E.; Bissell, Mina J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Zhang, Tuo] Weill Cornell Med, Genom Resources Core Facil, New York, NY 10021 USA; [Hernandez, Jonathan; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Dumont-Cole, Vanessa D.; Kramer, Kimberly; Wexler, Leonard H.; Lyden, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Narendran, Aru] Alberta Childrens Prov Gen Hosp, Div Pediat Oncol, Calgary, AB T3B 6A8, Canada; [Schwartz, Gary K.] Columbia Univ, Sch Med, Div Hematol Oncol, New York, NY 10032 USA; [Healey, John H.] Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, New York, NY 10065 USA; [Labori, Knut Jorgen] Oslo Univ Hosp, Dept Hepatopancreatobiliary Surg, N-0424 Oslo, Norway; [Kure, Elin H.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Genet, N-0424 Oslo, Norway; [Grandgenett, Paul M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Kaur, Sukhwinder; Jain, Maneesh; Mallya, Kavita; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Brady, Mary S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gastr & Mixed Tumor Serv, New York, NY 10065 USA; [Fodstad, Oystein] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, N-0424 Oslo, Norway; [Fodstad, Oystein] Univ Oslo, Inst Clin Med, Fac Med, N-0318 Oslo, Norway; [Muller, Volkmar] Univ Med Ctr, Dept Gynecol, D-20246 Hamburg, Germany; [Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, D-20246 Hamburg, Germany; [Minn, Andy J.] Univ Penn, Abramson Family Canc Res Inst, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kang, Yibin] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Med Serv, New York, NY 10065 USA; [Ghajar, Cyrus M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Peinado, Hector] Spanish Natl Canc Res Ctr CNIO, Dept Mol Oncol, Microenvironm & Metastasis Lab, Madrid 28029, Spain; [Bromberg, Jacqueline] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Bromberg, Jacqueline] Weill Cornell Med, Dept Med, New York, NY 10021 USA	Cornell University; Cornell University; National Taiwan University; National Taiwan University; Universidade do Porto; University of Tokyo; Rockefeller University; Memorial Sloan Kettering Cancer Center; Karolinska Institutet; Rockefeller University; Memorial Sloan Kettering Cancer Center; City Council Ostergotland; Linkoping University; Linkoping University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Alberta Childrens Hospital; University of Calgary; Columbia University; Memorial Sloan Kettering Cancer Center; University of Oslo; University of Oslo; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Memorial Sloan Kettering Cancer Center; University of Oslo; University of Oslo; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; Centro Nacional de Investigaciones Oncologicas (CNIO); Memorial Sloan Kettering Cancer Center; Cornell University	Peinado, H (corresponding author), Weill Cornell Med, Meyer Canc Ctr, Drukier Inst Childrens Hlth, Dept Pediat,Childrens Canc & Blood Fdn Labs, New York, NY 10021 USA.	hpeinado@cnio.es; bromberj@mskcc.org; dcl2001@med.cornell.edu	Costa-Silva, Bruno/AAY-2266-2020; Labori, Knut Jørgen/W-5510-2019; SandstrÃm, Per/AAF-1841-2019; Hoshino, Ayuko/AHD-6448-2022; Shen, Tang-Long/C-7460-2011; Peinado, Hector/A-6417-2013	Hoshino, Ayuko/0000-0003-4149-5073; Peinado, Hector/0000-0002-4256-3413; Kang, Yibin/0000-0002-1626-6730; Shen, Tang-Long/0000-0001-6264-3608; Ceder, Sophia/0000-0002-6195-9288; Weiss, Joshua/0000-0001-7340-4004; Healey, John/0000-0002-0802-1186; Vinagolu, Rajasekhar/0000-0002-7364-2675; Di Giannatale, Angela/0000-0001-8465-3612; Davies, Alexander/0000-0002-1917-8816; Minn, Andy/0000-0003-1418-0906; Rodrigues, Goncalo/0000-0001-5132-9568; Costa-Silva, Bruno/0000-0002-5932-6211	MSK Cancer Center Support Grant/Core Grant [P30 CA008748]; National Cancer Institute [U01-CA169538]; National Institutes of Health [R01-CA169416]; United States Department of Defense [W81XWH-13-10249, W81XWH-13-1-0425]; Melanoma Research Alliance; Sohn Conference Foundation; Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Fundacao para a Ciencia e a Tecnologia; Nancy C. and Daniel P. Paduano Foundation; Feldstein Foundation; Starr Cancer Consortium; Mary Kay Foundation; Pediatric Oncology Experimental Therapeutic Investigator Consortium (POETIC); James Paduano Foundation; Beth Tortolani Foundation; Malcolm Hewitt Weiner Foundation; Theodore A. Rapp Foundation; American Hellenic Educational Progressive Association 5th District Cancer Research Foundation; Charles and Marjorie Holloway Foundation; Sussman Family Fund; Lerner Foundation; Breast Cancer Alliance; Manhasset Women's Coalition Against Breast Cancer; Ministry of Science and Technology Taiwan [101-2918-I-002-016]; JSPS Postdoctoral Fellowships; Susan G. Komen Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [U01CA169538, P30CA008748, R01CA169416] Funding Source: NIH RePORTER	MSK Cancer Center Support Grant/Core Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Melanoma Research Alliance; Sohn Conference Foundation; Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Nancy C. and Daniel P. Paduano Foundation; Feldstein Foundation; Starr Cancer Consortium; Mary Kay Foundation; Pediatric Oncology Experimental Therapeutic Investigator Consortium (POETIC); James Paduano Foundation; Beth Tortolani Foundation; Malcolm Hewitt Weiner Foundation; Theodore A. Rapp Foundation; American Hellenic Educational Progressive Association 5th District Cancer Research Foundation; Charles and Marjorie Holloway Foundation; Sussman Family Fund; Lerner Foundation; Breast Cancer Alliance; Manhasset Women's Coalition Against Breast Cancer; Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); JSPS Postdoctoral Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Rudchenko at the Hospital for Special Surgery Flow Cytometry Core Facility. We acknowledge the MSK Cancer Center Support Grant/Core Grant (P30 CA008748). Our work is supported by grants from National Cancer Institute (U01-CA169538, D. L. and M. S. B.), National Institutes of Health (R01-CA169416, D. L. and H. P.), United States Department of Defense (W81XWH-13-10249, D. L.), W81XWH-13-1-0425 (D. L., J. B., B. A. G. and Y. K.), Melanoma Research Alliance (H. P.), Sohn Conference Foundation (H. P. and H. Z.), the Children's Cancer and Blood Foundation (H. P. and D. L.), The Manning Foundation (D. L.), The Hartwell Foundation (D. L.), Fundacao para a Ciencia e a Tecnologia (D. L.), The Nancy C. and Daniel P. Paduano Foundation (H. P. and D. L.), The Feldstein Foundation (H. P.), The Starr Cancer Consortium (H. P. and D. L.), The Mary Kay Foundation (D. L.), Pediatric Oncology Experimental Therapeutic Investigator Consortium (POETIC, D. L. and H. P.), James Paduano Foundation (D. L. and H. P.), Beth Tortolani Foundation (D. L. and J. B.), Malcolm Hewitt Weiner Foundation (D. L.), Theodore A. Rapp Foundation (D. L.), American Hellenic Educational Progressive Association 5th District Cancer Research Foundation (D. L., A. H.), Charles and Marjorie Holloway Foundation (J. B.), Sussman Family Fund (J. B.), Lerner Foundation (J. B.), Breast Cancer Alliance (J. B.), Manhasset Women's Coalition Against Breast Cancer (J. B.), Ministry of Science and Technology Taiwan (101-2918-I-002-016, T.-L. S.), The JSPS Postdoctoral Fellowships for Research Abroad and Susan G. Komen Postdoctoral Fellowship (A. H.).	Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Bauerle T, 2011, INT J CANCER, V128, P2453, DOI 10.1002/ijc.25563; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bunkenborg J, 2010, PROTEOMICS, V10, P3040, DOI 10.1002/pmic.201000103; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Fukuda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129704; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Grum-Schwensen B, 2010, CANCER RES, V70, P936, DOI 10.1158/0008-5472.CAN-09-3220; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; HART IR, 1980, CANCER RES, V40, P2281; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim TH, 2009, MOL CANCER RES, V7, P1605, DOI 10.1158/1541-7786.MCR-09-0102; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Mainiero F, 2003, EUR J IMMUNOL, V33, P3038, DOI 10.1002/eji.200323931; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; PAGET S, 1989, CANCER METAST REV, V8, P98; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Radisky D, 2002, CANCER INVEST, V20, P139, DOI 10.1081/CNV-120000374; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sroka TC, 2006, CANCER BIOL THER, V5, P1556, DOI 10.4161/cbt.5.11.3461; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Wu YJ, 2012, J NEURO-ONCOL, V110, P27, DOI 10.1007/s11060-012-0942-0; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	50	2713	2831	67	1314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					329	+		10.1038/nature15756	http://dx.doi.org/10.1038/nature15756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26524530	Green Accepted, Green Submitted			2022-12-28	WOS:000365356800046
J	Lehar, SM; Pillow, T; Xu, M; Staben, L; Kajihara, KK; Andlen, RV; DePalatis, L; Raab, H; Hazenbos, WL; Morisaki, JH; Kim, J; Park, S; Darwish, M; Lee, BC; Hernandez, H; Loyet, KM; Lupardus, P; Fong, RN; Yan, DH; Halouni, CC; Luis, E; Khalfin, Y; Plise, E; Heong, JC; Lyssikatos, JP; Strandh, M; Koefoed, K; Andersen, PS; Flygare, JA; Tan, MW; Brown, EJ; Ariathasan, SM				Lehar, Sophie M.; Pillow, Thomas; Xu, Min; Staben, Leanna; Kajihara, Kimberly K.; Andlen, Richard V.; DePalatis, Laura; Raab, Helga; Hazenbos, Wouter L.; Morisaki, J. Hiroshi; Kim, Janice; Park, Summer; Darwish, Martine; Lee, Byoung-Chul; Hernandez, Hilda; Loyet, Kelly M.; Lupardus, Patrick; Fong, Rina; Yan, Donghong; Halouni, Cecile C.; Luis, Elizabeth; Khalfin, Yana; Plise, Emile; Heong, Jonathan C.; Lyssikatos, Joseph P.; Strandh, Magnus; Koefoed, Klaus; Andersen, Peter S.; Flygare, John A.; Tan, Man Wah; Brown, Eric J.; Ariathasan, Sanjeev M.			Novel antibody-antibiotic conjugate eliminates intracellular S. aureus	NATURE			English	Article							STAPHYLOCOCCUS-AUREUS; BACTEREMIA; INFECTIONS; MODEL; INTERNALIZATION; GRANULOCYTES; PHAGOCYTOSIS; ENDOCARDITIS; REPERTOIRES; PERSISTERS	Staphylococcus aureus is considered to be an extracellular pathogen. However, survival of S. aureus within host cells may provide a reservoir relatively protected from antibiotics, thus enabling long-term colonization of the host and explaining clinical failures and relapses after antibiotic therapy. Here we confirm that intracellular reservoirs of S. aureus in mice comprise a virulent subset of bacteria that can establish infection even in the presence of vancomycin, and we introduce a novel therapeutic that effectively kills intracellular S. aureus. This antibody-antibiotic conjugate consists of an anti-S. aureus antibody conjugated to a highly efficacious antibiotic that is activated only after it is released in the proteolytic environment of the phagolysosome. The antibody-antibiotic conjugate is superior to vancomycin for treatment of bacteraemia and provides direct evidence that intracellular S. aureus represents an important component of invasive infections.	[Lehar, Sophie M.; Kajihara, Kimberly K.; Hazenbos, Wouter L.; Morisaki, J. Hiroshi; Tan, Man Wah; Brown, Eric J.; Ariathasan, Sanjeev M.] Genentech Inc, Dept Infect Dis, San Francisco, CA 94080 USA; [Pillow, Thomas; Staben, Leanna; Lyssikatos, Joseph P.; Flygare, John A.] Genentech Inc, Dept Med Chem, San Francisco, CA 94080 USA; [Xu, Min; Kim, Janice; Park, Summer; Yan, Donghong] Genentech Inc, Translat Immunol Dept, San Francisco, CA 94080 USA; [Andlen, Richard V.; DePalatis, Laura; Raab, Helga; Darwish, Martine; Lee, Byoung-Chul; Luis, Elizabeth] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Hernandez, Hilda; Loyet, Kelly M.; Khalfin, Yana] Genentech Inc, Biochem & Cellular Pharmacol Dept, San Francisco, CA 94080 USA; [Lupardus, Patrick; Fong, Rina] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Halouni, Cecile C.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Plise, Emile; Heong, Jonathan C.] Genentech Inc, Drug Metab & Pharmacokinet Dept, San Francisco, CA 94080 USA; [Strandh, Magnus; Koefoed, Klaus; Andersen, Peter S.] Symphogen AS, DK-2750 Ballerup, Denmark	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Symphogen	Brown, EJ (corresponding author), Genentech Inc, Dept Infect Dis, San Francisco, CA 94080 USA.	brown.eric@gene.com; sanj@gene.com	Loyet, Kelly/AAD-7544-2021	Strandh, Magnus/0000-0002-6878-1566	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE))	This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357.	Anwar S, 2009, CLIN EXP IMMUNOL, V157, P216, DOI 10.1111/j.1365-2249.2009.03950.x; Barcia-Macay M, 2006, ANTIMICROB AGENTS CH, V50, P841, DOI 10.1128/AAC.50.3.841-851.2006; Bosse MJ, 2005, J BONE JOINT SURG AM, V87A, P1343, DOI 10.2106/JBJS.D.02649; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BOULLANGER P, 1982, CARBOHYD RES, V110, P153, DOI 10.1016/0008-6215(82)85034-9; Bryskier Andre, 2005, Expert Rev Anti Infect Ther, V3, P505, DOI 10.1586/14787210.3.4.505; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Dubowchik GM, 2002, BIOCONJUGATE CHEM, V13, P855, DOI 10.1021/bc025536j; Fischer R, 2010, BIOCONJUGATE CHEM, V21, P64, DOI 10.1021/bc900301k; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Garzoni C, 2011, EMBO MOL MED, V3, P115, DOI 10.1002/emmm.201100123; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Greenlee-Wacker MC, 2014, J IMMUNOL, V192, P4709, DOI 10.4049/jimmunol.1302692; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Hazenbos WLW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003653; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Johnson LB, 2003, SCAND J INFECT DIS, V35, P782, DOI 10.1080/00365540310016682; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; KAPRAL FA, 1959, J EXP MED, V110, P123, DOI 10.1084/jem.110.1.123; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Kullar R, 2011, CLIN INFECT DIS, V52, P975, DOI 10.1093/cid/cir124; Levin BR, 2004, SCIENCE, V305, P1578, DOI 10.1126/science.1103077; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Meijer Per-Johan, 2009, V525, P261, DOI 10.1007/978-1-59745-554-1_13; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Nannini E, 2010, CURR OPIN PHARMACOL, V10, P516, DOI 10.1016/j.coph.2010.06.006; Nielsen SL, 1999, J ANTIMICROB CHEMOTH, V43, P407, DOI 10.1093/jac/43.3.407; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; ROGERS DE, 1956, J EXP MED, V103, P713, DOI 10.1084/jem.103.6.713; Sandberg A, 2009, ANTIMICROB AGENTS CH, V53, P1874, DOI 10.1128/AAC.01605-07; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Van Duzer J., 2005, RIFAMYCIN ANALOGS US; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; Velasco E, 2006, EUR J CLIN MICROBIOL, V25, P1, DOI 10.1007/s10096-005-0077-8; Venditti M, 2003, HAEMATOLOGICA, V88, P923; Winstel V, 2014, INT J MED MICROBIOL, V304, P215, DOI 10.1016/j.ijmm.2013.10.009; Yoon YK, 2010, J ANTIMICROB CHEMOTH, V65, P1015, DOI 10.1093/jac/dkq050	45	468	490	22	351	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					323	+		10.1038/nature16057	http://dx.doi.org/10.1038/nature16057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26536114				2022-12-28	WOS:000365356800045
J	Kelley, AS; McGarry, K; Gorges, R; Skinner, JS				Kelley, A. S.; McGarry, K.; Gorges, R.; Skinner, J. S.			Health Care Costs for Patients With Dementia at the End of Life	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10								10.7326/P15-9035	http://dx.doi.org/10.7326/P15-9035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26502381				2022-12-28	WOS:000365746400001
J	Sun, JH; O'Boyle, DR; Fridell, RA; Langley, DR; Wang, CF; Roberts, SB; Nower, P; Johnson, BM; Moulin, F; Nophsker, MJ; Wang, YK; Liu, MP; Rigat, K; Tu, Y; Hewawasam, P; Kadow, J; Meanwell, NA; Cockett, M; Lemm, JA; Kramer, M; Belema, M; Gao, M				Sun, Jin-Hua; O'Boyle, Donald R., II; Fridell, Robert A.; Langley, David R.; Wang, Chunfu; Roberts, Susan B.; Nower, Peter; Johnson, Benjamin M.; Moulin, Frederic; Nophsker, Michelle J.; Wang, Ying-Kai; Liu, Mengping; Rigat, Karen; Tu, Yong; Hewawasam, Piyasena; Kadow, John; Meanwell, Nicholas A.; Cockett, Mark; Lemm, Julie A.; Kramer, Melissa; Belema, Makonen; Gao, Min			Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A	NATURE			English	Article							INHIBITOR DACLATASVIR; REPLICATION COMPLEX; VIRUS-REPLICATION; CRYSTAL-STRUCTURE; DOMAIN; PROTEIN; POTENT; ACIDS	It is estimated that more than 170 million people are infected with hepatitis C virus (HCV) worldwide(1,2). Clinical trials have demonstrated that, for the first time in human history, the potential exists to eradicate a chronic viral disease using combination therapies that contain only direct-acting antiviral agents(3). HCV nonstructural protein 5A (NS5A) is a multifunctional protein required for several stages of the virus replication cycle(4). NS5A replication complex inhibitors, exemplified by daclatasvir (DCV; also known as BMS-790052 and Daklinza), belong to the most potent class of direct-acting anti-HCV agents described so far, with in vitro activity in the picomolar (pM) to low nanomolar (nM) range. The potency observed in vitro has translated into clinical efficacy, with HCV RNA declining by similar to 3-4 log(10) in infected patients after administration of single oral doses of DCV. Understanding the exceptional potency of DCV was a key objective of this study. Here we show that although DCV and an NS5A inhibitor analogue (Syn-395) are inactive against certain NS5A resistance variants, combinations of the pair enhance DCV potency by >1,000-fold, restoring activity to the pM range. This synergistic effect was validated in vivo using an HCV-infected chimaeric mouse model. The cooperative interaction of a pair of compounds suggests that NS5A protein molecules communicate with each other: one inhibitor binds to resistant NS5A, causing a conformational change that is transmitted to adjacent NS5As, resensitizing resistant NS5A so that the second inhibitor can act to restore inhibition. This unprecedented synergistic anti-HCV activity also enhances the resistance barrier of DCV, providing additional options for HCV combination therapy and new insight into the role of NS5A in the HCV replication cycle.	[Sun, Jin-Hua; O'Boyle, Donald R., II; Fridell, Robert A.; Wang, Chunfu; Roberts, Susan B.; Nower, Peter; Liu, Mengping; Rigat, Karen; Cockett, Mark; Lemm, Julie A.; Gao, Min] Bristol Myers Squibb Res & Dev, Dept Virol, Wallingford, CT 06492 USA; [Langley, David R.] Bristol Myers Squibb Res & Dev, Comp Assisted Drug Design, Wallingford, CT 06492 USA; [Johnson, Benjamin M.; Moulin, Frederic; Nophsker, Michelle J.; Kramer, Melissa] Bristol Myers Squibb Res & Dev, Pharmaceut Candidate Optimizat, Wallingford, CT 06492 USA; [Wang, Ying-Kai] Bristol Myers Squibb Res & Dev, Leads Discovery & Optimizat, Wallingford, CT 06492 USA; [Tu, Yong; Hewawasam, Piyasena; Kadow, John; Meanwell, Nicholas A.; Belema, Makonen] Bristol Myers Squibb Res & Dev, Discovery Chem, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Gao, M (corresponding author), Bristol Myers Squibb Res & Dev, Dept Virol, 5 Res Pkwy, Wallingford, CT 06492 USA.	Min.Gao@bms.com		Langley, David/0000-0002-0820-3190; Sun, Jin-hua/0000-0003-2813-3633; Meanwell, Nicholas/0000-0002-8857-1515; Moulin, Frederic/0000-0002-4465-5936				Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Everson G. T., 2013, 64 ANN M AASLD; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; He Y., 2006, HEPATITIS C VIRUSES, P267; Hernandez D, 2013, J CLIN VIROL, V57, P13, DOI 10.1016/j.jcv.2012.12.020; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Link JO, 2014, J MED CHEM, V57, P2033, DOI 10.1021/jm401499g; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; McCarville JF, 2013, J HEPATOL, V58, pS491, DOI 10.1016/S0168-8278(13)61210-6; Nagase R, 2006, SYNTHESIS-STUTTGART, P3915, DOI 10.1055/s-2006-950295; Nettles R. E., 2010, 61 ANN M AASLD; O'Boyle DR, 2013, VIROLOGY, V444, P343, DOI 10.1016/j.virol.2013.06.032; Pack S. K., 2015, US patent, Patent No. [9,006,455 B2, 9006455]; Pawlotsky JM, 2013, J HEPATOL, V59, P375, DOI 10.1016/j.jhep.2013.03.030; Pelosi LA, 2012, ANTIMICROB AGENTS CH, V56, P5230, DOI 10.1128/AAC.01209-12; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Reddy LR, 2011, J ORG CHEM, V76, P3409, DOI 10.1021/jo200401a; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SEEBACH D, 1984, TETRAHEDRON, V40, P1313, DOI 10.1016/S0040-4020(01)82417-0; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; St Laurent DR, 2014, J MED CHEM, V57, P1976, DOI 10.1021/jm301796k; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580	28	38	38	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					245	+		10.1038/nature15711	http://dx.doi.org/10.1038/nature15711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26536115				2022-12-28	WOS:000364396700047
J	Redding, S; Sternberg, SH; Marshall, M; Gibb, B; Bhat, P; Guegler, CK; Wiedenheft, B; Doudna, JA; Greene, EC				Redding, Sy; Sternberg, Samuel H.; Marshall, Myles; Gibb, Bryan; Bhat, Prashant; Guegler, Chantal K.; Wiedenheft, Blake; Doudna, Jennifer A.; Greene, Eric C.			Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System	CELL			English	Article							ADAPTIVE BACTERIAL IMMUNITY; SPACER ACQUISITION; RNA; TARGET; INTERFERENCE; DEGRADATION; PROKARYOTES; PROTEIN; MECHANISMS; NUCLEASE	CRISPR-Cas adaptive immune systems protect bacteria and archaea against foreign genetic elements. In Escherichia coli, Cascade (CRISPR-associated complex for antiviral defense) is an RNA-guided surveillance complex that binds foreign DNA and recruits Cas3, a trans-acting nuclease helicase for target degradation. Here, we use single-molecule imaging to visualize Cascade and Cas3 binding to foreign DNA targets. Our analysis reveals two distinct pathways dictated by the presence or absence of a protospacer-adjacent motif (PAM). Binding to a protospacer flanked by a PAM recruits a nuclease-active Cas3 for degradation of short single-stranded regions of target DNA, whereas PAM mutations elicit an alternative pathway that recruits a nuclease-inactive Cas3 through a mechanism that is dependent on the Cas1 and Cas2 proteins. These findings explain how target recognition by Cascade can elicit distinct outcomes and support a model for acquisition of new spacer sequences through a mechanism involving processive, ATP-dependent Cas3 translocation along foreign DNA.	[Redding, Sy] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Sternberg, Samuel H.; Guegler, Chantal K.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bhat, Prashant; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Marshall, Myles; Gibb, Bryan; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Montana State University System; Montana State University Bozeman; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Columbia University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	doudna@berkeley.edu; ecg2108@cumc.columbia.edu	Gibb, Bryan/AAW-5554-2020	Redding, Sy/0000-0003-3463-7985; Sternberg, Samuel/0000-0001-8240-9114; Bhat, Prashant/0000-0003-3832-4871; Gibb, Bryan/0000-0002-2094-344X	NSF; National Defense Science & Engineering Graduate Research Fellowship programs; NIH [GM074739, GM108888]; HHMI Early Career Scientist Award; NSF [MCB-1154511, MCB-1244557]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108888, R01GM074739] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Defense Science & Engineering Graduate Research Fellowship programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Early Career Scientist Award; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alison Marie Smith and Kaihong Zhou for technical assistance and members of the J.A.D. and E.C.G. laboratories for their helpful discussions and critical reading of the manuscript. S.H.S. acknowledges support from the NSF and National Defense Science & Engineering Graduate Research Fellowship programs. Funding was provided by the NIH (GM074739 to E.C.G.; GM108888 to B.W.), an HHMI Early Career Scientist Award (to E.C.G.), and the NSF (MCB-1154511 to E.C.G.; MCB-1244557 to J.A.D.). J.A.D. is an HHMI Investigator.	Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Rutkauskas M., 2015, CELL REP; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	34	119	128	4	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					854	865		10.1016/j.cell.2015.10.003	http://dx.doi.org/10.1016/j.cell.2015.10.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26522594	Green Accepted, Bronze			2022-12-28	WOS:000364829700012
J	Reich, MR; Shibuya, K				Reich, Michael R.; Shibuya, Kenji			The Future of Japan's Health System - Sustaining Good Health with Equity at Low Cost	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Reich, Michael R.] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	Harvard University; Harvard T.H. Chan School of Public Health; University of Tokyo	Reich, MR (corresponding author), Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.			Shibuya, Kenji/0000-0003-2528-7530				Bump JB, 2015, HEALTH SYST REFORM, V1, P28, DOI 10.4161/23288604.2014.991211; Fjeldsted M A, 2015, FUTURE JAPAN REIGNIT; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Ministry of Health Labour and Welfare, 2015, JAP VIS HLTH CAR 203; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2	5	41	41	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1793	1797		10.1056/NEJMp1410676	http://dx.doi.org/10.1056/NEJMp1410676			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3FK	26535509	Green Published			2022-12-28	WOS:000364144000001
J	Vollmer, D; Butt, HJ				Vollmer, Doris; Butt, Hans-Juergen			MATERIALS SCIENCE Droplets leap into action	NATURE			English	Editorial Material							CONTACT TIME		[Vollmer, Doris; Butt, Hans-Juergen] Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society	Vollmer, D (corresponding author), Max Planck Inst Polymer Res, D-55128 Mainz, Germany.	vollmerd@mpip-mainz.mpg.de; butt@mpip-mainz.mpd.de	Butt, Hans-Jürgen/C-4811-2011; Vollmer, Doris/I-3721-2014	Butt, Hans-Jürgen/0000-0001-5391-2618; Vollmer, Doris/0000-0001-9599-5589				Bird JC, 2013, NATURE, V503, P385, DOI 10.1038/nature12740; Boreyko JB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.184501; Bormashenko E., 2013, WETTING REAL SURFACE; Butt HJ, 2014, CURR OPIN COLLOID IN, V19, P343, DOI 10.1016/j.cocis.2014.04.009; Jung S, 2012, P NATL ACAD SCI USA, V109, P16073, DOI 10.1073/pnas.1206121109; Liu YH, 2014, NAT PHYS, V10, P515, DOI [10.1038/nphys2980, 10.1038/NPHYS2980]; Lv JY, 2014, ACS NANO, V8, P3152, DOI 10.1021/nn406522n; Richard D, 2002, NATURE, V417, P811, DOI 10.1038/417811a; Schutzius TM, 2015, NATURE, V527, P82, DOI 10.1038/nature15738	9	3	3	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					41	42		10.1038/527041a	http://dx.doi.org/10.1038/527041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536953	Green Submitted			2022-12-28	WOS:000364270700035
J	Cale, CM				Cale, Cynthia M.			Forensic DNA evidence is not infallible	NATURE			English	Editorial Material									[Cale, Cynthia M.] Univ Indianapolis, Indianapolis, IN 46227 USA; [Cale, Cynthia M.] Strand Diagnost, Indianapolis, IN USA		Cale, CM (corresponding author), Univ Indianapolis, Indianapolis, IN 46227 USA.	ccale@strandlabs.com						vanOorschot RAH, 1997, NATURE, V387, P767, DOI 10.1038/42838	1	7	7	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					611	611		10.1038/526611a	http://dx.doi.org/10.1038/526611a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8ZH	26511542	Bronze			2022-12-28	WOS:000363832100004
J	Dubilier, N; McFall-Ngai, M; Zhao, LP				Dubilier, Nicole; McFall-Ngai, Margaret; Zhao, Liping			Create a global microbiome effort	NATURE			English	Editorial Material									[Dubilier, Nicole] Max Planck Inst Marine Microbiol, Bremen, Germany; [McFall-Ngai, Margaret] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Zhao, Liping] Shanghai Jiao Tong Univ, Microbiol, Shanghai 200030, Peoples R China	Max Planck Society; University of Hawaii System; University of Hawaii Manoa; Shanghai Jiao Tong University	Dubilier, N (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	ndubilie@mpi-bremen.de	Dubilier, Nicole/I-8203-2018	Dubilier, Nicole/0000-0002-9394-825X				Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Alivisatos AP, 2015, SCIENCE, V350, P507, DOI 10.1126/science.aac8480; Chen W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070837; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Heath-Heckman EAC, 2013, MBIO, V4, DOI 10.1128/mBio.00167-13; La Scola B, 2003, SCIENCE, V299, P2033; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	9	80	98	0	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					631	634		10.1038/526631a	http://dx.doi.org/10.1038/526631a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511562	Bronze			2022-12-28	WOS:000363832100013
J	Mateo, J; Carreira, S; Sandhu, S; Miranda, S; Mossop, H; Perez-Lopez, R; Rodrigues, DN; Robinson, D; Omlin, A; Tunariu, N; Boysen, G; Porta, N; Flohr, P; Gillman, A; Figueiredo, I; Paulding, C; Seed, G; Jain, S; Ralph, C; Protheroe, A; Hussain, S; Jones, R; Elliott, T; McGovern, U; Bianchini, D; Goodall, J; Zafeiriou, Z; Williamson, CT; Ferraldeschi, R; Riisnaes, R; Ebbs, B; Fowler, G; Roda, D; Yuan, W; Wu, YM; Cao, X; Brough, R; Pemberton, H; A'Hern, R; Swain, A; Kunju, LP; Eeles, R; Attard, G; Lord, CJ; Ashworth, A; Rubin, MA; Knudsen, KE; Feng, FY; Chinnaiyan, AM; Hall, E; de Bono, JS				Mateo, J.; Carreira, S.; Sandhu, S.; Miranda, S.; Mossop, H.; Perez-Lopez, R.; Rodrigues, D. Nava; Robinson, D.; Omlin, A.; Tunariu, N.; Boysen, G.; Porta, N.; Flohr, P.; Gillman, A.; Figueiredo, I.; Paulding, C.; Seed, G.; Jain, S.; Ralph, C.; Protheroe, A.; Hussain, S.; Jones, R.; Elliott, T.; McGovern, U.; Bianchini, D.; Goodall, J.; Zafeiriou, Z.; Williamson, C. T.; Ferraldeschi, R.; Riisnaes, R.; Ebbs, B.; Fowler, G.; Roda, D.; Yuan, W.; Wu, Y. -M.; Cao, X.; Brough, R.; Pemberton, H.; A'Hern, R.; Swain, A.; Kunju, L. P.; Eeles, R.; Attard, G.; Lord, C. J.; Ashworth, A.; Rubin, M. A.; Knudsen, K. E.; Feng, F. Y.; Chinnaiyan, A. M.; Hall, E.; de Bono, J. S.			DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRCA MUTATION CARRIERS; POLY(ADP-RIBOSE) POLYMERASE; HOMOLOGOUS RECOMBINATION; MAINTENANCE THERAPY; IONIZING-RADIATION; PARP INHIBITORS; OVARIAN-CANCER; ATM; DAMAGE; SENSITIVITY	BACKGROUND Prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification. We hypothesized that metastatic, castration-resistant prostate cancers with DNA-repair defects would respond to poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibition with olaparib. METHODS We conducted a phase 2 trial in which patients with metastatic, castration-resistant prostate cancer were treated with olaparib tablets at a dose of 400 mg twice a day. The primary end point was the response rate, defined either as an objective response according to Response Evaluation Criteria in Solid Tumors, version 1.1, or as a reduction of at least 50% in the prostate-specific antigen level or a confirmed reduction in the circulating tumor-cell count from 5 or more cells per 7.5 ml of blood to less than 5 cells per 7.5 ml. Targeted next-generation sequencing, exome and transcriptome analysis, and digital polymerase-chain-reaction testing were performed on samples from mandated tumor biopsies. RESULTS Overall, 50 patients were enrolled; all had received prior treatment with docetaxel, 49 (98%) had received abiraterone or enzalutamide, and 29 (58%) had received cabazitaxel. Sixteen of 49 patients who could be evaluated had a response (33%; 95% confidence interval, 20 to 48), with 12 patients receiving the study treatment for more than 6 months. Next-generation sequencing identified homozygous deletions, deleterious mutations, or both in DNA-repair genes - including BRCA1/2, ATM, Fanconi's anemia genes, and CHEK2 - in 16 of 49 patients who could be evaluated (33%). Of these 16 patients, 14 (88%) had a response to olaparib, including all 7 patients with BRCA2 loss (4 with biallelic somatic loss, and 3 with germline mutations) and 4 of 5 with ATM aberrations. The specificity of the biomarker suite was 94%. Anemia (in 10 of the 50 patients [20%]) and fatigue (in 6 [12%]) were the most common grade 3 or 4 adverse events, findings that are consistent with previous studies of olaparib. CONCLUSIONS Treatment with the PARP inhibitor olaparib in patients whose prostate cancers were no longer responding to standard treatments and who had defects in DNA-repair genes led to a high response rate. (Funded by Cancer Research UK and others; ClinicalTrials.gov number, NCT01682772; Cancer Research UK number, CRUK/11/029.)	[Mateo, J.; Carreira, S.; Sandhu, S.; Miranda, S.; Mossop, H.; Perez-Lopez, R.; Rodrigues, D. Nava; Omlin, A.; Tunariu, N.; Boysen, G.; Porta, N.; Flohr, P.; Gillman, A.; Figueiredo, I.; Paulding, C.; Seed, G.; Bianchini, D.; Goodall, J.; Zafeiriou, Z.; Williamson, C. T.; Ferraldeschi, R.; Riisnaes, R.; Ebbs, B.; Fowler, G.; Roda, D.; Yuan, W.; Brough, R.; Pemberton, H.; A'Hern, R.; Swain, A.; Eeles, R.; Attard, G.; Lord, C. J.; Ashworth, A.; Hall, E.; de Bono, J. S.] Inst Canc Res, London, England; [Mateo, J.; Sandhu, S.; Perez-Lopez, R.; Omlin, A.; Tunariu, N.; Bianchini, D.; Zafeiriou, Z.; Ferraldeschi, R.; Roda, D.; Eeles, R.; Attard, G.; de Bono, J. S.] Royal Marsden NHS Fdn Trust, London, England; [McGovern, U.] Univ Coll London Hosp, London, England; [Jain, S.] Queens Univ, Belfast, Antrim, North Ireland; [Ralph, C.] Univ Leeds, Leeds, W Yorkshire, England; [Protheroe, A.] Churchill Hosp, Oxford, England; [Hussain, S.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Jones, R.] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Elliott, T.] Christie Hosp, Manchester, Lancs, England; [Robinson, D.; Wu, Y. -M.; Cao, X.; Kunju, L. P.; Feng, F. Y.; Chinnaiyan, A. M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Rubin, M. A.] Weill Cornell Med Coll, New York, NY USA; [Knudsen, K. E.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; Queens University Belfast; University of Leeds; University of Oxford; University of Liverpool; Beatson Oncology Centre; Christie NHS Foundation Trust; Christie Hospital; University of Michigan System; University of Michigan; Cornell University; Jefferson University	de Bono, JS (corresponding author), Royal Marsden NHS Fdn Trust, Inst Canc Res, Div Clin Studies, Downs Rd, Sutton SM2 5PT, Surrey, England.	johann.de-bono@icr.ac.uk	Lord, Christopher J/B-3295-2012; Mateo, Joaquin/AAG-9213-2019; Mossop, Helen/O-9147-2016; Porta, Nuria/H-4441-2015; Lord, Christopher/AAX-7130-2021; Hussain, Syed/D-3255-2016	Lord, Christopher J/0000-0002-3226-0515; Mossop, Helen/0000-0002-6260-3734; Porta, Nuria/0000-0003-2458-2167; Tunariu, Nina/0000-0001-6656-3699; Boysen, Gunther/0000-0002-7610-6085; Attard, Gerhardt/0000-0002-4811-7983; Rubin, Mark/0000-0002-8321-9950; Perez-Lopez, Raquel/0000-0002-9176-0130; Balmana, Judith/0000-0002-0762-6415; Jones, Robert/0000-0002-2904-6980; A'Hern, Roger/0000-0003-0593-8391; Miranda, Susana/0000-0002-5936-2706; Eeles, Rosalind/0000-0002-3698-6241; Carreira, Suzanne/0000-0002-5077-5379; Ralph, Christy/0000-0001-5581-2987; Hussain, Syed/0000-0003-1552-511X; Sandhu, Shahneen/0000-0002-8660-4475; Hall, Emma/0000-0001-5999-5020; Swain, Amanda/0000-0001-8666-1608; Knudsen, Karen/0000-0002-1301-890X; jain, suneil/0000-0001-7429-4791; Mateo, Joaquin/0000-0001-5336-2548; de Bono, Johann S/0000-0002-2034-595X	Cancer Research UK [C12540/A12829, C12540/A13230, C1491/A9895, C1491/A15955]; Cancer-Prostate Cancer Foundation; National Institute for Health Research; Medical Research Council-Prostate Cancer UK; Swiss Cancer League [BIL KLS-02592-02-2010]; Marie Curie International Incoming Fellowship [625792]; Prostate Cancer UK; AstraZeneca; National Institute for Health Research Cancer Research Network; NATIONAL CANCER INSTITUTE [R01CA182569, P30CA056036] Funding Source: NIH RePORTER; Cancer Research UK [13239, 12829, 13230, 17528, 15007, 8336, 14276] Funding Source: researchfish; Medical Research Council [MR/M003272/1] Funding Source: researchfish; National Institute for Health Research [CL-2008-22-001, NF-SI-0510-10096] Funding Source: researchfish; Public Health Agency [SPI/3315/06] Funding Source: researchfish; Prostate Cancer UK [PG12-49] Funding Source: researchfish; MRC [MR/M003272/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Cancer-Prostate Cancer Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council-Prostate Cancer UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss Cancer League; Marie Curie International Incoming Fellowship(European Commission); Prostate Cancer UK; AstraZeneca(AstraZeneca); National Institute for Health Research Cancer Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Public Health Agency; Prostate Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Cancer Research UK and others; Supported by grants from Cancer Research UK (C12540/A12829, C12540/A13230, C1491/A9895, and C1491/A15955, for trial CRUK/11/029), Stand Up To Cancer-Prostate Cancer Foundation (a Prostate Dream Team Translational Cancer Research Grant), and Prostate Cancer UK. Also supported by grants from Cancer Research UK and the National Institute for Health Research (to the Cancer Research UK Center, the Experimental Cancer Medicine Center, and the Biomedical Research Center of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust), as well as a Medical Research Council-Prostate Cancer UK fellowship (to Dr. Mateo), a grant from the Swiss Cancer League (BIL KLS-02592-02-2010, to Dr. Omlin), and a Marie Curie International Incoming Fellowship (625792, to Dr. Boysen). Dr. Perez-Lopez participated in this work in the Medicine Doctorate framework of Universitat Autonoma de Barcelona. This study was conducted with support from the Investigator-Sponsored Study Collaboration between AstraZeneca and the National Institute for Health Research Cancer Research Network.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1999, NAT GENET, V21, P359, DOI 10.1038/7684; Beamish H, 2002, J BIOL CHEM, V277, P30515, DOI 10.1074/jbc.M203801200; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Castro E, 2013, J CLIN ONCOL, V31, P1748, DOI 10.1200/JCO.2012.43.1882; Ceccaldi R, 2015, CANCER RES, V75, P628, DOI 10.1158/0008-5472.CAN-14-2593; Chao OS, 2014, MOL CANCER RES, V12, P1755, DOI 10.1158/1541-7786.MCR-14-0173; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Ferraldeschi R, 2015, EUR UROL, V67, P795, DOI 10.1016/j.eururo.2014.10.027; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kote-Jarai Z, 2011, BRIT J CANCER, V105, P1230, DOI 10.1038/bjc.2011.383; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Michels J, 2014, ONCOGENE, V33, P3894, DOI 10.1038/onc.2013.352; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; Morris MJ, 2015, J CLIN ONCOL, V33, P1356, DOI 10.1200/JCO.2014.55.3875; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Ong M, 2014, BRIT J CANCER, V111, P828, DOI 10.1038/bjc.2014.350; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sandhu SK, 2013, ANN ONCOL, V24, P1416, DOI 10.1093/annonc/mdt074; Sandhu SK, 2013, LANCET ONCOL, V14, P882, DOI 10.1016/S1470-2045(13)70240-7; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2015, J CLIN ONCOL, V33, P1348, DOI 10.1200/JCO.2014.55.3487; Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Thurn KT, 2013, MOL CANCER THER, V12, P2078, DOI 10.1158/1535-7163.MCT-12-1242; Turenne GA, 2001, ONCOGENE, V20, P5100, DOI 10.1038/sj.onc.1204665	41	1448	1485	2	201	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1697	1708		10.1056/NEJMoa1506859	http://dx.doi.org/10.1056/NEJMoa1506859			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26510020	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000363514100006
J	Wechsler, ME; Yawn, BP; Fuhlbrigge, AL; Pace, WD; Pencina, MJ; Doros, G; Kazani, S; Raby, BA; Lanzillotti, J; Madison, S; Israel, E				Wechsler, Michael E.; Yawn, Barbara P.; Fuhlbrigge, Anne L.; Pace, Wilson D.; Pencina, Michael J.; Doros, Gheorghe; Kazani, Shamsah; Raby, Benjamin A.; Lanzillotti, Jane; Madison, Suzanne; Israel, Elliot		BELT Investigators	Anticholinergic vs Long-Acting beta-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma The BELT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; ADRB2 POLYMORPHISMS; SALMETEROL; EXACERBATIONS; GENOTYPE; TIOTROPIUM; QUESTIONNAIRE; ALBUTEROL; THERAPY; RISK	IMPORTANCE The efficacy and safety of long-acting beta-agonists (LABAs) have been questioned. Black populations may be disproportionately affected by LABA risks. OBJECTIVE To compare the effectiveness and safety of tiotropium vs LABAs, when used with inhaled corticosteroids (ICS) in black adults with asthma and to determine whether allelic variation at the Arg16Gly locus of the beta 2-adrenergic receptor (ADRB2) gene is associated with treatment response. DESIGN, SETTING, AND PARTICIPANTS A multisite (n = 20), open-label, parallel-group, pragmatic randomized clinical trial conducted from March 2011 through July 2013, enrolling black adults with moderate to severe asthma in the United States. INTERVENTIONS Patients eligible for, or receiving, step 3 or step 4 combination therapy per National Heart, Lung, and Blood Institute guidelines, received ICS plus either once-daily tiotropium (n = 532) or twice-daily LABAs (n = 538,) and were followed up for up to 18 months. Patients underwent genotyping, attended study visits at baseline, 1, 6, 12, and 18 months, and completed monthly questionnaires. MAIN OUTCOMES AND MEASURES The primary outcome was time to asthma exacerbation, defined as a worsening asthma event requiring oral or parenteral corticosteroids. Secondary outcomes included patient-reported outcomes (Asthma Quality of Life Questionnaire, Asthma Control Questionnaire [ACQ], Asthma Symptom Utility Index, and Asthma Symptom-Free Days questionnaire), spirometry (FEV1), rescue medication use, asthma deteriorations, and adverse events. RESULTS There was no difference between LABA + ICS vs tiotropium + ICS in time to first exacerbation (mean No. of exacerbations/person-year, 0.42 vs0.37 (rate ratio, 0.90[95% CI, 0.73 to 1.11], log-rank P = .31). There was no difference in change in FEV1 at 12 months (0.003 L for LABA + ICS vs -0.018 L for tiotropium + ICS; between-group difference, 0.020[95% CI, -0.021 to 0.061], P = .33) and at 18 months (-0.053 L vs -0.078 L; between-group difference, 0.025 [95% CI, -0.045 to 0.095], P = .49). There were no differences in ACQ score at 18 months (change in score from baseline, -0.68 for LABA + ICS vs -0.72 for tiotropium + ICS; between-group difference, 0.04 [95% CI, -0.18 to 0.27], P = .70). There were no differences in other patient-reported outcomes. Arg16Gly ADRB2 alleles were not associated with differences in the effects of tiotropium + ICS vs LABA + ICS (hazard ratio for time to first exacerbation, 0.84 [95% CI, 0.47 to 1.51] for Arg/Arg vs0.85 [95% CI, 0.63 to 1.15] for Arg/Gly or Gly/Gly, P = .97). CONCLUSIONS/RELEVANCE Among black adults with asthma treated with ICS, adding a LABA did not improve time to asthma exacerbation compared with adding tiotropium. These findings were not affected by polymorphisms at the Arg16Gly locus of ADRB2. These findings do not support the superiority of LABA + ICS compared with tiotropium + ICS for black patients with asthma.	[Wechsler, Michael E.; Fuhlbrigge, Anne L.; Kazani, Shamsah; Raby, Benjamin A.; Israel, Elliot] Brigham & Womens Hosp, Boston, MA 02115 USA; [Yawn, Barbara P.; Madison, Suzanne] Olmsted Med Ctr, Rochester, MN USA; [Pace, Wilson D.] Univ Colorado, Denver, CO 80202 USA; [Pencina, Michael J.; Doros, Gheorghe; Lanzillotti, Jane] Harvard Clin Res Inst, Boston, MA USA; [Doros, Gheorghe] Boston Univ, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Olmsted Medical Center; University of Colorado System; University of Colorado Denver; Harvard University; Harvard Medical School; Boston University	Israel, E (corresponding author), Brigham & Womens Hosp, Pulm & Crit Care Div, 75 Francis St, Boston, MA 02115 USA.	eisrael@partners.org	Raby, Benjamin/AAK-3866-2021; Wechsler, Michael/AAC-5506-2019	Calhoun, William/0000-0001-7075-712X; , Gheorghe/0000-0001-5524-4721	Agency for Healthcare Research and Quality (AHRQ) [R01HS019408]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS019408] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by grant R01HS019408 from the Agency for Healthcare Research and Quality (AHRQ).	Bailey W, 2008, CURR MED RES OPIN, V24, P1669, DOI 10.1185/03007990802119111; Bime C, 2012, J ALLERGY CLIN IMMUN, V130, P1078, DOI 10.1016/j.jaci.2012.07.058; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Bleecker ER, 2006, J ALLERGY CLIN IMMUN, V118, P809, DOI 10.1016/j.jaci.2006.06.036; Chowdhury BA, 2011, NEW ENGL J MED, V364, P2473, DOI 10.1056/NEJMp1104375; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; Ducharme FM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005535.pub2; Engelkes M, 2015, EUR RESPIR J, V45, P396, DOI 10.1183/09031936.00075614; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Lipworth B, 2013, AM J RESP CRIT CARE, V188, P1386, DOI 10.1164/rccm.201311-1968ED; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Ortega VE, 2014, LANCET RESP MED, V2, P204, DOI 10.1016/S2213-2600(13)70289-3; Peters Jay, 2010, Ann Intern Med, V153, pJC3, DOI 10.7326/0003-4819-153-6-201009210-02005; Peters SP, 2013, J ALLERGY CLIN IMMUN, V132, P1068, DOI 10.1016/j.jaci.2013.08.003; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Rabe KF, 2014, LANCET RESP MED, V2, P44, DOI 10.1016/S2213-2600(13)70248-0; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Spector SL, 2012, J ASTHMA, V49, P70, DOI 10.3109/02770903.2011.633788; Sullivan SD, 2001, CONTROL CLIN TRIALS, V22, P420, DOI 10.1016/S0197-2456(01)00137-4; U.S. Food and Drug Administration, 2015, FDA DRUG SAF COMM FD; von Mutius E, 2010, NEW ENGL J MED, V362, P1042, DOI 10.1056/NEJMe1002058; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wechsler ME, 2011, AM J RESP CRIT CARE, V184, P1247, DOI 10.1164/rccm.201103-0514OC; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6; Yawn BP, 2013, OPEN ACCESS J CLIN T, V5, P23, DOI 10.2147/OAJCT.S38489	34	45	47	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1720	1730		10.1001/jama.2015.13277	http://dx.doi.org/10.1001/jama.2015.13277			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505596	Bronze			2022-12-28	WOS:000363706300021
J	Curchoe, CL				Curchoe, Carol Lynn			The power of mentoring	SCIENCE			English	Editorial Material									[Curchoe, Carol Lynn] 32ATPs, San Diego, CA 92101 USA; [Curchoe, Carol Lynn] EduPaper Prod, London, England		Curchoe, CL (corresponding author), 32ATPs, San Diego, CA 92101 USA.		Curchoe, Carol/AAL-6318-2021						0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					478	478		10.1126/science.350.6259.478	http://dx.doi.org/10.1126/science.350.6259.478			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0NG	26494760				2022-12-28	WOS:000363213400046
J	Cho, HS; Deng, HX; Miyasaka, K; Dong, ZY; Cho, M; Neimark, AV; Kang, JK; Yaghi, OM; Terasaki, O				Cho, Hae Sung; Deng, Hexiang; Miyasaka, Keiichi; Dong, Zhiyue; Cho, Minhyung; Neimark, Alexander V.; Kang, Jeung Ku; Yaghi, Omar M.; Terasaki, Osamu			Extra adsorption and adsorbate superlattice formation in metal-organic frameworks	NATURE			English	Article							POROUS COORDINATION POLYMERS; ULTRAHIGH SURFACE-AREA; X-RAY-DIFFRACTION; MESOPOROUS SILICA; HYDROGEN STORAGE; ARGON ADSORPTION; CRYSTAL; SITES; VISUALIZATION; SORPTION	Metal-organic frameworks (MOFs) have a high internal surface area and widely tunable composition(1,2), which make them useful for applications involving adsorption, such as hydrogen, methane or carbon dioxide storage(3-9). The selectivity and uptake capacity of the adsorption process are determined by interactions involving the adsorbates and their porous host materials. But, although the interactions of adsorbate molecules with the internal MOF surface(10-17) and also amongst themselves within individual pores(18-22) have been extensively studied, adsorbate-adsorbate interactions across pore walls have not been explored. Here we show that local strain in the MOF, induced by pore filling, can give rise to collective and long-range adsorbate-adsorbate interactions and the formation of adsorbate superlattices that extend beyond an original MOF unit cell. Specifically, we use in situ small-angle X-ray scattering to track and map the distribution and ordering of adsorbate molecules in five members of the mesoporous MOF-74 series along entire adsorption-desorption isotherms. We find in all cases that the capillary condensation that fills the pores gives rise to the formation of 'extra adsorption domains'-that is, domains spanning several neighbouring pores, which have a higher adsorbate density than non-domain pores. In the case of one MOF, IRMOF-74-V-hex, these domains form a superlattice structure that is difficult to reconcile with the prevailing view of pore-filling as a stochastic process. The visualization of the adsorption process provided by our data, with clear evidence for initial adsorbate aggregation in distinct domains and ordering before an even distribution is finally reached, should help to improve our understanding of this process and may thereby improve our ability to exploit it practically.	[Cho, Hae Sung; Miyasaka, Keiichi; Cho, Minhyung; Kang, Jeung Ku; Yaghi, Omar M.; Terasaki, Osamu] Korea Adv Inst Sci & Technol, Grad Sch Energy Environm Water & Sustainabil, WCU BK21Plus, Taejon 305701, South Korea; [Deng, Hexiang; Dong, Zhiyue] Wuhan Univ, Coll Chem & Mol Sci, Key Lab Biomed Polymers Minist Educ, Wuhan 430072, Peoples R China; [Deng, Hexiang] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Peoples R China; [Neimark, Alexander V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA; [Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Div Mat Sci, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Yaghi, Omar M.] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Yaghi, Omar M.] King Fahd Univ Petr & Minerals, Dhahran 31261, Saudi Arabia; [Terasaki, Osamu] Stockholm Univ, Berzelii Ctr EXSELENT Porous Mat, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden	Korea Advanced Institute of Science & Technology (KAIST); Wuhan University; Wuhan University; Rutgers State University New Brunswick; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; King Fahd University of Petroleum & Minerals; Stockholm University	Yaghi, OM (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Energy Environm Water & Sustainabil, WCU BK21Plus, Taejon 305701, South Korea.	yaghi@berkeley.edu; terasaki@kaist.ac.kr	Kang, Jeung ku/C-1610-2011; Cho, Hae Sung/F-3889-2018; Neimark, Alexander V./AAH-4463-2020; Deng, Hexiang/N-5616-2017; Terasaki, Osamu/Y-1137-2018; Yaghi, Omar M/C-6749-2013	Cho, Hae Sung/0000-0002-4192-6323; Neimark, Alexander V./0000-0002-3443-0389; Deng, Hexiang/0000-0002-9398-7996; Terasaki, Osamu/0000-0001-5803-0817; Miyasaka, Keiichi/0000-0002-2722-7024; Yaghi, Omar/0000-0002-5611-3325	WCU/BK21+; HIMC of Global Frontier Project - Ministry of Science, ICT and Future Planning [2013M3A6B1078884]; Korea Center for Artificial Photosynthesis; Berzelii Centre EXSELENT on Porous Materials; BASF (Ludwigshafen, Germany); 1000 Talent Plan of China; National Natural Science Foundation of China [21471118]; National Key Basic Research Program of China [2014CB239203]; NSF ERC 'Structured Organic Particulate Systems'	WCU/BK21+; HIMC of Global Frontier Project - Ministry of Science, ICT and Future Planning; Korea Center for Artificial Photosynthesis; Berzelii Centre EXSELENT on Porous Materials; BASF (Ludwigshafen, Germany)(BASF); 1000 Talent Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); NSF ERC 'Structured Organic Particulate Systems'	The authors acknowledge K. Ito, K. Sasaki, M. Kuribayashi and N. Muroyama (Rigaku America and Japan) and K. Nakai (Japan Bel) for technical support; N. Fujita and T. Nishimatsu (Tohoku University, Japan), H. Furukawa and Y. Zhang (University of California at Berkeley, USA) for their input; and A. Sawada (Kyoto University, Japan) for advice in designing the gas cell. Financial support was provided by WCU/BK21+ (to H.S.C., K.M., J.K.K., O.M.Y. and O.T.); HIMC of Global Frontier Project (2013M3A6B1078884) funded by the Ministry of Science, ICT and Future Planning and Korea Center for Artificial Photosynthesis (to J.K.K.); Berzelii Centre EXSELENT on Porous Materials (to O.T.); and BASF (Ludwigshafen, Germany) (to O.M.Y.). H.D. and Z.D. were supported by the 1000 Talent Plan of China, National Natural Science Foundation of China (21471118) and National Key Basic Research Program of China (2014CB239203). A.V.N. acknowledges support from the NSF ERC 'Structured Organic Particulate Systems'.	Bon V, 2014, MICROPOR MESOPOR MAT, V188, P190, DOI 10.1016/j.micromeso.2013.12.024; Bureekaew S, 2010, ANGEW CHEM INT EDIT, V49, P7660, DOI 10.1002/anie.201002259; Deng HX, 2012, SCIENCE, V336, P1018, DOI 10.1126/science.1220131; Dietzel PDC, 2008, EUR J INORG CHEM, P3624, DOI 10.1002/ejic.200701284; Dinca M, 2006, J AM CHEM SOC, V128, P16876, DOI 10.1021/ja0656853; Farha OK, 2010, NAT CHEM, V2, P944, DOI [10.1038/nchem.834, 10.1038/NCHEM.834]; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Gor GY, 2013, LANGMUIR, V29, P8601, DOI 10.1021/la401513n; Holst JR, 2010, ADV MATER, V22, P5212, DOI 10.1002/adma.201002440; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Lin LC, 2013, ANGEW CHEM INT EDIT, V52, P4410, DOI 10.1002/anie.201300446; Makal TA, 2012, CHEM SOC REV, V41, P7761, DOI 10.1039/c2cs35251f; Marra GL, 1997, J PHYS CHEM B, V101, P10653, DOI 10.1021/jp971747n; Miyasaka K, 2009, J PHYS CHEM C, V113, P791, DOI 10.1021/jp810368h; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Muroyama N, 2008, J PHYS CHEM C, V112, P10803, DOI 10.1021/jp800385t; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Petricek V., 2006, CRYSTALLINE MAT, V229, P345; Rabone J, 2010, SCIENCE, V329, P1053, DOI 10.1126/science.1190672; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Rowsell JLC, 2005, SCIENCE, V309, P1350, DOI 10.1126/science.1113247; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Scherb C, 2010, J MATER CHEM, V20, P3046, DOI 10.1039/b916953a; Serre C, 2007, SCIENCE, V315, P1828, DOI 10.1126/science.1137975; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Yang SH, 2012, NAT CHEM, V4, P887, DOI [10.1038/nchem.1457, 10.1038/NCHEM.1457]; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	30	164	167	34	851	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					503	U193		10.1038/nature15734	http://dx.doi.org/10.1038/nature15734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26550825				2022-12-28	WOS:000365352500045
J	Fox, JM; Long, F; Edeling, MA; Lin, H; van Duijl-Richter, MKS; Fong, RH; Kahle, KM; Smit, JM; Jin, J; Simmons, G; Doranz, BJ; Crowe, JE; Fremont, DH; Rossmann, MG; Diamond, MS				Fox, Julie M.; Long, Feng; Edeling, Melissa A.; Lin, Hueylie; van Duijl-Richter, Mareike K. S.; Fong, Rachel H.; Kahle, Kristen M.; Smit, Jolanda M.; Jin, Jing; Simmons, Graham; Doranz, Benjamin J.; Crowe, James E., Jr.; Fremont, Daved H.; Rossmann, Michael G.; Diamond, Michael S.			Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress	CELL			English	Article							CHIKUNGUNYA VIRUS-INFECTION; HUMAN MONOCLONAL-ANTIBODIES; MOUSE MODEL; GLYCOPROTEIN ORGANIZATION; ARTHRITIS; MICROSCOPY; MYOSITIS; THERAPY; DISEASE; PROTEIN	We screened a panel of mouse and human monoclonal antibodies (MAbs) against chikungunya virus and identified several with inhibitory activity against multiple alphaviruses. Passive transfer of broadly neutralizing MAbs protected mice against infection by chikungunya, Mayaro, and O'nyong'nyong alphaviruses. Using alanine-scanning mutagenesis, loss-of-function recombinant proteins and viruses, and multiple functional assays, we determined that broadly neutralizing MAbs block multiple steps in the viral lifecycle, including entry and egress, and bind to a conserved epitope on the B domain of the E2 glycoprotein. A 16 angstrom resolution cryo-electron microscopy structure of a Fab fragment bound to CHIKV E2 B domain provided an explanation for its neutralizing activity. Binding to the B domain was associated with repositioning of the A domain of E2 that enabled cross-linking of neighboring spikes. Our results suggest that B domain antigenic determinants could be targeted for vaccine or antibody therapeutic development against multiple alphaviruses of global concern.	[Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Fox, Julie M.; Lin, Hueylie; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Edeling, Melissa A.; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA; [Long, Feng; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [van Duijl-Richter, Mareike K. S.; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands; [Fong, Rachel H.; Kahle, Kristen M.; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA 19104 USA; [Jin, Jing; Simmons, Graham] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Microbiol, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Immunol, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Nashville, TN 37235 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Groningen; Vitalant; Vitalant Research Institute; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	diamond@wusm.wustl.edu	Diamond, Michael/AAH-1733-2019; Fox, Julie/GLQ-8895-2022; Crowe, James/B-5549-2009; Simmons, Graham/G-3523-2012	Diamond, Michael/0000-0002-8791-3165; Crowe, James/0000-0002-0049-1079; Simmons, Graham/0000-0002-9615-7023; Fox, Julie/0000-0003-0567-738X; Jin, Jing/0000-0003-3994-8600; Fremont, Daved/0000-0002-8544-2689	National Institutes of Health (NIH) [R01 AI095366, R01 AI089591, HHSN272200900055C, T32 AI007172, R01 AI114816]; Dutch Organization for Scientific Research (NWO-Earth and Life Sciences); University Medical Center Groningen; NRSA-Infectious Diseases training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, R01AI089591, R01AI114816, R01AI095366] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Organization for Scientific Research (NWO-Earth and Life Sciences)(Netherlands Organization for Scientific Research (NWO)); University Medical Center Groningen; NRSA-Infectious Diseases training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants R01 AI095366 (M.G.R.), R01 AI089591 (M.S.D.), HHSN272200900055C (B.J.D.), T32 AI007172 (J.M.F.), and R01 AI114816 (J.E.C. and M.S.D.); the Dutch Organization for Scientific Research (NWO-Earth and Life Sciences) (J.M.S.); the University Medical Center Groningen (M.K.S.v. D.-.R.); and a NRSA-Infectious Diseases training grant (J.M.F.). The authors thank S. Johnson (MacroGenics) and G. Sapparapu (Vanderbilt University) for providing purified MAbs, R. Tesh for providing many of the alphaviruses used in this study, P. Pal for the initial cross-reactivity studies, and K. O'Brien and N. DiStasio for technical assistance with mutant E2 protein production and epitope mapping. J.E.C. and M.S.D. have been consultants for Sanofi-Pasteur, which has an agreement with Vanderbilt University to evaluate antibody-based therapeutics against CHIKV. R.H.F, K.M.K, and B.J.D. are employees of Integral Molecular, and B.J.D. is a shareholder of Integral Molecular.	BLACKBURN NK, 1995, RES VIROLOGY, V146, P69, DOI 10.1016/0923-2516(96)80591-7; CHENG RH, 1995, CELL, V80, P621; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14; Fric J, 2013, J INFECT DIS, V207, P319, DOI 10.1093/infdis/jis674; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004; Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213; Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137; Kimoto K, 2003, ULTRAMICROSCOPY, V96, P219, DOI 10.1016/S0304-3991(03)00020-2; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006; Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Pal P, 2014, J VIROL, V88, P8213, DOI 10.1128/JVI.01032-14; Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099; Porta J, 2014, J VIROL, V88, P9616, DOI 10.1128/JVI.01286-14; PORTERFIELD J, 1961, B WORLD HEALTH ORGAN, V24, P735; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Seymour RL, 2013, AM J TROP MED HYG, V88, P1170, DOI 10.4269/ajtmh.12-0674; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; VRATI S, 1988, VIROLOGY, V162, P346, DOI 10.1016/0042-6822(88)90474-6; Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157; WUST CJ, 1987, P SOC EXP BIOL MED, V184, P56; Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013	38	120	126	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1095	1107		10.1016/j.cell.2015.10.050	http://dx.doi.org/10.1016/j.cell.2015.10.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26553503	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000366044700010
J	Iacobucci, G				Iacobucci, Gareth			INVESTIGATION General practice commissioning: in whose interests?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						House of Commons Committee of Public Accounts, 2014, OUT OF HOURS GP SERV, pHC583; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1569; NHS England, MAN CONFL INT STAT G	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2015	351								h6000	10.1136/bmj.h6000	http://dx.doi.org/10.1136/bmj.h6000			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4FX	26556820	Bronze			2022-12-28	WOS:000364947900013
J	Wardlaw, JM; Davies, H; Booth, TC; Laurie, G; Compston, A; Freeman, C; Leach, MO; Waldman, AD; Lomas, DJ; Kessler, K; Crabbe, F; Jackson, A				Wardlaw, J. M.; Davies, H.; Booth, T. C.; Laurie, G.; Compston, A.; Freeman, C.; Leach, M. O.; Waldman, A. D.; Lomas, D. J.; Kessler, K.; Crabbe, F.; Jackson, A.			Acting on incidental findings in research imaging	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WHOLE-BODY MRI; HEALTHY-VOLUNTEERS; CONSEQUENCES; MANAGEMENT; FREQUENCY		[Wardlaw, J. M.] Univ Edinburgh, Div Neuroimaging Sci, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Davies, H.] Hlth Res Author, London, England; [Booth, T. C.] Kings Coll Hosp NHS Fdn Trust, Dept Neuroradiol, London, England; [Laurie, G.] Univ Edinburgh, JK Mason Inst Med Life Sci & Law, Sch Law, Edinburgh EH8 9YL, Midlothian, Scotland; [Compston, A.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England; [Freeman, C.] Royal Coll Psychiatrists, Coll Ctr Qual Improvement, London SW1X 8PG, England; [Leach, M. O.] Inst Canc Res, Canc Res UK Canc Imaging Ctr, London SW3 6JB, England; [Leach, M. O.] Royal Marsden Hosp, London SW3 6JJ, England; [Waldman, A. D.] Univ London Imperial Coll Sci Technol & Med, Dept Imaging, London, England; [Lomas, D. J.] Univ Cambridge, Dept Radiol, Cambridge CB2 1TN, England; [Lomas, D. J.] Addenbrookes Hosp, Cambridge, England; [Kessler, K.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Crabbe, F.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland; [Jackson, A.] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester M13 9PL, Lancs, England	University of Edinburgh; King's College Hospital NHS Foundation Trust; University of Edinburgh; University of Cambridge; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Imperial College London; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Aston University; University of Glasgow; University of Manchester	Wardlaw, JM (corresponding author), Univ Edinburgh, Div Neuroimaging Sci, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	wardlaw@ed.ac.uk	leach, martin o/C-2248-2008; Wardlaw, Joanna M/Y-3456-2019; Hernandez, María/GYU-3543-2022	leach, martin o/0000-0002-0756-5368; Wardlaw, Joanna M/0000-0002-9812-6642; Laurie, Graeme/0000-0002-1571-8272; Kessler, Klaus/0000-0001-7307-9539; LOMAS, David/0000-0003-2904-8617; Waldman, Adam D/0000-0003-4398-6431; JACKSON, ALAN/0000-0002-1623-0383	Cancer Research UK [16464, 18097, 16465] Funding Source: researchfish; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162] Funding Source: researchfish; ESRC [ES/F028180/1] Funding Source: UKRI; MRC [MR/J001953/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; [Anonymous], 2008, NEW SCI; [Anonymous], 2011, RSNA NEWS; Belsky L, 2004, BRIT MED J, V328, P1494, DOI 10.1136/bmj.328.7454.1494; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; Booth TC, 2012, CLIN RADIOL, V67, P411, DOI 10.1016/j.crad.2011.09.014; Booth TC, 2012, BRIT J RADIOL, V85, P11, DOI 10.1259/bjr/73283917; Booth TC, 2010, BRIT J RADIOL, V83, P456, DOI 10.1259/bjr/15877332; Brown M, 2010, ATTITUDES PARTICIPAT; Cramer SC, 2011, NEUROIMAGE, V55, P1020, DOI 10.1016/j.neuroimage.2010.11.091; Ding A, 2011, RADIOL CLIN N AM, V49, P257, DOI 10.1016/j.rcl.2010.11.004; Farrar J, 2014, LANCET, V383, P1954, DOI 10.1016/S0140-6736(14)60545-6; Furtado CD, 2005, RADIOLOGY, V237, P385, DOI 10.1148/radiol.2372041741; Hartwigsen G, 2010, J COMPUT ASSIST TOMO, V34, P596, DOI 10.1097/RCT.0b013e3181d9c2bb; Hayward R, 2003, BRIT MED J, V326, P1273, DOI 10.1136/bmj.326.7401.1273; Hegenscheid K, 2013, EUR RADIOL, V23, P816, DOI 10.1007/s00330-012-2636-6; Heinemann T, 2009, KLIN NEURORADIOL, V19, P108; Illes J, 2008, NEUROLOGY, V70, P384, DOI 10.1212/01.wnl.0000280469.17461.94; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Illes J, 2004, J MAGN RESON IMAGING, V20, P743, DOI 10.1002/jmri.20180; Illes J, 2008, J LAW MED ETHICS, V36, P298, DOI 10.1111/j.1748-720X.2008.00273.x; Jackson A, 2007, IMAGING MANAGEMENT; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kirschen MP, 2006, J MAGN RESON IMAGING, V23, P205, DOI 10.1002/jmri.20499; Lo Gladys G., 2008, Hong Kong Medical Journal, V14, P90; Looney AT, 2014, SURG-J R COLL SURG E, V12, P301, DOI 10.1016/j.surge.2013.08.004; Lumbreras B, 2014, CLIN IMAG, V38, P249, DOI 10.1016/j.clinimag.2013.12.018; MacHaalany J, 2009, J AM COLL CARDIOL, V54, P1533, DOI 10.1016/j.jacc.2009.06.026; Mason JK, 2010, MASON M SMITHS LAW M, P122; Medical Research Council, 2014, FRAM FEEDB HLTH REL; Miller FG, 2008, J LAW MED ETHICS, V36, P271, DOI 10.1111/j.1748-720X.2008.00269.x; Milstein AC, 2008, J LAW MED ETHICS, V36, P356, DOI 10.1111/j.1748-720X.2008.00280.x; Morin SHX, 2009, EUR J RADIOL, V72, P529, DOI 10.1016/j.ejrad.2008.08.006; Morris Zoe, 2009, BMJ, V339, pb3016, DOI 10.1136/bmj.b3016; Orme NM, 2010, ARCH INTERN MED, V170, P1525, DOI 10.1001/archinternmed.2010.317; Pickard JD, 2005, NATURE, V435, P17, DOI 10.1038/435017a; Pinato DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049814; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Gonzalez DR, 2010, EUR RADIOL, V20, P1896, DOI 10.1007/s00330-010-1745-3; Sadatsafavi M, 2010, VALUE HEALTH, V13, P761, DOI 10.1111/j.1524-4733.2010.00755.x; Sandeman EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071467; Schaaf WE, 2014, ABDOM IMAGING, V39, P657, DOI 10.1007/s00261-014-0086-0; Schmidt CO, 2013, EUR RADIOL, V23, P1343, DOI 10.1007/s00330-012-2723-8; Siddiki H, 2008, J LAW MED ETHICS, V36, P320, DOI 10.1111/j.1748-720X.2008.00276.x; Sierink JC, 2014, INJURY, V45, P840, DOI 10.1016/j.injury.2013.10.009; Stone JH, 2006, NEW ENGL J MED, V354, P2748, DOI 10.1056/NEJMp058264; The Royal College of Radiologists, 2011, MAN INC FIND DET RES; UK Biobank, 2013, BIOB UK IM SUBST INC; UK Biobank Ethics and Governance Council, 2013, ANN REV; van der Lugt A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3107; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vogel-Claussen J, 2009, J COMPUT ASSIST TOMO, V33, P752, DOI 10.1097/RCT.0b013e318196bf2e; Warlow C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1940; Wellcome Trust Medical Research Council Opinion Leader, 2012, ASS PUBL ATT HLTH RE; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Woodward CI, 2009, CLIN RADIOL, V64, P951, DOI 10.1016/j.crad.2009.04.010	56	27	27	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2015	351								h5190	10.1136/bmj.h5190	http://dx.doi.org/10.1136/bmj.h5190			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4FR	26556813	Green Accepted			2022-12-28	WOS:000364947300001
J	Griffin, DM; Hoffman, DS; Strick, PL				Griffin, Darcy M.; Hoffman, Donna S.; Strick, Peter L.			Corticomotoneuronal cells are "functionally tuned"	SCIENCE			English	Article							PRIMARY MOTOR CORTEX; MUSCLE	Corticomotoneuronal (CM) cells in the primary motor cortex (M1) have monosynaptic connections with motoneurons. They are one of the few sources of descending commands that directly influence motor output. We examined the contribution of CM cells to the generation of activity in their target muscles. The preferred direction of many CM cells differed from that of their target muscles. Some CM cells were selectively active when a muscle was used as an agonist. Others were selectively active when the same muscle was used as a synergist, fixator, or antagonist. These observations suggest that the different functional uses of a muscle are generated by separate populations of CM cells. We propose that muscle function is one of the dimensions represented in the output of M1.	[Griffin, Darcy M.; Hoffman, Donna S.; Strick, Peter L.] Univ Pittsburgh, Inst Brain, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Griffin, Darcy M.; Hoffman, Donna S.; Strick, Peter L.] Syst Neurosci Inst, Pittsburgh, PA USA; [Griffin, Darcy M.; Hoffman, Donna S.; Strick, Peter L.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Hoffman, Donna S.; Strick, Peter L.] Dept Vet Affairs Med Ctr, Res Serv, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Strick, PL (corresponding author), Univ Pittsburgh, Inst Brain, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA.	strickp@pitt.edu			Department of Veterans Affairs; Medical Research Service; NIH [R01NS24328, P30NS076405, FNS070366A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS070366, P30NS076405, R01NS024328] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Medical Research Service; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Dum for surgical assistance; M. Watach and K. Thiel for technical assistance; K. Reinert for statistical assistance; and M. Page (Great Island Software, Chatham, MA) and S. Hoffman (Reflective Computing, Olympia, WA) for development of custom computer programs. This work was supported by funds from the Department of Veterans Affairs, Medical Research Service (P.L.S.) and NIH grants R01NS24328 (P.L.S.), P30NS076405 (P.L.S.), and FNS070366A (D.M.G.). The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The supplementary materials contain additional data. All other data are available upon request from the corresponding author.	FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; HOFFMAN DS, 1986, BRAIN RES, V367, P287, DOI 10.1016/0006-8993(86)91604-5; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106	6	55	55	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					667	670		10.1126/science.aaa8035	http://dx.doi.org/10.1126/science.aaa8035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542568	Green Accepted			2022-12-28	WOS:000364162800047
J	Martiny, JBH; Jones, SE; Lennon, JT; Martiny, AC				Martiny, Jennifer B. H.; Jones, Stuart E.; Lennon, Jay T.; Martiny, Adam C.			Microbiomes in light of traits: A phylogenetic perspective	SCIENCE			English	Review							PHOSPHATE ACQUISITION GENES; HUMAN SKIN MICROBIOME; PROCHLOROCOCCUS ECOTYPES; COMMUNITY ECOLOGY; ESCHERICHIA-COLI; GUT MICROBIOME; ENVIRONMENTAL GRADIENTS; LITTER DECOMPOSITION; TAXONOMIC RESOLUTION; MARINE SYNECHOCOCCUS	A focus on the phenotypic characteristics of microorganisms-their traits-offers a path for interpreting the growing amount of microbiome data. We review key aspects of microbial traits, as well as approaches used to assay their phylogenetic distribution. Recent studies reveal that microbial traits are differentially conserved across the tree of life and appear to be conserved in a hierarchical fashion, possibly linked to their biochemical complexity. These results suggest a predictive framework whereby the genetic (or taxonomic) resolution of microbiome variation among samples provides information about the traits under selection. The organizational parallels seen among human and free-living microbiomes seem to support this idea. Developments in this framework may offer predictions not only for how microbial composition responds to changing environmental conditions, but also for how these changes may alter the health or functioning in human, engineered, and environmental systems.	[Martiny, Jennifer B. H.; Martiny, Adam C.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Jones, Stuart E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Lennon, Jay T.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Martiny, Adam C.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA	University of California System; University of California Irvine; University of Notre Dame; Indiana University System; Indiana University Bloomington; University of California System; University of California Irvine	Martiny, JBH (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	jmartiny@uci.edu	Lennon, Jay T./ABE-6120-2020; Martiny, Jennifer/AAB-9323-2019; Martiny, Adam/AAC-4459-2019; Jones, Stuart/ABD-5264-2021	Lennon, Jay T./0000-0003-3126-6111; Martiny, Adam/0000-0003-2829-4314; Jones, Stuart/0000-0003-4740-6721; Martiny, Jennifer/0000-0002-2415-1247	National Science Foundation [DEB-1442230, DEB-144246, OCE-1332740, OCE-1046297]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research (BER) [DE-PS02-09ER09-25]; U.S. Army Research Office [W911NF-14-1-0411]	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE)); U.S. Army Research Office	We thank S. Allison and K. Whiteson for helpful discussions and comments. This work was supported by the National Science Foundation (DEB-1442230, DEB-144246, OCE-1332740, OCE-1046297); the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research (BER), under Award no. DE-PS02-09ER09-25; and the U.S. Army Research Office (W911NF-14-1-0411).	Agrawal A.A., 2010, EVOLUTION DARWIN 1 1, P243; Allen JP, 2014, TRENDS MICROBIOL, V22, P168, DOI 10.1016/j.tim.2014.02.013; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Amend AS, 2016, ISME J, V10, P109, DOI 10.1038/ismej.2015.96; Amend AS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00109; BENNETT AF, 1992, EVOLUTION, V46, P16, DOI 10.1111/j.1558-5646.1992.tb01981.x; Berlemont R, 2015, APPL ENVIRON MICROB, V81, P1513, DOI 10.1128/AEM.03718-14; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Curtis T, 2013, MICROB BIOTECHNOL, V6, P3, DOI 10.1111/1751-7915.12014; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edwards KF, 2013, ECOLOGY, V94, P1626, DOI 10.1890/12-1459.1; Eiler A, 2014, ENVIRON MICROBIOL, V16, P2682, DOI 10.1111/1462-2920.12301; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Falconer DS, 1996, INTRO QUANTITATIVE G; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00614; Fike DA, 2008, ISME J, V2, P749, DOI 10.1038/ismej.2008.39; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Koeppel AF, 2012, FEMS MICROBIOL ECOL, V81, P574, DOI 10.1111/j.1574-6941.2012.01387.x; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Li T, 2008, ENVIRON MICROBIOL, V10, P580, DOI 10.1111/j.1462-2920.2007.01478.x; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lomas MW, 2014, P NATL ACAD SCI USA, V111, P17540, DOI 10.1073/pnas.1420760111; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Mazard S, 2012, ENVIRON MICROBIOL, V14, P372, DOI 10.1111/j.1462-2920.2011.02514.x; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Olden JD, 2006, ECOL MONOGR, V76, P25, DOI 10.1890/05-0330; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; PECK HD, 1982, PHILOS T R SOC B, V298, P443, DOI 10.1098/rstb.1982.0091; Peralta AL, 2014, FRONT ECOL ENVIRON, V12, P524, DOI 10.1890/130308; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Philippot L, 2009, ENVIRON MICROBIOL, V11, P3096, DOI 10.1111/j.1462-2920.2009.02014.x; Placella SA, 2012, P NATL ACAD SCI USA, V109, P10931, DOI 10.1073/pnas.1204306109; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Prosser JI, 2015, NAT REV MICROBIOL, V13, P439, DOI 10.1038/nrmicro3468; RATKOWSKY DA, 1982, J BACTERIOL, V149, P1; Reed HE, 2013, ISME J, V7, P868, DOI 10.1038/ismej.2012.154; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; Sabarly V, 2011, J EVOLUTION BIOL, V24, P1559, DOI 10.1111/j.1420-9101.2011.02287.x; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Stetter KO, 1999, FEBS LETT, V452, P22, DOI 10.1016/S0014-5793(99)00663-8; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Talbot JM, 2015, SOIL BIOL BIOCHEM, V88, P441, DOI 10.1016/j.soilbio.2015.05.006; Tetart F, 1996, J MOL BIOL, V258, P726, DOI 10.1006/jmbi.1996.0281; TORRIANIGORINI A, 1994, PHOSPHATE MICROORGAN; Treseder KK, 2014, ECOL LETT, V17, P1086, DOI 10.1111/ele.12311; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Venail PA, 2014, J ECOL, V102, P1288, DOI 10.1111/1365-2745.12271; Venail PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072561; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wallenstein MD, 2012, BIOGEOCHEMISTRY, V109, P35, DOI 10.1007/s10533-011-9641-8; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhang Wei, 2014, Int J Bioinform Res Appl, V10, P461, DOI 10.1504/IJBRA.2014.062995; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zwart JA, 2015, ECOLOGY, V96, P2257, DOI 10.1890/14-2102.1; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	101	387	391	24	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261							aac9323	10.1126/science.aac9323	http://dx.doi.org/10.1126/science.aac9323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542581				2022-12-28	WOS:000364162800040
J	Abeshouse, A; Ahn, J; Akbani, R; Ally, A; Amin, S; Andry, CD; Annala, M; Aprikian, A; Armenia, J; Arora, A; Auman, JT; Balasundaram, M; Balu, S; Barbieri, CE; Bauer, T; Benz, CC; Bergeron, A; Beroukhim, R; Berrios, M; Bivol, A; Bodenheimer, T; Boice, L; Bootwalla, MS; dos Reis, RB; Boutros, PC; Bowen, J; Bowlby, R; Boyd, J; Bradley, RK; Breggia, A; Brimo, F; Bristow, CA; Brooks, D; Broom, BM; Bryce, AH; Bubley, G; Burks, E; Butterfield, YSN; Button, M; Canes, D; Carlotti, CG; Carlsen, R; Carmel, M; Carroll, PR; Carter, SL; Cartun, R; Carver, BS; Chan, JM; Chang, MT; Chen, Y; Cherniack, AD; Chevalier, S; Chin, L; Cho, J; Chu, A; Chuah, E; Chudamani, S; Cibulskis, K; Ciriello, G; Clarke, A; Cooperberg, MR; Corcoran, NM; Costello, AJ; Cowan, J; Crain, D; Curley, E; David, K; Demchok, JA; Demichelis, F; Dhalla, N; Dhir, R; Doueik, A; Drake, B; Dvinge, H; Dyakova, N; Felau, I; Ferguson, ML; Frazer, S; Freedland, S; Fu, Y; Gabriel, SB; Gao, JJ; Gardner, J; Gastier-Foster, JM; Gehlenborg, N; Gerken, M; Gerstein, MB; Getz, G; Godwin, AK; Gopalan, A; Graefen, M; Graim, K; Gribbin, T; Guin, R; Gupta, M; Hadjipanayis, A; Haider, S; Hamel, L; Hayes, DN; Heiman, DI; Hess, J; Hoadley, KA; Holbrook, AH; Holt, RA; Holway, A; Hovens, CM; Hoyle, AP; Huang, M; Hutter, CM; Ittmann, M; Iype, L; Jefferys, SR; Jones, CD; Jones, SJM; Juhl, H; Kahles, A; Kane, CJ; Kasaian, K; Kerger, M; Khurana, E; Kim, J; Klein, RJ; Kucherlapati, R; Lacombe, L; Ladanyi, M; Lai, PH; Laird, PW; Lander, ES; Latour, M; Lawrence, MS; Lau, K; LeBien, T; Lee, D; Lee, S; Lehmann, KV; Leraas, KM; Leshchiner, I; Leung, R; Libertino, JA; Lichtenberg, TM; Lin, P; Linehan, WM; Ling, S; Lippman, SM; Liu, J; Liu, W; Lochovsky, L; Loda, M; Logothetis, C; Lolla, L; Longacre, T; Lu, YL; Luo, JH; Ma, Y; Mahadeshwar, HS; Mallery, D; Mariamidze, A; Marra, MA; Mayo, M; McCall, S; McKercher, G; Meng, S; Mes-Masson, AM; Merino, MJ; Meyersson, M; Mieczkowski, PA; Mills, GB; Shaw, KRM; Minner, S; Moinzadeh, A; Moore, RA; Morris, S; Morrison, C; Mose, LE; Mungall, AJ; Murray, BA; Myers, JB; Naresh, R; Nelson, J; Nelson, MA; Nelson, PS; Newton, Y; Noble, MS; Noushmehr, H; Nykter, M; Pantazi, A; Parfenov, M; Park, PJ; Parker, JS; Paulauskis, J; Penny, R; Perou, CM; Piche, A; Pihl, T; Pinto, PA; Prandi, D; Protopopov, A; Ramirez, NC; Rao, A; Rathmell, WK; Ratsch, G; Ren, XJ; Reuter, VE; Reynolds, SM; Rhie, SK; Rieger-Christ, K; Roach, J; Robertson, AG; Robinson, B; Rubin, MA; Saad, F; Sadeghi, S; Saksena, G; Saller, C; Salner, A; Sanchez-Vega, F; Sander, C; Sandusky, G; Sauter, G; Sboner, A; Scardino, PT; Scarlata, E; Schein, JE; Schlomm, T; Schmidt, LS; Schultz, N; Schumacher, SE; Seidman, J; Neder, L; Seth, S; Sharp, A; Shelton, C; Shelton, T; Shen, H; Shen, RL; Sherman, M; Sheth, M; Shi, Y; Shih, J; Shmulevich, I; Simko, J; Simon, R; Simons, JV; Sipahimalani, P; Skelly, T; Sofia, HJ; Soloway, MG; Song, XZ; Sorcini, A; Sougnez, C; Stepa, S; Stewart, C; Stewart, J; Stuart, JM; Sullivan, TB; Sun, C; Sun, HD; Tam, A; Tan, DH; Tang, JB; Tarnuzzer, R; Tarvin, K; Taylor, BS; Teebagy, P; Tenggara, I; Tetu, B; Tewari, A; Thiessen, N; Thompson, T; Thorne, LB; Tirapelli, DP; Tomlins, SA; Trevisan, FA; Troncoso, P; True, LD; Tsourlakis, MC; Tyekucheva, S; Van Allen, E; Van den Berg, DJ; Veluvolu, U; Verhaak, R; Vocke, CD; Voet, D; Wan, YH; Wang, QG; Wang, WY; Wang, ZN; Weinhold, N; Weinstein, JN; Weisenberger, DJ; Wilkerson, MD; Wise, L; Witte, J; Wu, CC; Wu, JY; Wu, Y; Xu, AW; Yadav, SS; Yang, LM; Yang, LX; Yau, C; Ye, HH; Yena, P; Zeng, T; Zenklusen, JC; Zhang, HL; Zhang, JH; Zhang, JS; Zhang, W; Zhong, Y; Zhu, K; Zmuda, E				Abeshouse, Adam; Ahn, Jaeil; Akbani, Rehan; Ally, Adrian; Amin, Samirkumar; Andry, Christopher D.; Annala, Matti; Aprikian, Armen; Armenia, Joshua; Arora, Arshi; Auman, J. Todd; Balasundaram, Miruna; Balu, Saianand; Barbieri, Christopher E.; Bauer, Thomas; Benz, Christopher C.; Bergeron, Alain; Beroukhim, Rameen; Berrios, Mario; Bivol, Adrian; Bodenheimer, Tom; Boice, Lori; Bootwalla, Moiz S.; dos Reis, Rodolfo Borges; Boutros, Paul C.; Bowen, Jay; Bowlby, Reanne; Boyd, Jeffrey; Bradley, Robert K.; Breggia, Anne; Brimo, Fadi; Bristow, Christopher A.; Brooks, Denise; Broom, Bradley M.; Bryce, Alan H.; Bubley, Glenn; Burks, Eric; Butterfield, Yaron S. N.; Button, Michael; Canes, David; Carlotti, Carlos G.; Carlsen, Rebecca; Carmel, Michel; Carroll, Peter R.; Carter, Scott L.; Cartun, Richard; Carver, Brett S.; Chan, June M.; Chang, Matthew T.; Chen, Yu; Cherniack, Andrew D.; Chevalier, Simone; Chin, Lynda; Cho, Juok; Chu, Andy; Chuah, Eric; Chudamani, Sudha; Cibulskis, Kristian; Ciriello, Giovanni; Clarke, Amanda; Cooperberg, Matthew R.; Corcoran, Niall M.; Costello, Anthony J.; Cowan, Janet; Crain, Daniel; Curley, Erin; David, Kerstin; Demchok, John A.; Demichelis, Francesca; Dhalla, Noreen; Dhir, Rajiv; Doueik, Alexandre; Drake, Bettina; Dvinge, Heidi; Dyakova, Natalya; Felau, Ina; Ferguson, Martin L.; Frazer, Scott; Freedland, Stephen; Fu, Yao; Gabriel, Stacey B.; Gao, Jianjiong; Gardner, Johanna; Gastier-Foster, Julie M.; Gehlenborg, Nils; Gerken, Mark; Gerstein, Mark B.; Getz, Gad; Godwin, Andrew K.; Gopalan, Anuradha; Graefen, Markus; Graim, Kiley; Gribbin, Thomas; Guin, Ranabir; Gupta, Manaswi; Hadjipanayis, Angela; Haider, Syed; Hamel, Lucie; Hayes, D. Neil; Heiman, David I.; Hess, Julian; Hoadley, Katherine A.; Holbrook, Andrea H.; Holt, Robert A.; Holway, Antonia; Hovens, Christopher M.; Hoyle, Alan P.; Huang, Mei; Hutter, Carolyn M.; Ittmann, Michael; Iype, Lisa; Jefferys, Stuart R.; Jones, Corbin D.; Jones, Steven J. M.; Juhl, Hartmut; Kahles, Andre; Kane, Christopher J.; Kasaian, Katayoon; Kerger, Michael; Khurana, Ekta; Kim, Jaegil; Klein, Robert J.; Kucherlapati, Raju; Lacombe, Louis; Ladanyi, Marc; Lai, Phillip H.; Laird, Peter W.; Lander, Eric S.; Latour, Mathieu; Lawrence, Michael S.; Lau, Kevin; LeBien, Tucker; Lee, Darlene; Lee, Semin; Lehmann, Kjong-Van; Leraas, Kristen M.; Leshchiner, Ignaty; Leung, Robert; Libertino, John A.; Lichtenberg, Tara M.; Lin, Pei; Linehan, W. Marston; Ling, Shiyun; Lippman, Scott M.; Liu, Jia; Liu, Wenbin; Lochovsky, Lucas; Loda, Massimo; Logothetis, Christopher; Lolla, Laxmi; Longacre, Teri; Lu, Yiling; Luo, Jianhua; Ma, Yussanne; Mahadeshwar, Harshad S.; Mallery, David; Mariamidze, Armaz; Marra, Marco A.; Mayo, Michael; McCall, Shannon; McKercher, Ginette; Meng, Shaowu; Mes-Masson, Anne-Marie; Merino, Maria J.; Meyersson, Matthew; Mieczkowski, Piotr A.; Mills, Gordon B.; Shaw, Kenna R. Mills; Minner, Sarah; Moinzadeh, Alireza; Moore, Richard A.; Morris, Scott; Morrison, Carl; Mose, Lisle E.; Mungall, Andrew J.; Murray, Bradley A.; Myers, Jerome B.; Naresh, Rashi; Nelson, Joel; Nelson, Mark A.; Nelson, Peter S.; Newton, Yulia; Noble, Michael S.; Noushmehr, Houtan; Nykter, Matti; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Paulauskis, Joseph; Penny, Robert; Perou, Charles M.; Piche, Alain; Pihl, Todd; Pinto, Peter A.; Prandi, Davide; Protopopov, Alexei; Ramirez, Nilsa C.; Rao, Arvind; Rathmell, W. Kimryn; Raetsch, Gunnar; Ren, Xiaojia; Reuter, Victor E.; Reynolds, Sheila M.; Rhie, Suhn K.; Rieger-Christ, Kimberly; Roach, Jeffrey; Robertson, A. Gordon; Robinson, Brian; Rubin, Mark A.; Saad, Fred; Sadeghi, Sara; Saksena, Gordon; Saller, Charles; Salner, Andrew; Sanchez-Vega, Francisco; Sander, Chris; Sandusky, George; Sauter, Guido; Sboner, Andrea; Scardino, Peter T.; Scarlata, Eleonora; Schein, Jacqueline E.; Schlomm, Thorsten; Schmidt, Laura S.; Schultz, Nikolaus; Schumacher, Steven E.; Seidman, Jonathan; Neder, Luciano; Seth, Sahil; Sharp, Alexis; Shelton, Candace; Shelton, Troy; Shen, Hui; Shen, Ronglai; Sherman, Mark; Sheth, Margi; Shi, Yan; Shih, Juliann; Shmulevich, Ilya; Simko, Jeffry; Simon, Ronald; Simons, Janae V.; Sipahimalani, Payal; Skelly, Tara; Sofia, Heidi J.; Soloway, Matthew G.; Song, Xingzhi; Sorcini, Andrea; Sougnez, Carrie; Stepa, Serghei; Stewart, Chip; Stewart, John; Stuart, Joshua M.; Sullivan, Travis B.; Sun, Charlie; Sun, Huandong; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Tarvin, Katherine; Taylor, Barry S.; Teebagy, Patrick; Tenggara, Imelda; Tetu, Bernard; Tewari, Ashutosh; Thiessen, Nina; Thompson, Timothy; Thorne, Leigh B.; Tirapelli, Daniela P.; Tomlins, Scott A.; Trevisan, Felipe Amstalden; Troncoso, Patricia; True, Lawrence D.; Tsourlakis, Maria Christina; Tyekucheva, Svitlana; Van Allen, Eliezer; Van den Berg, David J.; Veluvolu, Umadevi; Verhaak, Roel; Vocke, Cathy D.; Voet, Doug; Wan, Yunhu; Wang, Qingguo; Wang, Wenyi; Wang, Zhining; Weinhold, Nils; Weinstein, John N.; Weisenberger, Daniel J.; Wilkerson, Matthew D.; Wise, Lisa; Witte, John; Wu, Chia-Chin; Wu, Junyuan; Wu, Ye; Xu, Andrew W.; Yadav, Shalini S.; Yang, Liming; Yang, Lixing; Yau, Christina; Ye, Huihui; Yena, Peggy; Zeng, Thomas; Zenklusen, Jean C.; Zhang, Hailei; Zhang, Jianhua; Zhang, Jiashan; Zhang, Wei; Zhong, Yi; Zhu, Kelsey; Zmuda, Erik		Canc Genome Atlas Res Network	The Molecular Taxonomy of Primary Prostate Cancer	CELL			English	Article							ETS GENE FUSIONS; ACTIVE ANDROGEN RECEPTOR; DNA METHYLATION; RADICAL PROSTATECTOMY; EXPRESSION PROFILES; WHOLE-GENOME; MUTATIONS; SPOP; RECURRENCE; REARRANGEMENTS	There is substantial heterogeneity among primary prostate cancers, evident in the spectrum of molecular abnormalities and its variable clinical course. As part of The Cancer Genome Atlas (TCGA), we present a comprehensive molecular analysis of 333 primary prostate carcinomas. Our results revealed a molecular taxonomy in which 74% of these tumors fell into one of seven subtypes defined by specific gene fusions (ERG, ETV1/4, and FLI1) or mutations (SPOP, FOXA1, and IDH1). Epigenetic profiles showed substantial heterogeneity, including an IDH1 mutant subset with a methylator phenotype. Androgen receptor (AR) activity varied widely and in a subtype-specific manner, with SPOP and FOXA1 mutant tumors having the highest levels of AR-induced transcripts. 25% of the prostate cancers had a presumed actionable lesion in the PI3K or MAPK signaling pathways, and DNA repair genes were inactivated in 19%. Our analysis reveals molecular heterogeneity among primary prostate cancers, as well as potentially actionable molecular defects.	[Canc Genome Atlas Res Network] NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA	International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Abeshouse, A (corresponding author), NCI, Canc Genome Atlas Program Off, NIH, 31 Ctr Dr,Bldg 31,Suite 3A20, Bethesda, MD 20892 USA.	massimo_loda@dfci.harvard.edu; sander.research@gmail.com; schultz@cbio.mskcc.org	Schultz, Nikolaus/ABE-6347-2020; Cooperberg, Matthew R/G-6249-2017; Perou, Charles M/H-9934-2014; brimo, fadi/AFF-8172-2022; Lawrence, Michael/AAC-8202-2020; Holt, Robert A/C-3303-2009; Schein, Jacquie E/G-3674-2015; Luo, jian/HGE-7331-2022; Burks, Eric/ABA-7743-2020; Amin, Samirkumar B/H-3184-2019; Demichelis, Francesca/J-9829-2016; Wu, Chia-Chin/ABD-5516-2021; Parker, Joel/AAG-1108-2019; Carlotti, Carlos G/C-1608-2012; Bryce, Alan/W-1765-2019; Mungall, Andrew J./U-7067-2018; Tirapelli, Daniela PC/F-9230-2012; Reis, Rodolfo B/F-5877-2014; Seth, Sahil/I-5809-2019; Verhaak, Roel/ABE-7058-2020; Shen, Hui/AAO-4387-2020; Weisenberger, Daniel/AAA-8314-2020; Kahles, Andre/ABB-8343-2020; Cherniack, Andrew/AAC-5310-2019; N, Houtan/C-9692-2013; brimo, fadi/AAE-9987-2022; Ladanyi, Marc/AAG-8585-2019; Rätsch, Gunnar/O-5914-2017; Akbani, Rehan/AAG-1490-2019; Marra, Marco A/B-5987-2008; Klein, Robert/ABI-7857-2020; Cherniack, Andrew D./AAY-8132-2020; Lee, Semin/S-2629-2016; Van Den Berg, David J/G-8598-2017; Kucherlapati, Raju/ABC-8807-2021; Gao, JianJiong/B-5673-2016; Cibulskis, Kristian/AAC-7380-2019; Laird, Peter W/G-8683-2012	Cooperberg, Matthew R/0000-0003-4339-6685; Perou, Charles M/0000-0001-9827-2247; Holt, Robert A/0000-0002-7259-1247; Burks, Eric/0000-0002-3122-2875; Amin, Samirkumar B/0000-0002-3207-9505; Demichelis, Francesca/0000-0002-8266-8631; Wu, Chia-Chin/0000-0002-5208-6016; Carlotti, Carlos G/0000-0002-7055-0564; Bryce, Alan/0000-0002-0206-3895; Mungall, Andrew J./0000-0002-0905-2742; Tirapelli, Daniela PC/0000-0002-1886-4988; Reis, Rodolfo B/0000-0003-0328-1840; Seth, Sahil/0000-0003-4579-3959; Weisenberger, Daniel/0000-0001-8303-2603; Kahles, Andre/0000-0002-3411-0692; N, Houtan/0000-0003-4051-8114; Rätsch, Gunnar/0000-0001-5486-8532; Marra, Marco A/0000-0001-7146-7175; Klein, Robert/0000-0003-3539-5391; Cherniack, Andrew D./0000-0003-0470-0111; Lee, Semin/0000-0002-9015-6046; Van Den Berg, David J/0000-0002-5404-5218; Gao, JianJiong/0000-0002-5739-1781; Laird, Peter W/0000-0001-9117-3641; Weinstein, John/0000-0001-9401-6908; Chan, June/0000-0002-7620-569X; Barbieri, Christopher/0000-0002-0381-1947; Tarnuzzer, Roy/0000-0002-3725-4173; Hovens, Christopher/0000-0002-0610-1289; Dvinge, Heidi/0000-0003-1741-0738; Lehmann, Kjong-Van/0000-0002-1936-298X; Ciriello, Giovanni/0000-0003-2021-8683; Bergeron, Alain/0000-0002-2875-0773; Auman, James/0000-0002-9328-8829; Meyerson, Matthew/0000-0002-9133-8108; Rubin, Mark/0000-0002-8321-9950; Drake, Bettina/0000-0001-9340-5848; Leshchiner, Ignaty/0000-0001-8942-9265; Bowen, Jay/0000-0001-6861-9043; Graim, Kiley/0000-0002-4569-8444; LeBien, Tucker/0000-0001-5011-2199; Nykter, Matti/0000-0001-6956-2843; Bootwalla, Moiz/0000-0001-6158-7114; Park, Peter/0000-0001-9378-960X; Hoadley, Katherine/0000-0002-1216-477X; Lacombe, Louis/0000-0003-4811-0308; Schlomm, Thorsten/0000-0001-9557-4653; McCall, Shannon/0000-0003-3957-061X; Wang, Wenyi/0000-0003-0617-9438; Wang, Qingguo/0000-0002-5125-3724; Stuart, Joshua/0000-0002-2171-565X; Gehlenborg, Nils/0000-0003-0327-8297; Heiman, David/0000-0001-7895-4259; Sanchez-Vega, Francisco/0000-0002-2990-4893; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Rhie, Suhn/0000-0002-5522-5296; Mieczkowski, Piotr/0000-0003-2418-0096; Cibulskis, Kristian/0000-0003-1343-1582; Bradley, Robert/0000-0002-8046-1063; Prandi, Davide/0000-0001-9885-6074	NIH [5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273, P30CA16672]; Bayer, AG; Novartis; Bayer; NATIONAL CANCER INSTITUTE [U24CA143799, U24CA143883, U24CA144025, R01CA182503, U24CA143840, U24CA143848, U24CA143867, U24CA143866, R01CA175491, P30CA016056, U24CA143882, U24CA143843, P30CA016672, R01CA183793, P50CA090381, U24CA143858, U24CA199461, U24CA143835, U24CA143845] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003067, U54HG003273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer, AG(Bayer AG); Novartis(Novartis); Bayer(Bayer AG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to all the affected individuals and families who contributed to this study. We thank Margi Sheth and Ina Felau for project management. This work was supported by the following grants from the NIH: 5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273, and P30CA16672. D.J.W. is a consultant for Zymo Research Corporation. S.A.T., M.A.R., and F.D. are coauthors on a patent issued to the University of Michigan and the Brigham and Women's Hospital regarding ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe, Inc., who has sub-licensed some rights to Ventana Medical Systems. S.A.T. is a coauthor on a patent filed by the University of Michigan regarding SPINK1 in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe, Inc., who has sub-licensed some rights to Ventana Medical Systems. S.A.T. has served as a consultant and received honoraria from Ventana Medical Systems. M.A.R. is a co-inventor of the patent for the detection and therapeutic field of SPOP mutations in prostate cancer filed by Cornell University. E.V.A. is a consultant for Syapse and Ventana Medical Systems and owns equity in Syapse and Microsoft. A.D.C. has received research support from Bayer, AG. M.B.G. serves on the SAB of BINA. R. Beroukhim is a consultant for and received grant funding from Novartis. M. Meyerson received research support from Bayer and has equity in and is a consultant for Foundation Medicine.	Ahn J, 2013, BIOINFORMATICS, V29, P1865, DOI 10.1093/bioinformatics/btt301; Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; An J, 2014, CELL REP, V6, P657, DOI 10.1016/j.celrep.2014.01.013; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blattner M, 2014, NEOPLASIA, V16, P14, DOI 10.1593/neo.131704; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; Bowyer SE, 2014, MELANOMA RES, V24, P504, DOI 10.1097/CMR.0000000000000099; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang M.T., 2015, NAT BIOTECHNOL; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dahlman KB, 2012, CANCER DISCOV, V2, P791, DOI 10.1158/2159-8290.CD-12-0097; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Delahaye-Sourdeix M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv037; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Farrugia DJ, 2008, CANCER RES, V68, P3523, DOI 10.1158/0008-5472.CAN-07-1587; Ferguson L.R., 2015, SEMIN CANC BIOL; Ferlay J, 2013, GLOBOCAN 2012 V10 CA; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Friedlander TW, 2012, CANCER RES, V72, P616, DOI 10.1158/0008-5472.CAN-11-2079; Gasi D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016332; Geng C, 2014, CANCER RES, V74, P5631, DOI 10.1158/0008-5472.CAN-14-0476; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Ghiam AF, 2012, ONCOGENE, V31, P3826, DOI 10.1038/onc.2011.546; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Hovelson DH, 2015, NEOPLASIA, V17, P385, DOI 10.1016/j.neo.2015.03.004; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Karanika S, 2015, ONCOGENE, V34, P2815, DOI 10.1038/onc.2014.238; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kluth M, 2013, MODERN PATHOL, V26, P975, DOI 10.1038/modpathol.2012.236; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kunju LP, 2014, APPL IMMUNOHISTO M M, V22, pE32, DOI 10.1097/PAI.0000000000000095; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lindberg J, 2015, EUR UROL, V67, P819, DOI 10.1016/j.eururo.2014.09.006; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Martin ST, 2005, ONCOGENE, V24, P3652, DOI 10.1038/sj.onc.1208411; Mateo J, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu438.20; Mostaghel EA, 2010, CANCER RES, V70, P1286, DOI 10.1158/0008-5472.CAN-09-2509; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Parikh C, 2012, P NATL ACAD SCI USA, V109, P19368, DOI 10.1073/pnas.1204384109; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Penney KL, 2013, CANCER RES, V73, P5163, DOI 10.1158/0008-5472.CAN-13-0427; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P1497, DOI 10.1158/1055-9965.EPI-12-0042; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Prandi D, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0439-6; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Quon G, 2013, GENOME MED, V5, DOI 10.1186/gm433; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rodrigues LU, 2015, CANCER RES, V75, P1021, DOI 10.1158/0008-5472.CAN-14-1596; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tomlins SA, 2015, EUR UROL, V68, P555, DOI 10.1016/j.eururo.2015.04.033; Tomlins SA, 2009, EUR UROL, V56, P275, DOI 10.1016/j.eururo.2009.04.036; van Dekken H, 2004, GENE CHROMOSOME CANC, V39, P249, DOI 10.1002/gcc.20001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107	91	1603	1621	8	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					1011	1025		10.1016/j.cell.2015.10.025	http://dx.doi.org/10.1016/j.cell.2015.10.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544944	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000364829700024
J	Ingen-Housz-Oro, S; Foulet, F; Chosidow, O				Ingen-Housz-Oro, Saskia; Foulet, Francoise; Chosidow, Olivier			CASE REVIEW Atypical psoriasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; DERMATOLOGISTS GUIDELINES; BRITISH ASSOCIATION; TERBINAFINE LAMISIL; ORAL TERBINAFINE; TINEA INCOGNITO; SKIN DISEASES; PRIMARY-CARE; ONYCHOMYCOSIS; DERMATOPHYTE		[Ingen-Housz-Oro, Saskia; Chosidow, Olivier] Henri Mondor Hosp, AP HP, Serv Dermatol, Creteil, France; [Ingen-Housz-Oro, Saskia; Chosidow, Olivier] EA 7379 EpiDermE Epidemiol Dermatol & Evaluat The, Creteil, France; [Foulet, Francoise] Henri Mondor Hosp, AP HP, Lab Mycol, Creteil, France; [Foulet, Francoise; Chosidow, Olivier] Univ Paris Est Val de Marne Creteil UPEC, Creteil, France; [Chosidow, Olivier] Ctr Invest Clin 1430, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ingen-Housz-Oro, S (corresponding author), Henri Mondor Hosp, AP HP, Serv Dermatol, Creteil, France.	saskia.oro@aphp.fr						Aguilar C, 2001, J AM ACAD DERMATOL, V45, P632, DOI 10.1067/mjd.2001.117520; Ameen M, 2014, BRIT J DERMATOL, V171, P937, DOI 10.1111/bjd.13358; Ansar Akram, 2011, Med Mycol J, V52, P25, DOI 10.3314/jjmm.52.25; Arenas R, 2010, CLIN DERMATOL, V28, P137, DOI 10.1016/j.clindermatol.2009.12.011; Atzori L, 2012, INT J DERMATOL, V51, P410, DOI 10.1111/j.1365-4632.2011.05049.x; Awadalla F, 2008, FAM MED, V40, P507; Baran R, 2007, BRIT J DERMATOL, V157, P149, DOI 10.1111/j.1365-2133.2007.07974.x; Beltraminelli HS, 2005, BRIT J DERMATOL, V152, P780, DOI 10.1111/j.1365-2133.2005.06393.x; Bontems O, 2009, BRIT J DERMATOL, V161, P791, DOI 10.1111/j.1365-2133.2009.09291.x; Crawford F, 2002, ARCH DERMATOL, V138, P811, DOI 10.1001/archderm.138.6.811; de Sa DC, 2014, AM J CLIN DERMATOL, V15, P17, DOI 10.1007/s40257-013-0056-2; Duparc A, 2010, ANN DERMATOL VENER, V137, P736, DOI 10.1016/j.annder.2010.06.028; Dupuy A, 1999, BRIT MED J, V318, P1591, DOI 10.1136/bmj.318.7198.1591; El-Gohary M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009992.pub2; FISHER DA, 1995, WESTERN J MED, V162, P123; Fuchs A, 2004, AM J MED SCI, V327, P77, DOI 10.1097/00000441-200402000-00004; Fuller LC, 2014, BRIT J DERMATOL, V171, P454, DOI 10.1111/bjd.13196; HAY RJ, 1995, BRIT J DERMATOL, V132, P604, DOI 10.1111/j.1365-2133.1995.tb08718.x; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; HERNANZ AD, 1990, CLIN EXP DERMATOL, V15, P210, DOI 10.1111/j.1365-2230.1990.tb02074.x; IVE FA, 1968, BRIT MED J, V3, P149, DOI 10.1136/bmj.3.5611.149; Karimzadegan-Nia M, 2007, AUSTRALAS J DERMATOL, V48, P18, DOI 10.1111/j.1440-0960.2007.00320.x; Kaur R, 2008, INDIAN J MED MICROBI, V26, P108; Kim WJ, 2013, J KOREAN MED SCI, V28, P145, DOI 10.3346/jkms.2013.28.1.145; Levitt JO, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/764843; LEYDEN JL, 1994, J AM ACAD DERMATOL, V31, pS31, DOI 10.1016/S0190-9622(08)81264-9; Loo DS, 2007, DRUG AGING, V24, P293, DOI 10.2165/00002512-200724040-00003; Mahe A, 2003, BRIT J DERMATOL, V148, P493, DOI 10.1046/j.1365-2133.2003.05161.x; McClellan KJ, 1999, DRUGS, V58, P179, DOI 10.2165/00003495-199958010-00018; Mokni M, 2006, DERMATOLOGY, V212, P108, DOI 10.1159/000090649; Morrell J, 2011, J AGROMEDICINE, V16, P244, DOI 10.1080/1059924X.2011.605715; Nenoff P, 2014, J DTSCH DERMATOL GES, V12, P188, DOI [10.1111/ddg.12245, 10.1111/ddg.12245_suppl]; PARISER RJ, 1987, J AM ACAD DERMATOL, V17, P239, DOI 10.1016/S0190-9622(87)70198-4; Perveze Z, 2007, LIVER TRANSPLANT, V13, P162, DOI 10.1002/lt.21034; Romano C, 2006, MYCOSES, V49, P383, DOI 10.1111/j.1439-0507.2006.01251.x; Schofield JK, 2011, BRIT J DERMATOL, V165, P1044, DOI 10.1111/j.1365-2133.2011.10464.x; Smith KJ, 2001, BRIT J DERMATOL, V145, P344, DOI 10.1046/j.1365-2133.2001.04331.x; Terrab Z, 2006, ANN DERMATOL VENER, V133, P463, DOI 10.1016/S0151-9638(06)70941-3; Tucker Rod, 2014, Int J Pharm Pract, V22, P119, DOI 10.1111/ijpp.12045; van Zuuren EJ, 2015, BRIT J DERMATOL, V172, P616, DOI 10.1111/bjd.13441; Voravutinon Virat, 1993, Journal of the Medical Association of Thailand, V76, P388; Weinberg JM, 2003, J AM ACAD DERMATOL, V49, P193, DOI 10.1067/S0190-9622(03)01480-4; WHITE JE, 1991, BRIT J DERMATOL, V125, P260, DOI 10.1111/j.1365-2133.1991.tb14752.x	43	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5510	10.1136/bmj.h5510	http://dx.doi.org/10.1136/bmj.h5510			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OS	26538349				2022-12-28	WOS:000364390100004
J	Campbell, TC				Campbell, Toby C.			When Minutes Matter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Campbell, Toby C.] Univ Wisconsin, Dept Med, Div Hematol Oncol, Madison, WI 53706 USA; [Campbell, Toby C.] Univ Wisconsin, Sch Nursing, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Campbell, TC (corresponding author), Univ Wisconsin, Dept Med, Div Hematol Oncol, Madison, WI 53706 USA.	tcc@medicine.wisc.edu	Campbell, Toby C/AAN-3249-2021	Campbell, Toby C/0000-0003-4910-1112					0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1799	1800		10.1001/jama.2015.9204	http://dx.doi.org/10.1001/jama.2015.9204			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529156				2022-12-28	WOS:000363960200009
J	St Clair, J; Moon, S; Holbrook, WS; Perron, JT; Riebe, CS; Martel, SJ; Carr, B; Harman, C; Singha, K; Richter, DD				St Clair, J.; Moon, S.; Holbrook, W. S.; Perron, J. T.; Riebe, C. S.; Martel, S. J.; Carr, B.; Harman, C.; Singha, K.; Richter, D. deB.			Geophysical imaging reveals topographic stress control of bedrock weathering	SCIENCE			English	Article							CRITICAL ZONE; PERMEABILITY; MOUNTAINS; FRACTURE; PERTURBATIONS; FAILURE; SOIL	Bedrock fracture systems facilitate weathering, allowing fresh mineral surfaces to interact with corrosive waters and biota from Earth's surface, while simultaneously promoting drainage of chemically equilibrated fluids. We show that topographic perturbations to regional stress fields explain bedrock fracture distributions, as revealed by seismic velocity and electrical resistivity surveys from three landscapes. The base of the fracture-rich zone mirrors surface topography where the ratio of horizontal compressive tectonic stresses to near-surface gravitational stresses is relatively large, and it parallels the surface topography where the ratio is relatively small. Three-dimensional stress calculations predict these results, suggesting that tectonic stresses interact with topography to influence bedrock disaggregation, groundwater flow, chemical weathering, and the depth of the "critical zone" in which many biogeochemical processes occur.	[St Clair, J.; Holbrook, W. S.; Riebe, C. S.; Carr, B.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [St Clair, J.; Holbrook, W. S.; Riebe, C. S.; Carr, B.] Univ Wyoming, Wyoming Ctr Environm Hydrol & Geophys, Laramie, WY 82071 USA; [Moon, S.; Perron, J. T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Martel, S. J.] Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Harman, C.] Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA; [Singha, K.] Colorado Sch Mines, Hydrol Sci & Engn Program, Golden, CO 80401 USA; [Richter, D. deB.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University of Wyoming; University of Wyoming; Massachusetts Institute of Technology (MIT); University of Hawaii System; Johns Hopkins University; Colorado School of Mines; Duke University	St Clair, J (corresponding author), Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA.	jstclai4@uwyo.edu; sgmoon@mit.edu	Richter, D.D./AAN-4583-2021; Holbrook, Steven/G-9800-2011; Harman, Ciaran/A-7974-2013	Holbrook, Steven/0000-0003-0065-8841; Harman, Ciaran/0000-0002-3185-002X; Singha, Kamini/0000-0002-0605-3774; Moon, Seulgi/0000-0001-5207-1781; Riebe, Clifford/0000-0002-8744-8208	NSF Experimental Program to Stimulate Competitive Research [EPS-1208909]; U.S. Army Research Office [W911NF-14-1-0037]; NSF Earth Sciences [EAR-0724960, EAR-1331846]; NSF Critical Zone Observatory Network; Directorate For Geosciences [1339015] Funding Source: National Science Foundation; Division Of Earth Sciences [1331846] Funding Source: National Science Foundation	NSF Experimental Program to Stimulate Competitive Research; U.S. Army Research Office; NSF Earth Sciences(National Science Foundation (NSF)); NSF Critical Zone Observatory Network; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by the NSF Experimental Program to Stimulate Competitive Research (award EPS-1208909), the U.S. Army Research Office (grant W911NF-14-1-0037), NSF Earth Sciences (awards EAR-0724960 to the University of Colorado-Boulder and EAR-1331846 to Duke University), and the NSF Critical Zone Observatory Network. Poly3D software was provided by Schlumberger. 3DMove software was provided by Midland Valley Software. Geophysical data presented in this paper are available through the Wyoming Center for Environmental Hydrology and Geophysics data repository at http://ecoinfo.wygisc.org/data-archive#PB_CCZO_BCCZO. The authors thank the editor and three anonymous reviewers for their suggestions.	Anderson RS, 2013, EARTH SURF PROC LAND, V38, P299, DOI 10.1002/esp.3330; Archie GE, 1942, T AM I MIN MET ENG, V146, P54, DOI 10.2118/942054-G; Barton C. A., 1997, LEADING EDGE, V16, P1653, DOI DOI 10.1190/1.1437547; Barton N., 2006, ROCK QUALITY SEISMIC; Blake OO, 2013, PURE APPL GEOPHYS, V170, P493, DOI 10.1007/s00024-012-0550-0; Buss HL, 2008, GEOCHIM COSMOCHIM AC, V72, P4488, DOI 10.1016/j.gca.2008.06.020; CLEAVES ET, 1970, GEOL SOC AM BULL, V81, P3015, DOI 10.1130/0016-7606(1970)81[3015:GBOASW]2.0.CO;2; Dixon JL, 2014, ELEMENTS, V10, P363, DOI 10.2113/gselements.10.5.363; Holbrook WS, 2014, EARTH SURF PROC LAND, V39, P366, DOI 10.1002/esp.3502; IVERSON RM, 1992, WATER RESOUR RES, V28, P925, DOI 10.1029/91WR02694; Lebedeva MI, 2013, EARTH SURF PROC LAND, V38, P1793, DOI 10.1002/esp.3424; LONG JCS, 1991, INT J ROCK MECH MIN, V28, P121, DOI 10.1016/0148-9062(91)92162-R; Martel SJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024710; Martel SJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049354; Miller DJ, 1996, J GEOPHYS RES-SOL EA, V101, P25523, DOI 10.1029/96JB02531; Milliman J. D., 2011, RIVER DISCHARGE COAS, DOI 10.1017/CBO9780511781247; Min KB, 2004, INT J ROCK MECH MIN, V41, P1191, DOI 10.1016/j.ijrmms.2004.05.005; Molnar P, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2003JF000097; Morin RH, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000488; NUR A, 1969, EARTH PLANET SC LETT, V7, P183, DOI 10.1016/0012-821X(69)90035-1; Owen R, 2007, HYDROGEOL J, V15, P1231, DOI 10.1007/s10040-007-0224-7; Rempe DM, 2014, P NATL ACAD SCI USA, V111, P6576, DOI 10.1073/pnas.1404763111; Richter DD, 2015, NEW PHYTOL, V206, P900, DOI 10.1111/nph.13338; Roering JJ, 2010, EARTH PLANET SC LETT, V298, P183, DOI 10.1016/j.epsl.2010.07.040; SAVAGE WZ, 1986, J GEOPHYS RES-SOLID, V91, P3677, DOI 10.1029/JB091iB03p03677; SCHWARTZMAN DW, 1989, NATURE, V340, P457, DOI 10.1038/340457a0; Slim M, 2015, EARTH SURF PROC LAND, V40, P512, DOI 10.1002/esp.3646; Upton P, 2014, EARTH PLANET SC LETT, V389, P176, DOI 10.1016/j.epsl.2013.12.032; WALDER JS, 1986, ARCTIC ALPINE RES, V18, P27, DOI 10.2307/1551211; WELLMAN HW, 1965, NATURE, V205, P1097, DOI 10.1038/2051097a0; Yeo IW, 1998, INT J ROCK MECH MIN, V35, P1051, DOI 10.1016/S0148-9062(98)00165-X	32	191	192	7	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					534	538		10.1126/science.aab2210	http://dx.doi.org/10.1126/science.aab2210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516279				2022-12-28	WOS:000363660000042
J	Bassham, DC				Bassham, Diane C.			PLANT BIOLOGY Pigments on the move	NATURE			English	Editorial Material							AUTOPHAGY		[Bassham, Diane C.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Bassham, Diane C.] Iowa State Univ, Inst Plant Sci, Ames, IA 50011 USA	Iowa State University; Iowa State University	Bassham, DC (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	bassham@iastate.edu						Chanoca A., 2015, PLANT; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Iwashina T, 2015, NAT PROD COMMUN, V10, P529; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Pourcel L, 2010, MOL PLANT, V3, P78, DOI 10.1093/mp/ssp071; Poustka F, 2007, PLANT PHYSIOL, V145, P1323, DOI 10.1104/pp.107.105064; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Sengupta B, 2004, FEBS LETT, V570, P77, DOI 10.1016/j.febslet.2004.06.027; Tohge T, 2011, PLANT SIGNAL BEHAV, V6, P1987, DOI 10.4161/psb.6.12.18240; van Doorn WG, 2013, AUTOPHAGY, V9, P1922, DOI 10.4161/auto.26275	10	2	2	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					644	645		10.1038/526644a	http://dx.doi.org/10.1038/526644a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511574				2022-12-28	WOS:000363832100033
J	Eisman, S; Sinclair, R				Eisman, Samantha; Sinclair, Rodney			Pityriasis rosea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EFFICACY		[Eisman, Samantha] Sinclair Dermatol, Melbourne, Vic 3002, Australia; [Sinclair, Rodney] Sinclair Dermatol, Dermatol, Melbourne, Vic 3002, Australia		Eisman, S (corresponding author), Sinclair Dermatol, Melbourne, Vic 3002, Australia.	drsamanthaeisman@gmail.com	Sinclair, Rodney/AAI-8355-2020	Sinclair, Rodney/0000-0001-6751-1428				Ahmed N, 2014, JCPSP-J COLL PHYSICI, V24, P802, DOI 11.2014/JCPSP.802805; Chuh A, 2005, J EUR ACAD DERMATOL, V19, P120, DOI 10.1111/j.1468-3083.2004.01105.x; Chuh A, 2012, OUR DERMATOL ONLINE, V3, P141; Chuh AAT, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005068.pub2; Chuh AAT, 2005, INT J DERMATOL, V44, P372, DOI 10.1111/j.1365-4632.2005.02007.x; Chuh AAT, 2001, ACTA DERM-VENEREOL, V81, P289, DOI 10.1080/00015550152572958; Chuh Antonio, 2005, Indian J Dermatol Venereol Leprol, V71, P311; Chuh A, 2012, INFECT DIS REP, V4, P38, DOI 10.4081/idr.2012.e12; Drago F, 2014, J AM ACAD DERMATOL, V71, P198, DOI 10.1016/j.jaad.2014.02.023; Drago F, 2014, J AM ACAD DERMATOL, V70, P196, DOI 10.1016/j.jaad.2013.08.056; Ganguly S, 2014, J CLIN DIAGN RES, V8, pYC1, DOI [10.7860/JCDR/2014/8140.4360, 10.7860/JCDR/2014/9457.4976]; Ozyurek GD, 2014, POSTEP DERM ALERGOL, V31, P216, DOI 10.5114/pdia.2014.40641; Pandhi D, 2014, INDIAN J DERMATOL VE, V80, P36, DOI 10.4103/0378-6323.125484; Sankararaman S, 2014, INDIAN J DERMATOL, V59, DOI 10.4103/0019-5154.131457; Watanabe T, 2002, J INVEST DERMATOL, V119, P793, DOI 10.1046/j.1523-1747.2002.00200.x	16	14	14	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2015	351								h5233	10.1136/bmj.h5233	http://dx.doi.org/10.1136/bmj.h5233			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IM	26514823				2022-12-28	WOS:000364152800001
J	Castaneda, J; Matzuk, MM				Castaneda, Julio; Matzuk, Martin M.			Toward a rapid and reversible male pill	SCIENCE			English	Editorial Material							CALCINEURIN		[Castaneda, Julio; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Castaneda, Julio; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Castaneda, Julio; Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Castaneda, J (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu	Castaneda, Julio/AAB-8797-2021	Castaneda, Julio/0000-0002-1819-4777				Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; NICHD, 2000, STRAT PLAN 2000 CELL; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SEETHALAKSHMI L, 1987, J UROLOGY, V138, P991, DOI 10.1016/S0022-5347(17)43479-3; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; STARZL TE, 1989, LANCET, V2, P1000	8	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					385	386		10.1126/science.aad4425	http://dx.doi.org/10.1126/science.aad4425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494747				2022-12-28	WOS:000363213400024
J	Denli, AM; Narvaiza, I; Kerman, BE; Pena, M; Benner, C; Marchetto, MCN; Diedrich, JK; Aslanian, A; Ma, J; Moresco, JJ; Moore, L; Hunter, T; Saghatelian, A; Gage, FH				Denli, Ahmet M. m; Narvaiza, Inigo; Kerman, Bilal E.; Pena, Monique; Benner, Christopher; Marchetto, Maria C. N.; Diedrich, Jolene K.; Aslanian, Aaron; Ma, Jiao; Moresco, James J.; Moore, Lynne; Hunter, Tony; Saghatelian, Alan; Gage, Fred H.			Primate-Specific ORF0 Contributes to Retrotransposon-Mediated Diversity	CELL			English	Article							TRANSPOSABLE ELEMENTS; STEM-CELLS; TRANSCRIPTION; EXPRESSION; PROTEIN; RNA; IDENTIFICATION; TRANSPOSITION; TRANSLATION; DYNAMICS	LINE-1 retrotransposons are fast-evolving mobile genetic entities that play roles in gene regulation, pathological conditions, and evolution. Here, we show that the primate LINE-1 5'UTR contains a primate-specific open reading frame (ORF) in the antisense orientation that we named ORF0. The gene product of this ORF localizes to promyelocytic leukemia-adjacent nuclear bodies. ORF0 is present in more than 3,000 loci across human and chimpanzee genomes and has a promoter and a conserved strong Kozak sequence that supports translation. By virtue of containing two splice donor sites, ORF0 can also form fusion proteins with proximal exons. ORF0 transcripts are readily detected in induced pluripotent stem (iPS) cells from both primate species. Capped and polyadenylated ORF0 mRNAs are present in the cytoplasm, and endogenous ORF0 peptides are identified upon proteomic analysis. Finally, ORF0 enhances LINE-1 mobility. Taken together, these results suggest a role for ORF0 in retrotransposon-mediated diversity.	[Denli, Ahmet M. m; Narvaiza, Inigo; Kerman, Bilal E.; Pena, Monique; Benner, Christopher; Marchetto, Maria C. N.; Moore, Lynne; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Aslanian, Aaron; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Ma, Jiao; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Hunter, Tony] Salk Inst Biol Studies, Ctr Canc, La Jolla, CA 92037 USA; [Diedrich, Jolene K.; Moresco, James J.] Salk Inst Biol Studies, Mass Spectrometry Ctr, La Jolla, CA 92037 USA; [Ma, Jiao] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gage, Fred H.] Univ Calif San Diego, Ctr Acad Res & Training Anthropogeny CARTA, La Jolla, CA 92093 USA; [Gage, Fred H.] Univ Calif San Diego, KIBM, La Jolla, CA 92093 USA	Salk Institute; Salk Institute; Salk Institute; Salk Institute; Salk Institute; Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Kerman, Bilal Ersen/W-7237-2019	Kerman, Bilal Ersen/0000-0003-1106-3288; Moresco, James/0000-0003-1178-1642; Benner, Christopher/0000-0002-4618-0719; Diedrich, Jolene/0000-0001-6489-4558	Leona M. and Harry B. Helmsley Charitable Trust; JPB Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; JPB Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from the Leona M. and Harry B. Helmsley Charitable Trust, the JPB Foundation, and the G. Harold and Leila Y. Mathers Charitable Foundation. We thank Gokhan Sxenturk, Ruth Keithley, Ana Mendes, Dilara Halim, and Iryna Gallina for technical help; Sara Linker, Christos Tzitzilonis, and Stephane Boissinot for discussions; Peter Hemmerich and Wenfeng An for reagents; James Fitzpatrick and Michael Adams for help with imaging; Mary Lynn Gage for editorial comments on the manuscript; and everybody involved in GEO and ENA database generation and data contributions.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruickshanks HA, 2013, NUCLEIC ACIDS RES, V41, P6857, DOI 10.1093/nar/gkt438; Cruickshanks HA, 2009, GENOMICS, V94, P397, DOI 10.1016/j.ygeno.2009.08.013; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; KLECKNER N, 1990, ANNU REV CELL BIOL, V6, P297, DOI 10.1146/annurev.cb.06.110190.001501; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodic N, 2014, AM J PATHOL, V184, P1280, DOI 10.1016/j.ajpath.2014.01.007; Romero IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07103; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wheelan SJ, 2005, GENOME RES, V15, P1073, DOI 10.1101/gr.3688905; Xie Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1076; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	53	131	136	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					583	593		10.1016/j.cell.2015.09.025	http://dx.doi.org/10.1016/j.cell.2015.09.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496605	Bronze			2022-12-28	WOS:000364828900013
J	Harris, N				Harris, Nicola			IMMUNOLOGY Chronic effects of acute infections	NATURE			English	Editorial Material								Acute infection of mice with an intestinal pathogen leads to long-lasting inflammation that is maintained by intestinal microorganisms. This observation reveals a path by which infection history can affect long-term immune function.	Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Harris, N (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland.	nicola.harris@epfl.ch	harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210				Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; CUNNINGHAM MW, 1988, J IMMUNOL, V141, P2760; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698	7	0	2	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					509	510		10.1038/526509a	http://dx.doi.org/10.1038/526509a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490613				2022-12-28	WOS:000364026100032
J	Tran, E; Ahmadzadeh, M; Lu, YC; Gros, A; Turcotte, S; Robbins, PF; Gartner, JJ; Zheng, ZL; Li, YF; Ray, S; Wunderlich, JR; Somerville, RP; Rosenberg, SA				Tran, Eric; Ahmadzadeh, Mojgan; Lu, Yong-Chen; Gros, Alena; Turcotte, Simon; Robbins, Paul F.; Gartner, Jared J.; Zheng, Zhili; Li, Yong F.; Ray, Satyajit; Wunderlich, John R.; Somerville, Robert P.; Rosenberg, Steven A.			Immunogenicity of somatic mutations in human gastrointestinal cancers	SCIENCE			English	Article							INTRATUMOR HETEROGENEITY; PD-1 BLOCKADE; CELLS; IPILIMUMAB; PATIENT; IDENTIFICATION; IMMUNOTHERAPY; NIVOLUMAB; ANTI-PD-1; REVEALS	It is unknown whether the human immune system frequently mounts a T cell response against mutations expressed by common epithelial cancers. Using a next-generation sequencing approach combined with high-throughput immunologic screening, we demonstrated that tumor-infiltrating lymphocytes (TILs) from 9 out of 10 patients with metastatic gastrointestinal cancers contained CD4(+) and/or CD8(+) T cells that recognized one to three neo-epitopes derived from somatic mutations expressed by the patient's own tumor. There were no immunogenic epitopes shared between these patients. However, we identified in one patient a human leukocyte antigen-C*08:02-restricted T cell receptor from CD8(+) TILs that targeted the KRAS(G12D) hotspot driver mutation found in many human cancers. Thus, a high frequency of patients with common gastrointestinal cancers harbor immunogenic mutations that can potentially be exploited for the development of highly personalized immunotherapies.	[Tran, Eric; Ahmadzadeh, Mojgan; Lu, Yong-Chen; Gros, Alena; Turcotte, Simon; Robbins, Paul F.; Gartner, Jared J.; Zheng, Zhili; Li, Yong F.; Ray, Satyajit; Wunderlich, John R.; Somerville, Robert P.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, NIH, Bethesda, MD 20892 USA.	sar@mail.nih.gov	Lu, Yong-Chen/G-4520-2014; Gros, Alena/AAH-2007-2019	Lu, Yong-Chen/0000-0002-0275-9825; Gros, Alena/0000-0002-1207-1880; Balmana, Judith/0000-0002-0762-6415	Milstein Family Foundation; Center for Cancer Research intramural research program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZICBC011569] Funding Source: NIH RePORTER	Milstein Family Foundation; Center for Cancer Research intramural research program of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Milstein Family Foundation for their generous support, Q. Wang and U. Rudloff for providing KRAS-genotyped pancreatic cancer cell lines, A. Mixon and S. Farid for flow cytometry support, M. El-Gamil for reagents, T. Prickett for RNA-sequencing assistance, and other members of the Surgery Branch for helpful discussions and technical support. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The raw whole-exome and genome sequence data are available through the National Center for Biotechnology Information Bioproject database, Bioproject PRJNA298330. E.T., Y-C.L., and S.A.R. have filed a patent application (U. S. application no. 62/218,688) that relates to the KRAS<SUP>G12D</SUP>-mutation reactive TCR. This research was supported by the Center for Cancer Research intramural research program of the National Cancer Institute.	Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Cox Adrienne D, 2010, Small GTPases, V1, P2; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gjertsen MK, 1997, INT J CANCER, V72, P784, DOI 10.1002/(SICI)1097-0215(19970904)72:5<784::AID-IJC14>3.0.CO;2-9; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Linard B, 2002, J IMMUNOL, V168, P4802, DOI 10.4049/jimmunol.168.9.4802; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Noh KH, 2014, CANCER RES, V74, P3556, DOI 10.1158/0008-5472.CAN-13-3225; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sharkey MS, 2004, CANCER RES, V64, P1595, DOI 10.1158/0008-5472.CAN-03-3231; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	26	468	501	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1387	1390		10.1126/science.aad1253	http://dx.doi.org/10.1126/science.aad1253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26516200	Green Accepted			2022-12-28	WOS:000366162400045
J	Yuen, CM; Amanullah, F; Dharmadhikari, A; Nardell, EA; Seddon, JA; Vasilyeva, I; Zhao, YL; Keshavjee, S; Becerra, MC				Yuen, Courtney M.; Amanullah, Farhana; Dharmadhikari, Ashwin; Nardell, Edward A.; Seddon, James A.; Vasilyeva, Irina; Zhao, Yanlin; Keshavjee, Salmaan; Becerra, Mercedes C.			Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment	LANCET			English	Article							PULMONARY TUBERCULOSIS; SUSPECTED TUBERCULOSIS; TREATMENT OUTCOMES; DRUG-RESISTANCE; SOUTHERN AFRICA; IMPACT; DISTRICT; YIELD; OUTPATIENTS; EMPLOYEES	To halt the global tuberculosis epidemic, transmission must be stopped to prevent new infections and new cases. Identification of individuals with tuberculosis and prompt initiation of effective treatment to rapidly render them non-infectious is crucial to this task. However, in settings of high tuberculosis burden, active case-finding is often not implemented, resulting in long delays in diagnosis and treatment. A range of strategies to find cases and ensure prompt and correct treatment have been shown to be effective in high tuberculosis-burden settings. The population-level effect of targeted active case-finding on reducing tuberculosis incidence has been shown by studies and projected by mathematical modelling. The inclusion of targeted active case-finding in a comprehensive epidemic-control strategy for tuberculosis should contribute substantially to a decrease in tuberculosis incidence.	[Yuen, Courtney M.; Dharmadhikari, Ashwin; Nardell, Edward A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Amanullah, Farhana] Indus Hosp Res Ctr, Karachi, Pakistan; [Seddon, James A.] Univ London Imperial Coll Sci Technol & Med, London, England; [Vasilyeva, Irina] Russian Acad Med Sci, Moscow, Russia; [Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Keshavjee, Salmaan; Becerra, Mercedes C.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Imperial College London; Russian Academy of Medical Sciences; Chinese Center for Disease Control & Prevention; Harvard University; Harvard Medical School	Becerra, MC (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	Mercedes_Becerra@hms.harvard.edu	; Seddon, James/HHC-2093-2022	Yuen, Courtney/0000-0002-5219-2599; Keshavjee, Salmaan/0000-0002-6967-3305; Seddon, James/0000-0002-2296-2302	Janssen Global to Harvard Medical School; Global Fund; TBREACH; US National Institutes of Health [K23 AI084548]; Academy of Medical Sciences (AMS) [AMS-SGCL11-Seddon] Funding Source: researchfish; National Institute for Health Research [CL-2012-21-006] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI084548] Funding Source: NIH RePORTER	Janssen Global to Harvard Medical School; Global Fund; TBREACH; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from Janssen Global to Harvard Medical School (CMY, SK, MCB); the Global Fund (FA); TBREACH (FA); and the US National Institutes of Health (award K23 AI084548 to AD). The funders had no role in the conception, preparation, review, approval, or submission of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the views of the US National Institutes of Health or any other funding body. We thank Carole Mitnick for her review and the important comments she contributed during drafting, and Carly Rodriguez for coordination and research assistance in the preparation of this Series paper.	ALUOCH JA, 1984, AM REV RESPIR DIS, V129, P915; ALUOCH JA, 1985, TUBERCLE, V66, P237, DOI 10.1016/0041-3879(85)90061-3; [Anonymous], 1992, MMWR Recomm Rep, V41, P13; [Anonymous], 2009, HLTH HUMAN RIGHTS J; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Azman AS, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0216-0; BAILY GVJ, 1967, B WORLD HEALTH ORGAN, V37, P875; Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Barrera E, 2015, INT J TUBERC LUNG D, V19, P381, DOI 10.5588/ijtld.14.0680; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Buu TN, 2003, INT J TUBERC LUNG D, V7, P735; Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203; Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Cruz AT, 2011, INFECT CONT HOSP EP, V32, P188, DOI 10.1086/657940; Detjen A., 2013, FRAMEWORK INTEGRATIN; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dharmadhikari A, 2013, INT J HEALTH SERV, V43, P651, DOI 10.2190/HS.43.4.d; Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077517; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Ferrara G, 2012, CURR OPIN PULM MED, V18, P233, DOI 10.1097/MCP.0b013e328351f9d6; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gopi P. G., 2005, Indian Journal of Tuberculosis, V52, P153; Hadley M, 2000, INT J TUBERC LUNG D, V4, P401; Harries AD, 2009, INT J TUBERC LUNG D, V13, P801; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Khan MS, 2015, HEALTH POLICY PLANN, V30, P1289, DOI 10.1093/heapol/czu137; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Lutge EE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007952.pub2; Maher D., 1997, TREATM TUB GUID NAT, VSecond; McMillan CW, 2015, DISCOVERING TUBERCUL; Mendoza-Ticona A, 2012, PUBLIC HEALTH ACTION, V2, P162, DOI 10.5588/pha.12.0033; Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Munoz FM, 2002, INFECT CONT HOSP EP, V23, P568, DOI 10.1086/501972; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Naidoo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103328; Ortblad KF, 2013, LANCET, V381, P104; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Public Health Agency of Canada Canadian Thoracic Society and the Canadian Lung Association, 2013, CANADIAN TUBERCULOSI; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Sanchez-Perez HJ, 2002, ANN EPIDEMIOL, V12, P166, DOI 10.1016/S1047-2797(01)00308-8; Shah NS, 2014, CLIN INFECT DIS, V58, P381, DOI 10.1093/cid/cit643; Shukshin A, 2006, B WORLD HEALTH ORGAN, V84, P265; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Theron G, 2015, LANCET, V386, P2324, DOI 10.1016/S0140-6736(15)00321-9; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tom-Aba D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131000; Toman K., 1979, TUBERCULOSIS CASE FI; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; WHO, 2014, GLOB TUB REP 2014; WHO, 2019, GLOB HLTH OBS DAT RE; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2013, REC INV CONT PERS IN; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027	77	92	96	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2334	2343		10.1016/S0140-6736(15)00322-0	http://dx.doi.org/10.1016/S0140-6736(15)00322-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8ZB	26515675	Bronze, Green Published			2022-12-28	WOS:000365993200033
J	Adamczyk, L; Adkins, JK; Agakishiev, G; Aggarwal, MM; Ahammed, Z; Alekseev, I; Alford, J; Aparin, A; Arkhipkin, D; Aschenauer, EC; Averichev, GS; Bairathi, V; Banerjee, A; Bellwied, R; Bhasin, A; Bhati, AK; Bhattarai, P; Bielcik, J; Bielcikova, J; Bland, LC; Bordyuzhin, IG; Bouchet, J; Brandenburg, JD; Brandin, AV; Bunzarov, I; Butterworth, J; Caines, H; Sanchez, MCD; Campbell, JM; Cebra, D; Cervantes, MC; Chakaberia, I; Chaloupka, P; Chang, Z; Chattopadhyay, S; Chen, JH; Chen, X; Cheng, J; Cherney, M; Christie, W; Contin, G; Crawford, HJ; Das, S; De Silva, LC; Debbe, RR; Dedovich, TG; Deng, J; Derevschikov, AA; di Ruzza, B; Didenko, L; Dilks, C; Dong, X; Drachenberg, JL; Draper, JE; Du, CM; Dunkelberger, LE; Dunlop, JC; Efimov, LG; Engelage, J; Eppley, G; Esha, R; Evdokimov, O; Eyser, O; Fatemi, R; Fazio, S; Federic, P; Fedorisin, J; Feng, Z; Filip, P; Fisyak, Y; Flores, CE; Fulek, L; Gagliardi, CA; Garand, D; Geurts, F; Gibson, A; Girard, M; Greiner, L; Grosnick, D; Gunarathne, DS; Guo, Y; Gupta, A; Gupta, S; Guryn, W; Hamad, A; Hamed, A; Haque, R; Harris, JW; He, L; Heppelmann, S; Heppelmann, S; Hirsch, A; Hoffmann, GW; Hofman, DJ; Horvat, S; Huang, B; Huang, HZ; Huang, X; Huck, P; Humanic, TJ; Igo, G; Jacobs, WW; Jang, H; Jiang, K; Judd, EG; Kabana, S; Kalinkin, D; Kang, K; Kauder, K; Ke, HW; Keane, D; Kechechyan, A; Khan, ZH; Kikola, DP; Kisel, I; Kisiel, A; Klein, S; Kochenda, L; Koetke, DD; Kollegger, T; Kosarzewski, LK; Kraishan, AF; Kravtsov, P; Krueger, K; Kulakov, I; Kumar, L; Kycia, RA; Lamont, MAC; Landgraf, JM; Landry, KD; Lauret, J; Lebedev, A; Lednicky, R; Lee, JH; Li, X; Li, ZM; Li, Y; Li, W; Li, X; Li, C; Lisa, MA; Liu, F; Ljubicic, T; Llope, WJ; Lomnitz, M; Longacre, RS; Luo, X; Ma, GL; Ma, R; Ma, YG; Ma, L; Magdy, N; Majka, R; Manion, A; Margetis, S; Markert, C; Masui, H; Matis, HS; McDonald, D; Meehan, K; Minaev, NG; Mioduszewski, S; Mishra, D; Mohanty, B; Mondal, MM; Morozov, DA; Mustafa, MK; Nandi, BK; Nasim, M; Nayak, TK; Nigmatkulov, G; Nogach, LV; Noh, SY; Novak, J; Nurushev, SB; Odyniec, G; Ogawa, A; Oh, K; Okorokov, V; Olvitt, D; Page, BS; Pak, R; Pan, YX; Pandit, Y; Panebratsev, Y; Pawlik, B; Pei, H; Perkins, C; Peterson, A; Pile, P; Planinic, M; Pluta, J; Poljak, N; Poniatowska, K; Porter, J; Posik, M; Poskanzer, AM; Putschke, J; Qiu, H; Quintero, A; Ramachandran, S; Raniwala, R; Raniwala, S; Ray, RL; Ritter, HG; Roberts, JB; Rogachevskiy, OV; Romero, JL; Roy, A; Ruan, L; Rusnak, J; Rusnakova, O; Sahoo, NR; Sahu, PK; Sakrejda, I; Salur, S; Sandweiss, J; Sarkar, A; Schambach, J; Scharenberg, RP; Schmah, AM; Schmidke, WB; Schmitz, N; Seger, J; Seyboth, P; Shah, N; Shahaliev, E; Shanmuganathan, PV; Shao, M; Sharma, MK; Sharma, B; Shen, WQ; Shi, S; Shou, QY; Sichtermann, EP; Sikora, R; Simko, M; Skoby, MJ; Smirnov, N; Smirnov, D; Song, L; Sorensen, P; Spinka, HM; Srivastava, B; Stanislaus, TDS; Stepanov, M; Stock, R; Strikhanov, M; Stringfellow, B; Sumbera, M; Summa, B; Sun, Z; Sun, XM; Sun, Y; Sun, X; Surrow, B; Svirida, N; Szelezniak, MA; Tang, Z; Tang, AH; Tarnowsky, T; Tawfik, A; Thomas, JH; Timmins, AR; Tlusty, D; Tokarev, M; Trentalange, S; Tribble, RE; Tribedy, P; Tripathy, SK; Trzeciak, BA; Tsai, OD; Ullrich, T; Underwood, DG; Upsal, I; Van Buren, G; van Nieuwenhuizen, G; Vandenbroucke, M; Varma, R; Vasiliev, AN; Vertesi, R; Videbaek, F; Viyogi, YP; Vokal, S; Voloshin, SA; Vossen, A; Wang, G; Wang, H; Wang, JS; Wang, Y; Wang, Y; Wang, F; Webb, JC; Webb, G; Wen, L; Westfall, GD; Wieman, H; Wissink, SW; Witt, R; Wu, YF; Xiao, ZG; Xie, W; Xin, K; Xu, YF; Xu, QH; Xu, H; Xu, N; Xu, Z; Yang, Y; Yang, C; Yang, S; Yang, Y; Yang, Q; Ye, Z; Yepes, P; Yi, L; Yip, K; Yoo, IK; Yu, N; Zbroszczyk, H; Zha, W; Zhang, JB; Zhang, Z; Zhang, J; Zhang, S; Zhang, XP; Zhang, J; Zhang, Y; Zhao, J; Zhong, C; Zhou, L; Zhu, X; Zoulkarneeva, Y; Zyzak, M				Adamczyk, L.; Adkins, J. K.; Agakishiev, G.; Aggarwal, M. M.; Ahammed, Z.; Alekseev, I.; Alford, J.; Aparin, A.; Arkhipkin, D.; Aschenauer, E. C.; Averichev, G. S.; Bairathi, V.; Banerjee, A.; Bellwied, R.; Bhasin, A.; Bhati, A. K.; Bhattarai, P.; Bielcik, J.; Bielcikova, J.; Bland, L. C.; Bordyuzhin, I. G.; Bouchet, J.; Brandenburg, J. D.; Brandin, A. V.; Bunzarov, I.; Butterworth, J.; Caines, H.; Sanchez, M. Calderon de la Barca; Campbell, J. M.; Cebra, D.; Cervantes, M. C.; Chakaberia, I.; Chaloupka, P.; Chang, Z.; Chattopadhyay, S.; Chen, J. H.; Chen, X.; Cheng, J.; Cherney, M.; Christie, W.; Contin, G.; Crawford, H. J.; Das, S.; De Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; Deng, J.; Derevschikov, A. A.; di Ruzza, B.; Didenko, L.; Dilks, C.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Du, C. M.; Dunkelberger, L. E.; Dunlop, J. C.; Efimov, L. G.; Engelage, J.; Eppley, G.; Esha, R.; Evdokimov, O.; Eyser, O.; Fatemi, R.; Fazio, S.; Federic, P.; Fedorisin, J.; Feng, Z.; Filip, P.; Fisyak, Y.; Flores, C. E.; Fulek, L.; Gagliardi, C. A.; Garand, D.; Geurts, F.; Gibson, A.; Girard, M.; Greiner, L.; Grosnick, D.; Gunarathne, D. S.; Guo, Y.; Gupta, A.; Gupta, S.; Guryn, W.; Hamad, A.; Hamed, A.; Haque, R.; Harris, J. W.; He, L.; Heppelmann, S.; Heppelmann, S.; Hirsch, A.; Hoffmann, G. W.; Hofman, D. J.; Horvat, S.; Huang, B.; Huang, H. Z.; Huang, X.; Huck, P.; Humanic, T. J.; Igo, G.; Jacobs, W. W.; Jang, H.; Jiang, K.; Judd, E. G.; Kabana, S.; Kalinkin, D.; Kang, K.; Kauder, K.; Ke, H. W.; Keane, D.; Kechechyan, A.; Khan, Z. H.; Kikola, D. P.; Kisel, I.; Kisiel, A.; Klein, S.; Kochenda, L.; Koetke, D. D.; Kollegger, T.; Kosarzewski, L. K.; Kraishan, A. F.; Kravtsov, P.; Krueger, K.; Kulakov, I.; Kumar, L.; Kycia, R. A.; Lamont, M. A. C.; Landgraf, J. M.; Landry, K. D.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, J. H.; Li, X.; Li, Z. M.; Li, Y.; Li, W.; Li, X.; Li, C.; Lisa, M. A.; Liu, F.; Ljubicic, T.; Llope, W. J.; Lomnitz, M.; Longacre, R. S.; Luo, X.; Ma, G. L.; Ma, R.; Ma, Y. G.; Ma, L.; Magdy, N.; Majka, R.; Manion, A.; Margetis, S.; Markert, C.; Masui, H.; Matis, H. S.; McDonald, D.; Meehan, K.; Minaev, N. G.; Mioduszewski, S.; Mishra, D.; Mohanty, B.; Mondal, M. M.; Morozov, D. A.; Mustafa, M. K.; Nandi, B. K.; Nasim, Md.; Nayak, T. K.; Nigmatkulov, G.; Nogach, L. V.; Noh, S. Y.; Novak, J.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Oh, K.; Okorokov, V.; Olvitt, D., Jr.; Page, B. S.; Pak, R.; Pan, Y. X.; Pandit, Y.; Panebratsev, Y.; Pawlik, B.; Pei, H.; Perkins, C.; Peterson, A.; Pile, P.; Planinic, M.; Pluta, J.; Poljak, N.; Poniatowska, K.; Porter, J.; Posik, M.; Poskanzer, A. M.; Putschke, J.; Qiu, H.; Quintero, A.; Ramachandran, S.; Raniwala, R.; Raniwala, S.; Ray, R. L.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Roy, A.; Ruan, L.; Rusnak, J.; Rusnakova, O.; Sahoo, N. R.; Sahu, P. K.; Sakrejda, I.; Salur, S.; Sandweiss, J.; Sarkar, A.; Schambach, J.; Scharenberg, R. P.; Schmah, A. M.; Schmidke, W. B.; Schmitz, N.; Seger, J.; Seyboth, P.; Shah, N.; Shahaliev, E.; Shanmuganathan, P. V.; Shao, M.; Sharma, M. K.; Sharma, B.; Shen, W. Q.; Shi, S.; Shou, Q. Y.; Sichtermann, E. P.; Sikora, R.; Simko, M.; Skoby, M. J.; Smirnov, N.; Smirnov, D.; Song, L.; Sorensen, P.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Stepanov, M.; Stock, R.; Strikhanov, M.; Stringfellow, B.; Sumbera, M.; Summa, B.; Sun, Z.; Sun, X. M.; Sun, Y.; Sun, X.; Surrow, B.; Svirida, N.; Szelezniak, M. A.; Tang, Z.; Tang, A. H.; Tarnowsky, T.; Tawfik, A.; Thomas, J. H.; Timmins, A. R.; Tlusty, D.; Tokarev, M.; Trentalange, S.; Tribble, R. E.; Tribedy, P.; Tripathy, S. K.; Trzeciak, B. A.; Tsai, O. D.; Ullrich, T.; Underwood, D. G.; Upsal, I.; Van Buren, G.; van Nieuwenhuizen, G.; Vandenbroucke, M.; Varma, R.; Vasiliev, A. N.; Vertesi, R.; Videbaek, F.; Viyogi, Y. P.; Vokal, S.; Voloshin, S. A.; Vossen, A.; Wang, G.; Wang, H.; Wang, J. S.; Wang, Y.; Wang, Y.; Wang, F.; Webb, J. C.; Webb, G.; Wen, L.; Westfall, G. D.; Wieman, H.; Wissink, S. W.; Witt, R.; Wu, Y. F.; Xiao, Z. G.; Xie, W.; Xin, K.; Xu, Y. F.; Xu, Q. H.; Xu, H.; Xu, N.; Xu, Z.; Yang, Y.; Yang, C.; Yang, S.; Yang, Y.; Yang, Q.; Ye, Z.; Yepes, P.; Yi, L.; Yip, K.; Yoo, I. -K.; Yu, N.; Zbroszczyk, H.; Zha, W.; Zhang, J. B.; Zhang, Z.; Zhang, J.; Zhang, S.; Zhang, X. P.; Zhang, J.; Zhang, Y.; Zhao, J.; Zhong, C.; Zhou, L.; Zhu, X.; Zoulkarneeva, Y.; Zyzak, M.		STAR Collaboration	Measurement of interaction between antiprotons	NATURE			English	Article							FEMTOSCOPY; COLLISIONS	One of the primary goals of nuclear physics is to understand the force between nucleons, which is a necessary step for understanding the structure of nuclei and how nuclei interact with each other. Rutherford discovered the atomic nucleus in 1911, and the large body of knowledge about the nuclear force that has since been acquired was derived from studies made on nucleons or nuclei. Although antinuclei up to antihelium-4 have been discovered(1) and their masses measured, little is known directly about the nuclear force between antinucleons. Here, we study antiproton pair correlations among data collected by the STAR experiment(2) at the Relativistic Heavy Ion Collider (RHIC)(3), where gold ions are collided with a centre-of-mass energy of 200 gigaelectronvolts per nucleon pair. Antiprotons are abundantly produced in such collisions, thus making it feasible to study details of the antiproton-antiproton interaction. By applying a technique similar to Hanbury Brown and Twiss intensity interferometry(4), we show that the force between two antiprotons is attractive. In addition, we report two key parameters that characterize the corresponding strong interaction: the scattering length and the effective range of the interaction. Our measured parameters are consistent within errors with the corresponding values for proton-proton interactions. Our results provide direct information on the interaction between two antiprotons, one of the simplest systems of antinucleons, and so are fundamental to understanding the structure of more-complex antinuclei and their properties.	[Adamczyk, L.; Fulek, L.; Sikora, R.] AGH Univ Sci & Technol, PL-30059 Krakow, Poland; [Adkins, J. K.; Fatemi, R.; Ramachandran, S.] Univ Kentucky, Lexington, KY 40506 USA; [Agakishiev, G.; Aparin, A.; Averichev, G. S.; Bunzarov, I.; Dedovich, T. G.; Efimov, L. G.; Fedorisin, J.; Filip, P.; Kechechyan, A.; Lednicky, R.; Panebratsev, Y.; Rogachevskiy, O. V.; Shahaliev, E.; Tokarev, M.; Vokal, S.; Zoulkarneeva, Y.] Joint Inst Nucl Res, Dubna 141980, Russia; [Aggarwal, M. M.; Bhati, A. K.; Kumar, L.; Sharma, B.] Panjab Univ, Chandigarh 160014, India; [Ahammed, Z.; Banerjee, A.; Chattopadhyay, S.; Nayak, T. K.; Roy, A.; Tribedy, P.; Viyogi, Y. P.] Ctr Variable Energy Cyclotron, Kolkata 700064, India; [Alekseev, I.; Bordyuzhin, I. G.; Kalinkin, D.; Svirida, N.] Alikhanov Inst Theoret & Expt Phys, Moscow 117218, Russia; [Alford, J.; Bouchet, J.; Hamad, A.; Kabana, S.; Keane, D.; Lomnitz, M.; Margetis, S.; Quintero, A.; Shanmuganathan, P. V.] Kent State Univ, Kent, OH 44242 USA; [Arkhipkin, D.; Aschenauer, E. C.; Bland, L. C.; Chakaberia, I.; Christie, W.; Debbe, R. R.; di Ruzza, B.; Didenko, L.; Dunlop, J. C.; Eyser, O.; Fazio, S.; Fisyak, Y.; Guryn, W.; Heppelmann, S.; Ke, H. W.; Lamont, M. A. C.; Landgraf, J. M.; Lauret, J.; Lebedev, A.; Lee, J. H.; Li, X.; Ljubicic, T.; Longacre, R. S.; Ma, R.; Ogawa, A.; Page, B. S.; Pak, R.; Pile, P.; Ruan, L.; Schmidke, W. B.; Smirnov, D.; Sorensen, P.; Tang, A. H.; Ullrich, T.; Van Buren, G.; van Nieuwenhuizen, G.; Videbaek, F.; Wang, H.; Webb, J. C.; Webb, G.; Xu, Z.; Yip, K.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Bairathi, V.; Haque, R.; Mishra, D.; Mohanty, B.] Natl Inst Sci Educ & Res, Bhubaneswar 751005, Orissa, India; [Bellwied, R.; McDonald, D.; Song, L.; Timmins, A. R.] Univ Houston, Houston, TX 77204 USA; [Bhasin, A.; Gupta, A.; Gupta, S.; Sharma, M. K.] Univ Jammu, Jammu 180001, India; [Bhattarai, P.; Hoffmann, G. W.; Markert, C.; Ray, R. L.; Schambach, J.] Univ Texas Austin, Austin, TX 78712 USA; [Bielcik, J.; Chaloupka, P.; Rusnakova, O.; Trzeciak, B. A.] Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-11519 Prague, Czech Republic; [Bielcikova, J.; Federic, P.; Rusnak, J.; Simko, M.; Sumbera, M.; Tlusty, D.; Vertesi, R.] Nucl Phys Inst AS CR, Prague 25068, Czech Republic; [Brandenburg, J. D.; Butterworth, J.; Eppley, G.; Geurts, F.; Roberts, J. B.; Xin, K.; Yepes, P.] Rice Univ, Houston, TX 77251 USA; [Brandin, A. V.; Kochenda, L.; Kravtsov, P.; Nigmatkulov, G.; Okorokov, V.; Strikhanov, M.] Moscow Engn Phys Inst, Moscow 115409, Russia; [Caines, H.; Harris, J. W.; Horvat, S.; Majka, R.; Sandweiss, J.; Smirnov, N.; Yi, L.] Yale Univ, New Haven, CT 06520 USA; [Sanchez, M. Calderon de la Barca; Cebra, D.; Draper, J. E.; Flores, C. E.; Meehan, K.; Romero, J. L.] Univ Calif Davis, Davis, CA 95616 USA; [Campbell, J. M.; Humanic, T. J.; Lisa, M. A.; Peterson, A.; Upsal, I.] Ohio State Univ, Columbus, OH 43210 USA; [Cervantes, M. C.; Chang, Z.; Gagliardi, C. A.; Hamed, A.; Mioduszewski, S.; Mondal, M. M.; Sahoo, N. R.; Tribble, R. E.] Texas A&M Univ, College Stn, TX 77843 USA; [Chen, J. H.; Li, W.; Ma, G. L.; Ma, Y. G.; Ma, L.; Shah, N.; Shen, W. Q.; Shou, Q. Y.; Xu, Y. F.; Zhang, Z.; Zhang, S.; Zhong, C.] Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Chen, X.; Du, C. M.; Sun, Z.; Wang, J. S.; Xu, H.; Yang, Y.; Zhang, J.] Inst Modern Phys, Lanzhou 730000, Peoples R China; [Cheng, J.; Huang, X.; Kang, K.; Li, Y.; Wang, Y.; Xiao, Z. G.; Zhang, X. P.; Zhu, X.] Tsinghua Univ, Beijing 100084, Peoples R China; [Cherney, M.; De Silva, L. C.; Seger, J.] Creighton Univ, Omaha, NE 68178 USA; [Contin, G.; Dong, X.; Greiner, L.; Klein, S.; Manion, A.; Masui, H.; Matis, H. S.; Mustafa, M. K.; Odyniec, G.; Porter, J.; Poskanzer, A. M.; Qiu, H.; Ritter, H. G.; Sakrejda, I.; Salur, S.; Schmah, A. M.; Sichtermann, E. P.; Sun, X.; Szelezniak, M. A.; Thomas, J. H.; Wieman, H.; Xu, N.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Crawford, H. J.; Engelage, J.; Judd, E. G.; Perkins, C.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Das, S.; Sahu, P. K.; Tripathy, S. K.] Inst Phys, Bhubaneswar 751005, Orissa, India; [Deng, J.; Xu, Q. H.; Zhang, J.] Shandong Univ, Jinan 250100, Shandong, Peoples R China; [Derevschikov, A. A.; Minaev, N. G.; Morozov, D. A.; Nogach, L. V.; Nurushev, S. B.; Vasiliev, A. N.] Inst High Energy Phys, Protvino 142281, Russia; [Dilks, C.; Heppelmann, S.; Summa, B.] Penn State Univ, University Pk, PA 16802 USA; [Drachenberg, J. L.; Gibson, A.; Grosnick, D.; Koetke, D. D.; Stanislaus, T. D. S.] Valparaiso Univ, Valparaiso, IN 46383 USA; [Dunkelberger, L. E.; Esha, R.; Huang, H. Z.; Igo, G.; Landry, K. D.; Nasim, Md.; Pan, Y. X.; Trentalange, S.; Tsai, O. D.; Wang, G.; Wen, L.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Evdokimov, O.; Hofman, D. J.; Huang, B.; Khan, Z. H.; Pandit, Y.; Ye, Z.] Univ Illinois, Chicago, IL 60607 USA; [Feng, Z.; Huck, P.; Li, Z. M.; Liu, F.; Luo, X.; Pei, H.; Shi, S.; Sun, X. M.; Wang, Y.; Wu, Y. F.; Yang, Y.; Yu, N.; Zhang, J. B.; Zhao, J.] Cent China Normal Univ HZNU, Wuhan 430079, Peoples R China; [Garand, D.; He, L.; Hirsch, A.; Scharenberg, R. P.; Srivastava, B.; Stepanov, M.; Stringfellow, B.; Wang, F.; Xie, W.; Zbroszczyk, H.] Purdue Univ, W Lafayette, IN 47907 USA; [Girard, M.; Kikola, D. P.; Kisiel, A.; Kosarzewski, L. K.; Pluta, J.; Poniatowska, K.] Warsaw Univ Technol, PL-00661 Warsaw, Poland; [Gunarathne, D. S.; Kraishan, A. F.; Li, X.; Olvitt, D., Jr.; Posik, M.; Surrow, B.; Vandenbroucke, M.] Temple Univ, Philadelphia, PA 19122 USA; [Guo, Y.; Jiang, K.; Li, C.; Shao, M.; Sun, Y.; Tang, Z.; Yang, C.; Yang, S.; Yang, Q.; Zha, W.; Zhang, Y.; Zhou, L.] Univ Sci & Technol China, Hefei 230026, Peoples R China; [Jacobs, W. W.; Skoby, M. J.; Vossen, A.; Wissink, S. W.] Indiana Univ, Bloomington, IN 47408 USA; [Jang, H.; Noh, S. Y.] Korea Inst Sci & Technol Informat, Daejeon 305701, South Korea; [Kauder, K.; Llope, W. J.; Putschke, J.; Voloshin, S. A.] Wayne State Univ, Detroit, MI 48201 USA; [Kisel, I.; Kollegger, T.; Kulakov, I.; Stock, R.; Zyzak, M.] FIAS, D-60438 Frankfurt, Germany; [Krueger, K.; Spinka, H. M.; Underwood, D. G.] Argonne Natl Lab, Argonne, IL 60439 USA; [Kycia, R. A.; Pawlik, B.] Inst Nucl Phys PAN, PL-31342 Krakow, Poland; [Magdy, N.; Tawfik, A.] WLCAPP, Cairo 11571, Egypt; [Nandi, B. K.; Sarkar, A.; Varma, R.] Indian Inst Technol, Mumbai 400076, Maharashtra, India; [Novak, J.; Tarnowsky, T.; Westfall, G. D.] Michigan State Univ, E Lansing, MI 48824 USA; [Oh, K.; Yoo, I. -K.] Pusan Natl Univ, Pusan 609735, South Korea; [Planinic, M.; Poljak, N.] Univ Zagreb, HR-10002 Zagreb, Croatia; [Raniwala, R.; Raniwala, S.] Univ Rajasthan, Jaipur 302004, Rajasthan, India; [Schmitz, N.; Seyboth, P.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Witt, R.] US Naval Acad, Annapolis, MD 21402 USA	AGH University of Science & Technology; University of Kentucky; Joint Institute for Nuclear Research - Russia; Panjab University; Variable Energy Cyclotron Centre; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; United States Department of Energy (DOE); Brookhaven National Laboratory; National Institute of Science Education & Research (NISER); University of Houston System; University of Houston; University of Jammu; University of Texas System; University of Texas Austin; Czech Technical University Prague; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences; Rice University; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Yale University; University of California System; University of California Davis; University System of Ohio; Ohio State University; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Tsinghua University; Creighton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Institute of Physics Bhubaneswar (IOPB); Shandong University; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Valparaiso University; University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Central China Normal University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Warsaw University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Indiana University System; Indiana University Bloomington; Korea Institute of Science & Technology Information (KISTI); Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Michigan State University; Pusan National University; University of Zagreb; University of Rajasthan; Max Planck Society; United States Department of Defense; United States Navy; United States Naval Academy	Adamczyk, L (corresponding author), AGH Univ Sci & Technol, PL-30059 Krakow, Poland.		Bielcikova, Jana/G-9342-2014; Hamed, Ahmed Abdeen/AAF-4658-2020; Okorokov, Vitaly/AFM-5721-2022; Xin, Kefeng/O-9195-2016; Huang, Bingchu/H-6343-2015; Tawfik, Abdel Nasser/M-6220-2013; Aparin, Alexey/AAE-1455-2022; Kisiel, Adam/O-8754-2015; Pan, Yuan-Xiang/C-6576-2019; Kisel, Ivan/H-7077-2017; Haque, Md Rihan/W-5921-2018; Alekseev, Igor G/J-8070-2014; Stepanov, Mikhail/GZM-6775-2022; Tokarev, Mikhail/GRE-9737-2022; Planinic, Mirko/E-8085-2012; Strikhanov, Mikhail N/P-7393-2014; Bielcikova, Jana/AAB-4862-2020; Bairathi, Vipul/AAR-3812-2021; Pawlik, Bogdan/W-2346-2018; Bordyuzhin, Igor/AGX-2537-2022; Kycia, Radosław/J-4397-2015; Lednicky, Richard/K-4164-2013; Nigmatkulov, Grigory/AAH-9428-2019; Gunarathne, Devika/C-4903-2017; Fulek, Lukasz/AAA-5721-2021; Matis, Howard/AAO-2082-2021; Sumbera, Michal/O-7497-2014; Bhasin, Anju/AAS-4745-2021; Chaloupka, Petr/E-5965-2012; Rusnak, Jan/G-8462-2014; Kumar, Lokesh/A-6154-2010; Li, Xuan/K-6034-2017; Okorokov, Vitaly/C-4800-2017; Yi, Li/GOV-3489-2022; XIAO, Zhi Gang/C-9460-2016; Shi, Shusu/ABC-6567-2021; Raniwala, Rashmi/AAA-3747-2022; Ma, Yu-Gang/M-8122-2013; Fazio, Salvatore/G-5156-2010; Di Ruzza, Benedetto/ABG-2800-2021; Vasiliev, Alexander N/N-4742-2017; Zhao, Jie/AAD-3191-2022; Sahoo, Nihar Ranjan/ABF-3516-2021; Sikora, Rafał/AAM-4274-2021; Poljak, Nikola/AAI-4178-2020; Kabana, Sonia/ABF-5974-2020; Li, Xuan/D-2549-2018; Zyzak, Maksym/J-4692-2017; Tang, Zebo/A-9939-2014; Fisyak, Yuri/K-2142-2017; Yip, Kin/D-6860-2013	Okorokov, Vitaly/0000-0002-7162-5345; Xin, Kefeng/0000-0003-4853-9219; Huang, Bingchu/0000-0002-3253-3210; Tawfik, Abdel Nasser/0000-0002-1679-0225; Kisiel, Adam/0000-0001-8322-9510; Pan, Yuan-Xiang/0000-0003-3219-4367; Kisel, Ivan/0000-0002-4808-419X; Haque, Md Rihan/0000-0001-7978-9638; Alekseev, Igor G/0000-0003-3358-9635; Stepanov, Mikhail/0000-0003-1331-8897; Planinic, Mirko/0000-0001-6760-2514; Strikhanov, Mikhail N/0000-0003-2586-0405; Pawlik, Bogdan/0000-0003-1197-5180; Kycia, Radosław/0000-0002-6390-4627; Lednicky, Richard/0000-0001-6887-1804; Nigmatkulov, Grigory/0000-0003-2232-5124; Gunarathne, Devika/0000-0002-7155-7418; Fulek, Lukasz/0000-0002-9606-5954; Sumbera, Michal/0000-0002-0639-7323; Rusnak, Jan/0000-0002-4738-7869; Kumar, Lokesh/0000-0002-2746-9840; Li, Xuan/0000-0002-3167-8629; Okorokov, Vitaly/0000-0002-7162-5345; Yi, Li/0000-0002-7512-2657; XIAO, Zhi Gang/0000-0001-9534-5981; Shi, Shusu/0000-0003-2032-0848; Ma, Yu-Gang/0000-0002-0233-9900; Fazio, Salvatore/0000-0002-4321-1946; Di Ruzza, Benedetto/0000-0001-9925-5254; Zhao, Jie/0000-0001-6408-2314; Sahoo, Nihar Ranjan/0000-0003-4518-6630; Sikora, Rafał/0000-0001-5185-2367; Kabana, Sonia/0000-0003-0568-5750; Li, Xuan/0000-0002-3167-8629; Tang, Zebo/0000-0002-4247-0081; Greiner, Leo/0000-0003-1476-6245; Trzeciak, Barbara/0000-0002-8672-2295; Klein, Spencer/0000-0003-2841-6553; Federic, Pavol/0000-0001-5137-473X; Thomas, James/0000-0002-6256-4536; Ke, Hongwei/0000-0003-1463-7291; Kikola, Daniel/0000-0001-6896-6475; Vossen, Anselm/0000-0003-0983-4936; Bhasin, Anju/0000-0002-3687-8179; Chang, Zilong/0000-0003-4729-8708; Bairathi, Vipul/0000-0003-3415-6911; Poljak, Nikola/0000-0002-4512-9620; Abdelrahman, Niseem/0000-0002-6458-6552; Shou, Qiye/0000-0001-5128-6238; M. Hamed, Ahmed/0000-0003-1732-8443; Chattopadhyay, Subhasis/0000-0003-1097-8806; Evdokimov, Olga/0000-0002-1250-8931; Chakaberia, Irakli/0000-0002-9614-4046; Sorensen, Paul/0000-0001-5056-9391; OH, Kunsu/0000-0002-8342-9747; Fisyak, Yuri/0000-0002-3151-8377; Tripathy, Srikanta Kumar/0000-0002-9367-0884; Aparin, Alexey/0000-0002-2421-7517; Adamczyk, Leszek/0000-0002-5859-2075; Roy, Ashim/0000-0002-5622-4260; Yip, Kin/0000-0002-8576-4311	RHIC Operations Group; RCF at BNL; NERSC Center at LBNL; KISTI Center in Korea; Open Science Grid consortium; Office of Nuclear Physics within the US DOE Office of Science; Ministry of Education and Science of the Russian Federation; NSFC; MoST of China [2014CB845400]; CAS of China; MoE of China; Korean Research Foundation; GA of the Czech Republic; MSMT of the Czech Republic; FIAS of Germany; DAE of India; DST of India; UGC of India; National Science Centre of Poland; National Research Foundation; Ministry of Science, Education and Sports of the Republic of Croatia; RosAtom of Russia; US NSF; Division Of Physics [1206009, 1352081, 1505716] Funding Source: National Science Foundation	RHIC Operations Group; RCF at BNL; NERSC Center at LBNL; KISTI Center in Korea(Korea Institute of Science & Technology Information (KISTI)); Open Science Grid consortium; Office of Nuclear Physics within the US DOE Office of Science(United States Department of Energy (DOE)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); NSFC(National Natural Science Foundation of China (NSFC)); MoST of China(Ministry of Science and Technology, China); CAS of China; MoE of China(Ministry of Education, China); Korean Research Foundation(National Research Foundation of Korea); GA of the Czech Republic; MSMT of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); FIAS of Germany; DAE of India; DST of India; UGC of India; National Science Centre of Poland(National Science Centre, Poland); National Research Foundation; Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); RosAtom of Russia; US NSF(National Science Foundation (NSF)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the RHIC Operations Group and RCF at BNL, the NERSC Center at LBNL, the KISTI Center in Korea, and the Open Science Grid consortium for providing resources and support. This work was supported in part by the Office of Nuclear Physics within the US DOE Office of Science, the US NSF, the Ministry of Education and Science of the Russian Federation, NSFC, the MoST of China (973 Programme No. 2014CB845400), CAS, MoST and MoE of China, the Korean Research Foundation, GA and MSMT of the Czech Republic, FIAS of Germany, DAE, DST and UGC of India, the National Science Centre of Poland, National Research Foundation, the Ministry of Science, Education and Sports of the Republic of Croatia, and RosAtom of Russia.	Ackermann KH, 2003, NUCL INSTRUM METH A, V499, P624, DOI 10.1016/S0168-9002(02)01960-5; Agakishiev H, 2011, NATURE, V473, P353, DOI 10.1038/nature10079; ALICE Collaboration, 2015, PREPRINT; Anderson M, 2003, NUCL INSTRUM METH A, V499, P659, DOI 10.1016/S0168-9002(02)01964-2; BERGERVOET JR, 1988, PHYS REV C, V38, P15, DOI 10.1103/PhysRevC.38.15; BOAL DH, 1990, REV MOD PHYS, V62, P553, DOI 10.1103/RevModPhys.62.553; BODMER AR, 1985, PHYS REV C, V31, P1400, DOI 10.1103/PhysRevC.31.1400; BROWN RH, 1954, PHILOS MAG, V45, P663; Chojnacki M, 2012, COMPUT PHYS COMMUN, V183, P746, DOI 10.1016/j.cpc.2011.11.018; ERAZMUS B, 1995, NUCL PHYS A, V583, pC395; GMITRO M, 1986, CZECH J PHYS, V36, P1281, DOI 10.1007/BF01598029; GOLDHABER G, 1960, PHYS REV, V120, P300, DOI 10.1103/PhysRev.120.300; GYULASSY M, 1979, PHYS REV C, V20, P2267, DOI 10.1103/PhysRevC.20.2267; Harrison M, 2003, NUCL INSTRUM METH A, V499, P235, DOI 10.1016/S0168-9002(02)01937-X; HELLER L, 1967, REV MOD PHYS, V39, P584, DOI 10.1103/RevModPhys.39.584; Kiesel H, 2002, NATURE, V418, P392, DOI 10.1038/nature00911; Kisiel A, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.054916; KOONIN SE, 1977, PHYS LETT B, V70, P43, DOI 10.1016/0370-2693(77)90340-9; Kopylov G. I., 1975, SOV PHYS JETP, V42, P211; Landau L. D., 1974, KVANTOVAYA MEKHANIKA, P585; Landau Lev Davidovich, 2013, QUANTUM MECH NONRELA; Lednicky R, 2008, PHYS ATOM NUCL+, V71, P1572, DOI 10.1134/S1063778808090123; Lednicky R, 2007, BRAZ J PHYS, V37, P939, DOI 10.1590/S0103-97332007000600011; Lednicky R, 2004, PHYS ATOM NUCL+, V67, P72, DOI 10.1134/1.1644010; LEDNICKY R, 1982, SOV J NUCL PHYS+, V35, P770; Lednicky R, 2009, PHYS PART NUCLEI+, V40, P307, DOI 10.1134/S1063779609030034; Lisa MA, 2005, ANNU REV NUCL PART S, V55, P357, DOI 10.1146/annurev.nucl.55.090704.151533; Llope WJ, 2012, NUCL INSTRUM METH A, V661, pS110, DOI 10.1016/j.nima.2010.07.086; MATHELITSCH L, 1984, PHYS REV C, V29, P739, DOI 10.1103/PhysRevC.29.739; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; POCHODZALLA J, 1987, PHYS REV C, V35, P1695, DOI 10.1103/PhysRevC.35.1695; Podgoretskii M. I., 1989, Soviet Journal of Particles and Nuclei, V20, P266; Riotto A, 1999, ANNU REV NUCL PART S, V49, P35, DOI 10.1146/annurev.nucl.49.1.35; Schellekens M, 2005, SCIENCE, V310, P648, DOI 10.1126/science.1118024; SLAUS I, 1989, PHYS REP, V173, P257, DOI 10.1016/0370-1573(89)90127-0; STAR Collaboration, 2011, NATURE, V475, P412, DOI 10.1038/nature10264; STAR Collaboration, 2006, PHYS REV C, V74; STAR Collaboration, 2015, PHYS REV LETT, V114	40	52	55	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					345	+		10.1038/nature15724	http://dx.doi.org/10.1038/nature15724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26536116	Green Submitted, Green Published			2022-12-28	WOS:000365356800049
J	Mason, JA; Oktawiec, J; Taylor, MK; Hudson, MR; Rodriguez, J; Bachman, JE; Gonzalez, MI; Cervellino, A; Guagliardi, A; Brown, CM; Llewellyn, PL; Masciocchi, N; Long, JR				Mason, Jarad A.; Oktawiec, Julia; Taylor, Mercedes K.; Hudson, Matthew R.; Rodriguez, Julien; Bachman, Jonathan E.; Gonzalez, Miguel I.; Cervellino, Antonio; Guagliardi, Antonietta; Brown, Craig M.; Llewellyn, Philip L.; Masciocchi, Norberto; Long, Jeffrey R.			Methane storage in flexible metal-organic frameworks with intrinsic thermal management	NATURE			English	Article							NATURAL-GAS STORAGE; ADSORPTION; CRYSTALS; CO(1,4-BENZENEDIPYRAZOLATE); THERMODYNAMICS; PRESSURE; MODEL	As a cleaner, cheaper, and more globally evenly distributed fuel, natural gas has considerable environmental, economic, and political advantages over petroleum as a source of energy for the transportation sector(1,2). Despite these benefits, its low volumetric energy density at ambient temperature and pressure presents substantial challenges, particularly for light-duty vehicles with little space available for on-board fuel storage(3). Adsorbed natural gas systems have the potential to store high densities of methane (CH4, the principal component of natural gas) within a porous material at ambient temperature and moderate pressures(4). Although activated carbons, zeolites, and metal-organic frameworks have been investigated extensively for CH4 storage(5-8), there are practical challenges involved in designing systems with high capacities and in managing the thermal fluctuations associated with adsorbing and desorbing gas from the adsorbent. Here, we use a reversible phase transition in a metal-organic framework to maximize the deliverable capacity of CH4 while also providing internal heat management during adsorption and desorption. In particular, the flexible compounds Fe(bdp) and Co(bdp) (bdp(2-) = 1,4-benzenedipyrazolate) are shown to undergo a structural phase transition in response to specific CH4 pressures, resulting in adsorption and desorption isotherms that feature a sharp 'step'. Such behaviour enables greater storage capacities than have been achieved for classical adsorbents(9), while also reducing the amount of heat released during adsorption and the impact of cooling during desorption. The pressure and energy associated with the phase transition can be tuned either chemically or by application of mechanical pressure.	[Mason, Jarad A.; Oktawiec, Julia; Taylor, Mercedes K.; Bachman, Jonathan E.; Gonzalez, Miguel I.; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hudson, Matthew R.; Brown, Craig M.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Rodriguez, Julien; Llewellyn, Philip L.] Aix Marseille Univ, CNRS, Lab MADIREL UMR 7246, Ctr St Jerome, F-13397 Marseille 20, France; [Cervellino, Antonio] Paul Scherrer Inst, Lab Synchrotron Radiat Condensed Matter, Swiss Light Source, CH-5232 Villigen, Switzerland; [Guagliardi, Antonietta] CNR, Ist Cristallog, I-22100 Como, Italy; [Brown, Craig M.] Univ Delaware, Chem & Biomol Engn, Newark, DE 19716 USA; [Masciocchi, Norberto] Univ Insubria, Dipartimento Sci & Alta Tecnol, I-22100 Como, Italy; [Masciocchi, Norberto] To Sca Lab, I-22100 Como, Italy	University of California System; University of California Berkeley; National Institute of Standards & Technology (NIST) - USA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); University of Delaware; University of Insubria	Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jrlong@berkeley.edu	MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019; Masciocchi, Norberto/K-4400-2015; Guagliardi, Antonietta/K-4471-2015; Cervellino, Antonio/AAK-1703-2020; LLEWELLYN, Philip L/J-3458-2012; Cervellino, Antonio/C-3007-2012; Guagliardi, Antonietta/ABD-9291-2021; Enrique, Colacio/L-6020-2014; Brown, Craig M/B-5430-2009; Bachman, Jonathan/H-3233-2014	Masciocchi, Norberto/0000-0001-9921-2350; Guagliardi, Antonietta/0000-0001-6390-2114; Cervellino, Antonio/0000-0002-9086-2717; LLEWELLYN, Philip L/0000-0001-5124-7052; Cervellino, Antonio/0000-0002-9086-2717; Guagliardi, Antonietta/0000-0001-6390-2114; Enrique, Colacio/0000-0002-6745-9241; Brown, Craig M/0000-0002-9637-9355; Oktawiec, Julia/0000-0002-2895-3327; Bachman, Jonathan/0000-0002-3313-2355; Gonzalez, Miguel/0000-0003-4250-9035; Taylor, Mercedes/0000-0002-0945-766X	Advanced Research Projects Agency - Energy (ARPA-E) of the US Department of Energy (DoE); Argonne National Laboratory [DE-AC02-06CH11357]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; National Science Foundation	Advanced Research Projects Agency - Energy (ARPA-E) of the US Department of Energy (DoE)(United States Department of Energy (DOE)); Argonne National Laboratory(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the Advanced Research Projects Agency - Energy (ARPA-E) of the US Department of Energy (DoE). Powder X-ray diffraction data were collected at beamline 17-BM-B at the Advanced Photon Source, a DoE Office of Science User Facility operated by Argonne National Laboratory under contract no. DE-AC02-06CH11357 and at beamline MS-X04SA of the Swiss Light Source (SLS) at the Paul Scherrer Institut. Single-crystal X-ray diffraction experiments were performed at beamline 11.3.1 at the Advanced Light Source, a DoE Office of Science User Facility operated by Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231. In addition, we thank M. Veenstra, D. A. Boysen, T. M. McDonald, D. J. Xiao, M. Nippe, Z. Hulvey, G. J. Halder, K. J. Gagnon, S. J. Teat, and the technical staff of the MS-X04SA beamline at SLS for experimental assistance and discussions. We also thank the National Science Foundation for providing graduate fellowship support for J.O. and J.E.B.	Advanced Research Projects Agency-Energy, 2012, METH OPP VEH EN; Beurroies I, 2010, ANGEW CHEM INT EDIT, V49, P7526, DOI 10.1002/anie.201003048; Choi HJ, 2008, J AM CHEM SOC, V130, P7848, DOI 10.1021/ja8024092; Coudert FX, 2008, J AM CHEM SOC, V130, P14294, DOI 10.1021/ja805129c; Coudert FX, 2015, CHEM MATER, V27, P1905, DOI 10.1021/acs.chemmater.5b00046; Ferey G, 2009, CHEM SOC REV, V38, P1380, DOI 10.1039/b804302g; Ghysels A, 2013, J PHYS CHEM C, V117, P11540, DOI 10.1021/jp311601q; He YB, 2014, CHEM SOC REV, V43, P5657, DOI 10.1039/c4cs00032c; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; Hosemann R., 1962, DIRECT ANAL DIFFRACT; Kitaura R, 2003, ANGEW CHEM INT EDIT, V42, P428, DOI 10.1002/anie.200390130; Lemmon E.W., 2007, NIST STANDARD REFERE; Li B, 2014, J AM CHEM SOC, V136, P6207, DOI 10.1021/ja501810r; Li D, 2001, CHEM PHYS LETT, V335, P50, DOI 10.1016/S0009-2614(00)01419-6; Llewellyn PL, 2005, CR CHIM, V8, P283, DOI 10.1016/j.crci.2004.11.004; Lu Y, 2008, Z ANORG ALLG CHEM, V634, P2411, DOI 10.1002/zaac.200800158; Makal TA, 2012, CHEM SOC REV, V41, P7761, DOI 10.1039/c2cs35251f; Mason JA, 2014, CHEM SCI, V5, P32, DOI 10.1039/c3sc52633j; Mota JPB, 1997, CARBON, V35, P1259, DOI 10.1016/S0008-6223(97)00075-4; Neimark AV, 2010, J PHYS CHEM LETT, V1, P445, DOI 10.1021/jz9003087; Noguchi H, 2005, J PHYS CHEM B, V109, P13851, DOI 10.1021/jp052515o; Patrick BO, 2001, POLYHEDRON, V20, P1577, DOI 10.1016/S0277-5387(01)00657-X; Peng Y, 2013, J AM CHEM SOC, V135, P11887, DOI 10.1021/ja4045289; Salles F, 2010, J AM CHEM SOC, V132, P13782, DOI 10.1021/ja104357r; Schneemann A, 2014, CHEM SOC REV, V43, P6062, DOI 10.1039/c4cs00101j; Service RF, 2014, SCIENCE, V346, P538, DOI 10.1126/science.346.6209.538; Simon CM, 2015, ENERG ENVIRON SCI, V8, P1190, DOI 10.1039/c4ee03515a; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Walton KS, 2006, ADSORPTION, V12, P227, DOI 10.1007/s10450-006-0142-3; Wegrzyn J, 1996, APPL ENERG, V55, P71, DOI 10.1016/S0306-2619(96)00015-3; Weickert M., 2015, World Intellectual Property Organization patent, Patent No. [WO 2015/022633 A1, 2015022633]; Whyatt G. A., 2010, PNNL19745 US DEP EN; Yeh S, 2007, ENERG POLICY, V35, P5865, DOI 10.1016/j.enpol.2007.06.012; Yot PG, 2012, CHEM SCI, V3, P1100, DOI 10.1039/c2sc00745b	34	639	650	34	683	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					357	+		10.1038/nature15732	http://dx.doi.org/10.1038/nature15732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26503057				2022-12-28	WOS:000365356800052
J	Li, P; Stuart, EA; Allison, DB				Li, Peng; Stuart, Elizabeth A.; Allison, David B.			Multiple Imputation A Flexible Tool for Handling Missing Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Li, Peng; Allison, David B.] Univ Alabama Birmingham, Off Energet & Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Li, Peng; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Allison, DB (corresponding author), Univ Alabama Birmingham, Off Energet & Nutr Obes Res Ctr, Ryals Bldg,Room 140J,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@uab.edu		Li, Peng/0000-0002-9026-9999; Stuart, Elizabeth/0000-0002-9042-8611	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL124208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, R25DK099080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099010] Funding Source: NIH RePORTER; NHLBI NIH HHS [R25 HL124208, R25HL124208] Funding Source: Medline; NIDDK NIH HHS [P30 DK056336, R25DK099080, P30DK056336, R25 DK099080] Funding Source: Medline; NIMH NIH HHS [R01 MH099010, R01MH099010] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asch DA, 2015, JAMA-J AM MED ASSOC, V314, P1926, DOI 10.1001/jama.2015.14850; Capers Patrice L, 2015, Front Nutr, V2, P6, DOI 10.3389/fnut.2015.00006; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Newgard CD, 2015, JAMA-J AM MED ASSOC, V314, P940, DOI 10.1001/jama.2015.10516; Padilla MA, 2009, HUM HERED, V68, P65, DOI 10.1159/000210450; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Wang H, 2012, ANN APPL STAT, V6, P229, DOI 10.1214/11-AOAS506; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	9	193	193	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1966	1967		10.1001/jama.2015.15281	http://dx.doi.org/10.1001/jama.2015.15281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547468	Green Accepted			2022-12-28	WOS:000364490700019
J	Polonsky, TS; Blankstein, R				Polonsky, Tamar S.; Blankstein, Ron			Exercise Treadmill Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR ANGIOGRAPHY; COMPUTED-TOMOGRAPHY; THORACIC SURGEONS; TASK-FORCE; INTERVENTIONS; GUIDELINES; MANAGEMENT; CARDIOLOGY		[Polonsky, Tamar S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Blankstein, Ron] Harvard Univ, Brigham & Womens Hosp, Dept Med & Radiol, Sch Med, Boston, MA 02115 USA	University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Polonsky, TS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC6080, Chicago, IL 60637 USA.	tpolonsky@medicine.bsd.uchicago.edu						Cheezum MK, 2015, EUR HEART J-CARD IMG, V16, P1338, DOI 10.1093/ehjci/jev087; Christman MP, 2014, J AM COLL CARDIOL, V63, P1264, DOI 10.1016/j.jacc.2013.11.052; Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Mieres JH, 2014, CIRCULATION, V130, P350, DOI 10.1161/CIR.0000000000000061; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Rywik TM, 1998, CIRCULATION, V97, P2117, DOI 10.1161/01.CIR.97.21.2117; Shaw LJ, 2011, CIRCULATION, V124, P1239, DOI 10.1161/CIRCULATIONAHA.111.029660; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009	10	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1968	1969		10.1001/jama.2015.11719	http://dx.doi.org/10.1001/jama.2015.11719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547469				2022-12-28	WOS:000364490700020
J	Bach, PB				Bach, Peter B.			New Math on Drug Cost-Effectiveness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.							Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Herper M., 2015, FORBES; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; Institute for Clinical and Economic Review, 2015, EV VAL NEW DRUGS DEV; Pollack A., 2006, NY TIMES	5	53	53	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1797	1799		10.1056/NEJMp1512750	http://dx.doi.org/10.1056/NEJMp1512750			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3FK	26535510				2022-12-28	WOS:000364144000002
J	Grun, D; van Oudenaarden, A				Gruen, Dominic; van Oudenaarden, Alexander			Design and Analysis of Single-Cell Sequencing Experiments	CELL			English	Article							WHOLE GENOME AMPLIFICATION; MESSENGER-RNA-SEQ; GENE-EXPRESSION; NOISE; HETEROGENEITY; MAPS; RECOMBINATION; QUANTITIES; EVOLUTION; DYNAMICS	Recent advances in single-cell sequencing hold great potential for exploring biological systems with unprecedented resolution. Sequencing the genome of individual cells can reveal somatic mutations and allows the investigation of clonal dynamics. Single-cell transcriptome sequencing can elucidate the cell type composition of a sample. However, single-cell sequencing comes with major technical challenges and yields complex data output. In this Primer, we provide an overview of available methods and discuss experimental design and single-cell data analysis. We hope that these guidelines will enable a growing number of researchers to leverage the power of single-cell sequencing.	[Gruen, Dominic; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Gruen, Dominic; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands; [Gruen, Dominic] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Max Planck Society	van Oudenaarden, A (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands.	a.vanoudenaarden@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019					Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Cheung VG, 1996, P NATL ACAD SCI USA, V93, P14676, DOI 10.1073/pnas.93.25.14676; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Leung ML, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0616-2; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mohlendick B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067031; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Ocone A, 2015, BIOINFORMATICS, V31, P89, DOI 10.1093/bioinformatics/btv257; Ottolini CS, 2015, NAT GENET, V47, P727, DOI 10.1038/ng.3306; Pan XH, 2013, P NATL ACAD SCI USA, V110, P594, DOI 10.1073/pnas.1217322109; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Van der Aa N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1352; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Voet T, 2013, NUCLEIC ACIDS RES, V41, P6119, DOI 10.1093/nar/gkt345; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054465, 10.1371/journal.pone.0059840, 10.1371/journal.pone.0059796, 10.1371/journal.pone.0066382]; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	73	269	280	9	145	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					799	810		10.1016/j.cell.2015.10.039	http://dx.doi.org/10.1016/j.cell.2015.10.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544934	Bronze			2022-12-28	WOS:000364829700008
J	Helbing, D; Pournaras, E				Helbing, Dirk; Pournaras, Evangelos			Society: Build digital democracy	NATURE			English	Editorial Material									[Helbing, Dirk; Pournaras, Evangelos] Swiss Fed Inst Technol, Computat Social Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helbing, D (corresponding author), Swiss Fed Inst Technol, Computat Social Sci, Zurich, Switzerland.	dhelbing@ethz.ch						Andris C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123507; Epstein R, 2015, P NATL ACAD SCI USA, V112, pE4512, DOI 10.1073/pnas.1419828112; Harris Shane, 2014, FOREIGN POLICY; Helbing D., AUTOMATION IN PRESS; Hsu C.-P., 2015, WANT CHINA TIMES; Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111; Medina E, 2011, CYBERNETIC REVOLUTIONARIES: TECHNOLOGY AND POLITICS IN ALLENDE'S CHILE, P1; Page SE, 2008, DIFFERENCE POWER DIV; Pariser E., 2011, FILTER BUBBLE WHAT I; Storm D, 2015, COMPUTERWORLD	10	39	40	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					33	34		10.1038/527033a	http://dx.doi.org/10.1038/527033a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV4XV	26536943	Bronze			2022-12-28	WOS:000364270700015
J	Takaba, H; Morishita, Y; Tomofuji, Y; Danks, L; Nitta, T; Komatsu, N; Kodama, T; Takayanagi, H				Takaba, Hiroyuki; Morishita, Yasuyuki; Tomofuji, Yoshihiko; Danks, Lynett; Nitta, Takeshi; Komatsu, Noriko; Kodama, Tatsuhiko; Takayanagi, Hiroshi			Fezf2 Orchestrates a Thymic Program of Self-Antigen Expression for Immune Tolerance	CELL			English	Article							PROMISCUOUS GENE-EXPRESSION; REGULATORY T-CELLS; LT-BETA-R; EPITHELIAL-CELLS; AUTOIMMUNE-DISEASE; LYMPHOTOXIN PATHWAY; NEGATIVE SELECTION; AIRE; DIFFERENTIATION; AUTOANTIBODIES	Self-tolerance to immune reactions is established via promiscuous expression of tissue-restricted antigens (TRAs) in medullary thymic epithelial cells (mTECs), leading to the elimination of T cells that respond to self-antigens. The transcriptional regulator Aire has been thought to be sufficient for the induction of TRAs, despite some indications that other factors may promote TRA expression in the thymus. Here, we show that the transcription factor Fezf2 directly regulates various TRA genes in mTECs independently of Aire. Mice lacking Fezf2 in mTECs displayed severe autoimmune symptoms, including the production of autoantibodies and inflammatory cell infiltration targeted to peripheral organs. These responses differed from those detected in Aire-deficient mice. Furthermore, Fezf2 expression and Aire expression are regulated by distinct signaling pathways and promote the expression of different classes of proteins. Thus, two independent factors, Fezf2 and Aire, permit the expression of TRAs in the thymus to ensure immune tolerance.	[Takaba, Hiroyuki; Tomofuji, Yoshihiko; Danks, Lynett; Nitta, Takeshi; Komatsu, Noriko; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; [Takaba, Hiroyuki; Morishita, Yasuyuki; Tomofuji, Yoshihiko; Danks, Lynett; Nitta, Takeshi; Komatsu, Noriko; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo 1130033, Japan; [Takaba, Hiroyuki; Danks, Lynett] Japan Sci & Technol Agcy JST, Takayanagi Osteonetwork Project, Exploratory Res Adv Technol Program, Tokyo 1130033, Japan; [Morishita, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Syst Biol & Med, Tokyo 1538904, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo	Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan.	takayana@m.u-tokyo.ac.jp			ERATO; Takayanagi Osteonetwork Project; JST; Japan Society for the Promotion of Science (JSPS)	ERATO(Japan Science & Technology Agency (JST)); Takayanagi Osteonetwork Project; JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Drs. M. Hibi, M. Kasai, and N. Sestan for providing Fezf2 antibodies, TEC lines, and Fezf2 floxed mice, respectively, and to Drs. N. Sestan, M. Grinne, S. Win, J. Tanimura, Y. Takeo, and T. Imai for insightful discussion and valuable comments. We thank T. Yokochi, K. Miyazono, and our laboratory members for discussion and assistance. This work was supported by a grant for the ERATO, Takayanagi Osteonetwork Project, from JST, Grants-in-Aid for Challenging Exploratory Research, and Specially Promoted Research from Japan Society for the Promotion of Science (JSPS).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Akirav EM, 2011, NAT REV ENDOCRINOL, V7, P25, DOI 10.1038/nrendo.2010.200; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Ali F, 2011, J AUTOIMMUN, V37, P79, DOI 10.1016/j.jaut.2011.05.005; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Eckler MJ, 2014, BIOESSAYS, V36, P788, DOI 10.1002/bies.201400039; Endo T, 2009, DIABETES, V58, P732, DOI 10.2337/db08-0493; Fatourou EM, 2009, EXPERT REV ANTICANC, V9, P1499, DOI 10.1586/ERA.09.103; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Hofmann J, 2010, TRENDS IMMUNOL, V31, P144, DOI 10.1016/j.it.2010.01.003; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2010, P NATL ACAD SCI USA, V107, P13016, DOI 10.1073/pnas.1004436107; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lodato S, 2014, NAT NEUROSCI, V17, P1046, DOI 10.1038/nn.3757; Martins VC, 2008, J IMMUNOL, V181, P400, DOI 10.4049/jimmunol.181.1.400; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Mouri Y, 2011, J IMMUNOL, V186, P5047, DOI 10.4049/jimmunol.1003533; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Roulois D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/871936; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Saltis M, 2008, IMMUNOGENETICS, V60, P105, DOI 10.1007/s00251-007-0268-9; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Seach N, 2008, J IMMUNOL, V180, P5384, DOI 10.4049/jimmunol.180.8.5384; Sharma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093905; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Shu XS, 2013, CARCINOGENESIS, V34, P1984, DOI 10.1093/carcin/bgt165; Takaba H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01716; Venanzi ES, 2007, J IMMUNOL, V179, P5693, DOI 10.4049/jimmunol.179.9.5693; Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	54	216	218	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					975	987		10.1016/j.cell.2015.10.013	http://dx.doi.org/10.1016/j.cell.2015.10.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544942	Bronze			2022-12-28	WOS:000364829700021
J	Snyder, A				Snyder, Alison			J Donald Millar Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1732	1732		10.1016/S0140-6736(15)00687-X	http://dx.doi.org/10.1016/S0140-6736(15)00687-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26545427	Bronze			2022-12-28	WOS:000363974200019
J	Jensen, MC				Jensen, Michael C.			Synthetic immunobiology boosts the IQ of T cells	SCIENCE			English	Editorial Material							SWITCH		Seattle Childrens Res Inst, Seattle, WA 98101 USA	Seattle Children's Hospital	Jensen, MC (corresponding author), Seattle Childrens Res Inst, Seattle, WA 98101 USA.	michael.jensen@seattlechildrens.org						Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Gallinari P, 2005, CHEM BIOL, V12, P883, DOI 10.1016/j.chembiol.2005.05.018; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Ye XH, 1999, SCIENCE, V283, P88, DOI 10.1126/science.283.5398.88	11	6	17	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					514	515		10.1126/science.aad5289	http://dx.doi.org/10.1126/science.aad5289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516270				2022-12-28	WOS:000363660000030
J	Bieler, A; Altwegg, K; Balsiger, H; Bar-Nun, A; Berthelier, JJ; Bochsler, P; Briois, C; Calmonte, U; Combi, M; De Keyser, J; van Dishoeck, EF; Fiethe, B; Fuselier, SA; Gasc, S; Gombosi, TI; Hansen, KC; Hassig, M; Jackel, A; Kopp, E; Korth, A; Le Roy, L; Mall, U; Maggiolo, R; Marty, B; Mousis, O; Owen, T; Reme, H; Rubin, M; Semon, T; Tzou, CY; Waite, JH; Walsh, C; Wurz, P				Bieler, A.; Altwegg, K.; Balsiger, H.; Bar-Nun, A.; Berthelier, J. -J.; Bochsler, P.; Briois, C.; Calmonte, U.; Combi, M.; De Keyser, J.; van Dishoeck, E. F.; Fiethe, B.; Fuselier, S. A.; Gasc, S.; Gombosi, T. I.; Hansen, K. C.; Haessig, M.; Jaeckel, A.; Kopp, E.; Korth, A.; Le Roy, L.; Mall, U.; Maggiolo, R.; Marty, B.; Mousis, O.; Owen, T.; Reme, H.; Rubin, M.; Semon, T.; Tzou, C. -Y.; Waite, J. H.; Walsh, C.; Wurz, P.			Abundant molecular oxygen in the coma of comet 67P/Churyumov-Gerasimenko	NATURE			English	Article							HYDROGEN-PEROXIDE; RHO-OPHIUCHI; WATER ICE; O-2; SURFACE; CONSTRAINTS	The composition of the neutral gas comas of most comets is dominated by H2O, CO and CO2, typically comprising as much as 95 per cent of the total gas density(1). In addition, cometary comas have been found to contain a rich array of other molecules, including sulfuric compounds and complex hydrocarbons. Molecular oxygen (O-2), however, despite its detection on other icy bodies such as the moons of Jupiter and Saturn(2,3), has remained undetected in cometary comas. Here we report in situ measurement of O-2 in the coma of comet 67P/Churyumov-Gerasimenko, with local abundances ranging from one per cent to ten per cent relative to H2O and with a mean value of 3.80 +/- 0.85 per cent. Our observations indicate that the O-2/H2O ratio is isotropic in the coma and does not change systematically with heliocentric distance. This suggests that primordial O-2 was incorporated into the nucleus during the comet's formation, which is unexpected given the low upper limits from remote sensing observations'. Current Solar System formation models do not predict conditions that would allow this to occur.	[Bieler, A.; Combi, M.; Gombosi, T. I.; Hansen, K. C.] Univ Michigan, Dept Climate & Space Sci & Engn, 2455 Hayward St, Ann Arbor, MI 48109 USA; [Bieler, A.; Altwegg, K.; Balsiger, H.; Bochsler, P.; Calmonte, U.; Gasc, S.; Haessig, M.; Jaeckel, A.; Kopp, E.; Rubin, M.; Semon, T.; Tzou, C. -Y.; Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Altwegg, K.; Le Roy, L.; Wurz, P.] Univ Bern, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [Bar-Nun, A.] Tel Aviv Univ, Dept Geosci, IL-6997801 Tel Aviv, Israel; [Berthelier, J. -J.] UPMC, UVSQ, CNRS, LATMOS,IPSL, F-94100 St Maur, France; [Briois, C.] Univ Orleans, CNRS, UMR 6115, Lab Phys & Chim Environm & Espace LPC2E, F-45071 Orleans, France; [De Keyser, J.; Maggiolo, R.] BIRA IASB, Belgian Inst Space Aeron, B-1180 Brussels, Belgium; [van Dishoeck, E. F.; Walsh, C.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Fiethe, B.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Comp & Network Engn IDA, D-38106 Braunschweig, Germany; [Fuselier, S. A.; Haessig, M.; Waite, J. H.] SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78228 USA; [Korth, A.; Mall, U.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Marty, B.] Univ Lorraine, CNRS, CRPG, F-54501 Vandoeuvre Les Nancy, France; [Mousis, O.] Aix Marseille Univ, CNRS, LAM, UMR 7326, F-13388 Marseille, France; [Owen, T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Reme, H.] Univ Toulouse, UPS, OMP, IRAP, F-31400 Toulouse, France; [Reme, H.] CNRS, IRAP, F-31028 Toulouse 4, France	University of Michigan System; University of Michigan; University of Bern; University of Bern; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Leiden University; Leiden University - Excl LUMC; Braunschweig University of Technology; Southwest Research Institute; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Hawaii System; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bieler, A (corresponding author), Univ Michigan, Dept Climate & Space Sci & Engn, 2455 Hayward St, Ann Arbor, MI 48109 USA.	abieler@umich.edu	Rubin, Martin/I-7777-2013; briois, christelle/B-2170-2015; Gombosi, Tamas I/G-4238-2011; Combi, Michael/J-1697-2012; Maggiolo, Romain/A-6621-2017; Wurz, Peter/R-2273-2017; Hansen, Kenneth C/F-3693-2011; Mousis, Olivier/X-2712-2019	Rubin, Martin/0000-0001-6549-3318; Gombosi, Tamas I/0000-0001-9360-4951; Combi, Michael/0000-0002-9805-0078; Maggiolo, Romain/0000-0002-5658-1313; Wurz, Peter/0000-0002-2603-1169; Hansen, Kenneth C/0000-0002-8502-1980; Walsh, Catherine/0000-0001-6078-786X; Le Roy, Lena/0000-0002-5984-6153; De Keyser, Johan/0000-0003-4805-5695; BRIOIS, Christelle/0000-0002-5616-0180	NASA [JPL-1266313]; State of Bern; Swiss National Science Foundation; European Space Agency PRODEX Program; Max-Planck Society; BMWI [50QP1302]; Jet Propulsion Laboratory [1496541]; Belgian Science Policy Office via PRODEX/ROSINA PEA [90020]; A*MIDEX - 'Investissements d'Avenir' French Government [ANR-11-IDEX-0001-02]; CNES at IRAP; CNES at LATMOS; CNES at LPC2E; CNES at UTINAM; CNES at CRPG; European Research Council [267255]; NASA JPL [NAS703001TONMO710889]; A-ERC [291141 CHEMPLAN]; NWO Veni award	NASA(National Aeronautics & Space Administration (NASA)); State of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Space Agency PRODEX Program(European Space Agency); Max-Planck Society(Max Planck SocietyFoundation CELLEX); BMWI(Federal Ministry for Economic Affairs and Energy (BMWi)); Jet Propulsion Laboratory; Belgian Science Policy Office via PRODEX/ROSINA PEA; A*MIDEX - 'Investissements d'Avenir' French Government(French National Research Agency (ANR)); CNES at IRAP; CNES at LATMOS; CNES at LPC2E; CNES at UTINAM; CNES at CRPG; European Research Council(European Research Council (ERC)European Commission); NASA JPL(National Aeronautics & Space Administration (NASA)); A-ERC; NWO Veni award	Work at the University of Michigan was funded by NASA contract JPL-1266313. Work at the University of Bern was funded by the State of Bern,the Swiss National Science Foundation and the European Space Agency PRODEX Program. Work at Max-Planck-Institut fur Sonnensystemforschung was funded by the Max-Planck Society and BMWI contract 50QP1302. Work at Southwest Research Institute was supported by subcontract 1496541 from the Jet Propulsion Laboratory. Work at BIRA-IASB was supported by the Belgian Science Policy Office via PRODEX/ROSINA PEA 90020. This work was carried out thanks to the support of the A*MIDEX project (no. ANR-11-IDEX-0001-02) funded by the 'Investissements d'Avenir' French Government programme, managed by the French National Research Agency (ANR). This work was supported by CNES grants at IRAP, LATMOS, LPC2E, UTINAM, CRPG, and by the European Research Council (grant no. 267255 to B.M.). A.B.-N. thanks the Ministry of Science and the Israel Space agency. Work by J.H.W. at Southwest Research Institute was funded by NASA JPL subcontract NAS703001TONMO710889. E.F.v.D. and C.W. are supported by A-ERC grant 291141 CHEMPLAN and an NWO Veni award. We acknowledge here the work of the whole ESA Rosetta team.	Altwegg K., 2015, SCIENCE, V347; Balsiger H, 2007, SPACE SCI REV, V128, P745, DOI 10.1007/s11214-006-8335-3; Bergman P, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201117170; Bockelee-Morvan D, 2004, SPACE SCI S, P391; BROWN WL, 1982, NUCL INSTRUM METHODS, V198, P1, DOI 10.1016/0167-5087(82)90043-6; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Carlson RW, 1999, SCIENCE, V283, P2062, DOI 10.1126/science.283.5410.2062; De Sanctis MC, 2015, NATURE, V525, P500, DOI 10.1038/nature14869; Du F, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118013; Goldsmith PF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/96; HALL DT, 1995, NATURE, V373, P677, DOI 10.1038/373677a0; Hassig M, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0276; Johnson RE, 2006, ICARUS, V180, P393, DOI 10.1016/j.icarus.2005.08.021; Johnson RE, 1997, ASTROPHYS J, V480, pL79, DOI 10.1086/310614; Larsson B, 2007, ASTRON ASTROPHYS, V466, P999, DOI 10.1051/0004-6361:20065500; Liseau R, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118575; Luspay-Kuti A, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526205; Parise B, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201219379; Pontoppidan KM, 2003, ASTRON ASTROPHYS, V408, P981, DOI 10.1051/0004-6361:20031030; Rubin M, 2015, SCIENCE, V348, P232, DOI 10.1126/science.aaa6100; Spencer JR, 2002, ASTRON J, V124, P3400, DOI 10.1086/344307; SPENCER JR, 1995, J GEOPHYS RES-PLANET, V100, P19049, DOI 10.1029/95JE01503; Taquet V, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117802; Vandenbussche B, 1999, ASTRON ASTROPHYS, V346, pL57; Walsh C, 2015, ASTRON ASTROPHYS, V582, DOI 10.1051/0004-6361/201526751; Yildiz UA, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321944	27	211	214	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					678	681		10.1038/nature15707	http://dx.doi.org/10.1038/nature15707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511578	Green Submitted			2022-12-28	WOS:000363832100043
J	Gregorieff, A; Liu, Y; Inanlou, MR; Khomchuk, Y; Wrana, JL				Gregorieff, Alex; Liu, Yu; Inanlou, Mohammad R.; Khomchuk, Yuliya; Wrana, Jeffrey L.			Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer	NATURE			English	Article							HIPPO PATHWAY; PANETH CELLS; PROLIFERATION; CRYPT; AMPHIREGULIN; INHIBITION; MARKER; DAMAGE; LRIG1	The gut epithelium has remarkable self-renewal capacity that under homeostatic conditions is driven by Wnt signalling hi Lgr5(+) intestinal stem cells (ISCs)(1). However, the mechanisms underlying ISC regeneration after injury remain poorly understood. The Hippo signalling pathway mediates tissue growth and is important for regeneration(2,3). Here we demonstrate in mice that Yap, a downstream transcriptional effector of Hippo, is critical for recovery of intestinal epithelium after exposure to ionizing radiation. Yap transiently reprograms Lgr5(+) ISCs by suppressing Wnt signalling and excessive Paneth cell differentiation, while promoting cell survival and inducing a regenerative program that includes Egf pathway activation. Accordingly, growth of Yap-deficient organoids is rescued by the Egfr ligand epiregulin, and we find that non-cell-autonomous production of stromal epiregulin may compensate for Yap loss in vivo. Consistent with key roles for regenerative signalling in tumorigenesis, we further demonstrate that Yap inactivation abolishes adenomas in the Apc(Min) mouse model of colon cancer, and that Yap-driven expansion of Apc(-/-) organoids requires the Egfr module of the Yap regenerative program. Finally, we show that in vivo Yap is required for progression of early Apc mutant tumour-initiating cells, suppresses their differentiation into Paneth cells, and induces a regenerative program and Egfr signalling. Our studies reveal that upon tissue injury, Yap reprograms Lgr5(+) ISCs by inhibiting the Wnt homeostatic program, while inducing a regenerative program that includes activation of Egfr signalling. Moreover, our findings reveal a key role for the Yap regenerative pathway in driving cancer initiation.	[Gregorieff, Alex; Liu, Yu; Inanlou, Mohammad R.; Khomchuk, Yuliya; Wrana, Jeffrey L.] Mt Sinai Hosp, Ctr Syst Biol, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Liu, Yu; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Wrana, JL (corresponding author), Mt Sinai Hosp, Ctr Syst Biol, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013	LIU, YU/0000-0001-8359-6732	CIHR [MOP-12860, MOP-106672]; Terry Fox Research Institute; Krembil Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute; Krembil Foundation	We would like to thank K. Chan for performing RNA-seq analysis, M. Moran for advice on Egfr analyses, and R. Bremner and L. Attisano for critical review of the manuscript This work was supported by the CIHR (MOP-12860 and MOP-106672), the Terry Fox Research Institute, and the Krembil Foundation. J.L.W. is the Mary Janigan Chair in Experimental Therapeutics and the CIBC Chair in Breast Cancer Research.	Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Karaca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083987; Lee D, 2004, MOL CELL BIOL, V24, P8907, DOI 10.1128/MCB.24.20.8907-8916.2004; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Neufert C, 2013, J CLIN INVEST, V123, P1428, DOI 10.1172/JCI63748; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Tao S., 2015, EMBO J; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Yu FX, 2015, ANNU REV PHYSIOL, V77, P201, DOI 10.1146/annurev-physiol-021014-071733; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	29	327	334	5	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					715	718		10.1038/nature15382	http://dx.doi.org/10.1038/nature15382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26503053				2022-12-28	WOS:000363832100051
J	Reynolds, D; Duray, GZ; Omar, R; Soejima, K; Neuzil, P; Zhang, S; Narasimhan, C; Steinwender, C; Brugada, J; Lloyd, M; Roberts, PR; Sagi, V; Hummel, J; Bongiorni, MG; Knops, RE; Ellis, CR; Gornick, CC; Bernabei, MA; Laager, V; Stromberg, K; Williams, ER; Hudnall, JH; Ritter, P				Reynolds, Dwight; Duray, Gabor Z.; Omar, Razali; Soejima, Kyoko; Neuzil, Petr; Zhang, Shu; Narasimhan, Calambur; Steinwender, Clemens; Brugada, Josep; Lloyd, Michael; Roberts, Paul R.; Sagi, Venkata; Hummel, John; Bongiorni, Maria Grazia; Knops, Reinoud E.; Ellis, Christopher R.; Gornick, Charles C.; Bernabei, Matthew A.; Laager, Verla; Stromberg, Kurt; Williams, Eric R.; Hudnall, J. Harrison; Ritter, Philippe		Micra Transcatheter Pacing Study	A Leadless Intracardiac Transcatheter Pacing System	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC PERFORATION; PACEMAKER; COMPLICATIONS; IMPLANTATION; PERFORMANCE; PREDICTORS; DESIGN	BACKGROUND A leadless intracardiac transcatheter pacing system has been designed to avoid the need for a pacemaker pocket and transvenous lead. METHODS In a prospective multicenter study without controls, a transcatheter pacemaker was implanted in patients who had guideline-based indications for ventricular pacing. The analysis of the primary end points began when 300 patients reached 6 months of follow-up. The primary safety end point was freedom from system-related or procedure-related major complications. The primary efficacy end point was the percentage of patients with low and stable pacing capture thresholds at 6 months (<= 2.0 V at a pulse width of 0.24 msec and an increase of <= 1.5 V from the time of implantation). The safety and efficacy end points were evaluated against performance goals (based on historical data) of 83% and 80%, respectively. We also performed a post hoc analysis in which the rates of major complications were compared with those in a control cohort of 2667 patients with transvenous pacemakers from six previously published studies. RESULTS The device was successfully implanted in 719 of 725 patients (99.2%). The Kaplan-Meier estimate of the rate of the primary safety end point was 96.0% (95% confidence interval [CI], 93.9 to 97.3; P< 0.001 for the comparison with the safety performance goal of 83%); there were 28 major complications in 25 of 725 patients, and no dislodgements. The rate of the primary efficacy end point was 98.3% (95% CI, 96.1 to 99.5; P< 0.001 for the comparison with the efficacy performance goal of 80%) among 292 of 297 patients with paired 6-month data. Although there were 28 major complications in 25 patients, patients with transcatheter pacemakers had significantly fewer major complications than did the control patients (hazard ratio, 0.49; 95% CI, 0.33 to 0.75; P = 0.001). CONCLUSIONS In this historical comparison study, the transcatheter pacemaker met the prespecified safety and efficacy goals; it had a safety profile similar to that of a transvenous system while providing low and stable pacing thresholds. (Funded by Medtronic; Micra Transcatheter Pacing Study ClinicalTrials.gov number, NCT02004873.)	[Reynolds, Dwight] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Sect, OU Med Ctr, 700 NE 13th St, Oklahoma City, OK 73104 USA; [Duray, Gabor Z.] Hungarian Def Forces, Med Ctr, Clin Electrophysiol Dept Cardiol, Budapest, Hungary; [Omar, Razali] Natl Heart Inst, Electrophysiol & Pacing Unit, Kuala Lumpur, Malaysia; [Soejima, Kyoko] Kyorin Univ Hosp, Dept Cardiol, Tokyo, Japan; [Neuzil, Petr] Na Homolce Hosp, Dept Cardiol, Prague, Czech Republic; [Zhang, Shu] Fuwai Hosp, Clin EP Lab, Beijing, Peoples R China; [Zhang, Shu] Fuwai Hosp, Arrhythmia Ctr, Beijing, Peoples R China; [Narasimhan, Calambur] CARE Hosp, Dept Cardiol, Div Electrophysiol, Hyderabad, Andhra Pradesh, India; [Narasimhan, Calambur] CARE Fdn, Hyderabad, Andhra Pradesh, India; [Steinwender, Clemens] Johannes Kepler Univ Linz, Sch Med, Linz Gen Hosp, Dept Cardiol, A-4040 Linz, Austria; [Brugada, Josep] Hosp Univ Clin Barcelona, Barcelona, Spain; [Lloyd, Michael] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA; [Roberts, Paul R.] Univ Southampton, Southampton, Hants, England; [Sagi, Venkata] Baptist Heart Specialists, Jacksonville, FL USA; [Hummel, John] Ohio State Univ, Columbus, OH 43210 USA; [Bongiorni, Maria Grazia] Azienda Osped Univ Pisana, Presidio Osped Cisanello, Pisa, Italy; [Knops, Reinoud E.] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Ellis, Christopher R.] Vanderbilt Univ, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gornick, Charles C.] Minneapolis Heart Inst, Minneapolis, MN USA; [Bernabei, Matthew A.] Lancaster Heart & Vasc Inst, Lancaster, PA USA; [Laager, Verla; Stromberg, Kurt; Williams, Eric R.; Hudnall, J. Harrison] Medtronic, Mounds View, MN USA; [Ritter, Philippe] Univ Bordeaux, IHU Inst Rythmol & Modelisat Cardiaque, Ctr Hosp Univ Bordeaux, Hop Cardiol Haut Leveque, Bordeaux, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; Institute Jantung Negara; Kyorin University; Na Homolce Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Johannes Kepler University Linz; Kepler University Hospital; Emory University; University of Southampton; University System of Ohio; Ohio State University; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Amsterdam; Vanderbilt University; Minneapolis Heart Institute Foundation; Medtronic; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Reynolds, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Sect, OU Med Ctr, 700 NE 13th St, Oklahoma City, OK 73104 USA.	dwight-reynolds@ouhsc.edu	Ellis, Christopher Randall/AAL-3749-2020; Asano, Taku/J-6681-2019; lloyd, michael/AAM-8920-2020; vardas, panos/ABF-7144-2020; Duray, Gabor/ABD-1455-2020; Knops, R/AAX-2027-2021; Wilcox, Ian/E-8360-2015	Ellis, Christopher Randall/0000-0002-7333-5720; Wilcox, Ian/0000-0002-6414-7453; Stromberg, Kurt/0000-0003-3201-7993	Medtronic	Medtronic(Medtronic)	Funded by Medtronic; Micra Transcatheter Pacing Study ClinicalTrials.gov number, NCT02004873.	[Anonymous], 2014, R LANG ENV STAT COMP; Eggen MD, 2015, IEEE T BIO-MED ENG, V62, P2316, DOI 10.1109/TBME.2015.2449320; Ellenbogen KA, 2003, AM J CARDIOL, V92, P740, DOI 10.1016/S0002-9149(03)00844-0; Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.hrthm.2008.04.014; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hauser RG, 2007, HEART RHYTHM, V4, P154, DOI 10.1016/j.hrthm.2006.10.009; Hsu JC, 2013, CIRC-CARDIOVASC QUAL, V6, P582, DOI 10.1161/CIRCOUTCOMES.113.000299; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Knops RE, 2015, J AM COLL CARDIOL, V65, P1497, DOI 10.1016/j.jacc.2015.02.022; Mahapatra S, 2005, HEART RHYTHM, V2, P907, DOI 10.1016/j.hrthm.2005.06.011; Reddy VY, 2015, NEW ENGL J MED, V373, P1125, DOI 10.1056/NEJMoa1507192; Ritter P, 2015, EUR HEART J, V36, P2510, DOI 10.1093/eurheartj/ehv214; Ritter P, 2015, EUROPACE, V17, P807, DOI 10.1093/europace/euv026; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Senaratne J, 2006, PACE, V29, P1044, DOI 10.1111/j.1540-8159.2006.00497.x; SPICKLER J W, 1970, Journal of Electrocardiology, V3, P325, DOI 10.1016/S0022-0736(70)80059-0; Udo EO, 2012, HEART RHYTHM, V9, P728, DOI 10.1016/j.hrthm.2011.12.014; Vardas P., 1991, EUR J CARD PACING EL, V1, P27; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108	20	398	403	3	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					533	541		10.1056/NEJMoa1511643	http://dx.doi.org/10.1056/NEJMoa1511643			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26551877	Bronze			2022-12-28	WOS:000369755800006
J	Capodanno, D				Capodanno, Davide			Long-term EXAMINATION of drug-eluting stents in acute myocardial infarction	LANCET			English	Editorial Material							BARE-METAL STENTS; EXAMINATION TRIAL; POLYMER; DESIGN		[Capodanno, Davide] Univ Catania, Ferrarotto Hosp, Cardiothorac Vasc Dept, I-95124 Catania, Italy	University of Catania	Capodanno, D (corresponding author), Univ Catania, Ferrarotto Hosp, Cardiothorac Vasc Dept, I-95124 Catania, Italy.	dcapodanno@gmail.com	Capodanno, Davide/AAP-4949-2020	Capodanno, Davide/0000-0002-5156-7723				Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Palmerini T, 2013, J AM COLL CARDIOL, V62, P1915, DOI 10.1016/j.jacc.2013.08.725; Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Sabate M., 2015, LANCET; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P64, DOI 10.1016/j.jcin.2013.09.006; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P55, DOI 10.1016/j.jcin.2013.07.012; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sabate M, 2011, EUROINTERVENTION, V7, P977, DOI 10.4244/EIJV7I8A154; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					316	318		10.1016/S0140-6736(15)00677-7	http://dx.doi.org/10.1016/S0140-6736(15)00677-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26520232				2022-12-28	WOS:000368516500008
J	Siegal, DM; Curnutte, JT; Connolly, SJ; Lu, GM; Conley, PB; Wiens, BL; Mathur, VS; Castillo, J; Bronson, MD; Leeds, JM; Mar, FA; Gold, A; Crowther, MA				Siegal, Deborah M.; Curnutte, John T.; Connolly, Stuart J.; Lu, Genmin; Conley, Pamela B.; Wiens, Brian L.; Mathur, Vandana S.; Castillo, Janice; Bronson, Michele D.; Leeds, Janet M.; Mar, Florie A.; Gold, Alex; Crowther, Mark A.			Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATRIAL-FIBRILLATION; WARFARIN; MANAGEMENT; APIXABAN	BACKGROUND Bleeding is a complication of treatment with factor Xa inhibitors, but there are no specific agents for the reversal of the effects of these drugs. Andexanet is designed to reverse the anticoagulant effects of factor Xa inhibitors. METHODS Healthy older volunteers were given 5 mg of apixaban twice daily or 20 mg of rivaroxaban daily. For each factor Xa inhibitor, a two-part randomized placebo-controlled study was conducted to evaluate andexanet administered as a bolus or as a bolus plus a 2-hour infusion. The primary outcome was the mean percent change in anti-factor Xa activity, which is a measure of factor Xa inhibition by the anticoagulant. RESULTS Among the apixaban-treated participants, anti-factor Xa activity was reduced by 94% among those who received an andexanet bolus (24 participants), as compared with 21% among those who received placebo (9 participants) (P<0.001), and un-bound apixaban concentration was reduced by 9.3 ng per milliliter versus 1.9 ng per milliliter (P<0.001); thrombin generation was fully restored in 100% versus 11% of the participants (P<0.001) within 2 to 5 minutes. Among the rivaroxaban-treated participants, anti-factor Xa activity was reduced by 92% among those who received an andexanet bolus (27 participants), as compared with 18% among those who received placebo (14 participants) (P<0.001), and unbound rivaroxaban concentration was reduced by 23.4 ng per milliliter versus 4.2 ng per milliliter (P<0.001); thrombin generation was fully restored in 96% versus 7% of the participants (P<0.001). These effects were sustained when andexanet was administered as a bolus plus an infusion. In a subgroup of participants, transient increases in levels of d-dimer and prothrombin fragments 1 and 2 were observed, which resolved within 24 to 72 hours. No serious adverse or thrombotic events were reported. CONCLUSIONS Andexanet reversed the anticoagulant activity of apixaban and rivaroxaban in older healthy participants within minutes after administration and for the duration of infusion, without evidence of clinical toxic effects.	[Siegal, Deborah M.; Connolly, Stuart J.; Crowther, Mark A.] McMaster Univ, Hamilton, ON L8N 4A6, Canada; [Connolly, Stuart J.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Curnutte, John T.; Lu, Genmin; Conley, Pamela B.; Wiens, Brian L.; Castillo, Janice; Bronson, Michele D.; Leeds, Janet M.; Mar, Florie A.; Gold, Alex] Portola Pharmaceut, San Francisco, CA USA; [Mathur, Vandana S.] Mathur Consulting, Woodside, CA USA	McMaster University; Population Health Research Institute	Crowther, MA (corresponding author), McMaster Univ, St Josephs Hosp, Rm L208,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.			Siegal, Deborah/0000-0003-3806-3245	Portola Pharmaceuticals	Portola Pharmaceuticals	Funded by Portola Pharmaceuticals and others; ANNEXA-A and ANNEXA-R ClinicalTrials.gov numbers, NCT02207725 and NCT02220725.	Beasley N, 2011, RIVAROXABAN CLIN REV; Beyer-Westendorf J, 2014, BLOOD, V124, P955, DOI 10.1182/blood-2014-03-563577; Bytniewski P, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0089-0; Chowdary P, 2015, J THROMB HAEMOST, V13, P743, DOI 10.1111/jth.12864; Crowther M, 2014, 56 ANN M AM SOC HEM; Crowther M, 2013, J THROMB HAEMOST S2, V11; Crowther M, 2013, 55 ANN M AM SOC HEM; Crowther MA, 2002, BLOOD COAGUL FIBRIN, V13, P49, DOI 10.1097/00001721-200201000-00007; Crowther M, 2014, CRIT CARE MED, V42; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Held C, 2015, EUR HEART J, V36, P1264, DOI 10.1093/eurheartj/ehu463; Hollenbach S, 2012, 54 ANN M AM SOC HEM; Hollenbach S, 2012, EUR SOC CARD C MUN G; Lu G, 2008, ASH ANN M, V112, P983; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Lu GM, 2010, CIRCULATION, V122; Omote M, 2008, THROMB RES, V123, P390, DOI 10.1016/j.thromres.2008.05.008; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pernod G, 2013, ARCH CARDIOVASC DIS, V106, P382, DOI 10.1016/j.acvd.2013.04.009; Pine P, 2015, EUR SOC CARD C LOND; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Rose M, 2012, APIXABAN CLIN REV AD; Tamayo S, 2015, CLIN CARDIOL, V38, P63, DOI 10.1002/clc.22373; Westfall PH, 2001, J STAT PLAN INFER, V99, P25, DOI 10.1016/S0378-3758(01)00077-5; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946	26	674	691	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2413	2424		10.1056/NEJMoa1510991	http://dx.doi.org/10.1056/NEJMoa1510991			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY5QD	26559317	Bronze			2022-12-28	WOS:000366461400008
J	Sahakyan, KR; Somers, VK; Rodriguez-Escudero, JP; Hodge, DO; Carter, RE; Sochor, O; Coutinho, T; Jensen, MD; Roger, VL; Singh, P; Lopez-Jimenez, F				Sahakyan, Karine R.; Somers, Virend K.; Rodriguez-Escudero, Juan P.; Hodge, David O.; Carter, Rickey E.; Sochor, Ondrej; Coutinho, Thais; Jensen, Michael D.; Roger, Veronique L.; Singh, Prachi; Lopez-Jimenez, Francisco			Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; ADIPOSITY; RISK; ASSOCIATION; OVERWEIGHT; ADULTS; FAT	Background: The relationship between central obesity and survival in community-dwelling adults with normal body mass index (BMI) is not well-known. Objective: To examine total and cardiovascular mortality risks associated with central obesity and normal BMI. Design: Stratified multistage probability design. Setting: NHANES III (Third National Health and Nutrition Examination Survey). Participants: 15 184 adults (52.3% women) aged 18 to 90 years. Measurements: Multivariable Cox proportional hazards models were used to evaluate the relationship of obesity patterns defined by BMI and waist-to-hip ratio (WHR) and total and cardiovascular mortality risk after adjustment for confounding factors. Results: Persons with normal-weight central obesity had the worst long-term survival. For example, a man with a normal BMI (22 kg/m(2)) and central obesity had greater total mortality risk than one with similar BMI but no central obesity (hazard ratio [HR], 1.87 [95% CI, 1.53 to 2.29]), and this man had twice the mortality risk of participants who were overweight or obese according to BMI only (HR, 2.24 [CI, 1.52 to 3.32] and 2.42 [CI, 1.30 to 4.53], respectively). Women with normal-weight central obesity also had a higher mortality risk than those with similar BMI but no central obesity (HR, 1.48 [CI, 1.35 to 1.62]) and those who were obese according to BMI only (HR, 1.32 [CI, 1.15 to 1.51]). Expected survival estimates were consistently lower for those with central obesity when age and BMI were controlled for. Limitations: Body fat distribution was assessed based on anthropometric indicators alone. Information on comorbidities was collected by self-report. Conclusion: Normal-weight central obesity defined by WHR is associated with higher mortality than BMI-defined obesity, particularly in the absence of central fat distribution.	[Sahakyan, Karine R.; Somers, Virend K.; Rodriguez-Escudero, Juan P.; Sochor, Ondrej; Roger, Veronique L.; Singh, Prachi; Lopez-Jimenez, Francisco] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; St Annes Univ Hosp Brno, Brno, Czech Republic; [Coutinho, Thais] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada	Mayo Clinic; St Anne's University Hospital Brno (FNUSA-ICRC); University of Ottawa; University of Ottawa Heart Institute	Lopez-Jimenez, F (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 First St Southwest, Rochester, MN 55905 USA.	lopez@mayo.edu	Roger, Veronique/AAV-5951-2020; Coutinho, Thais/AAM-2433-2021; Singh, Prachi/AAW-5028-2020	Singh, Prachi/0000-0002-7392-9035	National Institutes of Health; American Heart Association; European Regional Development Fund; Czech Ministry of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); European Regional Development Fund(European Commission); Czech Ministry of Health(Ministry of Health, Czech Republic); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health, American Heart Association, European Regional Development Fund, and Czech Ministry of Health.	Ashwell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103483; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Coutinho T, 2013, J AM COLL CARDIOL, V61, P553, DOI 10.1016/j.jacc.2012.10.035; Despres J P, 2006, J Endocrinol Invest, V29, P77; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2009, AM J CLIN NUTR, V89, P1213, DOI 10.3945/ajcn.2008.26698; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Kahn HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050428; Klein J. P., 2003, SURVIVAL ANAL TECHNI; MAKUCH RW, 1982, J CHRON DIS, V35, P437, DOI 10.1016/0021-9681(82)90058-3; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; National Center for Health Statistics, 2015, NAT HLTH NUTR EX SUR; National Center for Health Statistics; Office of Analysis and Epidemiology, 2009, 3 NAT HLTH NUTR EX S; Navab M, 2005, TRENDS CARDIOVAS MED, V15, P158, DOI 10.1016/j.tcm.2005.05.008; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; SEIDELL JC, 1989, INT J OBESITY, V13, P289; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	26	261	274	3	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					827	+		10.7326/M14-2525	http://dx.doi.org/10.7326/M14-2525			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26551006	Green Accepted			2022-12-28	WOS:000365866500006
J	Vacchelli, E; Ma, YT; Baracco, EE; Sistigu, A; Enot, DP; Pietrocola, F; Yang, H; Adjemian, S; Chaba, K; Semeraro, M; Signore, M; De Ninno, A; Lucarini, V; Peschiaroli, F; Businaro, L; Gerardino, A; Manic, G; Ulas, T; Gunther, P; Schultze, JL; Kepp, O; Stoll, G; Lefebvre, C; Mulot, C; Castoldi, F; Rusakiewicz, S; Ladoire, S; Apetoh, L; Bravo-San Pedro, JM; Lucattelli, M; Delarasse, C; Boige, V; Ducreux, M; Delaloge, S; Borg, C; Andre, F; Schiavoni, G; Vitale, I; Laurent-Puig, P; Mattei, F; Zitvogel, L; Kroemer, G				Vacchelli, Erika; Ma, Yuting; Baracco, Elisa E.; Sistigu, Antonella; Enot, David P.; Pietrocola, Federico; Yang, Heng; Adjemian, Sandy; Chaba, Kariman; Semeraro, Michaela; Signore, Michele; De Ninno, Adele; Lucarini, Valeria; Peschiaroli, Francesca; Businaro, Luca; Gerardino, Annamaria; Manic, Gwenola; Ulas, Thomas; Guenther, Patrick; Schultze, Joachim L.; Kepp, Oliver; Stoll, Gautier; Lefebvre, Celine; Mulot, Claire; Castoldi, Francesca; Rusakiewicz, Sylvie; Ladoire, Sylvain; Apetoh, Lionel; Bravo-San Pedro, Jose Manuel; Lucattelli, Monica; Delarasse, Cecile; Boige, Valerie; Ducreux, Michel; Delaloge, Suzette; Borg, Christophe; Andre, Fabrice; Schiavoni, Giovanna; Vitale, Ilio; Laurent-Puig, Pierre; Mattei, Fabrizio; Zitvogel, Laurence; Kroemer, Guido			Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1	SCIENCE			English	Article							ANTIGEN-PRESENTING CELLS; ANTICANCER CHEMOTHERAPY; BREAST-CANCER; IMMUNOSURVEILLANCE; TUMOR; INFLAMMATION; RECRUITMENT; NEUTROPHILS; MECHANISM; THERAPY	Antitumor immunity driven by intratumoral dendritic cells contributes to the efficacy of anthracycline-based chemotherapy in cancer. We identified a loss-of-function allele of the gene coding for formyl peptide receptor 1 (FPR1) that was associated with poor metastasis-free and overall survival in breast and colorectal cancer patients receiving adjuvant chemotherapy. The therapeutic effects of anthracyclines were abrogated in tumor-bearing Fpr1(-/-) mice due to impaired antitumor immunity. Fpr1-deficient dendritic cells failed to approach dying cancer cells and, as a result, could not elicit antitumor T cell immunity. Experiments performed in a microfluidic device confirmed that FPR1 and its ligand, annexin-1, promoted stable interactions between dying cancer cells and human or murine leukocytes. Altogether, these results highlight the importance of FPR1 in chemotherapy-induced anticancer immune responses.	[Vacchelli, Erika; Ma, Yuting; Baracco, Elisa E.; Enot, David P.; Pietrocola, Federico; Yang, Heng; Adjemian, Sandy; Chaba, Kariman; Semeraro, Michaela; Kepp, Oliver; Stoll, Gautier; Lefebvre, Celine; Castoldi, Francesca; Rusakiewicz, Sylvie; Bravo-San Pedro, Jose Manuel; Andre, Fabrice; Zitvogel, Laurence; Kroemer, Guido] Gustave Roussy Canc Campus, Villejuif, France; [Vacchelli, Erika; Ma, Yuting; Baracco, Elisa E.; Enot, David P.; Pietrocola, Federico; Yang, Heng; Adjemian, Sandy; Chaba, Kariman; Kepp, Oliver; Stoll, Gautier; Castoldi, Francesca; Bravo-San Pedro, Jose Manuel; Kroemer, Guido] INSERM, U1138, Paris, France; [Vacchelli, Erika; Ma, Yuting; Baracco, Elisa E.; Enot, David P.; Pietrocola, Federico; Yang, Heng; Adjemian, Sandy; Chaba, Kariman; Kepp, Oliver; Stoll, Gautier; Castoldi, Francesca; Bravo-San Pedro, Jose Manuel; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, Paris, France; [Vacchelli, Erika; Ma, Yuting; Yang, Heng; Chaba, Kariman; Kepp, Oliver; Stoll, Gautier; Bravo-San Pedro, Jose Manuel; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Vacchelli, Erika; Ma, Yuting; Yang, Heng; Kepp, Oliver; Stoll, Gautier; Bravo-San Pedro, Jose Manuel; Kroemer, Guido] Univ Paris 06, Paris, France; [Ma, Yuting; Yang, Heng] Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China; [Ma, Yuting; Yang, Heng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Ma, Yuting; Yang, Heng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Baracco, Elisa E.; Pietrocola, Federico; Castoldi, Francesca; Ducreux, Michel; Zitvogel, Laurence] Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France; [Sistigu, Antonella; Manic, Gwenola; Vitale, Ilio] Regina Elena Inst Canc Res, Rome, Italy; [Enot, David P.; Kroemer, Guido] Gustave Roussy Canc Campus, Metabol & Cell Biol Platforms, Villejuif, France; [Semeraro, Michaela; Rusakiewicz, Sylvie; Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Semeraro, Michaela; Rusakiewicz, Sylvie; Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France; [Signore, Michele; Lucarini, Valeria; Peschiaroli, Francesca; Schiavoni, Giovanna; Mattei, Fabrizio] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [De Ninno, Adele; Businaro, Luca; Gerardino, Annamaria] Italian Natl Res Council, Inst Photon & Nanotechnol, Rome, Italy; [Ulas, Thomas; Guenther, Patrick; Schultze, Joachim L.] Univ Bonn, Life & Med Sci Ctr Inst, Genom & Immunoregulat, Bonn, Germany; [Lefebvre, Celine; Delaloge, Suzette; Andre, Fabrice] INSERM, U981, Villejuif, France; [Mulot, Claire; Laurent-Puig, Pierre] Univ Paris Sorbonne Cite, UMRS 775, INSERM, Paris, France; [Mulot, Claire; Boige, Valerie; Laurent-Puig, Pierre] Ctr Ressources Biol CRB EPIGENETIC, INSERM, U1147, Paris, France; [Castoldi, Francesca] Sotio, Prague, Czech Republic; [Ladoire, Sylvain; Apetoh, Lionel] Ctr Georges Francois Leclerc, Dept Med Oncol, Dijon, France; [Ladoire, Sylvain; Apetoh, Lionel] Univ Bourgogne Franche Comte, Dijon, France; [Ladoire, Sylvain; Apetoh, Lionel] Ctr Georges Francois Leclerc, Dijon, France; [Lucattelli, Monica] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Delarasse, Cecile] Hop La Pitie Salpetriere, Equipe Neurogenet & Physiol, Inst Cerveau & Moelle Epiniere, ICM,CNRS,UMR 7225,INSERM,U1127,UPMC P6,UMR S 1127, F-75013 Paris, France; [Boige, Valerie; Ducreux, Michel] Gustave Roussy Canc Campus, Dept Med Oncol, Villejuif, France; [Delaloge, Suzette] Gustave Roussy Canc Campus, Dept Breast Oncol, Villejuif, France; [Borg, Christophe] Univ Franche Comte, INSERM 1098, F-25030 Besancon, France; [Andre, Fabrice] Gustave Roussy Canc Campus, Dept Biol & Pathol, Villejuif, France; [Andre, Fabrice] Gustave Roussy Canc Campus, Dept Med Oncol, Villejuif, France; [Vitale, Ilio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Laurent-Puig, Pierre; Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Inst, Dept Womens & Childrens Hlth, Karolinska Univ Hosp, S-17176 Stockholm, Sweden	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); University of Bonn; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Georges-Francois Leclerc; UNICANCER; Centre Georges-Francois Leclerc; University of Siena; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; University of Rome Tor Vergata; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Kroemer, G (corresponding author), Gustave Roussy Canc Campus, Villejuif, France.	laurence.zitvogel@gustaveroussy.fr; kroemer@orange.fr	Lucarini, Valeria/K-2122-2016; Sistigu, Antonella/J-8934-2018; Yang, Heng/GWV-0038-2022; Kroemer, Guido/AAY-9859-2020; Schiavoni, Giovanna/T-4418-2017; Schiavoni, Giovanna/K-2448-2019; San Pedro, Jose Manuel Bravo/Q-4061-2018; ADJEMIAN, Sandy/K-7632-2012; KROEMER, Guido/B-4263-2013; Ducreux, Michel/L-7012-2019; Vacchelli, Erika/E-5212-2018; Kepp, Oliver/N-2763-2017; Gerardino, Annamaria/AAB-4271-2019; Apetoh, Lionel/AIC-2384-2022; Apetoh, Lionel/G-3310-2014; Laurent-Puig, Pierre/K-3641-2019; Ducreux, Michel/AAG-9415-2019; Lefebvre, Celine/E-6290-2013; Schultze, Joachim L/D-7794-2011; Gerardino, Annamaria/C-8403-2012; Schultze, Joachim L./ABA-8176-2020; Kepp, Oliver/GPX-8627-2022; businaro, luca/F-9545-2012; Pietrocola, Federico/AAW-9621-2020; Vitale, Ilio/M-3960-2017; Mattei, Fabrizio/J-6585-2016; ANDRE, Fabrice/AAL-2683-2020; Manic, Gwenola/J-8496-2018; Signore, Michele/J-8563-2016; Delarasse, Cecile/K-8234-2017; De Ninno, Adele/M-8087-2017; laurent-puig, pierre/B-2226-2013	Sistigu, Antonella/0000-0002-2528-1238; Schiavoni, Giovanna/0000-0001-9135-0556; Schiavoni, Giovanna/0000-0001-9135-0556; San Pedro, Jose Manuel Bravo/0000-0002-5781-1133; ADJEMIAN, Sandy/0000-0001-5594-5499; KROEMER, Guido/0000-0002-9334-4405; Vacchelli, Erika/0000-0001-8010-0594; Kepp, Oliver/0000-0002-6081-9558; Gerardino, Annamaria/0000-0003-1869-1092; Apetoh, Lionel/0000-0002-2774-438X; Apetoh, Lionel/0000-0002-2774-438X; Laurent-Puig, Pierre/0000-0001-8475-5459; Ducreux, Michel/0000-0001-8649-7449; Schultze, Joachim L/0000-0003-2812-9853; Gerardino, Annamaria/0000-0003-1869-1092; Schultze, Joachim L./0000-0003-2812-9853; businaro, luca/0000-0002-5251-093X; Pietrocola, Federico/0000-0002-2930-234X; Vitale, Ilio/0000-0002-5918-1841; Mattei, Fabrizio/0000-0002-5357-7773; ANDRE, Fabrice/0000-0001-5795-8357; Signore, Michele/0000-0002-0262-842X; Delarasse, Cecile/0000-0001-9739-4306; De Ninno, Adele/0000-0003-3139-2820; laurent-puig, pierre/0000-0001-8475-5459; Boige, Valerie/0000-0002-7817-4663; Stoll, Gautier/0000-0002-0862-4139; ZITVOGEL, laurence/0000-0003-1596-0998; Manic, Gwenola/0000-0003-3759-8029; LADOIRE, Sylvain/0000-0002-0331-9194; Gunther, Patrick/0000-0002-9135-7819	Ligue Nationale Contre le Cancer (Equipes Labellisees); Sites de Recherche Integrees sur le Cancer (SIRIC) Socrates and Carpem; Swiss Institute for Experimental Cancer Research (ISREC) Foundation; Agence Nationale pour la Recherche (AUTOPH, Emergence); Canceropole Ile-de-France; European Commission (ArtForce); European Research Council; Fondation pour la Recherche Medicale; Fondation de France; LabEx Immuno-Oncology; Institut National du Cancer (INCa); Paris Alliance of Cancer Research Institutes; LabEx Immuno-Oncologie; Chinese National Thousand Talents Program; Deutsche Forschungsgemeinschaft [SFB704, SFB645]; Excellence Cluster ImmunoSensation; Italian Ministry of Health [RF-2011-02347120]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 14297]; AIRC [MFAG 14641]; Italian Ministry of Health; Programma per i Giovani Ricercatori "Rita Levi Montalcini"; AIRC	Ligue Nationale Contre le Cancer (Equipes Labellisees); Sites de Recherche Integrees sur le Cancer (SIRIC) Socrates and Carpem; Swiss Institute for Experimental Cancer Research (ISREC) Foundation; Agence Nationale pour la Recherche (AUTOPH, Emergence)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); LabEx Immuno-Oncology; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Paris Alliance of Cancer Research Institutes; LabEx Immuno-Oncologie; Chinese National Thousand Talents Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster ImmunoSensation; Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Programma per i Giovani Ricercatori "Rita Levi Montalcini"; AIRC(Fondazione AIRC per la ricerca sul cancro)	The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. L.Z. filed a patent (WO2011131472 A1) that relates to the predictive role of SNPs in cancer therapy. G.K. and L.Z. are supported by the Ligue Nationale Contre le Cancer (Equipes Labellisees), Sites de Recherche Integrees sur le Cancer (SIRIC) Socrates and Carpem, the Swiss Institute for Experimental Cancer Research (ISREC) Foundation, Agence Nationale pour la Recherche (AUTOPH, Emergence), Canceropole Ile-de-France, European Commission (ArtForce), European Research Council Advanced Investigator Grant (to G.K.), Fondation pour la Recherche Medicale, Fondation de France, the LabEx Immuno-Oncology, Institut National du Cancer (INCa), and the Paris Alliance of Cancer Research Institutes. Y.M. is supported by the LabEx Immuno-Oncologie and the Chinese National Thousand Talents Program; H.Y. by the Chinese National Thousand Talents Program; J.L.S. by the Deutsche Forschungsgemeinschaft (SFB704 and SFB645) and the Excellence Cluster ImmunoSensation; F.M. by the Italian Ministry of Health (RF-2011-02347120); G.S. by Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG 14297); I.V. by AIRC (MFAG 14641), Italian Ministry of Health (RF_GR 2011-2012), and Programma per i Giovani Ricercatori "Rita Levi Montalcini" 2011; and A.S. and G.M. by AIRC.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Businaro L, 2013, LAB CHIP, V13, P229, DOI 10.1039/c2lc40887b; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Huang J, 2010, BRIT J CANCER, V102, P1052, DOI 10.1038/sj.bjc.6605591; Kroemer G, 2015, NAT MED, V21, P1128, DOI 10.1038/nm.3944; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Ma YT, 2014, CANCER RES, V74, P436, DOI 10.1158/0008-5472.CAN-13-1265; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miettinen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028712; Prevete N, 2015, ONCOGENE, V34, P3826, DOI 10.1038/onc.2014.309; Sahagun-Ruiz A, 2001, GENES IMMUN, V2, P335, DOI 10.1038/sj.gene.6363787; Seifert R, 2003, LIFE SCI, V73, P2263, DOI 10.1016/S0024-3205(03)00654-4; Senovilla L, 2012, ONCOIMMUNOLOGY, V1, P1323, DOI 10.4161/onci.22009; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Sklan A, 2014, LANCET ONCOL, V15, pE422, DOI 10.1016/S1470-2045(14)70369-9; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; Sun RH, 2004, J IMMUNOL, V173, P428, DOI 10.4049/jimmunol.173.1.428; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Wang WY, 2015, CELL MOL IMMUNOL, V12, P615, DOI 10.1038/cmi.2014.61; Wenzel-Seifert K, 2003, N-S ARCH PHARMACOL, V367, P509, DOI 10.1007/s00210-003-0714-7; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	29	290	302	9	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					972	978		10.1126/science.aad0779	http://dx.doi.org/10.1126/science.aad0779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26516201				2022-12-28	WOS:000364955200048
J	Pargaonkar, VS; Perez, MV; Jindal, A; Mathur, MB; Myers, J; Froelicher, VF				Pargaonkar, Vedant S.; Perez, Marco V.; Jindal, Akash; Mathur, Maya B.; Myers, Jonathan; Froelicher, Victor F.			Long-Term Prognosis of Early Repolarization With J-Wave and QRS Slur Patterns on the Resting Electrocardiogram A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							POINT ELEVATION; RISK; ASSOCIATION; DEATH; FORM	Background: The prognostic value of early repolarization with J waves and QRS slurs remains controversial. Although these findings are more prevalent in patients with idiopathic ventricular fibrillation, their ability to predict cardiovascular death has varied across studies. Objective: To test the hypothesis that J waves and QRS slurs on electrocardiograms (ECGs) are associated with increased risk for cardiovascular death. Design: Retrospective cohort. Setting: Veterans Affairs Palo Alto Health Care System. Patients: Veterans younger than 56 years who had resting 12-lead electrocardiography, 90.5% of whom were men. Measurements: Electrocardiograms were manually measured and visually coded using criteria of 0.1 mV or greater in at least 2 contiguous leads. J waves were measured at the peak of an upward deflection or notch at the end of QRS, and QRS slurs were measured at the top of conduction delay on the QRS down-stroke. Absolute risk differences at 10 years were calculated to study the associations between J waves or QRS slurs and the primary outcome of cardiovascular death. Results: Over a median follow-up of 17.5 years, 859 cardiovascular deaths occurred. Of 20 661 ECGs, 4219 (20%) had J waves or QRS slurs in the inferior and/or lateral territories; of these, 3318 (78.6%) had J waves or QRS slurs in inferior leads and 1701 (40.3%) in lateral leads. The upper bound of differences in risk for cardiovascular death from any of the J-wave or QRS slur patterns suggests that an increased risk can be safely ruled out (inferior, -0.77% [95% CI, -1.27% to -0.27%]; lateral, -1.07% [CI, -1.72% to -0.43%]). Limitation: The study consisted of predominantly men, and deaths could be classified as cardiovascular but not arrhythmic. Conclusion: J waves and QRS slurs did not exhibit a clinically meaningful increased risk for cardiovascular death in long-term follow-up. Primary Funding Source: None.	[Perez, Marco V.] Stanford Hlth Care, Cardiac Arrhythmia & Electrophysiol, Stanford, CA 94305 USA; [Mathur, Maya B.] Stanford Univ, Quantitat Sci Unit, Palo Alto, CA 94305 USA; [Myers, Jonathan] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Froelicher, Victor F.] Ctr Inherited Cardiovasc Dis, Sports Cardiol Clin, Stanford, CA 94305 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Froelicher, VF (corresponding author), Ctr Inherited Cardiovasc Dis, Sports Cardiol Clin, 870 Quarry Rd,Falk Cardiovasc Res Bldg,MC-5406, Stanford, CA 94305 USA.	victorf@stanford.edu	Pargaonkar, Vedant S/AAZ-7893-2021	Froelicher, Victor/0000-0001-8831-4853				Borggrefe M, 2010, J AM COLL CARDIOL, V55, P798, DOI 10.1016/j.jacc.2009.12.006; Froelicher V, 2013, J ELECTROCARDIOL, V46, P381, DOI 10.1016/j.jelectrocard.2013.06.030; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; GRANT RP, 1951, CIRCULATION, V3, P182, DOI 10.1161/01.CIR.3.2.182; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Haruta D, 2011, CIRCULATION, V123, P2931, DOI 10.1161/CIRCULATIONAHA.110.006460; Hisamatsu T, 2013, CIRC J, V77, P1260, DOI 10.1253/circj.CJ-12-1273; KAMBARA H, 1976, AM J CARDIOL, V38, P157, DOI 10.1016/0002-9149(76)90142-9; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Kligfield P, 2007, J AM COLL CARDIOL, V49, P1109, DOI 10.1016/j.jacc.2007.01.024; Myers J, 2015, AM J MED, V128, P396, DOI 10.1016/j.amjmed.2014.10.061; Nademanee K, 2014, J AM COLL CARDIOL, V63, P2139, DOI 10.1016/j.jacc.2014.02.585; Olson KA, 2011, EUR HEART J, V32, P3098, DOI 10.1093/eurheartj/ehr264; Perez M, 2009, CURR PROB CARDIOLOGY, V34, P586, DOI 10.1016/j.cpcardiol.2009.08.002; Perez MV, 2012, AM J MED, V125, P843, DOI 10.1016/j.amjmed.2011.08.024; Perez MV, 2012, HEART RHYTHM, V9, P558, DOI 10.1016/j.hrthm.2011.11.020; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Rollin A, 2012, AM J CARDIOL, V110, P1302, DOI 10.1016/j.amjcard.2012.06.033; Sinner MF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000314; Soofi M, 2013, J ELECTROCARDIOL, V46, P404, DOI 10.1016/j.jelectrocard.2013.06.024; Stavrakis S, 2012, ANN NONINVAS ELECTRO, V17, P361, DOI 10.1111/j.1542-474X.2012.00533.x; Surawicz B, 2011, J AM COLL CARDIOL, V57, P1584, DOI 10.1016/j.jacc.2010.11.040; Therneau TM, 2000, MODELING SURVIVAL DA; Tikkanen JT, 2011, CIRCULATION, V123, P2666, DOI 10.1161/CIRCULATIONAHA.110.014068; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; Tokioka K, 2014, J AM COLL CARDIOL, V63, P2131, DOI 10.1016/j.jacc.2014.01.072; Uberoi A, 2012, MAYO CLIN PROC, V87, P614, DOI 10.1016/j.mayocp.2012.04.009; Uberoi A, 2011, CIRCULATION, V124, P2208, DOI 10.1161/CIRCULATIONAHA.111.047191; WILLEMS JL, 1985, EUR HEART J, V6, P815; Wu SH, 2013, J AM COLL CARDIOL, V61, P645, DOI 10.1016/j.jacc.2012.11.023; Yong CM, 2013, J ELECTROCARDIOL, V46, P408, DOI 10.1016/j.jelectrocard.2013.06.010	31	16	16	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					747	+		10.7326/M15-0598	http://dx.doi.org/10.7326/M15-0598			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26501238				2022-12-28	WOS:000365746400017
J	Delmaghani, S; Defourny, J; Aghaie, A; Beurg, M; Dulon, D; Thelen, N; Perfettini, I; Zelles, T; Aller, M; Meyer, A; Emptoz, A; Giraudet, F; Leibovici, M; Dartevelle, S; Soubigou, G; Thiry, M; Vizi, ES; Safieddine, S; Hardelin, JP; Avan, P; Petit, C				Delmaghani, Sedigheh; Defourny, Jean; Aghaie, Asadollah; Beurg, Maryline; Dulon, Didier; Thelen, Nicolas; Perfettini, Isabelle; Zelles, Tibor; Aller, Mate; Meyer, Anais; Emptoz, Alice; Giraudet, Fabrice; Leibovici, Michel; Dartevelle, Sylvie; Soubigou, Guillaume; Thiry, Marc; Vizi, E. Sylvester; Safieddine, Saaid; Hardelin, Jean-Pierre; Avan, Paul; Petit, Christine			Hypervulnerability to Sound Exposure through Impaired Adaptive Proliferation of Peroxisomes	CELL			English	Article							HEARING-LOSS; MUTATIONS; PROTECTS; GENETICS; PEJVAKIN; CHANNELS; STRESS; INJURY	A deficiency in pejvakin, a protein of unknown function, causes a strikingly heterogeneous form of human deafness. Pejvakin-deficient (Pjvk(-/-)) mice also exhibit variable auditory phenotypes. Correlation between their hearing thresholds and the number of pups per cage suggest a possible harmful effect of pup vocalizations. Direct sound or electrical stimulation show that the cochlear sensory hair cells and auditory pathway neurons of Pjvk(-/-) mice and patients are exceptionally vulnerable to sound. Subcellular analysis revealed that pejvakin is associated with peroxisomes and required for their oxidative-stress-induced proliferation. Pjvk(-/-) cochleas display features of marked oxidative stress and impaired antioxidant defenses, and peroxisomes in Pjvk(-/-) hair cells show structural abnormalities after the onset of hearing. Noise exposure rapidly upregulates Pjvk cochlear transcription in wildtype mice and triggers peroxisome proliferation in hair cells and primary auditory neurons. Our results reveal that the antioxidant activity of peroxisomes protects the auditory system against noise-induced damage.	[Delmaghani, Sedigheh; Defourny, Jean; Perfettini, Isabelle; Meyer, Anais; Emptoz, Alice; Leibovici, Michel; Safieddine, Saaid; Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France; [Delmaghani, Sedigheh; Defourny, Jean; Aghaie, Asadollah; Perfettini, Isabelle; Meyer, Anais; Emptoz, Alice; Leibovici, Michel; Safieddine, Saaid; Hardelin, Jean-Pierre; Petit, Christine] INSERM, UMRS 1120, F-75015 Paris, France; [Delmaghani, Sedigheh; Defourny, Jean; Aghaie, Asadollah; Perfettini, Isabelle; Meyer, Anais; Emptoz, Alice; Leibovici, Michel; Safieddine, Saaid; Hardelin, Jean-Pierre; Petit, Christine] Univ Paris 06, Sorbonne Univ, Complex Vivant, F-75005 Paris, France; [Aghaie, Asadollah] Inst Vis, Syndrome Usher & Autres Atteintes Retino Cochleai, F-75012 Paris, France; [Beurg, Maryline; Dulon, Didier] Univ Bordeaux, Equipe Neurophysiol Synapse Audit, Inst Neurosci, CHU Pellegrin, F-33076 Bordeaux, France; [Thelen, Nicolas; Thiry, Marc] Univ Liege, Unit Cell & Tissue Biol, GIGA Neurosci, CHU Sart Tilman, B-4000 Liege, Belgium; [Zelles, Tibor; Aller, Mate; Vizi, E. Sylvester] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Zelles, Tibor] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1089 Budapest, Hungary; [Giraudet, Fabrice; Avan, Paul] Univ Auvergne, Lab Biophys Sensorielle, F-63000 Clermont Ferrand, France; [Giraudet, Fabrice; Avan, Paul] INSERM, UMR 1107, F-63000 Clermont Ferrand, France; [Giraudet, Fabrice; Avan, Paul] Ctr Jean Perrin, F-63000 Clermont Ferrand, France; [Dartevelle, Sylvie] Inst Pasteur, Plateforme Ingn Anticorps, F-75015 Paris, France; [Soubigou, Guillaume] Inst Pasteur, Plateforme Transcriptome & Epigenome, F-75015 Paris, France; [Petit, Christine] Coll France, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Liege; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Jean Perrin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France	Petit, C (corresponding author), Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France.	christine.petit@pasteur.fr	Leibovici, Michel/ABB-6745-2020; DULON, Didier/I-7881-2016; GIRAUDET, Fabrice/Y-2287-2019; AVAN, Paul/J-6878-2015; Aller, Máté/AAN-3795-2020	DULON, Didier/0000-0003-1541-6861; GIRAUDET, Fabrice/0000-0001-7816-7503; AVAN, Paul/0000-0003-1054-1479; Aller, Máté/0000-0001-7096-5180; Aghaie, Asadollah Alain/0000-0002-3247-7087; Petit, Christine/0000-0002-9069-002X; Delmaghani, Sedigheh/0000-0003-2092-5097; Thelen, Nicolas/0000-0001-8042-1275; Defourny, Jean/0000-0002-9546-5091; Safieddine, Saaid/0000-0002-6159-0572; Beurg, Maryline/0000-0003-3069-267X	Louis-Jeantet Foundation; ANR-NKTH "HearDeafTreat'' [2010-INTB-1402-23 01, TET_10-1-2011-0421]; Fondation Bettencourt Schueller; Fondation Agir pour l'Audition; Humanis Novalis-Taitbout; Reunica- Prevoyance; BNP Paribas; French state program "Investissements d'Avenir'' [ANR-10-LABX-65]	Louis-Jeantet Foundation; ANR-NKTH "HearDeafTreat''(French National Research Agency (ANR)); Fondation Bettencourt Schueller; Fondation Agir pour l'Audition; Humanis Novalis-Taitbout; Reunica- Prevoyance; BNP Paribas; French state program "Investissements d'Avenir''(French National Research Agency (ANR))	We thank M. Aghaie and M. Mobasheri for clinical data, V. Michel for immuno-histolabeling, F. Langa-Vives (Centre d'ingenierie genetique murine platform) for Pvjk<SUP>fl/fl</SUP> mice engineering, J. Levilliers for her help in the preparation of the manuscript, J. Thornton and N. Furnham for protein structure prediction and analysis, and M. Ricchetti and P. Aubourg for fruitful discussions. This work was supported by the Louis-Jeantet Foundation, ANR-NKTH "HearDeafTreat'' (2010-INTB-1402-23 01 and TET_10-1-2011-0421), Fondation Bettencourt Schueller, Fondation Agir pour l'Audition, Humanis Novalis-Taitbout, Reunica- Prevoyance, BNP Paribas, and the French state program "Investissements d'Avenir'' (ANR-10-LABX-65) (to C.P.).	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Borck G, 2012, CLIN GENET, V82, P271, DOI 10.1111/j.1399-0004.2011.01741.x; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Collin RWJ, 2007, HUM MUTAT, V28, P718, DOI 10.1002/humu.20510; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dobie RA, 2008, EAR HEARING, V29, P565, DOI 10.1097/AUD.0b013e31817349ec; Ebberink MS, 2012, J MED GENET, V49, P307, DOI 10.1136/jmedgenet-2012-100778; Ebermann I, 2007, HUM MUTAT, V28, P571, DOI 10.1002/humu.20478; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110; Imig TJ, 2005, J COMP NEUROL, V490, P391, DOI 10.1002/cne.20674; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Lopez-Huertas E, 2000, EMBO J, V19, P6770, DOI 10.1093/emboj/19.24.6770; Mizuno Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S16; MOLLER AR, 1983, SCAND AUDIOL, V12, P125, DOI 10.3109/01050398309076235; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Rice ME, 2011, NEUROSCIENTIST, V17, P389, DOI 10.1177/1073858411404531; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Starr Arnold, 2015, Handb Clin Neurol, V129, P495, DOI 10.1016/B978-0-444-62630-1.00028-7; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006	30	107	119	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					894	906		10.1016/j.cell.2015.10.023	http://dx.doi.org/10.1016/j.cell.2015.10.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544938	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000364829700015
J	Anderson, RS				Anderson, Robert S.			Pinched topography initiates the critical zone	SCIENCE			English	Editorial Material							BOTTOM-UP CONTROL; EROSION		Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	Anderson, RS (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80303 USA.	robert.s.anderson@colorado.edu		Anderson, Robert/0000-0003-2759-4833				Anderson RS, 2013, EARTH SURF PROC LAND, V38, P299, DOI 10.1002/esp.3330; Anderson SP, 2007, ELEMENTS, V3, P315, DOI 10.2113/gselements.3.5.315; Befus KM, 2011, VADOSE ZONE J, V10, P1342, DOI 10.2136/vzj2010.0108er; Graham R.C., 2010, GSA TODAY, V20, P4, DOI [10.1130/GSAT57A.1, DOI 10.1130/GSAT57A.1]; Lebedeva MI, 2013, EARTH SURF PROC LAND, V38, P1793, DOI 10.1002/esp.3424; Milodowski DT, 2015, ECOLOGY, V96, P31, DOI 10.1890/14-0649.1; Molnar P, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2005JF000433; Parsekian AD, 2015, REV GEOPHYS, V53, P1, DOI 10.1002/2014RG000465; Rempe DM, 2014, P NATL ACAD SCI USA, V111, P6576, DOI 10.1073/pnas.1404763111; Richter DD, 2015, NEW PHYTOL, V206, P900, DOI 10.1111/nph.13338; Slim M, 2015, EARTH SURF PROC LAND, V40, P512, DOI 10.1002/esp.3646; St Clair J, 2015, SCIENCE, V350, P534, DOI 10.1126/science.aab2210	12	11	13	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					506	507		10.1126/science.aad2266	http://dx.doi.org/10.1126/science.aad2266			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516265				2022-12-28	WOS:000363660000024
J	Adler, HM				Adler, Herbert M.			A Piece of My Mind-Actually	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PSYCHOTHERAPY; EMPATHY		[Adler, Herbert M.] Thomas Jefferson Univ, Dept Family Med, Philadelphia, PA 19107 USA; [Adler, Herbert M.] Thomas Jefferson Univ, Dept Psychiat & Human Behav, Philadelphia, PA USA	Jefferson University; Jefferson University	Adler, HM (corresponding author), Thomas Jefferson Univ, Dept Family Med, Philadelphia, PA 19107 USA.	herbert.adler187@gmail.com						Adler H M, 1997, J Am Board Fam Pract, V10, P28; Adler HM, 2007, J GEN INTERN MED, V22, P280, DOI 10.1007/s11606-006-0037-8; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Jensen KB, 2014, MOL PSYCHIATR, V19, P392, DOI 10.1038/mp.2012.195; KANDEL ER, 1979, NEW ENGL J MED, V301, P1028, DOI 10.1056/NEJM197911083011904; Nummenmaa L, 2012, P NATL ACAD SCI USA, V109, P9599, DOI 10.1073/pnas.1206095109; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Riess H, 2010, JAMA-J AM MED ASSOC, V304, P1604, DOI 10.1001/jama.2010.1455; Siegel DJ, 2006, PSYCHIAT ANN, V36, P248; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107	10	0	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1693	1694		10.1001/jama.2015.8429	http://dx.doi.org/10.1001/jama.2015.8429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505594				2022-12-28	WOS:000363706300015
J	Jones, EK; Mingioni, N; Lee, JB				Jones, Elizabeth K.; Mingioni, Nina; Lee, Jason B.			Widespread Scaly Eruption in a Patient With Multiple Comorbidities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CUTANEOUS LUPUS-ERYTHEMATOSUS		[Jones, Elizabeth K.; Lee, Jason B.] Thomas Jefferson Univ Hosp, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Mingioni, Nina] Thomas Jefferson Univ Hosp, Dept Internal Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Lee, JB (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 833 Chestnut St,Ste 740, Philadelphia, PA 19107 USA.	jason.lee@jefferson.edu		Mingioni, Nina/0000-0001-7350-8604				Almebayadh M, 2013, DERMATOLOGY, V226, P119, DOI 10.1159/000346694; Callen JP, 2013, JAMA DERMATOL, V149, P1075, DOI 10.1001/jamadermatol.2013.4958; Chlebus E, 1998, J AM ACAD DERMATOL, V38, P405, DOI 10.1016/S0190-9622(98)70497-9; Lowe G, 2011, BRIT J DERMATOL, V164, P465, DOI 10.1111/j.1365-2133.2010.10110.x; Lowe GC, 2014, BRIT J DERMATOL, V170, P999, DOI 10.1111/bjd.13022; Marzano AV, 2009, LUPUS, V18, P935, DOI 10.1177/0961203309106176; McCauliffe DP, 1998, LANCET, V351, P1527, DOI 10.1016/S0140-6736(05)61117-8; Sandholdt LH, 2014, BRIT J DERMATOL, V170, P342, DOI 10.1111/bjd.12699; SONTHEIMER RD, 1979, ARCH DERMATOL, V115, P1409, DOI 10.1001/archderm.115.12.1409; Vera-Recabarren MA, 2010, BRIT J DERMATOL, V162, P91, DOI 10.1111/j.1365-2133.2009.09472.x	10	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1740	1741		10.1001/jama.2015.9391	http://dx.doi.org/10.1001/jama.2015.9391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505598				2022-12-28	WOS:000363706300023
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Flibanserin for low sexual desire is not feminism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DYSFUNCTION					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Angel K, 2010, CURR OPIN PSYCHIATR, V23, P536, DOI 10.1097/YCO.0b013e32833db7a1; Basson R, 2015, EBIOMEDICINE, V2, P772, DOI 10.1016/j.ebiom.2015.08.009; Food and Drug Administration, FDA ACC DAT FLIB; Ishak WW., 2013, REPROD SYSTEM SEXUAL, V2, P122, DOI [10.4172/2161-038X.1000122, DOI 10.4172/2161-038X.1000122]; Kingsberg SA, 2013, MENOPAUSE, V20, P1284, DOI [10.1097/GME.0000000000000131, 10.1097/gme.0000000000000131]; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Roehr B, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3097	7	2	2	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2015	351								h5650	10.1136/bmj.h5650	http://dx.doi.org/10.1136/bmj.h5650			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IC	26502743	Bronze			2022-12-28	WOS:000364151600002
J	Ohuchi, N; Suzuki, A; Sobue, T; Kawai, M; Yamamoto, S; Zheng, YF; Shiono, YN; Saito, H; Kuriyama, S; Tohno, E; Endo, T; Fukao, A; Tsuji, I; Yamaguchi, T; Ohashi, Y; Fukuda, M; Ishida, T				Ohuchi, Noriaki; Suzuki, Akihiko; Sobue, Tomotaka; Kawai, Masaaki; Yamamoto, Seiichiro; Zheng, Ying-Fang; Shiono, Yoko Narikawa; Saito, Hiroshi; Kuriyama, Shinichi; Tohno, Eriko; Endo, Tokiko; Fukao, Akira; Tsuji, Ichiro; Yamaguchi, Takuhiro; Ohashi, Yasuo; Fukuda, Mamoru; Ishida, Takanori		J-START Investigator Grp	Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial	LANCET			English	Article							DENSE BREASTS; WOMEN; ULTRASOUND; US; ASSOCIATION; HARMS; RATES	Background Mammography is the only proven method for breast cancer screening that reduces mortality, although it is inaccurate in young women or women with dense breasts. We investigated the efficacy of adjunctive ultrasonography. Methods Between July, 2007, and March, 2011, we enrolled asymptomatic women aged 40-49 years at 42 study sites in 23 prefectures into the Japan Strategic Anti-cancer Randomized Trial (J-START). Eligible women had no history of any cancer in the previous 5 years and were expected to live for more than 5 years. Randomisation was done centrally by the Japan Clinical Research Support Unit. Participants were randomly assigned in 1: 1 ratio to undergo mammography and ultrasonography (intervention group) or mammography alone (control group) twice in 2 years. The primary outcome was sensitivity, specificity, cancer detection rate, and stage distribution at the first round of screening. Analysis was by intention to treat. This study is registered, number UMIN000000757. Findings Of 72 998 women enrolled, 36 859 were assigned to the intervention group and 36 139 to the control group. Sensitivity was significantly higher in the intervention group than in the control group (91.1%, 95% CI 87.2-95.0 vs 77.0%, 70.3-83.7; p=0.0004), whereas specificity was significantly lower (87.7%, 87.3-88.0 vs 91.4%, 91.1-91.7; p<0.0001). More cancers were detected in the intervention group than in the control group (184 [0.50%] vs 117 [0.32%], p=0.0003) and were more frequently stage 0 and I (144 [71.3%] vs 79 [52.0%], p=0.0194). 18 (0.05%) interval cancers were detected in the intervention group compared with 35 (0.10%) in the control group (p=0.034).	[Ohuchi, Noriaki; Suzuki, Akihiko; Zheng, Ying-Fang; Shiono, Yoko Narikawa; Ishida, Takanori] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Sendai, Miyagi 9808574, Japan; [Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth, Sendai, Miyagi 9808574, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Dept Biostat, Sendai, Miyagi 9808574, Japan; [Kuriyama, Shinichi] Tohoku Univ, Int Res Inst Disaster Sci, Dept Disaster Related Publ Hlth, Sendai, Miyagi 9808574, Japan; [Sobue, Tomotaka] Osaka Univ, Grad Sch Med, Dept Environm & Populat Sci, Osaka, Japan; [Kawai, Masaaki] Miyagi Canc Ctr Hosp, Dept Breast Surg, Sendai, Miyagi, Japan; [Yamamoto, Seiichiro; Saito, Hiroshi] Natl Canc Ctr, Dept Screening Assessment & Management, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Tohno, Eriko] Tsukuba Hlth Evaluat Ctr, Dept Radiol, Tsukuba, Ibaraki, Japan; [Endo, Tokiko] Higashi Nagoya Natl Hosp, Dept Radiol, Nagoya, Aichi, Japan; [Fukao, Akira] Yamagata Univ, Sch Med, Dept Publ Hlth, Yamagata 99023, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan; [Fukuda, Mamoru] St Marianna Univ, Dept Surg, Breast & Imaging Ctr, Kawasaki, Kanagawa, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Osaka University; Miyagi Cancer Center; National Cancer Center - Japan; Yamagata University; Chuo University; Saint Marianna University	Ohuchi, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	noriaki-ohuchi@med.tohoku.ac.jp	Sobue, Tomotaka/ABE-4739-2021		Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare [H18-Senryaku-001, H23-Shitei-002, H25-Shitei-005]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Ministry of Health, Labour and Welfare of Japan.; This study was support by the third Comprehensive Control Research for Cancer programme of the Japanese Ministry of Health, Labour and Welfare (grant number H18-Senryaku-001, H23-Shitei-002, H25-Shitei-005).	Bae JM, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014027; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Chae EY, 2013, J ULTRAS MED, V32, P1573, DOI 10.7863/ultra.32.9.1573; Corsetti V, 2008, EUR J CANCER, V44, P539, DOI 10.1016/j.ejca.2008.01.009; Corsetti V, 2011, EUR J CANCER, V47, P1021, DOI 10.1016/j.ejca.2010.12.002; Dai HJ, 2014, INT J EPIDEMIOL, V43, P1240, DOI 10.1093/ije/dyu042; Duijm LEM, 1997, BRIT J CANCER, V76, P377, DOI 10.1038/bjc.1997.393; Gartlehner G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009632.pub2; Green M, 2008, ASIA-PAC J CLIN ONCO, V4, pS5, DOI 10.1111/j.1743-7563.2008.00191.x; Hooley RJ, 2012, RADIOLOGY, V265, P59, DOI 10.1148/radiol.12120621; Houssami N, 2011, PREV MED, V53, P123, DOI 10.1016/j.ypmed.2011.05.003; Irwig L, 2006, BMJ-BRIT MED J, V332, P678, DOI 10.1136/bmj.332.7543.678; Ishida T, 2014, JPN J CLIN ONCOL, V44, P134, DOI 10.1093/jjco/hyt199; Ishihara S, 2013, ACTA MED OKAYAMA, V67, P145; Kasahara Y, 2013, BREAST CANCER-TOKYO, V20, P310, DOI 10.1007/s12282-012-0333-6; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Maskarinec G, 2007, BREAST CANCER RES TR, V104, P47, DOI 10.1007/s10549-006-9387-5; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nothacker M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-335; OHUCHI N, 1993, JPN J CANCER RES, V84, P807, DOI 10.1111/j.1349-7006.1993.tb02048.x; OHUCHI N, 1995, JPN J CANCER RES, V86, P501, DOI 10.1111/j.1349-7006.1995.tb03084.x; Ohuchi N, 2011, JPN J CLIN ONCOL, V41, P275, DOI 10.1093/jjco/hyq214; Scheel JR, 2015, AM J OBSTET GYNECOL, V212, P9, DOI 10.1016/j.ajog.2014.06.048; Sickles E., 2003, ACR BI RADS ATLAS BR; Sobin LH., 2010, TNM CLASSIFICATION M; Sprague BL, 2015, ANN INTERN MED, V162, P157, DOI 10.7326/M14-0692; Suzuki A, 2008, CANCER SCI, V99, P2264, DOI 10.1111/j.1349-7006.2008.00926.x; Tohno E, 2012, BREAST CANCER-TOKYO, V19, P138, DOI 10.1007/s12282-010-0221-x; Tohno E, 2009, BREAST CANCER-TOKYO, V16, P18, DOI 10.1007/s12282-008-0082-8; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005	35	277	296	3	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					341	348		10.1016/S0140-6736(15)00774-6	http://dx.doi.org/10.1016/S0140-6736(15)00774-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26547101				2022-12-28	WOS:000368516500032
J	Penny, MA; Verity, R; Bever, CA; Sauboin, C; Galactionova, K; Flasche, S; White, MT; Wenger, EA; Van de Velde, N; Pemberton-Ross, P; Griffin, JT; Smith, TA; Eckhoff, PA; Muhib, F; Jit, M; Ghani, AC				Penny, Melissa A.; Verity, Robert; Bever, Caitlin A.; Sauboin, Christophe; Galactionova, Katya; Flasche, Stefan; White, Michael T.; Wenger, Edward A.; Van de Velde, Nicolas; Pemberton-Ross, Peter; Griffin, Jamie T.; Smith, Thomas A.; Eckhoff, Philip A.; Muhib, Farzana; Jit, Mark; Ghani, Azra C.			Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models	LANCET			English	Article							PLASMODIUM-FALCIPARUM; MORTALITY; EFFICACY; DISEASE; AFRICA; BURDEN	Background The phase 3 trial of the RTS, S/AS01 malaria vaccine candidate showed modest efficacy of the vaccine against Plasmodium falciparum malaria, but was not powered to assess mortality endpoints. Impact projections and cost-effectiveness estimates for longer timeframes than the trial follow-up and across a range of settings are needed to inform policy recommendations. We aimed to assess the public health impact and cost-effectiveness of routine use of the RTS, S/AS01 vaccine in African settings. Methods We compared four malaria transmission models and their predictions to assess vaccine cost-effectiveness and impact. We used trial data for follow-up of 32 months or longer to parameterise vaccine protection in the group aged 5-17 months. Estimates of cases, deaths, and disability-adjusted life-years (DALYs) averted were calculated over a 15 year time horizon for a range of levels of Plasmodium falciparum parasite prevalence in 2-10 year olds (PfPR(2-10); range 3-65%). We considered two vaccine schedules: three doses at ages 6, 7.5, and 9 months (three-dose schedule, 90% coverage) and including a fourth dose at age 27 months (four-dose schedule, 72% coverage). We estimated cost-effectiveness in the presence of existing malaria interventions for vaccine prices of US$2-10 per dose. Findings In regions with a PfPR(2-10) of 10-65%, RTS, S/AS01 is predicted to avert a median of 93 940 (range 20490-126540) clinical cases and 394 (127-708) deaths for the three-dose schedule, or 116 480 (31450-160410) clinical cases and 484 (189-859) deaths for the four-dose schedule, per 100 000 fully vaccinated children. A positive impact is also predicted at a PfPR(2-10) of 5-10%, but there is little impact at a prevalence of lower than 3%. At $5 per dose and a PfPR(2-10) of 10-65%, we estimated a median incremental cost-effectiveness ratio compared with current interventions of $30 (range 18-211) per clinical case averted and $80 (44-279) per DALY averted for the three-dose schedule, and of $25 (16-222) and $87 (48-244), respectively, for the four-dose schedule. Higher ICERs were estimated at low PfPR(2-10) levels. Interpretation We predict a significant public health impact and high cost-effectiveness of the RTS, S/AS01 vaccine across a wide range of settings. Decisions about implementation will need to consider levels of malaria burden, the cost-effectiveness and coverage of other malaria interventions, health priorities, financing, and the capacity of the health system to deliver the vaccine.	[Penny, Melissa A.; Galactionova, Katya; Pemberton-Ross, Peter; Smith, Thomas A.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4051 Basel, Switzerland; [Penny, Melissa A.; Galactionova, Katya; Pemberton-Ross, Peter; Smith, Thomas A.] Univ Basel, Basel, Switzerland; [Verity, Robert; White, Michael T.; Griffin, Jamie T.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Outbreak Anal & Modelling, London, England; [Bever, Caitlin A.; Wenger, Edward A.; Eckhoff, Philip A.] Inst Dis Modeling, Bellevue, WA USA; [Sauboin, Christophe; Van de Velde, Nicolas] GSK Vaccines, Wavre, Belgium; [Flasche, Stefan; Jit, Mark] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Muhib, Farzana] PATH, Washington, DC USA; [Jit, Mark] Publ Hlth England, Modelling & Econ Unit, London, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Imperial College London; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; Public Health England	Penny, MA (corresponding author), Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland.	melissa.penny@unibas.ch	Ghani, Azra/B-8560-2009; Penny, Melissa A/N-6838-2015; Smith, Thomas/B-5569-2015; Jit, Mark/HDM-7797-2022	Penny, Melissa A/0000-0002-4972-593X; Smith, Thomas/0000-0002-3650-9381; Galactionova, Katya/0000-0002-5743-7647; Jit, Mark/0000-0001-6658-8255; Verity, Robert/0000-0002-3902-8567; Ghani, Azra/0000-0002-0007-4910; Flasche, Stefan/0000-0002-5808-2606; White, Michael/0000-0002-7472-4138	PATH Malaria Vaccine Initiative; Bill & Melinda Gates Foundation; Global Good Fund; Medical Research Council; UK Department for International Development; GAVI, the Vaccine Alliance; WHO; Global Good Fund of Bellevue, WA, USA; Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; MRC [G1002284, MR/K010174/1] Funding Source: UKRI; Medical Research Council [G1002284, MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	PATH Malaria Vaccine Initiative; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Global Good Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; GAVI, the Vaccine Alliance; WHO(World Health Organization); Global Good Fund of Bellevue, WA, USA; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PATH Malaria Vaccine Initiative; Bill & Melinda Gates Foundation; Global Good Fund; Medical Research Council; UK Department for International Development; GAVI, the Vaccine Alliance; WHO.; Imperial College London and Swiss Tropical and Public Health Institute received funding from the PATH Malaria Vaccine Initiative and the Bill & Melinda Gates Foundation. Work done by the Institute for Disease Modeling was funded by the Global Good Fund of Bellevue, WA, USA. The London School of Hygiene & Tropical Medicine (SF, MJ) received funding from WHO and GAVI, the Vaccine Alliance. Imperial College London received additional fellowship (JTG, MTW) and centre (ACG) funding from the Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID concordat agreement. No funding was provided by GlaxoSmithKline Biologicals SA to the non-GSK modelling groups or the comparison process as a whole. We thank Vasee Moorthy and Raymond Hutubessy (WHO, Geneva, Switzerland) for their role in bringing this consortium together and initiating the work outlined in this report; members of the WHO Joint Technical Expert Group on malaria vaccine modelling subgroup for their constructive comments; and Alison Reynolds for her support in undertaking this work. Calculations for OpenMalaria were done at the Centre for Scientific Computing (sciCORE) at the University of Basel, Switzerland, and we thank the many volunteers who made their computers available via www.malariacontrol.net for the simulations.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P325; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136; Hamel MJ, 2014, 63 ANN M AM SOC TROP, P631; Hutubessy R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-55; INDEPTH Network, 2004, MOD LIF TABL SUBS AF; Lee LA, 2013, VACCINE, V31, pB61, DOI 10.1016/j.vaccine.2012.11.035; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; McCarthy KA, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-6; Moorthy VS, 2012, B WORLD HEALTH ORGAN, V90, P864, DOI 10.2471/BLT.12.107482; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; Penny MA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0408-2; Sauboin C, 2014, 3 INT C AFR HLTH EC, P40; Smith T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001157; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; White MT, 2014, J INFECT DIS, V210, P1115, DOI 10.1093/infdis/jiu219; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2008, WHO GUID STAND EC EV; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2013, WHO UNICEF EST DTP3; World Health Organization, 2015, ACHIEVING MALARIA MD; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	30	102	105	2	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					367	375		10.1016/S0140-6736(15)00725-4	http://dx.doi.org/10.1016/S0140-6736(15)00725-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26549466	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000368516500035
J	Guo, Y; Yin, H				Guo, Yan; Yin, Hui			Reducing child mortality in China: successes and challenges	LANCET			English	Editorial Material									[Guo, Yan; Yin, Hui] Peking Univ, Sch Publ Hlth, Beijing 100191, Peoples R China	Peking University	Guo, Y (corresponding author), Peking Univ, Sch Publ Hlth, Beijing 100191, Peoples R China.	guoyan@bjmu.edu.cn						China National Health and Family Planning Committee, 2015, CHIN HAS ACH MDG 4; Guo Y, 2015, SEMIN FETAL NEONAT M, V20, P309, DOI 10.1016/j.siny.2015.07.006; Meng QY, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001694; National Bureau of Statistics China, IND NAT ACC; National Bureau of Statistics of China, 2013, CHIN STAT YB 2013; UNAIDS UNICEF UNFPA WHO UN System Task Team on the post-2015 UN development agenda, 2012, UN SYSTEM TASK TEAM; Wang Y, 2015, LANCET; WHO, 2015, WHA6813; World Bank, WORLD DEV IND RUR PO	9	3	3	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					205	207		10.1016/S0140-6736(15)00555-3	http://dx.doi.org/10.1016/S0140-6736(15)00555-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26510779	Green Published, Bronze			2022-12-28	WOS:000368130700007
J	Notta, F; Zandi, S; Takayama, N; Dobson, S; Gan, OI; Wilson, G; Kaufmann, KB; McLeod, J; Laurenti, E; Dunant, CF; McPherson, JD; Stein, LD; Dror, Y; Dick, JE				Notta, Faiyaz; Zandi, Sasan; Takayama, Naoya; Dobson, Stephanie; Gan, Olga I.; Wilson, Gavin; Kaufmann, Kerstin B.; McLeod, Jessica; Laurenti, Elisa; Dunant, Cyrille F.; McPherson, John D.; Stein, Lincoln D.; Dror, Yigal; Dick, John E.			Distinct routes of lineage development reshape the human blood hierarchy across ontogeny	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; MYELOID PROGENITOR; DENDRITIC CELLS; APLASTIC-ANEMIA; C-MPL; IDENTIFICATION; QUIESCENCE; CYTOKINES; RULES; MAP	In a classical view of hematopoiesis, the various blood cell lineages arise via a hierarchical scheme starting with multipotent stem cells that become increasingly restricted in their differentiation potential through oligopotent and then unipotent progenitors. We developed a cell-sorting scheme to resolvemyeloid (My), erythroid (Er), and megakaryocytic (Mk) fates from single CD34(+) cells and then mapped the progenitor hierarchy across human development. Fetal liver contained large numbers of distinct oligopotent progenitors with intermingled My, Er, and Mk fates. However, few oligopotent progenitor intermediates were present in the adult bone marrow. Instead, only two progenitor classes predominate, multipotent and unipotent, with Er-Mk lineages emerging from multipotent cells. The developmental shift to an adult "two-tier" hierarchy challenges current dogma and provides a revised framework to understand normal and disease states of human hematopoiesis.	[Notta, Faiyaz; Zandi, Sasan; Takayama, Naoya; Dobson, Stephanie; Gan, Olga I.; Kaufmann, Kerstin B.; McLeod, Jessica; Dick, John E.] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Notta, Faiyaz; Zandi, Sasan; Takayama, Naoya; Dobson, Stephanie; Wilson, Gavin; Kaufmann, Kerstin B.; Stein, Lincoln D.; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [McPherson, John D.] Univ Toronto, Med Biophys, Toronto, ON, Canada; [Wilson, Gavin; McPherson, John D.; Stein, Lincoln D.] Ontario Inst Canc Res, Toronto, ON, Canada; [Dror, Yigal] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5S 1A1, Canada; [Laurenti, Elisa] Univ Cambridge, Med Res Council, Cambridge Stem Cell Inst, Dept Haematol,Wellcome Trust, Cambridge, England; [Dunant, Cyrille F.] Ecole Polytech Fed Lausanne, LMC, CH-1015 Lausanne, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Wellcome Trust Sanger Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Dick, JE (corresponding author), Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	jdick@uhnres.utoronto.ca	McPherson, John D/D-2633-2017	McPherson, John D/0000-0001-8049-9347; Dunant, Cyrille/0000-0001-5176-4439; Laurenti, Elisa/0000-0002-9917-9092; Kaufmann, Kerstin B./0000-0001-5013-6123; Dick, John/0000-0002-9527-8317; Wilson, Gavin/0000-0002-3557-6320	Canadian Institute of Health Research (CIHR); Aplastic Anemia and Myelodysplasia Association of Canada; Ontario Institute of Cancer Research (OICR) through Ontario Ministry of Research and Innovation; Wellcome Trust Sir Henry Dale Fellowship; Wellcome Trust; Medical Research Council; CIHR; Canadian Cancer Society; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; OICR; province of Ontario; Canada Research Chair; Ontario Ministry of Health and Long-Term Care (OMOHLTC)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Aplastic Anemia and Myelodysplasia Association of Canada; Ontario Institute of Cancer Research (OICR) through Ontario Ministry of Research and Innovation; Wellcome Trust Sir Henry Dale Fellowship; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); OICR; province of Ontario; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long-Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank all members of the Dick laboratory for critical review of the manuscript, especially J.C.Y. Wang, E. Lechman, and M. Cooper; and N. Simard and S. Zhao and members of the Sickkids-UHN Flow Cytometry facility for technical support. We thank K. Moore and the obstetrics unit of Trillium Hospital (Mississauga, Ontario) for providing cord blood. We thank J. Rohrer from BD Biosciences (La Jolla, CA) for supplying BAH-1 clone. This work was supported by postdoctoral fellowship awards from the Canadian Institute of Health Research (CIHR) to F.N. and S.Z. S.Z. is supported by the Aplastic Anemia and Myelodysplasia Association of Canada. F.N. is a recipient of a scholar's research award from the Ontario Institute of Cancer Research (OICR), through generous support from the Ontario Ministry of Research and Innovation. Research in E.L.'s laboratory is supported by a Wellcome Trust Sir Henry Dale Fellowship and a core support grant from the Wellcome Trust and the Medical Research Council to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. Work in the Dick laboratory is supported by grants from CIHR, Canadian Cancer Society, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, OICR with funds from the province of Ontario, a Canada Research Chair, and the Ontario Ministry of Health and Long-Term Care (OMOHLTC). Author Contributions: F.N., S.Z., and J.E.D. designed the study; F.N. and S.Z. analyzed and interpreted data; F.N., S.Z., N.T., S.D., O.I.G., and J. M. performed experiments; G.W., J.D.M., and L.D.S. performed RNA sequencing and analysis. K.B.K., S.Z., F.N., and J.E.D. generated the model; Y.D. provided clinical samples from aplastic anemia and matched controls for the study. F.N., S.Z., and J.E.D. wrote the manuscript; all authors reviewed and approved the manuscript; J.E.D. supervised the study. Aplastic anemia samples are available from Y.D. under a material transfer agreement with Toronto Sickkids Hospital. Gene expression data have been submitted to the Gene Expression Omnibus (no. GSE76234).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Deng BJ, 1998, BLOOD, V92, P1981, DOI 10.1182/blood.V92.6.1981.418k15_1981_1988; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Edvardsson L, 2006, EXP HEMATOL, V34, P599, DOI 10.1016/j.exphem.2006.01.017; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Heazlewood SY, 2013, STEM CELL RES, V11, P782, DOI 10.1016/j.scr.2013.05.007; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Maciejewski JP, 2003, ARCH MED RES, V34, P520, DOI 10.1016/j.arcmed.2003.09.009; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; MARSH JCW, 1990, BLOOD, V76, P1748; Matsui WH, 2006, LEUKEMIA, V20, P458, DOI 10.1038/sj.leu.2404119; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rizzo Sian, 2002, Hematol J, V3, P230, DOI 10.1038/sj.thj.6200187; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sankaran VG, 2015, NAT MED, V21, P221, DOI 10.1038/nm.3814; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; TILL JE, 1980, BIOCHIM BIOPHYS ACTA, V605, P431, DOI 10.1016/0304-419X(80)90009-8; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706	41	429	438	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					139	+		10.1126/science.aab2116	http://dx.doi.org/10.1126/science.aab2116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26541609	Green Accepted			2022-12-28	WOS:000367806500031
J	Pianko, S; Flamm, SL; Shiffman, ML; Kumar, S; Strasser, SI; Dore, GJ; McNally, J; Brainard, DM; Han, LL; Doehle, B; Mogalian, E; McHutchison, JG; Rabinovitz, M; Towner, WJ; Gane, EJ; Stedman, CAM; Reddy, KR; Roberts, SK				Pianko, Stephen; Flamm, Steven L.; Shiffman, Mitchell L.; Kumar, Sonal; Strasser, Simone I.; Dore, Gregory J.; McNally, John; Brainard, Diana M.; Han, Lingling; Doehle, Brian; Mogalian, Erik; McHutchison, John G.; Rabinovitz, Mordechai; Towner, William J.; Gane, Edward J.; Stedman, Catherine A. M.; Reddy, K. Rajender; Roberts, Stuart K.			Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIVIRAL ACTIVITY; HCV; RESISTANCE	Background: Effective treatment options are needed for patients with genotype 1 or 3 hepatitis C virus (HCV) infection in whom previous therapy has failed. Objective: To assess the efficacy and safety of sofosbuvir plus velpatasvir, with and without ribavirin, in treatment-experienced patients. Design: Randomized, phase 2, open-label study. (ClinicalTrials.gov:NCT01909804) Setting: 58 sites in Australia, New Zealand, and the United States. Patients: Treatment-experienced adults with genotype 3 HCV infection without cirrhosis (cohort 1) and with compensated cirrhosis (cohort 2) and patients with genotype 1 HCV infection that was unsuccessfully treated with a protease inhibitor with peginterferon and ribavirin (50% could have compensated cirrhosis) (cohort 3). Intervention: All patients received 12 weeks of treatment that included 400 mg of sofosbuvir once daily. Patients in each cohort were randomly assigned to 25 mg of velpatasvir once daily with or without ribavirin or 100 mg of velpatasvir once daily with or without ribavirin. Measurements: Proportion of patients with sustained virologic response at week 12 after treatment (SVR12). Results: In cohort 1, SVR12 rates were 85% with 25 mg of velpatasvir, 96% with 25 mg of velpatasvir plus ribavirin, 100% with 100 mg of velpatasvir, and 100% with 100 mg of velpatasvir plus ribavirin. In cohort 2, SVR12 rates were 58% with 25 mg of velpatasvir, 84% with 25 mg of velpatasvir plus ribavirin, 88% with 100 mg of velpatasvir, and 96% with 100 mg of velpatasvir plus ribavirin. In cohort 3, SVR12 rates were 100% with 25 mg of velpatasvir, 97% with 25 mg of velpatasvir plus ribavirin, 100% with 100 mg of velpatasvir, and 96% with 100 mg of velpatasvir plus ribavirin. The most common adverse events were headache, fatigue, and nausea. Limitation: Treatment assignments were not blinded, and no inferential statistics were planned. Conclusion: Treatment with 400 mg of sofosbuvir plus 100 mg of velpatasvir for 12 weeks was well-tolerated and highly effective in treatment-experienced patients with genotype 1 or 3 HCV infection.	Monash Hlth, Clayton, Vic, Australia; Monash Univ, Clayton, Vic 3800, Australia; Northwestern Univ, Chicago, IL 60611 USA; Liver Inst Virginia, Richmond, VA USA; Weill Cornell Med Coll, New York, NY 10021 USA; Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; Univ Sydney, Camperdown, NSW, Australia; Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; St Vincents Hosp, Sydney, NSW 2010, Australia; [McNally, John; Brainard, Diana M.; Han, Lingling; Doehle, Brian; Mogalian, Erik; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; Univ Pittsburgh, Pittsburgh, PA 15213 USA; Kaiser Permanente Med Ctr, Los Angeles, CA 90034 USA; Auckland Clin Studies, Auckland, New Zealand; Christchurch Clin Studies Trust, Christchurch, New Zealand; [Stedman, Catherine A. M.] Univ Otago, Christchurch 8011, New Zealand; Univ Penn, Philadelphia, PA 19104 USA; Alfred Hlth, Melbourne, Vic 3181, Australia; Monash Univ, Clayton, Vic 3800, Australia	Monash University; Northwestern University; Cornell University; University of Sydney; University of Sydney; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Gilead Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; University of Otago; University of Pennsylvania; Monash University	Pianko, S (corresponding author), Monash Univ, Monash Hlth, 10 Ancora Imparo Way, Clayton, Vic 3800, Australia.	spianko@geds.com.au	Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; American Association for the Study of Liver Diseases Infectious Diseases Society of America, HCV GUID REC TEST MA; Buti M, 2015, EXPERT REV GASTROENT, V9, P375, DOI 10.1586/17474124.2015.960396; Cheng G, 2013, J HEPATOL, V58, pS484, DOI 10.1016/S0168-8278(13)61192-7; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Doehle B, 2013, LIV M 2013 64 ANN M; Everson GT, 2015, ANN INTERN MED, V163, P818, DOI 10.7326/M15-1000; Foster GR, 2015, GASTROENTEROLOGY; Gao M, 2013, CURR OPIN VIROL, V3, P514, DOI 10.1016/j.coviro.2013.06.014; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Kanwal F, 2014, HEPATOLOGY, V60, P98, DOI 10.1002/hep.27095; Lawitz E, 2015, J VIRAL HEPAT; Mogalian E, 2013, LIV M 2013 64 ANN M; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	18	67	69	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					809	817		10.7326/M15-1014	http://dx.doi.org/10.7326/M15-1014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26551263				2022-12-28	WOS:000365866500004
J	Nunez, JK; Harrington, LB; Kranzusch, PJ; Engelman, AN; Doudna, JA				Nunez, James K.; Harrington, Lucas B.; Kranzusch, Philip J.; Engelman, Alan N.; Doudna, Jennifer A.			Foreign DNA capture during CRISPR-Cas adaptive immunity	NATURE			English	Article							SPACER ACQUISITION; REPEATS; SYSTEM; RNA; BACTERIOPHAGE; SEQUENCE; ELEMENTS; DEFENSE; MEMORY; TOOLS	Bacteria and archaea generate adaptive immunity against phages and plasmids by integrating foreign DNA of specific 30-40-base-pair lengths into clustered regularly interspaced short palindromic repeat (CRISPR) loci as spacer segments(1-6). The universally conserved Cas1-Cas2 integrase complex catalyses spacer acquisition using a direct nucleophilic integration mechanism similar to retroviral integrases and transposases(7-13). How the Cas1-Cas2 complex selects foreign DNA substrates for integration remains unknown. Here we present X-ray crystal structures of the Escherichia coli Cas1-Cas2 complex bound to cognate 33-nucleotide protospacer DNA substrates. The protein complex creates a curved binding surface spanning the length of the DNA and splays the ends of the protospacer to allow each terminal nucleophilic 3'-OH to enter a channel leading into the Cas1 active sites. Phosphodiester backbone interactions between the protospacer and the proteins explain the sequence-nonspecific substrate selection observed in vivo(2-4). Our results uncover the structural basis for foreign DNA capture and the mechanism by which Cas1-Cas2 functions as a molecular ruler to dictate the sequence architecture of CRISPR loci.	[Nunez, James K.; Harrington, Lucas B.; Kranzusch, Philip J.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kranzusch, Philip J.; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Engelman, Alan N.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Engelman, Alan N.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu			UC Office of the President; Multicampus Research Programs; Program for Breakthrough Biomedical Research - Sandler Foundation; US National Science Foundation [1244557]; NIH [AI070042]; US National Science Foundation Graduate Research Fellowships; UC Berkeley Chancellor's Graduate Fellowship;  [MR-15-328599]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042] Funding Source: NIH RePORTER	UC Office of the President; Multicampus Research Programs; Program for Breakthrough Biomedical Research - Sandler Foundation; US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); UC Berkeley Chancellor's Graduate Fellowship; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Meigs and the 8.3.1 beamline staff at the Advanced Light Source for assistance with data collection, J. Chen for input on experimental design and members of the Doudna laboratory for comments and discussions. The 8.3.1 beamline is supported by UC Office of the President, Multicampus Research Programs and Initiatives grant MR-15-328599 and Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. This project was funded by US National Science Foundation grant No. 1244557 to J.A.D. and by NIH grant AI070042 to A.N.E. J.K.N. and L.B.H. are supported by US National Science Foundation Graduate Research Fellowships and J.K.N. by a UC Berkeley Chancellor's Graduate Fellowship. P.J.K. is supported as a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. J.A.D. is an Investigator of the Howard Hughes Medical Institute and a member of the Center for RNA Systems Biology.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katz RA, 2011, J BIOL CHEM, V286, P25710, DOI 10.1074/jbc.M111.229179; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	29	118	125	0	79	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					535	+		10.1038/nature15760	http://dx.doi.org/10.1038/nature15760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26503043	Green Accepted, Green Submitted			2022-12-28	WOS:000365352500052
J	Frobisch, NB; Bickelmann, C; Olori, JC; Witzmann, F				Froebisch, Nadia B.; Bickelmann, Constanze; Olori, Jennifer C.; Witzmann, Florain			Deep-time evolution of regeneration and preaxial polarity in tetrapod limb development	NATURE			English	Article							LARVAL ONTOGENY; ORIGIN; TEMNOSPONDYLI; OSSIFICATION; GENES; TAIL	Among extant tetrapods, salamanders are unique in showing a reversed preaxial polarity in patterning of the skeletal elements of the limbs, and in displaying the highest capacity for regeneration, including full limb and tail regeneration. These features are particularly striking as tetrapod limb development has otherwise been shown to be a highly conserved process(1,2). It remains elusive whether the capacity to regenerate limbs in salamanders is mechanistically and evolutionarily linked to the aberrant pattern of limb development; both are features classically regarded as unique to urodeles(3). New molecular data suggest that salamander-specific orphan genes play a central role in limb regeneration and may also be involved in the preaxial patterning during limb development(4,5). Here we show that preaxial polarity in limb development was present in various groups of temnospondyl amphibians of the Carboniferous and Permian periods, including the dissorophoids Apateon and Micromelerpeton, as well as the stereospondylomorph Sclerocephalus. Limb regeneration has also been reported in Micromelerpeton(6), demonstrating that both features were already present together in antecedents of modern salamanders 290 million years ago. Furthermore, data from lepospondyl 'microsaurs' on the amniote stem indicate that these taxa may have shown some capacity for limb regeneration and were capable of tail regeneration(7), including re-patterning of the caudal vertebral column that is otherwise only seen in salamander tail regeneration. The data from fossils suggest that salamander-like regeneration is an ancient feature of tetrapods that was subsequently lost at least once in the lineage leading to amniotes. Salamanders are the only modern tetrapods that retained regenerative capacities as well as preaxial polarity in limb development.	[Froebisch, Nadia B.; Bickelmann, Constanze; Witzmann, Florain] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, D-10115 Berlin, Germany; [Olori, Jennifer C.] SUNY Coll Oswego, Dept Biol Sci, Oswego, NY 13126 USA; [Witzmann, Florain] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego; Brown University	Frobisch, NB (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	nadia.froebisch@mfn-berlin.de		Olori, Jennifer/0000-0003-0479-6264	DFG Emmy Noether Grant [FR 2647/5-1]; Jackson School of Geosciences; Banks Fellowship; Society of Vertebrate Paleontology Estes Memorial Grant; Paleontological Society Lane Student Award; Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation	DFG Emmy Noether Grant(German Research Foundation (DFG)); Jackson School of Geosciences; Banks Fellowship; Society of Vertebrate Paleontology Estes Memorial Grant; Paleontological Society Lane Student Award; Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank B. Ekrt, J. Muller, U. Gohlich, S. Walsh, C. Mehling, P. Barrett and R. Schoch for access to the collections under their care. H.J. Gotz took the photograph in Fig. 3c; S. Lokatis took the photograph in Fig. 3b. This research was funded by an DFG Emmy Noether Grant (FR 2647/5-1) to N.B.F.; the Jackson School of Geosciences, the Banks Fellowship, Society of Vertebrate Paleontology Estes Memorial Grant and Paleontological Society Lane Student Award to J.C.O.; and the Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation to F.W.	Alibardi, 2010, MORPHOLOGICAL CELLUL; Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Beck CW, 2009, DEV DYNAM, V238, P1226, DOI 10.1002/dvdy.21890; Brockes J., 2015, SALAMANDERS REGENERA; Brockes JP, 2014, BIOCHEM SOC T, V42, P625, DOI 10.1042/BST20140002; Carroll R. L., 1978, ORDER MICROSAURIA, P122; CONANT EB, 1970, J EXP ZOOL, V174, P15, DOI 10.1002/jez.1401740103; Fisher RE, 2012, ANAT REC, V295, P1609, DOI 10.1002/ar.22537; Frobisch NB, 2007, EVOL DEV, V9, P69; Frobisch NB, 2008, BIOL REV, V83, P571, DOI 10.1111/j.1469-185X.2008.00055.x; Frobisch NB, 2011, DEV DYNAM, V240, P1087, DOI 10.1002/dvdy.22629; Gardiner David M., 2007, P163; HOLTZER HOWARD, 1955, J MORPH, V96, P145, DOI 10.1002/jmor.1050960107; HOLTZER SYBIL W., 1956, J MORPH, V99, P1, DOI 10.1002/jmor.1050990102; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Olori JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128333; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; SCHMALHAUSEN JJ, 1910, ANAT ANZEIGER, V37, P431; Schoch RR, 2014, PALAEONTOLOGY, V57, P517, DOI 10.1111/pala.12100; Schoch RR, 2003, PALAEONTOLOGY, V46, P1055, DOI 10.1111/1475-4983.00333; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Simon A, 2013, WIRES DEV BIOL, V2, P291, DOI 10.1002/wdev.73; Vaglia JL, 1997, J MORPHOL, V233, P15, DOI 10.1002/(SICI)1097-4687(199707)233:1<15::AID-JMOR2>3.0.CO;2-N; Witzmann F, 2003, J VERTEBR PALEONTOL, V23, P750, DOI 10.1671/3; Witzmann F., 2014, P BIOL SCI; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	28	49	49	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					231	234		10.1038/nature15397	http://dx.doi.org/10.1038/nature15397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26503047				2022-12-28	WOS:000364396700044
J	Eijsvogels, TMH; Thompson, PD				Eijsvogels, Thijs M. H.; Thompson, Paul D.			Exercise Is Medicine At Any Dose?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TIME PHYSICAL-ACTIVITY; HEART-DISEASE; MORTALITY; ASSOCIATION; COHORT; RISK		[Eijsvogels, Thijs M. H.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Thompson, Paul D.] Hartford Hosp, Div Cardiol, Hartford, CT 06115 USA	Radboud University Nijmegen; Hartford Hospital	Eijsvogels, TMH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	thijs.eijsvogels@radboudumc.nl	Eijsvogels, Thijs/P-7201-2015	Eijsvogels, Thijs/0000-0003-0747-4471				Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Armstrong MEG, 2015, CIRCULATION, V131, P721, DOI 10.1161/CIRCULATIONAHA.114.010296; Fihn SD, 2014, CIRCULATION, V130, P1749, DOI 10.1161/CIR.0000000000000095; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Mons U, 2014, HEART, V100, P1043, DOI 10.1136/heartjnl-2013-305242; Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Williams PT, 2014, MAYO CLIN PROC, V89, P1187, DOI 10.1016/j.mayocp.2014.05.006	8	72	72	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1915	1916		10.1001/jama.2015.10858	http://dx.doi.org/10.1001/jama.2015.10858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547459	Green Accepted			2022-12-28	WOS:000364490700010
J	Arie, S				Arie, Sophie			BRIEFING Is too much hope placed in egg freezing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Glujovsky D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010047.pub2; HFEA, FERT TREATM 2013; IVI. Myth busting: the truth behind IVF treatment, 2015, MYTH BUST TRUTH IVF; Schattman GL, 2015, NEW ENGL J MED, V373, P1755, DOI 10.1056/NEJMcp1307341; Tran M., 2015, GUARDIAN	5	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2015	351								h5955	10.1136/bmj.h5955	http://dx.doi.org/10.1136/bmj.h5955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6PO	26546511				2022-12-28	WOS:000364392500002
J	Furukawa, Y				Furukawa, Yuji			Frustrating a quantum magnet	SCIENCE			English	Editorial Material							KAGOME ANTIFERROMAGNET		[Furukawa, Yuji] Iowa State Univ, Ames Lab, Ames, IA 50011 USA; [Furukawa, Yuji] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University	Furukawa, Y (corresponding author), Iowa State Univ, Ames Lab, Ames, IA 50011 USA.	furukawa@ameslab.gov						Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Diep HT, 2005, FRUSTRATED SPIN SYSTEMS, P1, DOI 10.1142/9789812567819; Fu MX, 2015, SCIENCE, V350, P655, DOI 10.1126/science.aab2120; Hermele M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224413; Imai T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.077203; Lacroix C, 2011, INTRO FRUSTRATED MAG; Mambrini M, 2000, EUR PHYS J B, V17, P651, DOI 10.1007/PL00011071; Olariu A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087202; Shores MP, 2005, J AM CHEM SOC, V127, P13462, DOI 10.1021/ja053891p	11	3	3	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					631	632		10.1126/science.aad3556	http://dx.doi.org/10.1126/science.aad3556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542555				2022-12-28	WOS:000364162800026
J	MacPherson, H; Tilbrook, H; Richmond, S; Woodman, J; Ballard, K; Atkin, K; Bland, M; Eldred, J; Essex, H; Hewitt, C; Hopton, A; Keding, A; Lansdown, H; Parrott, S; Torgerson, D; Wenham, A; Watt, I				MacPherson, Hugh; Tilbrook, Helen; Richmond, Stewart; Woodman, Julia; Ballard, Kathleen; Atkin, Karl; Bland, Martin; Eldred, Janet; Essex, Holly; Hewitt, Catherine; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Parrott, Steve; Torgerson, David; Wenham, Aniela; Watt, Ian			Alexander Technique Lessons or Acupuncture Sessions for Persons With Chronic Neck Pain A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							TRADITIONAL ACUPUNCTURE; USUAL PHYSIOTHERAPY; CARE; EXERCISE; ADVICE; PRACTITIONERS; QUESTIONNAIRE; DISABILITY; MANAGEMENT; DISORDERS	Background: Management of chronic neck pain may benefit from additional active self-care-oriented approaches. Objective: To evaluate clinical effectiveness of Alexander Technique lessons or acupuncture versus usual care for persons with chronic, nonspecific neck pain. Design: Three-group randomized, controlled trial. (Current Controlled Trials: ISRCTN15186354) Setting: U.K. primary care. Participants: Persons with neck pain lasting at least 3 months, a score of at least 28% on the Northwick Park Questionnaire (NPQ) for neck pain and associated disability, and no serious underlying pathology. Intervention: 12 acupuncture sessions or 20 one-to-one Alexander lessons (both 600 minutes total) plus usual care versus usual care alone. Measurements: NPQ score (primary outcome) at 0, 3, 6, and 12 months (primary end point) and Chronic Pain Self-Efficacy Scale score, quality of life, and adverse events (secondary outcomes). Results: 517 patients were recruited, and the median duration of neck pain was 6 years. Mean attendance was 10 acupuncture sessions and 14 Alexander lessons. Between-group reductions in NPQ score at 12 months versus usual care were 3.92 percent-age points for acupuncture (95% CI, 0.97 to 6.87 percentage points) (P = 0.009) and 3.79 percentage points for Alexander lessons (CI, 0.91 to 6.66 percentage points) (P = 0.010). The 12-month reductions in NPQ score from baseline were 32% for acupuncture and 31% for Alexander lessons. Participant self-efficacy improved for both interventions versus usual care at 6 months (P < 0.001) and was significantly associated (P < 0.001) with 12-month NPQ score reductions (acupuncture, 3.34 percentage points [CI, 2.31 to 4.38 percentage points]; Alexander lessons, 3.33 percentage points [CI, 2.22 to 4.44 percentage points]). No reported serious adverse events were considered probably or definitely related to either intervention. Limitation: Practitioners belonged to the 2 main U.K.-based professional associations, which may limit generalizability of the findings. Conclusion: Acupuncture sessions and Alexander Technique lessons both led to significant reductions in neck pain and associated disability compared with usual care at 12 months. Enhanced self-efficacy may partially explain why longer-term benefits were sustained.	[MacPherson, Hugh; Tilbrook, Helen; Atkin, Karl; Bland, Martin; Eldred, Janet; Essex, Holly; Hewitt, Catherine; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Parrott, Steve; Torgerson, David; Wenham, Aniela; Watt, Ian] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Woodman, Julia; Ballard, Kathleen] Alexander Tech, Soc Teachers, London N17 9TA, England; British Acupuncture Council, London, England	University of York - UK	MacPherson, H (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	hugh.macpherson@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Eldred, Janet/0000-0003-2858-8240; Parrott, Steven James/0000-0002-0165-1150; Hewitt, Catherine Elizabeth/0000-0002-0415-3536	University of York; Arthritis Research UK [19702]; Versus Arthritis [19702] Funding Source: researchfish	University of York(European Commission); Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	The trial was sponsored by the University of York. This research was funded by clinical studies grant 19702 from Arthritis Research UK.	ANDERSON KO, 1995, PAIN, V63, P77, DOI 10.1016/0304-3959(95)00021-J; Andersson S, 2012, ALTERN THER HEALTH M, V18, P25; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Bertozzi L, 2013, PHYS THER, V93, P1026, DOI 10.2522/ptj.20120412; Cacciatore TW, 2011, HUM MOVEMENT SCI, V30, P74, DOI 10.1016/j.humov.2010.10.002; Cacciatore TW, 2014, J NEUROPHYSIOL, V112, P719, DOI 10.1152/jn.00617.2013; Cacciatore TW, 2011, GAIT POSTURE, V34, P496, DOI 10.1016/j.gaitpost.2011.06.026; Dziedzic K, 2005, ARTHRIT RHEUM-ARTHR, V53, P214, DOI 10.1002/art.21087; Evans M, 2011, J ALTERN COMPLEM MED, V17, P519, DOI 10.1089/acm.2010.0749; Ferrari R, 2003, BEST PRACT RES CL RH, V17, P57, DOI 10.1016/S1521-6942(02)00097-9; Furlan AD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/953139; Gross A, 2010, MANUAL THER, V15, P315, DOI 10.1016/j.math.2010.04.002; Haldeman S, 2009, J MANIP PHYSIOL THER, V32, pS10, DOI 10.1016/j.jmpt.2008.11.006; Hewitt CE, 2006, CAN MED ASSOC J, V175, P347, DOI 10.1503/cmaj.051625; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Hurwitz EL, 2006, DISABIL REHABIL, V28, P1319, DOI 10.1080/09638280600641509; Jull G.A., 2008, WHIPLASH HEADACHE NE; Klaber Moffett J, 2006, RHEUMATOLOGY, V45, P1514, DOI 10.1093/rheumatology/kel339; Lauche R, 2016, CLIN REHABIL, V30, P247, DOI 10.1177/0269215515578699; LEAK AM, 1994, BRIT J RHEUMATOL, V33, P469; Little P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a884; MacPherscon H, 2008, COMPLEMENT THER MED, V16, P101, DOI 10.1016/j.ctim.2008.02.010; MacPherson H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-209; McClean S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0966-1; McLean SM, 2013, MANUAL THER, V18, P199, DOI 10.1016/j.math.2012.09.005; Miller J, 2010, MANUAL THER, V15, P334, DOI 10.1016/j.math.2010.02.007; Moffett JAK, 2005, BRIT MED J, V330, P75, DOI 10.1136/bmj.38286.493206.82; National Institute for Health and Care Excellence, 2009, LOW BACK PAIN EARL M, P4; National Institute for Health and Care Excellence, 2012, HEAD DIAGN MAN HEAD; Robinson N, 2012, J ETHNOPHARMACOL, V140, P604, DOI 10.1016/j.jep.2012.01.052; Salter GC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-99; Sim J, 2006, CLIN J PAIN, V22, P820, DOI 10.1097/01.ajp.0000210937.58439.39; Skills for Health, 2010, CNH3 DEL AL TECHN TE; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Trinh KV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004870.pub3; Tsakitzidis G, 2009, KCE REPORTS C; Vernon H, 2007, Eura Medicophys, V43, P91; White IR, 2011, STAT MED, V30, P3192, DOI 10.1002/sim.4360; Witt CM, 2006, PAIN, V125, P98, DOI 10.1016/j.pain.2006.05.013; Woodman JP, 2012, INT J CLIN PRACT, V66, P98, DOI 10.1111/j.1742-1241.2011.02817.x	41	59	62	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					653	+		10.7326/M15-0667	http://dx.doi.org/10.7326/M15-0667			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26524571				2022-12-28	WOS:000365610600001
J	Victora, GD; Wilson, PC				Victora, Gabriel D.; Wilson, Patrick C.			Germinal Center Selection and the Antibody Response to Influenza	CELL			English	Review							HEMAGGLUTININ-STEM; VACCINATION; INDUCTION; VACCINES; VIRUS	In this Minireview, we discuss basic aspects of germinal center biology in the context of immunity to influenza infection and speculate on how the simultaneous evolutionary races of virus and antibody may impact our efforts to design a universal influenza vaccine.	[Victora, Gabriel D.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wilson, Patrick C.] Univ Chicago, Knapp Ctr Lupus & Immunol Res, Comm Immunol, Dept Med,Sect Rheumatol, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Chicago	Victora, GD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	victora@wi.mit.edu; wilsonp@uchicago.edu	Wilson, Patrick/HGC-3157-2022	Victora, Gabriel/0000-0001-8807-348X	NIH [5DP5OD012146, 1P01AI097092-03, 2U19AI057266-11, U19AI109946, 1P01AI097092]; NIAID Center of Excellence for Influenza Research and Surveillance [HHSN272201400005C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, U19AI109946, U19AI082724, P01AI097092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Center of Excellence for Influenza Research and Surveillance(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Harrison, M. Nussenzweig, and F. Krammer for critical reading of our manuscript. G.D.V. is supported by NIH grant 5DP5OD012146. P.C.W. is supported by NIH grants 1P01AI097092-03, 2U19AI057266-11, U19AI109946, 1P01AI097092, and NIAID Center of Excellence for Influenza Research and Surveillance #HHSN272201400005C.	Del Giudice G, 2015, CURR TOP MICROBIOL, V386, P151, DOI 10.1007/82_2014_406; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Espeli M, 2012, J EXP MED, V209, P2307, DOI 10.1084/jem.20121752; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	19	63	63	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					545	548		10.1016/j.cell.2015.10.004	http://dx.doi.org/10.1016/j.cell.2015.10.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496601	Green Accepted, Bronze			2022-12-28	WOS:000364828900009
J	Lin, K; Lang, E				Lin, Katie; Lang, Eddy			Review: In acute ischemic stroke, adding endovascular therapy to t-PA improves functional independence at 90 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lin, Katie; Lang, Eddy] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada	University of Calgary	Lin, K (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.			Lin, Katie/0000-0003-2000-2073	Alberta Innovates [201300690] Funding Source: researchfish	Alberta Innovates		Broussalis E, 2013, AM J NEURORADIOL, V34, P366, DOI 10.3174/ajnr.A3195; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC4	10.7326/ACPJC-2015-163-8-004	http://dx.doi.org/10.7326/ACPJC-2015-163-8-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502141				2022-12-28	WOS:000363737400005
J	Inge, TH; Courcoulas, AP; Jenkins, TM; Michalsky, MP; Helmrath, MA; Brandt, ML; Harmon, CM; Zeller, MH; Chen, MK; Xanthakos, SA; Horlick, M; Buncher, CR				Inge, Thomas H.; Courcoulas, Anita P.; Jenkins, Todd M.; Michalsky, Marc P.; Helmrath, Michael A.; Brandt, Mary L.; Harmon, Carroll M.; Zeller, Meg H.; Chen, Mike K.; Xanthakos, Stavra A.; Horlick, Mary; Buncher, C. Ralph		Teen-LABS Consortium	Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC BYPASS-SURGERY; QUALITY-OF-LIFE; SEVERE OBESITY; CHILDREN; PREVALENCE; OUTCOMES; ANEMIA; TRENDS; RISK	BACKGROUND Bariatric surgery is increasingly considered for the treatment of adolescents with severe obesity, but few prospective adolescent-specific studies examining the efficacy and safety of weight-loss surgery are available to support clinical decision making. METHODS We prospectively enrolled 242 adolescents undergoing weight-loss surgery at five U.S. centers. Patients undergoing Roux-en-Y gastric bypass (161 participants) or sleeve gastrectomy (67) were included in the analysis. Changes in body weight, coexisting conditions, cardiometabolic risk factors, and weight-related quality of life and postoperative complications were evaluated through 3 years after the procedure. RESULTS The mean (+/- SD) baseline age of the participants was 17 +/- 1.6 years, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 53; 75% of the participants were female, and 72% were white. At 3 years after the procedure, the mean weight had decreased by 27% (95% confidence interval [CI], 25 to 29) in the total cohort, by 28% (95% CI, 25 to 30) among participants who underwent gastric bypass, and by 26% (95% CI, 22 to 30) among those who underwent sleeve gastrectomy. By 3 years after the procedure, remission of type 2 diabetes occurred in 95% (95% CI, 85 to 100) of participants who had had the condition at baseline, remission of abnormal kidney function occurred in 86% (95% CI, 72 to 100), remission of prediabetes in 76% (95% CI, 56 to 97), remission of elevated blood pressure in 74% (95% CI, 64 to 84), and remission of dyslipidemia in 66% (95% CI, 57 to 74). Weight-related quality of life also improved significantly. However, at 3 years after the bariatric procedure, hypoferritinemia was found in 57% (95% CI, 50 to 65) of the participants, and 13% (95% CI, 9 to 18) of the participants had undergone one or more additional intraabdominal procedures. CONCLUSIONS In this multicenter, prospective study of bariatric surgery in adolescents, we found significant improvements in weight, cardiometabolic health, and weight-related quality of life at 3 years after the procedure. Risks associated with surgery included specific micronutrient deficiencies and the need for additional abdominal procedures. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; Teen-LABS ClinicalTrials.gov number, NCT00474318.)	[Inge, Thomas H.; Jenkins, Todd M.; Helmrath, Michael A.; Zeller, Meg H.; Xanthakos, Stavra A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Buncher, C. Ralph] Univ Cincinnati, Cincinnati, OH 45221 USA; [Michalsky, Marc P.] Nationwide Childrens Hosp, Columbus, OH USA; [Courcoulas, Anita P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Brandt, Mary L.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Harmon, Carroll M.] Univ Buffalo, Women & Childrens Hosp, Buffalo, NY USA; [Chen, Mike K.] Univ Alabama Birmingham, Birmingham, AL USA; [Horlick, Mary] NIDDKD, Bethesda, MD USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Inge, TH (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 2023, Cincinnati, OH 45229 USA.		Jenkins, Todd/AAG-1901-2019; Inge, Thomas/AAG-3372-2020; Kleiner, David E/N-2770-2013	Inge, Thomas/0000-0001-7782-1112; Kleiner, David E/0000-0003-3442-4453; michalsky, marc/0000-0002-7119-3634	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [U01DK072493, UM1DK072493, UM1DK095710, UL1TR000077-04, UL1RR025755, M01-RR00188, UL1RR024153, UL1TR000005, UL1TR000165]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417, UL1TR001425, UL1TR001070, UL1TR000077, UL1TR000005, UL1TR000165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, M01RR000188, UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, UM1DK095710, UM1DK072493, P30DK078392, U01DK072493, U01DK066557] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (U01DK072493 and UM1DK072493 to Dr. Inge, UM1DK095710 to Dr. Buncher, UL1TR000077-04 to Cincinnati Children's Hospital Medical Center, UL1RR025755 to Nationwide Children's Hospital, M01-RR00188 to Texas Children's Hospital/Baylor College of Medicine, UL1RR024153 and UL1TR000005 to the University of Pittsburgh, and UL1TR000165 to the University of Alabama, Birmingham).	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Alqahtani AR, 2014, SURG OBES RELAT DIS, V10, P842, DOI 10.1016/j.soard.2014.01.020; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Daniels SR, 2014, CHILD OBES, V10, P283, DOI 10.1089/chi.2014.1041; de la Cruz-Munoz N, 2010, SURG OBES RELAT DIS, V6, P542, DOI 10.1016/j.soard.2010.06.004; Inge TH, 2007, J PEDIATR SURG, V42, P1969, DOI 10.1016/j.jpedsurg.2007.08.010; Inge TH, 2014, JAMA PEDIATR, V168, P47, DOI 10.1001/jamapediatrics.2013.4296; Inge TH, 2010, J PEDIATR-US, V156, P103, DOI 10.1016/j.jpeds.2009.07.028; Inge TH, 2009, PEDIATRICS, V123, P214, DOI 10.1542/peds.2008-0522; Karefylakis C, 2015, OBES SURG, V25, P1019, DOI 10.1007/s11695-014-1500-y; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Kolotkin RL, 2006, OBESITY, V14, P448, DOI 10.1038/oby.2006.59; Kotkiewicz A, 2015, CLIN MED INSIGHTS-BL, V8, P9, DOI 10.4137/CMBD.S21825; Loux TJ, 2008, J PEDIATR SURG, V43, P1275, DOI 10.1016/j.jpedsurg.2008.02.078; Olbers T, 2012, INT J OBESITY, V36, P1388, DOI 10.1038/ijo.2012.160; Paulus GF, 2015, OBES SURG, V25, P860, DOI 10.1007/s11695-015-1581-2; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Strauss RS, 2001, J PEDIATR-US, V138, P499, DOI 10.1067/mpd.2001.113043; Sugerman HJ, 2003, J GASTROINTEST SURG, V7, P102, DOI 10.1016/S1091-255X(02)00125-7; Teeple EA, 2012, PEDIATR BLOOD CANCER, V58, P112, DOI 10.1002/pbc.23370; Treadwell JR, 2008, ANN SURG, V248, P763, DOI 10.1097/SLA.0b013e31818702f4; Tsai WS, 2007, ARCH PEDIAT ADOL MED, V161, P217, DOI 10.1001/archpedi.161.3.217; van der Baan-Slootweg O, 2014, JAMA PEDIATR, V168, P807, DOI 10.1001/jamapediatrics.2014.521; Zwintscher NP, 2013, J PEDIATR SURG, V48, P2401, DOI 10.1016/j.jpedsurg.2013.08.015	25	366	383	4	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					113	123		10.1056/NEJMoa1506699	http://dx.doi.org/10.1056/NEJMoa1506699			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA7PQ	26544725	Green Accepted, Bronze			2022-12-28	WOS:000367996700006
J	Barson, NJ; Aykanat, T; Hindar, K; Baranski, M; Bolstad, GH; Fiske, P; Jacq, C; Jensen, AJ; Johnston, SE; Karlsson, S; Kent, M; Oen, TM; Niemela, E; Nome, T; Naesje, TF; Orell, P; Romakkaniemi, A; Saegrov, H; Urdal, K; Erkinaro, J; Lien, S; Primmer, CR				Barson, Nicola J.; Aykanat, Tutku; Hindar, Kjetil; Baranski, Matthew; Bolstad, Geir H.; Fiske, Peder; Jacq, Celeste; Jensen, Arne J.; Johnston, Susan E.; Karlsson, Sten; Kent, Matthew; Oen, Thomas M.; Niemelae, Eero; Nome, Torfinn; Naesje, Tor F.; Orell, Panu; Romakkaniemi, Atso; Saegrov, Harald; Urdal, Kurt; Erkinaro, Jaakko; Lien, Sigbjorn; Primmer, Craig R.			Sex-dependent dominance at a single locus maintains variation in age at maturity in salmon	NATURE			English	Article							LIFE-HISTORY VARIATION; ATLANTIC SALMON; BALANCING SELECTION; GROWTH-RATE; GENOME; POPULATION; ADAPTATION; EVOLUTION; REVEALS; ORIGIN	Males and females share many traits that have a common genetic basis; however, selection on these traits often differs between the sexes, leading to sexual conflict(1,2). Under such sexual antagonism, theory predicts the evolution of genetic architectures that resolve this sexual conflict(2-5). Yet, despite intense theoretical and empirical interest, the specific loci underlying sexually antagonistic phenotypes have rarely been identified, limiting our understanding of how sexual conflict impacts genome evolution(3,6) and the maintenance of genetic diversity(6,7). Here we identify a large effect locus controlling age at maturity in Atlantic salmon (Salmo salar), an important fitness trait in which selection favours earlier maturation in males than females(8), and show it is a clear example of sex-dependent dominance that reduces intralocus sexual conflict and maintains adaptive variation in wild populations. Using high-density single nucleotide polymorphism data across 57 wild populations and whole genome re-sequencing, we find that the vestigial-like family member 3 gene (VGLL3) exhibits sex-dependent dominance in salmon, promoting earlier and later maturation in males and females, respectively. VGLL3, an adiposity regulator associated with size and age at maturity in humans, explained 39% of phenotypic variation, an unexpectedly large proportion for what is usually considered a highly polygenic trait. Such large effects are predicted under balancing selection from either sexually antagonistic or spatially varying selection(9,10). Our results provide the first empirical example of dominance reversal allowing greater optimization of phenotypes within each sex, contributing to the resolution of sexual conflict in a major and widespread evolutionary trade-off between age and size at maturity. They also provide key empirical evidence for how variation in reproductive strategies can be maintained over large geographical scales. We anticipate these findings will have a substantial impact on population management in a range of harvested species where trends towards earlier maturation have been observed.	[Barson, Nicola J.; Kent, Matthew; Nome, Torfinn; Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, NO-1432 As, Norway; [Aykanat, Tutku; Primmer, Craig R.] Univ Turku, Dept Biol, FI-20014 Turku, Finland; [Hindar, Kjetil; Bolstad, Geir H.; Fiske, Peder; Jensen, Arne J.; Karlsson, Sten; Naesje, Tor F.] Norwegian Inst Nat Res NINA, NO-7485 Trondheim, Norway; [Baranski, Matthew; Jacq, Celeste] Nofima Norwegian Inst Food Fisheries & Aquacultur, NO-1431 As, Norway; [Johnston, Susan E.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Oen, Thomas M.] AquaGen, NO-7462 Trondheim, Norway; [Niemelae, Eero; Orell, Panu; Romakkaniemi, Atso; Erkinaro, Jaakko] Nat Resources Inst Finland, FI-90014 Oulu, Finland; [Saegrov, Harald; Urdal, Kurt] Radgivende Biologer, NO-5003 Bergen, Norway	Norwegian University of Life Sciences; University of Turku; Norwegian Institute Nature Research; Nofima; University of Edinburgh; Natural Resources Institute Finland (Luke)	Lien, S (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, NO-1432 As, Norway.	sigbjorn.lien@nmbu.no; Craig.primmer@utu.fi	Hindar, Kjetil/AAA-3479-2022; Primmer, Craig R/B-8179-2008; Barson, Nicola Jane/M-4090-2015; Bolstad, Geir/K-3631-2014; Baranski, Matthew/I-7839-2018; Nome, Torfinn/E-5475-2015	Primmer, Craig R/0000-0002-3687-8435; Barson, Nicola Jane/0000-0002-6257-315X; Bolstad, Geir/0000-0003-1356-8239; Jacq, Celeste/0000-0002-3518-5506; Baranski, Matthew/0000-0002-9138-071X; Aykanat, Tutku/0000-0002-4825-0231; Nome, Torfinn/0000-0003-1659-132X; Johnston, Susan/0000-0002-5623-8902; Jensen, Arne Johan/0000-0002-7274-344X	Finnish Academy [137710, 141231, 272836, 284941]; Research Council of Norway [216105, 221734/O30]; AquaGen	Finnish Academy(Academy of Finland); Research Council of Norway(Research Council of Norway); AquaGen	We thank L. Andersson, T. F. Hansen and H. Granroth-Wilding for commenting on earlier drafts of the manuscript. We also acknowledge the numerous fishers who contributed scales and phenotypic information. We thank J. Haantie, J. G. Jensas, J. Kuusela, I. Torvi and G. Ostborg for scale measurements, T. Andersstuen, T. Balstad, L. Birkeland Eriksen, S. Karoliussen, J. Kuismin, M. Lindqvist, T. Pajula, K. Salminen, K. Sostar, M. Spets and K. Vagonyte-Hallan for laboratory assistance, M. Ellmen, O. Guttorm, T. Kanniainen, A. Koskinen, T. Poyhonen and S. Uusi-Heikkila for sampling assistance, and T. Mulugeta for informatics support. Bioinformatic analyses used resources at the Finnish Centre for Scientific Computing, the Abel Cluster, owned by the University of Oslo and the Norwegian Metacenter for High Performance Computing, and operated by the Department for Research Computing at the University of Oslo IT Department and the Orion Computing Cluster at CIGENE. This study was funded by the Finnish Academy (grants 137710, 141231, 272836, 284941), the Research Council of Norway (QuantEscape, grant 216105 and RCN-project 221734/O30) and by AquaGen (SNP array development).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Aykanat T, 2015, MOL ECOL, V24, P5158, DOI 10.1111/mec.13383; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Chaput G, 2012, ICES J MAR SCI, V69, P1538, DOI 10.1093/icesjms/fss013; Christensen R.H.B, 2015, ORDINAL REGRESSION M; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Connallon T, 2014, GENETICS, V197, P991, DOI 10.1534/genetics.114.165605; Connallon T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2123; Cousminer DL, 2013, HUM MOL GENET, V22, P2735, DOI 10.1093/hmg/ddt104; DOBZHANSKY T, 1955, COLD SPRING HARB SYM, V20, P1; Einum S, 2002, J FISH BIOL, V60, P780, DOI 10.1111/j.1095-8649.2002.tb01704.x; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Fijarczyk A, 2015, MOL ECOL, V24, P3529, DOI 10.1111/mec.13226; FISHER JP, 1990, FISH B-NOAA, V88, P637; Fisher R. A., 1930, GENETICAL THEORY NAT, P139; Flatt T, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P1; Fleming Ian A., 2011, P33; Friedland KD, 1996, J FISH BIOL, V48, P1, DOI 10.1111/j.1095-8649.1996.tb01414.x; Fry JD, 2010, EVOLUTION, V64, P1510, DOI 10.1111/j.1558-5646.2009.00898.x; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Garud NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005004; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; GenABEL project developers, 2013, GENABEL GEN WID SNP; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; Halperin DS, 2013, J LIPID RES, V54, P473, DOI 10.1194/jlr.M032755; Hutchings JA, 1998, CAN J FISH AQUAT SCI, V55, P22, DOI 10.1139/cjfas-55-S1-22; ICES, 2011, 2011ACOM44 ICES CM; Johnston SE, 2014, MOL ECOL, V23, P3452, DOI 10.1111/mec.12832; Jonsson N, 2007, J FISH BIOL, V71, P245, DOI 10.1111/j.1095-8649.2007.01488.x; Karlsson S, 2014, ECOL EVOL, V4, P3256, DOI 10.1002/ece3.1169; KIDWELL JF, 1977, GENETICS, V85, P171; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lee B, 2012, DEV BIOL, V366, P393, DOI 10.1016/j.ydbio.2012.04.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Mokkonen M, 2011, SCIENCE, V334, P972, DOI 10.1126/science.1208708; Pennell TM, 2013, ECOL EVOL, V3, P1819, DOI 10.1002/ece3.540; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; R Development Core Team, 2009, R LANG ENV STAT COMP; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Rice W., 1984, EVOLUTION, V38, P1416, DOI DOI 10.2307/2408385; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Schaffer William M., 2004, P20; Sellis D, 2011, P NATL ACAD SCI USA, V108, P20666, DOI 10.1073/pnas.1114573108; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Thorpe JE, 1998, EVOL ECOL, V12, P581, DOI 10.1023/A:1022351814644; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; van Doorn GS, 2009, ANN NY ACAD SCI, V1168, P52, DOI 10.1111/j.1749-6632.2009.04573.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; Yano A, 2013, EVOL APPL, V6, P486, DOI 10.1111/eva.12032	60	322	323	6	227	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					405	+		10.1038/nature16062	http://dx.doi.org/10.1038/nature16062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26536110	Green Submitted			2022-12-28	WOS:000366678600054
J	Vetizou, M; Pitt, JM; Daillere, R; Lepage, P; Waldschmitt, N; Flament, C; Rusakiewicz, S; Routy, B; Roberti, MP; Duong, CPM; Poirier-Colame, V; Roux, A; Becharef, S; Formenti, S; Golden, E; Cording, S; Eberl, G; Schlitzer, A; Ginhoux, F; Mani, S; Yamazaki, T; Jacquelot, N; Enot, DP; Berard, M; Nigou, J; Opolon, P; Eggermont, A; Woerther, PL; Chachaty, E; Chaput, N; Robert, C; Mateus, C; Kroemer, G; Raoult, D; Boneca, IG; Carbonnel, F; Chamaillard, M; Zitvogel, L				Vetizou, Marie; Pitt, Jonathan M.; Daillere, Romain; Lepage, Patricia; Waldschmitt, Nadine; Flament, Caroline; Rusakiewicz, Sylvie; Routy, Bertrand; Roberti, Maria P.; Duong, Connie P. M.; Poirier-Colame, Vichnou; Roux, Antoine; Becharef, Sonia; Formenti, Silvia; Golden, Encouse; Cording, Sascha; Eberl, Gerard; Schlitzer, Andreas; Ginhoux, Florent; Mani, Sridhar; Yamazaki, Takahiro; Jacquelot, Nicolas; Enot, David P.; Berard, Marion; Nigou, Jerome; Opolon, Paule; Eggermont, Alexander; Woerther, Paul-Louis; Chachaty, Elisabeth; Chaput, Nathalie; Robert, Caroline; Mateus, Christina; Kroemer, Guido; Raoult, Didier; Boneca, Ivo Gomperts; Carbonnel, Franck; Chamaillard, Mathias; Zitvogel, Laurence			Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota	SCIENCE			English	Article							T-CELLS; ANTIBODY; MOLECULE; CANCER; INNATE; MODEL	Antibodies targeting CTLA-4 have been successfully used as cancer immunotherapy. We find that the antitumor effects of CTLA-4 blockade depend on distinct Bacteroides species. In mice and patients, Tcell responses specific for B. thetaiotaomicron or B. fragilis were associated with the efficacy of CTLA-4 blockade. Tumors in antibiotic-treated or germ-free mice did not respond to CTLA blockade. This defect was overcome by gavage with B. fragilis, by immunization with B. fragilis polysaccharides, or by adoptive transfer of B. fragilis-specific T cells. Fecal microbial transplantation from humans to mice confirmed that treatment of melanoma patients with antibodies against CTLA-4 favored the outgrowth of B. fragilis with anticancer properties. This study reveals a key role for Bacteroidales in the immunostimulatory effects of CTLA-4 blockade.	[Vetizou, Marie; Pitt, Jonathan M.; Daillere, Romain; Flament, Caroline; Rusakiewicz, Sylvie; Routy, Bertrand; Roberti, Maria P.; Duong, Connie P. M.; Poirier-Colame, Vichnou; Roux, Antoine; Becharef, Sonia; Yamazaki, Takahiro; Jacquelot, Nicolas; Enot, David P.; Opolon, Paule; Eggermont, Alexander; Chaput, Nathalie; Robert, Caroline; Mateus, Christina; Zitvogel, Laurence] Inst Cancerol Gustave Roussy Canc Campus GRCC, 114 Rue Edouard, F-94805 Villejuif, France; [Vetizou, Marie; Pitt, Jonathan M.; Daillere, Romain; Flament, Caroline; Rusakiewicz, Sylvie; Routy, Bertrand; Roberti, Maria P.; Duong, Connie P. M.; Poirier-Colame, Vichnou; Roux, Antoine; Becharef, Sonia; Yamazaki, Takahiro; Jacquelot, Nicolas; Eggermont, Alexander; Zitvogel, Laurence] GRCC, INSERM, U1015, Villejuif, France; [Vetizou, Marie; Pitt, Jonathan M.; Daillere, Romain; Routy, Bertrand; Jacquelot, Nicolas; Zitvogel, Laurence] Univ Paris Sud, Univ Paris 11, Le Kremlin Bicetre, France; [Lepage, Patricia] INRA, Micalis UMR1319, F-78360 Jouy En Josas, France; [Waldschmitt, Nadine] Univ Lille, Ctr Hosp Reg Univ Lille, Inst Pasteur Lille,CNRS,INSERM, U1019,UMR 8204,Ctr Infect Immunite Lille CIIL, F-59000 Lille, France; [Flament, Caroline; Rusakiewicz, Sylvie; Routy, Bertrand; Roberti, Maria P.; Duong, Connie P. M.; Poirier-Colame, Vichnou; Becharef, Sonia; Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc 1428, Villejuif, France; [Roux, Antoine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Formenti, Silvia; Golden, Encouse] NYU, Dept Radiat Oncol, New York, NY USA; [Cording, Sascha; Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France; [Schlitzer, Andreas; Ginhoux, Florent] Agcy Sci Technol & Res, A STAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Mani, Sridhar] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Enot, David P.; Kroemer, Guido] GRCC, Metab Platform, Villejuif, France; [Berard, Marion] Inst Pasteur, Animalerie Cent, Paris, France; [Nigou, Jerome] Inst Pharmacol & Biol Struct IPBS, CNRS, Toulouse, France; [Nigou, Jerome] Univ Paul Sabatier, Univ Toulouse, IPBS, F-31077 Toulouse, France; [Eggermont, Alexander] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; [Woerther, Paul-Louis; Chachaty, Elisabeth] GRCC, Serv Microbiol, Villejuif, France; [Chaput, Nathalie] GRCC, CNRS, INSERM, US 23,Lab Immunomonitoring Oncol,UMS 3655, Villejuif, France; [Robert, Caroline] GRCC, INSERM, U981, Villejuif, France; [Kroemer, Guido] INSERM, U848, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, INSERM, U1138, Paris, France; [Kroemer, Guido] Assistance Publ Hop Paris, Hop Europeen Georges Pom, Pole Biol, Paris, France; [Raoult, Didier] Aix Marseille Univ, Univ Mediterranee, Fac Med, Unite Rickettsies, Marseille, France; [Boneca, Ivo Gomperts] Inst Pasteur, Unit Biol & Genet Bacterial Cell Wall, Paris, France; [Boneca, Ivo Gomperts] INSERM, Equipe Avenir, Paris, France; [Carbonnel, Franck] Assistance Publ Hop Paris, Hop Bicetre, Dept Gastroenterol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; UDICE-French Research Universities; Universite Paris Cite; New York University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Zitvogel, L (corresponding author), Inst Cancerol Gustave Roussy Canc Campus GRCC, 114 Rue Edouard, F-94805 Villejuif, France.	laurence.zitvogel@gustaveroussy.fr	wang, edwin/G-5372-2010; Cording, Sascha/H-9470-2017; Eberl, Gerard/A-1160-2013; Nigou, Jérôme/D-6802-2019; Lepage, Patricia/D-4362-2014; Boneca, Ivo G/H-1677-2014; Jacquelot, Nicolas/AAY-6937-2020; Chamaillard, Mathias/L-6542-2013; Woerther, Paul-Louis/ABD-9084-2020; WOERTHER, Paul-Louis/AAC-4637-2019; Kroemer, Guido/AAY-9859-2020; RAOULT, Didier/A-8434-2008; Robert, Caroline/G-6157-2018; KROEMER, Guido/B-4263-2013; Schlitzer, Andreas/R-2237-2016	Cording, Sascha/0000-0003-1926-2425; Nigou, Jérôme/0000-0002-6233-2487; Lepage, Patricia/0000-0002-9501-6771; Boneca, Ivo G/0000-0001-8122-509X; Chamaillard, Mathias/0000-0002-0243-9717; Woerther, Paul-Louis/0000-0002-6957-9482; RAOULT, Didier/0000-0002-0633-5974; Robert, Caroline/0000-0002-9493-0238; KROEMER, Guido/0000-0002-9334-4405; Schlitzer, Andreas/0000-0001-7662-3712; ZITVOGEL, laurence/0000-0003-1596-0998; Eberl, Gerard/0000-0002-1119-5638; Jacquelot, Nicolas/0000-0003-0282-1892; Duong, Connie/0000-0002-9067-8557	La Ligue contre le cancer; ARC; Ligue Nationale contre le Cancer (Equipes labelisees); Agence Nationale pour la Recherche (ANR AUTOPH); Agence Nationale pour la Recherche (ANR Emergence); European Commission (ArtForce); European Research Council; Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Fondation de France; Canceropole Ile-de-France; Fondation Bettencourt-Schueller; Swiss Bridge Foundation; LabEx Immuno-Oncology; Institut national du cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); NIH [R01 CA161879]; Fondation pour la Recherche Medicale; Fondation ARC pour la recherche sur le cancer; Institut Nationale du Cancer; Agence Nationale de la Recherche; BMSI YIG; SIgN; Association pour la Recherche contre le Cancer [PGA120140200851]; INCA-DGOS [GOLD H78008, 2012-1-RT-14-IGR-01];  [IDPRJNA299112]; NATIONAL CANCER INSTITUTE [R01CA161879, R01CA222469] Funding Source: NIH RePORTER	La Ligue contre le cancer(Ligue nationale contre le cancer); ARC(Australian Research Council); Ligue Nationale contre le Cancer (Equipes labelisees)(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche (ANR AUTOPH)(French National Research Agency (ANR)); Agence Nationale pour la Recherche (ANR Emergence)(French National Research Agency (ANR)); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt-Schueller; Swiss Bridge Foundation; LabEx Immuno-Oncology; Institut national du cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Institut Nationale du Cancer; Agence Nationale de la Recherche(French National Research Agency (ANR)); BMSI YIG; SIgN; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); INCA-DGOS; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the staff of the animal facility of Gustave Roussy and Institut Pasteur. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. L.Z., M.V., and P.L. have filed patent application no. EP 14190167 that relates to the following: Methods and products for modulating microbiota composition for improving the efficacy of a cancer treatment with an immune checkpoint blocker. M.V. and J.M.P. were supported by La Ligue contre le cancer and ARC, respectively. L.Z. received a special prize from the Swiss Bridge Foundation and ISREC. G.K. and L.Z. were supported by the Ligue Nationale contre le Cancer (Equipes labelisees), Agence Nationale pour la Recherche (ANR AUTOPH, ANR Emergence), European Commission (ArtForce), European Research Council Advanced Investigator Grant (to G.K.), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Fondation de France, Canceropole Ile-de-France, Fondation Bettencourt-Schueller, Swiss Bridge Foundation, the LabEx Immuno-Oncology, the Institut national du cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM), and the Paris Alliance of Cancer Research Institutes (PACRI). S.M. was supported by NIH (R01 CA161879, as Principal Investigator). M.C. was supported by the Fondation pour la Recherche Medicale, the Fondation ARC pour la recherche sur le cancer, and Institut Nationale du Cancer. N.W. is a recipient of a Postdoctoral Fellowship from the Agence Nationale de la Recherche. A.S. was supported by BMSI YIG 2014. F.G. is supported by SIgN core funding. L.Z., M.C., and I.B.G. are all sponsored by Association pour la Recherche contre le Cancer (PGA120140200851). F.C. was supported by INCA-DGOS (GOLD H78008). N.C. was supported by INCA-DGOS (GOLD study; 2012-1-RT-14-IGR-01). L'Oreal awarded a prize to M.V. We are grateful to the staff of the animal facility of Gustave Roussy and Institut Pasteur. We thank P. Gonin, B. Ryffel, T. Angelique, N. Chanthapathet, H. Li, and S. Zuberogoitia for technical help. DNA sequence reads from this study have been submitted to the NCBI under the Bioproject IDPRJNA299112 and are available from the Sequence Read Archive (SRP Study accession SRP065109; run accession numbers SRR2758006, SRR2758031, SRR2758178, SRR2758179, SRR2758180, SRR2758181, SRR2768454, and SRR2768457.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Berman David, 2010, Cancer Immun, V10, P11; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang JY, 2011, ANAEROBE, V17, P137, DOI 10.1016/j.anaerobe.2011.05.017; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rogoz A, 2015, J IMMUNOL METHODS, V421, P89, DOI 10.1016/j.jim.2015.03.014; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stingele F, 2004, J IMMUNOL, V172, P1483, DOI 10.4049/jimmunol.172.3.1483; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449	18	1767	1880	45	550	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1079	+		10.1126/science.aad1329	http://dx.doi.org/10.1126/science.aad1329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26541610	Green Submitted, Green Accepted			2022-12-28	WOS:000366422600041
J	Vogelstein, B; Kinzler, KW				Vogelstein, Bert; Kinzler, Kenneth W.			The Path to Cancer - Three Strikes and You're Out	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc, Howard Hughes Med Inst, Baltimore, MD USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine					Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brosens LAA, 2015, J GASTROINTEST ONCOL, V6, P358, DOI 10.3978/j.issn.2078-6891.2015.032; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	5	190	197	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1895	1898		10.1056/NEJMp1508811	http://dx.doi.org/10.1056/NEJMp1508811			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26559569				2022-12-28	WOS:000364445500002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Is Jeremy Hunt our colleague?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Rimmer A, 2015, BMJ CAREERS	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2015	351								h5995	10.1136/bmj.h5995	http://dx.doi.org/10.1136/bmj.h5995			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6PO	26546585	Bronze			2022-12-28	WOS:000364392500007
J	Hatfield-Dodds, S; Schandl, H; Adams, PD; Baynes, TM; Brinsmead, TS; Bryan, BA; Chiew, FHS; Graham, PW; Grundy, M; Harwood, T; McCallum, R; McCrea, R; McKellar, LE; Newth, D; Nolan, M; Prosser, I; Wonhas, A				Hatfield-Dodds, Steve; Schandl, Heinz; Adams, Philip D.; Baynes, Timothy M.; Brinsmead, Thomas S.; Bryan, Brett A.; Chiew, Francis H. S.; Graham, Paul W.; Grundy, Mike; Harwood, Tom; McCallum, Rebecca; McCrea, Rod; McKellar, Lisa E.; Newth, David; Nolan, Martin; Prosser, Ian; Wonhas, Alex			Australia is 'free to choose' economic growth and falling environmental pressures	NATURE			English	Article							GREENHOUSE-GAS EMISSIONS; BIODIVERSITY; BENEFITS; CAPACITY; LAND	Over two centuries of economic growth have put undeniable pressure on the ecological systems that underpin human well-being. While it is agreed that these pressures are increasing, views divide on how they may be alleviated. Some suggest technological advances will automatically keep us from transgressing key environmental thresholds; others that policy reform can reconcile economic and ecological goals; while a third school argues that only a fundamental shift in societal values can keep human demands within the Earth's ecological limits. Here we use novel integrated analysis of the energy-water-food nexus, rural land use (including biodiversity), material flows and climate change to explore whether mounting ecological pressures in Australia can be reversed, while the population grows and living standards improve. We show that, in the right circumstances, economic and environmental outcomes can be decoupled. Although economic growth is strong across all scenarios, environmental performance varies widely: pressures are projected to more than double, stabilize or fall markedly by 2050. However, we find no evidence that decoupling will occur automatically. Nor do we find that a shift in societal values is required. Rather, extensions of current policies that mobilize technology and incentivize reduced pressure account for the majority of differences in environmental performance. Our results show that Australia can make great progress towards sustainable prosperity, if it chooses to do so.	[Hatfield-Dodds, Steve; Schandl, Heinz; Chiew, Francis H. S.; Harwood, Tom; McCallum, Rebecca; Prosser, Ian] CSIRO, Black Mt Labs, Acton, ACT 2601, Australia; [Adams, Philip D.] Victoria Univ, Melbourne, Vic 3000, Australia; [Baynes, Timothy M.; Wonhas, Alex] CSIRO, N Ryde, NSW 2113, Australia; [Brinsmead, Thomas S.; Graham, Paul W.] CSIRO, Energy Ctr, Mayfield West, NSW 2304, Australia; [Bryan, Brett A.] CSIRO, Urrbrae, SA 5064, Australia; [Grundy, Mike] CSIRO, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [McCrea, Rod; McKellar, Lisa E.] CSIRO, Ecosci Precinct, Dutton Park, Qld 4102, Australia; [Newth, David] CSIRO, Yarralumla Labs, Yarralumla, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Victoria University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hatfield-Dodds, S (corresponding author), CSIRO, Black Mt Labs, Acton, ACT 2601, Australia.	Steve.Hatfield-Dodds@csiro.au	Nolan, Martin/J-5483-2013; Schandl, Heinz/C-5055-2008; Baynes, Timothy/D-4738-2011; Newth, David/A-1848-2011; Grundy, Michael John/K-6335-2012; Harwood, Tom D/C-7271-2009; McCallum, Rebecca/G-2215-2016; Graham, Paul/J-6989-2017; Chiew, Francis/A-9743-2011; Brinsmead, Thomas S/D-4698-2013; Bryan, Brett Anthony/F-8949-2010; Hatfield-Dodds, Steve/K-1067-2013; McCrea, Rod/E-5407-2010; Prosser, Ian/F-5760-2013	Schandl, Heinz/0000-0001-6399-4231; Baynes, Timothy/0000-0001-8416-3365; Newth, David/0000-0001-6882-7440; Grundy, Michael John/0000-0003-0627-2093; Harwood, Tom D/0000-0002-3855-5306; Brinsmead, Thomas S/0000-0003-1469-6662; Bryan, Brett Anthony/0000-0003-4834-5641; McCrea, Rod/0000-0003-0066-6577; Graham, Paul/0000-0002-3745-0940; Graham, Paul/0000-0002-2753-2547; Chiew, Francis/0000-0001-8020-8773; Prosser, Ian/0000-0001-7252-1540	CSIRO Land and Water; CSIRO Energy; CSIRO Agriculture; CSIRO Oceans and Atmosphere	CSIRO Land and Water(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Energy(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Agriculture(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Oceans and Atmosphere	The authors thank CSIRO Land and Water, CSIRO Energy, CSIRO Agriculture, and CSIRO Oceans and Atmosphere for funding and support, and J. Dowse of Clarity Thought Partners for assistance in preparing this paper and the National Outlook report.	Adams P. D., 2013, HDB COMPUTABLE GEN E, V1A; [Anonymous], 2015, NATURE, V520, P407; [Anonymous], 1993, SYST NAT ACC 1993; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Asafu-Adjaye J., 2015, ECOMODERNIST MANIFES; Bryan BA, 2014, GLOBAL ENVIRON CHANG, V28, P166, DOI 10.1016/j.gloenvcha.2014.06.013; Chiew F., 2011, WATER SCI SOLUTIONS, P29; Climate Change Authority, 2014, RED AUSTR GREENH GAS; Costanza R., 2012, BUILDING SUSTAINABLE; Daly HE, 2005, SCI AM, V293, P100, DOI 10.1038/scientificamerican0905-100; DeFries R, 2015, SCIENCE, V349, P238, DOI 10.1126/science.aaa5766; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; European Environment Agency, 2013, EEA REPORT; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Garnaut R, 2011, GARNAUT CLIMATE CHAN; Garnaut Ross, 2008, GARNAUT CLIMATE CHAN; Graham P., 2013, MODELLING FUTURE GRI; Graham PW, 2015, ENERG POLICY, V86, P456, DOI 10.1016/j.enpol.2015.07.022; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hatfield-Dodds S., 2015, AUSTR NATL OUTLOOK 2; Hejazi MI, 2014, HYDROL EARTH SYST SC, V18, P2859, DOI 10.5194/hess-18-2859-2014; Hobday AJ, 2014, ANNU REV ENV RESOUR, V39, P1, DOI 10.1146/annurev-environ-012113-111451; Jotzo F., 2014, PATHWAYS DEEP DECARB; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Lebel L, 2006, ECOL SOC, V11; Liu J., 2015, SCIENCE, V347, P1; MEADOWS D H, 1972, P205; Nordhaus WD, 2010, P NATL ACAD SCI USA, V107, P11721, DOI 10.1073/pnas.1005985107; Oliver Alex, 2015, LOWY I POLL 2015; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Randers J., 2012, GLOBAL FORECAST NEXT; Rees WE., 1995, J PLAN LIT, V9, P343, DOI [10.1177/088541229500900402, DOI 10.1177/088541229500900402]; Schandl H, 2015, J CLEAN PROD; Simon J. L, 1981, ULTIMATE RESOURCE; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stern DI, 2004, WORLD DEV, V32, P1419, DOI 10.1016/j.worlddev.2004.03.004; Stern N, 2008, AM ECON REV, V98, P1, DOI 10.1257/aer.98.2.1; Stern N, 2013, J ECON LIT, V51, P838, DOI 10.1257/jel.51.3.838; The World Bank,, 2012, TURN HEAT WHY 4C WAR; Walker B, 2009, SCIENCE, V325, P1345, DOI 10.1126/science.1175325; Weizskker E. U., 2014, DEC 2 TECHN OPP POL, P1; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/NCLIMATE2009, 10.1038/nclimate2009]; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; WILDAVSKY A, 1990, DAEDALUS, V119, P41	48	105	110	9	166	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					49	53		10.1038/nature16065	http://dx.doi.org/10.1038/nature16065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV4XV	26536956	Green Published			2022-12-28	WOS:000364270700040
J	Jackson, ST				Jackson, Stephen T.			Going where the science matters	SCIENCE			English	Editorial Material									[Jackson, Stephen T.] US Geol Survey, Dept Interior Southwest Climate Sci Ctr, Tucson, AZ 85719 USA; [Jackson, Stephen T.] Univ Wyoming, Bot, Laramie, WY 82071 USA; [Jackson, Stephen T.] Univ Arizona, Geosci, Tucson, AZ USA	United States Department of the Interior; United States Geological Survey; University of Wyoming; University of Arizona	Jackson, ST (corresponding author), US Geol Survey, Dept Interior Southwest Climate Sci Ctr, Tucson, AZ 85719 USA.	SciCareerEditor@aaas.org		Jackson, Stephen/0000-0002-1487-4652					0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					594	594		10.1126/science.350.6260.594	http://dx.doi.org/10.1126/science.350.6260.594			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU6RG	26516284				2022-12-28	WOS:000363660000051
J	Spitzer, NC				Spitzer, Nicholas C.			Neurotransmitter-tailored dendritic trees	SCIENCE			English	Editorial Material							GABA; NEURONS; MATURATION		[Spitzer, Nicholas C.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Spitzer, Nicholas C.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Spitzer, NC (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	nspitzer@ucsd.edu		Spitzer, Nicholas/0000-0002-3523-1103				Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Chabrol FP, 2012, NEUROSCIENCE, V227, P30, DOI 10.1016/j.neuroscience.2012.09.040; Chen JD, 2015, SCIENCE, V350, P554, DOI 10.1126/science.aac6472; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Lauder JM, 1998, PERSPECT DEV NEUROBI, V5, P247; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tyzio R, 1999, J NEUROSCI, V19, P10372	13	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					510	511		10.1126/science.aad4876	http://dx.doi.org/10.1126/science.aad4876			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516267				2022-12-28	WOS:000363660000027
J	Gardiner, JR				Gardiner, Jennifer R.			ECOLOGY Foraging further	NATURE			English	Editorial Material																			0	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					646	646		10.1038/526646a	http://dx.doi.org/10.1038/526646a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511576	Bronze			2022-12-28	WOS:000363832100034
J	Wimmer, RD; Schmitt, LI; Davidson, TJ; Nakajima, M; Deisseroth, K; Halassa, MM				Wimmer, Ralf D.; Schmitt, L. Ian; Davidson, Thomas J.; Nakajima, Miho; Deisseroth, Karl; Halassa, Michael M.			Thalamic control of sensory selection in divided attention	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY AUDITORY-CORTEX; PRIMARY VISUAL-CORTEX; PREFRONTAL CORTEX; RETICULAR NUCLEUS; RECEPTIVE-FIELDS; TOP-DOWN; TASK; ARCHITECTURE; INFORMATION	How the brain selects appropriate sensory inputs and suppresses distractors is unknown. Given the well-established role of the prefrontal cortex (PFC) in executive function(1), its interactions with sensory cortical areas during attention have been hypothesized to control sensory selection(2-5). To test this idea and, more generally, dissect the circuits underlying sensory selection, we developed a cross-modal divided-attention task in mice that allowed genetic access to this cognitive process. By optogenetically perturbing PFC function in a temporally precise window, the ability of mice to select appropriately between conflicting visual and auditory stimuli was diminished. Equivalent sensory thalamocortical manipulations showed that behaviour was causally dependent on PFC interactions with the sensory thalamus, not sensory cortex. Consistent with this notion, we found neurons of the visual thalamic reticular nucleus (visTRN) to exhibit PFC-dependent changes in firing rate predictive of the modality selected. visTRN activity was causal to performance as confirmed by bidirectional optogenetic manipulations of this subnetwork. Using a combination of electrophysiology and intracellular chloride photometry, we demonstrated that visTRN dynamically controls visual thalamic gain through feedforward inhibition. Our experiments introduce a new subcortical model of sensory selection, in which the PFC biases thalamic reticular subnetworks to control thalamic sensory gain, selecting appropriate inputs for further processing.	[Wimmer, Ralf D.; Schmitt, L. Ian; Nakajima, Miho; Halassa, Michael M.] NYU, Inst Neurosci, Dept Neurosci & Physiol, Langone Med Ctr, New York, NY 10016 USA; [Davidson, Thomas J.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Cracking Neural Code Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Halassa, Michael M.] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Halassa, Michael M.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; NYU Langone Medical Center; Stanford University; Stanford University; Stanford University; New York University; NYU Langone Medical Center; New York University	Halassa, MM (corresponding author), NYU, Inst Neurosci, Dept Neurosci & Physiol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	michael.halassa@nyumc.org	Nakajima, Miho/AAU-3731-2020; Core, Vector/CAF-4832-2022	Schmitt, Luke/0000-0002-1104-2666	Swiss National Science Foundation [P2LAP3 151786]; Simons Foundation; Sloan Foundation; Brain and Behavior Research Foundation; US National Institutes of Health [R00 NS078115]; Feldstein Medical Foundation; Klingenstein-Simons Fellowship; Biobehavioral Research Award for Innovative New Scientists (BRAINS) from the National Institute of Mental Health [R01 (R01 MH107680)]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107680, R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS078115] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Simons Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Brain and Behavior Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feldstein Medical Foundation; Klingenstein-Simons Fellowship; Biobehavioral Research Award for Innovative New Scientists (BRAINS) from the National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. A. Movshon, W. Ma, R. W. Tsien, G. Fishell and D. Rinberg for helpful comments on the manuscript and G.J. Augustine for providing us with the SuperClomeleon construct and for helpful discussion around its use. The work was supported by the Swiss National Science Foundation (P2LAP3 151786) to R.D.W. and the Simons Foundation, the Sloan Foundation, the Brain and Behavior Research Foundation and the US National Institutes of Health (R00 NS078115) to M.M.H; M.M.H is additionally supported by the Feldstein Medical Foundation, a Klingenstein-Simons Fellowship and a Biobehavioral Research Award for Innovative New Scientists (BRAINS) R01 (R01 MH107680) from the National Institute of Mental Health.	Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Casagrande VA, 2005, PROG BRAIN RES, V149, P11, DOI 10.1016/S0079-6123(05)49002-0; Chen CF, 2003, J NEUROSCI, V23, P3130; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; Cremers T, 2007, EUR J PHARMACOL, V562, P47, DOI 10.1016/j.ejphar.2007.01.017; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2010, NAT NEUROSCI, V13, P1011, DOI 10.1038/nn.2598; Glickfeld LL, 2013, J NEUROSCI, V33, P19416, DOI 10.1523/JNEUROSCI.3560-13.2013; Grimley JS, 2013, J NEUROSCI, V33, P16297, DOI 10.1523/JNEUROSCI.4616-11.2013; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell AS, 2014, J NEUROSCI, V34, P15340, DOI 10.1523/JNEUROSCI.3289-14.2014; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Rodgers CC, 2014, NEURON, V82, P1157, DOI 10.1016/j.neuron.2014.04.031; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	28	266	266	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					705	709		10.1038/nature15398	http://dx.doi.org/10.1038/nature15398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26503050	Green Accepted			2022-12-28	WOS:000363832100049
J	Li, WY; Ma, MD; Feng, Y; Li, HJ; Wang, YC; Ma, YT; Li, MZ; An, FY; Guo, HW				Li, Wenyang; Ma, Mengdi; Feng, Ying; Li, Hongjiang; Wang, Yichuan; Ma, Yutong; Li, Mingzhe; An, Fengying; Guo, Hongwei			EIN2-Directed Translational Regulation of Ethylene Signaling in Arabidopsis	CELL			English	Article							F-BOX PROTEINS; RESPONSE PATHWAY; ENDOPLASMIC-RETICULUM; TRANSDUCTION PATHWAY; CERNA HYPOTHESIS; RNA DECAY; EIN2; HORMONE; GAS; CTR1	Ethylene is a gaseous phytohormone that plays vital roles in plant growth and development. Previous studies uncovered EIN2 as an essential signal transducer linking ethylene perception on ER to transcriptional regulation in the nucleus through a "cleave and shuttle'' model. In this study, we report another mechanism of EIN2-mediated ethylene signaling, whereby EIN2 imposes the translational repression of EBF1 and EBF2 mRNA. We find that the EBF1/2 3' UTRs mediate EIN2-directed translational repression and identify multiple poly-uridylates (PolyU) motifs as functional cis elements of 3' UTRs. Furthermore, we demonstrate that ethylene induces EIN2 to associate with 3' UTRs and target EBF1/2 mRNA to cytoplasmic processing-body (P-body) through interacting with multiple P-body factors, including EIN5 and PABs. Our study illustrates translational regulation as a key step in ethylene signaling and presents mRNA 3' UTR functioning as a "signal transducer'' to sense and relay cellular signaling in plants.	[Li, Wenyang; Ma, Mengdi; Feng, Ying; Li, Hongjiang; Wang, Yichuan; Ma, Yutong; Li, Mingzhe; An, Fengying; Guo, Hongwei] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [An, Fengying; Guo, Hongwei] Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University	Guo, HW (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	hongweig@pku.edu.cn	Li, Wenyang/AFU-5534-2022	Li, Hongjiang/0000-0001-5039-9660	National Natural Science Foundation of China [91217305, 91017010]; National Basic Research Program of China (973 Program) [2012CB910902]; 111 project of Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); 111 project of Peking University	We thank Dr. Robert H. Singer, Dr. Jianru Zuo, Dr. Jinsong Zhang, and Dr. Jianmin Zhou for their gift of vectors. We thank H.G.'s lab members for their technical assistance and critical discussions. This work was supported by the National Natural Science Foundation of China (91217305 and 91017010) and the National Basic Research Program of China (973 Program; 2012CB910902) to H.G. This study is also supported by the 111 project of Peking University.	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Bisson MMA, 2015, MOL PLANT, V8, P1165, DOI 10.1016/j.molp.2015.03.014; Bisson MMA, 2011, PLANT SIGNAL BEHAV, V6, P164, DOI [10.4161/psb.6.1.14034, 10.4161/psb.5.12.14034]; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Chang C, 2001, BIOESSAYS, V23, P619, DOI 10.1002/bies.1087; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; DROUET A, 1979, PLANT PHYSIOL, V64, P1104, DOI 10.1104/pp.64.6.1104; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Ji YS, 2013, MOL PLANT, V6, P11, DOI 10.1093/mp/sss150; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.4, 10.1038/NPLANTS.2014.4]; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Konishi M, 2008, PLANT SIGNAL BEHAV, V3, P749, DOI 10.4161/psb.3.9.6640; Maldonado-Bonilla LD, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00201; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Merchante C, 2015, CELL, V163, P684, DOI 10.1016/j.cell.2015.09.036; Missra A, 2014, METHODS MOL BIOL, V1158, P157, DOI 10.1007/978-1-4939-0700-7_10; Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Potuschak T, 2006, PLANT CELL, V18, P3047, DOI 10.1105/tpc.106.046508; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; TUCKER ML, 1984, PLANT PHYSIOL, V74, P307, DOI 10.1104/pp.74.2.307; Wen X, 2012, CELL RES, V22, P1613, DOI 10.1038/cr.2012.145; Xu J, 2011, CURR OPIN PLANT BIOL, V14, P88, DOI 10.1016/j.pbi.2010.10.003; Zhang XY, 2015, SCIENCE, V348, P120, DOI 10.1126/science.aaa2618; Zhao WX, 2014, NAT BIOTECHNOL, V32, P387, DOI 10.1038/nbt.2851	42	190	216	16	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					670	683		10.1016/j.cell.2015.09.037	http://dx.doi.org/10.1016/j.cell.2015.09.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496607	Bronze			2022-12-28	WOS:000364828900020
J	Sundaram, V; Kowdley, K				Sundaram, Vinay; Kowdley, Kris			Management of chronic hepatitis B infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TENOFOVIR DISOPROXIL FUMARATE; SUSTAINED VIROLOGICAL RESPONSE; E-ANTIGEN SEROCONVERSION; SIMPLE NONINVASIVE INDEX; CORE PROMOTER MUTATION; LIVER STIFFNESS VALUES; VIRUS INFECTION; HEPATOCELLULAR-CARCINOMA; SURFACE-ANTIGEN; PEGINTERFERON ALPHA-2A	Hepatitis B virus (HBV) is a global health problem that can lead to cirrhosis and hepatocellular carcinoma (HCC). Although HBV vaccination has reduced the prevalence Of HBV infection, the burden of disease remains high. Treatment with antiviral drugs reduces the risk of liver disease and the development of HCC, and it can even reverse liver fibrosis. However, challenges remain regarding optimal timing, as well as the modality and duration of treatment. Currently approved drugs include pegylated interferon and nucleos(t) ide analogs. Nucleos(t) ide analogs are better tolerated and provide excellent viral suppression with a low risk of antiviral resistance, but pegylated interferon offers the benefit of a finite duration of treatment. Monitoring of hepatitis B surface antigen (HBsAg) levels may help to predict the likelihood of response to treatment, particularly for pegylated interferon. Prolonged treatment is usually needed with oral antiviral agents, and relapse is common if treatment is discontinued. New treatments that result in sustained clearance of HBV DNA and the clearance of HBsAg are needed.	[Sundaram, Vinay] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Sundaram, Vinay] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA; [Kowdley, Kris] Swedish Med Ctr, Liver Care Network, Seattle, WA 98104 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Swedish Medical Center	Kowdley, K (corresponding author), Swedish Med Ctr, Liver Care Network, Seattle, WA 98104 USA.	Kris.Kowdley@swedish.org	Kowdley, Kris/AAF-5202-2019					Benhamou Y, 2006, HEPATOLOGY, V43, P548, DOI 10.1002/hep.21055; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chan HLY, 2010, ALIMENT PHARM THER, V32, P1323, DOI 10.1111/j.1365-2036.2010.04474.x; Chan HLY, 2014, GASTROENTEROLOGY, V146, P1240, DOI 10.1053/j.gastro.2014.01.044; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chao DT, 2014, ALIMENT PHARM THER, V39, P349, DOI 10.1111/apt.12590; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Chen CF, 2011, GASTROENTEROLOGY, V141, P1240, DOI 10.1053/j.gastro.2011.06.036; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; Chu CM, 2012, BRIT J CANCER, V107, P2010, DOI 10.1038/bjc.2012.474; Colombo S, 2011, DIGEST LIVER DIS, V43, P231, DOI 10.1016/j.dld.2010.07.008; Corsa AC, 2014, HEPATOLOGY, P1707; Deguchi M, 2004, J VIROL METHODS, V115, P217, DOI 10.1016/j.jviromet.2003.10.002; Di Bisceglie AM, 2015, HEPATOLOGY, V61, P703, DOI 10.1002/hep.27609; Ehrhardt S, 2015, CLIN INFECT DIS, V60, P275, DOI 10.1093/cid/ciu798; FATTOVICH G, 1995, HEPATOLOGY, V21, P77; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Fontaine H, 2015, GUT, V64, P139, DOI 10.1136/gutjnl-2013-305707; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung S, 2014, GASTROENTEROLOGY, V146, P980, DOI 10.1053/j.gastro.2013.12.028; Gerlich WH, 2007, J VIRAL HEPATITIS, V14, P16, DOI 10.1111/j.1365-2893.2007.00912.x; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834; Hadziyannis SJ, 2012, GASTROENTEROLOGY, V143, P629, DOI 10.1053/j.gastro.2012.05.039; Han GR, 2011, J HEPATOL, V55, P1215, DOI 10.1016/j.jhep.2011.02.032; Heidrich B, 2014, HEPATOLOGY, V60, P87, DOI 10.1002/hep.27102; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Hsu C, 2014, HEPATOLOGY, V59, P2092, DOI 10.1002/hep.26718; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Hwang JP, 2014, NAT REV GASTRO HEPAT, V11, P209, DOI 10.1038/nrgastro.2013.216; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Ioannou GN, 2011, ANN INTERN MED, V154, P319, DOI 10.7326/0003-4819-154-5-201103010-00006; Jayalakshmi MMK, 2013, IMMUNOLOGY MICRIOBIO; Jonas Maureen M, 2010, Hepatology, V52, P2192, DOI 10.1002/hep.23934; Kapoor R, 2014, FUTURE VIROL, V9, P565, DOI 10.2217/FVL.14.36; Kim SU, 2010, LIVER INT, V30, P268, DOI 10.1111/j.1478-3231.2009.02172.x; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Kurosaki M, 1996, J MED VIROL, V49, P115; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lampertico P, 2013, GUT, V62, P290, DOI 10.1136/gutjnl-2011-301430; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Lange CM, 2009, HEPATOLOGY, V50, P2001, DOI 10.1002/hep.23346; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee HW, 2010, HEPATOLOGY, V51, P415, DOI 10.1002/hep.23323; Liaw YF, 2011, HEPATOLOGY, V54, P1591, DOI 10.1002/hep.24555; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2011, HEPATOLOGY, V53, P62, DOI 10.1002/hep.23952; Lim YS, 2016, GUT, V65, P1042, DOI 10.1136/gutjnl-2014-308435; Liu CJ, 2006, J INFECT DIS, V194, P594, DOI 10.1086/505883; Liu CJ, 2006, J INFECT DIS, V193, P1258, DOI 10.1086/502978; Lok AS, 2012, GASTROENTEROLOGY, V143, P619, DOI 10.1053/j.gastro.2012.05.037; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahtab MA, 2011, HEPATOLOGY, V54, p478A; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martinot-Peignoux M, 2013, J HEPATOL, V58, P1089, DOI 10.1016/j.jhep.2013.01.028; McGovern BH, 2007, ANTIVIR THER, V12, pH3; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; MOYER LA, 1994, AM J PREV MED, V10, P45, DOI 10.1016/S0749-3797(18)30514-2; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; Noureddin Mazen, 2014, Curr Gastroenterol Rep, V16, P365, DOI 10.1007/s11894-013-0365-x; Pan CQ, 2012, DIGEST DIS SCI, V57, P2423, DOI 10.1007/s10620-012-2187-3; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P520, DOI 10.1016/j.cgh.2012.01.019; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2015, J HEPATOL, V62, P956, DOI 10.1016/j.jhep.2015.01.002; Patton H, 2014, NAT REV GASTRO HEPAT, V11, P402, DOI 10.1038/nrgastro.2014.30; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Phung BC, 2014, WORLD J GASTROENTERO, V20, P17360, DOI 10.3748/wjg.v20.i46.17360; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Price H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068152; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Reddy KR, 2015, GASTROENTEROLOGY, V148, P215, DOI 10.1053/j.gastro.2014.10.039; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Reijnders JGP, 2010, J HEPATOL, V52, P493, DOI 10.1016/j.jhep.2010.01.012; Rijckborst V, 2010, AM J GASTROENTEROL, V105, P1762, DOI 10.1038/ajg.2010.186; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Saab S, 2007, HEPATOLOGY, V46, P1049, DOI 10.1002/hep.21783; Santantonio TA, 2014, WORLD J HEPATOL, V6, P284, DOI 10.4254/wjh.v6.i5.284; SATO S, 1995, ANN INTERN MED, V122, P241, DOI 10.7326/0003-4819-122-4-199502150-00001; Seto WK, 2015, GUT, V64, P667, DOI 10.1136/gutjnl-2014-307237; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043087; Shaheen AAM, 2010, LIVER INT, V30, P275, DOI 10.1111/j.1478-3231.2009.02153.x; Shim JH, 2010, J HEPATOL, V52, P176, DOI 10.1016/j.jhep.2009.11.007; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Sonneveld MJ, 2010, HEPATOLOGY, V52, P1251, DOI 10.1002/hep.23844; Spellman M, 2011, J HEPATOL, V54, pS302, DOI 10.1016/S0168-8278(11)60753-8; Squadrito G, 2013, J HEPATOL, V59, P696, DOI 10.1016/j.jhep.2013.05.043; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stray SJ, 2006, J MOL RECOGNIT, V19, P542, DOI 10.1002/jmr.801; Takkenberg RB, 2013, ANTIVIR THER, V18, P895, DOI 10.3851/IMP2580; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tong MJ, 2013, J DIGEST DIS, V14, P311, DOI 10.1111/1751-2980.12051; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; US Department of Health and Human Services, 2005, MMWR COMPR IMM STRAT; van Bommel F, 2010, HEPATOLOGY, V51, P73, DOI 10.1002/hep.23246; Vassilopoulos D, 2012, NAT REV RHEUMATOL, V8, P348, DOI 10.1038/nrrheum.2012.63; Volz T, 2013, J HEPATOL, V58, P861, DOI 10.1016/j.jhep.2012.12.008; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang XY, 2014, WORLD J GASTROENTERO, V20, P7707, DOI 10.3748/wjg.v20.i24.7707; Wang XY, 2012, ANTIVIR THER, V17, P793, DOI 10.3851/IMP2152; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wedermeyer H, 2014, 49 EUR ASS STUD LIV; Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301; Wu CY, 2014, GASTROENTEROLOGY, V147, P143, DOI 10.1053/j.gastro.2014.03.048; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Yeh WC, 2002, ULTRASOUND MED BIOL, V28, P467, DOI 10.1016/S0301-5629(02)00489-1; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Yuen MF, 2011, AM J GASTROENTEROL, V106, P1264, DOI 10.1038/ajg.2011.45; Zacher BJ, 2011, CLIN VACCINE IMMUNOL, V18, P1943, DOI 10.1128/CVI.05122-11; Zimmerman KA, 2008, J VIROL, V82, P8013, DOI 10.1128/JVI.00366-08; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x; zu Siederdissen CH, 2014, ANN GASTROENTEROL, V27, P105	137	48	55	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2015	351								h4263	10.1136/bmj.h4263	http://dx.doi.org/10.1136/bmj.h4263			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GC	26491030				2022-12-28	WOS:000364146000001
J	Davis, A				Davis, Amy			SPOT DIAGNOSIS A woman with pelvic pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									St Georges Hosp NHS Trust, Dept Radiol, London SW17 0QT, England	St Georges University London	Davis, A (corresponding author), St Georges Hosp NHS Trust, Dept Radiol, London SW17 0QT, England.	davis@doctors.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2015	351								h4369	10.1136/bmj.h4369	http://dx.doi.org/10.1136/bmj.h4369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP7QB	26516233				2022-12-28	WOS:000360081800001
J	Jost, TS				Jost, Timothy Stoltzfus			The House and the ACA - A Lawsuit over Cost-Sharing Reductions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jost, Timothy Stoltzfus] Washington & Lee Univ, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Lexington, VA 24450 USA.								0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					5	7		10.1056/NEJMp1513600	http://dx.doi.org/10.1056/NEJMp1513600			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA1UH	26536301				2022-12-28	WOS:000367580500002
J	Yeh, JS				Yeh, James S.			CASE VIGNETTE A Woman with Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Yeh, James/0000-0003-3549-6096					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2180	2180		10.1056/NEJMclde1513565	http://dx.doi.org/10.1056/NEJMclde1513565			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26551540				2022-12-28	WOS:000365354800017
J	Kaufman, AM; Lester, BJ; Foss-Feig, M; Wall, ML; Rey, AM; Regal, CA				Kaufman, A. M.; Lester, B. J.; Foss-Feig, M.; Wall, M. L.; Rey, A. M.; Regal, C. A.			Entangling two transportable neutral atoms via local spin exchange	NATURE			English	Article							OPTICAL LATTICE; ULTRACOLD ATOMS; ENTANGLEMENT; INFORMATION; TRAP; IONS	To advance quantum information science, physical systems are sought that meet the stringent requirements for creating and preserving quantum entanglement. In atomic physics, robust two-qubit entanglement is typically achieved by strong, long-range interactions in the form of either Coulomb interactions between ions or dipolar interactions between Rydberg atoms(1-4). Although such interactions allow fast quantum gates, the interacting atoms must overcome the associated coupling to the environment and crosstalk among qubits(5-)8. Local interactions, such as those requiring substantial wavefunction overlap, can alleviate these detrimental effects; however, such interactions present a new challenge: to distribute entanglement, qubits must be transported, merged for interaction, and then isolated for storage and subsequent operations. Here we show how, using a mobile optical tweezer, it is possible to prepare and locally entangle two ultracold neutral atoms, and then separate them while preserving their entanglement(9-11). Ground-state neutral atom experiments have measured dynamics consistent with spin entanglement(10,12,13), and have detected entanglement with macroscopic observables(14,15); we are now able to demonstrate position-resolved two-particle coherence via application of a local gradient and parity measurements'. This new entanglement-verification protocol could be applied to arbitrary spin-entangled states of spatially separated atoms(16,17). The local entangling operation is achieved via spin-exchange interactions(9-11), and quantum tunnelling is used to combine and separate atoms. These techniques provide a framework for dynamically entangling remote qubits via local operations within a large-scale quantum register.	[Kaufman, A. M.; Lester, B. J.; Wall, M. L.; Rey, A. M.; Regal, C. A.] NIST, JILA, Boulder, CO 80309 USA; [Kaufman, A. M.; Lester, B. J.; Wall, M. L.; Rey, A. M.; Regal, C. A.] Univ Colorado, Boulder, CO 80309 USA; [Kaufman, A. M.; Lester, B. J.; Rey, A. M.; Regal, C. A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Foss-Feig, M.] Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Foss-Feig, M.] NIST, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Regal, CA (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	regal@colorado.edu		Lester, Brian/0000-0002-4297-2508; Wall, Michael/0000-0002-6223-0800; REGAL, CINDY/0000-0002-0000-2140	David and Lucile Packard Foundation; National Science Foundation [1125844]; Clare Boothe Luce Foundation; NSF-PIF; ARO; ARO-DARPA-OLE; AFOSR; NRC postdoctoral fellowship program	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); Clare Boothe Luce Foundation; NSF-PIF(National Science Foundation (NSF)); ARO; ARO-DARPA-OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NRC postdoctoral fellowship program	This work was supported by the David and Lucile Packard Foundation and the National Science Foundation under grant number 1125844. C.A.R. acknowledges support from the Clare Boothe Luce Foundation. M.L.W. and A.M.R. acknowledge funding from NSF-PIF, ARO, ARO-DARPA-OLE and AFOSR. M.L.W. and M.F.-F. acknowledge support from the NRC postdoctoral fellowship program.	Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; Beguin L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263201; Blakestad RB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.153002; Daley AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020505; DiVincenzo DP, 2000, NATURE, V408, P339, DOI 10.1038/35042541; Fukuhara T, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.035302; Fukuhara T, 2013, NAT PHYS, V9, P235, DOI [10.1038/nphys2561, 10.1038/NPHYS2561]; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Hart RA, 2015, NATURE, V519, P211, DOI 10.1038/nature14223; Hayes D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070501; Horodecki M., 1996, PREPRINT; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Kaufman AM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041014; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; Kotler S, 2014, NATURE, V510, P376, DOI 10.1038/nature13403; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Mazza L, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/013015; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Murmann S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.080402; Peres A, 1996, PHYS REV LETT, V77, P1413, DOI 10.1103/PhysRevLett.77.1413; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Strobel H, 2014, SCIENCE, V345, P424, DOI 10.1126/science.1250147; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Wall ML, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.013610; Weitenberg C, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032322; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502	34	93	94	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					208	+		10.1038/nature16073	http://dx.doi.org/10.1038/nature16073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26524533	Green Submitted			2022-12-28	WOS:000364396700039
J	Lachs, MS; Pillemer, KA				Lachs, Mark S.; Pillemer, Karl A.			Elder Abuse	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TO-RESIDENT AGGRESSION; LONG-TERM-CARE; UNITED-STATES; RISK-FACTORS; MISTREATMENT; PREVALENCE; COMMUNITY; MORTALITY; DEMENTIA; NEGLECT		[Lachs, Mark S.; Pillemer, Karl A.] Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, New York, NY 10065 USA; [Pillemer, Karl A.] Cornell Univ, Dept Human Dev, Ithaca, NY USA	Cornell University; Cornell University	Lachs, MS (corresponding author), Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, 1300 York Ave, New York, NY 10065 USA.			Pillemer, Karl/0000-0002-7700-3563				Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Amstadter AB, 2010, J ELDER ABUSE NEGL, V23, P43, DOI 10.1080/08946566.2011.534707; Blowers AN, 2012, AM J CRIM JUSTICE, V37, P276, DOI 10.1007/s12103-012-9156-4; Brozowski K, 2004, J ELDER ABUSE NEGL, V16, P65, DOI 10.1300/J084v16n03_04; Brozowski K, 2010, J INTERPERS VIOLENCE, V25, P1183, DOI 10.1177/0886260509340546; Burnes D, 2015, J AM GERIATR SOC, V63, P1906, DOI 10.1111/jgs.13601; BURSTON GR, 1975, BRIT MED J, V3, P592, DOI 10.1136/bmj.3.5983.592-a; Castle N, 2015, J APPL GERONTOL, V34, P407, DOI 10.1177/0733464813492583; Chokkanathan S, 2005, J ELDER ABUSE NEGL, V17, P45, DOI 10.1300/J084v17n02_03; Cooper C, 2008, INT J GERIATR PSYCH, V23, P283, DOI 10.1002/gps.1875; De Donder L, 2011, EUR J AGEING, V8, P129, DOI 10.1007/s10433-011-0187-3; Dong XQ, 2014, HEALTH AFFAIR, V33, P642, DOI 10.1377/hlthaff.2013.1261; Dong XQ, 2013, JAMA INTERN MED, V173, P911, DOI 10.1001/jamainternmed.2013.238; Dong XQ, 2013, GERONTOLOGY, V59, P132, DOI 10.1159/000341652; Dyer CB., 2003, ELDER MISTREATMENT A, P339; Gibbs L., 2010, AGING HLTH, V6, P739, DOI [10.2217/ahe.10.76, DOI 10.2217/AHE.10.76]; Giraldo-Rodriguez L, 2013, GERIATR GERONTOL INT, V13, P466, DOI 10.1111/j.1447-0594.2012.00894.x; Johannesen M, 2013, AGE AGEING, V42, P292, DOI 10.1093/ageing/afs195; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; Lachs MS, 2004, LANCET, V364, P1263, DOI 10.1016/S0140-6736(04)17144-4; Lachs MS, 2002, GERONTOLOGIST, V42, P734, DOI 10.1093/geront/42.6.734; Lachs MS, 1997, ANN EMERG MED, V30, P448, DOI 10.1016/S0196-0644(97)70003-9; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; McDonald L, 2015, CAN J AGING, V34, P215, DOI 10.1017/S0714980815000094; Mouton CP, 2010, ANN FAM MED, V8, P206, DOI 10.1370/afm.1095; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Murphy K, 2013, CAN ASSOC RADIOL J, V64, P10, DOI 10.1016/j.carj.2012.12.001; Navarro AE, 2013, GERONTOLOGIST, V53, P303, DOI 10.1093/geront/gns075; Navarro AE, 2010, GERONTOLOGIST, V50, P702, DOI 10.1093/geront/gnq018; O'Keeffe M, 2007, NURSING OLDER PEOPLE, DOI DOI 10.7748/NOP2007.10.19.8.24.C6268; Oh J, 2006, INT J NURS STUD, V43, P203, DOI 10.1016/j.ijnurstu.2005.03.005; Peterson JC, 2014, J GEN INTERN MED, V29, P1615, DOI 10.1007/s11606-014-2946-2; PILLEMER K, 1988, GERONTOLOGIST, V28, P51, DOI 10.1093/geront/28.1.51; Pillemer K, 2015, GERONTOLOGIST, V55, P320, DOI 10.1093/geront/gnu180; Pillemer K, 2012, GERONTOLOGIST, V52, P24, DOI 10.1093/geront/gnr107; Ploeg J, 2009, J ELDER ABUSE NEGL, V21, P187, DOI 10.1080/08946560902997181; Rizzo VM, 2015, J ELDER ABUSE NEGL, V27, P1, DOI 10.1080/08946566.2013.792104; Rosen T, 2008, J AM GERIATR SOC, V56, P1398, DOI 10.1111/j.1532-5415.2008.01808.x; Schofield MJ, 2013, J AM GERIATR SOC, V61, P679, DOI 10.1111/jgs.12212; Shinoda-Tagawa T, 2004, JAMA-J AM MED ASSOC, V291, P591, DOI 10.1001/jama.291.5.591; Soares JJ, 2010, ABUSE HLTH ELDERLY E; Sooryanarayana R, 2013, TRAUMA VIOLENCE ABUS, V14, P316, DOI 10.1177/1524838013495963; Teaster PB, 2003, J ELDER ABUSE NEGL, V15, P91, DOI 10.1300/J084v15n03_06; Wiglesworth A, 2009, J AM GERIATR SOC, V57, P1191, DOI 10.1111/j.1532-5415.2009.02330.x; Wu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033857	46	205	211	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1947	1956		10.1056/NEJMra1404688	http://dx.doi.org/10.1056/NEJMra1404688			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV7IL	26559573	Bronze			2022-12-28	WOS:000364445500009
J	Mullins, EA; Shi, RX; Parsons, ZD; Yuen, PK; David, SS; Igarashi, Y; Eichman, BF				Mullins, Elwood A.; Shi, Rongxin; Parsons, Zachary D.; Yuen, Philip K.; David, Sheila S.; Igarashi, Yasuhiro; Eichman, Brandt F.			The DNA glycosylase AlkD uses a non-base-flipping mechanism to excise bulky lesions	NATURE			English	Article							DAMAGE RECOGNITION; PI-INTERACTIONS; ALKYLATED DNA; REPAIR; ENZYME; SUPERFAMILY; YATAKEMYCIN; RESISTANCE; CHEMISTRY; CONTACTS	Threats to genomic integrity arising from DNA damage are mitigated by DNA glycosylases, which initiate the base excision repair pathway by locating and excising aberrant nucleobases(1,2). How these enzymes find small modifications within the genome is a current area of intensive research. A hallmark of these and other DNA repair enzymes is their use of base flipping to sequester modified nucleotides from the DNA helix and into an active site pocket(2-5). Consequently, base flipping is generally regarded as an essential aspect of lesion recognition and a necessary precursor to base excision. Here we present the first, to our knowledge, DNA glycosylase mechanism that does not require base flipping for either binding or catalysis. Using the DNA glycosylase AlkD from Bacillus cereus, we crystallographically monitored excision of an alkylpurine substrate as a function of time, and reconstructed the steps along the reaction coordinate through structures representing substrate, intermediate and product complexes. Instead of directly interacting with the damaged nucleobase, AlkD recognizes aberrant base pairs through interactions with the phosphoribose backbone, while the lesion remains stacked in the DNA duplex. Quantum mechanical calculations revealed that these contacts include catalytic charge-dipole and CH-p interactions that preferentially stabilize the transition state. We show in vitro and in vivo how this unique means of recognition and catalysis enables AlkD to repair large adducts formed by yatakemycin, a member of the duocarmycin family of antimicrobial natural products exploited in bacterial warfare and chemotherapeutic trials(6,7). Bulky adducts of this or any type are not excised by DNA glycosylases that use a traditional base-flipping mechanism(5). Hence, these findings represent a new model for DNA repair and provide insights into catalysis of base excision.	[Mullins, Elwood A.; Shi, Rongxin; Parsons, Zachary D.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Mullins, Elwood A.; Shi, Rongxin; Parsons, Zachary D.; Eichman, Brandt F.] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA; [Yuen, Philip K.; David, Sheila S.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Igarashi, Yasuhiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan	Vanderbilt University; Vanderbilt University; University of California System; University of California Davis; Toyama Prefectural University	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.	brandt.eichman@vanderbilt.edu		Mullins, Elwood/0000-0003-3834-1065; Shi, Rongxin/0000-0002-3930-8534; Eichman, Brandt/0000-0002-0965-2297	National Science Foundation [MCB-1122098, MCB-1517695]; National Institutes of Health [R01ES019625, R01CA067985, S10RR026915]; US Department of Energy [DE-AC02-06CH11357]; Vanderbilt Training Program in Environmental Toxicology [T32ES07028]; NATIONAL CANCER INSTITUTE [R01CA067985] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, R01ES019625] Funding Source: NIH RePORTER; Direct For Biological Sciences [1517695] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); Vanderbilt Training Program in Environmental Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. Rizzo and T. Johnson Salyard for assistance with oligodeoxynucleotide synthesis and E. Skaar and L. Mike for assistance with genetic manipulation of B. anthracis. This work was funded by the National Science Foundation (MCB-1122098 and MCB-1517695 to B.F.E.) and the National Institutes of Health (R01ES019625 to B.F.E. and R01CA067985 to S.S.D.). Support for the Vanderbilt Robotic Crystallization Facility was also provided by the National Institutes of Health (S10RR026915). Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy Office of Science by Argonne National Laboratory, was supported by the US Department of Energy (DE-AC02-06CH11357). Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tr-Corridor (085P1000817). E.A.M. and Z.D.P. were partially supported by the Vanderbilt Training Program in Environmental Toxicology (T32ES07028).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adhikary S, 2013, DNA REPAIR, V12, P196, DOI 10.1016/j.dnarep.2012.12.001; Adhikary S, 2011, EMBO REP, V12, P1286, DOI 10.1038/embor.2011.189; Alberts Steven R, 2007, J Gastrointest Cancer, V38, P10, DOI 10.1007/s12029-007-9007-6; Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x; BESLER BH, 1990, J COMPUT CHEM, V11, P431, DOI 10.1002/jcc.540110404; BJELLAND S, 1994, J BIOL CHEM, V269, P30489; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; Chu AM, 2011, BIOORG MED CHEM LETT, V21, P4969, DOI 10.1016/j.bmcl.2011.05.085; Dalhus B, 2007, NUCLEIC ACIDS RES, V35, P2451, DOI 10.1093/nar/gkm039; Dalhus B, 2013, STRUCTURE, V21, P154, DOI 10.1016/j.str.2012.11.004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Drohat AC, 2014, ORG BIOMOL CHEM, V12, P8367, DOI 10.1039/c4ob01063a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Hendershot JM, 2014, NUCLEIC ACIDS RES, V42, P12681, DOI 10.1093/nar/gku919; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Ho JM, 2010, THEOR CHEM ACC, V125, P3, DOI 10.1007/s00214-009-0667-0; Igarashi Y, 2003, J ANTIBIOT, V56, P107, DOI 10.7164/antibiotics.56.107; Imamura K, 2012, J BIOL CHEM, V287, P4288, DOI 10.1074/jbc.M111.315309; Kapinos LE, 2011, CHEM-EUR J, V17, P8156, DOI 10.1002/chem.201003544; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEOTNER M, 1985, J AM CHEM SOC, V107, P469, DOI 10.1021/ja00288a033; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Mike LA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004044; Mullins EA, 2014, DNA REPAIR, V13, P50, DOI 10.1016/j.dnarep.2013.10.009; Mullins EA, 2013, METHODS, V64, P59, DOI 10.1016/j.ymeth.2013.07.020; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; Osborne MR, 2000, CHEM RES TOXICOL, V13, P257, DOI 10.1021/tx990182e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plevin MJ, 2010, NAT CHEM, V2, P466, DOI [10.1038/NCHEM.650, 10.1038/nchem.650]; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; RAMSTEIN J, 1988, P NATL ACAD SCI USA, V85, P7231, DOI 10.1073/pnas.85.19.7231; Rubinson EH, 2008, J MOL BIOL, V381, P13, DOI 10.1016/j.jmb.2008.05.078; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Shibasaki K, 2006, J PHYS CHEM A, V110, P4397, DOI 10.1021/jp0605909; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; Sterne Max, 1946, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V21, P41; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Wilkinson OJ, 2012, P NATL ACAD SCI USA, V109, P18755, DOI 10.1073/pnas.1209451109; Wilson KA, 2014, NUCLEIC ACIDS RES, V42, P6726, DOI 10.1093/nar/gku269; Xu H, 2012, ANGEW CHEM INT EDIT, V51, P10532, DOI 10.1002/anie.201204109; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	56	42	43	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					254	+		10.1038/nature15728	http://dx.doi.org/10.1038/nature15728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26524531	Green Submitted, Green Accepted			2022-12-28	WOS:000364396700049
J	Makley, LN; McMenimen, KA; DeVree, BT; Goldman, JW; McGlasson, BN; Rajagopal, P; Dunyak, BM; McQuade, TJ; Thompson, AD; Sunahara, R; Klevit, RE; Andley, UP; Gestwicki, JE				Makley, Leah N.; McMenimen, Kathryn A.; DeVree, Brian T.; Goldman, Joshua W.; McGlasson, Brittney N.; Rajagopal, Ponni; Dunyak, Bryan M.; McQuade, Thomas J.; Thompson, Andrea D.; Sunahara, Roger; Klevit, Rachel E.; Andley, Usha P.; Gestwicki, Jason E.			Pharmacological chaperone for alpha-crystallin partially restores transparency in cataract models	SCIENCE			English	Article							AMYLOID FIBRIL FORMATION; B-CRYSTALLIN; DISEASE; PROTEINS; AGGREGATION; PREVENTION	Cataracts reduce vision in 50% of individuals over 70 years of age and are a common form of blindness worldwide. Cataracts are caused when damage to the major lens crystallin proteins causes their misfolding and aggregation into insoluble amyloids. Using a thermal stability assay, we identified a class of molecules that bind alpha-crystallins (cryAA and cryAB) and reversed their aggregation in vitro. The most promising compound improved lens transparency in the R49C cryAA and R120G cryAB mouse models of hereditary cataract. It also partially restored protein solubility in the lenses of aged mice in vivo and in human lenses ex vivo. These findings suggest an approach to treating cataracts by stabilizing alpha-crystallins.	[Makley, Leah N.; McMenimen, Kathryn A.; Dunyak, Bryan M.; Thompson, Andrea D.; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Makley, Leah N.; McMenimen, Kathryn A.; Dunyak, Bryan M.; Thompson, Andrea D.; Gestwicki, Jason E.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Makley, Leah N.; McMenimen, Kathryn A.; Dunyak, Bryan M.; Thompson, Andrea D.; Gestwicki, Jason E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Makley, Leah N.; McMenimen, Kathryn A.; Dunyak, Bryan M.; Thompson, Andrea D.; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Goldman, Joshua W.; McGlasson, Brittney N.; Andley, Usha P.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [DeVree, Brian T.; Sunahara, Roger] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Rajagopal, Ponni; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [McQuade, Thomas J.; Gestwicki, Jason E.] Univ Michigan, Ctr Chem Genom, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	andley@vision.wustl.edu; jason.gestwicki@ucsf.edu	Sunahara, Roger/AAJ-8667-2020; DeVree, Brian T/F-6205-2011; Thompson, Andrea/AAQ-5735-2020; Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; DeVree, Brian/0000-0003-0582-8125; Andley, Usha/0000-0001-7049-7591; Goldman, Joshua/0000-0001-9469-2295	NIH [EY017370, EY05681, EY02687, UL1RR024986, GM007767]; American Foundation for Pharmaceutical Education; Research to Prevent Blindness; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017370, P30EY002687, R01EY005681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-M. Fontaine for wild-type cryAB. This work was supported by NIH grants EY017370, EY05681, EY02687, UL1RR024986, and GM007767 and a predoctoral fellowship from the American Foundation for Pharmaceutical Education (L.N.M.). This work was also supported by a grant from Research to Prevent Blindness. J.E.G. is a co-founder of, and is on the Scientific Advisory Board of, Viewpoint Therapeutics, a biotechnology company developing treatments for cataract. L.N.M. is a co-founder and Chief Scientific Officer of Viewpoint Therapeutics. U.P.A. is on the Scientific Advisory Board of, and has stock options in, Viewpoint Therapeutics. The Regents of the University of Michigan hold U.S. Patent 13/944477 covering the method of using oxysterols to treat eye diseases. In addition, Viewpoint Therapeutics has filed provisional patent applications covering unrelated small molecules predicted to bind cryAB.	Andley UP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017671; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Fan JQ, 2007, FEBS J, V274, P4962, DOI 10.1111/j.1742-4658.2007.06041.x; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; Major LL, 2011, MOL BIOL INT, V2011; Makley LN, 2013, CHEM BIOL DRUG DES, V81, P22, DOI 10.1111/cbdd.12066; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	21	149	156	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					674	677		10.1126/science.aac9145	http://dx.doi.org/10.1126/science.aac9145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542570	Green Accepted			2022-12-28	WOS:000364162800049
J	Perelis, M; Marcheva, B; Ramsey, KM; Schipma, MJ; Hutchison, AL; Taguchi, A; Peek, CB; Hong, H; Huang, WY; Omura, C; Allred, AL; Bradfield, CA; Dinner, AR; Barish, GD; Bass, J				Perelis, Mark; Marcheva, Biliana; Ramsey, Kathryn Moynihan; Schipma, Matthew J.; Hutchison, Alan L.; Taguchi, Akihiko; Peek, Clara Bien; Hong, Heekyung; Huang, Wenyu; Omura, Chiaki; Allred, Amanda L.; Bradfield, Christopher A.; Dinner, Aaron R.; Barish, Grant D.; Bass, Joseph			Pancreatic beta cell enhancers regulate rhythmic transcription of genes controlling insulin secretion	SCIENCE			English	Article							CIRCADIAN CLOCK; PROTEIN-KINASE; DISTINCT; RELEASE; RNA; OSCILLATIONS; ARCHITECTURE; MECHANISMS; EXPRESSION; LANDSCAPE	The mammalian transcription factors CLOCK and BMAL1 are essential components of the molecular clock that coordinate behavior and metabolism with the solar cycle. Genetic or environmental perturbation of circadian cycles contributes to metabolic disorders including type 2 diabetes. To study the impact of the cell-autonomous clock on pancreatic beta cell function, we examined pancreatic islets from mice with either intact or disrupted BMAL1 expression both throughout life and limited to adulthood. We found pronounced oscillation of insulin secretion that was synchronized with the expression of genes encoding secretory machinery and signaling factors that regulate insulin release. CLOCK/BMAL1 colocalized with the pancreatic transcription factor PDX1 within active enhancers distinct from those controlling rhythmic metabolic gene networks in liver. We also found that beta cell clock ablation in adult mice caused severe glucose intolerance. Thus, cell type-specific enhancers underlie the circadian control of peripheral metabolism throughout life and may help to explain its dysregulation in diabetes.	[Perelis, Mark; Marcheva, Biliana; Ramsey, Kathryn Moynihan; Taguchi, Akihiko; Peek, Clara Bien; Hong, Heekyung; Huang, Wenyu; Omura, Chiaki; Allred, Amanda L.; Barish, Grant D.; Bass, Joseph] Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Schipma, Matthew J.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Hutchison, Alan L.] Univ Chicago, Med Scientist Training Program, Chicago, IL 60637 USA; [Hutchison, Alan L.; Dinner, Aaron R.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Hutchison, Alan L.; Dinner, Aaron R.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Bradfield, Christopher A.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 52705 USA; [Dinner, Aaron R.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; University of Chicago; University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Chicago	Bass, J (corresponding author), Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Hutchison, Alan L/B-5769-2015	Hutchison, Alan L/0000-0003-4161-0772; Marcheva, Biliana/0000-0001-8697-2625	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK090625]; National Institute on Aging [P01AG011412]; Chicago Biomedical Consortium [S-007]; Juvenile Diabetes Research Foundation [17-2013-511, 1-INO-2014-178-A-V, 1-INO-2015-23-A-V]; University of Chicago Diabetes Research and Training Center [P60DK020595]; NIDDK T32 [DK007169]; National Heart, Lung, and Blood Institute T32 grant [HL007909]; Defense Advanced Research Projects Agency [D12AP00023]; National Institute of Environmental Health Science [ES05703]; National Institute of General Medical Sciences [T32GM07281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090625, P60DK020595, P30DK020595, K01DK105137, R01DK100814, T32DK007169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES005703, R37ES005703, R01ES005703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chicago Biomedical Consortium; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); University of Chicago Diabetes Research and Training Center(University of Chicago); NIDDK T32; National Heart, Lung, and Blood Institute T32 grant; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01DK090625, National Institute on Aging grant P01AG011412, Chicago Biomedical Consortium S-007, Juvenile Diabetes Research Foundation grants17-2013-511, 1-INO-2014-178-A-V, and 1-INO-2015-23-A-V, and University of Chicago Diabetes Research and Training Center grant P60DK020595 (J.B.); NIDDK T32 grant DK007169 (B.M.); National Heart, Lung, and Blood Institute T32 grant HL007909 (M.P.); Defense Advanced Research Projects Agency grant D12AP00023 (A.R.D.); and National Institute of Environmental Health Science grant ES05703 (C.A.B.). A.L.H. is a trainee of the NIH Medical Scientist Training program at the University of Chicago (National Institute of General Medical Sciences grant T32GM07281). We thank E. Rosenzweig and The Next Generation Sequencing Core Facility at Northwestern University for assistance with library generation, sequencing, and analysis, as well as all members of the Bass and Barish laboratories for helpful discussions. J.B. has financial interest in and serves as an advisor to Reset Therapeutics. RNA-seq data sets, including lists of cycling genes in mouse and human islets, have been deposited in the NCBI's Gene Expression Omnibus accession GSE69889, and ChIP-seq data sets have been deposited in accession GSE70960.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Benner C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-620; Biden TJ, 2008, BIOCHEM SOC T, V36, P916, DOI 10.1042/BST0360916; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Fukuda M, 2003, J BIOCHEM, V133, P641, DOI 10.1093/jb/mvg082; Genc O, 2014, ELIFE, V3, DOI 10.7554/eLife.01715; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Gu GQ, 2002, DEVELOPMENT, V129, P2447; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Hutchison AL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004094; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Johnson BP, 2014, P NATL ACAD SCI USA, V111, P18757, DOI 10.1073/pnas.1421708111; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu Y, 2011, J PHYSIOL-LONDON, V589, P1603, DOI 10.1113/jphysiol.2010.201939; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Milochau A, 2014, FEBS LETT, V588, P2217, DOI 10.1016/j.febslet.2014.05.031; Morris CJ, 2015, P NATL ACAD SCI USA, V112, pE2225, DOI 10.1073/pnas.1418955112; Noble AJ, 2013, NAT STRUCT MOL BIOL, V20, P167, DOI 10.1038/nsmb.2467; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Ohara-Imaizumi M, 2004, DIABETOLOGIA, V47, P2200, DOI 10.1007/s00125-004-1579-0; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Pulimeno P, 2013, DIABETOLOGIA, V56, P497, DOI 10.1007/s00125-012-2779-7; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Takahashi H, 2015, DIABETES, V64, P1262, DOI 10.2337/db14-0576; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128	54	235	242	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261							aac4250	10.1126/science.aac4250	http://dx.doi.org/10.1126/science.aac4250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542580	Green Accepted			2022-12-28	WOS:000364162800041
J	Beagle, SD; Lockless, SW				Beagle, Sarah D.; Lockless, Steve W.			MICROBIOLOGY Electrical signalling goes bacterial	NATURE			English	Editorial Material							ESCHERICHIA-COLI; POTASSIUM; CHANNELS; PROTEIN		[Beagle, Sarah D.; Lockless, Steve W.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Beagle, SD (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	lockless@bio.tamu.edu						Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Booth IR, 2003, BIOCHEMISTRY-US, V42, P10045, DOI 10.1021/bi034953w; Cao Y, 2013, NATURE, V496, P317, DOI 10.1038/nature12056; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Kubalski A, 2005, BACTERIAL ION CHANNE; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; Lundberg ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060993; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; TOLNER B, 1995, J BACTERIOL, V177, P2863, DOI 10.1128/jb.177.10.2863-2869.1995	14	13	13	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					44	45		10.1038/nature15641	http://dx.doi.org/10.1038/nature15641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26503058				2022-12-28	WOS:000364270700037
J	Burkov, A				Burkov, Anton			Chiral anomaly without relativity	SCIENCE			English	Editorial Material							DISCOVERY; SEMIMETAL		[Burkov, Anton] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Burkov, Anton] Natl Res Univ ITMO, St Petersburg 197101, Russia	University of Waterloo; ITMO University	Burkov, A (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	aburkov@waterloo.edu						ADLER SL, 1969, PHYS REV, V177, P2426, DOI 10.1103/PhysRev.177.2426; Bell J. S., 1969, NUOVO CIMENTO A, V60, P4; Burkov AA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.245157; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Lu L, 2015, SCIENCE, V349, P622, DOI 10.1126/science.aaa9273; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; Son DT, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104412; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Xiong J, 2015, SCIENCE, V350, P413, DOI 10.1126/science.aac6089; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297	11	14	15	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					378	379		10.1126/science.aad2713	http://dx.doi.org/10.1126/science.aad2713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494743	Green Submitted			2022-12-28	WOS:000363213400019
J	Shen, QT; Ren, XF; Zhang, R; Lee, IH; Hurley, JH				Shen, Qing-Tao; Ren, Xuefeng; Zhang, Rui; Lee, Il-Hyung; Hurley, James H.			HIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygons	SCIENCE			English	Article							CLASS-I MHC; DOWN-REGULATION; MEMBRANE RECRUITMENT; ADAPTER COMPLEXES; PROTEIN COMPLEXES; CYTOPLASMIC TAIL; STRUCTURAL BASIS; GOLGI MEMBRANES; CRYO-EM; MICROSCOPY	The lentiviruses HIV and simian immunodeficiency virus (SIV) subvert intracellular membrane traffic as part of their replication cycle. The lentiviral Nef protein helps viruses evade innate and adaptive immune defenses by hijacking the adaptor protein 1 (AP-1) and AP-2 clathrin adaptors. We found that HIV-1 Nef and the guanosine triphosphatase Arf1 induced trimerization and activation of AP-1. Here we report the cryo-electron microscopy structures of the Nef- and Arf1-bound AP-1 trimer in the active and inactive states. A central nucleus of three Arf1 molecules organizes the trimers. We combined the open trimer with a known dimer structure and thus predicted a hexagonal assembly with inner and outer faces that bind the membranes and clathrin, respectively. Hexagons were directly visualized and the model validated by reconstituting clathrin cage assembly. Arf1 and Nef thus play interconnected roles in allosteric activation, cargo recruitment, and coat assembly, revealing an unexpectedly intricate organization of the inner AP-1 layer of the clathrin coat. Copyright 2015, American Association for the Advancement of Science.	[Shen, Qing-Tao; Ren, Xuefeng; Lee, Il-Hyung; Hurley, James H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shen, Qing-Tao; Ren, Xuefeng; Lee, Il-Hyung; Hurley, James H.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Zhang, Rui; Hurley, James H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hurley, JH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jimhurley@berkeley.edu		Lee, Il-Hyung/0000-0001-6755-3257	HARC Collaborative Opportunity Fund; HARC Collaborative Opportunity Fund (NIH) [P50GM082250]; NIH [R01AI120691]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	HARC Collaborative Opportunity Fund; HARC Collaborative Opportunity Fund (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Nogales for suggestions and advice; J. Bonifacino for discussions; P. Grob, S. Wu, Y. Cheng, and B. LaFrance for assistance at the outset of the project; and A. Johnson for assistance with figure preparation. This work was supported by the HARC Collaborative Opportunity Fund (J.H.H.; subaward of NIH grant P50GM082250 to A. Frankel) and NIH grant R01AI120691 (J.H.H). EM facilities were supported by the Howard Hughes Medical Institute (E. Nogales). All EM maps have been deposited in the Electron Microscopy Data Bank (accession codes: EMD-6385 for closed trimer, EMD-6388 for closed monomer, EMD-6389 for open trimer).	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Cherfils J, 2014, CURR OPIN STRUC BIOL, V29, P67, DOI 10.1016/j.sbi.2014.09.007; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Coleman SH, 2006, VIROLOGY, V345, P148, DOI 10.1016/j.virol.2005.09.045; Collins DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003851; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kluge SF, 2014, CELL HOST MICROBE, V16, P639, DOI 10.1016/j.chom.2014.10.002; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Riggs NL, 1999, VIROLOGY, V258, P203, DOI 10.1006/viro.1999.9736; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Wonderlich ER, 2011, J VIROL, V85, P12216, DOI 10.1128/JVI.00056-11; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015	48	34	34	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259							aac5137	10.1126/science.aac5137	http://dx.doi.org/10.1126/science.aac5137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494761	Green Accepted			2022-12-28	WOS:000363213400030
J	Wegener, G; Krukenberg, V; Riedel, D; Tegetmeyer, HE; Boetius, A				Wegener, Gunter; Krukenberg, Viola; Riedel, Dietmar; Tegetmeyer, Halina E.; Boetius, Antje			Intercellular wiring enables electron transfer between methanotrophic archaea and bacteria	NATURE			English	Article							ANAEROBIC OXIDATION; MICROBIAL COMMUNITIES; METHANE; SULFATE; PROTEIN; GENOME; IDENTIFICATION; REDUCTION; ENZYMES; METHANOGENESIS	The anaerobic oxidation of methane (AOM) with sulfate controls the emission of the greenhouse gas methane from the ocean floor(1,2). In marine sediments, AOM is performed by dual-species consortia of anaerobic methanotrophic archaea (ANME) and sulfate-reducing bacteria (SRB) inhabiting the methane-sulfate transition zone(3-5). The biochemical pathways and biological adaptations enabling this globally relevant process are not fully understood. Here we study the syntrophic interaction in thermophilic AOM (TAOM) between ANME-1 archaea and their consortium partner SRB HotSeep-1 (ref. 6) at 60 degrees C to test the hypothesis of a direct interspecies exchange of electrons(7,8.) The activity of TAOM consortia was compared to the first ANME-free culture of an AOM partner bacterium that grows using hydrogen as the sole electron donor. The thermophilic ANME-1 do not produce sufficient hydrogen to sustain the observed growth of the HotSeep-1 partner. Enhancing the growth of the HotSeep-1 partner by hydrogen addition represses methane oxidation and the metabolic activity of ANME-1. Further supporting the hypothesis of direct electron transfer between the partners, we observe that under TAOM conditions, both ANME and the HotSeep-1 bacteria overexpress genes for extracellular cytochrome production and form cell-to-cell connections that resemble the nanowire structures responsible for interspecies electron transfer between syntrophic consortia of Geobacter(9,10). HotSeep-1 highly expresses genes for pili production only during consortial growth using methane, and the nanowire-like structures are absent in HotSeep-1 cells isolated with hydrogen. These observations suggest that direct electron transfer is a principal mechanism in TAOM, which may also explain the enigmatic functioning and specificity of other methanotrophic ANME-SRB consortia.	[Wegener, Gunter; Krukenberg, Viola; Boetius, Antje] Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany; [Wegener, Gunter; Boetius, Antje] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Tegetmeyer, Halina E.; Boetius, Antje] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, D-27570 Bremerhaven, Germany; [Tegetmeyer, Halina E.] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany	Max Planck Society; University of Bremen; Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bielefeld	Wegener, G (corresponding author), Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany.	gwegener@mpi-bremen.de; vkrukenb@mpi-bremen.de	Albers, Pieter/I-2563-2017; Boetius, Antje/D-5459-2013	Boetius, Antje/0000-0003-2117-4176; Tegetmeyer, Halina E./0000-0003-1970-4457; Wegener, Gunter/0000-0002-6819-373X; Krukenberg, Viola/0000-0001-8369-8114	DFG Leibniz program; DFG excellence cluster MARUM, Center of Marine Environmental Sciences, Bremen; Max Planck Society	DFG Leibniz program(German Research Foundation (DFG)); DFG excellence cluster MARUM, Center of Marine Environmental Sciences, Bremen; Max Planck Society(Max Planck Society)	We thank K. Harding, I. Kattelmann, A. Ellrott and M. Meiners for technical support, and M. Richter, H. Gruber-Vodicka and P. Luigi Buttigieg for bioinformatic support, and K. Knittel, N. Dubilier, M. M. M. Kuypers and F. Widdel for discussions. Furthermore we thank A. Teske and the RV ATLANTIS and ALVIN team of cruise AT15-56 in 2009 for providing the initial sediment material. The project was funded by the DFG Leibniz program to A.B., and by the DFG excellence cluster MARUM, Center of Marine Environmental Sciences, Bremen. Further support was provided by the Max Planck Society to D.R. and A.B.	Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boetius A, 2013, NAT GEOSCI, V6, P725, DOI [10.1038/ngeo1926, 10.1038/NGEO1926]; CONRAD R, 1990, ARCH MICROBIOL, V155, P94, DOI 10.1007/BF00291281; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; Eddy S., 2003, HMMER USERS GUIDE BI; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD364, DOI 10.1093/nar/gkt1210; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kojima H, 2014, ENVIRON MICROBIOL, V16, P3431, DOI 10.1111/1462-2920.12475; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malvankar NS, 2015, MBIO, V6, DOI 10.1128/mBio.00084-15; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Milucka J, 2013, ENVIRON MICROBIOL, V15, P1561, DOI 10.1111/1462-2920.12003; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Nagarajan H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3809; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reitner J, 2005, PALAEOGEOGR PALAEOCL, V227, P18, DOI 10.1016/j.palaeo.2005.04.033; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Richter M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-177; Rotaru AE, 2014, ENERG ENVIRON SCI, V7, P408, DOI 10.1039/c3ee42189a; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; STEUDEL R, 1988, Z NATURFORSCH B, V43, P203; Stokke R, 2012, ENVIRON MICROBIOL, V14, P1333, DOI 10.1111/j.1462-2920.2012.02716.x; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; STUDER D, 1989, SCANNING MICROSCOPY, P253; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	54	298	323	32	572	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					587	U315		10.1038/nature15733	http://dx.doi.org/10.1038/nature15733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490622	Green Published			2022-12-28	WOS:000364026100053
J	Larson, E				Larson, Eric			Review: Brief screening tests for dementia have pooled sensitivity of 76% to 92% and specificity of 81% to 91%	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Grp Hlth Res Inst, Seattle, WA 98101 USA		Larson, E (corresponding author), Grp Hlth Res Inst, Seattle, WA 98101 USA.							JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC10	10.7326/ACPJC-2015-163-8-010	http://dx.doi.org/10.7326/ACPJC-2015-163-8-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502135				2022-12-28	WOS:000363737400011
J	Yaffe, MJ; Jong, RA				Yaffe, Martin J.; Jong, Roberta A.			Adjunctive ultrasonography in breast cancer screening	LANCET			English	Editorial Material							DIGITAL MAMMOGRAPHY; TOMOSYNTHESIS; ULTRASOUND; WOMEN; RISK		[Yaffe, Martin J.] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Yaffe, Martin J.] Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; [Jong, Roberta A.] Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON M4N 3M5, Canada; [Jong, Roberta A.] Univ Toronto, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Yaffe, MJ (corresponding author), Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	martin.yaffe@sri.utoronto.ca						Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; Coldman A, 2011, PREV MED, V53, P115, DOI 10.1016/j.ypmed.2011.07.005; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Ohuchi N, 2015, LANCET; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373	10	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					313	314		10.1016/S0140-6736(15)00787-4	http://dx.doi.org/10.1016/S0140-6736(15)00787-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26547099				2022-12-28	WOS:000368516500006
J	Hesketh, T; Zhou, XD; Wang, Y				Hesketh, Therese; Zhou, Xudong; Wang, Yun			The End of the One-Child Policy Lasting Implications for China	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hesketh, Therese] UCL, Inst Global Hlth, London WC1N 1EH, England; [Hesketh, Therese; Zhou, Xudong; Wang, Yun] Zhejiang Univ, Inst Social Med, Hangzhou, Zhejiang, Peoples R China	University of London; University College London; Zhejiang University	Hesketh, T (corresponding author), UCL, Inst Global Hlth, London WC1N 1EH, England.	t.hesketh@ucl.ac.uk	YUN, WANG/AAJ-9229-2020; YUN, WANG/AEQ-2146-2022	YUN, WANG/0000-0001-7650-6241; YUN, WANG/0000-0001-7650-6241; Hesketh, Therese/0000-0002-7564-9221; zhou, xudong/0000-0002-0784-5343; WANG, YUN/0000-0001-9438-5586	Economic and Social Research Council [ES/F034466/1] Funding Source: researchfish; ESRC [ES/F034466/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; Hesketh T, 2003, ARCH DIS CHILD, V88, P467, DOI 10.1136/adc.88.6.467; Hirschman C., 1994, International Family Planning Perspectives, V20, P82, DOI 10.2307/2133509; Lee MH, 2012, J FAM ECON ISS, V33, P41, DOI 10.1007/s10834-011-9277-9; National Bureau of Statistics of China, 2013, NUMB STUD FORM ED TY; Wang J., 2015, POPUL J, V2, P22; Zeng Y, 2014, J POPUL AGEING, V7, P255, DOI 10.1007/s12062-014-9102-y; Zhou XD, 2011, SOC SCI MED, V73, P1422, DOI 10.1016/j.socscimed.2011.07.033	8	51	52	2	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 29	2015	314	24					2619	2620		10.1001/jama.2015.16279	http://dx.doi.org/10.1001/jama.2015.16279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ2MR	26545258				2022-12-28	WOS:000366939800012
J	Doherty, R				Doherty, Robert		Amer Coll Phys	Assessing the Patient Care Implications of "Concierge" and Other Direct Patient Contracting Practices: A Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review								As physicians seek innovative practice models, one that is gaining ground is for practices to contract with patients to pay directly for some or all services-often called cash-only, retainer, boutique, concierge, or direct primary care or specialty care practices. Such descriptions do not reflect the variability found in practices. For the purposes of this paper, the American College of Physicians (ACP) defines a direct patient contracting practice (DPCP) as any practice that directly contracts with patients to pay out-of-pocket for some or all of the services provided by the practice, in lieu of or in addition to traditional insurance arrangements, and/or charges an administrative fee to patients, sometimes called a retainer or concierge fee, often in return for a promise of more personalized and accessible care. This definition encompasses the practice types previously described. The move to DPCPs is based on the premise that access and quality of care will be improved without third-party payers im-posing themselves between the patient and the physician. Yet concerns have been raised that DPCPs may cause access issues for patients who cannot afford to pay directly for care. This ACP position paper, initiated and written by its Medical Practice and Quality Committee and approved by the Board of Regents on 25 July 2015, assesses the impact of DPCPs on access, cost, and quality; discusses principles from the ACP Ethics Manual, Sixth Edition, that should apply to all practice types; and makes recommendations to mitigate any adverse effect on underserved patients.	[Doherty, Robert] Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Doherty, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	rdoherty@mail.acponline.org			ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Alexander GC, 2005, J GEN INTERN MED, V20, P1079, DOI 10.1111/j.1525-1497.2005.0233.x; American College of Physicians; ACP Research Center, 2015, MEMB SURV DET REP; [Anonymous], 2013, CONCIERGE MED T 0108; Beal AC, 2015, CLOSING DIVIDE MED H; Chase D, 2013, FORBES; Crowley R., 2010, RACIAL ETHNIC DISPAR; Englehard CL, 2014, BLOG            1013; Fleming D., 2014, AM COLL PHYS REACTS; Friedberg M.W., 2013, FACTORS AFFECTING PH; Gottschalk A, 2005, ANN FAM MED, V3, P488, DOI 10.1370/afm.404; Hargrave E, 2010, RETAINER BASED PHYS; HIRSCH MS, 1989, ANN INTERN MED, V110, P1, DOI 10.7326/0003-4819-110-1-1; Huff C, 2015, ACP INTERNIST    JAN; Japsen B., 2013, FORBES; Kirschner K, 2010, HEALTHCARE TRANSPARE; Klemes A, 2012, AM J MANAG CARE, V18, pE453; Lucier DJ, 2010, ACAD MED, V85, P959, DOI 10.1097/ACM.0b013e3181dbe19e; McCorry D, 2014, DIRECT PRIMARY CARE; Media Editorial Beck M, 2014, WALL STREET J; Neuhauser A., 2014, US NEWS WORLD REPORT; Paradise J., 2013, WHAT IS MED IMPACT A; Porter S, 2014, WHATS ALL BUZZ DIREC; Qamar S, 2014, BLOG            0824; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Rivero E, 2013, PATIENT CENTERED MED; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Solberg LI, 2014, AM J MANAG CARE; Steinwald AB, 2005, PHYS SERVICES CONCIE; Tashima KT, 2015, ANN INTERN MED, V163, P908, DOI 10.7326/M15-0949; Teske K, 2013, WHATS ALL HYPE RETAI; The Physicians Foundation, 2014, SURV AM PHYS PRACT P; Von Drehle D., 2014, TIME; Walton P, 2014, 5 BENEFITS CONCIERGE	33	20	20	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12					949	+		10.7326/M15-0366	http://dx.doi.org/10.7326/M15-0366			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY4BS	26551655				2022-12-28	WOS:000366354200021
J	Sigova, AA; Abraham, BJ; Ji, X; Molinie, B; Hannett, NM; Guo, YE; Jangi, M; Giallourakis, CC; Sharp, PA; Young, RA				Sigova, Alla A.; Abraham, Brian J.; Ji, Xiong; Molinie, Benoit; Hannett, Nancy M.; Guo, Yang Eric; Jangi, Mohini; Giallourakis, Cosmas C.; Sharp, Phillip A.; Young, Richard A.			Transcription factor trapping by RNA in gene regulatory elements	SCIENCE			English	Article							DIVERGENT TRANSCRIPTION; SUPER-ENHANCERS; HUMAN PROMOTERS; CELL IDENTITY; EXOSOME; YY1; DNA; ACTIVATION; MEDIATOR; DISEASE	Transcription factors (TFs) bind specific sequences in promoter-proximal and -distal DNA elements to regulate gene transcription. RNA is transcribed from both of these DNA elements, and some DNA binding TFs bind RNA. Hence, RNA transcribed from regulatory elements may contribute to stable TF occupancy at these sites. We show that the ubiquitously expressed TF Yin-Yang 1 (YY1) binds to both gene regulatory elements and their associated RNA species across the entire genome. Reduced transcription of regulatory elements diminishes YY1 occupancy, whereas artificial tethering of RNA enhances YY1 occupancy at these elements. We propose that RNA makes a modest but important contribution to the maintenance of certain TFs at gene regulatory elements and suggest that transcription of regulatory elements produces a positive-feedback loop that contributes to the stability of gene expression programs.	[Sigova, Alla A.; Abraham, Brian J.; Ji, Xiong; Hannett, Nancy M.; Guo, Yang Eric; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Molinie, Benoit; Giallourakis, Cosmas C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jangi, Mohini; Sharp, Phillip A.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Jangi, Mohini; Sharp, Phillip A.] David H Koch Inst Integrat Canc Res, Cambridge, MA 02140 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Abraham, Brian/C-2230-2019	Young, Richard A/0000-0001-8855-8647; Abraham, Brian/0000-0001-8085-3027; , Mohini/0000-0003-3138-4484	NIH [HG002668]; Hope Funds for Cancer Research; Cancer Research Institute; Biogen; NATIONAL CANCER INSTITUTE [P01CA042063] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Funds for Cancer Research; Cancer Research Institute; Biogen(Biogen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Orlando, C. Lin, V. Saint-Andre, Z. P. Fan, L. Zhang, and A. Chiu for help with computational analysis and advice. The lentiviral dCas9 and sgRNA expression plasmids are available from Addgene under the Uniform Biological Material Transfer Agreement. This work was supported by NIH grant HG002668 (R.A.Y.), the Hope Funds for Cancer Research (B.J.A.), the Cancer Research Institute (Y.E.G), and Biogen (R.A.Y.). The Whitehead Institute intends to file a patent application that relates to transcription factor trapping by RNA. R.A.Y. is a founder of Syros Pharmaceuticals.	Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lubas M, 2015, CELL REP, V10, P178, DOI 10.1016/j.celrep.2014.12.026; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	24	264	271	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					978	981		10.1126/science.aad3346	http://dx.doi.org/10.1126/science.aad3346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26516199	Green Accepted, Green Submitted			2022-12-28	WOS:000364955200049
J	Stolfi, A; Ryan, K; Meinertzhagen, IA; Christiaen, L				Stolfi, Alberto; Ryan, Kerrianne; Meinertzhagen, Ian A.; Christiaen, Lionel			Migratory neuronal progenitors arise from the neural plate borders in tunicates	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHORDATE CIONA-INTESTINALIS; PRIMARY SENSORY NEURONS; SENSING ION CHANNELS; HALOCYNTHIA-RORETZI; MERKEL CELLS; CI-MSXB; CREST; ORIGIN; EXPRESSION	The neural crest is an evolutionary novelty that fostered the emergence of vertebrate anatomical innovations such as the cranium and jaws(1). During embryonic development, multipotent neural crest cells are specified at the lateral borders of the neural plate before delaminating, migrating and differentiating into various cell types. In invertebrate chordates (cephalochordates and tunicates), neural plate border cells express conserved factors such as Msx, Snail and Pax3/7 and generate melanin-containing pigment cells(2-4), a derivative of the neural crest in vertebrates. However, invertebrate neural plate border cells have not been shown to generate homologues of other neural crest derivatives. Thus, proposed models of neural crest evolution postulate vertebrate-specific elaborations on an ancestral neural plate border program, through acquisition of migratory capabilities and the potential to generate several cell types(5-7). Here we show that a particular neuronal cell type in the tadpole larva of the tunicate Ciona intestinalis, the bipolar tail neuron, shares a set of features with neural-crest-derived spinal ganglia neurons in vertebrates. Bipolar tail neuron precursors derive from caudal neural plate border cells, delaminate and migrate along the paraxial mesoderm on either side of the neural tube, eventually differentiating into afferent neurons that form synaptic contacts with both epidermal sensory cells and motor neurons. We propose that the neural plate borders of the chordate ancestor already produced migratory peripheral neurons and pigment cells, and that the neural crest evolved through the acquisition of a multipotent progenitor regulatory state upstream of multiple, pre-existing neural plate border cell differentiation programs.	[Stolfi, Alberto; Christiaen, Lionel] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Ryan, Kerrianne; Meinertzhagen, Ian A.] Dalhousie Univ, Dept Psychol & Neurosci, Life Sci Ctr, Halifax, NS B3H 4R2, Canada	New York University; Dalhousie University	Christiaen, L (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	lc121@nyu.edu	Stolfi, Alberto/AAS-8031-2021	Christiaen, Lionel/0000-0001-5930-5667; Ryan, Kerrianne/0000-0002-9454-8768; Meinertzhagen, Ian/0000-0002-6578-4526	National Science Foundation [NSF-1161835]; National Institutes of Health [GM096032]; NSERC (Ottawa) [DIS0000065]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096032] Funding Source: NIH RePORTER; Direct For Biological Sciences [1161835] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC (Ottawa); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors would like to thank F. Razy-Krajka for assistance with Kaede photoconversion and comments on the manuscript, T. Tolkin for constructing the Mrf reporter plasmid, Z. Lu for ultramicrotomy, and C. Desplan, A. Di Gregorio and all members of the Christiaen and Meinertzhagen labs for feedback and suggestions. We thank H. Hashimoto, F. Robin and N. Takatori for embryo illustration template files. This work was funded by a National Science Foundation Postdoctoral Fellowship in Biology (under grant NSF-1161835) to A.S., by National Institutes of Health award GM096032 to L.C., and by grant DIS0000065 from NSERC (Ottawa) to I.A.M.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Aniello F, 1999, MECH DEVELOP, V88, P123, DOI 10.1016/S0925-4773(99)00178-1; Artinger KB, 1999, DEVELOPMENT, V126, P3969; Baker CVH, 1997, MECH DEVELOP, V69, P13, DOI 10.1016/S0925-4773(97)00129-9; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; BONE Q, 1960, J COMP NEUROL, V115, P27, DOI 10.1002/cne.901150105; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Buitrago-Delgado E, 2015, SCIENCE, V348, P1332, DOI 10.1126/science.aaa3655; Christiaen L, 2009, COLD SPRING HARB PRO; Coric T, 2008, FASEB J, V22, P1914, DOI 10.1096/fj.07-100313; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; FRITZSCH B, 1993, ACTA ANAT, V148, P96; Hashimoto H, 2015, DEV CELL, V32, P241, DOI 10.1016/j.devcel.2014.12.017; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Hudson C, 2006, DEVELOPMENT, V133, P2855, DOI 10.1242/dev.02466; Ikuta T, 2007, DEV BIOL, V312, P631, DOI 10.1016/j.ydbio.2007.10.005; Imai JH, 2007, J COMP NEUROL, V501, P335, DOI 10.1002/cne.21247; Imai KS, 2009, DEVELOPMENT, V136, P285, DOI 10.1242/dev.026419; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Kaltenbach SL, 2009, EVOL DEV, V11, P142, DOI 10.1111/j.1525-142X.2009.00315.x; Khoueiry P, 2010, CURR BIOL, V20, P792, DOI 10.1016/j.cub.2010.03.063; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; Morrison KM, 2009, DEV BIOL, V336, P76, DOI 10.1016/j.ydbio.2009.09.032; Nakamura MJ, 2012, DEV BIOL, V372, P274, DOI 10.1016/j.ydbio.2012.09.007; NICOL D, 1988, DEV BIOL, V130, P737, DOI 10.1016/0012-1606(88)90364-8; NISHIDA H, 1986, DEV GROWTH DIFFER, V28, P191; O'Brien GS, 2012, J COMP NEUROL, V520, P816, DOI 10.1002/cne.22791; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Razy-Krajka F, 2014, DEV CELL, V29, P263, DOI 10.1016/j.devcel.2014.04.001; Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stolfi A, 2012, GENETICS, V192, P55, DOI 10.1534/genetics.112.140590; Stolfi A, 2011, DEVELOPMENT, V138, P5429, DOI 10.1242/dev.072108; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Takamura K, 2010, ZOOL SCI, V27, P191, DOI 10.2108/zsj.27.191; Tang WJ, 2013, DEV BIOL, V378, P183, DOI 10.1016/j.ydbio.2013.03.016; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; TORRENCE SA, 1982, ZOOMORPHOLOGY, V99, P103, DOI 10.1007/BF00310303; Wada H, 2001, DEV GROWTH DIFFER, V43, P509; Wada H, 1997, DEV BIOL, V187, P240, DOI 10.1006/dbio.1997.8626; Wada S, 1999, DEV GROWTH DIFFER, V41, P9; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108	50	99	99	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					371	+		10.1038/nature15758	http://dx.doi.org/10.1038/nature15758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26524532	Green Accepted			2022-12-28	WOS:000365356800055
J	Hayek, SS; Sever, S; Ko, YA; Trachtman, H; Awad, M; Wadhwani, S; Altintas, MM; Wei, CL; Hotton, AL; French, AL; Sperling, LS; Lerakis, S; Quyyumi, AA; Reiser, J				Hayek, Salim S.; Sever, Sanja; Ko, Yi-An; Trachtman, Howard; Awad, Mosaab; Wadhwani, Shikha; Altintas, Mehmet M.; Wei, Changli; Hotton, Anna L.; French, Audrey L.; Sperling, Laurence S.; Lerakis, Stamatios; Quyyumi, Arshed A.; Reiser, Jochen			Soluble Urokinase Receptor and Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; CARDIOVASCULAR-DISEASE; SUPAR; RISK; POPULATION; EXPRESSION; PREDICTION; BIOMARKERS; CANCER	BACKGROUND Relatively high plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) have been associated with focal segmental glomerulosclerosis and poor clinical outcomes in patients with various conditions. It is unknown whether elevated suPAR levels in patients with normal kidney function are associated with future decline in the estimated glomerular filtration rate (eGFR) and with incident chronic kidney disease. METHODS We measured plasma suPAR levels in 3683 persons enrolled in the Emory Cardiovascular Biobank (mean age, 63 years; 65% men; median suPAR level, 3040 pg per milliliter) and determined renal function at enrollment and at subsequent visits in 2292 persons. The relationship between suPAR levels and the eGFR at baseline, the change in the eGFR over time, and the development of chronic kidney disease (eGFR <60 ml per minute per 1.73 m(2) of body-surface area) were analyzed with the use of linear mixed models and Cox regression after adjustment for demographic and clinical variables. RESULTS A higher suPAR level at baseline was associated with a greater decline in the eGFR during follow-up; the annual change in the eGFR was -0.9 ml per minute per 1.73 m(2) among participants in the lowest quartile of suPAR levels as compared with -4.2 ml per minute per 1.73 m(2) among participants in the highest quartile (P<0.001). The 921 participants with a normal eGFR (>= 90 ml per minute per 1.73 m(2)) at baseline had the largest suPAR-related decline in the eGFR. In 1335 participants with a baseline eGFR of at least 60 ml per minute per 1.73 m(2), the risk of progression to chronic kidney disease in the highest quartile of suPAR levels was 3.13 times as high (95% confidence interval, 2.11 to 4.65) as that in the lowest quartile. CONCLUSIONS An elevated level of suPAR was independently associated with incident chronic kidney disease and an accelerated decline in the eGFR in the groups studied. (Funded by the Abraham J. and Phyllis Katz Foundation and others.)	[Hayek, Salim S.; Ko, Yi-An; Awad, Mosaab; Sperling, Laurence S.; Lerakis, Stamatios; Quyyumi, Arshed A.] Emory Univ, Sch Med, Emory Clin Cardiovasc Res Inst, Div Cardiol, Atlanta, GA 30322 USA; [Ko, Yi-An] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Sever, Sanja] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sever, Sanja] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Trachtman, Howard] NYU, Dept Pediat, Langone Med Ctr, New York, NY 10016 USA; [Wadhwani, Shikha; Altintas, Mehmet M.; Wei, Changli; French, Audrey L.; Reiser, Jochen] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Hotton, Anna L.; French, Audrey L.] CORE Ctr Cook Cty, Womens Interagency HIV Study, Chicago, IL USA	Emory University; Emory University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; New York University; NYU Langone Medical Center; Rush University	Reiser, J (corresponding author), Rush Univ, Med Ctr, Kellogg Bldg,Suite 1003, Chicago, IL 60612 USA.	aquyyum@emory.edu; jochen_reiser@rush.edu	Altintas, Mehmet Mete/ABI-5904-2020; Lerakis, Stamatios/AAR-7597-2021; Trachtman, Howard/GSE-2340-2022; Altintas, Mehmet Mete/T-5333-2018; Hayek, Salim S./E-6932-2013	Altintas, Mehmet Mete/0000-0002-1871-6985; Hayek, Salim S./0000-0003-0180-349X; Trachtman, Howard/0000-0001-7447-9489	Abraham J. and Phyllis Katz Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089650, P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034993, U01AI103401, U01AI042590, U01AI035004, U01AI103397, U01AI034994, U01AI103390, U01AI031834, U01AI103408, U01AI034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101350] Funding Source: NIH RePORTER	Abraham J. and Phyllis Katz Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Abraham J. and Phyllis Katz Foundation and others.	Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Backes Y, 2012, INTENS CARE MED, V38, P1418, DOI 10.1007/s00134-012-2613-1; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Borne Y, 2014, EUR J HEART FAIL, V16, P377, DOI 10.1002/ejhf.49; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; De Witte H, 1998, INT J CANCER, V77, P236, DOI 10.1002/(SICI)1097-0215(19980717)77:2<236::AID-IJC12>3.0.CO;2-9; Delville M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008538; Eapen DJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001118; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fuhrman B, 2012, ATHEROSCLEROSIS, V222, P8, DOI 10.1016/j.atherosclerosis.2011.10.044; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gustafsson A, 2011, BIOMARK INSIGHTS, V6, P119, DOI 10.4137/BMI.S8326; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hessol NA, 2001, AM J EPIDEMIOL, V154, P563, DOI 10.1093/aje/154.6.563; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jeppesen J, 2008, EUR J CARDIOV PREV R, V15, P594, DOI 10.1097/HJR.0b013e328308bb8b; Johnson DW, 2004, INTERN MED J, V34, P50, DOI 10.1111/j.1444-0903.2004.t01-6-.x; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lyngbaek S, 2013, INT J CARDIOL, V167, P2904, DOI 10.1016/j.ijcard.2012.07.018; Maile LA, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/421827; Maile LA, 2014, ENDOCRINOLOGY, V155, P4665, DOI 10.1210/en.2014-1318; Meijers B, 2015, KIDNEY INT, V87, P210, DOI 10.1038/ki.2014.197; Sier CFM, 1999, LAB INVEST, V79, P717; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Theilade S, 2015, J INTERN MED, V277, P362, DOI 10.1111/joim.12269; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Wang TJ, 2011, CIRCULATION, V123, P551, DOI 10.1161/CIRCULATIONAHA.109.912568; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213	38	250	256	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1916	1925		10.1056/NEJMoa1506362	http://dx.doi.org/10.1056/NEJMoa1506362			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26539835	Bronze, Green Accepted			2022-12-28	WOS:000364445500006
J	Nakatsuji, S; Kiyohara, N; Higo, T				Nakatsuji, Satoru; Kiyohara, Naoki; Higo, Tomoya			Large anomalous Hall effect in a non-collinear antiferromagnet at room temperature	NATURE			English	Article							WEAK FERROMAGNETISM; MAGNETIC-STRUCTURE; SPIN STRUCTURE; MN3SN; PHASE; SPINTRONICS	In ferromagnetic conductors, an electric current may induce a transverse voltage drop in zero applied magnetic field: this anomalous Hall effect(1) is observed to be proportional to magnetization, and thus is not usually seen in antiferromagnets in zero field(2). Recent developments in theory and experiment have provided a framework for understanding the anomalous Hall effect using Berry-phase concepts', and this perspective has led to predictions that, under certain conditions, a large anomalous Hall effect may appear in spin liquids and antiferromagnets without net spin magnetization(4-8). Although such a spontaneous Hall effect has now been observed in a spin liquid state(9), a zero-field anomalous Hall effect has hitherto not been reported for antiferromagnets. Here we report empirical evidence for a large anomalous Hall effect in an antiferromagnet that has vanishingly small magnetization. In particular, we find that Mn3Sn, an antiferromagnet that has a non-collinear 120-degree spin order(10,11), exhibits a large anomalous Hall conductivity of around 20 per ohm per centimetre at room temperature and more than 100 per ohm per centimetre at low temperatures, reaching the same order of magnitude as in ferromagnetic metals(3). Notably, the chiral antiferromagnetic state has a very weak and soft ferromagnetic moment of about 0.002 Bohr magnetons per Mn atom (refs 10, 12), allowing us to switch the sign of the Hall effect with a small magnetic field of around a few hundred oersted. This soft response of the large anomalous Hall effect could be useful for various applications including spintronics for example, to develop a memory device that produces almost no perturbing stray fields.	[Nakatsuji, Satoru; Kiyohara, Naoki; Higo, Tomoya] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Nakatsuji, Satoru] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Nakatsuji, S (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	satoru@issp.u-tokyo.ac.jp	Kiyohara, Naoki/AAV-4257-2021	Kiyohara, Naoki/0000-0001-9702-9595; Higo, Tomoya/0000-0003-3308-6536; Nakatsuji, Satoru/0000-0001-9134-659X	PRESTO; Japan Science and Technology Agency; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [R2604]; Japanese Society for the Promotion of Science [15H05882, 15H05883];  [25707030]; Grants-in-Aid for Scientific Research [15H05883] Funding Source: KAKEN	PRESTO; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Ikhlas and A. Nevidomskyy for discussions. This work was partially supported by PRESTO, by the Japan Science and Technology Agency, by Grants-in-Aid for Scientific Research (no. 25707030) and the Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (no. R2604), and by Grants-in-Aid for Scientific Research on Innovative Areas (15H05882, 15H05883) from the Japanese Society for the Promotion of Science. The use of the facilities of the Materials Design and Characterization Laboratory at the Institute for Solid State Physics, The University of Tokyo, is acknowledged.	[Anonymous], 1880, P PHYS SOC LOND; BROWN PJ, 1990, J PHYS-CONDENS MAT, V2, P9409, DOI 10.1088/0953-8984/2/47/015; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; Chen H, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.017205; Chien C., 2013, HALL EFFECT ITS APPL; Chun SH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026601; DHEER PN, 1967, PHYS REV, V156, P637, DOI 10.1103/PhysRev.156.637; Feng WJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205105; Gomonay EV, 2014, LOW TEMP PHYS+, V40, P17, DOI 10.1063/1.4862467; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Husmann A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.172417; JAN JP, 1952, PHYSICA, V18, P339, DOI 10.1016/S0031-8914(52)80157-0; KREN E, 1975, PHYSICA B & C, V80, P226, DOI 10.1016/0378-4363(75)90066-2; Kubler J, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/67001; MacDonald AH, 2011, PHILOS T R SOC A, V369, P3098, DOI 10.1098/rsta.2011.0014; Machida Y, 2010, NATURE, V463, P210, DOI 10.1038/nature08680; Manyala N, 2004, NAT MATER, V3, P255, DOI 10.1038/nmat1103; Marti X, 2014, NAT MATER, V13, P367, DOI [10.1038/nmat3861, 10.1038/NMAT3861]; Martin I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.156402; Metalidis G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045327; Miyasato T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.086602; NAGAMIYA T, 1982, SOLID STATE COMMUN, V42, P385, DOI 10.1016/0038-1098(82)90159-4; Neubauer A, 2009, PHYSICA B, V404, P3163, DOI 10.1016/j.physb.2009.07.055; Nunez AS, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.214426; OHMORI H, 1987, J MAGN MAGN MATER, V70, P249, DOI 10.1016/0304-8853(87)90427-6; Onose Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174421; Park BG, 2011, NAT MATER, V10, P347, DOI [10.1038/nmat2983, 10.1038/NMAT2983]; Shick AB, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.212409; Shindou R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.116801; Surgers C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4400; TOMIYOSHI S, 1986, J MAGN MAGN MATER, V54-7, P1001, DOI 10.1016/0304-8853(86)90353-7; TOMIYOSHI S, 1982, J PHYS SOC JPN, V51, P2478, DOI 10.1143/JPSJ.51.2478; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959	36	695	701	45	681	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					212	+		10.1038/nature15723	http://dx.doi.org/10.1038/nature15723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26524519				2022-12-28	WOS:000364396700040
J	Ben Freedman, S; Lowres, N				Ben Freedman, S.; Lowres, Nicole			Asymptomatic Atrial Fibrillation The Case for Screening to Prevent Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ben Freedman, S.; Lowres, Nicole] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Ben Freedman, S.; Lowres, Nicole] Concord Hosp, Dept Cardiol, Sydney, NSW 2137, Australia; [Ben Freedman, S.; Lowres, Nicole] Anzac Res Inst, Sydney, NSW, Australia	University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute	Ben Freedman, S (corresponding author), Concord Hosp, Dept Cardiol, Hosp Rd Concord 3W, Sydney, NSW 2137, Australia.	ben.freedman@sydney.edu.au	Ekanayake, Kanchana/P-8817-2016; Research Institute, ANZAC/CAE-9030-2022; Freedman, Saul B/C-1625-2013	Freedman, Saul B/0000-0002-3809-2911; Lowres, Nicole/0000-0001-9061-3406				Camm AJ, 2012, EUR HEART J, V33; Fitzmaurice DA, 2007, BMJ-BRIT MED J, V335, P383; Friberg L, 2014, STROKE, V45, P2599, DOI 10.1161/STROKEAHA.114.006070; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Lowres N, 2014, THROMB HAEMOSTASIS, V111, P1167, DOI 10.1160/TH14-03-0231; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; Martinez C, 2014, THROMB HAEMOSTASIS, V112, P276, DOI 10.1160/TH4-04-0383; Ovbiagele B, 2013, STROKE, V44, P2361, DOI 10.1161/STR.0b013e31829734f2; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Tsang TS, 2011, CAN J CARDIOL, V27, pS122, DOI 10.1016/j.cjca.2011.07.121	10	35	36	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1911	1912		10.1001/jama.2015.9846	http://dx.doi.org/10.1001/jama.2015.9846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547457				2022-12-28	WOS:000364490700008
J	Fakhry, F; Spronk, S; van der Laan, L; Wever, JJ; Teijink, JAW; Hoffmann, WH; Smits, TM; van Brussel, JP; Stultiens, GNM; Derom, A; den Hoed, PT; Ho, GH; van Dijk, LC; Verhofstad, N; Orsini, M; van Petersen, A; Woltman, K; Hulst, I; van Sambeek, MRHM; Rizopoulos, D; Rouwet, EV; Hunink, MGM				Fakhry, Farzin; Spronk, Sandra; van der Laan, Lijckle; Wever, Jan J.; Teijink, Joep A. W.; Hoffmann, Wolter H.; Smits, Taco M.; van Brussel, Jerome P.; Stultiens, Guido N. M.; Derom, Alex; den Hoed, P. Ted; Ho, Gwan H.; van Dijk, Lukas C.; Verhofstad, Nicole; Orsini, Mariella; van Petersen, Andre; Woltman, Kristel; Hulst, Ingrid; van Sambeek, Marc R. H. M.; Rizopoulos, Dimitris; Rouwet, Ellen V.; Hunink, M. G. Myriam			Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; MEDICAL THERAPY; LOWER-EXTREMITY; TASK-FORCE; FEMOROPOPLITEAL; QUESTIONNAIRE; GUIDELINES; SOCIETY; TESTS	IMPORTANCE Supervised exercise is recommended as a first-line treatment for intermittent claudication. Combination therapy of endovascular revascularization plus supervised exercise may be more promising but few data comparing the 2 therapies are available. OBJECTIVE To assess the effectiveness of endovascular revascularization plus supervised exercise for intermittent claudication compared with supervised exercise only. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of 212 patients allocated to either endovascular revascularization plus supervised exercise or supervised exercise only. Data were collected between May 17, 2010, and February 16, 2013, in the Netherlands at 10 sites. Patients were followed up for 12 months and the data were analyzed according to the intention-to-treat principle. INTERVENTIONS A combination of endovascular revascularization (selective stenting) plus supervised exercise (n = 106) or supervised exercise only (n = 106). MAIN OUTCOMES AND MEASURES The primary end point was the difference in maximum treadmill walking distance at 12 months between the groups. Secondary end points included treadmill pain-free walking distance, vascular quality of life (VascuQol) score (1 [worst outcome] to 7 [best outcome]), and 36-item Short-Form Health Survey (SF-36) domain scores for physical functioning, physical role functioning, bodily pain, and general health perceptions (0 [severe limitation] to 100 [no limitation]). RESULTS Endovascular revascularization plus supervised exercise (combination therapy) was associated with significantly greater improvement in maximum walking distance (from 264 m to 1501 m for an improvement of 1237 m) compared with the supervised exercise only group (from 285m to 1240m for improvement of 955 m) (mean difference between groups, 282m; 99% CI, 60-505 m) and in pain-free walking distance (from 117m to 1237m for an improvement of 1120m vs from 135m to 847m for improvement of 712m, respectively) (mean difference, 408 m; 99% CI, 195-622 m). Similarly, the combination therapy group demonstrated significantly greater improvement in the disease-specific VascuQol score (1.34 [99% CI, 1.04-1.64] in the combination therapy group vs 0.73 [99% CI, 0.43-1.03] in the exercise group; mean difference, 0.62 [99% CI, 0.20-1.03]) and in the score for the SF-36 physical functioning (22.4 [99% CI, 16.3-28.5] vs 12.6 [99% CI, 6.3-18.9], respectively; mean difference, 9.8 [99% CI, 1.4-18.2]). No significant differences were found for the SF-36 domains of physical role functioning, bodily pain, and general health perceptions. CONCLUSIONS AND RELEVANCE Among patients with intermittent claudication after 1 year of follow-up, a combination therapy of endovascular revascularization followed by supervised exercise resulted in significantly greater improvement in walking distances and health-related quality-of-life scores compared with supervised exercise only.	[Fakhry, Farzin; Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Fakhry, Farzin; Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Spronk, Sandra] Dutch Hlth Care Inspectorate, Dept Res & Innovat, Utrecht, Netherlands; [van der Laan, Lijckle; Ho, Gwan H.] Amphia Hosp, Dept Vasc Surg, Breda, Netherlands; [Wever, Jan J.; van Dijk, Lukas C.; Hulst, Ingrid] Haga Hosp, Dept Vasc Surg, The Hague, Netherlands; [Wever, Jan J.; van Dijk, Lukas C.; Hulst, Ingrid] Haga Hosp, Dept Intervent Radiol, The Hague, Netherlands; [Teijink, Joep A. W.; Verhofstad, Nicole; van Sambeek, Marc R. H. M.] Catharina Hosp, Dept Vasc Surg, Eindhoven, Netherlands; [Hoffmann, Wolter H.; Orsini, Mariella] Reinier Graaf Hosp, Dept Vasc Surg, Delft, Netherlands; [Smits, Taco M.; van Petersen, Andre] Bernhoven Hosp, Dept Vasc Surg, Uden, Netherlands; [van Brussel, Jerome P.; Woltman, Kristel] Sint Franciscus Hosp, Dept Vasc Surg, Rotterdam, Netherlands; [Stultiens, Guido N. M.] Elkerliek Hosp, Dept Vasc Surg, Helmond, Netherlands; [Derom, Alex] Zorgsaam Hosp, Dept Vasc Surg, Terneuzen, Netherlands; [den Hoed, P. Ted] Ikazia Hosp, Dept Vasc Surg, Rotterdam, Netherlands; [Rizopoulos, Dimitris] Erasmus Univ, Dept Biostat, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Rouwet, Ellen V.] Erasmus Univ, Dept Vasc Surg, Med Ctr, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Amphia Hospital; Haga Hospital; Haga Hospital; Catharina Hospital; Reinier de Graaf Hospital; Franciscus Gasthuis; Ikazia Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health	Hunink, MGM (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Room NA 2818,POB 2040, Rotterdam, Netherlands.	m.hunink@erasmusmc.nl	van Sambeek, marc/CAF-1289-2022; Wever, Jan/AAJ-6870-2021	van der laan, lijckle/0000-0001-5631-594X	Netherlands Organisation for Health Research and Development	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	All study funding was provided by the Netherlands Organisation for Health Research and Development.	Ahimastos AA, 2011, J VASC SURG, V54, P1511, DOI 10.1016/j.jvs.2011.06.106; Beckman JA, 2007, CIRCULATION, V115, P550, DOI 10.1161/CIRCULATIONAHA.106.682203; Bendermacher BLW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005263.pub2; Bosch JL, 1999, CIRCULATION, V99, P3155, DOI 10.1161/01.CIR.99.24.3155; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Fakhry F, 2012, J VASC SURG, V56, P1132, DOI 10.1016/j.jvs.2012.04.046; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Frans FA, 2014, EUR J VASC ENDOVASC, V47, P180, DOI 10.1016/j.ejvs.2013.10.012; Frans FA, 2012, BRIT J SURG, V99, P16, DOI 10.1002/bjs.7656; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P459, DOI 10.1016/0895-4356(89)90136-4; Gardner AW, 2012, J VASC SURG, V55, P1346, DOI 10.1016/j.jvs.2011.11.123; Gardner AW, 2011, CIRCULATION, V123, P491, DOI 10.1161/CIRCULATIONAHA.110.963066; GARDNER AW, 1991, MED SCI SPORT EXER, V23, P402; Greenhalgh RM, 2008, EUR J VASC ENDOVASC, V36, P680, DOI 10.1016/j.ejvs.2008.10.007; HIATT WR, 1994, CIRCULATION, V90, P1866, DOI 10.1161/01.CIR.90.4.1866; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Khaira HS, 1996, EUR J VASC ENDOVASC, V11, P65, DOI 10.1016/S1078-5884(96)80136-5; Klaasboer-Kogelman K, 2003, NED TIJASCHR FYSIOTH, V6, P1; Lauret GJ, 2012, VASC HEALTH RISK MAN, V8, P495, DOI 10.2147/VHRM.S34095; Makris GC, 2012, EUR J VASC ENDOVASC, V44, P569, DOI 10.1016/j.ejvs.2012.09.009; Mazari FAK, 2013, BRIT J SURG, V100, P1172, DOI 10.1002/bjs.9200; Mazari FAK, 2012, BRIT J SURG, V99, P39, DOI 10.1002/bjs.7710; McDermott MM, 2014, CIRCULATION, V130, P61, DOI 10.1161/CIRCULATIONAHA.114.007002; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Morgan MBF, 2001, J VASC SURG, V33, P679, DOI 10.1067/mva.2001.112326; Murphy TP, 2015, J AM COLL CARDIOL, V65, P999, DOI 10.1016/j.jacc.2014.12.043; Murphy TP, 2012, CIRCULATION, V125, P130, DOI 10.1161/CIRCULATIONAHA.111.075770; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Reynolds MR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001233; Rooke TW, 2011, CIRCULATION, V124, P2020, DOI 10.1161/CIR.0b013e31822e80c3; Rubin DB, 1987, MULTIPLE IMPUTATION; Sieminski D J, 1997, Vasc Med, V2, P286; Spronk S, 2009, RADIOLOGY, V250, P586, DOI 10.1148/radiol.2501080607; Spronk S, 2008, J VASC SURG, V48, P1472, DOI 10.1016/j.jvs.2008.06.016; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Treasure T, 1998, BRIT MED J, V317, P362; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	129	133	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1936	1944		10.1001/jama.2015.14851	http://dx.doi.org/10.1001/jama.2015.14851			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547465	Bronze			2022-12-28	WOS:000364490700016
J	Moses, SA; Covey, JP; Miecnikowski, MT; Yan, B; Gadway, B; Ye, J; Jin, DS				Moses, Steven A.; Covey, Jacob P.; Miecnikowski, Matthew T.; Yan, Bo; Gadway, Bryce; Ye, Jun; Jin, Deborah S.			Creation of a low-entropy quantum gas of polar molecules in an optical lattice	SCIENCE			English	Article							MOTT INSULATOR; ATOMS; PROPAGATION; DYNAMICS; FERMIONS; PHASES; SYSTEM	Ultracold polar molecules, with their long-range electric dipolar interactions, offer a unique platform for studying correlated quantum many-body phenomena. However, realizing a highly degenerate quantum gas of molecules with a low entropy per particle is challenging. We report the synthesis of a low-entropy quantum gas of potassium-rubidium molecules (KRb) in a three-dimensional optical lattice. We simultaneously load into the optical lattice a Mott insulator of bosonic Rb atoms and a single-band insulator of fermionic K atoms. Then, using magnetoassociation and optical state transfer, we efficiently produce ground-state molecules in the lattice at those sites that contain one Rb and one K atom. The achieved filling fraction of 25% should enable future studies of transport and entanglement propagation in a many-body system with long-range dipolar interactions.	[Ye, Jun] NIST, JILA, Boulder, CO 80309 USA; Univ Colorado, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ye, J (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	ye@jila.colorado.edu; jin@jilau1.colorado.edu	Ye, Jun/C-3312-2011; Yan, Bo/B-3810-2012	Ye, Jun/0000-0003-0076-2112; Yan, Bo/0000-0002-5708-2460	National Defense Science and Engineering graduate fellowship; National Institute of Standards and Technology; Air Force Office of Scientific Research Multidisciplinary University Research Initiative (MURI); Army Research Office MURI; NSF [1125844]	National Defense Science and Engineering graduate fellowship; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); Air Force Office of Scientific Research Multidisciplinary University Research Initiative (MURI)(MURI); Army Research Office MURI(MURI); NSF(National Science Foundation (NSF))	We thank Z. Fu for experimental assistance and M. Wall, A. Safavi, K. Hazzard, and A. M. Rey for many useful discussions. Supported by a National Defense Science and Engineering graduate fellowship (J.P.C.), the National Institute of Standards and Technology, the Air Force Office of Scientific Research Multidisciplinary University Research Initiative (MURI), the Army Research Office MURI, and NSF grant 1125844.	Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Barnett R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.190401; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Budker D., 2008, ATOMIC PHYS EXPLORAT, V2nd ed; Buchler HP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060404; Cai JM, 2013, NAT PHYS, V9, P168, DOI 10.1038/nphys2519; Chotia A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.080405; Damski B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.110401; de Miranda MHG, 2011, NAT PHYS, V7, P502, DOI [10.1038/NPHYS1939, 10.1038/nphys1939]; de Paz A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185305; DeMarco B, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.063601; Freericks JK, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.011605; Fukuhara T, 2013, NAT PHYS, V9, P235, DOI [10.1038/nphys2561, 10.1038/NPHYS2561]; Gemelke N, 2009, NATURE, V460, P995, DOI 10.1038/nature08244; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115301; Hazzard KRA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063622; Hazzard KRA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.195302; Hazzard KRA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075301; He L, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.053629; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; Klempt C, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.061602; Knap M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064501; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Kuns KA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063639; Manmana SR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.081106; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Molony PK, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.255301; Neyenhuis B, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.230403; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Park JW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.205302; Ravets S, 2014, NAT PHYS, V10, P914, DOI [10.1038/nphys3119, 10.1038/NPHYS3119]; Richerme P, 2014, NATURE, V511, P198, DOI 10.1038/nature13450; Schachenmayer J, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031015; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; STAUFFER D, 1994, INTRO PERCOLATION TH; Sugawa S, 2011, NAT PHYS, V7, P642, DOI [10.1038/NPHYS2028, 10.1038/nphys2028]; Syzranov SV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6391; Takekoshi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.205301; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Yao NY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.243002; Yao NY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.185302; Zirbel JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143201	46	135	135	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					659	662		10.1126/science.aac6400	http://dx.doi.org/10.1126/science.aac6400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542566	Green Submitted			2022-12-28	WOS:000364162800045
J	Kielpinski, D				Kielpinski, Dave			QUANTUM PHYSICS Quantum sound waves stick together	NATURE			English	Editorial Material									Hewlett Packard Labs, Palo Alto, CA 94304 USA	Hewlett-Packard	Kielpinski, D (corresponding author), Hewlett Packard Labs, Palo Alto, CA 94304 USA.	david.kielpinski@hpe.com			Grants-in-Aid for Scientific Research [26400418] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bocquillon E, 2013, SCIENCE, V339, P1054, DOI 10.1126/science.1232572; Cohen JD, 2015, NATURE, V520, P522, DOI 10.1038/nature14349; Grudinin IS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.083901; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; Toyoda K, 2015, NATURE, V527, P74, DOI 10.1038/nature15735; Vahala K, 2009, NAT PHYS, V5, P682, DOI 10.1038/NPHYS1367	7	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					45	46		10.1038/527045a	http://dx.doi.org/10.1038/527045a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536955				2022-12-28	WOS:000364270700038
J	Pirrotta, V				Pirrotta, Vincenzo			Histone Marks Direct Chromosome Segregation	CELL			English	Editorial Material							STEM-CELL DIVISION	Germline stem cells divide asymmetrically, producing a self-renewing stem cell and a differentiating progenitor. Xie et al. now show that this depends on two asymmetric events that together partition a genome copy, carrying the old histones to the stem cell daughter and a copy with new, unmarked histones to the differentiating daughter.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, 604 Allison Rd, Piscataway, NJ 08854 USA.	pirrotta@dls.rutgers.edu						CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Evano B, 2013, CHROMOSOME RES, V21, P225, DOI 10.1007/s10577-013-9359-7; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Tran V, 2012, SCIENCE, V338, P679, DOI 10.1126/science.1226028; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002; Yadlapalli S, 2013, NATURE, V498, P251, DOI 10.1038/nature12106; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	8	5	6	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					792	793		10.1016/j.cell.2015.10.043	http://dx.doi.org/10.1016/j.cell.2015.10.043			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544931	Bronze			2022-12-28	WOS:000364829700005
J	Warren, MP; Harvey, VM				Warren, Mildred P.; Harvey, Valerie M.			Acral Lentiginous Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Warren, Mildred P.; Harvey, Valerie M.] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Eastern Virginia Medical School	Warren, MP (corresponding author), Eastern Virginia Med Sch, Norfolk, VA 23501 USA.	harveyvm@evms.edu							0	1	1	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1864	1864		10.1056/NEJMicm1500906	http://dx.doi.org/10.1056/NEJMicm1500906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26535515				2022-12-28	WOS:000364144000010
J	Yamanaka, N; Marques, G; O'Connor, MB				Yamanaka, Naoki; Marques, Guillermo; O'Connor, Michael B.			Vesicle-Mediated Steroid Hormone Secretion in Drosophila melanogaster	CELL			English	Article							BINDING-CASSETTE TRANSPORTER; OVINE CORPORA-LUTEA; PLASMA-MEMBRANE; NEUROTRANSMITTER RELEASE; GALLERIA-MELLONELLA; PROTHORACIC GLAND; IN-VIVO; GENE; EXOCYTOSIS; METAMORPHOSIS	Steroid hormones are a large family of cholesterol derivatives regulating development and physiology in both the animal and plant kingdoms, but little is known concerning mechanisms of their secretion from steroidogenic tissues. Here, we present evidence that in Drosophila, endocrine release of the steroid hormone ecdysone is mediated through a regulated vesicular trafficking mechanism. Inhibition of calcium signaling in the steroidogenic prothoracic gland results in the accumulation of unreleased ecdysone, and the knockdown of calcium-mediated vesicle exocytosis components in the gland caused developmental defects due to deficiency of ecdysone. Accumulation of synaptotagmin-labeled vesicles in the gland is observed when calcium signaling is disrupted, and these vesicles contain an ABC transporter that functions as an ecdysone pump to fill vesicles. We propose that trafficking of steroid hormones out of endocrine cells is not always through a simple diffusion mechanism as presently thought, but instead can involve a regulated vesicle-mediated release process.	[Yamanaka, Naoki; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Yamanaka, Naoki] Univ Calif Riverside, Dept Entomol, Inst Integrat Genome Biol, Ctr Dis Vector Res, Riverside, CA 92521 USA; [Marques, Guillermo] Univ Minnesota, Univ Imaging Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Riverside; University of Minnesota System; University of Minnesota Twin Cities	Yamanaka, N (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	naoki.yamanaka@ucr.edu; moconnor@umn.edu	Yamanaka, Naoki/F-1358-2010; O'Connor, Michael B/C-9977-2014	Yamanaka, Naoki/0000-0002-6244-2686; O'Connor, Michael B/0000-0002-3067-5506	Japan Society for the Promotion of Science; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K99/R00 HD073239]; National Institute of General Medical Sciences (NIGMS) [R01 GM093301]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD073239, R00HD073239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093301] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Vienna Drosophila Resource Center, Bloomington Drosophila Stock Center, NIG-FLY at National Institute of Genetics, Transgenic RNAi Project at Harvard Medical School, and K. Broadie for fly stocks; Drosophila Genomics Resource Center for cDNA clones; members of M.B.O. lab for fruitful discussion; and M.J. Shimell, A. Peterson, J. Simon, and S. Conner for critical reading of the manuscript. GCaMP5 imaging and analysis was performed at the University Imaging Centers, University of Minnesota. This study was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science to N.Y., NIH grants K99/R00 HD073239 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to N.Y., and R01 GM093301 from the National Institute of General Medical Sciences (NIGMS) to M.B.O.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Andrews HK, 2002, TRAFFIC, V3, P906, DOI 10.1034/j.1600-0854.2002.31206.x; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; BIRKENBEIL H, 1979, CELL TISSUE RES, V200, P285; BIRKENBEIL H, 1983, CELL TISSUE RES, V229, P433; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; GEMMELL RT, 1979, CELL TISSUE RES, V197, P413, DOI 10.1007/BF00233566; Ghayee HK, 2007, REV ENDOCR METAB DIS, V8, P289, DOI 10.1007/s11154-007-9052-2; Graf ER, 2012, J NEUROSCI, V32, P16586, DOI 10.1523/JNEUROSCI.0965-12.2012; HIGUCHI T, 1976, ENDOCRINOLOGY, V99, P1023, DOI 10.1210/endo-99-4-1023; HIRST JJ, 1986, BIOL REPROD, V35, P1106, DOI 10.1095/biolreprod35.5.1106; Hock T, 2000, P NATL ACAD SCI USA, V97, P9519, DOI 10.1073/pnas.160271797; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Kanno E, 2008, J NEUROSCI RES, V86, P1036, DOI 10.1002/jnr.21568; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kralli A, 1996, J BIOL CHEM, V271, P17152, DOI 10.1074/jbc.271.29.17152; KRALLI A, 1995, P NATL ACAD SCI USA, V92, P4701, DOI 10.1073/pnas.92.10.4701; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuwana H, 1996, BBA-GENE STRUCT EXPR, V1309, P47, DOI 10.1016/S0167-4781(96)00137-6; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; Mahe Y, 1996, J BIOL CHEM, V271, P25167, DOI 10.1074/jbc.271.41.25167; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Muller M, 2012, J NEUROSCI, V32, P16574, DOI 10.1523/JNEUROSCI.0981-12.2012; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Oren I, 2004, BIOPHYS J, V87, P768, DOI 10.1529/biophysj.103.035527; Ou QX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001160; Raven PH, 2002, BIOLOGY, P1125; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SAWYER HR, 1979, ENDOCRINOLOGY, V104, P476, DOI 10.1210/endo-104-2-476; Sherwood L., 2011, FUNDAMENTALS HUMAN P, P71; Shortridge RD, 1995, INVERTEBR NEUROSCI, V1, P199, DOI 10.1007/BF02211021; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Sorrentino V, 2000, CURR OPIN GENET DEV, V10, P662, DOI 10.1016/S0959-437X(00)00139-8; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Suzuki M, 2003, J BIOL CHEM, V278, P22644, DOI 10.1074/jbc.M212399200; Talamillo A, 2008, DEVELOPMENT, V135, P1659, DOI 10.1242/dev.020685; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; THEODOSIS DT, 1986, CELL TISSUE RES, V243, P129, DOI 10.1007/BF00221861; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Venkatesh K, 1997, CURR BIOL, V7, P500, DOI 10.1016/S0960-9822(06)00221-1; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; WATANABE S, 1991, BIOCHIM BIOPHYS ACTA, V1073, P275, DOI 10.1016/0304-4165(91)90132-Z; Whitton B.A., 2012, ECOLOGY CYANOBACTERI, P1, DOI DOI 10.1007/978-94-007-3855-3; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yu LQ, 2005, J BIOL CHEM, V280, P8742, DOI 10.1074/jbc.M411080200; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	62	79	80	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					907	919		10.1016/j.cell.2015.10.022	http://dx.doi.org/10.1016/j.cell.2015.10.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544939	Green Accepted, Bronze			2022-12-28	WOS:000364829700016
J	Evarts, EC				Evarts, Eric C.			Lithium batteries To the limits of lithium	NATURE			English	Editorial Material																			0	282	292	7	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S93	S95		10.1038/526S93a	http://dx.doi.org/10.1038/526S93a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509953	Bronze			2022-12-28	WOS:000363832100025
J	Boeke, JD; Fenyo, D				Boeke, Jef D.; Fenyo, David			Much Ado about Zero	CELL			English	Editorial Material							RETROTRANSPOSITION	LINE retrotransposons actively shape mammalian genomes. Denli et al. reveal a new open reading frame, ORF0, on the antisense strand of human LINE-1 encoding a small regulatory protein. This finding may represent the birth of an emerging retrotransposon gene that can adopt various fates, as it can be fused to adjacent host sequences.	[Boeke, Jef D.; Fenyo, David] NYU, Langone Sch Med, Inst Syst Genet, New York, NY 10016 USA; [Boeke, Jef D.; Fenyo, David] NYU, Langone Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Boeke, JD (corresponding author), NYU, Langone Sch Med, Inst Syst Genet, New York, NY 10016 USA.	jef.boeke@nyumc.org		Fenyo, David/0000-0001-5049-3825	NIGMS NIH HHS [P50 GM107632] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107632] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Denli AM, 2015, CELL, V163, P583, DOI 10.1016/j.cell.2015.09.025; Goodier JL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-11; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6	6	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					534	535		10.1016/j.cell.2015.10.033	http://dx.doi.org/10.1016/j.cell.2015.10.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496595	Bronze			2022-12-28	WOS:000364828900003
J	Branson, K; Freeman, J				Branson, Kristin; Freeman, Jeremy			Imaging the Neural Basis of Locomotion	CELL			English	Editorial Material								To investigate the fundamental question of how nervous systems encode, organize, and sequence behaviors, Kato et al. imaged neural activity with cellular resolution across the brain of the worm Caenorhabditis elegans. Locomotion behavior seems to be continuously represented by cyclical patterns of distributed neural activity that are present even in immobilized animals.	[Branson, Kristin; Freeman, Jeremy] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Branson, K (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	bransonk@janelia.hhmi.org						Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Gordus A, 2015, CELL, V161, P215, DOI 10.1016/j.cell.2015.02.018; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011	10	1	1	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					541	542		10.1016/j.cell.2015.10.014	http://dx.doi.org/10.1016/j.cell.2015.10.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496599	Bronze			2022-12-28	WOS:000364828900007
J	Kazak, L; Chouchani, ET; Jedrychowski, MP; Erickson, BK; Shinoda, K; Cohen, P; Vetrivelan, R; Lu, GZ; Laznik-Bogoslavski, D; Hasenfuss, SC; Kajimura, S; Gygi, SP; Spiegelman, BM				Kazak, Lawrence; Chouchani, Edward T.; Jedrychowski, Mark P.; Erickson, Brian K.; Shinoda, Kosaku; Cohen, Paul; Vetrivelan, Ramalingam; Lu, Gina Z.; Laznik-Bogoslavski, Dina; Hasenfuss, Sebastian C.; Kajimura, Shingo; Gygi, Steve P.; Spiegelman, Bruce M.			A Creatine-Driven Substrate Cycle Enhances Energy Expenditure and Thermogenesis in Beige Fat	CELL			English	Article							BROWN ADIPOSE-TISSUE; UCP1-INDEPENDENT THERMOGENESIS; WILD-TYPE; MICE; MITOCHONDRIA; COLD; ABLATION; OBESITY; MUSCLE; UCP1	Thermogenic brown and beige adipose tissues dissipate chemical energy as heat, and their thermogenic activities can combat obesity and diabetes. Herein the functional adaptations to cold of brown and beige adipose depots are examined using quantitative mitochondrial proteomics. We identify arginine/creatine metabolism as a beige adipose signature and demonstrate that creatine enhances respiration in beige-fat mitochondria when ADP is limiting. In murine beige fat, cold exposure stimulates mitochondrial creatine kinase activity and induces coordinated expression of genes associated with creatine metabolism. Pharmacological reduction of creatine levels decreases whole-body energy expenditure after administration of a beta 3-agonist and reduces beige and brown adipose metabolic rate. Genes of creatine metabolism are compensatorily induced when UCP1-dependent thermogenesis is ablated, and creatine reduction in Ucp1-deficient mice reduces core body temperature. These findings link a futile cycle of creatine metabolism to adipose tissue energy expenditure and thermal homeostasis.	[Kazak, Lawrence; Chouchani, Edward T.; Cohen, Paul; Lu, Gina Z.; Laznik-Bogoslavski, Dina; Hasenfuss, Sebastian C.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kazak, Lawrence; Chouchani, Edward T.; Jedrychowski, Mark P.; Erickson, Brian K.; Cohen, Paul; Hasenfuss, Sebastian C.; Gygi, Steve P.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shinoda, Kosaku; Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Vetrivelan, Ramalingam] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Vetrivelan, Ramalingam] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Chouchani, Edward T./HCH-3775-2022; Shinoda, Kosaku/V-1698-2019; Kajimura, Shingo/AAC-5090-2019	Shinoda, Kosaku/0000-0002-1928-0749; Kajimura, Shingo/0000-0003-0672-5910; Erickson, Brian/0000-0002-1150-5042	Canadian Institutes of Health Research postdoctoral fellowship; Human Frontier Science Program postdoctoral fellowship; NIH [DK031405]; JPB foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, R01DK031405, R01DK108822, P30DK098722, R01DK097441, R37DK031405] Funding Source: NIH RePORTER	Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program postdoctoral fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Marc W. Kirschner, Mike P. Murphy, BeWieringa, and members of the Spiegelman lab for helpful discussions. pBAD-TOPO-TA/hPhospho1 was a kind gift from Colin Farquharson. The Biophysical Instrumentation Facility (NSF-0070319) is acknowledged for help with DSC. This work was supported by a Canadian Institutes of Health Research postdoctoral fellowship to L.K., by a Human Frontier Science Program postdoctoral fellowship to E.T.C., and by an NIH grant (DK031405) and the JPB foundation to B.M.S.	Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BERLET HH, 1976, BIOCHIM BIOPHYS ACTA, V437, P166, DOI 10.1016/0304-4165(76)90358-5; BLOCK BA, 1994, J CELL BIOL, V127, P1275, DOI 10.1083/jcb.127.5.1275; BLOOM JD, 1992, J MED CHEM, V35, P3081, DOI 10.1021/jm00094a025; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FITCH CD, 1980, METABOLISM, V29, P686, DOI 10.1016/0026-0495(80)90115-8; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Grimpo K, 2014, J LIPID RES, V55, P398, DOI 10.1194/jlr.M042895; JACOBUS WE, 1973, J BIOL CHEM, V248, P4803; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Oudman I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052879; RICQUIER D, 1979, FEBS LETT, V99, P203, DOI 10.1016/0014-5793(79)80279-3; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; SIPILA I, 1980, BIOCHIM BIOPHYS ACTA, V613, P79, DOI 10.1016/0005-2744(80)90194-1; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Terblanche SE, 1998, CELL BIOL INT, V22, P701, DOI 10.1006/cbir.1998.0310; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Wakatsuki T, 1996, JPN J PHYSIOL, V46, P171, DOI 10.2170/jjphysiol.46.171; Watanabe M, 2008, BBA-BIOENERGETICS, V1777, P104, DOI 10.1016/j.bbabio.2007.10.014; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YAMASHITA H, 1995, BBA-BIOENERGETICS, V1230, P69, DOI 10.1016/0005-2728(95)00067-S	34	430	434	4	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					643	655		10.1016/j.cell.2015.09.035	http://dx.doi.org/10.1016/j.cell.2015.09.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496606	Bronze, Green Accepted			2022-12-28	WOS:000364828900018
J	Swanson, MD; Boudreaux, DM; Salmon, L; Chugh, J; Winter, HC; Meagher, JL; Andre, S; Murphy, PV; Oscarson, S; Roy, R; King, S; Kaplan, MH; Goldstein, IJ; Tarbet, EB; Hurst, BL; Smee, DF; de la Fuente, C; Hoffmann, HH; Xue, Y; Rice, CM; Schols, D; Garcia, JV; Stuckey, JA; Gabius, HJ; Al-Hashimi, HM; Markovitz, DM				Swanson, Michael D.; Boudreaux, Daniel M.; Salmon, Loic; Chugh, Jeetender; Winter, Harry C.; Meagher, Jennifer L.; Andre, Sabine; Murphy, Paul V.; Oscarson, Stefan; Roy, Rene; King, Steven; Kaplan, Mark H.; Goldstein, Irwin J.; Tarbet, E. Bart; Hurst, Brett L.; Smee, Donald F.; de la Fuente, Cynthia; Hoffmann, Hans-Heinrich; Xue, Yi; Rice, Charles M.; Schols, Dominique; Garcia, J. Victor; Stuckey, Jeanne A.; Gabius, Hans-Joachim; Al-Hashimi, Hashim M.; Markovitz, David M.			Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity	CELL			English	Article							BANANA LECTIN; SUGAR CODE; GLYCODENDRIMERSOMES; RECOGNITION; SPECIFICITY; GALECTIN; DYNAMICS	A key effector route of the Sugar Code involves lectins that exert crucial regulatory controls by targeting distinct cellular glycans. We demonstrate that a single amino-acid substitution in a banana lectin, replacing histidine 84 with a threonine, significantly reduces its mitogenicity, while preserving its broad-spectrum antiviral potency. X-ray crystallography, NMR spectroscopy, and glycocluster assays reveal that loss of mitogenicity is strongly correlated with loss of pi-pi stacking between aromatic amino acids H84 and Y83, which removes a wall separating two carbohydrate binding sites, thus diminishing multivalent interactions. On the other hand, monovalent interactions and antiviral activity are preserved by retaining other wild-type conformational features and possibly through unique contacts involving the T84 side chain. Through such fine-tuning, target selection and downstream effects of a lectin can be modulated so as to knock down one activity, while preserving another, thus providing tools for therapeutics and for understanding the Sugar Code.	[Swanson, Michael D.; Boudreaux, Daniel M.; King, Steven; Kaplan, Mark H.; Markovitz, David M.] Univ Michigan, Div Infect Dis, Dept Internal Med, Program Immunol, Ann Arbor, MI 48109 USA; [Boudreaux, Daniel M.; Salmon, Loic; Chugh, Jeetender; Al-Hashimi, Hashim M.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Winter, Harry C.; Goldstein, Irwin J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Meagher, Jennifer L.; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Andre, Sabine; Gabius, Hans-Joachim] Univ Munich, Fac Vet Med, Inst Physiol Chem, D-80539 Munich, Germany; [Murphy, Paul V.] Natl Univ Ireland, Sch Chem, Galway, Ireland; [Oscarson, Stefan] Univ Coll Dublin, Ctr Synth & Chem Biol, Dublin 4, Ireland; [Roy, Rene] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada; [Tarbet, E. Bart; Hurst, Brett L.; Smee, Donald F.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA; [de la Fuente, Cynthia; Hoffmann, Hans-Heinrich; Rice, Charles M.] Rockefeller Univ, New York, NY 10065 USA; [Xue, Yi; Al-Hashimi, Hashim M.] Duke Univ, Dept Biochem, Durham, NC 27710 USA; [Schols, Dominique] Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, B-3000 Leuven, Belgium; [Swanson, Michael D.; Garcia, J. Victor] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Swanson, Michael D.; Garcia, J. Victor] Univ N Carolina, UNC AIDS Ctr, Chapel Hill, NC 27599 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Munich; Ollscoil na Gaillimhe-University of Galway; University College Dublin; University of Quebec; University of Quebec Montreal; Utah System of Higher Education; Utah State University; Rockefeller University; Duke University; KU Leuven; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	ha57@duke.edu; dmarkov@umich.edu	Murphy, Paul V/F-7655-2010; Schols, Dominique/S-9057-2017; Chugh, Jeetender/S-4436-2019; King, Steven/AAE-2526-2019; Schols, Dominique/AAC-1309-2021; Salmon, Loic/C-9162-2018	Schols, Dominique/0000-0003-3256-5850; Chugh, Jeetender/0000-0002-9996-5202; Schols, Dominique/0000-0003-3256-5850; Salmon, Loic/0000-0002-0249-6279; Andre, Sabine/0000-0003-0850-0432; Gabius, Hans-Joachim/0000-0003-3467-3900; Murphy, Paul/0000-0002-1529-6540; Tarbet, Bart/0000-0002-4255-9094; Oscarson, Stefan/0000-0002-8273-4918	NIH [1R01CA144043, AI096138, AI073146, P30 AI50410, P50 GM103297]; EC-funded GlycoHIT program [260600]; Training Network GLYCOPHARM [PITN-GA-2012-317297]; Marie Curie Intra-European Fellowships [500748, 514958, 220948]; Programme for Research in Third-Level Institutions (PRTLI); Science Foundation Ireland [04/BR/C0192, 06/RFP/CHO032, 12/IA/1398]; Natural Sciences and Engineering Research Council of Canada (NSERC); KU Leuven [GOA 10/014, PF 10/18]; European CHAARM grant [242135]; Fondation Dormeur, Vaduz; PHS [R01 AI099284, R01 AI072613, R01 CA057973]; Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH [HHSN2722010000391/HHSN27200005/A37]; University of Michigan Center for Structural Biology; U.S. Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA144043, R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072613, P30AI050410, R01AI096138, R01AI073146, R01AI099284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EC-funded GlycoHIT program; Training Network GLYCOPHARM; Marie Curie Intra-European Fellowships(European Commission); Programme for Research in Third-Level Institutions (PRTLI); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); KU Leuven(KU Leuven); European CHAARM grant; Fondation Dormeur, Vaduz; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH; University of Michigan Center for Structural Biology(University of Michigan System); U.S. Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Evelyn Coves-Datson, Anjan Saha, Dana Huskens, Jen Lewis, and Dr. Derek Dube for assistance, Dr. David Smith of LS-CAT for help with remote data collection, and Drs. B. Friday and A. Leddoz for inspiring discussions. Work in the laboratories of D.M.M. and H.M.A-H. was supported by an NIH grant (1R01CA144043). H.-J.G. was supported by the EC-funded GlycoHIT program (contract no. 260600) and Training Network GLYCOPHARM (PITN-GA-2012-317297). M.D.S. and J.V.G. were supported by grants from the NIH (AI096138, AI073146, and P30 AI50410). P.V.M. has been supported by Marie Curie Intra-European Fellowships (500748, 514958, and 220948), the Programme for Research in Third-Level Institutions (PRTLI), administered by the Higher Education Authority, the Irish Research Council, Enterprise Ireland, and Science Foundation Ireland (04/BR/C0192, 06/RFP/CHO032, and 12/IA/1398). R.R. is grateful to the Natural Sciences and Engineering Research Council of Canada (NSERC) for financial support and for a Canadian Research Chair in Therapeutic Chemistry. The participation of A. Papadopoulos and T.C. Shiao is also acknowledged in the preparation of compounds 4-8. M.H.K. received support from the Concerned Parents for AIDS Research. D.S. was supported by KU Leuven grants (GOA 10/014 and PF 10/18), a European CHAARM grant (242135), and an equipment grant from the Fondation Dormeur, Vaduz. Work in the laboratory of C.M.R. was supported in part by PHS grants (R01 AI099284, R01 AI072613, and R01 CA057973). Work at the Utah State University was supported by a grant (contract number HHSN2722010000391/HHSN27200005/A37) from the Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH. J.A.S., J.L.M, and H.M.A.-H. were partially supported by a grant (P50 GM103297) from the NIH. J.A.S. and J.L.M were also supported in part by the University of Michigan Center for Structural Biology. Use of the Advanced Photon Source was funded by the U.S. Department of Energy (under contract no. DE-AC02-06CH11357), and use of the LS-CAT Sector 21 was funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (085P1000817). D.M.M. is the founder of Virule, a company formed to commercialize H84T BanLec. This work is dedicated to the memory of Dr. John Hilfinger, who taught D.M.M. to appreciate biochemistry.	Aman AT, 2001, P NATL ACAD SCI USA, V98, P8536, DOI 10.1073/pnas.161273098; Andre S, 2015, MOLECULES, V20, P1788, DOI 10.3390/molecules20021788; Borrebaeck C.A.K., 1989, ADV LECTIN RES, V2, P1; Boyd W. C., 1954, THE PROTEINS 2, V2, P756; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Ferir G, 2011, ANTIVIR RES, V90, P200, DOI 10.1016/j.antiviral.2011.03.188; Gabius HJ, 2015, TRENDS BIOCHEM SCI, V40, P360, DOI 10.1016/j.tibs.2015.03.013; Gabius HJ, 2015, TRENDS BIOCHEM SCI, V40, P341, DOI 10.1016/j.tibs.2015.04.003; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Kaltner H, 2012, HISTOL HISTOPATHOL, V27, P397, DOI 10.14670/HH-27.397; Khan JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062428; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Markwick PRL, 2011, PHYS CHEM CHEM PHYS, V13, P20053, DOI 10.1039/c1cp22100k; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Mo HQ, 2001, EUR J BIOCHEM, V268, P2609, DOI 10.1046/j.1432-1327.2001.02148.x; Murphy PV, 2013, MOLECULES, V18, P4026, DOI 10.3390/molecules18044026; Nakamura-Tsuruta S, 2008, FEBS J, V275, P1227, DOI 10.1111/j.1742-4658.2008.06282.x; Ng WC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732191; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Reyes-del Valle J, 2012, J VIROL, V86, P11558, DOI 10.1128/JVI.01776-12; Ruiz FM, 2014, FEBS J, V281, P1446, DOI 10.1111/febs.12716; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Singh DD, 2005, GLYCOBIOLOGY, V15, P1025, DOI 10.1093/glycob/cwi087; Singh SS, 2014, MOLECULES, V19, P18817, DOI 10.3390/molecules191118817; Smee DF, 2008, ANTIVIR RES, V80, P266, DOI 10.1016/j.antiviral.2008.06.003; Solis D, 2015, BBA-GEN SUBJECTS, V1850, P186, DOI 10.1016/j.bbagen.2014.03.016; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Winter HC, 2005, GLYCOBIOLOGY, V15, P1043, DOI 10.1093/glycob/cwi074; Zhang SD, 2015, P NATL ACAD SCI USA, V112, P5585, DOI 10.1073/pnas.1506220112; Zhang SD, 2015, ANGEW CHEM INT EDIT, V54, P4036, DOI 10.1002/anie.201410882	36	74	76	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					746	758		10.1016/j.cell.2015.09.056	http://dx.doi.org/10.1016/j.cell.2015.09.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496612	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000364828900026
J	Vanderburg, A; Johnson, JA; Rappaport, S; Bieryla, A; Irwin, J; Lewis, JA; Kipping, D; Brown, WR; Dufour, P; Ciardi, DR; Angus, R; Schaefer, L; Latham, DW; Charbonneau, D; Beichman, C; Eastman, J; McCrady, N; Wittenmyer, RA; Wright, JT				Vanderburg, Andrew; Johnson, John Asher; Rappaport, Saul; Bieryla, Allyson; Irwin, Jonathan; Lewis, John Arban; Kipping, David; Brown, Warren R.; Dufour, Patrick; Ciardi, David R.; Angus, Ruth; Schaefer, Laura; Latham, David W.; Charbonneau, David; Beichman, Charles; Eastman, Jason; McCrady, Nate; Wittenmyer, Robert A.; Wright, Jason T.			A disintegrating minor planet transiting a white dwarf	NATURE			English	Article							EXCESS INFRARED RADIATION; DEBRIS DISKS; DUSTY DISK; FREQUENCY; SYSTEMS; GD-362; CANDIDATE; ACCRETION; ASTEROIDS; DIFFUSION	Most stars become white dwarfs after they have exhausted their nuclear fuel (the Sun will be one such). Between one-quarter and one-half of white dwarfs have elements heavier than helium in their atmospheres(1,2), even though these elements ought to sink rapidly into the stellar interiors (unless they are occasionally replenished) (3-5). The abundance ratios of heavy elements in the atmospheres of white dwarfs are similar to the ratios in rocky bodies in the Solar System(6,7). This fact, together with the existence of warm, dusty debris disks(8-13) surrounding about four per cent of white dwarfs(14-16), suggests that rocky debris from the planetary systems of white-dwarf progenitors occasionally pollutes the atmospheres of the stars(17). The total accreted mass of this debris is sometimes comparable to the mass of large asteroids in the Solar System(1). However, rocky, disintegrating bodies around a white dwarf have not yet been observed. Here we report observations of a white dwarf-WD 1145+017-being transited by at least one, and probably several, disintegrating planetesimals, with periods ranging from 4.5 hours to 4.9 hours. The strongest transit signals occur every 4.5 hours and exhibit varying depths (blocking up to 40 per cent of the star's brightness) and asymmetric profiles, indicative of a small object with a cometary tail of dusty effluent material. The star has a dusty debris disk, and the star's spectrum shows prominent lines from heavy elements such as magnesium, aluminium, silicon, calcium, iron, and nickel. This system provides further evidence that the pollution of white dwarfs by heavy elements might originate from disrupted rocky bodies such as asteroids and minor planets.	[Vanderburg, Andrew; Johnson, John Asher; Bieryla, Allyson; Irwin, Jonathan; Lewis, John Arban; Kipping, David; Brown, Warren R.; Angus, Ruth; Schaefer, Laura; Latham, David W.; Charbonneau, David; Eastman, Jason] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rappaport, Saul] MIT, Dept Phys, Cambridge, MA 02139 USA; [Rappaport, Saul] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Kipping, David] Columbia Univ, Dept Astron, New York, NY 10027 USA; [Dufour, Patrick] Univ Montreal, Dept Phys, Inst Rech Exoplanetes, Montreal, PQ H3C 3J7, Canada; [Ciardi, David R.; Beichman, Charles] CALTECH, NASA, Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Angus, Ruth] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [McCrady, Nate] Univ Montana, Dept Phys & Astron, Missoula, MT 59812 USA; [Wittenmyer, Robert A.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Wittenmyer, Robert A.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW 2052, Australia; [Wright, Jason T.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Wright, Jason T.] Penn State Univ, Ctr Exoplanets & Habitable Worlds, University Pk, PA 16802 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Columbia University; Universite de Montreal; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of Oxford; University of Montana System; University of Montana; University of New South Wales Sydney; University of New South Wales Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Vanderburg, A (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	avanderburg@cfa.harvard.edu	Vanderburg, Andrew/AAF-6208-2021	Vanderburg, Andrew/0000-0001-7246-5438; Bieryla, Allyson/0000-0001-6637-5401; Wright, Jason/0000-0001-6160-5888; Schaefer, Laura/0000-0003-2915-5025; Lewis, John/0000-0001-5199-3522; Kipping, David/0000-0002-4365-7366; Ciardi, David/0000-0002-5741-3047; Latham, David/0000-0001-9911-7388	National Science Foundation Graduate Research Fellowship [DGE 1144152]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; David and Lucile Packard Fellowship for Science and Engineering; National Science Foundation [AST-0807690, AST-1109468, AST-1004488]; John Templeton Foundation; Division Of Astronomical Sciences [1516242] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; David and Lucile Packard Fellowship for Science and Engineering(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank B. Croll, D. Veras, M. Holman, R. Loomis, J. Becker, K. Deck, H. Schlichting, H. Lin, A. Loeb, and D. Osip for discussions and assistance. We thank C. Allinson, S. Dillet, D. Frostig, A. Johnson, D. Hellstrom, S. Johnson, B. Peak, and T. Reneau for conducting MINERVA observations. We thank M. Wyatt for suggesting how to present Supplementary Fig. 8. A.V. is supported by a National Science Foundation Graduate Research Fellowship (grant DGE 1144152). J. A. J. is supported by grants from the David and Lucile Packard Foundation and the Alfred P. Sloan Foundation. The Center for Exoplanets and Habitable Worlds is supported by Pennsylvania State University, the Eberly College of Science, and the Pennsylvania Space Grant Consortium. The MEarth Team acknowledges funding from the David and Lucile Packard Fellowship for Science and Engineering (to D. C.), the National Science Foundation under grants AST-0807690, AST-1109468, and AST-1004488 (Alan T. Waterman Award), and a grant from the John Templeton Foundation. The opinions expressed here are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. This research has made use of NASA's Astrophysics Data System, the SIMBAD database and VizieR catalog access tool operated at the Centre de Donnees astronomiques de Strasbourg, France. Some of the data presented here were obtained from the Mikulski Archive for Space Telescopes (MAST). This paper includes data from the Kepler/K2 mission, the Wide-field Infrared Survey Explorer, the MMT Observatory, the Sloan Digital Sky Survey (SDSS-III), the National Geographic Society Palomar Observatory Sky Atlas (POSS-I) and the W.M. Keck Observatory. MINERVA is made possible by contributions from its collaborating institutions and Mt Cuba Astronomical Foundation, the David and Lucile Packard Foundation, the National Aeronautics and Space Administration, and the Australian Research Council. We acknowledge the cultural significance of the summit of Maunakea within the indigenous Hawai'ian community. We are grateful for the opportunity to conduct observations from this mountain.	AANNESTAD PA, 1993, ASTRON J, V105, P1033, DOI 10.1086/116491; Barber SD, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/26; Becklin EE, 2005, ASTROPHYS J, V632, pL119, DOI 10.1086/497826; Croll B, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/100; Davidsson BJR, 1999, ICARUS, V142, P525, DOI 10.1006/icar.1999.6214; Debes JH, 2002, ASTROPHYS J, V572, P556, DOI 10.1086/340291; Farihi J, 2008, ASTROPHYS J, V674, P431, DOI 10.1086/521715; Farihi J, 2013, SCIENCE, V342, P218, DOI 10.1126/science.1239447; Farihi J, 2009, ASTROPHYS J, V694, P805, DOI 10.1088/0004-637X/694/2/805; Jura M, 2007, ASTRON J, V133, P1927, DOI 10.1086/512734; Jura M, 2003, ASTROPHYS J, V584, pL91, DOI 10.1086/374036; Kilic M, 2005, ASTROPHYS J, V632, pL115, DOI 10.1086/497825; Kilic M, 2006, ASTROPHYS J, V646, P474, DOI 10.1086/504682; Koester D, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423691; Koester D, 2009, ASTRON ASTROPHYS, V498, P517, DOI 10.1051/0004-6361/200811468; Kovacs G, 2002, ASTRON ASTROPHYS, V391, P369, DOI 10.1051/0004-6361:20020802; Lin HW, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L43; PAQUETTE C, 1986, ASTROPHYS J SUPPL S, V61, P197, DOI 10.1086/191112; Perez-Becker D, 2013, MON NOT R ASTRON SOC, V433, P2294, DOI 10.1093/mnras/stt895; Rappaport S, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/1; Rappaport S, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/40; Rappaport S, 2013, ASTROPHYS J LETT, V773, DOI 10.1088/2041-8205/773/1/L15; Rocchetto M, 2015, MON NOT R ASTRON SOC, V449, P574, DOI 10.1093/mnras/stv282; Sanchis-Ojeda R., 2015, PREPRINT; Vanderburg A, 2014, PUBL ASTRON SOC PAC, V126, P948, DOI 10.1086/678764; Veras D, 2015, MON NOT R ASTRON SOC, V452, P1945, DOI 10.1093/mnras/stv1417; Veras D, 2014, MON NOT R ASTRON SOC, V445, P2244, DOI 10.1093/mnras/stu1871; Zuckerman B, 2007, ASTROPHYS J, V671, P872, DOI 10.1086/522223; ZUCKERMAN B, 1987, NATURE, V330, P138, DOI 10.1038/330138a0; Zuckerman B, 2010, ASTROPHYS J, V722, P725, DOI 10.1088/0004-637X/722/1/725	30	288	290	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					546	549		10.1038/nature15527	http://dx.doi.org/10.1038/nature15527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490620	Green Accepted, Green Submitted			2022-12-28	WOS:000364026100044
J	Fekete, T				Fekete, Thomas			Review: Dutasteride, fesoterodine, and finasteride are beneficial for lower urinary tract symptoms in older patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022						0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC7	10.7326/ACPJC-2015-163-8-007	http://dx.doi.org/10.7326/ACPJC-2015-163-8-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502144				2022-12-28	WOS:000363737400008
J	Kirshner, HS				Kirshner, Howard S.			A risk calculator based on self-reported information predicted 5-year mortality in adults in the UK	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University	Kirshner, HS (corresponding author), Vanderbilt Univ, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.							Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P300; McGee DL, 1999, AM J EPIDEMIOL, V149, P41	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC13	10.7326/ACPJC-2015-163-8-013	http://dx.doi.org/10.7326/ACPJC-2015-163-8-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502138				2022-12-28	WOS:000363737400014
J	Emanuel, EJ				Emanuel, Ezekiel J.			Reform of Clinical Research Regulations, Finally	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.							Department of Homeland Security, 2015, FED REGISTER, V80, P53942; Emanuel EJ, 2004, ANN INTERN MED, V141, P282, DOI 10.7326/0003-4819-141-4-200408170-00008; Kingdon J.W., 1995, AGENDA ALTERNATIVES; Porter JP., 2008, OXFORD TXB CLIN RES, P156	4	18	18	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2296	2299		10.1056/NEJMp1512463	http://dx.doi.org/10.1056/NEJMp1512463			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CY0QW	26536071				2022-12-28	WOS:000366111600002
J	Boualem, A; Troadec, C; Camps, C; Lemhemdi, A; Morin, H; Sari, MA; Fraenkel-Zagouri, R; Kovalski, I; Dogimont, C; Perl-Treves, R; Bendahmane, A				Boualem, Adnane; Troadec, Christelle; Camps, Celine; Lemhemdi, Afef; Morin, Halima; Sari, Marie-Agnes; Fraenkel-Zagouri, Rina; Kovalski, Irina; Dogimont, Catherine; Perl-Treves, Rafael; Bendahmane, Abdelhafid			A cucurbit androecy gene reveals how unisexual flowers develop and dioecy emerges	SCIENCE			English	Article							CUCUMBER CUCUMIS-SATIVUS; SEX DETERMINATION; EVOLUTION; GYNODIOECY; MONOECY; PLANTS; LEADS; MELON	Understanding the evolution of sex determination in plants requires identifying the mechanisms underlying the transition from monoecious plants, where male and female flowers coexist, to unisexual individuals found in dioecious species. We show that in melon and cucumber, the androecy gene controls female flower development and encodes a limiting enzyme of ethylene biosynthesis, ACS11. ACS11 is expressed in phloem cells connected to flowers programmed to become female, and ACS11 loss-of-function mutants lead to male plants (androecy). CmACS11 represses the expression of the male promoting gene CmWIP1 to control the development and the coexistence of male and female flowers in monoecious species. Because monoecy can lead to dioecy, we show how a combination of alleles of CmACS11 and CmWIP1 can create artificial dioecy.	[Boualem, Adnane; Troadec, Christelle; Camps, Celine; Lemhemdi, Afef; Morin, Halima; Bendahmane, Abdelhafid] Univ Paris Sud, Univ Evry, Univ Paris Diderot, CNRS,Inst Plant Sci Paris Saclay,INRA,, Batiment 630, F-91405 Orsay, France; [Sari, Marie-Agnes] Univ Paris 05, CNRS, UMR 8601, Lab Chim & Biochim Pharmacol & Toxicol, Paris, France; [Fraenkel-Zagouri, Rina; Kovalski, Irina; Perl-Treves, Rafael] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Dogimont, Catherine] INRA, UR 1052, Unite Genet & Ameliorat Fruits & Legumes, BP 94, F-84143 Montfavet, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Bar Ilan University; INRAE	Bendahmane, A (corresponding author), Univ Paris Sud, Univ Evry, Univ Paris Diderot, CNRS,Inst Plant Sci Paris Saclay,INRA,, Batiment 630, F-91405 Orsay, France.	bendahm@evry.inra.fr	Herrero, Carlos Camps/L-3073-2017; Boualem, Adnane/ABC-5019-2021	Herrero, Carlos Camps/0000-0002-0648-5403; Boualem, Adnane/0000-0003-4428-6496; TROADEC, Christelle/0000-0003-1927-7352; Catherine, DOGIMONT/0000-0001-7399-768X	Plant Biology and Breeding department in INRA; grants Program Saclay Plant Sciences (SPS) [ANR-10-LABX-40]; Inititiative d'Excellence Paris-Saclay [Lidex-3P, ANR-11-IDEX-0003-02]; L'Agence Nationale de la Recherche MELODY [ANR-11-BSV7-0024]; European Research Council (ERC-SEXYPARTH)	Plant Biology and Breeding department in INRA; grants Program Saclay Plant Sciences (SPS); Inititiative d'Excellence Paris-Saclay; L'Agence Nationale de la Recherche MELODY(French National Research Agency (ANR)); European Research Council (ERC-SEXYPARTH)(European Research Council (ERC))	We thank P. Audigier, F. Vion, N. Giovinazzo, and V. Sarnette for plant care; S. Renner, S. Grant, and G. Marais for critical comments on the manuscript; and V. Gomez-Roldan and C. Clepet for helpful discussions on the manuscript. This work was supported by the Plant Biology and Breeding department in INRA, the grants Program Saclay Plant Sciences (SPS, ANR-10-LABX-40), Inititiative d'Excellence Paris-Saclay (Lidex-3P, ANR-11-IDEX-0003-02), L'Agence Nationale de la Recherche MELODY (ANR-11-BSV7-0024), and the European Research Council (ERC-SEXYPARTH). We declare no financial conflicts of interest in relation to this work. Gene sequences of CsACS11 and CmACS11 have been deposited into GenBank (accession nos. KT715743 and KT715744). A provisional patent (WO/2013/107632) has been deposited by A. Be., A.Bo., and C.T. that covers the use of the androecy gene for cucurbit breeding. The described material can be obtained from A. Be. under a materials transfer agreement with INRA. The supplementary materials contain additional data.	Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH D, 1978, HEREDITY, V41, P137, DOI 10.1038/hdy.1978.83; Kocyan A, 2007, MOL PHYLOGENET EVOL, V44, P553, DOI 10.1016/j.ympev.2006.12.022; KUBICKI B, 1969, GENET POL, V10, P101; Law TF, 2002, AM J BOT, V89, P1014, DOI 10.3732/ajb.89.6.1014; Lewis D, 1942, BIOL REV CAMB PHILOS, V17, P46, DOI 10.1111/j.1469-185X.1942.tb00431.x; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Renner SS, 2014, AM J BOT, V101, P1588, DOI 10.3732/ajb.1400196; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Tang ML, 2012, STAT METHODS MED RES, V21, P331, DOI 10.1177/0962280210381176; Turgeon R, 2010, P NATL ACAD SCI USA, V107, P13201, DOI 10.1073/pnas.1008134107	16	133	145	10	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					688	691		10.1126/science.aac8370	http://dx.doi.org/10.1126/science.aac8370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542573				2022-12-28	WOS:000364162800053
J	Bender, E				Bender, Eric			Big data in biomedicine: 4 big questions	NATURE			English	Editorial Material																			0	15	16	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					S19	S19		10.1038/527S19a	http://dx.doi.org/10.1038/527S19a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536221	Bronze			2022-12-28	WOS:000364270700058
J	Mertens, J; Wang, QW; Kim, Y; Yu, DX; Pham, S; Yang, B; Zheng, Y; Diffenderfer, KE; Zhang, J; Soltani, S; Eames, T; Schafer, ST; Boyer, L; Marchetto, MC; Nurnberger, JI; Calabrese, JR; Odegaard, KJ; McCarthy, MJ; Zandi, PP; Alba, M; Nievergelt, CM; Mi, SL; Brennand, KJ; Kelsoe, JR; Gage, FH; Yao, J				Mertens, Jerome; Wang, Qiu-Wen; Kim, Yongsung; Yu, Diana X.; Pham, Son; Yang, Bo; Zheng, Yi; Diffenderfer, Kenneth E.; Zhang, Jian; Soltani, Sheila; Eames, Tameji; Schafer, Simon T.; Boyer, Leah; Marchetto, Maria C.; Nurnberger, John I.; Calabrese, Joseph R.; Odegaard, Ketil J.; McCarthy, Michael J.; Zandi, Peter P.; Alba, Martin; Nievergelt, Caroline M.; Mi, Shuangli; Brennand, Kristen J.; Kelsoe, John R.; Gage, Fred H.; Yao, Jun		Pharmacogenomics Bipolar Disorder	Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder	NATURE			English	Article							PROTEIN-KINASE-C; PYRAMIDAL NEURONS; RECEPTOR; NEUROBIOLOGY; BEHAVIOR; BRAIN; MODEL	Bipolar disorder is a complex neuropsychiatric disorder that is characterized by intermittent episodes of mania and depression; without treatment, 15% of patients commit suicide(1). Hence, it has been ranked by the World Health Organization as a top disorder of morbidity and lost productivity(2). Previous neuropathological studies have revealed a series of alterations in the brains of patients with bipolar disorder or animal models', such as reduced glial cell number in the prefrontal cortex of patients(4), upregulated activities of the protein kinase A and C pathways(5-7) and changes in neurotransmission(8-11). However, the roles and causation of these changes in bipolar disorder have been too complex to exactly determine the pathology of the disease. Furthermore, although some patients show remarkable improvement with lithium treatment for yet unknown reasons, others are refractory to lithium treatment. Therefore, developing an accurate and powerful biological model for bipolar disorder has been a challenge. The introduction of induced pluripotent stem-cell (iPSC) technology has provided a new approach. Here we have developed an iPSC model for human bipolar disorder and investigated the cellular phenotypes of hippocampal dentate gyrus-like neurons derived from iPSCs of patients with bipolar disorder. Guided by RNA sequencing expression profiling, we have detected mitochondrial abnormalities in young neurons from patients with bipolar disorder by using mitochondrial assays; in addition, using both patch-clamp recording and somatic Ca2+ imaging, we have observed hyperactive action-potential firing. This hyperexcitability phenotype of young neurons in bipolar disorder was selectively reversed by lithium treatment only in neurons derived from patients who also responded to lithium treatment. Therefore, hyperexcitability is one early endophenotype of bipolar disorder, and our model of iPSCs in this disease might be useful in developing new therapies and drugs aimed at its clinical treatment.	[Mertens, Jerome; Wang, Qiu-Wen; Yang, Bo; Zheng, Yi; Yao, Jun] Tsinghua Univ, Sch Life Sci, McGovern Inst Brain Res, State Key Lab Membrane Biol,Tsinghua Peking Joint, Beijing 100084, Peoples R China; [Mertens, Jerome; Kim, Yongsung; Yu, Diana X.; Pham, Son; Soltani, Sheila; Eames, Tameji; Schafer, Simon T.; Boyer, Leah; Marchetto, Maria C.; Gage, Fred H.; Yao, Jun] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Diffenderfer, Kenneth E.] Salk Inst Biol Studies, Stem Cell Core, La Jolla, CA 92037 USA; [Zhang, Jian; Mi, Shuangli] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genom & Precis Med, Beijing 100101, Peoples R China; [Nurnberger, John I.] Indiana Univ, Dept Psychiat, Indianapolis, IN 46202 USA; [Calabrese, Joseph R.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Odegaard, Ketil J.] Univ Bergen, Dept Psychiat, N-5020 Bergen, Norway; [McCarthy, Michael J.; Kelsoe, John R.] VA San Diego Healthcare Syst, Dept Psychiat, La Jolla, CA 92151 USA; [McCarthy, Michael J.; Nievergelt, Caroline M.; Kelsoe, John R.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Zandi, Peter P.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21218 USA; [Alba, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS B3H 2E2, Canada; [Brennand, Kristen J.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Yao, Jun] Jiangsu Normal Univ, Jiangsu Collaborat Innovat Ctr Language Abil, Xuzhou 221009, Peoples R China	Tsinghua University; Salk Institute; Salk Institute; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University; University of Bergen; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Johns Hopkins University; Dalhousie University; Icahn School of Medicine at Mount Sinai; Jiangsu Normal University	Yao, J (corresponding author), Tsinghua Univ, Sch Life Sci, McGovern Inst Brain Res, State Key Lab Membrane Biol,Tsinghua Peking Joint, Beijing 100084, Peoples R China.	jkelsoe@ucsd.edu; gage@salk.edu; jyao@mail.tsinghua.edu.cn	Alda, Martin/F-5812-2010; Brennand, Kristen J/U-5470-2019; Wang, Qiuwen/AAN-6521-2020; Brennand, Kristen J/J-8704-2012; McCarthy, Michael/K-9302-2017; Mertens, Jerome/P-1931-2015	Alda, Martin/0000-0001-9544-3944; Brennand, Kristen J/0000-0003-0993-5956; McCarthy, Michael/0000-0001-6219-4945; Mertens, Jerome/0000-0002-4291-4121; Boyer, Leah/0000-0002-0546-4344; Nievergelt, Caroline/0000-0001-5766-8923; Schafer, Simon/0000-0002-2370-3652; Nurnberger, John/0000-0002-7674-1767; Zheng, Yi/0000-0002-5230-0254; Yao, Jun/0000-0002-4916-3412; mi, shuang li/0000-0001-8883-3215	National Natural Science Foundation of China [31471020, 31161120358, 31123004]; National Basic Research Program of China [2015CB910603, 2011CB510106]; Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences; Engmann Foundation; JPB Foundation; Helmsley Trust; Mather's Foundation; Glenn Foundation for Aging Research; National Institute of Health [MH106056]; New York Stem Cell Foundation - Robertson Award; National Institute of Mental Health [U01 MH92758]; Department of Veterans Affairs [5I01CX000363]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106056, R01MH101454, U01MH092758] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000363] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences; Engmann Foundation; JPB Foundation; Helmsley Trust; Mather's Foundation; Glenn Foundation for Aging Research; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation - Robertson Award; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	We thank the patients who participated in this study. We thank M. Ku for help in the RNA-seq analysis, and L. McHenry, D. Lisuk and C. Bardy for help with the somatic Ca<SUP>2+</SUP> imaging experiments. We thank L. Moore, E. Mejia, B. Miller, R. Wright, T. Berggren and S. Lu for technical assistance. We also thank C. O'Connor for help on flow cytometry. This work was supported by the National Natural Science Foundation of China (grant numbers 31471020, 31161120358, 31123004), the National Basic Research Program of China (2015CB910603, 2011CB510106), the Open Project of Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences, by the Engmann Foundation, the JPB Foundation, the Helmsley Trust, the Mather's Foundation, the Glenn Foundation for Aging Research, by National Institute of Health grant MH106056 (K.J.B.), New York Stem Cell Foundation - Robertson Award (K.J.B.), and by grants/contracts to J.R.K. from the National Institute of Mental Health (U01 MH92758) supporting the Pharmacogenomics of Bipolar Disorder Study and from the Department of Veterans Affairs (5I01CX000363). K.J.B. is a New York Stem Cell Foundation - Robertson Investigator. J.Y. is an Investigator of the Young Thousand Talents Program of China.	Andreazza AC, 2014, INT J NEUROPSYCHOPH, V17, P1039, DOI 10.1017/S1461145713000096; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Bertolino A, 2003, BIOL PSYCHIAT, V53, P906, DOI 10.1016/S0006-3223(02)01911-X; Bezchlibnyk Y, 2002, CAN J PSYCHIAT, V47, P135, DOI 10.1177/070674370204700203; Chang A, 2003, MOL BRAIN RES, V116, P27, DOI 10.1016/S0169-328X(03)00211-0; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Coque L, 2011, NEUROPSYCHOPHARMACOL, V36, P1478, DOI 10.1038/npp.2011.33; Deicken RF, 2003, AM J PSYCHIAT, V160, P873, DOI 10.1176/appi.ajp.160.5.873; Du J, 2004, NEURON GLIA BIOL, V1, P231, DOI 10.1017/S1740925X05000098; Dusetzina SB, 2012, PSYCHIAT SERV, V63, P1019, DOI 10.1176/appi.ps.201100516; Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Kobayashi M, 2008, NEUROSCI LETT, V430, P175, DOI 10.1016/j.neulet.2007.10.047; Mahmood T, 2001, J AFFECT DISORDERS, V66, P1, DOI 10.1016/S0165-0327(00)00226-3; Marazziti D, 2012, EUR REV MED PHARMACO, V16, P270; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martinowich K, 2009, J CLIN INVEST, V119, P726, DOI 10.1172/JCI37703; Scarr E, 2003, BIPOLAR DISORD, V5, P257, DOI 10.1034/j.1399-5618.2003.00024.x; SHARMA R, 1994, J AFFECT DISORDERS, V31, P91, DOI 10.1016/0165-0327(94)90112-0; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Szulczyk B, 2012, ACTA NEUROBIOL EXP, V72, P351; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang HY, 2001, BIOL PSYCHIAT, V50, P364, DOI 10.1016/S0006-3223(01)01147-7; Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuste Rafael, 2011, Cold Spring Harb Protoc, V2011, P985, DOI 10.1101/pdb.prot5650	27	301	309	14	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					95	99		10.1038/nature15526	http://dx.doi.org/10.1038/nature15526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26524527	Green Submitted, Green Accepted			2022-12-28	WOS:000364270700050
J	Maynard, H				Maynard, Heather			CHEMICAL BIOLOGY Protein modification in a trice	NATURE			English	Editorial Material							THERAPEUTICS; CANCER		[Maynard, Heather] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Maynard, Heather] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Maynard, H (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	maynard@chem.ucla.edu						Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a; Antos JM, 2006, CURR OPIN CHEM BIOL, V10, P253, DOI 10.1016/j.cbpa.2006.04.009; Boutureira O, 2015, CHEM REV, V115, P2174, DOI 10.1021/cr500399p; Chari RVJ, 2014, ANGEW CHEM INT EDIT, V53, P3796, DOI 10.1002/anie.201307628; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; He Y., 2015, ONCOGENE; Lyon RP, 2014, NAT BIOTECHNOL, V32, P1059, DOI 10.1038/nbt.2968; Vinogradova EV, 2015, NATURE, V526, P687, DOI 10.1038/nature15739; Wu AM, 2014, METHODS, V65, P139, DOI 10.1016/j.ymeth.2013.09.015	10	4	5	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					646	647		10.1038/526646b	http://dx.doi.org/10.1038/526646b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511575				2022-12-28	WOS:000363832100035
J	Lind, M; Hirsch, IB; Tuomilehto, J; Dahlqvist, S; Ahren, B; Torffvit, O; Attvall, S; Ekelund, M; Filipsson, K; Tengmark, BO; Sjoberg, S; Pehrsson, NG				Lind, Marcus; Hirsch, Irl B.; Tuomilehto, Jaakko; Dahlqvist, Sofia; Ahren, Bo; Torffvit, Ole; Attvall, Stig; Ekelund, Magnus; Filipsson, Karin; Tengmark, Bengt-Olov; Sjoberg, Stefan; Pehrsson, Nils-Gunnar			Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ONCE-DAILY LIXISENATIDE; GLYCEMIC CONTROL; BASAL INSULIN; EUROPEAN ASSOCIATION; POSITION STATEMENT; ADDING LIRAGLUTIDE; PARALLEL-GROUP; EXENATIDE; WEIGHT; INCRETIN	STUDY QUESTION What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections? METHODS The study was a randomised, double blind, placebo controlled trial with a parallel group design carried out at 13 hospital based outpatient clinics and one primary care unit in Sweden. Patients were considered eligible for inclusion if they had type 2 diabetes and inadequate glycaemic control (HbA1c concentrations >= 58 mmol/mol (7.5%) and <= 102 mmol/mol (11.5%)), a body mass index of 27.5-45 kg/m(2), and required multiple daily insulin injections. Overall, 124 participants were randomised 1: 1 to subcutaneous liraglutide or placebo by minimisation allocation. The main outcome measure was change in HbA1c level from baseline to week 24. STUDY ANSWER AND LIMITATIONS Liraglutide was associated with a significant reduction of 16.9 mmol/mol (1.5%) in HbA1c versus 4.6 mmol/mol (0.4%) for placebo, difference -12.3 mmol/mol (95% confidence interval -15.8 to -8.8 mmol/mol; -1.13%, -1.45 to -0.81 mmol/mol). Body weight was significantly reduced in participants in the liraglutide compared with placebo group (3.8 v 0.0 kg, difference -3.8, -4.9 to -2.8 kg), and total daily insulin doses were significantly reduced, by 18.1 units and 2.3 units (difference -15.8, -23.1 to -8.5 units). Reductions in mean and standard deviation of glucose levels estimated by masked continuous glucose monitoring were significantly greater in the liraglutide group than placebo group (-1.9 and -0.5 mmol/L). Neither group experienced severe hypoglycaemic events nor were there any significant differences in symptomatic or asymptomatic non-severe hypoglycaemia (<4.0 or <3.0 mmol/L). The mean number of non-severe symptomatic hypoglycaemic events (<4.0 mmol/L) during follow-up was 1.29 in the liraglutide group and 1.24 in the placebo group (P=0.96). One of the study's limitations was its relatively short duration. Sustained effects of liraglutide have, however, been found over lengthier periods in connection with other treatment regimens. Cardiovascular safety and potential adverse events during longer exposure to liraglutide need to be evaluated. Nausea was experienced by 21 (32.8%) participants in the liraglutide group and 5 (7.8%) in the placebo group and 3 (5%) and 4 (7%) participants in these groups, respectively, had any serious adverse event. WHAT THIS STUDY ADDS Adding liraglutide to multiple daily insulin injections in people with type 2 diabetes improves glycaemic control without an increased risk of hypoglycaemia, reduces body weight, and enables patients to lower their insulin doses.	[Lind, Marcus; Attvall, Stig] Univ Gothenburg, Inst Med, Gothenburg, Sweden; [Lind, Marcus; Dahlqvist, Sofia] NU Hosp Grp, Uddevalla Hosp, Dept Med, S-45180 Uddevalla, Sweden; [Hirsch, Irl B.] Univ Washington, Seattle, WA 98195 USA; [Tuomilehto, Jaakko] Danube Univ, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Ahren, Bo; Torffvit, Ole; Ekelund, Magnus; Filipsson, Karin] Lund Univ, Lund, Sweden; [Tengmark, Bengt-Olov] Citydiabetes, Stockholm, Sweden; [Sjoberg, Stefan] Karolinska Inst, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Sjoberg, Stefan] Halland Cty Hosp, Dept Med, Halmstad, Sweden; [Pehrsson, Nils-Gunnar] Stat Konsultgrp, Gothenburg, Sweden	University of Gothenburg; NU Hospital Group; University of Washington; University of Washington Seattle; Danube University Krems; Finland National Institute for Health & Welfare; King Abdulaziz University; Lund University; Karolinska Institutet; Karolinska University Hospital	Lind, M (corresponding author), Univ Gothenburg, Inst Med, Gothenburg, Sweden.	lind.marcus@telia.com	Lind, Marcus/AAI-6733-2021; Lind, Marcus/GRJ-4946-2022	Lind, Marcus/0000-0002-3796-9283; Attvall, Stig/0000-0003-2163-2341; Sjoberg, Stefan/0000-0001-6467-9284	Novo Nordisk; NordicInfu Care	Novo Nordisk(Novo Nordisk); NordicInfu Care	The current study was an investigator initiated trial, where Novo Nordisk provided financial support and study drugs but had no role in the design or execution of the trial; the interpretation, analysis, or publication of data; or the decision to submit the written report. NordicInfu Care provided continuous glucose monitoring systems and support.	Ahren B, 2014, WORLD J DIABETES, V5, P40, DOI 10.4239/wjd.v5.i1.40; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2015, NAT RIKTL DIAB; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2011, ANN INTERN MED, V154, P103, DOI 10.7326/0003-4819-154-2-201101180-00300; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Childs BP, 2005, DIABETES CARE, V28, P1245; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Fonseca V, 2007, DIABETOLOGIA, V50, P1148, DOI 10.1007/s00125-007-0633-0; Fujiwara D, 2013, J DIABETES INVEST, V4, P618, DOI 10.1111/jdi.12103; Garber A, 2011, DIABETES OBES METAB, V13, P348, DOI 10.1111/j.1463-1326.2010.01356.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hegedus L, 2011, J CLIN ENDOCR METAB, V96, P853, DOI 10.1210/jc.2010-2318; Hirsch IB, 2009, J CLIN ENDOCR METAB, V94, P2232, DOI 10.1210/jc.2008-2625; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kothny W, 2013, DIABETES OBES METAB, V15, P252, DOI 10.1111/dom.12020; Lind M, 2012, DIABETOLOGIA, V55, P2946, DOI 10.1007/s00125-012-2681-3; Lind M, 2015, PRIM CARE DIABETES, V9, P15, DOI 10.1016/j.pcd.2014.07.010; Lind M, 2014, DIABETOLOGIA, V57, P1586, DOI 10.1007/s00125-014-3250-8; Lind M, 2012, PRIM CARE DIABETES, V6, P187, DOI 10.1016/j.pcd.2012.04.006; Lind M, 2012, PRIM CARE DIABETES, V6, P41, DOI 10.1016/j.pcd.2011.09.002; Marso SP, 2013, AM HEART J, V166, P823, DOI 10.1016/j.ahj.2013.07.012; Marso SP, 2011, DIABETES VASC DIS RE, V8, P237, DOI 10.1177/1479164111408937; Mathieu C, 2014, DIABETES OBES METAB, V16, P636, DOI 10.1111/dom.12262; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pfeffer MA, 2015, S 75 SCI SESS AM DIA; Pi-Sunyer FX, 2009, POSTGRAD MED, V121, P94, DOI 10.3810/pgm.2009.09.2056; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Riddle MC, 2013, DIABETES CARE, V36, P2497, DOI 10.2337/dc12-2462; Robinson LE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001986; Rosenstock J, 2007, DIABETES CARE, V30, P2972, DOI 10.2337/dc07-1592; Rosenstock J, 2014, DIABETES CARE, V37, P2317, DOI 10.2337/dc14-0001; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vilsboll T, 2010, DIABETES OBES METAB, V12, P167, DOI 10.1111/j.1463-1326.2009.01173.x; Yki-Jarvinen H, 2013, DIABETES CARE, V36, P3875, DOI 10.2337/dc12-2718	41	52	52	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2015	351								h5364	10.1136/bmj.h5364	http://dx.doi.org/10.1136/bmj.h5364			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IK	26512041	Green Published, hybrid			2022-12-28	WOS:000364152500001
J	[Anonymous]				[Anonymous]			The Cleveland Museum of Health (Reprinted from JAMA, vol 115, pg 1457-1458, 1940)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1940, JAMA, V115, P1457	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1761	1761		10.1001/jama.2014.12056	http://dx.doi.org/10.1001/jama.2014.12056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505610				2022-12-28	WOS:000363706300034
J	Lloyd, K				Lloyd, Karen			Beyond known methanogens	SCIENCE			English	Editorial Material							ARCHAEA; METABOLISM		Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Lloyd, K (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	klloyd@utk.edu						Battistuzzi F. U., 2004, BMC EVOLUTIONARY BIO, V14, P1; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Evans PN, 2015, SCIENCE, V350, P434, DOI 10.1126/science.aac7745; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Meng J, 2014, ISME J, V8, P650, DOI 10.1038/ismej.2013.174; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Ritter D, 2015, INT J COAL GEOL, V146, P28, DOI 10.1016/j.coal.2015.04.013; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	11	11	12	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					384	384		10.1126/science.aad4066	http://dx.doi.org/10.1126/science.aad4066			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494746				2022-12-28	WOS:000363213400023
J	Rosenberg, AB; Patwardhan, RP; Shendure, J; Seelig, G				Rosenberg, Alexander B.; Patwardhan, Rupali P.; Shendure, Jay; Seelig, Georg			Learning the Sequence Determinants of Alternative Splicing from Millions of Random Sequences	CELL			English	Article							SYSTEMATIC IDENTIFICATION; REGULATORY SEQUENCES; RNA; ENHANCERS; DEFINITION; ELEMENTS; MOTIFS; DISSECTION; SILENCERS; SELECTION	Most human transcripts are alternatively spliced, and many disease-causing mutations affect RNA splicing. Toward better modeling the sequence determinants of alternative splicing, we measured the splicing patterns of over two million (M) synthetic mini-genes, which include degenerate subsequences totaling over 100 M bases of variation. The massive size of these training data allowed us to improve upon current models of splicing, as well as to gain new mechanistic insights. Our results show that the vast majority of hexamer sequence motifs measurably influence splice site selection when positioned within alternative exons, with multiple motifs acting additively rather than cooperatively. Intriguingly, motifs that enhance (suppress) exon inclusion in alternative 50 splicing also enhance (suppress) exon inclusion in alternative 30 or cassette exon splicing, suggesting a universal mechanism for alternative exon recognition. Finally, our empirically trained models are highly predictive of the effects of naturally occurring variants on alternative splicing in vivo.	[Rosenberg, Alexander B.; Seelig, Georg] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Patwardhan, Rupali P.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Seelig, Georg] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Seelig, G (corresponding author), Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA.	gseelig@uw.edu	Shendure, Jay/AAU-3684-2021	Rosenberg, Alexander/0000-0003-2276-2412	National Science Foundation (NSF) [0954566]; Burroughs Wellcome Career Award at the Scientific Interface	National Science Foundation (NSF)(National Science Foundation (NSF)); Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund)	This work was supported by a National Science Foundation (NSF) Career Award (0954566) and a Burroughs Wellcome Career Award at the Scientific Interface (to G.S.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Culler SJ, 2010, NUCLEIC ACIDS RES, V38, P5152, DOI 10.1093/nar/gkq248; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Q., 2012, P INT C MACH LEARN; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mercer TR, 2015, GENOME RES, V25, P290, DOI 10.1101/gr.182899.114; Noderer WL, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145136; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2013, NAT STRUCT MOL BIOL, V20, P36, DOI 10.1038/nsmb.2459; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu Y, 2008, CELL, V135, P1224, DOI 10.1016/j.cell.2008.10.046; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	44	120	124	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					698	711		10.1016/j.cell.2015.09.054	http://dx.doi.org/10.1016/j.cell.2015.09.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496609	Bronze			2022-12-28	WOS:000364828900022
J	Beard, JR; Officer, A; de Carvalho, IA; Sadana, R; Pot, AM; Michel, JP; Lloyd-Sherlock, P; Epping-Jordan, JE; Peeters, GMEE; Mahanani, WR; Thiyagarajan, JA; Chatterji, S				Beard, John R.; Officer, Alana; de Carvalho, Islene Araujo; Sadana, Ritu; Pot, Anne Margriet; Michel, Jean-Pierre; Lloyd-Sherlock, Peter; Epping-Jordan, JoAnne E.; Peeters, G. M. E. E. (Geeske); Mahanani, Wahyu Retno; Thiyagarajan, Jotheeswaran Amuthavalli; Chatterji, Somnath			The World report on ageing and health: a policy framework for healthy ageing	LANCET			English	Article							LIFE EXPECTANCY; ELDERLY-PEOPLE; OLDER PERSONS; TRENDS; POPULATION; DISABILITY; COUNTRIES; FRAILTY; MULTIMORBIDITY; CARE	Although populations around the world are rapidly ageing, evidence that increasing longevity is being accompanied by an extended period of good health is scarce. A coherent and focused public health response that spans multiple sectors and stakeholders is urgently needed. To guide this global response, WHO has released the first World report on ageing and health, reviewing current knowledge and gaps and providing a public health framework for action. The report is built around a redefinition of healthy ageing that centres on the notion of functional ability: the combination of the intrinsic capacity of the individual, relevant environmental characteristics, and the interactions between the individual and these characteristics. This Health Policy highlights key findings and recommendations from the report.	[Beard, John R.; Officer, Alana; de Carvalho, Islene Araujo; Sadana, Ritu; Pot, Anne Margriet; Thiyagarajan, Jotheeswaran Amuthavalli] World Hlth Org, Ageing & Life Course, CH-1206 Geneva, Switzerland; [Mahanani, Wahyu Retno; Chatterji, Somnath] World Hlth Org, Hlth Stat & Informat Syst, Geneva, Switzerland; [Epping-Jordan, JoAnne E.] World Hlth Org, Geneva, Switzerland; [Michel, Jean-Pierre] Univ Geneva, Geneva, Switzerland; [Lloyd-Sherlock, Peter] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [Peeters, G. M. E. E. (Geeske)] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	World Health Organization; World Health Organization; World Health Organization; University of Geneva; University of East Anglia; University of Queensland	Beard, JR (corresponding author), World Hlth Org, Ageing & Life Course, CH-1206 Geneva, Switzerland.	beardj@who.int	Beard, John/AAI-4592-2021; CHATTERJI, Somnath/ABE-6832-2020; Peeters, Geeske/AAB-9102-2021; Peeters, Geeske/G-3314-2010; Beard, John R/K-9621-2014; Beard, John/AAP-5388-2021	Beard, John/0000-0002-8557-0242; Peeters, Geeske/0000-0003-4460-7026; Beard, John R/0000-0002-8557-0242; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; Pot, Anne Margriet/0000-0003-2917-4322; Lloyd-Sherlock, Peter/0000-0002-1367-0703	WHO [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479, R21-AG034263]; US National Institute on Ageing; Australian National Health and Medical Research Council centre for research excellence grant [APP1000986]; NATIONAL INSTITUTE ON AGING [R01AG034479, R21AG034263] Funding Source: NIH RePORTER	WHO(World Health Organization); US National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Australian National Health and Medical Research Council centre for research excellence grant(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The views expressed in this paper are those of the authors and do not necessarily reflect the views of WHO. We acknowledge the significant contributions of the many other people who participated in the production of the World report on ageing and health (appendix). We are particularly grateful for the editorial guidance provided by Flavia Bustreo, Anne Marie Worning, Anarfi Asamoa-Baah, and Andrew Cassels; the contributions of the other members of the core writing group Lisa Warth, Norah Keating, Aki Kuroda, and Alison Harvey; the authors of the 19 background papers; and the large number of people who gave direct administrative or technical inputs. SAGE is supported by WHO and the US National Institute on Ageing through interagency agreements with WHO (OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01) and through research grants (R01-AG034479, R21-AG034263). GMEEP was funded by the Australian National Health and Medical Research Council centre for research excellence grant (APP1000986)	Age Wave SunAmerica, 2011, AG WAV SUNAMERICA AG; [Anonymous], WORLD HLTH SURV 2002; [Anonymous], 2007, TRENDS SEVERE DISABI; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beard J., 2015, WORLD REPORT AGEING; Beard JR, 2015, LANCET, V385, P658, DOI 10.1016/S0140-6736(14)61461-6; Bloom DE, 2011, SCIENCE, V333, P562, DOI 10.1126/science.1209290; Cesari M, 2015, J GERONTOL A-BIOL, V70, P216, DOI 10.1093/gerona/glu099; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Cheng ER, 2012, PREV CHRONIC DIS, V9, pE75; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; CSDH, 2008, CLOS GAP GEN HLTH EQ; Eklund K, 2009, HEALTH SOC CARE COMM, V17, P447, DOI 10.1111/j.1365-2524.2009.00844.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gaspar D., 2007, J SOCIO-ECON, V36, DOI [10.1016/j.socec.2006.12.001, DOI 10.1016/J.SOCEC.2006.12.001]; Ham C, 2010, HEALTH ECON POLICY L, V5, P71, DOI 10.1017/S1744133109990120; Harttgen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075847; Hearps AC, 2014, CURR HIV-AIDS REP, V11, P20, DOI 10.1007/s11904-013-0190-8; HRS, 2010, HLTH RET STUD; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Liao YL, 2001, J AM GERIATR SOC, V49, P443, DOI 10.1046/j.1532-5415.2001.49089.x; Lin SF, 2012, AM J PUBLIC HEALTH, V102, P2157, DOI 10.2105/AJPH.2011.300602; Lloyd-Sherlock P, 2012, LANCET, V379, P1295, DOI 10.1016/S0140-6736(12)60519-4; Lordos EF, 2008, REJUV RES, V11, P829, DOI 10.1089/rej.2008.0721; Low G, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-146; Low LF, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-93; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; Sourdet S, 2015, J AM MED DIR ASSOC, V16, P674, DOI 10.1016/j.jamda.2015.03.011; Stewart ST, 2013, AM J PUBLIC HEALTH, V103, pE78, DOI 10.2105/AJPH.2013.301250; UNDESA, 2007, WORLD EC SOC SURV 20; WHO, 2013, GLOB HLTH EST LIF EX; WHO, 2013, GLOB HLTH EST DEATHS; WHO, 2015, AG FRIENDL WORLD; WHO, WHO STUD GLOB AGEING; Wu Y-T, 2015, LANCET NEUROL	49	892	929	52	304	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2145	2154		10.1016/S0140-6736(15)00516-4	http://dx.doi.org/10.1016/S0140-6736(15)00516-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM6HC	26520231	Green Accepted			2022-12-28	WOS:000376450800038
J	Siu, AL				Siu, Albert L.		US Preventive Services Task Force	Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED FASTING GLUCOSE; LIFE-STYLE INTERVENTION; ALL-CAUSE MORTALITY; LOW-DOSE ASPIRIN; FOLLOW-UP; CARDIOVASCULAR OUTCOMES; PRESSURE CONTROL; ADDITION-EUROPE; PEOPLE; TOLERANCE	Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. Methods: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. Population: This recommendation applies to adults aged 40 to 70 years seen in primary care settings who do not have symptoms of diabetes and are overweight or obese. Recommendation: The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (B recommendation)	[Siu, Albert L.; US Preventive Services Task Force] US Prevent Serv Task Force, Rockville, MD USA		Siu, AL (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.							American Academy of Family Physicians, 2008, CLIN PREV SERV REC D; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Araki A, 2012, GERIATR GERONTOL INT, V12, P7, DOI 10.1111/j.1447-0594.2011.00808.x; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Colagiuri S, 2009, NATL EVIDENCE BASED; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Dagenais GR, 2008, DIABETES CARE, V31, P1007, DOI 10.2337/dc07-1868; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; De Berardis G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4531; Diabetes UK, 2014, EARL ID PEOPL TYP 2; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hemmingsen B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub3; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Howard BV, 2008, JAMA-J AM MED ASSOC, V299, P1678, DOI 10.1001/jama.299.14.1678; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Mortaz S, 2012, CLINICOECONOMIC OUTC, V4, P91, DOI 10.2147/CEOR.S30547; Nijpels G, 2008, DIABETES-METAB RES, V24, P611, DOI 10.1002/dmrr.839; Paddison CAM, 2011, BRIT J HEALTH PSYCH, V16, P213, DOI 10.1348/135910710X495366; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Pottie K, 2012, CAN MED ASSOC J, V184, P1687, DOI 10.1503/cmaj.120732; Rahman M, 2012, DIABETIC MED, V29, P886, DOI 10.1111/j.1464-5491.2012.03570.x; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Selph S, 2014, AHRQ PUBLICATION; Selph S, 2015, ANN INTERN MED, V162, P765, DOI 10.7326/M14-2221; Simmons RK, 2012, DIABETIC MED, V29, pE409, DOI 10.1111/j.1464-5491.2012.03759.x; Simmons RK, 2011, DIABETOLOGIA, V54, P312, DOI 10.1007/s00125-010-1949-8; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Stavrakis S, 2011, AM J MED SCI, V341, P1, DOI 10.1097/MAJ.0b013e3181f1fba8; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tajima N, 2008, ATHEROSCLEROSIS, V199, P455, DOI 10.1016/j.atherosclerosis.2008.05.027; Takahashi O, 2010, DIABETES CARE, V33, P2016, DOI 10.2337/dc10-0588; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959	51	197	199	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11					861	+		10.7326/M15-2345	http://dx.doi.org/10.7326/M15-2345			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26501513				2022-12-28	WOS:000365866500009
J	Clevers, H; Firestein, S; Ringrose, L; Bernards, R; Darwin, KH; Vance, RE				Clevers, Hans; Firestein, Stuart; Ringrose, Leonie; Bernards, Rene; Darwin, K. Heran; Vance, Russell E.			Radical Sabbaticals	CELL			English	Editorial Material									[Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Firestein, Stuart] Columbia Univ, New York, NY 10027 USA; [Ringrose, Leonie] Humboldt Univ, Utrecht, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Utrecht, Netherlands; [Darwin, K. Heran; Vance, Russell E.] NYU, Med Ctr, New York, NY 10003 USA; [Darwin, K. Heran; Vance, Russell E.] Univ Calif, Berkeley HHMI, Berkeley, CA USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Columbia University; Netherlands Cancer Institute; New York University; University of California System; University of California Berkeley	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.		Ringrose, Leonie/AAV-4734-2021	Bernards, Rene/0000-0001-8677-3423; Darwin, K Heran/0000-0002-5043-7548					0	2	2	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					788	789						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544929	Bronze			2022-12-28	WOS:000364829700003
J	Piou, T; Rovis, T				Piou, Tiffany; Rovis, Tomislav			Rhodium-catalysed syn-carboamination of alkenes via a transient directing group	NATURE			English	Article							C-H ACTIVATION; FUNCTIONALIZATION; HYDROAMINATION	Alkenes are the most ubiquitous prochiral functional groups-those that can be converted from achiral to chiral in a single step that are accessible to synthetic chemists. For this reason, difunctionalization reactions of alkenes (whereby two functional groups are added to the same double bond) are particularly important, as they can be used to produce highly complex molecular architectures(1,2). Stereoselective oxidation reactions, including dihydroxylation, aminohydroxylation and halogenation(3-6), are well established methods for functionalizing alkenes. However, the intermolecular incorporation of both carbon- and nitrogen-based functionalities stereoselectively across an alkene has not been reported. Here we describe the rhodium-catalysed carboamination of alkenes at the same (syn) face of a double bond, initiated by a carbon-hydrogen activation event that uses enoxyphthalimides as the source of both the carbon and the nitrogen functionalities. The reaction methodology allows for the intermolecular, stereospecific formation of one carbon-carbon and one carbon-nitrogen bond across an alkene, which is, to our knowledge, unprecedented. The reaction design involves the in situ generation of a bidentate directing group and the use of a new cyclopentadienyl ligand to control the reactivity of rhodium. The results provide a new way of synthesizing functionalized alkenes, and should lead to the convergent and stereoselective assembly of amine-containing acyclic molecules.	[Piou, Tiffany; Rovis, Tomislav] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Rovis, T (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	rovis@colostate.edu			National Institute of General Medical Sciences [GM80442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080442] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of General Medical Sciences (grant no. GM80442) for support. We thank Johnson Matthey for rhodium salts, and J. Chu and B. Newell (at Colorado State University) for solving X-ray structures.	Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048; Beller M, 2004, ANGEW CHEM INT EDIT, V43, P3368, DOI 10.1002/anie.200300616; Berkesell A., 2005, ASYMMETRIC ORGANOCAT; Chemler SR, 2013, ACS CATAL, V3, P1076, DOI 10.1021/cs400138b; Coldham I, 2005, CHEM REV, V105, P2765, DOI 10.1021/cr040004c; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Hennecke U, 2012, CHEM-ASIAN J, V7, P456, DOI 10.1002/asia.201100856; Hyster TK, 2011, CHEM SCI, V2, P1606, DOI 10.1039/c1sc00235j; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, P1309; Mai DN, 2010, J AM CHEM SOC, V132, P12157, DOI 10.1021/ja106989h; McDonald RI, 2011, CHEM REV, V111, P2981, DOI 10.1021/cr100371y; Mo JY, 2015, SYNTHESIS-STUTTGART, V47, P439, DOI 10.1055/s-0034-1379890; Nakamura I, 2004, CHEM REV, V104, P2127, DOI 10.1021/cr020095i; Neely JM, 2013, J AM CHEM SOC, V135, P66, DOI 10.1021/ja3104389; Piou T, 2014, J AM CHEM SOC, V136, P11292, DOI 10.1021/ja506579t; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Shen XQ, 2010, ANGEW CHEM INT EDIT, V49, P564, DOI 10.1002/anie.200905402; Tan CK, 2014, CHIRALITY, V26, P328, DOI 10.1002/chir.22272; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Webb NJ, 2014, ORG LETT, V16, P4718, DOI 10.1021/ol502095z; Weidner K, 2010, J AM CHEM SOC, V132, P17511, DOI 10.1021/ja1068036; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208; Wolfe J. P., 2013, TOP HETEROCYCL CHEM, V32, P1, DOI [10.1007/7081_2012_98, DOI 10.1007/7081_2012_98]; Zeng W, 2007, J AM CHEM SOC, V129, P12948, DOI 10.1021/ja0762240; Zhang HW, 2013, ANGEW CHEM INT EDIT, V52, P2529, DOI 10.1002/anie.201209142; Zhou JR, 2008, J AM CHEM SOC, V130, P12220, DOI 10.1021/ja803523z	26	164	162	6	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					86	90		10.1038/nature15691	http://dx.doi.org/10.1038/nature15691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26503048	Green Accepted			2022-12-28	WOS:000364270700048
J	Savage, N				Savage, Neil			Proteomics: High-protein research	NATURE			English	Editorial Material																		Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Ezkurdia I, 2014, J PROTEOME RES, V13, P3854, DOI 10.1021/pr500572z; Horvatovich P, 2015, J PROTEOME RES, V14, P3415, DOI 10.1021/pr5013009; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319	5	7	7	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					S6	S7		10.1038/527S6a	http://dx.doi.org/10.1038/527S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB5XK	26536224	Bronze			2022-12-28	WOS:000415924500001
J	Yu, FX; Zhao, B; Guan, KL				Yu, Fa-Xing; Zhao, Bin; Guan, Kun-Liang			Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer	CELL			English	Review							TUMOR-SUPPRESSOR PATHWAY; YES-ASSOCIATED PROTEIN; STEM-CELL PROLIFERATION; AMPK-MEDIATED REGULATION; GENOME-WIDE ASSOCIATION; SIGNALING PATHWAY; EFFECTOR YAP; CARDIOMYOCYTE PROLIFERATION; UVEAL MELANOMA; EPITHELIOID HEMANGIOENDOTHELIOMA	Two decades of studies in multiple model organisms have established the Hippo pathway as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ transcription co-activators, the Hippo pathway regulates cell proliferation, apoptosis, and stemness in response to a wide range of extracellular and intracellular signals, including cell-cell contact, cell polarity, mechanical cues, ligands of G-protein-coupled receptors, and cellular energy status. Dysregulation of the Hippo pathway exerts a significant impact on cancer development. Further investigation of the functions and regulatory mechanisms of this pathway will help uncovering the mystery of organ size control and identify new targets for cancer treatment.	[Yu, Fa-Xing] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Yu, Fa-Xing] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Zhao, Bin] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Zhejiang University; Zhejiang University; University of California System; University of California San Diego; University of California System; University of California San Diego	Yu, FX (corresponding author), Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China.	fxyu@fudan.edu.cn; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Yu, Fa-Xing/0000-0003-4834-9335	NIH [CA196878, CA132809, DE015964, EY022611, GM51586]; "Thousand Youth Talents," Shanghai "Oriental Scholar"; NSFC [31571479, 31422036, 31271508, 31471316]; State Key Development Program for Basic Research of China [2013CB945303]; NSF of Zhejiang [LR12C07001]; NATIONAL CANCER INSTITUTE [R35CA196878, R01CA132809, R01CA108941] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Thousand Youth Talents," Shanghai "Oriental Scholar"; NSFC(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); NSF of Zhejiang(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.-L.G. is supported by grants from NIH (CA196878, CA132809, DE015964, EY022611, GM51586). F.-X.Y. is supported by grants from "Thousand Youth Talents," Shanghai "Oriental Scholar," and NSFC (31571479). B.Z. is supported by grants from NSFC (31422036, 31271508, 31471316), State Key Development Program for Basic Research of China (2013CB945303), and the NSF of Zhejiang (LR12C07001). We thank Jean Guan, Hyun Woo Park, and Steven Plouffe for critical reading of the manuscript.	Antonescu CR, 2013, GENE CHROMOSOME CANC, V52, P775, DOI 10.1002/gcc.22073; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Benham-Pyle BW, 2015, SCIENCE, V348, P1024, DOI 10.1126/science.aaa4559; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Cai J, 2015, GENE DEV, V29, P1493, DOI 10.1101/gad.264515.115; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chaulk SG, 2014, J BIOL CHEM, V289, P1886, DOI 10.1074/jbc.C113.529362; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen HY, 2015, J CLIN ONCOL, V33, P2303, DOI 10.1200/JCO.2014.59.3590; Chen Q, 2015, GENE DEV, V29, P1285, DOI 10.1101/gad.264234.115; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Codelia VA, 2014, CURR BIOL, V24, P2012, DOI 10.1016/j.cub.2014.07.034; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Dai XM, 2015, CELL RES, V25, P1175, DOI 10.1038/cr.2015.101; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Deng H, 2015, ELIFE, V4, DOI 10.7554/eLife.06567; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Errani C, 2011, GENE CHROMOSOME CANC, V50, P644, DOI 10.1002/gcc.20886; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Fletcher GC, 2015, EMBO J, V34, P940, DOI 10.15252/embj.201489642; Flucke U, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-131; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Gailite I, 2015, P NATL ACAD SCI USA, V112, pE5169, DOI 10.1073/pnas.1505512112; Gao T, 2013, GASTROENTEROLOGY, V144, P1543, DOI 10.1053/j.gastro.2013.02.037; Gao YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5629; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; George NM, 2012, MOL CELL BIOL, V32, P5116, DOI 10.1128/MCB.01034-12; Gong R, 2015, CELL RES, V25, P985, DOI 10.1038/cr.2015.88; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Grijalva JL, 2014, AM J PHYSIOL-GASTR L, V307, pG196, DOI 10.1152/ajpgi.00077.2014; Guo T, 2013, CELL RES, V23, P1201, DOI 10.1038/cr.2013.120; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Judson RN, 2012, J CELL SCI, V125, P6009, DOI 10.1242/jcs.109546; Jukam D, 2013, SCIENCE, V342, P211, DOI 10.1126/science.1238016; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kono K, 2014, DEV BIOL, V394, P142, DOI 10.1016/j.ydbio.2014.06.023; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lavado A, 2013, DEVELOPMENT, V140, P3323, DOI 10.1242/dev.096537; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Q, 2014, DEV CELL, V31, P291, DOI 10.1016/j.devcel.2014.09.012; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Lin CW, 2015, DEV BIOL, V403, P101, DOI 10.1016/j.ydbio.2015.04.014; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Lin ZQ, 2014, CIRC RES, V115, P354, DOI 10.1161/CIRCRESAHA.115.303632; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu G, 2015, ONCOGENE, V34, P3536, DOI 10.1038/onc.2014.281; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P3372, DOI 10.1167/iovs.09-4321; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lorthongpanich C, 2013, GENE DEV, V27, P1441, DOI 10.1101/gad.219618.113; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Mahoney JE, 2014, DEV CELL, V30, P137, DOI 10.1016/j.devcel.2014.06.003; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mi W, 2015, ONCOGENE, V34, P3095, DOI 10.1038/onc.2014.251; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mitani A, 2009, AM J RESP CRIT CARE, V180, P326, DOI 10.1164/rccm.200812-1827OC; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2013, CELL REP, V3, P309, DOI 10.1016/j.celrep.2013.01.008; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Porazinski S, 2015, NATURE, V521, P217, DOI 10.1038/nature14215; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qing Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02564; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sasaki H., 2015, SEMIN CELL DEV BIOL, VS1084-9521, P00100; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schrauwen I, 2015, INVEST OPHTH VIS SCI, V56, P3896, DOI 10.1167/iovs.14-16261; Sekido Y, 2011, PATHOL INT, V61, P331, DOI 10.1111/j.1440-1827.2011.02666.x; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Sharma P, 2013, PROG MOL BIOL TRANSL, V116, P215, DOI 10.1016/B978-0-12-394311-8.00010-8; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shen SY, 2015, CELL RES, V25, P997, DOI 10.1038/cr.2015.98; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Su T, 2015, ELIFE, V4, DOI 10.7554/eLife.02948; Tanas MR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002409; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Watt KI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7048; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Williamson KA, 2014, AM J HUM GENET, V94, P295, DOI 10.1016/j.ajhg.2014.01.001; Wong KKL, 2015, J BIOL CHEM, V290, P6397, DOI 10.1074/jbc.M114.629493; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xiang LS, 2014, ONCOTARGET, V5, P12509, DOI 10.18632/oncotarget.2997; Xiao GH, 2003, GENE CHROMOSOME CANC, V38, P389, DOI 10.1002/gcc.10282; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; XU TA, 1995, DEVELOPMENT, V121, P1053; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2015, ANNU REV PHYSIOL, V77, P201, DOI 10.1146/annurev-physiol-021014-071733; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Yu T, 2013, GENETICS, V195, P1193, DOI 10.1534/genetics.113.156372; Yue T, 2012, DEV CELL, V22, P255, DOI 10.1016/j.devcel.2011.12.011; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573	205	1263	1308	21	332	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					811	828		10.1016/j.cell.2015.10.044	http://dx.doi.org/10.1016/j.cell.2015.10.044			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544935	Green Accepted, Bronze			2022-12-28	WOS:000364829700009
J	Burke, JF; Sussman, JB; Kent, DM; Hayward, RA				Burke, James F.; Sussman, Jeremy B.; Kent, David M.; Hayward, Rodney A.			Three simple rules to ensure reasonably credible subgroup analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED-TRIALS; TIME; ANGIOPLASTY; CREDIBILITY; MORTALITY	The limitations of subgroup analyses are well established-false positives due to multiple comparisons, false negatives due to inadequate power, and limited ability to inform individual treatment decisions because patients have multiple characteristics that vary simultaneously. In this article, we apply Bayes's rule to determine the probability that a positive subgroup analysis is a true positive. From this framework, we derive simple rules to determine when subgroup analyses can be performed as hypothesis testing analyses and thus inform when subgroup analyses should influence how we practice medicine.	[Burke, James F.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Burke, James F.; Sussman, Jeremy B.; Hayward, Rodney A.] VA Ctr Clin Management & Res, Ann Arbor, MI USA; [Sussman, Jeremy B.; Hayward, Rodney A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kent, David M.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA; [Kent, David M.] Tufts Univ, Sch Med, Tufts Med Ctr, Predict Analyt & Comparat Effectiveness Ctr, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tufts University; Tufts Medical Center; Tufts University	Burke, JF (corresponding author), Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA.	jamesbur@umich.edu	Sussman, Jeremy/W-3394-2019	Sussman, Jeremy/0000-0002-2158-3618	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS082597] Funding Source: NIH RePORTER; Veterans Affairs [IK2HX001368] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)		Alderman EL, 1996, NEW ENGL J MED, V335, P217; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Brookes S T, 2001, Health Technol Assess, V5, P1; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Chopra V, 2012, AM J MED, V125, pE1, DOI 10.1016/j.amjmed.2011.09.024; Daemen J, 2008, CIRCULATION, V118, P1146, DOI 10.1161/CIRCULATIONAHA.107.752147; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kahnemann D, 2013, THINKING FAST SLOW; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; SOX HC, 1986, ANN INTERN MED, V104, P60, DOI 10.7326/0003-4819-104-1-60; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Tukey JW, 1977, EXPLORATORY DATA ANA; Weiss CO, 2014, J GEN INTERN MED, V29, P653, DOI 10.1007/s11606-013-2660-5	23	116	118	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h5651	10.1136/bmj.h5651	http://dx.doi.org/10.1136/bmj.h5651			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OS	26537915	hybrid, Green Published			2022-12-28	WOS:000364390100006
J	Beyrer, C				Beyrer, Chris			The proper study of mankind	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu						Hopkins I, 2012, 14 DALAI LAMA KINDNE; Shantideva, 2008, GUIDE BODDHISATTVAS; Tenzin Gyatso HH, 2011, 14 DALAI LAMA MINDS; Williams William Carlos, 1967, AUTOBIOGRAPHY WC WIL	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1724	1725		10.1016/S0140-6736(15)61217-X	http://dx.doi.org/10.1016/S0140-6736(15)61217-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26545422				2022-12-28	WOS:000363974200018
J	Charness, G; Fehr, E				Charness, Gary; Fehr, Ernst			From the lab to the real world	SCIENCE			English	Editorial Material							ECONOMICS		[Charness, Gary] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA; [Fehr, Ernst] Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland	University of California System; University of California Santa Barbara; University of Zurich	Charness, G (corresponding author), Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA.	gary.charness@ucsb.edu; ernst.fehr@econ.uzh.ch						Banerjee A., 2011, POOR EC RADICAL RETH; Barmettler F, 2012, GAME ECON BEHAV, V75, P17, DOI 10.1016/j.geb.2011.09.003; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Camerer CF., 2015, HDB EXPT EC METHODOL; Charness G, 2011, HBK ECON, V4, P229, DOI 10.1016/S0169-7218(11)00409-6; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Herbst D, 2015, SCIENCE, V350, P545, DOI 10.1126/science.aac9555; Kessler J. B., 2015, HDB EXPT EC METHODOL; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; List JA, 2011, HBK ECON, V4, P103, DOI 10.1016/S0169-7218(11)00408-4; Samuelson P., 1985, ECONOMICS	13	18	18	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					512	513		10.1126/science.aad4343	http://dx.doi.org/10.1126/science.aad4343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU6RG	26516269				2022-12-28	WOS:000363660000029
J	Gies, E				Gies, Erica			Lazarus batteries	NATURE			English	Editorial Material																			0	27	28	5	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S100	S101		10.1038/526S100a	http://dx.doi.org/10.1038/526S100a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509947	Bronze			2022-12-28	WOS:000363832100028
J	Khosroshahi, A; Digumarthy, SR; Gibbons, FK; Deshpande, V				Khosroshahi, Arezou; Digumarthy, Subba R.; Gibbons, Fiona K.; Deshpande, Vikram			Case 34-2015: A 36-Year-Old Woman with a Lung Mass, Pleural Effusion, and Hip Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERDHEIM-CHESTER DISEASE; INFLAMMATORY MYOFIBROBLASTIC TUMOR; IGG4-RELATED DISEASE; RETROPERITONEAL FIBROSIS; MANIFESTATIONS; PERIAORTITIS		[Khosroshahi, Arezou] Emory Univ, Dept Med, Sch Med, Atlanta, GA 30322 USA; [Digumarthy, Subba R.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Gibbons, Fiona K.] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Deshpande, Vikram] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Digumarthy, Subba R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Gibbons, Fiona K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Deshpande, Vikram] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Emory University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Khosroshahi, A (corresponding author), Emory Univ, Dept Med, Sch Med, Atlanta, GA 30322 USA.				Affymetrix	Affymetrix	Dr. Deshpande reports receiving grant support to his institution from Affymetrix and holding a pending patent related to the detection of IgG4 and IgG with the use of in situ hybridization. No other potential conflict of interest relevant to this article was reported.	Antunes C, 2014, INSIGHTS IMAGING, V5, P473, DOI 10.1007/s13244-014-0331-7; Betancourt SL, 2010, AM J ROENTGENOL, V194, P103, DOI 10.2214/AJR.09.3040; Bhagat P, 2013, VIRCHOWS ARCH, V463, P743, DOI 10.1007/s00428-013-1493-2; Choi IH, 2014, TUBERC RESPIR DIS, V76, P42, DOI 10.4046/trd.2014.76.1.42; Coffin CM, 2001, MODERN PATHOL, V14, P569, DOI 10.1038/modpathol.3880352; CORDIER JF, 1990, CHEST, V97, P906, DOI 10.1378/chest.97.4.906; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; Fujinaga Y, 2010, EUR J RADIOL, V76, P228, DOI 10.1016/j.ejrad.2009.06.010; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Heo SH, 2014, RADIOGRAPHICS, V34, P19, DOI 10.1148/rg.341135077; Huggins JT, 2006, CHEST, V129, P1599, DOI 10.1378/chest.129.6.1599; Inoue D, 2011, RADIOLOGY, V261, P625, DOI 10.1148/radiol.11102250; Khosroshahi A, 2013, MEDICINE, V92, P82, DOI 10.1097/MD.0b013e318289610f; Mazor RD, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-137; Molloy CB, 2005, RHEUMATOLOGY, V44, P696, DOI 10.1093/rheumatology/keh604; Seth A, 2001, J UROLOGY, V166, P622, DOI 10.1016/S0022-5347(05)66007-7; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Takeda Shin-ichi, 2008, Interact Cardiovasc Thorac Surg, V7, P629, DOI 10.1510/icvts.2007.173476; Wallace ZS, 2014, SEMIN ARTHRITIS RHEU, V43, P806, DOI 10.1016/j.semarthrit.2013.11.008; Zen Y, 2010, AM J SURG PATHOL, V34, P1812, DOI 10.1097/PAS.0b013e3181f7266b; Zen Y, 2009, AM J SURG PATHOL, V33, P1833, DOI 10.1097/PAS.0b013e3181b72882	23	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1762	1772		10.1056/NEJMcpc1502151	http://dx.doi.org/10.1056/NEJMcpc1502151			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26510025				2022-12-28	WOS:000363514100013
J	Tedstone, AJ; Nienow, PW; Gourmelen, N; Dehecq, A; Goldberg, D; Hanna, E				Tedstone, Andrew J.; Nienow, Peter W.; Gourmelen, Noel; Dehecq, Amaury; Goldberg, Daniel; Hanna, Edward			Decadal slowdown of a land-terminating sector of the Greenland Ice Sheet despite warming	NATURE			English	Article							SURFACE MELT; MASS-BALANCE; ACCELERATION; DRAINAGE; GLACIER; SYSTEM; FLOW; VARIABILITY; EVOLUTION; ELEVATION	Ice flow along land-terminating margins of the Greenland Ice Sheet (GIS) varies considerably in response to fluctuating inputs of surface meltwater to the bed of the ice sheet. Such inputs lubricate the ice-bed interface, transiently speeding up the flow of ice(1,2). Greater melting results in faster ice motion during summer, but slower motion over the subsequent winter, owing to the evolution of an efficient drainage system that enables water to drain from regions of the ice-sheet bed that have a high basal water pressure(2,3). However, the impact of hydrodynamic coupling on ice motion over decadal timescales remains poorly constrained. Here we show that annual ice motion across an 8,000-km(2) land-terminating region of the west GIS margin, extending to 1,100 m above sea level, was 12% slower in 2007-14 compared with 198594, despite a 50% increase in surface meltwater production. Our findings suggest that, over these three decades, hydrodynamic coupling in this section of the ablation zone resulted in a net slow-down of ice motion (not a speed-up, as previously postulated(1)). Increases in meltwater production from projected climate warming may therefore further reduce the motion of land-terminating margins of the GIS. Our findings suggest that these sectors of the ice sheet are more resilient to the dynamic impacts of enhanced meltwater production than previously thought.	[Tedstone, Andrew J.; Nienow, Peter W.; Gourmelen, Noel; Dehecq, Amaury; Goldberg, Daniel] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Dehecq, Amaury] Univ Savoie Mt Blanc, Polytech Annecy Chambery, LISTIC, F-74944 Annecy Le Vieux, France; [Hanna, Edward] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England	University of Edinburgh; University of Sheffield	Tedstone, AJ (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland.	a.j.tedstone@ed.ac.uk	Hanna, Edward/W-5927-2019; Tedstone, Andrew/B-3573-2019; Dehecq, Amaury/ABD-3344-2020; Hanna, Edward/H-2219-2016	Hanna, Edward/0000-0002-8683-182X; Tedstone, Andrew/0000-0002-9211-451X; Dehecq, Amaury/0000-0002-5157-1183; Hanna, Edward/0000-0002-8683-182X	UK Natural Environment Research Council (NERC) [NE/152830X/1, NE/J500021/1]; Scottish Alliance for Geoscience, Environment and Society (SAGES) Postdoctoral/Early Career Researcher Exchange (PECRE) award; University of Edinburgh GeoSciences Moss scholarship; European Space Agency Dragon 3 [10302]; Centre National d'Etudes Spatiales; Natural Environment Research Council [1089772] Funding Source: researchfish	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Alliance for Geoscience, Environment and Society (SAGES) Postdoctoral/Early Career Researcher Exchange (PECRE) award; University of Edinburgh GeoSciences Moss scholarship; European Space Agency Dragon 3(European Space Agency); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.J.T. acknowledges UK Natural Environment Research Council (NERC) studentships NE/152830X/1 and NE/J500021/1, a Scottish Alliance for Geoscience, Environment and Society (SAGES) Postdoctoral/Early Career Researcher Exchange (PECRE) award, and a University of Edinburgh GeoSciences Moss scholarship. N.G. acknowledges European Space Agency Dragon 3 grant 10302, the Centre National d'Etudes Spatiales Tosca CESTENG project, and a fellowship from the Centre National d'Etudes Spatiales to A.D. This work made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF) (http://www.ecdf.ed.ac.uk/). We thank P. Huybrechts for his work on the runoff/retention model used in this study. The Landsat imagery was provided by the United States Geological Survey and the European Space Agency third party missions program.	Andrews LC, 2014, NATURE, V514, P80, DOI 10.1038/nature13796; Bartholomew ID, 2011, EARTH PLANET SC LETT, V307, P271, DOI 10.1016/j.epsl.2011.04.014; Box JE, 2009, J CLIMATE, V22, P4029, DOI 10.1175/2009JCLI2816.1; Chandler DM, 2013, NAT GEOSCI, V6, P195, DOI 10.1038/ngeo1737; Cowton T, 2013, J GEOPHYS RES-EARTH, V118, P29, DOI 10.1029/2012JF002540; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Dehecq A, 2015, REMOTE SENS ENVIRON, V162, P55, DOI 10.1016/j.rse.2015.01.031; Doyle SH, 2014, GEOPHYS RES LETT, V41, P899, DOI 10.1002/2013GL058933; Enderlin EM, 2014, GEOPHYS RES LETT, V41, P866, DOI 10.1002/2013GL059010; Fettweis X, 2013, CRYOSPHERE, V7, P241, DOI 10.5194/tc-7-241-2013; Hanna E, 2013, NATURE, V498, P51, DOI 10.1038/nature12238; Helm V, 2014, CRYOSPHERE, V8, P1539, DOI 10.5194/tc-8-1539-2014; Hoffman M., 2014, J GEOPHYS RES-EARTH, V119, P414; Howat IM, 2014, CRYOSPHERE, V8, P1509, DOI 10.5194/tc-8-1509-2014; Howat IM, 2010, J GLACIOL, V56, P601, DOI 10.3189/002214310793146232; HUBBARD BP, 1995, J GLACIOL, V41, P572, DOI 10.3189/S0022143000034894; Morlighem M, 2014, NAT GEOSCI, V7, P418, DOI [10.1038/NGEO2167, 10.1038/ngeo2167]; Parizek BR, 2004, QUATERNARY SCI REV, V23, P1013, DOI 10.1016/j.quascirev.2003.12.024; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Richards K, 1996, HYDROL PROCESS, V10, P479, DOI 10.1002/(SICI)1099-1085(199604)10:4&lt;479::AID-HYP406&gt;3.0.CO;2-D; Ru┬thlisberger H., 1972, J GLACIOL, V11, P177, DOI [10.3189/S0022143000022188, DOI 10.1017/S0022143000022188]; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Shannon SR, 2013, P NATL ACAD SCI USA, V110, P14156, DOI 10.1073/pnas.1212647110; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Sole A, 2008, CRYOSPHERE, V2, P205, DOI 10.5194/tc-2-205-2008; Sole A, 2013, GEOPHYS RES LETT, V40, P3940, DOI 10.1002/grl.50764; Tedstone AJ, 2013, P NATL ACAD SCI USA, V110, P19719, DOI 10.1073/pnas.1315843110; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; van de Wal RSW, 2015, CRYOSPHERE, V9, P603, DOI 10.5194/tc-9-603-2015; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	30	102	102	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					692	695		10.1038/nature15722	http://dx.doi.org/10.1038/nature15722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511580	Green Accepted			2022-12-28	WOS:000363832100046
J	Vinogradova, EV; Zhang, C; Spokoyny, AM; Pentelute, BL; Buchwald, SL				Vinogradova, Ekaterina V.; Zhang, Chi; Spokoyny, Alexander M.; Pentelute, Bradley L.; Buchwald, Stephen L.			Organometallic palladium reagents for cysteine bioconjugation	NATURE			English	Article							STRUCTURAL INSIGHTS; STAPLED PEPTIDES; COMPLEXES; CHEMISTRY; MALEIMIDE; PROTEINS	Reactions based on transition metals have found wide use in organic synthesis, in particular for the functionalization of small molecules(1,2). However, there are very few reports of using transition-metal-based reactions to modify complex biomolecules(3,4),, which is due to the need for stringent reaction conditions (for example, aqueous media, low temperature and mild pH) and the existence of multiple reactive functional groups found in biomolecules. Here we report that palladium(II) complexes can be used for efficient and highly selective cysteine conjugation (bioconjugation) reactions that are rapid and robust under a range of bio-compatible reaction conditions. The straightforward synthesis of the palladium reagents from diverse and easily accessible aryl halide and trifluoromethanesulfonate precursors makes the method highly practical, providing access to a large structural space for protein modification. The resulting aryl bioconjugates are stable towards acids, bases, oxidants and external thiol nucleo-philes. The broad utility of the bioconjugation platform was further corroborated by the synthesis of new classes of stapled peptides and antibody-drug conjugates. These palladium complexes show potential as benchtop reagents for diverse bioconjugation applications.	[Vinogradova, Ekaterina V.; Zhang, Chi; Spokoyny, Alexander M.; Pentelute, Bradley L.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Pentelute, BL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	blp@mit.edu; sbuchwal@mit.edu	Spokoyny, Alexander/V-3526-2019	Spokoyny, Alexander/0000-0002-5683-6240; /0000-0001-9519-7456	National Institutes of Health [GM-58160, GM-110535, 1F32GM101762]; MIT; Damon Runyon Cancer Research Foundation; Sontag Foundation; George Buchi Research Fellowship; Koch Graduate Fellowship in Cancer Research of MIT; NSF [CHE-9808061, CHE-0946721]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058160, R01GM110535, F32GM101762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT; Damon Runyon Cancer Research Foundation; Sontag Foundation; George Buchi Research Fellowship; Koch Graduate Fellowship in Cancer Research of MIT; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by the National Institutes of Health (GM-58160; GM-110535; postdoctoral fellowship for A.M.S., 1F32GM101762), the MIT start-up fund (B.L.P.), a Damon Runyon Cancer Research Foundation Award (B.L.P.) and the Sontag Foundation Distinguished Scientist Award (B.L.P.). C.Z. is the recipient of the George Buchi Research Fellowship and the Koch Graduate Fellowship in Cancer Research of MIT. We thank R. J. Collier (Harvard) for contributing select laboratory equipment used in this study. We thank the Biological Instrument Facility of MIT for providing the Octet BioLayer Interferometry System (NSF S10 OD016326). We are indebted to the NERCE facility (U54A1057159) for expressing the toxin proteins. We thank M. Lu and A. Rabideu for help with cell assays. The Varian 300 spectrometer used for portions of this work was purchased with funds from NSF (grant CHE-9808061). The departmental X-ray diffraction instrumentation was purchased with the help of funding from NSF (CHE-0946721). We are grateful to P. Muller (MIT) for X-ray crystallographic analysis of 1A-OTf center dot CH<INF>3</INF>CN and to A. Rancier (Merck) for the ICP-MS analysis.	[Anonymous], 2014, NAT CHEM BIOL, V10, P693; Antos JM, 2006, CURR OPIN CHEM BIOL, V10, P253, DOI 10.1016/j.cbpa.2006.04.009; ARORA N, 1994, INFECT IMMUN, V62, P4955, DOI 10.1128/IAI.62.11.4955-4961.1994; Barder TE, 2007, ORGANOMETALLICS, V26, P2183, DOI 10.1021/om0701017; Bird GH, 2014, ACS CHEM BIOL, V9, P831, DOI 10.1021/cb4003305; Bong DT, 2001, ORG LETT, V3, P2509, DOI 10.1021/ol016169e; Cal PMSD, 2014, ANGEW CHEM INT EDIT, V53, P10585, DOI 10.1002/anie.201405702; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Chari RVJ, 2014, ANGEW CHEM INT EDIT, V53, P3796, DOI 10.1002/anie.201307628; Cheng G, 2013, CHEM COMMUN, V49, P6809, DOI 10.1039/c3cc43479f; Crabtree RH, 2014, ORGANOMETALLIC CHEMISTRY OF THE TRANSITION METALS, 6TH EDITION, P1, DOI 10.1002/9781118788301; Diederich F., 2008, METAL CATALYZED CROS; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; GORIN G, 1966, ARCH BIOCHEM BIOPHYS, V115, P593, DOI 10.1016/0003-9861(66)90079-8; Korneeva EN, 1996, INORG CHIM ACTA, V243, P9, DOI 10.1016/0020-1693(95)04885-5; Kung KKY, 2014, CHEM COMMUN, V50, P11899, DOI 10.1039/c4cc04467c; Lau YH, 2015, CHEM SOC REV, V44, P91, DOI 10.1039/c4cs00246f; Lee CF, 2014, CHEM-ASIAN J, V9, P706, DOI 10.1002/asia.201301500; Lyon RP, 2014, NAT BIOTECHNOL, V32, P1059, DOI 10.1038/nbt.2968; Rabuka D, 2010, CURR OPIN CHEM BIOL, V14, P790, DOI 10.1016/j.cbpa.2010.09.020; Shafer DE, 2000, ANAL BIOCHEM, V282, P161, DOI 10.1006/abio.2000.4609; Simmons RL, 2011, J AM CHEM SOC, V133, P15870, DOI 10.1021/ja206339s; Spicer CD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5740; Spokoyny AM, 2013, J AM CHEM SOC, V135, P5946, DOI 10.1021/ja400119t; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Tilley SD, 2006, J AM CHEM SOC, V128, P1080, DOI 10.1021/ja057106k; Toda N, 2013, ANGEW CHEM INT EDIT, V52, P12592, DOI 10.1002/anie.201306241; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Yang MY, 2014, CHEM SOC REV, V43, P6511, DOI 10.1039/c4cs00117f	30	286	289	13	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					687	691		10.1038/nature15739	http://dx.doi.org/10.1038/nature15739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26511579	Green Accepted, Green Submitted			2022-12-28	WOS:000363832100045
J	Naci, H; Carter, AW; Mossialos, E				Naci, Huseyin; Carter, Alexander W.; Mossialos, Elias			Why the drug development pipeline is not delivering better medicines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESEARCH-AND-DEVELOPMENT; EFFICACY; COST; INNOVATION; SAFETY; FDA; PROMOTION; APPROVAL; MERGERS; GROWTH		[Naci, Huseyin; Mossialos, Elias] Univ London London Sch Econ & Polit Sci, Dept Social Policy, LSE Hlth, London WC2A 2AE, England; [Carter, Alexander W.] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England	University of London; London School Economics & Political Science; Imperial College London	Naci, H (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Social Policy, LSE Hlth, Houghton St, London WC2A 2AE, England.	h.naci@lse.ac.uk	Mossialos, Elias/ABE-1301-2021					[Anonymous], 2000, NEW ENGL J MED, V343, P1415; Barbui C, 2007, PSYCHOPHARMACOLOGY, V190, P265, DOI 10.1007/s00213-006-0629-3; Belleli R, 2015, NAT REV DRUG DISCOV, V14, P156, DOI 10.1038/nrd4563; Berndt ER, 2015, HEALTH AFFAIR, V34, P245, DOI 10.1377/hlthaff.2014.1029; Catlin A, 2007, HEALTH AFFAIR, V26, P142, DOI 10.1377/hlthaff.26.1.142; Chalkidou K, 2009, MILBANK Q, V87, P339, DOI 10.1111/j.1468-0009.2009.00560.x; Comanor WS, 2013, J HEALTH ECON, V32, P106, DOI 10.1016/j.jhealeco.2012.09.006; Danzon PM, 2007, MANAG DECIS ECON, V28, P307, DOI 10.1002/mde.1343; Demirel P, 2008, DOES MARKET SELECTIO; Dukes MNG, 2002, LANCET, V360, P1682, DOI 10.1016/S0140-6736(02)11599-6; Fojo T, 2014, JAMA OTOLARYNGOL, V140, P1225, DOI 10.1001/jamaoto.2014.1570; Frank C, 2014, HEALTH AFFAIR, V33, P1453, DOI 10.1377/hlthaff.2014.0122; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Garattini S, 2003, EUR J CLIN PHARMACOL, V59, P701, DOI 10.1007/s00228-003-0634-y; Garattini S, 2003, EUR J CLIN PHARMACOL, V59, P79, DOI 10.1007/s00228-003-0569-3; Garattini S, 2002, BMJ-BRIT MED J, V325, P269, DOI 10.1136/bmj.325.7358.269; Garnier JP, 2008, HARVARD BUS REV, V86, P68; Green JB, 2013, JAMA INTERN MED, V173, P229, DOI 10.1001/jamainternmed.2013.1529; Hwang TJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1429; IMS Institute for Healthcare Informatics, 1600, REV US MED US 2013; Jayadev A, 2009, HEALTH AFFAIR, V28, pW165, DOI 10.1377/hlthaff.28.1.w165; Kanavos Panos, 2014, Pharmaceut Med, V28, P245; Kesselheim AS, 2013, CLIN PHARMACOL THER, V94, P336, DOI 10.1038/clpt.2013.115; Kesselheim AS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4633; Kesselheim AS, 2013, NAT REV DRUG DISCOV, V12, P425, DOI 10.1038/nrd3977; Kesselheim AS, 2011, MILBANK Q, V89, P450, DOI 10.1111/j.1468-0009.2011.00636.x; KESSLER DA, 1994, NEW ENGL J MED, V331, P1350, DOI 10.1056/NEJM199411173312007; Lexchin J, 2012, HEALTH POLICY, V105, P221, DOI 10.1016/j.healthpol.2012.02.005; Light DW, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4897; Light DW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2068; Light DW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4348; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; Mazzucato M., 2013, ENTREPRENEURIAL STAT; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Morgan SG, 2005, BMJ-BRIT MED J, V331, P815, DOI 10.1136/bmj.38582.703866.AE; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Mossialos E., 2004, REGULATING PHARM EUR; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Naci H, 2014, HEALTH AFFAIR, V33, P1435, DOI 10.1377/hlthaff.2013.1067; Naci H, 2013, EUR J PREV CARDIOL, V20, P658, DOI 10.1177/2047487313483600; Naci H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4261; Nicod E, 2012, HEALTH POLICY, V108, P167, DOI 10.1016/j.healthpol.2012.09.012; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Rafols I, 2014, TECHNOL FORECAST SOC, V81, P22, DOI 10.1016/j.techfore.2012.06.007; Ravenscraft DJ, 2000, NBER CONF R, P287; Ruof J, 2014, EUR J HEALTH ECON, V15, P577, DOI 10.1007/s10198-013-0495-y; Sheppard A, 2010, GENERIC MED ESSENTIA; Statista, 2014, ASTRAZENECAS REV TOP; van Luijn JCF, 2010, EUR J CLIN PHARMACOL, V66, P445, DOI 10.1007/s00228-010-0808-3; Ward DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002088; WHO, 2014, NAT HLTH ACC DAT; Wilensky G, 2015, JAMA-J AM MED ASSOC, V314, P440, DOI 10.1001/jama.2015.8733	52	22	23	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2015	351								h5542	10.1136/bmj.h5542	http://dx.doi.org/10.1136/bmj.h5542			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3GL	26496934	Green Accepted, Green Published			2022-12-28	WOS:000364146900001
J	Gomez, N				Gomez, Natalya			Small glacier has big effect on sea-level rise	NATURE			English	Editorial Material							ICE-SHEET; THWAITES	Models of the West Antarctic Ice Sheet predict substantial ice loss over the next few centuries - and that a glacier expected to contribute greatly to sea-level rise may already be unstable.	McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A OE8, Canada	McGill University	Gomez, N (corresponding author), McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A OE8, Canada.	natalya.gomez@mcgill.ca	Gomez, Natalya/AAU-4323-2020	Gomez, Natalya/0000-0002-2463-7917				Alley RB, 2015, ANNU REV EARTH PL SC, V43, P207, DOI 10.1146/annurev-earth-060614-105344; Cornford SL, 2015, CRYOSPHERE, V9, P1579, DOI 10.5194/tc-9-1579-2015; Cornford SL, 2013, J COMPUT PHYS, V232, P529, DOI 10.1016/j.jcp.2012.08.037; Gomez N., NATURE COMM IN PRESS; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; IPCC, 2013, CLIMATE CHANGE 2022; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Timmermann R, 2013, OCEAN DYNAM, V63, P1011, DOI 10.1007/s10236-013-0642-0; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	11	1	1	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					510	512		10.1038/526510a	http://dx.doi.org/10.1038/526510a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490614				2022-12-28	WOS:000364026100033
J	Kluge, SF; Sauter, D; Kirchhoff, F				Kluge, Silvia F.; Sauter, Daniel; Kirchhoff, Frank			SnapShot: Antiviral Restriction Factors	CELL			English	Editorial Material							HIV-1 INFECTION; PROTEIN; RELEASE; SAMHD1; GENE; VPU	Restriction factors are cellular proteins that inhibit viruses at different steps of their replication cycle and represent an important first line of defense against viral pathogens. This SnapShot provides an overview of cell-intrinsic antiviral factors, describes their properties, and illustrates the striking variety of antiviral mechanisms as well the sophisticated viral countermeasures. To view this SnapShot, open or download the PDF.	[Kluge, Silvia F.; Sauter, Daniel; Kirchhoff, Frank] Ulm Univ Med Ctr, Inst Mol Virol, D-89081 Ulm, Germany	Ulm University	Kluge, SF (corresponding author), Ulm Univ Med Ctr, Inst Mol Virol, D-89081 Ulm, Germany.		Kirchhoff, Frank/O-8367-2018	Kirchhoff, Frank/0000-0002-7052-2360				Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; LILLY F, 1970, J NATL CANCER I, V45, P163; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Rosa A., 2015, NATURE; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Usami Y., 2015, NATURE; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001	10	61	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3							774.e1	10.1016/j.cell.2015.10.019	http://dx.doi.org/10.1016/j.cell.2015.10.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26496613	Bronze			2022-12-28	WOS:000364828900029
J	Lang, E				Lang, Eddy			In adult smokers in the ED, a multicomponent intervention increased smoking cessation at 3 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cumming Sch Med, Calgary, AB, Canada		Lang, E (corresponding author), Cumming Sch Med, Calgary, AB, Canada.		Lang, Eddy/AAS-2080-2020					Rabe GL, 2013, NICOTINE TOB RES, V15, P643, DOI 10.1093/ntr/nts212; Walters EL, 2014, ACAD EMERG MED, V21, P785, DOI 10.1111/acem.12421	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2015	163	8							JC9	10.7326/ACPJC-2015-163-8-009	http://dx.doi.org/10.7326/ACPJC-2015-163-8-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7QV	26502146				2022-12-28	WOS:000363737400010
J	Balk, EM; Earley, A; Avendano, EA; Raman, G				Balk, Ethan M.; Earley, Amy; Avendano, Esther A.; Raman, Gowri			Long-Term Health Outcomes in Women With Silicone Gel Breast Implants A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CONNECTIVE-TISSUE DISEASE; AUGMENTATION MAMMAPLASTY; DANISH WOMEN; CANCER-RISK; LOS-ANGELES; FOLLOW-UP; RHEUMATIC CONDITIONS; PROSTHETIC IMPLANTS; REDUCTION SURGERY; COSMETIC SURGERY	Background: Silicone gel breast implants were removed from the U.S. market for cosmetic use in 1992 owing to safety concerns. They were reintroduced in 2006, with a call for improved surveillance of clinical outcomes. Purpose: To systematically review the literature regarding specific long-term health outcomes in women with silicone gel breast implants, including cancer; connective tissue, rheumato-logic, and autoimmune diseases; neurologic diseases; reproductive issues, including lactation; offspring issues; and mental health issues (depression and suicide). Data Sources: MEDLINE, EMBASE, and Ovid Healthstar (inception through 30 June 2015), and the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the first quarter of 2015). Study Selection: 4 researchers double-screened articles for longitudinal studies that compared women with and without breast implants and reported long-term health outcomes of interest. Data Extraction: 4 researchers extracted data on participant and implant characteristics, analytic methods, and results. Data Synthesis: 32 studies (in 58 publications) met eligibility criteria. Random-effects model meta-analyses of effect sizes were conducted when feasible. For most outcomes, there was at most only a single adequately adjusted study, which usually found no significant associations. There were possible associations with decreased risk for primary breast and endometrial cancers and increased risks for lung cancer, rheumatoid arthritis, Sjogren syndrome, and Raynaud syndrome. Evidence on breast implants and other outcomes either was limited or did not exist. Limitation: The evidence was most frequently not specific to silicone gel implants, and studies were rarely adequately adjusted for potential confounders. Conclusion: The evidence remains inconclusive about any association between silicone gel implants and long-term health outcomes. Better evidence is needed from existing large studies, which can be reanalyzed to clarify the strength of associations between silicone gel implants and health outcomes.	[Balk, Ethan M.] Brown Univ, Sch Publ Hlth, Ctr Evidence Based Med, Box G S121-8, Providence, RI 02912 USA; [Earley, Amy] Mapi USA, 180 Canal St,Suite 503, Boston, MA 02114 USA; [Avendano, Esther A.; Raman, Gowri] Tufts Med Ctr, Ctr Clin Evidence Synth, Box 063,800 Washington St, Boston, MA 02111 USA	Brown University; Tufts Medical Center	Balk, EM (corresponding author), Brown Univ, Sch Publ Hlth, Ctr Evidence Based Med, Box G S121-8, Providence, RI 02912 USA.	ethan_balk@brown.edu	Balk, Ethan/AAJ-2547-2020		Plastic Surgery Foundation	Plastic Surgery Foundation	The Plastic Surgery Foundation.	Altekruse SF, 2010, SEER CANC STAT REV 1; [Anonymous], 2014, METH GUID EFF COMP E, P220; [Anonymous], 2012, SUMMARY SAFETY EFFEC; [Anonymous], 2013, SUMMARY SAFETY EFFET; [Anonymous], 2012, SUMM BAS DEC SBD NAT; [Anonymous], 2006, SUMMARY SAFETY EFFEC; [Anonymous], 2014, SUMM BAS DEC SBD MEN; Berner I, 2002, EUR J OBSTET GYN R B, V102, P61, DOI 10.1016/S0301-2115(01)00561-9; Bondurant S., 1999, SAFETY SILICONE BREA; Breiting VB, 2004, PLAST RECONSTR SURG, V114, P217, DOI 10.1097/01.PRS.0000128823.77637.8A; Brinton LA, 2000, CANCER CAUSE CONTROL, V11, P819, DOI 10.1023/A:1008941110816; Brinton LA, 2006, EPIDEMIOLOGY, V17, P162, DOI 10.1097/01.ede.0000197056.84629.19; Brinton LA, 1996, PLAST RECONSTR SURG, V97, P269, DOI 10.1097/00006534-199602000-00001; Brinton LA, 2000, PLAST RECONSTR SURG, V105, P919, DOI 10.1097/00006534-200003000-00014; Brinton LA, 2004, AM J EPIDEMIOL, V160, P619, DOI 10.1093/aje/kwh272; Brinton LA, 2001, ANN EPIDEMIOL, V11, P248, DOI 10.1016/S1047-2797(00)00223-4; Brisson J, 2006, INT J CANCER, V118, P2854, DOI 10.1002/ijc.21711; BRYANT H, 1995, NEW ENGL J MED, V332, P1535, DOI 10.1056/NEJM199506083322302; Burns CJ, 1996, J RHEUMATOL, V23, P1904; Center for Devices and Radiological Health and U.S. Food and Drug Administration, 2011, FDA UPD SAF SIL GEL; Center for Devices and Radiological Health U.S. Food and Drug, 2011, AN LARG CELL LYMPH A; Chen JY, 2015, J RHEUMATOL, V42, P55, DOI 10.3899/jrheum.140367; Collado Delfa J, 1998, CIR PLAST IBERO-LATI, V24, P385; Cook LS, 1997, JAMA-J AM MED ASSOC, V277, P1612, DOI 10.1001/jama.277.20.1612; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Deapen DM, 2007, PLAST RECONSTR SURG, V119, P1987, DOI 10.1097/01.prs.0000260582.23971.02; Deapen DM, 2012, PLAST RECONSTR SURG, V129, p575E, DOI 10.1097/PRS.0b013e31824199f1; DEAPEN DM, 1986, PLAST RECONSTR SURG, V77, P361, DOI 10.1097/00006534-198603000-00001; DEAPEN DM, 1992, PLAST RECONSTR SURG, V89, P660, DOI 10.1097/00006534-199204000-00010; DIAMOND BA, 1998, SILICONE BREAST IMPL; Edworthy SM, 1998, J RHEUMATOL, V25, P254; Englert H, 2001, INTERN MED J, V31, P77; Friis S, 2006, INT J CANCER, V118, P998, DOI 10.1002/ijc.21433; Friis S, 1997, ANN PLAS SURG, V39, P1, DOI 10.1097/00000637-199707000-00001; Fryzek JP, 2007, ANN EPIDEMIOL, V17, P374, DOI 10.1016/j.annepidem.2006.11.001; Fryzek JP, 2000, ANN PLAS SURG, V45, P349, DOI 10.1097/00000637-200045040-00001; Fryzek JP, 2001, PLAST RECONSTR SURG, V107, P206, DOI 10.1097/00006534-200101000-00034; GABRIEL SE, 1994, NEW ENGL J MED, V330, P1697, DOI 10.1056/NEJM199406163302401; GILTAY EJ, 1994, ANN RHEUM DIS, V53, P194, DOI 10.1136/ard.53.3.194; Greenland S, 1998, ANN EPIDEMIOL, V8, P319, DOI 10.1016/S1047-2797(97)00212-3; Greenland S, 1996, ANN EPIDEMIOL, V6, P530, DOI 10.1016/S1047-2797(96)00109-3; Harel-Meir M, 2007, NAT CLIN PRACT RHEUM, V3, P707, DOI 10.1038/ncprheum0655; Hemminki E, 2004, ACTA OBSTET GYN SCAN, V83, P1135, DOI 10.1111/j.0001-6349.2004.00437.x; Hurst NM, 1996, OBSTET GYNECOL, V87, P30, DOI 10.1016/0029-7844(95)00349-5; Jacobsen PH, 2004, ARCH INTERN MED, V164, P2450, DOI 10.1001/archinte.164.22.2450; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Karlson EW, 2001, ARCH INTERN MED, V161, P864, DOI 10.1001/archinte.161.6.864; Kern KA, 1997, PLAST RECONSTR SURG, V100, P737, DOI 10.1097/00006534-199709000-00032; Kessler D, 1992, COMMUNICATION; Kjoller K, 2004, ANN PLAS SURG, V52, P1, DOI 10.1097/01.sap.0000101930.75241.55; Kjoller K, 2003, ANN PLAS SURG, V50, P6, DOI 10.1097/00000637-200301000-00002; Kjoller K, 2002, ANN PLAS SURG, V48, P238; Laing TJ, 2001, AM J EPIDEMIOL, V154, P610, DOI 10.1093/aje/154.7.610; Le GM, 2005, BREAST CANCER RES, V7, pR184, DOI 10.1186/bcr974; Lee IM, 2011, INT J EPIDEMIOL, V40, P230, DOI 10.1093/ije/dyq164; Lewy RI, 1993, TEX MED, V89, P7; Lipworth L, 2009, INT J CANCER, V124, P490, DOI 10.1002/ijc.23932; Lipworth L, 2007, ANN PLAS SURG, V59, P119, DOI 10.1097/SAP.0b013e318052ac50; Lipworth L, 2011, SEMIN IMMUNOPATHOL, V33, P287, DOI 10.1007/s00281-010-0238-4; Loyo-Berrios N, 2013, BUILDING NATL INFRAS; Majka DS, 2006, ANN RHEUM DIS, V65, P561, DOI 10.1136/ard.2005.046052; McLaughlin JK, 2006, J NATL CANCER I, V98, P557, DOI 10.1093/jnci/djj134; McLaughlin JK, 2004, ANN PLAS SURG, V52, P115, DOI 10.1097/01.sap.0000108560.71339.6c; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Nabel EG, 2006, SCIENCE, V313, P1703, DOI 10.1126/science.1134995; Nyren O, 1998, NEUROLOGY, V50, P956, DOI 10.1212/WNL.50.4.956; Nyren O, 1998, BRIT MED J, V316, P417, DOI 10.1136/bmj.316.7129.417; Oberto E, 1993, RIV ITALIANA CHIR S1, V25, P131; Pan SY, 2012, INT J CANCER, V131, pE1148, DOI 10.1002/ijc.27603; Park AJ, 1998, PLAST RECONSTR SURG, V101, P261, DOI 10.1097/00006534-199802000-00001; PETIT JY, 1994, PLAST RECONSTR SURG, V94, P115, DOI 10.1097/00006534-199407000-00011; POTTER M, 1994, J NATL CANCER I, V86, P1058, DOI 10.1093/jnci/86.14.1058; Pukkala E, 2003, ANN PLAS SURG, V51, P339, DOI 10.1097/01.sap.0000080407.97677.A5; Pukkala Eero, 2002, J Long Term Eff Med Implants, V12, P271; Rubin JP, 2010, PLAST RECONSTR SURG, V125, P799, DOI 10.1097/PRS.0b013e3181cb5e29; SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502; Sarwer DB, 2003, PLAST RECONSTR SURG, V112, P83, DOI 10.1097/01.PRS.0000066005.07796.51; Schaefer CJ, 1999, ANN RHEUM DIS, V58, P503, DOI 10.1136/ard.58.8.503; Schaefer CJ, 1999, J RHEUMATOL, V26, P2215; SCHUSTERMAN MA, 1993, ANN PLAS SURG, V31, P1; Signorello LB, 2001, ANN PLAS SURG, V46, P279, DOI 10.1097/00000637-200103000-00014; Tinkler J, 1993, 9242 UK DEP HLTH; U.S. Food and Drug Administration, 2013, REG HIST BREAT IMP; Villeneuve PJ, 2006, AM J EPIDEMIOL, V164, P334, DOI 10.1093/aje/kwj214; Wells G., NEWCASTLE OTTAWA SCA; WELLS KE, 1994, PLAST RECONSTR SURG, V93, P907, DOI 10.1097/00006534-199404001-00002; Winther JF, 2001, ACTA NEUROL SCAND, V103, P93, DOI 10.1034/j.1600-0404.2001.103002093.x	87	84	87	1	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2016	164	3					164	U161		10.7326/M15-1169	http://dx.doi.org/10.7326/M15-1169			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4DD	26550776				2022-12-28	WOS:000369169400005
J	Coles, CE; Yarnold, JR				Coles, C. E.; Yarnold, J. R.			Accelerated partial breast irradiation: the new standard?	LANCET			English	Editorial Material							RADIATION-THERAPY; CANCER; RADIOTHERAPY; TRIALS; WOMEN		[Coles, C. E.] Cambridge Univ NHS Fdn Trust, Ctr Oncol, Cambridge CB2 0QQ, England; [Yarnold, J. R.] Inst Canc Res, London SW3 6JB, England; [Yarnold, J. R.] Royal Marsden Hosp NHS Fdn Trust, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Coles, CE (corresponding author), Cambridge Univ NHS Fdn Trust, Ctr Oncol, Cambridge CB2 0QQ, England.	charlotte.coles@addenbrookes.nhs.uk		Yarnold, John/0000-0002-9010-1854	Cancer Research UK [19727] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10026] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))		Bellon JR, 2015, J CLIN ONCOL, V33, P1998, DOI 10.1200/JCO.2015.61.2069; Coles C, 2006, CLIN ONCOL-UK, V18, P587, DOI 10.1016/j.clon.2006.07.010; Coles CE, 2013, CLIN ONCOL-UK, V25, P127, DOI 10.1016/j.clon.2012.10.013; Haviland JS, 2015, INT J RADIAT ONCOL, V92, P954, DOI 10.1016/j.ijrobp.2015.05.026; Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3; Marta GN, 2015, RADIOTHER ONCOL, V114, P42, DOI 10.1016/j.radonc.2014.11.014; Olivotto IA, 2013, J CLIN ONCOL, V31, P4038, DOI 10.1200/JCO.2013.50.5511; Strnad V, 2015, LANCET; Taylor CW, 2015, CLIN ONCOL-UK, V27, P621, DOI 10.1016/j.clon.2015.06.007; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Yarnold J, 2011, INT J RADIAT ONCOL, V79, P1, DOI 10.1016/j.ijrobp.2010.08.035	11	8	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					201	202		10.1016/S0140-6736(15)00518-8	http://dx.doi.org/10.1016/S0140-6736(15)00518-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26494414	Green Submitted			2022-12-28	WOS:000368130700004
J	Yun, J; Mullarky, E; Lu, CY; Bosch, KN; Kavalier, A; Rivera, K; Roper, J; Chio, IIC; Giannopoulou, EG; Rago, C; Muley, A; Asara, JM; Paik, J; Elemento, O; Chen, ZM; Pappin, DJ; Dow, LE; Papadopoulos, N; Gross, SS; Cantley, LC				Yun, Jihye; Mullarky, Edouard; Lu, Changyuan; Bosch, Kaitlyn N.; Kavalier, Adam; Rivera, Keith; Roper, Jatin; Chio, Iok In Christine; Giannopoulou, Eugenia G.; Rago, Carlo; Muley, Ashlesha; Asara, John M.; Paik, Jihye; Elemento, Olivier; Chen, Zhengming; Pappin, Darryl J.; Dow, Lukas E.; Papadopoulos, Nickolas; Gross, Steven S.; Cantley, Lewis C.			Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH	SCIENCE			English	Article							I CLINICAL-TRIAL; TERMINAL HUMAN CANCER; ASCORBIC-ACID; SUPPLEMENTAL ASCORBATE; DEHYDROASCORBIC ACID; SUPPORTIVE TREATMENT; SURVIVAL TIMES; S-THIOLATION; K-RAS; PHARMACOKINETICS	More than half of human colorectal cancers (CRCs) carry either KRAS or BRAF mutations and are often refractory to approved targeted therapies. We found that cultured human CRC cells harboring KRAS or BRAF mutations are selectively killed when exposed to high levels of vitamin C. This effect is due to increased uptake of the oxidized form of vitamin C, dehydroascorbate (DHA), via the GLUT1 glucose transporter. Increased DHA uptake causes oxidative stress as intracellular DHA is reduced to vitamin C, depleting glutathione. Thus, reactive oxygen species accumulate and inactivate glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Inhibition of GAPDH in highly glycolytic KRAS or BRAF mutant cells leads to an energetic crisis and cell death not seen in KRAS and BRAF wild-type cells. High-dose vitamin C impairs tumor growth in Apc/Kras(G12D) mutant mice. These results provide a mechanistic rationale for exploring the therapeutic use of vitamin C for CRCs with KRAS or BRAF mutations.	[Yun, Jihye; Mullarky, Edouard; Bosch, Kaitlyn N.; Muley, Ashlesha; Dow, Lukas E.; Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, Meyer Canc Ctr, New York, NY 10065 USA; [Mullarky, Edouard] Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Boston, MA 02115 USA; [Lu, Changyuan; Kavalier, Adam; Gross, Steven S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Rivera, Keith; Chio, Iok In Christine; Pappin, Darryl J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Roper, Jatin] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Roper, Jatin] Tufts Med Ctr, Div Gastroenterol, Boston, MA 02111 USA; [Giannopoulou, Eugenia G.; Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Rago, Carlo; Papadopoulos, Nickolas] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Rago, Carlo; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Asara, John M.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Paik, Jihye] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Chen, Zhengming] Weill Cornell Med Coll, Dept Biostat & Epidemiol, New York, NY 10065 USA	Cornell University; Harvard University; Harvard Medical School; Cornell University; Cold Spring Harbor Laboratory; Tufts Medical Center; Tufts Medical Center; Cornell University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Cornell University; Cornell University	Cantley, LC (corresponding author), Weill Cornell Med Coll, Dept Med, Meyer Canc Ctr, New York, NY 10065 USA.	lcantley@med.cornell.edu	Cantley, Lewis C/D-1800-2014; Giannopoulou, Evgenia/K-9576-2019	Cantley, Lewis C/0000-0002-1298-7653; Roper, Jatin/0000-0002-8851-1352; Dow, Lukas/0000-0001-7048-1418; Rivera, Keith/0000-0003-2979-9576; Bosch, Kaitlyn/0000-0002-6847-6609	Damon Runyon Cancer Research Foundation; KL2 Career Development Awards; U.S. Department of Defense; National Cancer Institute [P01 CA120964-07, P01 CA117969-09]; NIH [P01 CA120964]; NATIONAL CANCER INSTITUTE [K08CA198002, P01CA120964, P01CA117969, K22CA181280, P30CA045508] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, KL2TR000458] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048284] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; KL2 Career Development Awards; U.S. Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Vogelstein and K. W. Kinzler for helpful suggestions; the Cantley lab members, B. Hopkins, F. Karreth, C. Lyssiotis, and G. DeNicola for comments on the manuscript; and M. Yuan, S. Breitkopf, J. Wong, and O. Mashadova for technical assistance. We apologize for publications not cited because of space limitations. L.C.C. owns equity in, receives compensation from, and serves on the board of directors and scientific advisory board of Agios Pharmaceuticals. Agios Pharmaceuticals is identifying metabolic pathways of cancer cells and developing drugs to inhibit such enzymes in order to disrupt tumor cell growth and survival. Supported by the Damon Runyon Cancer Research Foundation (J.Y. and I.I.C.C.), KL2 Career Development Awards (J.Y.), the U.S. Department of Defense (J.P.), National Cancer Institute grants P01 CA120964-07 and P01 CA117969-09 (L.C.C.), and NIH grant P01 CA120964 (J. M. A.). The authors declare no competing financial interests.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen SW, 2014, CLIN NUCL MED, V39, P685, DOI 10.1097/RLU.0000000000000481; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kawada K, 2012, CLIN CANCER RES, V18, P1696, DOI 10.1158/1078-0432.CCR-11-1909; Kim J, 2012, FREE RADICAL BIO MED, V53, P1607, DOI 10.1016/j.freeradbiomed.2012.07.079; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Stephenson CM, 2013, CANCER CHEMOTH PHARM, V72, P139, DOI 10.1007/s00280-013-2179-9; Tian WH, 2014, J BIOL CHEM, V289, P3339, DOI 10.1074/jbc.M113.538157; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; VERA JC, 1994, BLOOD, V84, P1628; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Vuyyuri SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067081; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Welsh JL, 2013, CANCER CHEMOTH PHARM, V71, P765, DOI 10.1007/s00280-013-2070-8; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	38	536	561	12	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1391	1396		10.1126/science.aaa5004	http://dx.doi.org/10.1126/science.aaa5004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26541605	Green Accepted			2022-12-28	WOS:000366162400046
J	Redfield, MM; Anstrom, KJ; Levine, JA; Koepp, GA; Borlaug, BA; Chen, HH; LeWinter, MM; Joseph, SM; Shah, SJ; Semigran, MJ; Felker, GM; Cole, RT; Reeves, GR; Tedford, RJ; Tang, WHW; McNulty, SE; Velazquez, EJ; Shah, MR; Braunwald, E				Redfield, Margaret M.; Anstrom, Kevin J.; Levine, James A.; Koepp, Gabe A.; Borlaug, Barry A.; Chen, Horng H.; LeWinter, Martin M.; Joseph, Susan M.; Shah, Sanjiv J.; Semigran, Marc J.; Felker, G. Michael; Cole, Robert T.; Reeves, Gordon R.; Tedford, Ryan J.; Tang, W. H. Wilson; McNulty, Steven E.; Velazquez, Eric J.; Shah, Monica R.; Braunwald, Eugene		NHLBI Heart Failure Clinical Res	Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXERCISE CAPACITY; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; SEDENTARY TIME; DOUBLE-BLIND; TRIAL; THERAPY; ACCELEROMETRY; INTOLERANCE; INHIBITION	BACKGROUND Nitrates are commonly prescribed to enhance activity tolerance in patients with heart failure and a preserved ejection fraction. We compared the effect of isosorbide mononitrate or placebo on daily activity in such patients. METHODS In this multicenter, double-blind, crossover study, 110 patients with heart failure and a preserved ejection fraction were randomly assigned to a 6-week dose-escalation regimen of isosorbide mononitrate (from 30 mg to 60 mg to 120 mg once daily) or placebo, with subsequent crossover to the other group for 6 weeks. The primary end point was the daily activity level, quantified as the average daily accelerometer units during the 120-mg phase, as assessed by patient-worn accelerometers. Secondary end points included hours of activity per day during the 120-mg phase, daily accelerometer units during all three dose regimens, quality-of-life scores, 6-minute walk distance, and levels of N-terminal pro-brain natriuretic peptide (NT-proBNP). RESULTS In the group receiving the 120-mg dose of isosorbide mononitrate, as compared with the placebo group, there was a nonsignificant trend toward lower daily activity (-381 accelerometer units; 95% confidence interval [CI], -780 to 17; P = 0.06) and a significant decrease in hours of activity per day (-0.30 hours; 95% CI, -0.55 to -0.05; P = 0.02). During all dose regimens, activity in the isosorbide mononitrate group was lower than that in the placebo group (-439 accelerometer units; 95% CI, -792 to -86; P = 0.02). Activity levels decreased progressively and significantly with increased doses of isosorbide mononitrate (but not placebo). There were no significant between-group differences in the 6-minute walk distance, quality-of-life scores, or NT-proBNP levels. CONCLUSIONS Patients with heart failure and a preserved ejection fraction who received isosorbide mononitrate were less active and did not have better quality of life or submaximal exercise capacity than did patients who received placebo.	[Redfield, Margaret M.; Borlaug, Barry A.; Chen, Horng H.] Mayo Clin, Rochester, MN 55905 USA; [Anstrom, Kevin J.; McNulty, Steven E.; Velazquez, Eric J.] Duke Clin Res Inst, Durham, NC USA; [Felker, G. Michael] Duke Univ, Med Ctr, Durham, NC USA; [Levine, James A.; Koepp, Gabe A.] Mayo Clin, Scottsdale, AZ USA; [LeWinter, Martin M.] Univ Vermont, Med Ctr, Burlington, VT 05405 USA; [Joseph, Susan M.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Shah, Sanjiv J.] Northwestern Univ, Chicago, IL 60611 USA; [Semigran, Marc J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Braunwald, Eugene] Harvard Univ, Sch Med, Boston, MA USA; [Cole, Robert T.] Emory Univ, Atlanta, GA 30322 USA; [Reeves, Gordon R.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Tedford, Ryan J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Shah, Monica R.] NHLBI, Bethesda, MD 20892 USA; [Tang, W. H. Wilson] Cleveland Clin Fdn, Cleveland, OH USA	Mayo Clinic; Duke University; Duke University; Mayo Clinic; Mayo Clinic Phoenix; University of Vermont; University of Vermont Medical Center; Washington University (WUSTL); Northwestern University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Emory University; Jefferson University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cleveland Clinic Foundation	Redfield, MM (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	redfield.margaret@mayo.edu	Felker, Michael/AAX-2288-2021; Shah, Sanjiv J./AFQ-9480-2022; Tang, Wai Hong Wilson/I-1238-2013	Borlaug, Barry/0000-0001-9375-0596; Felker, Gary/0000-0002-5931-1239; Tang, W. H. Wilson/0000-0002-8335-735X; Shah, Sanjiv/0000-0002-5655-8201	National Heart, Lung, and Blood Institute (NHLBI) [U10 HL084904, U01 HL084861, U10 HL110312, U109 HL110337, U01 HL084889, U01 HL084890, U01 HL084891, U10 HL110342, U10 HL110262, U01 HL084931, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, U10 HL110338]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL110337, U10HL110312, U10HL110302, U10HL110309, U01HL084891, U01HL084889, U10HL110336, U10HL110338, U10HL110262, U10HL084904, U01HL084861, U01HL084931, U10HL110297, U10HL110342, U01HL084890] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (coordinating center: U10 HL084904; regional clinical centers: U01 HL084861, U10 HL110312, U109 HL110337, U01 HL084889, U01 HL084890, U01 HL084891, U10 HL110342, U10 HL110262, U01 HL084931, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, and U10 HL110338).	Adamson PB, 2014, CIRC-HEART FAIL, V7, P935, DOI 10.1161/CIRCHEARTFAILURE.113.001229; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745; Borlaug BA, 2015, J AM COLL CARDIOL, V66, P1672, DOI 10.1016/j.jacc.2015.07.067; Cheung VH, 2011, ARCH PHYS MED REHAB, V92, P998, DOI 10.1016/j.apmr.2010.12.040; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Conraads VM, 2014, CIRC-HEART FAIL, V7, P279, DOI 10.1161/CIRCHEARTFAILURE.113.000883; Elkayam U, 1999, CIRCULATION, V99, P2652, DOI 10.1161/01.CIR.99.20.2652; Fleg JL, 2011, NAT REV CARDIOL, V8, P13, DOI 10.1038/nrcardio.2010.162; FRANCIOSA JA, 1980, AM J MED, V69, P559, DOI 10.1016/0002-9343(80)90468-4; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Kelly JP, 2015, J AM COLL CARDIOL, V65, P1668, DOI 10.1016/j.jacc.2015.03.043; LEIER CV, 1983, CIRCULATION, V67, P817, DOI 10.1161/01.CIR.67.4.817; Levine J, 2003, EUR J CLIN NUTR, V57, P1176, DOI 10.1038/sj.ejcn.1601673; Levine J, 2001, AM J PHYSIOL-ENDOC M, V281, pE670, DOI 10.1152/ajpendo.2001.281.4.E670; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2005, PUBLIC HEALTH NUTR, V8, P1123, DOI 10.1079/PHN2005800; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Maurer MS, 2012, J AM COLL CARDIOL, V60, P129, DOI 10.1016/j.jacc.2012.04.012; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Schwartzenberg S, 2012, J AM COLL CARDIOL, V59, P442, DOI 10.1016/j.jacc.2011.09.062; Senn S, 2002, CROSS OVER TRIALS CL; Shah SJ, 2013, CIRC-HEART FAIL, V6, P184, DOI 10.1161/CIRCHEARTFAILURE.112.972794; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Thompson WG, 2014, ARCH GERONTOL GERIAT, V58, P314, DOI 10.1016/j.archger.2014.01.004; Upadhya B, 2015, J GERIATR CARDIOL, V12, P294, DOI 10.11909/j.issn.1671-5411.2015.03.013; von Lueder TG, 2014, HEART FAIL CLIN, V10, P367, DOI 10.1016/j.hfc.2013.12.001; Young DR, 2014, CIRC-HEART FAIL, V7, P21, DOI 10.1161/CIRCHEARTFAILURE.113.000529; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zakeri R, 2015, CIRC-HEART FAIL, V8, P221, DOI 10.1161/CIRCHEARTFAILURE.114.001598; Zamani P, 2015, CIRCULATION, V131, P371, DOI 10.1161/CIRCULATIONAHA.114.012957	36	329	340	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2314	2324		10.1056/NEJMoa1510774	http://dx.doi.org/10.1056/NEJMoa1510774			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26549714	Green Submitted, Green Accepted			2022-12-28	WOS:000366111600006
J	Ortblad, KF; Salomon, JA; Barnighausen, T; Atun, R				Ortblad, Katrina F.; Salomon, Joshua A.; Baernighausen, Till; Atun, Rifat			Stopping tuberculosis: a biosocial model for sustainable development	LANCET			English	Article							PULMONARY TUBERCULOSIS; SYSTEMATIC ANALYSIS; RUSSIAN-FEDERATION; DRUG-RESISTANT; GLOBAL BURDEN; ALCOHOL-USE; HEALTH; DISEASE; MORTALITY; DOTS	Tuberculosis transmission and progression are largely driven by social factors such as poor living conditions and poor nutrition. Increased standards of living and social approaches helped to decrease the burden of tuberculosis before the introduction of chemotherapy in the 1940s. Since then, management of tuberculosis has been largely biomedical. More funding for tuberculosis since 2000, coinciding with the Millennium Development Goals, has yielded progress in tuberculosis mortality but smaller reductions in incidence, which continues to pose a risk to sustainable development, especially in poor and susceptible populations. These at-risk populations need accelerated progress to end tuberculosis as resolved by the World Health Assembly in 2015. Effectively addressing the worldwide tuberculosis burden will need not only enhancement of biomedical approaches but also rebuilding of the social approaches of the past. To combine a biosocial approach, underpinned by social, economic, and environmental actions, with new treatments, new diagnostics, and universal health coverage, will need multisectoral coordination and action involving the health and other governmental sectors, as well as participation of the civil society, and especially the poor and susceptible populations. A biosocial approach to stopping tuberculosis will not only target morbidity and mortality from disease but would also contribute substantially to poverty alleviation and sustainable development that promises to meet the needs of the present, especially the poor, and provide them and subsequent generations an opportunity for a better future.	[Ortblad, Katrina F.; Salomon, Joshua A.; Baernighausen, Till; Atun, Rifat] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Baernighausen, Till] Wellcome Trust Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa	Harvard University; Harvard T.H. Chan School of Public Health	Atun, R (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Salomon, Joshua/S-1929-2019; Bärnighausen, Till/Y-2388-2019; Atun, Rifat/AAH-5537-2021; Ortblad, Katrina/ABF-9070-2020; Salomon, Joshua A/D-3898-2009	Salomon, Joshua/0000-0003-3929-5515; Ortblad, Katrina/0000-0002-5675-8836; Salomon, Joshua A/0000-0003-3929-5515; Atun, Rifat/0000-0002-1531-5983	Wellcome Trust; US National Institutes of Health [1P01AG041710-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG041710] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors declare no conflicts of interest. Role of funding: TB was supported by the Wellcome Trust and the US National Institutes of Health (1P01AG041710-01). KFO, JAS, and RA have no external funding sources to disclose in relation to this Series paper. The funders had no roles in the conception, preparation, review, approval, or submission of this manuscript.	Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370; Atun RA, 2006, HEALTH POLICY PLANN, V21, P353, DOI 10.1093/heapol/czl023; Atun RA, 2005, B WORLD HEALTH ORGAN, V83, P217; Atun R, 2008, B WORLD HEALTH ORGAN, V86, P147, DOI 10.2471/BLT.06.034991; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; CDC, 2011, EX COMM REP TUB US; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Coker RJ, 2005, PUBLIC HEALTH, V119, P837, DOI 10.1016/j.puhe.2004.10.019; Coker RJ, 2004, LANCET, V363, P1389, DOI 10.1016/S0140-6736(04)16053-4; Commission B., 1987, OUR COMMON FUTURE WO; Cordaid, 2014, UN HAB NUMB SLUM DWE; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; da Costa C, 2015, INT J INFECT DIS, V32, P5, DOI 10.1016/j.ijid.2014.11.026; de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dormandy T, 2000, THE WHITE DEATH; Dye C, 2007, INT J TUBERC LUNG D, V11, P1225; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Edelstein M, 2015, LANCET, V385, P2234, DOI 10.1016/S0140-6736(15)60203-3; FISCHER PJ, 1986, INT J MENT HEALTH, V14, P6; Fitbomb, 2012, NO MOR SUG; Fraser Hamish, 2006, AMIA Annu Symp Proc, P924; Fraser HSF, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.4.e29; Government of South Africa, TUB STRAT PLAN S AFR; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Hasan R, 2014, INT J MYCOBACT, V3, P79, DOI 10.1016/j.ijmyco.2014.01.005; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Kernodle DS, 2010, CLIN INFECT DIS, V51, P177, DOI 10.1086/653533; Lam D, 2011, DEMOGRAPHY, V48, P1231, DOI 10.1007/s13524-011-0070-z; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lienhardt C, 2010, CURR OPIN PULM MED, V16, P186, DOI 10.1097/MCP.0b013e328337580c; Lin HH, 2014, INT J TUBERC LUNG D, V18, P613, DOI 10.5588/ijtld.13.0765; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lygizos M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-300; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Masters WA, 2014, ANN NY ACAD SCI, V1331, P258, DOI 10.1111/nyas.12352; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117; McMichael P, 2011, THIRD WORLD Q, V32, P119, DOI 10.1080/01436597.2011.543818; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Minetti A, 2010, INT J TUBERC LUNG D, V14, P1589; de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NARDELL EA, 1993, INFECT CONT HOSP EP, V14, P681; Nglazi MD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-566; Northridge ME, 2003, AM J PUBLIC HEALTH, V93, P118, DOI 10.2105/AJPH.93.1.118; Pachi Argiro, 2013, Tuberc Res Treat, V2013, P489865, DOI 10.1155/2013/489865; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Podewils LJ, 2011, EPIDEMIOL INFECT, V139, P113, DOI 10.1017/S0950268810000907; RAMAKRISHNAN C, 1961, B WORLD HEALTH ORGAN, V25, P339; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Reeves A, 2014, LANCET INFECT DIS, V14, P1105, DOI 10.1016/S1473-3099(14)70927-2; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Reid PJ, 1996, OCCUP ENVIRON MED, V53, P11, DOI 10.1136/oem.53.1.11; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; Rodger AJ, 2002, B WORLD HEALTH ORGAN, V80, P451; Shah R, 2012, USAID FRONTIERS DEV; Sinclair D, 2011, NUTR SUPPLEMENTS PEO; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P524, DOI 10.2105/AJPH.2009.175646; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; Ullah ANZ, 2012, INT J TUBERC LUNG D, V16, P1637, DOI 10.5588/ijtld.12.0378; UN, 2012, UN C SUST DEV RIO DE; UN Habitat, 2003, CHALL SLUMGLOB REP; UN-Habitat, 2013, STAT WORLDS CIT 2012; United Nations, MILL DEV GOALS REP 2; United Nations, 2014, REV WORLD URB PROSP; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; Vree M, 2007, EMERG INFECT DIS, V13, P796, DOI 10.3201/eid1305.060904; Wagstaff K, 2011, UTOPIANIST; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Wei XL, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-9; Weiner J, 2014, J INTERN MED, V275, P467, DOI 10.1111/joim.12212; *WHO, 1993, WHO DECL TUB GLOB EM; WHO, STOP TB STRAT; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; World Health Organization, 5 EL DOTS; World Health Organization, GLOB PLAN STOP TB 20; World Health Organization, STOP TB PARTN OP STR; World Health Organization, WHOCDSSTB20004; World Health Organization, 2013, SYST SCREEN ACT TUB; Yasinskaya Y, 2011, INT J TUBERC LUNG D, V15, P985, DOI 10.5588/ijtld.10.0712; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	100	59	63	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 5	2015	386	10010					2354	2362		10.1016/S0140-6736(15)00324-4	http://dx.doi.org/10.1016/S0140-6736(15)00324-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8ZB	26515678	Green Accepted			2022-12-28	WOS:000365993200035
J	Akiyama, T; Gibson, MC				Akiyama, Takuya; Gibson, Matthew C.			Decapentaplegic and growth control in the developing Drosophila wing	NATURE			English	Article							MORPHOGEN GRADIENT FORMATION; GENE-EXPRESSION; BMP ACTIVITY; DPP; PROTEIN; RANGE; SIZE; PROLIFERATION; HEDGEHOG	As a central model for morphogen action during animal development, the bone morphogenetic protein 2/4 (BMP2/4)-like ligand Decapentaplegic (Dpp) is proposed to form a long-range signalling gradient that directs both growth and pattern formation during Drosophila wing disc development(1-6). While the patterning role of Dpp secreted from a stripe of cells along the anterior-posterior compartmental boundary is well established(1,2,6), the mechanism by which a Dpp gradient directs uniform cell proliferation remains controversial and poorly understood(7-13). Here, to determine the precise spatiotemporal requirements for Dpp during wing disc development, we use CRISPR-Cas9-mediated genome editing to generate a flippase recognition target (FRT)-dependent conditional null allele. By genetically removing Dpp from its endogenous stripe domain, we confirm the requirement of Dpp for the activation of a downstream phospho-Mothers against dpp (p-Mad) gradient and the regulation of the patterning targets spalt (sal), optomotor blind (omb; also known as bifid) and brinker (brk). Surprisingly, however, third-instar wing blade primordia devoid of compartmental dpp expression maintain relatively normal rates of cell proliferation and exhibit only mild defects in growth. These results indicate that during the latter half of larval development, the Dpp morphogen gradient emanating from the anterior-posterior compartment boundary is not directly required for wing disc growth.	[Akiyama, Takuya; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gibson, Matthew C.] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Gibson, MC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	MG2@stowers.org		Gibson, Matthew/0000-0001-5588-8842	Stowers Institute for Medical Research	Stowers Institute for Medical Research	We thank G. Struhl and K. Wharton for extensive discussion and suggestions, S. Kondo for technical advice with CRISPR, K. Irvine, W. Deng and the Bloomington Stock Center for fly stocks, and R. Barrio, G. Pflugfelder, A. Teleman and the Developmental Studies Hybridoma Bank for antibodies. We thank K. Marr and L. Ellington for a critical reading of the manuscript, L. Gutchewsky for administrative support, and members of the Gibson laboratory for discussions and advice. This work was supported by funding from the Stowers Institute for Medical Research.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Akiyama T, 2015, WIRES DEV BIOL, V4, P99, DOI 10.1002/wdev.167; Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown T, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0209as21; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Croker JA, 2006, DEV BIOL, V291, P368, DOI 10.1016/j.ydbio.2005.12.020; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Doumpas N, 2013, EMBO REP, V14, P261, DOI 10.1038/embor.2013.1; Foronda D, 2009, MECH DEVELOP, V126, P99, DOI 10.1016/j.mod.2008.12.002; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Kicheva A, 2012, CURR OPIN GENET DEV, V22, P527, DOI 10.1016/j.gde.2012.08.004; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Paul L, 2013, P NATL ACAD SCI USA, V110, P5058, DOI 10.1073/pnas.1217538110; Raftery LA, 2012, CURR OPIN CELL BIOL, V24, P158, DOI 10.1016/j.ceb.2011.11.004; Restrepo S, 2014, CURR BIOL, V24, pR245, DOI 10.1016/j.cub.2014.01.055; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Rubin G. M., 2009, COLD SPRING HARB PRO, V2009; Schwank G, 2012, SCIENCE, V335, DOI 10.1126/science.1210997; Schwank G, 2011, DEV CELL, V20, P123, DOI 10.1016/j.devcel.2010.11.007; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635; Shen J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-23; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; XU T, 1993, DEVELOPMENT, V117, P1223; ZECCA M, 1995, DEVELOPMENT, V121, P2265	45	60	61	0	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					375	+		10.1038/nature15730	http://dx.doi.org/10.1038/nature15730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26550824				2022-12-28	WOS:000365356800056
J	Sterner, T				Sterner, Thomas			ECONOMICS Higher costs of climate change	NATURE			English	Editorial Material							TEMPERATURE		Univ Gothenburg, Dept Econ, SE-40530 Gothenburg, Sweden	University of Gothenburg	Sterner, T (corresponding author), Univ Gothenburg, Dept Econ, SE-40530 Gothenburg, Sweden.	thomas.sterner@economics.gu.se	Sterner, Thomas/AGZ-2537-2022					Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Revesz RL, 2014, NATURE, V508, P173, DOI 10.1038/508173a; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766	5	15	17	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					177	178						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RC	26503044				2022-12-28	WOS:000364396700033
J	van Asch, CJJ; Velthuis, BK; Rinkel, GJE; Algra, A; de Kort, GAP; Witkamp, TD; de Ridder, JCM; van Nieuwenhuizen, KM; de Leeuw, FE; Schonewille, WJ; de Kort, PLM; Dippel, DW; Raaymakers, TWM; Hofmeijer, J; Wermer, MJH; Kerkhoff, H; Jellema, K; Bronner, IM; Remmers, MJM; Bienfait, HP; Witjes, RJGM; Greving, JP; Klijn, CJM				van Asch, Charlotte J. J.; Velthuis, Birgitta K.; Rinkel, Gabrel J. E.; Algra, Ale; de Kort, Gerard A. P.; Witkamp, Theo D.; de Ridder, Johanna C. M.; van Nieuwenhuizen, Koen M.; de Leeuw, Frank-Erik; Schonewille, Wouter J.; de Kort, Paul L. M.; Dippel, Diederik W.; Raaymakers, Theodora W. M.; Hofmeijer, Jeannette; Wermer, Marieke J. H.; Kerkhoff, Henk; Jellema, Korne; Bronner, Irene M.; Remmers, Michel J. M.; Bienfait, Henri Paul; Witjes, Ron J. G. M.; Greving, Jacoba P.; Klijn, Catharina J. M.		DIAGRAM Investigators	Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE; GUIDELINES; MANAGEMENT; SCORE	STUDY QUESTION What are the diagnostic yield and accuracy of early computed tomography (CT) angiography followed by magnetic resonance imaging/angiography (MRI/MRA) and digital subtraction angiography (DSA) in patients with non-traumatic intracerebral haemorrhage? METHODS This prospective diagnostic study enrolled 298 adults (18-70 years) treated in 22 hospitals in the Netherlands over six years. CT angiography was performed within seven days of haemorrhage. If the result was negative, MRI/MRA was performed four to eight weeks later. DSA was performed when the CT angiography or MRI/MRA results were inconclusive or negative. The main outcome was a macrovascular cause, including arteriovenous malformation, aneurysm, dural arteriovenous fistula, and cavernoma. Three blinded neuroradiologists independently evaluated the images for macrovascular causes of haemorrhage. The reference standard was the best available evidence from all findings during one year's follow-up. STUDY ANSWER AND LIMITATIONS A macrovascular cause was identified in 69 patients (23%). 291 patients (98%) underwent CT angiography; 214 with a negative result underwent additional MRI/MRA and 97 with a negative result for both CT angiography and MRI/MRA underwent DSA. Early CT angiography detected 51 macrovascular causes (yield 17%, 95% confidence interval 13% to 22%). CT angiography with MRI/MRA identified two additional macrovascular causes (18%, 14% to 23%) and these modalities combined with DSA another 15 (23%, 18% to 28%). This last extensive strategy failed to detect a cavernoma, which was identified on MRI during follow-up (reference strategy). The positive predictive value of CT angiography was 72% (60% to 82%), of additional MRI/MRA was 35% (14% to 62%), and of additional DSA was 100% (75% to 100%). None of the patients experienced complications with CT angiography or MRI/MRA; 0.6% of patients who underwent DSA experienced permanent sequelae. Not all patients with negative CT angiography and MRI/MRA results underwent DSA. Although the previous probability of finding a macrovascular cause was lower in patients who did not undergo DSA, some small arteriovenous malformations or dural arteriovenous fistulas may have been missed. WHAT THIS STUDY ADDS CT angiography is an appropriate initial investigation to detect macrovascular causes of non-traumatic intracerebral haemorrhage, but accuracy is modest. Additional MRI/MRA may find cavernomas or alternative diagnoses, but DSA is needed to diagnose macrovascular causes undetected by CT angiography or MRI/MRA. FUNDING, COMPETING INTERESTS, DATA SHARING Dutch Heart Foundation and The Netherlands Organisation for Health Research and Development, ZonMw. The authors have no competing interests. Direct requests for additional data to the corresponding author.	[van Asch, Charlotte J. J.; Rinkel, Gabrel J. E.; Algra, Ale; de Ridder, Johanna C. M.; van Nieuwenhuizen, Koen M.; Klijn, Catharina J. M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, NL-3508 GA Utrecht, Netherlands; [Velthuis, Birgitta K.; de Kort, Gerard A. P.; Witkamp, Theo D.] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands; [Algra, Ale; Greving, Jacoba P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [de Leeuw, Frank-Erik; Klijn, Catharina J. M.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Schonewille, Wouter J.] St Elizabeth Hosp, Dept Neurol, Nieuwegein, Netherlands; [de Kort, Paul L. M.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Dippel, Diederik W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Raaymakers, Theodora W. M.] Meander Med Ctr, Dept Neurol, Amersfoort, Netherlands; [Hofmeijer, Jeannette] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands; [Wermer, Marieke J. H.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Kerkhoff, Henk] Albert Schweitzer Hosp, Dept Neurol, Dordrecht, Netherlands; [Jellema, Korne] MCH Westeinde, Dept Neurol, The Hague, Netherlands; [Bronner, Irene M.] Flevo Hosp, Dept Neurol, Almere, Netherlands; [Remmers, Michel J. M.] Amphia Hosp, Dept Neurol, Breda, Netherlands; [Bienfait, Henri Paul] Gelre Hosp, Dept Neurol, Apeldoorn, Netherlands; [Witjes, Ron J. G. M.] Tergooi Hosp, Dept Neurol, Blaricum, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Elisabeth-TweeSteden Ziekenhuis (ETZ); Erasmus University Rotterdam; Erasmus MC; Meander Medisch Centrum; Rijnstate Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Albert Schweitzer Ziekenhuis; Amphia Hospital; Gelre Hospitals; Tergooi Blaricum	van Asch, CJJ (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, NL-3508 GA Utrecht, Netherlands.	c.j.j.vanasch@gmail.com	Dippel, Diederik/AAJ-2192-2020; Boogaarts, Jeroen/L-4216-2015; van Nieuwenhuizen, Koen/AAR-9923-2021; van Dijk, Ewoud J/J-7951-2012; Klijn, C.J.M./E-1700-2016; de Leeuw, Frank-Erik/E-4795-2012	Dippel, Diederik/0000-0002-9234-3515; Boogaarts, Jeroen/0000-0001-5855-2447; van Nieuwenhuizen, Koen/0000-0002-4815-002X; Klijn, C.J.M./0000-0002-8495-4578; 	Dutch Heart Foundation [2007B048, 2012 T077]; Netherlands Organisation for Health Research and Development, ZonMw [015008048]	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organisation for Health Research and Development, ZonMw(Netherlands Organization for Health Research and Development)	This study was supported by a Dutch Heart Foundation grant (No 2007B048, to CJMK). CJMK is also supported by a clinical established investigator grant of the Dutch Heart Foundation (grant No 2012 T077), and an Aspasia grant from the Netherlands Organisation for Health Research and Development, ZonMw (015008048). Statement of independence of researchers from funders: The corresponding and the guarantor (CJMK) had full access to all study data and final responsibility for the decision to submit for publication.	Al-Shahi Salman R, 2009, BMJ-BRIT MED J, V339, P284; Almandoz JED, 2010, AM J NEURORADIOL, V31, P1653, DOI 10.3174/ajnr.A2156; Almandoz JED, 2009, AM J NEURORADIOL, V30, P1213, DOI 10.3174/ajnr.A1546; Ang DSC, 2008, J HUM HYPERTENS, V22, P460, DOI 10.1038/jhh.2008.24; Bekelis K, 2012, J NEUROSURG, V117, P761, DOI 10.3171/2012.7.JNS12281; Bossuyt PM, 2003, CLIN RADIOL, V58, P575, DOI 10.1016/S0009-9260(03)00258-7; Casolla B, 2012, NEUROLOGY, V79, P1109, DOI 10.1212/WNL.0b013e3182698d00; Cordonnier C, 2010, STROKE, V41, P685, DOI 10.1161/STROKEAHA.109.572495; Domingues R, 2015, NEUROL CLIN, V33, P315, DOI 10.1016/j.ncl.2014.12.001; Hegde AN, 2012, CLIN RADIOL, V67, P380, DOI 10.1016/j.crad.2011.10.013; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Josephson CB, 2014, COCHRANE DB SYST REV, V9, P1; Kadkhodayan Y, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010077; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Macellari F, 2014, STROKE, V45, P903, DOI 10.1161/STROKEAHA.113.003701; Masdeu JC, 2006, EUR J NEUROL, V13, P1271, DOI 10.1111/j.1468-1331.2006.01507.x; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Ohtani R, 2003, INTERNAL MED, V42, P576, DOI 10.2169/internalmedicine.42.576; Olavarria VV, 2014, J STROKE CEREBROVASC, V23, P2069, DOI 10.1016/j.jstrokecerebrovasdis.2014.03.009; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; van Asch CJJ, 2013, STROKE, V44, P2904, DOI 10.1161/STROKEAHA.113.002386; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Westerlaan HE, 2011, RADIOLOGY, V258, P134, DOI 10.1148/radiol.10092373; Wong GKC, 2011, STROKE, V42, P211, DOI 10.1161/STROKEAHA.110.592337; Zhu XL, 1997, STROKE, V28, P1406, DOI 10.1161/01.STR.28.7.1406	27	43	43	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2015	351								h5762	10.1136/bmj.h5762	http://dx.doi.org/10.1136/bmj.h5762			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4FO	26553142	Green Published, hybrid			2022-12-28	WOS:000364947000002
J	Andersson, L; Weber, TD; Malaspina, D; Crary, F; Ergun, RE; Delory, GT; Fowler, CM; Morooka, MW; McEnulty, T; Eriksson, AI; Andrews, DJ; Horanyi, M; Collette, A; Yelle, R; Jakosky, BM				Andersson, L.; Weber, T. D.; Malaspina, D.; Crary, F.; Ergun, R. E.; Delory, G. T.; Fowler, C. M.; Morooka, M. W.; McEnulty, T.; Eriksson, A. I.; Andrews, D. J.; Horanyi, M.; Collette, A.; Yelle, R.; Jakosky, B. M.			Dust observations at orbital altitudes surrounding Mars	SCIENCE			English	Article							INTERPLANETARY; INSTRUMENT; SPACECRAFT; IMPACTS	Dust is common close to the martian surface, but no known process can lift appreciable concentrations of particles to altitudes above similar to 150 kilometers. We present observations of dust at altitudes ranging from 150 to above 1000 kilometers by the Langmuir Probe and Wave instrument on the Mars Atmosphere and Volatile Evolution spacecraft. Based on its distribution, we interpret this dust to be interplanetary in origin. A comparison with laboratory measurements indicates that the dust grain size ranges from 1 to 12 micrometers, assuming a typical grain velocity of similar to 18 kilometers per second. These direct observations of dust entering the martian atmosphere improve our understanding of the sources, sinks, and transport of interplanetary dust throughout the inner solar system and the associated impacts on Mars's atmosphere.	[Andersson, L.; Weber, T. D.; Malaspina, D.; Crary, F.; Ergun, R. E.; Fowler, C. M.; Morooka, M. W.; McEnulty, T.; Horanyi, M.; Collette, A.; Jakosky, B. M.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Delory, G. T.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Eriksson, A. I.; Andrews, D. J.] Swedish Inst Space Phys, Uppsala, Sweden; [Yelle, R.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; University of Arizona	Andersson, L (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA.	laila.andersson@lasp.colorado.edu	Eriksson, Anders I/C-2887-2009; Morooka, Michiko/AAO-8594-2020; Andrews, David/B-2591-2009	Eriksson, Anders I/0000-0003-2926-6761; Morooka, Michiko/0000-0001-9958-0241; Andrews, David/0000-0002-7933-0322; MALASPINA, DAVID/0000-0003-1191-1558	NASA through the Mars Exploration Program	NASA through the Mars Exploration Program	The data used in our analyses are available via NASA's Planetary Data System at http://atmos.nmsu.edu/data_and_services/atmospheres_data/MAVEN/maven_main.html. NASA funding for the MAVEN project through the Mars Exploration Program supported this work.	Andersson L, 2015, SPACE SCI REV, V195, P173, DOI 10.1007/s11214-015-0194-3; Collette A, 2015, J GEOPHYS RES-SPACE, V120, P5298, DOI 10.1002/2015JA021198; Collette A, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020042; Fechtig R. H., 1985, ICARUS, V62, P244, DOI [10.1016/0019-1035(85)90121-6, DOI 10.1016/0019-1035(85)90121-6]; GURNETT DA, 1983, ICARUS, V53, P236, DOI 10.1016/0019-1035(83)90145-8; Haider SA, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA016125; IP WH, 1990, GEOPHYS RES LETT, V17, P857, DOI 10.1029/GL017i006p00857; Jakosky BM, 2015, SPACE SCI REV, V195, P3, DOI 10.1007/s11214-015-0139-x; Kurth WS, 2006, PLANET SPACE SCI, V54, P988, DOI 10.1016/j.pss.2006.05.011; LEBEDINETS VN, 1973, PLANET SPACE SCI, V21, P1317, DOI 10.1016/0032-0633(73)90224-9; Malaspina DM, 2014, GEOPHYS RES LETT, V41, P266, DOI 10.1002/2013GL058786; Mann I, 2011, SPACE SCI REV, V161, P1, DOI 10.1007/s11214-011-9762-3; Molina-Cuberos GJ, 2003, PLANET SPACE SCI, V51, P239, DOI 10.1016/S0032-0633(02)00197-6; Molina-Cuberos JG, 2008, SPACE SCI REV, V137, P175, DOI 10.1007/s11214-008-9340-5; Oberc P., 1996, Advances in Space Research, V17, P105, DOI 10.1016/0273-1177(95)00766-8; OBERC P, 1990, ICARUS, V86, P314, DOI 10.1016/0019-1035(90)90221-T; Sanchez-Lavega A, 2015, NATURE, V518, P525, DOI 10.1038/nature14162; Tsurutani BT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017580; Zakharov A, 2014, PLANET SPACE SCI, V102, P171, DOI 10.1016/j.pss.2013.12.011; Zaslavsky A, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017480	20	34	35	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261							aad0398	10.1126/science.aad0398	http://dx.doi.org/10.1126/science.aad0398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542578				2022-12-28	WOS:000364162800003
J	Arakawa, T; Kobayashi-Yurugi, T; Alguel, Y; Iwanari, H; Hatae, H; Iwata, M; Abe, Y; Hino, T; Ikeda-Suno, C; Kuma, H; Kang, DC; Murata, T; Hamakubo, T; Cameron, AD; Kobayashi, T; Hamasaki, N; Iwata, S				Arakawa, Takatoshi; Kobayashi-Yurugi, Takami; Alguel, Yilmaz; Iwanari, Hiroko; Hatae, Hinako; Iwata, Momi; Abe, Yoshito; Hino, Tomoya; Ikeda-Suno, Chiyo; Kuma, Hiroyuki; Kang, Dongchon; Murata, Takeshi; Hamakubo, Takao; Cameron, Alexander D.; Kobayashi, Takuya; Hamasaki, Naotaka; Iwata, So			Crystal structure of the anion exchanger domain of human erythrocyte band 3	SCIENCE			English	Article							SITE-DIRECTED MUTAGENESIS; BLOOD-CELL BAND-3; MEMBRANE DOMAIN; CYTOPLASMIC DOMAIN; TRANSPORT PROTEIN; MOLECULAR-BASIS; BINDING-SITE; CATION LEAK; HUMAN AE1; IDENTIFICATION	Anion exchanger 1 (AE1), also known as band 3 or SLC4A1, plays a key role in the removal of carbon dioxide from tissues by facilitating the exchange of chloride and bicarbonate across the plasma membrane of erythrocytes. An isoform of AE1 is also present in the kidney. Specific mutations in human AE1 cause several types of hereditary hemolytic anemias and/or distal renal tubular acidosis. Here we report the crystal structure of the band 3 anion exchanger domain (AE1(CTD)) at 3.5 angstroms. The structure is locked in an outward-facing open conformation by an inhibitor. Comparing this structure with a substrate-bound structure of the uracil transporter UraA in an inward-facing conformation allowed us to identify the anion-binding position in the AE1(CTD), and to propose a possible transport mechanism that could explain why selected mutations lead to disease.	[Arakawa, Takatoshi; Kobayashi-Yurugi, Takami; Hino, Tomoya; Ikeda-Suno, Chiyo; Murata, Takeshi; Cameron, Alexander D.; Kobayashi, Takuya; Iwata, So] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Arakawa, Takatoshi; Ikeda-Suno, Chiyo; Kobayashi, Takuya; Iwata, So] JST, Res Accelerat Program, Membrane Prot Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Arakawa, Takatoshi; Kobayashi-Yurugi, Takami; Hino, Tomoya; Ikeda-Suno, Chiyo; Murata, Takeshi; Kobayashi, Takuya; Iwata, So] Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Alguel, Yilmaz; Iwata, Momi; Cameron, Alexander D.; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Alguel, Yilmaz; Iwata, Momi; Cameron, Alexander D.; Iwata, So] Diamond Light Source, Membrane Prot Lab, Chilton OX11 0DE, Oxon, England; [Alguel, Yilmaz; Cameron, Alexander D.; Iwata, So] Harwell Oxford, Appleton Lab, Harwell Rutherford, Didcot OX11 0FA, Oxon, England; [Iwanari, Hiroko; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Hatae, Hinako; Kuma, Hiroyuki; Hamasaki, Naotaka] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo, Nagasaki 8593298, Japan; [Abe, Yoshito] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Higashi Ku, Fukuoka 8128582, Japan; [Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 8128582, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Cameron, Alexander D.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; Platform Drug Discovery Informat & Struct Life Sc, Sakyo Ku, Kyoto 6068501, Japan	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyoto University; Imperial College London; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Tokyo; Nagasaki International University; Kyushu University; Kyushu University; Chiba University; University of Warwick	Cameron, AD (corresponding author), Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Human Receptor Crystallog Project, Sakyo Ku, Konoe Cho, Kyoto 6068501, Japan.	a.cameron@warwick.ac.uk; t-coba@mfour.med.kyoto-u.ac.jp; naotaka.hamasaki@city.sasebo.lg.jp; s.iwata@mfour.med.kyoto-u.ac.jp	Abe, Yoshito/D-8370-2012; Arakawa, Takatoshi/K-9739-2013; Murata, Takeshi/J-6181-2017; Abe, Yoshito/AAH-6141-2021	Abe, Yoshito/0000-0002-0016-8490; Arakawa, Takatoshi/0000-0001-6496-5440; Murata, Takeshi/0000-0002-5748-4670; Abe, Yoshito/0000-0002-0016-8490; Cameron, Alexander/0000-0001-8776-3518; Kuma, Hiroyuki/0000-0003-2027-8790	Biotechnology and Biological Sciences Research Council [BB/G023425/1, BB/D019516/1]; ERATO Human Receptor Crystallography Project of JST; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); MEXT's Platform for Drug Discovery, Informatics, and Structural Life Science; European Union's European Drug Initiative for Channels and Transporters [201924]; Wellcome Trust at the Diamond Light Source [WT089809];  [20370035];  [23370049]; BBSRC [BB/G023425/1, BB/D019516/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERATO Human Receptor Crystallography Project of JST; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); MEXT's Platform for Drug Discovery, Informatics, and Structural Life Science; European Union's European Drug Initiative for Channels and Transporters; Wellcome Trust at the Diamond Light Source(Wellcome Trust); ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the beamline scientists at Diamond Light Source, European Synchrotron Radiation Facility and SPring-8 for help with data collection; L. Bruce at the Bristol Institute for Transfusion Sciences; National Health Service Blood and Transplant; and A. Toye at the University of Bristol for useful discussion. S. Weyand contributed to the refinement of the Fab fragment, and R. Suno at Kyoto University contributed to the preparation of the figures. The project was funded by the Biotechnology and Biological Sciences Research Council (grants BB/G023425/1 and BB/D019516/1 to S.I.); the ERATO Human Receptor Crystallography Project of JST (to S.I.); the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) (to S.I.); a Grant-in-Aid for Scientific Research (B) (grants 20370035 and 23370049 to T.K.); MEXT's Platform for Drug Discovery, Informatics, and Structural Life Science (to T.K. and S.I.); and the European Union's European Drug Initiative for Channels and Transporters (grant 201924 to S.I. and A.C.). The authors are grateful for the use of the Membrane Protein Laboratory, funded by the Wellcome Trust (grant WT089809) at the Diamond Light Source. The authors declare no competing interests. The project was conceived by S.I., D.K., and N.H. H.H., H.K., and N.H. purified the AE1<INF>CTD</INF> protein. H.I. and T.Ha. raised the antibody using the AE1<INF>CTD</INF>-expressing baculovirus as an antigen. T.A., T.Hi., C.I.-S., and T.M. screened the antibody. T.K.-Y., T.K., T.A., Y.Ab., and M.I. crystallized the AE1<INF>CTD</INF> protein. T.K., Y.Al., A.D.C., and S.I. collected diffraction data. The structure was solved and refined by T.A., Y.Al. and A.D.C. The manuscript was written by T.K., A.D.C., Y.Al., and S.I. The coordinates and structure factors have been deposited with the Protein Data Bank (4YZF, band 3 with Fab4201; 5a16, Fab4201). T.A., T.K., T.K.-Y., T.Hi., T.M., N.N., S.I., T.Ha., H.I., Y.M., and N.H. are authors on a patent filed by JST Agency (JP 2013-103881 A) that covers the monoclonal antibody to human band 3.	Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; ALPER SL, 1988, J BIOL CHEM, V263, P17092; Barneaud-Rocca D, 2011, INT J CELL BIOL, V2011; Barneaud-Rocca D, 2013, J BIOL CHEM, V288, P26372, DOI 10.1074/jbc.M113.465989; Bonar P, 2013, J MOL BIOL, V425, P2591, DOI 10.1016/j.jmb.2013.04.005; BRAHM J, 1977, J GEN PHYSIOL, V70, P283, DOI 10.1085/jgp.70.3.283; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Bruce LJ, 1999, BBA-BIOMEMBRANES, V1416, P258, DOI 10.1016/S0005-2736(98)00231-4; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; CASEY JR, 1991, J BIOL CHEM, V266, P15726; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Cheung JC, 2005, MOL MEMBR BIOL, V22, P203, DOI 10.1080/09687860500093115; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; DAVIS L, 1989, J BIOL CHEM, V264, P9665; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; FURUYA W, 1984, J GEN PHYSIOL, V83, P657, DOI 10.1085/jgp.83.5.657; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Grey JL, 2012, BIOCHEMISTRY-US, V51, P6838, DOI 10.1021/bi300693k; GRINSTEIN S, 1978, BIOCHIM BIOPHYS ACTA, V507, P294, DOI 10.1016/0005-2736(78)90424-8; Hirai T, 2011, BIOCHEM CELL BIOL, V89, P148, DOI [10.1139/o10-160, 10.1139/O10-160]; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; JAROLIM P, 1995, BLOOD, V85, P634, DOI 10.1182/blood.V85.3.634.bloodjournal853634; JENNINGS ML, 1978, J MEMBRANE BIOL, V40, P365, DOI 10.1007/BF01874164; JENNINGS ML, 1976, J MEMBRANE BIOL, V28, P187, DOI 10.1007/BF01869697; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; Karbach D, 1998, BBA-BIOMEMBRANES, V1371, P114, DOI 10.1016/S0005-2736(98)00010-8; KNAUF PA, 1977, J GEN PHYSIOL, V69, P363, DOI 10.1085/jgp.69.3.363; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; LEPKE S, 1992, BIOCHIM BIOPHYS ACTA, V1106, P13, DOI 10.1016/0005-2736(92)90215-8; LEPKE S, 1976, BIOCHIM BIOPHYS ACTA, V455, P353, DOI 10.1016/0005-2736(76)90311-4; LINDENTHAL S, 1991, P NATL ACAD SCI USA, V88, P6540, DOI 10.1073/pnas.88.15.6540; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; OKUBO K, 1994, J BIOL CHEM, V269, P1918; PASSOW H, 1986, REV PHYSIOL BIOCH P, V103, P61; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; SHAMI Y, 1978, BIOCHIM BIOPHYS ACTA, V508, P357, DOI 10.1016/0005-2736(78)90337-1; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Stewart AK, 2011, AM J PHYSIOL-CELL PH, V300, pC1034, DOI 10.1152/ajpcell.00447.2010; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; Vastermark A, 2014, PROTEINS, V82, P336, DOI 10.1002/prot.24401; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; WALDER JA, 1984, J BIOL CHEM, V259, P238; WANG DN, 1993, EMBO J, V12, P2233, DOI 10.1002/j.1460-2075.1993.tb05876.x; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; WOOD PG, 1992, J MEMBRANE BIOL, V127, P139; Yamaguchi T, 2010, J MOL BIOL, V397, P179, DOI 10.1016/j.jmb.2010.01.027; Zhang DC, 2000, BLOOD, V96, P2925; Zhou XM, 2014, NATURE, V505, P569, DOI 10.1038/nature12811; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	61	148	151	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					680	684		10.1126/science.aaa4335	http://dx.doi.org/10.1126/science.aaa4335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542571	Green Submitted			2022-12-28	WOS:000364162800051
J	Dibner, C; Schibler, U				Dibner, Charna; Schibler, Ueli			A pancreatic clock times insulin release	SCIENCE			English	Editorial Material							METABOLISM		[Dibner, Charna] Univ Geneva, Dept Endocrinol Diabet Nutr & Hypertens, Ctr Diabet, Fac Med, CH-1211 Geneva 14, Switzerland; [Schibler, Ueli] Univ Geneva, Dept Mol Biol, Sci 3, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Dibner, C (corresponding author), Univ Geneva, Dept Endocrinol Diabet Nutr & Hypertens, Ctr Diabet, Fac Med, CH-1211 Geneva 14, Switzerland.	ueli.schibler@unige.ch						Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Chen Z, 2012, P NATL ACAD SCI USA, V109, P101, DOI 10.1073/pnas.1118034108; Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Perelis M, 2015, SCIENCE, V350, DOI 10.1126/science.aac4250; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; UNGER RH, 1975, LANCET, V1, P14; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	12	11	11	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					628	629		10.1126/science.aad5412	http://dx.doi.org/10.1126/science.aad5412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542553				2022-12-28	WOS:000364162800024
J	Mardones, P; Hetz, C				Mardones, Pablo; Hetz, Claudio			Peroxisomes Get Loud: A Redox Antidote to Hearing Loss	CELL			English	Editorial Material							PEJVAKIN; DAMAGE; MICE	Pejvakin (PJVK), a protein originally identified in Persian families with sensorineural hearing loss, regulates peroxisomal dynamics and the antioxidant defense triggered by noise exposure in hair cells and auditory neurons of the inner ear. These findings bring peroxisomes to the forefront of noise-induced hearing loss research.	[Mardones, Pablo; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago 7, Chile; [Mardones, Pablo; Hetz, Claudio] Univ Chile, Fac Med, Program Cellular & Mol Biol, Ctr Mol Studies Cell,Inst Biomed Sci, Santiago 7, Chile; [Hetz, Claudio] Univ Chile, FONDAP Ctr Gerosci Brain Hlth & Metab, Santiago 7, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Universidad de Chile; Harvard University; Harvard T.H. Chan School of Public Health	Hetz, C (corresponding author), Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago 7, Chile.	chetz@hsph.harvard.edu	Mardones, Pablo/ABG-3418-2021; Hetz, Claudio/ABD-7514-2021					Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Delmaghani S, 2015, CELL, V163, P894, DOI 10.1016/j.cell.2015.10.023; Fetoni AR, 2013, J NEUROSCI, V33, P4011, DOI 10.1523/JNEUROSCI.2282-12.2013; Heman-Ackah SE, 2010, OTOLARYNG HEAD NECK, V143, P429, DOI 10.1016/j.otohns.2010.04.266; Konings A, 2007, HUM MOL GENET, V16, P1872, DOI 10.1093/hmg/ddm135; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Wong ACY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00058; Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230	10	7	7	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					790	791		10.1016/j.cell.2015.10.060	http://dx.doi.org/10.1016/j.cell.2015.10.060			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544930	Bronze			2022-12-28	WOS:000364829700004
J	Xie, J; Wooten, M; Tran, V; Chen, BC; Pozmanter, C; Simbolon, C; Betzig, E; Chen, X				Xie, Jing; Wooten, Matthew; Vuong Tran; Chen, Bi-Chang; Pozmanter, Caitlin; Simbolon, Christine; Betzig, Eric; Chen, Xin			Histone H3 Threonine Phosphorylation Regulates Asymmetric Histone Inheritance in the Drosophila Male Germline	CELL			English	Article							STEM-CELL NICHE; THR-3 PHOSPHORYLATION; AURORA B; DIVISION; TESTIS; HASPIN; DNA; SPECIFICATION; SEGREGATION; CANCER	A long-standing question concerns how stem cells maintain their identity through multiple divisions. Previously, we reported that pre-existing and newly synthesized histone H3 are asymmetrically distributed during Drosophila male germline stem cell (GSC) asymmetric division. Here, we show that phosphorylation at threonine 3 of H3 (H3T3P) distinguishes pre-existing versus newly synthesized H3. Converting T3 to the unphosphorylatable residue alanine (H3T3A) or to the phosphomimetic aspartate (H3T3D) disrupts asymmetric H3 inheritance. Expression of H3T3A or H3T3D specifically in early-stage germline also leads to cellular defects, including GSC loss and germline tumors. Finally, compromising the activity of the H3T3 kinase Haspin enhances the H3T3A but suppresses the H3T3D phenotypes. These studies demonstrate that H3T3P distinguishes sister chromatids enriched with distinct pools of H3 in order to coordinate asymmetric segregation of "old'' H3 into GSCs and that tight regulation of H3T3 phosphorylation is required for male germline activity.	[Xie, Jing; Wooten, Matthew; Vuong Tran; Pozmanter, Caitlin; Simbolon, Christine; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Chen, Bi-Chang; Betzig, Eric] HHMI, Ashburn, VA 20147 USA	Johns Hopkins University; Howard Hughes Medical Institute	Chen, X (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	xchen32@jhu.edu	, jxie10@live.johnshopkins.edu/B-5028-2015; Chen, Bi-Chang/F-3480-2014	, jxie10@live.johnshopkins.edu/0000-0001-9715-3369; Chen, Bi-Chang/0000-0002-1876-7432; Wooten, Matthew/0000-0001-8629-9899; Pozmanter, Caitlin/0000-0001-5143-3955	NIH [R01HD065816, R01GM112008, 5T32GM007231]; David and Lucile Packard Foundation; Johns Hopkins University; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112008, T32GM007231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Johns Hopkins University(Johns Hopkins University); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Erhardt for anti-CID and Y-S. Lee, A. Spradling, M. Van Doren, R. Johnston, E. Moudrianakis, A. Hoyt, Y. Yamashita, K. Zhao, and X.C. lab members for suggestions. We thank Johns Hopkins Integrated Imaging Center for confocal imaging. Supported by NIH R01HD065816 and R01GM112008, the David and Lucile Packard Foundation, Johns Hopkins University start-up (X.C.), NIH 5T32GM007231 (M.W.), and Howard Hughes Medical Institute (E.B. and B.-C.C.).	Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Caperta AD, 2008, CYTOGENET GENOME RES, V122, P73, DOI 10.1159/000151319; Escriba MC, 2013, J CELL SCI, V126, P3214, DOI 10.1242/jcs.128900; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DiNardo S, 2011, DEVELOPMENT, V138, P1687, DOI 10.1242/dev.057364; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Eliazer S, 2011, P NATL ACAD SCI USA, V108, P7064, DOI 10.1073/pnas.1015874108; Eun SH, 2014, SCIENCE, V343, P1513, DOI 10.1126/science.1246514; Evano B, 2013, CHROMOSOME RES, V21, P225, DOI 10.1007/s10577-013-9359-7; Falconer E, 2010, NATURE, V463, P93, DOI 10.1038/nature08644; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Higgins JMG, 2010, CHROMOSOMA, V119, P137, DOI 10.1007/s00412-009-0250-4; Hime GR, 1996, J CELL SCI, V109, P2779; Inaba M, 2012, CELL STEM CELL, V11, P461, DOI 10.1016/j.stem.2012.09.003; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; KLAR AJS, 1994, TRENDS GENET, V10, P392, DOI 10.1016/0168-9525(94)90055-8; Klar AJS, 2007, ANNU REV GENET, V41, P213, DOI 10.1146/annurev.genet.39.073103.094316; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; LIN HF, 1994, DEVELOPMENT, V120, P947; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Monk AC, 2010, CELL STEM CELL, V6, P348, DOI 10.1016/j.stem.2010.02.016; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Panigada D, 2013, DEV CELL, V26, P483, DOI 10.1016/j.devcel.2013.07.013; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Tajbakhsh S, 2009, NAT REV MOL CELL BIO, V10, P804, DOI 10.1038/nrm2784; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Tazuke SI, 2002, DEVELOPMENT, V129, P2529; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tran V, 2013, CHROMOSOME RES, V21, P255, DOI 10.1007/s10577-013-9356-x; Van Doren M, 1998, CURR BIOL, V8, P243; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Tran V, 2012, SCIENCE, V338, P679, DOI 10.1126/science.1226028; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wu Q, 2010, ONCOGENE, V29, P4183, DOI 10.1038/onc.2010.165; Yadlapalli S, 2013, NATURE, V498, P251, DOI 10.1038/nature12106; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yennek S, 2013, SEMIN CELL DEV BIOL, V24, P627, DOI 10.1016/j.semcdb.2013.05.008; Yuan HB, 2012, DEV BIOL, V361, P57, DOI 10.1016/j.ydbio.2011.10.010	53	71	74	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					920	933		10.1016/j.cell.2015.10.002	http://dx.doi.org/10.1016/j.cell.2015.10.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26522592	Green Accepted, Bronze			2022-12-28	WOS:000364829700017
J	van Zuuren, EJ; Fedorowicz, Z				van Zuuren, Esther J.; Fedorowicz, Zbys			Interventions for Hirsutism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE	CLINICAL QUESTION What medical therapies are associated with greatest efficacy and fewest adverse events for treating hirsutism? BOTTOM LINE Oral contraceptive pills (OCPs) have been associated with improvement for mild hirsutism, as has flutamide (250mg) twice daily and spironolactone for more severe cases. Finasteride and gonadotropin-releasing analogues are associated with inconsistent results and metformin is not associated with benefit.	[van Zuuren, Esther J.] Leiden Univ, Dept Dermatol, Med Ctr, Leiden, Netherlands; [Fedorowicz, Zbys] Bahrain Branch Cochrane, Awali, Bahrain	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Zuuren, EJ (corresponding author), Leiden Univ, Dept Dermatol, Med Ctr, B1-Q,POB 2300 RC, Leiden, Netherlands.	e.j.van_zuuren@lumc.nl	van Zuuren, Esther/A-9512-2011; Fedorowicz, Zbys/C-6659-2008; Fedorowicz, Zbys/AAV-1691-2021	van Zuuren, Esther/0000-0002-4780-0182; Fedorowicz, Zbys/0000-0003-3952-965X; 				Ekback MP, 2013, DERMATOLOGY, V227, P278, DOI 10.1159/000355356; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Martin KA, 2008, J CLIN ENDOCR METAB, V93, P1105, DOI 10.1210/jc.2007-2437; van Zuuren EJ, 2015, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD010334.PUB2	4	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1863	1864		10.1001/jama.2015.11743	http://dx.doi.org/10.1001/jama.2015.11743			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529164				2022-12-28	WOS:000363960200019
J	Motavalli, J				Motavalli, Jim			Technology A solid future	NATURE			English	Editorial Material																		Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/NMAT3066, 10.1038/nmat3066]; Wang Y, 2015, NAT MATER, V14, P1026, DOI [10.1038/NMAT4369, 10.1038/nmat4369]	2	58	59	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S96	S97		10.1038/526S96a	http://dx.doi.org/10.1038/526S96a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8ZH	26509954	Bronze			2022-12-28	WOS:000363832100026
J	Tritos, NA; Klibanski, A				Tritos, Nicholas A.; Klibanski, Anne			Hyperprolactinemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROLACTIN; CABERGOLINE; DIAGNOSIS; SOCIETY		[Tritos, Nicholas A.; Klibanski, Anne] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Tritos, Nicholas A.; Klibanski, Anne] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Klibanski, A (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Zero Emerson Pl,Ste 112, Boston, MA 02114 USA.	aklibanski@partners.org	Jones, Thomas Hugh/E-8406-2015; Tritos, Nicholas/W-1594-2019; Jacobs, Howard/A-9845-2009	Jones, Thomas Hugh/0000-0002-9158-8393; Tritos, Nicholas/0000-0001-8867-607X; 				Biller BMK, 1996, J CLIN ENDOCR METAB, V81, P2338, DOI 10.1210/jc.81.6.2338; Casanueva FF, 2006, CLIN ENDOCRINOL, V65, P265, DOI 10.1111/j.1365-2265.2006.02562.x; Centers for Medicare & Medicaid Services, FEE SCHED CLAB2015; Karavitaki N, 2006, CLIN ENDOCRINOL, V65, P524, DOI 10.1111/j.1365-2265.2006.02627.x; Kars M, 2009, J CLIN ENDOCR METAB, V94, P2729, DOI 10.1210/jc.2009-0177; KLEINBERG DL, 1977, NEW ENGL J MED, V296, P589, DOI 10.1056/NEJM197703172961103; Klibanski A, 2010, NEW ENGL J MED, V362, P1219, DOI 10.1056/NEJMcp0912025; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Misra M, 2004, J CLIN PSYCHIAT, V65, P1607, DOI 10.4088/JCP.v65n1205; WEBSTER J, 1994, NEW ENGL J MED, V331, P904, DOI 10.1056/NEJM199410063311403	10	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1742	1743		10.1001/jama.2015.7871	http://dx.doi.org/10.1001/jama.2015.7871			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505599				2022-12-28	WOS:000363706300024
J	Hamilton, ES; Jensen, GS; Maksaev, G; Katims, A; Sherp, AM; Haswell, ES				Hamilton, Eric S.; Jensen, Gregory S.; Maksaev, Grigory; Katims, Andrew; Sherp, Ashley M.; Haswell, Elizabeth S.			Mechanosensitive channel MSL8 regulates osmotic forces during pollen hydration and germination	SCIENCE			English	Article							POLARIZED TIP GROWTH; ION CHANNELS; TUBE GROWTH; MSCS; EXPRESSION; DIVERSITY; FAMILIES; SURVIVAL; PLANTS; GENES	Pollen grains undergo dramatic changes in cellular water potential as they deliver the male germ line to female gametes, and it has been proposed that mechanosensitive ion channels may sense the resulting mechanical stress. Here, we identify and characterize MscS-like 8 (MSL8), a pollen-specific, membrane tension-gated ion channel required for pollen to survive the hypoosmotic shock of rehydration and for full male fertility. MSL8 negatively regulates pollen germination but is required for cellular integrity during germination and tube growth. MSL8 thus senses and responds to changes in membrane tension associated with pollen hydration and germination. These data further suggest that homologs of bacterial MscS have been repurposed in eukaryotes to function as mechanosensors in multiple developmental and environmental contexts.	[Hamilton, Eric S.; Jensen, Gregory S.; Maksaev, Grigory; Katims, Andrew; Sherp, Ashley M.; Haswell, Elizabeth S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Haswell, ES (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	ehaswell@wustl.edu	Haswell, Elizabeth/AAE-9370-2021	Haswell, Elizabeth/0000-0002-4246-065X	NSF [MCB1253103]; NIH [2R01GM084211]; Monsanto Excellence Fund Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084211] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Monsanto Excellence Fund Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NSF MCB1253103 and NIH 2R01GM084211 to E. S. Haswell and by the Monsanto Excellence Fund Fellowship to E. S. Hamilton. We acknowledge M. Wilson and the Donald Danforth Plant Science Center imaging facility for technical assistance, J. Harper for plasmid ps819, M. Johnson for line ms1-1, and the Arabidopsis Biological Resource Center for T-DNA insertion lines and ER-rk (CD3-959) and G-rk (CD3-967) membrane markers. The authors do not have any conflicts of interest. The supplementary materials contain additional data.	Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Arunkumar R, 2013, MOL BIOL EVOL, V30, P2475, DOI 10.1093/molbev/mst149; Beauzamy L, 2014, ANN BOT-LONDON, V114, P1517, DOI 10.1093/aob/mcu187; Bialecka-Fornal M, 2015, J BACTERIOL, V197, P231, DOI 10.1128/JB.02175-14; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Dutta R, 2004, PLANT PHYSIOL, V135, P1398, DOI 10.1104/pp.104.041483; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; FEIJO JA, 1995, PROTOPLASMA, V187, P155, DOI 10.1007/BF01280244; Firon N, 2012, ANN BOT-LONDON, V109, P1201, DOI 10.1093/aob/mcs070; Franchi GG, 2011, J EXP BOT, V62, P5267, DOI 10.1093/jxb/err154; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Hamant O, 2013, CURR OPIN PLANT BIOL, V16, P654, DOI 10.1016/j.pbi.2013.06.006; Hamilton ES, 2015, ANNU REV PLANT BIOL, V66, P113, DOI 10.1146/annurev-arplant-043014-114700; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Kroeger J, 2012, CURR OPIN PLANT BIOL, V15, P618, DOI 10.1016/j.pbi.2012.09.007; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Maksaev G, 2013, CHANNELS, V7, P215, DOI 10.4161/chan.24505; Maksaev G, 2011, J GEN PHYSIOL, V138, P641, DOI 10.1085/jgp.201110723; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Tunc-Ozdemir M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055277; TWELL D, 1989, PLANT PHYSIOL, V91, P1270, DOI 10.1104/pp.91.4.1270; Wang HJ, 2010, ADV BOT RES, V54, P1, DOI 10.1016/S0065-2296(10)54001-1	25	109	112	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					438	441		10.1126/science.aac6014	http://dx.doi.org/10.1126/science.aac6014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494758	Green Submitted, Green Accepted			2022-12-28	WOS:000363213400041
J	Kirk, PDW; Babtie, AC; Stumpf, MPH				Kirk, P. D. W.; Babtie, A. C.; Stumpf, M. P. H.			Systems biology (un)certainties	SCIENCE			English	Editorial Material							DYNAMIC-MODELS		[Kirk, P. D. W.] Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 0SR, England; [Babtie, A. C.; Stumpf, M. P. H.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England	MRC Biostatistics Unit; University of Cambridge; Imperial College London	Kirk, PDW (corresponding author), Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 0SR, England.	paul.kirk@mrc-bsu.cam.ac.uk; a.babtie@imperial.ac.uk; m.stumpf@imperial.ac.uk	Kirk, Paul/T-4991-2018	Kirk, Paul/0000-0002-5931-7489	Medical Research Council [MC_UP_0801/1] Funding Source: Medline; BBSRC [BB/K017284/1] Funding Source: UKRI; MRC [MC_UP_0801/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017284/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Azeloglu EU, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0880; Babtie AC, 2014, P NATL ACAD SCI USA, V111, P18507, DOI 10.1073/pnas.1414026112; Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Cohen JE, 2004, PLOS BIOL, V2, P2017, DOI 10.1371/journal.pbio.0020439; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Johnston IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07464; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Liepe J, 2015, ELIFE, V4, DOI 10.7554/eLife.07545; Meyer P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-13; Oates CJ, 2014, STAT APPL GENET MOL, V13, P611, DOI 10.1515/sagmb-2014-0012; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; Ruess J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0588; Silk D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003650; Sunnaker M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003621; Villaverde AF, 2015, COMPUT METH PROG BIO, V119, P17, DOI 10.1016/j.cmpb.2015.02.001	15	54	54	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					386	388		10.1126/science.aac9505	http://dx.doi.org/10.1126/science.aac9505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494748	Green Submitted			2022-12-28	WOS:000363213400025
J	Moreno-Risueno, MA; Sozzani, R; Yardimci, GG; Petricka, JJ; Vernoux, T; Blilou, I; Alonso, J; Winter, CM; Ohler, U; Scheres, B; Benfey, PN				Moreno-Risueno, Miguel A.; Sozzani, Rosangela; Yardimci, Galip Guerkan; Petricka, Jalean J.; Vernoux, Teva; Blilou, Ikram; Alonso, Jose; Winter, Cara M.; Ohler, Uwe; Scheres, Ben; Benfey, Philip N.			Transcriptional control of tissue formation throughout root development	SCIENCE			English	Article							ARABIDOPSIS ROOT; CELL-DIVISION; BOUNDARIES; GENES	Tissue patterns are dynamically maintained. Continuous formation of plant tissues during postembryonic growth requires asymmetric divisions and the specification of cell lineages. We show that the BIRDs and SCARECROW regulate lineage identity, positional signals, patterning, and formative divisions throughout Arabidopsis root growth. These transcription factors are postembryonic determinants of the ground tissue stem cells and their lineage. Upon further activation by the positional signal SHORT-ROOT (a mobile transcription factor), they direct asymmetric cell divisions and patterning of cell types. The BIRDs and SCARECROW with SHORT-ROOT organize tissue patterns at all formative steps during growth, ensuring developmental plasticity.	[Moreno-Risueno, Miguel A.] Univ Politecn Madrid, Ctr Plant Genom & Biotechnol, Dept Biotechnol, Pozuelo De Alarcon 28223, Madrid, Spain; [Sozzani, Rosangela; Yardimci, Galip Guerkan; Petricka, Jalean J.; Winter, Cara M.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Sozzani, Rosangela; Yardimci, Galip Guerkan; Petricka, Jalean J.; Winter, Cara M.; Benfey, Philip N.] Duke Univ, Howard Hughes Med Inst, Durham, NC 27708 USA; [Vernoux, Teva] Univ Lyon, Lab Reprod & Dev Plantes, ENS Lyon, CNRS,INRA,UCBL, F-69364 Lyon, France; [Blilou, Ikram; Scheres, Ben] Wageningen Univ Res, Dept Plant Biol, Wageningen, Netherlands; [Alonso, Jose] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Ohler, Uwe] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany	Universidad Politecnica de Madrid; Duke University; Duke University; Howard Hughes Medical Institute; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Wageningen University & Research; University of North Carolina; North Carolina State University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Alonso, Jose M/K-6826-2014; MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016; Vernoux, Teva/J-1695-2019	Alonso, Jose M/0000-0001-7087-1571; MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450; Vernoux, Teva/0000-0002-8257-4088; Scheres, Ben/0000-0001-5400-9578; Blilou, Ikram/0000-0001-8003-3782	NIH [R01-GM043778]; Gordon and Betty Moore Foundation [GBMF3405]; NSF [IOS-1021619-002]; MINECO; FEDER/EFDR [BFU2013-41160-P]; FP7 [PCIG11-GA-2012-322082]; Ramon y Cajal program (MINECO); NRSA [F32 GM106690-01]; NWO VIDI grant; ERC; NIH Ruth L. Kirschstein NRSA fellowship [F32 GM086976]; ERC Advanced Grant SysArc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778, F32GM106690, F32GM086976] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); MINECO(Spanish Government); FEDER/EFDR; FP7; Ramon y Cajal program (MINECO)(Spanish Government); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO VIDI grant(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); NIH Ruth L. Kirschstein NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC Advanced Grant SysArc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (R01-GM043778) and the Gordon and Betty Moore Foundation (GBMF3405) to P.N.B.; from the NSF (IOS-1021619-002) to U.O. and P.N.B.; and from MINECO, FEDER/EFDR (BFU2013-41160-P), and FP7 (PCIG11-GA-2012-322082) to M.A.M.-R. M.A.M.-R is supported by the Ramon y Cajal program (MINECO), C.M.W. by a NRSA F32 GM106690-01 fellowship, I.B. by a NWO VIDI grant, and B.S. by an ERC Advanced Grant SysArc. J.J.P. was supported by a NIH Ruth L. Kirschstein NRSA F32 GM086976 fellowship I.B. by a NWO VIDI grant, and B.S. by an ERC Advanced Grant SysArc. We thank D.R. McClay, D.M. Pernas, and Y. Long for critical reading of the manuscript. Additional data are in the supplementary materials. The National Center for Biotechnology Information Gene Expression Omnibus accession numbers are GSE60157 (microarrays) and GSE60011 (ChIP-Seq). The authors declare that they have no competing interests.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Cruz-Ramirez A, 2012, CELL, V150, P1002, DOI 10.1016/j.cell.2012.07.017; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Long YC, 2015, PLANT CELL, V27, P1185, DOI 10.1105/tpc.114.132407; Pernas M, 2010, CURR BIOL, V20, P818, DOI 10.1016/j.cub.2010.02.062; Petricka JJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000497; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Ten Hove CA, 2010, CURR BIOL, V20, P452, DOI 10.1016/j.cub.2010.01.018; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Zhou RR, 2011, PLANT J, V66, P712, DOI 10.1111/j.1365-313X.2011.04524.x	14	88	91	5	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					426	430		10.1126/science.aad1171	http://dx.doi.org/10.1126/science.aad1171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494755	Green Accepted			2022-12-28	WOS:000363213400038
J	Sartipy, U; Holzmann, MJ; Hjalgrim, H; Edgren, G				Sartipy, Ulrik; Holzmann, Martin J.; Hjalgrim, Henrik; Edgren, Gustaf			Red Blood Cell Concentrate Storage and Survival After Cardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DURATION		[Sartipy, Ulrik] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, SE-17176 Stockholm, Sweden; [Holzmann, Martin J.] Karolinska Univ Hosp, Dept Emergency Med, SE-17176 Stockholm, Sweden; [Hjalgrim, Henrik] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Edgren, Gustaf] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Statens Serum Institut; Karolinska Institutet	Sartipy, U (corresponding author), Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, SE-17176 Stockholm, Sweden.	ulrik.sartipy@karolinska.se	Edgren, Gustaf/F-4013-2014; Sartipy, Ulrik/E-9780-2014; Hjalgrim, Henrik/AAG-4973-2021	Edgren, Gustaf/0000-0002-2198-4745; Sartipy, Ulrik/0000-0003-2707-0263; 				Edgren G, 2015, TRANSFUSION, V55, P1600, DOI 10.1111/trf.12986; Edgren G, 2010, TRANSFUSION, V50, P1185, DOI 10.1111/j.1537-2995.2010.02583.x; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219	6	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1641	1643		10.1001/jama.2015.8690	http://dx.doi.org/10.1001/jama.2015.8690			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501540	Bronze			2022-12-28	WOS:000363028500024
J	Huang, XP; Karpiak, J; Kroeze, WK; Zhu, H; Chen, X; Moy, SS; Saddoris, KA; Nikolova, VD; Farrell, MS; Wang, S; Mangano, TJ; Deshpande, DA; Jiang, A; Penn, RB; Jin, J; Koller, BH; Kenakin, T; Shoichet, BK; Roth, BL				Huang, Xi-Ping; Karpiak, Joel; Kroeze, Wesley K.; Zhu, Hu; Chen, Xin; Moy, Sheryl S.; Saddoris, Kara A.; Nikolova, Viktoriya D.; Farrell, Martilias S.; Wang, Sheng; Mangano, Thomas J.; Deshpande, Deepak A.; Jiang, Alice; Penn, Raymond B.; Jin, Jian; Koller, Beverly H.; Kenakin, Terry; Shoichet, Brian K.; Roth, Bryan L.			Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; AIRWAY SMOOTH-MUSCLE; EXTRACELLULAR ACIDIFICATION; OGR1; EXPRESSION; PH; ACTIVATION; HIPPOCAMPUS; LORAZEPAM; ACIDOSIS	At least 120 non-olfactory G-protein-coupled receptors in the human genome are 'orphans' for which endogenous ligands are unknown, and many have no selective ligands, hindering the determination of their biological functions and clinical relevance. Among these is GPR68, a proton receptor that lacks small molecule modulators for probing its biology. Using yeast-based screens against GPR68, here we identify the benzodiazepine drug lorazepam as a non-selective GPR68 positive allosteric modulator. More than 3,000 GPR68 homology models were refined to recognize lorazepam in a putative allosteric site. Docking 3.1 million molecules predicted new GPR68 modulators, many of which were confirmed in functional assays. One potent GPR68 modulator, ogerin, suppressed recall in fear conditioning in wild-type but not in GPR68-knockout mice. The same approach led to the discovery of allosteric agonists and negative allosteric modulators for GPR65. Combining physical and structure-based screening may be broadly useful for ligand discovery for understudied and orphan GPCRs.	[Huang, Xi-Ping; Kroeze, Wesley K.; Zhu, Hu; Farrell, Martilias S.; Wang, Sheng; Mangano, Thomas J.; Jiang, Alice; Kenakin, Terry; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Huang, Xi-Ping; Mangano, Thomas J.; Jiang, Alice; Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth, Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA; [Karpiak, Joel; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Chen, Xin; Jin, Jian] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery CICBDD, Chapel Hill, NC 27599 USA; [Chen, Xin; Jin, Jian; Roth, Bryan L.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Moy, Sheryl S.; Saddoris, Kara A.; Nikolova, Viktoriya D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Moy, Sheryl S.; Saddoris, Kara A.; Nikolova, Viktoriya D.] Univ N Carolina, Carolina Inst Dev Disabil CIDD, Chapel Hill, NC 27599 USA; [Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Koller, Beverly H.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Jefferson University; Jefferson University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Roth, BL (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	bshoichet@gmail.com; bryan_roth@med.unc.edu	Roth, Bryan/ABE-7032-2020; zhu, hu/GQQ-8365-2022; Roth, Bryan L/F-3928-2010	Roth, Bryan/0000-0002-0561-6520; Huang, Xi-Ping/0000-0002-2585-653X; Chen, Xin/0000-0002-5208-2154	National Institutes of Health (NIH) [U01104974, R01 DA017204]; National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP); Michael Hooker Chair for Protein Therapeutics and Translational Proteomics; Genentech Foundation Predoctoral Fellowship; NIH [GM59957, GM71896, U19MH082441]; Structural Genomics Consortium; NICHD [U54 HD079124];  [P01 HL114471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059957, R01GM071896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, U01MH104974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R01DA027170] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP); Michael Hooker Chair for Protein Therapeutics and Translational Proteomics; Genentech Foundation Predoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Genomics Consortium(University of Toronto); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants U01104974 (B.L.R., B.K.S. and W.K.K.), R01 DA017204 (B.L.R. and W.K.K.) and the National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP) (X.-P.H., H.Z., M.S.F., W.K.K., T.J.M., A.J. and B.L.R.), the Michael Hooker Chair for Protein Therapeutics and Translational Proteomics to B.L.R.; Genentech Foundation Predoctoral Fellowship (J.K.); NIH grants GM59957 and GM71896 (B.K.S.) and the Structural Genomics Consortium (B.K.S.); grant P01 HL114471 (R.B.P. and D.A.D.); NICHD grant U54 HD079124 (M.S.M., K.A.S., V.N.); NIH grant U19MH082441 (B.L.R., J.J. and X.C.). We thank Mark Pausch (Merck & Co.) for providing us G<INF>s</INF>- and G<INF>q</INF>-yeast strains for yeast screening assays.	Aoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079985; Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m; Chen YJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-39; Chung S, 2008, BRIT J PHARMACOL, V153, pS339, DOI 10.1038/sj.bjp.0707606; Daumas S, 2007, NEUROBIOL LEARN MEM, V88, P94, DOI 10.1016/j.nlm.2007.02.001; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Evers A, 2004, ANGEW CHEM INT EDIT, V43, P248, DOI 10.1002/anie.200352776; Ferguson FM, 2013, J MED CHEM, V56, P10183, DOI 10.1021/jm401582c; Frick KK, 2009, J BONE MINER RES, V24, P305, DOI 10.1359/JBMR.081015; Gravius A, 2006, NEUROPHARMACOLOGY, V51, P1146, DOI 10.1016/j.neuropharm.2006.07.008; GREENBLATT DJ, 1976, CLIN PHARMACOL THER, V20, P329; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Kalk P, 2007, BRIT J PHARMACOL, V151, P1025, DOI 10.1038/sj.bjp.0707319; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Knapp S, 2013, NAT CHEM BIOL, V9, P3, DOI 10.1038/nchembio.1113; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Li Jing, 2013, J Mol Signal, V8, P6, DOI 10.1186/1750-2187-8-6; Liu JP, 2010, AM J PHYSIOL-HEART C, V299, pH731, DOI 10.1152/ajpheart.00977.2009; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsuzaki S, 2011, BIOCHEM BIOPH RES CO, V413, P499, DOI 10.1016/j.bbrc.2011.08.087; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Mogi C, 2014, ENDOCR J, V61, P101, DOI 10.1507/endocrj.EJ13-0380; Mohebbi N, 2012, CELL PHYSIOL BIOCHEM, V29, P313, DOI 10.1159/000338486; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Onozawa Y, 2012, EUR J PHARMACOL, V683, P325, DOI 10.1016/j.ejphar.2012.03.007; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pompeia S, 2005, J PHYSIOL-LONDON, V569, P709, DOI 10.1113/jphysiol.2005.569005; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; Russell JL, 2012, ACS CHEM BIOL, V7, P1077, DOI 10.1021/cb300001m; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Schneider JW, 2012, ACS CHEM NEUROSCI, V3, P557, DOI 10.1021/cn300025a; Schoepp DD, 2011, NAT REV DRUG DISCOV, V10, P715, DOI 10.1038/nrd3559; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Thompson SA, 2002, MOL PHARMACOL, V61, P861, DOI 10.1124/mol.61.4.861; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Wang JQ, 2012, INT J BIOCHEM CELL B, V44, P1937, DOI 10.1016/j.biocel.2012.07.015; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200	44	155	159	5	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					477	+		10.1038/nature15699	http://dx.doi.org/10.1038/nature15699			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26550826	Green Accepted, Green Submitted			2022-12-28	WOS:000365352500039
J	Chen, W; Wu, YZ; Yue, YF; Liu, J; Zhang, WJ; Yang, XD; Chen, H; Bi, EB; Ashraful, I; Gratzel, M; Han, LY				Chen, Wei; Wu, Yongzhen; Yue, Youfeng; Liu, Jian; Zhang, Wenjun; Yang, Xudong; Chen, Han; Bi, Enbing; Ashraful, Islam; Graetzel, Michael; Han, Liyuan			Efficient and stable large-area perovskite solar cells with inorganic charge extraction layers	SCIENCE			English	Article							HIGH-PERFORMANCE; TITANIUM-OXIDE; THIN-FILMS; ELECTRON; LENGTHS; LIGHT	The recent dramatic rise in power conversion efficiencies (PCEs) of perovskite solar cells (PSCs) has triggered intense research worldwide. However, high PCE values have often been reached with poor stability at an illuminated area of typically less than 0.1 square centimeter. We used heavily doped inorganic charge extraction layers in planar PSCs to achieve very rapid carrier extraction, even with 10- to 20-nanometer-thick layers, avoiding pinholes and eliminating local structural defects over large areas. The robust inorganic nature of the layers allowed for the fabrication of PSCs with an aperture area >1 square centimeter that have a PCE >15%, as certified by an accredited photovoltaic calibration laboratory. Hysteresis in the current-voltage characteristics was eliminated; the PSCs were stable, with >90% of the initial PCE remaining after 1000 hours of light soaking.	[Chen, Wei; Wu, Yongzhen; Yue, Youfeng; Liu, Jian; Ashraful, Islam; Han, Liyuan] Natl Inst Mat Sci, Photovolta Mat Unit, Tsukuba, Ibaraki 3050047, Japan; [Chen, Wei; Zhang, Wenjun] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Michael Gratzel Ctr Mesoscop Solar Cells, Wuhan 430074, Peoples R China; [Yang, Xudong; Chen, Han; Bi, Enbing; Han, Liyuan] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China; [Graetzel, Michael] Swiss Fed Inst Technol, Dept Chem & Chem Engn, Lab Photon & Interfaces, CH-1015 Lausanne, Switzerland	National Institute for Materials Science; Huazhong University of Science & Technology; Shanghai Jiao Tong University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gratzel, M (corresponding author), Swiss Fed Inst Technol, Dept Chem & Chem Engn, Lab Photon & Interfaces, Stn 6, CH-1015 Lausanne, Switzerland.	michael.graetzel@epfl.ch; han.liyuan@nims.go.jp	Wu, Yongzhen/O-3796-2016; Chen, Han/S-4723-2017; Yang, Xudong/S-4750-2017; ISLAM, Ashraful/H-2973-2011; Han, Liyuan/O-2856-2019; Wu, Yongzhen/GNM-8356-2022; Chen, Wei/T-7147-2019; Chen, Wei/C-7964-2017; Yue, Youfeng/K-9606-2018; Nazeeruddin, Mohammad K/B-1323-2008	Wu, Yongzhen/0000-0003-3000-403X; Chen, Han/0000-0002-3727-6823; Yang, Xudong/0000-0002-3877-7830; ISLAM, Ashraful/0000-0002-1633-1432; Han, Liyuan/0000-0001-9766-9015; Wu, Yongzhen/0000-0003-3000-403X; Yue, Youfeng/0000-0002-5600-1112; Nazeeruddin, Mohammad K/0000-0001-5955-4786; Chen, Wei/0000-0002-2418-9210	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Swiss Nanotera; Swiss National Science Foundation [PV2050]	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Swiss Nanotera; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was partially supported by the Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency. The authors thank H. Kanai at the Materials Analysis Station of the National Institute for Materials Science, Japan, for high-resolution SEM image measurement and T. Shimizu and T. Ishikawa for technical support. L.H. thanks for H. Naito of Osaka Prefecture University and M. Shimizu of the Institute of Advanced Energy, Kyoto University for their useful discussions. M.G. acknowledges financial support of this work under the Swiss Nanotera and Swiss National Science Foundation PV2050 program and acknowledges his affiliation as a visiting faculty member with Nanyang Technological University, Singapore and the Advanced Institute for Nanotechnology at Sungkyunkwan University, Suwon, South Korea.	Aberle AG, 2000, PROG PHOTOVOLTAICS, V8, P473, DOI 10.1002/1099-159X(200009/10)8:5<473::AID-PIP337>3.0.CO;2-D; Alidoust N, 2014, CHEMSUSCHEM, V7, P195, DOI 10.1002/cssc.201300595; [Anonymous], 2014, NAT NANOTECHNOL, V9, P657, DOI DOI 10.1038/NNANO.2014.206; Beard MC, 2014, NAT NANOTECHNOL, V9, P951, DOI 10.1038/nnano.2014.292; Braun S, 2009, ADV MATER, V21, P1450, DOI 10.1002/adma.200802893; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chen XF, 2015, INT J CLIN EXP MED, V8, P5044; Deng JK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4769210; Dong QF, 2015, SCIENCE, V347, P967, DOI 10.1126/science.aaa5760; Furubayashi Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1949728; Gratzel M, 2014, NAT MATER, V13, P838, DOI 10.1038/nmat4065; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P805, DOI 10.1002/pip.2637; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Gunther Ma, 2015, CHEM WORLD; Heo JH, 2015, ADV MATER, V27, P3424, DOI 10.1002/adma.201500048; Heo JH, 2015, ENERG ENVIRON SCI, V8, P1602, DOI 10.1039/c5ee00120j; Hodes G, 2013, SCIENCE, V342, P317, DOI 10.1126/science.1245473; Huang ZF, 2014, RSC ADV, V4, P60670, DOI 10.1039/c4ra09727k; Jayawardena KDGI, 2015, NAT PHOTONICS, V9, P207, DOI 10.1038/nphoton.2015.45; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Joshi US, 2006, APPL SURF SCI, V252, P2524, DOI 10.1016/j.apsusc.2005.03.239; Kim JH, 2015, ADV MATER, V27, P695, DOI 10.1002/adma.201404189; Kim YH, 2011, ADV FUNCT MATER, V21, P1076, DOI 10.1002/adfm.201002290; Kuwabara T, 2008, SOL ENERG MAT SOL C, V92, P1476, DOI 10.1016/j.solmat.2008.06.012; Kuwabara T, 2009, THIN SOLID FILMS, V517, P3766, DOI 10.1016/j.tsf.2008.12.039; Lee K, 2007, ADV MATER, V19, P2445, DOI 10.1002/adma.200602653; Li X, 2015, ENERGY TECHNOL-GER, V3, P551, DOI 10.1002/ente.201500045; Lin QQ, 2015, NAT PHOTONICS, V9, P106, DOI [10.1038/NPHOTON.2014.284, 10.1038/nphoton.2014.284]; Liu J, 2015, ADV MATER, V27, P4918, DOI 10.1002/adma.201501489; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Liu XD, 2015, ACS APPL MATER INTER, V7, P6230, DOI 10.1021/acsami.5b00468; Malinkiewicz O, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400345; Malinkiewicz O, 2014, NAT PHOTONICS, V8, P128, DOI [10.1038/NPHOTON.2013.141, 10.1038/nphoton.2013.341]; Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763; Nie WY, 2015, SCIENCE, V347, P522, DOI 10.1126/science.aaa0472; Park JH, 2015, ADV MATER, V27, P4013, DOI 10.1002/adma.201500523; WITTENAUER MA, 1982, PHILOS MAG B, V46, P659, DOI 10.1080/01418638208223551; Wojciechowski K, 2014, ENERG ENVIRON SCI, V7, P1142, DOI 10.1039/c3ee43707h; Wu CC, 2015, SOL ENERG MAT SOL C, V132, P492, DOI 10.1016/j.solmat.2014.09.017; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; Yang Z, 2015, NANO ENERGY, V15, P670, DOI 10.1016/j.nanoen.2015.05.027; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Zhu ZL, 2014, ANGEW CHEM INT EDIT, V53, P12571, DOI 10.1002/anie.201405176; Zimmermann E, 2014, NAT PHOTONICS, V8, P669, DOI 10.1038/nphoton.2014.210	46	1773	1803	48	1821	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					944	948		10.1126/science.aad1015	http://dx.doi.org/10.1126/science.aad1015			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26516198				2022-12-28	WOS:000364955200041
J	Gerber, S; Jang, H; Nojiri, H; Matsuzawa, S; Yasumura, H; Bonn, DA; Liang, R; Hardy, WN; Islam, Z; Mehta, A; Song, S; Sikorski, M; Stefanescu, D; Feng, Y; Kivelson, SA; Devereaux, TP; Shen, ZX; Kao, CC; Lee, WS; Zhu, D; Lee, JS				Gerber, S.; Jang, H.; Nojiri, H.; Matsuzawa, S.; Yasumura, H.; Bonn, D. A.; Liang, R.; Hardy, W. N.; Islam, Z.; Mehta, A.; Song, S.; Sikorski, M.; Stefanescu, D.; Feng, Y.; Kivelson, S. A.; Devereaux, T. P.; Shen, Z. -X.; Kao, C. -C.; Lee, W. -S.; Zhu, D.; Lee, J. -S.			Three-dimensional charge density wave order in YBa2Cu3O6.67 at high magnetic fields	SCIENCE			English	Article							QUASI-PARTICLE STATES; FERMI-SURFACE; SUPERCONDUCTIVITY	Charge density wave (CDW) correlations have been shown to universally exist in cuprate superconductors. However, their nature at high fields inferred from nuclear magnetic resonance is distinct from that measured with x-ray scattering at zero and low fields. We combined a pulsed magnet with an x-ray free-electron laser to characterize the CDW in YBa2Cu3O6.67 via x-ray scattering in fields of up to 28 tesla. While the zero-field CDW order, which develops at temperatures below similar to 150 kelvin, is essentially two dimensional, at lower temperature and beyond 15 tesla, another three-dimensionally ordered CDW emerges. The field-induced CDW appears around the zero-field superconducting transition temperature; in contrast, the incommensurate in-plane ordering vector is field-independent. This implies that the two forms of CDW and high-temperature superconductivity are intimately linked.	[Gerber, S.; Devereaux, T. P.; Shen, Z. -X.; Lee, W. -S.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Gerber, S.; Devereaux, T. P.; Shen, Z. -X.; Lee, W. -S.] Stanford Univ, Menlo Pk, CA 94025 USA; [Jang, H.; Mehta, A.; Lee, J. -S.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Nojiri, H.; Matsuzawa, S.; Yasumura, H.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Bonn, D. A.; Liang, R.; Hardy, W. N.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Bonn, D. A.; Liang, R.; Hardy, W. N.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Islam, Z.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Song, S.; Sikorski, M.; Stefanescu, D.; Feng, Y.; Zhu, D.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Kivelson, S. A.; Shen, Z. -X.] Stanford Univ, Dept Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Kivelson, S. A.; Shen, Z. -X.] Stanford Univ, Dept Appl Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Kao, C. -C.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Tohoku University; University of British Columbia; Canadian Institute for Advanced Research (CIFAR); United States Department of Energy (DOE); Argonne National Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Zhu, D (corresponding author), SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA.	leews@stanford.edu; dlzhu@slac.stanford.edu; jslee@slac.stanford.edu	Nojiri, Hiroyuki/B-3688-2011; song, sanghoon/AAE-1798-2022; Hardy, Walter Newbold/AAN-7827-2020; Gerber, Simon/A-4566-2012	Nojiri, Hiroyuki/0000-0002-9676-7710; song, sanghoon/0000-0003-3493-1850; Gerber, Simon/0000-0002-5717-2626; Kivelson, Steven/0000-0001-9149-9502; Jang, Hoyoung/0000-0002-7160-9038	U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Swiss National Science Foundation [P2EZP2_148737]; KAKENHI [23224009]; International Collaboration Center-Institute for Materials Research; MD-program	U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); International Collaboration Center-Institute for Materials Research; MD-program	We thank J. Hastings, J. Defever, D. Damiani, G. Curie, and V. Borzenet for technical assistance in developing the scattering setup. Discussions with C. Mielke are acknowledged. This work was supported by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-76SF00515. X-ray FEL studies were carried out at the Linac Coherent Light Source, a Directorate of SLAC and an Office of Science User Facility operated for the DOE, Office of Science by Stanford University. Soft and hard x-ray scattering studies were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC and an Office of Science User Facility operated for the DOE, Office of Science by Stanford University. Hard x-ray scattering studies were also conducted at the Advanced Photon Source, supported by the DOE, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-06CH11357. S.G. acknowledges partial support by the Swiss National Science Foundation under fellowship P2EZP2_148737. H.N. acknowledges the support by Grants-in-Aid for Scientific Research (KAKENHI) 23224009, International Collaboration Center-Institute for Materials Research, and MD-program. Materials development was supported by the Natural Sciences and Engineering Research Council and by the Canadian Institute for Advanced Research.	Agterberg DF, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.104512; Blackburn E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137004; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; Chen HD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187002; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; da Silva Neto EH, 2015, SCIENCE, V347, P282, DOI [10.1126/science.1256441, 10.1126/science.aaa2148]; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Fradkin E, 2012, NAT PHYS, V8, P864, DOI 10.1038/nphys2498; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Grissonnanche G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4280; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Lake B, 2005, NAT MATER, V4, P658, DOI 10.1038/nmat1452; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; LeBoeuf D, 2013, NAT PHYS, V9, P79, DOI 10.1038/nphys2502; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Lee PA, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031017; Leos NG, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.044709; Sebastian SE, 2014, NATURE, V511, P61, DOI 10.1038/nature13326; Sebastian SE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102501; Tabis W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6875; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wu T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7438; Wu T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3113; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345	28	228	230	8	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					949	952		10.1126/science.aac6257	http://dx.doi.org/10.1126/science.aac6257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26541608	Green Submitted			2022-12-28	WOS:000364955200042
J	Hardt, WD				Hardt, Wolf-Dietrich			Homed to the hideout	NATURE			English	Editorial Material							THERAPY		[Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hardt, WD (corresponding author), ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.	hardt@micro.biol.ethz.ch		Hardt, Wolf-Dietrich/0000-0002-9892-6420				Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Giang I, 2014, AAPS J, V16, P899, DOI 10.1208/s12248-014-9638-z; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Joller N, 2010, P NATL ACAD SCI USA, V107, P20441, DOI 10.1073/pnas.1013827107; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Lehar SM, 2015, NATURE, V527, P323, DOI 10.1038/nature16057; Porte R, 2015, ANTIMICROB AGENTS CH, V59, P6064, DOI 10.1128/AAC.01210-15; World Health Organization, 2016, ANTIMICROBIAL RESIST; Yacoby Iftach, 2007, Infectious Disorders - Drug Targets, V7, P221, DOI 10.2174/187152607782109998	10	3	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					309	310		10.1038/nature15647	http://dx.doi.org/10.1038/nature15647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26536107				2022-12-28	WOS:000365356800038
J	Rak, J				Rak, Janusz			CANCER Organ-seeking vesicles	NATURE			English	Editorial Material							PRE-METASTATIC NICHE; EXTRACELLULAR VESICLES; EXOSOMES; CELLS; INITIATE		[Rak, Janusz] McGill Univ, Dept Pediat, Montreal, PQ H4A 3J1, Canada; [Rak, Janusz] McGill Univ, Res Inst, Ctr Hlth, Montreal Childrens Hospital, Montreal, PQ H4A 3J1, Canada	McGill University; McGill University	Rak, J (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ H4A 3J1, Canada.	janusz.rak@mcgill.ca		Rak, Janusz/0000-0002-2912-5566				Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; POSTE G, 1980, P NATL ACAD SCI-BIOL, V77, P399, DOI 10.1073/pnas.77.1.399; Rak J, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00021; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053	13	27	29	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					312	314		10.1038/nature15642	http://dx.doi.org/10.1038/nature15642			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26524529				2022-12-28	WOS:000365356800041
J	Harris, IS; Brugge, JS				Harris, Isaac S.; Brugge, Joan S.			CANCER The enemy of my enemy is my friend	NATURE			English	Editorial Material							OXIDATIVE STRESS; ANTIOXIDANTS; ROS		[Harris, Isaac S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ludwig Ctr Harvard, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harris, IS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	isaac_harris@hms.harvard.edu; joan_brugge@hms.harvard.edu		Harris, Isaac/0000-0002-6855-2763				Chandel NS, 2014, NEW ENGL J MED, V371, P177, DOI 10.1056/NEJMcibr1405701; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268	14	34	34	4	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					170	171		10.1038/nature15644	http://dx.doi.org/10.1038/nature15644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26503052				2022-12-28	WOS:000364396700028
J	Ervin, AM; Taylor, HA; Meinert, CL; Ehrhardt, S				Ervin, Ann-Margret; Taylor, Holly A.; Meinert, Curtis L.; Ehrhardt, Stephan			Evidence gaps and ethical review of multicenter studies	SCIENCE			English	Editorial Material							TRIALS; BOARD		[Ervin, Ann-Margret; Taylor, Holly A.; Meinert, Curtis L.; Ehrhardt, Stephan] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Taylor, Holly A.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Ervin, AM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	aervin@jhu.edu	Ehrhardt, Stephan/D-8957-2017		National Human Genome Research Institute, NIH [1R01HG008558-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008558] Funding Source: NIH RePORTER	National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	A.-M.E., H.A.T., C.L.M., and S.E. are supported by National Human Genome Research Institute, NIH. grant 1R01HG008558-01.	Abbott D, 2013, THER INNOV REGUL SCI, V47, P152, DOI 10.1177/2168479012464371; Alberti KGMM, 2000, BRIT MED J, V320, P1157, DOI 10.1136/bmj.320.7243.1157; [Anonymous], 2015, FED REGISTER, V80, P53931; [Anonymous], 2006, NAT C ALT IRB MOD OP; Check DK, 2013, CLIN TRIALS, V10, P560, DOI 10.1177/1740774513484393; Christian MC, 2002, NEW ENGL J MED, V346, P1405, DOI 10.1056/NEJM200205023461814; Kaufmann P, 2015, ACAD MED, V90, P321, DOI 10.1097/ACM.0000000000000562; McDeavitt J. T., 2010, USE EXTERNAL IRBS IS; Millum J, 2010, ANN INTERN MED, V153, P655, DOI 10.7326/0003-4819-153-10-201011160-00008; National Institutes of Health, 2014, REQ COMM DRAFT NIH P; Taylor Holly A, 2007, IRB, V29, P9	11	9	9	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					632	633		10.1126/science.aac4872	http://dx.doi.org/10.1126/science.aac4872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV3MH	26542556	Green Accepted			2022-12-28	WOS:000364162800027
J	Eisenstein, M				Eisenstein, Michael			The power of petabytes	NATURE			English	Editorial Material																			0	32	32	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					S2	S4		10.1038/527S2a	http://dx.doi.org/10.1038/527S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536222	hybrid			2022-12-28	WOS:000364270700024
J	Badhiwala, JH; Nassiri, F; Alhazzani, W; Selim, MH; Farrokhyar, F; Spears, J; Kulkarni, AV; Singh, S; Alqahtani, A; Rochwerg, B; Alshahrani, M; Murty, NK; Alhazzani, A; Yarascavitch, B; Reddy, K; Zaidat, OO; Almenawer, SA				Badhiwala, Jetan H.; Nassiri, Farshad; Alhazzani, Waleed; Selim, Magdy H.; Farrokhyar, Forough; Spears, Julian; Kulkarni, Abhaya V.; Singh, Sheila; Alqahtani, Abdulrahman; Rochwerg, Bram; Alshahrani, Mohammad; Murty, Naresh K.; Alhazzani, Adel; Yarascavitch, Blake; Reddy, Kesava; Zaidat, Osama O.; Almenawer, Saleh A.			Endovascular Thrombectomy for Acute Ischemic Stroke A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS T-PA; EARLY MANAGEMENT; THERAPY; RETRIEVER; BIAS; THROMBOLYSIS; GUIDELINES; ECASS; TRIAL	IMPORTANCE Endovascular intervention for acute ischemic stroke improves revascularization. But trials examining endovascular therapy yielded variable functional outcomes, and the effect of endovascular intervention among subgroups needs better definition. OBJECTIVE To examine the association between endovascular mechanical thrombectomy and clinical outcomes among patients with acute ischemic stroke. DATA SOURCES We systematically searched MEDLINE, EMBASE, CINAHL, Google Scholar, and the Cochrane Library without language restriction through August 2015. STUDY SELECTION Eligible studies were randomized clinical trials of endovascular therapy with mechanical thrombectomy vs standard medical care, which includes the use of intravenous tissue plasminogen activator (tPA). DATA EXTRACTION AND SYNTHESIS Independent reviewers evaluated the quality of studies and abstracted the data. We calculated odds ratios (ORs) and 95% CIs for all outcomes using random-effects meta-analyses and performed subgroup and sensitivity analyses to examine whether certain imaging, patient, treatment, or study characteristics were associated with improved functional outcome. The strength of the evidence was examined for all outcomes using the GRADE method. MAIN OUTCOMES AND MEASURES Ordinal improvement across modified Rankin scale (mRS) scores at 90 days, functional independence (mRS score, 0-2), angiographic revascularization at 24 hours, symptomatic intracranial hemorrhage within 90 days, and all-cause mortality at 90 days. RESULTS Data were included from 8 trials involving 2423 patients (mean [SD] age, 67.4 [14.4] years; 1131 [46.7%] women), including 1313 who underwent endovascular thrombectomy and 1110 who received standard medical care with tPA. In ameta-analysis of these trials, endovascular therapy was associated with a significant proportional treatment benefit across mRS scores (OR, 1.56; 95% CI, 1.14-2.13; P = .005). Functional independence at 90 days (mRS score, 0-2) occurred among 557 of 1293 patients (44.6%; 95% CI, 36.6%-52.8%) in the endovascular therapy group vs 351 of 1094 patients (31.8%; 95% CI, 24.6%-40.0%) in the standard medical care group (risk difference, 12%; 95% CI, 3.8%-20.3%; OR, 1.71; 95% CI, 1.18-2.49; P = .005). Compared with standard medical care, endovascular thrombectomy was associated with significantly higher rates of angiographic revascularization at 24 hours (75.8% vs 34.1%; OR, 6.49; 95% CI, 4.79-8.79; P < .001) but no significant difference in rates of symptomatic intracranial hemorrhage within 90 days (70 events [5.7%] vs 53 events [5.1%]; OR, 1.12; 95% CI, 0.77-1.63; P = .56) or all-cause mortality at 90 days (218 deaths [15.8%] vs 201 deaths [17.8%]; OR, 0.87; 95% CI, 0.68-1.12; P = .27). CONCLUSIONS AND RELEVANCE Among patients with acute ischemic stroke, endovascular therapy with mechanical thrombectomy vs standard medical care with tPA was associated with improved functional outcomes and higher rates of angiographic revascularization, but no significant difference in symptomatic intracranial hemorrhage or all-cause mortality at 90 days.	[Badhiwala, Jetan H.; Nassiri, Farshad; Spears, Julian; Kulkarni, Abhaya V.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Alhazzani, Waleed; Farrokhyar, Forough; Singh, Sheila; Rochwerg, Bram; Murty, Naresh K.; Reddy, Kesava; Almenawer, Saleh A.] McMaster Univ, Dept Clin Epidemiol & Biostat, Div Neurosurg, Hamilton, ON L8S 4L8, Canada; [Selim, Magdy H.] Beth Israel Deaconess Med Ctr, Dept Neurol, Stroke Div, Boston, MA 02215 USA; [Selim, Magdy H.] Harvard Univ, Sch Med, Boston, MA USA; [Alqahtani, Abdulrahman] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Alshahrani, Mohammad] Dammam Univ, Dept Med, Dammam, Saudi Arabia; [Alhazzani, Adel] King Khalid Univ, Dept Neurol, Abha, Saudi Arabia; [Yarascavitch, Blake] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA	University of Toronto; McMaster University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Ottawa; Imam Abdulrahman Bin Faisal University; King Khalid University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Almenawer, SA (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Div Neurosurg, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.	Dr_menawer@hotmail.com	Farrokhyar, Forough/AAQ-6005-2021; Reddy, Kesava/AAR-8866-2021; Alqahtani, Abdulrahman/R-7755-2019; Alhazzani, Adel/AAK-1166-2021; Alhazzani, Adel/AAS-1283-2021; Rochwerg, Bram/AAE-7606-2020; Singh, Sheila K/W-2799-2018; Yarascavitch, Blake/AAR-8800-2021	Farrokhyar, Forough/0000-0001-9928-9016; Alhazzani, Adel/0000-0002-9884-2243; Alhazzani, Adel/0000-0002-9884-2243; Singh, Sheila K/0000-0003-1272-5300; Yarascavitch, Blake/0000-0003-1810-1267				Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bhatia R, 2014, INT J STROKE, V9, P974, DOI 10.1111/j.1747-4949.2012.00890.x; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; Copas JB, 2001, STAT METHODS MED RES, V10, P251, DOI 10.1191/096228001678227776; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Katz JM, 2006, EXPERT REV MED DEVIC, V3, P273, DOI 10.1586/17434440.3.3.273; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; la Rosa FD, 2012, STROKE, V43, P1591, DOI 10.1161/STROKEAHA.111.645986; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mazighi M, 2012, STROKE, V43, P1302, DOI 10.1161/STROKEAHA.111.635029; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Meyers PM, 2011, CIRCULATION, V123, P2591, DOI 10.1161/CIRCULATIONAHA.110.971564; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Osanai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122806; Ribo M, 2006, STROKE, V37, P1000, DOI 10.1161/01.STR.0000206443.96112.d9; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Singh B, 2013, MAYO CLIN PROC, V88, P1056, DOI 10.1016/j.mayocp.2013.07.015; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Wechsler LR, 2003, STROKE, V34, P1224, DOI 10.1161/01.STR.0000068782.15297.28; Yoo DS, 2010, AM J NEURORADIOL, V31, P1536, DOI 10.3174/ajnr.A2084; Zivin JA, 1998, NEUROLOGY, V50, P599, DOI 10.1212/WNL.50.3.599	46	318	329	0	69	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2015	314	17					1832	1843		10.1001/jama.2015.13767	http://dx.doi.org/10.1001/jama.2015.13767			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0RO	26529161	Bronze			2022-12-28	WOS:000363960200015
J	McCoy, D				McCoy, David			Re-engaging the health community around peace	LANCET			English	Editorial Material							PUBLIC-HEALTH		Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England	University of London; Queen Mary University London	McCoy, D (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England.	d.mccoy@qmul.ac.uk						Anrig Jr G, 2013, WAR OUR FREEDOMS CIV; Bezruchka S, 2008, AM J PUBLIC HEALTH, V98, P589, DOI 10.2105/AJPH.2007.116012; Bowles DC, 2015, J ROY SOC MED, V108, P390, DOI 10.1177/0141076815603234; Center for Responsive Politics, 2013, DEFENCE INFLUENCE AN; Institute for Economics and Peace, 2015, WORLD GLOB PEAC IND; Levy BS, 2008, WAR PUBLIC HLTH; McCleary DF, 2009, PEACE CONFL, V15, P161, DOI 10.1080/10781910902837248; Reisch Nikki, 2008, CLIMATE WAR WAR IRAQ; Ritchie N, 2014, NUCL DISARMAMENT HUM; Stockholm International Peace Research Institute, 2015, SIPRI YB 2015 ARM DI; UNHCR-United Nations High Commissioner for Refugees, 2014, WORLD WAR GLOB TREND; WEINBERG J, 1995, SOC SCI MED, V40, P1663, DOI 10.1016/0277-9536(95)00022-Y; Wiist WH, 2014, AM J PUBLIC HEALTH, V104, pE34, DOI 10.2105/AJPH.2013.301778; Woodward R, 2005, PROG HUM GEOG, V29, P718, DOI 10.1191/0309132505ph579oa	14	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1714	1716		10.1016/S0140-6736(15)00726-6	http://dx.doi.org/10.1016/S0140-6736(15)00726-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26545417				2022-12-28	WOS:000363974200011
J	Herbst, D; Mas, A				Herbst, Daniel; Mas, Alexandre			Peer effects on worker output in the laboratory generalize to the field	SCIENCE			English	Article							TEAMS; HETEROGENEITY; INCENTIVES; WORKPLACE; SHIRKING; PRESSURE	We compare estimates of peer effects on worker output in laboratory experiments and field studies from naturally occurring environments. The mean study-level estimate of a change in a worker's productivity in response to an increase in a co-worker's productivity (gamma) is (gamma) over cap = 0.12 (SE = 0.03, n(studies) = 34), with a between-study standard deviation tau = 0.16. The mean estimated (gamma) over cap -values are close between laboratory and field studies ((gamma) over cap (lab) - (gamma) over cap (field) = 0.04, P = 0.55, n(lab) = 11, n(field) = 23), as are estimates of between-study variance tau(2) ((tau) over cap (2)(lab) - (tau) over cap (2)(field) = -0: 003, P = 0.89). The small mean difference between laboratory and field estimates holds even after controlling for sample characteristics such as incentive schemes and work complexity ((gamma) over cap (lab) - (gamma) over cap (field) = 0.03, P = 0.62, n(samples) = 46). Laboratory experiments generalize quantitatively in that they provide an accurate description of the mean and variance of productivity spillovers.	[Herbst, Daniel; Mas, Alexandre] Princeton Univ, Firestone Lib, Ind Relat Sect, Dept Econ, Princeton, NJ 08544 USA; [Mas, Alexandre] NBER, Cambridge, MA 02138 USA; [Mas, Alexandre] Inst Study Labor IZA, D-53113 Bonn, Germany	Princeton University; National Bureau of Economic Research; IZA Institute Labor Economics	Mas, A (corresponding author), Princeton Univ, Firestone Lib, Ind Relat Sect, Dept Econ, Princeton, NJ 08544 USA.	amas@princeton.edu							0	74	75	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					545	549		10.1126/science.aac9555	http://dx.doi.org/10.1126/science.aac9555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU6RG	26516281				2022-12-28	WOS:000363660000045
J	He, WW; Bai, G; Zhou, HH; Wei, N; White, NM; Lauer, J; Liu, HQ; Shi, Y; Dumitru, CD; Lettieri, K; Shubayev, V; Jordanova, A; Guergueltcheva, V; Griffin, PR; Burgess, RW; Pfaff, SL; Yang, XL				He, Weiwei; Bai, Ge; Zhou, Huihao; Wei, Na; White, Nicholas M.; Lauer, Janelle; Liu, Huaqing; Shi, Yi; Dumitru, Calin Dan; Lettieri, Karen; Shubayev, Veronica; Jordanova, Albena; Guergueltcheva, Velina; Griffin, Patrick R.; Burgess, Robert W.; Pfaff, Samuel L.; Yang, Xiang-Lei			CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase	NATURE			English	Article							MOUSE ALS MODEL; TOOTH TYPE 2D; PROLONGS SURVIVAL; GENE MUTATION; GARS; DISEASE; DEGENERATION; PHENOTYPES; MIGRATION; DELIVERY	Selective neuronal loss is a hallmark of neurodegenerative diseases, which, counterintuitively, are often caused by mutations in widely expressed genes'. Charcot-Marie-Tooth (CMT) diseases are the most common hereditary peripheral neuropathies, for which there are no effective therapies(2,3). A subtype of these diseases CMT type 2D (CMT2D)-is caused by dominant mutations in GARS, encoding the ubiquitously expressed enzyme glycyl-transfer RNA (tRNA) synthetase (GlyRS). Despite the broad requirement of GlyRS for protein biosynthesis in all cells, mutations in this gene cause a selective degeneration of peripheral axons, leading to deficits in distal motor function(4). How mutations in GlyRS (GlyRS(CMT2D)) are linked to motor neuron vulnerability has remained elusive. Here we report that GlyRS(CMT2D) acquires a neomorphic binding activity that directly antagonizes an essential signalling pathway for motor neuron survival. We find that CMT2D mutations alter the conformation of GlyRS, enabling GlyRS(CMT2D) to bind the neuropilin 1 (Nrpl) receptor. This aberrant interaction competitively interferes with the binding of the cognate ligand vascular endothelial growth factor (VEGF) to Nrpl. Genetic reduction of Nrpl in mice worsens CMT2D symptoms, whereas enhanced expression of VEGF improves motor function. These findings link the selective pathology of CMT2D to the neomorphic binding activity of GlyRS(CMT2D) that antagonizes the VEGF-Nrp1 interaction, and indicate that the VEGF-Nrp1 signalling axis is an actionable target for treating CMT2D.	[He, Weiwei; Zhou, Huihao; Wei, Na; Shi, Yi; Dumitru, Calin Dan; Yang, Xiang-Lei] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [He, Weiwei; Zhou, Huihao; Wei, Na; Shi, Yi; Dumitru, Calin Dan; Yang, Xiang-Lei] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Bai, Ge; White, Nicholas M.; Lettieri, Karen; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Bai, Ge; White, Nicholas M.; Lettieri, Karen; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Lauer, Janelle; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Liu, Huaqing; Shubayev, Veronica] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Jordanova, Albena] Univ Antwerp, Mol Neurogen Grp, VIB Dept Mol Genet, BE-2610 Antwerp, Belgium; [Guergueltcheva, Velina] Med Univ Sofia, Dept Neurol, Sofia 1431, Bulgaria; [Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA	Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Scripps Research Institute; University of California System; University of California San Diego; Flanders Institute for Biotechnology (VIB); University of Antwerp; Medical University Sofia; Jackson Laboratory	Yang, XL (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	pfaff@salk.edu; xlyang@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; ZHOU, HUIHAO/L-6133-2016	ZHOU, HUIHAO/0000-0002-9675-5007; Burgess, Robert/0000-0002-9229-3407; Yang, Xiang-Lei/0000-0003-2554-084X	National Foundation for Cancer Research; Pioneer fund; Howard Hughes Medical Institute; US National Institutes of Health [R01GM088278, R21NS084254, R01NS054154]; Marshall Heritage Foundation; Sol Goldman Trust; aTyr Pharma through Scripps Research Institute; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084254, P30NS072031, R01NS054154, R01NS054172, R01NS037116] Funding Source: NIH RePORTER	National Foundation for Cancer Research; Pioneer fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshall Heritage Foundation; Sol Goldman Trust; aTyr Pharma through Scripps Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Schimmel, J. Dolkas, C. Farrokhi, L. Lisowski, C. Ly, S. Chalasani, T. Liu, Q. Hu, P. Li, N. Sheng and members of The Scripps Laboratories of tRNA Synthetase Research and the Pfaff laboratory for advice and discussions on the experiments and manuscript We are grateful to S. Ackerman, K.-F. Lee, D. O'leary and D. Ginty for providing mouse lines. W.H., H.Z. and N.W. were supported by fellowships from the National Foundation for Cancer Research. G.B. was supported by the Pioneer fund and Howard Hughes Medical Institute. S.L.P. is a Howard Hughes Medical Institute investigator and a Benjamin H. Lewis chair in Neuroscience. This research is supported by grants from the US National Institutes of Health (R01GM088278, R21NS084254 and R01NS054154), The Marshall Heritage Foundation and the Sol Goldman Trust, and by aTyr Pharma through an agreement with The Scripps Research Institute.	Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kawakami Nobuko, 2014, Rinsho Shinkeigaku, V54, P911; Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; Nayak MS, 2006, BBA-MOL BASIS DIS, V1762, P1128, DOI 10.1016/j.bbadis.2006.06.004; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schwarz Q, 2004, GENE DEV, V18, P2822, DOI 10.1101/gad.322904; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; SKRE H, 1974, CLIN GENET, V6, P98; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Sun AP, 2015, NEUROL RES, V37, P782, DOI 10.1179/1743132815Y.0000000055; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang LJ, 2002, J NEUROSCI, V22, P6920; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626	30	98	104	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					710	714		10.1038/nature15510	http://dx.doi.org/10.1038/nature15510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26503042	Green Accepted			2022-12-28	WOS:000363832100050
J	Miller, JM; Kaastra, JS; Miller, MC; Reynolds, MT; Brown, G; Cenko, SB; Drake, JJ; Gezari, S; Guillochon, J; Gultekin, K; Irwin, J; Levan, A; Maitra, D; Maksym, WP; Mushotzky, R; O'Brien, P; Paerels, F; de Plaa, J; Ramirez-Ruiz, E; Strohmayer, T; Tanvir, N				Miller, Jon M.; Kaastra, Jelle S.; Miller, M. Coleman; Reynolds, Mark T.; Brown, Gregory; Cenko, S. Bradley; Drake, Jeremy J.; Gezari, Suvi; Guillochon, James; Gultekin, Kayhan; Irwin, Jimmy; Levan, Andrew; Maitra, Dipankar; Maksym, W. Peter; Mushotzky, Richard; O'Brien, Paul; Paerels, Frits; de Plaa, Jelle; Ramirez-Ruiz, Enrico; Strohmayer, Tod; Tanvir, Nial			Flows of X-ray gas reveal the disruption of a star by a massive black hole	NATURE			English	Article							TIDAL DISRUPTION; EVENTS; GALAXY; CALIBRATION; TELESCOPE; OUTBURST; MISSION; WINDS	Tidal forces close to massive black holes can violently disrupt stars that make a close approach. These extreme events are discovered via bright X-ray(1-4) and optical/ultraviolet(5,6) flares in galactic centres. Prior studies based on modelling decaying flux trends have been able to estimate broad properties, such as the mass accretion rate(6,7). Here we report the detection of flows of hot, ionized gas in high-resolution X-ray spectra of a nearby tidal disruption event, ASASSN-14li in the galaxy PGC043234. Variability within the absorption-dominated spectra indicates that the gas is relatively close to the black hole. Narrow linewidths indicate that the gas does not stretch over a large range of radii, giving a low volume filling factor. Modest outflow speeds of a few hundred kilometres per second are observed; these are below the escape speed from the radius set by variability. The gas flow is consistent with a rotating wind from the inner, super-Eddington region of a nascent accretion disk, or with a filament of disrupted stellar gas near to the apocentre of an elliptical orbit. Flows of this sort are predicted by fundamental analytical theory(8) and more recent numerical simulations(7,9-14).	[Miller, Jon M.; Reynolds, Mark T.; Gultekin, Kayhan] Univ Michigan, Dept Astron, Ann Arbor, MI 48103 USA; [Kaastra, Jelle S.; de Plaa, Jelle] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Kaastra, Jelle S.] Univ Utrecht, Dept Phys & Astron, NL-3508 TA Utrecht, Netherlands; [Kaastra, Jelle S.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Miller, M. Coleman; Gezari, Suvi; Mushotzky, Richard] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Brown, Gregory; Levan, Andrew] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Cenko, S. Bradley; Strohmayer, Tod] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA; [Cenko, S. Bradley] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Drake, Jeremy J.] Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; [Guillochon, James] Harvard Smithsonian Ctr Astrophys, Inst Theory & Computat, Cambridge, MA 02138 USA; [Irwin, Jimmy; Maksym, W. Peter] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Maitra, Dipankar] Wheaton Coll, Dept Phys & Astron, Norton, MA 02766 USA; [O'Brien, Paul; Tanvir, Nial] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Paerels, Frits] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Paerels, Frits] Columbia Univ, Dept Astron, New York, NY 10027 USA; [Ramirez-Ruiz, Enrico] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	University of Michigan System; University of Michigan; Utrecht University; Leiden University; Leiden University - Excl LUMC; University System of Maryland; University of Maryland College Park; University of Warwick; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Harvard University; Smithsonian Institution; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Alabama System; University of Alabama Tuscaloosa; University of Leicester; Columbia University; Columbia University; University of California System; University of California Santa Cruz	Miller, JM (corresponding author), Univ Michigan, Dept Astron, 1085 South Univ Ave, Ann Arbor, MI 48103 USA.	jonmm@umich.edu	Guillochon, James/G-9351-2018; Mushotzky, Richard/AAW-9465-2021; Levan, Andrew/F-6179-2014	Guillochon, James/0000-0002-9809-8215; Mushotzky, Richard/0000-0002-7962-5446; Maksym, Walter/0000-0002-2203-7889; de Plaa, Jelle/0000-0002-2697-7106; O'Brien, Paul/0000-0002-5128-1899; Kaastra, Jelle/0000-0001-5540-2822; Gultekin, Kayhan/0000-0002-1146-0198; Miller, Cole/0000-0002-2666-728X; Levan, Andrew/0000-0001-7821-9369; Miller, Jon/0000-0003-2869-7682	NASA [NAS8-03060]; Netherlands Organization for Scientific Research (NWO); University of Alabama Research Stimulation Program; STFC [ST/H001972/1, ST/L000733/1, ST/K001000/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K001000/1, ST/L000733/1, ST/H001972/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); University of Alabama Research Stimulation Program; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank Chandra Director B. Wilkes and the Chandra team for accepting our request for Director's Discretionary Time, XMM-Newton Director N. Schartel and the XMM-Newton team for executing our approved target-of-opportunity program, and Swift Director N. Gehrels and the Swift team for monitoring this important source. J.M.M. is supported by NASA funding, through Chandra and XMM-Newton guest observer programs. The SRON Netherlands Institute for Space Research is supported by The Netherlands Organization for Scientific Research (NWO). J.J.D. was supported by NASA contract NAS8-03060 to the Chandra X-ray Center. W.P.M. is grateful for support by the University of Alabama Research Stimulation Program.	Ahn CP, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/17; Bade N, 1996, ASTRON ASTROPHYS, V309, pL35; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Cappelluti N, 2009, ASTRON ASTROPHYS, V495, pL9, DOI 10.1051/0004-6361/200811479; Esquej P, 2007, ASTRON ASTROPHYS, V462, pL49, DOI 10.1051/0004-6361:20066072; Gezari S, 2008, ASTROPHYS J, V676, P944, DOI 10.1086/529008; Gezari S, 2012, NATURE, V485, P217, DOI 10.1038/nature10990; Guillochon J, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/2/166; Guillochon J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/23; Guillochon J, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/25; Holoien TWS, 2014, MON NOT R ASTRON SOC, V445, P3263, DOI 10.1093/mnras/stu1922; Jose J., 2014, ATEL, V6777, P1; Kaastra J.S., 1996, 11 C UV XRAY SPECTRO, P411; Kaastra JS, 2005, IAU SYMP, V13, P648; Komossa S, 1999, ASTRON ASTROPHYS, V349, pL45; Kriek M, 2009, ASTROPHYS J, V700, P221, DOI 10.1088/0004-637X/700/1/221; Lodato G, 2009, MON NOT R ASTRON SOC, V392, P332, DOI 10.1111/j.1365-2966.2008.14049.x; Lodato G, 2011, MON NOT R ASTRON SOC, V410, P359, DOI 10.1111/j.1365-2966.2010.17448.x; Loeb A, 1997, ASTROPHYS J, V489, P573, DOI 10.1086/304814; Miller MC, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/83; Phinney E. S., 1989, IAU S, V136, P543; Piran T, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/164; Poole TS, 2008, MON NOT R ASTRON SOC, V383, P627, DOI 10.1111/j.1365-2966.2007.12563.x; Ramirez JM, 2011, REV MEX ASTRON ASTR, V47, P385; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Shaviv NJ, 2001, MON NOT R ASTRON SOC, V326, P126, DOI 10.1046/j.1365-8711.2001.04574.x; Shiokawa H, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/2/85; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Stone N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.061302; Strubbe LE, 2011, MON NOT R ASTRON SOC, V415, P168, DOI 10.1111/j.1365-2966.2011.18686.x; Strubbe LE, 2009, MON NOT R ASTRON SOC, V400, P2070, DOI 10.1111/j.1365-2966.2009.15599.x; Vinko J, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/12; Voges W, 1999, ASTRON ASTROPHYS, V349, P389	37	113	113	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					542	U173		10.1038/nature15708	http://dx.doi.org/10.1038/nature15708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490619	Green Submitted, Green Published			2022-12-28	WOS:000364026100043
J	Wagner, M				Wagner, Michael			MICROBIOLOGY Conductive consortia	NATURE			English	Editorial Material							ANAEROBIC OXIDATION; METHANE OXIDATION	Physiological analyses, electron microscopy and single-cell chemical imaging suggest that direct electron transfer occurs between the members of methaneoxidizing microbial consortia. SEE ARTICLE P.531 AND LETTER P.587	[Wagner, Michael] Univ Vienna, Dept Microbiol & Ecosyst Sci, A-1090 Vienna, Austria; [Wagner, Michael] Univ Vienna, Res Network Chem Meets Microbiol, A-1090 Vienna, Austria	University of Vienna; University of Vienna	Wagner, M (corresponding author), Univ Vienna, Dept Microbiol & Ecosyst Sci, Waehringer Guertel 18, A-1090 Vienna, Austria.	wagner@microbial-ecology.net	Wagner, Michael/A-7801-2011	Wagner, Michael/0000-0002-9778-7684				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lovley DR, 2012, ANNU REV MICROBIOL, V66, P391, DOI 10.1146/annurev-micro-092611-150104; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Rotaru AE, 2014, APPL ENVIRON MICROB, V80, P4599, DOI 10.1128/AEM.00895-14; Shrestha PM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00237; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Wegener G, 2015, NATURE, V526, P587, DOI 10.1038/nature15733	13	13	14	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					513	514		10.1038/526513a	http://dx.doi.org/10.1038/526513a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490616				2022-12-28	WOS:000364026100036
J	Rimmer, A				Rimmer, Abi			MEDICINE AND THE MEDIA Junior doctors: it's not about the money	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Clark R., 2015, TIMES; Dejevsky M., 2015, INDEPENDENT; Pickles K., 2015, DAILY MAIL	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2015	351								h5591	10.1136/bmj.h5591	http://dx.doi.org/10.1136/bmj.h5591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GC	26490624				2022-12-28	WOS:000364146000020
J	Cole, TB				Cole, Thomas B.			Aurora Borealis Frederic Edwin Church	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1546	1547		10.1001/jama.2014.12035	http://dx.doi.org/10.1001/jama.2014.12035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501521				2022-12-28	WOS:000363028500001
J	Sukumaran, L; McCarthy, NL; Kharbanda, EO; McNeil, MM; Naleway, AL; Klein, NP; Jackson, ML; Hambidge, SJ; Lugg, MM; Li, RX; Weintraub, ES; Bednarczyk, RA; King, JP; DeStefano, F; Orenstein, WA; Omer, SB				Sukumaran, Lakshmi; McCarthy, Natalie L.; Kharbanda, Elyse O.; McNeil, Michael M.; Naleway, Allison L.; Klein, Nicola P.; Jackson, Michael L.; Hambidge, Simon J.; Lugg, Marlene M.; Li, Rongxia; Weintraub, Eric S.; Bednarczyk, Robert A.; King, Jennifer P.; DeStefano, Frank; Orenstein, Walter A.; Omer, Saad B.			Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INACTIVATED INFLUENZA VACCINE; ACELLULAR PERTUSSIS-VACCINE; DIPHTHERIA; SAFETY; EPIDEMIC; INFANTS	IMPORTANCE The Advisory Committee on Immunization Practices (ACIP) recommends the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine for pregnant women during each pregnancy, regardless of prior immunization status. However, safety data on repeated Tdap vaccination in pregnancy is lacking. OBJECTIVE To determine whether receipt of Tdap vaccine during pregnancy administered in close intervals from prior tetanus-containing vaccinations is associated with acute adverse events in mothers and adverse birth outcomes in neonates. DESIGN, SETTING, ANDPARTICIPANTS A retrospective cohort study in 29 155 pregnant women aged 14 through 49 years from January 1, 2007, through November 15, 2013, using data from 7 Vaccine Safety Datalink sites in California, Colorado, Minnesota, Oregon, Washington, and Wisconsin. EXPOSURES Women who received Tdap in pregnancy following a prior tetanus-containing vaccine less than 2 years before, 2 to 5 years before, and more than 5 years before. MAIN OUTCOMES AND MEASURES Acute adverse events (fever, allergy, and local reactions) and adverse birth outcomes (small for gestational age, preterm delivery, and low birth weight) were evaluated. Women who were vaccinated with Tdap in pregnancy and had a prior tetanus-containing vaccine more than 5 years before served as controls. RESULTS There were no statistically significant differences in rates of medically attended acute adverse events or adverse birth outcomes related to timing since prior tetanus-containing vaccination. [GRAPHCIS] CONCLUSIONS AND RELEVANCE Among women who received Tdap vaccination during pregnancy, there was no increased risk of acute adverse events or adverse birth outcomes for those who had been previously vaccinated less than 2 years before or 2 to 5 years before compared with those who had been vaccinated more than 5 years before. These findings suggest that relatively recent receipt of a prior tetanus-containing vaccination does not increase risk after Tdap vaccination in pregnancy.	[Sukumaran, Lakshmi; McCarthy, Natalie L.; McNeil, Michael M.; Li, Rongxia; Weintraub, Eric S.; DeStefano, Frank] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA 30333 USA; [Sukumaran, Lakshmi] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Kharbanda, Elyse O.] HealthPartners Inst Educ & Res, Minneapolis, MN USA; [Naleway, Allison L.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Klein, Nicola P.] Kaiser Permanente, Vaccine Study Ctr, Oakland, CA USA; [Jackson, Michael L.] Grp Hlth Res Inst, Seattle, WA USA; [Hambidge, Simon J.] Denver Hlth, Dept Ambulatory Care Serv, Denver, CO USA; [Hambidge, Simon J.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Hambidge, Simon J.] Univ Colorado, Dept Pediat, Denver, CO 80202 USA; [Lugg, Marlene M.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Bednarczyk, Robert A.; Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [King, Jennifer P.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Orenstein, Walter A.; Omer, Saad B.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Kaiser Permanente; Kaiser Permanente; Denver Health Medical Center; Kaiser Permanente; University of Colorado System; University of Colorado Denver; Kaiser Permanente; Emory University; Rollins School Public Health; Emory University	Sukumaran, L (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, 1600 Clifton Rd NE,Bldg 16,MS D-26, Atlanta, GA 30333 USA.	xfq3@cdc.gov	Bednarczyk, Robert/L-9403-2017	Bednarczyk, Robert/0000-0002-6812-0928; King, Jennifer/0000-0003-4627-1378; Kharbanda, Elyse/0000-0003-1806-6502; Hambidge, Simon/0000-0002-7535-0668; McNeil, Michael/0000-0003-0713-8312	Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases [T32AI074492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074492] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centers for Disease Control and Prevention and grant T32AI074492 from the National Institute of Allergy and Infectious Diseases (Dr Sukumaran).	Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1424; Centers for Disease Control and Prevention, PERT OUTBR TRENDS; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Donegan K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4219; Halperin SA, 2006, PEDIATR INFECT DIS J, V25, P195, DOI 10.1097/01.inf.0000202082.56403.c4; Jackson LA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-165; Kharbanda EO, 2014, JAMA-J AM MED ASSOC, V312, P1897, DOI 10.1001/jama.2014.14825; Kharbanda EO, 2013, OBSTET GYNECOL, V122, P659, DOI 10.1097/AOG.0b013e3182a1118a; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; McNeil MM, 2014, VACCINE, V32, P5390, DOI 10.1016/j.vaccine.2014.07.073; Morgan JL, 2015, OBSTET GYNECOL, V125, P1433, DOI 10.1097/AOG.0000000000000862; Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Naleway AL, 2013, VACCINE, V31, P2898, DOI 10.1016/j.vaccine.2013.03.069; Nordin JD, 2013, OBSTET GYNECOL, V121, P519, DOI 10.1097/AOG.0b013e3182831b83; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Shakib JH, 2013, J PEDIATR-US, V163, P1422, DOI 10.1016/j.jpeds.2013.06.021; Sukumaran L, 2015, VACCINE, V33, P4446, DOI 10.1016/j.vaccine.2015.07.037; Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017; Talbot EA, 2010, VACCINE, V28, P8001, DOI 10.1016/j.vaccine.2010.09.034; Winter K, 2014, MMWR-MORBID MORTAL W, V63, P1129	22	77	80	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1581	1587		10.1001/jama.2015.12790	http://dx.doi.org/10.1001/jama.2015.12790			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501534	Green Accepted, Bronze			2022-12-28	WOS:000363028500018
J	Megaly, M; Boshra, N				Megaly, Michael; Boshra, Nasser			Pyogenic granuloma-like Kaposi's sarcoma	LANCET			English	Editorial Material									[Megaly, Michael; Boshra, Nasser] Mercy Hosp & Med Ctr, Dept Internal Med, Chicago, IL 60616 USA		Megaly, M (corresponding author), Mercy Hosp & Med Ctr, Dept Internal Med, Chicago, IL 60616 USA.	michaelmegaly@hotmail.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2022	399	10335					E38	E38		10.1016/S0140-6736(15)00467-5	http://dx.doi.org/10.1016/S0140-6736(15)00467-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1G1JW	26498707				2022-12-28	WOS:000795612300002
J	Forlino, A; Marini, JC				Forlino, Antonella; Marini, Joan C.			Osteogenesis imperfecta	LANCET			English	Review							EHLERS-DANLOS-SYNDROME; EPITHELIUM-DERIVED FACTOR; COLLAGEN TRIPLE-HELIX; CIS-TRANS ISOMERASE; PROLYL 3-HYDROXYLATION; CYCLOPHILIN-B; MOUSE MODEL; INTRAVENOUS PAMIDRONATE; PRO-ALPHA-2(I) CHAIN; GENOTYPE-PHENOTYPE	Osteogenesis imperfecta is a phenotypically and molecularly heterogeneous group of inherited connective tissue disorders that share similar skeletal abnormalities causing bone fragility and deformity. Previously, the disorder was thought to be an autosomal dominant bone dysplasia caused by defects in type I collagen, but in the past 10 years discoveries of novel (mainly recessive) causative genes have lent support to a predominantly collagen-related pathophysiology and have contributed to an improved understanding of normal bone development. Defects in proteins with very different functions, ranging from structural to enzymatic and from intracellular transport to chaperones, have been described in patients with osteogenesis imperfecta. Knowledge of the specific molecular basis of each form of the disorder will advance clinical diagnosis and potentially stimulate targeted therapeutic approaches. In this Seminar, together with diagnosis, management, and treatment, we describe the defects causing osteogenesis imperfecta and their mechanism and interrelations, and classify them into five groups on the basis of the metabolic pathway compromised, specifically those related to collagen synthesis, structure, and processing; post-translational modification; folding and cross-linking; mineralisation; and osteoblast differentiation.	[Forlino, Antonella] Univ Pavia, Dept Mol Med, Biochem Unit, Via Palestro 3, I-27100 Pavia, Italy; [Marini, Joan C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20855 USA	University of Pavia; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Marini, JC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20855 USA.	oidoc@helix.nih.gov			NICHD; Fondazione Cariplo [2013-0612]; Telethon [GGP13098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fondazione Cariplo(Fondazione Cariplo); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank the members of the Marini Laboratory for critical review of the manuscript, especially Wayne A Cabral and Aileen M Barnes for feedback on figures. Figures were prepared by Jeremy Swan and Erin Fincher of The Unit on Computer Support Services, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). When writing this Seminar, JCM was supported by intramural funding from the NICHD and AF was supported by the Fondazione Cariplo grant n. 2013-0612 and Telethon grant n. GGP13098. The funders did not have any role in study design, the collection, analysis, and interpretation of data, the writing of the Seminar, or the decision to submit the Seminar for publication.	Aglan MS, 2012, J CHILD ORTHOP, V6, P29, DOI 10.1007/s11832-012-0385-3; Akiyama T, 2010, BIOCHEM BIOPH RES CO, V391, P789, DOI 10.1016/j.bbrc.2009.11.139; Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Anissipour AK, 2014, J BONE JOINT SURG AM, V96A, P237, DOI 10.2106/JBJS.L.01596; Antoniazzi F, 2010, EUR J ENDOCRINOL, V163, P479, DOI 10.1530/EJE-10-0208; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; Balasubramanian M, 2013, CLIN DYSMORPHOL, V22, P93, DOI 10.1097/MCD.0b013e32836032f0; Barnes AM, 2013, HUM MUTAT, V34, P1279, DOI 10.1002/humu.22362; Barnes AM, 2012, HUM MUTAT, V33, P1589, DOI 10.1002/humu.22139; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Becerra SP, 2013, NAT REV CANCER, V13, P258, DOI 10.1038/nrc3484; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bishop N, 2013, LANCET, V382, P1424, DOI 10.1016/S0140-6736(13)61091-0; Bogan R, 2013, J BONE MINER RES, V28, P1531, DOI 10.1002/jbmr.1892; Bradbury LA, 2012, OSTEOPOROSIS INT, V23, P285, DOI 10.1007/s00198-011-1658-2; Brizola E, 2014, PEDIATR PHYS THER, V26, P245, DOI 10.1097/PEP.0000000000000042; Burr DB, 2015, BONE, V71, P58, DOI 10.1016/j.bone.2014.10.010; Byers PH, 1997, AM J MED GENET, V72, P94, DOI 10.1002/(SICI)1096-8628(19971003)72:1<94::AID-AJMG20>3.0.CO;2-O; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2014, BONE ABSTR, V3, pCC3; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Cabral WA, 2012, GENET MED, V14, P543, DOI 10.1038/gim.2011.44; Chang WZ, 2010, HUM MOL GENET, V19, P223, DOI 10.1093/hmg/ddp481; CHARNAS LR, 1993, NEUROLOGY, V43, P2603, DOI 10.1212/WNL.43.12.2603; Cheung MS, 2011, J BONE MINER RES, V26, P405, DOI 10.1002/jbmr.220; Cho SY, 2013, J KOREAN MED SCI, V28, P1107, DOI 10.3346/jkms.2013.28.7.1107; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; De Paepe A, 2012, CLIN GENET, V82, P1, DOI 10.1111/j.1399-0004.2012.01858.x; DEAK SB, 1983, J BIOL CHEM, V258, P5192; DEWET WJ, 1983, J BIOL CHEM, V258, P7721; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Dwan K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005088.pub3; Engelbert RH, 2004, ARCH PHYS MED REHAB, V85, P772, DOI 10.1016/j.apmr.2003.08.085; Esposito P, 2008, CURR OPIN PEDIATR, V20, P52, DOI 10.1097/MOP.0b013e3282f35f03; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; Faqeih E, 2013, J MED GENET, V50, P491, DOI 10.1136/jmedgenet-2013-101750; Farber CR, 2014, J BONE MINER RES, V29, P1402, DOI 10.1002/jbmr.2173; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gioia R, 2012, STEM CELLS, V30, P1465, DOI 10.1002/stem.1107; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Hald JD, 2015, J BONE MINER RES, V30, P929, DOI 10.1002/jbmr.2410; Hanagata N, 2011, BIOCHEM BIOPH RES CO, V409, P378, DOI 10.1016/j.bbrc.2011.04.136; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Homan EP, 2011, J BONE MINER RES, V26, P2798, DOI 10.1002/jbmr.487; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Imajima Y, 2015, J PEDIATR ORTHOPED, V35, P431, DOI 10.1097/BPO.0000000000000285; Ishida Y, 2009, AUTOPHAGY, V5, P1217, DOI 10.4161/auto.5.8.10168; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Janus GJM, 2000, EUR SPINE J, V9, P486, DOI 10.1007/s005860000165; Kasaai B, 2013, J BIOL CHEM, V288, P13278, DOI 10.1074/jbc.M113.457010; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Krishnan H, 2013, HIP INT, V23, P303, DOI 10.5301/hipint.5000014; Kuurila K, 2000, EUR J PEDIATR, V159, P515, DOI 10.1007/s004310051322; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Lamanna A, 2013, HEART LUNG CIRC, V22, P801, DOI 10.1016/j.hlc.2013.05.640; Land C, 2007, BONE, V40, P638, DOI 10.1016/j.bone.2006.10.010; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Lee K, 2015, J PEDIATR ORTHOPED, V35, P178, DOI 10.1097/BPO.0000000000000228; Letocha AD, 2005, J BONE MINER RES, V20, P977, DOI 10.1359/JBMR.050109; Li F, 2013, STEM CELLS, V31, P2714, DOI 10.1002/stem.1505; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; Lindahl K, 2011, HUM MUTAT, V32, P598, DOI 10.1002/humu.21475; LoMauro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035965; Malfait F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038224; Malfait F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-78; Marini J. C, 2011, NELSON TXB PEDIAT, P2437; Marini JC, 2003, J BONE MINER RES, V18, P237, DOI 10.1359/jbmr.2003.18.2.237; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Marini JC, 2010, CELL TISSUE RES, V339, P59, DOI 10.1007/s00441-009-0872-0; Marini Joan C, 2006, Nat Clin Pract Endocrinol Metab, V2, P14, DOI 10.1038/ncpendmet0075; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; Menezes AH, 2008, CHILD NERV SYST, V24, P1169, DOI 10.1007/s00381-008-0602-z; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Montpetit K, 2011, J PEDIATR REHAB MED, V4, P13, DOI 10.3233/PRM-2011-0149; Morello R, 1999, MATRIX BIOL, V18, P319, DOI 10.1016/S0945-053X(99)00002-5; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P18, DOI 10.3109/03008207.2010.511354; Orwoll ES, 2014, J CLIN INVEST, V124, P491, DOI 10.1172/JCI71101; Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200; Palmieri D, 2008, EXP CELL RES, V314, P2289, DOI 10.1016/j.yexcr.2008.04.016; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Phillipi CA, 2008, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD005088.PUB2]; Pollitt R, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9430; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; Quan GMY, 2005, CALCIFIED TISSUE INT, V76, P146, DOI 10.1007/s00223-004-0068-2; Radunovic Z, 2011, AM HEART J, V161, P523, DOI 10.1016/j.ahj.2010.11.006; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; Rauch F, 2002, J CLIN INVEST, V110, P1293, DOI 10.1172/JCI200215952; Rauch F, 2007, BONE, V40, P821, DOI 10.1016/j.bone.2006.11.020; Rauch F, 2013, J MED GENET, V50, P21, DOI 10.1136/jmedgenet-2012-101307; Rohrbach M, 2012, AM J MED GENET C, V160C, P175, DOI 10.1002/ajmg.c.31334; Rubinato E, 2014, GENE, V545, P290, DOI 10.1016/j.gene.2014.05.028; Ruck J, 2011, J CHILD ORTHOP, V5, P217, DOI 10.1007/s11832-011-0341-7; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Sekiya A, 2011, J BIOL CHEM, V286, P26364, DOI 10.1074/jbc.M111.252684; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Sillence D O, 1979, Birth Defects Orig Artic Ser, V15, P113; Sinder BP, 2013, J BONE MINER RES, V28, P73, DOI 10.1002/jbmr.1717; Singer R B, 2001, J Insur Med, V33, P216; Sousa T, 2014, J PEDIATR ORTHOPED, V34, P118, DOI 10.1097/BPO.0b013e3182a006a0; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Swinnen FKR, 2012, AUDIOL NEURO-OTOL, V17, P198, DOI 10.1159/000336211; Swinnen FKR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-88; Symoens S, 2014, HUM MUTAT, V35, P1330, DOI 10.1002/humu.22677; Symoens Sofie, 2013, Orphanet J Rare Dis, V8, P154, DOI 10.1186/1750-1172-8-154; Thiele F, 2012, HUM MOL GENET, V21, P3535, DOI 10.1093/hmg/dds183; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Topouchian V, 2004, REV CHIR ORTHOP, V90, P525; Tsukamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075831; Uveges TE, 2009, J BONE MINER RES, V24, P849, DOI [10.1359/JBMR.081238, 10.1359/jbmr.081238]; van Dijk FS, 2011, MOL SYNDROMOL, V2, P1, DOI 10.1159/000332228; Volodarsky M, 2013, HUM MUTAT, V34, P582, DOI 10.1002/humu.22274; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Widmann RF, 1999, SPINE, V24, P1673, DOI 10.1097/00007632-199908150-00008; Willing MC, 1996, AM J HUM GENET, V59, P799	140	462	492	9	166	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1657	1671		10.1016/S0140-6736(15)00728-X	http://dx.doi.org/10.1016/S0140-6736(15)00728-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26542481	Green Accepted			2022-12-28	WOS:000374145100033
J	Peng, DJ; Kryczek, I; Nagarsheth, N; Zhao, LL; Wei, S; Wang, WM; Sun, YQ; Zhao, ED; Vatan, L; Szeliga, W; Kotarski, J; Tarkowski, R; Dou, YL; Cho, K; Hensley-Alford, S; Munkarah, A; Liu, R; Zou, WP				Peng, Dongjun; Kryczek, Ilona; Nagarsheth, Nisha; Zhao, Lili; Wei, Shuang; Wang, Weimin; Sun, Yuqing; Zhao, Ende; Vatan, Linda; Szeliga, Wojciech; Kotarski, Jan; Tarkowski, Rafal; Dou, Yali; Cho, Kathleen; Hensley-Alford, Sharon; Munkarah, Adnan; Liu, Rebecca; Zou, Weiping			Epigenetic silencing of T(H)1-type chemokines shapes tumour immunity and immunotherapy	NATURE			English	Article							T-CELLS; CANCER; BLOCKADE; INHIBITION; SURVIVAL; DEATH; MODEL; EZH2; UTX	Epigenetic silencing including histone modifications and DNA methylation is an important tumorigenic mechanism(1). However, its role in cancer immunopathology and immunotherapy is poorly understood. Using human ovarian cancers as our model, here we show that enhancer of zeste homologue 2 (EZH2)-mediated histone H3 lysine 27 trimethylation (H3K27me3) and DNA methyltransferase 1 (DNMT1)-mediated DNA methylation repress the tumour production of T helper 1 (T(H)1)-type chemokines CXCL9 and CXCL10, and subsequently determine effector T-cell trafficking to the tumour microenvironment. Treatment with epigenetic modulators removes the repression and increases effector T-cell tumour infiltration, slows down tumour progression, and improves the therapeutic efficacy of programmed death-ligand 1 (PD-L1; also known as B7-H1) checkpoint blockade(2-4) and adoptive T-cell transfusion(5) in tumour-bearing mice. Moreover, tumour EZH2 and DNMT1 are negatively associated with tumour-infiltrating CD8(+) T cells and patient outcome. Thus, epigenetic silencing of T(H)1-type chemokines is a novel immune-evasion mechanism of tumours. Selective epigenetic reprogramming alters the T-cell landscape(6) in cancer and may enhance the clinical efficacy of cancer therapy.	[Peng, Dongjun; Kryczek, Ilona; Nagarsheth, Nisha; Wei, Shuang; Wang, Weimin; Zhao, Ende; Vatan, Linda; Szeliga, Wojciech; Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Kryczek, Ilona; Nagarsheth, Nisha; Zou, Weiping] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Zhao, Lili] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Sun, Yuqing; Dou, Yali; Cho, Kathleen] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Kotarski, Jan; Tarkowski, Rafal] Med Univ Lublin, Dept Gynecol Oncol & Gynecol 1, PL-20081 Lublin, Poland; [Cho, Kathleen; Liu, Rebecca; Zou, Weiping] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Hensley-Alford, Sharon; Munkarah, Adnan] Henry Ford Hlth Syst, Dept Womens Hlth Serv, Detroit, MI 48202 USA; [Liu, Rebecca] Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Grad Program Tumor Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical University of Lublin; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	wzou@med.umich.edu	Zhao, Ende/B-9851-2013; Tarkowski, Rafał/GQQ-9740-2022	Zhao, Ende/0000-0002-1355-6919; Cho, Kathleen/0000-0003-0500-9998; Nagarsheth, Nisha/0000-0002-9508-1530	NIH [CA190176, CA123088, CA099985, CA156685, CA193136, CA152470, CA171306, 5P30CA46592]; Rivkin Ovarian Cancer Center; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA123088, R01CA156685, R01CA171306, R01CA152470, P30CA046592, R01CA099985, R01CA190176, R01CA193136, F31CA189440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rivkin Ovarian Cancer Center; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported (in part) by the NIH grants (CA190176; CA123088; CA099985; CA156685; CA193136; CA152470; CA171306; 5P30CA46592), the Rivkin Ovarian Cancer Center, and the Ovarian Cancer Research Fund. We appreciate discussion with B. Richardson. We thank L. Cabrera, D. Postiff, M. Vinco, R. Craig and J. Barikdar for their technical assistance. We are grateful for the professional help from W. Wu and C. Johnson in our Microarray Core and Bioinformatics Core. We particularly appreciate the support of B. Leclair and D. Leclair.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I., 2014, IMMUNITY; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; Kryczek I, 2012, INT J CANCER, V130, P29, DOI 10.1002/ijc.25967; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang YX, 2014, BLOOD, V124, P737, DOI 10.1182/blood-2013-12-544106; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	35	651	681	11	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					249	+		10.1038/nature15520	http://dx.doi.org/10.1038/nature15520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26503055	Green Accepted			2022-12-28	WOS:000364396700048
J	Fanaroff, AC; Rymer, JA; Goldstein, SA; Simel, DL; Newby, LK				Fanaroff, Alexander C.; Rymer, Jennifer A.; Goldstein, Sarah A.; Simel, David L.; Newby, L. Kristin			Does This Patient With Chest Pain Have Acute Coronary Syndrome? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							EMERGENCY-DEPARTMENT PATIENTS; MYOCARDIAL-INFARCTION RISK; HIGH-SENSITIVITY TROPONIN; ACCELERATED DIAGNOSTIC PROTOCOL; ACUTE CARDIAC ISCHEMIA; PROSPECTIVE VALIDATION; MODIFIED THROMBOLYSIS; SUBLINGUAL NITROGLYCERIN; STRATIFICATION TOOLS; EARLY DISCHARGE	IMPORTANCE About 10% of patients with acute chest pain are ultimately diagnosed with acute coronary syndrome (ACS). Early, accurate estimation of the probability of ACS in these patients using the clinical examination could prevent many hospital admissions among low-risk patients and ensure that high-risk patients are promptly treated. OBJECTIVE To review systematically the accuracy of the initial history, physical examination, electrocardiogram, and risk scores incorporating these elements with the first cardiac-specific troponin. STUDY SELECTION MEDLINE and EMBASE were searched (January 1, 1995-July 31, 2015), along with reference lists from retrieved articles, to identify prospective studies of diagnostic test accuracy among patients admitted to the emergency department with symptoms suggesting ACS. DATA EXTRACTION AND SYNTHESIS We identified 2992 unique articles; 58 met inclusion criteria. MAIN OUTCOMES AND MEASURES Sensitivity, specificity, and likelihood ratio (LR) of findings for the diagnosis of ACS. The reference standard for ACS was either a final hospital diagnosis of ACS or occurrence of a cardiovascular event within 6 weeks. RESULTS The clinical findings and risk factors most suggestive of ACS were prior abnormal stress test (specificity, 96%; LR, 3.1 [95% CI, 2.0-4.7]), peripheral arterial disease (specificity, 97%; LR, 2.7 [95% CI, 1.5-4.8]), and pain radiation to both arms (specificity, 96%; LR, 2.6 [95% CI, 1.8-3.7]). The most useful electrocardiogram findings were ST-segment depression (specificity, 95%; LR, 5.3 [95% CI, 2.1-8.6]) and any evidence of ischemia (specificity, 91%; LR, 3.6 [95% CI, 1.6-5.7]). Both the History, Electrocardiogram, Age, Risk Factors, Troponin (HEART) and Thrombolysis in Myocardial Infarction (TIMI) risk scores performed well in diagnosing ACS: LR, 13 (95% CI, 7.0-24) for the high-risk range of the HEART score (7-10) and LR, 6.8 (95% CI, 5.2-8.9) for the high-risk range of the TIMI score (5-7). The most useful for identifying patients less likely to have ACS were the low-risk range HEART score (0-3) (LR, 0.20 [95% CI, 0.13-0.30]), low-risk range TIMI score (0-1) (LR, 0.31 [95% CI, 0.23-0.43]), or low to intermediate risk designation by the Heart Foundation of Australia and Cardiac Society of Australia and New Zealand risk algorithm (LR, 0.24 [95% CI, 0.19-0.31]). CONCLUSIONS AND RELEVANCE Among patients with suspected ACS presenting to emergency departments, the initial history, physical examination, and electrocardiogram alone did not confirm or exclude the diagnosis of ACS. Instead, the HEART or TIMI risk scores, which incorporate the first cardiac troponin, provided more diagnostic information.	[Fanaroff, Alexander C.; Rymer, Jennifer A.; Newby, L. Kristin] Duke Univ, Div Cardiol, Durham, NC 27710 USA; [Fanaroff, Alexander C.; Rymer, Jennifer A.; Goldstein, Sarah A.; Newby, L. Kristin] Duke Univ, Dept Med, Durham, NC 27710 USA; [Simel, David L.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Newby, L. Kristin] Duke Univ, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Fanaroff, AC (corresponding author), Duke Univ, Med Ctr, 2301 Erwin Rd, Durham, NC 27710 USA.	alexander.fanaroff@dm.duke.edu		Fanaroff, Alexander/0000-0002-9060-5307; Rymer, Jennifer/0000-0001-9841-2393	Duke University from Google Life Sciences; Amgen; Patient-Centered Outcomes Research Institute; National Institutes of Health	Duke University from Google Life Sciences(Google Incorporated); Amgen(Amgen); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Simel reports receiving honoraria for contributions to JAMAevidence.com and being section editor of the Rational Clinical Examination series. Dr Newby reports receiving research grant funding through Duke University from Google Life Sciences, Amgen, Patient-Centered Outcomes Research Institute, National Institutes of Health, and a philanthropic gift from the David H. Murdock Research Institute for Business and Culture; consulting honoraria from Philips Healthcare, Roche Diagnostics, and Merck; stock options for consulting for Biokier; an honorarium as a senior associate editor for the Journal of the American Heart Association; and being a member of board of directors for the Society of Cardiovascular Patient Care and the board of trustees for the AstraZeneca Healthcare Foundation. No other disclosures are reported.	Aldous SJ, 2012, AM HEART J, V164, P516, DOI 10.1016/j.ahj.2012.06.025; Aldous SJ, 2012, ACAD EMERG MED, V19, P510, DOI 10.1111/j.1553-2712.2012.01352.x; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Amsterdam EA, 2010, CIRCULATION, V122, P1756, DOI 10.1161/CIR.0b013e3181ec61df; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Aroney CN, 2006, MED J AUSTRALIA, V184, pS1; Backus BE, 2013, INT J CARDIOL, V168, P2153, DOI 10.1016/j.ijcard.2013.01.255; Backus Barbra E, 2010, Crit Pathw Cardiol, V9, P164, DOI 10.1097/HPC.0b013e3181ec36d8; Bandstein N, 2014, J AM COLL CARDIOL, V63, P2569, DOI 10.1016/j.jacc.2014.03.017; Bhuiya Farida A, 2010, NCHS Data Brief, P1; Biener M, 2015, CLIN CHEM, V61, P744, DOI 10.1373/clinchem.2014.235317; Bjork Jonas, 2006, BMC Med Inform Decis Mak, V6, P28, DOI 10.1186/1472-6947-6-28; Body R, 2009, EMERG MED J, V26, P95, DOI 10.1136/emj.2008.058495; Body R, 2014, EMERG MED J, V31, P872, DOI 10.1136/emermed-2014-203832; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Borenstein M., 2009, INTRO METAANALYSIS; Bossuyt P., 2013, COCHRANE HDB SYSTEMA, P3; Burkett E, 2014, INT J EMERG MED, V7, DOI 10.1186/1865-1380-7-10; Campbell CF, 2009, AM J EMERG MED, V27, P37, DOI 10.1016/j.ajem.2008.01.028; Chang AM, 2009, AM J EMERG MED, V27, P916, DOI 10.1016/j.ajem.2008.07.007; Chase M, 2006, ANN EMERG MED, V48, P252, DOI 10.1016/j.annemergmed.2006.01.032; Christenson J, 2006, ANN EMERG MED, V47, P1, DOI 10.1016/j.annemergmed.2005.08.007; Cullen L, 2013, HEART LUNG CIRC, V22, P844, DOI 10.1016/j.hlc.2013.03.074; Cullen L, 2013, J AM COLL CARDIOL, V62, P1242, DOI 10.1016/j.jacc.2013.02.078; Cullen L, 2010, EMERG MED AUSTRALAS, V22, P35, DOI 10.1111/j.1742-6723.2010.01256.x; Diercks DB, 2005, ANN EMERG MED, V45, P581, DOI 10.1016/j.annemergmed.2004.12.009; Dooley J, 2013, ACAD EMERG MED, V20, P904, DOI 10.1111/acem.12211; Edwards M, 2011, ANN EMERG MED, V58, P501, DOI 10.1016/j.annemergmed.2011.05.036; Farkouh ME, 2009, MEDICINE, V88, P307, DOI 10.1097/MD.0b013e3181b98782; Fermann GJ, 2009, AM J EMERG MED, V27, P816, DOI 10.1016/j.ajem.2008.06.031; Fesmire FM, 2012, AM J EMERG MED, V30, P1829, DOI 10.1016/j.ajem.2012.03.017; Forest RS, 2004, ANN EMERG MED, V44, P206, DOI 10.1016/j.annemergmed.2004.02.031; Goldman L, 1996, NEW ENGL J MED, V334, P1498, DOI 10.1056/NEJM199606063342303; Graham CA, 2013, INT J CARDIOL, V168, P597, DOI 10.1016/j.ijcard.2013.01.233; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Han JH, 2007, ACAD EMERG MED, V14, P732, DOI 10.1197/j.aem.2007.04.008; Hendrikson CA, 2003, ANN INTERN MED, V139, P979, DOI 10.7326/0003-4819-139-12-200312160-00007; Hess EP, 2012, ANN EMERG MED, V59, P115, DOI 10.1016/j.annemergmed.2011.07.026; Hess EP, 2010, ACAD EMERG MED, V17, P368, DOI 10.1111/j.1553-2712.2010.00696.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoilund-Carlsen PF, 2007, CAN J CARDIOL, V23, P641, DOI 10.1016/S0828-282X(07)70226-X; Ilgen JS, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-49; Jaffery Z, 2007, J THROMB THROMBOLYS, V24, P137, DOI 10.1007/s11239-007-0013-0; Jellema LJC, 2014, CLIN CHEM LAB MED, V52, P259, DOI 10.1515/cclm-2012-0771; Kelly AM, 2015, EMERG MED J, V32, P760, DOI 10.1136/emermed-2014-204442; Kelly AM, 2014, EUR J EMERG MED, V21, P276, DOI 10.1097/MEJ.0000000000000079; Kelly AM, 2012, EMERG MED AUSTRALAS, V24, P260, DOI 10.1111/j.1742-6723.2012.01536.x; Kwong RY, 2003, CIRCULATION, V107, P531, DOI 10.1161/01.CIR.0000047527.11221.29; Lee Betsy, 2011, Crit Pathw Cardiol, V10, P64, DOI 10.1097/HPC.0b013e31821c79bd; Liu N, 2014, INT J CARDIOL, V177, P1095, DOI 10.1016/j.ijcard.2014.09.199; Lyon R, 2007, RESUSCITATION, V74, P90, DOI 10.1016/j.resuscitation.2006.11.023; Macdonald SPJ, 2014, EMERG MED J, V31, P281, DOI 10.1136/emermed-2012-201323; Macdonald SPJ, 2011, EMERG MED AUSTRALAS, V23, P717, DOI 10.1111/j.1742-6723.2011.01480.x; Mahler SA, 2015, CIRC-CARDIOVASC QUAL, V8, P195, DOI 10.1161/CIRCOUTCOMES.114.001384; Mahler SA, 2013, INT J CARDIOL, V168, P795, DOI 10.1016/j.ijcard.2012.10.010; Marcoon Shannon, 2013, Crit Pathw Cardiol, V12, P1, DOI 10.1097/HPC.0b013e31827377e1; Marini MG, 2013, J CARDIOL, V62, P205, DOI 10.1016/j.jjcc.2013.04.005; Melki Dina, 2013, Crit Pathw Cardiol, V12, P127, DOI 10.1097/HPC.0b013e3182953359; Milner KA, 2001, NURS RES, V50, P233, DOI 10.1097/00006199-200107000-00007; Mitchell AM, 2006, ANN EMERG MED, V47, P438, DOI 10.1016/j.annemergmed.2005.10.013; Nerenberg RH, 2007, AM J EMERG MED, V25, P39, DOI 10.1016/j.ajem.2006.05.027; Ngako A, 2009, AM J EMERG MED, V27, P675, DOI 10.1016/j.ajem.2008.05.011; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; Parsonage WA, 2014, MED J AUSTRALIA, V200, P161, DOI 10.5694/mja13.10466; Pelliccia F, 2006, AM J CARDIOL, V97, P781, DOI 10.1016/j.amjcard.2005.09.126; Penumetsa SC, 2012, ARCH INTERN MED, V172, P873, DOI 10.1001/archinternmed.2012.940; Pollack CV, 2006, ACAD EMERG MED, V13, P13, DOI 10.1197/j.aem.2005.06.031; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Reichlin T, 2015, CAN MED ASSOC J, V187, pE243, DOI 10.1503/cmaj.141349; Sanders S, 2015, J CLIN EPIDEMIOL SO; Shry EA, 2002, AM J CARDIOL, V90, P1264, DOI 10.1016/S0002-9149(02)02850-3; Simel DL, 2009, RATIONAL CLIN EXAMIN; Six AJ, 2008, NETH HEART J, V16, P191, DOI 10.1007/BF03086144; Six A Jacob, 2013, Crit Pathw Cardiol, V12, P121, DOI 10.1097/HPC.0b013e31828b327e; Storrow AB, 2015, CLIN BIOCHEM, V48, P260, DOI 10.1016/j.clinbiochem.2014.09.012; Taylor BT, 2015, WEST J EMERG MED, V16, P24, DOI 10.5811/westjem.2014.9.21685; Than M, 2014, EMERG MED AUSTRALAS, V26, P34, DOI 10.1111/1742-6723.12164; Than M, 2013, INT J CARDIOL, V166, P752, DOI 10.1016/j.ijcard.2012.09.171; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035; Than M, 2011, LANCET, V377, P1077, DOI 10.1016/S0140-6736(11)60310-3; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Tong KL, 2005, J AM COLL CARDIOL, V46, P920, DOI 10.1016/j.jacc.2005.03.076; van der Meer MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116431; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	85	123	125	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2015	314	18					1955	1965		10.1001/jama.2015.12735	http://dx.doi.org/10.1001/jama.2015.12735			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7XQ	26547467				2022-12-28	WOS:000364490700018
J	Bodirsky, BL; Popp, A				Bodirsky, Benjamin L.; Popp, Alexander			SUSTAINABILITY Australia at the crossroads	NATURE			English	Editorial Material									[Bodirsky, Benjamin L.; Popp, Alexander] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Bodirsky, Benjamin L.] Commonwealth Sci & Ind Res Org, St Lucia, Qld, Australia	Potsdam Institut fur Klimafolgenforschung; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bodirsky, BL (corresponding author), Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany.	bodirsky@pik-potsdam.de; popp@pik-potsdam.de	Bodirsky, Benjamin Leon/ABH-9170-2020; Popp, Alexander/N-7064-2014	Bodirsky, Benjamin Leon/0000-0002-8242-6712; Popp, Alexander/0000-0001-9500-1986				[Anonymous], 2000, SPECIAL REPORT EMISS; Becker N., 2010, WATER RESOU IN PRESS, DOI DOI 10.4236/JWARP.2010.212124; Bodirsky BL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/111005; Hatfield-Dodds S., 2015, CSIRO AUSTR NATL OUT; Hatfield-Dodds S, 2015, NATURE, V527, P49, DOI 10.1038/nature16065; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; MEA (Millenium Ecosystem Assessment), 2003, ECOSYSTEMS HUMAN WEL; O'Neill B. C., 2015, GLOB ENV CHANGE; Schiermeier Q, 2014, NATURE, V511, P392, DOI 10.1038/511392a; Smith P, 2013, GLOBAL CHANGE BIOL, V19, P2285, DOI 10.1111/gcb.12160	10	3	3	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					40	41		10.1038/527040a	http://dx.doi.org/10.1038/527040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV4XV	26536952				2022-12-28	WOS:000364270700034
J	Janoschka, T; Martin, N; Martin, U; Friebe, C; Morgenstern, S; Hiller, H; Hager, MD; Schubert, US				Janoschka, Tobias; Martin, Norbert; Martin, Udo; Friebe, Christian; Morgenstern, Sabine; Hiller, Hannes; Hager, Martin D.; Schubert, Ulrich S.			An aqueous, polymer-based redox-flow battery using non-corrosive, safe, and low-cost materials	NATURE			English	Article							ELECTRICAL ENERGY-STORAGE; ELECTROCHEMICAL PROPERTIES; RADICAL POLYMERS; MEMBRANES; REDUCTION; PROGRESS	For renewable energy sources such as solar, wind, and hydroelectric to be effectively used in the grid of the future, flexible and scalable energy-storage solutions are necessary to mitigate output fluctuations(1). Redox-flow batteries (RFBs) were first built in the 1940s(2) and are considered a promising large-scale energy-storage technology(1,3,4). A limited number of redox-active materials(4,5-10)-mainly metal salts, corrosive halogens, and low-molar-mass organic compounds have been investigated as active materials, and only a few membrane materials(3,5,11-14), such as Nafion, have been considered for RFBs. However, for systems that are intended for both domestic and large-scale use, safety and cost must be taken into account as well as energy density and capacity, particularly regarding long-term access to metal resources, which places limits on the lithium-ion-based and vanadium-based RFB development(15,16). Here we describe an affordable, safe, and scalable battery system, which uses organic polymers as the charge-storage material in combination with inexpensive dialysis membranes, which separate the anode and the cathode by the retention of the non-metallic, active (macro-molecular) species, and an aqueous sodium chloride solution as the electrolyte. This water- and polymer-based RFB has an energy density of 10 watt hours per litre, current densities of up to 100 milliamperes per square centimetre, and stable long-term cycling capability. The polymer-based RFB we present uses an environmentally benign sodium chloride solution and cheap, commercially available filter membranes instead of highly corrosive acid electrolytes and expensive membrane materials.	[Janoschka, Tobias; Friebe, Christian; Morgenstern, Sabine; Hiller, Hannes; Hager, Martin D.; Schubert, Ulrich S.] Univ Jena, Lab Organ & Macromol Chem IOMC, D-07743 Jena, Germany; [Janoschka, Tobias; Friebe, Christian; Morgenstern, Sabine; Hiller, Hannes; Hager, Martin D.; Schubert, Ulrich S.] Univ Jena, CEEC Jena, D-07743 Jena, Germany; [Martin, Norbert; Martin, Udo] JenaBattenes GmbH, D-07743 Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schubert, US (corresponding author), Univ Jena, Lab Organ & Macromol Chem IOMC, D-07743 Jena, Germany.	ulrich.schubert@uni-jena.de	Schubert, Ulrich/M-8136-2019; Schubert, Ulrich S/B-5777-2009; Friebe, Christian/F-5122-2010; Hager, Martin D./D-9084-2011	Schubert, Ulrich/0000-0003-4978-4670; Schubert, Ulrich S/0000-0003-4978-4670; Friebe, Christian/0000-0001-8587-6658; Hager, Martin D./0000-0002-6373-6600	European Regional Development Fund for Thuringia (EFRE); Thuringer Aufbaubank (TAB); Thuringian Ministry for Economic Affairs, Science and Digital Society (TMWWdG); Fonds der Chemischen Industrie	European Regional Development Fund for Thuringia (EFRE); Thuringer Aufbaubank (TAB); Thuringian Ministry for Economic Affairs, Science and Digital Society (TMWWdG); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We acknowledge the European Regional Development Fund for Thuringia (EFRE), the Thuringer Aufbaubank (TAB), the Thuringian Ministry for Economic Affairs, Science and Digital Society (TMWWdG), and the Fonds der Chemischen Industrie for financial support. We thank J. Stammer, C. Oder, K. Wolkersdorfer, C. Stolze, C. Schmerbauch, B. Haupler, M. Wagner, T. Bus, A. Ignaszak, and F. Schacher for their assistance and comments.	Alotto P, 2014, RENEW SUST ENERG REV, V29, P325, DOI 10.1016/j.rser.2013.08.001; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Barnhart CJ, 2013, ENERG ENVIRON SCI, V6, P1083, DOI 10.1039/c3ee24040a; Brushett FR, 2012, ADV ENERGY MATER, V2, P1390, DOI 10.1002/aenm.201200322; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; IMABAYASHI SI, 1988, J ELECTROANAL CHEM, V239, P397, DOI 10.1016/0022-0728(88)80294-8; IMABAYASHI SI, 1988, J ELECTROANAL CHEM, V243, P143, DOI 10.1016/0022-0728(88)85035-6; Janoschka T, 2012, ADV MATER, V24, P6397, DOI 10.1002/adma.201203119; Kangro W., 1949, German patent DE, Patent No. [DE914264C, 914264, 914, 264]; Leung P, 2012, RSC ADV, V2, P10125, DOI 10.1039/c2ra21342g; Li XF, 2011, ENERG ENVIRON SCI, V4, P1147, DOI 10.1039/c0ee00770f; Li Z, 2011, ELECTROCHEM SOLID ST, V14, pA171, DOI 10.1149/2.012112esl; Nagarjuna G, 2014, J AM CHEM SOC, V136, P16309, DOI 10.1021/ja508482e; Nishide H, 2009, PURE APPL CHEM, V81, P1961, DOI 10.1351/PAC-CON-08-12-03; Prifti H, 2015, MEMBRANES, V2, P275, DOI 10.3390/membranes2020275; Schwenzer B, 2011, CHEMSUSCHEM, V4, P1388, DOI 10.1002/cssc.201100068; Shin SH, 2013, RSC ADV, V3, P9095, DOI 10.1039/c3ra00115f; Sukegawa T, 2014, MACROMOLECULES, V47, P8611, DOI 10.1021/ma501632t; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; Wang W, 2013, ADV FUNCT MATER, V23, P970, DOI 10.1002/adfm.201200694; Wang W, 2012, CHEM COMMUN, V48, P6669, DOI 10.1039/c2cc32466k; Weber AZ, 2011, J APPL ELECTROCHEM, V41, P1137, DOI 10.1007/s10800-011-0348-2; Wei XL, 2014, ADV MATER, V26, P7649, DOI 10.1002/adma.201403746; Xi XL, 2015, J POWER SOURCES, V274, P1126, DOI 10.1016/j.jpowsour.2014.10.160; Yang B, 2014, J ELECTROCHEM SOC, V161, pA1371, DOI 10.1149/2.1001409jes; Yang ZG, 2011, CHEM REV, V111, P3577, DOI 10.1021/cr100290v; Zhang HZ, 2011, ENERG ENVIRON SCI, V4, P1676, DOI 10.1039/c1ee01117k; Zhou XL, 2015, ELECTROCHIM ACTA, V153, P492, DOI 10.1016/j.electacta.2014.11.185	29	570	595	53	1149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					78	81		10.1038/nature15746	http://dx.doi.org/10.1038/nature15746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26503039				2022-12-28	WOS:000364270700046
J	Savage, N				Savage, Neil			Mobile data Made to measure	NATURE			English	Editorial Material																			0	18	19	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					S12	S13		10.1038/527S12a	http://dx.doi.org/10.1038/527S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536217	Bronze			2022-12-28	WOS:000364270700029
J	Crossley, KM; Callaghan, MJ; van Linschoten, R				Crossley, Kay M.; Callaghan, Michael J.; van Linschoten, Robbart			PRACTICE POINTER Patellofemoral pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTERIOR KNEE PAIN; OSTEOARTHRITIS; PREVALENCE; DIAGNOSIS		[Crossley, Kay M.] La Trobe Univ, Sch Allied Hlth, La Trobe Sport & Exercise Med Res Ctr, Melbourne, Vic 3086, Australia; [Callaghan, Michael J.] Univ Manchester, Inst Inflammat & Repair, Ctr Musculoskeletal Res, Manchester M13 9PL, Lancs, England; [van Linschoten, Robbart] Qatar Orthopaed & Sports Med Hosp, Aspetar, Weill Cornell Med Coll, Doha, Qatar	La Trobe University; University of Manchester; Aspetar Orthopaedic & Sports Medicine Hospital; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Crossley, KM (corresponding author), La Trobe Univ, Sch Allied Hlth, La Trobe Sport & Exercise Med Res Ctr, Melbourne, Vic 3086, Australia.	k.crossley@latrobe.edu.au	Crossley, Kay M/G-4436-2010	Callaghan, Michael/0000-0003-3540-2838; Crossley, Kay/0000-0001-5892-129X				Callaghan MJ, 2015, ANN RHEUM DIS, V74, P1164, DOI 10.1136/annrheumdis-2014-206376; Callaghan MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006717.pub2; Collins NJ, 2013, BRIT J SPORT MED, V47, P227, DOI 10.1136/bjsports-2012-091696; Collins NJ, 2012, SPORTS MED, V42, P31, DOI 10.2165/11594460-000000000-00000; Crossley KM, 2015, OSTEOARTHR CARTILAGE, V23, P1457, DOI 10.1016/j.joca.2015.04.024; Duncan RC, 2006, RHEUMATOLOGY, V45, P757, DOI 10.1093/rheumatology/kei270; Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0; Heintjes EM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003472.pub2; Hinman RS, 2014, ARTHRIT CARE RES, V66, P1252, DOI 10.1002/acr.22274; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Lack S, 2014, SPORTS MED, V44, P1703, DOI 10.1007/s40279-014-0231-5; Lake DA, 2011, SPORTS HEALTH, V3, P182, DOI 10.1177/1941738111398583; Lankhorst NE, 2013, BRIT J SPORT MED, V47, P193, DOI 10.1136/bjsports-2011-090369; Nunes GS, 2013, PHYS THER SPORT, V14, P54, DOI 10.1016/j.ptsp.2012.11.003; Pihlajamaki HK, 2010, J BONE JOINT SURG AM, V92A, P927, DOI 10.2106/JBJS.H.01527; Rathleff MS, 2015, BRIT J SPORT MED, V49, P406, DOI 10.1136/bjsports-2014-093929; Thomas MJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-201; Van Linschoten R, 2009, BMJ-BRIT MED J, V20, P339; van Middelkoop M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-36; Witvrouw E, 2014, BRIT J SPORT MED, V48, P411, DOI 10.1136/bjsports-2014-093450; Wood Laurence, 2011, Prim Health Care Res Dev, V12, P157, DOI 10.1017/S1463423610000460	21	16	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2015	351								h3939	10.1136/bmj.h3939	http://dx.doi.org/10.1136/bmj.h3939			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OS	26537829	Green Submitted			2022-12-28	WOS:000364390100001
J	Fairley, P				Fairley, Peter			Energy storage: Power revolution	NATURE			English	Editorial Material																			0	37	37	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S102	S104		10.1038/526S102a	http://dx.doi.org/10.1038/526S102a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509948	Bronze			2022-12-28	WOS:000363832100029
J	Yi, M; Hunt, KK				Yi, Min; Hunt, Kelly K.			Optimizing Mammography Screening Intervals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER; BENEFITS	Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status Diana L. Miglioretti, PhD; Weiwei Zhu, MS; Karla Kerlikowske, MD; Brian L. Sprague, PhD; Tracy Onega, PhD; Diana S. M. Buist, PhD; Louise M. Henderson, PhD; Robert A. Smith, PhD; for the Breast Cancer Surveillance Consortium IMPORTANCE Screening mammography intervals remain under debate in the United States. OBJECTIVE To compare the proportion of breast cancers with less vs more favorable prognostic characteristics in women screening annually vs biennially by age, menopausal status, and postmenopausal hormone therapy (HT) use. DESIGN, SETTING, AND PARTICIPANTS This was a study of a prospective cohort from 1996 to 2012 at Breast Cancer Surveillance Consortium facilities. A total of 15 440 women ages 40 to 85 years with breast cancer diagnosed within 1 year of an annual or within 2 years of a biennial screening mammogram. EXPOSURES We updated previous analyses by using narrower intervals for defining annual (11-14 months) and biennial (23-26 months) screening. MAIN OUTCOMES AND MEASURES We defined less favorable prognostic characteristics as tumors that were stage IIB or higher, size greater than 15 mm, positive nodes, and any 1 or more of these characteristics. We used log-binomial regression to model the proportion of breast cancers with less favorable characteristics following an annual vs biennial screen by 10-year age groups and by menopausal status and current postmenopausal HT use. RESULTS Among 15 440 women with breast cancer, most were 50 years or older (13 182 [85.4%]), white (12 063 [78.1%]), and postmenopausal (9823 [63.6%]). Among 2027 premenopausal women (13.1%), biennial screeners had higher proportions of tumors that were stage IIB or higher (relative risk [RR], 1.28 [95% CI, 1.01-1.63]; P=.04), size greater than 15mm(RR, 1.21 [95% CI, 1.07-1.37]; P=.002), and with any less favorable prognostic characteristic (RR, 1.11 [95% CI, 1.00-1.22]; P=.047) compared with annual screeners. Among women currently taking postmenopausal HT, biennial screeners tended to have tumors with less favorable prognostic characteristics compared with annual screeners; however, 95% CIs were wide, and differences were not statistically significant (for stage 2B+, RR, 1.14 [95% CI, 0.89-1.47], P=.29; size >15 mm, RR, 1.13 [95% CI, 0.98-1.31], P=.09; node positive, RR, 1.18 [95% CI, 0.98-1.42], P=.09; any less favorable characteristic, RR, 1.12 [95% CI, 1.00-1.25], P=.053). The proportions of tumors with less favorable prognostic characteristics were not significantly larger for biennial vs annual screeners among postmenopausal women not taking HT (eg, any characteristic: RR, 1.03 [95% CI, 0.95-1.12]; P=.45), postmenopausal HT users after subdividing by type of hormone use (eg, any characteristic: estrogen + progestogen users, RR, 1.16 [95% CI, 0.91-1.47]; P=.22; estrogen-only users, RR, 1.14 [95% CI, 0.94-1.37]; P=.18), or any 10-year age group (eg, any characteristic: ages 40-49 years, RR, 1.04 [95% CI, 0.94-1.14]; P=.48; ages 50-59 years, RR, 1.03 [95% CI, 0.94-1.12]; P=.58; ages 60-69 years, RR, 1.07 [95% CI, 0.97-1.19]; P=.18; ages 70-85 years, RR, 1.05 [95% CI, 0.94-1.18]; P=.35). CONCLUSIONS AND RELEVANCE Premenopausal women diagnosed as having breast cancer following biennial vs annual screening mammography are more likely to have tumors with less favorable prognostic characteristics. Postmenopausal women not using HT who are diagnosed as having breast cancer following a biennial or annual screen have similar proportions of tumors with less favorable prognostic characteristics.	[Yi, Min; Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Hunt, KK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, 1400 Pressler St,Unit 1434, Houston, TX 77030 USA.	khunt@mdanderson.org	Yi, Min/J-8963-2017	Yi, Min/0000-0001-8662-6546				[Anonymous], 2011, Obstet Gynecol, V118, P372, DOI 10.1097/AOG.0b013e31822c98e5; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Miglioretti DL, 2015, JAMA ONCOL, V1, P1069, DOI 10.1001/jamaoncol.2015.3084; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; O'Donoghue C, 2014, ANN INTERN MED, V160, P145, DOI 10.7326/M13-1217; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003	11	1	1	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1635	+		10.1001/jama.2015.13149	http://dx.doi.org/10.1001/jama.2015.13149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501538				2022-12-28	WOS:000363028500022
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			Egyptian cowrie necklace	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1525	1525		10.1016/S0140-6736(15)00477-8	http://dx.doi.org/10.1016/S0140-6736(15)00477-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26530609				2022-12-28	WOS:000362878200014
J	DeSalvo, KB				DeSalvo, Karen B.			New Orleans Rises Anew: Community Health After Katrina	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[DeSalvo, Karen B.] US Dept HHS, Washington, DC 20201 USA		DeSalvo, KB (corresponding author), US Dept HHS, 200 Independence Ave SW, Washington, DC 20201 USA.							DeSalvo KB, 2005, ANN INTERN MED, V143, P905, DOI 10.7326/0003-4819-143-12-200512200-00008	1	5	5	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					57	+		10.7326/M15-2284	http://dx.doi.org/10.7326/M15-2284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4WC	26502034				2022-12-28	WOS:000367801700011
J	Nichol, G; Leroux, B; Wang, H; Callaway, CW; Sopko, G; Weisfeldt, M; Stiell, I; Morrison, LJ; Aufderheide, TP; Cheskes, S; Christenson, J; Kudenchuk, P; Vaillancourt, C; Rea, TD; Idris, AH; Colella, R; Isaacs, M; Straight, R; Stephens, S; Richardson, J; Condle, J; Schmicker, RH; Egan, D; May, S; Ornato, JP				Nichol, Graham; Leroux, Brian; Wang, Henry; Callaway, Clifton W.; Sopko, George; Weisfeldt, Myron; Stiell, Ian; Morrison, Laurie J.; Aufderheide, Tom P.; Cheskes, Sheldon; Christenson, Jim; Kudenchuk, Peter; Vaillancourt, Christian; Rea, Thomas D.; Idris, Ahamed H.; Colella, Riccardo; Isaacs, Marshal; Straight, Ron; Stephens, Shannon; Richardson, Joe; Condle, Joe; Schmicker, Robert H.; Egan, Debra; May, Susanne; Ornato, Joseph P.		ROC Investigators	Trial of Continuous or Interrupted Chest Compressions during CPR	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL CARDIAC-ARREST; EMERGENCY CARDIOVASCULAR CARE; HEART-ASSOCIATION GUIDELINES; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; LAY RESCUERS; SURVIVAL; OUTCOMES; CATHETERIZATION; RATIONALE	BACKGROUND During cardiopulmonary resuscitation (CPR) in patients with out-of-hospital cardiac arrest, the interruption of manual chest compressions for rescue breathing reduces blood flow and possibly survival. We assessed whether outcomes after continuous compressions with positive-pressure ventilation differed from those after compressions that were interrupted for ventilations at a ratio of 30 compressions to two ventilations. METHODS This cluster-randomized trial with crossover included 114 emergency medical service (EMS) agencies. Adults with non-trauma-related cardiac arrest who were treated by EMS providers received continuous chest compressions (intervention group) or interrupted chest compressions (control group). The primary outcome was the rate of survival to hospital discharge. Secondary outcomes included the modified Rankin scale score (on a scale from 0 to 6, with a score of <= 3 indicating favorable neurologic function). CPR process was measured to assess compliance. RESULTS Of 23,711 patients included in the primary analysis, 12,653 were assigned to the intervention group and 11,058 to the control group. A total of 1129 of 12,613 patients with available data (9.0%) in the intervention group and 1072 of 11,035 with available data (9.7%) in the control group survived until discharge (difference, -0.7 percentage points; 95% confidence interval [CI], -1.5 to 0.1; P = 0.07); 7.0% of the patients in the intervention group and 7.7% of those in the control group survived with favorable neurologic function at discharge (difference, -0.6 percentage points; 95% CI, -1.4 to 0.1, P = 0.09). Hospital-free survival was significantly shorter in the intervention group than in the control group (mean difference, -0.2 days; 95% CI, -0.3 to -0.1; P = 0.004). CONCLUSIONS In patients with out-of-hospital cardiac arrest, continuous chest compressions during CPR performed by EMS providers did not result in significantly higher rates of survival or favorable neurologic function than did interrupted chest compressions. (Funded by the National Heart, Lung, and Blood Institute and others; ROC CCC ClinicalTrials.gov number, NCT01372748.)	[Nichol, Graham] Univ Washington, Harborview Ctr Prehospital Emergency Care, Seattle, WA 98195 USA; [Nichol, Graham; Leroux, Brian; Schmicker, Robert H.; May, Susanne] Clin Trial Ctr, Seattle, WA USA; [Kudenchuk, Peter; Rea, Thomas D.] Univ Washington, Seattle King Cty Ctr Resuscitat Res, Seattle, WA 98195 USA; [Wang, Henry; Stephens, Shannon] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Richardson, Joe] Birmingham Fire & Rescue Serv, Birmingham, AL USA; [Callaway, Clifton W.; Condle, Joe] Univ Pittsburgh, Pittsburgh Resuscitat Network, Pittsburgh, PA USA; [Sopko, George; Egan, Debra] NHLBI, Bethesda, MD 20892 USA; [Weisfeldt, Myron] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Stiell, Ian; Vaillancourt, Christian] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa Ontario Prehosp Adv Life Support Resuscita, Ottawa, ON, Canada; [Morrison, Laurie J.; Cheskes, Sheldon] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Christenson, Jim; Straight, Ron] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Aufderheide, Tom P.; Colella, Riccardo] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Idris, Ahamed H.; Isaacs, Marshal] Univ Texas SW Med Ctr Dallas, Dallas Ft Worth Ctr Resuscitat Res, Dallas, TX 75390 USA; [Ornato, Joseph P.] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of British Columbia; Medical College of Wisconsin; University of Texas System; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University	Nichol, G (corresponding author), Box 359727,325 Ninth Ave, Seattle, WA 98104 USA.	nichol@uw.edu	Ferguson, Niall/D-7619-2019; Christian, Mike/AAO-6338-2020; Cheskes, Sheldon/I-4456-2015; Christian, Michael/AAZ-4452-2020; colella, riccardo/AAA-4306-2020; McLeod, Shelley/AAE-9636-2019; Morrison, Laurie Jean/A-6325-2012; Nichol, Graham/Z-4996-2019; Welsford, Michelle/H-5535-2017	Ferguson, Niall/0000-0002-6213-5264; Christian, Mike/0000-0001-9644-9950; Cheskes, Sheldon/0000-0001-7835-3074; Christian, Michael/0000-0001-9644-9950; colella, riccardo/0000-0001-9764-5179; McLeod, Shelley/0000-0003-2686-6307; Morrison, Laurie Jean/0000-0001-8369-9774; Guffey, Danielle/0000-0003-3721-614X; Welsford, Michelle/0000-0003-2682-641X; Stephens, Shannon/0000-0001-5898-5170; MENA, JORGE/0000-0002-4421-2764; Gruen, Danielle/0000-0003-1019-4390; Zelnick, Leila/0000-0002-8461-5111	National Heart, Lung, and Blood Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077881, U01HL077867, U01HL077885, U01HL077863, U01HL077871, U01HL077887, U01HL077872, U01HL077866] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and others	Agarwal R, 2006, AM J RESP CRIT CARE, V174, P1055; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2011, NEW ENGL J MED, V365, P798, DOI 10.1056/NEJMoa1010821; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Berg RA, 2000, CIRCULATION, V101, P1743; Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Brown SP, 2015, AM HEART J, V169, P334, DOI 10.1016/j.ahj.2014.11.011; Callaway CW, 2014, RESUSCITATION, V85, P657, DOI 10.1016/j.resuscitation.2013.12.028; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Garza AG, 2009, CIRCULATION, V119, P2597, DOI 10.1161/CIRCULATIONAHA.108.815621; Hollenbeck RD, 2014, RESUSCITATION, V85, P88, DOI 10.1016/j.resuscitation.2013.07.027; Hostler David, 2011, BMJ, V342, pd512, DOI 10.1136/bmj.d512; Huber P. J., 1967, PROCESSING 5 BERKELE; Kellum MJ, 2006, AM J MED, V119, P335, DOI 10.1016/j.amjmed.2005.11.014; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kudenchuk PJ, 2014, AM HEART J, V167, P653, DOI 10.1016/j.ahj.2014.02.010; Link MS, 2010, CIRCULATION, V122, pS706, DOI 10.1161/CIRCULATIONAHA.110.970954; Little R.J.A., 2002, STAT ANAL MISSING DA; Panchal AR, 2013, RESUSCITATION, V84, P435, DOI 10.1016/j.resuscitation.2012.07.038; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Strote JA, 2012, AM J CARDIOL, V109, P451, DOI 10.1016/j.amjcard.2011.09.036; Stub D, 2015, RESUSCITATION, V92, P45, DOI 10.1016/j.resuscitation.2015.04.015; Vaillancourt C, 2011, RESUSCITATION, V82, P1501, DOI 10.1016/j.resuscitation.2011.07.011; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Young P, 2014, RESUSCITATION, V85, P1686, DOI 10.1016/j.resuscitation.2014.09.011	32	186	191	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2203	2214		10.1056/NEJMoa1509139	http://dx.doi.org/10.1056/NEJMoa1509139			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26550795	Bronze			2022-12-28	WOS:000365743100004
J	Zhang, X; Ding, K; Yu, XK; Chang, W; Sun, JC; Zhou, ZH				Zhang, Xing; Ding, Ke; Yu, Xuekui; Chang, Winston; Sun, Jingchen; Zhou, Z. Hong			In situ structures of the segmented genome and RNA polymerase complex inside a dsRNA virus	NATURE			English	Article							CYTOPLASMIC POLYHEDROSIS-VIRUS; CRYO-EM STRUCTURE; PROTEIN; DNA; CLASSIFICATION; TRANSCRIPTASE; REPLICATION; NUCLEOSIDE; RESOLUTION; MECHANISM	Viruses in the Reoviridae, like the triple-shelled human rotavirus and the single-shelled insect cytoplasmic polyhedrosis virus (CPV), all package a genome of segmented double-stranded RNAs (dsRNAs) inside the viral capsid and carry out endogenous messenger RNA synthesis through a transcriptional enzyme complex (TEC)(1). By direct electron-counting cryoelectron microscopy and asymmetric reconstruction, we have determined the organization of the dsRNA genome inside quiescent CPV (q-CPV) and the in situ atomic structures of TEC within CPV in both quiescent and transcribing (t-CPV) states. We show that the ten segmented dsRNAs in CPV are organized with ten TECs in a specific, non-symmetric manner, with each dsRNA segment attached directly to a TEC. The TEC consists of two extensively interacting subunits: an RNA-dependent RNA polymerase (RdRP) and an NTPase VP4. We find that the bracelet domain of RdRP undergoes marked conformational change when q-CPV is converted to t-CPV, leading to formation of the RNA template entry channel and access to the polymerase active site. An amino-terminal helix from each of two subunits of the capsid shell protein (CSP) interacts with VP4 and RdRP. These findings establish the link between sensing of environmental cues by the external proteins and activation of endogenous RNA transcription by the TEC inside the virus.	[Zhang, Xing; Chang, Winston; Zhou, Z. Hong] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Ding, Ke; Yu, Xuekui; Sun, Jingchen; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ding, Ke; Zhou, Z. Hong] Univ Calif Los Angeles, Bioengn, Los Angeles, CA 90095 USA; [Sun, Jingchen] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Subtrop Sericulture & Mulberry Resources Protect, Guangzhou 510642, Guangdong, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; South China Agricultural University	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA.	cyfz@scau.edu.cn; Hong.Zhou@ucla.edu	Zhou, Z Hong/HDN-0747-2022	Ding, Ke/0000-0002-0115-5931	National Institutes of Health [AI094386, GM071940]; NSFC [31172263]; NSFGD [S2013010016750]; UCLA; NIH [1S10RR23057, 1S10OD018111]; NSF [DBI-1338135]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1338135] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NSFGD; UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grants from the National Institutes of Health (AI094386 and GM071940 to Z.H.Z.), NSFC (31172263 to J.S.) and NSFGD (S2013010016750 to J.S.). We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines supported by UCLA and by instrumentation grants from NIH (1S10RR23057, 1S10OD018111) and NSF (DBI-1338135). We thank P. Ge for carrying out a Relion reconstruction without an initial model as an independent verification step, S. Schein and L. Wang for proof-reading the paper, and P. Afonine for model refinement.	Abels JA, 2005, BIOPHYS J, V88, P2737, DOI 10.1529/biophysj.104.052811; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker Matthew L., 2008, P89; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; Briggs JAG, 2005, J STRUCT BIOL, V150, P332, DOI 10.1016/j.jsb.2005.03.009; Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrozi LF, 2013, J MOL BIOL, V425, P124, DOI 10.1016/j.jmb.2012.10.011; FURUICHI Y, 1974, NUCLEIC ACIDS RES, V1, P809, DOI 10.1093/nar/1.6.809; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Gridley CL, 2014, CURR OPIN VIROL, V9, P31, DOI 10.1016/j.coviro.2014.08.008; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Huiskonen JT, 2007, J STRUCT BIOL, V158, P156, DOI 10.1016/j.jsb.2006.08.021; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kim J, 2004, J BIOL CHEM, V279, P4394, DOI 10.1074/jbc.M308637200; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Luongo CL, 2002, VIROLOGY, V296, P24, DOI 10.1006/viro.2001.1258; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; MANSELL EA, 1990, J VIROL, V64, P4988, DOI 10.1128/JVI.64.10.4988-4996.1990; McDonald SM, 2011, J VIROL, V85, P3095, DOI 10.1128/JVI.02360-10; Mertens PPC, 2004, VIRUS TAXONOMY, P522; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nason EL, 2004, J VIROL, V78, P8059, DOI 10.1128/JVI.78.15.8059-8067.2004; Nibert ML, 2004, J VIROL, V78, P5528, DOI 10.1128/JVI.78.10.5528-5530.2004; Patton JT, 1997, J VIROL, V71, P9618, DOI 10.1128/JVI.71.12.9618-9626.1997; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; STARNES MC, 1993, VIROLOGY, V193, P356, DOI 10.1006/viro.1993.1132; Stauber N, 1997, J VIROL, V71, P7220; Sutton G, 2007, NAT STRUCT MOL BIOL, V14, P449, DOI 10.1038/nsmb1225; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Xia Q, 2003, J BIOL CHEM, V278, P1094, DOI 10.1074/jbc.M205964200; Yang CW, 2012, P NATL ACAD SCI USA, V109, P6118, DOI 10.1073/pnas.1200206109; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Yu XK, 2015, ELIFE, V4, DOI 10.7554/eLife.07901; Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009; Zhang XF, 2013, ADV ENERGY MATER, V3, P1299, DOI 10.1002/aenm.201300269; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhang Y, 2007, J STRUCT BIOL, V157, P356, DOI 10.1016/j.jsb.2006.09.002; Zhao SL, 2003, ARCH VIROL, V148, P1357, DOI 10.1007/s00705-003-0103-z	45	69	72	0	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					531	+		10.1038/nature15767	http://dx.doi.org/10.1038/nature15767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26503045	Green Accepted, Green Submitted			2022-12-28	WOS:000365352500051
J	Hayashi, Y; Kashiwagi, M; Yasuda, K; Ando, R; Kanuka, M; Sakai, K; Itohara, S				Hayashi, Yu; Kashiwagi, Mitsuaki; Yasuda, Kosuke; Ando, Reiko; Kanuka, Mika; Sakai, Kazuya; Itohara, Shigeyoshi			Cells of a common developmental origin regulate REM/non-REM sleep and wakefulness in mice	SCIENCE			English	Article							PARADOXICAL SLEEP; GABAERGIC NEURONS; RHOMBIC-LIP; BRAIN-STEM; MATH1 EXPRESSION; NUCLEUS; LOCALIZATION; OSCILLATIONS; DEPRIVATION; GENERATION	Mammalian sleep comprises rapid eye movement (REM) sleep and non-REM (NREM) sleep. To functionally isolate from the complex mixture of neurons populating the brainstem pons those involved in switching between REM and NREM sleep, we chemogenetically manipulated neurons of a specific embryonic cell lineage in mice. We identified excitatory glutamatergic neurons that inhibit REM sleep and promote NREM sleep. These neurons shared a common developmental origin with neurons promoting wakefulness; both derived from a pool of proneural hindbrain cells expressing Atoh1 at embryonic day 10.5. We also identified inhibitory gamma-aminobutyric acid-releasing neurons that act downstream to inhibit REM sleep. Artificial reduction or prolongation of REM sleep in turn affected slow-wave activity during subsequent NREM sleep, implicating REM sleep in the regulation of NREM sleep.	[Hayashi, Yu; Kashiwagi, Mitsuaki; Kanuka, Mika] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Hayashi, Yu] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Yasuda, Kosuke; Ando, Reiko; Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; [Sakai, Kazuya] Univ Lyon 1, Lyon Neurosci Res Ctr, INSERM CNRS UMR5292 U1028, Sch Med,Integrat Physiol Brain Arousal Syst, F-69373 Lyon, France	University of Tsukuba; Japan Science & Technology Agency (JST); RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Franche-Comte	Hayashi, Y (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hayashi.yu.fp@u.tsukuba.ac.jp; sitohara@brain.riken.jp	Hayashi, Yu/AAF-5179-2019; Itohara, Shigeyoshi/I-8769-2012	Hayashi, Yu/0000-0001-5007-4532; Itohara, Shigeyoshi/0000-0002-2410-9989	Japan Science and Technology Agency PRESTO program; Ministry of Education, Cutlure, Sports, Science, and Technology of Japan (MEXT) World Premier International Research Center Initiative (WPI); MEXT KAKENHI [23115724, 26115503]; Japan Society for the Promotion of Science KAKENHI [23700403, 21800090]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Sumitomo Foundation; SENSHIN Medical Research Foundation; Japan Foundation for Applied Enzymology (TMFC); RIKEN Special Postdoctoral Researcher Program; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) - Council for Science and Technology Policy (CSTP); RIKEN intramural fund	Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); Ministry of Education, Cutlure, Sports, Science, and Technology of Japan (MEXT) World Premier International Research Center Initiative (WPI); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Sumitomo Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Foundation for Applied Enzymology (TMFC); RIKEN Special Postdoctoral Researcher Program; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) - Council for Science and Technology Policy (CSTP); RIKEN intramural fund	We thank M. Yanagisawa for support of experiments and critical reading of the manuscript; H. Hirase, Y. Koyama, and M. Matsumata for technical advice; C. Yokoyama and S. Tonegawa for comments on the manuscript; L. Luo, S. Tonegawa, T. Kaneko, B. Roth, C. Cepko, and K. Deisseroth for providing reagents; and all members of the Itohara laboratory and Hayashi laboratory for their support and discussion. CAG-LSL-tTA and Camk2-LSL-tTA mice were provided under a materials transfer agreement with Stanford University and the Massachusetts Institute of Technology, respectively. This work was supported by the Japan Science and Technology Agency PRESTO program; the Ministry of Education, Cutlure, Sports, Science, and Technology of Japan (MEXT) World Premier International Research Center Initiative (WPI); the MEXT KAKENHI for Scientific Research on Innovative Areas "Systems Molecular Ethology" (23115724) and "Memory Dynamism" (26115503); the Japan Society for the Promotion of Science KAKENHI grant nos. 23700403 and 21800090; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Astellas Foundation for Research on Metabolic Disorders; the Sumitomo Foundation Grant for Basic Science Research Projects; the SENSHIN Medical Research Foundation; the Japan Foundation for Applied Enzymology (TMFC), and the RIKEN Special Postdoctoral Researcher Program (to Y.H.); and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy (CSTP) and the RIKEN intramural fund (to S.I.). All data are stored in the International Institute for Integrative Sleep Medicine, University of Tsukuba and the Brain Science Institute, RIKEN.	Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BEERSMA DGM, 1990, ELECTROEN CLIN NEURO, V76, P114, DOI 10.1016/0013-4694(90)90209-3; BENINGTON JH, 1994, PROG NEUROBIOL, V44, P433, DOI 10.1016/0301-0082(94)90005-1; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Crochet S, 2006, EUR J NEUROSCI, V24, P1404, DOI 10.1111/j.1460-9568.2006.04995.x; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; Green MJ, 2014, DEVELOPMENT, V141, P389, DOI 10.1242/dev.099119; Helms AW, 2000, DEVELOPMENT, V127, P1185; Kaur S, 2013, J NEUROSCI, V33, P7627, DOI 10.1523/JNEUROSCI.0173-13.2013; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; Krenzer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024998; Le Bon O, 2013, J NEUROPHYSIOL, V110, P162, DOI 10.1152/jn.00020.2013; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2012, PFLUG ARCH EUR J PHY, V463, P43, DOI 10.1007/s00424-011-1054-y; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Sakai K, 2001, ARCH ITAL BIOL, V139, P93; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Suzuki A, 2013, P NATL ACAD SCI USA, V110, P10288, DOI 10.1073/pnas.1308295110; VANNIMERCIER G, 1989, ARCH ITAL BIOL, V127, P133; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; Vyazovskiy VV, 2004, ARCH ITAL BIOL, V142, P511; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	32	111	113	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					957	961		10.1126/science.aad1023	http://dx.doi.org/10.1126/science.aad1023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26494173				2022-12-28	WOS:000364955200044
J	Kelley, AS; McGarry, K; Gorges, R; Skinner, JS				Kelley, Amy S.; McGarry, Kathleen; Gorges, Rebecca; Skinner, Jonathan S.			The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL EXPENDITURES; UNITED-STATES; REFORM	Background: Common diseases, particularly dementia, have large social costs for the U.S. population. However, less is known about the end-of-life costs of specific diseases and the associated financial risk for individual households. Objective: To examine social costs and financial risks faced by Medicare beneficiaries 5 years before death. Design: Retrospective cohort. Setting: The HRS (Health and Retirement Study). Participants: Medicare fee-for-service beneficiaries, aged 70 years or older, who died between 2005 and 2010 (n = 1702), stratified into 4 groups: persons with a high probability of dementia or those who died because of heart disease, cancer, or other causes. Measurements: Total social costs and their components, including Medicare, Medicaid, private insurance, out-of-pocket spending, and informal care, measured over the last 5 years of life; and out-of-pocket spending as a proportion of household wealth. Results: Average total cost per decedent with dementia ($287 038) was significantly greater than that of those who died of heart disease ($175 136), cancer ($173 383), or other causes ($197 286) (P < 0.001). Although Medicare expenditures were similar across groups, average out-of-pocket spending for patients with dementia ($61 522) was 81% higher than that for patients without dementia ($34 068); a similar pattern held for informal care. Out-of-pocket spending for the dementia group (median, $36 919) represented 32% of wealth measured 5 years before death compared with 11% for the nondementia group (P < 0.001). This proportion was greater for black persons (84%), persons with less than a high school education (48%), and unmarried or widowed women (58%). Limitation: Imputed Medicaid, private insurance, and informal care costs. Conclusion: Health care expenditures among persons with dementia were substantially larger than those for other diseases, and many of the expenses were uncovered (uninsured). This places a large financial burden on families, and these burdens are particularly pronounced among the demographic groups that are least prepared for financial risk. Primary Funding Source: National Institute on Aging.	[Kelley, Amy S.; Gorges, Rebecca] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, New York, NY 10029 USA; [McGarry, Kathleen] Univ Calif Los Angeles, Dept Econ, Los Angeles, CA 90095 USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; Dartmouth College	Kelley, AS (corresponding author), Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	amy.kelley@mssm.edu			National Institute on Aging; NATIONAL INSTITUTE ON AGING [U01AG009740, K23AG040774, U01AG046830, P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging.	Aaron HJ, 2011, NEW ENGL J MED, V364, P1588, DOI 10.1056/NEJMp1103764; Antos JR, 2012, NEW ENGL J MED, V366, P879, DOI 10.1056/NEJMp1200446; Baicker K, 2013, BROOKINGS PAPERS EC, P303; Blumenthal D, 2013, NEW ENGL J MED, V369, P2551, DOI 10.1056/NEJMhpr1310415; Centers for Medicare and Medicaid Services. Baltimore (MD), 2013, NAT HLTH EXP 2013 HI; Centers for Medicare & Medicaid Services, 2013, NAT HLTH EXP TABL; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Graaff J de V, 1987, NEW PALGRAVE DICT EC, P393; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Kelley AS, 2013, J GEN INTERN MED, V28, P304, DOI 10.1007/s11606-012-2199-x; Kelley AS, 2011, ANN INTERN MED, V154, P235, DOI 10.7326/0003-4819-154-4-201102150-00004; Marshall S., 2011, EXPLORATIONS EC AGIN; McGarry K, 2005, J GERONTOL B-PSYCHOL, V60, pS160, DOI 10.1093/geronb/60.3.S160; McGarry Kathleen, 2005, Soc Secur Bull, V66, P58; MetLife Mature Market Institute, 2010, MARK SURV LONG TERM; Oberlander J, 2014, J HEALTH POLIT POLIC, V39, P467, DOI 10.1215/03616878-2416348; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R., 2011, CAREGIVING COSTS DEC	19	203	206	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					729	U175		10.7326/M15-0381	http://dx.doi.org/10.7326/M15-0381			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26502320	Green Accepted			2022-12-28	WOS:000365746400015
J	Chin, WW				Chin, William W.			A Delicate Balance - Pharmaceutical Innovation and Access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Altarum Institute, 2015, CTR SUST HLTH SPEND; [Anonymous], 2014, NICE LIM REIMB ONC P; Fein AJ., 2015, DRUG CHANNELS B 0331; Levit L., 2013, DELIVERING HIGH QUAL	4	7	7	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1799	1801		10.1056/NEJMp1513227	http://dx.doi.org/10.1056/NEJMp1513227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3FK	26535511				2022-12-28	WOS:000364144000003
J	Bielicki, JA; Barker, CIS; Saxena, S; Wong, ICK; Long, PF; Sharland, M				Bielicki, J. A.; Barker, C. I. S.; Saxena, S.; Wong, I. C. K.; Long, P. F.; Sharland, M.			Not too little, not too much: problems of selecting oral antibiotic dose for children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUG		[Bielicki, J. A.; Barker, C. I. S.; Sharland, M.] Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England; [Bielicki, J. A.] Univ Basel, Childrens Hosp, Paediat Pharmacol, Basel, Switzerland; [Barker, C. I. S.] UCL, Inst Child Hlth, London, England; [Saxena, S.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Wong, I. C. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China; [Wong, I. C. K.] UCL, UCL Sch Pharm, Ctr Paediat Pharm Res, London, England; [Long, P. F.] Kings Coll London, Inst Pharmaceut Sci, London, England	University of London; University of Basel; University of London; University College London; Imperial College London; University of Hong Kong; University of London; University College London; University of London; King's College London	Bielicki, JA (corresponding author), Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England.	jbielick@sgul.ac.uk	Barker, Charlotte/AAO-4131-2021; Saxena, Sonia K/G-4821-2013; Saxena, Sonia/ABD-7737-2021; Barker, Charlotte I S/D-5527-2014	Barker, Charlotte/0000-0002-6757-5867; Saxena, Sonia K/0000-0003-3787-2083; Saxena, Sonia/0000-0003-3787-2083; Barker, Charlotte I S/0000-0002-6757-5867; sharland, mike/0000-0001-8626-8291; Wong, Ian Chi Kei/0000-0001-8242-0014	European Commission Directorate General for Health and Consumers DG Sanco through the Executive Agency for Health and Consumers [2009 11 01]; Global Research in Paediatrics Network of Excellence (GRiP), European Union [261060]; National Institute for Health Research Career Development Fellowship (NIHR) [CDF-2011-04-048]	European Commission Directorate General for Health and Consumers DG Sanco through the Executive Agency for Health and Consumers; Global Research in Paediatrics Network of Excellence (GRiP), European Union; National Institute for Health Research Career Development Fellowship (NIHR)(National Institute for Health Research (NIHR))	We have read and understood BMJ policy on declaration of interests and declare MS chairs the Department of Health expert advisory committee on antimicrobial resistance and healthcare associated infection. The ARPEC project was cofunded by the European Commission Directorate General for Health and Consumers DG Sanco through the Executive Agency for Health and Consumers (agreement number 2009 11 01). CISB is funded as a clinical research fellow by the Global Research in Paediatrics Network of Excellence (GRiP), part of the European Union seventh framework programme (FP7/2007-2013, grant agreement number 261060). SS is funded by a National Institute for Health Research Career Development Fellowship (NIHR CDF-2011-04-048). The views expressed are not necessarily those of the NHS, NIHR, or Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed U, 2011, BMJ-BRIT MED J, V343, pd7803; Anderson BJ, 2013, ARCH DIS CHILD, V98, P737, DOI 10.1136/archdischild-2013-303720; Batchelor HK, 2015, BRIT J CLIN PHARMACO, V79, P405, DOI 10.1111/bcp.12268; Bielicki J, 2015, PEDIATR INFECT DIS J, V34, P311, DOI 10.1097/INF.0000000000000621; Canafax DM, 1998, PEDIATR INFECT DIS J, V17, P149, DOI 10.1097/00006454-199802000-00014; Chiou CC, 2006, CLIN INFECT DIS, V42, P234, DOI 10.1086/499596; Easton J, 2003, DRUGS, V63, P311, DOI 10.2165/00003495-200363030-00005; Esposito S, 2012, PEDIATR INFECT DIS J, V31, pE78, DOI 10.1097/INF.0b013e318255dc5b; FDA, AM SUSP; Head of Medicines Agencies, HUM MUT REC PROD IND; Holstiege J, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-174; Huijben S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003578; Katz MG, 2006, AM J HEALTH-SYST PH, V63, P2391, DOI 10.2146/ajhp060162; Kaushal R, 2007, AMBUL PEDIATR, V7, P383, DOI 10.1016/j.ambp.2007.05.005; Le Doare K, 2015, BRIT J CLIN PHARMACO, V79, P446, DOI 10.1111/bcp.12320; Madhi SA, 2013, PEDIATR INFECT DIS J, V32, pE119, DOI 10.1097/INF.0b013e3182784b26; Make Medicines Child Size, 2009, TECHN CONS US PHARM; Martinez MN, 2012, ANTIMICROB AGENTS CH, V56, P2795, DOI 10.1128/AAC.05360-11; Paediatric Formulary Committee, 2014, BMJ; Saxena S, 2014, BRIT J GEN PRACT, V64, pE217, DOI 10.3399/bjgp14X677842; Sturkenboom MCJM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2245; Versporten A, 2013, PEDIATR INFECT DIS J, V32, pE242, DOI 10.1097/INF.0b013e318286c612; World Health Organization, 2013, GUIDELINES MANAGEMEN; Yin HS, 2010, JAMA-J AM MED ASSOC, V304, P2595, DOI 10.1001/jama.2010.1797; Yin HS, 2010, ARCH PEDIAT ADOL MED, V164, P181, DOI 10.1001/archpediatrics.2009.269	25	13	13	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2015	351								h5447	10.1136/bmj.h5447	http://dx.doi.org/10.1136/bmj.h5447			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV6OC	26537515				2022-12-28	WOS:000364388500001
J	Schieber, AMP; Lee, YM; Chang, MW; Leblanc, M; Collins, B; Downes, M; Evans, RM; Ayres, JS				Schieber, Alexandria M. Palaferri; Lee, Yujung Michelle; Chang, Max W.; Leblanc, Mathias; Collins, Brett; Downes, Michael; Evans, Ronald M.; Ayres, Janelle S.			Disease tolerance mediated by microbiome E-coli involves inflammasome and IGF-1 signaling	SCIENCE			English	Article							MUSCLE ATROPHY; UBIQUITIN LIGASES; CANCER CACHEXIA; GUT MICROBIOTA; GROWTH; MICE; ACTIVATION; MECHANISMS; EXPRESSION; INFECTION	Infections and inflammation can lead to cachexia and wasting of skeletal muscle and fat tissue by as yet poorly understood mechanisms. We observed that gut colonization of mice by a strain of Escherichia coli prevents wasting triggered by infections or physical damage to the intestine. During intestinal infection with the pathogen Salmonella Typhimurium or pneumonic infection with Burkholderia thailandensis, the presence of this E. coli did not alter changes in host metabolism, caloric uptake, or inflammation but instead sustained signaling of the insulin-like growth factor 1/phosphatidylinositol 3-kinase/AKT pathway in skeletal muscle, which is required for prevention of muscle wasting. This effect was dependent on engagement of the NLRC4 inflammasome. Therefore, this commensal promotes tolerance to diverse diseases.	[Schieber, Alexandria M. Palaferri; Lee, Yujung Michelle; Ayres, Janelle S.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Chang, Max W.] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA; [Leblanc, Mathias; Collins, Brett; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Ayres, JS (corresponding author), Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA.	jayres@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Palaferri Schieber, Alexandria/0000-0001-9468-8325; Chang, Max/0000-0002-4526-489X	NIH [R01AI114929, DK0577978, CA014195]; NOMIS Foundation; Searle Scholar Foundation; Ray Thomas Edward Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NOMIS Foundation; Searle Scholar Foundation; Ray Thomas Edward Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Vance for mice and reagents; G. Barton and M. Koch for TLR4-ELAM NFkB reagents; M. Montminy and E. Wiater for use of the EchoMRI and MiSeq sequencer and technical assistance; S. Mazmanian, S. McBride, J. Sonnenburg, and S. Higginbottom for germ-free mice and advice; D. Monack and F. Re for Salmonella and Burkholderia strains; W. Fan and S. Bapat for reagents and help with muscle and fat anatomy and physiology; I. Verma for use of the BioRad Bio-Plex MAGPIX multiplex reader; D. Cook for technical assistance with Luminex assays; M. Ku and S. Heinz for advice and technical assistance with RNA-seq and metagenomics analyses; R. Shaw and P. Hollstein for Western blot reagents and advice; G. Van Gerpen, K. Kujawa, and M. Bouchard for administrative assistance with establishing our gnotobiotic facility; and D. Schneider and D. Green for helpful discussions and thoughtful comments on the manuscript. A special thanks to R. Lamberton for continuous support. This work was supported by NIH grant R01AI114929 (J. S. A), the NOMIS Foundation, the Searle Scholar Foundation (J. S. A), the Ray Thomas Edward Foundation (J. S. A.), NIH grants DK0577978 (R. M. E.) and CA014195, the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the Samuel Waxman Cancer Research Foundation, and Ipsen/Biomeasure. R. M. E. is an investigator of the Howard Hughes Medical Institute at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology. Data described in this paper can be found in the supplementary materials. The authors declare no conflicts of interest.	Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Delano Matthew J, 2006, Nutr Clin Pract, V21, P68, DOI 10.1177/011542650602100168; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fisher RL, 1999, J NUTR, V129, p252S, DOI 10.1093/jn/129.1.252S; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hasselgren PO, 2000, WORLD J SURG, V24, P1452, DOI 10.1007/s002680010262; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kalantar-Zadeh K, 2013, J CACHEXIA SARCOPENI, V4, P89, DOI 10.1007/s13539-013-0111-0; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; OVESEN L, 1993, J CLIN ONCOL, V11, P2043, DOI 10.1200/JCO.1993.11.10.2043; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Villamor E, 2006, EUR J CLIN NUTR, V60, P163, DOI 10.1038/sj.ejcn.1602281; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944	32	124	131	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260					558	563		10.1126/science.aac6468	http://dx.doi.org/10.1126/science.aac6468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516283	Green Accepted			2022-12-28	WOS:000363660000048
J	Owens, B				Owens, Brian			Batteries	NATURE			English	Editorial Material																			0	12	13	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2015	526	7575					S89	S89		10.1038/526S89a	http://dx.doi.org/10.1038/526S89a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8ZH	26509950	Bronze			2022-12-28	WOS:000363832100066
J	Misra, S; Oliver, NS				Misra, Shivani; Oliver, Nick S.			Diabetic ketoacidosis in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HYPERGLYCEMIC CRISES; SEVERE HYPOGLYCEMIA; 0.9-PERCENT SALINE; MANAGEMENT; ACIDOSIS; INSULIN; HYDROXYBUTYRATE; RESUSCITATION; BICARBONATE; PREVENTION		[Misra, Shivani; Oliver, Nick S.] Univ London Imperial Coll Sci Technol & Med, Dept Diabet Endocrinol & Metab, London W2 1PG, England; [Misra, Shivani] Imperial Healthcare NHS Trust, Clin Biochem & Metab Med, London, England; [Oliver, Nick S.] Imperial Healthcare NHS Trust, Diabet & Endocrinol, London, England	Imperial College London	Oliver, NS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Diabet Endocrinol & Metab, London W2 1PG, England.	nick.oliver@imperial.ac.uk	Oliver, Nick S/G-9109-2016	Oliver, Nick S/0000-0003-3525-3633; Misra, Shivani/0000-0003-2886-0726	Diabetes Research & Wellness Foundation Sutherland-Earl Clinical Research Fellowship	Diabetes Research & Wellness Foundation Sutherland-Earl Clinical Research Fellowship	SM is a clinical research fellow funded by the Diabetes Research & Wellness Foundation Sutherland-Earl Clinical Research Fellowship.	Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Arora S, 2011, DIABETES CARE, V34, P852, DOI 10.2337/dc10-1844; Chua HR, 2012, J CRIT CARE, V27, P138, DOI 10.1016/j.jcrc.2012.01.007; Crasto W, 2015, BRIT J DIABETES VASC, V15, P11, DOI 10.15277/bjdvd.2014.040; Dhatariya KK, 2015, DIABET MED; Dhatariya KK, 2013, JOINT BRIT DIABETES; Elliott J, 2014, DIABETIC MED, V31, P847, DOI 10.1111/dme.12441; English P, 2004, POSTGRAD MED J, V80, P253, DOI 10.1136/pgmj.2002.004291; Green SM, 1998, ANN EMERG MED, V31, P41, DOI 10.1016/S0196-0644(98)70279-3; Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148; Henriksen OM, 2007, DIABETES RES CLIN PR, V76, P51, DOI 10.1016/j.diabres.2006.07.024; Hsia E, 2012, J CLIN ENDOCR METAB, V97, P3132, DOI 10.1210/jc.2012-1244; JOLOBE OMP, 1993, DIABETIC MED, V10, P782; Karges B, 2015, EUR J ENDOCRINOL, V173, P341, DOI 10.1530/EJE-15-0129; Kitabchi AE, 2008, DIABETES CARE, V31, P2081, DOI 10.2337/dc08-0509; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Klocker AA, 2013, DIABETIC MED, V30, P818, DOI 10.1111/dme.12136; Laffel LMB, 2006, DIABETIC MED, V23, P278, DOI 10.1111/j.1464-5491.2005.01771.x; Mahler SA, 2011, AM J EMERG MED, V29, P670, DOI 10.1016/j.ajem.2010.02.004; Misra S, 2015, DIABETIC MED, V32, P14, DOI 10.1111/dme.12604; Misra S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3501; Okuda Y, 1996, J CLIN ENDOCR METAB, V81, P314, DOI 10.1210/jc.81.1.314; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Samuelsson Ulf, 2002, Diabetes Technol Ther, V4, P645, DOI 10.1089/152091502320798286; Savage MW, 2011, DIABETIC MED, V28, P508, DOI 10.1111/j.1464-5491.2011.03246.x; Schade D, 1981, DIABETIC COMA KETOAC; Sheikh-Ali M, 2008, DIABETES CARE, V31, P643, DOI 10.2337/dc07-1683; Skellett S, 2000, ARCH DIS CHILD, V83, P514, DOI 10.1136/adc.83.6.514; Umpierrez GE, 2009, DIABETES CARE, V32, P1164, DOI 10.2337/dc09-0169; Van Zyl DG, 2012, QJM-INT J MED, V105, P337, DOI 10.1093/qjmed/hcr226	30	32	31	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2015	351								h5660	10.1136/bmj.h5660	http://dx.doi.org/10.1136/bmj.h5660			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IK	26510442	Green Published			2022-12-28	WOS:000364152500004
J	Ma, JM; Ward, EM; Siegel, RL; Jemal, A				Ma, Jiemin; Ward, Elizabeth M.; Siegel, Rebecca L.; Jemal, Ahmedin			Temporal Trends in Mortality in the United States, 1969-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DEATH CERTIFICATES; US; PREVALENCE; ACCURACY; CANCER; OBESITY; DECLINE; NATION; ADULTS	IMPORTANCE A systematic and comprehensive evaluation of long-term trends in mortality is important for health planning and priority setting and for identifying modifiable factors that may contribute to the trends. OBJECTIVE To examine temporal trends in deaths in the United States for all causes and for the 6 leading causes. DESIGN, SETTING, AND PARTICIPANTS Joinpoint analysis of US national vital statistics data from 1969 through 2013. EXPOSURE Causes of death. MAIN OUTCOMES AND MEASURES Total and annual percent change in age-standardized death rates and years of potential life lost before age 75 years for all causes combined and for heart disease, cancer, chronic obstructive pulmonary disease (COPD), stroke, unintentional injuries, and diabetes mellitus. RESULTS Between 1969 and 2013, the age-standardized death rate per 100 000 decreased from 1278.8 to 729.8 for all causes (42.9% reduction; 95% CI, 42.8%-43.0%), from 156.8 to 36.0 for stroke (77.0% reduction; 95% CI, 76.9%-77.2%), from 520.4 to 169.1 for heart disease (67.5% reduction; 95% CI, 67.4%-67.6%), from 65.1 to 39.2 for unintentional injuries (39.8% reduction; 95% CI, 39.3%-40.3%), from 198.6 to 163.1 for cancer (17.9% reduction; 95% CI, 17.5%-18.2%), and from 25.3 to 21.1 for diabetes (16.5% reduction; 95% CI, 15.4%-17.5%). In contrast, the rate for COPD increased from 21.0 to 42.2 (100.6% increase; 95% CI, 98.2%-103.1%). However, during the last time segment detected by joinpoint analysis, death rate for COPD in men began to decrease and the declines in rates slowed for heart disease, stroke, and diabetes. For example, the annual decline for heart disease slowed from 3.9% (95% CI, 3.5%-4.2%) during the 2000-2010 period to 1.4%(95% CI, -3.4% to 0.6%) during the 2010-2013 period (P = .02 for slope difference). Between 1969 and 2013, age-standardized years of potential life lost per 1000 decreased from 1.9 to 1.6 for diabetes (14.5% reduction; 95% CI, 12.6%-16.4%), from 21.4 to 12.7 for cancer (40.6%; 95% CI, 40.2%-41.1%), from 19.9 to 10.4 for unintentional injuries (47.5%; 95% CI, 47.0%-48.0%), from 28.8 to 9.1 for heart disease (68.3%; 95% CI, 68.1%-68.5%), and from 6.0 to 1.5 for stroke (74.8%; 95% CI, 74.4%-75.3%). For COPD, the rate for years of potential life lost did not decrease over this time interval. CONCLUSIONS AND RELEVANCE According to death certificate data between 1969 and 2013, an overall decreasing trend in age-standardized death rate was observed for all causes combined, heart disease, cancer, stroke, unintentional injuries, and diabetes, although the rate of decrease appears to have slowed for heart disease, stroke, and diabetes. The death rate for COPD increased during this period.	[Ma, Jiemin; Siegel, Rebecca L.; Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res Program, Intramural Res Dept, Atlanta, GA 30303 USA; [Ward, Elizabeth M.] Amer Canc Soc, Intramural Res Dept, Atlanta, GA 30303 USA	American Cancer Society; American Cancer Society	Ma, JM (corresponding author), Amer Canc Soc, 250 Williams St,Sixth Floor, Atlanta, GA 30303 USA.	Jiemin.ma@cancer.org			Intramural Research Department of the American Cancer Society	Intramural Research Department of the American Cancer Society	This work was supported by the Intramural Research Department of the American Cancer Society.	Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Burke JF, 2012, STROKE, V43, P2207, DOI 10.1161/STROKEAHA.112.656967; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P369; Drummond MB, 2010, COPD, V7, P179, DOI 10.3109/15412555.2010.481695; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; German RR, 2011, CANCER EPIDEMIOL, V35, P126, DOI 10.1016/j.canep.2010.09.005; Halanych JH, 2011, AM J EPIDEMIOL, V173, P1319, DOI 10.1093/aje/kwr033; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Klebba AJ, 1980, ESTIMATES SELECTED C; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lenfant C, 1998, ANN INTERN MED, V129, P1066, DOI 10.7326/0003-4819-129-12-199812150-00013; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McEwen LN, 2011, DIABETES CARE, V34, P1529, DOI 10.2337/dc10-2312; MOYER LA, 1989, AM J EPIDEMIOL, V130, P1024, DOI 10.1093/oxfordjournals.aje.a115403; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; National Cancer Institute, 2014, JOINP REGR PROGR; National Center for Health Statistics, 2014, DHHS PUBL, V2014-1232; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Racz M, 2005, J AM GERIATR SOC, V53, pS245, DOI 10.1111/j.1532-5415.2005.53350.x; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; Xu Jiaquan, 2014, NCHS Data Brief, P1; Young F, 2010, AM J PREV MED, V39, P228, DOI 10.1016/j.amepre.2010.05.009	33	182	186	3	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1731	1739		10.1001/jama.2015.12319	http://dx.doi.org/10.1001/jama.2015.12319			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26505597	Bronze			2022-12-28	WOS:000363706300022
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Cash as a treatment for poverty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Akee R, 2015, 21562 NAT BUR EC RES; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Ebell M., 2015, TAXES TAX CREDITS WE; Joseph Rowntree Foundation, 2010, PROV PERS SUPP ROUGH; Kennedy S, 2015, CBP7300 HOUS COMM LI; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2015	351								h5752	10.1136/bmj.h5752	http://dx.doi.org/10.1136/bmj.h5752			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3GN	26506957	Bronze			2022-12-28	WOS:000364147200025
J	Farah, MJ				Farah, Martha J.			The unknowns of cognitive enhancement	SCIENCE			English	Editorial Material							MODAFINIL		Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA	University of Pennsylvania	Farah, MJ (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	mfarah@psych.upenn.edu						Battleday RM, 2015, EUR NEUROPSYCHOPHARM, V25, P1865, DOI 10.1016/j.euroneuro.2015.07.028; Dubljevic V, 2014, NEURON, V82, P731, DOI 10.1016/j.neuron.2014.05.003; Horvath J.C., 2015, BRAIN STIMUL, V2, P318, DOI [DOI 10.1016/J.BRS.2015.01.034, 10.1016/j.brs.2015.01.034]; Ilieva I. P., 2015, J ATTEN DISORD; Ilieva IP, 2015, J COGNITIVE NEUROSCI, V27, P1069, DOI 10.1162/jocn_a_00776; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jwa A., 2015, J LAW BIOSCI; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; Muller U, 2013, NEUROPHARMACOLOGY, V64, P490, DOI 10.1016/j.neuropharm.2012.07.009; Price AR, 2015, BRAIN STIMUL, V8, P663, DOI 10.1016/j.brs.2015.03.007; Schwarz A, 2015, NY TIMES; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; Substance Abuse and Mental Health Services Administration, 2013, RES 2013 NAT SURV DR; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Vrecko Scott, 2013, AJOB Neurosci, V4, P4	15	47	50	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					379	+		10.1126/science.aad5893	http://dx.doi.org/10.1126/science.aad5893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26494744	Green Submitted			2022-12-28	WOS:000363213400020
J	Faedi, F				Faedi, Francesca			EXOPLANETS A glimpse of Earth's fate	NATURE			English	Editorial Material							WHITE-DWARFS; PLANETARY SYSTEMS; MINOR PLANET; DEBRIS	Analysis of data from the Kepler space observatory and ground-based telescopes has led to the detection of one, and possibly several, minor planets that are in a state of disintegration in orbit around a white dwarf star. SEE LETTER P.546	Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warwick	Faedi, F (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	f.faedi@warwick.ac.uk	Faedi, Francesca/AAT-5081-2020	Faedi, Francesca/0000-0001-5872-6048				Agol E, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/2/L31; Barber SD, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/26; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Debes JH, 2002, ASTROPHYS J, V572, P556, DOI 10.1086/340291; Faedi F, 2011, MON NOT R ASTRON SOC, V410, P899, DOI 10.1111/j.1365-2966.2010.17488.x; Farihi J, 2013, SCIENCE, V342, P218, DOI 10.1126/science.1239447; Farihi J, 2009, ASTROPHYS J, V694, P805, DOI 10.1088/0004-637X/694/2/805; Jura M, 2003, ASTROPHYS J, V584, pL91, DOI 10.1086/374036; Kovacs G, 2002, ASTRON ASTROPHYS, V391, P369, DOI 10.1051/0004-6361:20020802; Rappaport S, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/1; Sanchis-Ojeda R., 2015, PREPRINT; Vanderburg A, 2015, NATURE, V526, P546, DOI 10.1038/nature15527; Veras D, 2014, MON NOT R ASTRON SOC, V445, P2244, DOI 10.1093/mnras/stu1871; Zuckerman B, 2010, ASTROPHYS J, V722, P725, DOI 10.1088/0004-637X/722/1/725	15	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					515	516		10.1038/526515b	http://dx.doi.org/10.1038/526515b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490617				2022-12-28	WOS:000364026100037
J	Wiske, CP; Ogbechie, OA; Schulman, KA				Wiske, Clay P.; Ogbechie, Oluwatobi A.; Schulman, Kevin A.			Options to Promote Competitive Generics Markets in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHARMACEUTICALS; ENTRY		[Wiske, Clay P.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Wiske, Clay P.; Ogbechie, Oluwatobi A.; Schulman, Kevin A.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Ogbechie, Oluwatobi A.] Harvard Univ, Sch Med, Boston, MA USA; [Schulman, Kevin A.] Duke Clin Res Inst, Durham 17969, NC USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Brown University; Harvard University; Harvard University; Harvard Medical School; Duke University; Duke University	Schulman, KA (corresponding author), Duke Clin Res Inst, POB 17696, Durham 17969, NC USA.	kevin.schulman@duke.edu						Committee on Oversight and Government Reform, CUMM SAND INV STAGG; Frank RG, 1997, J ECON MANAGE STRAT, V6, P75, DOI 10.1162/105864097567039; GRABOWSKI HG, 1992, J LAW ECON, V35, P331, DOI 10.1086/467257; IMS Institute for Healthcare Informatics, MED US SHIFT COST HE; US Government Accountability Office, DRUG SHORT PUBL HLTH	5	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2129	2130		10.1001/jama.2015.13498	http://dx.doi.org/10.1001/jama.2015.13498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26513309	Bronze			2022-12-28	WOS:000365351900013
J	Lauer, MS; Nakamura, R				Lauer, Michael S.; Nakamura, Richard			Reviewing Peer Review at the NIH	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lauer, Michael S.] NIH, Off Extramural Res, Bethesda, MD 20892 USA; [Nakamura, Richard] NIH, Ctr Sci Review, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Lauer, MS (corresponding author), NIH, Off Extramural Res, Bldg 10, Bethesda, MD 20892 USA.			Nakamura, Richard/0000-0002-7846-6017				Ioannidis JP, 2014, JAMA-J AM MED ASSOC, V312, P483; Lauer MS, 2015, CIRC RES, V117, P239, DOI 10.1161/CIRCRESAHA.115.306830; Li D, 2015, SCIENCE, V348, P434, DOI 10.1126/science.aaa0185; Lindner MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126938; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825	5	10	11	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1893	1895		10.1056/NEJMp1507427	http://dx.doi.org/10.1056/NEJMp1507427			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV7IL	26559568	Bronze			2022-12-28	WOS:000364445500001
J	Klankermayer, J; Leitner, W				Klankermayer, Juergen; Leitner, Walter			Love at second sight for CO2 and H-2 in organic synthesis	SCIENCE			English	Editorial Material							CARBON-DIOXIDE; MOLECULAR-HYDROGEN; METHYLATION; OLEFINS; AMINES		[Klankermayer, Juergen; Leitner, Walter] Rhein Westfal TH Aachen, Inst Tech & Makromol Chem, D-52074 Aachen, Germany	RWTH Aachen University	Klankermayer, J (corresponding author), Rhein Westfal TH Aachen, Inst Tech & Makromol Chem, D-52074 Aachen, Germany.	jklankermayer@itmc.rwth-aachen.de; leitner@itmc.rwth-aachen.de	Klankermayer, Jürgen/J-5697-2014; Leitner, Walter/D-3031-2015	Klankermayer, Jürgen/0000-0003-2143-9402; Leitner, Walter/0000-0001-6100-9656				Beydoun K, 2014, ANGEW CHEM INT EDIT, V53, P11010, DOI 10.1002/anie.201403711; Beydoun K, 2013, ANGEW CHEM INT EDIT, V52, P9554, DOI 10.1002/anie.201304656; Centi G, 2013, ENERG ENVIRON SCI, V6, P1711, DOI 10.1039/c3ee00056g; Jessop PG, 2004, COORDIN CHEM REV, V248, P2425, DOI 10.1016/j.ccr.2004.05.019; Li YH, 2014, ANGEW CHEM INT EDIT, V53, P10476, DOI 10.1002/anie.201405779; Li YH, 2013, ANGEW CHEM INT EDIT, V52, P12156, DOI 10.1002/anie.201306850; Liu Q, 2014, CHEM-EUR J, V20, P6888, DOI 10.1002/chem.201400358; Ostapowicz TG, 2013, ANGEW CHEM INT EDIT, V52, P12119, DOI 10.1002/anie.201304529; Schlogl R, 2015, ANGEW CHEM INT EDIT, V54, P4436, DOI 10.1002/anie.201405876; Srivastava VK, 2009, CATAL COMMUN, V10, P1791, DOI 10.1016/j.catcom.2009.05.019; Tominaga K., 2000, CATAL COMMUN, V1, P1, DOI [10.1016/S1566-7367(00)00006-6, DOI 10.1016/S1566-7367(00)00006-6]; Wesselbaum S, 2015, CHEM SCI, V6, P693, DOI 10.1039/c4sc02087a; Wu LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4091	13	82	83	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2015	350	6261					629	630		10.1126/science.aac7997	http://dx.doi.org/10.1126/science.aac7997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3MH	26542554				2022-12-28	WOS:000364162800025
J	Han, SJ; Jung, SY; Wu, SP; Hawkins, SM; Park, MJ; Kyo, S; Qin, J; Lydon, JP; Tsai, SY; Tsai, MJ; DeMayo, FJ; O'Malley, BW				Han, Sang Jun; Jung, Sung Yun; Wu, San-Pin; Hawkins, Shannon M.; Park, Mi Jin; Kyo, Satoru; Qin, Jun; Lydon, John P.; Tsai, Sophia Y.; Tsai, Ming-Jer; DeMayo, Francesco J.; O'Malley, Bert W.			Estrogen Receptor beta Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis	CELL			English	Article							REGULATING KINASE 1; ACTIVATION; CELLS; MODEL; ALPHA; INTERLEUKIN-1; EPIDEMIOLOGY; INHIBITION; EXPRESSION; RESISTANCE	Alterations in estrogen-mediated cellular signaling play an essential role in the pathogenesis of endometriosis. In addition to higher estrogen receptor (ER) beta levels, enhanced ER beta activity was detected in endometriotic tissues, and the inhibition of enhanced ER beta activity by an ER beta-selective antagonist suppressed mouse ectopic lesion growth. Notably, gain of ER beta function stimulated the progression of endometriosis. As a mechanism to evade endogenous immune surveillance for cell survival, ER beta interacts with cellular apoptotic machinery in the cytoplasm to inhibit TNF-alpha-induced apoptosis. ER beta also interacts with components of the cytoplasmic inflammasome to increase interleukin-1 beta and thus enhance its cellular adhesion and proliferation properties. Furthermore, this gain of ER beta function enhances epithelial-mesenchymal transition signaling, thereby increasing the invasion activity of endometriotic tissues for establishment of ectopic lesions. Collectively, we reveal how endometrial tissue generated by retrograde menstruation can escape immune surveillance and develop into sustained ectopic lesions via gain of ER beta function.	[Han, Sang Jun; Jung, Sung Yun; Wu, San-Pin; Park, Mi Jin; Qin, Jun; Lydon, John P.; Tsai, Sophia Y.; Tsai, Ming-Jer; DeMayo, Francesco J.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hawkins, Shannon M.] Baylor Coll Med, Dept Obstet, Houston, TX 77030 USA; [Hawkins, Shannon M.] Baylor Coll Med, Dept Gynecol, Houston, TX 77030 USA; [Kyo, Satoru] Kanazawa Univ, Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa 9208640, Japan; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Alkek Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Kanazawa University; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu	Hawkins, Shannon/AAX-5216-2020; , San Pin Wu/AAF-8371-2020; DeMayo, Francesco/C-6255-2019; Han, Sang Jun/V-2882-2017	Hawkins, Shannon/0000-0002-0727-3971; , San Pin Wu/0000-0001-9626-784X; DeMayo, Francesco/0000-0002-9480-7336; Jung, Sung Yun/0000-0003-1521-7977; Han, Sang Jun/0000-0003-3692-6756	US National Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD0077495, 5K12HD050128, U54HD007495, R01 HD082786, R01 HD07857, R01 HD08188, R01 HD-042311]; NIDDK [U19 DK62434]; CPRIT [CPRIT RPI10471, RP120092]; NCI [P30 CA123125]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD008188, U54HD007495, R01HD042311, R01HD082786, R03HD077495, R01HD007857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD050128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103311] Funding Source: NIH RePORTER	US National Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CPRIT; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the US National Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD0077495 and 5K12HD050128 to S.M.H.; U54HD007495 to F.J.D.; R01 HD082786, R01 HD07857, R01 HD08188, and Clayton Fdn. to B.W.O.; U54HD007495 pilot grant to S.J.H.; R01 HD-042311 to J.P.L.), a grant from NIDDK (U19 DK62434 to M.-J.T., S.Y.T., and F.J.D.), and a grant from CPRIT (CPRIT RPI10471 to M.-J.T. and S.Y.T.). We also thank CPRIT (RP120092) Facilities Support Award and NCI P30 CA123125 Cancer Center Support Grant for the Proteomics Core.	Acien P, 2007, FERTIL STERIL, V88, P32, DOI 10.1016/j.fertnstert.2006.11.188; Ahn SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795976; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Bulun SE, 2012, SEMIN REPROD MED, V30, P39, DOI 10.1055/s-0031-1299596; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2013, CURR OPIN OBSTET GYN, V25, P280, DOI 10.1097/GCO.0b013e3283630d56; Burns KA, 2012, ENDOCRINOLOGY, V153, P3960, DOI 10.1210/en.2012-1294; Cao WG, 2005, BIOL REPROD, V73, P565, DOI 10.1095/biolreprod.104.038331; Cheng CW, 2011, J PATHOL, V224, P261, DOI 10.1002/path.2852; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Delvoux B, 2009, J CLIN ENDOCR METAB, V94, P876, DOI 10.1210/jc.2008-2218; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Han SJ, 2014, HUM REPROD UPDATE, V20, P467, DOI 10.1093/humupd/dmu002; Han SJ, 2012, NAT MED, V18, P1102, DOI 10.1038/nm.2826; Han SJ, 2009, GENESIS, V47, P815, DOI 10.1002/dvg.20572; Harris HA, 2005, HUM REPROD, V20, P936, DOI 10.1093/humrep/deh711; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71; HUGHESDON PE, 1958, J OBSTET GYNAECOL, V65, P944; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Monsivais D, 2014, MOL ENDOCRINOL, V28, P1304, DOI 10.1210/me.2013-1421; Moradi M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-123; Nasu K, 2009, HISTOL HISTOPATHOL, V24, P1181, DOI 10.14670/HH-24.1181; Ozkan S, 2008, ANN NY ACAD SCI, V1127, P92, DOI 10.1196/annals.1434.007; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Salmassi A, 2011, BIOIMPACTS, V1, P129, DOI 10.5681/bi.2011.017; SHAH A, 1987, BRIT MED J, V294, P1323, DOI 10.1136/bmj.294.6583.1323; Sillem M, 1999, EUR J OBSTET GYN R B, V87, P123, DOI 10.1016/S0301-2115(99)00114-1; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vanderschueren D, 1997, ENDOCRINOLOGY, V138, P2301, DOI 10.1210/en.138.6.2301; Walker VR, 2004, ILAR J, V45, P455, DOI 10.1093/ilar.45.4.455; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Wei Q, 2015, LAB INVEST, V95, P804, DOI 10.1038/labinvest.2015.63; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Zhang H, 2010, MOL CELL ENDOCRINOL, V317, P31, DOI 10.1016/j.mce.2009.11.009; Zhao YC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010626	47	182	199	4	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					960	974		10.1016/j.cell.2015.10.034	http://dx.doi.org/10.1016/j.cell.2015.10.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26544941	Green Accepted, Bronze			2022-12-28	WOS:000364829700020
J	Schmidt, C				Schmidt, Charlie			Reshaping the cancer clinic	NATURE			English	Editorial Material																			0	25	26	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2015	527	7576					S10	S11		10.1038/527S10a	http://dx.doi.org/10.1038/527S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV4XV	26536216	Bronze			2022-12-28	WOS:000364270700028
J	Wang, JM				Wang, Jimin			Comment on "Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism"	SCIENCE			English	Editorial Material							18 KDA	Li et al. (Reports, 30 January, p. 555) reported on a crystal structure for a translocator protein (TSPO) from Rhodobacter sphaeroides in which some of the electron density is modeled as a porphyrin. The analysis of the x-ray data discussed here suggests that this assignment is incorrect.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Wang, JM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	jimin.wang@yale.edu			NIGMS NIH HHS [P01 GM022778] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ginter C, 2013, BIOCHEMISTRY-US, V52, P3609, DOI 10.1021/bi400364z; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Kroon-Batenburg LMJ, 2014, ACTA CRYSTALLOGR D, V70, P2502, DOI 10.1107/S1399004713029817; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Liu Q, 2014, ACTA CRYSTALLOGR D, V70, P2544, DOI 10.1107/S1399004714013376; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Wang JM, 2015, PROTEIN SCI, V24, P661, DOI 10.1002/pro.2639	8	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2015	350	6260								10.1126/science.aab1432	http://dx.doi.org/10.1126/science.aab1432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU6RG	26516276				2022-12-28	WOS:000363660000036
J	French, RNE; Brillhart, D				French, Robert N. E.; Brillhart, Daniel			Erucism Due to Lepidoptera Caterpillar Envenomation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[French, Robert N. E.] Univ Arizona, Coll Med, Tucson, AZ 85721 USA; [Brillhart, Daniel] Carl R Darnall Army Med Ctr, Ft Hood, TX USA	University of Arizona	French, RNE (corresponding author), Univ Arizona, Coll Med, Tucson, AZ 85721 USA.	danbrillhart@gmail.com							0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					E21	E21		10.1056/NEJMicm1414613	http://dx.doi.org/10.1056/NEJMicm1414613			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26510046				2022-12-28	WOS:000363514100001
J	Tancredi, M; Rosengren, A; Svensson, AM; Kosiborod, M; Pivodic, A; Gudbjoornsdottir, S; Wedel, H; Clements, M; Dahlqvist, S; Lind, M				Tancredi, Mauro; Rosengren, Annika; Svensson, Ann-Marie; Kosiborod, Mikhail; Pivodic, Aldina; Gudbjornsdottir, Soffia; Wedel, Hans; Clements, Mark; Dahlqvist, Sofia; Lind, Marcus			Excess Mortality among Persons with Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; US ADULTS; TRENDS; MELLITUS; GLUCOSE; WOMEN; RISK; MEN; PREVENTION; PREVALENCE	BACKGROUND The excess risks of death from any cause and death from cardiovascular causes among persons with type 2 diabetes and various levels of glycemic control and renal complications are unknown. In this registry-based study, we assessed these risks according to glycemic control and renal complications among persons with type 2 diabetes. METHODS We included patients with type 2 diabetes who were registered in the Swedish National Diabetes Register on or after January 1, 1998. For each patient, five controls were randomly selected from the general population and matched according to age, sex, and county. All the participants were followed until December 31, 2011, in the Swedish Registry for Cause-Specific Mortality. RESULTS The mean follow-up was 4.6 years in the diabetes group and 4.8 years in the control group. Overall, 77,117 of 435,369 patients with diabetes (17.7%) died, as compared with 306,097 of 2,117,483 controls (14.5%) (adjusted hazard ratio, 1.15; 95% confidence interval [CI], 1.14 to 1.16). The rate of cardiovascular death was 7.9% among patients versus 6.1% among controls (adjusted hazard ratio, 1.14; 95% CI, 1.13 to 1.15). The excess risks of death from any cause and cardiovascular death increased with younger age, worse glycemic control, and greater severity of renal complications. As compared with controls, the hazard ratio for death from any cause among patients younger than 55 years of age who had a glycated hemoglobin level of 6.9% or less (<= 52 mmol per mole of nonglycated hemoglobin) was 1.92 (95% CI, 1.75 to 2.11); the corresponding hazard ratio among patients 75 years of age or older was 0.95 (95% CI, 0.94 to 0.96). Among patients with normoalbumin-uria, the hazard ratio for death among those younger than 55 years of age with a glycated hemoglobin level of 6.9% or less, as compared with controls, was 1.60 (95% CI, 1.40 to 1.82); the corresponding hazard ratio among patients 75 years of age or older was 0.76 (95% CI, 0.75 to 0.78), and patients 65 to 74 years of age also had a significantly lower risk of death (hazard ratio, 0.87; 95% CI, 0.84 to 0.91). CONCLUSIONS Mortality among persons with type 2 diabetes, as compared with that in the general population, varied greatly, from substantial excess risks in large patient groups to lower risks of death depending on age, glycemic control, and renal complications. (Funded by the Swedish government and others.)	[Tancredi, Mauro; Rosengren, Annika; Gudbjornsdottir, Soffia; Lind, Marcus] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Svensson, Ann-Marie] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden; [Pivodic, Aldina] Stat Konsultgrp, Gothenburg, Sweden; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Tancredi, Mauro; Dahlqvist, Sofia; Lind, Marcus] NU Hosp Grp, Dept Med, Trollhattan, Sweden; [Tancredi, Mauro; Dahlqvist, Sofia; Lind, Marcus] NU Hosp Grp, Dept Med, Uddevalla, Sweden; [Kosiborod, Mikhail] Univ Missouri, Sch Med, St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Clements, Mark] Univ Missouri, Sch Med, Childrens Mercy Hosp, Kansas City, MO USA; [Clements, Mark] Univ Kansas, Sch Med, Kansas City, KS USA	University of Gothenburg; NU Hospital Group; NU Hospital Group; Voestalpine AG; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas Medical Center	Lind, M (corresponding author), Uddevalla Cent Hosp, Dept Med, S-45180 Uddevalla, Sweden.	lind.marcus@telia.com	Kosiborod, Mikhail/HDO-1541-2022; Lind, Marcus/AAI-6733-2021; Lind, Marcus/GRJ-4946-2022	Kosiborod, Mikhail/0000-0002-3750-9789; Lind, Marcus/0000-0002-3796-9283; Clements, Mark/0000-0002-2368-0331	Swedish government	Swedish government	Funded by the Swedish government and others.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], SURV LIV COND SWED; [Anonymous], 2013, ANN REP 2013 SWED NA; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Dale AC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39582.447998.BE; Eberly LE, 2003, DIABETES CARE, V26, P848, DOI 10.2337/diacare.26.3.848; Eliasson M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-32; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Grant RW, 2004, ARCH INTERN MED, V164, P1134, DOI 10.1001/archinte.164.10.1134; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Gulliford MC, 2009, AM J EPIDEMIOL, V169, P455, DOI 10.1093/aje/kwn342; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lind M, 2013, DIABETOLOGIA, V56, P2601, DOI 10.1007/s00125-013-3063-1; Lind M, 2012, DIABETOLOGIA, V55, P2946, DOI 10.1007/s00125-012-2681-3; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lind M, 2008, DIABETES METAB SYND, V2, P282, DOI 10.1016/j.dsx.2008.04.006; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Olen O, 2012, DIGEST LIVER DIS, V44, P471, DOI 10.1016/j.dld.2012.01.006; Parving H., 2004, BRENNER RECTORS KIDN, P1777; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stokes A, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-3; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	30	577	591	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2015	373	18					1720	1732		10.1056/NEJMoa1504347	http://dx.doi.org/10.1056/NEJMoa1504347			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4QH	26510021				2022-12-28	WOS:000363514100008
J	Graham, MD				Graham, Michael D.			FLUID DYNAMICS Turbulence spreads like wildfire	NATURE			English	Editorial Material							CHANNEL FLOW	A simple model captures the key features of the transition from smooth to turbulent flow for a fluid in a pipe. The findings pave the way for more-complex models and may have engineering ramifications. SEE LETTER P.550	Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Graham, MD (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	mdgraham@wisc.edu	Graham, Michael/A-8356-2009	Graham, Michael/0000-0003-4983-4949				Barkley D, 2015, NATURE, V526, P550, DOI 10.1038/nature15701; Duguet Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.034502; Fife Council, 2022, DYNAMICS INTERNAL LA; Graham MD, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4895780; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kawahara G, 2012, ANNU REV FLUID MECH, V44, P203, DOI 10.1146/annurev-fluid-120710-101228; Lemoult G, 2014, EUR PHYS J E, V37, DOI 10.1140/epje/i2014-14025-2; Matas JP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.014501; POMEAU Y, 1986, PHYSICA D, V23, P3, DOI 10.1016/0167-2789(86)90104-1; Waleffe F, 2001, J FLUID MECH, V435, P93, DOI 10.1017/S0022112001004189	10	8	8	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					508	509		10.1038/526508a	http://dx.doi.org/10.1038/526508a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26490612				2022-12-28	WOS:000364026100031
J	Friedman, BW; Dym, AA; Davitt, M; Holden, L; Solorzano, C; Esses, D; Bijur, PE; Gallagher, EJ				Friedman, Benjamin W.; Dym, Andrew A.; Davitt, Michelle; Holden, Lynne; Solorzano, Clemencia; Esses, David; Bijur, Polly E.; Gallagher, E. John			Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; EMERGENCY-DEPARTMENT; DOUBLE-BLIND; COCHRANE COLLABORATION; PROGNOSTIC-FACTORS; INCEPTION COHORT; MUSCLE SPASM; FRAMEWORK; IBUPROFEN; THERAPY	IMPORTANCE Low back pain (LBP) is responsible for more than 2.5 million visits to US emergency departments (EDs) annually. These patients are usually treated with nonsteroidal anti-inflammatory drugs, acetaminophen, opioids, or skeletal muscle relaxants, often in combination. OBJECTIVE To compare functional outcomes and pain at 1 week and 3 months after an ED visit for acute LBP among patients randomized to a 10-day course of (1) naproxen + placebo; (2) naproxen + cyclobenzaprine; or (3) naproxen + oxycodone/acetaminophen. DESIGN, SETTING, AND PARTICIPANTS This randomized, double-blind, 3-group study was conducted at one urban ED in the Bronx, New York City. Patients who presented with nontraumatic, nonradicular LBP of 2 weeks' duration or less were eligible for enrollment upon ED discharge if they had a score greater than 5 on the Roland-Morris Disability Questionnaire (RMDQ). The RMDQ is a 24-item questionnaire commonly used to measure LBP and related functional impairment on which 0 indicates no functional impairment and 24 indicates maximum impairment. Beginning in April 2012, a total of 2588 patients were approached for enrollment. Of the 323 deemed eligible for participation, 107 were randomized to receive placebo and 108 each to cyclobenzaprine and to oxycodone/acetaminophen. Follow-up was completed in December 2014. INTERVENTIONS All participants were given 20 tablets of naproxen, 500 mg, to be taken twice a day. They were randomized to receive either 60 tablets of placebo; cyclobenzaprine, 5 mg; or oxycodone, 5 mg/acetaminophen, 325 mg. Participants were instructed to take 1 or 2 of these tablets every 8 hours, as needed for LBP. They also received a standardized 10-minute LBP educational session prior to discharge. MAIN OUTCOMES AND MEASURES The primary outcome was improvement in RMDQ between ED discharge and 1 week later. RESULTS Demographic characteristics were comparable among the 3 groups. At baseline, median RMDQ score in the placebo group was 20(interquartile range [IQR], 17-21), in the cyclobenzaprine group 19 (IQR, 17-21), and in the oxycodone/acetaminophen group 20(IQR, 1722). At 1-week follow-up, the mean RMDQ improvement was 9.8 in the placebo group, 10.1 in the cyclobenzaprine group, and 11.1 in the oxycodone/acetaminophen group. Between-group difference in mean RMDQ improvement for cyclobenzaprine vs placebo was 0.3 (98.3% CI,-2.6 to 3.2; P=.77), for oxycodone/acetaminophen vs placebo, 1.3 (98.3% CI, -1.5 to 4.1; P=.28), and for oxycodone/acetaminophen vs cyclobenzaprine, 0.9 (98.3% CI, -2.1 to 3.9; P=.45). CONCLUSIONS AND RELEVANCE Among patients with acute, nontraumatic, nonradicular LBP presenting to the ED, adding cyclobenzaprine or oxycodone/acetaminophen to naproxen alone did not improve functional outcomes or pain at 1-week follow-up. These findings do not support use of these additional medications in this setting.	[Friedman, Benjamin W.; Davitt, Michelle; Holden, Lynne; Esses, David; Bijur, Polly E.; Gallagher, E. John] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Emergency Med, Bronx, NY 10467 USA; [Dym, Andrew A.] Albert Einstein Coll Med, Coll Med, Bronx, NY 10467 USA; [Solorzano, Clemencia] Montefiore Med Ctr, Dept Pharm, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Friedman, BW (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Dept Emergency Med, 111 E 210th, Bronx, NY 10467 USA.	bwfriedmanmd@gmail.com						BASMAJIAN JV, 1989, SPINE, V14, P438, DOI 10.1097/00007632-198904000-00019; BERRY H, 1988, J INT MED RES, V16, P83, DOI 10.1177/030006058801600202; BORENSTEIN DG, 1990, CLIN THER, V12, P125; Cantrill SV, 2012, ANN EMERG MED, V60, P499, DOI 10.1016/j.annemergmed.2012.06.013; Cherkin DC, 1996, SPINE, V21, P345, DOI 10.1097/00007632-199602010-00019; Cherkin DC, 1998, SPINE, V23, P607, DOI 10.1097/00007632-199803010-00015; Childers MK, 2005, CURR MED RES OPIN, V21, P1485, DOI 10.1185/030079905X61938; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2010, DRUGS, V70, P387, DOI 10.2165/11318690-000000000-00000; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Deyo RA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g6380; Fosnocht DE, 2005, EMERG MED CLIN N AM, V23, P297, DOI 10.1016/j.emc.2004.12.003; Friedman BW, 2006, J EMERG MED, V31, P365, DOI 10.1016/j.jemermed.2005.09.023; Friedman BW, 2012, AM J EMERG MED, V30, P1852, DOI 10.1016/j.ajem.2012.03.027; Friedman BW, 2012, ANN EMERG MED, V59, P128, DOI 10.1016/j.annemergmed.2011.09.012; Friedman BW, 2010, SPINE, V35, pE1406, DOI 10.1097/BRS.0b013e3181d952a5; Friedman BW, 1976, SPINE, V35, pE1406; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Furlan AD, 2009, SPINE, V34, P1669, DOI 10.1097/BRS.0b013e3181ad7bd6; Grotle M, 2005, SPINE, V30, P976, DOI 10.1097/01.brs.0000158972.34102.6f; Hagen KB, 2005, SPINE, V30, P542, DOI 10.1097/01.brs.0000154625.02586.95; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Juni P, 2009, ANN RHEUM DIS, V68, P1420, DOI 10.1136/ard.2008.093757; National Institute of Arthritis and Musculoskeletal and Skin Diseases, WHAT IS BACK PAIN FA; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pareek A, 2009, EUR SPINE J, V18, P1836, DOI 10.1007/s00586-009-1019-4; Roelofs PD, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000396.PUB3; Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; ROLAND MO, 1983, PRACTITIONER, V227, P1119; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; Turturro MA, 2003, ANN EMERG MED, V41, P818, DOI 10.1067/mem.2003.188; van Tulder MW, 2003, SPINE, V28, P1978, DOI 10.1097/01.BRS.0000090503.38830.AD; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9	36	110	120	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1572	1580		10.1001/jama.2015.13043	http://dx.doi.org/10.1001/jama.2015.13043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26501533	Bronze			2022-12-28	WOS:000363028500017
J	Bossuyt, PM; Reitsma, JB; Bruns, DE; Gatsonis, CA; Glasziou, PP; Irwig, L; Lijmer, JG; Moher, D; Rennie, D; de Vet, HCW; Kressel, HY; Rifai, N; Golub, RM; Altman, DG; Hooft, L; Korevaar, DA; Cohen, JF				Bossuyt, Patrick M.; Reitsma, Johannes B.; Bruns, David E.; Gatsonis, Constantine A.; Glasziou, Paul P.; Irwig, Les; Lijmer, Jeroen G.; Moher, David; Rennie, Drummond; de Vet, Henrica C. W.; Kressel, Herbert Y.; Rifai, Nader; Golub, Robert M.; Altman, Douglas G.; Hooft, Lotty; Korevaar, Daniel A.; Cohen, Jeremie F.		STARD Grp	STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUIDELINES; TRANSPARENT; EQUATOR; UTILITY; BIAS		[Bossuyt, Patrick M.; Korevaar, Daniel A.; Cohen, Jeremie F.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bruns, David E.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Gatsonis, Constantine A.] Brown Univ, Sch Publ Hlth, Ctr Stat Sci, Providence, RI 02912 USA; [Glasziou, Paul P.] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia; [Irwig, Les] Univ Sydney, Sch Publ Hlth, Screening & Diagnost Test Evaluat Program, Sydney, NSW 2006, Australia; [Lijmer, Jeroen G.] Onze Lieve Vrouw Hosp, Dept Psychiat, Amsterdam, Netherlands; [Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Rennie, Drummond] Peer Review Congress, Chicago, IL USA; [Rennie, Drummond] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [de Vet, Henrica C. W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Kressel, Herbert Y.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiol, Boston, MA 02215 USA; [Kressel, Herbert Y.] Radiol Editorial Off, Boston, MA USA; [Rifai, Nader] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Rifai, Nader] Clin Chem Editorial Off, Washington, DC USA; [Golub, Robert M.] Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med & Geriatr, Chicago, IL 60611 USA; [Golub, Robert M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Golub, Robert M.] JAMA Editorial Off, Chicago, IL USA; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Hooft, Lotty] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dutch Cochrane Ctr, Utrecht, Netherlands; [Cohen, Jeremie F.] Paris Descartes Univ, INSERM, UMR 1153, Paris, France; [Cohen, Jeremie F.] Paris Descartes Univ, Necker Hosp, AP HP, Dept Pediat, Paris, France	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Virginia; Brown University; Bond University; University of Sydney; Onze Lieve Vrouwe Gasthuis Hospital; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of California System; University of California San Francisco; Vrije Universiteit Amsterdam; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Oxford; Utrecht University; Utrecht University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bossuyt, PM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.m.bossuyt@amc.uva.nl	Petersen, Steffen E/A-8389-2011; Rutjes, Anne/L-8750-2017; Moher, David/I-3408-2019; Bossuyt, Patrick M./B-4557-2016; Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M/AAR-1183-2021; Cohen, Jérémie/H-4707-2019; Korevaar, Daniël A./O-5809-2019; Dinnes, Jacqueline/Y-3673-2018; Virgili, Gianni/P-6607-2014; Deeks, Jonathan/AAV-5745-2020	Petersen, Steffen E/0000-0003-4622-5160; Rutjes, Anne/0000-0001-9782-779X; Moher, David/0000-0003-2434-4206; Bossuyt, Patrick M./0000-0003-4427-0128; Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M/0000-0003-4427-0128; Cohen, Jérémie/0000-0003-3572-8985; Mallett, Sue/0000-0002-0596-8200; Takwoingi, Yemisi/0000-0002-5828-9746; Simera, Iveta/0000-0001-5785-6756; Morris, Katie/0000-0003-1247-429X; Dinnes, Jacqueline/0000-0003-1343-7335; Boutron, Isabelle/0000-0002-5263-6241; Virgili, Gianni/0000-0002-9960-2989; Schunemann, Holger/0000-0003-3211-8479; Azuara-Blanco, Augusto/0000-0002-4805-9322; Ravaud, Philippe/0000-0001-8264-9206; Lord, Sarah (Sally) J/0000-0003-2763-5949; Reitsma, Johannes/0000-0003-4026-4345; Fleming, Kenneth/0000-0002-3200-1302; Onderdonk, Andrew/0000-0001-8998-8972; Whiting, Penny/0000-0003-1138-5682; de Groot, Joris/0000-0002-4846-5697; Christopher, Hyde/0000-0002-7349-0616; Lumbreras, Blanca/0000-0003-1665-0860; Deeks, Jonathan/0000-0002-8850-1971; de Vet, Henrica/0000-0002-5454-2804; Macaskill, Petra/0000-0001-5879-6193	Academic Medical Center of University of Amsterdam, Netherlands; MRC [MR/J00488X/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J00488X/1] Funding Source: researchfish	Academic Medical Center of University of Amsterdam, Netherlands(Netherlands Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	There was no explicit funding for the development of STARD 2015. The Academic Medical Center of the University of Amsterdam, the Netherlands, partly funded the meeting of the STARD steering group but had no influence on the development or dissemination of the list of essential items. STARD steering group members and STARD group members covered additional personal costs individually.	Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bossuyt PMM, 2012, CLIN CHEM, V58, P1636, DOI 10.1373/clinchem.2012.182576; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; Korevaar DA, 2015, RADIOLOGY, V274, P781, DOI 10.1148/radiol.14141160; Korevaar Daniel A, 2014, Evid Based Med, V19, P47, DOI 10.1136/eb-2013-101637; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Noel-Storr AH, 2014, NEUROLOGY, V83, P364, DOI 10.1212/WNL.0000000000000621; Ochodo EA, 2013, RADIOLOGY, V267, P581, DOI 10.1148/radiol.12120527; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; Whiting PF, 2013, J CLIN EPIDEMIOL, V66, P1093, DOI 10.1016/j.jclinepi.2013.05.014	20	1759	1782	5	55	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2015	351								h5527	10.1136/bmj.h5527	http://dx.doi.org/10.1136/bmj.h5527			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3IK	26511519	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000364152500002
